data_1qck_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qck _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.576 0.703 . . . . 1.6899999999999999 109.804 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -51.75 -21.0 2.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.641 . . . . 2.77 109.693 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.58 -37.23 83.09 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.316 -0.865 . . . . 2.6899999999999999 109.947 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -59.99 -50.07 75.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.029 -1.045 . . . . 0.53000000000000003 110.047 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -69.92 -36.86 75.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.964 -1.085 . . . . 3.9100000000000001 110.182 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.863 -0.791 . . . . 0.68999999999999995 108.863 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -64.73 -49.6 70.2 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.516 -0.74 . . . . 0.39000000000000001 110.14 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 m -83.36 8.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.085 -1.009 . . . . 1.1000000000000001 110.672 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.51 -13.48 16.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.153 -0.967 . . . . 1.1299999999999999 110.163 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.85 152.08 24.76 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.125 -0.984 . . . . 1.27 108.839 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -40.01 160.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.927 1.751 . . . . 0.46999999999999997 112.065 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' B' ' 89' ' ' LEU . 3.2 ptp -89.2 -28.11 20.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.933 . . . . 1.3799999999999999 109.738 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.09 -141.1 43.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.787 -1.725 . . . . 0.54000000000000004 108.787 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.08 33.55 4.06 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.304 -1.115 . . . . 1.0700000000000001 109.806 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.9 148.96 75.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 2.7400000000000002 109.568 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.81 152.16 80.17 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.71 2.273 . . . . 0.42999999999999999 112.911 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.464 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.7 p -53.69 -43.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.448 0.642 . . . . 1.1200000000000001 110.191 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.57 -3.85 1.17 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.384 -1.086 . . . . 0.25 110.384 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 20' ' ' VAL . 42.1 t -84.08 -22.5 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.337 . . . . 1.8999999999999999 110.163 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.7 mt -64.16 138.52 58.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.994 -1.066 . . . . 1.0600000000000001 109.895 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 134.43 54.36 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.792 -0.763 . . . . 1.0800000000000001 109.712 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.78 49.29 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.339 -1.504 . . . . 0.20000000000000001 109.339 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.416 ' CD1' ' SG ' ' A' ' 77' ' ' CYS . 36.4 mm -98.51 112.26 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.331 -1.099 . . . . 1.0900000000000001 108.126 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.06 177.28 42.87 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.855 -1.298 . . . . 0.20999999999999999 109.855 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -58.54 -40.0 81.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.477 -1.014 . . . . 1.8 109.957 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.14 -46.71 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.96 -1.088 . . . . 1.0900000000000001 108.834 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.94 -39.75 83.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 1.1100000000000001 109.877 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.27 -33.92 77.7 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.879 -1.688 . . . . 0.34000000000000002 108.879 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.03 -40.4 87.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.505 -0.997 . . . . 3.3399999999999999 110.292 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -68.47 -44.53 74.61 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.95 -1.094 . . . . 2.0600000000000001 109.1 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.48 -39.41 93.35 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.933 -1.104 . . . . 1.0700000000000001 108.029 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.99 -42.22 93.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.75 . . . . 1.53 109.269 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -68.05 -18.74 64.77 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.311 -0.996 . . . . 2.4500000000000002 108.311 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.77 3.19 53.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.728 -0.608 . . . . 2.9700000000000002 109.789 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.05 7.57 49.75 Favored Glycine 0 N--CA 1.502 3.073 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 111.335 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -106.43 74.31 1.01 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.907 -1.349 . . . . 0.40000000000000002 109.048 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -80.23 -9.95 59.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.40000000000000002 110.665 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -129.33 152.36 48.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.227 -0.921 . . . . 2.0600000000000001 109.149 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.95 94.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 1.0600000000000001 110.786 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 7.1 p90 -60.66 -17.84 49.95 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.915 -1.115 . . . . 0.88 110.975 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.97 -32.72 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.309 -1.367 . . . . 1.1100000000000001 107.309 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.93 -39.84 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.582 -0.895 . . . . 1.02 108.582 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.87 -35.12 74.16 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.079 -1.452 . . . . 1.1599999999999999 107.079 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.95 -40.76 95.79 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.63 -1.388 . . . . 0.22 109.63 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.97 -42.46 94.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.296 -1.12 . . . . 1.8400000000000001 108.596 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.06 -39.96 87.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.45000000000000001 109.57 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.52 -37.72 77.25 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.602 -0.839 . . . . 1.1000000000000001 108.948 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.53 -28.57 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.252 -0.905 . . . . 1.0600000000000001 109.744 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.29 13.16 10.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.122 -0.986 . . . . 1.1799999999999999 110.584 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt 49.94 38.96 17.51 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.538 -1.351 . . . . 2.73 110.405 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mttm 56.85 19.47 4.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 2.4399999999999999 110.095 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.27 106.77 1.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 117.775 -1.57 . . . . 1.8400000000000001 106.972 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.1 -40.09 88.43 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.664 -0.647 . . . . 1.05 111.304 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -69.67 -40.03 76.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.263 -1.523 . . . . 0.90000000000000002 110.053 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.2 mt -70.6 -40.0 73.48 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.55 -1.26 . . . . 1.1599999999999999 109.196 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.88 -49.93 72.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.34999999999999998 110.511 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -63.23 -41.11 99.07 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.054 -1.059 . . . . 3.3799999999999999 109.909 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.31 -40.07 93.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.629 -1.294 . . . . 2.1499999999999999 108.14 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.459 ' O ' ' OG1' ' A' ' 66' ' ' THR . 67.6 t90 -64.53 -50.03 68.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 0.28999999999999998 111.217 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.89 -46.1 83.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.132 -0.98 . . . . 1.0900000000000001 109.667 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -63.27 -49.79 72.69 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.483 -0.76 . . . . 2.4700000000000002 109.954 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.65 -30.51 70.79 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.515 -0.741 . . . . 1.7 109.678 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 86.7 m -78.36 -37.68 43.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 1.0600000000000001 111.096 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.0 p -127.24 -26.9 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.529 -1.357 . . . . 0.93999999999999995 112.261 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 13.7 27.12 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.249 -1.541 . . . . 0.28999999999999998 109.249 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.12 155.54 1.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.291 . . . . 1.01 108.916 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -88.67 166.38 14.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 2.46 109.603 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.89 62.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 1.1200000000000001 108.351 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -70.16 -48.86 55.51 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.305 0.574 . . . . 4.1399999999999997 112.029 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.96 -30.01 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.068 -1.02 . . . . 2.6600000000000001 110.834 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.9 p -70.02 -34.7 73.62 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.979 -1.088 . . . . 2.0 109.254 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -60.29 -38.84 84.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 3.3300000000000001 109.34 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -66.86 -38.8 87.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 109.597 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.416 ' SG ' ' CD1' ' A' ' 26' ' ' ILE . 93.9 m -69.91 -40.08 75.81 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.994 -1.066 . . . . 0.81999999999999995 109.702 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.74 -61.15 2.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.761 -1.212 . . . . 0.40000000000000002 109.769 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.7 -33.89 88.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.46 -1.056 . . . . 0.32000000000000001 110.46 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.41 -48.37 61.29 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.73 -1.453 . . . . 0.94999999999999996 109.943 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.9 mt -70.08 -40.07 75.22 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.9 -1.12 . . . . 1.1699999999999999 108.867 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -65.53 -40.12 92.56 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.4 -0.813 . . . . 3.3500000000000001 111.006 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -70.04 -35.36 74.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.74 -1.225 . . . . 2.0699999999999998 109.319 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.528 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 87.3 t90 -60.07 -43.69 95.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.991 -1.485 . . . . 0.34999999999999998 106.991 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.5 m -61.45 -40.18 93.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.613 0.72 . . . . 0.89000000000000001 109.896 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.96 -34.44 73.28 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.968 -1.082 . . . . 0.59999999999999998 110.328 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.33 -31.99 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.116 -0.99 . . . . 1.21 110.299 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 66.0 m-85 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.542 -0.724 . . . . 1.23 112.606 -176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.657 0.742 . . . . 1.71 109.699 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.66 -21.17 2.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.629 -0.669 . . . . 2.7599999999999998 109.659 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.33 -37.29 82.77 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.291 -0.881 . . . . 2.6899999999999999 109.876 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -60.05 -49.95 75.64 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.025 -1.047 . . . . 0.52000000000000002 110.038 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.02 -36.91 75.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 3.9100000000000001 110.227 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.06 -38.78 82.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.345 -0.847 . . . . 0.67000000000000004 108.732 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.68 -49.95 71.14 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.595 -0.69 . . . . 0.39000000000000001 110.08 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.88 10.43 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.1 -1.0 . . . . 1.1000000000000001 110.659 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.67 -14.93 14.89 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.114 -0.991 . . . . 1.1200000000000001 110.192 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -153.51 151.2 24.94 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.139 -0.975 . . . . 1.27 108.748 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.97 160.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.97 1.78 . . . . 0.47999999999999998 112.052 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ptp -89.06 -26.54 21.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.269 -0.895 . . . . 1.3799999999999999 109.46 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.54 -138.27 46.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.709 -1.756 . . . . 0.53000000000000003 108.709 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.59 35.44 3.47 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.355 -1.086 . . . . 1.0800000000000001 109.61 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 149.76 83.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 2.75 109.798 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.64 152.21 79.23 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.702 2.268 . . . . 0.41999999999999998 112.742 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.5 p -53.85 -42.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.622 -0.674 . . . . 1.1100000000000001 110.349 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.56 -3.34 1.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.514 -1.034 . . . . 0.25 110.514 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 20' ' ' VAL . 45.7 t -83.28 -22.62 32.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.872 -1.37 . . . . 1.9099999999999999 110.014 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 73.8 mt -64.35 139.0 58.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 1.0700000000000001 109.746 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.19 135.63 55.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.828 -0.749 . . . . 1.0800000000000001 109.668 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.14 -21.73 44.61 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.348 -1.501 . . . . 0.20000000000000001 109.348 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.416 ' CD1' ' SG ' ' B' ' 77' ' ' CYS . 36.2 mm -98.48 113.69 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.845 -1.169 . . . . 1.1000000000000001 107.845 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.78 179.36 39.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.787 -1.325 . . . . 0.20999999999999999 109.787 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -58.72 -40.03 82.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.473 -1.016 . . . . 1.8200000000000001 110.206 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.73 -45.76 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.941 -1.099 . . . . 1.0900000000000001 109.058 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.8 -39.99 79.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 1.1200000000000001 109.87 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.12 -33.56 75.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.869 -1.692 . . . . 0.35999999999999999 108.869 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -39.97 86.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.965 . . . . 3.2999999999999998 110.247 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -68.91 -44.62 72.75 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.924 -1.11 . . . . 2.0699999999999998 109.158 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.52 -39.47 93.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.948 -1.13 . . . . 1.0800000000000001 107.948 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -60.04 -41.86 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.58 -0.7 . . . . 1.52 109.289 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -68.48 -18.37 64.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.472 -0.936 . . . . 2.4300000000000002 108.472 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -89.93 1.63 56.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 2.98 109.775 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 8.45 43.47 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.114 -0.991 . . . . 0.46000000000000002 111.267 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -107.15 74.18 0.96 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.886 -1.361 . . . . 0.40000000000000002 108.984 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -80.07 -10.41 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.38 110.718 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -129.3 150.69 50.56 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.208 -0.933 . . . . 2.0499999999999998 109.084 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.28 99.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.199 -0.938 . . . . 1.0600000000000001 110.726 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 6.2 p90 -56.96 -18.27 12.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.113 . . . . 0.91000000000000003 110.762 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.49 -33.92 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.296 -1.372 . . . . 1.0900000000000001 107.296 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.38 -39.63 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 1.02 108.727 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.4 tp -59.83 -34.28 72.88 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.869 -1.53 . . . . 1.1599999999999999 106.869 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.39 -40.68 96.37 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.503 -1.439 . . . . 0.20999999999999999 109.503 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -60.06 -42.64 94.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.24 -1.153 . . . . 1.8600000000000001 108.891 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 0.42999999999999999 109.658 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -69.16 -38.07 78.55 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.877 -0.786 . . . . 1.1000000000000001 108.877 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.04 -29.31 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.259 -0.901 . . . . 1.0700000000000001 109.717 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 94.5 mt -87.16 14.56 7.45 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.002 -1.062 . . . . 1.1799999999999999 110.684 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 49.97 35.48 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.626 -1.296 . . . . 2.75 110.917 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 60.05 19.84 9.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.206 -0.934 . . . . 2.4700000000000002 109.923 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 108.93 2.73 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.638 -1.615 . . . . 1.8100000000000001 106.638 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.78 -40.03 93.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 1.04 111.22 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -69.28 -40.06 78.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.375 -1.453 . . . . 0.90000000000000002 110.008 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.74 -38.82 73.56 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.903 -1.119 . . . . 1.1399999999999999 109.191 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.54 -49.99 69.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.34999999999999998 110.414 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -63.1 -41.61 99.41 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.049 -1.032 . . . . 3.3900000000000001 109.843 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.19 -40.08 93.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.691 -1.256 . . . . 2.1600000000000001 108.055 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.473 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -64.33 -49.07 73.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.28000000000000003 111.138 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.7 tp -66.05 -48.34 71.35 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.943 -1.098 . . . . 1.0900000000000001 109.722 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -60.87 -49.84 75.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.501 -0.749 . . . . 2.4500000000000002 110.156 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -67.53 -28.24 67.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 1.6899999999999999 109.793 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.84 -33.62 34.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 1.0600000000000001 110.954 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 22.4 p -131.11 -28.44 1.94 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.453 -1.405 . . . . 0.93000000000000005 112.208 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.31 13.12 25.46 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.149 -1.581 . . . . 0.31 109.149 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 154.68 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.242 . . . . 1.03 108.735 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.49 168.12 12.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.976 -1.077 . . . . 2.4500000000000002 109.691 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.81 63.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.333 -0.988 . . . . 1.1000000000000001 108.333 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -70.06 -49.33 52.21 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-O 121.323 0.582 . . . . 4.1200000000000001 112.07 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.69 -29.99 69.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.977 -1.077 . . . . 2.6600000000000001 110.883 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -69.91 -34.65 73.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.062 -1.055 . . . . 2.0 109.159 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -60.73 -38.83 86.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.758 -1.214 . . . . 3.3100000000000001 109.579 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.83 -39.14 87.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.796 -1.19 . . . . 0.28999999999999998 109.647 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.416 ' SG ' ' CD1' ' B' ' 26' ' ' ILE . 93.0 m -69.42 -40.02 77.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.019 -1.05 . . . . 0.82999999999999996 109.484 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.93 -60.73 3.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.75 -1.219 . . . . 0.40000000000000002 109.758 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.8 -33.94 88.59 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.526 -1.03 . . . . 0.29999999999999999 110.526 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.49 -48.42 60.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.747 -1.443 . . . . 0.94999999999999996 109.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.97 -40.0 75.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.972 -1.091 . . . . 1.1699999999999999 108.539 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -66.9 -40.11 87.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.855 . . . . 3.3799999999999999 111.41 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -69.87 -34.9 74.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.594 -1.316 . . . . 2.0600000000000001 108.813 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.568 ' O ' ' HB2' ' B' ' 88' ' ' PHE . 85.4 t90 -59.46 -48.65 80.83 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.661 -1.978 . . . . 0.35999999999999999 105.661 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.657 ' O ' ' N ' ' B' ' 89' ' ' LEU . 36.5 m -58.07 -39.93 79.75 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.765 -0.584 . . . . 0.90000000000000002 110.29 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -61.25 -35.24 76.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.31 -1.494 . . . . 0.58999999999999997 111.171 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.03 -25.5 20.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.121 . . . . 1.22 107.983 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' B' ' 84' ' ' TRP . 60.6 m-85 -115.15 -2.98 12.61 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 114.792 1.404 . . . . 1.24 114.792 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' B' ' 85' ' ' CYS . 14.5 tp . . . . . 0 C--N 1.282 -2.344 0 O-C-N 119.009 -2.307 . . . . 1.9399999999999999 110.051 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.627 0.727 . . . . 1.98 109.251 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.37 -20.81 1.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.618 . . . . 2.6000000000000001 109.734 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.87 -35.81 79.41 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 2.5099999999999998 108.81 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -60.05 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.51000000000000001 109.934 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 8' ' ' ARG . 30.9 mtt-85 -69.96 -34.62 73.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 3.7200000000000002 109.959 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.95 -39.81 75.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.367 -0.833 . . . . 0.76000000000000001 109.738 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -65.62 -42.49 91.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.379 -0.826 . . . . 0.5 110.338 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.32 14.63 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.901 -1.125 . . . . 1.1799999999999999 109.869 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.39 -10.33 12.02 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.365 -0.834 . . . . 1.1799999999999999 110.488 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.49 149.98 22.47 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 1.26 109.575 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -39.67 161.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.903 1.735 . . . . 0.53000000000000003 111.619 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.47 -18.0 23.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.998 -1.064 . . . . 1.1399999999999999 109.677 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -143.24 12.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.954 -1.259 . . . . 0.41999999999999998 109.954 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.71 29.89 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.416 -1.049 . . . . 0.84999999999999998 110.274 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -60.05 149.06 75.91 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.093 -1.004 . . . . 2.4900000000000002 108.609 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.7 160.11 41.98 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.26 1.974 . . . . 0.39000000000000001 112.407 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 22' ' ' SER . 6.4 p -57.2 -47.09 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.75 . . . . 1.1200000000000001 110.403 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.54 -1.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.346 -1.102 . . . . 0.27000000000000002 110.346 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 20' ' ' VAL . 21.7 m -82.95 -23.16 33.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.77 -1.429 . . . . 1.75 109.72 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.19 140.03 58.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 1.05 109.751 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.471 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -64.3 134.68 55.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.747 0.784 . . . . 1.0600000000000001 109.857 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.23 -17.05 58.48 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.583 -1.407 . . . . 0.23000000000000001 109.583 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.37 115.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -1.155 . . . . 1.0800000000000001 107.971 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.03 172.44 40.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.697 -1.361 . . . . 0.31 109.697 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -55.86 -40.05 72.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.0099999999999998 109.92 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.04 -44.19 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.997 -1.064 . . . . 1.1399999999999999 109.741 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.37 -34.21 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 1.1299999999999999 109.825 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.93 95.19 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.022 -1.631 . . . . 0.34999999999999998 109.022 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.23 -38.83 92.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -1.171 . . . . 3.2200000000000002 109.575 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.27 -52.88 28.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 2.1000000000000001 109.172 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.58 -40.0 90.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.082 -1.011 . . . . 1.0800000000000001 108.36 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -42.07 93.58 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.885 -0.726 . . . . 1.6699999999999999 109.223 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.3 -20.17 66.02 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.603 -0.888 . . . . 2.0 108.603 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.8 OUTLIER -91.09 4.39 52.28 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 3.1499999999999999 110.286 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.04 7.95 51.71 Favored Glycine 0 N--CA 1.502 3.054 0 O-C-N 120.976 -1.077 . . . . 0.47999999999999998 111.611 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -104.81 73.48 1.08 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.717 -1.461 . . . . 0.38 108.417 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 22.9 p-10 -77.56 -9.74 59.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.428 -0.795 . . . . 0.40999999999999998 111.104 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -137.46 158.06 45.22 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.056 -1.028 . . . . 2.1600000000000001 110.417 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.67 93.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.577 . . . . 1.03 112.327 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -59.25 -18.1 34.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.586 -1.321 . . . . 0.92000000000000004 110.439 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -79.91 -31.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.878 -1.139 . . . . 1.0700000000000001 108.285 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.5 t -77.03 -37.71 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.942 -1.133 . . . . 1.0600000000000001 107.942 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.8 tp -59.96 -37.85 80.78 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.286 -1.375 . . . . 1.1599999999999999 107.286 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.54 89.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.98 -1.248 . . . . 0.20000000000000001 109.98 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -60.04 -42.66 94.9 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.89 -1.359 . . . . 1.8200000000000001 109.134 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -60.03 -40.82 90.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 0.40000000000000002 108.793 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.01 -38.27 79.14 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.544 -0.909 . . . . 1.0900000000000001 108.544 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.94 -22.65 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 110.575 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.8 15.05 13.71 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.006 -1.059 . . . . 1.0900000000000001 110.676 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.12 42.77 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.671 -1.268 . . . . 2.2200000000000002 110.778 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 57.82 20.02 6.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.478 -0.764 . . . . 2.7999999999999998 110.421 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -69.2 104.53 2.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.412 -1.43 . . . . 1.8 107.706 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.16 -40.05 92.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.959 0.726 . . . . 0.87 112.959 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 95.0 m-20 -69.93 -39.98 75.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.457 -1.402 . . . . 0.72999999999999998 110.475 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.82 -40.04 72.69 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.985 -1.086 . . . . 1.2 109.033 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.27 -49.88 73.94 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.836 . . . . 0.44 110.054 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 79.3 mtm180 -61.5 -43.67 98.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 3.3399999999999999 110.317 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.61 -39.85 94.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.265 -0.897 . . . . 2.3700000000000001 108.747 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.0 t90 -62.41 -49.22 76.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.275 -0.891 . . . . 0.40999999999999998 110.693 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 63.4 tp -67.78 -47.91 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.161 -0.962 . . . . 1.0800000000000001 110.131 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.49 -45.99 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 2.6099999999999999 109.642 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.84 -30.15 68.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.742 . . . . 1.8999999999999999 109.82 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 67.7 m -77.83 -36.89 49.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.945 . . . . 1.1100000000000001 111.227 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 13.5 p -130.44 -29.92 1.95 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.593 -1.317 . . . . 0.96999999999999997 111.783 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.33 15.86 11.94 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.311 -1.516 . . . . 0.38 109.311 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.29 154.63 2.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.315 . . . . 1.1000000000000001 109.03 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 168.84 12.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 2.3700000000000001 109.95 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.99 71.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 1.1200000000000001 110.192 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -72.78 -39.98 66.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.935 -1.103 . . . . 2.9700000000000002 109.346 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -68.39 -38.8 81.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.6200000000000001 110.35 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.71 -36.06 77.97 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.13 -0.981 . . . . 1.8899999999999999 109.516 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.93 -38.07 81.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 3.3199999999999998 109.401 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.13 -39.95 82.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.744 -1.222 . . . . 0.40000000000000002 110.451 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 93.4 m -69.45 -40.7 77.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.667 -1.271 . . . . 0.95999999999999996 109.507 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -58.82 -60.21 4.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.534 -1.354 . . . . 0.5 109.41 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.5 90.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.86 -0.896 . . . . 0.27000000000000002 110.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.91 -49.32 59.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.364 . . . . 0.93999999999999995 110.217 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.0 -39.62 75.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.902 -1.119 . . . . 1.0900000000000001 108.757 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.94 -41.03 90.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 3.1800000000000002 109.691 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.01 -37.8 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.9099999999999999 110.628 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.526 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 85.8 t90 -60.86 -42.01 97.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.40000000000000002 108.974 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.8 m -62.08 -40.04 94.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.96999999999999997 109.752 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.66 -31.16 67.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.344 -0.848 . . . . 0.55000000000000004 109.646 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.89 -37.06 12.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.305 -0.872 . . . . 1.1200000000000001 111.325 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 . . . . . 0 N--CA 1.504 2.264 0 O-C-N 121.132 -0.98 . . . . 1.24 112.399 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.561 0.696 . . . . 1.97 109.236 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.49 -20.72 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.714 -0.616 . . . . 2.5899999999999999 109.727 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.81 -35.91 79.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 2.5 108.875 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.92 -48.96 79.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.51000000000000001 110.015 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' B' ' 8' ' ' ARG . 31.0 mtt-85 -69.94 -34.61 73.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 3.73 110.007 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -69.95 -39.59 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.299 -0.876 . . . . 0.76000000000000001 109.855 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -65.75 -42.47 90.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.448 -0.783 . . . . 0.5 110.36 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -84.31 14.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.946 -1.096 . . . . 1.1799999999999999 109.88 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.3 -10.02 12.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.397 -0.814 . . . . 1.1799999999999999 110.466 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.63 150.02 22.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.86 -1.15 . . . . 1.27 109.456 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.59 161.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.918 1.745 . . . . 0.53000000000000003 111.603 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.44 -18.15 23.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.043 -1.035 . . . . 1.1299999999999999 109.708 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.32 -143.15 12.98 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.018 -1.233 . . . . 0.40999999999999998 110.018 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.88 29.94 5.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.484 -1.01 . . . . 0.83999999999999997 110.221 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -60.16 149.07 76.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 2.4900000000000002 108.632 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 160.18 41.52 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.194 1.929 . . . . 0.38 112.424 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' B' ' 22' ' ' SER . 6.3 p -57.27 -47.05 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.734 . . . . 1.1200000000000001 110.441 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.43 -2.1 0.1 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.475 -1.05 . . . . 0.27000000000000002 110.475 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.545 ' H ' ' C ' ' B' ' 20' ' ' VAL . 21.1 m -82.67 -23.26 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.806 -1.408 . . . . 1.75 109.806 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.12 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.04 -1.037 . . . . 1.0600000000000001 109.718 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.468 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.24 134.93 55.72 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.69 0.757 . . . . 1.05 109.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.09 58.66 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.489 -1.444 . . . . 0.22 109.489 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.33 115.41 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.245 -1.15 . . . . 1.0800000000000001 107.951 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.94 172.51 40.37 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.725 -1.35 . . . . 0.29999999999999999 109.725 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -56.01 -39.94 72.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -1.089 . . . . 2.0 109.907 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.19 -43.99 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.008 -1.057 . . . . 1.1399999999999999 109.749 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.51 -34.13 77.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 1.1299999999999999 109.742 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.17 -40.03 95.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.973 -1.651 . . . . 0.35999999999999999 108.973 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.26 -38.64 91.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -1.154 . . . . 3.2200000000000002 109.545 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.4 -52.88 28.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.124 . . . . 2.1200000000000001 109.12 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.7 -39.95 90.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.286 -1.005 . . . . 1.0800000000000001 108.286 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.08 -41.97 93.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.839 -0.744 . . . . 1.6799999999999999 109.168 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.42 -20.07 65.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.653 -0.869 . . . . 1.99 108.653 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.8 OUTLIER -90.98 4.17 52.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.561 -0.712 . . . . 3.1499999999999999 110.321 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.05 7.96 51.65 Favored Glycine 0 N--CA 1.502 3.067 0 C-N-CA 120.139 -1.029 . . . . 0.48999999999999999 111.664 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -104.75 73.44 1.08 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.401 . . . . 0.38 108.485 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 40' ' ' ASP . 22.7 p-10 -77.61 -9.75 59.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.40999999999999998 111.021 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -137.39 157.92 45.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.999 -1.063 . . . . 2.1499999999999999 110.423 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.0 94.56 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.702 -0.624 . . . . 1.03 112.318 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.476 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 4.6 p90 -59.1 -17.88 30.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.61 -1.306 . . . . 0.92000000000000004 110.578 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -80.01 -31.93 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.924 -1.11 . . . . 1.0800000000000001 108.231 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.92 -37.65 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.954 -1.128 . . . . 1.0700000000000001 107.954 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.0 -37.65 80.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.265 -1.383 . . . . 1.1499999999999999 107.265 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.47 90.35 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.96 -1.256 . . . . 0.19 109.96 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.774 -1.427 . . . . 1.8200000000000001 109.154 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -59.95 -40.93 90.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.40000000000000002 108.785 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 80.9 mt -68.96 -38.0 79.16 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.622 -0.881 . . . . 1.0700000000000001 108.622 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.14 -22.79 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.263 -0.898 . . . . 1.0900000000000001 110.499 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.58 14.69 14.31 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.088 -1.008 . . . . 1.0900000000000001 110.732 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.44 42.4 14.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.7 -1.25 . . . . 2.23 110.742 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 58.27 19.95 6.75 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.403 -0.811 . . . . 2.7999999999999998 110.43 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -69.23 104.52 2.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 1.8 107.817 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.18 -39.99 92.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.899 0.703 . . . . 0.88 112.899 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 94.8 m-20 -70.05 -39.94 75.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.465 -1.397 . . . . 0.73999999999999999 110.362 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.969 -1.092 . . . . 1.2 108.92 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.15 -49.98 73.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.328 -0.857 . . . . 0.44 109.939 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.486 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 79.3 mtm180 -61.7 -43.38 98.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 3.3399999999999999 110.295 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -64.71 -39.9 94.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.076 -1.015 . . . . 2.3799999999999999 108.782 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.432 ' O ' ' OG1' ' B' ' 66' ' ' THR . 68.1 t90 -62.39 -49.32 75.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.343 -0.848 . . . . 0.40999999999999998 110.703 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.439 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 63.5 tp -67.6 -47.85 68.49 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.184 -0.948 . . . . 1.0700000000000001 110.209 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.48 -46.13 87.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 2.6000000000000001 109.636 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -68.85 -29.97 68.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 1.8999999999999999 109.903 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 66.9 m -77.91 -36.82 49.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 1.1000000000000001 111.189 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 13.4 p -130.64 -29.77 1.92 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.564 -1.335 . . . . 0.95999999999999996 111.712 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.31 15.72 12.16 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.345 -1.502 . . . . 0.37 109.345 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.08 154.52 2.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.968 -1.313 . . . . 1.0900000000000001 109.125 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -88.34 168.93 12.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.991 -1.068 . . . . 2.3700000000000001 109.922 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.31 71.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 1.1100000000000001 110.167 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -72.47 -40.01 67.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 2.9700000000000002 109.409 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -68.54 -38.6 80.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.45 -0.781 . . . . 2.6200000000000001 110.447 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.72 -36.06 77.95 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 1.8899999999999999 109.564 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.87 -38.21 81.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 3.3199999999999998 109.342 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.92 -40.02 83.45 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.40000000000000002 110.428 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.1 m -69.53 -40.73 76.71 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.653 -1.279 . . . . 0.95999999999999996 109.46 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.78 -60.36 3.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.635 -1.291 . . . . 0.5 109.37 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.05 -34.58 90.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.779 -0.928 . . . . 0.27000000000000002 110.779 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 51.1 t -68.79 -49.4 58.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.927 -1.337 . . . . 0.93999999999999995 110.215 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.99 -39.5 75.86 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.842 -1.143 . . . . 1.0900000000000001 108.799 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.04 -41.0 91.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 3.1899999999999999 109.605 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -70.0 -37.72 75.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.9099999999999999 110.711 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 85.7 t90 -60.81 -42.16 97.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.516 -1.365 . . . . 0.40000000000000002 108.986 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' B' ' 89' ' ' LEU . 69.7 m -62.04 -39.96 94.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.474 -0.766 . . . . 0.96999999999999997 109.735 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -58.61 -31.43 68.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.433 -0.792 . . . . 0.55000000000000004 109.67 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.7 -37.19 12.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 1.1299999999999999 111.416 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.9 m-85 -105.74 -4.35 21.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.084 -1.01 . . . . 1.24 112.501 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.444 -1.41 . . . . 1.8300000000000001 109.419 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.781 0.8 . . . . 1.98 110.078 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -54.57 -19.28 5.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.778 -0.576 . . . . 2.6000000000000001 110.05 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -60.05 -38.36 82.58 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.031 -1.043 . . . . 2.5099999999999998 109.366 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -58.93 -50.06 75.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.51000000000000001 110.515 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -69.97 -33.78 72.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.02 . . . . 3.7200000000000002 109.831 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -67.17 -39.9 86.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.849 -0.741 . . . . 0.76000000000000001 109.904 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.92 -47.15 75.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.5 110.362 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 m -85.77 5.18 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.128 -0.982 . . . . 1.1799999999999999 110.929 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.97 17.98 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.06 -1.025 . . . . 1.1799999999999999 109.935 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.6 pt-20 -153.59 153.35 28.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 1.26 108.712 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 13' ' ' GLU . 64.1 Cg_exo -35.87 156.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.236 1.958 . . . . 0.53000000000000003 112.024 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.54 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 10.4 ptm -93.12 -31.59 14.75 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.238 -0.913 . . . . 1.1399999999999999 109.983 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.24 -133.58 41.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.612 -0.995 . . . . 0.41999999999999998 110.612 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.56 -0.964 . . . . 0.84999999999999998 110.972 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.31 65.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.704 -1.248 . . . . 2.4900000000000002 108.23 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.47 155.48 47.02 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.084 1.856 . . . . 0.39000000000000001 112.246 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' SER . 10.8 p -56.23 -47.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.554 -0.716 . . . . 1.1200000000000001 110.384 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -58.03 -3.28 1.18 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.681 -0.967 . . . . 0.27000000000000002 110.681 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' VAL . 9.6 t -84.52 -22.31 30.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.742 -1.446 . . . . 1.75 109.633 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.88 138.87 58.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 1.05 109.263 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -63.83 136.27 57.27 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.91 0.862 . . . . 1.0600000000000001 110.507 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.05 59.67 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.301 -1.52 . . . . 0.23000000000000001 109.301 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 26' ' ' ILE . 27.1 mm -100.29 113.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.436 -1.038 . . . . 1.0800000000000001 108.384 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.75 177.72 40.49 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.422 -1.471 . . . . 0.31 109.422 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -55.77 -39.72 71.61 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.465 -1.021 . . . . 2.0099999999999998 109.562 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.02 -46.36 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.06 -1.025 . . . . 1.1399999999999999 110.127 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.68 -39.05 87.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 1.1299999999999999 109.972 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 -39.96 97.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.168 -1.173 . . . . 0.34999999999999998 110.168 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.34 -39.66 92.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.106 -1.232 . . . . 3.2200000000000002 110.241 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -67.66 -45.68 74.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.936 -1.103 . . . . 2.1000000000000001 108.974 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.91 -39.42 89.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.655 -1.239 . . . . 1.0800000000000001 107.655 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.02 -40.94 91.04 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.827 -0.749 . . . . 1.6699999999999999 109.141 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -68.03 -20.35 64.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.246 -0.909 . . . . 2.0 108.882 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -91.16 2.43 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 3.1499999999999999 109.679 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.02 38.0 3.72 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 120.346 -0.93 . . . . 0.47999999999999998 111.352 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -133.63 72.29 1.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.959 -1.318 . . . . 0.38 109.073 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 22.9 p-10 -80.07 -10.73 59.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.165 . . . . 0.40999999999999998 110.437 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -129.75 150.93 50.84 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.193 -0.942 . . . . 2.1600000000000001 109.422 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.06 90.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 1.03 111.274 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.74 -17.1 32.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.741 -1.224 . . . . 0.92000000000000004 110.182 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.86 -31.8 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.748 -1.204 . . . . 1.0700000000000001 107.748 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.34 -36.47 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.774 -1.195 . . . . 1.0600000000000001 107.774 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.01 -36.34 77.01 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.237 -1.394 . . . . 1.1599999999999999 107.237 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.07 98.12 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.736 -1.346 . . . . 0.20000000000000001 109.736 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -60.08 -43.8 95.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.903 -1.351 . . . . 1.8200000000000001 108.431 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.11 -40.91 91.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.40000000000000002 109.222 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.6 -38.45 80.62 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.426 -0.953 . . . . 1.0900000000000001 108.426 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.76 -21.08 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.259 -0.9 . . . . 1.0900000000000001 110.853 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.48 13.27 14.21 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.933 -1.105 . . . . 1.0900000000000001 111.351 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 49.92 36.21 11.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.648 -1.282 . . . . 2.2200000000000002 110.065 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.28 19.96 8.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.411 -0.805 . . . . 2.7999999999999998 110.257 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.9 105.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.526 -1.359 . . . . 1.8 108.209 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 82.5 tt0 -65.11 -40.29 94.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.486 -0.759 . . . . 0.87 112.44 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.61 -39.99 80.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.704 -1.248 . . . . 0.72999999999999998 109.594 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.59 -39.31 77.37 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.385 -0.926 . . . . 1.2 108.756 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.5 -46.62 89.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.44 109.117 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 96.9 mtt180 -59.99 -48.21 82.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.497 -0.752 . . . . 3.3399999999999999 110.694 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.32 -39.95 89.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.703 -1.248 . . . . 2.3700000000000001 108.913 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' A' ' 66' ' ' THR . 62.3 t90 -62.76 -49.94 73.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.40999999999999998 110.647 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 56.6 tp -66.35 -47.64 72.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.328 -0.857 . . . . 1.0800000000000001 109.724 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.27 -44.93 95.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.359 -0.838 . . . . 2.6099999999999999 109.772 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.36 -32.08 70.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.327 -0.858 . . . . 1.8999999999999999 109.244 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 94.4 m -77.1 -38.0 53.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 1.1100000000000001 111.323 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 10.5 p -131.0 -37.0 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.622 -1.299 . . . . 0.96999999999999997 111.86 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.21 17.75 7.57 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.214 -1.555 . . . . 0.38 109.214 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.31 153.84 3.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.034 -1.274 . . . . 1.1000000000000001 109.191 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -91.06 171.66 9.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 2.3700000000000001 109.589 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.84 70.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.467 -0.771 . . . . 1.1200000000000001 110.593 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -71.79 -41.16 68.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.739 -1.226 . . . . 2.9700000000000002 110.317 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.41 -39.16 88.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.198 -0.939 . . . . 2.6200000000000001 110.451 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -66.03 -38.65 88.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.441 -0.787 . . . . 1.8899999999999999 110.195 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.825 -1.172 . . . . 3.3199999999999998 109.384 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -67.9 -39.99 83.53 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.697 -1.252 . . . . 0.40000000000000002 110.476 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 92.4 m -69.74 -39.94 76.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.683 -1.26 . . . . 0.95999999999999996 109.778 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.48 -60.41 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.61 -1.307 . . . . 0.5 109.792 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.58 84.67 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 120.305 -0.95 . . . . 0.27000000000000002 110.843 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.21 -49.27 45.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.832 -1.393 . . . . 0.93999999999999995 110.014 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.0 -39.98 75.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 1.0900000000000001 108.745 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 82' ' ' ARG . 16.4 ttt-85 -64.57 -39.87 94.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.282 -0.886 . . . . 3.1800000000000002 110.051 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.92 -39.45 79.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 1.9099999999999999 110.345 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.588 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 88.3 t90 -60.14 -43.63 95.57 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.411 -1.431 . . . . 0.40000000000000002 107.666 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.1 m -61.57 -40.02 93.26 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.457 0.646 . . . . 0.96999999999999997 109.695 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.99 -31.91 70.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.835 . . . . 0.55000000000000004 109.145 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.73 13.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.4 -0.813 . . . . 1.1200000000000001 110.654 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.588 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 85.5 m-85 . . . . . 0 N--CA 1.505 2.315 0 O-C-N 121.278 -0.889 . . . . 1.24 112.831 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.793 0.806 . . . . 1.97 110.07 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -54.73 -19.28 5.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.77 -0.581 . . . . 2.5899999999999999 110.039 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.96 -38.37 82.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.024 -1.047 . . . . 2.5 109.364 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -58.95 -50.12 75.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.996 . . . . 0.51000000000000001 110.428 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -70.01 -33.72 72.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.035 -1.041 . . . . 3.73 109.825 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.2 -39.93 86.4 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.418 -0.801 . . . . 0.76000000000000001 109.792 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.83 -47.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.5 110.303 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 24.2 m -85.77 5.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.132 -0.98 . . . . 1.1799999999999999 110.907 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.56 -15.09 17.94 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.049 -1.032 . . . . 1.1799999999999999 109.915 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' B' ' 14' ' ' PRO . 4.6 pt-20 -153.65 153.38 28.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 1.27 108.606 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -35.93 156.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.333 2.022 . . . . 0.53000000000000003 112.001 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.531 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 10.3 ptm -93.24 -31.64 14.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.359 -0.838 . . . . 1.1299999999999999 109.916 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.62 42.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.557 -1.017 . . . . 0.40999999999999998 110.557 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.968 . . . . 0.83999999999999997 110.938 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.34 64.83 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.748 -1.22 . . . . 2.4900000000000002 108.272 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.54 155.55 46.96 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.016 1.81 . . . . 0.38 112.298 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' B' ' 22' ' ' SER . 10.6 p -56.26 -47.25 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.536 -0.728 . . . . 1.1200000000000001 110.43 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.414 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -58.01 -3.12 1.1 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.781 -0.928 . . . . 0.27000000000000002 110.781 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.433 ' H ' ' C ' ' B' ' 20' ' ' VAL . 9.8 t -84.65 -22.34 29.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.696 -1.473 . . . . 1.75 109.573 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.91 138.87 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 1.0600000000000001 109.276 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.442 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -63.77 136.15 57.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.782 0.801 . . . . 1.05 110.552 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -16.95 59.9 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.393 -1.483 . . . . 0.22 109.393 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.409 HG23 HD13 ' B' ' 26' ' ' ILE . 27.2 mm -100.38 113.19 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.398 -1.06 . . . . 1.0800000000000001 108.343 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.74 177.56 40.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.419 -1.472 . . . . 0.29999999999999999 109.419 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -55.63 -39.7 71.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.506 -0.996 . . . . 2.0 109.519 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.05 -46.35 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.053 -1.029 . . . . 1.1399999999999999 110.096 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.72 -38.96 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 1.1299999999999999 109.865 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.81 -40.1 97.73 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.083 -1.207 . . . . 0.35999999999999999 110.083 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.26 -39.71 93.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.254 . . . . 3.2200000000000002 110.187 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.56 -45.67 74.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.105 . . . . 2.1200000000000001 109.041 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.95 -39.53 89.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.595 -1.261 . . . . 1.0800000000000001 107.595 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.96 -40.98 90.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.803 -0.759 . . . . 1.6799999999999999 109.082 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.97 -20.26 65.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 1.99 108.934 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -91.39 2.64 56.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.695 . . . . 3.1499999999999999 109.667 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 37.97 3.74 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 121.165 -0.959 . . . . 0.48999999999999999 111.37 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -133.54 72.2 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.921 -1.341 . . . . 0.38 109.095 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 40' ' ' ASP . 22.9 p-10 -80.06 -10.63 59.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.40999999999999998 110.413 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -129.81 150.83 50.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.294 -0.879 . . . . 2.1499999999999999 109.489 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -40.09 90.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.461 -0.774 . . . . 1.03 111.291 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.79 -17.13 33.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.745 -1.222 . . . . 0.92000000000000004 110.217 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.87 -31.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.745 -1.205 . . . . 1.0800000000000001 107.745 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 59.2 t -78.49 -36.39 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.727 -1.212 . . . . 1.0700000000000001 107.727 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.06 -36.25 76.93 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.166 -1.42 . . . . 1.1499999999999999 107.166 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.18 98.25 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.635 -1.386 . . . . 0.19 109.635 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -59.98 -43.89 94.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.944 -1.327 . . . . 1.8200000000000001 108.514 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -59.91 -41.07 90.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.769 . . . . 0.40000000000000002 109.275 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.44 -38.52 81.24 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.513 -0.921 . . . . 1.0700000000000001 108.513 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.87 -20.95 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.936 . . . . 1.0900000000000001 110.779 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.52 13.19 14.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.863 -1.148 . . . . 1.0900000000000001 111.41 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 50.05 36.15 11.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.667 -1.271 . . . . 2.23 110.125 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.11 20.03 7.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.38 -0.825 . . . . 2.7999999999999998 110.285 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -67.92 105.28 1.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.553 -1.342 . . . . 1.8 108.258 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 82.5 tt0 -65.06 -40.32 94.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 0.88 112.375 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.6 -39.82 80.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.844 -1.16 . . . . 0.73999999999999999 109.577 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.79 -39.25 76.72 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.29 -0.964 . . . . 1.2 108.764 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.53 -46.72 88.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.44 109.021 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 97.0 mtt180 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.504 -0.748 . . . . 3.3399999999999999 110.664 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.3 -40.01 89.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.782 -1.199 . . . . 2.3799999999999999 108.952 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.409 ' O ' ' OG1' ' B' ' 66' ' ' THR . 62.2 t90 -62.77 -49.93 73.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.989 -1.069 . . . . 0.40999999999999998 110.656 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.469 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 56.7 tp -66.42 -47.62 72.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.391 -0.818 . . . . 1.0700000000000001 109.708 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.27 -44.86 95.56 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.376 -0.827 . . . . 2.6000000000000001 109.783 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -69.48 -31.95 70.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 1.8999999999999999 109.22 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 94.2 m -77.06 -37.98 53.52 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.448 -0.782 . . . . 1.1000000000000001 111.467 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 10.5 p -131.0 -37.04 1.3 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.649 -1.282 . . . . 0.95999999999999996 111.886 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.17 17.81 7.56 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.282 -1.527 . . . . 0.37 109.282 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.35 153.92 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.053 -1.263 . . . . 1.0900000000000001 109.153 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.19 171.77 9.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 2.3700000000000001 109.466 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.85 70.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.413 -0.805 . . . . 1.1100000000000001 110.511 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.79 -41.22 68.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.784 -1.197 . . . . 2.9700000000000002 110.247 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.37 -39.16 88.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -0.918 . . . . 2.6200000000000001 110.439 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 51.0 m -66.02 -38.74 89.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 1.8899999999999999 110.182 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -59.89 -38.32 81.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.857 -1.152 . . . . 3.3199999999999998 109.452 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -68.11 -39.98 82.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.69 -1.256 . . . . 0.40000000000000002 110.499 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.0 m -69.67 -40.06 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.95999999999999996 109.757 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.38 -60.38 3.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.592 -1.318 . . . . 0.5 109.777 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.68 85.01 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.797 -0.921 . . . . 0.27000000000000002 110.797 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.09 -49.41 44.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.758 -1.436 . . . . 0.93999999999999995 109.982 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.02 -39.9 75.51 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.004 -1.078 . . . . 1.0900000000000001 108.823 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.469 HH11 ' HG2' ' B' ' 82' ' ' ARG . 16.5 ttt-85 -64.4 -40.07 95.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 3.1899999999999999 110.061 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.7 -39.65 80.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 1.9099999999999999 110.45 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.586 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 88.3 t90 -60.03 -43.61 95.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.409 -1.432 . . . . 0.40000000000000002 107.658 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.6 m -61.69 -40.01 93.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.96999999999999997 109.647 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -59.99 -31.85 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 0.55000000000000004 109.227 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.16 -35.1 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.307 -0.871 . . . . 1.1299999999999999 110.611 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.586 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 86.9 m-85 -107.2 -6.64 17.18 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.239 -0.913 . . . . 1.24 112.951 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.4 tp . . . . . 0 N--CA 1.504 2.262 0 O-C-N 120.202 -1.561 . . . . 1.8300000000000001 109.342 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.753 0.787 . . . . 1.98 109.557 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -59.72 -22.52 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 2.6000000000000001 110.253 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.13 -38.5 83.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 2.5099999999999998 109.157 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 14.1 t60 -56.86 -49.84 74.25 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.256 -0.903 . . . . 0.51000000000000001 110.132 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -70.03 -34.0 72.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.922 . . . . 3.7200000000000002 110.086 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.68 -36.84 73.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.327 -0.858 . . . . 0.76000000000000001 109.74 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -64.49 -43.18 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.5 109.803 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -84.11 15.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.209 -0.932 . . . . 1.1799999999999999 110.243 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.42 -9.49 10.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.298 -0.876 . . . . 1.1799999999999999 110.311 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.71 149.73 19.45 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.859 -1.15 . . . . 1.26 109.461 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -40.61 155.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.742 1.628 . . . . 0.53000000000000003 111.168 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.3 ptp -91.21 -19.65 22.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.966 -1.084 . . . . 1.1399999999999999 109.174 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -138.6 39.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.195 -1.162 . . . . 0.41999999999999998 110.195 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -106.18 30.53 5.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.621 -0.929 . . . . 0.84999999999999998 110.487 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -60.06 148.52 77.52 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 2.4900000000000002 107.927 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.81 159.08 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.06 1.84 . . . . 0.39000000000000001 112.633 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.5 p -57.12 -49.25 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 1.1200000000000001 110.517 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.39 -1.86 0.14 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.763 -0.935 . . . . 0.27000000000000002 110.763 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 20' ' ' VAL . 64.9 p -82.42 -24.72 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.69 -1.476 . . . . 1.75 109.847 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.11 138.72 58.2 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.887 0.851 . . . . 1.05 109.84 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 133.43 53.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.725 0.774 . . . . 1.0600000000000001 109.982 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 97.37 -20.25 51.47 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.213 -1.555 . . . . 0.23000000000000001 109.213 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 26' ' ' ILE . 38.0 mm -99.75 113.17 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -1.162 . . . . 1.0800000000000001 107.892 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.44 179.94 39.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.31 109.692 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' C ' ' HZ3' ' A' ' 32' ' ' LYS . 79.6 mm-40 -56.01 -39.96 72.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.544 -0.974 . . . . 2.0099999999999998 109.874 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.73 -43.17 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.95 -1.094 . . . . 1.1399999999999999 109.524 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.73 -39.91 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 1.1299999999999999 109.526 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.29 97.81 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.135 -1.186 . . . . 0.34999999999999998 110.135 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HZ3' ' C ' ' A' ' 28' ' ' GLU . 33.6 mtmm -64.36 -38.79 92.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.998 -1.295 . . . . 3.2200000000000002 110.079 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -65.43 -48.87 71.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.872 -1.142 . . . . 2.1000000000000001 109.177 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.85 -38.6 86.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.21 -0.931 . . . . 1.0800000000000001 108.59 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.11 -40.05 88.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.768 -0.827 . . . . 1.6699999999999999 108.768 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.87 -18.89 64.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.407 -0.96 . . . . 2.0 108.407 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.33 2.89 56.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.594 -0.691 . . . . 3.1499999999999999 110.166 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.56 6.86 49.65 Favored Glycine 0 N--CA 1.503 3.115 0 O-C-N 120.997 -1.064 . . . . 0.47999999999999998 112.244 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 39' ' ' PHE . 44.3 m-85 -106.23 77.12 1.2 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 119.208 1.504 . . . . 0.38 109.32 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -77.46 -8.19 57.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.40999999999999998 111.024 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.79 158.54 44.15 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.977 -1.077 . . . . 2.1600000000000001 109.418 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.2 90.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.462 -0.774 . . . . 1.03 112.183 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.32 -17.58 20.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.636 -1.29 . . . . 0.92000000000000004 110.635 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.18 -30.02 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.927 -1.108 . . . . 1.0700000000000001 108.152 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.72 -39.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.994 -1.113 . . . . 1.0600000000000001 107.994 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.217 -1.401 . . . . 1.1599999999999999 107.217 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.56 -43.79 67.71 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.156 -1.577 . . . . 0.20000000000000001 109.156 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -1.225 . . . . 1.8200000000000001 108.634 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.86 -41.19 90.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.852 . . . . 0.40000000000000002 109.09 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.03 -39.98 75.44 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.883 -0.727 . . . . 1.0900000000000001 109.073 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.78 -20.27 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.115 -0.991 . . . . 1.0900000000000001 110.626 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.75 18.17 9.27 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.058 -1.026 . . . . 1.0900000000000001 109.79 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.04 32.44 10.26 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.942 -1.099 . . . . 2.2200000000000002 110.103 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 60.02 19.91 9.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.62 -0.675 . . . . 2.7999999999999998 109.913 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -67.84 111.88 4.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.777 -1.202 . . . . 1.8 107.927 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.5 -41.17 98.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.87 112.601 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.42 -40.05 77.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.548 -1.345 . . . . 0.72999999999999998 109.669 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.91 -40.01 75.85 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.977 -1.089 . . . . 1.2 108.785 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.06 -49.98 70.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.44 110.026 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -61.19 -44.85 96.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 3.3399999999999999 110.431 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 98.8 mt-10 -64.81 -37.92 89.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.805 -1.185 . . . . 2.3700000000000001 108.846 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.455 ' O ' ' OG1' ' A' ' 66' ' ' THR . 65.1 t90 -64.05 -48.04 77.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.303 -0.873 . . . . 0.40999999999999998 110.974 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.17 -46.89 66.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.956 -1.09 . . . . 1.0800000000000001 109.862 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -61.52 -47.0 87.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.067 -1.021 . . . . 2.6099999999999999 109.714 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 61' ' ' GLU . 71.7 m-20 -70.02 -28.33 65.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.849 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 54.5 m -80.61 -31.56 36.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 1.1100000000000001 111.732 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.6 p -133.19 -23.37 1.94 Allowed 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.374 -1.453 . . . . 0.96999999999999997 111.916 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.85 13.09 32.85 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.171 -1.572 . . . . 0.38 109.171 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.88 154.74 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.097 -1.237 . . . . 1.1000000000000001 109.371 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.93 171.88 9.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 2.3700000000000001 110.214 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.51 75.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.694 -0.629 . . . . 1.1200000000000001 110.38 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -73.06 -40.68 64.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.851 -1.155 . . . . 2.9700000000000002 110.105 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.3 mm100 -67.94 -35.13 77.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.974 . . . . 2.6200000000000001 110.284 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.4 -38.22 81.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.363 -0.836 . . . . 1.8899999999999999 110.085 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.06 -36.27 76.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.886 -1.134 . . . . 3.3199999999999998 109.547 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -68.97 -39.89 79.18 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.749 -1.22 . . . . 0.40000000000000002 110.806 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.03 -40.36 75.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.674 -1.266 . . . . 0.95999999999999996 110.061 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.77 -60.01 4.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.717 -1.239 . . . . 0.5 109.482 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.64 -33.7 87.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.351 -1.1 . . . . 0.27000000000000002 110.351 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.73 -46.55 62.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.761 -1.435 . . . . 0.93999999999999995 109.356 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.926 -1.11 . . . . 1.0900000000000001 108.659 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.43 -40.06 95.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 3.1800000000000002 110.295 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.534 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.6 mt-10 -69.85 -37.74 76.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 1.9099999999999999 110.165 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.8 t90 -60.0 -42.85 95.18 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.53 -1.356 . . . . 0.40000000000000002 107.821 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 88.3 m -60.79 -40.09 91.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -0.84 . . . . 0.96999999999999997 109.668 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.91 -32.28 69.4 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.017 -1.052 . . . . 0.55000000000000004 110.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.5 -34.03 14.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.107 -0.995 . . . . 1.1200000000000001 110.999 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 91.4 m-85 . . . . . 0 N--CA 1.504 2.251 0 O-C-N 121.089 -1.007 . . . . 1.24 111.357 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.673 0.749 . . . . 1.97 109.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.52 -22.67 61.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.727 -0.608 . . . . 2.5899999999999999 110.202 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -60.09 -38.59 83.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.094 -1.004 . . . . 2.5 109.189 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.541 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 14.2 t60 -56.85 -49.73 74.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.51000000000000001 110.144 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -70.11 -34.02 72.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 3.73 110.034 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.73 -36.52 73.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.312 -0.868 . . . . 0.76000000000000001 109.744 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.987 ' CD1' ' CD2' ' B' ' 10' ' ' PHE . . . -64.91 -42.94 94.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.479 -0.763 . . . . 0.5 109.869 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 m -84.0 14.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.161 -0.962 . . . . 1.1799999999999999 110.302 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.07 -9.3 11.09 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.34 -0.85 . . . . 1.1799999999999999 110.297 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.87 149.76 19.34 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.102 . . . . 1.27 109.37 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -40.58 155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.761 1.64 . . . . 0.53000000000000003 111.205 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.2 ptp -91.16 -19.83 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.895 -1.128 . . . . 1.1299999999999999 109.239 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.82 -138.44 41.81 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.341 -1.104 . . . . 0.40999999999999998 110.341 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.52 30.52 5.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.635 -0.921 . . . . 0.83999999999999997 110.408 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -60.03 148.31 77.84 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 2.4900000000000002 107.933 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.78 159.12 34.43 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.096 1.864 . . . . 0.38 112.591 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.5 p -57.19 -49.15 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.485 0.659 . . . . 1.1200000000000001 110.554 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.38 -2.21 0.15 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.791 -0.924 . . . . 0.27000000000000002 110.791 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.527 ' H ' ' C ' ' B' ' 20' ' ' VAL . 61.1 p -81.91 -24.73 35.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.766 -1.432 . . . . 1.75 110.032 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.2 138.79 58.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.296 -0.877 . . . . 1.0600000000000001 109.867 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.69 53.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.702 0.763 . . . . 1.05 109.836 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.513 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 97.17 -20.42 50.85 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.219 -1.552 . . . . 0.22 109.219 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.412 HD12 HG23 ' B' ' 26' ' ' ILE . 37.8 mm -99.69 113.18 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.894 -1.15 . . . . 1.0800000000000001 107.894 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.48 179.98 39.14 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.714 -1.354 . . . . 0.29999999999999999 109.714 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -56.07 -39.98 72.89 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.437 -1.037 . . . . 2.0 109.787 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.84 -42.99 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.956 -1.09 . . . . 1.1399999999999999 109.534 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.81 -39.99 83.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 1.1299999999999999 109.437 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.18 97.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.057 -1.217 . . . . 0.35999999999999999 110.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -64.55 -38.46 91.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.248 . . . . 3.2200000000000002 110.111 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.67 -48.82 70.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.824 -1.173 . . . . 2.1200000000000001 109.211 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.88 -38.63 86.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.26 -0.9 . . . . 1.0800000000000001 108.579 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.95 -40.16 88.04 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.692 -0.855 . . . . 1.6799999999999999 108.692 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.89 -18.82 64.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.47 -0.937 . . . . 1.99 108.47 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.23 2.44 56.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 3.1499999999999999 110.163 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 7.01 48.44 Favored Glycine 0 N--CA 1.503 3.118 0 O-C-N 121.08 -1.013 . . . . 0.48999999999999999 112.242 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' B' ' 39' ' ' PHE . 45.6 m-85 -106.36 76.95 1.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 119.19 1.495 . . . . 0.38 109.314 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -77.18 -8.47 57.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.377 -0.827 . . . . 0.40999999999999998 110.98 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.67 158.31 44.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 2.1499999999999999 109.437 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.4 91.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.48 -0.763 . . . . 1.03 112.173 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -58.17 -17.32 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.695 -1.253 . . . . 0.92000000000000004 110.765 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.45 -29.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.908 -1.12 . . . . 1.0800000000000001 108.104 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.88 -39.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.928 -1.138 . . . . 1.0700000000000001 107.928 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.98 -39.84 87.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.257 -1.386 . . . . 1.1499999999999999 107.257 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.7 -43.82 69.2 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.173 -1.571 . . . . 0.19 109.173 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.96 -44.62 94.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -1.207 . . . . 1.8200000000000001 108.791 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.97 -41.28 91.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.40000000000000002 109.007 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 mt -69.96 -39.7 75.86 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.878 -0.729 . . . . 1.0700000000000001 109.186 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.98 -20.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.166 -0.959 . . . . 1.0900000000000001 110.561 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.47 17.82 9.44 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.0 -1.063 . . . . 1.0900000000000001 109.907 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.25 32.52 10.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.959 -1.088 . . . . 2.23 110.151 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt 60.0 20.08 9.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.746 . . . . 2.7999999999999998 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -67.96 111.5 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.817 -1.177 . . . . 1.8 108.072 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.39 -40.69 97.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.88 112.641 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.86 -39.91 76.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.523 -1.361 . . . . 0.73999999999999999 109.663 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.96 -39.99 75.7 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.929 -1.108 . . . . 1.2 108.73 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.02 -50.04 70.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.99 . . . . 0.44 110.096 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -61.27 -44.46 97.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 3.3399999999999999 110.548 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.413 ' O ' ' OD2' ' B' ' 65' ' ' ASP . 98.9 mt-10 -65.03 -38.1 89.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.776 -1.203 . . . . 2.3799999999999999 108.866 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.445 ' O ' ' OG1' ' B' ' 66' ' ' THR . 65.2 t90 -63.83 -48.27 77.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.40999999999999998 111.013 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.05 -46.46 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.909 -1.119 . . . . 1.0700000000000001 109.989 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -61.73 -47.17 86.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 2.6000000000000001 109.707 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' B' ' 61' ' ' GLU . 71.3 m-20 -69.93 -28.35 65.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.906 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 54.2 m -80.54 -31.6 36.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 1.1000000000000001 111.737 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.8 p -133.3 -23.2 1.92 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.326 -1.484 . . . . 0.95999999999999996 111.919 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.71 34.11 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 109.237 -1.545 . . . . 0.37 109.237 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.55 154.53 1.85 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.091 -1.241 . . . . 1.0900000000000001 109.39 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.74 171.96 9.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 2.3700000000000001 110.177 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.75 75.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.646 -0.658 . . . . 1.1100000000000001 110.417 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -72.89 -40.69 65.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.859 -1.151 . . . . 2.9700000000000002 110.128 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.2 mm100 -67.92 -35.2 78.03 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.248 -0.907 . . . . 2.6200000000000001 110.354 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.27 -38.37 81.66 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.179 -0.951 . . . . 1.8899999999999999 110.074 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.92 -36.53 77.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.86 -1.15 . . . . 3.3199999999999998 109.531 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -68.6 -40.03 80.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.778 -1.201 . . . . 0.40000000000000002 110.747 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.2 m -70.06 -40.37 75.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.95999999999999996 110.123 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.75 -59.97 4.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.699 -1.251 . . . . 0.5 109.525 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.75 87.42 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.344 -1.102 . . . . 0.27000000000000002 110.344 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.73 -46.41 63.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.725 -1.456 . . . . 0.93999999999999995 109.337 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.6 -40.43 69.86 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.935 -1.106 . . . . 1.0900000000000001 108.628 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.24 -39.99 95.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.98 . . . . 3.1899999999999999 110.316 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.4 mt-10 -69.8 -37.76 76.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.9099999999999999 110.167 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.549 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 87.0 t90 -60.04 -42.72 95.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.5 -1.375 . . . . 0.40000000000000002 107.866 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' B' ' 89' ' ' LEU . 89.4 m -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.96999999999999997 109.748 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.02 -32.55 69.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.049 -1.032 . . . . 0.55000000000000004 109.912 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.2 -34.11 14.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.135 -0.978 . . . . 1.1299999999999999 111.06 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.549 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 92.4 m-85 -107.41 2.02 24.03 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.195 -0.941 . . . . 1.24 111.465 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' B' ' 85' ' ' CYS . 54.7 tp . . . . . 0 N--CA 1.495 1.785 0 O-C-N 120.695 -1.253 . . . . 1.8300000000000001 109.321 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.714 0.769 . . . . 1.98 109.314 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.74 -26.46 63.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.687 -0.633 . . . . 2.6000000000000001 110.074 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -36.0 76.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.001 -1.062 . . . . 2.5099999999999998 109.567 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.404 ' HE2' ' NH2' ' A' ' 8' ' ' ARG . 67.8 t60 -58.86 -50.01 75.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.51000000000000001 110.127 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' NH2' ' HE2' ' A' ' 7' ' ' HIS . 3.6 mmp_? -69.96 -32.83 71.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.044 -1.035 . . . . 3.7200000000000002 109.751 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.47 -40.02 89.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.234 -0.917 . . . . 0.76000000000000001 109.628 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.97 -49.04 76.28 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.246 -0.909 . . . . 0.5 109.792 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.21 4.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.232 -0.917 . . . . 1.1799999999999999 111.863 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.57 -18.92 18.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.686 -1.259 . . . . 1.1799999999999999 110.359 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 1.4 pp20? -155.83 152.26 23.6 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 1.26 108.596 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 48.5 Cg_exo -35.36 155.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.174 1.916 . . . . 0.53000000000000003 112.034 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.42 ' H ' ' HG2' ' A' ' 15' ' ' MET . 11.4 ptm -90.92 -23.08 20.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.145 -0.972 . . . . 1.1399999999999999 110.484 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.09 -136.35 20.58 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.984 -1.073 . . . . 0.41999999999999998 110.715 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.06 28.37 8.67 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.523 -0.986 . . . . 0.84999999999999998 111.02 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.6 148.34 56.63 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 118.557 -1.257 . . . . 2.4900000000000002 107.756 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.19 159.34 19.12 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.619 2.213 . . . . 0.39000000000000001 113.183 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 22' ' ' SER . 4.3 p -59.63 -48.52 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 1.1200000000000001 110.576 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.95 -1.87 0.07 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.435 -1.066 . . . . 0.27000000000000002 110.435 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.553 ' H ' ' C ' ' A' ' 20' ' ' VAL . 10.6 p -83.3 -26.42 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.385 . . . . 1.75 109.973 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.65 137.29 58.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 1.05 110.296 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -65.91 132.63 49.08 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.789 0.804 . . . . 1.0600000000000001 110.234 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.95 -18.1 56.29 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.003 -1.639 . . . . 0.23000000000000001 109.003 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.88 114.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.827 -1.175 . . . . 1.0800000000000001 107.827 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.1 177.58 38.29 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.458 -1.457 . . . . 0.31 109.458 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -58.83 -40.14 83.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -1.125 . . . . 2.0099999999999998 109.494 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.22 -48.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.042 -1.037 . . . . 1.1399999999999999 109.42 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.41 -39.99 81.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 1.1299999999999999 109.212 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.03 96.42 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.236 -1.546 . . . . 0.34999999999999998 109.236 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.535 ' NZ ' ' OE2' ' A' ' 36' ' ' GLU . 14.7 tmtt? -61.36 -40.0 92.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.338 -1.096 . . . . 3.2200000000000002 110.775 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.04 -40.1 87.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.736 -1.227 . . . . 2.1000000000000001 109.986 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.58 -38.04 83.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.923 -1.11 . . . . 1.0800000000000001 108.893 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.424 -0.91 . . . . 1.6699999999999999 108.992 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 32' ' ' LYS . 98.9 mt-10 -68.06 -18.62 64.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 2.0 108.822 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -89.97 2.01 55.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.46 -0.775 . . . . 3.1499999999999999 109.859 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.49 5.18 42.89 Favored Glycine 0 N--CA 1.502 3.077 0 O-C-N 121.115 -0.991 . . . . 0.47999999999999998 112.18 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.7 76.97 1.32 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.694 -1.474 . . . . 0.38 109.141 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -75.48 -8.86 57.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.40999999999999998 110.437 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.16 160.02 40.78 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.079 -1.013 . . . . 2.1600000000000001 110.263 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.84 92.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.558 -0.714 . . . . 1.03 112.512 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 7.5 p90 -58.73 -17.74 25.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.515 -1.366 . . . . 0.92000000000000004 110.555 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -80.01 -32.71 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.794 -1.191 . . . . 1.0700000000000001 108.315 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.06 -39.1 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 1.0600000000000001 108.237 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 tp -59.98 -36.38 77.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.866 -1.161 . . . . 1.1599999999999999 107.866 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.52 97.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.20000000000000001 110.02 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.98 -40.03 87.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.245 . . . . 1.8200000000000001 109.035 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.96 -39.95 87.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.373 -0.973 . . . . 0.40000000000000002 108.373 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.053 -0.721 . . . . 1.0900000000000001 109.053 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.22 -23.97 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.246 -0.909 . . . . 1.0900000000000001 111.001 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.37 17.61 11.06 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.045 -1.034 . . . . 1.0900000000000001 110.154 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' B' ' 38' ' ' GLY . 12.7 mptt 52.47 29.31 6.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.944 -1.098 . . . . 2.2200000000000002 109.828 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.03 19.94 9.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 2.7999999999999998 110.255 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.23 117.75 9.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.511 -1.368 . . . . 1.8 107.683 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.11 -40.95 97.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.311 -0.868 . . . . 0.87 112.99 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 60' ' ' ARG . 7.6 m-20 -69.68 -39.93 76.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.669 -1.27 . . . . 0.72999999999999998 110.115 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.3 mt -69.95 -39.99 75.71 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.007 -1.077 . . . . 1.2 109.036 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.46 -49.91 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.44 109.71 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' A' ' 57' ' ' ASP . 87.7 mtm180 -60.37 -45.79 92.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.354 -0.841 . . . . 3.3399999999999999 110.622 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.64 -39.77 94.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.931 -1.105 . . . . 2.3700000000000001 108.788 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 66' ' ' THR . 63.4 t90 -65.51 -48.76 71.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.40999999999999998 111.362 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.5 tp -67.42 -47.09 71.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 1.0800000000000001 110.095 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.01 -45.95 92.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.38 -0.825 . . . . 2.6099999999999999 109.714 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.03 -27.33 64.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.8999999999999999 109.945 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 97.0 m -80.59 -33.9 35.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 1.1100000000000001 111.526 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.2 p -130.59 -27.27 2.16 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.555 -1.34 . . . . 0.96999999999999997 112.083 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.16 22.64 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.171 -1.572 . . . . 0.38 109.171 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 153.1 2.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -1.196 . . . . 1.1000000000000001 109.618 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.6 172.96 8.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.115 -0.991 . . . . 2.3700000000000001 109.715 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.23 72.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 1.1200000000000001 111.025 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.1 -39.71 63.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.711 -1.243 . . . . 2.9700000000000002 110.05 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.5 mm100 -67.38 -39.88 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 2.6200000000000001 110.694 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -67.52 -37.51 82.89 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.288 -0.882 . . . . 1.8899999999999999 109.958 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.45 ' HG2' HH11 ' A' ' 75' ' ' ARG . 25.7 mtt-85 -60.41 -37.24 80.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.114 . . . . 3.3199999999999998 109.632 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.78 -39.9 84.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.571 -1.33 . . . . 0.40000000000000002 110.552 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 88.8 m -67.94 -40.0 83.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.95999999999999996 109.806 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.43 -60.05 4.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.879 -1.138 . . . . 0.5 109.954 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.66 -34.28 88.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.448 -1.061 . . . . 0.27000000000000002 110.448 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.25 -47.33 57.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -1.202 . . . . 0.93999999999999995 109.804 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.61 -40.07 73.38 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.695 -1.202 . . . . 1.0900000000000001 108.328 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -63.01 -40.07 96.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 3.1800000000000002 110.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -69.41 -37.81 77.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.02 -1.05 . . . . 1.9099999999999999 110.474 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.487 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 84.6 t90 -59.97 -43.86 94.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.39 -1.444 . . . . 0.40000000000000002 107.363 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.3 m -60.6 -40.67 92.64 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.894 -0.78 . . . . 0.96999999999999997 108.894 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.631 -0.668 . . . . 0.55000000000000004 109.695 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -36.78 16.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 1.1200000000000001 110.125 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 83.9 m-85 . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.35 -0.844 . . . . 1.24 110.032 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.768 0.794 . . . . 1.97 109.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.81 -26.53 64.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.702 -0.624 . . . . 2.5899999999999999 110.094 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.13 -35.73 75.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.085 . . . . 2.5 109.575 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.409 ' HE2' ' NH2' ' B' ' 8' ' ' ARG . 67.6 t60 -58.96 -49.94 75.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.51000000000000001 110.213 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.409 ' NH2' ' HE2' ' B' ' 7' ' ' HIS . 3.6 mmp_? -70.06 -32.76 71.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 3.73 109.749 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.45 -39.92 89.14 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.483 -0.887 . . . . 0.76000000000000001 109.743 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.0 -49.16 75.76 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.263 -0.898 . . . . 0.5 109.71 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.12 4.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.144 -0.973 . . . . 1.1799999999999999 111.834 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.29 -19.0 18.84 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.661 -1.274 . . . . 1.1799999999999999 110.418 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' B' ' 14' ' ' PRO . 1.4 pp20? -155.84 152.34 23.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.955 . . . . 1.27 108.63 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' OE1' ' B' ' 13' ' ' GLU . 48.7 Cg_exo -35.37 155.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.266 1.977 . . . . 0.53000000000000003 111.989 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 11.3 ptm -90.89 -23.25 20.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 1.1299999999999999 110.432 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.33 21.13 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.894 -1.128 . . . . 0.40999999999999998 110.7 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.2 28.72 8.35 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.634 -0.921 . . . . 0.83999999999999997 111.021 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.77 148.4 58.18 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.648 -1.283 . . . . 2.4900000000000002 107.608 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.18 159.44 18.84 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.639 2.226 . . . . 0.38 113.207 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' B' ' 22' ' ' SER . 4.2 p -59.79 -48.6 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 1.1200000000000001 110.512 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.7 -2.14 0.07 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.443 -1.063 . . . . 0.27000000000000002 110.443 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.563 ' H ' ' C ' ' B' ' 20' ' ' VAL . 10.6 p -83.09 -26.43 31.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.787 -1.419 . . . . 1.75 110.055 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.79 137.29 58.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.27 -0.894 . . . . 1.0600000000000001 110.273 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.429 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -65.82 132.63 49.16 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.82 0.819 . . . . 1.05 110.175 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.99 -18.31 55.95 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.902 -1.679 . . . . 0.22 108.902 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -101.68 114.78 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.848 -1.167 . . . . 1.0800000000000001 107.848 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.16 177.65 38.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.493 -1.443 . . . . 0.29999999999999999 109.493 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -58.95 -40.01 83.39 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.337 -1.096 . . . . 2.0 109.48 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.47 -48.9 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 1.1399999999999999 109.333 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.51 -39.9 81.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 1.1299999999999999 109.178 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.98 96.43 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.251 -1.54 . . . . 0.35999999999999999 109.251 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.53 ' NZ ' ' OE2' ' B' ' 36' ' ' GLU . 14.7 tmtt? -61.25 -39.94 92.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 3.2200000000000002 110.798 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.2 -40.02 86.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.687 -1.258 . . . . 2.1200000000000001 109.977 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -60.74 -38.01 83.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.923 -1.11 . . . . 1.0800000000000001 108.889 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -40.51 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.429 -0.909 . . . . 1.6799999999999999 108.973 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' B' ' 32' ' ' LYS . 98.9 mt-10 -68.01 -18.61 64.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 1.99 108.88 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -90.03 2.14 55.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.818 . . . . 3.1499999999999999 109.793 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.434 ' O ' ' NZ ' ' A' ' 53' ' ' LYS . . . 104.4 5.26 43.06 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.246 -0.978 . . . . 0.48999999999999999 112.154 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.72 76.89 1.31 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.49 . . . . 0.38 109.144 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -75.43 -8.89 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.104 -0.997 . . . . 0.40999999999999998 110.522 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.13 159.95 40.93 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.067 -1.021 . . . . 2.1499999999999999 110.162 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.93 93.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.647 -0.658 . . . . 1.03 112.542 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.466 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 7.4 p90 -58.66 -17.77 25.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.532 -1.355 . . . . 0.92000000000000004 110.614 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -79.9 -32.76 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.796 -1.19 . . . . 1.0800000000000001 108.286 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 77.2 t -76.0 -39.13 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.216 -1.031 . . . . 1.0700000000000001 108.216 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 tp -60.06 -36.2 76.82 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.876 -1.157 . . . . 1.1499999999999999 107.876 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.68 97.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.028 -1.229 . . . . 0.19 110.028 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.9 -40.02 87.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.094 -1.239 . . . . 1.8200000000000001 109.154 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.95 -40.07 87.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.297 -1.001 . . . . 0.40000000000000002 108.297 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.082 -0.71 . . . . 1.0700000000000001 109.082 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.29 -23.99 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.357 -0.84 . . . . 1.0900000000000001 110.973 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.33 17.58 11.05 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.945 -1.097 . . . . 1.0900000000000001 110.164 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mptt 52.72 29.11 7.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.921 -1.112 . . . . 2.23 109.818 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.0 19.99 9.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.416 -0.803 . . . . 2.7999999999999998 110.208 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.33 117.57 9.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.318 . . . . 1.8 107.739 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.0 -40.92 97.45 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.075 0.769 . . . . 0.88 113.075 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' B' ' 60' ' ' ARG . 7.6 m-20 -69.65 -39.98 76.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.535 -1.353 . . . . 0.73999999999999999 110.056 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.98 -40.0 75.62 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.01 -1.076 . . . . 1.2 108.94 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.48 -49.96 73.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.44 109.68 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' B' ' 57' ' ' ASP . 87.8 mtm180 -60.4 -45.54 93.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.407 -0.808 . . . . 3.3399999999999999 110.62 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.77 -39.78 94.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.957 -1.09 . . . . 2.3799999999999999 108.756 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.446 ' O ' ' OG1' ' B' ' 66' ' ' THR . 63.0 t90 -65.53 -48.75 71.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.40999999999999998 111.383 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -67.26 -47.19 71.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.007 -1.058 . . . . 1.0700000000000001 110.09 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.03 -45.94 92.76 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.389 -0.819 . . . . 2.6000000000000001 109.787 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.03 -27.34 64.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.445 -0.784 . . . . 1.8999999999999999 109.884 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 96.8 m -80.54 -33.84 35.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 1.1000000000000001 111.574 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.1 p -130.63 -27.35 2.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.595 -1.316 . . . . 0.95999999999999996 112.027 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 14.09 22.59 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.154 -1.578 . . . . 0.37 109.154 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.01 153.24 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -1.185 . . . . 1.0900000000000001 109.654 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.62 172.96 8.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.174 -0.954 . . . . 2.3700000000000001 109.728 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.48 -33.34 72.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 1.1100000000000001 110.959 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.02 -39.67 63.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.66 -1.275 . . . . 2.9700000000000002 110.049 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.6 mm100 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 2.6200000000000001 110.675 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.8 t -67.5 -37.48 82.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.851 . . . . 1.8899999999999999 110.004 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' B' ' 75' ' ' ARG . 25.2 mtt-85 -60.36 -37.33 80.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 3.3199999999999998 109.584 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -67.65 -39.93 84.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.698 -1.251 . . . . 0.40000000000000002 110.588 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 86.8 m -67.93 -39.99 83.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.854 -1.154 . . . . 0.95999999999999996 109.809 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.39 -59.98 4.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.95 -1.094 . . . . 0.5 109.967 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.57 -34.52 88.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.452 -1.059 . . . . 0.27000000000000002 110.452 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 49.4 t -71.14 -47.22 59.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -1.179 . . . . 0.93999999999999995 109.832 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.68 -40.13 73.12 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.716 -1.194 . . . . 1.0900000000000001 108.326 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -63.03 -40.1 96.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 3.1899999999999999 109.93 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -69.47 -37.6 77.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.054 -1.029 . . . . 1.9099999999999999 110.482 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.484 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 84.8 t90 -60.02 -43.86 94.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.456 -1.403 . . . . 0.40000000000000002 107.318 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 51.6 m -60.65 -40.66 92.83 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.93 -0.767 . . . . 0.96999999999999997 108.93 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.96 -38.19 85.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.615 -0.678 . . . . 0.55000000000000004 109.626 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.8 -37.75 16.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 1.1299999999999999 110.075 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 85.2 m-85 -104.34 -87.69 0.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.901 . . . . 1.24 110.413 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.133 -0.937 . . . . 1.8300000000000001 109.711 -178.544 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.641 0.734 . . . . 1.98 109.15 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -62.16 -22.61 66.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.744 -0.597 . . . . 2.6000000000000001 110.648 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.29 -39.26 89.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 2.5099999999999998 108.998 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -60.1 -50.28 74.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.51000000000000001 110.806 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 8' ' ' ARG . 20.5 mtt-85 -69.94 -35.59 74.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.998 -1.064 . . . . 3.7200000000000002 109.85 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -66.96 -39.79 87.33 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.436 -0.79 . . . . 0.76000000000000001 109.529 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 50.7 t80 -65.25 -45.5 84.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.818 . . . . 0.5 110.194 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.62 5.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.007 -1.058 . . . . 1.1799999999999999 111.55 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.957 -1.089 . . . . 1.1799999999999999 110.319 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.0 pt-20 -152.06 153.15 30.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.374 -0.973 . . . . 1.26 108.374 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 13' ' ' GLU . 58.0 Cg_exo -37.29 155.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.944 1.763 . . . . 0.53000000000000003 111.641 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.522 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 12.6 ptm -92.75 -28.9 16.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 1.1399999999999999 109.968 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.65 -134.99 46.29 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.422 -1.071 . . . . 0.41999999999999998 110.422 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.5 34.5 3.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.64 -0.918 . . . . 0.84999999999999998 110.061 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -58.81 148.76 67.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 2.4900000000000002 108.695 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.81 155.93 35.48 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.086 1.857 . . . . 0.39000000000000001 112.15 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' SER . 13.8 p -58.31 -41.9 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.693 0.759 . . . . 1.1200000000000001 110.167 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -61.51 -2.25 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.103 -1.199 . . . . 0.27000000000000002 110.103 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 20' ' ' VAL . 37.7 t -81.59 -21.17 38.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.728 -1.454 . . . . 1.75 108.919 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.39 138.52 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.369 -0.832 . . . . 1.05 109.652 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.428 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -64.17 136.98 57.72 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.948 -0.701 . . . . 1.0600000000000001 109.578 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 -18.41 56.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.572 -1.411 . . . . 0.23000000000000001 109.572 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 mm -99.52 112.0 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.715 -1.217 . . . . 1.0800000000000001 107.715 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.89 -179.05 36.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.649 -1.38 . . . . 0.31 109.649 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 mp0 -57.28 -40.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -1.119 . . . . 2.0099999999999998 109.532 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.9 -45.87 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 1.1399999999999999 109.32 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.89 -39.59 83.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 1.1299999999999999 109.39 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.82 -39.96 96.08 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.96 -1.656 . . . . 0.34999999999999998 108.96 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.91 -39.97 96.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 3.2200000000000002 109.72 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.92 -44.1 77.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 2.1000000000000001 108.809 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.1 mt -64.84 -40.61 95.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 1.0800000000000001 108.64 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.14 -44.15 95.18 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.642 -0.661 . . . . 1.6699999999999999 109.55 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.21 -19.58 66.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.398 -0.814 . . . . 2.0 108.917 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -90.39 3.99 52.19 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.521 -0.737 . . . . 3.1499999999999999 109.981 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.81 48.35 Favored Glycine 0 N--CA 1.502 3.048 0 O-C-N 121.167 -0.958 . . . . 0.47999999999999998 111.579 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -106.51 75.59 1.08 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.714 -1.462 . . . . 0.38 109.55 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.73 -9.9 59.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.074 -1.016 . . . . 0.40999999999999998 110.316 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.2 mmtm -134.87 156.67 48.53 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.203 -0.936 . . . . 2.1600000000000001 110.001 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.65 94.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.63 -0.669 . . . . 1.03 111.233 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 23.6 p90 -58.59 -20.07 43.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.704 -1.248 . . . . 0.92000000000000004 110.951 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -78.58 -34.51 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.643 -1.286 . . . . 1.0700000000000001 108.022 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.32 -38.92 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.187 -1.042 . . . . 1.0600000000000001 108.187 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.09 -38.8 84.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.296 -1.001 . . . . 1.1599999999999999 108.296 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.84 97.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.817 -1.313 . . . . 0.20000000000000001 109.817 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.275 . . . . 1.8200000000000001 109.341 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -59.22 -40.09 84.76 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.296 -1.001 . . . . 0.40000000000000002 108.296 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.08 -38.72 79.16 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.377 -0.972 . . . . 1.0900000000000001 108.377 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.14 -24.61 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 1.0900000000000001 110.251 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.24 16.14 17.39 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.118 -0.989 . . . . 1.0900000000000001 110.678 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.54 40.4 15.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.726 -1.234 . . . . 2.2200000000000002 110.719 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 59.19 19.62 7.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 2.7999999999999998 109.843 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.31 107.01 2.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.743 -1.223 . . . . 1.8 107.994 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.511 ' CD ' HH21 ' A' ' 60' ' ' ARG . 88.1 tt0 -61.75 -40.5 95.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.501 -0.75 . . . . 0.87 112.562 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.63 -40.07 76.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.534 -1.353 . . . . 0.72999999999999998 109.728 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.66 -39.99 76.73 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.726 -1.19 . . . . 1.2 109.199 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.31 -50.14 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.44 109.483 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.511 HH21 ' CD ' ' A' ' 56' ' ' GLU . 34.1 mtt-85 -60.88 -46.12 91.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.372 -0.83 . . . . 3.3399999999999999 110.682 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.04 -38.31 90.59 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.819 -1.175 . . . . 2.3700000000000001 108.841 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.443 ' O ' ' OG1' ' A' ' 66' ' ' THR . 50.8 t90 -66.8 -45.25 78.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.40999999999999998 110.396 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.27 -48.91 68.92 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.149 -0.969 . . . . 1.0800000000000001 110.046 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -62.0 -44.56 96.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.242 -0.911 . . . . 2.6099999999999999 109.257 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.59 -32.39 71.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.567 -0.708 . . . . 1.8999999999999999 109.739 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 86.5 m -79.97 -31.86 39.86 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 1.1100000000000001 111.345 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.32 -30.15 1.53 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.572 -1.33 . . . . 0.96999999999999997 112.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.12 19.89 Favored Glycine 0 N--CA 1.501 3.025 0 N-CA-C 109.196 -1.561 . . . . 0.38 109.196 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.0 152.9 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.242 . . . . 1.1000000000000001 109.467 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -91.9 175.18 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.071 -1.018 . . . . 2.3700000000000001 109.623 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.81 77.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 1.1200000000000001 110.103 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -73.79 -39.97 63.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.109 -0.994 . . . . 2.9700000000000002 109.995 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.85 -36.96 83.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 2.6200000000000001 110.539 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 p -69.22 -37.17 77.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.133 -0.979 . . . . 1.8899999999999999 110.027 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.03 -37.61 80.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.831 -1.168 . . . . 3.3199999999999998 109.707 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.05 -40.0 87.02 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.746 -1.221 . . . . 0.40000000000000002 110.442 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 61.5 m -70.04 -42.5 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.726 -1.234 . . . . 0.95999999999999996 110.398 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -60.14 -60.17 4.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.57 -1.331 . . . . 0.5 110.113 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.86 -34.52 90.03 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.334 -1.106 . . . . 0.27000000000000002 110.334 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.71 -47.91 57.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.726 -1.455 . . . . 0.93999999999999995 109.781 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.11 -40.03 75.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.798 -1.161 . . . . 1.0900000000000001 108.345 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' HG2' HH11 ' A' ' 82' ' ' ARG . 4.6 ttt-85 -61.36 -40.11 93.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 3.1800000000000002 109.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -68.8 -37.42 79.24 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 1.9099999999999999 109.878 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.522 ' CZ2' ' SD ' ' A' ' 15' ' ' MET . 80.4 t90 -59.65 -45.67 91.32 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.94 -1.504 . . . . 0.40000000000000002 106.94 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -61.83 -41.52 97.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.716 -0.615 . . . . 0.96999999999999997 109.46 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -60.27 -37.24 79.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.2 -0.937 . . . . 0.55000000000000004 109.954 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.1 -35.87 19.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 1.1200000000000001 109.888 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.363 -0.836 . . . . 1.24 110.395 -178.563 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.591 0.71 . . . . 1.97 109.233 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.94 -22.75 65.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.703 -0.623 . . . . 2.5899999999999999 110.671 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -61.21 -39.24 89.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.017 -1.052 . . . . 2.5 108.852 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -60.1 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.51000000000000001 110.746 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' B' ' 8' ' ' ARG . 20.8 mtt-85 -70.05 -35.65 74.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.903 -1.123 . . . . 3.73 109.758 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -66.73 -40.03 88.2 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.638 -0.664 . . . . 0.76000000000000001 109.642 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.431 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 49.7 t80 -64.99 -45.91 83.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.5 110.25 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -88.38 5.71 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.16 -0.962 . . . . 1.1799999999999999 111.48 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.92 -15.98 17.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.881 -1.137 . . . . 1.1799999999999999 110.26 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -152.11 153.26 30.98 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 1.27 108.352 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -37.35 155.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.998 1.798 . . . . 0.53000000000000003 111.584 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.516 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 12.5 ptm -92.77 -28.85 16.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 1.1299999999999999 110.035 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.71 -135.03 46.47 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.357 -1.097 . . . . 0.40999999999999998 110.357 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.61 34.55 3.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.468 -1.019 . . . . 0.83999999999999997 109.944 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -58.75 148.63 67.21 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 2.4900000000000002 108.601 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.76 155.82 35.75 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.06 1.84 . . . . 0.38 112.175 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' B' ' 22' ' ' SER . 14.0 p -58.29 -41.84 82.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.496 -0.753 . . . . 1.1200000000000001 110.093 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.417 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -61.33 -2.31 2.96 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.119 -1.192 . . . . 0.27000000000000002 110.119 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 20' ' ' VAL . 38.7 t -81.73 -21.1 38.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.895 -1.356 . . . . 1.75 108.914 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.31 138.52 58.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 1.0600000000000001 109.676 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.434 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.36 136.94 57.61 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.743 -0.783 . . . . 1.05 109.744 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 -18.34 56.91 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.604 -1.398 . . . . 0.22 109.604 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.52 111.87 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.709 -1.219 . . . . 1.0800000000000001 107.709 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.87 36.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.731 -1.348 . . . . 0.29999999999999999 109.731 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mp0 -57.48 -39.86 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -1.07 . . . . 2.0 109.567 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.05 -45.89 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 1.1399999999999999 109.344 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.88 -39.54 83.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -0.889 . . . . 1.1299999999999999 109.518 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.92 -39.77 95.98 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.915 -1.674 . . . . 0.35999999999999999 108.915 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.05 -40.04 96.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 3.2200000000000002 109.771 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.74 -43.99 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.074 -1.016 . . . . 2.1200000000000001 108.962 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.01 -40.4 94.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 1.0800000000000001 108.699 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.19 -44.27 95.23 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.034 -0.666 . . . . 1.6799999999999999 109.478 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.16 -19.71 66.11 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 1.99 109.016 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -90.35 3.93 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.654 -0.654 . . . . 3.1499999999999999 109.925 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 7.4 48.41 Favored Glycine 0 N--CA 1.502 3.08 0 O-C-N 121.095 -1.003 . . . . 0.48999999999999999 111.697 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.26 75.45 1.09 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.866 -1.373 . . . . 0.38 109.658 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.76 -10.0 59.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.40999999999999998 110.36 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.473 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.3 mmtm -134.68 156.87 48.01 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.136 -0.978 . . . . 2.1499999999999999 109.886 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.71 94.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.754 -0.591 . . . . 1.03 111.242 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 24.0 p90 -58.56 -20.01 42.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.92000000000000004 111.042 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 t -78.68 -34.47 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 1.0800000000000001 107.916 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 74.0 t -76.23 -39.1 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.164 -1.05 . . . . 1.0700000000000001 108.164 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.95 -39.02 84.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.305 -0.998 . . . . 1.1499999999999999 108.305 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -41.05 97.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.845 -1.302 . . . . 0.19 109.845 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.04 -41.94 93.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.112 -1.228 . . . . 1.8200000000000001 109.343 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.26 -40.0 84.62 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 0.40000000000000002 108.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.17 -38.76 78.9 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.434 -0.95 . . . . 1.0700000000000001 108.434 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.16 -24.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.304 -0.872 . . . . 1.0900000000000001 110.194 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.34 16.15 17.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.108 -0.995 . . . . 1.0900000000000001 110.784 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.41 40.64 15.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.698 -1.252 . . . . 2.23 110.73 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 58.93 19.74 7.42 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.468 -0.77 . . . . 2.7999999999999998 109.853 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.28 107.04 2.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.698 -1.251 . . . . 1.8 107.729 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' B' ' 60' ' ' ARG . 88.2 tt0 -61.63 -40.52 95.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.429 -0.794 . . . . 0.88 112.584 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.75 -39.58 76.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.73999999999999999 109.855 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.96 -39.96 75.69 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.685 -1.206 . . . . 1.2 109.025 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.31 -50.32 68.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.44 109.457 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' B' ' 56' ' ' GLU . 34.0 mtt-85 -60.76 -46.19 91.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.815 . . . . 3.3399999999999999 110.572 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.92 -38.34 90.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.854 -1.154 . . . . 2.3799999999999999 108.933 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.459 ' O ' ' OG1' ' B' ' 66' ' ' THR . 51.2 t90 -66.79 -45.24 79.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.40999999999999998 110.415 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.32 -48.79 69.17 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.266 -0.896 . . . . 1.0700000000000001 109.989 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.391 -0.818 . . . . 2.6000000000000001 109.249 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.43 -32.63 71.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.58 -0.7 . . . . 1.8999999999999999 109.684 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 87.5 m -79.66 -31.92 41.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 1.1000000000000001 111.471 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.41 -30.0 1.53 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.436 -1.415 . . . . 0.95999999999999996 112.193 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.73 15.02 19.91 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.138 -1.585 . . . . 0.37 109.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.77 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.245 . . . . 1.0900000000000001 109.416 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -91.83 175.37 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 2.3700000000000001 109.731 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.96 78.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.483 -0.761 . . . . 1.1100000000000001 110.122 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -73.81 -39.78 63.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 2.9700000000000002 109.99 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.03 -36.88 83.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 2.6200000000000001 110.545 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 18.8 p -69.25 -37.23 77.84 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.171 -0.956 . . . . 1.8899999999999999 110.003 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -37.88 80.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 3.3199999999999998 109.593 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.98 -39.84 87.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.502 -1.374 . . . . 0.40000000000000002 110.441 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 61.2 m -70.16 -42.62 72.26 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.69 -1.256 . . . . 0.95999999999999996 110.401 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -59.99 -60.12 4.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.575 -1.328 . . . . 0.5 110.068 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.95 -34.47 90.0 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.368 -1.093 . . . . 0.27000000000000002 110.368 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.52 -48.1 57.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.793 -1.416 . . . . 0.93999999999999995 109.84 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 97.0 mt -70.04 -39.96 75.43 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.799 -1.16 . . . . 1.0900000000000001 108.435 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' B' ' 82' ' ' ARG . 4.7 ttt-85 -61.47 -40.0 92.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 3.1899999999999999 109.515 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.95 -37.23 78.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.379 -0.826 . . . . 1.9099999999999999 109.91 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.516 ' CZ2' ' SD ' ' B' ' 15' ' ' MET . 80.8 t90 -60.0 -45.68 91.93 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.972 -1.492 . . . . 0.40000000000000002 106.972 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 32.7 m -61.83 -41.22 97.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.69 -0.631 . . . . 0.96999999999999997 109.527 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.35 -37.18 79.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.55000000000000004 109.939 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.38 -36.36 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 1.1299999999999999 109.824 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -104.57 -86.24 0.46 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -0.886 . . . . 1.24 110.777 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 11.5 tp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.106 -0.95 . . . . 1.8300000000000001 109.117 -179.246 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.805 0.812 . . . . 1.98 109.339 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.85 -30.14 68.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.795 -0.566 . . . . 2.6000000000000001 110.598 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.11 -33.67 72.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 2.5099999999999998 108.965 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 23.8 t60 -59.92 -48.75 80.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.51000000000000001 110.088 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -69.88 -34.06 73.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.157 -0.964 . . . . 3.7200000000000002 109.888 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.11 -39.84 82.69 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.383 -0.823 . . . . 0.76000000000000001 109.61 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.4 t80 -61.91 -47.3 85.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.429 -0.794 . . . . 0.5 110.107 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 m -82.19 9.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.154 -0.966 . . . . 1.1799999999999999 110.12 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.94 -16.4 15.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.156 -0.965 . . . . 1.1799999999999999 110.944 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -156.63 152.84 23.42 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.115 . . . . 1.26 109.198 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -40.33 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.702 1.601 . . . . 0.53000000000000003 110.839 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.5 ptp -90.37 -24.76 20.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.825 -1.172 . . . . 1.1399999999999999 109.646 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.22 -136.72 45.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.704 -1.358 . . . . 0.41999999999999998 109.704 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.57 28.93 6.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -1.006 . . . . 0.84999999999999998 111.221 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -60.75 148.44 82.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.709 -1.244 . . . . 2.4900000000000002 107.802 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.19 163.33 32.11 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.151 1.901 . . . . 0.39000000000000001 112.801 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 22' ' ' SER . 8.0 p -58.14 -47.36 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.58 -0.7 . . . . 1.1200000000000001 110.391 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.13 -3.29 0.12 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.783 -0.927 . . . . 0.27000000000000002 110.783 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 20' ' ' VAL . 11.6 p -82.33 -25.3 34.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.799 -1.412 . . . . 1.75 109.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.54 137.82 58.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.708 0.766 . . . . 1.05 109.759 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.92 135.31 55.55 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.692 0.758 . . . . 1.0600000000000001 109.912 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 73' ' ' GLN . . . 96.98 -20.26 51.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.245 -1.542 . . . . 0.23000000000000001 109.245 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.425 HG21 HD12 ' A' ' 26' ' ' ILE . 37.6 mm -99.56 112.82 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.641 -1.244 . . . . 1.0800000000000001 107.641 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.1 177.76 43.06 Favored Glycine 0 N--CA 1.492 2.39 0 O-C-N 120.678 -1.264 . . . . 0.31 110.043 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -56.6 -39.94 74.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -1.033 . . . . 2.0099999999999998 109.643 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.76 -44.98 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.076 -1.015 . . . . 1.1399999999999999 109.496 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.35 -36.92 84.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 1.1299999999999999 109.466 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.82 97.43 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.816 -1.314 . . . . 0.34999999999999998 109.816 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -65.33 -37.03 85.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -1.219 . . . . 3.2200000000000002 109.736 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.59 -48.52 69.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.804 -1.185 . . . . 2.1000000000000001 109.372 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.99 -38.66 89.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 1.0800000000000001 108.448 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.04 -42.19 93.88 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.906 -0.717 . . . . 1.6699999999999999 109.296 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.23 -19.42 65.53 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.533 -0.914 . . . . 2.0 108.533 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 2.83 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.747 . . . . 3.1499999999999999 109.725 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.78 5.46 50.9 Favored Glycine 0 N--CA 1.503 3.132 0 C-N-CA 120.264 -0.969 . . . . 0.47999999999999998 111.856 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -106.56 77.07 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.899 -1.353 . . . . 0.38 108.942 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -79.36 -7.54 58.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.40999999999999998 110.929 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.05 158.58 44.03 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.053 -1.029 . . . . 2.1600000000000001 110.406 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -40.64 90.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.747 -0.595 . . . . 1.03 112.307 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.6 p90 -61.13 -18.49 58.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.499 -1.376 . . . . 0.92000000000000004 110.622 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -80.06 -31.03 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.876 -1.157 . . . . 1.0700000000000001 107.876 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.4 t -77.5 -37.41 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 1.0600000000000001 108.324 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.94 -35.67 75.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.638 -1.245 . . . . 1.1599999999999999 107.638 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.22 96.69 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.573 -1.411 . . . . 0.20000000000000001 109.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.15 -43.32 95.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.942 -1.328 . . . . 1.8200000000000001 109.096 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.98 -41.62 92.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.40000000000000002 109.019 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.94 -40.06 75.72 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.808 -0.757 . . . . 1.0900000000000001 108.966 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -66.11 -22.81 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.218 -0.926 . . . . 1.0900000000000001 110.448 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.95 17.05 9.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.204 -0.935 . . . . 1.0900000000000001 109.777 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.08 -1.013 . . . . 2.2200000000000002 110.346 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.699 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 64.3 mttm 58.85 19.44 7.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.714 -0.616 . . . . 2.7999999999999998 110.011 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -67.74 106.71 2.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.76 -1.213 . . . . 1.8 108.297 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.32 -41.3 98.42 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.406 -0.809 . . . . 0.87 112.631 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 92.5 m-20 -68.99 -39.94 79.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.789 -1.195 . . . . 0.72999999999999998 109.433 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -69.99 -39.9 75.62 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.032 -1.067 . . . . 1.2 108.614 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.26 -50.03 71.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.44 109.772 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.434 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.0 mtm180 -62.45 -44.6 96.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 3.3399999999999999 110.288 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.26 -38.34 90.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 2.3700000000000001 108.989 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.433 ' O ' ' OG1' ' A' ' 66' ' ' THR . 67.6 t90 -63.28 -49.57 73.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.263 -0.898 . . . . 0.40999999999999998 110.853 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 58.1 tp -65.3 -47.43 76.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.84 . . . . 1.0800000000000001 109.874 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -63.45 -45.25 91.72 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.402 -0.811 . . . . 2.6099999999999999 109.274 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -68.43 -34.06 75.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.418 0.628 . . . . 1.8999999999999999 109.592 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 89.7 m -79.72 -33.56 40.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -0.79 . . . . 1.1100000000000001 111.336 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 31.6 p -130.63 -28.95 1.99 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.503 -1.373 . . . . 0.96999999999999997 112.239 -177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.32 25.62 Favored Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.226 -1.55 . . . . 0.38 109.226 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.99 153.0 1.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.122 -1.222 . . . . 1.1000000000000001 109.337 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.08 172.57 8.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 2.3700000000000001 110.036 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.08 78.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 1.1200000000000001 110.487 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.06 -40.4 75.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.738 -1.226 . . . . 2.9700000000000002 109.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 25' ' ' GLY . 94.0 mm-40 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.452 -0.78 . . . . 2.6200000000000001 110.69 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p -66.34 -38.18 87.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.139 -0.975 . . . . 1.8899999999999999 110.039 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -60.17 -38.79 84.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.828 -1.17 . . . . 3.3199999999999998 109.341 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.27 -39.24 82.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.764 -1.21 . . . . 0.40000000000000002 110.444 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -68.09 -40.32 82.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.766 -1.209 . . . . 0.95999999999999996 109.476 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.44 -60.33 3.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.014 -1.054 . . . . 0.5 109.533 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.72 87.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.199 -1.16 . . . . 0.27000000000000002 110.199 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.21 -47.3 65.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.93999999999999995 109.638 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -69.97 -40.02 75.63 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.667 -1.213 . . . . 1.0900000000000001 108.591 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.699 HH12 ' NZ ' ' A' ' 54' ' ' LYS . 8.5 tpm_? -63.71 -41.93 98.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 3.1800000000000002 110.006 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 94.4 mt-10 -69.66 -39.65 76.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 1.9099999999999999 110.665 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 79.1 t90 -60.04 -41.91 93.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.316 -1.49 . . . . 0.40000000000000002 107.7 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -62.82 -40.51 97.63 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.975 -0.75 . . . . 0.96999999999999997 108.975 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD1' ' NH2' ' A' ' 82' ' ' ARG . 96.1 m-20 -60.27 -36.84 78.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.553 -0.717 . . . . 0.55000000000000004 109.905 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.66 -38.29 18.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 1.1200000000000001 109.952 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.602 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 76.3 m-85 . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.289 -0.882 . . . . 1.24 110.5 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.752 0.787 . . . . 1.97 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -59.88 -30.15 68.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.925 -0.484 . . . . 2.5899999999999999 110.521 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.07 -33.53 72.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -0.992 . . . . 2.5 109.034 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 23.9 t60 -59.86 -48.89 79.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.074 -1.016 . . . . 0.51000000000000001 110.139 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -69.85 -34.13 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.994 . . . . 3.73 109.882 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.12 -39.85 82.65 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.426 -0.797 . . . . 0.76000000000000001 109.664 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.1 t80 -61.83 -47.51 84.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.5 110.092 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.98 9.92 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.144 -0.972 . . . . 1.1799999999999999 110.242 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.97 -16.45 15.83 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.204 -0.935 . . . . 1.1799999999999999 110.951 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.64 152.83 23.36 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 1.27 109.14 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.25 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.701 1.6 . . . . 0.53000000000000003 110.966 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.6 ptp -90.4 -24.62 20.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.845 -1.159 . . . . 1.1299999999999999 109.658 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.09 -136.68 45.59 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.831 -1.308 . . . . 0.40999999999999998 109.831 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.8 29.04 6.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -1.076 . . . . 0.83999999999999997 111.124 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.72 148.41 82.23 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.667 -1.234 . . . . 2.4900000000000002 107.667 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.19 163.3 32.24 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.204 1.936 . . . . 0.38 112.794 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.525 ' C ' ' H ' ' B' ' 22' ' ' SER . 8.0 p -58.07 -47.47 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.466 0.65 . . . . 1.1200000000000001 110.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.11 -3.31 0.12 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.754 -0.939 . . . . 0.27000000000000002 110.754 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.525 ' H ' ' C ' ' B' ' 20' ' ' VAL . 11.5 p -82.23 -25.32 34.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.817 -1.402 . . . . 1.75 109.495 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.52 137.91 58.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 1.0600000000000001 109.768 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 135.45 55.65 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.795 0.807 . . . . 1.05 109.832 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' B' ' 73' ' ' GLN . . . 96.78 -20.03 52.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.326 -1.51 . . . . 0.22 109.326 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.79 112.72 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.669 -1.234 . . . . 1.0800000000000001 107.669 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.99 177.84 43.28 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.609 -1.282 . . . . 0.29999999999999999 110.108 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.74 -39.89 74.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 2.0 109.601 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.78 -44.9 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.008 -1.058 . . . . 1.1399999999999999 109.484 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.7 mt -66.35 -36.84 83.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 1.1299999999999999 109.472 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.79 97.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.76 -1.336 . . . . 0.35999999999999999 109.76 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -65.34 -36.92 85.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.074 -1.251 . . . . 3.2200000000000002 109.85 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.65 -48.61 68.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.708 -1.245 . . . . 2.1200000000000001 109.321 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.85 -38.67 89.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.06 -1.025 . . . . 1.0800000000000001 108.63 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.94 -42.41 93.93 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.933 -0.707 . . . . 1.6799999999999999 109.228 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -66.95 -19.59 65.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.579 -0.897 . . . . 1.99 108.579 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 3.0 54.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.452 -0.78 . . . . 3.1499999999999999 109.797 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.77 5.47 50.92 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.168 -0.957 . . . . 0.48999999999999999 111.836 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -106.3 77.0 1.18 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.772 -1.428 . . . . 0.38 109.071 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -79.33 -7.47 58.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.905 . . . . 0.40999999999999998 110.914 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.14 158.44 44.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.965 -1.084 . . . . 2.1499999999999999 110.498 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.72 90.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.628 -0.67 . . . . 1.03 112.389 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 7.6 p90 -60.96 -18.61 58.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.526 -1.359 . . . . 0.92000000000000004 110.584 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 16.8 t -79.88 -31.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.964 -1.124 . . . . 1.0800000000000001 107.964 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.61 -37.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.34 -0.985 . . . . 1.0700000000000001 108.34 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.11 -35.71 75.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.505 -1.294 . . . . 1.1499999999999999 107.505 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.33 96.73 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.706 -1.358 . . . . 0.19 109.706 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.03 -43.47 95.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.967 -1.314 . . . . 1.8200000000000001 108.971 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.0 -41.48 92.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.40000000000000002 108.964 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.01 -39.92 75.55 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.864 -0.734 . . . . 1.0700000000000001 109.064 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.37 -22.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 110.339 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -91.92 17.02 9.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.168 -0.958 . . . . 1.0900000000000001 109.734 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.998 -1.064 . . . . 2.23 110.327 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . 0.701 ' NZ ' HH12 ' B' ' 82' ' ' ARG . 64.3 mttm 58.66 19.63 6.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.729 -0.607 . . . . 2.7999999999999998 110.058 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.75 106.67 2.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.614 -1.304 . . . . 1.8 108.201 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.41 -41.3 98.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.379 -0.826 . . . . 0.88 112.523 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 92.3 m-20 -68.86 -39.84 79.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.886 -1.133 . . . . 0.73999999999999999 109.49 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.06 -40.02 75.32 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 119.063 -1.055 . . . . 1.2 108.578 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -63.16 -50.05 71.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.44 109.842 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 82.9 mtm180 -62.3 -44.94 95.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.366 -0.834 . . . . 3.3399999999999999 110.342 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.03 -38.45 90.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.988 -1.07 . . . . 2.3799999999999999 109.042 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.444 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.7 t90 -63.4 -49.4 73.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.40999999999999998 110.818 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.496 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 57.7 tp -65.3 -47.39 76.75 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.342 -0.849 . . . . 1.0700000000000001 109.953 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -63.42 -45.19 92.14 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.317 -0.864 . . . . 2.6000000000000001 109.387 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 35.5 t0 -68.61 -33.78 74.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.735 -0.603 . . . . 1.8999999999999999 109.607 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 90.4 m -79.88 -33.64 39.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 1.1000000000000001 111.249 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 31.6 p -130.57 -29.04 1.99 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.526 -1.359 . . . . 0.95999999999999996 112.272 -177.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.13 26.09 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.205 -1.558 . . . . 0.37 109.205 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.91 152.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.096 -1.238 . . . . 1.0900000000000001 109.409 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.03 172.62 8.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.068 -1.02 . . . . 2.3700000000000001 110.041 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.19 79.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.674 . . . . 1.1100000000000001 110.548 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.04 -40.39 75.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.839 -1.163 . . . . 2.9700000000000002 109.705 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' B' ' 25' ' ' GLY . 93.8 mm-40 -67.54 -39.55 85.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.444 -0.785 . . . . 2.6200000000000001 110.757 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -66.09 -38.23 87.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.161 -0.962 . . . . 1.8899999999999999 110.106 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.09 -39.02 84.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.723 -1.235 . . . . 3.3199999999999998 109.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.2 -39.3 82.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.842 -1.161 . . . . 0.40000000000000002 110.439 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.2 -40.22 82.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.752 -1.217 . . . . 0.95999999999999996 109.472 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -60.47 -60.08 4.38 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.95 -1.094 . . . . 0.5 109.649 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.24 -35.63 88.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.275 -1.13 . . . . 0.27000000000000002 110.275 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.03 -47.34 65.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.93999999999999995 109.778 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.07 -40.28 75.14 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.735 -1.186 . . . . 1.0900000000000001 108.529 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.701 HH12 ' NZ ' ' B' ' 54' ' ' LYS . 8.5 tpm_? -63.4 -41.91 98.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 3.1899999999999999 110.083 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 94.4 mt-10 -69.77 -39.6 76.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.816 -1.178 . . . . 1.9099999999999999 110.775 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.609 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 79.7 t90 -59.96 -42.08 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.436 -1.415 . . . . 0.40000000000000002 107.534 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 67.4 m -62.74 -40.44 97.23 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.056 -0.72 . . . . 0.96999999999999997 109.056 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' B' ' 82' ' ' ARG . 96.2 m-20 -60.27 -36.9 78.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.552 -0.717 . . . . 0.55000000000000004 109.781 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.72 -38.43 18.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 1.1299999999999999 110.06 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 76.3 m-85 -102.25 -84.94 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.311 -0.868 . . . . 1.24 110.547 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 118.012 -0.994 . . . . 1.8300000000000001 109.911 -178.529 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.6 0.714 . . . . 1.98 109.49 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -54.55 -18.84 4.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.641 -0.662 . . . . 2.6000000000000001 110.266 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -59.99 -37.09 78.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 2.5099999999999998 109.75 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -59.88 -50.83 72.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.007 -1.058 . . . . 0.51000000000000001 110.597 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -69.87 -33.28 72.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.068 -1.02 . . . . 3.7200000000000002 109.881 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.37 -39.7 77.9 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.276 -0.89 . . . . 0.76000000000000001 109.317 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.8 t80 -63.86 -48.52 76.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.525 -0.734 . . . . 0.5 110.433 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.6 11.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 1.1799999999999999 110.464 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.64 -12.62 14.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.243 -0.911 . . . . 1.1799999999999999 109.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.04 151.23 22.54 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 1.26 109.395 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -42.12 157.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.738 1.625 . . . . 0.53000000000000003 110.994 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.05 -23.24 18.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.847 -1.158 . . . . 1.1399999999999999 109.922 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.77 -138.59 48.21 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.981 -1.247 . . . . 0.41999999999999998 109.981 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.58 29.33 5.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.501 -0.999 . . . . 0.84999999999999998 110.042 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -60.02 148.98 76.0 Favored Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 107.83 -1.174 . . . . 2.4900000000000002 107.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.16 160.93 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.326 2.017 . . . . 0.39000000000000001 113.257 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.3 p -57.29 -49.08 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.739 -0.601 . . . . 1.1200000000000001 110.096 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.22 -2.78 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.223 -1.151 . . . . 0.27000000000000002 110.223 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 20' ' ' VAL . 22.1 p -81.49 -24.68 36.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.33 . . . . 1.75 108.511 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.43 139.73 58.57 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.783 0.802 . . . . 1.05 109.579 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -65.81 134.12 52.42 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.831 0.824 . . . . 1.0600000000000001 110.16 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.98 -20.51 48.74 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.925 -1.67 . . . . 0.23000000000000001 108.925 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 26' ' ' ILE . 30.1 mm -99.89 116.8 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.764 -1.198 . . . . 1.0800000000000001 107.764 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.3 177.4 39.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.669 -1.372 . . . . 0.31 109.669 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.49 -39.84 73.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.54 -0.976 . . . . 2.0099999999999998 109.539 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.13 -42.67 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 1.1399999999999999 109.447 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.4 -40.06 81.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.214 -0.929 . . . . 1.1299999999999999 109.438 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.99 97.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.34999999999999998 109.583 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.29 -39.97 94.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.4 -1.059 . . . . 3.2200000000000002 110.058 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.84 -49.94 68.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.832 -1.168 . . . . 2.1000000000000001 109.599 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.5 mt -60.03 -39.45 85.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 1.0800000000000001 108.966 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.02 -44.5 94.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.723 . . . . 1.6699999999999999 110.533 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.76 -19.07 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 2.0 109.113 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 37' ' ' ARG . 27.1 mtt-85 -89.97 1.93 55.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.794 -0.762 . . . . 3.1499999999999999 110.52 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.43 4.37 34.95 Favored Glycine 0 N--CA 1.506 3.353 0 O-C-N 121.019 -1.051 . . . . 0.47999999999999998 112.006 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.08 73.81 1.07 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.794 -1.415 . . . . 0.38 108.659 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -80.07 -10.0 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.40999999999999998 110.515 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 29.8 mmtp -130.82 152.68 49.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.171 -0.955 . . . . 2.1600000000000001 109.424 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.393 -0.817 . . . . 1.03 111.55 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 22.5 p90 -56.15 -17.61 7.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.711 -1.243 . . . . 0.92000000000000004 110.32 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.66 -33.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.832 -1.167 . . . . 1.0700000000000001 108.073 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.2 t -76.88 -39.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.266 -1.013 . . . . 1.0600000000000001 108.266 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.03 -38.07 81.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.578 -1.267 . . . . 1.1599999999999999 107.578 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.98 -41.12 96.21 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.552 -1.419 . . . . 0.20000000000000001 109.552 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -59.9 -43.29 94.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.252 . . . . 1.8200000000000001 108.456 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.02 -39.93 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.40000000000000002 108.725 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.72 -40.01 76.5 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.509 -0.923 . . . . 1.0900000000000001 108.509 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.81 -26.01 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 1.0900000000000001 110.198 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.01 13.63 14.32 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.16 -0.962 . . . . 1.0900000000000001 110.166 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER 48.95 51.63 15.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.881 -1.137 . . . . 2.2200000000000002 110.312 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.76 20.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.945 -1.097 . . . . 2.7999999999999998 110.913 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-20 -65.33 105.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.937 -1.505 . . . . 1.8 106.937 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.43 -40.27 93.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.361 -0.837 . . . . 0.87 112.62 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.77 -40.03 76.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.256 -1.527 . . . . 0.72999999999999998 109.823 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.3 -40.07 74.45 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.944 -1.102 . . . . 1.2 109.2 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.9 -50.03 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.44 109.402 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.79 -45.01 94.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.437 -0.79 . . . . 3.3399999999999999 109.896 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 65' ' ' ASP . 8.3 tm-20 -64.88 -39.99 94.4 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.159 -0.963 . . . . 2.3700000000000001 108.706 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.445 ' O ' ' OG1' ' A' ' 66' ' ' THR . 63.2 t90 -65.25 -48.02 74.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.40999999999999998 110.866 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.66 -45.88 73.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.208 -0.932 . . . . 1.0800000000000001 110.558 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.65 -48.5 79.07 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.167 -0.958 . . . . 2.6099999999999999 110.213 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 61' ' ' GLU . 57.2 m-20 -70.06 -24.75 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.807 . . . . 1.8999999999999999 110.066 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 27.0 m -79.62 -34.51 40.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.143 -0.973 . . . . 1.1100000000000001 111.236 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -132.91 -19.84 2.25 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.483 -1.386 . . . . 0.96999999999999997 111.899 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.8 11.5 43.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.137 -1.585 . . . . 0.38 109.137 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.68 1.6 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 1.1000000000000001 109.248 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.461 ' H ' HE21 ' A' ' 73' ' ' GLN . 26.9 t-20 -89.26 170.02 10.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 2.3700000000000001 109.817 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -34.36 73.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.562 -0.711 . . . . 1.1200000000000001 110.552 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -71.66 -39.97 69.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.64 -1.287 . . . . 2.9700000000000002 110.222 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.461 HE21 ' H ' ' A' ' 70' ' ' ASN . 37.4 mt-30 -68.61 -37.98 80.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.43 -0.794 . . . . 2.6200000000000001 110.722 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.9 m -67.41 -38.0 83.93 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.048 -1.032 . . . . 1.8899999999999999 109.958 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.01 -38.06 81.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 3.3199999999999998 109.476 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -68.33 -39.93 81.77 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.705 -1.247 . . . . 0.40000000000000002 110.349 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 66.9 m -66.97 -39.97 87.35 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.82 -1.175 . . . . 0.95999999999999996 108.968 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.15 -60.73 3.39 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.984 -1.073 . . . . 0.5 109.822 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.03 88.82 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.507 -1.037 . . . . 0.27000000000000002 110.507 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.28 -49.88 52.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.432 . . . . 0.93999999999999995 109.625 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.01 -39.99 75.5 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.983 -1.087 . . . . 1.0900000000000001 109.019 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -63.01 -40.05 96.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 3.1800000000000002 110.186 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.049 -1.032 . . . . 1.9099999999999999 109.924 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 71.0 t90 -59.91 -42.76 94.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.437 -1.32 . . . . 0.40000000000000002 107.437 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.94 -40.01 95.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 0.96999999999999997 108.968 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.39 -37.99 82.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.425 -0.797 . . . . 0.55000000000000004 109.678 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.13 17.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 1.1200000000000001 109.938 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 73.0 m-85 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.165 -0.959 . . . . 1.24 110.311 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.583 0.706 . . . . 1.97 109.466 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -54.63 -18.87 5.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.634 -0.666 . . . . 2.5899999999999999 110.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -60.02 -36.89 78.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.055 -1.028 . . . . 2.5 109.701 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -60.11 -50.58 73.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.995 -1.066 . . . . 0.51000000000000001 110.571 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -70.16 -33.14 71.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.018 -1.051 . . . . 3.73 109.758 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -69.43 -39.59 77.75 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.307 -0.871 . . . . 0.76000000000000001 109.288 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.4 t80 -63.96 -48.52 76.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.5 110.462 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -83.51 11.11 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.029 -1.044 . . . . 1.1799999999999999 110.423 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.54 -12.67 14.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.316 -0.865 . . . . 1.1799999999999999 109.793 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.04 151.14 22.36 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.065 -1.022 . . . . 1.27 109.329 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -42.16 157.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.705 1.603 . . . . 0.53000000000000003 110.926 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.2 ptp -93.01 -23.3 18.72 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.872 -1.143 . . . . 1.1299999999999999 109.958 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.11 -138.48 48.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.081 -1.208 . . . . 0.40999999999999998 110.081 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.82 29.34 5.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.83999999999999997 110.051 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.93 148.88 75.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 107.823 -1.177 . . . . 2.4900000000000002 107.823 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.99 161.1 38.29 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.285 1.99 . . . . 0.38 113.236 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.504 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.4 p -57.36 -49.15 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.568 0.699 . . . . 1.1200000000000001 110.146 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.04 -3.05 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.259 -1.136 . . . . 0.27000000000000002 110.259 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.504 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.2 p -81.35 -24.4 37.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.955 -1.32 . . . . 1.75 108.53 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.61 139.69 58.64 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.823 0.821 . . . . 1.0600000000000001 109.581 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.435 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -65.65 134.14 52.62 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.776 0.798 . . . . 1.05 110.173 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -20.92 46.95 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.883 -1.687 . . . . 0.22 108.883 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.411 HD13 HG21 ' B' ' 26' ' ' ILE . 30.1 mm -99.6 116.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.916 -1.142 . . . . 1.0800000000000001 107.916 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.3 177.48 39.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.679 -1.368 . . . . 0.29999999999999999 109.679 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -56.41 -39.92 73.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.455 -1.027 . . . . 2.0 109.553 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.15 -42.68 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 1.1399999999999999 109.438 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.42 -39.91 81.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.219 -0.925 . . . . 1.1299999999999999 109.528 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.76 -39.91 97.38 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.35999999999999999 109.591 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.33 -39.98 94.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -1.108 . . . . 3.2200000000000002 110.049 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.82 -49.99 68.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.837 -1.164 . . . . 2.1200000000000001 109.552 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.02 -39.45 85.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 1.0800000000000001 108.893 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.05 -44.38 94.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 1.6799999999999999 110.501 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.95 -18.91 65.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.031 -1.043 . . . . 1.99 109.152 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' B' ' 37' ' ' ARG . 27.6 mtt-85 -90.0 1.62 56.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.466 -0.771 . . . . 3.1499999999999999 110.507 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.91 4.27 33.9 Favored Glycine 0 N--CA 1.506 3.309 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 112.024 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -105.08 73.87 1.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.81 -1.406 . . . . 0.38 108.755 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.1 -10.03 59.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.40999999999999998 110.405 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.464 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 29.8 mmtp -130.79 152.59 49.97 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.224 -0.922 . . . . 2.1499999999999999 109.493 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.95 92.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.529 -0.732 . . . . 1.03 111.501 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.464 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 22.8 p90 -56.1 -17.46 7.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.733 -1.23 . . . . 0.92000000000000004 110.418 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.3 t -79.7 -33.34 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.819 -1.176 . . . . 1.0800000000000001 108.039 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.2 t -76.68 -39.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.262 -1.014 . . . . 1.0700000000000001 108.262 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.8 tp -60.08 -37.6 80.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.534 -1.284 . . . . 1.1499999999999999 107.534 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 -41.04 96.54 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.627 -1.389 . . . . 0.19 109.627 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -60.07 -43.24 95.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.274 . . . . 1.8200000000000001 108.397 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.40000000000000002 108.794 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.74 -39.91 76.48 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 1.0700000000000001 108.617 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.85 -26.1 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.312 -0.868 . . . . 1.0900000000000001 110.193 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.93 13.49 14.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.197 -0.939 . . . . 1.0900000000000001 110.131 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 49.01 51.73 15.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.771 -1.205 . . . . 2.23 110.185 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.79 20.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.833 -1.167 . . . . 2.7999999999999998 110.954 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 53' ' ' LYS . 71.1 m-20 -65.5 105.34 1.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.946 -1.501 . . . . 1.8 106.946 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.42 -40.03 92.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.241 -0.912 . . . . 0.88 112.674 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.99 -39.95 75.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.342 -1.474 . . . . 0.73999999999999999 109.865 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.38 -39.94 74.27 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.846 -1.142 . . . . 1.2 109.298 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.86 -49.94 70.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.44 109.433 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.98 -44.82 94.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.461 -0.774 . . . . 3.3399999999999999 109.821 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.444 ' OE2' ' OD2' ' B' ' 65' ' ' ASP . 8.3 tm-20 -64.93 -40.1 94.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.111 -0.993 . . . . 2.3799999999999999 108.745 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' B' ' 66' ' ' THR . 63.3 t90 -65.11 -48.1 74.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.40999999999999998 110.92 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.0 tp -67.79 -45.64 74.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.28 -0.888 . . . . 1.0700000000000001 110.572 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.84 -48.48 78.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.191 -0.943 . . . . 2.6000000000000001 110.162 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.444 ' OD2' ' OE2' ' B' ' 61' ' ' GLU . 57.3 m-20 -69.96 -24.84 63.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 1.8999999999999999 110.119 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 29.5 m -79.59 -34.34 40.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.996 . . . . 1.1000000000000001 111.33 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -133.02 -19.91 2.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.548 -1.345 . . . . 0.95999999999999996 111.802 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.75 11.51 43.53 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.116 -1.594 . . . . 0.37 109.116 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.08 152.87 1.55 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.998 -1.295 . . . . 1.0900000000000001 109.166 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.467 ' H ' HE21 ' B' ' 73' ' ' GLN . 27.0 t-20 -89.43 169.98 10.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.058 . . . . 2.3700000000000001 109.843 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.42 73.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.58 -0.7 . . . . 1.1100000000000001 110.507 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.63 -39.97 70.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.703 -1.248 . . . . 2.9700000000000002 110.202 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.467 HE21 ' H ' ' B' ' 70' ' ' ASN . 37.2 mt-30 -68.68 -37.99 80.02 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.815 . . . . 2.6200000000000001 110.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -67.27 -38.12 84.57 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.036 -1.04 . . . . 1.8899999999999999 109.911 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 -60.05 -38.1 81.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 3.3199999999999998 109.441 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.12 -39.98 82.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.77 -1.206 . . . . 0.40000000000000002 110.348 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 67.2 m -67.01 -39.96 87.2 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.735 -1.228 . . . . 0.95999999999999996 109.053 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.05 -60.82 3.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.984 -1.072 . . . . 0.5 109.867 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.13 -34.15 89.14 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.504 -1.038 . . . . 0.27000000000000002 110.504 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.29 -49.8 52.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.825 -1.397 . . . . 0.93999999999999995 109.713 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.98 -40.0 75.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.987 -1.085 . . . . 1.0900000000000001 108.969 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -63.11 -40.03 96.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.172 -0.955 . . . . 3.1899999999999999 110.144 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.2 -36.72 77.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 1.9099999999999999 109.882 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.533 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 71.8 t90 -59.95 -42.64 94.49 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.449 -1.315 . . . . 0.40000000000000002 107.449 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.409 ' O ' ' OXT' ' B' ' 89' ' ' LEU . 92.6 m -64.11 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 0.96999999999999997 108.952 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.25 -38.21 82.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.758 . . . . 0.55000000000000004 109.578 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.46 -39.69 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 1.1299999999999999 110.01 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.533 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.6 m-85 -97.84 -82.49 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 1.24 110.495 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.409 ' OXT' ' O ' ' B' ' 85' ' ' CYS . 18.4 tp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.975 -1.012 . . . . 1.8300000000000001 110.065 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.834 0.826 . . . . 1.98 109.324 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.48 -28.69 67.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.753 -0.592 . . . . 2.6000000000000001 109.95 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.02 -36.9 78.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.939 . . . . 2.5099999999999998 109.456 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -59.25 -50.08 75.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.041 -1.037 . . . . 0.51000000000000001 110.064 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.98 -34.41 73.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.192 -0.943 . . . . 3.7200000000000002 110.096 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 91.3 m-20 -67.8 -39.31 84.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.255 -0.903 . . . . 0.76000000000000001 109.447 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -60.03 -47.45 85.8 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.481 -0.888 . . . . 0.5 109.369 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 m -83.76 10.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.026 -1.047 . . . . 1.1799999999999999 110.483 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.6 -19.04 17.04 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.012 -1.055 . . . . 1.1799999999999999 110.91 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -156.95 152.93 23.01 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.886 -1.133 . . . . 1.26 108.606 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' GLU . 55.0 Cg_exo -36.47 150.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.012 1.808 . . . . 0.53000000000000003 111.867 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.0 ptm -89.51 -22.74 22.28 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.041 -1.037 . . . . 1.1399999999999999 110.503 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.08 -134.61 40.65 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.101 -1.047 . . . . 0.41999999999999998 110.593 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.98 35.14 3.5 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.99 . . . . 0.84999999999999998 110.557 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -58.55 147.85 68.19 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 120.781 -1.199 . . . . 2.4900000000000002 107.97 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.25 153.69 51.43 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.996 1.797 . . . . 0.39000000000000001 112.08 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.23 -42.03 63.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.544 -0.723 . . . . 1.1200000000000001 109.933 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.12 -3.6 5.15 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.281 -1.128 . . . . 0.27000000000000002 110.281 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -83.33 -21.0 33.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.888 -1.36 . . . . 1.75 109.242 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.14 137.73 58.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 1.05 109.68 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -62.98 133.89 55.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.754 0.788 . . . . 1.0600000000000001 109.841 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 96.89 -17.34 59.44 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.167 -1.573 . . . . 0.23000000000000001 109.167 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 26' ' ' ILE . 34.3 mm -101.17 114.79 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -1.128 . . . . 1.0800000000000001 108.094 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.76 178.55 36.48 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.724 -1.351 . . . . 0.31 109.724 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.23 -40.01 73.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -1.148 . . . . 2.0099999999999998 109.958 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.28 -44.44 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.974 -1.079 . . . . 1.1399999999999999 109.545 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.29 -38.35 87.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 1.1299999999999999 109.707 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.98 94.5 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.37 -1.492 . . . . 0.34999999999999998 109.37 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.96 -40.0 90.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -1.09 . . . . 3.2200000000000002 110.594 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.19 -45.35 73.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.738 -1.226 . . . . 2.1000000000000001 109.632 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.49 -39.96 95.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.073 -1.017 . . . . 1.0800000000000001 108.59 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.14 -40.82 91.15 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.809 -0.756 . . . . 1.6699999999999999 109.605 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.17 -19.55 65.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.332 -0.988 . . . . 2.0 108.332 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.6 OUTLIER -91.12 6.39 45.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.649 -0.657 . . . . 3.1499999999999999 110.043 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.62 9.23 53.33 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.256 -0.973 . . . . 0.47999999999999998 111.899 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -106.26 74.52 1.04 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.764 -1.433 . . . . 0.38 109.312 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -79.96 -9.74 59.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.40999999999999998 110.522 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.1 mmtm -132.72 154.97 49.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.088 -1.008 . . . . 2.1600000000000001 109.559 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.92 94.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.657 -0.652 . . . . 1.03 111.071 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 21.6 p90 -57.39 -18.85 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.758 -1.214 . . . . 0.92000000000000004 110.7 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -79.27 -34.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.619 -1.301 . . . . 1.0700000000000001 107.976 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.75 -39.96 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.472 -0.936 . . . . 1.0600000000000001 108.472 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.98 -38.33 82.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.623 -1.251 . . . . 1.1599999999999999 107.623 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.97 97.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.664 -1.374 . . . . 0.20000000000000001 109.664 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 1.8200000000000001 109.37 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.97 -40.03 87.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.098 -1.075 . . . . 0.40000000000000002 108.098 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.7 -39.0 77.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.666 -0.813 . . . . 1.0900000000000001 108.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.34 -24.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 1.0900000000000001 110.147 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.57 15.2 14.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.172 -0.955 . . . . 1.0900000000000001 110.252 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt 48.82 42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.732 -1.23 . . . . 2.2200000000000002 110.866 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 56.76 19.41 4.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.389 -0.819 . . . . 2.7999999999999998 109.5 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.82 107.02 2.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.718 -1.239 . . . . 1.8 108.123 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -40.52 97.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.87 112.342 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.11 -39.96 78.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.363 -1.461 . . . . 0.72999999999999998 109.724 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.47 -39.99 73.91 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.917 -1.113 . . . . 1.2 108.987 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.9 -49.88 70.92 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.856 . . . . 0.44 109.668 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.22 -46.29 91.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.347 -0.846 . . . . 3.3399999999999999 110.443 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.35 -39.89 94.78 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.064 -1.022 . . . . 2.3700000000000001 108.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.449 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.2 t90 -63.23 -49.49 73.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.269 -0.894 . . . . 0.40999999999999998 110.93 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 59.1 tp -66.98 -49.64 64.76 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 1.0800000000000001 109.784 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HZ3' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -61.72 -47.25 86.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.765 . . . . 2.6099999999999999 110.007 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.9 t0 -68.45 -29.62 68.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.521 -0.737 . . . . 1.8999999999999999 109.838 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.9 m -80.45 -32.91 37.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 1.1100000000000001 111.562 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 25.2 p -131.65 -28.77 1.79 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.52 -1.363 . . . . 0.96999999999999997 111.982 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.56 14.1 20.68 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.059 -1.616 . . . . 0.38 109.059 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.89 153.28 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.014 -1.286 . . . . 1.1000000000000001 109.362 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.54 170.15 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.1 -1.0 . . . . 2.3700000000000001 109.654 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.23 70.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 1.1200000000000001 110.727 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.18 -40.1 68.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 2.9700000000000002 109.734 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.2 mm100 -67.71 -38.3 83.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.349 -0.844 . . . . 2.6200000000000001 110.236 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -68.45 -37.74 80.49 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.907 . . . . 1.8899999999999999 110.02 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.56 -38.8 85.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 3.3199999999999998 109.412 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -68.46 -39.94 81.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.624 -1.298 . . . . 0.40000000000000002 110.318 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 93.7 m -68.4 -39.98 81.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.143 . . . . 0.95999999999999996 109.171 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.69 -60.1 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.771 -1.206 . . . . 0.5 109.779 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.29 -34.42 89.16 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.298 -1.121 . . . . 0.27000000000000002 110.298 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.32 -46.58 60.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.847 -1.384 . . . . 0.93999999999999995 109.705 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -70.32 -40.56 74.11 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.793 -1.163 . . . . 1.0900000000000001 108.432 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -64.54 -39.98 94.75 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.84 . . . . 3.1800000000000002 110.448 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -68.73 -37.64 79.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.983 -1.073 . . . . 1.9099999999999999 109.758 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.592 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.4 t90 -60.01 -45.54 92.41 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.431 -1.322 . . . . 0.40000000000000002 107.431 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 75.6 m -60.74 -40.02 90.87 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.808 -0.812 . . . . 0.96999999999999997 108.808 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.43 -37.76 81.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.55000000000000004 109.739 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.61 -36.86 18.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 1.1200000000000001 109.934 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 1.24 110.226 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.801 0.81 . . . . 1.97 109.426 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.71 -28.5 67.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.761 -0.587 . . . . 2.5899999999999999 109.905 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -59.99 -37.03 78.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 2.5 109.483 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -59.32 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.101 -1.0 . . . . 0.51000000000000001 109.974 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.96 -34.53 73.53 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.073 -1.017 . . . . 3.73 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . 0.447 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 91.6 m-20 -67.72 -39.26 84.33 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.223 -0.923 . . . . 0.76000000000000001 109.413 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -59.91 -47.6 85.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.434 -0.906 . . . . 0.5 109.39 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.67 10.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.168 -0.957 . . . . 1.1799999999999999 110.512 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -19.04 17.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 1.1799999999999999 110.981 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' B' ' 9' ' ' ASP . 0.0 OUTLIER -156.92 152.93 23.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.831 -1.168 . . . . 1.27 108.603 179.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' B' ' 13' ' ' GLU . 54.8 Cg_exo -36.36 150.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.088 1.859 . . . . 0.53000000000000003 111.86 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 8.0 ptm -89.38 -22.61 22.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.114 -0.991 . . . . 1.1299999999999999 110.539 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.19 -134.63 41.06 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.918 -1.114 . . . . 0.40999999999999998 110.63 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.02 35.04 3.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.471 -1.017 . . . . 0.83999999999999997 110.552 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -58.4 147.79 66.97 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 120.76 -1.213 . . . . 2.4900000000000002 108.04 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.28 153.48 52.98 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.019 1.813 . . . . 0.38 112.161 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p -54.96 -42.07 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 1.1200000000000001 110.03 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.15 -3.68 5.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.263 -1.135 . . . . 0.27000000000000002 110.263 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -83.08 -21.1 33.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.897 -1.355 . . . . 1.75 109.261 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.15 137.83 58.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 1.0600000000000001 109.662 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -62.97 133.81 55.21 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.62 0.724 . . . . 1.05 109.833 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 96.99 -17.48 59.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.084 -1.607 . . . . 0.22 109.084 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.424 HD11 HG22 ' B' ' 26' ' ' ILE . 34.3 mm -101.01 114.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -1.101 . . . . 1.0800000000000001 108.212 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.62 178.56 36.68 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.725 -1.35 . . . . 0.29999999999999999 109.725 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.27 -40.09 73.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -1.115 . . . . 2.0 109.948 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.22 -44.34 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.02 -1.05 . . . . 1.1399999999999999 109.566 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 1.1299999999999999 109.657 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.53 -39.05 94.49 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.343 -1.503 . . . . 0.35999999999999999 109.343 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.99 -40.03 90.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 3.2200000000000002 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.27 -45.41 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.664 -1.272 . . . . 2.1200000000000001 109.533 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.25 -40.03 96.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.092 -1.005 . . . . 1.0800000000000001 108.673 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.05 -40.87 90.91 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.859 -0.736 . . . . 1.6799999999999999 109.634 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.19 -19.49 65.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.353 -0.98 . . . . 1.99 108.353 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.6 OUTLIER -91.14 6.25 45.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.648 -0.657 . . . . 3.1499999999999999 110.029 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 9.34 52.97 Favored Glycine 0 N--CA 1.501 3.027 0 O-C-N 121.141 -0.975 . . . . 0.48999999999999999 111.834 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -106.22 74.12 1.02 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.761 -1.434 . . . . 0.38 109.323 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 -9.97 59.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.912 . . . . 0.40999999999999998 110.534 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.481 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.0 mmtm -132.57 154.94 49.51 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.206 -0.934 . . . . 2.1499999999999999 109.581 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.02 95.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.655 -0.653 . . . . 1.03 111.112 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.481 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 20.2 p90 -57.27 -18.72 17.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.238 . . . . 0.92000000000000004 110.672 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 24.7 t -79.38 -34.24 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.58 -1.325 . . . . 1.0800000000000001 108.001 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 75.0 t -77.77 -39.95 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.477 -0.934 . . . . 1.0700000000000001 108.477 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.07 -38.12 81.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 1.1499999999999999 107.628 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.88 97.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.759 -1.336 . . . . 0.19 109.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -40.04 88.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -1.18 . . . . 1.8200000000000001 109.336 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.85 -40.05 87.28 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.107 -1.071 . . . . 0.40000000000000002 108.107 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.74 -38.65 76.92 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.609 -0.836 . . . . 1.0700000000000001 108.836 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.76 -24.17 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.178 -0.951 . . . . 1.0900000000000001 110.086 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.38 14.87 15.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.058 -1.026 . . . . 1.0900000000000001 110.262 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 49.19 42.24 21.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.772 -1.205 . . . . 2.23 110.824 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 81.5 mttt 57.14 19.6 4.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 2.7999999999999998 109.484 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.02 107.08 2.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.701 -1.249 . . . . 1.8 108.14 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -40.2 96.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.43 -0.794 . . . . 0.88 112.39 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.39 -40.04 77.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.252 -1.53 . . . . 0.73999999999999999 109.702 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.3 -40.07 74.47 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.924 -1.11 . . . . 1.2 109.024 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.74 -49.99 70.86 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.44 109.662 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.36 -45.96 92.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.459 -0.776 . . . . 3.3399999999999999 110.466 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -64.52 -39.93 94.68 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 120.99 -1.068 . . . . 2.3799999999999999 108.788 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.449 ' O ' ' OG1' ' B' ' 66' ' ' THR . 68.0 t90 -63.16 -49.64 73.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.864 . . . . 0.40999999999999998 110.887 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.488 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 59.3 tp -66.95 -49.45 65.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.084 -1.01 . . . . 1.0700000000000001 109.795 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.444 ' HZ3' ' CB ' ' B' ' 64' ' ' LYS . 0.0 OUTLIER -61.85 -47.21 86.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 2.6000000000000001 109.96 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 36.5 t0 -68.61 -29.37 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 1.8999999999999999 109.797 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 64.3 m -80.64 -33.06 35.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 1.1000000000000001 111.451 -178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 25.2 p -131.54 -28.62 1.83 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.405 -1.435 . . . . 0.95999999999999996 112.137 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.42 14.03 21.11 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 109.096 -1.601 . . . . 0.37 109.096 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.85 153.23 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.05 -1.265 . . . . 1.0900000000000001 109.306 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.46 170.16 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.101 -0.999 . . . . 2.3700000000000001 109.655 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.36 70.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.478 -0.764 . . . . 1.1100000000000001 110.73 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.06 -40.07 68.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.784 -1.197 . . . . 2.9700000000000002 109.68 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.2 mm100 -67.81 -38.17 82.92 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.323 -0.861 . . . . 2.6200000000000001 110.301 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -68.53 -37.93 80.42 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.266 -0.896 . . . . 1.8899999999999999 110.005 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.41 -38.91 85.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.852 -1.155 . . . . 3.3199999999999998 109.399 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -68.22 -39.97 82.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.651 -1.28 . . . . 0.40000000000000002 110.354 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.1 m -68.45 -39.98 81.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.712 -1.242 . . . . 0.95999999999999996 109.209 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -60.18 4.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.739 -1.226 . . . . 0.5 109.8 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -34.49 89.11 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.364 -1.094 . . . . 0.27000000000000002 110.364 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.3 t -71.41 -46.33 60.46 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.809 -1.406 . . . . 0.93999999999999995 109.792 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.44 -40.59 73.67 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.812 -1.155 . . . . 1.0900000000000001 108.403 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.47 -40.11 95.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 3.1899999999999999 110.454 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -68.85 -37.4 79.1 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.94 -1.1 . . . . 1.9099999999999999 109.672 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.4 t90 -59.92 -45.77 91.52 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.433 -1.321 . . . . 0.40000000000000002 107.433 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' B' ' 89' ' ' LEU . 73.5 m -60.62 -39.95 90.09 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.813 -0.755 . . . . 0.96999999999999997 108.964 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.57 -37.79 82.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 109.721 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.51 -36.83 18.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -0.889 . . . . 1.1299999999999999 109.957 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.1 m-85 -103.62 -85.02 0.46 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.28 -0.887 . . . . 1.24 110.39 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 85' ' ' CYS . 24.6 tp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.051 -0.976 . . . . 1.8300000000000001 109.573 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.67 0.748 . . . . 1.98 109.81 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.45 -20.66 13.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 2.6000000000000001 110.076 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.02 -37.52 79.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.14 -0.975 . . . . 2.5099999999999998 109.293 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 12.4 t60 -59.97 -50.01 75.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.021 -1.049 . . . . 0.51000000000000001 110.628 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.427 HH11 ' HG3' ' A' ' 8' ' ' ARG . 17.9 mmm-85 -70.01 -35.11 74.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.859 -1.151 . . . . 3.7200000000000002 109.735 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.74 -39.99 84.2 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.386 -0.822 . . . . 0.76000000000000001 109.336 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -63.54 -49.08 74.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.428 -0.795 . . . . 0.5 110.085 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.53 9.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.971 -1.081 . . . . 1.1799999999999999 110.747 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.9 -15.01 16.31 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.189 -0.944 . . . . 1.1799999999999999 110.267 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.4 pt-20 -152.71 155.03 32.22 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.169 -0.957 . . . . 1.26 108.938 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' GLU . 65.1 Cg_exo -36.84 152.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.101 1.867 . . . . 0.53000000000000003 111.441 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 11.6 ptm -89.75 -23.23 21.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.038 -1.039 . . . . 1.1399999999999999 109.673 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.0 -138.54 20.64 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.097 -1.201 . . . . 0.41999999999999998 110.097 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.54 43.23 1.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.577 -0.955 . . . . 0.84999999999999998 109.657 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -61.21 147.98 85.84 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.475 -0.935 . . . . 2.4900000000000002 108.475 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 155.09 39.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.275 1.983 . . . . 0.39000000000000001 112.826 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.68 -35.28 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.632 0.73 . . . . 1.1200000000000001 110.202 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.24 -0.48 57.31 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.546 -1.021 . . . . 0.27000000000000002 110.546 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 p -82.44 -25.8 33.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.783 -1.422 . . . . 1.75 109.706 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.78 138.52 58.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 1.05 109.953 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.84 134.5 55.32 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.8 -0.76 . . . . 1.0600000000000001 109.483 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.11 -21.72 44.58 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.511 -1.436 . . . . 0.23000000000000001 109.511 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 26' ' ' ILE . 36.2 mm -98.76 114.73 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.143 -1.21 . . . . 1.0800000000000001 108.195 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.68 -179.2 36.4 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.645 -1.382 . . . . 0.31 109.645 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -58.21 -40.04 80.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -1.038 . . . . 2.0099999999999998 109.652 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.67 -47.65 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.06 -1.025 . . . . 1.1399999999999999 109.285 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.89 -35.99 82.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 1.1299999999999999 109.348 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.78 -39.97 92.19 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.464 -1.454 . . . . 0.34999999999999998 109.464 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -66.79 -37.49 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.268 . . . . 3.2200000000000002 110.308 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.65 -51.74 46.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.709 -1.245 . . . . 2.1000000000000001 109.303 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.49 -39.81 89.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.051 -1.031 . . . . 1.0800000000000001 108.471 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.06 -42.66 95.0 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.55 -0.86 . . . . 1.6699999999999999 109.409 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.0 -19.12 65.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.178 -0.951 . . . . 2.0 108.6 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -90.75 5.42 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.539 -0.725 . . . . 3.1499999999999999 109.831 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.89 8.96 53.53 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.007 -1.058 . . . . 0.47999999999999998 111.585 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.25 75.09 1.01 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.418 . . . . 0.38 109.071 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.54 -7.98 58.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.40999999999999998 110.562 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -138.04 158.62 43.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.071 -1.018 . . . . 2.1600000000000001 110.149 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.5 84.45 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.965 0.728 . . . . 1.03 112.965 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -59.98 -17.84 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.38 -1.45 . . . . 0.92000000000000004 110.376 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 t -79.48 -31.93 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.25 -1.389 . . . . 1.0700000000000001 107.25 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 79.4 t -77.17 -39.58 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.236 -1.024 . . . . 1.0600000000000001 108.236 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.01 -35.93 76.13 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.466 -1.309 . . . . 1.1599999999999999 107.466 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.29 98.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.703 -1.359 . . . . 0.20000000000000001 109.703 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.94 -43.99 94.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 1.8200000000000001 108.908 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.97 -40.46 89.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.505 -0.747 . . . . 0.40000000000000002 109.195 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -69.05 -38.44 79.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.813 -0.81 . . . . 1.0900000000000001 108.813 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.69 -19.89 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.137 -0.977 . . . . 1.0900000000000001 110.517 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.2 mt -88.26 14.27 9.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.123 -0.985 . . . . 1.0900000000000001 110.786 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.12 31.86 7.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.778 -1.201 . . . . 2.2200000000000002 109.868 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 57.98 19.95 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.704 -0.623 . . . . 2.7999999999999998 110.044 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -69.93 108.81 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.732 -1.23 . . . . 1.8 108.077 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.83 -40.01 96.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.084 0.772 . . . . 0.87 113.084 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.44 -39.94 85.41 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.405 -1.434 . . . . 0.72999999999999998 109.996 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.45 -39.51 74.29 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.104 -1.038 . . . . 1.2 108.941 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.39 -41.65 93.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.44 109.095 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmm-85 -60.06 -51.18 70.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 3.3399999999999999 110.147 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.58 -37.3 84.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 2.3700000000000001 110.078 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.446 ' O ' ' OG1' ' A' ' 66' ' ' THR . 73.8 t90 -63.33 -47.99 79.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.40999999999999998 110.799 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.414 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 19.8 tp -66.8 -47.6 71.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.036 -1.04 . . . . 1.0800000000000001 109.707 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.08 -48.55 78.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.293 -0.879 . . . . 2.6099999999999999 109.945 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -67.17 -32.17 73.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.475 -0.766 . . . . 1.8999999999999999 109.758 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 91.3 m -80.17 -34.68 37.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 1.1100000000000001 111.397 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 31.8 p -128.72 -26.69 2.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.59 -1.318 . . . . 0.96999999999999997 112.004 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.99 13.53 33.69 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.684 -1.766 . . . . 0.38 108.684 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 152.99 2.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -1.095 . . . . 1.1000000000000001 109.421 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.76 174.9 7.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -0.912 . . . . 2.3700000000000001 109.724 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.27 74.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 1.1200000000000001 110.728 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.46 -39.66 64.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.604 -1.31 . . . . 2.9700000000000002 110.35 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.015 -1.053 . . . . 2.6200000000000001 110.732 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -69.05 -37.96 78.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.176 -0.952 . . . . 1.8899999999999999 110.52 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HG2' HH11 ' A' ' 75' ' ' ARG . 27.1 mtt-85 -60.03 -37.38 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 3.3199999999999998 109.489 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.52 -40.03 80.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.716 -1.24 . . . . 0.40000000000000002 110.478 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.8 m -69.48 -40.12 77.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.783 -1.198 . . . . 0.95999999999999996 109.8 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.33 -60.13 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.5 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.07 86.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.828 -0.909 . . . . 0.27000000000000002 110.828 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.7 t -70.77 -48.66 53.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.946 -1.326 . . . . 0.93999999999999995 110.223 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.998 -1.081 . . . . 1.0900000000000001 108.176 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.52 -40.02 93.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 3.1800000000000002 110.169 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 92.1 mt-10 -70.27 -38.23 75.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 1.9099999999999999 110.956 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 89.3 t90 -60.59 -42.32 96.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.308 -1.495 . . . . 0.40000000000000002 108.456 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 92.7 m -61.57 -40.43 94.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.509 -0.744 . . . . 0.96999999999999997 110.273 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -29.44 68.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.121 -0.987 . . . . 0.55000000000000004 109.917 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.37 13.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 1.1200000000000001 110.81 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 88.7 m-85 . . . . . 0 N--CA 1.503 2.208 0 O-C-N 121.312 -0.867 . . . . 1.24 112.42 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.703 0.764 . . . . 1.97 109.809 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.51 -20.68 13.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 2.5899999999999999 110.057 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.03 -37.43 79.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.156 -0.965 . . . . 2.5 109.324 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.519 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 12.3 t60 -59.97 -50.06 75.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.029 -1.044 . . . . 0.51000000000000001 110.564 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.433 HH11 ' HG3' ' B' ' 8' ' ' ARG . 18.1 mmm-85 -70.02 -35.18 74.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.881 -1.137 . . . . 3.73 109.67 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.71 -40.03 84.33 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.445 -0.785 . . . . 0.76000000000000001 109.26 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.65 -49.0 74.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.408 -0.808 . . . . 0.5 110.069 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -83.48 9.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.975 -1.078 . . . . 1.1799999999999999 110.755 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.71 -15.02 16.44 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.129 -0.982 . . . . 1.1799999999999999 110.363 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' B' ' 14' ' ' PRO . 4.4 pt-20 -152.72 154.93 32.09 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.047 -1.033 . . . . 1.27 109.019 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -36.8 152.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.124 1.883 . . . . 0.53000000000000003 111.522 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.463 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 11.5 ptm -89.52 -23.21 22.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.044 -1.035 . . . . 1.1299999999999999 109.718 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -138.48 21.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.188 -1.165 . . . . 0.40999999999999998 110.188 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.56 43.03 1.58 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.535 -0.979 . . . . 0.83999999999999997 109.662 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -60.92 147.91 84.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 2.4900000000000002 108.512 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.84 155.12 39.73 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.304 2.003 . . . . 0.38 112.774 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.73 -35.4 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 1.1200000000000001 110.232 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.09 -0.58 57.04 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.599 -1.0 . . . . 0.27000000000000002 110.599 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 8.5 p -82.22 -25.93 33.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.727 -1.454 . . . . 1.75 109.731 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.69 138.51 58.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.411 -0.806 . . . . 1.0600000000000001 109.953 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.78 134.51 55.41 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.86 -0.736 . . . . 1.05 109.417 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.0 -21.6 45.22 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.519 -1.432 . . . . 0.22 109.519 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.43 HD11 HG22 ' B' ' 26' ' ' ILE . 36.0 mm -98.95 114.74 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.273 -1.134 . . . . 1.0800000000000001 108.203 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.79 -179.26 36.22 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.613 -1.395 . . . . 0.29999999999999999 109.613 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -58.08 -40.0 79.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -1.071 . . . . 2.0 109.783 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.76 -47.57 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.017 -1.052 . . . . 1.1399999999999999 109.314 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -35.86 82.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 1.1299999999999999 109.43 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.8 -39.96 92.23 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.447 . . . . 0.35999999999999999 109.481 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.77 -37.35 84.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 3.2200000000000002 110.39 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.85 -51.58 46.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.62 -1.3 . . . . 2.1200000000000001 109.363 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.63 -39.87 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 1.0800000000000001 108.306 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.0 -42.54 94.51 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.559 -0.856 . . . . 1.6799999999999999 109.419 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.12 -19.09 65.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 1.99 108.68 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -90.75 5.35 48.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.535 -0.728 . . . . 3.1499999999999999 109.813 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.02 8.92 53.35 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 120.225 -0.988 . . . . 0.48999999999999999 111.575 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.09 75.04 1.01 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.805 -1.409 . . . . 0.38 109.116 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.39 -8.14 58.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.40999999999999998 110.542 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -137.98 158.57 44.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.159 -0.963 . . . . 2.1499999999999999 110.179 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.43 84.47 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.925 0.713 . . . . 1.03 112.925 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -60.06 -17.68 41.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.431 -1.418 . . . . 0.92000000000000004 110.489 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 t -79.56 -31.96 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.258 -1.386 . . . . 1.0800000000000001 107.258 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 79.6 t -77.18 -39.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.244 -1.021 . . . . 1.0700000000000001 108.244 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 24.5 tp -59.97 -35.87 75.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.432 -1.322 . . . . 1.1499999999999999 107.432 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.34 98.22 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.791 -1.324 . . . . 0.19 109.791 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.061 -1.258 . . . . 1.8200000000000001 108.838 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -59.97 -40.5 89.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.40000000000000002 109.222 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.93 -38.34 79.44 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.828 -0.804 . . . . 1.0700000000000001 108.828 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.78 -19.97 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.187 -0.946 . . . . 1.0900000000000001 110.562 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 14.07 9.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.064 -1.022 . . . . 1.0900000000000001 110.808 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.14 32.1 7.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.693 -1.254 . . . . 2.23 109.848 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 57.91 20.02 6.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.637 -0.664 . . . . 2.7999999999999998 110.023 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -70.05 108.7 4.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.632 -1.293 . . . . 1.8 108.126 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.74 -40.07 96.07 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.076 0.769 . . . . 0.88 113.076 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.53 -40.03 85.05 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.434 -1.416 . . . . 0.73999999999999999 109.932 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.31 -39.65 74.68 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.061 -1.056 . . . . 1.2 109.0 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.16 -41.84 94.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.44 109.132 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -59.96 -51.04 71.4 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.771 . . . . 3.3399999999999999 110.187 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.73 -37.44 84.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.119 -0.988 . . . . 2.3799999999999999 110.025 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.455 ' O ' ' OG1' ' B' ' 66' ' ' THR . 74.3 t90 -63.22 -48.0 80.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.40999999999999998 110.882 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -66.83 -47.36 72.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.038 -1.039 . . . . 1.0700000000000001 109.752 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.24 -48.6 77.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.299 -0.875 . . . . 2.6000000000000001 109.859 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -67.27 -32.06 72.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.574 -0.704 . . . . 1.8999999999999999 109.769 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.22 -34.67 37.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 1.1000000000000001 111.331 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.7 p -128.84 -26.47 2.67 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.615 -1.303 . . . . 0.95999999999999996 111.984 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.31 34.59 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.7 -1.76 . . . . 0.37 108.7 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.6 152.92 2.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 1.0900000000000001 109.412 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.64 174.97 6.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.962 . . . . 2.3700000000000001 109.745 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -35.38 74.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 1.1100000000000001 110.691 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.4 -39.59 64.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.673 -1.267 . . . . 2.9700000000000002 110.339 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -67.48 -40.12 85.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.047 . . . . 2.6200000000000001 110.7 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.9 m -69.06 -37.92 78.78 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.138 -0.976 . . . . 1.8899999999999999 110.522 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' B' ' 75' ' ' ARG . 27.1 mtt-85 -60.0 -37.47 79.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.751 -1.218 . . . . 3.3199999999999998 109.509 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.43 -39.99 81.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.645 -1.285 . . . . 0.40000000000000002 110.526 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.57 -40.08 76.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.787 -1.196 . . . . 0.95999999999999996 109.821 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.27 -60.24 4.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.647 -1.283 . . . . 0.5 109.824 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.0 -33.08 86.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.83 -0.908 . . . . 0.27000000000000002 110.83 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -70.8 -48.63 53.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.039 -1.271 . . . . 0.93999999999999995 110.188 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.02 -39.89 75.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.998 -1.081 . . . . 1.0900000000000001 108.161 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.47 -40.02 93.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 3.1899999999999999 110.114 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 91.9 mt-10 -70.31 -38.24 74.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.965 -1.084 . . . . 1.9099999999999999 110.907 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.498 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 89.3 t90 -60.43 -42.49 96.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.314 -1.491 . . . . 0.40000000000000002 108.478 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.499 ' O ' ' N ' ' B' ' 89' ' ' LEU . 92.7 m -61.33 -40.49 94.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.513 -0.742 . . . . 0.96999999999999997 110.237 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -29.59 68.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.123 -0.986 . . . . 0.55000000000000004 109.896 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.26 -35.58 13.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.222 -0.924 . . . . 1.1299999999999999 110.863 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 90.1 m-85 -108.53 -3.81 17.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.285 -0.884 . . . . 1.24 112.552 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' B' ' 85' ' ' CYS . 9.2 tp . . . . . 0 N--CA 1.503 2.184 0 O-C-N 120.492 -1.38 . . . . 1.8300000000000001 109.384 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.569 0.7 . . . . 1.98 109.188 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -57.54 -20.1 29.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.589 -0.694 . . . . 2.6000000000000001 109.602 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -61.41 -37.65 84.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 2.5099999999999998 109.129 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -59.94 -49.98 75.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.149 -0.97 . . . . 0.51000000000000001 110.317 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.23 -34.63 73.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.124 -0.985 . . . . 3.7200000000000002 110.103 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.7 -40.07 80.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.76000000000000001 109.559 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.63 -46.8 81.01 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.557 -0.857 . . . . 0.5 109.988 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.63 9.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.097 -1.002 . . . . 1.1799999999999999 110.895 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.43 -15.06 15.5 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.994 -1.066 . . . . 1.1799999999999999 110.206 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 14' ' ' PRO . 8.2 pt-20 -151.97 152.52 30.01 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.066 -1.022 . . . . 1.26 108.941 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 13' ' ' GLU . 66.8 Cg_exo -36.99 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.222 1.948 . . . . 0.53000000000000003 111.636 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 13.2 ptm -95.68 -30.23 13.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 1.1399999999999999 109.958 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.34 -133.58 49.18 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.363 -1.095 . . . . 0.41999999999999998 110.363 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.77 35.51 3.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.767 -0.843 . . . . 0.84999999999999998 110.088 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -54.88 149.81 21.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.925 -1.139 . . . . 2.4900000000000002 107.925 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.23 157.49 34.95 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.076 1.851 . . . . 0.39000000000000001 112.244 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 21' ' ' GLY . 12.7 p -56.85 -45.37 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.742 0.782 . . . . 1.1200000000000001 110.231 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -61.94 -1.39 2.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.61 -0.996 . . . . 0.27000000000000002 110.61 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 20' ' ' VAL . 60.2 p -82.95 -27.54 30.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.484 . . . . 1.75 109.582 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.92 138.24 57.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 1.05 109.562 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.59 134.86 54.22 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.733 0.778 . . . . 1.0600000000000001 109.979 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.76 -20.03 51.99 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.246 -1.542 . . . . 0.23000000000000001 109.246 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.5 mm -99.44 115.58 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -1.133 . . . . 1.0800000000000001 108.246 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.57 37.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 0.31 109.463 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.84 -40.0 75.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -1.064 . . . . 2.0099999999999998 109.86 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.38 -45.3 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.929 -1.107 . . . . 1.1399999999999999 109.719 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.59 -37.79 85.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 1.1299999999999999 109.53 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.115 -1.594 . . . . 0.34999999999999998 109.115 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -1.134 . . . . 3.2200000000000002 110.073 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -66.51 -48.44 69.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.851 -1.156 . . . . 2.1000000000000001 109.609 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.6 -38.1 83.56 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.008 -1.108 . . . . 1.0800000000000001 108.008 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -42.49 94.25 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.245 -0.65 . . . . 1.6699999999999999 109.245 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.5 -19.34 65.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 2.0 108.718 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -90.48 1.64 56.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 3.1499999999999999 110.285 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.61 7.0 43.15 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.944 -1.098 . . . . 0.47999999999999998 111.583 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.2 76.25 1.08 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.878 -1.366 . . . . 0.38 109.131 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.72 -7.26 57.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.865 . . . . 0.40999999999999998 111.162 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.18 158.88 43.43 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.072 -1.017 . . . . 2.1600000000000001 110.54 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.9 86.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.762 -0.586 . . . . 1.03 112.107 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 3.5 p90 -61.99 -18.82 61.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.433 -1.417 . . . . 0.92000000000000004 109.861 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -79.95 -31.87 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.773 -1.195 . . . . 1.0700000000000001 107.773 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -77.94 -37.34 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.061 -1.089 . . . . 1.0600000000000001 108.061 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.93 -35.21 74.43 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.993 -1.484 . . . . 1.1599999999999999 106.993 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -43.0 98.75 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 110.198 -1.161 . . . . 0.20000000000000001 110.198 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.078 -1.248 . . . . 1.8200000000000001 109.053 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.92 -41.5 91.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.40000000000000002 108.66 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.94 -40.04 75.73 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.742 -0.836 . . . . 1.0900000000000001 108.742 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.18 -25.41 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.109 -0.994 . . . . 1.0900000000000001 110.684 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.67 16.29 8.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 109.785 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 55' ' ' ASP . 8.8 mtmp? 51.94 44.94 29.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 2.2200000000000002 110.609 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 pttt 40.7 18.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.971 -1.081 . . . . 2.7999999999999998 111.528 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' LYS . 57.9 m-20 -66.59 115.56 6.58 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.847 -1.538 . . . . 1.8 106.847 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.59 -40.37 96.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.87 112.784 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.04 -39.94 75.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.378 -1.451 . . . . 0.72999999999999998 110.107 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.55 -40.0 73.63 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.121 -1.032 . . . . 1.2 109.105 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.66 -49.74 73.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.44 109.491 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.526 HH12 ' NH2' ' A' ' 75' ' ' ARG . 64.9 mtp180 -60.01 -46.35 89.79 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.444 -0.785 . . . . 3.3399999999999999 111.249 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.21 -36.36 83.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.674 -1.266 . . . . 2.3700000000000001 108.905 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.45 ' O ' ' OG1' ' A' ' 66' ' ' THR . 69.6 t90 -63.62 -48.96 75.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.40999999999999998 111.067 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.403 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 60.9 tp -67.75 -46.98 70.52 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.054 -1.029 . . . . 1.0800000000000001 110.548 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -63.11 -46.48 87.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.983 . . . . 2.6099999999999999 109.424 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.4 t0 -67.55 -31.08 70.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.618 . . . . 1.8999999999999999 109.605 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 95.9 m -78.52 -36.61 44.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 1.1100000000000001 111.653 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 18.7 p -130.41 -27.45 2.19 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.474 -1.391 . . . . 0.96999999999999997 112.228 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.17 14.22 19.21 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.3 -1.52 . . . . 0.38 109.3 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.14 153.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.913 -1.345 . . . . 1.1000000000000001 109.159 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.02 173.33 8.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.076 -1.015 . . . . 2.3700000000000001 110.133 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.98 74.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.558 -0.714 . . . . 1.1200000000000001 110.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.87 -40.43 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.856 -1.153 . . . . 2.9700000000000002 110.157 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.35 -40.02 81.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.139 -0.975 . . . . 2.6200000000000001 110.676 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 t -68.15 -38.37 82.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.128 -0.982 . . . . 1.8899999999999999 109.927 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.526 ' NH2' HH12 ' A' ' 60' ' ' ARG . 52.6 mtt-85 -60.02 -38.46 82.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.961 -1.087 . . . . 3.3199999999999998 108.973 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -67.94 -40.02 83.37 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.712 -1.242 . . . . 0.40000000000000002 110.392 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.22 -39.94 82.21 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.743 -1.223 . . . . 0.95999999999999996 109.493 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.1 -59.99 4.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.848 -1.157 . . . . 0.5 109.899 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.79 -34.26 89.24 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.278 -0.963 . . . . 0.27000000000000002 110.736 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.09 -47.61 61.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.3 . . . . 0.93999999999999995 110.061 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.9 mt -70.0 -39.87 75.62 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 1.0900000000000001 108.234 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.23 -40.5 96.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 3.1800000000000002 109.883 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -69.23 -39.96 78.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.999 . . . . 1.9099999999999999 110.754 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 84.5 t90 -59.98 -43.79 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.419 -1.426 . . . . 0.40000000000000002 107.734 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.5 m -60.89 -40.07 91.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.63 0.729 . . . . 0.96999999999999997 109.694 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.01 -34.24 73.08 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.105 -0.997 . . . . 0.55000000000000004 110.148 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.78 -35.26 14.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.963 . . . . 1.1200000000000001 111.151 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 88.0 m-85 . . . . . 0 N--CA 1.505 2.316 0 O-C-N 121.116 -0.99 . . . . 1.24 111.265 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.115 -0.698 . . . . 1.97 109.115 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.64 -20.09 30.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.548 -0.72 . . . . 2.5899999999999999 109.609 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -61.32 -37.55 83.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 2.5 109.201 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -60.06 -49.93 75.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.51000000000000001 110.35 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.25 -34.67 73.1 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.125 -0.984 . . . . 3.73 110.11 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.61 -40.05 80.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.76000000000000001 109.573 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.73 -46.71 81.1 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.5 110.051 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 m -86.57 9.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.123 -0.986 . . . . 1.1799999999999999 110.812 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.24 -15.01 15.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.992 -1.068 . . . . 1.1799999999999999 110.258 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' B' ' 14' ' ' PRO . 8.2 pt-20 -152.0 152.52 29.97 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.144 -0.973 . . . . 1.27 108.98 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' B' ' 13' ' ' GLU . 69.0 Cg_exo -37.11 155.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.204 1.936 . . . . 0.53000000000000003 111.65 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 13.2 ptm -95.49 -30.44 13.85 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -0.923 . . . . 1.1299999999999999 110.057 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.73 -133.43 50.07 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.343 -1.103 . . . . 0.40999999999999998 110.343 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -113.02 35.48 3.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.729 -0.865 . . . . 0.83999999999999997 110.089 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -54.9 149.63 22.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.98 -1.119 . . . . 2.4900000000000002 107.98 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.01 157.57 33.53 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.071 1.848 . . . . 0.38 112.274 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' B' ' 21' ' ' GLY . 12.7 p -57.09 -45.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.666 0.746 . . . . 1.1200000000000001 110.215 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.421 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -61.97 -1.59 3.04 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.615 -0.994 . . . . 0.27000000000000002 110.615 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -82.75 -27.4 31.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.706 -1.467 . . . . 1.75 109.644 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.07 138.17 57.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 1.0600000000000001 109.487 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 135.15 54.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.753 0.787 . . . . 1.05 109.838 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.49 -20.07 51.88 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.238 -1.545 . . . . 0.22 109.238 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 33.4 mm -99.42 115.45 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.335 -1.097 . . . . 1.0800000000000001 108.306 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.32 177.55 37.92 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.567 -1.413 . . . . 0.29999999999999999 109.567 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.76 -40.02 75.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.407 -1.055 . . . . 2.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.47 -45.3 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.088 . . . . 1.1399999999999999 109.722 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.48 -37.94 86.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 1.1299999999999999 109.449 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.0 95.76 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.139 -1.585 . . . . 0.35999999999999999 109.139 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.808 ' CA ' ' N ' ' B' ' 33' ' ' LYS . 7.3 ttpm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.402 -1.058 . . . . 3.2200000000000002 . 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.808 ' N ' ' CA ' ' B' ' 32' ' ' LYS . 62.5 mttm . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.628 -0.508 . . . . 2.1200000000000001 109.628 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.5 -38.18 83.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.979 -1.119 . . . . 1.0800000000000001 107.979 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.05 -42.28 94.11 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.204 -0.665 . . . . 1.6799999999999999 109.204 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.75 -19.24 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.691 -0.855 . . . . 1.99 108.691 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -90.25 1.29 56.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 3.1499999999999999 110.299 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.06 6.75 42.18 Favored Glycine 0 N--CA 1.503 3.117 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.558 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -106.98 76.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.789 -1.418 . . . . 0.38 109.246 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -78.3 -7.45 57.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.126 -0.984 . . . . 0.40999999999999998 111.112 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.12 158.78 43.63 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.97 -1.081 . . . . 2.1499999999999999 110.529 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.93 -40.38 87.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 1.03 111.952 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 2.8 p90 -61.4 -18.64 59.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.506 -1.371 . . . . 0.92000000000000004 110.24 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -80.22 -31.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.788 -1.19 . . . . 1.0800000000000001 107.788 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 69.8 t -78.15 -37.25 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.029 -1.1 . . . . 1.0700000000000001 108.029 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 tp -59.98 -35.06 74.19 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.017 -1.475 . . . . 1.1499999999999999 107.017 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -43.18 98.55 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 110.223 -1.151 . . . . 0.19 110.223 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.136 -1.214 . . . . 1.8200000000000001 109.113 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.99 -41.42 91.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.40000000000000002 108.669 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.01 -39.87 75.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.686 -0.857 . . . . 1.0700000000000001 108.686 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.48 -25.41 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.062 -1.024 . . . . 1.0900000000000001 110.6 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.5 15.96 8.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.091 -1.005 . . . . 1.0900000000000001 109.762 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 55' ' ' ASP . 8.8 mtmp? 52.04 45.11 28.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 2.23 110.556 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 pttt 40.6 19.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.912 -1.117 . . . . 2.7999999999999998 111.564 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 53' ' ' LYS . 61.6 m-20 -66.67 115.21 6.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.917 -1.512 . . . . 1.8 106.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.5 -40.27 96.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.262 -0.899 . . . . 0.88 112.746 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -69.86 -40.07 75.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.341 -1.475 . . . . 0.73999999999999999 110.257 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.67 -39.95 73.25 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.093 -1.043 . . . . 1.2 109.008 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.5 -49.89 73.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.44 109.459 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.534 HH12 ' NH2' ' B' ' 75' ' ' ARG . 64.5 mtp180 -60.03 -45.92 91.23 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.528 -0.733 . . . . 3.3399999999999999 111.292 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.58 -36.54 84.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.678 -1.264 . . . . 2.3799999999999999 108.857 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' B' ' 66' ' ' THR . 69.4 t90 -63.4 -49.07 75.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.40999999999999998 111.038 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.81 -46.75 70.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.1 -1.0 . . . . 1.0700000000000001 110.564 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -63.3 -46.32 87.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 2.6000000000000001 109.393 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 34.8 t0 -67.64 -31.16 70.97 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.746 -0.596 . . . . 1.8999999999999999 109.652 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 97.2 m -78.49 -36.61 44.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.939 . . . . 1.1000000000000001 111.687 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 18.5 p -130.44 -27.2 2.21 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.49 -1.381 . . . . 0.95999999999999996 112.217 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.98 13.96 20.25 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.333 -1.507 . . . . 0.37 109.333 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.98 153.36 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.922 -1.34 . . . . 1.0900000000000001 109.183 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -91.04 173.39 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 2.3700000000000001 110.094 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 1.1100000000000001 110.154 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.79 -40.44 69.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 2.9700000000000002 110.097 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 2.6200000000000001 110.656 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 5.7 t -68.14 -38.45 82.17 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -0.983 . . . . 1.8899999999999999 109.916 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.534 ' NH2' HH12 ' B' ' 60' ' ' ARG . 52.6 mtt-85 -59.95 -38.64 83.05 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.907 -1.121 . . . . 3.3199999999999998 109.013 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.81 -39.94 83.92 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.871 -1.143 . . . . 0.40000000000000002 110.304 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.21 -40.06 82.21 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.789 -1.195 . . . . 0.95999999999999996 109.508 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.95 -60.15 4.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.894 -1.129 . . . . 0.5 109.888 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.73 -34.35 89.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.653 -0.979 . . . . 0.27000000000000002 110.653 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.1 -47.56 61.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.322 . . . . 0.93999999999999995 110.024 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.91 -40.0 75.85 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.1 -1.04 . . . . 1.0900000000000001 108.314 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -62.08 -40.75 96.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.312 -0.868 . . . . 3.1899999999999999 109.819 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -69.0 -39.92 79.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 1.9099999999999999 110.754 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 84.8 t90 -59.96 -44.03 94.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.451 -1.406 . . . . 0.40000000000000002 107.622 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' B' ' 89' ' ' LEU . 41.2 m -60.81 -40.01 91.13 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 0.96999999999999997 109.737 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -59.97 -34.46 73.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.988 -1.07 . . . . 0.55000000000000004 110.2 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.6 -35.14 14.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.068 -1.02 . . . . 1.1299999999999999 111.162 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 89.7 m-85 -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.115 -0.991 . . . . 1.24 111.407 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.1 tp . . . . . 0 N--CA 1.496 1.861 0 O-C-N 120.809 -1.182 . . . . 1.8300000000000001 109.535 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.1 -0.704 . . . . 1.98 109.1 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -55.23 -20.65 11.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 2.6000000000000001 110.234 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.25 -36.96 81.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 2.5099999999999998 109.218 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.427 ' NE2' ' OE2' ' A' ' 83' ' ' GLU . 16.1 t60 -60.06 -50.15 74.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.067 . . . . 0.51000000000000001 110.731 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 8' ' ' ARG . 4.1 mmt-85 -70.05 -34.3 73.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.045 -1.034 . . . . 3.7200000000000002 109.743 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -72.08 -37.55 69.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.76000000000000001 109.987 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.49 84.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.5 109.913 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -82.99 15.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 1.1799999999999999 109.401 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.39 -8.49 10.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.557 -0.714 . . . . 1.1799999999999999 110.362 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.29 151.0 23.25 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.887 -1.133 . . . . 1.26 109.554 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.5 161.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.916 1.744 . . . . 0.53000000000000003 111.831 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.8 ptp -96.13 -24.71 16.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.218 -0.926 . . . . 1.1399999999999999 109.788 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.84 -136.85 44.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.346 -1.501 . . . . 0.41999999999999998 109.346 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -110.83 34.77 3.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.41 -1.053 . . . . 0.84999999999999998 109.965 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -60.0 149.6 73.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.943 -1.098 . . . . 2.4900000000000002 108.974 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.79 156.52 37.58 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.334 2.022 . . . . 0.39000000000000001 112.301 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 22' ' ' SER . 10.4 p -57.95 -48.12 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.819 . . . . 1.1200000000000001 110.267 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -55.35 -1.44 0.18 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.494 -1.042 . . . . 0.27000000000000002 110.494 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 20' ' ' VAL . 80.3 p -81.32 -24.82 36.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.714 -1.462 . . . . 1.75 109.179 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.6 138.88 58.68 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.65 0.738 . . . . 1.05 109.893 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 134.63 54.32 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.815 -0.754 . . . . 1.0600000000000001 109.426 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.2 -20.62 46.52 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.746 -1.342 . . . . 0.23000000000000001 109.746 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.32 118.57 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.123 -1.222 . . . . 1.0800000000000001 108.396 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.03 179.95 34.09 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.618 -1.393 . . . . 0.31 109.618 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -58.16 -40.09 80.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -1.139 . . . . 2.0099999999999998 110.428 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.89 -47.19 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.793 -1.192 . . . . 1.1399999999999999 109.326 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.68 -38.56 87.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.827 . . . . 1.1299999999999999 109.412 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.97 96.19 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.439 -1.464 . . . . 0.34999999999999998 109.439 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.32 -39.94 94.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -1.12 . . . . 3.2200000000000002 110.018 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.32 -47.39 73.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 2.1000000000000001 109.369 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.14 -39.66 93.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 1.0800000000000001 108.964 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -43.16 95.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.437 -0.905 . . . . 1.6699999999999999 108.867 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -64.72 -19.87 66.02 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 2.0 108.443 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HG2' HH11 ' A' ' 37' ' ' ARG . 1.1 mmt-85 -90.06 2.42 55.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.438 -0.789 . . . . 3.1499999999999999 110.271 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.76 6.29 46.69 Favored Glycine 0 N--CA 1.505 3.286 0 O-C-N 121.083 -1.011 . . . . 0.47999999999999998 111.948 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -105.3 75.14 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.726 -1.455 . . . . 0.38 109.236 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' B' ' 53' ' ' LYS . 37.2 p-10 -80.02 -10.52 59.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.40999999999999998 110.389 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.75 153.28 51.35 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.182 -0.948 . . . . 2.1600000000000001 110.001 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.93 92.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.731 -0.606 . . . . 1.03 111.969 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 27.0 p90 -56.85 -17.95 11.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.834 -1.166 . . . . 0.92000000000000004 110.665 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.63 -33.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.87 -1.144 . . . . 1.0700000000000001 108.204 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.7 t -74.09 -38.83 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.562 -1.273 . . . . 1.0600000000000001 107.562 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.26 -38.81 77.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.808 -1.182 . . . . 1.1599999999999999 107.808 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.34 -43.22 93.84 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.932 -1.267 . . . . 0.20000000000000001 109.932 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -60.16 -42.75 95.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.268 . . . . 1.8200000000000001 108.559 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.04 -40.05 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.539 -0.911 . . . . 0.40000000000000002 108.539 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.9 mt -69.92 -39.96 75.83 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.594 -0.891 . . . . 1.0900000000000001 108.594 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.22 -25.65 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 1.0900000000000001 110.678 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.7 15.23 9.96 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.921 -1.112 . . . . 1.0900000000000001 109.886 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' B' ' 40' ' ' ASP . 67.9 mttm 52.15 29.47 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.063 -1.023 . . . . 2.2200000000000002 110.607 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.687 ' HZ1' HH12 ' A' ' 82' ' ' ARG . 83.4 mttt 60.06 19.83 9.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 2.7999999999999998 110.685 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.19 115.73 7.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.406 -1.434 . . . . 1.8 107.957 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.72 -40.14 96.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.87 112.281 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 90.2 m-20 -68.3 -39.94 81.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.554 -1.341 . . . . 0.72999999999999998 109.961 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.5 -39.69 67.43 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.166 -1.013 . . . . 1.2 109.101 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.35 -49.43 73.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.44 110.401 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.534 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 81.3 mtm180 -60.04 -44.8 94.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 3.3399999999999999 110.693 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.71 -37.8 87.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 2.3700000000000001 108.902 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 66' ' ' THR . 72.5 t90 -64.83 -48.73 73.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -0.983 . . . . 0.40999999999999998 110.8 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 54.8 tp -66.97 -46.57 74.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.997 . . . . 1.0800000000000001 109.391 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.88 -46.52 87.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 2.6099999999999999 109.412 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -31.0 69.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.688 -0.633 . . . . 1.8999999999999999 109.91 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 91.4 m -77.95 -37.51 47.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 1.1100000000000001 111.809 -177.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 6.2 p -130.13 -25.73 2.45 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.503 -1.373 . . . . 0.96999999999999997 111.933 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 13.43 26.51 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.063 -1.615 . . . . 0.38 109.063 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.93 153.94 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.238 . . . . 1.1000000000000001 109.031 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -91.15 -180.0 5.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.989 -1.069 . . . . 2.3700000000000001 109.779 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -33.19 75.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.772 . . . . 1.1200000000000001 110.823 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -71.49 -40.07 70.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.862 -1.149 . . . . 2.9700000000000002 109.789 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.92 -37.7 84.83 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.426 -0.796 . . . . 2.6200000000000001 110.438 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.626 ' HG ' ' N ' ' A' ' 75' ' ' ARG . 20.5 p -67.03 -37.82 84.81 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.135 -0.978 . . . . 1.8899999999999999 110.004 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.626 ' N ' ' HG ' ' A' ' 74' ' ' SER . 47.3 mtt-85 -59.97 -37.85 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.762 -1.211 . . . . 3.3199999999999998 108.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.88 -40.01 83.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.837 -1.164 . . . . 0.40000000000000002 110.718 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.25 -40.05 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.605 -1.309 . . . . 0.95999999999999996 109.948 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.27 -60.2 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.741 -1.225 . . . . 0.5 109.451 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.01 -33.58 79.73 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.339 -1.105 . . . . 0.27000000000000002 110.339 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.16 -51.06 50.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.105 -1.232 . . . . 0.93999999999999995 109.91 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.913 -1.115 . . . . 1.0900000000000001 109.619 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.687 HH12 ' HZ1' ' A' ' 54' ' ' LYS . 23.8 tpt180 -60.12 -44.48 94.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 3.1800000000000002 110.117 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' OE2' ' NE2' ' A' ' 7' ' ' HIS . 44.7 mt-10 -70.39 -38.1 74.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.86 . . . . 1.9099999999999999 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 89.3 t90 -61.88 -43.0 99.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.442 -1.411 . . . . 0.40000000000000002 108.397 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.8 m -61.29 -40.48 94.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.441 -0.787 . . . . 0.96999999999999997 110.379 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.83 -27.88 67.0 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.198 -0.939 . . . . 0.55000000000000004 109.338 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.82 -34.45 12.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 1.1200000000000001 110.801 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.9 m-85 . . . . . 0 N--CA 1.505 2.29 0 O-C-N 121.259 -0.9 . . . . 1.24 112.812 -177.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.009 -0.737 . . . . 1.97 109.009 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -55.2 -20.77 11.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 2.5899999999999999 110.265 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.23 -36.99 81.47 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.891 -1.131 . . . . 2.5 109.206 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.421 ' CE1' ' OE2' ' B' ' 83' ' ' GLU . 16.1 t60 -59.99 -50.18 74.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.51000000000000001 110.76 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.488 ' HG2' HH11 ' B' ' 8' ' ' ARG . 4.0 mmt-85 -69.91 -34.45 73.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 3.73 109.785 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -72.06 -37.53 69.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.76000000000000001 109.959 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.407 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.48 84.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.5 109.88 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -83.1 15.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 1.1799999999999999 109.374 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.62 -8.41 9.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.597 -0.689 . . . . 1.1799999999999999 110.358 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.33 151.07 23.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.872 -1.142 . . . . 1.27 109.53 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -42.6 161.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.824 1.683 . . . . 0.53000000000000003 111.971 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.6 ptp -96.25 -24.4 16.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 1.1299999999999999 109.769 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.91 43.11 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.364 -1.494 . . . . 0.40999999999999998 109.364 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -110.71 34.78 3.78 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.429 -1.042 . . . . 0.83999999999999997 110.025 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -59.98 149.71 72.69 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.966 -1.084 . . . . 2.4900000000000002 108.967 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.87 156.42 38.46 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.304 2.003 . . . . 0.38 112.352 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.508 ' C ' ' H ' ' B' ' 22' ' ' SER . 10.7 p -57.87 -48.15 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 1.1200000000000001 110.271 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.421 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -55.43 -1.19 0.16 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.506 -1.038 . . . . 0.27000000000000002 110.506 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.508 ' H ' ' C ' ' B' ' 20' ' ' VAL . 81.0 p -81.5 -24.72 36.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.699 -1.471 . . . . 1.75 109.148 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.69 138.8 58.64 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.649 0.738 . . . . 1.0600000000000001 109.952 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.94 134.49 54.06 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.765 -0.774 . . . . 1.05 109.582 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.38 -20.73 45.73 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.749 -1.34 . . . . 0.22 109.749 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.18 118.62 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.213 -1.169 . . . . 1.0800000000000001 108.398 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.99 179.96 34.16 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.59 -1.404 . . . . 0.29999999999999999 109.59 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.28 -39.98 80.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.261 -1.14 . . . . 2.0 110.425 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 66.1 t -66.88 -47.25 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 1.1399999999999999 109.402 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.46 -38.65 87.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.336 -0.852 . . . . 1.1299999999999999 109.531 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.91 -40.01 96.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.353 -1.499 . . . . 0.35999999999999999 109.353 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.31 -39.88 94.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 3.2200000000000002 110.107 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.4 -47.21 74.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.86 -1.15 . . . . 2.1200000000000001 109.33 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.28 -39.58 93.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 1.0800000000000001 109.039 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.464 -0.894 . . . . 1.6799999999999999 108.86 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.68 -19.88 65.99 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.439 -0.949 . . . . 1.99 108.439 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' B' ' 37' ' ' ARG . 1.1 mmt-85 -90.1 2.68 54.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 3.1499999999999999 110.376 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 6.37 47.43 Favored Glycine 0 N--CA 1.504 3.223 0 O-C-N 120.988 -1.07 . . . . 0.48999999999999999 112.057 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -105.4 75.25 1.14 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.808 -1.407 . . . . 0.38 109.143 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 37.3 p-10 -80.21 -10.23 59.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.40999999999999998 110.432 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -133.0 153.37 51.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.246 -0.909 . . . . 2.1499999999999999 109.916 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.77 93.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.838 -0.539 . . . . 1.03 112.068 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 27.3 p90 -57.08 -18.01 12.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.92000000000000004 110.524 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.51 -33.56 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.901 -1.124 . . . . 1.0800000000000001 108.248 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.1 t -74.19 -38.79 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.472 -1.307 . . . . 1.0700000000000001 107.472 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 24.8 tp -58.38 -38.98 78.41 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.769 -1.197 . . . . 1.1499999999999999 107.769 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.31 -43.13 93.81 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.856 -1.297 . . . . 0.19 109.856 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -60.03 -42.83 95.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.93 -1.335 . . . . 1.8200000000000001 108.548 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.09 -39.95 87.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.559 -0.904 . . . . 0.40000000000000002 108.559 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.97 -40.04 75.62 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 1.0700000000000001 108.538 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.05 -25.56 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.242 -0.911 . . . . 1.0900000000000001 110.694 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.84 15.34 9.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.921 -1.112 . . . . 1.0900000000000001 109.838 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 67.9 mttm 51.98 29.46 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 2.23 110.661 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . 0.692 ' HZ1' HH12 ' B' ' 82' ' ' ARG . 83.5 mttt 60.01 19.74 8.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.782 -0.573 . . . . 2.7999999999999998 110.718 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -68.02 115.7 7.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.445 -1.41 . . . . 1.8 107.947 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.65 -40.32 96.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.88 112.205 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 90.4 m-20 -68.28 -39.97 81.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.512 -1.368 . . . . 0.73999999999999999 109.921 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.39 -39.67 67.79 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.141 -1.023 . . . . 1.2 109.215 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.45 -49.43 73.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.44 110.43 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 81.5 mtm180 -59.97 -45.03 94.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 3.3399999999999999 110.658 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.53 -37.61 87.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.855 -1.153 . . . . 2.3799999999999999 108.931 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.455 ' O ' ' OG1' ' B' ' 66' ' ' THR . 72.6 t90 -65.03 -48.55 73.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.004 . . . . 0.40999999999999998 110.876 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.465 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 54.6 tp -67.04 -46.67 73.7 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.135 -0.978 . . . . 1.0700000000000001 109.392 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.84 -46.4 88.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 2.6000000000000001 109.481 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.25 -30.94 69.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 1.8999999999999999 109.835 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.8 m -77.97 -37.52 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 1.1000000000000001 111.741 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 6.1 p -130.03 -25.94 2.45 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.398 -1.439 . . . . 0.95999999999999996 111.945 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.49 13.65 25.74 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 108.997 -1.641 . . . . 0.37 108.997 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.02 154.0 2.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.279 . . . . 1.0900000000000001 108.983 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -91.31 -179.98 5.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.035 -1.04 . . . . 2.3700000000000001 109.829 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.06 74.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 1.1100000000000001 110.832 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -71.61 -40.07 70.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 2.9700000000000002 109.823 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.9 -37.64 84.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.503 -0.748 . . . . 2.6200000000000001 110.542 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.62 ' HG ' ' N ' ' B' ' 75' ' ' ARG . 20.4 p -67.14 -37.73 84.31 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.122 -0.987 . . . . 1.8899999999999999 110.004 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.62 ' N ' ' HG ' ' B' ' 74' ' ' SER . 46.9 mtt-85 -60.01 -37.77 80.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.77 -1.206 . . . . 3.3199999999999998 108.778 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.0 -39.96 83.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.871 -1.143 . . . . 0.40000000000000002 110.728 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.1 m -68.27 -40.05 82.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.641 -1.287 . . . . 0.95999999999999996 109.884 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.35 -60.04 4.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.784 -1.197 . . . . 0.5 109.499 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -33.57 79.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.359 -1.096 . . . . 0.27000000000000002 110.359 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -68.25 -51.01 49.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.046 -1.267 . . . . 0.93999999999999995 109.903 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 82.0 mt -73.18 -41.16 64.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.953 -1.099 . . . . 1.0900000000000001 109.591 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.692 HH12 ' HZ1' ' B' ' 54' ' ' LYS . 23.8 tpt180 -60.16 -44.33 95.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.959 . . . . 3.1899999999999999 110.192 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.421 ' OE2' ' CE1' ' B' ' 7' ' ' HIS . 44.7 mt-10 -70.38 -38.21 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 1.9099999999999999 110.585 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.422 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 89.1 t90 -61.79 -43.04 99.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.486 -1.384 . . . . 0.40000000000000002 108.409 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.2 m -61.34 -40.41 94.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.96999999999999997 110.391 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.88 -27.76 66.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.3 -0.875 . . . . 0.55000000000000004 109.368 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.91 -35.01 12.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 1.1299999999999999 110.724 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.422 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 88.7 m-85 -109.97 -8.08 14.89 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.235 -0.915 . . . . 1.24 112.996 -177.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' B' ' 85' ' ' CYS . 13.2 tp . . . . . 0 N--CA 1.502 2.141 0 O-C-N 120.224 -1.547 . . . . 1.8300000000000001 109.414 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.694 -0.854 . . . . 1.98 108.694 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.92 -24.9 64.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.542 -0.724 . . . . 2.6000000000000001 109.304 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.28 -36.93 81.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.909 . . . . 2.5099999999999998 109.256 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.563 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 60.0 t60 -59.9 -54.37 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.51000000000000001 110.839 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.9 -33.64 72.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.993 -1.067 . . . . 3.7200000000000002 110.154 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.97 -39.6 75.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.313 -0.867 . . . . 0.76000000000000001 109.342 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.54 -47.62 80.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.5 110.384 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.5 m -80.89 14.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.01 -1.056 . . . . 1.1799999999999999 109.685 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.4 -11.08 13.71 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.508 -0.745 . . . . 1.1799999999999999 110.081 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 14' ' ' PRO . 12.6 pt-20 -153.97 150.99 23.76 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.093 -1.004 . . . . 1.26 109.105 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLU . 93.5 Cg_exo -40.48 166.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.883 1.722 . . . . 0.53000000000000003 112.123 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.0 ptp -92.24 -20.22 21.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.213 -0.93 . . . . 1.1399999999999999 109.171 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.6 -141.52 5.97 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.339 -1.504 . . . . 0.41999999999999998 109.339 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.26 30.05 6.57 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.439 -1.036 . . . . 0.84999999999999998 109.812 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -60.4 148.84 79.1 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 2.4900000000000002 108.908 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.46 155.36 53.12 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.265 1.977 . . . . 0.39000000000000001 112.79 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.2 p -57.23 -47.18 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.626 0.727 . . . . 1.1200000000000001 110.184 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.97 -3.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.514 -1.034 . . . . 0.27000000000000002 110.514 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 20' ' ' VAL . 23.0 t -83.08 -22.3 33.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.758 -1.436 . . . . 1.75 109.47 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.11 58.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.146 -0.971 . . . . 1.05 109.766 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.34 133.83 51.32 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.857 -0.737 . . . . 1.0600000000000001 109.83 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.79 -20.01 51.04 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.315 -1.514 . . . . 0.23000000000000001 109.315 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -99.89 113.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.736 -1.209 . . . . 1.0800000000000001 107.736 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.47 176.29 43.11 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.828 -1.309 . . . . 0.31 109.828 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -58.31 -39.96 80.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.502 -0.999 . . . . 2.0099999999999998 109.702 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.03 -47.88 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 1.1399999999999999 109.548 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.84 -39.83 83.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 1.1299999999999999 109.307 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.97 96.43 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.32 -1.512 . . . . 0.34999999999999998 109.32 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -61.13 -39.98 92.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -1.094 . . . . 3.2200000000000002 110.664 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.19 -41.84 89.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.731 -1.231 . . . . 2.1000000000000001 110.133 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.9 mt -60.03 -39.61 86.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 1.0800000000000001 109.089 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -59.96 -40.04 87.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.375 -0.93 . . . . 1.6699999999999999 109.639 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.05 -19.42 64.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.908 . . . . 2.0 108.804 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -90.1 1.35 56.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.587 -0.695 . . . . 3.1499999999999999 109.515 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.11 38.78 3.47 Favored Glycine 0 N--CA 1.497 2.754 0 O-C-N 121.232 -0.918 . . . . 0.47999999999999998 110.985 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -132.37 71.9 1.48 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.212 -1.17 . . . . 0.38 108.321 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -75.48 -12.38 60.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.053 -1.029 . . . . 0.40999999999999998 110.495 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -134.34 156.86 47.73 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.165 -0.96 . . . . 2.1600000000000001 109.434 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -40.22 93.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 1.03 111.678 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -58.44 -17.34 19.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.837 -1.164 . . . . 0.92000000000000004 110.717 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.77 -31.62 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.87 -1.159 . . . . 1.0700000000000001 107.87 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.81 -38.69 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.739 -1.208 . . . . 1.0600000000000001 107.739 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.66 -38.75 82.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.286 -1.375 . . . . 1.1599999999999999 107.286 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.08 71.59 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.965 -1.254 . . . . 0.20000000000000001 109.965 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -60.05 -42.56 94.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -1.213 . . . . 1.8200000000000001 109.885 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.07 -39.96 87.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.096 -1.003 . . . . 0.40000000000000002 108.68 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.1 -38.34 75.63 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.616 -0.883 . . . . 1.0900000000000001 108.616 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.53 -22.51 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.153 -0.967 . . . . 1.0900000000000001 110.733 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.86 17.85 7.29 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.053 -1.03 . . . . 1.0900000000000001 109.735 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 52.06 29.43 6.33 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.073 -1.017 . . . . 2.2200000000000002 109.611 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.4 mttt 60.08 19.88 9.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.855 -0.528 . . . . 2.7999999999999998 109.944 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.99 114.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.821 -1.178 . . . . 1.8 107.821 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.72 -39.99 90.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.87 112.856 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.56 -39.57 84.93 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.462 -1.399 . . . . 0.72999999999999998 110.687 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.98 -38.97 76.21 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.018 -1.073 . . . . 1.2 109.566 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.63 -43.69 92.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.44 109.884 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -60.04 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 3.3399999999999999 110.941 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.77 -38.83 90.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.896 -1.127 . . . . 2.3700000000000001 109.25 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.442 ' O ' ' OG1' ' A' ' 66' ' ' THR . 75.9 t90 -64.34 -49.48 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.019 -1.051 . . . . 0.40999999999999998 110.993 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.3 tp -66.9 -47.25 72.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.04 -1.037 . . . . 1.0800000000000001 109.998 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.83 -44.47 89.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 2.6099999999999999 109.8 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.3 t0 -69.63 -30.95 68.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.557 -0.715 . . . . 1.8999999999999999 109.664 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 97.1 m -79.31 -34.73 42.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 1.1100000000000001 111.332 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.7 p -130.39 -29.68 1.98 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.598 -1.314 . . . . 0.96999999999999997 112.078 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.98 14.48 20.8 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.401 -1.48 . . . . 0.38 109.401 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.73 154.79 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.034 -1.274 . . . . 1.1000000000000001 109.296 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -89.22 169.91 11.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.984 -1.073 . . . . 2.3700000000000001 110.266 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.36 73.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.687 . . . . 1.1200000000000001 111.02 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.01 -40.05 75.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.629 -1.295 . . . . 2.9700000000000002 109.654 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -64.88 -30.1 71.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.537 -0.727 . . . . 2.6200000000000001 110.572 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.61 ' HG ' ' N ' ' A' ' 75' ' ' ARG . 36.7 p -68.79 -39.6 80.07 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.987 -1.07 . . . . 1.8899999999999999 110.611 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -60.01 -37.85 80.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.547 -1.346 . . . . 3.3199999999999998 109.092 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.58 -1.325 . . . . 0.40000000000000002 110.412 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 86.2 m -70.01 -40.27 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.791 -1.193 . . . . 0.95999999999999996 109.502 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.17 -61.03 2.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 0.5 109.789 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.53 -33.08 83.55 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.196 -1.161 . . . . 0.27000000000000002 110.196 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 46.7 t -71.0 -46.88 61.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.922 -1.34 . . . . 0.93999999999999995 109.797 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.89 -40.98 68.52 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.01 -1.076 . . . . 1.0900000000000001 109.068 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.75 -40.44 97.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.121 -0.987 . . . . 3.1800000000000002 110.147 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.563 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 96.0 mt-10 -70.14 -38.38 75.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 1.9099999999999999 110.459 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.7 t90 -61.49 -47.81 83.93 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.527 -1.358 . . . . 0.40000000000000002 108.087 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.4 m -59.99 -40.14 88.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.498 -0.751 . . . . 0.96999999999999997 109.841 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.47 -29.82 68.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.005 . . . . 0.55000000000000004 109.364 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.52 -33.67 12.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.302 -0.874 . . . . 1.1200000000000001 110.705 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 86.3 m-85 . . . . . 0 N--CA 1.504 2.273 0 O-C-N 121.277 -0.889 . . . . 1.24 112.45 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 108.653 -0.869 . . . . 1.97 108.653 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.93 -25.0 64.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 2.5899999999999999 109.352 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.19 -36.97 81.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 2.5 109.322 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.56 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 60.3 t60 -59.93 -54.17 49.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.51000000000000001 110.793 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.95 -33.65 72.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 3.73 110.127 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.01 -39.41 75.84 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.348 -0.845 . . . . 0.76000000000000001 109.367 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.8 -47.59 80.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.5 110.316 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.93 14.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.042 -1.036 . . . . 1.1799999999999999 109.68 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.34 -11.01 13.75 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.552 -0.717 . . . . 1.1799999999999999 110.121 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 14' ' ' PRO . 12.6 pt-20 -154.0 151.17 24.09 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 1.27 109.02 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.5 Cg_exo -40.44 166.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.958 1.772 . . . . 0.53000000000000003 112.074 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 1.9 ptp -92.57 -20.11 21.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.15 -0.968 . . . . 1.1299999999999999 109.081 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.71 -141.43 6.17 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.427 -1.469 . . . . 0.40999999999999998 109.427 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.27 29.95 6.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.527 -0.984 . . . . 0.83999999999999997 109.787 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.47 148.82 79.65 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.89 -1.131 . . . . 2.4900000000000002 108.812 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.43 155.49 52.12 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.218 1.945 . . . . 0.38 112.774 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.3 p -57.21 -47.15 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.674 0.75 . . . . 1.1200000000000001 110.222 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.403 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -52.01 -3.42 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.572 -1.011 . . . . 0.27000000000000002 110.572 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.543 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.8 t -82.92 -22.21 33.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.413 . . . . 1.75 109.485 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.07 58.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 1.0600000000000001 109.807 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.9 51.42 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.591 0.71 . . . . 1.05 109.792 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.518 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.76 -20.06 50.88 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.399 -1.48 . . . . 0.22 109.399 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.406 HG23 HD13 ' B' ' 26' ' ' ILE . 37.9 mm -99.9 113.53 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 107.622 -1.251 . . . . 1.0800000000000001 107.622 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.51 176.26 43.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.829 -1.308 . . . . 0.29999999999999999 109.829 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -58.26 -39.97 80.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.445 -1.032 . . . . 2.0 109.678 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.21 -47.67 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.049 -1.032 . . . . 1.1399999999999999 109.559 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.91 -39.86 83.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 1.1299999999999999 109.301 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.97 96.27 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.343 -1.503 . . . . 0.35999999999999999 109.343 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -61.21 -39.9 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -1.073 . . . . 3.2200000000000002 110.66 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -66.24 -41.82 89.49 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.705 -1.247 . . . . 2.1200000000000001 110.154 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 63.7 mt -60.03 -39.56 86.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.087 -1.008 . . . . 1.0800000000000001 109.084 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -60.12 -39.93 87.99 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.207 -0.997 . . . . 1.6799999999999999 109.607 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -19.52 64.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 1.99 108.844 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -90.1 1.47 56.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.667 -0.646 . . . . 3.1499999999999999 109.522 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.94 38.88 3.48 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.236 -0.915 . . . . 0.48999999999999999 111.032 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -132.5 71.9 1.48 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -1.213 . . . . 0.38 108.323 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -75.46 -12.3 60.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.963 -1.086 . . . . 0.40999999999999998 110.406 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -134.43 156.8 47.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.165 -0.959 . . . . 2.1499999999999999 109.392 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.21 92.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.426 -0.796 . . . . 1.03 111.608 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -58.41 -17.32 19.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.805 -1.185 . . . . 0.92000000000000004 110.671 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.71 -31.78 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 1.0800000000000001 107.943 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.76 -38.56 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.837 -1.171 . . . . 1.0700000000000001 107.837 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -59.76 -38.78 82.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.28 -1.378 . . . . 1.1499999999999999 107.28 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.41 -45.81 74.58 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.955 -1.258 . . . . 0.19 109.955 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -60.08 -42.63 95.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.24 . . . . 1.8200000000000001 109.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.1 -39.91 87.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.136 -0.978 . . . . 0.40000000000000002 108.776 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.96 -38.38 76.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.694 -0.854 . . . . 1.0700000000000001 108.694 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.1 t -66.57 -22.43 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 110.716 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.92 17.79 7.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.001 -1.062 . . . . 1.0900000000000001 109.737 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 52.02 29.64 6.49 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.031 -1.043 . . . . 2.23 109.499 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 59.93 20.08 9.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.802 -0.562 . . . . 2.7999999999999998 109.986 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -68.98 114.46 7.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.843 -1.16 . . . . 1.8 107.925 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.68 -40.0 90.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.388 -0.82 . . . . 0.88 112.78 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -67.65 -39.52 84.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.524 -1.36 . . . . 0.73999999999999999 110.634 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.97 -39.06 76.2 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.034 -1.066 . . . . 1.2 109.538 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.57 -43.72 92.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.44 109.813 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -59.96 -49.98 75.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 3.3399999999999999 110.959 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.8 -38.79 89.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.78 -1.2 . . . . 2.3799999999999999 109.273 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' B' ' 66' ' ' THR . 76.1 t90 -64.33 -49.44 71.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.014 -1.054 . . . . 0.40999999999999998 110.991 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.09 -47.03 72.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.028 -1.045 . . . . 1.0700000000000001 110.0 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -64.92 -44.4 89.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.33 -0.856 . . . . 2.6000000000000001 109.8 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.0 t0 -69.73 -30.97 68.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 1.8999999999999999 109.724 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 96.5 m -79.23 -34.8 42.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 1.1000000000000001 111.399 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.9 p -130.29 -29.78 1.99 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.58 -1.325 . . . . 0.95999999999999996 112.092 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.07 14.33 21.01 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.363 -1.495 . . . . 0.37 109.363 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 154.69 1.84 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.015 -1.285 . . . . 1.0900000000000001 109.34 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.17 169.99 10.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 2.3700000000000001 110.241 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.29 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.642 -0.661 . . . . 1.1100000000000001 110.992 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.11 -39.94 75.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.699 -1.25 . . . . 2.9700000000000002 109.694 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.7 mm100 -65.0 -29.99 70.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.454 -0.779 . . . . 2.6200000000000001 110.489 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.614 ' HG ' ' N ' ' B' ' 75' ' ' ARG . 35.7 p -68.82 -39.48 80.0 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.007 -1.058 . . . . 1.8899999999999999 110.62 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.614 ' N ' ' HG ' ' B' ' 74' ' ' SER . 0.3 OUTLIER -60.25 -37.76 81.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.577 -1.327 . . . . 3.3199999999999998 108.768 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.69 -40.11 76.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.6 -1.312 . . . . 0.40000000000000002 110.431 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.04 -40.19 75.29 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.723 -1.236 . . . . 0.95999999999999996 109.354 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.26 -61.01 2.91 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.041 -1.037 . . . . 0.5 109.71 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.56 -33.06 83.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.236 -1.146 . . . . 0.27000000000000002 110.236 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -70.91 -46.95 61.61 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.933 -1.334 . . . . 0.93999999999999995 109.703 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.9 -41.01 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.957 -1.097 . . . . 1.0900000000000001 109.089 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.59 -40.6 97.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.155 -0.966 . . . . 3.1899999999999999 110.139 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 95.9 mt-10 -70.08 -38.34 75.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 1.9099999999999999 110.502 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.434 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.7 t90 -61.46 -47.87 83.72 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.542 -1.349 . . . . 0.40000000000000002 108.09 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' B' ' 89' ' ' LEU . 56.3 m -59.99 -40.13 88.11 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.365 -0.834 . . . . 0.96999999999999997 109.826 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.41 -29.83 68.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.069 -1.02 . . . . 0.55000000000000004 109.404 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.58 -33.78 12.89 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.323 -0.86 . . . . 1.1299999999999999 110.75 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.0 m-85 -108.3 -5.96 16.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.248 -0.907 . . . . 1.24 112.584 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.503 2.203 0 O-C-N 120.61 -1.306 . . . . 1.8300000000000001 109.548 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.757 0.789 . . . . 1.98 109.742 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.574 ' NE2' ' NH2' ' A' ' 8' ' ' ARG . 7.3 tp-100 -54.68 -24.35 21.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 2.6000000000000001 109.9 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.02 -38.66 86.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.034 -1.041 . . . . 2.5099999999999998 109.228 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -59.16 -50.63 73.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.141 -0.974 . . . . 0.51000000000000001 110.169 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.574 ' NH2' ' NE2' ' A' ' 5' ' ' GLN . 89.3 mtm180 -69.4 -34.75 74.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.132 -0.98 . . . . 3.7200000000000002 110.423 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.57 -39.86 80.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.155 -0.966 . . . . 0.76000000000000001 109.289 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.53 -48.94 78.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.445 -0.784 . . . . 0.5 109.761 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -83.22 10.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.266 -0.896 . . . . 1.1799999999999999 110.711 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.66 -14.97 17.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.246 -0.909 . . . . 1.1799999999999999 110.364 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' PRO . 18.6 pt-20 -152.45 152.61 29.37 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.031 -1.043 . . . . 1.26 108.632 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . 75.0 Cg_exo -37.37 155.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.96 1.773 . . . . 0.53000000000000003 111.089 178.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.3 ptm -92.64 -24.75 18.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.055 -1.028 . . . . 1.1399999999999999 110.443 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.81 -136.01 37.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.971 -1.109 . . . . 0.41999999999999998 110.401 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.15 42.78 1.71 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.631 -0.923 . . . . 0.84999999999999998 109.902 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -60.12 148.1 79.01 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.146 -0.971 . . . . 2.4900000000000002 108.452 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.38 159.85 33.98 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.037 1.825 . . . . 0.39000000000000001 112.085 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.58 -39.47 69.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.677 -0.639 . . . . 1.1200000000000001 110.994 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.79 -3.81 30.14 Favored Glycine 0 N--CA 1.491 2.331 0 O-C-N 121.432 -0.793 . . . . 0.27000000000000002 111.346 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -83.82 -20.94 32.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.423 -1.633 . . . . 1.75 109.532 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.5 mt -64.15 136.29 57.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.033 -1.042 . . . . 1.05 109.078 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -63.82 136.13 57.16 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.678 -0.809 . . . . 1.0600000000000001 109.763 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.7 -18.16 57.94 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.296 -1.522 . . . . 0.23000000000000001 109.296 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.56 114.78 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.251 -1.147 . . . . 1.0800000000000001 108.215 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.27 175.17 37.61 Favored Glycine 0 N--CA 1.492 2.382 0 O-C-N 120.608 -1.307 . . . . 0.31 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.86 -40.02 83.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -1.048 . . . . 2.0099999999999998 109.549 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.41 -47.72 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 1.1399999999999999 109.36 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.96 -38.51 88.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 1.1299999999999999 109.327 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.22 95.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.707 -1.357 . . . . 0.34999999999999998 109.707 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -63.53 -39.78 95.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.376 -1.073 . . . . 3.2200000000000002 110.719 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.21 -43.05 83.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.592 -1.318 . . . . 2.1000000000000001 109.982 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.95 -39.85 93.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.011 -1.056 . . . . 1.0800000000000001 108.532 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.93 -42.1 93.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 1.6699999999999999 111.007 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -64.68 -20.48 66.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.998 . . . . 2.0 109.418 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -93.54 8.46 40.63 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.841 -0.744 . . . . 3.1499999999999999 110.845 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.8 7.9 49.69 Favored Glycine 0 N--CA 1.501 3.014 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 112.31 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.64 73.48 1.02 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.553 -1.557 . . . . 0.38 108.518 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -78.0 -8.1 57.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.40999999999999998 110.952 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -137.15 157.35 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.134 -0.979 . . . . 2.1600000000000001 110.602 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.643 -0.661 . . . . 1.03 111.684 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 4.2 p90 -60.7 -18.1 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.622 -1.299 . . . . 0.92000000000000004 110.772 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.6 t -80.24 -30.7 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.414 -1.328 . . . . 1.0700000000000001 107.414 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -78.25 -39.32 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.151 -1.055 . . . . 1.0600000000000001 108.151 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.77 -36.29 74.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.793 -1.558 . . . . 1.1599999999999999 106.793 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.29 -43.6 93.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.186 -1.165 . . . . 0.20000000000000001 110.186 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -60.18 -42.03 94.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -1.228 . . . . 1.8200000000000001 109.332 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.1 -39.97 88.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.082 -1.011 . . . . 0.40000000000000002 108.66 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.3 mt -69.09 -39.58 78.91 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.095 -0.706 . . . . 1.0900000000000001 109.095 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -67.79 -23.14 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 110.912 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.5 16.85 8.18 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.99 -1.069 . . . . 1.0900000000000001 110.042 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.65 29.67 7.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.061 -1.024 . . . . 2.2200000000000002 110.388 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt 59.96 19.8 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.495 -0.753 . . . . 2.7999999999999998 110.367 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -67.65 115.99 7.85 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.377 -1.342 . . . . 1.8 107.377 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.42 -39.98 95.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.894 . . . . 0.87 113.251 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.8 -39.73 76.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.359 -1.463 . . . . 0.72999999999999998 110.437 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.9 -40.07 72.39 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 118.836 -1.145 . . . . 1.2 109.379 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.63 -49.87 69.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.44 109.528 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -61.78 -45.31 94.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 3.3399999999999999 109.799 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -64.21 -39.26 93.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.041 -1.037 . . . . 2.3700000000000001 108.664 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 66' ' ' THR . 76.2 t90 -66.87 -47.17 72.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.40999999999999998 110.512 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.11 -49.15 68.51 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.129 -0.982 . . . . 1.0800000000000001 109.575 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -61.5 -49.05 78.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.36 -0.837 . . . . 2.6099999999999999 110.101 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.94 -26.14 64.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.467 -0.77 . . . . 1.8999999999999999 109.748 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 22.9 m -79.32 -34.14 42.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.078 -1.014 . . . . 1.1100000000000001 111.294 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.3 p -134.46 -21.66 1.76 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.328 -1.482 . . . . 0.96999999999999997 112.294 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.23 12.16 34.5 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.679 -1.368 . . . . 0.38 109.679 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.1 153.72 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.935 -1.332 . . . . 1.1000000000000001 109.169 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -87.7 169.81 11.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.913 -1.117 . . . . 2.3700000000000001 109.772 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.24 -33.08 71.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.588 -0.695 . . . . 1.1200000000000001 110.24 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -72.9 -39.61 66.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 2.9700000000000002 109.804 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.64 -37.1 85.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.84 . . . . 2.6200000000000001 110.491 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -36.6 82.42 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 1.8899999999999999 109.963 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.12 -39.04 84.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.027 -1.046 . . . . 3.3199999999999998 109.117 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.39 -39.66 81.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.898 -1.126 . . . . 0.40000000000000002 110.981 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 58.0 m -68.23 -40.09 82.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 0.95999999999999996 110.369 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.6 -59.53 5.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.512 -1.367 . . . . 0.5 109.554 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.01 79.26 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.621 -0.992 . . . . 0.27000000000000002 110.621 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.44 -51.06 32.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -1.202 . . . . 0.93999999999999995 110.337 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.57 -40.39 73.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.847 -1.141 . . . . 1.0900000000000001 108.531 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.78 -41.08 97.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 3.1800000000000002 110.255 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.74 -38.4 76.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.9099999999999999 110.404 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 90.0 t90 -60.11 -43.5 95.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.437 -1.414 . . . . 0.40000000000000002 107.895 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 27.8 m -60.12 -40.24 89.05 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.739 0.781 . . . . 0.96999999999999997 109.553 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -33.4 71.93 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.268 -0.895 . . . . 0.55000000000000004 109.871 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.92 -33.98 13.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.991 -1.068 . . . . 1.1200000000000001 111.037 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 97.4 m-85 . . . . . 0 N--CA 1.507 2.404 0 O-C-N 121.094 -1.003 . . . . 1.24 111.794 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.734 0.778 . . . . 1.97 109.716 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 8' ' ' ARG . 7.3 tp-100 -55.05 -24.17 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.342 0.591 . . . . 2.5899999999999999 109.88 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -38.85 87.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.992 -1.068 . . . . 2.5 109.212 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -58.96 -50.71 73.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.1 -1.0 . . . . 0.51000000000000001 110.317 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 5' ' ' GLN . 89.2 mtm180 -69.32 -34.95 75.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 3.73 110.234 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.28 -40.03 81.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.187 -0.946 . . . . 0.76000000000000001 109.272 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -61.59 -48.81 79.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.5 109.912 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -83.49 10.73 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.238 -0.914 . . . . 1.1799999999999999 110.664 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.75 -14.95 17.12 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.176 -0.953 . . . . 1.1799999999999999 110.267 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 14' ' ' PRO . 18.7 pt-20 -152.14 152.25 29.23 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 1.27 108.615 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' B' ' 13' ' ' GLU . 68.1 Cg_exo -37.21 155.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.022 1.814 . . . . 0.53000000000000003 111.076 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 14.0 ptm -92.57 -25.1 18.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.093 -1.004 . . . . 1.1299999999999999 110.598 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.0 -136.02 38.77 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.064 -1.065 . . . . 0.40999999999999998 110.44 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.17 42.9 1.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.619 -0.93 . . . . 0.83999999999999997 110.071 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -60.27 148.08 80.0 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.426 -0.953 . . . . 2.4900000000000002 108.426 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.61 159.41 36.88 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.07 1.847 . . . . 0.38 112.033 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.38 -38.91 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.721 -0.612 . . . . 1.1200000000000001 111.168 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.03 -3.73 31.34 Favored Glycine 0 N--CA 1.493 2.447 0 O-C-N 121.435 -0.79 . . . . 0.27000000000000002 111.343 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.8 m -84.12 -21.13 31.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.575 -1.544 . . . . 1.75 109.587 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.18 136.14 56.95 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -0.969 . . . . 1.0600000000000001 109.032 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.475 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -63.23 136.11 57.51 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.753 0.787 . . . . 1.05 109.882 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.19 -17.75 58.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.375 -1.49 . . . . 0.22 109.375 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.78 114.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -1.143 . . . . 1.0800000000000001 108.088 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.85 174.72 37.86 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.907 -1.277 . . . . 0.29999999999999999 109.907 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.52 -39.83 81.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.424 -1.045 . . . . 2.0 109.677 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.59 -47.68 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 1.1399999999999999 109.27 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.04 -38.57 88.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.386 -0.821 . . . . 1.1299999999999999 109.46 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -39.07 95.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.35999999999999999 109.692 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -63.7 -39.73 95.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -1.112 . . . . 3.2200000000000002 110.667 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.07 -43.05 83.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.578 -1.326 . . . . 2.1200000000000001 109.834 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.2 -39.95 94.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 1.0800000000000001 108.586 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -59.9 -41.73 92.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.787 -0.57 . . . . 1.6799999999999999 110.97 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.67 -20.94 66.59 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.212 -0.93 . . . . 1.99 109.295 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -93.22 8.33 40.68 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 3.1499999999999999 110.79 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.95 8.03 48.98 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 120.911 -1.118 . . . . 0.48999999999999999 112.319 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.79 73.66 1.02 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 119.314 1.557 . . . . 0.38 108.368 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -78.04 -8.28 57.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.40999999999999998 110.758 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -137.07 157.46 46.66 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.145 -0.972 . . . . 2.1499999999999999 110.605 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -39.83 89.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.711 -0.618 . . . . 1.03 111.724 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 3.3 p90 -60.59 -18.35 52.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.532 -1.355 . . . . 0.92000000000000004 110.849 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -80.19 -30.84 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.429 -1.323 . . . . 1.0800000000000001 107.429 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.91 -39.12 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.204 -1.036 . . . . 1.0700000000000001 108.204 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.07 -36.14 74.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.865 -1.531 . . . . 1.1499999999999999 106.865 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -43.73 93.83 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.241 -1.144 . . . . 0.19 110.241 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -60.05 -41.71 92.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 1.8200000000000001 109.438 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.13 -40.23 89.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.40000000000000002 108.762 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 77.6 mt -69.03 -39.8 78.99 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.987 -0.745 . . . . 1.0700000000000001 108.987 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.43 -23.07 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 1.0900000000000001 111.02 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.98 17.18 8.23 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 1.0900000000000001 110.094 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.33 29.86 7.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.07 -1.019 . . . . 2.23 110.47 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 59.88 19.82 8.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.523 -0.736 . . . . 2.7999999999999998 110.407 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -67.65 115.71 7.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.692 -1.255 . . . . 1.8 107.635 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -62.15 -40.33 95.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.402 -0.811 . . . . 0.88 113.083 -177.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -69.35 -40.02 77.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.393 -1.442 . . . . 0.73999999999999999 110.629 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.82 -40.06 72.7 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.867 -1.133 . . . . 1.2 109.296 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.81 -50.01 68.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.44 109.533 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.62 -45.23 94.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.241 -0.912 . . . . 3.3399999999999999 109.786 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -64.2 -39.43 93.96 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.991 -1.068 . . . . 2.3799999999999999 108.708 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.454 ' O ' ' OG1' ' B' ' 66' ' ' THR . 75.8 t90 -66.61 -47.49 72.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.40999999999999998 110.652 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.88 -49.15 69.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.15 -0.969 . . . . 1.0700000000000001 109.576 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.54 -49.06 78.23 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.482 -0.762 . . . . 2.6000000000000001 110.107 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.69 -26.38 65.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 1.8999999999999999 109.625 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 22.6 m -79.33 -34.47 42.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 1.1000000000000001 111.34 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 16.3 p -133.85 -22.19 1.87 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.464 -1.398 . . . . 0.95999999999999996 112.334 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 12.03 33.95 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.628 -1.389 . . . . 0.37 109.628 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.01 153.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.387 . . . . 1.0900000000000001 109.213 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.92 169.69 11.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.972 -1.08 . . . . 2.3700000000000001 109.829 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.14 71.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.534 -0.729 . . . . 1.1100000000000001 110.335 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -73.19 -39.25 65.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.915 -1.116 . . . . 2.9700000000000002 109.774 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.96 -36.83 84.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 2.6200000000000001 110.441 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.9 p -66.93 -36.81 83.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.297 -0.877 . . . . 1.8899999999999999 109.918 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -60.02 -39.19 84.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.95 -1.094 . . . . 3.3199999999999998 109.216 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -68.25 -39.9 82.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.788 -1.195 . . . . 0.40000000000000002 111.059 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 63.3 m -68.13 -39.97 82.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.782 -1.199 . . . . 0.95999999999999996 110.457 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.55 -59.37 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.559 -1.338 . . . . 0.5 109.625 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.44 -33.0 79.4 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.567 -1.013 . . . . 0.27000000000000002 110.567 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.74 -50.96 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.243 . . . . 0.93999999999999995 110.41 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.59 -40.48 73.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.768 -1.173 . . . . 1.0900000000000001 108.529 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -61.6 -41.04 96.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.434 -0.791 . . . . 3.1899999999999999 110.207 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -69.8 -38.51 76.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 1.9099999999999999 110.53 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 90.0 t90 -60.03 -43.38 95.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.423 -1.423 . . . . 0.40000000000000002 107.871 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' B' ' 89' ' ' LEU . 23.9 m -60.34 -40.08 89.4 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.7 0.762 . . . . 0.96999999999999997 109.539 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.13 -33.2 71.81 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.256 -0.902 . . . . 0.55000000000000004 109.905 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.07 -34.39 13.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.02 -1.05 . . . . 1.1299999999999999 111.095 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 97.8 m-85 -110.04 1.92 19.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.083 -1.011 . . . . 1.24 111.654 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.5 tp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.837 -1.164 . . . . 1.8300000000000001 109.317 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.655 0.741 . . . . 1.98 110.016 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -58.04 -19.99 35.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.669 -0.644 . . . . 2.6000000000000001 110.845 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.21 -38.38 86.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 2.5099999999999998 109.197 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.481 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 24.3 t60 -59.95 -53.92 52.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.196 -0.94 . . . . 0.51000000000000001 110.516 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -69.97 -35.57 74.55 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.958 -1.088 . . . . 3.7200000000000002 110.105 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.02 -39.91 75.53 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.295 -0.878 . . . . 0.76000000000000001 109.737 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.64 -44.52 96.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.5 109.784 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.7 m -83.39 15.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.056 -1.027 . . . . 1.1799999999999999 109.598 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.79 -13.12 14.53 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.486 -0.759 . . . . 1.1799999999999999 110.32 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.77 151.59 20.88 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.979 -1.076 . . . . 1.26 109.537 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -40.13 156.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.067 1.845 . . . . 0.53000000000000003 111.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.64 -18.73 23.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.878 -1.139 . . . . 1.1399999999999999 109.941 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.09 -140.18 35.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.735 -1.346 . . . . 0.41999999999999998 109.735 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -103.82 30.69 4.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.37 -1.077 . . . . 0.84999999999999998 109.982 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -60.07 147.76 79.56 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.065 -1.022 . . . . 2.4900000000000002 108.431 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.67 158.3 46.97 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.372 2.048 . . . . 0.39000000000000001 112.557 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 22' ' ' SER . 2.3 p -56.93 -48.71 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 1.1200000000000001 110.233 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.07 -3.71 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.402 -1.079 . . . . 0.27000000000000002 110.402 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 20' ' ' VAL . 7.8 t -82.84 -20.76 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.935 -1.333 . . . . 1.75 109.165 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.11 139.96 58.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 1.05 109.73 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 133.07 50.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.812 0.815 . . . . 1.0600000000000001 110.282 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.08 -20.34 47.97 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 109.839 -1.304 . . . . 0.23000000000000001 109.839 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.2 117.1 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -1.198 . . . . 1.0800000000000001 108.019 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.23 177.31 37.91 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.726 -1.35 . . . . 0.31 109.726 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.02 -40.02 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -1.08 . . . . 2.0099999999999998 109.888 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.03 -47.36 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.085 . . . . 1.1399999999999999 109.1 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.04 -39.41 93.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.376 -0.828 . . . . 1.1299999999999999 109.407 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.7 97.38 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 110.044 -1.222 . . . . 0.34999999999999998 110.044 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -60.28 -40.02 88.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.406 . . . . 3.2200000000000002 110.517 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.2 -45.95 75.37 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.797 -1.161 . . . . 2.1000000000000001 109.771 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.0 -41.13 99.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.858 -1.151 . . . . 1.0800000000000001 109.917 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.22 -40.64 90.89 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.114 -1.034 . . . . 1.6699999999999999 109.383 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.65 -19.66 65.81 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.648 -0.871 . . . . 2.0 108.648 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' A' ' 37' ' ' ARG . 51.0 mtt-85 -91.01 5.62 48.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.487 -0.758 . . . . 3.1499999999999999 110.433 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.57 49.19 Favored Glycine 0 N--CA 1.502 3.045 0 O-C-N 121.09 -1.006 . . . . 0.47999999999999998 112.075 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -102.38 72.81 1.29 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.597 -1.531 . . . . 0.38 108.579 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -77.9 -12.56 59.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.40999999999999998 110.679 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.853 ' C ' ' CA ' ' A' ' 42' ' ' ALA . 43.9 mmtm . . . . . 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 2.1600000000000001 109.423 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.853 ' CA ' ' C ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 120.773 0.32 . . . . 1.03 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.462 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 26.3 p90 -55.68 -17.4 5.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.683 -1.261 . . . . 0.92000000000000004 110.478 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.25 -33.14 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.844 -1.169 . . . . 1.0700000000000001 107.844 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.36 -38.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.235 -1.024 . . . . 1.0600000000000001 108.235 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.97 -36.82 77.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.89 -1.152 . . . . 1.1599999999999999 107.89 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.04 98.16 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.96 -1.256 . . . . 0.20000000000000001 109.96 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.97 -41.12 91.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.886 -1.361 . . . . 1.8200000000000001 109.208 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.94 -39.99 87.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.99 . . . . 0.40000000000000002 108.525 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.26 -37.55 80.86 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.573 -0.851 . . . . 1.0900000000000001 108.716 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.07 -26.75 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.289 -0.882 . . . . 1.0900000000000001 110.142 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -91.59 14.89 13.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.099 -1.001 . . . . 1.0900000000000001 110.52 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 50.09 40.01 20.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.726 -1.234 . . . . 2.2200000000000002 111.055 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.28 18.99 4.63 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.267 -0.895 . . . . 2.7999999999999998 110.492 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.78 107.77 3.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.776 -1.203 . . . . 1.8 108.193 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 85.1 tt0 -62.91 -40.81 98.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.407 -0.808 . . . . 0.87 112.679 -178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -68.69 -39.64 80.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.847 -1.158 . . . . 0.72999999999999998 109.686 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.96 -38.63 76.15 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.18 -1.008 . . . . 1.2 109.026 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -62.83 -45.91 90.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.44 109.444 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mtt180 -60.0 -47.7 84.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.393 -0.817 . . . . 3.3399999999999999 110.927 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.4 -39.68 94.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.889 -1.132 . . . . 2.3700000000000001 108.923 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.465 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.3 t90 -61.91 -49.97 74.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.40999999999999998 111.46 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 22.5 tp -66.67 -46.13 76.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.852 -1.155 . . . . 1.0800000000000001 109.923 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.68 -46.67 81.43 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.322 -0.861 . . . . 2.6099999999999999 109.874 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.1 -31.53 70.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.386 -0.821 . . . . 1.8999999999999999 109.538 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 75.7 m -77.74 -38.26 47.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.259 -0.901 . . . . 1.1100000000000001 111.463 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 26.6 p -129.45 -24.33 2.8 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.479 -1.388 . . . . 0.96999999999999997 111.854 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.46 13.55 28.0 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.182 -1.567 . . . . 0.38 109.182 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.81 154.57 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.035 -1.274 . . . . 1.1000000000000001 109.097 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.91 170.04 11.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 2.3700000000000001 109.53 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -31.61 70.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 1.1200000000000001 110.773 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -73.89 -40.02 63.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 2.9700000000000002 110.214 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.51 -33.7 76.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.416 -0.803 . . . . 2.6200000000000001 110.328 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p -68.39 -37.68 80.63 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.219 -0.926 . . . . 1.8899999999999999 109.824 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.47 -38.45 84.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.94 -1.1 . . . . 3.3199999999999998 109.644 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.45 -39.96 81.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.622 -1.299 . . . . 0.40000000000000002 110.485 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -70.01 -40.7 75.08 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.882 -1.136 . . . . 0.95999999999999996 109.327 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -60.19 -60.02 4.48 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.809 -1.182 . . . . 0.5 109.654 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.22 91.78 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.212 -0.93 . . . . 0.27000000000000002 110.876 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -68.21 -50.13 56.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.734 -1.45 . . . . 0.93999999999999995 109.847 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.14 -39.93 75.1 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.146 -1.022 . . . . 1.0900000000000001 109.218 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -62.35 -39.97 94.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -0.99 . . . . 3.1800000000000002 109.743 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.481 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.8 mt-10 -70.01 -36.62 75.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 1.9099999999999999 109.83 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.596 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 80.5 t90 -59.92 -41.75 92.42 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.488 -1.383 . . . . 0.40000000000000002 107.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.0 m -63.1 -40.02 96.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.768 -0.827 . . . . 0.96999999999999997 108.768 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.1 -38.16 82.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.593 -0.692 . . . . 0.55000000000000004 109.835 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 -37.07 17.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 1.1200000000000001 110.065 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.596 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 72.2 m-85 . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 1.24 110.327 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.715 0.769 . . . . 1.97 110.011 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' B' ' 5' ' ' GLN . 0.0 OUTLIER -58.13 -20.05 37.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.632 -0.668 . . . . 2.5899999999999999 110.756 -178.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -61.15 -38.52 86.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.06 -1.025 . . . . 2.5 109.188 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.479 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 24.2 t60 -59.74 -53.91 52.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.51000000000000001 110.667 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -70.05 -35.43 74.26 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.002 -1.061 . . . . 3.73 110.162 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.15 -39.9 75.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 0.76000000000000001 109.647 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.51 -44.6 96.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.348 -0.845 . . . . 0.5 109.785 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 31.8 m -83.51 15.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.089 -1.007 . . . . 1.1799999999999999 109.572 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.82 -13.0 14.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.53 -0.731 . . . . 1.1799999999999999 110.368 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.84 151.57 20.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.908 -1.12 . . . . 1.27 109.498 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.06 156.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.992 1.795 . . . . 0.53000000000000003 111.775 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.72 -18.61 23.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.947 -1.095 . . . . 1.1299999999999999 109.963 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.86 -140.11 35.16 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.768 -1.333 . . . . 0.40999999999999998 109.768 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.82 30.59 5.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.45 -1.029 . . . . 0.83999999999999997 109.981 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -59.99 147.66 79.35 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 2.4900000000000002 108.45 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.59 158.28 46.72 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.365 2.043 . . . . 0.38 112.603 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' B' ' 22' ' ' SER . 2.2 p -57.0 -48.64 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.476 -0.765 . . . . 1.1200000000000001 110.169 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.14 -3.58 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.374 -1.09 . . . . 0.27000000000000002 110.374 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.516 ' H ' ' C ' ' B' ' 20' ' ' VAL . 7.8 t -82.96 -20.85 34.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.295 . . . . 1.75 109.129 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 98.7 mt -65.02 139.93 58.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 1.0600000000000001 109.78 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.17 132.9 50.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.784 0.802 . . . . 1.05 110.371 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.35 47.76 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.802 -1.319 . . . . 0.22 109.802 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.11 117.07 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.177 -1.19 . . . . 1.0800000000000001 108.044 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.09 177.26 38.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.697 -1.361 . . . . 0.29999999999999999 109.697 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -40.09 79.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 2.0 109.951 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.94 -47.49 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 1.1399999999999999 109.129 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.93 -39.54 93.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 1.1299999999999999 109.436 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.66 97.24 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 110.041 -1.224 . . . . 0.35999999999999999 110.041 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -60.24 -40.1 89.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.852 -1.381 . . . . 3.2200000000000002 110.503 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.21 -45.76 75.87 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.785 -1.166 . . . . 2.1200000000000001 109.786 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.01 -41.27 99.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 1.0800000000000001 110.002 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.77 90.5 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.171 -1.012 . . . . 1.6799999999999999 109.382 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.69 -19.62 65.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.631 -0.877 . . . . 1.99 108.631 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' B' ' 37' ' ' ARG . 50.7 mtt-85 -91.1 5.78 47.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.817 . . . . 3.1499999999999999 110.423 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.19 7.54 49.38 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.034 -1.041 . . . . 0.48999999999999999 112.112 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -102.43 72.93 1.29 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.704 -1.468 . . . . 0.38 108.624 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -78.06 -12.46 59.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.40999999999999998 110.664 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.46 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 44.0 mmtm -132.31 154.11 50.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.055 -1.028 . . . . 2.1499999999999999 109.419 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.99 91.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.298 -0.876 . . . . 1.03 111.73 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 25.7 p90 -55.82 -17.32 5.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.671 -1.268 . . . . 0.92000000000000004 110.397 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.21 -33.02 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.93 -1.137 . . . . 1.0800000000000001 107.93 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.5 -38.73 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.208 -1.034 . . . . 1.0700000000000001 108.208 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.99 -36.9 78.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.899 -1.148 . . . . 1.1499999999999999 107.899 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.89 -42.1 98.05 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.997 -1.241 . . . . 0.19 109.997 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.96 -40.99 90.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.004 -1.292 . . . . 1.8200000000000001 109.231 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.95 -40.14 87.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.40000000000000002 108.43 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.21 -37.84 81.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.611 -0.885 . . . . 1.0700000000000001 108.611 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.93 -26.59 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.829 . . . . 1.0900000000000001 110.179 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.6 14.95 13.6 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.097 -1.002 . . . . 1.0900000000000001 110.539 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.705 -1.247 . . . . 2.23 111.045 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.26 19.02 4.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.371 -0.831 . . . . 2.7999999999999998 110.504 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.73 107.82 3.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.809 -1.182 . . . . 1.8 108.131 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 85.2 tt0 -62.84 -41.09 99.2 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.398 -0.813 . . . . 0.88 112.704 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.54 -39.59 81.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.805 -1.184 . . . . 0.73999999999999999 109.692 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.0 -38.52 76.01 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.201 -1.0 . . . . 1.2 109.06 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.06 -45.72 90.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.44 109.507 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 98.9 mtt180 -60.05 -47.76 84.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.785 . . . . 3.3399999999999999 110.974 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -64.3 -39.68 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.896 -1.128 . . . . 2.3799999999999999 108.946 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.46 ' O ' ' OG1' ' B' ' 66' ' ' THR . 68.3 t90 -61.92 -50.05 73.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.40999999999999998 111.423 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.469 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 22.6 tp -66.63 -46.23 76.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.897 -1.127 . . . . 1.0700000000000001 109.952 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.56 -46.71 81.63 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 2.6000000000000001 109.9 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.08 -31.51 70.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 1.8999999999999999 109.49 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 77.1 m -77.7 -38.3 47.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.868 . . . . 1.1000000000000001 111.496 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 26.6 p -129.43 -24.3 2.81 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.581 -1.325 . . . . 0.95999999999999996 111.891 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.45 13.63 27.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.189 -1.564 . . . . 0.37 109.189 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.74 154.63 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.264 . . . . 1.0900000000000001 109.114 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.97 170.02 11.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 2.3700000000000001 109.515 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.03 -31.47 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 1.1100000000000001 110.741 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -74.04 -40.0 63.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.961 -1.087 . . . . 2.9700000000000002 110.204 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -66.6 -33.57 75.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.412 -0.805 . . . . 2.6200000000000001 110.272 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 32.9 p -68.52 -37.55 80.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.208 -0.933 . . . . 1.8899999999999999 109.805 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.49 -38.5 84.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.885 -1.134 . . . . 3.3199999999999998 109.689 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -68.34 -39.97 81.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.679 -1.263 . . . . 0.40000000000000002 110.595 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.98 -40.8 75.13 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.845 -1.16 . . . . 0.95999999999999996 109.33 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -60.08 -60.04 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.141 . . . . 0.5 109.718 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.18 91.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.829 -0.908 . . . . 0.27000000000000002 110.829 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.27 -50.16 55.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.731 -1.453 . . . . 0.93999999999999995 109.85 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.03 -40.02 75.44 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.123 -1.031 . . . . 1.0900000000000001 109.256 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -62.14 -40.11 94.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.123 -0.986 . . . . 3.1899999999999999 109.762 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.479 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.8 mt-10 -70.05 -36.57 75.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.09 -1.006 . . . . 1.9099999999999999 109.866 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 80.2 t90 -59.89 -41.89 92.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.525 -1.36 . . . . 0.40000000000000002 107.702 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.8 m -63.02 -40.11 96.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.816 -0.809 . . . . 0.96999999999999997 108.816 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.0 -38.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.627 -0.671 . . . . 0.55000000000000004 109.858 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -37.65 16.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.198 -0.939 . . . . 1.1299999999999999 110.057 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.8 m-85 -102.26 -86.66 0.42 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.188 -0.945 . . . . 1.24 110.376 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.016 -0.992 . . . . 1.8300000000000001 109.945 -178.39 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.792 0.806 . . . . 1.98 110.349 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.91 -19.52 65.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.88 -0.513 . . . . 2.6000000000000001 110.219 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -60.02 -37.45 79.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.049 -1.032 . . . . 2.5099999999999998 109.573 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -59.92 -50.78 72.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.167 -0.958 . . . . 0.51000000000000001 110.507 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 8' ' ' ARG . 38.7 mtt-85 -70.02 -33.7 72.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.954 -1.091 . . . . 3.7200000000000002 110.224 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.66 -38.99 77.32 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.305 -0.872 . . . . 0.76000000000000001 109.43 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -64.6 -47.4 78.75 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.393 -0.817 . . . . 0.5 110.506 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -85.11 11.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.154 -0.966 . . . . 1.1799999999999999 111.054 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.08 -11.73 15.57 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.193 -0.942 . . . . 1.1799999999999999 109.821 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.58 151.49 20.96 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.963 . . . . 1.26 108.976 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -39.9 161.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.892 1.728 . . . . 0.53000000000000003 111.506 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.8 ptp -90.6 -20.22 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.029 -1.044 . . . . 1.1399999999999999 109.479 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.56 -139.96 21.01 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.205 -1.158 . . . . 0.41999999999999998 110.205 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.97 24.95 10.55 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.544 -0.974 . . . . 0.84999999999999998 109.792 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -60.8 148.69 82.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.098 -1.001 . . . . 2.4900000000000002 108.934 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.17 158.76 33.34 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.508 2.139 . . . . 0.39000000000000001 113.307 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' A' ' 22' ' ' SER . 11.1 p -59.59 -44.96 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.657 0.742 . . . . 1.1200000000000001 110.328 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.21 -3.0 0.18 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.567 -1.013 . . . . 0.27000000000000002 110.567 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 20' ' ' VAL . 68.4 m -82.7 -19.15 38.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.769 -1.43 . . . . 1.75 109.436 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.18 137.41 56.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 1.05 109.639 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.2 134.75 54.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.737 -0.785 . . . . 1.0600000000000001 109.842 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.08 48.07 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.316 -1.514 . . . . 0.23000000000000001 109.316 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -98.35 113.18 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 1.0800000000000001 108.007 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.8 179.27 38.33 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 120.623 -1.298 . . . . 0.31 109.952 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -57.29 -40.1 77.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.525 -0.985 . . . . 2.0099999999999998 110.374 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.95 -46.26 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 1.1399999999999999 109.743 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.57 -37.55 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 1.1299999999999999 109.62 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.79 95.73 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.128 -1.589 . . . . 0.34999999999999998 109.128 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.18 -39.98 95.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -1.087 . . . . 3.2200000000000002 109.935 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.66 -44.72 69.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.88 -1.137 . . . . 2.1000000000000001 109.44 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.66 -40.01 95.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.955 -1.128 . . . . 1.0800000000000001 107.955 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.04 -41.52 92.43 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.976 -0.75 . . . . 1.6699999999999999 108.976 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.28 -19.91 64.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.682 -0.859 . . . . 2.0 108.682 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -90.35 0.94 57.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 3.1499999999999999 109.68 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 37.79 3.84 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 120.305 -0.95 . . . . 0.47999999999999998 111.239 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -133.84 72.6 1.48 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.968 -1.313 . . . . 0.38 108.995 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -80.28 -10.73 59.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.40999999999999998 110.729 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.88 152.04 51.31 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.127 -0.983 . . . . 2.1600000000000001 110.017 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.96 90.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 1.03 111.823 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.46 -17.77 9.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.758 -1.214 . . . . 0.92000000000000004 110.603 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.4 -31.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.821 -1.174 . . . . 1.0700000000000001 107.914 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.54 -36.7 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.343 -0.984 . . . . 1.0600000000000001 108.343 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.01 -37.84 80.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.983 -1.488 . . . . 1.1599999999999999 106.983 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.3 87.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.986 -1.246 . . . . 0.20000000000000001 109.986 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.08 -42.27 94.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.339 . . . . 1.8200000000000001 108.901 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.357 -0.979 . . . . 0.40000000000000002 108.357 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.06 -39.93 75.39 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.756 -0.831 . . . . 1.0900000000000001 108.756 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.81 -26.7 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.176 -0.952 . . . . 1.0900000000000001 111.358 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.2 16.13 6.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.9 -1.125 . . . . 1.0900000000000001 110.217 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.34 21.67 5.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 2.2200000000000002 110.167 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.15 19.6 8.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.707 -0.62 . . . . 2.7999999999999998 110.311 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.9 122.1 17.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.585 -1.322 . . . . 1.8 107.777 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' OE2' ' CG ' ' A' ' 78' ' ' PHE . 8.5 tp10 -61.97 -41.56 98.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.286 0.847 . . . . 0.87 113.286 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -69.96 -39.86 75.75 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.411 -1.431 . . . . 0.72999999999999998 110.787 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.08 -39.9 75.33 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.917 -1.113 . . . . 1.2 109.067 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.6 -48.48 79.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.268 -0.895 . . . . 0.44 109.482 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.08 -47.12 87.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.356 -0.84 . . . . 3.3399999999999999 110.978 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.13 -39.88 94.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.749 -1.219 . . . . 2.3700000000000001 108.885 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.442 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.0 t90 -61.58 -50.05 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.40999999999999998 111.414 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.42 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 61.7 tp -67.65 -47.29 69.97 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.145 -0.972 . . . . 1.0800000000000001 110.146 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -63.33 -46.7 85.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 2.6099999999999999 109.869 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.37 -30.81 69.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 1.8999999999999999 109.696 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 99.6 m -79.01 -35.14 43.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 1.1100000000000001 111.247 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 27.9 p -131.79 -34.73 1.3 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.541 -1.35 . . . . 0.96999999999999997 111.722 -178.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.97 15.87 10.37 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.422 -1.471 . . . . 0.38 109.422 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 153.05 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.282 . . . . 1.1000000000000001 109.04 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.496 ' H ' HE21 ' A' ' 73' ' ' GLN . 28.1 t-20 -89.68 170.68 10.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 2.3700000000000001 109.348 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.27 72.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.504 -0.748 . . . . 1.1200000000000001 110.94 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -71.63 -41.43 68.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.717 -1.24 . . . . 2.9700000000000002 110.566 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.496 HE21 ' H ' ' A' ' 70' ' ' ASN . 36.6 mt-30 -67.32 -36.52 81.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 2.6200000000000001 110.386 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.135 -0.978 . . . . 1.8899999999999999 110.466 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -59.95 -36.59 77.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.675 -1.266 . . . . 3.3199999999999998 108.701 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.4 -39.29 81.71 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.83 -1.169 . . . . 0.40000000000000002 110.27 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.21 -41.14 81.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.791 -1.193 . . . . 0.95999999999999996 109.59 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CG ' ' OE2' ' A' ' 56' ' ' GLU . 64.7 t80 -60.01 -59.81 4.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.819 -1.176 . . . . 0.5 109.41 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -34.88 85.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.992 -1.243 . . . . 0.27000000000000002 109.992 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.8 -45.45 67.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -1.186 . . . . 0.93999999999999995 109.465 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.58 -41.91 68.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 1.0900000000000001 109.117 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.15 -41.16 96.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 3.1800000000000002 109.527 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -70.05 -37.89 75.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 1.9099999999999999 110.603 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.48 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.8 t90 -59.99 -43.5 95.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.393 -1.442 . . . . 0.40000000000000002 107.815 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.0 m -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.572 -0.705 . . . . 0.96999999999999997 109.358 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -59.2 -34.21 71.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.55000000000000004 110.21 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.75 -34.34 13.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.296 -0.878 . . . . 1.1200000000000001 111.352 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 94.8 m-85 . . . . . 0 N--CA 1.506 2.364 0 O-C-N 120.984 -1.073 . . . . 1.24 112.033 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.86 0.838 . . . . 1.97 110.326 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.86 -19.6 65.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.819 -0.551 . . . . 2.5899999999999999 110.21 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.0 -37.35 79.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.108 -0.995 . . . . 2.5 109.665 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -59.96 -50.85 72.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.126 -0.984 . . . . 0.51000000000000001 110.449 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' B' ' 8' ' ' ARG . 38.8 mtt-85 -70.04 -33.71 72.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 3.73 110.165 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.58 -39.26 77.44 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.202 -0.936 . . . . 0.76000000000000001 109.377 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.32 -47.54 79.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.838 . . . . 0.5 110.457 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -85.3 11.6 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 1.1799999999999999 111.139 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.21 -11.92 15.49 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.238 -0.914 . . . . 1.1799999999999999 109.759 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.45 151.63 21.43 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.091 -1.006 . . . . 1.27 108.97 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.97 161.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.847 1.698 . . . . 0.53000000000000003 111.585 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 8.9 ptp -90.74 -19.79 23.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 1.1299999999999999 109.561 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.11 -140.1 18.32 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.047 -1.221 . . . . 0.40999999999999998 110.047 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.74 25.09 10.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.981 . . . . 0.83999999999999997 109.848 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -61.03 148.92 83.35 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.908 -1.12 . . . . 2.4900000000000002 108.879 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.22 158.78 33.49 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.412 2.075 . . . . 0.38 113.315 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' B' ' 22' ' ' SER . 11.2 p -59.64 -44.95 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.625 0.726 . . . . 1.1200000000000001 110.273 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.403 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -54.22 -2.81 0.17 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.591 -1.003 . . . . 0.27000000000000002 110.591 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.518 ' H ' ' C ' ' B' ' 20' ' ' VAL . 68.5 m -82.91 -19.33 37.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.793 -1.416 . . . . 1.75 109.34 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.97 137.42 57.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.965 . . . . 1.0600000000000001 109.651 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.47 134.4 53.34 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.805 . . . . 1.05 109.995 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 -20.91 48.79 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.236 -1.545 . . . . 0.22 109.236 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 mm -98.44 113.1 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.263 -1.139 . . . . 1.0800000000000001 107.961 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.74 179.05 38.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.913 -1.275 . . . . 0.29999999999999999 109.913 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.16 -40.04 76.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 2.0 110.353 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.99 -46.41 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 1.1399999999999999 109.725 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 93.3 mt -65.26 -37.68 87.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 1.1299999999999999 109.666 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.82 95.68 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.256 -1.538 . . . . 0.35999999999999999 109.256 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.24 -39.92 94.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.392 -1.064 . . . . 3.2200000000000002 109.922 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.6 -44.9 69.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.844 -1.16 . . . . 2.1200000000000001 109.331 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.55 -39.92 95.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.016 -1.105 . . . . 1.0800000000000001 108.016 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -41.56 92.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.945 -0.761 . . . . 1.6799999999999999 108.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -68.19 -20.13 64.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.633 -0.877 . . . . 1.99 108.633 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -90.15 1.3 56.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.495 -0.753 . . . . 3.1499999999999999 109.646 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.45 37.8 3.91 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.115 -0.991 . . . . 0.48999999999999999 111.127 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -134.01 72.75 1.48 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.977 -1.308 . . . . 0.38 108.956 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -80.57 -10.57 59.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.089 -1.007 . . . . 0.40999999999999998 110.8 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.95 152.31 51.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.204 -0.935 . . . . 2.1499999999999999 110.038 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.63 91.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 1.03 111.848 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.58 -17.96 10.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.577 -1.327 . . . . 0.92000000000000004 110.51 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 43.8 t -79.43 -31.65 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.797 -1.19 . . . . 1.0800000000000001 107.841 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.46 -36.76 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.39 -0.967 . . . . 1.0700000000000001 108.39 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.0 tp -60.01 -38.12 81.73 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.802 -1.555 . . . . 1.1499999999999999 106.802 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.63 85.42 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.936 -1.266 . . . . 0.19 109.936 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -42.31 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.881 -1.364 . . . . 1.8200000000000001 108.819 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -40.16 88.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.356 -0.979 . . . . 0.40000000000000002 108.356 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 65.4 mt -69.96 -40.06 75.63 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.725 -0.843 . . . . 1.0700000000000001 108.725 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.62 -26.66 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.167 -0.958 . . . . 1.0900000000000001 111.276 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.38 16.45 6.39 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.035 -1.041 . . . . 1.0900000000000001 110.237 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.16 21.79 5.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.885 . . . . 2.23 110.092 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 80.5 mttt 59.99 19.19 8.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.75 -0.593 . . . . 2.7999999999999998 110.386 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.62 122.29 17.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.561 -1.337 . . . . 1.8 107.664 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE2' ' CG ' ' B' ' 78' ' ' PHE . 8.5 tp10 -62.0 -42.04 98.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.88 113.289 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.54 -39.97 77.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.339 -1.476 . . . . 0.73999999999999999 110.694 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.09 -40.01 75.23 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.99 -1.084 . . . . 1.2 109.035 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.56 -48.38 79.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.44 109.544 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.03 -47.61 85.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 3.3399999999999999 110.846 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.03 -39.46 94.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.715 -1.241 . . . . 2.3799999999999999 108.953 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -61.83 -49.91 74.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.339 -0.85 . . . . 0.40999999999999998 111.377 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.408 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 61.5 tp -67.68 -47.67 68.79 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.196 -0.94 . . . . 1.0700000000000001 110.069 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -62.94 -46.78 86.14 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.917 . . . . 2.6000000000000001 109.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.32 -30.75 69.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.8999999999999999 109.655 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 99.7 m -79.11 -35.14 42.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 1.1000000000000001 111.354 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 27.9 p -131.59 -35.18 1.31 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.639 -1.288 . . . . 0.95999999999999996 111.787 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.26 16.22 9.82 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 109.341 -1.503 . . . . 0.37 109.341 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.51 153.14 1.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.866 -1.373 . . . . 1.0900000000000001 109.078 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.513 ' H ' HE21 ' B' ' 73' ' ' GLN . 28.1 t-20 -89.86 170.56 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.089 -1.007 . . . . 2.3700000000000001 109.329 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.35 -32.97 71.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.507 -0.746 . . . . 1.1100000000000001 111.0 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -71.89 -41.45 67.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.751 -1.218 . . . . 2.9700000000000002 110.441 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.513 HE21 ' H ' ' B' ' 70' ' ' ASN . 36.6 mt-30 -67.32 -36.38 81.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 2.6200000000000001 110.447 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.65 -38.35 83.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.352 -0.842 . . . . 1.8899999999999999 110.442 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -60.01 -36.45 77.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.748 -1.22 . . . . 3.3199999999999998 108.746 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.64 -39.47 80.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.782 -1.199 . . . . 0.40000000000000002 110.187 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.07 -41.23 82.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.987 -1.07 . . . . 0.95999999999999996 109.529 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.526 ' CG ' ' OE2' ' B' ' 56' ' ' GLU . 64.4 t80 -60.02 -59.77 4.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.819 -1.176 . . . . 0.5 109.507 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.03 -34.86 85.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.935 -1.266 . . . . 0.27000000000000002 109.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.87 -45.71 67.09 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.152 -1.205 . . . . 0.93999999999999995 109.364 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.41 -41.67 69.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.999 . . . . 1.0900000000000001 109.151 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.37 -40.98 96.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.881 . . . . 3.1899999999999999 109.605 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.96 -38.04 75.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.164 -0.96 . . . . 1.9099999999999999 110.604 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.481 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.9 t90 -59.99 -43.5 95.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.332 -1.48 . . . . 0.40000000000000002 107.718 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' B' ' 89' ' ' LEU . 22.3 m -60.06 -40.05 88.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.637 -0.664 . . . . 0.96999999999999997 109.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -59.07 -34.11 71.58 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 110.288 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.76 -35.02 13.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.009 -1.057 . . . . 1.1299999999999999 111.377 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.481 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.2 m-85 -109.91 2.16 19.62 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.12 -0.987 . . . . 1.24 112.272 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.0 tp . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.716 -1.24 . . . . 1.8300000000000001 109.944 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.734 0.778 . . . . 1.98 109.928 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.75 -23.96 46.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.783 -0.573 . . . . 2.6000000000000001 110.208 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.13 -38.41 82.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.921 . . . . 2.5099999999999998 108.932 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -60.04 -52.23 66.24 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.463 -0.773 . . . . 0.51000000000000001 110.795 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -69.94 -35.41 74.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.963 -1.086 . . . . 3.7200000000000002 109.766 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -65.49 -40.01 92.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.82 . . . . 0.76000000000000001 109.342 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 44.4 t80 -63.14 -49.65 73.53 Favored 'General case' 0 C--N 1.298 -1.63 0 C-N-CA 119.642 -0.823 . . . . 0.5 110.003 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.35 6.04 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.105 -0.997 . . . . 1.1799999999999999 111.231 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.27 -18.77 17.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.93 -1.106 . . . . 1.1799999999999999 110.057 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' PRO . 6.5 pt-20 -151.96 151.94 28.96 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.154 -0.967 . . . . 1.26 108.917 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 13' ' ' GLU . 69.6 Cg_exo -36.76 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.2 1.933 . . . . 0.53000000000000003 111.688 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 15.6 ptm -93.66 -29.64 15.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.104 -0.997 . . . . 1.1399999999999999 110.15 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 -135.28 44.7 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.205 -1.158 . . . . 0.41999999999999998 110.205 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.97 35.3 3.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.676 -0.896 . . . . 0.84999999999999998 110.014 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.26 148.59 71.76 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 2.4900000000000002 108.47 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.28 156.2 41.85 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.025 1.817 . . . . 0.39000000000000001 112.048 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.4 p -57.01 -48.13 82.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.442 -0.786 . . . . 1.1200000000000001 110.22 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.84 -3.81 0.23 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.716 -0.954 . . . . 0.27000000000000002 110.716 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 20' ' ' VAL . 70.7 m -83.16 -21.54 33.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.709 -1.465 . . . . 1.75 109.422 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.36 136.79 57.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.038 -1.039 . . . . 1.05 109.418 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.59 136.17 56.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.763 0.792 . . . . 1.0600000000000001 109.758 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.27 -20.07 52.24 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.741 -1.744 . . . . 0.23000000000000001 108.741 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.83 115.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.908 -1.145 . . . . 1.0800000000000001 107.908 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.21 177.02 42.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.825 -1.31 . . . . 0.31 109.825 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.76 -39.93 74.9 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.629 -0.924 . . . . 2.0099999999999998 109.914 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.82 -44.47 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.05 . . . . 1.1399999999999999 109.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.77 -37.46 84.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.9 . . . . 1.1299999999999999 109.47 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.246 -1.542 . . . . 0.34999999999999998 109.246 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.82 -39.86 94.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.405 -1.056 . . . . 3.2200000000000002 110.367 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 67' ' ' CYS . 50.6 mtpt -65.44 -48.45 72.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.859 -1.151 . . . . 2.1000000000000001 109.948 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.69 -36.03 79.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.909 -1.119 . . . . 1.0800000000000001 108.485 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.739 -0.601 . . . . 1.6699999999999999 110.058 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.02 -19.37 65.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.995 . . . . 2.0 108.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 37' ' ' ARG . 33.8 mtt-85 -91.05 6.59 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.595 -0.691 . . . . 3.1499999999999999 110.25 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.7 55.43 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.978 -1.076 . . . . 0.47999999999999998 111.688 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -103.86 72.99 1.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.835 -1.391 . . . . 0.38 108.341 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.06 -10.72 59.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.459 -0.776 . . . . 0.40999999999999998 110.628 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.5 150.27 50.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.167 -0.958 . . . . 2.1600000000000001 109.62 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.99 94.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 1.03 110.827 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 17.0 p90 -60.55 -18.64 53.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.016 -1.052 . . . . 0.92000000000000004 110.371 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.57 -32.74 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.434 -1.321 . . . . 1.0700000000000001 107.434 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.74 -37.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.096 -1.075 . . . . 1.0600000000000001 108.096 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.8 tp -59.99 -35.46 75.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.569 -1.271 . . . . 1.1599999999999999 107.569 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.54 97.08 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.166 -1.173 . . . . 0.20000000000000001 110.166 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -59.97 -41.66 92.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.01 -1.288 . . . . 1.8200000000000001 109.778 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.40000000000000002 108.741 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -38.77 81.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.723 -0.843 . . . . 1.0900000000000001 108.723 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.02 -24.54 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.347 -0.846 . . . . 1.0900000000000001 110.629 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.23 18.37 9.61 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.121 -0.987 . . . . 1.0900000000000001 110.444 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.36 33.55 7.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.768 -1.207 . . . . 2.2200000000000002 110.126 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.05 19.92 9.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.751 -0.593 . . . . 2.7999999999999998 110.382 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.47 113.38 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.609 -1.307 . . . . 1.8 107.719 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.84 -40.03 93.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.87 113.16 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -69.81 -39.7 76.37 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.615 -1.303 . . . . 0.72999999999999998 110.578 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.57 -38.77 77.54 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.75 -1.18 . . . . 1.2 108.921 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.92 -50.59 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.44 109.983 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.498 HH11 ' HG3' ' A' ' 60' ' ' ARG . 5.4 mtm-85 -62.54 -43.71 98.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 3.3399999999999999 109.841 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.95 -39.78 94.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 2.3700000000000001 108.797 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.461 ' O ' ' OG1' ' A' ' 66' ' ' THR . 55.9 t90 -65.45 -46.32 80.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.40999999999999998 110.526 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 tp -67.56 -49.45 63.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 1.0800000000000001 110.017 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.75 -48.87 79.86 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.381 -0.825 . . . . 2.6099999999999999 109.969 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 28.8 t0 -68.95 -28.97 67.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.704 . . . . 1.8999999999999999 109.862 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 50.3 m -79.5 -34.55 41.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.254 -0.903 . . . . 1.1100000000000001 111.019 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.412 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 23.3 p -131.56 -29.52 1.74 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.648 -1.283 . . . . 0.96999999999999997 111.749 -178.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.6 14.19 20.38 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.382 -1.487 . . . . 0.38 109.382 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.44 1.69 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.047 -1.266 . . . . 1.1000000000000001 109.015 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -90.6 171.19 9.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.084 -1.01 . . . . 2.3700000000000001 109.737 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -34.01 72.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 1.1200000000000001 110.746 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.19 -40.54 67.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.618 -1.301 . . . . 2.9700000000000002 109.993 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.79 -39.98 79.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.112 -0.993 . . . . 2.6200000000000001 110.409 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -67.41 -39.05 85.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.27 -0.894 . . . . 1.8899999999999999 110.028 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -59.97 -38.65 83.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 3.3199999999999998 109.421 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.43 -39.94 85.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.712 -1.243 . . . . 0.40000000000000002 110.482 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -66.78 -40.03 88.03 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.915 -1.115 . . . . 0.95999999999999996 109.86 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.03 -59.97 4.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.599 -1.313 . . . . 0.5 110.044 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.67 84.97 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.443 -1.063 . . . . 0.27000000000000002 110.443 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.13 -49.94 52.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -1.134 . . . . 0.93999999999999995 109.867 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.07 -39.98 75.31 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.792 -1.163 . . . . 1.0900000000000001 108.775 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.23 -41.18 99.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 3.1800000000000002 110.18 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -69.87 -35.94 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.927 -1.108 . . . . 1.9099999999999999 109.569 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.443 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 80.2 t90 -59.98 -43.92 94.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.944 -1.502 . . . . 0.40000000000000002 106.944 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 34.9 m -60.98 -40.03 91.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.827 -0.805 . . . . 0.96999999999999997 108.827 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.66 81.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.431 -0.793 . . . . 0.55000000000000004 110.032 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.58 -38.18 16.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -0.991 . . . . 1.1200000000000001 110.6 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.228 -0.92 . . . . 1.24 110.102 -178.756 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.709 0.766 . . . . 1.97 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.79 -23.86 46.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.752 -0.593 . . . . 2.5899999999999999 110.272 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.12 -38.48 83.15 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.216 -0.928 . . . . 2.5 108.931 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -59.97 -52.21 66.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.51000000000000001 110.867 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -70.01 -35.38 74.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.955 -1.091 . . . . 3.73 109.738 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -65.47 -40.01 92.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.37 -0.831 . . . . 0.76000000000000001 109.385 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 44.1 t80 -63.1 -49.67 73.54 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.343 -0.848 . . . . 0.5 110.026 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.32 6.07 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.078 -1.014 . . . . 1.1799999999999999 111.241 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.36 -18.68 17.4 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.894 -1.129 . . . . 1.1799999999999999 110.0 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' B' ' 14' ' ' PRO . 6.5 pt-20 -152.0 151.89 28.8 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.097 -1.002 . . . . 1.27 108.95 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' B' ' 13' ' ' GLU . 70.2 Cg_exo -36.75 156.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 122.16 1.907 . . . . 0.53000000000000003 111.795 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 15.7 ptm -93.58 -29.72 15.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.094 -1.004 . . . . 1.1299999999999999 110.158 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -135.3 44.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.227 -1.149 . . . . 0.40999999999999998 110.227 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.94 35.16 3.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.619 -0.93 . . . . 0.83999999999999997 110.005 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.18 148.54 71.39 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.991 . . . . 2.4900000000000002 108.445 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.3 156.24 41.79 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.998 1.799 . . . . 0.38 112.039 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.4 p -57.02 -48.19 82.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.543 -0.723 . . . . 1.1200000000000001 110.237 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.7 -3.94 0.22 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.776 -0.93 . . . . 0.27000000000000002 110.776 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.49 ' H ' ' C ' ' B' ' 20' ' ' VAL . 70.6 m -83.08 -21.6 33.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.761 -1.435 . . . . 1.75 109.462 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.33 136.79 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 1.0600000000000001 109.406 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.4 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.58 136.18 56.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.755 0.788 . . . . 1.05 109.824 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.31 -20.15 51.9 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.742 -1.743 . . . . 0.22 108.742 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.42 HG21 HD12 ' B' ' 26' ' ' ILE . 32.3 mm -99.76 114.99 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.933 -1.136 . . . . 1.0800000000000001 107.933 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.31 177.0 42.33 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.825 -1.31 . . . . 0.29999999999999999 109.825 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.62 -39.97 74.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.591 -0.946 . . . . 2.0 110.015 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.84 -44.37 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 1.1399999999999999 109.837 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.78 -37.5 84.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 1.1299999999999999 109.487 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.0 96.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.288 -1.525 . . . . 0.35999999999999999 109.288 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -39.76 94.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -1.12 . . . . 3.2200000000000002 110.371 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' B' ' 67' ' ' CYS . 50.5 mtpt -65.4 -48.38 73.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.201 . . . . 2.1200000000000001 109.971 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.8 -36.02 79.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.953 -1.092 . . . . 1.0800000000000001 108.492 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -59.92 -42.51 94.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.732 -0.605 . . . . 1.6799999999999999 110.008 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.05 -19.32 65.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 1.99 108.607 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' B' ' 37' ' ' ARG . 34.0 mtt-85 -90.97 6.56 44.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.595 -0.691 . . . . 3.1499999999999999 110.291 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.73 55.49 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.063 -1.065 . . . . 0.48999999999999999 111.766 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -103.9 73.1 1.14 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.801 -1.411 . . . . 0.38 108.328 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.17 -10.61 59.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.40999999999999998 110.639 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.52 150.3 50.92 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.92 . . . . 2.1499999999999999 109.62 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.07 94.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 1.03 110.766 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 16.7 p90 -60.49 -18.57 52.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.92000000000000004 110.514 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 50.8 t -79.62 -32.77 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.426 -1.324 . . . . 1.0800000000000001 107.426 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.83 -37.26 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.109 -1.071 . . . . 1.0700000000000001 108.109 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.04 -35.44 75.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.611 -1.255 . . . . 1.1499999999999999 107.611 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.61 97.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.067 -1.213 . . . . 0.19 110.067 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -60.02 -41.64 92.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.006 -1.291 . . . . 1.8200000000000001 109.742 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.04 -39.88 87.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.40000000000000002 108.82 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.52 -38.77 81.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.816 -0.809 . . . . 1.0700000000000001 108.816 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.03 -24.44 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.401 -0.812 . . . . 1.0900000000000001 110.648 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.8 mt -93.18 18.16 9.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.111 -0.993 . . . . 1.0900000000000001 110.434 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.46 33.55 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.67 -1.269 . . . . 2.23 110.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.06 19.89 9.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.764 -0.585 . . . . 2.7999999999999998 110.332 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -68.48 113.4 6.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 1.8 107.726 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.82 -39.96 93.6 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 113.11 0.782 . . . . 0.88 113.11 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.87 -39.61 76.23 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.575 -1.328 . . . . 0.73999999999999999 110.604 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.59 -38.82 77.49 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.848 -1.141 . . . . 1.2 108.937 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.98 -50.44 68.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.44 110.005 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' B' ' 60' ' ' ARG . 5.4 mtm-85 -62.62 -43.66 98.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 3.3399999999999999 109.803 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.94 -39.79 94.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 2.3799999999999999 108.745 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.463 ' O ' ' OG1' ' B' ' 66' ' ' THR . 55.7 t90 -65.54 -46.29 80.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.912 . . . . 0.40999999999999998 110.513 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -49.45 63.17 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.06 -1.025 . . . . 1.0700000000000001 110.074 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.78 -48.72 80.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.288 -0.882 . . . . 2.6000000000000001 109.937 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.8 t0 -69.13 -28.89 66.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 1.8999999999999999 109.852 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 50.5 m -79.51 -34.61 41.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 1.1000000000000001 111.011 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . 0.438 ' O ' ' NZ ' ' B' ' 33' ' ' LYS . 23.3 p -131.61 -29.45 1.74 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.611 -1.305 . . . . 0.95999999999999996 111.77 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.57 14.27 20.22 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.321 -1.512 . . . . 0.37 109.321 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.48 1.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.322 . . . . 1.0900000000000001 109.077 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -90.7 171.12 9.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.075 -1.015 . . . . 2.3700000000000001 109.685 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.97 72.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.52 -0.738 . . . . 1.1100000000000001 110.828 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.07 -40.63 68.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.558 -1.339 . . . . 2.9700000000000002 110.003 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.81 -39.98 79.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 2.6200000000000001 110.382 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 56.6 m -67.19 -39.22 86.34 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.279 -0.888 . . . . 1.8899999999999999 110.044 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -60.09 -38.46 82.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 3.3199999999999998 109.387 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.58 -39.9 84.86 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.722 -1.236 . . . . 0.40000000000000002 110.357 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.5 m -66.91 -39.93 87.53 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.947 -1.096 . . . . 0.95999999999999996 109.886 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 -59.97 4.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.638 -1.289 . . . . 0.5 110.066 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.54 84.51 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.518 -1.033 . . . . 0.27000000000000002 110.518 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.18 -50.06 50.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -1.19 . . . . 0.93999999999999995 109.77 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.94 -40.06 75.69 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.827 -1.149 . . . . 1.0900000000000001 108.809 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.15 -41.23 99.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 3.1899999999999999 110.159 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.88 -35.92 75.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.017 -1.052 . . . . 1.9099999999999999 109.594 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.43 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 80.2 t90 -60.03 -43.95 94.95 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.929 -1.508 . . . . 0.40000000000000002 106.929 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.0 m -60.99 -39.96 91.64 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.849 -0.797 . . . . 0.96999999999999997 108.849 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.59 81.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.55000000000000004 110.117 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -38.71 15.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.155 -0.966 . . . . 1.1299999999999999 110.579 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -104.51 -86.79 0.45 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.169 -0.957 . . . . 1.24 110.265 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 118.084 -0.96 . . . . 1.8300000000000001 109.602 -178.563 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.585 0.707 . . . . 1.98 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.68 -21.14 62.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.538 -0.726 . . . . 2.6000000000000001 110.69 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.99 -37.84 80.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.777 -1.202 . . . . 2.5099999999999998 109.613 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -60.0 -51.85 67.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.841 -1.162 . . . . 0.51000000000000001 110.48 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -69.72 -36.59 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.012 -1.055 . . . . 3.7200000000000002 109.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.49 -39.96 73.86 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.76000000000000001 109.69 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.32 -41.33 96.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.216 -0.928 . . . . 0.5 109.945 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 m -84.31 15.58 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 1.1799999999999999 109.842 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.8 -9.78 11.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.449 -0.782 . . . . 1.1799999999999999 110.294 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.476 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 10.6 pt-20 -149.86 149.2 27.31 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.943 -1.098 . . . . 1.26 109.252 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 13' ' ' GLU . 89.7 Cg_exo -41.1 166.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.811 1.674 . . . . 0.53000000000000003 111.776 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 ptp -93.05 -24.95 18.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 1.1399999999999999 108.621 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.96 -140.65 16.48 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.021 -1.632 . . . . 0.41999999999999998 109.021 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -109.74 30.03 7.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.481 -1.011 . . . . 0.84999999999999998 109.477 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 90.2 mttt -60.18 149.39 75.52 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 2.4900000000000002 108.986 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.12 153.98 54.77 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.182 1.921 . . . . 0.39000000000000001 112.439 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 22' ' ' SER . 14.5 p -57.52 -44.03 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.603 -0.686 . . . . 1.1200000000000001 110.522 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -54.64 -2.78 0.2 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.16 -1.176 . . . . 0.27000000000000002 110.16 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 20' ' ' VAL . 40.7 t -82.59 -23.42 34.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.774 -1.427 . . . . 1.75 109.093 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 1.05 109.874 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.14 134.28 52.45 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.763 0.792 . . . . 1.0600000000000001 109.96 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.94 -20.53 48.71 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.283 -1.527 . . . . 0.23000000000000001 109.283 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.6 mm -99.75 114.2 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.281 -1.129 . . . . 1.0800000000000001 108.011 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.71 178.4 39.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.271 -1.532 . . . . 0.31 109.271 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -57.24 -39.71 76.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.337 -1.096 . . . . 2.0099999999999998 109.209 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.33 -48.38 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 1.1399999999999999 109.706 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.0 -39.97 83.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 1.1299999999999999 109.285 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.98 98.69 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.565 -1.414 . . . . 0.34999999999999998 109.565 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.85 -41.06 95.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -1.201 . . . . 3.2200000000000002 110.352 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.46 -40.16 85.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.823 -1.173 . . . . 2.1000000000000001 109.689 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.83 -40.06 93.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.963 -1.085 . . . . 1.0800000000000001 109.106 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.08 -40.89 91.12 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.723 -0.791 . . . . 1.6699999999999999 109.363 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.77 -19.53 64.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.809 -0.811 . . . . 2.0 108.809 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -89.0 0.18 56.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.631 -0.668 . . . . 3.1499999999999999 109.898 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' NZ ' ' B' ' 53' ' ' LYS . . . 107.01 4.35 35.93 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 120.254 -0.974 . . . . 0.47999999999999998 111.577 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.17 75.64 1.38 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.825 -1.397 . . . . 0.38 109.137 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.16 -11.14 59.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.40999999999999998 111.159 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -135.08 157.84 45.89 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.939 -1.101 . . . . 2.1600000000000001 109.397 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.59 88.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 1.03 112.078 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -56.15 -18.15 9.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.768 -1.208 . . . . 0.92000000000000004 110.457 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.15 -31.43 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.832 -1.168 . . . . 1.0700000000000001 108.287 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.52 -38.7 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.413 -0.958 . . . . 1.0600000000000001 108.413 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.85 -38.2 81.43 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.654 -1.61 . . . . 1.1599999999999999 106.654 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.41 -45.98 58.3 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.878 -1.289 . . . . 0.20000000000000001 109.878 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -41.93 93.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -1.181 . . . . 1.8200000000000001 109.329 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.93 -40.57 89.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.0 -1.063 . . . . 0.40000000000000002 108.828 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.74 -39.7 76.61 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.688 -0.856 . . . . 1.0900000000000001 108.688 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.09 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 110.554 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.77 13.83 13.39 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.096 . . . . 1.0900000000000001 110.858 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 51.32 35.91 14.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.209 . . . . 2.2200000000000002 110.223 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 56.08 19.42 3.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.228 -0.92 . . . . 2.7999999999999998 110.524 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -69.16 105.34 2.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.712 -1.242 . . . . 1.8 108.263 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.538 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 83.3 tt0 -62.94 -39.95 96.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 0.87 111.973 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.65 -39.89 88.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.72999999999999998 109.57 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.32 -37.92 71.73 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.445 -0.902 . . . . 1.2 108.747 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.56 -42.13 95.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.565 -0.71 . . . . 0.44 109.941 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.538 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 99.2 mtt180 -60.11 -48.5 81.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.249 -0.907 . . . . 3.3399999999999999 110.361 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.94 -39.89 90.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.682 -1.261 . . . . 2.3700000000000001 109.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.443 ' O ' ' OG1' ' A' ' 66' ' ' THR . 67.7 t90 -61.65 -50.1 73.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 0.40999999999999998 110.664 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 55.9 tp -68.4 -48.44 64.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.089 -1.007 . . . . 1.0800000000000001 110.103 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.19 -47.16 85.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 2.6099999999999999 109.797 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -68.71 -30.12 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.555 -0.715 . . . . 1.8999999999999999 109.682 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 55.3 m -80.22 -32.52 38.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 1.1100000000000001 111.029 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 32.1 p -133.0 -35.05 1.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.575 -1.328 . . . . 0.96999999999999997 112.098 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.65 16.04 9.71 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.338 -1.505 . . . . 0.38 109.338 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 152.24 2.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.272 . . . . 1.1000000000000001 109.89 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -90.22 173.49 8.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.109 -0.994 . . . . 2.3700000000000001 109.953 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.61 75.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.715 . . . . 1.1200000000000001 110.03 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.24 -40.01 71.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 2.9700000000000002 109.633 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -66.61 -39.28 88.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.548 -0.72 . . . . 2.6200000000000001 110.151 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.1 m -62.84 -38.61 91.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.299 -0.876 . . . . 1.8899999999999999 109.747 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 3.3199999999999998 109.614 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -69.31 -39.91 77.98 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.737 -1.227 . . . . 0.40000000000000002 110.742 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -70.2 -39.96 74.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.661 -1.275 . . . . 0.95999999999999996 109.996 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.33 -60.38 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.81 -1.181 . . . . 0.5 110.046 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.46 82.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.388 -1.085 . . . . 0.27000000000000002 110.388 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.7 t -68.54 -49.63 58.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.295 . . . . 0.93999999999999995 109.681 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.1 mt -70.09 -40.07 75.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.323 -0.951 . . . . 1.0900000000000001 109.327 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -62.0 -40.59 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 3.1800000000000002 109.596 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.02 -38.63 75.98 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.277 -0.889 . . . . 1.9099999999999999 110.077 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.557 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.4 t90 -61.69 -46.57 89.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.473 -1.392 . . . . 0.40000000000000002 108.688 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.9 m -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.462 -0.774 . . . . 0.96999999999999997 109.573 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -58.87 -30.97 68.15 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 109.423 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.48 -34.75 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.269 -0.894 . . . . 1.1200000000000001 111.063 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 87.2 m-85 . . . . . 0 N--CA 1.507 2.42 0 O-C-N 121.149 -0.969 . . . . 1.24 112.717 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 54.3 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.652 0.739 . . . . 1.97 109.642 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.84 -21.06 62.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 2.5899999999999999 110.624 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.97 -37.82 80.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.799 -1.188 . . . . 2.5 109.619 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -60.0 -51.9 67.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.081 . . . . 0.51000000000000001 110.527 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -69.73 -36.51 75.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 3.73 109.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.41 -39.93 74.17 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.35 -0.844 . . . . 0.76000000000000001 109.793 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.44 -41.15 96.73 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.503 -0.879 . . . . 0.5 109.933 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.53 15.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.081 -1.012 . . . . 1.1799999999999999 109.857 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.97 -9.81 11.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.466 -0.771 . . . . 1.1799999999999999 110.362 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' B' ' 18' ' ' LYS . 10.5 pt-20 -149.86 149.14 27.14 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 120.903 -1.123 . . . . 1.27 109.208 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' B' ' 13' ' ' GLU . 92.3 Cg_exo -41.04 166.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.798 1.665 . . . . 0.53000000000000003 111.705 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 3.3 ptp -93.29 -24.69 18.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 1.1299999999999999 108.699 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.61 -140.55 14.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.03 -1.628 . . . . 0.40999999999999998 109.03 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -109.65 30.1 6.97 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.512 -0.993 . . . . 0.83999999999999997 109.464 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' B' ' 13' ' ' GLU . 89.8 mttt -60.27 149.55 75.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.938 . . . . 2.4900000000000002 108.856 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.35 153.98 56.14 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.204 1.936 . . . . 0.38 112.422 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' B' ' 22' ' ' SER . 14.5 p -57.64 -43.84 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.567 -0.708 . . . . 1.1200000000000001 110.545 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -54.83 -2.56 0.2 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.118 -1.193 . . . . 0.27000000000000002 110.118 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.519 ' H ' ' C ' ' B' ' 20' ' ' VAL . 40.6 t -82.87 -23.39 33.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.399 . . . . 1.75 109.125 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 1.0600000000000001 109.869 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.16 134.22 52.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.788 0.804 . . . . 1.05 110.075 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.528 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.98 -20.5 48.78 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.287 -1.525 . . . . 0.22 109.287 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.65 114.05 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -1.125 . . . . 1.0800000000000001 108.024 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.6 178.3 39.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.262 -1.535 . . . . 0.29999999999999999 109.262 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -57.19 -39.57 75.62 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.315 -1.109 . . . . 2.0 109.236 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.28 -48.53 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 1.1399999999999999 109.721 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.86 -40.07 83.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.159 -0.963 . . . . 1.1299999999999999 109.354 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.95 98.66 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.594 -1.403 . . . . 0.35999999999999999 109.594 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.83 -41.21 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -1.23 . . . . 3.2200000000000002 110.301 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.41 -39.9 85.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.83 -1.169 . . . . 2.1200000000000001 109.772 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.94 -39.98 93.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.026 . . . . 1.0800000000000001 109.06 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.09 -40.94 91.34 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.79 -0.764 . . . . 1.6799999999999999 109.317 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -68.81 -19.46 64.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.824 -0.806 . . . . 1.99 108.824 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -89.01 0.39 56.71 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.092 -0.643 . . . . 3.1499999999999999 109.969 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.79 4.33 36.58 Favored Glycine 0 N--CA 1.504 3.17 0 O-C-N 121.105 -0.997 . . . . 0.48999999999999999 111.734 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -103.33 75.83 1.38 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.818 -1.401 . . . . 0.38 109.096 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -77.43 -10.97 59.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.40999999999999998 111.019 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -135.19 157.95 45.61 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.902 -1.124 . . . . 2.1499999999999999 109.444 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.49 88.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.547 -0.72 . . . . 1.03 112.051 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -56.36 -18.13 9.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.721 -1.237 . . . . 0.92000000000000004 110.551 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.13 -31.36 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.884 -1.135 . . . . 1.0800000000000001 108.279 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.52 -38.75 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 1.0700000000000001 108.425 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.03 -38.3 82.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.573 -1.64 . . . . 1.1499999999999999 106.573 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.74 -45.6 60.43 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.68 -1.368 . . . . 0.19 109.68 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -41.8 93.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.225 . . . . 1.8200000000000001 109.356 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.0 -40.49 89.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.017 -1.052 . . . . 0.40000000000000002 108.753 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -69.77 -40.04 76.31 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.662 -0.866 . . . . 1.0700000000000001 108.662 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.68 -21.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 110.613 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.91 14.02 13.14 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.048 -1.032 . . . . 1.0900000000000001 110.663 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 38' ' ' GLY . 59.8 mttp 50.79 36.32 14.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.812 -1.18 . . . . 2.23 110.227 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 55.91 19.41 3.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.308 -0.87 . . . . 2.7999999999999998 110.618 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -69.01 105.58 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.72 -1.237 . . . . 1.8 108.18 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 83.5 tt0 -63.17 -39.96 96.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.88 111.977 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.45 -40.08 89.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.815 -1.178 . . . . 0.73999999999999999 109.553 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -71.1 -37.79 72.38 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.396 -0.921 . . . . 1.2 108.848 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.8 -42.19 95.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.612 -0.68 . . . . 0.44 109.898 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 99.2 mtt180 -59.99 -48.96 79.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.244 -0.91 . . . . 3.3399999999999999 110.35 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.54 -39.94 92.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.689 -1.257 . . . . 2.3799999999999999 109.832 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.8 t90 -61.7 -49.97 74.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.921 -1.112 . . . . 0.40999999999999998 110.706 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.2 tp -68.43 -48.7 63.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.079 -1.013 . . . . 1.0700000000000001 110.032 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.06 -47.12 86.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 2.6000000000000001 109.767 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -68.85 -29.96 68.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 1.8999999999999999 109.656 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 53.4 m -80.17 -32.58 38.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 1.1000000000000001 111.045 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 32.0 p -132.94 -35.29 1.07 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.66 -1.275 . . . . 0.95999999999999996 112.045 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.72 16.48 9.28 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.292 -1.523 . . . . 0.37 109.292 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 152.32 3.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.063 -1.257 . . . . 1.0900000000000001 109.76 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.1 173.62 8.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 2.3700000000000001 109.98 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.92 -34.3 75.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 1.1100000000000001 110.093 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -71.38 -40.1 70.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 2.9700000000000002 109.593 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.6 mm100 -66.53 -39.15 88.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.488 -0.757 . . . . 2.6200000000000001 110.25 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 74.2 m -62.94 -38.58 91.61 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.268 -0.895 . . . . 1.8899999999999999 109.748 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.158 -0.964 . . . . 3.3199999999999998 109.626 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -69.32 -39.99 77.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.839 -1.163 . . . . 0.40000000000000002 110.716 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -70.14 -40.05 75.03 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.682 -1.261 . . . . 0.95999999999999996 109.968 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -61.18 -60.31 3.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.861 -1.149 . . . . 0.5 110.162 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.34 82.14 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.46 -1.056 . . . . 0.27000000000000002 110.46 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.66 -49.63 57.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.302 . . . . 0.93999999999999995 109.699 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.03 -40.04 75.42 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.295 -0.962 . . . . 1.0900000000000001 109.324 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -62.0 -40.68 96.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 3.1899999999999999 109.566 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -38.69 76.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.166 -0.959 . . . . 1.9099999999999999 110.153 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.555 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.2 t90 -61.75 -46.61 88.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.456 -1.403 . . . . 0.40000000000000002 108.702 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' B' ' 89' ' ' LEU . 51.6 m -60.08 -39.91 87.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.751 -0.78 . . . . 0.96999999999999997 109.686 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.05 -30.79 68.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.384 -0.822 . . . . 0.55000000000000004 109.406 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 -35.21 13.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.835 . . . . 1.1299999999999999 111.057 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.4 m-85 -108.31 -6.13 16.44 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.129 -0.982 . . . . 1.24 112.663 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.4 tp . . . . . 0 N--CA 1.502 2.171 0 O-C-N 120.355 -1.466 . . . . 1.8300000000000001 109.371 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.7 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.609 0.718 . . . . 1.98 109.124 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.91 -28.66 67.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.548 -0.72 . . . . 2.6000000000000001 110.114 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -60.32 -39.62 87.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.949 -1.095 . . . . 2.5099999999999998 109.644 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -59.85 -51.17 70.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.931 . . . . 0.51000000000000001 110.656 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -70.25 -34.45 72.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.814 -1.179 . . . . 3.7200000000000002 109.685 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -68.74 -38.88 80.46 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.368 -0.833 . . . . 0.76000000000000001 110.023 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.55 -45.78 82.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.5 110.173 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -86.26 7.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.124 -0.985 . . . . 1.1799999999999999 110.812 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.2 -13.62 17.35 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.201 -0.937 . . . . 1.1799999999999999 110.056 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -154.54 153.55 28.05 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.977 . . . . 1.26 108.998 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -37.72 156.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 122.071 1.847 . . . . 0.53000000000000003 111.741 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.7 ptm -93.31 -28.2 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 1.1399999999999999 110.296 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.51 42.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.433 -1.067 . . . . 0.41999999999999998 110.433 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.64 35.89 3.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.614 -0.933 . . . . 0.84999999999999998 110.379 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -57.93 149.58 54.04 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.047 -1.033 . . . . 2.4900000000000002 108.313 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.94 155.31 55.93 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.069 1.846 . . . . 0.39000000000000001 112.551 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 22' ' ' SER . 3.4 p -57.07 -47.16 84.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.479 0.657 . . . . 1.1200000000000001 110.387 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.67 -5.42 0.86 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 121.467 -0.77 . . . . 0.27000000000000002 111.223 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 20' ' ' VAL . 60.8 m -84.21 -19.94 33.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.448 -1.619 . . . . 1.75 109.498 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.46 134.07 55.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 1.05 109.29 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -64.21 133.33 52.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.669 -0.812 . . . . 1.0600000000000001 109.675 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.52 -21.22 47.07 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.129 -1.588 . . . . 0.23000000000000001 109.129 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.75 112.4 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 1.0800000000000001 108.405 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.98 -178.77 36.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.287 -1.525 . . . . 0.31 109.287 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.88 -40.28 83.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -1.093 . . . . 2.0099999999999998 110.631 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.05 -46.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.72 -1.238 . . . . 1.1399999999999999 109.14 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.3 -40.07 86.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 1.1299999999999999 109.483 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.69 96.73 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.913 -1.275 . . . . 0.34999999999999998 109.913 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.34 -38.18 85.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.001 -1.294 . . . . 3.2200000000000002 110.332 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.84 -45.15 87.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 2.1000000000000001 109.748 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.8 mt -62.17 -40.09 94.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.013 -1.055 . . . . 1.0800000000000001 109.798 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.03 -40.1 88.19 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.476 -0.889 . . . . 1.6699999999999999 109.053 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -67.79 -19.16 65.06 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.81 6.61 40.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 3.1499999999999999 109.601 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 9.05 57.06 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 121.005 -1.059 . . . . 0.47999999999999998 111.544 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -103.71 75.36 1.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.854 -1.38 . . . . 0.38 108.858 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' H ' ' HZ2' ' B' ' 53' ' ' LYS . 44.8 p-10 -74.18 -10.08 59.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.40999999999999998 111.248 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -140.69 161.57 37.47 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.896 -1.127 . . . . 2.1600000000000001 110.69 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.67 -43.64 92.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 1.03 112.355 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 6.4 p90 -58.2 -18.43 25.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.801 -1.187 . . . . 0.92000000000000004 110.669 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.06 -31.37 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.79 -1.189 . . . . 1.0700000000000001 107.79 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.63 -40.03 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.185 -1.042 . . . . 1.0600000000000001 108.185 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.8 tp -59.02 -34.65 72.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.882 -1.525 . . . . 1.1599999999999999 106.882 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.01 -40.72 97.37 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.593 -1.403 . . . . 0.20000000000000001 109.593 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -41.97 93.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.261 . . . . 1.8200000000000001 108.987 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -60.24 -41.54 93.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.40000000000000002 108.705 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -70.27 -40.0 74.61 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.548 -0.861 . . . . 1.0900000000000001 108.921 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.93 -25.11 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 1.0900000000000001 110.671 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -92.29 15.3 14.05 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.949 -1.095 . . . . 1.0900000000000001 110.491 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 67.8 mttm 52.41 40.29 29.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.088 -1.007 . . . . 2.2200000000000002 110.548 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 pttt 40.3 19.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.01 -1.056 . . . . 2.7999999999999998 111.873 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 17.9 t0 -66.85 117.55 9.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.671 -1.603 . . . . 1.8 106.671 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.87 -40.17 94.45 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.483 0.92 . . . . 0.87 113.483 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 96.1 m-20 -70.21 -39.86 74.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.416 -1.428 . . . . 0.72999999999999998 109.937 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.09 -39.86 68.64 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.935 -1.106 . . . . 1.2 108.6 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -61.83 -49.92 74.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.44 109.957 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.4 mtm180 -61.84 -42.65 99.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 3.3399999999999999 110.616 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.73 -39.24 93.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 2.3700000000000001 109.25 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.422 ' O ' ' OG1' ' A' ' 66' ' ' THR . 70.3 t90 -61.22 -49.28 77.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.029 -1.044 . . . . 0.40999999999999998 110.735 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.23 -49.28 65.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 1.0800000000000001 109.857 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -61.89 -47.26 85.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.393 -0.817 . . . . 2.6099999999999999 109.864 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.0 t0 -69.04 -31.13 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 1.8999999999999999 109.864 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 56.6 m -79.75 -33.08 41.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 1.1100000000000001 111.366 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.1 p -132.54 -31.72 1.36 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.58 -1.325 . . . . 0.96999999999999997 111.574 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 15.79 12.63 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.075 -1.61 . . . . 0.38 109.075 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.02 153.49 3.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -1.205 . . . . 1.1000000000000001 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -94.93 176.22 6.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 2.3700000000000001 109.825 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -35.35 75.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.586 -0.696 . . . . 1.1200000000000001 111.23 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -70.13 -42.84 72.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.52 -1.362 . . . . 2.9700000000000002 110.57 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 73' ' ' GLN . 16.7 mp0 -67.94 -39.18 83.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -0.963 . . . . 2.6200000000000001 110.965 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 t -67.95 -38.35 82.7 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.809 -1.182 . . . . 1.8899999999999999 110.198 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -60.72 -38.79 86.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.742 -1.224 . . . . 3.3199999999999998 109.913 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.26 -39.62 82.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.561 -1.337 . . . . 0.40000000000000002 110.417 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 96.5 m -69.71 -40.09 76.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.965 -1.085 . . . . 0.95999999999999996 109.518 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -59.4 -60.34 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.179 -0.95 . . . . 0.5 109.424 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.51 -33.63 87.76 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.694 -0.962 . . . . 0.27000000000000002 110.694 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -1.234 . . . . 0.93999999999999995 109.636 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.1 mt -70.27 -39.97 74.62 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.962 -1.095 . . . . 1.0900000000000001 108.391 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -65.1 -40.16 94.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.86 . . . . 3.1800000000000002 110.309 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.62 -39.69 80.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 1.9099999999999999 110.6 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 88.4 t90 -60.23 -42.28 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.343 -1.473 . . . . 0.40000000000000002 107.581 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.16 -40.09 88.7 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.783 0.801 . . . . 0.96999999999999997 109.279 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.6 -33.95 72.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.218 -0.927 . . . . 0.55000000000000004 109.698 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.18 -34.56 14.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.195 -0.94 . . . . 1.1200000000000001 111.285 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.551 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.8 m-85 . . . . . 0 N--CA 1.505 2.285 0 O-C-N 121.116 -0.99 . . . . 1.24 111.482 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.656 0.741 . . . . 1.97 109.1 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.19 -28.24 67.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.612 -0.68 . . . . 2.5899999999999999 110.07 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.5 -39.57 88.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.123 -0.986 . . . . 2.5 109.637 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -59.84 -51.32 70.23 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.261 -0.899 . . . . 0.51000000000000001 110.635 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -70.19 -34.23 72.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.896 -1.127 . . . . 3.73 109.854 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -68.88 -39.35 79.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.376 -0.828 . . . . 0.76000000000000001 109.785 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.13 -46.17 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.5 110.119 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.0 m -86.09 8.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.141 -0.975 . . . . 1.1799999999999999 110.749 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.7 -13.44 17.08 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.192 -0.942 . . . . 1.1799999999999999 109.911 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.54 153.38 27.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 1.27 108.98 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -37.89 156.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.059 1.839 . . . . 0.53000000000000003 111.719 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.401 ' H ' ' HG2' ' B' ' 15' ' ' MET . 11.6 ptm -93.2 -28.13 16.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 1.1299999999999999 110.271 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.18 -133.33 41.87 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.412 -1.075 . . . . 0.40999999999999998 110.412 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.81 36.01 3.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.596 -0.944 . . . . 0.83999999999999997 110.302 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -58.09 149.83 54.53 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.871 -1.143 . . . . 2.4900000000000002 108.329 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.87 155.17 56.34 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.168 1.912 . . . . 0.38 112.537 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' B' ' 22' ' ' SER . 3.5 p -57.16 -46.53 84.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.602 0.715 . . . . 1.1200000000000001 110.496 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.07 -5.25 0.95 Allowed Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.45 -0.782 . . . . 0.27000000000000002 111.248 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 20' ' ' VAL . 59.5 m -84.4 -20.32 32.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.553 -1.557 . . . . 1.75 109.435 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.14 133.86 55.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 1.0600000000000001 109.237 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.14 133.34 52.75 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.586 -0.845 . . . . 1.05 109.714 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.62 -20.98 48.26 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.25 -1.54 . . . . 0.22 109.25 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.03 112.6 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -1.088 . . . . 1.0800000000000001 108.365 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.22 -178.86 35.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.174 -1.57 . . . . 0.29999999999999999 109.174 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -58.65 -40.07 82.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.422 -1.046 . . . . 2.0 110.713 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.04 -46.57 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.642 -1.286 . . . . 1.1399999999999999 109.196 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.21 -39.95 86.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 1.1299999999999999 109.545 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.56 97.19 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.835 -1.306 . . . . 0.35999999999999999 109.835 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.21 -38.64 87.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.266 . . . . 3.2200000000000002 110.189 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.59 -45.06 88.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.712 -1.243 . . . . 2.1200000000000001 109.603 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.13 -39.9 94.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.835 -1.166 . . . . 1.0800000000000001 109.822 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.42 -40.05 89.66 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.579 -0.848 . . . . 1.6799999999999999 108.896 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -67.82 -19.18 65.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.215 -1.031 . . . . 1.99 108.215 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.86 6.87 39.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.533 -0.73 . . . . 3.1499999999999999 109.603 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.42 9.07 57.06 Favored Glycine 0 N--CA 1.5 2.939 0 O-C-N 120.961 -1.087 . . . . 0.48999999999999999 111.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -104.1 75.46 1.27 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.929 -1.336 . . . . 0.38 108.948 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.37 -9.98 59.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.883 . . . . 0.40999999999999998 111.176 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -140.66 161.78 36.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.852 -1.155 . . . . 2.1499999999999999 110.712 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.77 -43.84 91.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.835 -0.54 . . . . 1.03 112.314 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 5.7 p90 -57.84 -18.72 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.92000000000000004 110.733 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.12 -31.11 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.79 -1.194 . . . . 1.0800000000000001 107.849 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.81 -39.92 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.173 -1.047 . . . . 1.0700000000000001 108.173 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.6 tp -59.03 -34.84 72.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.983 -1.488 . . . . 1.1499999999999999 106.983 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.99 97.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.494 -1.442 . . . . 0.19 109.494 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.84 -42.04 92.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 1.8200000000000001 108.961 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.11 -41.54 92.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.40000000000000002 108.727 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.41 -40.18 74.02 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.537 -0.865 . . . . 1.0700000000000001 108.889 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.92 -24.66 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 110.785 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.55 15.81 13.4 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.037 -1.039 . . . . 1.0900000000000001 110.368 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' B' ' 55' ' ' ASP . 67.8 mttm 51.98 40.19 27.74 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.904 -1.122 . . . . 2.23 110.635 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 47.8 pttt 40.49 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.135 -0.978 . . . . 2.7999999999999998 111.711 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 53' ' ' LYS . 19.3 t0 -66.78 117.77 9.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.52 -1.659 . . . . 1.8 106.52 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.62 -40.93 96.61 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.127 -0.983 . . . . 0.88 113.458 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.52 -39.97 77.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.437 -1.414 . . . . 0.73999999999999999 110.107 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.18 -39.95 68.29 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.005 -1.078 . . . . 1.2 108.552 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.7 -50.14 73.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.833 . . . . 0.44 109.96 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -61.56 -43.05 99.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 3.3399999999999999 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -64.54 -38.9 92.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.848 -1.158 . . . . 2.3799999999999999 109.392 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -61.33 -49.17 78.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.40999999999999998 110.818 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 32.8 tp -67.38 -49.49 63.71 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.329 -0.857 . . . . 1.0700000000000001 109.835 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.77 -47.02 87.05 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.373 -0.829 . . . . 2.6000000000000001 109.939 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.7 t0 -69.17 -31.08 69.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.436 -0.79 . . . . 1.8999999999999999 109.926 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 55.4 m -79.76 -33.2 40.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 1.1000000000000001 111.341 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.32 -32.26 1.37 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.718 -1.239 . . . . 0.95999999999999996 111.62 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.32 16.13 11.58 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.144 -1.582 . . . . 0.37 109.144 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.16 153.53 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.301 . . . . 1.0900000000000001 109.358 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -94.81 176.22 6.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 2.3700000000000001 109.77 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.17 75.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.608 -0.682 . . . . 1.1100000000000001 111.255 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -70.07 -42.73 72.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.511 -1.368 . . . . 2.9700000000000002 110.611 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' B' ' 73' ' ' GLN . 16.5 mp0 -67.99 -39.43 83.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.198 -0.939 . . . . 2.6200000000000001 111.021 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.8 t -67.83 -38.04 82.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.037 -1.039 . . . . 1.8899999999999999 110.08 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -61.2 -38.34 86.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.775 -1.203 . . . . 3.3199999999999998 109.92 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.5 -39.88 81.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.439 -1.413 . . . . 0.40000000000000002 110.322 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 99.0 m -69.7 -40.2 76.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.824 -1.173 . . . . 0.95999999999999996 109.473 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.51 -60.02 4.51 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.096 -1.003 . . . . 0.5 109.339 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.69 -33.63 87.75 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.618 -0.993 . . . . 0.27000000000000002 110.618 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.38 -46.12 61.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.985 -1.303 . . . . 0.93999999999999995 109.588 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.85 -40.14 75.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.095 -1.042 . . . . 1.0900000000000001 108.247 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -65.14 -40.08 93.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 3.1899999999999999 110.214 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.49 -39.9 81.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 1.9099999999999999 110.419 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.544 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 88.5 t90 -60.44 -42.34 95.91 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.314 -1.491 . . . . 0.40000000000000002 107.521 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' B' ' 89' ' ' LEU . 63.7 m -60.03 -40.14 88.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.436 -0.79 . . . . 0.96999999999999997 109.271 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.46 -33.82 71.77 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.364 -0.835 . . . . 0.55000000000000004 109.842 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.11 13.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.121 -0.987 . . . . 1.1299999999999999 111.192 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.544 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 97.1 m-85 -107.84 2.25 23.38 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.206 -0.934 . . . . 1.24 111.636 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.498 1.962 0 O-C-N 120.938 -1.101 . . . . 1.8300000000000001 109.363 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.481 ' HG ' ' H ' ' A' ' 5' ' ' GLN . 8.4 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.761 0.791 . . . . 1.98 110.097 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' H ' ' HG ' ' A' ' 4' ' ' SER . 92.3 mm-40 -59.96 -20.87 59.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.75 -0.594 . . . . 2.6000000000000001 110.896 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -60.05 -38.48 82.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.868 -1.145 . . . . 2.5099999999999998 109.543 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -59.93 -51.69 68.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.08 . . . . 0.51000000000000001 110.652 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -69.96 -35.19 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.837 -1.164 . . . . 3.7200000000000002 110.139 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.78 -39.95 84.03 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.396 -0.815 . . . . 0.76000000000000001 109.321 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.19 -48.21 76.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.465 -0.772 . . . . 0.5 109.967 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 m -86.59 8.13 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.129 -0.982 . . . . 1.1799999999999999 110.992 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.5 -16.94 18.14 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.937 -1.102 . . . . 1.1799999999999999 110.035 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.5 pt-20 -155.6 152.49 24.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 1.26 108.469 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 92.4 Cg_exo -35.49 154.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.2 1.933 . . . . 0.53000000000000003 111.713 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.4 ptp -91.16 -23.76 20.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.909 -1.12 . . . . 1.1399999999999999 109.89 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.35 -135.47 32.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.384 -1.086 . . . . 0.41999999999999998 110.384 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -110.0 38.78 2.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.597 -0.943 . . . . 0.84999999999999998 110.158 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -59.93 149.99 71.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.044 . . . . 2.4900000000000002 108.738 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.03 148.92 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.32 2.013 . . . . 0.39000000000000001 112.588 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 p -52.73 -30.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.475 0.655 . . . . 1.1200000000000001 110.387 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.61 -3.57 67.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.745 -0.942 . . . . 0.27000000000000002 110.745 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.0 t -83.29 -20.79 33.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.746 -1.444 . . . . 1.75 109.339 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.54 135.57 57.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 1.05 109.703 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.72 133.19 53.11 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.694 0.759 . . . . 1.0600000000000001 109.671 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.73 -19.98 52.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 0.23000000000000001 109.255 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.423 HG23 HD12 ' A' ' 26' ' ' ILE . 42.3 mm -98.55 112.78 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.069 -1.085 . . . . 1.0800000000000001 108.069 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.48 178.06 39.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.803 -1.319 . . . . 0.31 109.803 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.76 -40.01 75.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.461 -1.023 . . . . 2.0099999999999998 109.766 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.35 -44.9 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 1.1399999999999999 109.671 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.69 -38.05 85.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 1.1299999999999999 109.413 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.43 -38.61 91.24 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.546 -1.422 . . . . 0.34999999999999998 109.546 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.49 -39.16 93.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -1.151 . . . . 3.2200000000000002 110.823 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.1 -44.58 79.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.742 -1.224 . . . . 2.1000000000000001 109.808 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.53 -39.93 95.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 1.0800000000000001 108.742 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.0 -42.46 94.31 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.656 -0.818 . . . . 1.6699999999999999 109.411 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.3 -19.5 65.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.0 108.783 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -91.11 1.81 56.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.654 -0.654 . . . . 3.1499999999999999 109.948 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.45 4.22 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.083 -1.011 . . . . 0.47999999999999998 110.801 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -132.41 70.94 1.46 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -1.231 . . . . 0.38 108.239 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.43 -10.53 59.52 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.272 -0.971 . . . . 0.40999999999999998 109.905 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -131.29 153.16 49.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.375 -0.828 . . . . 2.1600000000000001 108.808 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.9 90.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 1.03 111.205 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.483 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -56.59 -17.67 9.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.884 -1.135 . . . . 0.92000000000000004 110.994 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.77 -29.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.178 . . . . 1.0700000000000001 107.936 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.1 -36.8 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.308 -0.997 . . . . 1.0600000000000001 108.308 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.03 -39.29 85.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.134 -1.432 . . . . 1.1599999999999999 107.134 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.71 -43.7 94.37 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.108 -1.197 . . . . 0.20000000000000001 110.108 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.98 -42.69 94.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.752 -1.44 . . . . 1.8200000000000001 109.053 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.98 -42.27 93.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.863 . . . . 0.40000000000000002 108.943 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -68.96 -38.19 79.27 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.727 -0.842 . . . . 1.0900000000000001 108.727 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.43 -22.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 1.0900000000000001 110.046 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 16.75 10.99 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.144 -0.972 . . . . 1.0900000000000001 109.789 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.8 mttm 50.0 39.55 19.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.975 -1.078 . . . . 2.2200000000000002 110.505 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.31 19.28 4.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.7999999999999998 109.747 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.13 108.54 4.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.727 -1.233 . . . . 1.8 108.021 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -61.04 -40.0 91.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.555 -0.716 . . . . 0.87 112.556 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.09 -40.09 78.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.644 -1.285 . . . . 0.72999999999999998 110.385 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.21 75.34 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.93 -1.108 . . . . 1.2 109.009 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.85 -50.1 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.83 . . . . 0.44 110.05 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -59.94 -46.37 89.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 3.3399999999999999 110.587 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -65.74 -38.57 89.49 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.042 -1.036 . . . . 2.3700000000000001 109.14 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' A' ' 66' ' ' THR . 67.7 t90 -66.06 -48.34 71.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.40999999999999998 111.073 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.446 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 64.5 tp -66.22 -46.32 77.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.211 -0.931 . . . . 1.0800000000000001 109.152 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.91 -45.75 91.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.389 -0.819 . . . . 2.6099999999999999 109.089 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.63 -31.87 70.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.641 -0.662 . . . . 1.8999999999999999 109.85 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 94.3 m -80.41 -31.37 37.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 1.1100000000000001 111.487 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.587 ' HG ' ' H ' ' A' ' 69' ' ' ALA . 31.9 p -132.73 -25.78 1.84 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.528 -1.358 . . . . 0.96999999999999997 111.876 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.14 29.19 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.422 -1.471 . . . . 0.38 109.422 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.587 ' H ' ' HG ' ' A' ' 67' ' ' CYS . . . -50.43 153.49 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.046 -1.267 . . . . 1.1000000000000001 109.252 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -92.12 174.29 7.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.034 -1.041 . . . . 2.3700000000000001 110.242 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.08 78.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.668 -0.645 . . . . 1.1200000000000001 110.826 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.737 ' HZ2' HE21 ' A' ' 73' ' ' GLN . 22.0 pttp -75.11 -38.23 61.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.84 -1.163 . . . . 2.9700000000000002 109.731 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.737 HE21 ' HZ2' ' A' ' 72' ' ' LYS . 85.6 mm-40 -67.13 -38.77 86.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 2.6200000000000001 110.013 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 p -67.12 -37.75 84.39 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 1.8899999999999999 109.895 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.32 -38.39 83.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.079 -1.013 . . . . 3.3199999999999998 109.604 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.56 -40.07 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.707 -1.246 . . . . 0.40000000000000002 110.797 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.1 -40.02 78.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 0.95999999999999996 110.111 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.52 -60.45 3.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.628 -1.295 . . . . 0.5 110.246 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.72 -32.47 81.72 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.483 -1.047 . . . . 0.27000000000000002 110.483 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.72 -47.77 58.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.273 . . . . 0.93999999999999995 109.87 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.1 mt -70.22 -39.92 74.82 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.105 -1.038 . . . . 1.0900000000000001 109.067 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 82' ' ' ARG . 33.2 ttt-85 -63.66 -39.99 95.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 3.1800000000000002 110.322 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.39 -38.18 77.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.105 -0.997 . . . . 1.9099999999999999 110.285 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.448 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.5 t90 -59.99 -45.46 92.64 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.405 -1.435 . . . . 0.40000000000000002 107.809 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.2 m -59.98 -40.11 88.0 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.687 0.756 . . . . 0.96999999999999997 109.344 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.97 -34.61 73.52 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.348 -0.845 . . . . 0.55000000000000004 110.099 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.0 -36.31 13.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.196 -0.94 . . . . 1.1200000000000001 111.176 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.3 m-85 . . . . . 0 N--CA 1.503 2.209 0 O-C-N 121.176 -0.952 . . . . 1.24 111.324 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.474 ' HG ' ' H ' ' B' ' 5' ' ' GLN . 8.4 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.82 0.819 . . . . 1.97 110.055 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HG ' ' B' ' 4' ' ' SER . 92.4 mm-40 -60.04 -20.89 60.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 2.5899999999999999 110.892 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -60.04 -38.42 82.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.902 -1.124 . . . . 2.5 109.506 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -60.03 -51.73 68.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.979 -1.075 . . . . 0.51000000000000001 110.58 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -69.95 -34.99 74.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 3.73 110.094 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.95 -39.96 83.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.76000000000000001 109.311 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -64.32 -48.28 76.2 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.832 -0.747 . . . . 0.5 109.859 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -86.51 8.33 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.083 -1.011 . . . . 1.1799999999999999 111.014 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.65 -16.86 18.05 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 1.1799999999999999 109.985 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' B' ' 14' ' ' PRO . 13.3 pt-20 -155.64 152.44 24.29 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.111 -0.993 . . . . 1.27 108.422 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' B' ' 13' ' ' GLU . 97.9 Cg_exo -35.42 154.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.159 1.906 . . . . 0.53000000000000003 111.748 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 7.5 ptp -90.92 -23.84 20.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.022 -1.049 . . . . 1.1299999999999999 109.881 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.3 -135.59 31.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.309 -1.117 . . . . 0.40999999999999998 110.309 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -109.95 38.83 2.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.65 -0.912 . . . . 0.83999999999999997 110.092 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.9 149.94 71.07 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 120.999 -1.063 . . . . 2.4900000000000002 108.851 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.95 148.83 92.32 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.398 2.065 . . . . 0.38 112.499 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.1 p -52.81 -29.92 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.62 -0.675 . . . . 1.1200000000000001 110.409 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.77 -3.27 67.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.742 -0.943 . . . . 0.27000000000000002 110.742 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t -83.44 -20.67 33.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.699 -1.471 . . . . 1.75 109.318 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.7 135.62 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 1.0600000000000001 109.642 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.67 133.09 53.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 1.05 109.725 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 -20.01 52.34 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.271 -1.531 . . . . 0.22 109.271 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -98.56 112.73 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.024 -1.102 . . . . 1.0800000000000001 108.024 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.49 178.05 39.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.76 -1.336 . . . . 0.29999999999999999 109.76 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.8 -39.9 74.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.391 -1.064 . . . . 2.0 109.75 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.41 -45.01 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 1.1399999999999999 109.577 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.73 -37.72 85.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 1.1299999999999999 109.437 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.57 -38.68 91.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.509 -1.436 . . . . 0.35999999999999999 109.509 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.45 -39.2 93.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -1.101 . . . . 3.2200000000000002 110.793 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.04 -44.62 79.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.155 . . . . 2.1200000000000001 109.746 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.67 -39.93 95.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.014 . . . . 1.0800000000000001 108.684 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.39 94.13 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.637 -0.825 . . . . 1.6799999999999999 109.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -66.37 -19.52 65.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 1.99 108.765 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -90.97 1.76 56.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.712 -0.617 . . . . 3.1499999999999999 109.973 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.72 37.43 4.21 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.219 -0.991 . . . . 0.48999999999999999 110.734 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -132.34 70.95 1.46 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.027 -1.278 . . . . 0.38 108.213 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -77.53 -10.46 59.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.109 -0.994 . . . . 0.40999999999999998 109.823 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -131.43 153.17 49.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.345 -0.847 . . . . 2.1499999999999999 108.885 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.98 91.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 1.03 111.244 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 4.5 p90 -56.5 -17.81 9.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.999 -1.063 . . . . 0.92000000000000004 111.034 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.62 -29.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 1.0800000000000001 108.003 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.34 -36.75 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.15 -1.056 . . . . 1.0700000000000001 108.15 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.91 -39.32 85.02 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.195 -1.409 . . . . 1.1499999999999999 107.195 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -43.78 94.17 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.134 -1.186 . . . . 0.19 110.134 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.95 -42.63 94.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.868 -1.372 . . . . 1.8200000000000001 109.078 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.02 -42.33 94.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.40000000000000002 108.887 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.94 -38.4 79.46 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.69 -0.856 . . . . 1.0700000000000001 108.69 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.27 -22.68 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -0.9 . . . . 1.0900000000000001 110.065 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 93.8 mt -92.59 16.88 11.08 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.125 -0.984 . . . . 1.0900000000000001 109.786 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 58.8 mttm 49.98 39.64 19.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.926 -1.108 . . . . 2.23 110.539 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.19 19.15 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 2.7999999999999998 109.796 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' B' ' 55' ' ' ASP . 19.8 t0 -70.11 108.54 4.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.714 -1.241 . . . . 1.8 108.089 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.01 -39.93 91.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.685 -0.635 . . . . 0.88 112.653 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.17 -39.97 78.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.648 -1.282 . . . . 0.73999999999999999 110.401 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.32 75.27 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.005 -1.078 . . . . 1.2 109.071 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.78 -50.07 70.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.354 -0.841 . . . . 0.44 110.042 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -60.07 -46.4 89.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 3.3399999999999999 110.513 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -65.8 -38.45 88.99 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.899 -1.125 . . . . 2.3799999999999999 109.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.6 t90 -66.0 -48.33 71.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.99 -1.069 . . . . 0.40999999999999998 111.063 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.432 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 64.3 tp -66.14 -46.61 76.89 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.175 -0.953 . . . . 1.0700000000000001 109.129 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.85 -45.67 91.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.342 -0.849 . . . . 2.6000000000000001 109.125 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.65 -31.85 70.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.653 . . . . 1.8999999999999999 109.839 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 94.3 m -80.36 -31.54 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 1.1000000000000001 111.486 -177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . 0.572 ' HG ' ' H ' ' B' ' 69' ' ' ALA . 31.9 p -132.53 -25.67 1.9 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.486 -1.384 . . . . 0.95999999999999996 112.011 -177.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.39 13.04 29.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.428 -1.469 . . . . 0.37 109.428 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.572 ' H ' ' HG ' ' B' ' 67' ' ' CYS . . . -50.43 153.38 1.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.964 -1.315 . . . . 1.0900000000000001 109.205 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -92.01 174.2 7.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.043 -1.036 . . . . 2.3700000000000001 110.294 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.96 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 1.1100000000000001 110.936 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.738 ' HZ2' HE21 ' B' ' 73' ' ' GLN . 22.0 pttp -75.13 -38.32 61.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.115 . . . . 2.9700000000000002 109.697 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.738 HE21 ' HZ2' ' B' ' 72' ' ' LYS . 85.7 mm-40 -67.13 -38.68 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 2.6200000000000001 109.99 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -67.17 -37.69 84.15 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 1.8899999999999999 109.916 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.33 -38.38 83.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.147 -0.971 . . . . 3.3199999999999998 109.606 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.68 -39.99 84.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.613 -1.305 . . . . 0.40000000000000002 110.727 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -69.26 -39.98 78.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.838 -1.164 . . . . 0.95999999999999996 110.086 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.49 -60.36 3.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.564 -1.335 . . . . 0.5 110.235 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.61 82.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.47 -1.052 . . . . 0.27000000000000002 110.47 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.0 t -70.69 -47.77 58.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.064 -1.256 . . . . 0.93999999999999995 109.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.15 -39.98 75.03 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.089 -1.044 . . . . 1.0900000000000001 109.074 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.4 ' HG2' HH11 ' B' ' 82' ' ' ARG . 33.3 ttt-85 -63.62 -40.04 95.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 3.1899999999999999 110.312 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.31 -38.32 78.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 1.9099999999999999 110.213 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.435 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 86.6 t90 -60.0 -45.35 93.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.468 -1.395 . . . . 0.40000000000000002 107.869 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 52.6 m -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.643 0.735 . . . . 0.96999999999999997 109.284 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.0 -34.64 73.6 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.397 -0.814 . . . . 0.55000000000000004 110.071 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.05 -36.75 13.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.167 -0.958 . . . . 1.1299999999999999 111.161 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.4 m-85 -107.0 0.76 23.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.232 -0.918 . . . . 1.24 111.467 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 85' ' ' CYS . 6.9 tp . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.865 -1.147 . . . . 1.8300000000000001 109.11 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.65 0.738 . . . . 1.98 109.488 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.92 -24.59 64.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.746 -0.596 . . . . 2.6000000000000001 110.127 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.921 -1.112 . . . . 2.5099999999999998 108.98 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -60.04 -49.07 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.51000000000000001 110.201 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 8' ' ' ARG . 53.9 mtt-85 -70.07 -31.99 69.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 3.7200000000000002 109.648 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.54 -40.02 80.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.98 . . . . 0.76000000000000001 109.801 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.3 t80 -62.58 -48.17 80.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.5 110.133 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.98 10.11 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.155 -0.966 . . . . 1.1799999999999999 110.506 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.67 -14.22 15.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.23 -0.919 . . . . 1.1799999999999999 109.881 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.31 152.84 27.17 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.148 -0.97 . . . . 1.26 109.025 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.2 162.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.751 1.634 . . . . 0.53000000000000003 111.5 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.8 ptp -92.49 -21.44 20.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 109.787 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.79 -139.91 16.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.037 -1.225 . . . . 0.41999999999999998 110.037 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.73 30.89 5.4 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.427 -1.043 . . . . 0.84999999999999998 110.481 -178.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -60.1 149.23 75.6 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.872 -1.142 . . . . 2.4900000000000002 108.676 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.2 158.68 50.91 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.984 1.79 . . . . 0.39000000000000001 111.992 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' SER . 14.4 p -57.16 -45.77 84.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.457 -0.777 . . . . 1.1200000000000001 110.483 -179.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.419 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -55.54 -3.19 0.38 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.757 -0.937 . . . . 0.27000000000000002 110.757 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' VAL . 47.0 m -82.08 -22.14 36.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.781 -1.423 . . . . 1.75 109.424 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.0 139.2 58.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 1.05 109.776 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 136.38 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.756 -0.777 . . . . 1.0600000000000001 109.718 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.54 -18.43 57.5 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.235 -1.546 . . . . 0.23000000000000001 109.235 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.4 110.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.875 -1.158 . . . . 1.0800000000000001 107.875 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.56 178.65 41.37 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.665 -1.374 . . . . 0.31 109.665 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.31 -40.02 73.68 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.498 -1.001 . . . . 2.0099999999999998 110.351 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.72 -41.22 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.637 -1.289 . . . . 1.1399999999999999 109.625 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.72 -38.45 83.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 1.1299999999999999 109.745 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -40.08 96.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.119 -1.192 . . . . 0.34999999999999998 110.119 -179.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.78 -36.27 83.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.885 -1.362 . . . . 3.2200000000000002 109.486 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.6 -53.65 26.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.139 . . . . 2.1000000000000001 109.546 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.02 -39.96 87.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.118 -1.067 . . . . 1.0800000000000001 108.118 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.09 -46.04 90.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.484 -0.76 . . . . 1.6699999999999999 109.344 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.68 -19.83 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.44 -0.948 . . . . 2.0 108.44 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.91 3.74 52.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.696 -0.627 . . . . 3.1499999999999999 109.726 -179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.21 50.7 Favored Glycine 0 N--CA 1.503 3.107 0 O-C-N 121.039 -1.038 . . . . 0.47999999999999998 111.432 177.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.2 74.98 1.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.913 -1.346 . . . . 0.38 108.941 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -80.31 -9.24 59.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.40999999999999998 110.965 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.92 152.77 50.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.122 -0.986 . . . . 2.1600000000000001 109.836 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.19 96.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.622 -0.674 . . . . 1.03 111.13 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 8.6 p90 -58.45 -18.99 32.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.826 -1.171 . . . . 0.92000000000000004 110.414 -178.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.9 t -80.71 -30.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.904 -1.123 . . . . 1.0700000000000001 108.366 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.64 -39.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.172 -1.047 . . . . 1.0600000000000001 108.172 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.1 tp -59.95 -39.45 85.6 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.624 -1.25 . . . . 1.1599999999999999 107.624 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.13 -45.04 74.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.654 -1.379 . . . . 0.20000000000000001 109.654 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.99 -43.19 95.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.119 -1.224 . . . . 1.8200000000000001 109.153 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.06 -39.98 87.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.427 -0.953 . . . . 0.40000000000000002 108.427 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.81 -38.67 83.59 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.429 -0.952 . . . . 1.0900000000000001 108.429 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.99 -22.13 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 1.0900000000000001 110.736 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -93.15 17.06 11.59 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.96 -1.087 . . . . 1.0900000000000001 110.388 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.77 34.39 10.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.873 -1.142 . . . . 2.2200000000000002 110.229 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.6 mttp 59.55 20.0 8.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.456 -0.778 . . . . 2.7999999999999998 109.83 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.02 114.52 5.25 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.623 -1.251 . . . . 1.8 107.623 178.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 40.0 tt0 -63.46 -41.38 98.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.87 112.519 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.04 -39.76 75.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.604 -1.31 . . . . 0.72999999999999998 110.765 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.16 -39.93 78.47 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.873 -1.131 . . . . 1.2 109.551 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.69 -49.83 71.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.44 109.402 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.439 ' HE ' ' CG ' ' A' ' 56' ' ' GLU . 44.3 mtt-85 -60.0 -46.61 88.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.809 . . . . 3.3399999999999999 110.513 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.37 -38.55 90.38 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.966 -1.084 . . . . 2.3700000000000001 108.943 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' A' ' 66' ' ' THR . 59.5 t90 -64.29 -47.01 81.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.40999999999999998 110.541 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 tp -67.57 -47.02 71.01 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.274 -0.891 . . . . 1.0800000000000001 110.254 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -62.58 -47.5 83.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 2.6099999999999999 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -69.47 -28.68 66.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.885 . . . . 1.8999999999999999 109.732 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.8 m -80.43 -33.94 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.331 -0.856 . . . . 1.1100000000000001 111.41 -178.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.4 p -132.23 -29.82 1.58 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.53 -1.356 . . . . 0.96999999999999997 111.93 -178.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.51 20.95 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.231 -1.548 . . . . 0.38 109.231 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.38 2.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.275 . . . . 1.1000000000000001 109.23 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.584 ' H ' HE21 ' A' ' 73' ' ' GLN . 6.8 m120 -90.61 171.49 9.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 2.3700000000000001 109.529 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.5 75.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 1.1200000000000001 110.416 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.53 -41.26 69.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 2.9700000000000002 109.975 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.584 HE21 ' H ' ' A' ' 70' ' ' ASN . 36.7 mt-30 -67.11 -40.04 86.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 2.6200000000000001 110.12 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.49 -38.94 92.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.436 -0.79 . . . . 1.8899999999999999 110.233 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -60.0 -38.66 83.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 3.3199999999999998 109.016 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -68.48 -39.89 81.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.88 -1.137 . . . . 0.40000000000000002 110.614 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -69.12 -40.18 78.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.632 -1.292 . . . . 0.95999999999999996 109.821 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.31 -60.01 4.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.633 -1.292 . . . . 0.5 109.867 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' OE2' ' A' ' 83' ' ' GLU . . . -59.9 -32.57 75.43 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.047 -1.221 . . . . 0.27000000000000002 110.047 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.3 t -69.08 -49.79 54.14 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.075 -1.25 . . . . 0.93999999999999995 110.014 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.58 -40.23 70.05 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.746 -1.182 . . . . 1.0900000000000001 109.124 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' A' ' 82' ' ' ARG . 1.2 tpt180 -60.8 -42.67 98.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.161 -0.962 . . . . 3.1800000000000002 110.055 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -70.0 -36.42 75.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 1.9099999999999999 110.271 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 84.8 t90 -60.01 -43.18 95.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.521 -1.362 . . . . 0.40000000000000002 107.709 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.2 m -61.02 -40.29 93.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.604 -0.685 . . . . 0.96999999999999997 110.026 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.04 -33.92 72.69 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -0.969 . . . . 0.55000000000000004 110.274 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.11 14.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.124 -0.985 . . . . 1.1200000000000001 111.028 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.506 2.339 0 O-C-N 121.161 -0.962 . . . . 1.24 111.82 -178.048 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.647 0.737 . . . . 1.97 109.557 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.9 -24.7 64.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 2.5899999999999999 110.178 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.91 -35.31 74.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.034 -1.042 . . . . 2.5 108.971 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.403 ' CD2' ' C ' ' B' ' 7' ' ' HIS . 7.7 t60 -60.06 -49.09 79.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.034 -1.041 . . . . 0.51000000000000001 110.237 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' B' ' 8' ' ' ARG . 54.1 mtt-85 -70.02 -31.89 69.78 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.113 -0.992 . . . . 3.73 109.716 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.68 -39.97 80.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.76000000000000001 109.761 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.439 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.2 t80 -62.54 -48.25 80.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.5 110.098 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.99 10.19 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.052 -1.03 . . . . 1.1799999999999999 110.51 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.61 -14.31 15.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 1.1799999999999999 109.857 178.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' B' ' 14' ' ' PRO . 13.5 pt-20 -154.27 152.78 27.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 1.27 109.12 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.9 Cg_exo -40.15 162.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.879 1.719 . . . . 0.53000000000000003 111.483 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 6.8 ptp -92.45 -21.4 20.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 1.1299999999999999 109.764 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.68 -139.82 16.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.06 -1.216 . . . . 0.40999999999999998 110.06 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.8 30.83 5.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.549 -0.971 . . . . 0.83999999999999997 110.47 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.98 149.24 74.62 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.189 . . . . 2.4900000000000002 108.777 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.19 158.77 50.38 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.941 1.761 . . . . 0.38 112.087 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' B' ' 22' ' ' SER . 14.4 p -57.29 -45.6 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 1.1200000000000001 110.545 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.423 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -55.77 -3.04 0.4 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.725 -0.95 . . . . 0.27000000000000002 110.725 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.473 ' H ' ' C ' ' B' ' 20' ' ' VAL . 47.6 m -82.11 -22.15 36.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.713 -1.463 . . . . 1.75 109.3 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.09 139.22 58.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 1.0600000000000001 109.768 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.89 136.4 56.08 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.758 -0.777 . . . . 1.05 109.781 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.3 57.73 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.264 -1.534 . . . . 0.22 109.264 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.48 110.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.817 -1.179 . . . . 1.0800000000000001 107.817 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.66 178.61 41.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.675 -1.37 . . . . 0.29999999999999999 109.675 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.36 -39.95 73.71 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.595 -0.944 . . . . 2.0 110.333 -178.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.68 -41.25 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.604 -1.31 . . . . 1.1399999999999999 109.69 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.72 -38.43 83.56 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.262 -0.898 . . . . 1.1299999999999999 109.755 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.104 -1.198 . . . . 0.35999999999999999 110.104 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.75 -36.32 83.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.368 . . . . 3.2200000000000002 109.502 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.49 -53.72 26.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.751 -1.218 . . . . 2.1200000000000001 109.562 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.208 -1.034 . . . . 1.0800000000000001 108.208 178.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.07 -46.09 90.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 1.6799999999999999 109.345 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -63.58 -19.98 65.27 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.411 -0.959 . . . . 1.99 108.411 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.78 3.72 51.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.612 -0.68 . . . . 3.1499999999999999 109.83 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.2 50.72 Favored Glycine 0 N--CA 1.502 3.044 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 111.468 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -106.16 74.88 1.06 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.96 -1.318 . . . . 0.38 108.971 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -80.25 -9.27 59.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.40999999999999998 111.003 -178.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.97 152.84 50.86 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.093 -1.004 . . . . 2.1499999999999999 109.832 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.576 -0.702 . . . . 1.03 111.096 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 8.7 p90 -58.58 -18.98 34.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 0.92000000000000004 110.486 -177.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 25.8 t -80.77 -30.36 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.047 . . . . 1.0800000000000001 108.343 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.66 -39.05 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.149 -1.056 . . . . 1.0700000000000001 108.149 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.09 -39.3 85.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.632 -1.247 . . . . 1.1499999999999999 107.632 177.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.15 -45.03 74.22 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.579 -1.409 . . . . 0.19 109.579 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.03 -43.19 95.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -1.216 . . . . 1.8200000000000001 109.099 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.441 -0.948 . . . . 0.40000000000000002 108.441 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.88 -38.65 83.31 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.464 -0.939 . . . . 1.0700000000000001 108.464 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.02 -21.97 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.373 -0.83 . . . . 1.0900000000000001 110.764 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 98.6 mt -93.27 17.15 11.65 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.993 -1.067 . . . . 1.0900000000000001 110.363 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.86 34.29 10.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.894 -1.129 . . . . 2.23 110.272 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 59.46 19.91 8.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 2.7999999999999998 109.813 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.88 114.67 5.27 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.571 -1.27 . . . . 1.8 107.571 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.434 ' CG ' ' HE ' ' B' ' 60' ' ' ARG . 40.0 tt0 -63.63 -41.39 98.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.88 112.452 -177.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.04 -39.75 75.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.64 -1.288 . . . . 0.73999999999999999 110.742 -179.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.21 -39.88 78.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.827 -1.149 . . . . 1.2 109.611 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.76 -49.84 71.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.091 -1.006 . . . . 0.44 109.415 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.434 ' HE ' ' CG ' ' B' ' 56' ' ' GLU . 44.8 mtt-85 -59.93 -46.61 88.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.364 -0.835 . . . . 3.3399999999999999 110.55 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.28 -38.69 91.05 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.029 -1.044 . . . . 2.3799999999999999 108.952 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 62' ' ' TRP . . . . . 0.442 ' O ' ' OG1' ' B' ' 66' ' ' THR . 59.6 t90 -64.29 -46.95 81.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.40999999999999998 110.523 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.55 -47.06 70.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.238 -0.914 . . . . 1.0700000000000001 110.17 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -62.54 -47.56 83.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 2.6000000000000001 110.161 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.43 -28.62 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 1.8999999999999999 109.739 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 65.5 m -80.37 -34.14 36.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 1.1000000000000001 111.304 -178.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.6 p -132.24 -29.67 1.59 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.501 -1.375 . . . . 0.95999999999999996 111.839 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.75 14.58 21.02 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.21 -1.556 . . . . 0.37 109.21 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.27 151.27 2.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -1.228 . . . . 1.0900000000000001 109.279 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.573 ' H ' HE21 ' B' ' 73' ' ' GLN . 6.8 m120 -90.52 171.48 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.0 . . . . 2.3700000000000001 109.527 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.33 74.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 1.1100000000000001 110.465 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.65 -41.18 69.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.828 -1.17 . . . . 2.9700000000000002 110.014 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.573 HE21 ' H ' ' B' ' 70' ' ' ASN . 36.7 mt-30 -67.2 -39.97 86.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 2.6200000000000001 110.185 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.53 -38.86 92.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.355 -0.841 . . . . 1.8899999999999999 110.253 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -60.03 -38.63 83.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.954 -1.092 . . . . 3.3199999999999998 109.035 -179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -68.54 -40.03 80.86 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.915 -1.116 . . . . 0.40000000000000002 110.592 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.95 -40.19 79.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.702 -1.249 . . . . 0.95999999999999996 109.901 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.36 -59.98 4.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.61 -1.306 . . . . 0.5 109.915 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 83' ' ' GLU . . . -59.88 -32.52 75.2 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.054 -1.218 . . . . 0.27000000000000002 110.054 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -69.13 -49.83 53.42 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.099 -1.236 . . . . 0.93999999999999995 110.064 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.63 -40.14 69.95 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.744 -1.182 . . . . 1.0900000000000001 109.147 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' B' ' 82' ' ' ARG . 1.2 tpt180 -60.83 -42.67 98.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.147 -0.97 . . . . 3.1899999999999999 110.037 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' B' ' 79' ' ' GLY . 0.3 OUTLIER -70.09 -36.39 74.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 1.9099999999999999 110.053 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 84' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 84.8 t90 -59.98 -43.37 95.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.537 -1.352 . . . . 0.40000000000000002 107.743 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' B' ' 89' ' ' LEU . 50.3 m -60.72 -40.37 92.06 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.562 0.696 . . . . 0.96999999999999997 110.099 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.96 -33.94 72.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.064 -1.023 . . . . 0.55000000000000004 110.342 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.29 14.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.148 -0.97 . . . . 1.1299999999999999 110.969 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 88' ' ' PHE . . . . . 0.403 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 91.0 m-85 -109.78 1.66 19.5 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.275 -0.891 . . . . 1.24 111.925 -178.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.6 tp . . . . . 0 N--CA 1.499 1.992 0 O-C-N 120.795 -1.191 . . . . 1.8300000000000001 109.746 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.61 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 106.857 -1.534 . . . . 5.8700000000000001 106.857 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.474 ' H ' ' HG1' ' A' ' 2' ' ' THR . 2.8 p -56.3 61.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.631 -0.713 . . . . 2.73 111.291 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.61 ' N ' ' O ' ' A' ' 1' ' ' MET . 72.5 p -72.43 152.07 42.2 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.28 -1.008 . . . . 1.49 108.28 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t -71.26 164.44 25.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 1.6899999999999999 109.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -51.75 -21.0 2.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.641 . . . . 2.77 109.693 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.58 -37.23 83.09 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.316 -0.865 . . . . 2.6899999999999999 109.947 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -59.99 -50.07 75.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.029 -1.045 . . . . 0.53000000000000003 110.047 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -69.92 -36.86 75.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.964 -1.085 . . . . 3.9100000000000001 110.182 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.863 -0.791 . . . . 0.68999999999999995 108.863 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -64.73 -49.6 70.2 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.516 -0.74 . . . . 0.39000000000000001 110.14 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 m -83.36 8.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.085 -1.009 . . . . 1.1000000000000001 110.672 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.51 -13.48 16.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.153 -0.967 . . . . 1.1299999999999999 110.163 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.85 152.08 24.76 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.125 -0.984 . . . . 1.27 108.839 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -40.01 160.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.927 1.751 . . . . 0.46999999999999997 112.065 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' B' ' 89' ' ' LEU . 3.2 ptp -89.2 -28.11 20.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.933 . . . . 1.3799999999999999 109.738 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.09 -141.1 43.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.787 -1.725 . . . . 0.54000000000000004 108.787 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.08 33.55 4.06 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.304 -1.115 . . . . 1.0700000000000001 109.806 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.9 148.96 75.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 2.7400000000000002 109.568 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.81 152.16 80.17 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.71 2.273 . . . . 0.42999999999999999 112.911 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.464 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.7 p -53.69 -43.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.448 0.642 . . . . 1.1200000000000001 110.191 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.57 -3.85 1.17 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.384 -1.086 . . . . 0.25 110.384 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 20' ' ' VAL . 42.1 t -84.08 -22.5 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.337 . . . . 1.8999999999999999 110.163 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.7 mt -64.16 138.52 58.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.994 -1.066 . . . . 1.0600000000000001 109.895 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 134.43 54.36 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.792 -0.763 . . . . 1.0800000000000001 109.712 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.78 49.29 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.339 -1.504 . . . . 0.20000000000000001 109.339 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.416 ' CD1' ' SG ' ' A' ' 77' ' ' CYS . 36.4 mm -98.51 112.26 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.331 -1.099 . . . . 1.0900000000000001 108.126 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.06 177.28 42.87 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.855 -1.298 . . . . 0.20999999999999999 109.855 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -58.54 -40.0 81.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.477 -1.014 . . . . 1.8 109.957 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.14 -46.71 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.96 -1.088 . . . . 1.0900000000000001 108.834 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.94 -39.75 83.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 1.1100000000000001 109.877 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.27 -33.92 77.7 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.879 -1.688 . . . . 0.34000000000000002 108.879 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.03 -40.4 87.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.505 -0.997 . . . . 3.3399999999999999 110.292 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -68.47 -44.53 74.61 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.95 -1.094 . . . . 2.0600000000000001 109.1 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.48 -39.41 93.35 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.933 -1.104 . . . . 1.0700000000000001 108.029 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.99 -42.22 93.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.75 . . . . 1.53 109.269 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -68.05 -18.74 64.77 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.311 -0.996 . . . . 2.4500000000000002 108.311 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.77 3.19 53.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.728 -0.608 . . . . 2.9700000000000002 109.789 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.05 7.57 49.75 Favored Glycine 0 N--CA 1.502 3.073 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 111.335 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -106.43 74.31 1.01 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.907 -1.349 . . . . 0.40000000000000002 109.048 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -80.23 -9.95 59.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.40000000000000002 110.665 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -129.33 152.36 48.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.227 -0.921 . . . . 2.0600000000000001 109.149 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.95 94.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 1.0600000000000001 110.786 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 7.1 p90 -60.66 -17.84 49.95 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.915 -1.115 . . . . 0.88 110.975 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.97 -32.72 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.309 -1.367 . . . . 1.1100000000000001 107.309 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.93 -39.84 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.582 -0.895 . . . . 1.02 108.582 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.87 -35.12 74.16 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.079 -1.452 . . . . 1.1599999999999999 107.079 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.95 -40.76 95.79 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.63 -1.388 . . . . 0.22 109.63 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.97 -42.46 94.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.296 -1.12 . . . . 1.8400000000000001 108.596 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.06 -39.96 87.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.45000000000000001 109.57 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.52 -37.72 77.25 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.602 -0.839 . . . . 1.1000000000000001 108.948 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.53 -28.57 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.252 -0.905 . . . . 1.0600000000000001 109.744 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.29 13.16 10.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.122 -0.986 . . . . 1.1799999999999999 110.584 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt 49.94 38.96 17.51 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.538 -1.351 . . . . 2.73 110.405 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mttm 56.85 19.47 4.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 2.4399999999999999 110.095 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.27 106.77 1.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 117.775 -1.57 . . . . 1.8400000000000001 106.972 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.1 -40.09 88.43 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.664 -0.647 . . . . 1.05 111.304 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -69.67 -40.03 76.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.263 -1.523 . . . . 0.90000000000000002 110.053 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.2 mt -70.6 -40.0 73.48 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.55 -1.26 . . . . 1.1599999999999999 109.196 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.88 -49.93 72.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.34999999999999998 110.511 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -63.23 -41.11 99.07 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.054 -1.059 . . . . 3.3799999999999999 109.909 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.31 -40.07 93.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.629 -1.294 . . . . 2.1499999999999999 108.14 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.459 ' O ' ' OG1' ' A' ' 66' ' ' THR . 67.6 t90 -64.53 -50.03 68.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 0.28999999999999998 111.217 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.89 -46.1 83.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.132 -0.98 . . . . 1.0900000000000001 109.667 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -63.27 -49.79 72.69 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.483 -0.76 . . . . 2.4700000000000002 109.954 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.65 -30.51 70.79 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.515 -0.741 . . . . 1.7 109.678 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 86.7 m -78.36 -37.68 43.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 1.0600000000000001 111.096 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.0 p -127.24 -26.9 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.529 -1.357 . . . . 0.93999999999999995 112.261 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 13.7 27.12 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.249 -1.541 . . . . 0.28999999999999998 109.249 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.12 155.54 1.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.291 . . . . 1.01 108.916 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -88.67 166.38 14.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 2.46 109.603 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.89 62.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 1.1200000000000001 108.351 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -70.16 -48.86 55.51 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.305 0.574 . . . . 4.1399999999999997 112.029 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.96 -30.01 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.068 -1.02 . . . . 2.6600000000000001 110.834 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.9 p -70.02 -34.7 73.62 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.979 -1.088 . . . . 2.0 109.254 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -60.29 -38.84 84.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 3.3300000000000001 109.34 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -66.86 -38.8 87.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 109.597 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.416 ' SG ' ' CD1' ' A' ' 26' ' ' ILE . 93.9 m -69.91 -40.08 75.81 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.994 -1.066 . . . . 0.81999999999999995 109.702 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.74 -61.15 2.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.761 -1.212 . . . . 0.40000000000000002 109.769 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.7 -33.89 88.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.46 -1.056 . . . . 0.32000000000000001 110.46 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.41 -48.37 61.29 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.73 -1.453 . . . . 0.94999999999999996 109.943 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.9 mt -70.08 -40.07 75.22 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.9 -1.12 . . . . 1.1699999999999999 108.867 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -65.53 -40.12 92.56 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.4 -0.813 . . . . 3.3500000000000001 111.006 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -70.04 -35.36 74.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.74 -1.225 . . . . 2.0699999999999998 109.319 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.528 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 87.3 t90 -60.07 -43.69 95.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.991 -1.485 . . . . 0.34999999999999998 106.991 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.547 ' O ' ' N ' ' A' ' 89' ' ' LEU . 51.5 m -61.45 -40.18 93.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.613 0.72 . . . . 0.89000000000000001 109.896 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.96 -34.44 73.28 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.968 -1.082 . . . . 0.59999999999999998 110.328 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.33 -31.99 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.116 -0.99 . . . . 1.21 110.299 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 66.0 m-85 -110.36 -3.13 16.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.542 -0.724 . . . . 1.23 112.606 -176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 85' ' ' CYS . 18.4 tp . . . . . 0 N--CA 1.504 2.226 0 O-C-N 120.77 -1.206 . . . . 1.96 109.714 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.634 ' O ' ' N ' ' B' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 106.836 -1.542 . . . . 5.8700000000000001 106.836 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 2.8 p -56.03 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.55 -0.75 . . . . 2.73 111.347 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.634 ' N ' ' O ' ' B' ' 1' ' ' MET . 72.2 p -72.73 152.18 41.77 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.319 -0.993 . . . . 1.48 108.319 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t -71.28 164.37 25.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.117 -0.989 . . . . 1.71 109.699 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.66 -21.17 2.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.629 -0.669 . . . . 2.7599999999999998 109.659 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.33 -37.29 82.77 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.291 -0.881 . . . . 2.6899999999999999 109.876 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -60.05 -49.95 75.64 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.025 -1.047 . . . . 0.52000000000000002 110.038 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.02 -36.91 75.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 3.9100000000000001 110.227 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.06 -38.78 82.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.345 -0.847 . . . . 0.67000000000000004 108.732 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.68 -49.95 71.14 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.595 -0.69 . . . . 0.39000000000000001 110.08 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.88 10.43 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.1 -1.0 . . . . 1.1000000000000001 110.659 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.67 -14.93 14.89 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.114 -0.991 . . . . 1.1200000000000001 110.192 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -153.51 151.2 24.94 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.139 -0.975 . . . . 1.27 108.748 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.97 160.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.97 1.78 . . . . 0.47999999999999998 112.052 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ptp -89.06 -26.54 21.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.269 -0.895 . . . . 1.3799999999999999 109.46 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.54 -138.27 46.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.709 -1.756 . . . . 0.53000000000000003 108.709 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.59 35.44 3.47 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.355 -1.086 . . . . 1.0800000000000001 109.61 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 149.76 83.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 2.75 109.798 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.64 152.21 79.23 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.702 2.268 . . . . 0.41999999999999998 112.742 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.5 p -53.85 -42.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.622 -0.674 . . . . 1.1100000000000001 110.349 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.56 -3.34 1.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.514 -1.034 . . . . 0.25 110.514 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 20' ' ' VAL . 45.7 t -83.28 -22.62 32.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.872 -1.37 . . . . 1.9099999999999999 110.014 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 73.8 mt -64.35 139.0 58.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 1.0700000000000001 109.746 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.19 135.63 55.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.828 -0.749 . . . . 1.0800000000000001 109.668 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.14 -21.73 44.61 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.348 -1.501 . . . . 0.20000000000000001 109.348 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.416 ' CD1' ' SG ' ' B' ' 77' ' ' CYS . 36.2 mm -98.48 113.69 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.845 -1.169 . . . . 1.1000000000000001 107.845 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.78 179.36 39.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.787 -1.325 . . . . 0.20999999999999999 109.787 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -58.72 -40.03 82.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.473 -1.016 . . . . 1.8200000000000001 110.206 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.73 -45.76 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.941 -1.099 . . . . 1.0900000000000001 109.058 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.8 -39.99 79.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 1.1200000000000001 109.87 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.12 -33.56 75.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.869 -1.692 . . . . 0.35999999999999999 108.869 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -39.97 86.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.965 . . . . 3.2999999999999998 110.247 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -68.91 -44.62 72.75 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.924 -1.11 . . . . 2.0699999999999998 109.158 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.52 -39.47 93.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.948 -1.13 . . . . 1.0800000000000001 107.948 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -60.04 -41.86 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.58 -0.7 . . . . 1.52 109.289 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -68.48 -18.37 64.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.472 -0.936 . . . . 2.4300000000000002 108.472 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -89.93 1.63 56.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 2.98 109.775 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 8.45 43.47 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.114 -0.991 . . . . 0.46000000000000002 111.267 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -107.15 74.18 0.96 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.886 -1.361 . . . . 0.40000000000000002 108.984 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -80.07 -10.41 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.38 110.718 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -129.3 150.69 50.56 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.208 -0.933 . . . . 2.0499999999999998 109.084 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.28 99.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.199 -0.938 . . . . 1.0600000000000001 110.726 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 6.2 p90 -56.96 -18.27 12.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.113 . . . . 0.91000000000000003 110.762 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.49 -33.92 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.296 -1.372 . . . . 1.0900000000000001 107.296 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.38 -39.63 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 1.02 108.727 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.4 tp -59.83 -34.28 72.88 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.869 -1.53 . . . . 1.1599999999999999 106.869 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.39 -40.68 96.37 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.503 -1.439 . . . . 0.20999999999999999 109.503 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -60.06 -42.64 94.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.24 -1.153 . . . . 1.8600000000000001 108.891 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 0.42999999999999999 109.658 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -69.16 -38.07 78.55 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.877 -0.786 . . . . 1.1000000000000001 108.877 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.04 -29.31 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.259 -0.901 . . . . 1.0700000000000001 109.717 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 94.5 mt -87.16 14.56 7.45 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.002 -1.062 . . . . 1.1799999999999999 110.684 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 49.97 35.48 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.626 -1.296 . . . . 2.75 110.917 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 60.05 19.84 9.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.206 -0.934 . . . . 2.4700000000000002 109.923 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 108.93 2.73 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.638 -1.615 . . . . 1.8100000000000001 106.638 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.78 -40.03 93.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 1.04 111.22 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -69.28 -40.06 78.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.375 -1.453 . . . . 0.90000000000000002 110.008 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.74 -38.82 73.56 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.903 -1.119 . . . . 1.1399999999999999 109.191 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.54 -49.99 69.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.34999999999999998 110.414 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -63.1 -41.61 99.41 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.049 -1.032 . . . . 3.3900000000000001 109.843 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.19 -40.08 93.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.691 -1.256 . . . . 2.1600000000000001 108.055 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.473 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -64.33 -49.07 73.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.28000000000000003 111.138 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.7 tp -66.05 -48.34 71.35 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.943 -1.098 . . . . 1.0900000000000001 109.722 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -60.87 -49.84 75.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.501 -0.749 . . . . 2.4500000000000002 110.156 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -67.53 -28.24 67.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 1.6899999999999999 109.793 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.84 -33.62 34.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 1.0600000000000001 110.954 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 22.4 p -131.11 -28.44 1.94 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.453 -1.405 . . . . 0.93000000000000005 112.208 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.31 13.12 25.46 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.149 -1.581 . . . . 0.31 109.149 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 154.68 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.242 . . . . 1.03 108.735 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.49 168.12 12.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.976 -1.077 . . . . 2.4500000000000002 109.691 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.81 63.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.333 -0.988 . . . . 1.1000000000000001 108.333 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -70.06 -49.33 52.21 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-O 121.323 0.582 . . . . 4.1200000000000001 112.07 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.69 -29.99 69.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.977 -1.077 . . . . 2.6600000000000001 110.883 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -69.91 -34.65 73.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.062 -1.055 . . . . 2.0 109.159 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -60.73 -38.83 86.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.758 -1.214 . . . . 3.3100000000000001 109.579 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.83 -39.14 87.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.796 -1.19 . . . . 0.28999999999999998 109.647 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.416 ' SG ' ' CD1' ' B' ' 26' ' ' ILE . 93.0 m -69.42 -40.02 77.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.019 -1.05 . . . . 0.82999999999999996 109.484 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.93 -60.73 3.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.75 -1.219 . . . . 0.40000000000000002 109.758 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.8 -33.94 88.59 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.526 -1.03 . . . . 0.29999999999999999 110.526 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.49 -48.42 60.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.747 -1.443 . . . . 0.94999999999999996 109.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.97 -40.0 75.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.972 -1.091 . . . . 1.1699999999999999 108.539 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -66.9 -40.11 87.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.855 . . . . 3.3799999999999999 111.41 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -69.87 -34.9 74.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.594 -1.316 . . . . 2.0600000000000001 108.813 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.568 ' O ' ' HB2' ' B' ' 88' ' ' PHE . 85.4 t90 -59.46 -48.65 80.83 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.661 -1.978 . . . . 0.35999999999999999 105.661 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.657 ' O ' ' N ' ' B' ' 89' ' ' LEU . 36.5 m -58.07 -39.93 79.75 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.765 -0.584 . . . . 0.90000000000000002 110.29 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -61.25 -35.24 76.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.31 -1.494 . . . . 0.58999999999999997 111.171 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.03 -25.5 20.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.121 . . . . 1.22 107.983 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' B' ' 84' ' ' TRP . 60.6 m-85 -115.15 -2.98 12.61 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 114.792 1.404 . . . . 1.24 114.792 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' B' ' 85' ' ' CYS . 14.5 tp . . . . . 0 C--N 1.282 -2.344 0 O-C-N 119.009 -2.307 . . . . 1.9399999999999999 110.051 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.328 0.585 . . . . 6.1100000000000003 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.39 -159.9 0.22 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 3.5800000000000001 109.113 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -100.03 127.3 46.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.267 -0.895 . . . . 1.3200000000000001 109.498 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 t -79.46 162.43 25.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 1.98 109.251 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.37 -20.81 1.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.618 . . . . 2.6000000000000001 109.734 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.87 -35.81 79.41 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 2.5099999999999998 108.81 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -60.05 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.51000000000000001 109.934 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 8' ' ' ARG . 30.9 mtt-85 -69.96 -34.62 73.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 3.7200000000000002 109.959 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.95 -39.81 75.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.367 -0.833 . . . . 0.76000000000000001 109.738 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -65.62 -42.49 91.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.379 -0.826 . . . . 0.5 110.338 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.32 14.63 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.901 -1.125 . . . . 1.1799999999999999 109.869 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.39 -10.33 12.02 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.365 -0.834 . . . . 1.1799999999999999 110.488 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.49 149.98 22.47 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 1.26 109.575 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -39.67 161.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.903 1.735 . . . . 0.53000000000000003 111.619 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.47 -18.0 23.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.998 -1.064 . . . . 1.1399999999999999 109.677 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -143.24 12.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.954 -1.259 . . . . 0.41999999999999998 109.954 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.71 29.89 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.416 -1.049 . . . . 0.84999999999999998 110.274 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -60.05 149.06 75.91 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.093 -1.004 . . . . 2.4900000000000002 108.609 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.7 160.11 41.98 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.26 1.974 . . . . 0.39000000000000001 112.407 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 22' ' ' SER . 6.4 p -57.2 -47.09 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.75 . . . . 1.1200000000000001 110.403 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.54 -1.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.346 -1.102 . . . . 0.27000000000000002 110.346 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 20' ' ' VAL . 21.7 m -82.95 -23.16 33.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.77 -1.429 . . . . 1.75 109.72 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.19 140.03 58.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 1.05 109.751 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.471 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -64.3 134.68 55.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.747 0.784 . . . . 1.0600000000000001 109.857 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.23 -17.05 58.48 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.583 -1.407 . . . . 0.23000000000000001 109.583 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.37 115.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -1.155 . . . . 1.0800000000000001 107.971 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.03 172.44 40.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.697 -1.361 . . . . 0.31 109.697 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -55.86 -40.05 72.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.0099999999999998 109.92 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.04 -44.19 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.997 -1.064 . . . . 1.1399999999999999 109.741 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.37 -34.21 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 1.1299999999999999 109.825 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.93 95.19 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.022 -1.631 . . . . 0.34999999999999998 109.022 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.23 -38.83 92.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -1.171 . . . . 3.2200000000000002 109.575 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.27 -52.88 28.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 2.1000000000000001 109.172 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.58 -40.0 90.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.082 -1.011 . . . . 1.0800000000000001 108.36 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -42.07 93.58 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.885 -0.726 . . . . 1.6699999999999999 109.223 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.3 -20.17 66.02 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.603 -0.888 . . . . 2.0 108.603 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.8 OUTLIER -91.09 4.39 52.28 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 3.1499999999999999 110.286 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.04 7.95 51.71 Favored Glycine 0 N--CA 1.502 3.054 0 O-C-N 120.976 -1.077 . . . . 0.47999999999999998 111.611 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -104.81 73.48 1.08 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.717 -1.461 . . . . 0.38 108.417 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 22.9 p-10 -77.56 -9.74 59.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.428 -0.795 . . . . 0.40999999999999998 111.104 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -137.46 158.06 45.22 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.056 -1.028 . . . . 2.1600000000000001 110.417 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.67 93.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.577 . . . . 1.03 112.327 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -59.25 -18.1 34.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.586 -1.321 . . . . 0.92000000000000004 110.439 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -79.91 -31.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.878 -1.139 . . . . 1.0700000000000001 108.285 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.5 t -77.03 -37.71 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.942 -1.133 . . . . 1.0600000000000001 107.942 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.8 tp -59.96 -37.85 80.78 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.286 -1.375 . . . . 1.1599999999999999 107.286 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.54 89.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.98 -1.248 . . . . 0.20000000000000001 109.98 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -60.04 -42.66 94.9 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.89 -1.359 . . . . 1.8200000000000001 109.134 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -60.03 -40.82 90.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 0.40000000000000002 108.793 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.01 -38.27 79.14 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.544 -0.909 . . . . 1.0900000000000001 108.544 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.94 -22.65 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 110.575 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.8 15.05 13.71 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.006 -1.059 . . . . 1.0900000000000001 110.676 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.12 42.77 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.671 -1.268 . . . . 2.2200000000000002 110.778 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 57.82 20.02 6.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.478 -0.764 . . . . 2.7999999999999998 110.421 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -69.2 104.53 2.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.412 -1.43 . . . . 1.8 107.706 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.16 -40.05 92.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.959 0.726 . . . . 0.87 112.959 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 95.0 m-20 -69.93 -39.98 75.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.457 -1.402 . . . . 0.72999999999999998 110.475 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.82 -40.04 72.69 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.985 -1.086 . . . . 1.2 109.033 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.27 -49.88 73.94 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.836 . . . . 0.44 110.054 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 79.3 mtm180 -61.5 -43.67 98.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 3.3399999999999999 110.317 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.61 -39.85 94.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.265 -0.897 . . . . 2.3700000000000001 108.747 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.0 t90 -62.41 -49.22 76.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.275 -0.891 . . . . 0.40999999999999998 110.693 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 63.4 tp -67.78 -47.91 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.161 -0.962 . . . . 1.0800000000000001 110.131 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.49 -45.99 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 2.6099999999999999 109.642 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.84 -30.15 68.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.742 . . . . 1.8999999999999999 109.82 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 67.7 m -77.83 -36.89 49.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.945 . . . . 1.1100000000000001 111.227 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 13.5 p -130.44 -29.92 1.95 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.593 -1.317 . . . . 0.96999999999999997 111.783 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.33 15.86 11.94 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.311 -1.516 . . . . 0.38 109.311 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.29 154.63 2.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.315 . . . . 1.1000000000000001 109.03 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 168.84 12.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 2.3700000000000001 109.95 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.99 71.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 1.1200000000000001 110.192 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -72.78 -39.98 66.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.935 -1.103 . . . . 2.9700000000000002 109.346 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -68.39 -38.8 81.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.6200000000000001 110.35 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.71 -36.06 77.97 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.13 -0.981 . . . . 1.8899999999999999 109.516 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.93 -38.07 81.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 3.3199999999999998 109.401 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.13 -39.95 82.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.744 -1.222 . . . . 0.40000000000000002 110.451 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 93.4 m -69.45 -40.7 77.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.667 -1.271 . . . . 0.95999999999999996 109.507 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -58.82 -60.21 4.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.534 -1.354 . . . . 0.5 109.41 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.5 90.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.86 -0.896 . . . . 0.27000000000000002 110.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.91 -49.32 59.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.364 . . . . 0.93999999999999995 110.217 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.0 -39.62 75.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.902 -1.119 . . . . 1.0900000000000001 108.757 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.94 -41.03 90.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 3.1800000000000002 109.691 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.01 -37.8 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.9099999999999999 110.628 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.526 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 85.8 t90 -60.86 -42.01 97.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.40000000000000002 108.974 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.419 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 69.8 m -62.08 -40.04 94.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.96999999999999997 109.752 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.66 -31.16 67.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.344 -0.848 . . . . 0.55000000000000004 109.646 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.89 -37.06 12.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.305 -0.872 . . . . 1.1200000000000001 111.325 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 -106.05 -4.38 20.52 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.132 -0.98 . . . . 1.24 112.399 -177.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 85' ' ' CYS . 8.3 tp . . . . . 0 N--CA 1.502 2.154 0 O-C-N 120.54 -1.35 . . . . 1.8300000000000001 109.317 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.465 -0.568 . . . . 6.0999999999999996 109.465 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.45 -160.01 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 3.5800000000000001 109.094 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -100.03 127.29 46.26 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.35 -0.844 . . . . 1.3200000000000001 109.467 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t -79.44 162.41 25.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 1.97 109.236 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.49 -20.72 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.714 -0.616 . . . . 2.5899999999999999 109.727 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.81 -35.91 79.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 2.5 108.875 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.92 -48.96 79.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.51000000000000001 110.015 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' B' ' 8' ' ' ARG . 31.0 mtt-85 -69.94 -34.61 73.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 3.73 110.007 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -69.95 -39.59 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.299 -0.876 . . . . 0.76000000000000001 109.855 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -65.75 -42.47 90.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.448 -0.783 . . . . 0.5 110.36 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -84.31 14.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.946 -1.096 . . . . 1.1799999999999999 109.88 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.3 -10.02 12.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.397 -0.814 . . . . 1.1799999999999999 110.466 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.63 150.02 22.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.86 -1.15 . . . . 1.27 109.456 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.59 161.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.918 1.745 . . . . 0.53000000000000003 111.603 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.44 -18.15 23.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.043 -1.035 . . . . 1.1299999999999999 109.708 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.32 -143.15 12.98 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.018 -1.233 . . . . 0.40999999999999998 110.018 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.88 29.94 5.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.484 -1.01 . . . . 0.83999999999999997 110.221 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -60.16 149.07 76.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 2.4900000000000002 108.632 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 160.18 41.52 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.194 1.929 . . . . 0.38 112.424 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' B' ' 22' ' ' SER . 6.3 p -57.27 -47.05 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.734 . . . . 1.1200000000000001 110.441 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.43 -2.1 0.1 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.475 -1.05 . . . . 0.27000000000000002 110.475 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.545 ' H ' ' C ' ' B' ' 20' ' ' VAL . 21.1 m -82.67 -23.26 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.806 -1.408 . . . . 1.75 109.806 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.12 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.04 -1.037 . . . . 1.0600000000000001 109.718 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.468 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.24 134.93 55.72 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.69 0.757 . . . . 1.05 109.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.09 58.66 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.489 -1.444 . . . . 0.22 109.489 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.33 115.41 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.245 -1.15 . . . . 1.0800000000000001 107.951 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.94 172.51 40.37 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.725 -1.35 . . . . 0.29999999999999999 109.725 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -56.01 -39.94 72.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -1.089 . . . . 2.0 109.907 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.19 -43.99 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.008 -1.057 . . . . 1.1399999999999999 109.749 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.51 -34.13 77.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 1.1299999999999999 109.742 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.17 -40.03 95.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.973 -1.651 . . . . 0.35999999999999999 108.973 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.26 -38.64 91.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -1.154 . . . . 3.2200000000000002 109.545 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.4 -52.88 28.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.124 . . . . 2.1200000000000001 109.12 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.7 -39.95 90.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.286 -1.005 . . . . 1.0800000000000001 108.286 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.08 -41.97 93.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.839 -0.744 . . . . 1.6799999999999999 109.168 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.42 -20.07 65.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.653 -0.869 . . . . 1.99 108.653 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.8 OUTLIER -90.98 4.17 52.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.561 -0.712 . . . . 3.1499999999999999 110.321 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.05 7.96 51.65 Favored Glycine 0 N--CA 1.502 3.067 0 C-N-CA 120.139 -1.029 . . . . 0.48999999999999999 111.664 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -104.75 73.44 1.08 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.401 . . . . 0.38 108.485 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 40' ' ' ASP . 22.7 p-10 -77.61 -9.75 59.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.40999999999999998 111.021 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -137.39 157.92 45.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.999 -1.063 . . . . 2.1499999999999999 110.423 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.0 94.56 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.702 -0.624 . . . . 1.03 112.318 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.476 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 4.6 p90 -59.1 -17.88 30.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.61 -1.306 . . . . 0.92000000000000004 110.578 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -80.01 -31.93 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.924 -1.11 . . . . 1.0800000000000001 108.231 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.92 -37.65 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.954 -1.128 . . . . 1.0700000000000001 107.954 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.0 -37.65 80.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.265 -1.383 . . . . 1.1499999999999999 107.265 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.47 90.35 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.96 -1.256 . . . . 0.19 109.96 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.774 -1.427 . . . . 1.8200000000000001 109.154 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -59.95 -40.93 90.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.40000000000000002 108.785 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 80.9 mt -68.96 -38.0 79.16 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.622 -0.881 . . . . 1.0700000000000001 108.622 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.14 -22.79 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.263 -0.898 . . . . 1.0900000000000001 110.499 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.58 14.69 14.31 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.088 -1.008 . . . . 1.0900000000000001 110.732 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.44 42.4 14.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.7 -1.25 . . . . 2.23 110.742 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 58.27 19.95 6.75 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.403 -0.811 . . . . 2.7999999999999998 110.43 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -69.23 104.52 2.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 1.8 107.817 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.18 -39.99 92.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.899 0.703 . . . . 0.88 112.899 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 94.8 m-20 -70.05 -39.94 75.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.465 -1.397 . . . . 0.73999999999999999 110.362 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.969 -1.092 . . . . 1.2 108.92 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.15 -49.98 73.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.328 -0.857 . . . . 0.44 109.939 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.486 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 79.3 mtm180 -61.7 -43.38 98.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 3.3399999999999999 110.295 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -64.71 -39.9 94.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.076 -1.015 . . . . 2.3799999999999999 108.782 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.432 ' O ' ' OG1' ' B' ' 66' ' ' THR . 68.1 t90 -62.39 -49.32 75.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.343 -0.848 . . . . 0.40999999999999998 110.703 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.439 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 63.5 tp -67.6 -47.85 68.49 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.184 -0.948 . . . . 1.0700000000000001 110.209 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.48 -46.13 87.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 2.6000000000000001 109.636 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -68.85 -29.97 68.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 1.8999999999999999 109.903 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 66.9 m -77.91 -36.82 49.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 1.1000000000000001 111.189 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 13.4 p -130.64 -29.77 1.92 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.564 -1.335 . . . . 0.95999999999999996 111.712 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.31 15.72 12.16 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.345 -1.502 . . . . 0.37 109.345 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.08 154.52 2.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.968 -1.313 . . . . 1.0900000000000001 109.125 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -88.34 168.93 12.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.991 -1.068 . . . . 2.3700000000000001 109.922 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.31 71.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 1.1100000000000001 110.167 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -72.47 -40.01 67.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 2.9700000000000002 109.409 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -68.54 -38.6 80.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.45 -0.781 . . . . 2.6200000000000001 110.447 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.72 -36.06 77.95 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 1.8899999999999999 109.564 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.87 -38.21 81.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 3.3199999999999998 109.342 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.92 -40.02 83.45 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.40000000000000002 110.428 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.1 m -69.53 -40.73 76.71 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.653 -1.279 . . . . 0.95999999999999996 109.46 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.78 -60.36 3.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.635 -1.291 . . . . 0.5 109.37 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.05 -34.58 90.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.779 -0.928 . . . . 0.27000000000000002 110.779 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 51.1 t -68.79 -49.4 58.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.927 -1.337 . . . . 0.93999999999999995 110.215 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.99 -39.5 75.86 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.842 -1.143 . . . . 1.0900000000000001 108.799 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.04 -41.0 91.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 3.1899999999999999 109.605 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -70.0 -37.72 75.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.9099999999999999 110.711 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 85.7 t90 -60.81 -42.16 97.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.516 -1.365 . . . . 0.40000000000000002 108.986 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' B' ' 89' ' ' LEU . 69.7 m -62.04 -39.96 94.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.474 -0.766 . . . . 0.96999999999999997 109.735 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -58.61 -31.43 68.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.433 -0.792 . . . . 0.55000000000000004 109.67 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.7 -37.19 12.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 1.1299999999999999 111.416 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.9 m-85 -105.74 -4.35 21.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.084 -1.01 . . . . 1.24 112.501 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.444 -1.41 . . . . 1.8300000000000001 109.419 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.315 -0.624 . . . . 6.1100000000000003 109.315 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 m -86.33 12.23 10.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.188 -0.945 . . . . 3.5800000000000001 109.254 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.2 p -69.48 165.25 21.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 1.3200000000000001 109.396 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p -71.93 170.07 14.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 1.98 110.078 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -54.57 -19.28 5.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.778 -0.576 . . . . 2.6000000000000001 110.05 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -60.05 -38.36 82.58 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.031 -1.043 . . . . 2.5099999999999998 109.366 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -58.93 -50.06 75.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.51000000000000001 110.515 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -69.97 -33.78 72.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.02 . . . . 3.7200000000000002 109.831 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -67.17 -39.9 86.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.849 -0.741 . . . . 0.76000000000000001 109.904 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.92 -47.15 75.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.5 110.362 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 m -85.77 5.18 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.128 -0.982 . . . . 1.1799999999999999 110.929 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.97 17.98 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.06 -1.025 . . . . 1.1799999999999999 109.935 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.6 pt-20 -153.59 153.35 28.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 1.26 108.712 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 13' ' ' GLU . 64.1 Cg_exo -35.87 156.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.236 1.958 . . . . 0.53000000000000003 112.024 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.54 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 10.4 ptm -93.12 -31.59 14.75 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.238 -0.913 . . . . 1.1399999999999999 109.983 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.24 -133.58 41.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.612 -0.995 . . . . 0.41999999999999998 110.612 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.56 -0.964 . . . . 0.84999999999999998 110.972 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.31 65.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.704 -1.248 . . . . 2.4900000000000002 108.23 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.47 155.48 47.02 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.084 1.856 . . . . 0.39000000000000001 112.246 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' SER . 10.8 p -56.23 -47.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.554 -0.716 . . . . 1.1200000000000001 110.384 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -58.03 -3.28 1.18 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.681 -0.967 . . . . 0.27000000000000002 110.681 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' VAL . 9.6 t -84.52 -22.31 30.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.742 -1.446 . . . . 1.75 109.633 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.88 138.87 58.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 1.05 109.263 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -63.83 136.27 57.27 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.91 0.862 . . . . 1.0600000000000001 110.507 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.05 59.67 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.301 -1.52 . . . . 0.23000000000000001 109.301 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 26' ' ' ILE . 27.1 mm -100.29 113.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.436 -1.038 . . . . 1.0800000000000001 108.384 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.75 177.72 40.49 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.422 -1.471 . . . . 0.31 109.422 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -55.77 -39.72 71.61 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.465 -1.021 . . . . 2.0099999999999998 109.562 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.02 -46.36 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.06 -1.025 . . . . 1.1399999999999999 110.127 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.68 -39.05 87.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 1.1299999999999999 109.972 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 -39.96 97.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.168 -1.173 . . . . 0.34999999999999998 110.168 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.34 -39.66 92.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.106 -1.232 . . . . 3.2200000000000002 110.241 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -67.66 -45.68 74.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.936 -1.103 . . . . 2.1000000000000001 108.974 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.91 -39.42 89.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.655 -1.239 . . . . 1.0800000000000001 107.655 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.02 -40.94 91.04 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.827 -0.749 . . . . 1.6699999999999999 109.141 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -68.03 -20.35 64.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.246 -0.909 . . . . 2.0 108.882 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -91.16 2.43 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 3.1499999999999999 109.679 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.02 38.0 3.72 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 120.346 -0.93 . . . . 0.47999999999999998 111.352 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -133.63 72.29 1.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.959 -1.318 . . . . 0.38 109.073 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 22.9 p-10 -80.07 -10.73 59.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.165 . . . . 0.40999999999999998 110.437 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -129.75 150.93 50.84 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.193 -0.942 . . . . 2.1600000000000001 109.422 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.06 90.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 1.03 111.274 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.74 -17.1 32.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.741 -1.224 . . . . 0.92000000000000004 110.182 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.86 -31.8 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.748 -1.204 . . . . 1.0700000000000001 107.748 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.34 -36.47 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.774 -1.195 . . . . 1.0600000000000001 107.774 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.01 -36.34 77.01 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.237 -1.394 . . . . 1.1599999999999999 107.237 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.07 98.12 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.736 -1.346 . . . . 0.20000000000000001 109.736 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -60.08 -43.8 95.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.903 -1.351 . . . . 1.8200000000000001 108.431 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.11 -40.91 91.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.40000000000000002 109.222 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.6 -38.45 80.62 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.426 -0.953 . . . . 1.0900000000000001 108.426 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.76 -21.08 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.259 -0.9 . . . . 1.0900000000000001 110.853 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.48 13.27 14.21 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.933 -1.105 . . . . 1.0900000000000001 111.351 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 49.92 36.21 11.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.648 -1.282 . . . . 2.2200000000000002 110.065 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.28 19.96 8.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.411 -0.805 . . . . 2.7999999999999998 110.257 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.9 105.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.526 -1.359 . . . . 1.8 108.209 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 82.5 tt0 -65.11 -40.29 94.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.486 -0.759 . . . . 0.87 112.44 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.61 -39.99 80.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.704 -1.248 . . . . 0.72999999999999998 109.594 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.59 -39.31 77.37 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.385 -0.926 . . . . 1.2 108.756 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.5 -46.62 89.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.44 109.117 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 96.9 mtt180 -59.99 -48.21 82.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.497 -0.752 . . . . 3.3399999999999999 110.694 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.32 -39.95 89.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.703 -1.248 . . . . 2.3700000000000001 108.913 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' A' ' 66' ' ' THR . 62.3 t90 -62.76 -49.94 73.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.40999999999999998 110.647 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 56.6 tp -66.35 -47.64 72.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.328 -0.857 . . . . 1.0800000000000001 109.724 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.27 -44.93 95.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.359 -0.838 . . . . 2.6099999999999999 109.772 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.36 -32.08 70.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.327 -0.858 . . . . 1.8999999999999999 109.244 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 94.4 m -77.1 -38.0 53.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 1.1100000000000001 111.323 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 10.5 p -131.0 -37.0 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.622 -1.299 . . . . 0.96999999999999997 111.86 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.21 17.75 7.57 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.214 -1.555 . . . . 0.38 109.214 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.31 153.84 3.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.034 -1.274 . . . . 1.1000000000000001 109.191 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -91.06 171.66 9.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 2.3700000000000001 109.589 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.84 70.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.467 -0.771 . . . . 1.1200000000000001 110.593 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -71.79 -41.16 68.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.739 -1.226 . . . . 2.9700000000000002 110.317 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.41 -39.16 88.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.198 -0.939 . . . . 2.6200000000000001 110.451 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -66.03 -38.65 88.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.441 -0.787 . . . . 1.8899999999999999 110.195 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.825 -1.172 . . . . 3.3199999999999998 109.384 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -67.9 -39.99 83.53 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.697 -1.252 . . . . 0.40000000000000002 110.476 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 92.4 m -69.74 -39.94 76.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.683 -1.26 . . . . 0.95999999999999996 109.778 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.48 -60.41 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.61 -1.307 . . . . 0.5 109.792 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.58 84.67 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 120.305 -0.95 . . . . 0.27000000000000002 110.843 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.21 -49.27 45.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.832 -1.393 . . . . 0.93999999999999995 110.014 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.0 -39.98 75.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 1.0900000000000001 108.745 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 82' ' ' ARG . 16.4 ttt-85 -64.57 -39.87 94.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.282 -0.886 . . . . 3.1800000000000002 110.051 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.92 -39.45 79.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 1.9099999999999999 110.345 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.588 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 88.3 t90 -60.14 -43.63 95.57 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.411 -1.431 . . . . 0.40000000000000002 107.666 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 89' ' ' LEU . 59.1 m -61.57 -40.02 93.26 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.457 0.646 . . . . 0.96999999999999997 109.695 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.99 -31.91 70.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.835 . . . . 0.55000000000000004 109.145 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.73 13.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.4 -0.813 . . . . 1.1200000000000001 110.654 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.588 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 85.5 m-85 -107.8 -6.34 16.81 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.278 -0.889 . . . . 1.24 112.831 -177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 85' ' ' CYS . 10.5 tp . . . . . 0 N--CA 1.504 2.258 0 O-C-N 120.335 -1.478 . . . . 1.8300000000000001 109.297 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptp . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.302 -0.629 . . . . 6.0999999999999996 109.302 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 2.6 m -86.29 12.17 10.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.92 . . . . 3.5800000000000001 109.223 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 59.6 p -69.46 165.18 21.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 1.3200000000000001 109.459 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p -71.89 170.21 14.2 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.793 0.806 . . . . 1.97 110.07 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -54.73 -19.28 5.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.77 -0.581 . . . . 2.5899999999999999 110.039 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.96 -38.37 82.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.024 -1.047 . . . . 2.5 109.364 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -58.95 -50.12 75.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.996 . . . . 0.51000000000000001 110.428 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -70.01 -33.72 72.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.035 -1.041 . . . . 3.73 109.825 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.2 -39.93 86.4 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.418 -0.801 . . . . 0.76000000000000001 109.792 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.83 -47.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.5 110.303 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 24.2 m -85.77 5.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.132 -0.98 . . . . 1.1799999999999999 110.907 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.56 -15.09 17.94 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.049 -1.032 . . . . 1.1799999999999999 109.915 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' B' ' 14' ' ' PRO . 4.6 pt-20 -153.65 153.38 28.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 1.27 108.606 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -35.93 156.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.333 2.022 . . . . 0.53000000000000003 112.001 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.531 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 10.3 ptm -93.24 -31.64 14.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.359 -0.838 . . . . 1.1299999999999999 109.916 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.62 42.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.557 -1.017 . . . . 0.40999999999999998 110.557 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.968 . . . . 0.83999999999999997 110.938 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.34 64.83 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.748 -1.22 . . . . 2.4900000000000002 108.272 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.54 155.55 46.96 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.016 1.81 . . . . 0.38 112.298 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' B' ' 22' ' ' SER . 10.6 p -56.26 -47.25 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.536 -0.728 . . . . 1.1200000000000001 110.43 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.414 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -58.01 -3.12 1.1 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.781 -0.928 . . . . 0.27000000000000002 110.781 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.433 ' H ' ' C ' ' B' ' 20' ' ' VAL . 9.8 t -84.65 -22.34 29.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.696 -1.473 . . . . 1.75 109.573 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.91 138.87 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 1.0600000000000001 109.276 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.442 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -63.77 136.15 57.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.782 0.801 . . . . 1.05 110.552 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -16.95 59.9 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.393 -1.483 . . . . 0.22 109.393 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.409 HG23 HD13 ' B' ' 26' ' ' ILE . 27.2 mm -100.38 113.19 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.398 -1.06 . . . . 1.0800000000000001 108.343 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.74 177.56 40.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.419 -1.472 . . . . 0.29999999999999999 109.419 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -55.63 -39.7 71.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.506 -0.996 . . . . 2.0 109.519 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.05 -46.35 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.053 -1.029 . . . . 1.1399999999999999 110.096 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.72 -38.96 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 1.1299999999999999 109.865 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.81 -40.1 97.73 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.083 -1.207 . . . . 0.35999999999999999 110.083 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.26 -39.71 93.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.254 . . . . 3.2200000000000002 110.187 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.56 -45.67 74.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.105 . . . . 2.1200000000000001 109.041 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.95 -39.53 89.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.595 -1.261 . . . . 1.0800000000000001 107.595 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.96 -40.98 90.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.803 -0.759 . . . . 1.6799999999999999 109.082 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.97 -20.26 65.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 1.99 108.934 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -91.39 2.64 56.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.695 . . . . 3.1499999999999999 109.667 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 37.97 3.74 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 121.165 -0.959 . . . . 0.48999999999999999 111.37 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -133.54 72.2 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.921 -1.341 . . . . 0.38 109.095 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 40' ' ' ASP . 22.9 p-10 -80.06 -10.63 59.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.40999999999999998 110.413 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -129.81 150.83 50.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.294 -0.879 . . . . 2.1499999999999999 109.489 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -40.09 90.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.461 -0.774 . . . . 1.03 111.291 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.79 -17.13 33.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.745 -1.222 . . . . 0.92000000000000004 110.217 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.87 -31.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.745 -1.205 . . . . 1.0800000000000001 107.745 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 59.2 t -78.49 -36.39 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.727 -1.212 . . . . 1.0700000000000001 107.727 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.06 -36.25 76.93 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.166 -1.42 . . . . 1.1499999999999999 107.166 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.18 98.25 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.635 -1.386 . . . . 0.19 109.635 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -59.98 -43.89 94.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.944 -1.327 . . . . 1.8200000000000001 108.514 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -59.91 -41.07 90.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.769 . . . . 0.40000000000000002 109.275 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.44 -38.52 81.24 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.513 -0.921 . . . . 1.0700000000000001 108.513 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.87 -20.95 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.936 . . . . 1.0900000000000001 110.779 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.52 13.19 14.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.863 -1.148 . . . . 1.0900000000000001 111.41 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 50.05 36.15 11.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.667 -1.271 . . . . 2.23 110.125 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.11 20.03 7.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.38 -0.825 . . . . 2.7999999999999998 110.285 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -67.92 105.28 1.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.553 -1.342 . . . . 1.8 108.258 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 82.5 tt0 -65.06 -40.32 94.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 0.88 112.375 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.6 -39.82 80.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.844 -1.16 . . . . 0.73999999999999999 109.577 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.79 -39.25 76.72 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.29 -0.964 . . . . 1.2 108.764 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.53 -46.72 88.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.44 109.021 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 97.0 mtt180 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.504 -0.748 . . . . 3.3399999999999999 110.664 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.3 -40.01 89.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.782 -1.199 . . . . 2.3799999999999999 108.952 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.409 ' O ' ' OG1' ' B' ' 66' ' ' THR . 62.2 t90 -62.77 -49.93 73.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.989 -1.069 . . . . 0.40999999999999998 110.656 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.469 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 56.7 tp -66.42 -47.62 72.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.391 -0.818 . . . . 1.0700000000000001 109.708 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.27 -44.86 95.56 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.376 -0.827 . . . . 2.6000000000000001 109.783 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -69.48 -31.95 70.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 1.8999999999999999 109.22 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 94.2 m -77.06 -37.98 53.52 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.448 -0.782 . . . . 1.1000000000000001 111.467 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 10.5 p -131.0 -37.04 1.3 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.649 -1.282 . . . . 0.95999999999999996 111.886 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.17 17.81 7.56 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.282 -1.527 . . . . 0.37 109.282 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.35 153.92 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.053 -1.263 . . . . 1.0900000000000001 109.153 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.19 171.77 9.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 2.3700000000000001 109.466 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.85 70.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.413 -0.805 . . . . 1.1100000000000001 110.511 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.79 -41.22 68.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.784 -1.197 . . . . 2.9700000000000002 110.247 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.37 -39.16 88.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -0.918 . . . . 2.6200000000000001 110.439 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 51.0 m -66.02 -38.74 89.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 1.8899999999999999 110.182 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -59.89 -38.32 81.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.857 -1.152 . . . . 3.3199999999999998 109.452 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -68.11 -39.98 82.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.69 -1.256 . . . . 0.40000000000000002 110.499 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.0 m -69.67 -40.06 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.95999999999999996 109.757 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.38 -60.38 3.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.592 -1.318 . . . . 0.5 109.777 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.68 85.01 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.797 -0.921 . . . . 0.27000000000000002 110.797 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.09 -49.41 44.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.758 -1.436 . . . . 0.93999999999999995 109.982 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.02 -39.9 75.51 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.004 -1.078 . . . . 1.0900000000000001 108.823 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.469 HH11 ' HG2' ' B' ' 82' ' ' ARG . 16.5 ttt-85 -64.4 -40.07 95.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 3.1899999999999999 110.061 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.7 -39.65 80.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 1.9099999999999999 110.45 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.586 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 88.3 t90 -60.03 -43.61 95.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.409 -1.432 . . . . 0.40000000000000002 107.658 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.6 m -61.69 -40.01 93.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.96999999999999997 109.647 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -59.99 -31.85 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 0.55000000000000004 109.227 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.16 -35.1 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.307 -0.871 . . . . 1.1299999999999999 110.611 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.586 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 86.9 m-85 -107.2 -6.64 17.18 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.239 -0.913 . . . . 1.24 112.951 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.4 tp . . . . . 0 N--CA 1.504 2.262 0 O-C-N 120.202 -1.561 . . . . 1.8300000000000001 109.342 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' OG1' ' A' ' 2' ' ' THR . 19.5 mmm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.006 -0.739 . . . . 6.1100000000000003 109.006 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 1' ' ' MET . 3.4 p 49.62 42.65 23.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 3.5800000000000001 109.685 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.465 ' HG1' ' CG ' ' A' ' 7' ' ' HIS . 43.9 p -78.71 161.63 26.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 1.3200000000000001 109.815 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.3 p -72.53 169.29 16.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.342 -0.849 . . . . 1.98 109.557 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -59.72 -22.52 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 2.6000000000000001 110.253 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.13 -38.5 83.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 2.5099999999999998 109.157 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 14.1 t60 -56.86 -49.84 74.25 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.256 -0.903 . . . . 0.51000000000000001 110.132 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -70.03 -34.0 72.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.922 . . . . 3.7200000000000002 110.086 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.68 -36.84 73.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.327 -0.858 . . . . 0.76000000000000001 109.74 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -64.49 -43.18 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.5 109.803 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -84.11 15.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.209 -0.932 . . . . 1.1799999999999999 110.243 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.42 -9.49 10.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.298 -0.876 . . . . 1.1799999999999999 110.311 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.71 149.73 19.45 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.859 -1.15 . . . . 1.26 109.461 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -40.61 155.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.742 1.628 . . . . 0.53000000000000003 111.168 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.3 ptp -91.21 -19.65 22.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.966 -1.084 . . . . 1.1399999999999999 109.174 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -138.6 39.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.195 -1.162 . . . . 0.41999999999999998 110.195 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -106.18 30.53 5.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.621 -0.929 . . . . 0.84999999999999998 110.487 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -60.06 148.52 77.52 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 2.4900000000000002 107.927 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.81 159.08 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.06 1.84 . . . . 0.39000000000000001 112.633 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.5 p -57.12 -49.25 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 1.1200000000000001 110.517 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.39 -1.86 0.14 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.763 -0.935 . . . . 0.27000000000000002 110.763 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 20' ' ' VAL . 64.9 p -82.42 -24.72 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.69 -1.476 . . . . 1.75 109.847 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.11 138.72 58.2 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.887 0.851 . . . . 1.05 109.84 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 133.43 53.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.725 0.774 . . . . 1.0600000000000001 109.982 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 97.37 -20.25 51.47 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.213 -1.555 . . . . 0.23000000000000001 109.213 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 26' ' ' ILE . 38.0 mm -99.75 113.17 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -1.162 . . . . 1.0800000000000001 107.892 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.44 179.94 39.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.31 109.692 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' C ' ' HZ3' ' A' ' 32' ' ' LYS . 79.6 mm-40 -56.01 -39.96 72.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.544 -0.974 . . . . 2.0099999999999998 109.874 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.73 -43.17 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.95 -1.094 . . . . 1.1399999999999999 109.524 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.73 -39.91 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 1.1299999999999999 109.526 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.29 97.81 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.135 -1.186 . . . . 0.34999999999999998 110.135 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HZ3' ' C ' ' A' ' 28' ' ' GLU . 33.6 mtmm -64.36 -38.79 92.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.998 -1.295 . . . . 3.2200000000000002 110.079 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -65.43 -48.87 71.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.872 -1.142 . . . . 2.1000000000000001 109.177 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.85 -38.6 86.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.21 -0.931 . . . . 1.0800000000000001 108.59 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.11 -40.05 88.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.768 -0.827 . . . . 1.6699999999999999 108.768 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.87 -18.89 64.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.407 -0.96 . . . . 2.0 108.407 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.33 2.89 56.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.594 -0.691 . . . . 3.1499999999999999 110.166 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.56 6.86 49.65 Favored Glycine 0 N--CA 1.503 3.115 0 O-C-N 120.997 -1.064 . . . . 0.47999999999999998 112.244 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 39' ' ' PHE . 44.3 m-85 -106.23 77.12 1.2 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 119.208 1.504 . . . . 0.38 109.32 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -77.46 -8.19 57.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.40999999999999998 111.024 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.79 158.54 44.15 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.977 -1.077 . . . . 2.1600000000000001 109.418 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.2 90.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.462 -0.774 . . . . 1.03 112.183 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.32 -17.58 20.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.636 -1.29 . . . . 0.92000000000000004 110.635 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.18 -30.02 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.927 -1.108 . . . . 1.0700000000000001 108.152 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.72 -39.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.994 -1.113 . . . . 1.0600000000000001 107.994 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.217 -1.401 . . . . 1.1599999999999999 107.217 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.56 -43.79 67.71 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.156 -1.577 . . . . 0.20000000000000001 109.156 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -1.225 . . . . 1.8200000000000001 108.634 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.86 -41.19 90.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.852 . . . . 0.40000000000000002 109.09 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.03 -39.98 75.44 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.883 -0.727 . . . . 1.0900000000000001 109.073 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.78 -20.27 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.115 -0.991 . . . . 1.0900000000000001 110.626 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.75 18.17 9.27 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.058 -1.026 . . . . 1.0900000000000001 109.79 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.04 32.44 10.26 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.942 -1.099 . . . . 2.2200000000000002 110.103 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 60.02 19.91 9.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.62 -0.675 . . . . 2.7999999999999998 109.913 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -67.84 111.88 4.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.777 -1.202 . . . . 1.8 107.927 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.5 -41.17 98.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.87 112.601 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.42 -40.05 77.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.548 -1.345 . . . . 0.72999999999999998 109.669 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.91 -40.01 75.85 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.977 -1.089 . . . . 1.2 108.785 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.06 -49.98 70.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.44 110.026 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -61.19 -44.85 96.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 3.3399999999999999 110.431 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 98.8 mt-10 -64.81 -37.92 89.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.805 -1.185 . . . . 2.3700000000000001 108.846 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.455 ' O ' ' OG1' ' A' ' 66' ' ' THR . 65.1 t90 -64.05 -48.04 77.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.303 -0.873 . . . . 0.40999999999999998 110.974 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.17 -46.89 66.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.956 -1.09 . . . . 1.0800000000000001 109.862 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -61.52 -47.0 87.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.067 -1.021 . . . . 2.6099999999999999 109.714 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 61' ' ' GLU . 71.7 m-20 -70.02 -28.33 65.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.849 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 54.5 m -80.61 -31.56 36.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 1.1100000000000001 111.732 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.6 p -133.19 -23.37 1.94 Allowed 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.374 -1.453 . . . . 0.96999999999999997 111.916 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.85 13.09 32.85 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.171 -1.572 . . . . 0.38 109.171 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.88 154.74 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.097 -1.237 . . . . 1.1000000000000001 109.371 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.93 171.88 9.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 2.3700000000000001 110.214 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.51 75.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.694 -0.629 . . . . 1.1200000000000001 110.38 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -73.06 -40.68 64.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.851 -1.155 . . . . 2.9700000000000002 110.105 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.3 mm100 -67.94 -35.13 77.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.974 . . . . 2.6200000000000001 110.284 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.4 -38.22 81.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.363 -0.836 . . . . 1.8899999999999999 110.085 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.06 -36.27 76.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.886 -1.134 . . . . 3.3199999999999998 109.547 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -68.97 -39.89 79.18 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.749 -1.22 . . . . 0.40000000000000002 110.806 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.03 -40.36 75.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.674 -1.266 . . . . 0.95999999999999996 110.061 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.77 -60.01 4.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.717 -1.239 . . . . 0.5 109.482 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.64 -33.7 87.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.351 -1.1 . . . . 0.27000000000000002 110.351 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.73 -46.55 62.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.761 -1.435 . . . . 0.93999999999999995 109.356 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.926 -1.11 . . . . 1.0900000000000001 108.659 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.43 -40.06 95.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 3.1800000000000002 110.295 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.534 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.6 mt-10 -69.85 -37.74 76.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 1.9099999999999999 110.165 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.8 t90 -60.0 -42.85 95.18 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.53 -1.356 . . . . 0.40000000000000002 107.821 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 89' ' ' LEU . 88.3 m -60.79 -40.09 91.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -0.84 . . . . 0.96999999999999997 109.668 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.91 -32.28 69.4 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.017 -1.052 . . . . 0.55000000000000004 110.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.5 -34.03 14.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.107 -0.995 . . . . 1.1200000000000001 110.999 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 91.4 m-85 -107.61 2.2 23.79 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.089 -1.007 . . . . 1.24 111.357 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 85' ' ' CYS . 54.9 tp . . . . . 0 N--CA 1.495 1.802 0 O-C-N 120.856 -1.152 . . . . 1.8300000000000001 109.404 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.449 ' O ' ' OG1' ' B' ' 2' ' ' THR . 19.3 mmm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.946 -0.761 . . . . 6.0999999999999996 108.946 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' B' ' 1' ' ' MET . 3.4 p 49.62 42.54 23.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.905 . . . . 3.5800000000000001 109.726 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.471 ' HG1' ' CG ' ' B' ' 7' ' ' HIS . 44.0 p -78.66 161.63 26.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -0.959 . . . . 1.3200000000000001 109.828 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 98.0 p -72.51 169.14 17.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.442 -0.786 . . . . 1.97 109.582 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.52 -22.67 61.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.727 -0.608 . . . . 2.5899999999999999 110.202 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -60.09 -38.59 83.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.094 -1.004 . . . . 2.5 109.189 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.541 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 14.2 t60 -56.85 -49.73 74.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.51000000000000001 110.144 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -70.11 -34.02 72.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 3.73 110.034 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.73 -36.52 73.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.312 -0.868 . . . . 0.76000000000000001 109.744 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.987 ' CD1' ' CD2' ' B' ' 10' ' ' PHE . . . -64.91 -42.94 94.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.479 -0.763 . . . . 0.5 109.869 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 m -84.0 14.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.161 -0.962 . . . . 1.1799999999999999 110.302 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.07 -9.3 11.09 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.34 -0.85 . . . . 1.1799999999999999 110.297 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.87 149.76 19.34 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.102 . . . . 1.27 109.37 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -40.58 155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.761 1.64 . . . . 0.53000000000000003 111.205 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.2 ptp -91.16 -19.83 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.895 -1.128 . . . . 1.1299999999999999 109.239 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.82 -138.44 41.81 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.341 -1.104 . . . . 0.40999999999999998 110.341 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.52 30.52 5.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.635 -0.921 . . . . 0.83999999999999997 110.408 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -60.03 148.31 77.84 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 2.4900000000000002 107.933 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.78 159.12 34.43 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.096 1.864 . . . . 0.38 112.591 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.5 p -57.19 -49.15 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.485 0.659 . . . . 1.1200000000000001 110.554 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.38 -2.21 0.15 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.791 -0.924 . . . . 0.27000000000000002 110.791 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.527 ' H ' ' C ' ' B' ' 20' ' ' VAL . 61.1 p -81.91 -24.73 35.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.766 -1.432 . . . . 1.75 110.032 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.2 138.79 58.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.296 -0.877 . . . . 1.0600000000000001 109.867 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.69 53.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.702 0.763 . . . . 1.05 109.836 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.513 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 97.17 -20.42 50.85 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.219 -1.552 . . . . 0.22 109.219 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.412 HD12 HG23 ' B' ' 26' ' ' ILE . 37.8 mm -99.69 113.18 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.894 -1.15 . . . . 1.0800000000000001 107.894 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.48 179.98 39.14 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.714 -1.354 . . . . 0.29999999999999999 109.714 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -56.07 -39.98 72.89 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.437 -1.037 . . . . 2.0 109.787 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.84 -42.99 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.956 -1.09 . . . . 1.1399999999999999 109.534 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.81 -39.99 83.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 1.1299999999999999 109.437 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.18 97.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.057 -1.217 . . . . 0.35999999999999999 110.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -64.55 -38.46 91.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.248 . . . . 3.2200000000000002 110.111 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.67 -48.82 70.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.824 -1.173 . . . . 2.1200000000000001 109.211 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.88 -38.63 86.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.26 -0.9 . . . . 1.0800000000000001 108.579 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.95 -40.16 88.04 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.692 -0.855 . . . . 1.6799999999999999 108.692 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.89 -18.82 64.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.47 -0.937 . . . . 1.99 108.47 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.23 2.44 56.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 3.1499999999999999 110.163 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 7.01 48.44 Favored Glycine 0 N--CA 1.503 3.118 0 O-C-N 121.08 -1.013 . . . . 0.48999999999999999 112.242 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' B' ' 39' ' ' PHE . 45.6 m-85 -106.36 76.95 1.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 119.19 1.495 . . . . 0.38 109.314 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -77.18 -8.47 57.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.377 -0.827 . . . . 0.40999999999999998 110.98 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.67 158.31 44.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 2.1499999999999999 109.437 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.4 91.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.48 -0.763 . . . . 1.03 112.173 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -58.17 -17.32 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.695 -1.253 . . . . 0.92000000000000004 110.765 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.45 -29.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.908 -1.12 . . . . 1.0800000000000001 108.104 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.88 -39.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.928 -1.138 . . . . 1.0700000000000001 107.928 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.98 -39.84 87.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.257 -1.386 . . . . 1.1499999999999999 107.257 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.7 -43.82 69.2 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.173 -1.571 . . . . 0.19 109.173 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.96 -44.62 94.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -1.207 . . . . 1.8200000000000001 108.791 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.97 -41.28 91.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.40000000000000002 109.007 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 mt -69.96 -39.7 75.86 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.878 -0.729 . . . . 1.0700000000000001 109.186 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.98 -20.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.166 -0.959 . . . . 1.0900000000000001 110.561 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.47 17.82 9.44 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.0 -1.063 . . . . 1.0900000000000001 109.907 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.25 32.52 10.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.959 -1.088 . . . . 2.23 110.151 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt 60.0 20.08 9.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.746 . . . . 2.7999999999999998 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -67.96 111.5 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.817 -1.177 . . . . 1.8 108.072 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.39 -40.69 97.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.88 112.641 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.86 -39.91 76.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.523 -1.361 . . . . 0.73999999999999999 109.663 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.96 -39.99 75.7 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.929 -1.108 . . . . 1.2 108.73 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.02 -50.04 70.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.99 . . . . 0.44 110.096 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -61.27 -44.46 97.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 3.3399999999999999 110.548 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.413 ' O ' ' OD2' ' B' ' 65' ' ' ASP . 98.9 mt-10 -65.03 -38.1 89.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.776 -1.203 . . . . 2.3799999999999999 108.866 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.445 ' O ' ' OG1' ' B' ' 66' ' ' THR . 65.2 t90 -63.83 -48.27 77.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.40999999999999998 111.013 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.05 -46.46 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.909 -1.119 . . . . 1.0700000000000001 109.989 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -61.73 -47.17 86.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 2.6000000000000001 109.707 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' B' ' 61' ' ' GLU . 71.3 m-20 -69.93 -28.35 65.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.906 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 54.2 m -80.54 -31.6 36.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 1.1000000000000001 111.737 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.8 p -133.3 -23.2 1.92 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.326 -1.484 . . . . 0.95999999999999996 111.919 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.71 34.11 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 109.237 -1.545 . . . . 0.37 109.237 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.55 154.53 1.85 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.091 -1.241 . . . . 1.0900000000000001 109.39 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.74 171.96 9.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 2.3700000000000001 110.177 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.75 75.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.646 -0.658 . . . . 1.1100000000000001 110.417 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -72.89 -40.69 65.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.859 -1.151 . . . . 2.9700000000000002 110.128 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.2 mm100 -67.92 -35.2 78.03 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.248 -0.907 . . . . 2.6200000000000001 110.354 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.27 -38.37 81.66 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.179 -0.951 . . . . 1.8899999999999999 110.074 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.92 -36.53 77.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.86 -1.15 . . . . 3.3199999999999998 109.531 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -68.6 -40.03 80.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.778 -1.201 . . . . 0.40000000000000002 110.747 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.2 m -70.06 -40.37 75.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.95999999999999996 110.123 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.75 -59.97 4.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.699 -1.251 . . . . 0.5 109.525 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.75 87.42 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.344 -1.102 . . . . 0.27000000000000002 110.344 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.73 -46.41 63.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.725 -1.456 . . . . 0.93999999999999995 109.337 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.6 -40.43 69.86 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.935 -1.106 . . . . 1.0900000000000001 108.628 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.24 -39.99 95.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.98 . . . . 3.1899999999999999 110.316 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.4 mt-10 -69.8 -37.76 76.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.9099999999999999 110.167 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.549 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 87.0 t90 -60.04 -42.72 95.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.5 -1.375 . . . . 0.40000000000000002 107.866 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' B' ' 89' ' ' LEU . 89.4 m -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.96999999999999997 109.748 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.02 -32.55 69.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.049 -1.032 . . . . 0.55000000000000004 109.912 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.2 -34.11 14.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.135 -0.978 . . . . 1.1299999999999999 111.06 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.549 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 92.4 m-85 -107.41 2.02 24.03 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.195 -0.941 . . . . 1.24 111.465 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' B' ' 85' ' ' CYS . 54.7 tp . . . . . 0 N--CA 1.495 1.785 0 O-C-N 120.695 -1.253 . . . . 1.8300000000000001 109.321 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtm . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.525 -0.546 . . . . 6.1100000000000003 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.7 m -86.18 110.1 19.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.946 . . . . 3.5800000000000001 109.438 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.2 p -98.81 164.61 12.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.37 -0.831 . . . . 1.3200000000000001 109.273 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 t -69.92 164.86 22.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 1.98 109.314 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.74 -26.46 63.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.687 -0.633 . . . . 2.6000000000000001 110.074 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -36.0 76.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.001 -1.062 . . . . 2.5099999999999998 109.567 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.404 ' HE2' ' NH2' ' A' ' 8' ' ' ARG . 67.8 t60 -58.86 -50.01 75.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.51000000000000001 110.127 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' NH2' ' HE2' ' A' ' 7' ' ' HIS . 3.6 mmp_? -69.96 -32.83 71.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.044 -1.035 . . . . 3.7200000000000002 109.751 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.47 -40.02 89.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.234 -0.917 . . . . 0.76000000000000001 109.628 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.97 -49.04 76.28 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.246 -0.909 . . . . 0.5 109.792 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.21 4.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.232 -0.917 . . . . 1.1799999999999999 111.863 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.57 -18.92 18.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.686 -1.259 . . . . 1.1799999999999999 110.359 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 1.4 pp20? -155.83 152.26 23.6 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 1.26 108.596 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 48.5 Cg_exo -35.36 155.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.174 1.916 . . . . 0.53000000000000003 112.034 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.42 ' H ' ' HG2' ' A' ' 15' ' ' MET . 11.4 ptm -90.92 -23.08 20.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.145 -0.972 . . . . 1.1399999999999999 110.484 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.09 -136.35 20.58 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.984 -1.073 . . . . 0.41999999999999998 110.715 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.06 28.37 8.67 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.523 -0.986 . . . . 0.84999999999999998 111.02 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.6 148.34 56.63 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 118.557 -1.257 . . . . 2.4900000000000002 107.756 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.19 159.34 19.12 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.619 2.213 . . . . 0.39000000000000001 113.183 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 22' ' ' SER . 4.3 p -59.63 -48.52 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 1.1200000000000001 110.576 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.95 -1.87 0.07 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.435 -1.066 . . . . 0.27000000000000002 110.435 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.553 ' H ' ' C ' ' A' ' 20' ' ' VAL . 10.6 p -83.3 -26.42 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.385 . . . . 1.75 109.973 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.65 137.29 58.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 1.05 110.296 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -65.91 132.63 49.08 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.789 0.804 . . . . 1.0600000000000001 110.234 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.95 -18.1 56.29 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.003 -1.639 . . . . 0.23000000000000001 109.003 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.88 114.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.827 -1.175 . . . . 1.0800000000000001 107.827 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.1 177.58 38.29 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.458 -1.457 . . . . 0.31 109.458 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -58.83 -40.14 83.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -1.125 . . . . 2.0099999999999998 109.494 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.22 -48.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.042 -1.037 . . . . 1.1399999999999999 109.42 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.41 -39.99 81.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 1.1299999999999999 109.212 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.03 96.42 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.236 -1.546 . . . . 0.34999999999999998 109.236 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.535 ' NZ ' ' OE2' ' A' ' 36' ' ' GLU . 14.7 tmtt? -61.36 -40.0 92.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.338 -1.096 . . . . 3.2200000000000002 110.775 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.04 -40.1 87.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.736 -1.227 . . . . 2.1000000000000001 109.986 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.58 -38.04 83.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.923 -1.11 . . . . 1.0800000000000001 108.893 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.424 -0.91 . . . . 1.6699999999999999 108.992 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 32' ' ' LYS . 98.9 mt-10 -68.06 -18.62 64.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 2.0 108.822 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -89.97 2.01 55.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.46 -0.775 . . . . 3.1499999999999999 109.859 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.49 5.18 42.89 Favored Glycine 0 N--CA 1.502 3.077 0 O-C-N 121.115 -0.991 . . . . 0.47999999999999998 112.18 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.7 76.97 1.32 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.694 -1.474 . . . . 0.38 109.141 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -75.48 -8.86 57.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.40999999999999998 110.437 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.16 160.02 40.78 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.079 -1.013 . . . . 2.1600000000000001 110.263 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.84 92.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.558 -0.714 . . . . 1.03 112.512 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 7.5 p90 -58.73 -17.74 25.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.515 -1.366 . . . . 0.92000000000000004 110.555 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -80.01 -32.71 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.794 -1.191 . . . . 1.0700000000000001 108.315 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.06 -39.1 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 1.0600000000000001 108.237 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 tp -59.98 -36.38 77.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.866 -1.161 . . . . 1.1599999999999999 107.866 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.52 97.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.20000000000000001 110.02 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.98 -40.03 87.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.245 . . . . 1.8200000000000001 109.035 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.96 -39.95 87.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.373 -0.973 . . . . 0.40000000000000002 108.373 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.053 -0.721 . . . . 1.0900000000000001 109.053 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.22 -23.97 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.246 -0.909 . . . . 1.0900000000000001 111.001 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.37 17.61 11.06 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.045 -1.034 . . . . 1.0900000000000001 110.154 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' B' ' 38' ' ' GLY . 12.7 mptt 52.47 29.31 6.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.944 -1.098 . . . . 2.2200000000000002 109.828 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.03 19.94 9.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 2.7999999999999998 110.255 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.23 117.75 9.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.511 -1.368 . . . . 1.8 107.683 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.11 -40.95 97.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.311 -0.868 . . . . 0.87 112.99 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 60' ' ' ARG . 7.6 m-20 -69.68 -39.93 76.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.669 -1.27 . . . . 0.72999999999999998 110.115 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.3 mt -69.95 -39.99 75.71 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.007 -1.077 . . . . 1.2 109.036 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.46 -49.91 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.44 109.71 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' A' ' 57' ' ' ASP . 87.7 mtm180 -60.37 -45.79 92.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.354 -0.841 . . . . 3.3399999999999999 110.622 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.64 -39.77 94.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.931 -1.105 . . . . 2.3700000000000001 108.788 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 66' ' ' THR . 63.4 t90 -65.51 -48.76 71.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.40999999999999998 111.362 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.5 tp -67.42 -47.09 71.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 1.0800000000000001 110.095 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.01 -45.95 92.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.38 -0.825 . . . . 2.6099999999999999 109.714 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.03 -27.33 64.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.8999999999999999 109.945 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 97.0 m -80.59 -33.9 35.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 1.1100000000000001 111.526 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.2 p -130.59 -27.27 2.16 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.555 -1.34 . . . . 0.96999999999999997 112.083 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.16 22.64 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.171 -1.572 . . . . 0.38 109.171 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 153.1 2.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -1.196 . . . . 1.1000000000000001 109.618 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.6 172.96 8.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.115 -0.991 . . . . 2.3700000000000001 109.715 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.23 72.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 1.1200000000000001 111.025 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.1 -39.71 63.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.711 -1.243 . . . . 2.9700000000000002 110.05 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.5 mm100 -67.38 -39.88 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 2.6200000000000001 110.694 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -67.52 -37.51 82.89 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.288 -0.882 . . . . 1.8899999999999999 109.958 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.45 ' HG2' HH11 ' A' ' 75' ' ' ARG . 25.7 mtt-85 -60.41 -37.24 80.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.114 . . . . 3.3199999999999998 109.632 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.78 -39.9 84.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.571 -1.33 . . . . 0.40000000000000002 110.552 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 88.8 m -67.94 -40.0 83.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.95999999999999996 109.806 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.43 -60.05 4.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.879 -1.138 . . . . 0.5 109.954 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.66 -34.28 88.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.448 -1.061 . . . . 0.27000000000000002 110.448 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.25 -47.33 57.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -1.202 . . . . 0.93999999999999995 109.804 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.61 -40.07 73.38 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.695 -1.202 . . . . 1.0900000000000001 108.328 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -63.01 -40.07 96.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 3.1800000000000002 110.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -69.41 -37.81 77.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.02 -1.05 . . . . 1.9099999999999999 110.474 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.487 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 84.6 t90 -59.97 -43.86 94.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.39 -1.444 . . . . 0.40000000000000002 107.363 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.3 m -60.6 -40.67 92.64 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.894 -0.78 . . . . 0.96999999999999997 108.894 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.631 -0.668 . . . . 0.55000000000000004 109.695 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -36.78 16.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 1.1200000000000001 110.125 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 83.9 m-85 -105.56 -88.17 0.45 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.35 -0.844 . . . . 1.24 110.032 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.097 -0.954 . . . . 1.8300000000000001 109.78 -178.518 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.472 -0.566 . . . . 6.0999999999999996 109.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 89.0 m -86.25 110.13 19.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.079 -1.013 . . . . 3.5800000000000001 109.434 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 82.4 p -98.75 164.61 12.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.32 -0.863 . . . . 1.3200000000000001 109.24 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t -69.87 164.94 22.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.91 . . . . 1.97 109.21 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.81 -26.53 64.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.702 -0.624 . . . . 2.5899999999999999 110.094 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.13 -35.73 75.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.085 . . . . 2.5 109.575 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.409 ' HE2' ' NH2' ' B' ' 8' ' ' ARG . 67.6 t60 -58.96 -49.94 75.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.51000000000000001 110.213 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.409 ' NH2' ' HE2' ' B' ' 7' ' ' HIS . 3.6 mmp_? -70.06 -32.76 71.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 3.73 109.749 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.45 -39.92 89.14 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.483 -0.887 . . . . 0.76000000000000001 109.743 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.0 -49.16 75.76 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.263 -0.898 . . . . 0.5 109.71 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.12 4.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.144 -0.973 . . . . 1.1799999999999999 111.834 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.29 -19.0 18.84 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.661 -1.274 . . . . 1.1799999999999999 110.418 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' B' ' 14' ' ' PRO . 1.4 pp20? -155.84 152.34 23.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.955 . . . . 1.27 108.63 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' OE1' ' B' ' 13' ' ' GLU . 48.7 Cg_exo -35.37 155.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.266 1.977 . . . . 0.53000000000000003 111.989 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 11.3 ptm -90.89 -23.25 20.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 1.1299999999999999 110.432 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.33 21.13 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.894 -1.128 . . . . 0.40999999999999998 110.7 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.2 28.72 8.35 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.634 -0.921 . . . . 0.83999999999999997 111.021 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.77 148.4 58.18 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.648 -1.283 . . . . 2.4900000000000002 107.608 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.18 159.44 18.84 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.639 2.226 . . . . 0.38 113.207 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' B' ' 22' ' ' SER . 4.2 p -59.79 -48.6 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 1.1200000000000001 110.512 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.7 -2.14 0.07 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.443 -1.063 . . . . 0.27000000000000002 110.443 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.563 ' H ' ' C ' ' B' ' 20' ' ' VAL . 10.6 p -83.09 -26.43 31.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.787 -1.419 . . . . 1.75 110.055 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.79 137.29 58.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.27 -0.894 . . . . 1.0600000000000001 110.273 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.429 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -65.82 132.63 49.16 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.82 0.819 . . . . 1.05 110.175 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.99 -18.31 55.95 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.902 -1.679 . . . . 0.22 108.902 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -101.68 114.78 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.848 -1.167 . . . . 1.0800000000000001 107.848 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.16 177.65 38.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.493 -1.443 . . . . 0.29999999999999999 109.493 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -58.95 -40.01 83.39 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.337 -1.096 . . . . 2.0 109.48 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.47 -48.9 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 1.1399999999999999 109.333 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.51 -39.9 81.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 1.1299999999999999 109.178 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.98 96.43 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.251 -1.54 . . . . 0.35999999999999999 109.251 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.53 ' NZ ' ' OE2' ' B' ' 36' ' ' GLU . 14.7 tmtt? -61.25 -39.94 92.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 3.2200000000000002 110.798 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.2 -40.02 86.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.687 -1.258 . . . . 2.1200000000000001 109.977 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -60.74 -38.01 83.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.923 -1.11 . . . . 1.0800000000000001 108.889 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -40.51 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.429 -0.909 . . . . 1.6799999999999999 108.973 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' B' ' 32' ' ' LYS . 98.9 mt-10 -68.01 -18.61 64.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 1.99 108.88 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -90.03 2.14 55.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.818 . . . . 3.1499999999999999 109.793 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.434 ' O ' ' NZ ' ' A' ' 53' ' ' LYS . . . 104.4 5.26 43.06 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.246 -0.978 . . . . 0.48999999999999999 112.154 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.72 76.89 1.31 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.49 . . . . 0.38 109.144 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -75.43 -8.89 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.104 -0.997 . . . . 0.40999999999999998 110.522 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.13 159.95 40.93 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.067 -1.021 . . . . 2.1499999999999999 110.162 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.93 93.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.647 -0.658 . . . . 1.03 112.542 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.466 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 7.4 p90 -58.66 -17.77 25.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.532 -1.355 . . . . 0.92000000000000004 110.614 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -79.9 -32.76 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.796 -1.19 . . . . 1.0800000000000001 108.286 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 77.2 t -76.0 -39.13 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.216 -1.031 . . . . 1.0700000000000001 108.216 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 tp -60.06 -36.2 76.82 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.876 -1.157 . . . . 1.1499999999999999 107.876 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.68 97.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.028 -1.229 . . . . 0.19 110.028 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.9 -40.02 87.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.094 -1.239 . . . . 1.8200000000000001 109.154 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.95 -40.07 87.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.297 -1.001 . . . . 0.40000000000000002 108.297 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.082 -0.71 . . . . 1.0700000000000001 109.082 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.29 -23.99 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.357 -0.84 . . . . 1.0900000000000001 110.973 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.33 17.58 11.05 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.945 -1.097 . . . . 1.0900000000000001 110.164 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mptt 52.72 29.11 7.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.921 -1.112 . . . . 2.23 109.818 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.0 19.99 9.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.416 -0.803 . . . . 2.7999999999999998 110.208 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.33 117.57 9.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.318 . . . . 1.8 107.739 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.0 -40.92 97.45 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.075 0.769 . . . . 0.88 113.075 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' B' ' 60' ' ' ARG . 7.6 m-20 -69.65 -39.98 76.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.535 -1.353 . . . . 0.73999999999999999 110.056 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.98 -40.0 75.62 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.01 -1.076 . . . . 1.2 108.94 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.48 -49.96 73.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.44 109.68 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' B' ' 57' ' ' ASP . 87.8 mtm180 -60.4 -45.54 93.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.407 -0.808 . . . . 3.3399999999999999 110.62 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.77 -39.78 94.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.957 -1.09 . . . . 2.3799999999999999 108.756 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.446 ' O ' ' OG1' ' B' ' 66' ' ' THR . 63.0 t90 -65.53 -48.75 71.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.40999999999999998 111.383 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -67.26 -47.19 71.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.007 -1.058 . . . . 1.0700000000000001 110.09 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.03 -45.94 92.76 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.389 -0.819 . . . . 2.6000000000000001 109.787 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.03 -27.34 64.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.445 -0.784 . . . . 1.8999999999999999 109.884 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 96.8 m -80.54 -33.84 35.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 1.1000000000000001 111.574 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.1 p -130.63 -27.35 2.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.595 -1.316 . . . . 0.95999999999999996 112.027 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 14.09 22.59 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.154 -1.578 . . . . 0.37 109.154 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.01 153.24 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -1.185 . . . . 1.0900000000000001 109.654 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.62 172.96 8.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.174 -0.954 . . . . 2.3700000000000001 109.728 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.48 -33.34 72.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 1.1100000000000001 110.959 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.02 -39.67 63.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.66 -1.275 . . . . 2.9700000000000002 110.049 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.6 mm100 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 2.6200000000000001 110.675 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.8 t -67.5 -37.48 82.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.851 . . . . 1.8899999999999999 110.004 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' B' ' 75' ' ' ARG . 25.2 mtt-85 -60.36 -37.33 80.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 3.3199999999999998 109.584 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -67.65 -39.93 84.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.698 -1.251 . . . . 0.40000000000000002 110.588 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 86.8 m -67.93 -39.99 83.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.854 -1.154 . . . . 0.95999999999999996 109.809 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.39 -59.98 4.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.95 -1.094 . . . . 0.5 109.967 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.57 -34.52 88.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.452 -1.059 . . . . 0.27000000000000002 110.452 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 49.4 t -71.14 -47.22 59.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -1.179 . . . . 0.93999999999999995 109.832 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.68 -40.13 73.12 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.716 -1.194 . . . . 1.0900000000000001 108.326 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -63.03 -40.1 96.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 3.1899999999999999 109.93 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -69.47 -37.6 77.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.054 -1.029 . . . . 1.9099999999999999 110.482 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.484 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 84.8 t90 -60.02 -43.86 94.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.456 -1.403 . . . . 0.40000000000000002 107.318 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 51.6 m -60.65 -40.66 92.83 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.93 -0.767 . . . . 0.96999999999999997 108.93 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.96 -38.19 85.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.615 -0.678 . . . . 0.55000000000000004 109.626 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.8 -37.75 16.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 1.1299999999999999 110.075 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 85.2 m-85 -104.34 -87.69 0.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.901 . . . . 1.24 110.413 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 16.4 tp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.133 -0.937 . . . . 1.8300000000000001 109.711 -178.544 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.189 0.518 . . . . 6.1100000000000003 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.7 m -82.2 110.42 17.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.069 -1.02 . . . . 3.5800000000000001 109.433 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.9 p -112.0 156.75 21.64 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.431 -0.793 . . . . 1.3200000000000001 109.842 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -84.88 177.74 7.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.232 -0.918 . . . . 1.98 109.15 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -62.16 -22.61 66.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.744 -0.597 . . . . 2.6000000000000001 110.648 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.29 -39.26 89.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 2.5099999999999998 108.998 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -60.1 -50.28 74.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.51000000000000001 110.806 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 8' ' ' ARG . 20.5 mtt-85 -69.94 -35.59 74.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.998 -1.064 . . . . 3.7200000000000002 109.85 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -66.96 -39.79 87.33 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.436 -0.79 . . . . 0.76000000000000001 109.529 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 50.7 t80 -65.25 -45.5 84.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.818 . . . . 0.5 110.194 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.62 5.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.007 -1.058 . . . . 1.1799999999999999 111.55 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.957 -1.089 . . . . 1.1799999999999999 110.319 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.0 pt-20 -152.06 153.15 30.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.374 -0.973 . . . . 1.26 108.374 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 13' ' ' GLU . 58.0 Cg_exo -37.29 155.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.944 1.763 . . . . 0.53000000000000003 111.641 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.522 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 12.6 ptm -92.75 -28.9 16.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 1.1399999999999999 109.968 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.65 -134.99 46.29 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.422 -1.071 . . . . 0.41999999999999998 110.422 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.5 34.5 3.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.64 -0.918 . . . . 0.84999999999999998 110.061 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -58.81 148.76 67.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 2.4900000000000002 108.695 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.81 155.93 35.48 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.086 1.857 . . . . 0.39000000000000001 112.15 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' SER . 13.8 p -58.31 -41.9 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.693 0.759 . . . . 1.1200000000000001 110.167 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -61.51 -2.25 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.103 -1.199 . . . . 0.27000000000000002 110.103 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 20' ' ' VAL . 37.7 t -81.59 -21.17 38.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.728 -1.454 . . . . 1.75 108.919 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.39 138.52 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.369 -0.832 . . . . 1.05 109.652 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -64.17 136.98 57.72 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.948 -0.701 . . . . 1.0600000000000001 109.578 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 -18.41 56.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.572 -1.411 . . . . 0.23000000000000001 109.572 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 mm -99.52 112.0 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.715 -1.217 . . . . 1.0800000000000001 107.715 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.89 -179.05 36.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.649 -1.38 . . . . 0.31 109.649 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 mp0 -57.28 -40.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -1.119 . . . . 2.0099999999999998 109.532 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.9 -45.87 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 1.1399999999999999 109.32 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.89 -39.59 83.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 1.1299999999999999 109.39 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.82 -39.96 96.08 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.96 -1.656 . . . . 0.34999999999999998 108.96 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.91 -39.97 96.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 3.2200000000000002 109.72 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.92 -44.1 77.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 2.1000000000000001 108.809 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.1 mt -64.84 -40.61 95.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 1.0800000000000001 108.64 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.14 -44.15 95.18 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.642 -0.661 . . . . 1.6699999999999999 109.55 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.21 -19.58 66.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.398 -0.814 . . . . 2.0 108.917 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -90.39 3.99 52.19 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.521 -0.737 . . . . 3.1499999999999999 109.981 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.81 48.35 Favored Glycine 0 N--CA 1.502 3.048 0 O-C-N 121.167 -0.958 . . . . 0.47999999999999998 111.579 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -106.51 75.59 1.08 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.714 -1.462 . . . . 0.38 109.55 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.73 -9.9 59.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.074 -1.016 . . . . 0.40999999999999998 110.316 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.2 mmtm -134.87 156.67 48.53 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.203 -0.936 . . . . 2.1600000000000001 110.001 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.65 94.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.63 -0.669 . . . . 1.03 111.233 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 23.6 p90 -58.59 -20.07 43.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.704 -1.248 . . . . 0.92000000000000004 110.951 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -78.58 -34.51 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.643 -1.286 . . . . 1.0700000000000001 108.022 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.32 -38.92 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.187 -1.042 . . . . 1.0600000000000001 108.187 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.09 -38.8 84.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.296 -1.001 . . . . 1.1599999999999999 108.296 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.84 97.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.817 -1.313 . . . . 0.20000000000000001 109.817 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.275 . . . . 1.8200000000000001 109.341 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -59.22 -40.09 84.76 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.296 -1.001 . . . . 0.40000000000000002 108.296 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.08 -38.72 79.16 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.377 -0.972 . . . . 1.0900000000000001 108.377 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.14 -24.61 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 1.0900000000000001 110.251 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.24 16.14 17.39 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.118 -0.989 . . . . 1.0900000000000001 110.678 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.54 40.4 15.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.726 -1.234 . . . . 2.2200000000000002 110.719 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 59.19 19.62 7.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 2.7999999999999998 109.843 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.31 107.01 2.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.743 -1.223 . . . . 1.8 107.994 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.511 ' CD ' HH21 ' A' ' 60' ' ' ARG . 88.1 tt0 -61.75 -40.5 95.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.501 -0.75 . . . . 0.87 112.562 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.63 -40.07 76.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.534 -1.353 . . . . 0.72999999999999998 109.728 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.66 -39.99 76.73 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.726 -1.19 . . . . 1.2 109.199 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.31 -50.14 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.44 109.483 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.511 HH21 ' CD ' ' A' ' 56' ' ' GLU . 34.1 mtt-85 -60.88 -46.12 91.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.372 -0.83 . . . . 3.3399999999999999 110.682 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.04 -38.31 90.59 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.819 -1.175 . . . . 2.3700000000000001 108.841 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.443 ' O ' ' OG1' ' A' ' 66' ' ' THR . 50.8 t90 -66.8 -45.25 78.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.40999999999999998 110.396 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.27 -48.91 68.92 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.149 -0.969 . . . . 1.0800000000000001 110.046 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -62.0 -44.56 96.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.242 -0.911 . . . . 2.6099999999999999 109.257 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.59 -32.39 71.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.567 -0.708 . . . . 1.8999999999999999 109.739 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 86.5 m -79.97 -31.86 39.86 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 1.1100000000000001 111.345 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.32 -30.15 1.53 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.572 -1.33 . . . . 0.96999999999999997 112.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.12 19.89 Favored Glycine 0 N--CA 1.501 3.025 0 N-CA-C 109.196 -1.561 . . . . 0.38 109.196 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.0 152.9 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.242 . . . . 1.1000000000000001 109.467 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -91.9 175.18 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.071 -1.018 . . . . 2.3700000000000001 109.623 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.81 77.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 1.1200000000000001 110.103 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -73.79 -39.97 63.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.109 -0.994 . . . . 2.9700000000000002 109.995 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.85 -36.96 83.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 2.6200000000000001 110.539 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 p -69.22 -37.17 77.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.133 -0.979 . . . . 1.8899999999999999 110.027 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.03 -37.61 80.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.831 -1.168 . . . . 3.3199999999999998 109.707 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.05 -40.0 87.02 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.746 -1.221 . . . . 0.40000000000000002 110.442 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 61.5 m -70.04 -42.5 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.726 -1.234 . . . . 0.95999999999999996 110.398 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -60.14 -60.17 4.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.57 -1.331 . . . . 0.5 110.113 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.86 -34.52 90.03 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.334 -1.106 . . . . 0.27000000000000002 110.334 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.71 -47.91 57.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.726 -1.455 . . . . 0.93999999999999995 109.781 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.11 -40.03 75.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.798 -1.161 . . . . 1.0900000000000001 108.345 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' HG2' HH11 ' A' ' 82' ' ' ARG . 4.6 ttt-85 -61.36 -40.11 93.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 3.1800000000000002 109.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -68.8 -37.42 79.24 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 1.9099999999999999 109.878 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.522 ' CZ2' ' SD ' ' A' ' 15' ' ' MET . 80.4 t90 -59.65 -45.67 91.32 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.94 -1.504 . . . . 0.40000000000000002 106.94 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -61.83 -41.52 97.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.716 -0.615 . . . . 0.96999999999999997 109.46 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -60.27 -37.24 79.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.2 -0.937 . . . . 0.55000000000000004 109.954 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.1 -35.87 19.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 1.1200000000000001 109.888 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -105.7 -86.73 0.47 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.363 -0.836 . . . . 1.24 110.395 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.148 -0.93 . . . . 1.8300000000000001 109.161 -179.348 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.561 -0.533 . . . . 6.0999999999999996 109.561 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 41.8 m -81.95 110.41 17.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.075 -1.016 . . . . 3.5800000000000001 109.357 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.6 p -112.0 156.6 21.88 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.586 -0.696 . . . . 1.3200000000000001 109.997 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 50.4 m -84.63 177.34 8.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.19 -0.944 . . . . 1.97 109.233 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.94 -22.75 65.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.703 -0.623 . . . . 2.5899999999999999 110.671 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -61.21 -39.24 89.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.017 -1.052 . . . . 2.5 108.852 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -60.1 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.51000000000000001 110.746 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' B' ' 8' ' ' ARG . 20.8 mtt-85 -70.05 -35.65 74.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.903 -1.123 . . . . 3.73 109.758 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -66.73 -40.03 88.2 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.638 -0.664 . . . . 0.76000000000000001 109.642 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.431 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 49.7 t80 -64.99 -45.91 83.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.5 110.25 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -88.38 5.71 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.16 -0.962 . . . . 1.1799999999999999 111.48 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.92 -15.98 17.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.881 -1.137 . . . . 1.1799999999999999 110.26 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -152.11 153.26 30.98 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 1.27 108.352 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -37.35 155.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.998 1.798 . . . . 0.53000000000000003 111.584 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.516 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 12.5 ptm -92.77 -28.85 16.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 1.1299999999999999 110.035 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.71 -135.03 46.47 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.357 -1.097 . . . . 0.40999999999999998 110.357 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.61 34.55 3.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.468 -1.019 . . . . 0.83999999999999997 109.944 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -58.75 148.63 67.21 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 2.4900000000000002 108.601 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.76 155.82 35.75 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.06 1.84 . . . . 0.38 112.175 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' B' ' 22' ' ' SER . 14.0 p -58.29 -41.84 82.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.496 -0.753 . . . . 1.1200000000000001 110.093 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.417 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -61.33 -2.31 2.96 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.119 -1.192 . . . . 0.27000000000000002 110.119 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 20' ' ' VAL . 38.7 t -81.73 -21.1 38.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.895 -1.356 . . . . 1.75 108.914 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.31 138.52 58.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 1.0600000000000001 109.676 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.434 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.36 136.94 57.61 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.743 -0.783 . . . . 1.05 109.744 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 -18.34 56.91 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.604 -1.398 . . . . 0.22 109.604 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.52 111.87 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.709 -1.219 . . . . 1.0800000000000001 107.709 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.87 36.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.731 -1.348 . . . . 0.29999999999999999 109.731 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mp0 -57.48 -39.86 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -1.07 . . . . 2.0 109.567 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.05 -45.89 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 1.1399999999999999 109.344 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.88 -39.54 83.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -0.889 . . . . 1.1299999999999999 109.518 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.92 -39.77 95.98 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.915 -1.674 . . . . 0.35999999999999999 108.915 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.05 -40.04 96.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 3.2200000000000002 109.771 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.74 -43.99 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.074 -1.016 . . . . 2.1200000000000001 108.962 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.01 -40.4 94.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 1.0800000000000001 108.699 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.19 -44.27 95.23 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.034 -0.666 . . . . 1.6799999999999999 109.478 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.16 -19.71 66.11 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 1.99 109.016 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -90.35 3.93 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.654 -0.654 . . . . 3.1499999999999999 109.925 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 7.4 48.41 Favored Glycine 0 N--CA 1.502 3.08 0 O-C-N 121.095 -1.003 . . . . 0.48999999999999999 111.697 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.26 75.45 1.09 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.866 -1.373 . . . . 0.38 109.658 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.76 -10.0 59.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.40999999999999998 110.36 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.473 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.3 mmtm -134.68 156.87 48.01 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.136 -0.978 . . . . 2.1499999999999999 109.886 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.71 94.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.754 -0.591 . . . . 1.03 111.242 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 24.0 p90 -58.56 -20.01 42.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.92000000000000004 111.042 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 t -78.68 -34.47 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 1.0800000000000001 107.916 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 74.0 t -76.23 -39.1 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.164 -1.05 . . . . 1.0700000000000001 108.164 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.95 -39.02 84.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.305 -0.998 . . . . 1.1499999999999999 108.305 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -41.05 97.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.845 -1.302 . . . . 0.19 109.845 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.04 -41.94 93.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.112 -1.228 . . . . 1.8200000000000001 109.343 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.26 -40.0 84.62 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 0.40000000000000002 108.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.17 -38.76 78.9 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.434 -0.95 . . . . 1.0700000000000001 108.434 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.16 -24.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.304 -0.872 . . . . 1.0900000000000001 110.194 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.34 16.15 17.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.108 -0.995 . . . . 1.0900000000000001 110.784 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.41 40.64 15.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.698 -1.252 . . . . 2.23 110.73 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 58.93 19.74 7.42 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.468 -0.77 . . . . 2.7999999999999998 109.853 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.28 107.04 2.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.698 -1.251 . . . . 1.8 107.729 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' B' ' 60' ' ' ARG . 88.2 tt0 -61.63 -40.52 95.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.429 -0.794 . . . . 0.88 112.584 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.75 -39.58 76.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.73999999999999999 109.855 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.96 -39.96 75.69 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.685 -1.206 . . . . 1.2 109.025 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.31 -50.32 68.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.44 109.457 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' B' ' 56' ' ' GLU . 34.0 mtt-85 -60.76 -46.19 91.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.815 . . . . 3.3399999999999999 110.572 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.92 -38.34 90.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.854 -1.154 . . . . 2.3799999999999999 108.933 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.459 ' O ' ' OG1' ' B' ' 66' ' ' THR . 51.2 t90 -66.79 -45.24 79.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.40999999999999998 110.415 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.32 -48.79 69.17 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.266 -0.896 . . . . 1.0700000000000001 109.989 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.391 -0.818 . . . . 2.6000000000000001 109.249 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.43 -32.63 71.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.58 -0.7 . . . . 1.8999999999999999 109.684 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 87.5 m -79.66 -31.92 41.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 1.1000000000000001 111.471 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.41 -30.0 1.53 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.436 -1.415 . . . . 0.95999999999999996 112.193 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.73 15.02 19.91 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.138 -1.585 . . . . 0.37 109.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.77 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.245 . . . . 1.0900000000000001 109.416 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -91.83 175.37 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 2.3700000000000001 109.731 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.96 78.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.483 -0.761 . . . . 1.1100000000000001 110.122 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -73.81 -39.78 63.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 2.9700000000000002 109.99 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.03 -36.88 83.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 2.6200000000000001 110.545 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 18.8 p -69.25 -37.23 77.84 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.171 -0.956 . . . . 1.8899999999999999 110.003 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -37.88 80.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 3.3199999999999998 109.593 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.98 -39.84 87.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.502 -1.374 . . . . 0.40000000000000002 110.441 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 61.2 m -70.16 -42.62 72.26 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.69 -1.256 . . . . 0.95999999999999996 110.401 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -59.99 -60.12 4.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.575 -1.328 . . . . 0.5 110.068 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.95 -34.47 90.0 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.368 -1.093 . . . . 0.27000000000000002 110.368 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.52 -48.1 57.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.793 -1.416 . . . . 0.93999999999999995 109.84 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 97.0 mt -70.04 -39.96 75.43 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.799 -1.16 . . . . 1.0900000000000001 108.435 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' B' ' 82' ' ' ARG . 4.7 ttt-85 -61.47 -40.0 92.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 3.1899999999999999 109.515 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.95 -37.23 78.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.379 -0.826 . . . . 1.9099999999999999 109.91 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.516 ' CZ2' ' SD ' ' B' ' 15' ' ' MET . 80.8 t90 -60.0 -45.68 91.93 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.972 -1.492 . . . . 0.40000000000000002 106.972 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 32.7 m -61.83 -41.22 97.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.69 -0.631 . . . . 0.96999999999999997 109.527 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.35 -37.18 79.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.55000000000000004 109.939 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.38 -36.36 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 1.1299999999999999 109.824 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -104.57 -86.24 0.46 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -0.886 . . . . 1.24 110.777 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 11.5 tp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.106 -0.95 . . . . 1.8300000000000001 109.117 -179.246 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.559 ' C ' ' H ' ' A' ' 3' ' ' THR . 26.1 ptt? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.462 -0.569 . . . . 6.1100000000000003 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 65.58 -37.67 0.25 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 3.5800000000000001 110.163 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.559 ' H ' ' C ' ' A' ' 1' ' ' MET . 68.8 p -80.02 169.76 17.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.067 -1.021 . . . . 1.3200000000000001 109.873 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m -75.82 170.05 16.96 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.805 0.812 . . . . 1.98 109.339 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.85 -30.14 68.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.795 -0.566 . . . . 2.6000000000000001 110.598 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.11 -33.67 72.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 2.5099999999999998 108.965 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 23.8 t60 -59.92 -48.75 80.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.51000000000000001 110.088 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -69.88 -34.06 73.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.157 -0.964 . . . . 3.7200000000000002 109.888 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.11 -39.84 82.69 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.383 -0.823 . . . . 0.76000000000000001 109.61 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.4 t80 -61.91 -47.3 85.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.429 -0.794 . . . . 0.5 110.107 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 m -82.19 9.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.154 -0.966 . . . . 1.1799999999999999 110.12 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.94 -16.4 15.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.156 -0.965 . . . . 1.1799999999999999 110.944 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -156.63 152.84 23.42 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.115 . . . . 1.26 109.198 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -40.33 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.702 1.601 . . . . 0.53000000000000003 110.839 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.5 ptp -90.37 -24.76 20.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.825 -1.172 . . . . 1.1399999999999999 109.646 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.22 -136.72 45.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.704 -1.358 . . . . 0.41999999999999998 109.704 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.57 28.93 6.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -1.006 . . . . 0.84999999999999998 111.221 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -60.75 148.44 82.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.709 -1.244 . . . . 2.4900000000000002 107.802 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.19 163.33 32.11 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.151 1.901 . . . . 0.39000000000000001 112.801 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 22' ' ' SER . 8.0 p -58.14 -47.36 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.58 -0.7 . . . . 1.1200000000000001 110.391 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.13 -3.29 0.12 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.783 -0.927 . . . . 0.27000000000000002 110.783 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 20' ' ' VAL . 11.6 p -82.33 -25.3 34.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.799 -1.412 . . . . 1.75 109.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.54 137.82 58.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.708 0.766 . . . . 1.05 109.759 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.92 135.31 55.55 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.692 0.758 . . . . 1.0600000000000001 109.912 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 73' ' ' GLN . . . 96.98 -20.26 51.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.245 -1.542 . . . . 0.23000000000000001 109.245 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.425 HG21 HD12 ' A' ' 26' ' ' ILE . 37.6 mm -99.56 112.82 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.641 -1.244 . . . . 1.0800000000000001 107.641 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.1 177.76 43.06 Favored Glycine 0 N--CA 1.492 2.39 0 O-C-N 120.678 -1.264 . . . . 0.31 110.043 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -56.6 -39.94 74.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -1.033 . . . . 2.0099999999999998 109.643 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.76 -44.98 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.076 -1.015 . . . . 1.1399999999999999 109.496 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.35 -36.92 84.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 1.1299999999999999 109.466 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.82 97.43 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.816 -1.314 . . . . 0.34999999999999998 109.816 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -65.33 -37.03 85.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -1.219 . . . . 3.2200000000000002 109.736 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.59 -48.52 69.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.804 -1.185 . . . . 2.1000000000000001 109.372 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.99 -38.66 89.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 1.0800000000000001 108.448 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.04 -42.19 93.88 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.906 -0.717 . . . . 1.6699999999999999 109.296 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.23 -19.42 65.53 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.533 -0.914 . . . . 2.0 108.533 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 2.83 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.747 . . . . 3.1499999999999999 109.725 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.78 5.46 50.9 Favored Glycine 0 N--CA 1.503 3.132 0 C-N-CA 120.264 -0.969 . . . . 0.47999999999999998 111.856 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -106.56 77.07 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.899 -1.353 . . . . 0.38 108.942 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -79.36 -7.54 58.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.40999999999999998 110.929 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.05 158.58 44.03 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.053 -1.029 . . . . 2.1600000000000001 110.406 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -40.64 90.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.747 -0.595 . . . . 1.03 112.307 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.6 p90 -61.13 -18.49 58.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.499 -1.376 . . . . 0.92000000000000004 110.622 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -80.06 -31.03 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.876 -1.157 . . . . 1.0700000000000001 107.876 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.4 t -77.5 -37.41 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 1.0600000000000001 108.324 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.94 -35.67 75.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.638 -1.245 . . . . 1.1599999999999999 107.638 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.22 96.69 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.573 -1.411 . . . . 0.20000000000000001 109.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.15 -43.32 95.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.942 -1.328 . . . . 1.8200000000000001 109.096 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.98 -41.62 92.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.40000000000000002 109.019 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.94 -40.06 75.72 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.808 -0.757 . . . . 1.0900000000000001 108.966 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -66.11 -22.81 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.218 -0.926 . . . . 1.0900000000000001 110.448 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.95 17.05 9.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.204 -0.935 . . . . 1.0900000000000001 109.777 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.08 -1.013 . . . . 2.2200000000000002 110.346 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.699 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 64.3 mttm 58.85 19.44 7.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.714 -0.616 . . . . 2.7999999999999998 110.011 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -67.74 106.71 2.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.76 -1.213 . . . . 1.8 108.297 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.32 -41.3 98.42 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.406 -0.809 . . . . 0.87 112.631 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 92.5 m-20 -68.99 -39.94 79.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.789 -1.195 . . . . 0.72999999999999998 109.433 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -69.99 -39.9 75.62 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.032 -1.067 . . . . 1.2 108.614 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.26 -50.03 71.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.44 109.772 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.434 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.0 mtm180 -62.45 -44.6 96.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 3.3399999999999999 110.288 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.26 -38.34 90.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 2.3700000000000001 108.989 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.433 ' O ' ' OG1' ' A' ' 66' ' ' THR . 67.6 t90 -63.28 -49.57 73.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.263 -0.898 . . . . 0.40999999999999998 110.853 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 58.1 tp -65.3 -47.43 76.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.84 . . . . 1.0800000000000001 109.874 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -63.45 -45.25 91.72 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.402 -0.811 . . . . 2.6099999999999999 109.274 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -68.43 -34.06 75.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.418 0.628 . . . . 1.8999999999999999 109.592 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 89.7 m -79.72 -33.56 40.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -0.79 . . . . 1.1100000000000001 111.336 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 31.6 p -130.63 -28.95 1.99 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.503 -1.373 . . . . 0.96999999999999997 112.239 -177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.32 25.62 Favored Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.226 -1.55 . . . . 0.38 109.226 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.99 153.0 1.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.122 -1.222 . . . . 1.1000000000000001 109.337 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.08 172.57 8.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 2.3700000000000001 110.036 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.08 78.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 1.1200000000000001 110.487 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.06 -40.4 75.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.738 -1.226 . . . . 2.9700000000000002 109.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 25' ' ' GLY . 94.0 mm-40 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.452 -0.78 . . . . 2.6200000000000001 110.69 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p -66.34 -38.18 87.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.139 -0.975 . . . . 1.8899999999999999 110.039 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -60.17 -38.79 84.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.828 -1.17 . . . . 3.3199999999999998 109.341 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.27 -39.24 82.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.764 -1.21 . . . . 0.40000000000000002 110.444 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -68.09 -40.32 82.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.766 -1.209 . . . . 0.95999999999999996 109.476 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.44 -60.33 3.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.014 -1.054 . . . . 0.5 109.533 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.72 87.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.199 -1.16 . . . . 0.27000000000000002 110.199 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.21 -47.3 65.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.93999999999999995 109.638 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -69.97 -40.02 75.63 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.667 -1.213 . . . . 1.0900000000000001 108.591 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.699 HH12 ' NZ ' ' A' ' 54' ' ' LYS . 8.5 tpm_? -63.71 -41.93 98.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 3.1800000000000002 110.006 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 94.4 mt-10 -69.66 -39.65 76.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 1.9099999999999999 110.665 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 79.1 t90 -60.04 -41.91 93.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.316 -1.49 . . . . 0.40000000000000002 107.7 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -62.82 -40.51 97.63 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.975 -0.75 . . . . 0.96999999999999997 108.975 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD1' ' NH2' ' A' ' 82' ' ' ARG . 96.1 m-20 -60.27 -36.84 78.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.553 -0.717 . . . . 0.55000000000000004 109.905 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.66 -38.29 18.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 1.1200000000000001 109.952 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.602 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 76.3 m-85 -102.59 -84.86 0.45 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.289 -0.882 . . . . 1.24 110.5 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 117.963 -1.018 . . . . 1.8300000000000001 109.932 -178.529 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.563 ' C ' ' H ' ' B' ' 3' ' ' THR . 26.1 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.485 -0.561 . . . . 6.0999999999999996 109.485 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.407 ' H ' ' H1 ' ' B' ' 1' ' ' MET . 1.8 m 65.57 -37.83 0.26 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.458 -0.776 . . . . 3.5800000000000001 110.07 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.563 ' H ' ' C ' ' B' ' 1' ' ' MET . 68.3 p -79.84 169.67 17.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.123 -0.986 . . . . 1.3200000000000001 110.083 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m -75.69 170.01 17.01 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.752 0.787 . . . . 1.97 109.306 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -59.88 -30.15 68.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.925 -0.484 . . . . 2.5899999999999999 110.521 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.07 -33.53 72.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -0.992 . . . . 2.5 109.034 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 23.9 t60 -59.86 -48.89 79.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.074 -1.016 . . . . 0.51000000000000001 110.139 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -69.85 -34.13 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.994 . . . . 3.73 109.882 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.12 -39.85 82.65 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.426 -0.797 . . . . 0.76000000000000001 109.664 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.1 t80 -61.83 -47.51 84.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.5 110.092 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.98 9.92 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.144 -0.972 . . . . 1.1799999999999999 110.242 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.97 -16.45 15.83 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.204 -0.935 . . . . 1.1799999999999999 110.951 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.64 152.83 23.36 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 1.27 109.14 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.25 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.701 1.6 . . . . 0.53000000000000003 110.966 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.6 ptp -90.4 -24.62 20.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.845 -1.159 . . . . 1.1299999999999999 109.658 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.09 -136.68 45.59 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.831 -1.308 . . . . 0.40999999999999998 109.831 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.8 29.04 6.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -1.076 . . . . 0.83999999999999997 111.124 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.72 148.41 82.23 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.667 -1.234 . . . . 2.4900000000000002 107.667 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.19 163.3 32.24 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.204 1.936 . . . . 0.38 112.794 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.525 ' C ' ' H ' ' B' ' 22' ' ' SER . 8.0 p -58.07 -47.47 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.466 0.65 . . . . 1.1200000000000001 110.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.11 -3.31 0.12 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.754 -0.939 . . . . 0.27000000000000002 110.754 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.525 ' H ' ' C ' ' B' ' 20' ' ' VAL . 11.5 p -82.23 -25.32 34.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.817 -1.402 . . . . 1.75 109.495 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.52 137.91 58.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 1.0600000000000001 109.768 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 135.45 55.65 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.795 0.807 . . . . 1.05 109.832 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' B' ' 73' ' ' GLN . . . 96.78 -20.03 52.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.326 -1.51 . . . . 0.22 109.326 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.79 112.72 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.669 -1.234 . . . . 1.0800000000000001 107.669 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.99 177.84 43.28 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.609 -1.282 . . . . 0.29999999999999999 110.108 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.74 -39.89 74.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 2.0 109.601 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.78 -44.9 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.008 -1.058 . . . . 1.1399999999999999 109.484 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.7 mt -66.35 -36.84 83.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 1.1299999999999999 109.472 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.79 97.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.76 -1.336 . . . . 0.35999999999999999 109.76 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -65.34 -36.92 85.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.074 -1.251 . . . . 3.2200000000000002 109.85 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.65 -48.61 68.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.708 -1.245 . . . . 2.1200000000000001 109.321 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.85 -38.67 89.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.06 -1.025 . . . . 1.0800000000000001 108.63 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.94 -42.41 93.93 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.933 -0.707 . . . . 1.6799999999999999 109.228 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -66.95 -19.59 65.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.579 -0.897 . . . . 1.99 108.579 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 3.0 54.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.452 -0.78 . . . . 3.1499999999999999 109.797 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.77 5.47 50.92 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.168 -0.957 . . . . 0.48999999999999999 111.836 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -106.3 77.0 1.18 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.772 -1.428 . . . . 0.38 109.071 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -79.33 -7.47 58.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.905 . . . . 0.40999999999999998 110.914 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.14 158.44 44.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.965 -1.084 . . . . 2.1499999999999999 110.498 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.72 90.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.628 -0.67 . . . . 1.03 112.389 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 7.6 p90 -60.96 -18.61 58.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.526 -1.359 . . . . 0.92000000000000004 110.584 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 16.8 t -79.88 -31.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.964 -1.124 . . . . 1.0800000000000001 107.964 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.61 -37.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.34 -0.985 . . . . 1.0700000000000001 108.34 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.11 -35.71 75.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.505 -1.294 . . . . 1.1499999999999999 107.505 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.33 96.73 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.706 -1.358 . . . . 0.19 109.706 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.03 -43.47 95.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.967 -1.314 . . . . 1.8200000000000001 108.971 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.0 -41.48 92.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.40000000000000002 108.964 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.01 -39.92 75.55 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.864 -0.734 . . . . 1.0700000000000001 109.064 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.37 -22.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 110.339 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -91.92 17.02 9.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.168 -0.958 . . . . 1.0900000000000001 109.734 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.998 -1.064 . . . . 2.23 110.327 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . 0.701 ' NZ ' HH12 ' B' ' 82' ' ' ARG . 64.3 mttm 58.66 19.63 6.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.729 -0.607 . . . . 2.7999999999999998 110.058 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.75 106.67 2.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.614 -1.304 . . . . 1.8 108.201 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.41 -41.3 98.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.379 -0.826 . . . . 0.88 112.523 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 92.3 m-20 -68.86 -39.84 79.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.886 -1.133 . . . . 0.73999999999999999 109.49 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.06 -40.02 75.32 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 119.063 -1.055 . . . . 1.2 108.578 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -63.16 -50.05 71.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.44 109.842 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 82.9 mtm180 -62.3 -44.94 95.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.366 -0.834 . . . . 3.3399999999999999 110.342 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.03 -38.45 90.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.988 -1.07 . . . . 2.3799999999999999 109.042 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.444 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.7 t90 -63.4 -49.4 73.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.40999999999999998 110.818 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.496 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 57.7 tp -65.3 -47.39 76.75 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.342 -0.849 . . . . 1.0700000000000001 109.953 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -63.42 -45.19 92.14 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.317 -0.864 . . . . 2.6000000000000001 109.387 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 35.5 t0 -68.61 -33.78 74.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.735 -0.603 . . . . 1.8999999999999999 109.607 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 90.4 m -79.88 -33.64 39.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 1.1000000000000001 111.249 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 31.6 p -130.57 -29.04 1.99 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.526 -1.359 . . . . 0.95999999999999996 112.272 -177.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.13 26.09 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.205 -1.558 . . . . 0.37 109.205 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.91 152.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.096 -1.238 . . . . 1.0900000000000001 109.409 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.03 172.62 8.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.068 -1.02 . . . . 2.3700000000000001 110.041 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.19 79.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.674 . . . . 1.1100000000000001 110.548 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.04 -40.39 75.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.839 -1.163 . . . . 2.9700000000000002 109.705 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' B' ' 25' ' ' GLY . 93.8 mm-40 -67.54 -39.55 85.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.444 -0.785 . . . . 2.6200000000000001 110.757 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -66.09 -38.23 87.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.161 -0.962 . . . . 1.8899999999999999 110.106 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.09 -39.02 84.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.723 -1.235 . . . . 3.3199999999999998 109.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.2 -39.3 82.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.842 -1.161 . . . . 0.40000000000000002 110.439 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.2 -40.22 82.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.752 -1.217 . . . . 0.95999999999999996 109.472 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -60.47 -60.08 4.38 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.95 -1.094 . . . . 0.5 109.649 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.24 -35.63 88.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.275 -1.13 . . . . 0.27000000000000002 110.275 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.03 -47.34 65.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.93999999999999995 109.778 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.07 -40.28 75.14 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.735 -1.186 . . . . 1.0900000000000001 108.529 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.701 HH12 ' NZ ' ' B' ' 54' ' ' LYS . 8.5 tpm_? -63.4 -41.91 98.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 3.1899999999999999 110.083 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 94.4 mt-10 -69.77 -39.6 76.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.816 -1.178 . . . . 1.9099999999999999 110.775 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.609 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 79.7 t90 -59.96 -42.08 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.436 -1.415 . . . . 0.40000000000000002 107.534 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 67.4 m -62.74 -40.44 97.23 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.056 -0.72 . . . . 0.96999999999999997 109.056 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' B' ' 82' ' ' ARG . 96.2 m-20 -60.27 -36.9 78.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.552 -0.717 . . . . 0.55000000000000004 109.781 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.72 -38.43 18.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 1.1299999999999999 110.06 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 76.3 m-85 -102.25 -84.94 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.311 -0.868 . . . . 1.24 110.547 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 118.012 -0.994 . . . . 1.8300000000000001 109.911 -178.529 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.433 -0.58 . . . . 6.1100000000000003 109.433 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.1 m -89.94 96.17 10.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.113 -0.992 . . . . 3.5800000000000001 108.72 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.3 p -112.12 164.26 13.37 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.56 0.695 . . . . 1.3200000000000001 110.215 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t -73.11 173.3 9.58 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.6 0.714 . . . . 1.98 109.49 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -54.55 -18.84 4.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.641 -0.662 . . . . 2.6000000000000001 110.266 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -59.99 -37.09 78.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 2.5099999999999998 109.75 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -59.88 -50.83 72.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.007 -1.058 . . . . 0.51000000000000001 110.597 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -69.87 -33.28 72.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.068 -1.02 . . . . 3.7200000000000002 109.881 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.37 -39.7 77.9 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.276 -0.89 . . . . 0.76000000000000001 109.317 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.8 t80 -63.86 -48.52 76.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.525 -0.734 . . . . 0.5 110.433 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.6 11.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 1.1799999999999999 110.464 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.64 -12.62 14.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.243 -0.911 . . . . 1.1799999999999999 109.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.04 151.23 22.54 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 1.26 109.395 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -42.12 157.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.738 1.625 . . . . 0.53000000000000003 110.994 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.05 -23.24 18.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.847 -1.158 . . . . 1.1399999999999999 109.922 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.77 -138.59 48.21 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.981 -1.247 . . . . 0.41999999999999998 109.981 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.58 29.33 5.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.501 -0.999 . . . . 0.84999999999999998 110.042 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -60.02 148.98 76.0 Favored Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 107.83 -1.174 . . . . 2.4900000000000002 107.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.16 160.93 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.326 2.017 . . . . 0.39000000000000001 113.257 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.3 p -57.29 -49.08 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.739 -0.601 . . . . 1.1200000000000001 110.096 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.22 -2.78 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.223 -1.151 . . . . 0.27000000000000002 110.223 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 20' ' ' VAL . 22.1 p -81.49 -24.68 36.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.33 . . . . 1.75 108.511 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.43 139.73 58.57 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.783 0.802 . . . . 1.05 109.579 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -65.81 134.12 52.42 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.831 0.824 . . . . 1.0600000000000001 110.16 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.98 -20.51 48.74 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.925 -1.67 . . . . 0.23000000000000001 108.925 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 26' ' ' ILE . 30.1 mm -99.89 116.8 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.764 -1.198 . . . . 1.0800000000000001 107.764 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.3 177.4 39.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.669 -1.372 . . . . 0.31 109.669 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.49 -39.84 73.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.54 -0.976 . . . . 2.0099999999999998 109.539 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.13 -42.67 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 1.1399999999999999 109.447 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.4 -40.06 81.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.214 -0.929 . . . . 1.1299999999999999 109.438 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.99 97.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.34999999999999998 109.583 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.29 -39.97 94.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.4 -1.059 . . . . 3.2200000000000002 110.058 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.84 -49.94 68.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.832 -1.168 . . . . 2.1000000000000001 109.599 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.5 mt -60.03 -39.45 85.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 1.0800000000000001 108.966 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.02 -44.5 94.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.723 . . . . 1.6699999999999999 110.533 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.76 -19.07 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 2.0 109.113 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 37' ' ' ARG . 27.1 mtt-85 -89.97 1.93 55.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.794 -0.762 . . . . 3.1499999999999999 110.52 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.43 4.37 34.95 Favored Glycine 0 N--CA 1.506 3.353 0 O-C-N 121.019 -1.051 . . . . 0.47999999999999998 112.006 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.08 73.81 1.07 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.794 -1.415 . . . . 0.38 108.659 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -80.07 -10.0 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.40999999999999998 110.515 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 29.8 mmtp -130.82 152.68 49.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.171 -0.955 . . . . 2.1600000000000001 109.424 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.393 -0.817 . . . . 1.03 111.55 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 22.5 p90 -56.15 -17.61 7.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.711 -1.243 . . . . 0.92000000000000004 110.32 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.66 -33.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.832 -1.167 . . . . 1.0700000000000001 108.073 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.2 t -76.88 -39.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.266 -1.013 . . . . 1.0600000000000001 108.266 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.03 -38.07 81.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.578 -1.267 . . . . 1.1599999999999999 107.578 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.98 -41.12 96.21 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.552 -1.419 . . . . 0.20000000000000001 109.552 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -59.9 -43.29 94.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.252 . . . . 1.8200000000000001 108.456 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.02 -39.93 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.40000000000000002 108.725 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.72 -40.01 76.5 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.509 -0.923 . . . . 1.0900000000000001 108.509 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.81 -26.01 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 1.0900000000000001 110.198 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.01 13.63 14.32 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.16 -0.962 . . . . 1.0900000000000001 110.166 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER 48.95 51.63 15.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.881 -1.137 . . . . 2.2200000000000002 110.312 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.76 20.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.945 -1.097 . . . . 2.7999999999999998 110.913 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-20 -65.33 105.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.937 -1.505 . . . . 1.8 106.937 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.43 -40.27 93.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.361 -0.837 . . . . 0.87 112.62 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.77 -40.03 76.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.256 -1.527 . . . . 0.72999999999999998 109.823 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.3 -40.07 74.45 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.944 -1.102 . . . . 1.2 109.2 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.9 -50.03 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.44 109.402 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.79 -45.01 94.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.437 -0.79 . . . . 3.3399999999999999 109.896 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 65' ' ' ASP . 8.3 tm-20 -64.88 -39.99 94.4 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.159 -0.963 . . . . 2.3700000000000001 108.706 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.445 ' O ' ' OG1' ' A' ' 66' ' ' THR . 63.2 t90 -65.25 -48.02 74.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.40999999999999998 110.866 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.66 -45.88 73.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.208 -0.932 . . . . 1.0800000000000001 110.558 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.65 -48.5 79.07 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.167 -0.958 . . . . 2.6099999999999999 110.213 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 61' ' ' GLU . 57.2 m-20 -70.06 -24.75 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.807 . . . . 1.8999999999999999 110.066 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 27.0 m -79.62 -34.51 40.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.143 -0.973 . . . . 1.1100000000000001 111.236 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -132.91 -19.84 2.25 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.483 -1.386 . . . . 0.96999999999999997 111.899 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.8 11.5 43.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.137 -1.585 . . . . 0.38 109.137 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.68 1.6 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 1.1000000000000001 109.248 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.461 ' H ' HE21 ' A' ' 73' ' ' GLN . 26.9 t-20 -89.26 170.02 10.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 2.3700000000000001 109.817 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -34.36 73.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.562 -0.711 . . . . 1.1200000000000001 110.552 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -71.66 -39.97 69.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.64 -1.287 . . . . 2.9700000000000002 110.222 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.461 HE21 ' H ' ' A' ' 70' ' ' ASN . 37.4 mt-30 -68.61 -37.98 80.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.43 -0.794 . . . . 2.6200000000000001 110.722 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.9 m -67.41 -38.0 83.93 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.048 -1.032 . . . . 1.8899999999999999 109.958 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.01 -38.06 81.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 3.3199999999999998 109.476 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -68.33 -39.93 81.77 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.705 -1.247 . . . . 0.40000000000000002 110.349 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 66.9 m -66.97 -39.97 87.35 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.82 -1.175 . . . . 0.95999999999999996 108.968 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.15 -60.73 3.39 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.984 -1.073 . . . . 0.5 109.822 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.03 88.82 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.507 -1.037 . . . . 0.27000000000000002 110.507 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.28 -49.88 52.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.432 . . . . 0.93999999999999995 109.625 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.01 -39.99 75.5 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.983 -1.087 . . . . 1.0900000000000001 109.019 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -63.01 -40.05 96.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 3.1800000000000002 110.186 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.049 -1.032 . . . . 1.9099999999999999 109.924 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 71.0 t90 -59.91 -42.76 94.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.437 -1.32 . . . . 0.40000000000000002 107.437 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.415 ' O ' ' OXT' ' A' ' 89' ' ' LEU . 92.1 m -63.94 -40.01 95.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 0.96999999999999997 108.968 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.39 -37.99 82.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.425 -0.797 . . . . 0.55000000000000004 109.678 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.13 17.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 1.1200000000000001 109.938 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 73.0 m-85 -98.93 -82.2 0.44 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.165 -0.959 . . . . 1.24 110.311 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' OXT' ' O ' ' A' ' 85' ' ' CYS . 18.5 tp . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.989 -1.005 . . . . 1.8300000000000001 110.217 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.502 -0.555 . . . . 6.0999999999999996 109.502 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m -89.86 96.18 10.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.082 -1.011 . . . . 3.5800000000000001 108.778 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 77.7 p -112.12 164.4 13.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.553 -0.717 . . . . 1.3200000000000001 110.282 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 28.4 t -73.2 173.28 9.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.468 -0.77 . . . . 1.97 109.466 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -54.63 -18.87 5.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.634 -0.666 . . . . 2.5899999999999999 110.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -60.02 -36.89 78.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.055 -1.028 . . . . 2.5 109.701 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -60.11 -50.58 73.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.995 -1.066 . . . . 0.51000000000000001 110.571 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -70.16 -33.14 71.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.018 -1.051 . . . . 3.73 109.758 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -69.43 -39.59 77.75 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.307 -0.871 . . . . 0.76000000000000001 109.288 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.4 t80 -63.96 -48.52 76.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.5 110.462 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -83.51 11.11 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.029 -1.044 . . . . 1.1799999999999999 110.423 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.54 -12.67 14.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.316 -0.865 . . . . 1.1799999999999999 109.793 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.04 151.14 22.36 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.065 -1.022 . . . . 1.27 109.329 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -42.16 157.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.705 1.603 . . . . 0.53000000000000003 110.926 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.2 ptp -93.01 -23.3 18.72 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.872 -1.143 . . . . 1.1299999999999999 109.958 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.11 -138.48 48.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.081 -1.208 . . . . 0.40999999999999998 110.081 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.82 29.34 5.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.83999999999999997 110.051 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.93 148.88 75.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 107.823 -1.177 . . . . 2.4900000000000002 107.823 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.99 161.1 38.29 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.285 1.99 . . . . 0.38 113.236 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.504 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.4 p -57.36 -49.15 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.568 0.699 . . . . 1.1200000000000001 110.146 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.04 -3.05 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.259 -1.136 . . . . 0.27000000000000002 110.259 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.504 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.2 p -81.35 -24.4 37.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.955 -1.32 . . . . 1.75 108.53 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.61 139.69 58.64 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.823 0.821 . . . . 1.0600000000000001 109.581 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.435 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -65.65 134.14 52.62 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.776 0.798 . . . . 1.05 110.173 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -20.92 46.95 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.883 -1.687 . . . . 0.22 108.883 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.411 HD13 HG21 ' B' ' 26' ' ' ILE . 30.1 mm -99.6 116.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.916 -1.142 . . . . 1.0800000000000001 107.916 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.3 177.48 39.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.679 -1.368 . . . . 0.29999999999999999 109.679 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -56.41 -39.92 73.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.455 -1.027 . . . . 2.0 109.553 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.15 -42.68 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 1.1399999999999999 109.438 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.42 -39.91 81.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.219 -0.925 . . . . 1.1299999999999999 109.528 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.76 -39.91 97.38 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.35999999999999999 109.591 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.33 -39.98 94.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -1.108 . . . . 3.2200000000000002 110.049 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.82 -49.99 68.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.837 -1.164 . . . . 2.1200000000000001 109.552 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.02 -39.45 85.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 1.0800000000000001 108.893 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.05 -44.38 94.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 1.6799999999999999 110.501 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.95 -18.91 65.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.031 -1.043 . . . . 1.99 109.152 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' B' ' 37' ' ' ARG . 27.6 mtt-85 -90.0 1.62 56.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.466 -0.771 . . . . 3.1499999999999999 110.507 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.91 4.27 33.9 Favored Glycine 0 N--CA 1.506 3.309 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 112.024 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -105.08 73.87 1.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.81 -1.406 . . . . 0.38 108.755 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.1 -10.03 59.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.40999999999999998 110.405 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.464 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 29.8 mmtp -130.79 152.59 49.97 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.224 -0.922 . . . . 2.1499999999999999 109.493 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.95 92.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.529 -0.732 . . . . 1.03 111.501 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.464 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 22.8 p90 -56.1 -17.46 7.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.733 -1.23 . . . . 0.92000000000000004 110.418 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.3 t -79.7 -33.34 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.819 -1.176 . . . . 1.0800000000000001 108.039 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.2 t -76.68 -39.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.262 -1.014 . . . . 1.0700000000000001 108.262 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.8 tp -60.08 -37.6 80.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.534 -1.284 . . . . 1.1499999999999999 107.534 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 -41.04 96.54 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.627 -1.389 . . . . 0.19 109.627 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -60.07 -43.24 95.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.274 . . . . 1.8200000000000001 108.397 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.40000000000000002 108.794 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.74 -39.91 76.48 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 1.0700000000000001 108.617 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.85 -26.1 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.312 -0.868 . . . . 1.0900000000000001 110.193 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.93 13.49 14.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.197 -0.939 . . . . 1.0900000000000001 110.131 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 49.01 51.73 15.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.771 -1.205 . . . . 2.23 110.185 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.79 20.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.833 -1.167 . . . . 2.7999999999999998 110.954 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 53' ' ' LYS . 71.1 m-20 -65.5 105.34 1.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.946 -1.501 . . . . 1.8 106.946 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.42 -40.03 92.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.241 -0.912 . . . . 0.88 112.674 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.99 -39.95 75.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.342 -1.474 . . . . 0.73999999999999999 109.865 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.38 -39.94 74.27 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.846 -1.142 . . . . 1.2 109.298 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.86 -49.94 70.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.44 109.433 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.98 -44.82 94.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.461 -0.774 . . . . 3.3399999999999999 109.821 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.444 ' OE2' ' OD2' ' B' ' 65' ' ' ASP . 8.3 tm-20 -64.93 -40.1 94.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.111 -0.993 . . . . 2.3799999999999999 108.745 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' B' ' 66' ' ' THR . 63.3 t90 -65.11 -48.1 74.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.40999999999999998 110.92 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.0 tp -67.79 -45.64 74.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.28 -0.888 . . . . 1.0700000000000001 110.572 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.84 -48.48 78.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.191 -0.943 . . . . 2.6000000000000001 110.162 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.444 ' OD2' ' OE2' ' B' ' 61' ' ' GLU . 57.3 m-20 -69.96 -24.84 63.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 1.8999999999999999 110.119 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 29.5 m -79.59 -34.34 40.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.996 . . . . 1.1000000000000001 111.33 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -133.02 -19.91 2.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.548 -1.345 . . . . 0.95999999999999996 111.802 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.75 11.51 43.53 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.116 -1.594 . . . . 0.37 109.116 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.08 152.87 1.55 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.998 -1.295 . . . . 1.0900000000000001 109.166 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.467 ' H ' HE21 ' B' ' 73' ' ' GLN . 27.0 t-20 -89.43 169.98 10.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.058 . . . . 2.3700000000000001 109.843 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.42 73.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.58 -0.7 . . . . 1.1100000000000001 110.507 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.63 -39.97 70.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.703 -1.248 . . . . 2.9700000000000002 110.202 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.467 HE21 ' H ' ' B' ' 70' ' ' ASN . 37.2 mt-30 -68.68 -37.99 80.02 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.815 . . . . 2.6200000000000001 110.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -67.27 -38.12 84.57 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.036 -1.04 . . . . 1.8899999999999999 109.911 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 -60.05 -38.1 81.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 3.3199999999999998 109.441 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.12 -39.98 82.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.77 -1.206 . . . . 0.40000000000000002 110.348 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 67.2 m -67.01 -39.96 87.2 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.735 -1.228 . . . . 0.95999999999999996 109.053 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.05 -60.82 3.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.984 -1.072 . . . . 0.5 109.867 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.13 -34.15 89.14 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.504 -1.038 . . . . 0.27000000000000002 110.504 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.29 -49.8 52.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.825 -1.397 . . . . 0.93999999999999995 109.713 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.98 -40.0 75.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.987 -1.085 . . . . 1.0900000000000001 108.969 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -63.11 -40.03 96.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.172 -0.955 . . . . 3.1899999999999999 110.144 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.2 -36.72 77.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 1.9099999999999999 109.882 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.533 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 71.8 t90 -59.95 -42.64 94.49 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.449 -1.315 . . . . 0.40000000000000002 107.449 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.409 ' O ' ' OXT' ' B' ' 89' ' ' LEU . 92.6 m -64.11 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 0.96999999999999997 108.952 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.25 -38.21 82.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.758 . . . . 0.55000000000000004 109.578 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.46 -39.69 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 1.1299999999999999 110.01 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.533 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.6 m-85 -97.84 -82.49 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 1.24 110.495 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.409 ' OXT' ' O ' ' B' ' 85' ' ' CYS . 18.4 tp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.975 -1.012 . . . . 1.8300000000000001 110.065 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.274 0.559 . . . . 6.1100000000000003 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.3 p -91.0 98.6 11.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.103 -0.998 . . . . 3.5800000000000001 109.121 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.7 p -97.99 162.19 13.35 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.247 -0.908 . . . . 1.3200000000000001 109.738 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.1 t -69.59 164.92 22.22 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.834 0.826 . . . . 1.98 109.324 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.48 -28.69 67.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.753 -0.592 . . . . 2.6000000000000001 109.95 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.02 -36.9 78.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.939 . . . . 2.5099999999999998 109.456 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -59.25 -50.08 75.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.041 -1.037 . . . . 0.51000000000000001 110.064 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.98 -34.41 73.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.192 -0.943 . . . . 3.7200000000000002 110.096 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 91.3 m-20 -67.8 -39.31 84.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.255 -0.903 . . . . 0.76000000000000001 109.447 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -60.03 -47.45 85.8 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.481 -0.888 . . . . 0.5 109.369 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 m -83.76 10.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.026 -1.047 . . . . 1.1799999999999999 110.483 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.6 -19.04 17.04 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.012 -1.055 . . . . 1.1799999999999999 110.91 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -156.95 152.93 23.01 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.886 -1.133 . . . . 1.26 108.606 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' GLU . 55.0 Cg_exo -36.47 150.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.012 1.808 . . . . 0.53000000000000003 111.867 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.0 ptm -89.51 -22.74 22.28 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.041 -1.037 . . . . 1.1399999999999999 110.503 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.08 -134.61 40.65 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.101 -1.047 . . . . 0.41999999999999998 110.593 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.98 35.14 3.5 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.99 . . . . 0.84999999999999998 110.557 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -58.55 147.85 68.19 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 120.781 -1.199 . . . . 2.4900000000000002 107.97 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.25 153.69 51.43 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.996 1.797 . . . . 0.39000000000000001 112.08 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.23 -42.03 63.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.544 -0.723 . . . . 1.1200000000000001 109.933 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.12 -3.6 5.15 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.281 -1.128 . . . . 0.27000000000000002 110.281 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -83.33 -21.0 33.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.888 -1.36 . . . . 1.75 109.242 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.14 137.73 58.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 1.05 109.68 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -62.98 133.89 55.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.754 0.788 . . . . 1.0600000000000001 109.841 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 96.89 -17.34 59.44 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.167 -1.573 . . . . 0.23000000000000001 109.167 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 26' ' ' ILE . 34.3 mm -101.17 114.79 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -1.128 . . . . 1.0800000000000001 108.094 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.76 178.55 36.48 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.724 -1.351 . . . . 0.31 109.724 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.23 -40.01 73.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -1.148 . . . . 2.0099999999999998 109.958 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.28 -44.44 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.974 -1.079 . . . . 1.1399999999999999 109.545 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.29 -38.35 87.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 1.1299999999999999 109.707 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.98 94.5 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.37 -1.492 . . . . 0.34999999999999998 109.37 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.96 -40.0 90.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -1.09 . . . . 3.2200000000000002 110.594 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.19 -45.35 73.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.738 -1.226 . . . . 2.1000000000000001 109.632 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.49 -39.96 95.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.073 -1.017 . . . . 1.0800000000000001 108.59 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.14 -40.82 91.15 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.809 -0.756 . . . . 1.6699999999999999 109.605 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.17 -19.55 65.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.332 -0.988 . . . . 2.0 108.332 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.6 OUTLIER -91.12 6.39 45.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.649 -0.657 . . . . 3.1499999999999999 110.043 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.62 9.23 53.33 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.256 -0.973 . . . . 0.47999999999999998 111.899 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -106.26 74.52 1.04 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.764 -1.433 . . . . 0.38 109.312 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -79.96 -9.74 59.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.40999999999999998 110.522 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.1 mmtm -132.72 154.97 49.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.088 -1.008 . . . . 2.1600000000000001 109.559 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.92 94.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.657 -0.652 . . . . 1.03 111.071 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 21.6 p90 -57.39 -18.85 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.758 -1.214 . . . . 0.92000000000000004 110.7 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -79.27 -34.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.619 -1.301 . . . . 1.0700000000000001 107.976 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.75 -39.96 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.472 -0.936 . . . . 1.0600000000000001 108.472 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.98 -38.33 82.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.623 -1.251 . . . . 1.1599999999999999 107.623 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.97 97.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.664 -1.374 . . . . 0.20000000000000001 109.664 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 1.8200000000000001 109.37 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.97 -40.03 87.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.098 -1.075 . . . . 0.40000000000000002 108.098 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.7 -39.0 77.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.666 -0.813 . . . . 1.0900000000000001 108.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.34 -24.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 1.0900000000000001 110.147 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.57 15.2 14.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.172 -0.955 . . . . 1.0900000000000001 110.252 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt 48.82 42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.732 -1.23 . . . . 2.2200000000000002 110.866 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 56.76 19.41 4.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.389 -0.819 . . . . 2.7999999999999998 109.5 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.82 107.02 2.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.718 -1.239 . . . . 1.8 108.123 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -40.52 97.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.87 112.342 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.11 -39.96 78.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.363 -1.461 . . . . 0.72999999999999998 109.724 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.47 -39.99 73.91 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.917 -1.113 . . . . 1.2 108.987 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.9 -49.88 70.92 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.856 . . . . 0.44 109.668 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.22 -46.29 91.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.347 -0.846 . . . . 3.3399999999999999 110.443 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.35 -39.89 94.78 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.064 -1.022 . . . . 2.3700000000000001 108.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.449 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.2 t90 -63.23 -49.49 73.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.269 -0.894 . . . . 0.40999999999999998 110.93 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 59.1 tp -66.98 -49.64 64.76 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 1.0800000000000001 109.784 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HZ3' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -61.72 -47.25 86.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.765 . . . . 2.6099999999999999 110.007 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.9 t0 -68.45 -29.62 68.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.521 -0.737 . . . . 1.8999999999999999 109.838 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.9 m -80.45 -32.91 37.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 1.1100000000000001 111.562 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 25.2 p -131.65 -28.77 1.79 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.52 -1.363 . . . . 0.96999999999999997 111.982 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.56 14.1 20.68 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.059 -1.616 . . . . 0.38 109.059 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.89 153.28 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.014 -1.286 . . . . 1.1000000000000001 109.362 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.54 170.15 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.1 -1.0 . . . . 2.3700000000000001 109.654 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.23 70.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 1.1200000000000001 110.727 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.18 -40.1 68.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 2.9700000000000002 109.734 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.2 mm100 -67.71 -38.3 83.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.349 -0.844 . . . . 2.6200000000000001 110.236 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -68.45 -37.74 80.49 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.907 . . . . 1.8899999999999999 110.02 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.56 -38.8 85.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 3.3199999999999998 109.412 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -68.46 -39.94 81.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.624 -1.298 . . . . 0.40000000000000002 110.318 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 93.7 m -68.4 -39.98 81.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.143 . . . . 0.95999999999999996 109.171 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.69 -60.1 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.771 -1.206 . . . . 0.5 109.779 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.29 -34.42 89.16 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.298 -1.121 . . . . 0.27000000000000002 110.298 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.32 -46.58 60.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.847 -1.384 . . . . 0.93999999999999995 109.705 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -70.32 -40.56 74.11 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.793 -1.163 . . . . 1.0900000000000001 108.432 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -64.54 -39.98 94.75 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.84 . . . . 3.1800000000000002 110.448 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -68.73 -37.64 79.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.983 -1.073 . . . . 1.9099999999999999 109.758 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.592 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.4 t90 -60.01 -45.54 92.41 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.431 -1.322 . . . . 0.40000000000000002 107.431 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.411 ' O ' ' O ' ' A' ' 89' ' ' LEU . 75.6 m -60.74 -40.02 90.87 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.808 -0.812 . . . . 0.96999999999999997 108.808 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.43 -37.76 81.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.55000000000000004 109.739 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.61 -36.86 18.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 1.1200000000000001 109.934 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 -103.74 -85.26 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 1.24 110.226 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 85' ' ' CYS . 24.4 tp . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.086 -0.959 . . . . 1.8300000000000001 109.63 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.284 0.564 . . . . 6.0999999999999996 109.598 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 69.0 p -91.17 98.85 11.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 3.5800000000000001 109.144 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -98.23 162.35 13.24 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.313 -0.867 . . . . 1.3200000000000001 109.642 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 35.8 t -69.66 165.02 22.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 1.97 109.426 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.71 -28.5 67.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.761 -0.587 . . . . 2.5899999999999999 109.905 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -59.99 -37.03 78.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 2.5 109.483 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -59.32 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.101 -1.0 . . . . 0.51000000000000001 109.974 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.96 -34.53 73.53 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.073 -1.017 . . . . 3.73 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . 0.447 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 91.6 m-20 -67.72 -39.26 84.33 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.223 -0.923 . . . . 0.76000000000000001 109.413 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -59.91 -47.6 85.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.434 -0.906 . . . . 0.5 109.39 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.67 10.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.168 -0.957 . . . . 1.1799999999999999 110.512 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -19.04 17.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 1.1799999999999999 110.981 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' B' ' 9' ' ' ASP . 0.0 OUTLIER -156.92 152.93 23.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.831 -1.168 . . . . 1.27 108.603 179.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' B' ' 13' ' ' GLU . 54.8 Cg_exo -36.36 150.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.088 1.859 . . . . 0.53000000000000003 111.86 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 8.0 ptm -89.38 -22.61 22.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.114 -0.991 . . . . 1.1299999999999999 110.539 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.19 -134.63 41.06 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.918 -1.114 . . . . 0.40999999999999998 110.63 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.02 35.04 3.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.471 -1.017 . . . . 0.83999999999999997 110.552 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -58.4 147.79 66.97 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 120.76 -1.213 . . . . 2.4900000000000002 108.04 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.28 153.48 52.98 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.019 1.813 . . . . 0.38 112.161 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p -54.96 -42.07 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 1.1200000000000001 110.03 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.15 -3.68 5.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.263 -1.135 . . . . 0.27000000000000002 110.263 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -83.08 -21.1 33.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.897 -1.355 . . . . 1.75 109.261 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.15 137.83 58.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 1.0600000000000001 109.662 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -62.97 133.81 55.21 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.62 0.724 . . . . 1.05 109.833 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 96.99 -17.48 59.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.084 -1.607 . . . . 0.22 109.084 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.424 HD11 HG22 ' B' ' 26' ' ' ILE . 34.3 mm -101.01 114.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -1.101 . . . . 1.0800000000000001 108.212 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.62 178.56 36.68 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.725 -1.35 . . . . 0.29999999999999999 109.725 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.27 -40.09 73.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -1.115 . . . . 2.0 109.948 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.22 -44.34 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.02 -1.05 . . . . 1.1399999999999999 109.566 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 1.1299999999999999 109.657 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.53 -39.05 94.49 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.343 -1.503 . . . . 0.35999999999999999 109.343 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.99 -40.03 90.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 3.2200000000000002 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.27 -45.41 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.664 -1.272 . . . . 2.1200000000000001 109.533 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.25 -40.03 96.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.092 -1.005 . . . . 1.0800000000000001 108.673 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.05 -40.87 90.91 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.859 -0.736 . . . . 1.6799999999999999 109.634 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.19 -19.49 65.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.353 -0.98 . . . . 1.99 108.353 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.6 OUTLIER -91.14 6.25 45.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.648 -0.657 . . . . 3.1499999999999999 110.029 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 9.34 52.97 Favored Glycine 0 N--CA 1.501 3.027 0 O-C-N 121.141 -0.975 . . . . 0.48999999999999999 111.834 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -106.22 74.12 1.02 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.761 -1.434 . . . . 0.38 109.323 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 -9.97 59.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.912 . . . . 0.40999999999999998 110.534 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.481 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.0 mmtm -132.57 154.94 49.51 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.206 -0.934 . . . . 2.1499999999999999 109.581 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.02 95.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.655 -0.653 . . . . 1.03 111.112 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.481 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 20.2 p90 -57.27 -18.72 17.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.238 . . . . 0.92000000000000004 110.672 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 24.7 t -79.38 -34.24 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.58 -1.325 . . . . 1.0800000000000001 108.001 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 75.0 t -77.77 -39.95 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.477 -0.934 . . . . 1.0700000000000001 108.477 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.07 -38.12 81.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 1.1499999999999999 107.628 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.88 97.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.759 -1.336 . . . . 0.19 109.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -40.04 88.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -1.18 . . . . 1.8200000000000001 109.336 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.85 -40.05 87.28 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.107 -1.071 . . . . 0.40000000000000002 108.107 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.74 -38.65 76.92 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.609 -0.836 . . . . 1.0700000000000001 108.836 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.76 -24.17 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.178 -0.951 . . . . 1.0900000000000001 110.086 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.38 14.87 15.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.058 -1.026 . . . . 1.0900000000000001 110.262 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 49.19 42.24 21.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.772 -1.205 . . . . 2.23 110.824 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 81.5 mttt 57.14 19.6 4.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 2.7999999999999998 109.484 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.02 107.08 2.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.701 -1.249 . . . . 1.8 108.14 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -40.2 96.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.43 -0.794 . . . . 0.88 112.39 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.39 -40.04 77.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.252 -1.53 . . . . 0.73999999999999999 109.702 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.3 -40.07 74.47 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.924 -1.11 . . . . 1.2 109.024 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.74 -49.99 70.86 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.44 109.662 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.36 -45.96 92.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.459 -0.776 . . . . 3.3399999999999999 110.466 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -64.52 -39.93 94.68 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 120.99 -1.068 . . . . 2.3799999999999999 108.788 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.449 ' O ' ' OG1' ' B' ' 66' ' ' THR . 68.0 t90 -63.16 -49.64 73.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.864 . . . . 0.40999999999999998 110.887 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.488 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 59.3 tp -66.95 -49.45 65.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.084 -1.01 . . . . 1.0700000000000001 109.795 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.444 ' HZ3' ' CB ' ' B' ' 64' ' ' LYS . 0.0 OUTLIER -61.85 -47.21 86.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 2.6000000000000001 109.96 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 36.5 t0 -68.61 -29.37 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 1.8999999999999999 109.797 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 64.3 m -80.64 -33.06 35.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 1.1000000000000001 111.451 -178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 25.2 p -131.54 -28.62 1.83 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.405 -1.435 . . . . 0.95999999999999996 112.137 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.42 14.03 21.11 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 109.096 -1.601 . . . . 0.37 109.096 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.85 153.23 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.05 -1.265 . . . . 1.0900000000000001 109.306 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.46 170.16 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.101 -0.999 . . . . 2.3700000000000001 109.655 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.36 70.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.478 -0.764 . . . . 1.1100000000000001 110.73 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.06 -40.07 68.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.784 -1.197 . . . . 2.9700000000000002 109.68 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.2 mm100 -67.81 -38.17 82.92 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.323 -0.861 . . . . 2.6200000000000001 110.301 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -68.53 -37.93 80.42 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.266 -0.896 . . . . 1.8899999999999999 110.005 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.41 -38.91 85.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.852 -1.155 . . . . 3.3199999999999998 109.399 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -68.22 -39.97 82.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.651 -1.28 . . . . 0.40000000000000002 110.354 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.1 m -68.45 -39.98 81.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.712 -1.242 . . . . 0.95999999999999996 109.209 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -60.18 4.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.739 -1.226 . . . . 0.5 109.8 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -34.49 89.11 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.364 -1.094 . . . . 0.27000000000000002 110.364 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.3 t -71.41 -46.33 60.46 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.809 -1.406 . . . . 0.93999999999999995 109.792 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.44 -40.59 73.67 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.812 -1.155 . . . . 1.0900000000000001 108.403 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.47 -40.11 95.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 3.1899999999999999 110.454 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -68.85 -37.4 79.1 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.94 -1.1 . . . . 1.9099999999999999 109.672 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.4 t90 -59.92 -45.77 91.52 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.433 -1.321 . . . . 0.40000000000000002 107.433 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' B' ' 89' ' ' LEU . 73.5 m -60.62 -39.95 90.09 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.813 -0.755 . . . . 0.96999999999999997 108.964 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.57 -37.79 82.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 109.721 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.51 -36.83 18.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -0.889 . . . . 1.1299999999999999 109.957 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.1 m-85 -103.62 -85.02 0.46 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.28 -0.887 . . . . 1.24 110.39 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 85' ' ' CYS . 24.6 tp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.051 -0.976 . . . . 1.8300000000000001 109.573 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.305 0.574 . . . . 6.1100000000000003 109.585 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.9 m -76.48 125.12 28.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 3.5800000000000001 109.623 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.1 p -92.34 170.05 10.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.268 -0.895 . . . . 1.3200000000000001 110.045 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t -79.99 170.04 17.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 1.98 109.81 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.45 -20.66 13.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 2.6000000000000001 110.076 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.02 -37.52 79.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.14 -0.975 . . . . 2.5099999999999998 109.293 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 12.4 t60 -59.97 -50.01 75.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.021 -1.049 . . . . 0.51000000000000001 110.628 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.427 HH11 ' HG3' ' A' ' 8' ' ' ARG . 17.9 mmm-85 -70.01 -35.11 74.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.859 -1.151 . . . . 3.7200000000000002 109.735 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.74 -39.99 84.2 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.386 -0.822 . . . . 0.76000000000000001 109.336 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -63.54 -49.08 74.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.428 -0.795 . . . . 0.5 110.085 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.53 9.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.971 -1.081 . . . . 1.1799999999999999 110.747 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.9 -15.01 16.31 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.189 -0.944 . . . . 1.1799999999999999 110.267 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.4 pt-20 -152.71 155.03 32.22 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.169 -0.957 . . . . 1.26 108.938 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' GLU . 65.1 Cg_exo -36.84 152.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.101 1.867 . . . . 0.53000000000000003 111.441 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 11.6 ptm -89.75 -23.23 21.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.038 -1.039 . . . . 1.1399999999999999 109.673 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.0 -138.54 20.64 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.097 -1.201 . . . . 0.41999999999999998 110.097 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.54 43.23 1.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.577 -0.955 . . . . 0.84999999999999998 109.657 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -61.21 147.98 85.84 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.475 -0.935 . . . . 2.4900000000000002 108.475 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 155.09 39.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.275 1.983 . . . . 0.39000000000000001 112.826 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.68 -35.28 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.632 0.73 . . . . 1.1200000000000001 110.202 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.24 -0.48 57.31 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.546 -1.021 . . . . 0.27000000000000002 110.546 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 p -82.44 -25.8 33.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.783 -1.422 . . . . 1.75 109.706 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.78 138.52 58.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 1.05 109.953 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.84 134.5 55.32 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.8 -0.76 . . . . 1.0600000000000001 109.483 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.11 -21.72 44.58 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.511 -1.436 . . . . 0.23000000000000001 109.511 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 26' ' ' ILE . 36.2 mm -98.76 114.73 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.143 -1.21 . . . . 1.0800000000000001 108.195 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.68 -179.2 36.4 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.645 -1.382 . . . . 0.31 109.645 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -58.21 -40.04 80.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -1.038 . . . . 2.0099999999999998 109.652 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.67 -47.65 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.06 -1.025 . . . . 1.1399999999999999 109.285 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.89 -35.99 82.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 1.1299999999999999 109.348 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.78 -39.97 92.19 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.464 -1.454 . . . . 0.34999999999999998 109.464 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -66.79 -37.49 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.268 . . . . 3.2200000000000002 110.308 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.65 -51.74 46.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.709 -1.245 . . . . 2.1000000000000001 109.303 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.49 -39.81 89.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.051 -1.031 . . . . 1.0800000000000001 108.471 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.06 -42.66 95.0 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.55 -0.86 . . . . 1.6699999999999999 109.409 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.0 -19.12 65.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.178 -0.951 . . . . 2.0 108.6 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -90.75 5.42 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.539 -0.725 . . . . 3.1499999999999999 109.831 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.89 8.96 53.53 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.007 -1.058 . . . . 0.47999999999999998 111.585 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.25 75.09 1.01 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.418 . . . . 0.38 109.071 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.54 -7.98 58.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.40999999999999998 110.562 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -138.04 158.62 43.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.071 -1.018 . . . . 2.1600000000000001 110.149 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.5 84.45 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.965 0.728 . . . . 1.03 112.965 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -59.98 -17.84 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.38 -1.45 . . . . 0.92000000000000004 110.376 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 t -79.48 -31.93 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.25 -1.389 . . . . 1.0700000000000001 107.25 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 79.4 t -77.17 -39.58 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.236 -1.024 . . . . 1.0600000000000001 108.236 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.01 -35.93 76.13 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.466 -1.309 . . . . 1.1599999999999999 107.466 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.29 98.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.703 -1.359 . . . . 0.20000000000000001 109.703 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.94 -43.99 94.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 1.8200000000000001 108.908 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.97 -40.46 89.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.505 -0.747 . . . . 0.40000000000000002 109.195 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -69.05 -38.44 79.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.813 -0.81 . . . . 1.0900000000000001 108.813 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.69 -19.89 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.137 -0.977 . . . . 1.0900000000000001 110.517 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.2 mt -88.26 14.27 9.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.123 -0.985 . . . . 1.0900000000000001 110.786 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.12 31.86 7.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.778 -1.201 . . . . 2.2200000000000002 109.868 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 57.98 19.95 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.704 -0.623 . . . . 2.7999999999999998 110.044 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -69.93 108.81 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.732 -1.23 . . . . 1.8 108.077 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.83 -40.01 96.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.084 0.772 . . . . 0.87 113.084 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.44 -39.94 85.41 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.405 -1.434 . . . . 0.72999999999999998 109.996 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.45 -39.51 74.29 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.104 -1.038 . . . . 1.2 108.941 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.39 -41.65 93.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.44 109.095 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmm-85 -60.06 -51.18 70.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 3.3399999999999999 110.147 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.58 -37.3 84.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 2.3700000000000001 110.078 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.446 ' O ' ' OG1' ' A' ' 66' ' ' THR . 73.8 t90 -63.33 -47.99 79.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.40999999999999998 110.799 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.414 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 19.8 tp -66.8 -47.6 71.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.036 -1.04 . . . . 1.0800000000000001 109.707 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.08 -48.55 78.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.293 -0.879 . . . . 2.6099999999999999 109.945 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -67.17 -32.17 73.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.475 -0.766 . . . . 1.8999999999999999 109.758 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 91.3 m -80.17 -34.68 37.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 1.1100000000000001 111.397 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 31.8 p -128.72 -26.69 2.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.59 -1.318 . . . . 0.96999999999999997 112.004 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.99 13.53 33.69 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.684 -1.766 . . . . 0.38 108.684 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 152.99 2.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -1.095 . . . . 1.1000000000000001 109.421 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.76 174.9 7.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -0.912 . . . . 2.3700000000000001 109.724 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.27 74.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 1.1200000000000001 110.728 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.46 -39.66 64.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.604 -1.31 . . . . 2.9700000000000002 110.35 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.015 -1.053 . . . . 2.6200000000000001 110.732 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -69.05 -37.96 78.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.176 -0.952 . . . . 1.8899999999999999 110.52 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HG2' HH11 ' A' ' 75' ' ' ARG . 27.1 mtt-85 -60.03 -37.38 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 3.3199999999999998 109.489 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.52 -40.03 80.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.716 -1.24 . . . . 0.40000000000000002 110.478 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.8 m -69.48 -40.12 77.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.783 -1.198 . . . . 0.95999999999999996 109.8 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.33 -60.13 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.5 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.07 86.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.828 -0.909 . . . . 0.27000000000000002 110.828 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.7 t -70.77 -48.66 53.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.946 -1.326 . . . . 0.93999999999999995 110.223 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.998 -1.081 . . . . 1.0900000000000001 108.176 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.52 -40.02 93.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 3.1800000000000002 110.169 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 92.1 mt-10 -70.27 -38.23 75.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 1.9099999999999999 110.956 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 89.3 t90 -60.59 -42.32 96.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.308 -1.495 . . . . 0.40000000000000002 108.456 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 89' ' ' LEU . 92.7 m -61.57 -40.43 94.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.509 -0.744 . . . . 0.96999999999999997 110.273 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -29.44 68.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.121 -0.987 . . . . 0.55000000000000004 109.917 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.37 13.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 1.1200000000000001 110.81 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 88.7 m-85 -109.02 -3.64 17.28 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.312 -0.867 . . . . 1.24 112.42 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . 9.4 tp . . . . . 0 N--CA 1.503 2.214 0 O-C-N 120.586 -1.321 . . . . 1.8300000000000001 109.254 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.506 -0.553 . . . . 6.0999999999999996 109.506 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 96.0 m -76.29 125.2 28.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 3.5800000000000001 109.587 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 74.0 p -92.45 170.04 10.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.332 -0.855 . . . . 1.3200000000000001 110.098 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t -80.07 170.15 16.85 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.703 0.764 . . . . 1.97 109.809 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.51 -20.68 13.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 2.5899999999999999 110.057 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.03 -37.43 79.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.156 -0.965 . . . . 2.5 109.324 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.519 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 12.3 t60 -59.97 -50.06 75.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.029 -1.044 . . . . 0.51000000000000001 110.564 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.433 HH11 ' HG3' ' B' ' 8' ' ' ARG . 18.1 mmm-85 -70.02 -35.18 74.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.881 -1.137 . . . . 3.73 109.67 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.71 -40.03 84.33 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.445 -0.785 . . . . 0.76000000000000001 109.26 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.65 -49.0 74.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.408 -0.808 . . . . 0.5 110.069 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -83.48 9.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.975 -1.078 . . . . 1.1799999999999999 110.755 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.71 -15.02 16.44 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.129 -0.982 . . . . 1.1799999999999999 110.363 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' B' ' 14' ' ' PRO . 4.4 pt-20 -152.72 154.93 32.09 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.047 -1.033 . . . . 1.27 109.019 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -36.8 152.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.124 1.883 . . . . 0.53000000000000003 111.522 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.463 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 11.5 ptm -89.52 -23.21 22.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.044 -1.035 . . . . 1.1299999999999999 109.718 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -138.48 21.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.188 -1.165 . . . . 0.40999999999999998 110.188 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.56 43.03 1.58 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.535 -0.979 . . . . 0.83999999999999997 109.662 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -60.92 147.91 84.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 2.4900000000000002 108.512 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.84 155.12 39.73 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.304 2.003 . . . . 0.38 112.774 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.73 -35.4 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 1.1200000000000001 110.232 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.09 -0.58 57.04 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.599 -1.0 . . . . 0.27000000000000002 110.599 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 8.5 p -82.22 -25.93 33.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.727 -1.454 . . . . 1.75 109.731 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.69 138.51 58.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.411 -0.806 . . . . 1.0600000000000001 109.953 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.78 134.51 55.41 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.86 -0.736 . . . . 1.05 109.417 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.0 -21.6 45.22 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.519 -1.432 . . . . 0.22 109.519 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.43 HD11 HG22 ' B' ' 26' ' ' ILE . 36.0 mm -98.95 114.74 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.273 -1.134 . . . . 1.0800000000000001 108.203 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.79 -179.26 36.22 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.613 -1.395 . . . . 0.29999999999999999 109.613 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -58.08 -40.0 79.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -1.071 . . . . 2.0 109.783 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.76 -47.57 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.017 -1.052 . . . . 1.1399999999999999 109.314 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -35.86 82.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 1.1299999999999999 109.43 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.8 -39.96 92.23 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.447 . . . . 0.35999999999999999 109.481 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.77 -37.35 84.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 3.2200000000000002 110.39 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.85 -51.58 46.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.62 -1.3 . . . . 2.1200000000000001 109.363 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.63 -39.87 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 1.0800000000000001 108.306 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.0 -42.54 94.51 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.559 -0.856 . . . . 1.6799999999999999 109.419 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.12 -19.09 65.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 1.99 108.68 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -90.75 5.35 48.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.535 -0.728 . . . . 3.1499999999999999 109.813 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.02 8.92 53.35 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 120.225 -0.988 . . . . 0.48999999999999999 111.575 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.09 75.04 1.01 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.805 -1.409 . . . . 0.38 109.116 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.39 -8.14 58.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.40999999999999998 110.542 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -137.98 158.57 44.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.159 -0.963 . . . . 2.1499999999999999 110.179 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.43 84.47 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.925 0.713 . . . . 1.03 112.925 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -60.06 -17.68 41.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.431 -1.418 . . . . 0.92000000000000004 110.489 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 t -79.56 -31.96 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.258 -1.386 . . . . 1.0800000000000001 107.258 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 79.6 t -77.18 -39.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.244 -1.021 . . . . 1.0700000000000001 108.244 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 24.5 tp -59.97 -35.87 75.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.432 -1.322 . . . . 1.1499999999999999 107.432 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.34 98.22 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.791 -1.324 . . . . 0.19 109.791 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.061 -1.258 . . . . 1.8200000000000001 108.838 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -59.97 -40.5 89.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.40000000000000002 109.222 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.93 -38.34 79.44 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.828 -0.804 . . . . 1.0700000000000001 108.828 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.78 -19.97 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.187 -0.946 . . . . 1.0900000000000001 110.562 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 14.07 9.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.064 -1.022 . . . . 1.0900000000000001 110.808 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.14 32.1 7.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.693 -1.254 . . . . 2.23 109.848 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 57.91 20.02 6.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.637 -0.664 . . . . 2.7999999999999998 110.023 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -70.05 108.7 4.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.632 -1.293 . . . . 1.8 108.126 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.74 -40.07 96.07 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.076 0.769 . . . . 0.88 113.076 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.53 -40.03 85.05 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.434 -1.416 . . . . 0.73999999999999999 109.932 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.31 -39.65 74.68 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.061 -1.056 . . . . 1.2 109.0 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.16 -41.84 94.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.44 109.132 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -59.96 -51.04 71.4 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.771 . . . . 3.3399999999999999 110.187 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.73 -37.44 84.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.119 -0.988 . . . . 2.3799999999999999 110.025 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.455 ' O ' ' OG1' ' B' ' 66' ' ' THR . 74.3 t90 -63.22 -48.0 80.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.40999999999999998 110.882 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -66.83 -47.36 72.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.038 -1.039 . . . . 1.0700000000000001 109.752 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.24 -48.6 77.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.299 -0.875 . . . . 2.6000000000000001 109.859 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -67.27 -32.06 72.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.574 -0.704 . . . . 1.8999999999999999 109.769 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.22 -34.67 37.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 1.1000000000000001 111.331 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.7 p -128.84 -26.47 2.67 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.615 -1.303 . . . . 0.95999999999999996 111.984 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.31 34.59 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.7 -1.76 . . . . 0.37 108.7 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.6 152.92 2.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 1.0900000000000001 109.412 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.64 174.97 6.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.962 . . . . 2.3700000000000001 109.745 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -35.38 74.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 1.1100000000000001 110.691 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.4 -39.59 64.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.673 -1.267 . . . . 2.9700000000000002 110.339 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -67.48 -40.12 85.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.047 . . . . 2.6200000000000001 110.7 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.9 m -69.06 -37.92 78.78 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.138 -0.976 . . . . 1.8899999999999999 110.522 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' B' ' 75' ' ' ARG . 27.1 mtt-85 -60.0 -37.47 79.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.751 -1.218 . . . . 3.3199999999999998 109.509 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.43 -39.99 81.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.645 -1.285 . . . . 0.40000000000000002 110.526 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.57 -40.08 76.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.787 -1.196 . . . . 0.95999999999999996 109.821 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.27 -60.24 4.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.647 -1.283 . . . . 0.5 109.824 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.0 -33.08 86.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.83 -0.908 . . . . 0.27000000000000002 110.83 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -70.8 -48.63 53.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.039 -1.271 . . . . 0.93999999999999995 110.188 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.02 -39.89 75.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.998 -1.081 . . . . 1.0900000000000001 108.161 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.47 -40.02 93.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 3.1899999999999999 110.114 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 91.9 mt-10 -70.31 -38.24 74.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.965 -1.084 . . . . 1.9099999999999999 110.907 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.498 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 89.3 t90 -60.43 -42.49 96.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.314 -1.491 . . . . 0.40000000000000002 108.478 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.499 ' O ' ' N ' ' B' ' 89' ' ' LEU . 92.7 m -61.33 -40.49 94.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.513 -0.742 . . . . 0.96999999999999997 110.237 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -29.59 68.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.123 -0.986 . . . . 0.55000000000000004 109.896 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.26 -35.58 13.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.222 -0.924 . . . . 1.1299999999999999 110.863 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 90.1 m-85 -108.53 -3.81 17.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.285 -0.884 . . . . 1.24 112.552 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' B' ' 85' ' ' CYS . 9.2 tp . . . . . 0 N--CA 1.503 2.184 0 O-C-N 120.492 -1.38 . . . . 1.8300000000000001 109.384 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.384 0.612 . . . . 6.1100000000000003 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -80.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.228 -0.92 . . . . 3.5800000000000001 109.233 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.0 p -78.84 130.3 35.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 1.3200000000000001 109.941 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.7 p -84.38 175.66 9.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.38 -0.825 . . . . 1.98 109.188 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -57.54 -20.1 29.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.589 -0.694 . . . . 2.6000000000000001 109.602 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -61.41 -37.65 84.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 2.5099999999999998 109.129 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -59.94 -49.98 75.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.149 -0.97 . . . . 0.51000000000000001 110.317 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.23 -34.63 73.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.124 -0.985 . . . . 3.7200000000000002 110.103 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.7 -40.07 80.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.76000000000000001 109.559 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.63 -46.8 81.01 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.557 -0.857 . . . . 0.5 109.988 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.63 9.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.097 -1.002 . . . . 1.1799999999999999 110.895 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.43 -15.06 15.5 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.994 -1.066 . . . . 1.1799999999999999 110.206 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 14' ' ' PRO . 8.2 pt-20 -151.97 152.52 30.01 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.066 -1.022 . . . . 1.26 108.941 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 13' ' ' GLU . 66.8 Cg_exo -36.99 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.222 1.948 . . . . 0.53000000000000003 111.636 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 13.2 ptm -95.68 -30.23 13.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 1.1399999999999999 109.958 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.34 -133.58 49.18 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.363 -1.095 . . . . 0.41999999999999998 110.363 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.77 35.51 3.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.767 -0.843 . . . . 0.84999999999999998 110.088 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -54.88 149.81 21.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.925 -1.139 . . . . 2.4900000000000002 107.925 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.23 157.49 34.95 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.076 1.851 . . . . 0.39000000000000001 112.244 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 21' ' ' GLY . 12.7 p -56.85 -45.37 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.742 0.782 . . . . 1.1200000000000001 110.231 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -61.94 -1.39 2.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.61 -0.996 . . . . 0.27000000000000002 110.61 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 20' ' ' VAL . 60.2 p -82.95 -27.54 30.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.484 . . . . 1.75 109.582 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.92 138.24 57.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 1.05 109.562 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.59 134.86 54.22 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.733 0.778 . . . . 1.0600000000000001 109.979 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.76 -20.03 51.99 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.246 -1.542 . . . . 0.23000000000000001 109.246 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.5 mm -99.44 115.58 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -1.133 . . . . 1.0800000000000001 108.246 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.57 37.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 0.31 109.463 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.84 -40.0 75.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -1.064 . . . . 2.0099999999999998 109.86 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.38 -45.3 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.929 -1.107 . . . . 1.1399999999999999 109.719 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.59 -37.79 85.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 1.1299999999999999 109.53 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.115 -1.594 . . . . 0.34999999999999998 109.115 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -1.134 . . . . 3.2200000000000002 110.073 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -66.51 -48.44 69.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.851 -1.156 . . . . 2.1000000000000001 109.609 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.6 -38.1 83.56 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.008 -1.108 . . . . 1.0800000000000001 108.008 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -42.49 94.25 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.245 -0.65 . . . . 1.6699999999999999 109.245 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.5 -19.34 65.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 2.0 108.718 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -90.48 1.64 56.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 3.1499999999999999 110.285 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.61 7.0 43.15 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.944 -1.098 . . . . 0.47999999999999998 111.583 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.2 76.25 1.08 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.878 -1.366 . . . . 0.38 109.131 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.72 -7.26 57.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.865 . . . . 0.40999999999999998 111.162 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.18 158.88 43.43 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.072 -1.017 . . . . 2.1600000000000001 110.54 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.9 86.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.762 -0.586 . . . . 1.03 112.107 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 3.5 p90 -61.99 -18.82 61.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.433 -1.417 . . . . 0.92000000000000004 109.861 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -79.95 -31.87 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.773 -1.195 . . . . 1.0700000000000001 107.773 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -77.94 -37.34 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.061 -1.089 . . . . 1.0600000000000001 108.061 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.93 -35.21 74.43 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.993 -1.484 . . . . 1.1599999999999999 106.993 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -43.0 98.75 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 110.198 -1.161 . . . . 0.20000000000000001 110.198 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.078 -1.248 . . . . 1.8200000000000001 109.053 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.92 -41.5 91.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.40000000000000002 108.66 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.94 -40.04 75.73 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.742 -0.836 . . . . 1.0900000000000001 108.742 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.18 -25.41 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.109 -0.994 . . . . 1.0900000000000001 110.684 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.67 16.29 8.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 109.785 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 55' ' ' ASP . 8.8 mtmp? 51.94 44.94 29.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 2.2200000000000002 110.609 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 pttt 40.7 18.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.971 -1.081 . . . . 2.7999999999999998 111.528 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' LYS . 57.9 m-20 -66.59 115.56 6.58 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.847 -1.538 . . . . 1.8 106.847 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.59 -40.37 96.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.87 112.784 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.04 -39.94 75.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.378 -1.451 . . . . 0.72999999999999998 110.107 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.55 -40.0 73.63 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.121 -1.032 . . . . 1.2 109.105 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.66 -49.74 73.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.44 109.491 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.526 HH12 ' NH2' ' A' ' 75' ' ' ARG . 64.9 mtp180 -60.01 -46.35 89.79 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.444 -0.785 . . . . 3.3399999999999999 111.249 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.21 -36.36 83.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.674 -1.266 . . . . 2.3700000000000001 108.905 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.45 ' O ' ' OG1' ' A' ' 66' ' ' THR . 69.6 t90 -63.62 -48.96 75.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.40999999999999998 111.067 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.403 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 60.9 tp -67.75 -46.98 70.52 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.054 -1.029 . . . . 1.0800000000000001 110.548 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -63.11 -46.48 87.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.983 . . . . 2.6099999999999999 109.424 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.4 t0 -67.55 -31.08 70.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.618 . . . . 1.8999999999999999 109.605 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 95.9 m -78.52 -36.61 44.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 1.1100000000000001 111.653 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 18.7 p -130.41 -27.45 2.19 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.474 -1.391 . . . . 0.96999999999999997 112.228 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.17 14.22 19.21 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.3 -1.52 . . . . 0.38 109.3 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.14 153.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.913 -1.345 . . . . 1.1000000000000001 109.159 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.02 173.33 8.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.076 -1.015 . . . . 2.3700000000000001 110.133 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.98 74.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.558 -0.714 . . . . 1.1200000000000001 110.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.87 -40.43 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.856 -1.153 . . . . 2.9700000000000002 110.157 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.35 -40.02 81.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.139 -0.975 . . . . 2.6200000000000001 110.676 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 t -68.15 -38.37 82.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.128 -0.982 . . . . 1.8899999999999999 109.927 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.526 ' NH2' HH12 ' A' ' 60' ' ' ARG . 52.6 mtt-85 -60.02 -38.46 82.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.961 -1.087 . . . . 3.3199999999999998 108.973 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -67.94 -40.02 83.37 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.712 -1.242 . . . . 0.40000000000000002 110.392 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.22 -39.94 82.21 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.743 -1.223 . . . . 0.95999999999999996 109.493 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.1 -59.99 4.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.848 -1.157 . . . . 0.5 109.899 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.79 -34.26 89.24 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.278 -0.963 . . . . 0.27000000000000002 110.736 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.09 -47.61 61.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.3 . . . . 0.93999999999999995 110.061 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.9 mt -70.0 -39.87 75.62 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 1.0900000000000001 108.234 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.23 -40.5 96.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 3.1800000000000002 109.883 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -69.23 -39.96 78.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.999 . . . . 1.9099999999999999 110.754 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 84.5 t90 -59.98 -43.79 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.419 -1.426 . . . . 0.40000000000000002 107.734 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . 41.5 m -60.89 -40.07 91.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.63 0.729 . . . . 0.96999999999999997 109.694 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.01 -34.24 73.08 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.105 -0.997 . . . . 0.55000000000000004 110.148 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.78 -35.26 14.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.963 . . . . 1.1200000000000001 111.151 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 88.0 m-85 -108.51 2.46 22.24 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.116 -0.99 . . . . 1.24 111.265 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' CYS . 7.6 tp . . . . . 0 N--CA 1.497 1.89 0 O-C-N 120.889 -1.132 . . . . 1.8300000000000001 109.484 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.38 -0.6 . . . . 6.0999999999999996 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.52 -80.06 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -0.878 . . . . 3.5800000000000001 109.294 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 73.0 p -78.84 130.25 35.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.091 -1.006 . . . . 1.3200000000000001 109.863 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -84.35 175.79 9.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.496 -0.752 . . . . 1.97 109.115 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.64 -20.09 30.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.548 -0.72 . . . . 2.5899999999999999 109.609 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -61.32 -37.55 83.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 2.5 109.201 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -60.06 -49.93 75.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.51000000000000001 110.35 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.25 -34.67 73.1 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.125 -0.984 . . . . 3.73 110.11 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.61 -40.05 80.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.76000000000000001 109.573 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.73 -46.71 81.1 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.5 110.051 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 m -86.57 9.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.123 -0.986 . . . . 1.1799999999999999 110.812 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.24 -15.01 15.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.992 -1.068 . . . . 1.1799999999999999 110.258 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' B' ' 14' ' ' PRO . 8.2 pt-20 -152.0 152.52 29.97 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.144 -0.973 . . . . 1.27 108.98 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' B' ' 13' ' ' GLU . 69.0 Cg_exo -37.11 155.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.204 1.936 . . . . 0.53000000000000003 111.65 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 13.2 ptm -95.49 -30.44 13.85 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -0.923 . . . . 1.1299999999999999 110.057 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.73 -133.43 50.07 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.343 -1.103 . . . . 0.40999999999999998 110.343 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -113.02 35.48 3.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.729 -0.865 . . . . 0.83999999999999997 110.089 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -54.9 149.63 22.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.98 -1.119 . . . . 2.4900000000000002 107.98 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.01 157.57 33.53 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.071 1.848 . . . . 0.38 112.274 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' B' ' 21' ' ' GLY . 12.7 p -57.09 -45.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.666 0.746 . . . . 1.1200000000000001 110.215 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.421 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -61.97 -1.59 3.04 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.615 -0.994 . . . . 0.27000000000000002 110.615 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -82.75 -27.4 31.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.706 -1.467 . . . . 1.75 109.644 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.07 138.17 57.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 1.0600000000000001 109.487 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 135.15 54.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.753 0.787 . . . . 1.05 109.838 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.49 -20.07 51.88 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.238 -1.545 . . . . 0.22 109.238 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 33.4 mm -99.42 115.45 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.335 -1.097 . . . . 1.0800000000000001 108.306 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.32 177.55 37.92 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.567 -1.413 . . . . 0.29999999999999999 109.567 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.76 -40.02 75.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.407 -1.055 . . . . 2.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.47 -45.3 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.088 . . . . 1.1399999999999999 109.722 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.48 -37.94 86.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 1.1299999999999999 109.449 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.0 95.76 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.139 -1.585 . . . . 0.35999999999999999 109.139 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.808 ' CA ' ' N ' ' B' ' 33' ' ' LYS . 7.3 ttpm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.402 -1.058 . . . . 3.2200000000000002 . 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.808 ' N ' ' CA ' ' B' ' 32' ' ' LYS . 62.5 mttm . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.628 -0.508 . . . . 2.1200000000000001 109.628 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.5 -38.18 83.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.979 -1.119 . . . . 1.0800000000000001 107.979 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.05 -42.28 94.11 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.204 -0.665 . . . . 1.6799999999999999 109.204 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.75 -19.24 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.691 -0.855 . . . . 1.99 108.691 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -90.25 1.29 56.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 3.1499999999999999 110.299 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.06 6.75 42.18 Favored Glycine 0 N--CA 1.503 3.117 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.558 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -106.98 76.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.789 -1.418 . . . . 0.38 109.246 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -78.3 -7.45 57.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.126 -0.984 . . . . 0.40999999999999998 111.112 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.12 158.78 43.63 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.97 -1.081 . . . . 2.1499999999999999 110.529 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.93 -40.38 87.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 1.03 111.952 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 2.8 p90 -61.4 -18.64 59.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.506 -1.371 . . . . 0.92000000000000004 110.24 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -80.22 -31.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.788 -1.19 . . . . 1.0800000000000001 107.788 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 69.8 t -78.15 -37.25 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.029 -1.1 . . . . 1.0700000000000001 108.029 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 tp -59.98 -35.06 74.19 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.017 -1.475 . . . . 1.1499999999999999 107.017 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -43.18 98.55 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 110.223 -1.151 . . . . 0.19 110.223 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.136 -1.214 . . . . 1.8200000000000001 109.113 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.99 -41.42 91.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.40000000000000002 108.669 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.01 -39.87 75.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.686 -0.857 . . . . 1.0700000000000001 108.686 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.48 -25.41 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.062 -1.024 . . . . 1.0900000000000001 110.6 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.5 15.96 8.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.091 -1.005 . . . . 1.0900000000000001 109.762 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 55' ' ' ASP . 8.8 mtmp? 52.04 45.11 28.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 2.23 110.556 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 pttt 40.6 19.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.912 -1.117 . . . . 2.7999999999999998 111.564 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 53' ' ' LYS . 61.6 m-20 -66.67 115.21 6.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.917 -1.512 . . . . 1.8 106.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.5 -40.27 96.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.262 -0.899 . . . . 0.88 112.746 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -69.86 -40.07 75.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.341 -1.475 . . . . 0.73999999999999999 110.257 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.67 -39.95 73.25 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.093 -1.043 . . . . 1.2 109.008 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.5 -49.89 73.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.44 109.459 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.534 HH12 ' NH2' ' B' ' 75' ' ' ARG . 64.5 mtp180 -60.03 -45.92 91.23 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.528 -0.733 . . . . 3.3399999999999999 111.292 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.58 -36.54 84.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.678 -1.264 . . . . 2.3799999999999999 108.857 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' B' ' 66' ' ' THR . 69.4 t90 -63.4 -49.07 75.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.40999999999999998 111.038 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.81 -46.75 70.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.1 -1.0 . . . . 1.0700000000000001 110.564 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -63.3 -46.32 87.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 2.6000000000000001 109.393 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 34.8 t0 -67.64 -31.16 70.97 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.746 -0.596 . . . . 1.8999999999999999 109.652 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 97.2 m -78.49 -36.61 44.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.939 . . . . 1.1000000000000001 111.687 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 18.5 p -130.44 -27.2 2.21 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.49 -1.381 . . . . 0.95999999999999996 112.217 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.98 13.96 20.25 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.333 -1.507 . . . . 0.37 109.333 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.98 153.36 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.922 -1.34 . . . . 1.0900000000000001 109.183 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -91.04 173.39 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 2.3700000000000001 110.094 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 1.1100000000000001 110.154 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.79 -40.44 69.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 2.9700000000000002 110.097 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 2.6200000000000001 110.656 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 5.7 t -68.14 -38.45 82.17 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -0.983 . . . . 1.8899999999999999 109.916 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.534 ' NH2' HH12 ' B' ' 60' ' ' ARG . 52.6 mtt-85 -59.95 -38.64 83.05 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.907 -1.121 . . . . 3.3199999999999998 109.013 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.81 -39.94 83.92 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.871 -1.143 . . . . 0.40000000000000002 110.304 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.21 -40.06 82.21 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.789 -1.195 . . . . 0.95999999999999996 109.508 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.95 -60.15 4.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.894 -1.129 . . . . 0.5 109.888 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.73 -34.35 89.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.653 -0.979 . . . . 0.27000000000000002 110.653 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.1 -47.56 61.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.322 . . . . 0.93999999999999995 110.024 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.91 -40.0 75.85 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.1 -1.04 . . . . 1.0900000000000001 108.314 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -62.08 -40.75 96.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.312 -0.868 . . . . 3.1899999999999999 109.819 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -69.0 -39.92 79.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 1.9099999999999999 110.754 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 84.8 t90 -59.96 -44.03 94.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.451 -1.406 . . . . 0.40000000000000002 107.622 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' B' ' 89' ' ' LEU . 41.2 m -60.81 -40.01 91.13 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 0.96999999999999997 109.737 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -59.97 -34.46 73.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.988 -1.07 . . . . 0.55000000000000004 110.2 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.6 -35.14 14.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.068 -1.02 . . . . 1.1299999999999999 111.162 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 89.7 m-85 -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.115 -0.991 . . . . 1.24 111.407 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.1 tp . . . . . 0 N--CA 1.496 1.861 0 O-C-N 120.809 -1.182 . . . . 1.8300000000000001 109.535 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.189 -0.671 . . . . 6.1100000000000003 109.189 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.8 p -90.03 -0.08 57.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.022 -1.049 . . . . 3.5800000000000001 109.004 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -95.06 136.24 35.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 1.3200000000000001 109.325 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -78.33 165.11 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 1.98 109.1 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -55.23 -20.65 11.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 2.6000000000000001 110.234 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.25 -36.96 81.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 2.5099999999999998 109.218 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.427 ' NE2' ' OE2' ' A' ' 83' ' ' GLU . 16.1 t60 -60.06 -50.15 74.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.067 . . . . 0.51000000000000001 110.731 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 8' ' ' ARG . 4.1 mmt-85 -70.05 -34.3 73.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.045 -1.034 . . . . 3.7200000000000002 109.743 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -72.08 -37.55 69.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.76000000000000001 109.987 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.49 84.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.5 109.913 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -82.99 15.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 1.1799999999999999 109.401 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.39 -8.49 10.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.557 -0.714 . . . . 1.1799999999999999 110.362 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.29 151.0 23.25 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.887 -1.133 . . . . 1.26 109.554 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.5 161.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.916 1.744 . . . . 0.53000000000000003 111.831 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.8 ptp -96.13 -24.71 16.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.218 -0.926 . . . . 1.1399999999999999 109.788 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.84 -136.85 44.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.346 -1.501 . . . . 0.41999999999999998 109.346 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -110.83 34.77 3.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.41 -1.053 . . . . 0.84999999999999998 109.965 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -60.0 149.6 73.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.943 -1.098 . . . . 2.4900000000000002 108.974 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.79 156.52 37.58 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.334 2.022 . . . . 0.39000000000000001 112.301 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 22' ' ' SER . 10.4 p -57.95 -48.12 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.819 . . . . 1.1200000000000001 110.267 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -55.35 -1.44 0.18 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.494 -1.042 . . . . 0.27000000000000002 110.494 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 20' ' ' VAL . 80.3 p -81.32 -24.82 36.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.714 -1.462 . . . . 1.75 109.179 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.6 138.88 58.68 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.65 0.738 . . . . 1.05 109.893 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 134.63 54.32 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.815 -0.754 . . . . 1.0600000000000001 109.426 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.2 -20.62 46.52 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.746 -1.342 . . . . 0.23000000000000001 109.746 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.32 118.57 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.123 -1.222 . . . . 1.0800000000000001 108.396 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.03 179.95 34.09 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.618 -1.393 . . . . 0.31 109.618 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -58.16 -40.09 80.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -1.139 . . . . 2.0099999999999998 110.428 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.89 -47.19 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.793 -1.192 . . . . 1.1399999999999999 109.326 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.68 -38.56 87.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.827 . . . . 1.1299999999999999 109.412 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.97 96.19 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.439 -1.464 . . . . 0.34999999999999998 109.439 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.32 -39.94 94.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -1.12 . . . . 3.2200000000000002 110.018 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.32 -47.39 73.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 2.1000000000000001 109.369 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.14 -39.66 93.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 1.0800000000000001 108.964 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -43.16 95.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.437 -0.905 . . . . 1.6699999999999999 108.867 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -64.72 -19.87 66.02 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 2.0 108.443 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HG2' HH11 ' A' ' 37' ' ' ARG . 1.1 mmt-85 -90.06 2.42 55.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.438 -0.789 . . . . 3.1499999999999999 110.271 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.76 6.29 46.69 Favored Glycine 0 N--CA 1.505 3.286 0 O-C-N 121.083 -1.011 . . . . 0.47999999999999998 111.948 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -105.3 75.14 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.726 -1.455 . . . . 0.38 109.236 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' B' ' 53' ' ' LYS . 37.2 p-10 -80.02 -10.52 59.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.40999999999999998 110.389 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.75 153.28 51.35 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.182 -0.948 . . . . 2.1600000000000001 110.001 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.93 92.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.731 -0.606 . . . . 1.03 111.969 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 27.0 p90 -56.85 -17.95 11.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.834 -1.166 . . . . 0.92000000000000004 110.665 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.63 -33.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.87 -1.144 . . . . 1.0700000000000001 108.204 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.7 t -74.09 -38.83 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.562 -1.273 . . . . 1.0600000000000001 107.562 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.26 -38.81 77.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.808 -1.182 . . . . 1.1599999999999999 107.808 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.34 -43.22 93.84 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.932 -1.267 . . . . 0.20000000000000001 109.932 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -60.16 -42.75 95.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.268 . . . . 1.8200000000000001 108.559 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.04 -40.05 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.539 -0.911 . . . . 0.40000000000000002 108.539 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.9 mt -69.92 -39.96 75.83 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.594 -0.891 . . . . 1.0900000000000001 108.594 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.22 -25.65 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 1.0900000000000001 110.678 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.7 15.23 9.96 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.921 -1.112 . . . . 1.0900000000000001 109.886 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' B' ' 40' ' ' ASP . 67.9 mttm 52.15 29.47 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.063 -1.023 . . . . 2.2200000000000002 110.607 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.687 ' HZ1' HH12 ' A' ' 82' ' ' ARG . 83.4 mttt 60.06 19.83 9.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 2.7999999999999998 110.685 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.19 115.73 7.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.406 -1.434 . . . . 1.8 107.957 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.72 -40.14 96.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.87 112.281 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 90.2 m-20 -68.3 -39.94 81.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.554 -1.341 . . . . 0.72999999999999998 109.961 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.5 -39.69 67.43 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.166 -1.013 . . . . 1.2 109.101 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.35 -49.43 73.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.44 110.401 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.534 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 81.3 mtm180 -60.04 -44.8 94.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 3.3399999999999999 110.693 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.71 -37.8 87.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 2.3700000000000001 108.902 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 66' ' ' THR . 72.5 t90 -64.83 -48.73 73.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -0.983 . . . . 0.40999999999999998 110.8 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 54.8 tp -66.97 -46.57 74.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.997 . . . . 1.0800000000000001 109.391 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.88 -46.52 87.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 2.6099999999999999 109.412 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -31.0 69.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.688 -0.633 . . . . 1.8999999999999999 109.91 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 91.4 m -77.95 -37.51 47.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 1.1100000000000001 111.809 -177.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 6.2 p -130.13 -25.73 2.45 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.503 -1.373 . . . . 0.96999999999999997 111.933 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 13.43 26.51 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.063 -1.615 . . . . 0.38 109.063 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.93 153.94 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.238 . . . . 1.1000000000000001 109.031 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -91.15 -180.0 5.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.989 -1.069 . . . . 2.3700000000000001 109.779 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -33.19 75.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.772 . . . . 1.1200000000000001 110.823 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -71.49 -40.07 70.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.862 -1.149 . . . . 2.9700000000000002 109.789 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.92 -37.7 84.83 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.426 -0.796 . . . . 2.6200000000000001 110.438 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.626 ' HG ' ' N ' ' A' ' 75' ' ' ARG . 20.5 p -67.03 -37.82 84.81 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.135 -0.978 . . . . 1.8899999999999999 110.004 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.626 ' N ' ' HG ' ' A' ' 74' ' ' SER . 47.3 mtt-85 -59.97 -37.85 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.762 -1.211 . . . . 3.3199999999999998 108.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.88 -40.01 83.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.837 -1.164 . . . . 0.40000000000000002 110.718 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.25 -40.05 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.605 -1.309 . . . . 0.95999999999999996 109.948 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.27 -60.2 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.741 -1.225 . . . . 0.5 109.451 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.01 -33.58 79.73 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.339 -1.105 . . . . 0.27000000000000002 110.339 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.16 -51.06 50.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.105 -1.232 . . . . 0.93999999999999995 109.91 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.913 -1.115 . . . . 1.0900000000000001 109.619 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.687 HH12 ' HZ1' ' A' ' 54' ' ' LYS . 23.8 tpt180 -60.12 -44.48 94.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 3.1800000000000002 110.117 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' OE2' ' NE2' ' A' ' 7' ' ' HIS . 44.7 mt-10 -70.39 -38.1 74.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.86 . . . . 1.9099999999999999 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 89.3 t90 -61.88 -43.0 99.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.442 -1.411 . . . . 0.40000000000000002 108.397 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 89' ' ' LEU . 58.8 m -61.29 -40.48 94.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.441 -0.787 . . . . 0.96999999999999997 110.379 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.83 -27.88 67.0 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.198 -0.939 . . . . 0.55000000000000004 109.338 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.82 -34.45 12.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 1.1200000000000001 110.801 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.9 m-85 -110.68 -7.83 14.63 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.259 -0.9 . . . . 1.24 112.812 -177.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' CYS . 13.2 tp . . . . . 0 N--CA 1.502 2.142 0 O-C-N 120.331 -1.481 . . . . 1.8300000000000001 109.442 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.203 -0.665 . . . . 6.0999999999999996 109.203 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 43.8 p -90.07 -0.02 57.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.037 -1.039 . . . . 3.5800000000000001 109.033 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 17.9 p -95.06 136.32 35.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.456 -0.778 . . . . 1.3200000000000001 109.382 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.7 m -78.4 165.12 24.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 1.97 109.009 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -55.2 -20.77 11.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 2.5899999999999999 110.265 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.23 -36.99 81.47 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.891 -1.131 . . . . 2.5 109.206 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.421 ' CE1' ' OE2' ' B' ' 83' ' ' GLU . 16.1 t60 -59.99 -50.18 74.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.51000000000000001 110.76 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.488 ' HG2' HH11 ' B' ' 8' ' ' ARG . 4.0 mmt-85 -69.91 -34.45 73.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 3.73 109.785 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -72.06 -37.53 69.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.76000000000000001 109.959 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.407 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.48 84.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.5 109.88 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -83.1 15.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 1.1799999999999999 109.374 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.62 -8.41 9.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.597 -0.689 . . . . 1.1799999999999999 110.358 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.33 151.07 23.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.872 -1.142 . . . . 1.27 109.53 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -42.6 161.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.824 1.683 . . . . 0.53000000000000003 111.971 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.6 ptp -96.25 -24.4 16.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 1.1299999999999999 109.769 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.91 43.11 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.364 -1.494 . . . . 0.40999999999999998 109.364 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -110.71 34.78 3.78 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.429 -1.042 . . . . 0.83999999999999997 110.025 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -59.98 149.71 72.69 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.966 -1.084 . . . . 2.4900000000000002 108.967 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.87 156.42 38.46 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.304 2.003 . . . . 0.38 112.352 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.508 ' C ' ' H ' ' B' ' 22' ' ' SER . 10.7 p -57.87 -48.15 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 1.1200000000000001 110.271 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.421 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -55.43 -1.19 0.16 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.506 -1.038 . . . . 0.27000000000000002 110.506 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.508 ' H ' ' C ' ' B' ' 20' ' ' VAL . 81.0 p -81.5 -24.72 36.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.699 -1.471 . . . . 1.75 109.148 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.69 138.8 58.64 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.649 0.738 . . . . 1.0600000000000001 109.952 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.94 134.49 54.06 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.765 -0.774 . . . . 1.05 109.582 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.38 -20.73 45.73 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.749 -1.34 . . . . 0.22 109.749 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.18 118.62 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.213 -1.169 . . . . 1.0800000000000001 108.398 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.99 179.96 34.16 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.59 -1.404 . . . . 0.29999999999999999 109.59 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.28 -39.98 80.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.261 -1.14 . . . . 2.0 110.425 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 66.1 t -66.88 -47.25 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 1.1399999999999999 109.402 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.46 -38.65 87.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.336 -0.852 . . . . 1.1299999999999999 109.531 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.91 -40.01 96.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.353 -1.499 . . . . 0.35999999999999999 109.353 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.31 -39.88 94.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 3.2200000000000002 110.107 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.4 -47.21 74.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.86 -1.15 . . . . 2.1200000000000001 109.33 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.28 -39.58 93.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 1.0800000000000001 109.039 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.464 -0.894 . . . . 1.6799999999999999 108.86 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.68 -19.88 65.99 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.439 -0.949 . . . . 1.99 108.439 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' B' ' 37' ' ' ARG . 1.1 mmt-85 -90.1 2.68 54.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 3.1499999999999999 110.376 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 6.37 47.43 Favored Glycine 0 N--CA 1.504 3.223 0 O-C-N 120.988 -1.07 . . . . 0.48999999999999999 112.057 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -105.4 75.25 1.14 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.808 -1.407 . . . . 0.38 109.143 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 37.3 p-10 -80.21 -10.23 59.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.40999999999999998 110.432 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -133.0 153.37 51.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.246 -0.909 . . . . 2.1499999999999999 109.916 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.77 93.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.838 -0.539 . . . . 1.03 112.068 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 27.3 p90 -57.08 -18.01 12.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.92000000000000004 110.524 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.51 -33.56 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.901 -1.124 . . . . 1.0800000000000001 108.248 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.1 t -74.19 -38.79 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.472 -1.307 . . . . 1.0700000000000001 107.472 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 24.8 tp -58.38 -38.98 78.41 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.769 -1.197 . . . . 1.1499999999999999 107.769 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.31 -43.13 93.81 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.856 -1.297 . . . . 0.19 109.856 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -60.03 -42.83 95.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.93 -1.335 . . . . 1.8200000000000001 108.548 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.09 -39.95 87.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.559 -0.904 . . . . 0.40000000000000002 108.559 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.97 -40.04 75.62 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 1.0700000000000001 108.538 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.05 -25.56 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.242 -0.911 . . . . 1.0900000000000001 110.694 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.84 15.34 9.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.921 -1.112 . . . . 1.0900000000000001 109.838 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 67.9 mttm 51.98 29.46 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 2.23 110.661 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . 0.692 ' HZ1' HH12 ' B' ' 82' ' ' ARG . 83.5 mttt 60.01 19.74 8.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.782 -0.573 . . . . 2.7999999999999998 110.718 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -68.02 115.7 7.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.445 -1.41 . . . . 1.8 107.947 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.65 -40.32 96.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.88 112.205 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 90.4 m-20 -68.28 -39.97 81.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.512 -1.368 . . . . 0.73999999999999999 109.921 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.39 -39.67 67.79 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.141 -1.023 . . . . 1.2 109.215 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.45 -49.43 73.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.44 110.43 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 81.5 mtm180 -59.97 -45.03 94.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 3.3399999999999999 110.658 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.53 -37.61 87.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.855 -1.153 . . . . 2.3799999999999999 108.931 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.455 ' O ' ' OG1' ' B' ' 66' ' ' THR . 72.6 t90 -65.03 -48.55 73.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.004 . . . . 0.40999999999999998 110.876 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.465 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 54.6 tp -67.04 -46.67 73.7 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.135 -0.978 . . . . 1.0700000000000001 109.392 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.84 -46.4 88.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 2.6000000000000001 109.481 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.25 -30.94 69.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 1.8999999999999999 109.835 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.8 m -77.97 -37.52 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 1.1000000000000001 111.741 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 6.1 p -130.03 -25.94 2.45 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.398 -1.439 . . . . 0.95999999999999996 111.945 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.49 13.65 25.74 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 108.997 -1.641 . . . . 0.37 108.997 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.02 154.0 2.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.279 . . . . 1.0900000000000001 108.983 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -91.31 -179.98 5.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.035 -1.04 . . . . 2.3700000000000001 109.829 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.06 74.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 1.1100000000000001 110.832 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -71.61 -40.07 70.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 2.9700000000000002 109.823 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.9 -37.64 84.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.503 -0.748 . . . . 2.6200000000000001 110.542 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.62 ' HG ' ' N ' ' B' ' 75' ' ' ARG . 20.4 p -67.14 -37.73 84.31 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.122 -0.987 . . . . 1.8899999999999999 110.004 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.62 ' N ' ' HG ' ' B' ' 74' ' ' SER . 46.9 mtt-85 -60.01 -37.77 80.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.77 -1.206 . . . . 3.3199999999999998 108.778 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.0 -39.96 83.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.871 -1.143 . . . . 0.40000000000000002 110.728 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.1 m -68.27 -40.05 82.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.641 -1.287 . . . . 0.95999999999999996 109.884 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.35 -60.04 4.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.784 -1.197 . . . . 0.5 109.499 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -33.57 79.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.359 -1.096 . . . . 0.27000000000000002 110.359 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -68.25 -51.01 49.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.046 -1.267 . . . . 0.93999999999999995 109.903 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 82.0 mt -73.18 -41.16 64.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.953 -1.099 . . . . 1.0900000000000001 109.591 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.692 HH12 ' HZ1' ' B' ' 54' ' ' LYS . 23.8 tpt180 -60.16 -44.33 95.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.959 . . . . 3.1899999999999999 110.192 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.421 ' OE2' ' CE1' ' B' ' 7' ' ' HIS . 44.7 mt-10 -70.38 -38.21 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 1.9099999999999999 110.585 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.422 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 89.1 t90 -61.79 -43.04 99.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.486 -1.384 . . . . 0.40000000000000002 108.409 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.2 m -61.34 -40.41 94.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.96999999999999997 110.391 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.88 -27.76 66.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.3 -0.875 . . . . 0.55000000000000004 109.368 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.91 -35.01 12.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 1.1299999999999999 110.724 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.422 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 88.7 m-85 -109.97 -8.08 14.89 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.235 -0.915 . . . . 1.24 112.996 -177.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' B' ' 85' ' ' CYS . 13.2 tp . . . . . 0 N--CA 1.502 2.141 0 O-C-N 120.224 -1.547 . . . . 1.8300000000000001 109.414 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.578 -0.527 . . . . 6.1100000000000003 109.578 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.6 m -68.87 125.41 26.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 3.5800000000000001 108.878 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 p -106.92 135.16 48.95 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.471 -0.768 . . . . 1.3200000000000001 110.037 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.5 m -88.65 178.28 6.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 1.98 108.694 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.92 -24.9 64.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.542 -0.724 . . . . 2.6000000000000001 109.304 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.28 -36.93 81.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.909 . . . . 2.5099999999999998 109.256 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.563 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 60.0 t60 -59.9 -54.37 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.51000000000000001 110.839 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.9 -33.64 72.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.993 -1.067 . . . . 3.7200000000000002 110.154 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.97 -39.6 75.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.313 -0.867 . . . . 0.76000000000000001 109.342 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.54 -47.62 80.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.5 110.384 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.5 m -80.89 14.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.01 -1.056 . . . . 1.1799999999999999 109.685 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.4 -11.08 13.71 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.508 -0.745 . . . . 1.1799999999999999 110.081 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 14' ' ' PRO . 12.6 pt-20 -153.97 150.99 23.76 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.093 -1.004 . . . . 1.26 109.105 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLU . 93.5 Cg_exo -40.48 166.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.883 1.722 . . . . 0.53000000000000003 112.123 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.0 ptp -92.24 -20.22 21.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.213 -0.93 . . . . 1.1399999999999999 109.171 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.6 -141.52 5.97 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.339 -1.504 . . . . 0.41999999999999998 109.339 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.26 30.05 6.57 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.439 -1.036 . . . . 0.84999999999999998 109.812 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -60.4 148.84 79.1 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 2.4900000000000002 108.908 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.46 155.36 53.12 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.265 1.977 . . . . 0.39000000000000001 112.79 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.2 p -57.23 -47.18 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.626 0.727 . . . . 1.1200000000000001 110.184 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.97 -3.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.514 -1.034 . . . . 0.27000000000000002 110.514 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 20' ' ' VAL . 23.0 t -83.08 -22.3 33.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.758 -1.436 . . . . 1.75 109.47 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.11 58.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.146 -0.971 . . . . 1.05 109.766 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.34 133.83 51.32 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.857 -0.737 . . . . 1.0600000000000001 109.83 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.79 -20.01 51.04 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.315 -1.514 . . . . 0.23000000000000001 109.315 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -99.89 113.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.736 -1.209 . . . . 1.0800000000000001 107.736 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.47 176.29 43.11 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.828 -1.309 . . . . 0.31 109.828 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -58.31 -39.96 80.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.502 -0.999 . . . . 2.0099999999999998 109.702 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.03 -47.88 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 1.1399999999999999 109.548 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.84 -39.83 83.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 1.1299999999999999 109.307 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.97 96.43 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.32 -1.512 . . . . 0.34999999999999998 109.32 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -61.13 -39.98 92.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -1.094 . . . . 3.2200000000000002 110.664 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.19 -41.84 89.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.731 -1.231 . . . . 2.1000000000000001 110.133 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.9 mt -60.03 -39.61 86.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 1.0800000000000001 109.089 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -59.96 -40.04 87.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.375 -0.93 . . . . 1.6699999999999999 109.639 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.05 -19.42 64.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.908 . . . . 2.0 108.804 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -90.1 1.35 56.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.587 -0.695 . . . . 3.1499999999999999 109.515 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.11 38.78 3.47 Favored Glycine 0 N--CA 1.497 2.754 0 O-C-N 121.232 -0.918 . . . . 0.47999999999999998 110.985 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -132.37 71.9 1.48 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.212 -1.17 . . . . 0.38 108.321 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -75.48 -12.38 60.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.053 -1.029 . . . . 0.40999999999999998 110.495 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -134.34 156.86 47.73 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.165 -0.96 . . . . 2.1600000000000001 109.434 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -40.22 93.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 1.03 111.678 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -58.44 -17.34 19.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.837 -1.164 . . . . 0.92000000000000004 110.717 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.77 -31.62 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.87 -1.159 . . . . 1.0700000000000001 107.87 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.81 -38.69 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.739 -1.208 . . . . 1.0600000000000001 107.739 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.66 -38.75 82.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.286 -1.375 . . . . 1.1599999999999999 107.286 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.08 71.59 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.965 -1.254 . . . . 0.20000000000000001 109.965 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -60.05 -42.56 94.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -1.213 . . . . 1.8200000000000001 109.885 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.07 -39.96 87.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.096 -1.003 . . . . 0.40000000000000002 108.68 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.1 -38.34 75.63 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.616 -0.883 . . . . 1.0900000000000001 108.616 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.53 -22.51 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.153 -0.967 . . . . 1.0900000000000001 110.733 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.86 17.85 7.29 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.053 -1.03 . . . . 1.0900000000000001 109.735 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 52.06 29.43 6.33 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.073 -1.017 . . . . 2.2200000000000002 109.611 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.4 mttt 60.08 19.88 9.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.855 -0.528 . . . . 2.7999999999999998 109.944 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.99 114.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.821 -1.178 . . . . 1.8 107.821 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.72 -39.99 90.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.87 112.856 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.56 -39.57 84.93 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.462 -1.399 . . . . 0.72999999999999998 110.687 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.98 -38.97 76.21 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.018 -1.073 . . . . 1.2 109.566 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.63 -43.69 92.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.44 109.884 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -60.04 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 3.3399999999999999 110.941 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.77 -38.83 90.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.896 -1.127 . . . . 2.3700000000000001 109.25 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.442 ' O ' ' OG1' ' A' ' 66' ' ' THR . 75.9 t90 -64.34 -49.48 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.019 -1.051 . . . . 0.40999999999999998 110.993 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.3 tp -66.9 -47.25 72.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.04 -1.037 . . . . 1.0800000000000001 109.998 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.83 -44.47 89.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 2.6099999999999999 109.8 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.3 t0 -69.63 -30.95 68.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.557 -0.715 . . . . 1.8999999999999999 109.664 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 97.1 m -79.31 -34.73 42.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 1.1100000000000001 111.332 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.7 p -130.39 -29.68 1.98 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.598 -1.314 . . . . 0.96999999999999997 112.078 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.98 14.48 20.8 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.401 -1.48 . . . . 0.38 109.401 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.73 154.79 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.034 -1.274 . . . . 1.1000000000000001 109.296 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -89.22 169.91 11.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.984 -1.073 . . . . 2.3700000000000001 110.266 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.36 73.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.687 . . . . 1.1200000000000001 111.02 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.01 -40.05 75.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.629 -1.295 . . . . 2.9700000000000002 109.654 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -64.88 -30.1 71.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.537 -0.727 . . . . 2.6200000000000001 110.572 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.61 ' HG ' ' N ' ' A' ' 75' ' ' ARG . 36.7 p -68.79 -39.6 80.07 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.987 -1.07 . . . . 1.8899999999999999 110.611 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -60.01 -37.85 80.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.547 -1.346 . . . . 3.3199999999999998 109.092 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.58 -1.325 . . . . 0.40000000000000002 110.412 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 86.2 m -70.01 -40.27 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.791 -1.193 . . . . 0.95999999999999996 109.502 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.17 -61.03 2.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 0.5 109.789 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.53 -33.08 83.55 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.196 -1.161 . . . . 0.27000000000000002 110.196 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 46.7 t -71.0 -46.88 61.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.922 -1.34 . . . . 0.93999999999999995 109.797 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.89 -40.98 68.52 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.01 -1.076 . . . . 1.0900000000000001 109.068 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.75 -40.44 97.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.121 -0.987 . . . . 3.1800000000000002 110.147 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.563 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 96.0 mt-10 -70.14 -38.38 75.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 1.9099999999999999 110.459 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.7 t90 -61.49 -47.81 83.93 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.527 -1.358 . . . . 0.40000000000000002 108.087 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 89' ' ' LEU . 56.4 m -59.99 -40.14 88.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.498 -0.751 . . . . 0.96999999999999997 109.841 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.47 -29.82 68.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.005 . . . . 0.55000000000000004 109.364 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.52 -33.67 12.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.302 -0.874 . . . . 1.1200000000000001 110.705 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 86.3 m-85 -108.79 -5.82 16.11 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.277 -0.889 . . . . 1.24 112.45 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 85' ' ' CYS . 8.2 tp . . . . . 0 N--CA 1.503 2.225 0 O-C-N 120.451 -1.406 . . . . 1.8300000000000001 109.512 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.641 -0.503 . . . . 6.0999999999999996 109.641 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 29.1 m -68.8 125.28 26.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 3.5800000000000001 108.95 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.8 p -106.76 135.09 48.88 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.533 -0.729 . . . . 1.3200000000000001 110.042 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m -88.59 178.37 6.53 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.653 -0.869 . . . . 1.97 108.653 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.93 -25.0 64.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 2.5899999999999999 109.352 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.19 -36.97 81.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 2.5 109.322 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.56 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 60.3 t60 -59.93 -54.17 49.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.51000000000000001 110.793 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.95 -33.65 72.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 3.73 110.127 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.01 -39.41 75.84 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.348 -0.845 . . . . 0.76000000000000001 109.367 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.8 -47.59 80.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.5 110.316 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.93 14.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.042 -1.036 . . . . 1.1799999999999999 109.68 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.34 -11.01 13.75 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.552 -0.717 . . . . 1.1799999999999999 110.121 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 14' ' ' PRO . 12.6 pt-20 -154.0 151.17 24.09 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 1.27 109.02 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.5 Cg_exo -40.44 166.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.958 1.772 . . . . 0.53000000000000003 112.074 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 1.9 ptp -92.57 -20.11 21.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.15 -0.968 . . . . 1.1299999999999999 109.081 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.71 -141.43 6.17 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.427 -1.469 . . . . 0.40999999999999998 109.427 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.27 29.95 6.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.527 -0.984 . . . . 0.83999999999999997 109.787 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.47 148.82 79.65 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.89 -1.131 . . . . 2.4900000000000002 108.812 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.43 155.49 52.12 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.218 1.945 . . . . 0.38 112.774 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.3 p -57.21 -47.15 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.674 0.75 . . . . 1.1200000000000001 110.222 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.403 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -52.01 -3.42 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.572 -1.011 . . . . 0.27000000000000002 110.572 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.543 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.8 t -82.92 -22.21 33.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.413 . . . . 1.75 109.485 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.07 58.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 1.0600000000000001 109.807 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.9 51.42 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.591 0.71 . . . . 1.05 109.792 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.518 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.76 -20.06 50.88 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.399 -1.48 . . . . 0.22 109.399 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.406 HG23 HD13 ' B' ' 26' ' ' ILE . 37.9 mm -99.9 113.53 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 107.622 -1.251 . . . . 1.0800000000000001 107.622 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.51 176.26 43.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.829 -1.308 . . . . 0.29999999999999999 109.829 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -58.26 -39.97 80.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.445 -1.032 . . . . 2.0 109.678 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.21 -47.67 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.049 -1.032 . . . . 1.1399999999999999 109.559 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.91 -39.86 83.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 1.1299999999999999 109.301 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.97 96.27 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.343 -1.503 . . . . 0.35999999999999999 109.343 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -61.21 -39.9 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -1.073 . . . . 3.2200000000000002 110.66 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -66.24 -41.82 89.49 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.705 -1.247 . . . . 2.1200000000000001 110.154 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 63.7 mt -60.03 -39.56 86.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.087 -1.008 . . . . 1.0800000000000001 109.084 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -60.12 -39.93 87.99 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.207 -0.997 . . . . 1.6799999999999999 109.607 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -19.52 64.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 1.99 108.844 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -90.1 1.47 56.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.667 -0.646 . . . . 3.1499999999999999 109.522 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.94 38.88 3.48 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.236 -0.915 . . . . 0.48999999999999999 111.032 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -132.5 71.9 1.48 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -1.213 . . . . 0.38 108.323 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -75.46 -12.3 60.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.963 -1.086 . . . . 0.40999999999999998 110.406 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -134.43 156.8 47.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.165 -0.959 . . . . 2.1499999999999999 109.392 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.21 92.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.426 -0.796 . . . . 1.03 111.608 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -58.41 -17.32 19.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.805 -1.185 . . . . 0.92000000000000004 110.671 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.71 -31.78 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 1.0800000000000001 107.943 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.76 -38.56 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.837 -1.171 . . . . 1.0700000000000001 107.837 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -59.76 -38.78 82.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.28 -1.378 . . . . 1.1499999999999999 107.28 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.41 -45.81 74.58 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.955 -1.258 . . . . 0.19 109.955 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -60.08 -42.63 95.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.24 . . . . 1.8200000000000001 109.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.1 -39.91 87.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.136 -0.978 . . . . 0.40000000000000002 108.776 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.96 -38.38 76.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.694 -0.854 . . . . 1.0700000000000001 108.694 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.1 t -66.57 -22.43 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 110.716 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.92 17.79 7.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.001 -1.062 . . . . 1.0900000000000001 109.737 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 52.02 29.64 6.49 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.031 -1.043 . . . . 2.23 109.499 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 59.93 20.08 9.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.802 -0.562 . . . . 2.7999999999999998 109.986 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -68.98 114.46 7.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.843 -1.16 . . . . 1.8 107.925 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.68 -40.0 90.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.388 -0.82 . . . . 0.88 112.78 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -67.65 -39.52 84.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.524 -1.36 . . . . 0.73999999999999999 110.634 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.97 -39.06 76.2 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.034 -1.066 . . . . 1.2 109.538 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.57 -43.72 92.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.44 109.813 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -59.96 -49.98 75.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 3.3399999999999999 110.959 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.8 -38.79 89.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.78 -1.2 . . . . 2.3799999999999999 109.273 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' B' ' 66' ' ' THR . 76.1 t90 -64.33 -49.44 71.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.014 -1.054 . . . . 0.40999999999999998 110.991 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.09 -47.03 72.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.028 -1.045 . . . . 1.0700000000000001 110.0 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -64.92 -44.4 89.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.33 -0.856 . . . . 2.6000000000000001 109.8 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.0 t0 -69.73 -30.97 68.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 1.8999999999999999 109.724 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 96.5 m -79.23 -34.8 42.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 1.1000000000000001 111.399 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.9 p -130.29 -29.78 1.99 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.58 -1.325 . . . . 0.95999999999999996 112.092 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.07 14.33 21.01 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.363 -1.495 . . . . 0.37 109.363 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 154.69 1.84 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.015 -1.285 . . . . 1.0900000000000001 109.34 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.17 169.99 10.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 2.3700000000000001 110.241 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.29 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.642 -0.661 . . . . 1.1100000000000001 110.992 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.11 -39.94 75.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.699 -1.25 . . . . 2.9700000000000002 109.694 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.7 mm100 -65.0 -29.99 70.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.454 -0.779 . . . . 2.6200000000000001 110.489 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.614 ' HG ' ' N ' ' B' ' 75' ' ' ARG . 35.7 p -68.82 -39.48 80.0 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.007 -1.058 . . . . 1.8899999999999999 110.62 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.614 ' N ' ' HG ' ' B' ' 74' ' ' SER . 0.3 OUTLIER -60.25 -37.76 81.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.577 -1.327 . . . . 3.3199999999999998 108.768 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.69 -40.11 76.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.6 -1.312 . . . . 0.40000000000000002 110.431 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.04 -40.19 75.29 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.723 -1.236 . . . . 0.95999999999999996 109.354 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.26 -61.01 2.91 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.041 -1.037 . . . . 0.5 109.71 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.56 -33.06 83.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.236 -1.146 . . . . 0.27000000000000002 110.236 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -70.91 -46.95 61.61 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.933 -1.334 . . . . 0.93999999999999995 109.703 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.9 -41.01 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.957 -1.097 . . . . 1.0900000000000001 109.089 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.59 -40.6 97.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.155 -0.966 . . . . 3.1899999999999999 110.139 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 95.9 mt-10 -70.08 -38.34 75.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 1.9099999999999999 110.502 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.434 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.7 t90 -61.46 -47.87 83.72 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.542 -1.349 . . . . 0.40000000000000002 108.09 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' B' ' 89' ' ' LEU . 56.3 m -59.99 -40.13 88.11 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.365 -0.834 . . . . 0.96999999999999997 109.826 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.41 -29.83 68.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.069 -1.02 . . . . 0.55000000000000004 109.404 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.58 -33.78 12.89 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.323 -0.86 . . . . 1.1299999999999999 110.75 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.0 m-85 -108.3 -5.96 16.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.248 -0.907 . . . . 1.24 112.584 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.503 2.203 0 O-C-N 120.61 -1.306 . . . . 1.8300000000000001 109.548 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.331 0.586 . . . . 6.1100000000000003 109.812 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.9 t -165.01 125.18 1.91 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 3.5800000000000001 109.451 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -100.96 123.65 45.48 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.339 -0.851 . . . . 1.3200000000000001 109.585 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.4 m -81.07 172.56 13.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.321 -0.862 . . . . 1.98 109.742 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.574 ' NE2' ' NH2' ' A' ' 8' ' ' ARG . 7.3 tp-100 -54.68 -24.35 21.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 2.6000000000000001 109.9 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.02 -38.66 86.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.034 -1.041 . . . . 2.5099999999999998 109.228 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -59.16 -50.63 73.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.141 -0.974 . . . . 0.51000000000000001 110.169 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.574 ' NH2' ' NE2' ' A' ' 5' ' ' GLN . 89.3 mtm180 -69.4 -34.75 74.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.132 -0.98 . . . . 3.7200000000000002 110.423 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.57 -39.86 80.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.155 -0.966 . . . . 0.76000000000000001 109.289 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.53 -48.94 78.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.445 -0.784 . . . . 0.5 109.761 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -83.22 10.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.266 -0.896 . . . . 1.1799999999999999 110.711 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.66 -14.97 17.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.246 -0.909 . . . . 1.1799999999999999 110.364 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' PRO . 18.6 pt-20 -152.45 152.61 29.37 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.031 -1.043 . . . . 1.26 108.632 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . 75.0 Cg_exo -37.37 155.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.96 1.773 . . . . 0.53000000000000003 111.089 178.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.3 ptm -92.64 -24.75 18.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.055 -1.028 . . . . 1.1399999999999999 110.443 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.81 -136.01 37.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.971 -1.109 . . . . 0.41999999999999998 110.401 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.15 42.78 1.71 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.631 -0.923 . . . . 0.84999999999999998 109.902 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -60.12 148.1 79.01 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.146 -0.971 . . . . 2.4900000000000002 108.452 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.38 159.85 33.98 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.037 1.825 . . . . 0.39000000000000001 112.085 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.58 -39.47 69.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.677 -0.639 . . . . 1.1200000000000001 110.994 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.79 -3.81 30.14 Favored Glycine 0 N--CA 1.491 2.331 0 O-C-N 121.432 -0.793 . . . . 0.27000000000000002 111.346 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -83.82 -20.94 32.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.423 -1.633 . . . . 1.75 109.532 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.5 mt -64.15 136.29 57.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.033 -1.042 . . . . 1.05 109.078 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -63.82 136.13 57.16 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.678 -0.809 . . . . 1.0600000000000001 109.763 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.7 -18.16 57.94 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.296 -1.522 . . . . 0.23000000000000001 109.296 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.56 114.78 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.251 -1.147 . . . . 1.0800000000000001 108.215 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.27 175.17 37.61 Favored Glycine 0 N--CA 1.492 2.382 0 O-C-N 120.608 -1.307 . . . . 0.31 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.86 -40.02 83.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -1.048 . . . . 2.0099999999999998 109.549 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.41 -47.72 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 1.1399999999999999 109.36 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.96 -38.51 88.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 1.1299999999999999 109.327 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.22 95.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.707 -1.357 . . . . 0.34999999999999998 109.707 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -63.53 -39.78 95.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.376 -1.073 . . . . 3.2200000000000002 110.719 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.21 -43.05 83.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.592 -1.318 . . . . 2.1000000000000001 109.982 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.95 -39.85 93.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.011 -1.056 . . . . 1.0800000000000001 108.532 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.93 -42.1 93.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 1.6699999999999999 111.007 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -64.68 -20.48 66.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.998 . . . . 2.0 109.418 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -93.54 8.46 40.63 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.841 -0.744 . . . . 3.1499999999999999 110.845 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.8 7.9 49.69 Favored Glycine 0 N--CA 1.501 3.014 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 112.31 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.64 73.48 1.02 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.553 -1.557 . . . . 0.38 108.518 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -78.0 -8.1 57.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.40999999999999998 110.952 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -137.15 157.35 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.134 -0.979 . . . . 2.1600000000000001 110.602 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.643 -0.661 . . . . 1.03 111.684 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 4.2 p90 -60.7 -18.1 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.622 -1.299 . . . . 0.92000000000000004 110.772 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.6 t -80.24 -30.7 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.414 -1.328 . . . . 1.0700000000000001 107.414 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -78.25 -39.32 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.151 -1.055 . . . . 1.0600000000000001 108.151 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.77 -36.29 74.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.793 -1.558 . . . . 1.1599999999999999 106.793 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.29 -43.6 93.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.186 -1.165 . . . . 0.20000000000000001 110.186 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -60.18 -42.03 94.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -1.228 . . . . 1.8200000000000001 109.332 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.1 -39.97 88.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.082 -1.011 . . . . 0.40000000000000002 108.66 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.3 mt -69.09 -39.58 78.91 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.095 -0.706 . . . . 1.0900000000000001 109.095 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -67.79 -23.14 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 110.912 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.5 16.85 8.18 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.99 -1.069 . . . . 1.0900000000000001 110.042 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.65 29.67 7.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.061 -1.024 . . . . 2.2200000000000002 110.388 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt 59.96 19.8 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.495 -0.753 . . . . 2.7999999999999998 110.367 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -67.65 115.99 7.85 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.377 -1.342 . . . . 1.8 107.377 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.42 -39.98 95.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.894 . . . . 0.87 113.251 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.8 -39.73 76.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.359 -1.463 . . . . 0.72999999999999998 110.437 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.9 -40.07 72.39 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 118.836 -1.145 . . . . 1.2 109.379 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.63 -49.87 69.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.44 109.528 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -61.78 -45.31 94.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 3.3399999999999999 109.799 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -64.21 -39.26 93.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.041 -1.037 . . . . 2.3700000000000001 108.664 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 66' ' ' THR . 76.2 t90 -66.87 -47.17 72.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.40999999999999998 110.512 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.11 -49.15 68.51 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.129 -0.982 . . . . 1.0800000000000001 109.575 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -61.5 -49.05 78.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.36 -0.837 . . . . 2.6099999999999999 110.101 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.94 -26.14 64.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.467 -0.77 . . . . 1.8999999999999999 109.748 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 22.9 m -79.32 -34.14 42.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.078 -1.014 . . . . 1.1100000000000001 111.294 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.3 p -134.46 -21.66 1.76 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.328 -1.482 . . . . 0.96999999999999997 112.294 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.23 12.16 34.5 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.679 -1.368 . . . . 0.38 109.679 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.1 153.72 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.935 -1.332 . . . . 1.1000000000000001 109.169 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -87.7 169.81 11.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.913 -1.117 . . . . 2.3700000000000001 109.772 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.24 -33.08 71.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.588 -0.695 . . . . 1.1200000000000001 110.24 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -72.9 -39.61 66.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 2.9700000000000002 109.804 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.64 -37.1 85.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.84 . . . . 2.6200000000000001 110.491 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -36.6 82.42 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 1.8899999999999999 109.963 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.12 -39.04 84.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.027 -1.046 . . . . 3.3199999999999998 109.117 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.39 -39.66 81.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.898 -1.126 . . . . 0.40000000000000002 110.981 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 58.0 m -68.23 -40.09 82.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 0.95999999999999996 110.369 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.6 -59.53 5.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.512 -1.367 . . . . 0.5 109.554 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.01 79.26 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.621 -0.992 . . . . 0.27000000000000002 110.621 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.44 -51.06 32.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -1.202 . . . . 0.93999999999999995 110.337 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.57 -40.39 73.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.847 -1.141 . . . . 1.0900000000000001 108.531 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.78 -41.08 97.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 3.1800000000000002 110.255 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.74 -38.4 76.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.9099999999999999 110.404 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 90.0 t90 -60.11 -43.5 95.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.437 -1.414 . . . . 0.40000000000000002 107.895 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 89' ' ' LEU . 27.8 m -60.12 -40.24 89.05 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.739 0.781 . . . . 0.96999999999999997 109.553 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -33.4 71.93 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.268 -0.895 . . . . 0.55000000000000004 109.871 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.92 -33.98 13.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.991 -1.068 . . . . 1.1200000000000001 111.037 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 97.4 m-85 -110.65 1.98 18.3 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.094 -1.003 . . . . 1.24 111.794 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 85' ' ' CYS . 9.0 tp . . . . . 0 N--CA 1.497 1.912 0 O-C-N 120.945 -1.097 . . . . 1.8300000000000001 109.185 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.362 0.601 . . . . 6.0999999999999996 109.849 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 12.4 t -165.54 125.95 1.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -0.918 . . . . 3.5800000000000001 109.346 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 69.2 p -101.76 123.97 46.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.41 -0.806 . . . . 1.3200000000000001 109.543 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m -81.26 172.88 13.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.255 -0.903 . . . . 1.97 109.716 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 8' ' ' ARG . 7.3 tp-100 -55.05 -24.17 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.342 0.591 . . . . 2.5899999999999999 109.88 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -38.85 87.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.992 -1.068 . . . . 2.5 109.212 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -58.96 -50.71 73.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.1 -1.0 . . . . 0.51000000000000001 110.317 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 5' ' ' GLN . 89.2 mtm180 -69.32 -34.95 75.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 3.73 110.234 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.28 -40.03 81.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.187 -0.946 . . . . 0.76000000000000001 109.272 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -61.59 -48.81 79.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.5 109.912 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -83.49 10.73 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.238 -0.914 . . . . 1.1799999999999999 110.664 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.75 -14.95 17.12 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.176 -0.953 . . . . 1.1799999999999999 110.267 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 14' ' ' PRO . 18.7 pt-20 -152.14 152.25 29.23 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 1.27 108.615 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' B' ' 13' ' ' GLU . 68.1 Cg_exo -37.21 155.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.022 1.814 . . . . 0.53000000000000003 111.076 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 14.0 ptm -92.57 -25.1 18.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.093 -1.004 . . . . 1.1299999999999999 110.598 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.0 -136.02 38.77 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.064 -1.065 . . . . 0.40999999999999998 110.44 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.17 42.9 1.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.619 -0.93 . . . . 0.83999999999999997 110.071 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -60.27 148.08 80.0 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.426 -0.953 . . . . 2.4900000000000002 108.426 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.61 159.41 36.88 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.07 1.847 . . . . 0.38 112.033 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.38 -38.91 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.721 -0.612 . . . . 1.1200000000000001 111.168 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.03 -3.73 31.34 Favored Glycine 0 N--CA 1.493 2.447 0 O-C-N 121.435 -0.79 . . . . 0.27000000000000002 111.343 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.8 m -84.12 -21.13 31.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.575 -1.544 . . . . 1.75 109.587 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.18 136.14 56.95 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -0.969 . . . . 1.0600000000000001 109.032 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.475 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -63.23 136.11 57.51 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.753 0.787 . . . . 1.05 109.882 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.19 -17.75 58.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.375 -1.49 . . . . 0.22 109.375 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.78 114.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -1.143 . . . . 1.0800000000000001 108.088 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.85 174.72 37.86 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.907 -1.277 . . . . 0.29999999999999999 109.907 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.52 -39.83 81.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.424 -1.045 . . . . 2.0 109.677 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.59 -47.68 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 1.1399999999999999 109.27 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.04 -38.57 88.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.386 -0.821 . . . . 1.1299999999999999 109.46 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -39.07 95.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.35999999999999999 109.692 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -63.7 -39.73 95.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -1.112 . . . . 3.2200000000000002 110.667 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.07 -43.05 83.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.578 -1.326 . . . . 2.1200000000000001 109.834 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.2 -39.95 94.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 1.0800000000000001 108.586 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -59.9 -41.73 92.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.787 -0.57 . . . . 1.6799999999999999 110.97 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.67 -20.94 66.59 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.212 -0.93 . . . . 1.99 109.295 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -93.22 8.33 40.68 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 3.1499999999999999 110.79 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.95 8.03 48.98 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 120.911 -1.118 . . . . 0.48999999999999999 112.319 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.79 73.66 1.02 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 119.314 1.557 . . . . 0.38 108.368 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -78.04 -8.28 57.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.40999999999999998 110.758 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -137.07 157.46 46.66 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.145 -0.972 . . . . 2.1499999999999999 110.605 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -39.83 89.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.711 -0.618 . . . . 1.03 111.724 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 3.3 p90 -60.59 -18.35 52.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.532 -1.355 . . . . 0.92000000000000004 110.849 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -80.19 -30.84 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.429 -1.323 . . . . 1.0800000000000001 107.429 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.91 -39.12 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.204 -1.036 . . . . 1.0700000000000001 108.204 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.07 -36.14 74.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.865 -1.531 . . . . 1.1499999999999999 106.865 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -43.73 93.83 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.241 -1.144 . . . . 0.19 110.241 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -60.05 -41.71 92.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 1.8200000000000001 109.438 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.13 -40.23 89.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.40000000000000002 108.762 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 77.6 mt -69.03 -39.8 78.99 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.987 -0.745 . . . . 1.0700000000000001 108.987 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.43 -23.07 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 1.0900000000000001 111.02 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.98 17.18 8.23 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 1.0900000000000001 110.094 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.33 29.86 7.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.07 -1.019 . . . . 2.23 110.47 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 59.88 19.82 8.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.523 -0.736 . . . . 2.7999999999999998 110.407 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -67.65 115.71 7.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.692 -1.255 . . . . 1.8 107.635 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -62.15 -40.33 95.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.402 -0.811 . . . . 0.88 113.083 -177.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -69.35 -40.02 77.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.393 -1.442 . . . . 0.73999999999999999 110.629 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.82 -40.06 72.7 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.867 -1.133 . . . . 1.2 109.296 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.81 -50.01 68.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.44 109.533 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.62 -45.23 94.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.241 -0.912 . . . . 3.3399999999999999 109.786 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -64.2 -39.43 93.96 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.991 -1.068 . . . . 2.3799999999999999 108.708 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.454 ' O ' ' OG1' ' B' ' 66' ' ' THR . 75.8 t90 -66.61 -47.49 72.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.40999999999999998 110.652 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.88 -49.15 69.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.15 -0.969 . . . . 1.0700000000000001 109.576 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.54 -49.06 78.23 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.482 -0.762 . . . . 2.6000000000000001 110.107 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.69 -26.38 65.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 1.8999999999999999 109.625 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 22.6 m -79.33 -34.47 42.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 1.1000000000000001 111.34 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 16.3 p -133.85 -22.19 1.87 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.464 -1.398 . . . . 0.95999999999999996 112.334 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 12.03 33.95 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.628 -1.389 . . . . 0.37 109.628 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.01 153.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.387 . . . . 1.0900000000000001 109.213 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.92 169.69 11.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.972 -1.08 . . . . 2.3700000000000001 109.829 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.14 71.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.534 -0.729 . . . . 1.1100000000000001 110.335 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -73.19 -39.25 65.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.915 -1.116 . . . . 2.9700000000000002 109.774 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.96 -36.83 84.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 2.6200000000000001 110.441 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.9 p -66.93 -36.81 83.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.297 -0.877 . . . . 1.8899999999999999 109.918 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -60.02 -39.19 84.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.95 -1.094 . . . . 3.3199999999999998 109.216 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -68.25 -39.9 82.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.788 -1.195 . . . . 0.40000000000000002 111.059 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 63.3 m -68.13 -39.97 82.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.782 -1.199 . . . . 0.95999999999999996 110.457 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.55 -59.37 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.559 -1.338 . . . . 0.5 109.625 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.44 -33.0 79.4 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.567 -1.013 . . . . 0.27000000000000002 110.567 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.74 -50.96 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.243 . . . . 0.93999999999999995 110.41 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.59 -40.48 73.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.768 -1.173 . . . . 1.0900000000000001 108.529 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -61.6 -41.04 96.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.434 -0.791 . . . . 3.1899999999999999 110.207 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -69.8 -38.51 76.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 1.9099999999999999 110.53 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 90.0 t90 -60.03 -43.38 95.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.423 -1.423 . . . . 0.40000000000000002 107.871 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' B' ' 89' ' ' LEU . 23.9 m -60.34 -40.08 89.4 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.7 0.762 . . . . 0.96999999999999997 109.539 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.13 -33.2 71.81 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.256 -0.902 . . . . 0.55000000000000004 109.905 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.07 -34.39 13.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.02 -1.05 . . . . 1.1299999999999999 111.095 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 97.8 m-85 -110.04 1.92 19.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.083 -1.011 . . . . 1.24 111.654 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.5 tp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.837 -1.164 . . . . 1.8300000000000001 109.317 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.28 0.562 . . . . 6.1100000000000003 109.522 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m -89.99 -1.41 57.96 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.699 -0.852 . . . . 3.5800000000000001 108.699 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -71.45 164.82 25.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.485 -0.76 . . . . 1.3200000000000001 109.843 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.8 p -62.02 169.98 2.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 1.98 110.016 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -58.04 -19.99 35.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.669 -0.644 . . . . 2.6000000000000001 110.845 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.21 -38.38 86.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 2.5099999999999998 109.197 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.481 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 24.3 t60 -59.95 -53.92 52.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.196 -0.94 . . . . 0.51000000000000001 110.516 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -69.97 -35.57 74.55 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.958 -1.088 . . . . 3.7200000000000002 110.105 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.02 -39.91 75.53 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.295 -0.878 . . . . 0.76000000000000001 109.737 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.64 -44.52 96.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.5 109.784 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.7 m -83.39 15.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.056 -1.027 . . . . 1.1799999999999999 109.598 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.79 -13.12 14.53 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.486 -0.759 . . . . 1.1799999999999999 110.32 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.77 151.59 20.88 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.979 -1.076 . . . . 1.26 109.537 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -40.13 156.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.067 1.845 . . . . 0.53000000000000003 111.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.64 -18.73 23.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.878 -1.139 . . . . 1.1399999999999999 109.941 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.09 -140.18 35.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.735 -1.346 . . . . 0.41999999999999998 109.735 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -103.82 30.69 4.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.37 -1.077 . . . . 0.84999999999999998 109.982 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -60.07 147.76 79.56 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.065 -1.022 . . . . 2.4900000000000002 108.431 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.67 158.3 46.97 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.372 2.048 . . . . 0.39000000000000001 112.557 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 22' ' ' SER . 2.3 p -56.93 -48.71 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 1.1200000000000001 110.233 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.07 -3.71 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.402 -1.079 . . . . 0.27000000000000002 110.402 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 20' ' ' VAL . 7.8 t -82.84 -20.76 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.935 -1.333 . . . . 1.75 109.165 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.11 139.96 58.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 1.05 109.73 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 133.07 50.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.812 0.815 . . . . 1.0600000000000001 110.282 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.08 -20.34 47.97 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 109.839 -1.304 . . . . 0.23000000000000001 109.839 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.2 117.1 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -1.198 . . . . 1.0800000000000001 108.019 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.23 177.31 37.91 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.726 -1.35 . . . . 0.31 109.726 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.02 -40.02 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -1.08 . . . . 2.0099999999999998 109.888 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.03 -47.36 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.085 . . . . 1.1399999999999999 109.1 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.04 -39.41 93.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.376 -0.828 . . . . 1.1299999999999999 109.407 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.7 97.38 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 110.044 -1.222 . . . . 0.34999999999999998 110.044 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -60.28 -40.02 88.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.406 . . . . 3.2200000000000002 110.517 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.2 -45.95 75.37 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.797 -1.161 . . . . 2.1000000000000001 109.771 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.0 -41.13 99.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.858 -1.151 . . . . 1.0800000000000001 109.917 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.22 -40.64 90.89 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.114 -1.034 . . . . 1.6699999999999999 109.383 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.65 -19.66 65.81 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.648 -0.871 . . . . 2.0 108.648 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' A' ' 37' ' ' ARG . 51.0 mtt-85 -91.01 5.62 48.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.487 -0.758 . . . . 3.1499999999999999 110.433 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.57 49.19 Favored Glycine 0 N--CA 1.502 3.045 0 O-C-N 121.09 -1.006 . . . . 0.47999999999999998 112.075 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -102.38 72.81 1.29 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.597 -1.531 . . . . 0.38 108.579 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -77.9 -12.56 59.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.40999999999999998 110.679 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.853 ' C ' ' CA ' ' A' ' 42' ' ' ALA . 43.9 mmtm . . . . . 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 2.1600000000000001 109.423 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.853 ' CA ' ' C ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 120.773 0.32 . . . . 1.03 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.462 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 26.3 p90 -55.68 -17.4 5.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.683 -1.261 . . . . 0.92000000000000004 110.478 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.25 -33.14 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.844 -1.169 . . . . 1.0700000000000001 107.844 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.36 -38.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.235 -1.024 . . . . 1.0600000000000001 108.235 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.97 -36.82 77.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.89 -1.152 . . . . 1.1599999999999999 107.89 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.04 98.16 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.96 -1.256 . . . . 0.20000000000000001 109.96 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.97 -41.12 91.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.886 -1.361 . . . . 1.8200000000000001 109.208 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.94 -39.99 87.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.99 . . . . 0.40000000000000002 108.525 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.26 -37.55 80.86 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.573 -0.851 . . . . 1.0900000000000001 108.716 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.07 -26.75 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.289 -0.882 . . . . 1.0900000000000001 110.142 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -91.59 14.89 13.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.099 -1.001 . . . . 1.0900000000000001 110.52 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 50.09 40.01 20.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.726 -1.234 . . . . 2.2200000000000002 111.055 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.28 18.99 4.63 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.267 -0.895 . . . . 2.7999999999999998 110.492 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.78 107.77 3.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.776 -1.203 . . . . 1.8 108.193 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 85.1 tt0 -62.91 -40.81 98.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.407 -0.808 . . . . 0.87 112.679 -178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -68.69 -39.64 80.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.847 -1.158 . . . . 0.72999999999999998 109.686 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.96 -38.63 76.15 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.18 -1.008 . . . . 1.2 109.026 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -62.83 -45.91 90.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.44 109.444 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mtt180 -60.0 -47.7 84.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.393 -0.817 . . . . 3.3399999999999999 110.927 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.4 -39.68 94.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.889 -1.132 . . . . 2.3700000000000001 108.923 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.465 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.3 t90 -61.91 -49.97 74.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.40999999999999998 111.46 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 22.5 tp -66.67 -46.13 76.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.852 -1.155 . . . . 1.0800000000000001 109.923 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.68 -46.67 81.43 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.322 -0.861 . . . . 2.6099999999999999 109.874 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.1 -31.53 70.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.386 -0.821 . . . . 1.8999999999999999 109.538 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 75.7 m -77.74 -38.26 47.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.259 -0.901 . . . . 1.1100000000000001 111.463 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 26.6 p -129.45 -24.33 2.8 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.479 -1.388 . . . . 0.96999999999999997 111.854 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.46 13.55 28.0 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.182 -1.567 . . . . 0.38 109.182 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.81 154.57 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.035 -1.274 . . . . 1.1000000000000001 109.097 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.91 170.04 11.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 2.3700000000000001 109.53 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -31.61 70.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 1.1200000000000001 110.773 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -73.89 -40.02 63.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 2.9700000000000002 110.214 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.51 -33.7 76.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.416 -0.803 . . . . 2.6200000000000001 110.328 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p -68.39 -37.68 80.63 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.219 -0.926 . . . . 1.8899999999999999 109.824 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.47 -38.45 84.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.94 -1.1 . . . . 3.3199999999999998 109.644 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.45 -39.96 81.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.622 -1.299 . . . . 0.40000000000000002 110.485 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -70.01 -40.7 75.08 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.882 -1.136 . . . . 0.95999999999999996 109.327 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -60.19 -60.02 4.48 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.809 -1.182 . . . . 0.5 109.654 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.22 91.78 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.212 -0.93 . . . . 0.27000000000000002 110.876 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -68.21 -50.13 56.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.734 -1.45 . . . . 0.93999999999999995 109.847 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.14 -39.93 75.1 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.146 -1.022 . . . . 1.0900000000000001 109.218 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -62.35 -39.97 94.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -0.99 . . . . 3.1800000000000002 109.743 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.8 mt-10 -70.01 -36.62 75.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 1.9099999999999999 109.83 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.596 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 80.5 t90 -59.92 -41.75 92.42 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.488 -1.383 . . . . 0.40000000000000002 107.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.0 m -63.1 -40.02 96.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.768 -0.827 . . . . 0.96999999999999997 108.768 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.1 -38.16 82.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.593 -0.692 . . . . 0.55000000000000004 109.835 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 -37.07 17.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 1.1200000000000001 110.065 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.596 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 72.2 m-85 -103.24 -86.68 0.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 1.24 110.327 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.917 -1.04 . . . . 1.8300000000000001 109.915 -178.55 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.328 0.585 . . . . 6.0999999999999996 109.501 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m -90.03 -1.53 57.98 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.641 -0.874 . . . . 3.5800000000000001 108.641 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -71.34 164.65 25.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.506 -0.746 . . . . 1.3200000000000001 109.814 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 99.5 p -61.89 170.03 2.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.452 -0.78 . . . . 1.97 110.011 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' B' ' 5' ' ' GLN . 0.0 OUTLIER -58.13 -20.05 37.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.632 -0.668 . . . . 2.5899999999999999 110.756 -178.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -61.15 -38.52 86.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.06 -1.025 . . . . 2.5 109.188 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.479 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 24.2 t60 -59.74 -53.91 52.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.51000000000000001 110.667 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -70.05 -35.43 74.26 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.002 -1.061 . . . . 3.73 110.162 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.15 -39.9 75.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 0.76000000000000001 109.647 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.51 -44.6 96.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.348 -0.845 . . . . 0.5 109.785 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 31.8 m -83.51 15.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.089 -1.007 . . . . 1.1799999999999999 109.572 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.82 -13.0 14.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.53 -0.731 . . . . 1.1799999999999999 110.368 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.84 151.57 20.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.908 -1.12 . . . . 1.27 109.498 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.06 156.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.992 1.795 . . . . 0.53000000000000003 111.775 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.72 -18.61 23.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.947 -1.095 . . . . 1.1299999999999999 109.963 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.86 -140.11 35.16 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.768 -1.333 . . . . 0.40999999999999998 109.768 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.82 30.59 5.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.45 -1.029 . . . . 0.83999999999999997 109.981 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -59.99 147.66 79.35 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 2.4900000000000002 108.45 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.59 158.28 46.72 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.365 2.043 . . . . 0.38 112.603 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' B' ' 22' ' ' SER . 2.2 p -57.0 -48.64 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.476 -0.765 . . . . 1.1200000000000001 110.169 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.14 -3.58 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.374 -1.09 . . . . 0.27000000000000002 110.374 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.516 ' H ' ' C ' ' B' ' 20' ' ' VAL . 7.8 t -82.96 -20.85 34.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.295 . . . . 1.75 109.129 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 98.7 mt -65.02 139.93 58.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 1.0600000000000001 109.78 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.17 132.9 50.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.784 0.802 . . . . 1.05 110.371 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.35 47.76 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.802 -1.319 . . . . 0.22 109.802 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.11 117.07 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.177 -1.19 . . . . 1.0800000000000001 108.044 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.09 177.26 38.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.697 -1.361 . . . . 0.29999999999999999 109.697 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -40.09 79.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 2.0 109.951 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.94 -47.49 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 1.1399999999999999 109.129 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.93 -39.54 93.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 1.1299999999999999 109.436 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.66 97.24 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 110.041 -1.224 . . . . 0.35999999999999999 110.041 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -60.24 -40.1 89.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.852 -1.381 . . . . 3.2200000000000002 110.503 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.21 -45.76 75.87 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.785 -1.166 . . . . 2.1200000000000001 109.786 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.01 -41.27 99.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 1.0800000000000001 110.002 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.77 90.5 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.171 -1.012 . . . . 1.6799999999999999 109.382 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.69 -19.62 65.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.631 -0.877 . . . . 1.99 108.631 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' B' ' 37' ' ' ARG . 50.7 mtt-85 -91.1 5.78 47.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.817 . . . . 3.1499999999999999 110.423 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.19 7.54 49.38 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.034 -1.041 . . . . 0.48999999999999999 112.112 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -102.43 72.93 1.29 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.704 -1.468 . . . . 0.38 108.624 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -78.06 -12.46 59.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.40999999999999998 110.664 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.46 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 44.0 mmtm -132.31 154.11 50.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.055 -1.028 . . . . 2.1499999999999999 109.419 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.99 91.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.298 -0.876 . . . . 1.03 111.73 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 25.7 p90 -55.82 -17.32 5.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.671 -1.268 . . . . 0.92000000000000004 110.397 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.21 -33.02 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.93 -1.137 . . . . 1.0800000000000001 107.93 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.5 -38.73 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.208 -1.034 . . . . 1.0700000000000001 108.208 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.99 -36.9 78.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.899 -1.148 . . . . 1.1499999999999999 107.899 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.89 -42.1 98.05 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.997 -1.241 . . . . 0.19 109.997 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.96 -40.99 90.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.004 -1.292 . . . . 1.8200000000000001 109.231 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.95 -40.14 87.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.40000000000000002 108.43 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.21 -37.84 81.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.611 -0.885 . . . . 1.0700000000000001 108.611 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.93 -26.59 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.829 . . . . 1.0900000000000001 110.179 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.6 14.95 13.6 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.097 -1.002 . . . . 1.0900000000000001 110.539 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.705 -1.247 . . . . 2.23 111.045 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.26 19.02 4.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.371 -0.831 . . . . 2.7999999999999998 110.504 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.73 107.82 3.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.809 -1.182 . . . . 1.8 108.131 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 85.2 tt0 -62.84 -41.09 99.2 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.398 -0.813 . . . . 0.88 112.704 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.54 -39.59 81.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.805 -1.184 . . . . 0.73999999999999999 109.692 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.0 -38.52 76.01 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.201 -1.0 . . . . 1.2 109.06 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.06 -45.72 90.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.44 109.507 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 98.9 mtt180 -60.05 -47.76 84.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.785 . . . . 3.3399999999999999 110.974 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -64.3 -39.68 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.896 -1.128 . . . . 2.3799999999999999 108.946 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.46 ' O ' ' OG1' ' B' ' 66' ' ' THR . 68.3 t90 -61.92 -50.05 73.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.40999999999999998 111.423 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.469 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 22.6 tp -66.63 -46.23 76.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.897 -1.127 . . . . 1.0700000000000001 109.952 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.56 -46.71 81.63 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 2.6000000000000001 109.9 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.08 -31.51 70.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 1.8999999999999999 109.49 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 77.1 m -77.7 -38.3 47.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.868 . . . . 1.1000000000000001 111.496 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 26.6 p -129.43 -24.3 2.81 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.581 -1.325 . . . . 0.95999999999999996 111.891 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.45 13.63 27.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.189 -1.564 . . . . 0.37 109.189 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.74 154.63 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.264 . . . . 1.0900000000000001 109.114 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.97 170.02 11.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 2.3700000000000001 109.515 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.03 -31.47 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 1.1100000000000001 110.741 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -74.04 -40.0 63.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.961 -1.087 . . . . 2.9700000000000002 110.204 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -66.6 -33.57 75.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.412 -0.805 . . . . 2.6200000000000001 110.272 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 32.9 p -68.52 -37.55 80.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.208 -0.933 . . . . 1.8899999999999999 109.805 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.49 -38.5 84.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.885 -1.134 . . . . 3.3199999999999998 109.689 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -68.34 -39.97 81.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.679 -1.263 . . . . 0.40000000000000002 110.595 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.98 -40.8 75.13 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.845 -1.16 . . . . 0.95999999999999996 109.33 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -60.08 -60.04 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.141 . . . . 0.5 109.718 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.18 91.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.829 -0.908 . . . . 0.27000000000000002 110.829 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.27 -50.16 55.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.731 -1.453 . . . . 0.93999999999999995 109.85 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.03 -40.02 75.44 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.123 -1.031 . . . . 1.0900000000000001 109.256 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -62.14 -40.11 94.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.123 -0.986 . . . . 3.1899999999999999 109.762 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.479 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.8 mt-10 -70.05 -36.57 75.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.09 -1.006 . . . . 1.9099999999999999 109.866 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 80.2 t90 -59.89 -41.89 92.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.525 -1.36 . . . . 0.40000000000000002 107.702 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.8 m -63.02 -40.11 96.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.816 -0.809 . . . . 0.96999999999999997 108.816 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.0 -38.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.627 -0.671 . . . . 0.55000000000000004 109.858 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -37.65 16.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.198 -0.939 . . . . 1.1299999999999999 110.057 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.8 m-85 -102.26 -86.66 0.42 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.188 -0.945 . . . . 1.24 110.376 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.016 -0.992 . . . . 1.8300000000000001 109.945 -178.39 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 76.1 mtm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.382 0.61 . . . . 6.1100000000000003 109.398 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.2 p -90.77 6.04 45.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.382 -0.823 . . . . 3.5800000000000001 109.356 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.433 ' OG1' ' CB ' ' A' ' 7' ' ' HIS . 19.7 p -69.57 167.17 17.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 1.3200000000000001 109.941 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.4 p -55.24 176.61 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -0.81 . . . . 1.98 110.349 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.91 -19.52 65.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.88 -0.513 . . . . 2.6000000000000001 110.219 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -60.02 -37.45 79.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.049 -1.032 . . . . 2.5099999999999998 109.573 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.433 ' CB ' ' OG1' ' A' ' 3' ' ' THR . 30.9 t60 -59.92 -50.78 72.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.167 -0.958 . . . . 0.51000000000000001 110.507 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' NH2' ' O ' ' A' ' 1' ' ' MET . 38.7 mtt-85 -70.02 -33.7 72.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.954 -1.091 . . . . 3.7200000000000002 110.224 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.66 -38.99 77.32 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.305 -0.872 . . . . 0.76000000000000001 109.43 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -64.6 -47.4 78.75 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.393 -0.817 . . . . 0.5 110.506 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -85.11 11.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.154 -0.966 . . . . 1.1799999999999999 111.054 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.08 -11.73 15.57 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.193 -0.942 . . . . 1.1799999999999999 109.821 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.58 151.49 20.96 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.963 . . . . 1.26 108.976 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -39.9 161.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.892 1.728 . . . . 0.53000000000000003 111.506 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.8 ptp -90.6 -20.22 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.029 -1.044 . . . . 1.1399999999999999 109.479 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.56 -139.96 21.01 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.205 -1.158 . . . . 0.41999999999999998 110.205 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.97 24.95 10.55 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.544 -0.974 . . . . 0.84999999999999998 109.792 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -60.8 148.69 82.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.098 -1.001 . . . . 2.4900000000000002 108.934 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.17 158.76 33.34 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.508 2.139 . . . . 0.39000000000000001 113.307 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' A' ' 22' ' ' SER . 11.1 p -59.59 -44.96 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.657 0.742 . . . . 1.1200000000000001 110.328 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.21 -3.0 0.18 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.567 -1.013 . . . . 0.27000000000000002 110.567 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 20' ' ' VAL . 68.4 m -82.7 -19.15 38.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.769 -1.43 . . . . 1.75 109.436 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.18 137.41 56.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 1.05 109.639 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.2 134.75 54.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.737 -0.785 . . . . 1.0600000000000001 109.842 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.08 48.07 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.316 -1.514 . . . . 0.23000000000000001 109.316 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -98.35 113.18 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 1.0800000000000001 108.007 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.8 179.27 38.33 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 120.623 -1.298 . . . . 0.31 109.952 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -57.29 -40.1 77.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.525 -0.985 . . . . 2.0099999999999998 110.374 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.95 -46.26 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 1.1399999999999999 109.743 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.57 -37.55 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 1.1299999999999999 109.62 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.79 95.73 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.128 -1.589 . . . . 0.34999999999999998 109.128 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.18 -39.98 95.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -1.087 . . . . 3.2200000000000002 109.935 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.66 -44.72 69.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.88 -1.137 . . . . 2.1000000000000001 109.44 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.66 -40.01 95.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.955 -1.128 . . . . 1.0800000000000001 107.955 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.04 -41.52 92.43 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.976 -0.75 . . . . 1.6699999999999999 108.976 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.28 -19.91 64.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.682 -0.859 . . . . 2.0 108.682 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -90.35 0.94 57.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 3.1499999999999999 109.68 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 37.79 3.84 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 120.305 -0.95 . . . . 0.47999999999999998 111.239 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -133.84 72.6 1.48 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.968 -1.313 . . . . 0.38 108.995 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -80.28 -10.73 59.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.40999999999999998 110.729 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.88 152.04 51.31 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.127 -0.983 . . . . 2.1600000000000001 110.017 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.96 90.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 1.03 111.823 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.46 -17.77 9.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.758 -1.214 . . . . 0.92000000000000004 110.603 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.4 -31.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.821 -1.174 . . . . 1.0700000000000001 107.914 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.54 -36.7 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.343 -0.984 . . . . 1.0600000000000001 108.343 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.01 -37.84 80.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.983 -1.488 . . . . 1.1599999999999999 106.983 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.3 87.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.986 -1.246 . . . . 0.20000000000000001 109.986 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.08 -42.27 94.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.339 . . . . 1.8200000000000001 108.901 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.357 -0.979 . . . . 0.40000000000000002 108.357 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.06 -39.93 75.39 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.756 -0.831 . . . . 1.0900000000000001 108.756 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.81 -26.7 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.176 -0.952 . . . . 1.0900000000000001 111.358 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.2 16.13 6.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.9 -1.125 . . . . 1.0900000000000001 110.217 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.34 21.67 5.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 2.2200000000000002 110.167 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.15 19.6 8.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.707 -0.62 . . . . 2.7999999999999998 110.311 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.9 122.1 17.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.585 -1.322 . . . . 1.8 107.777 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' OE2' ' CG ' ' A' ' 78' ' ' PHE . 8.5 tp10 -61.97 -41.56 98.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.286 0.847 . . . . 0.87 113.286 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -69.96 -39.86 75.75 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.411 -1.431 . . . . 0.72999999999999998 110.787 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.08 -39.9 75.33 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.917 -1.113 . . . . 1.2 109.067 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.6 -48.48 79.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.268 -0.895 . . . . 0.44 109.482 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.08 -47.12 87.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.356 -0.84 . . . . 3.3399999999999999 110.978 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.13 -39.88 94.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.749 -1.219 . . . . 2.3700000000000001 108.885 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.442 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.0 t90 -61.58 -50.05 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.40999999999999998 111.414 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.42 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 61.7 tp -67.65 -47.29 69.97 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.145 -0.972 . . . . 1.0800000000000001 110.146 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -63.33 -46.7 85.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 2.6099999999999999 109.869 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.37 -30.81 69.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 1.8999999999999999 109.696 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 99.6 m -79.01 -35.14 43.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 1.1100000000000001 111.247 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 27.9 p -131.79 -34.73 1.3 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.541 -1.35 . . . . 0.96999999999999997 111.722 -178.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.97 15.87 10.37 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.422 -1.471 . . . . 0.38 109.422 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 153.05 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.282 . . . . 1.1000000000000001 109.04 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.496 ' H ' HE21 ' A' ' 73' ' ' GLN . 28.1 t-20 -89.68 170.68 10.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 2.3700000000000001 109.348 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.27 72.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.504 -0.748 . . . . 1.1200000000000001 110.94 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -71.63 -41.43 68.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.717 -1.24 . . . . 2.9700000000000002 110.566 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.496 HE21 ' H ' ' A' ' 70' ' ' ASN . 36.6 mt-30 -67.32 -36.52 81.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 2.6200000000000001 110.386 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.135 -0.978 . . . . 1.8899999999999999 110.466 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -59.95 -36.59 77.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.675 -1.266 . . . . 3.3199999999999998 108.701 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.4 -39.29 81.71 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.83 -1.169 . . . . 0.40000000000000002 110.27 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.21 -41.14 81.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.791 -1.193 . . . . 0.95999999999999996 109.59 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CG ' ' OE2' ' A' ' 56' ' ' GLU . 64.7 t80 -60.01 -59.81 4.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.819 -1.176 . . . . 0.5 109.41 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -34.88 85.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.992 -1.243 . . . . 0.27000000000000002 109.992 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.8 -45.45 67.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -1.186 . . . . 0.93999999999999995 109.465 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.58 -41.91 68.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 1.0900000000000001 109.117 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.15 -41.16 96.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 3.1800000000000002 109.527 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -70.05 -37.89 75.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 1.9099999999999999 110.603 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.48 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.8 t90 -59.99 -43.5 95.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.393 -1.442 . . . . 0.40000000000000002 107.815 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 89' ' ' LEU . 22.0 m -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.572 -0.705 . . . . 0.96999999999999997 109.358 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -59.2 -34.21 71.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.55000000000000004 110.21 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.75 -34.34 13.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.296 -0.878 . . . . 1.1200000000000001 111.352 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 94.8 m-85 -111.19 3.08 18.18 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 120.984 -1.073 . . . . 1.24 112.033 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . 10.5 tp . . . . . 0 N--CA 1.5 2.07 0 O-C-N 120.839 -1.163 . . . . 1.8300000000000001 109.892 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.48 ' O ' ' NH2' ' B' ' 8' ' ' ARG . 76.2 mtm . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.448 0.642 . . . . 6.0999999999999996 109.402 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 39.9 p -90.76 6.05 45.76 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.334 -0.854 . . . . 3.5800000000000001 109.348 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.423 ' OG1' ' CB ' ' B' ' 7' ' ' HIS . 20.0 p -69.53 167.17 17.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 1.3200000000000001 110.007 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p -55.23 176.7 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.86 0.838 . . . . 1.97 110.326 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.86 -19.6 65.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.819 -0.551 . . . . 2.5899999999999999 110.21 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.0 -37.35 79.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.108 -0.995 . . . . 2.5 109.665 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.423 ' CB ' ' OG1' ' B' ' 3' ' ' THR . 31.4 t60 -59.96 -50.85 72.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.126 -0.984 . . . . 0.51000000000000001 110.449 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' B' ' 1' ' ' MET . 38.8 mtt-85 -70.04 -33.71 72.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 3.73 110.165 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.58 -39.26 77.44 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.202 -0.936 . . . . 0.76000000000000001 109.377 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.32 -47.54 79.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.838 . . . . 0.5 110.457 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -85.3 11.6 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 1.1799999999999999 111.139 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.21 -11.92 15.49 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.238 -0.914 . . . . 1.1799999999999999 109.759 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.45 151.63 21.43 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.091 -1.006 . . . . 1.27 108.97 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.97 161.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.847 1.698 . . . . 0.53000000000000003 111.585 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 8.9 ptp -90.74 -19.79 23.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 1.1299999999999999 109.561 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.11 -140.1 18.32 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.047 -1.221 . . . . 0.40999999999999998 110.047 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.74 25.09 10.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.981 . . . . 0.83999999999999997 109.848 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -61.03 148.92 83.35 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.908 -1.12 . . . . 2.4900000000000002 108.879 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.22 158.78 33.49 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.412 2.075 . . . . 0.38 113.315 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' B' ' 22' ' ' SER . 11.2 p -59.64 -44.95 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.625 0.726 . . . . 1.1200000000000001 110.273 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.403 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -54.22 -2.81 0.17 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.591 -1.003 . . . . 0.27000000000000002 110.591 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.518 ' H ' ' C ' ' B' ' 20' ' ' VAL . 68.5 m -82.91 -19.33 37.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.793 -1.416 . . . . 1.75 109.34 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.97 137.42 57.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.965 . . . . 1.0600000000000001 109.651 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.47 134.4 53.34 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.805 . . . . 1.05 109.995 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 -20.91 48.79 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.236 -1.545 . . . . 0.22 109.236 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 mm -98.44 113.1 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.263 -1.139 . . . . 1.0800000000000001 107.961 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.74 179.05 38.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.913 -1.275 . . . . 0.29999999999999999 109.913 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.16 -40.04 76.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 2.0 110.353 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.99 -46.41 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 1.1399999999999999 109.725 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 93.3 mt -65.26 -37.68 87.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 1.1299999999999999 109.666 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.82 95.68 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.256 -1.538 . . . . 0.35999999999999999 109.256 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.24 -39.92 94.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.392 -1.064 . . . . 3.2200000000000002 109.922 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.6 -44.9 69.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.844 -1.16 . . . . 2.1200000000000001 109.331 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.55 -39.92 95.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.016 -1.105 . . . . 1.0800000000000001 108.016 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -41.56 92.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.945 -0.761 . . . . 1.6799999999999999 108.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -68.19 -20.13 64.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.633 -0.877 . . . . 1.99 108.633 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -90.15 1.3 56.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.495 -0.753 . . . . 3.1499999999999999 109.646 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.45 37.8 3.91 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.115 -0.991 . . . . 0.48999999999999999 111.127 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -134.01 72.75 1.48 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.977 -1.308 . . . . 0.38 108.956 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -80.57 -10.57 59.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.089 -1.007 . . . . 0.40999999999999998 110.8 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.95 152.31 51.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.204 -0.935 . . . . 2.1499999999999999 110.038 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.63 91.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 1.03 111.848 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.58 -17.96 10.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.577 -1.327 . . . . 0.92000000000000004 110.51 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 43.8 t -79.43 -31.65 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.797 -1.19 . . . . 1.0800000000000001 107.841 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.46 -36.76 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.39 -0.967 . . . . 1.0700000000000001 108.39 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.0 tp -60.01 -38.12 81.73 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.802 -1.555 . . . . 1.1499999999999999 106.802 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.63 85.42 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.936 -1.266 . . . . 0.19 109.936 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -42.31 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.881 -1.364 . . . . 1.8200000000000001 108.819 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -40.16 88.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.356 -0.979 . . . . 0.40000000000000002 108.356 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 65.4 mt -69.96 -40.06 75.63 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.725 -0.843 . . . . 1.0700000000000001 108.725 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.62 -26.66 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.167 -0.958 . . . . 1.0900000000000001 111.276 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.38 16.45 6.39 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.035 -1.041 . . . . 1.0900000000000001 110.237 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.16 21.79 5.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.885 . . . . 2.23 110.092 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 80.5 mttt 59.99 19.19 8.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.75 -0.593 . . . . 2.7999999999999998 110.386 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.62 122.29 17.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.561 -1.337 . . . . 1.8 107.664 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE2' ' CG ' ' B' ' 78' ' ' PHE . 8.5 tp10 -62.0 -42.04 98.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.88 113.289 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.54 -39.97 77.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.339 -1.476 . . . . 0.73999999999999999 110.694 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.09 -40.01 75.23 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.99 -1.084 . . . . 1.2 109.035 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.56 -48.38 79.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.44 109.544 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.03 -47.61 85.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 3.3399999999999999 110.846 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.03 -39.46 94.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.715 -1.241 . . . . 2.3799999999999999 108.953 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -61.83 -49.91 74.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.339 -0.85 . . . . 0.40999999999999998 111.377 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.408 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 61.5 tp -67.68 -47.67 68.79 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.196 -0.94 . . . . 1.0700000000000001 110.069 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -62.94 -46.78 86.14 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.917 . . . . 2.6000000000000001 109.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.32 -30.75 69.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.8999999999999999 109.655 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 99.7 m -79.11 -35.14 42.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 1.1000000000000001 111.354 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 27.9 p -131.59 -35.18 1.31 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.639 -1.288 . . . . 0.95999999999999996 111.787 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.26 16.22 9.82 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 109.341 -1.503 . . . . 0.37 109.341 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.51 153.14 1.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.866 -1.373 . . . . 1.0900000000000001 109.078 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.513 ' H ' HE21 ' B' ' 73' ' ' GLN . 28.1 t-20 -89.86 170.56 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.089 -1.007 . . . . 2.3700000000000001 109.329 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.35 -32.97 71.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.507 -0.746 . . . . 1.1100000000000001 111.0 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -71.89 -41.45 67.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.751 -1.218 . . . . 2.9700000000000002 110.441 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.513 HE21 ' H ' ' B' ' 70' ' ' ASN . 36.6 mt-30 -67.32 -36.38 81.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 2.6200000000000001 110.447 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.65 -38.35 83.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.352 -0.842 . . . . 1.8899999999999999 110.442 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -60.01 -36.45 77.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.748 -1.22 . . . . 3.3199999999999998 108.746 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.64 -39.47 80.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.782 -1.199 . . . . 0.40000000000000002 110.187 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.07 -41.23 82.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.987 -1.07 . . . . 0.95999999999999996 109.529 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.526 ' CG ' ' OE2' ' B' ' 56' ' ' GLU . 64.4 t80 -60.02 -59.77 4.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.819 -1.176 . . . . 0.5 109.507 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.03 -34.86 85.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.935 -1.266 . . . . 0.27000000000000002 109.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.87 -45.71 67.09 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.152 -1.205 . . . . 0.93999999999999995 109.364 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.41 -41.67 69.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.999 . . . . 1.0900000000000001 109.151 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.37 -40.98 96.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.881 . . . . 3.1899999999999999 109.605 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.96 -38.04 75.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.164 -0.96 . . . . 1.9099999999999999 110.604 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.481 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.9 t90 -59.99 -43.5 95.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.332 -1.48 . . . . 0.40000000000000002 107.718 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' B' ' 89' ' ' LEU . 22.3 m -60.06 -40.05 88.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.637 -0.664 . . . . 0.96999999999999997 109.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -59.07 -34.11 71.58 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 110.288 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.76 -35.02 13.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.009 -1.057 . . . . 1.1299999999999999 111.377 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.481 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.2 m-85 -109.91 2.16 19.62 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.12 -0.987 . . . . 1.24 112.272 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.0 tp . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.716 -1.24 . . . . 1.8300000000000001 109.944 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' C ' ' H ' ' A' ' 3' ' ' THR . 16.1 mmt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.313 -0.625 . . . . 6.1100000000000003 109.313 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 59.94 8.28 1.38 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.919 . . . . 3.5800000000000001 109.013 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 1' ' ' MET . 20.1 p -87.03 169.99 11.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.459 -0.776 . . . . 1.3200000000000001 109.564 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.5 m -62.44 162.96 9.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 1.98 109.928 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.75 -23.96 46.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.783 -0.573 . . . . 2.6000000000000001 110.208 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.13 -38.41 82.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.921 . . . . 2.5099999999999998 108.932 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -60.04 -52.23 66.24 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.463 -0.773 . . . . 0.51000000000000001 110.795 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -69.94 -35.41 74.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.963 -1.086 . . . . 3.7200000000000002 109.766 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -65.49 -40.01 92.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.82 . . . . 0.76000000000000001 109.342 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 44.4 t80 -63.14 -49.65 73.53 Favored 'General case' 0 C--N 1.298 -1.63 0 C-N-CA 119.642 -0.823 . . . . 0.5 110.003 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.35 6.04 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.105 -0.997 . . . . 1.1799999999999999 111.231 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.27 -18.77 17.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.93 -1.106 . . . . 1.1799999999999999 110.057 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' PRO . 6.5 pt-20 -151.96 151.94 28.96 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.154 -0.967 . . . . 1.26 108.917 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 13' ' ' GLU . 69.6 Cg_exo -36.76 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.2 1.933 . . . . 0.53000000000000003 111.688 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 15.6 ptm -93.66 -29.64 15.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.104 -0.997 . . . . 1.1399999999999999 110.15 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 -135.28 44.7 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.205 -1.158 . . . . 0.41999999999999998 110.205 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.97 35.3 3.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.676 -0.896 . . . . 0.84999999999999998 110.014 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.26 148.59 71.76 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 2.4900000000000002 108.47 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.28 156.2 41.85 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.025 1.817 . . . . 0.39000000000000001 112.048 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 22' ' ' SER . 7.4 p -57.01 -48.13 82.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.442 -0.786 . . . . 1.1200000000000001 110.22 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.84 -3.81 0.23 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.716 -0.954 . . . . 0.27000000000000002 110.716 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 20' ' ' VAL . 70.7 m -83.16 -21.54 33.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.709 -1.465 . . . . 1.75 109.422 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.36 136.79 57.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.038 -1.039 . . . . 1.05 109.418 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.59 136.17 56.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.763 0.792 . . . . 1.0600000000000001 109.758 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.27 -20.07 52.24 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.741 -1.744 . . . . 0.23000000000000001 108.741 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.83 115.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.908 -1.145 . . . . 1.0800000000000001 107.908 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.21 177.02 42.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.825 -1.31 . . . . 0.31 109.825 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.76 -39.93 74.9 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.629 -0.924 . . . . 2.0099999999999998 109.914 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.82 -44.47 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.05 . . . . 1.1399999999999999 109.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.77 -37.46 84.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.9 . . . . 1.1299999999999999 109.47 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.246 -1.542 . . . . 0.34999999999999998 109.246 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.82 -39.86 94.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.405 -1.056 . . . . 3.2200000000000002 110.367 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 67' ' ' CYS . 50.6 mtpt -65.44 -48.45 72.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.859 -1.151 . . . . 2.1000000000000001 109.948 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.69 -36.03 79.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.909 -1.119 . . . . 1.0800000000000001 108.485 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.739 -0.601 . . . . 1.6699999999999999 110.058 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.02 -19.37 65.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.995 . . . . 2.0 108.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 37' ' ' ARG . 33.8 mtt-85 -91.05 6.59 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.595 -0.691 . . . . 3.1499999999999999 110.25 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.7 55.43 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.978 -1.076 . . . . 0.47999999999999998 111.688 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -103.86 72.99 1.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.835 -1.391 . . . . 0.38 108.341 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.06 -10.72 59.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.459 -0.776 . . . . 0.40999999999999998 110.628 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.5 150.27 50.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.167 -0.958 . . . . 2.1600000000000001 109.62 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.99 94.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 1.03 110.827 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 17.0 p90 -60.55 -18.64 53.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.016 -1.052 . . . . 0.92000000000000004 110.371 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.57 -32.74 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.434 -1.321 . . . . 1.0700000000000001 107.434 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.74 -37.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.096 -1.075 . . . . 1.0600000000000001 108.096 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.8 tp -59.99 -35.46 75.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.569 -1.271 . . . . 1.1599999999999999 107.569 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.54 97.08 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.166 -1.173 . . . . 0.20000000000000001 110.166 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -59.97 -41.66 92.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.01 -1.288 . . . . 1.8200000000000001 109.778 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.40000000000000002 108.741 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -38.77 81.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.723 -0.843 . . . . 1.0900000000000001 108.723 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.02 -24.54 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.347 -0.846 . . . . 1.0900000000000001 110.629 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.23 18.37 9.61 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.121 -0.987 . . . . 1.0900000000000001 110.444 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.36 33.55 7.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.768 -1.207 . . . . 2.2200000000000002 110.126 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.05 19.92 9.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.751 -0.593 . . . . 2.7999999999999998 110.382 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.47 113.38 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.609 -1.307 . . . . 1.8 107.719 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.84 -40.03 93.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.87 113.16 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -69.81 -39.7 76.37 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.615 -1.303 . . . . 0.72999999999999998 110.578 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.57 -38.77 77.54 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.75 -1.18 . . . . 1.2 108.921 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.92 -50.59 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.44 109.983 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.498 HH11 ' HG3' ' A' ' 60' ' ' ARG . 5.4 mtm-85 -62.54 -43.71 98.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 3.3399999999999999 109.841 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.95 -39.78 94.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 2.3700000000000001 108.797 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.461 ' O ' ' OG1' ' A' ' 66' ' ' THR . 55.9 t90 -65.45 -46.32 80.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.40999999999999998 110.526 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 tp -67.56 -49.45 63.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 1.0800000000000001 110.017 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.75 -48.87 79.86 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.381 -0.825 . . . . 2.6099999999999999 109.969 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 28.8 t0 -68.95 -28.97 67.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.704 . . . . 1.8999999999999999 109.862 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 50.3 m -79.5 -34.55 41.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.254 -0.903 . . . . 1.1100000000000001 111.019 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.412 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 23.3 p -131.56 -29.52 1.74 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.648 -1.283 . . . . 0.96999999999999997 111.749 -178.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.6 14.19 20.38 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.382 -1.487 . . . . 0.38 109.382 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.44 1.69 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.047 -1.266 . . . . 1.1000000000000001 109.015 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -90.6 171.19 9.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.084 -1.01 . . . . 2.3700000000000001 109.737 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -34.01 72.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 1.1200000000000001 110.746 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.19 -40.54 67.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.618 -1.301 . . . . 2.9700000000000002 109.993 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.79 -39.98 79.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.112 -0.993 . . . . 2.6200000000000001 110.409 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -67.41 -39.05 85.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.27 -0.894 . . . . 1.8899999999999999 110.028 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -59.97 -38.65 83.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 3.3199999999999998 109.421 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.43 -39.94 85.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.712 -1.243 . . . . 0.40000000000000002 110.482 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -66.78 -40.03 88.03 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.915 -1.115 . . . . 0.95999999999999996 109.86 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.03 -59.97 4.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.599 -1.313 . . . . 0.5 110.044 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.67 84.97 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.443 -1.063 . . . . 0.27000000000000002 110.443 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.13 -49.94 52.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -1.134 . . . . 0.93999999999999995 109.867 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.07 -39.98 75.31 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.792 -1.163 . . . . 1.0900000000000001 108.775 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.23 -41.18 99.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 3.1800000000000002 110.18 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -69.87 -35.94 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.927 -1.108 . . . . 1.9099999999999999 109.569 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.443 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 80.2 t90 -59.98 -43.92 94.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.944 -1.502 . . . . 0.40000000000000002 106.944 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 34.9 m -60.98 -40.03 91.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.827 -0.805 . . . . 0.96999999999999997 108.827 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.66 81.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.431 -0.793 . . . . 0.55000000000000004 110.032 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.58 -38.18 16.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -0.991 . . . . 1.1200000000000001 110.6 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.22 -87.09 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.228 -0.92 . . . . 1.24 110.102 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 118.099 -0.953 . . . . 1.8300000000000001 109.659 -178.7 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.423 ' C ' ' H ' ' B' ' 3' ' ' THR . 16.2 mmt . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.274 -0.639 . . . . 6.0999999999999996 109.274 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 60.09 7.98 1.36 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 3.5800000000000001 108.98 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.423 ' H ' ' C ' ' B' ' 1' ' ' MET . 20.3 p -86.87 170.0 12.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.307 -0.871 . . . . 1.3200000000000001 109.626 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -62.43 162.94 9.37 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.35 -0.844 . . . . 1.97 109.91 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.79 -23.86 46.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.752 -0.593 . . . . 2.5899999999999999 110.272 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.12 -38.48 83.15 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.216 -0.928 . . . . 2.5 108.931 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -59.97 -52.21 66.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.51000000000000001 110.867 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -70.01 -35.38 74.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.955 -1.091 . . . . 3.73 109.738 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -65.47 -40.01 92.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.37 -0.831 . . . . 0.76000000000000001 109.385 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 44.1 t80 -63.1 -49.67 73.54 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.343 -0.848 . . . . 0.5 110.026 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.32 6.07 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.078 -1.014 . . . . 1.1799999999999999 111.241 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.36 -18.68 17.4 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.894 -1.129 . . . . 1.1799999999999999 110.0 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' B' ' 14' ' ' PRO . 6.5 pt-20 -152.0 151.89 28.8 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.097 -1.002 . . . . 1.27 108.95 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' B' ' 13' ' ' GLU . 70.2 Cg_exo -36.75 156.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 122.16 1.907 . . . . 0.53000000000000003 111.795 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 15.7 ptm -93.58 -29.72 15.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.094 -1.004 . . . . 1.1299999999999999 110.158 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -135.3 44.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.227 -1.149 . . . . 0.40999999999999998 110.227 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.94 35.16 3.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.619 -0.93 . . . . 0.83999999999999997 110.005 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.18 148.54 71.39 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.991 . . . . 2.4900000000000002 108.445 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.3 156.24 41.79 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.998 1.799 . . . . 0.38 112.039 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' B' ' 22' ' ' SER . 7.4 p -57.02 -48.19 82.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.543 -0.723 . . . . 1.1200000000000001 110.237 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.7 -3.94 0.22 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.776 -0.93 . . . . 0.27000000000000002 110.776 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.49 ' H ' ' C ' ' B' ' 20' ' ' VAL . 70.6 m -83.08 -21.6 33.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.761 -1.435 . . . . 1.75 109.462 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.33 136.79 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 1.0600000000000001 109.406 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.4 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.58 136.18 56.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.755 0.788 . . . . 1.05 109.824 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.31 -20.15 51.9 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.742 -1.743 . . . . 0.22 108.742 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.42 HG21 HD12 ' B' ' 26' ' ' ILE . 32.3 mm -99.76 114.99 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.933 -1.136 . . . . 1.0800000000000001 107.933 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.31 177.0 42.33 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.825 -1.31 . . . . 0.29999999999999999 109.825 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.62 -39.97 74.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.591 -0.946 . . . . 2.0 110.015 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.84 -44.37 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 1.1399999999999999 109.837 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.78 -37.5 84.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 1.1299999999999999 109.487 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.0 96.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.288 -1.525 . . . . 0.35999999999999999 109.288 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -39.76 94.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -1.12 . . . . 3.2200000000000002 110.371 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' B' ' 67' ' ' CYS . 50.5 mtpt -65.4 -48.38 73.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.201 . . . . 2.1200000000000001 109.971 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.8 -36.02 79.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.953 -1.092 . . . . 1.0800000000000001 108.492 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -59.92 -42.51 94.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.732 -0.605 . . . . 1.6799999999999999 110.008 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.05 -19.32 65.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 1.99 108.607 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' B' ' 37' ' ' ARG . 34.0 mtt-85 -90.97 6.56 44.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.595 -0.691 . . . . 3.1499999999999999 110.291 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.73 55.49 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.063 -1.065 . . . . 0.48999999999999999 111.766 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -103.9 73.1 1.14 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.801 -1.411 . . . . 0.38 108.328 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.17 -10.61 59.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.40999999999999998 110.639 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.52 150.3 50.92 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.92 . . . . 2.1499999999999999 109.62 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.07 94.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 1.03 110.766 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 16.7 p90 -60.49 -18.57 52.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.92000000000000004 110.514 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 50.8 t -79.62 -32.77 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.426 -1.324 . . . . 1.0800000000000001 107.426 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.83 -37.26 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.109 -1.071 . . . . 1.0700000000000001 108.109 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.04 -35.44 75.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.611 -1.255 . . . . 1.1499999999999999 107.611 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.61 97.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.067 -1.213 . . . . 0.19 110.067 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -60.02 -41.64 92.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.006 -1.291 . . . . 1.8200000000000001 109.742 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.04 -39.88 87.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.40000000000000002 108.82 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.52 -38.77 81.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.816 -0.809 . . . . 1.0700000000000001 108.816 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.03 -24.44 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.401 -0.812 . . . . 1.0900000000000001 110.648 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.8 mt -93.18 18.16 9.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.111 -0.993 . . . . 1.0900000000000001 110.434 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.46 33.55 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.67 -1.269 . . . . 2.23 110.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.06 19.89 9.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.764 -0.585 . . . . 2.7999999999999998 110.332 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -68.48 113.4 6.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 1.8 107.726 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.82 -39.96 93.6 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 113.11 0.782 . . . . 0.88 113.11 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.87 -39.61 76.23 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.575 -1.328 . . . . 0.73999999999999999 110.604 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.59 -38.82 77.49 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.848 -1.141 . . . . 1.2 108.937 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.98 -50.44 68.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.44 110.005 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' B' ' 60' ' ' ARG . 5.4 mtm-85 -62.62 -43.66 98.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 3.3399999999999999 109.803 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.94 -39.79 94.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 2.3799999999999999 108.745 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.463 ' O ' ' OG1' ' B' ' 66' ' ' THR . 55.7 t90 -65.54 -46.29 80.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.912 . . . . 0.40999999999999998 110.513 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -49.45 63.17 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.06 -1.025 . . . . 1.0700000000000001 110.074 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.78 -48.72 80.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.288 -0.882 . . . . 2.6000000000000001 109.937 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.8 t0 -69.13 -28.89 66.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 1.8999999999999999 109.852 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 50.5 m -79.51 -34.61 41.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 1.1000000000000001 111.011 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . 0.438 ' O ' ' NZ ' ' B' ' 33' ' ' LYS . 23.3 p -131.61 -29.45 1.74 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.611 -1.305 . . . . 0.95999999999999996 111.77 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.57 14.27 20.22 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.321 -1.512 . . . . 0.37 109.321 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.48 1.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.322 . . . . 1.0900000000000001 109.077 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -90.7 171.12 9.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.075 -1.015 . . . . 2.3700000000000001 109.685 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.97 72.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.52 -0.738 . . . . 1.1100000000000001 110.828 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.07 -40.63 68.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.558 -1.339 . . . . 2.9700000000000002 110.003 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.81 -39.98 79.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 2.6200000000000001 110.382 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 56.6 m -67.19 -39.22 86.34 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.279 -0.888 . . . . 1.8899999999999999 110.044 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -60.09 -38.46 82.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 3.3199999999999998 109.387 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.58 -39.9 84.86 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.722 -1.236 . . . . 0.40000000000000002 110.357 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.5 m -66.91 -39.93 87.53 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.947 -1.096 . . . . 0.95999999999999996 109.886 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 -59.97 4.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.638 -1.289 . . . . 0.5 110.066 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.54 84.51 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.518 -1.033 . . . . 0.27000000000000002 110.518 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.18 -50.06 50.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -1.19 . . . . 0.93999999999999995 109.77 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.94 -40.06 75.69 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.827 -1.149 . . . . 1.0900000000000001 108.809 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.15 -41.23 99.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 3.1899999999999999 110.159 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.88 -35.92 75.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.017 -1.052 . . . . 1.9099999999999999 109.594 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.43 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 80.2 t90 -60.03 -43.95 94.95 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.929 -1.508 . . . . 0.40000000000000002 106.929 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.0 m -60.99 -39.96 91.64 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.849 -0.797 . . . . 0.96999999999999997 108.849 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.59 81.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.55000000000000004 110.117 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -38.71 15.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.155 -0.966 . . . . 1.1299999999999999 110.579 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -104.51 -86.79 0.45 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.169 -0.957 . . . . 1.24 110.265 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 118.084 -0.96 . . . . 1.8300000000000001 109.602 -178.563 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptm . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.349 0.595 . . . . 6.1100000000000003 109.457 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 64.9 p -77.93 125.16 28.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 3.5800000000000001 109.403 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.9 p -99.25 158.29 15.8 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.433 -0.792 . . . . 1.3200000000000001 109.608 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 p -80.13 177.61 8.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.22 -0.925 . . . . 1.98 109.576 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.68 -21.14 62.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.538 -0.726 . . . . 2.6000000000000001 110.69 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.99 -37.84 80.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.777 -1.202 . . . . 2.5099999999999998 109.613 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -60.0 -51.85 67.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.841 -1.162 . . . . 0.51000000000000001 110.48 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -69.72 -36.59 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.012 -1.055 . . . . 3.7200000000000002 109.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.49 -39.96 73.86 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.76000000000000001 109.69 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.32 -41.33 96.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.216 -0.928 . . . . 0.5 109.945 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 m -84.31 15.58 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 1.1799999999999999 109.842 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.8 -9.78 11.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.449 -0.782 . . . . 1.1799999999999999 110.294 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.476 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 10.6 pt-20 -149.86 149.2 27.31 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.943 -1.098 . . . . 1.26 109.252 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 13' ' ' GLU . 89.7 Cg_exo -41.1 166.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.811 1.674 . . . . 0.53000000000000003 111.776 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 ptp -93.05 -24.95 18.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 1.1399999999999999 108.621 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.96 -140.65 16.48 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.021 -1.632 . . . . 0.41999999999999998 109.021 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -109.74 30.03 7.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.481 -1.011 . . . . 0.84999999999999998 109.477 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 90.2 mttt -60.18 149.39 75.52 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 2.4900000000000002 108.986 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.12 153.98 54.77 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.182 1.921 . . . . 0.39000000000000001 112.439 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 22' ' ' SER . 14.5 p -57.52 -44.03 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.603 -0.686 . . . . 1.1200000000000001 110.522 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -54.64 -2.78 0.2 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.16 -1.176 . . . . 0.27000000000000002 110.16 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 20' ' ' VAL . 40.7 t -82.59 -23.42 34.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.774 -1.427 . . . . 1.75 109.093 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 1.05 109.874 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.14 134.28 52.45 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.763 0.792 . . . . 1.0600000000000001 109.96 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.94 -20.53 48.71 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.283 -1.527 . . . . 0.23000000000000001 109.283 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.6 mm -99.75 114.2 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.281 -1.129 . . . . 1.0800000000000001 108.011 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.71 178.4 39.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.271 -1.532 . . . . 0.31 109.271 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -57.24 -39.71 76.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.337 -1.096 . . . . 2.0099999999999998 109.209 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.33 -48.38 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 1.1399999999999999 109.706 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.0 -39.97 83.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 1.1299999999999999 109.285 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.98 98.69 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.565 -1.414 . . . . 0.34999999999999998 109.565 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.85 -41.06 95.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -1.201 . . . . 3.2200000000000002 110.352 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.46 -40.16 85.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.823 -1.173 . . . . 2.1000000000000001 109.689 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.83 -40.06 93.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.963 -1.085 . . . . 1.0800000000000001 109.106 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.08 -40.89 91.12 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.723 -0.791 . . . . 1.6699999999999999 109.363 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.77 -19.53 64.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.809 -0.811 . . . . 2.0 108.809 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -89.0 0.18 56.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.631 -0.668 . . . . 3.1499999999999999 109.898 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' NZ ' ' B' ' 53' ' ' LYS . . . 107.01 4.35 35.93 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 120.254 -0.974 . . . . 0.47999999999999998 111.577 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.17 75.64 1.38 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.825 -1.397 . . . . 0.38 109.137 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.16 -11.14 59.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.40999999999999998 111.159 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -135.08 157.84 45.89 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.939 -1.101 . . . . 2.1600000000000001 109.397 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.59 88.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 1.03 112.078 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -56.15 -18.15 9.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.768 -1.208 . . . . 0.92000000000000004 110.457 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.15 -31.43 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.832 -1.168 . . . . 1.0700000000000001 108.287 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.52 -38.7 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.413 -0.958 . . . . 1.0600000000000001 108.413 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.85 -38.2 81.43 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.654 -1.61 . . . . 1.1599999999999999 106.654 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.41 -45.98 58.3 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.878 -1.289 . . . . 0.20000000000000001 109.878 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -41.93 93.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -1.181 . . . . 1.8200000000000001 109.329 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.93 -40.57 89.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.0 -1.063 . . . . 0.40000000000000002 108.828 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.74 -39.7 76.61 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.688 -0.856 . . . . 1.0900000000000001 108.688 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.09 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 110.554 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.77 13.83 13.39 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.096 . . . . 1.0900000000000001 110.858 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 51.32 35.91 14.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.209 . . . . 2.2200000000000002 110.223 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 56.08 19.42 3.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.228 -0.92 . . . . 2.7999999999999998 110.524 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -69.16 105.34 2.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.712 -1.242 . . . . 1.8 108.263 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.538 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 83.3 tt0 -62.94 -39.95 96.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 0.87 111.973 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.65 -39.89 88.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.72999999999999998 109.57 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.32 -37.92 71.73 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.445 -0.902 . . . . 1.2 108.747 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.56 -42.13 95.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.565 -0.71 . . . . 0.44 109.941 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.538 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 99.2 mtt180 -60.11 -48.5 81.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.249 -0.907 . . . . 3.3399999999999999 110.361 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.94 -39.89 90.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.682 -1.261 . . . . 2.3700000000000001 109.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.443 ' O ' ' OG1' ' A' ' 66' ' ' THR . 67.7 t90 -61.65 -50.1 73.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 0.40999999999999998 110.664 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 55.9 tp -68.4 -48.44 64.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.089 -1.007 . . . . 1.0800000000000001 110.103 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.19 -47.16 85.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 2.6099999999999999 109.797 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -68.71 -30.12 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.555 -0.715 . . . . 1.8999999999999999 109.682 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 55.3 m -80.22 -32.52 38.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 1.1100000000000001 111.029 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 32.1 p -133.0 -35.05 1.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.575 -1.328 . . . . 0.96999999999999997 112.098 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.65 16.04 9.71 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.338 -1.505 . . . . 0.38 109.338 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 152.24 2.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.272 . . . . 1.1000000000000001 109.89 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -90.22 173.49 8.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.109 -0.994 . . . . 2.3700000000000001 109.953 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.61 75.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.715 . . . . 1.1200000000000001 110.03 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.24 -40.01 71.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 2.9700000000000002 109.633 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -66.61 -39.28 88.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.548 -0.72 . . . . 2.6200000000000001 110.151 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.1 m -62.84 -38.61 91.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.299 -0.876 . . . . 1.8899999999999999 109.747 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 3.3199999999999998 109.614 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -69.31 -39.91 77.98 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.737 -1.227 . . . . 0.40000000000000002 110.742 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -70.2 -39.96 74.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.661 -1.275 . . . . 0.95999999999999996 109.996 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.33 -60.38 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.81 -1.181 . . . . 0.5 110.046 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.46 82.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.388 -1.085 . . . . 0.27000000000000002 110.388 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.7 t -68.54 -49.63 58.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.295 . . . . 0.93999999999999995 109.681 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.1 mt -70.09 -40.07 75.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.323 -0.951 . . . . 1.0900000000000001 109.327 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -62.0 -40.59 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 3.1800000000000002 109.596 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.02 -38.63 75.98 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.277 -0.889 . . . . 1.9099999999999999 110.077 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.557 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.4 t90 -61.69 -46.57 89.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.473 -1.392 . . . . 0.40000000000000002 108.688 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 89' ' ' LEU . 51.9 m -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.462 -0.774 . . . . 0.96999999999999997 109.573 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -58.87 -30.97 68.15 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 109.423 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.48 -34.75 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.269 -0.894 . . . . 1.1200000000000001 111.063 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 87.2 m-85 -108.94 -5.52 16.09 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.149 -0.969 . . . . 1.24 112.717 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 85' ' ' CYS . 10.5 tp . . . . . 0 N--CA 1.502 2.151 0 O-C-N 120.382 -1.448 . . . . 1.8300000000000001 109.288 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.46 -0.57 . . . . 6.0999999999999996 109.46 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 64.0 p -77.65 125.52 29.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 3.5800000000000001 109.363 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -99.59 158.59 15.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.411 -0.806 . . . . 1.3200000000000001 109.467 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 54.3 p -80.17 177.72 8.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 1.97 109.642 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.84 -21.06 62.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 2.5899999999999999 110.624 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.97 -37.82 80.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.799 -1.188 . . . . 2.5 109.619 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -60.0 -51.9 67.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.081 . . . . 0.51000000000000001 110.527 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -69.73 -36.51 75.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 3.73 109.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.41 -39.93 74.17 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.35 -0.844 . . . . 0.76000000000000001 109.793 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.44 -41.15 96.73 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.503 -0.879 . . . . 0.5 109.933 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.53 15.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.081 -1.012 . . . . 1.1799999999999999 109.857 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.97 -9.81 11.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.466 -0.771 . . . . 1.1799999999999999 110.362 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' B' ' 18' ' ' LYS . 10.5 pt-20 -149.86 149.14 27.14 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 120.903 -1.123 . . . . 1.27 109.208 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' B' ' 13' ' ' GLU . 92.3 Cg_exo -41.04 166.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.798 1.665 . . . . 0.53000000000000003 111.705 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 3.3 ptp -93.29 -24.69 18.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 1.1299999999999999 108.699 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.61 -140.55 14.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.03 -1.628 . . . . 0.40999999999999998 109.03 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -109.65 30.1 6.97 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.512 -0.993 . . . . 0.83999999999999997 109.464 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' B' ' 13' ' ' GLU . 89.8 mttt -60.27 149.55 75.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.938 . . . . 2.4900000000000002 108.856 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.35 153.98 56.14 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.204 1.936 . . . . 0.38 112.422 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' B' ' 22' ' ' SER . 14.5 p -57.64 -43.84 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.567 -0.708 . . . . 1.1200000000000001 110.545 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -54.83 -2.56 0.2 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.118 -1.193 . . . . 0.27000000000000002 110.118 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.519 ' H ' ' C ' ' B' ' 20' ' ' VAL . 40.6 t -82.87 -23.39 33.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.399 . . . . 1.75 109.125 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 1.0600000000000001 109.869 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.16 134.22 52.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.788 0.804 . . . . 1.05 110.075 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.528 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.98 -20.5 48.78 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.287 -1.525 . . . . 0.22 109.287 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.65 114.05 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -1.125 . . . . 1.0800000000000001 108.024 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.6 178.3 39.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.262 -1.535 . . . . 0.29999999999999999 109.262 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -57.19 -39.57 75.62 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.315 -1.109 . . . . 2.0 109.236 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.28 -48.53 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 1.1399999999999999 109.721 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.86 -40.07 83.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.159 -0.963 . . . . 1.1299999999999999 109.354 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.95 98.66 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.594 -1.403 . . . . 0.35999999999999999 109.594 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.83 -41.21 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -1.23 . . . . 3.2200000000000002 110.301 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.41 -39.9 85.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.83 -1.169 . . . . 2.1200000000000001 109.772 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.94 -39.98 93.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.026 . . . . 1.0800000000000001 109.06 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.09 -40.94 91.34 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.79 -0.764 . . . . 1.6799999999999999 109.317 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -68.81 -19.46 64.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.824 -0.806 . . . . 1.99 108.824 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -89.01 0.39 56.71 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.092 -0.643 . . . . 3.1499999999999999 109.969 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.79 4.33 36.58 Favored Glycine 0 N--CA 1.504 3.17 0 O-C-N 121.105 -0.997 . . . . 0.48999999999999999 111.734 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -103.33 75.83 1.38 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.818 -1.401 . . . . 0.38 109.096 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -77.43 -10.97 59.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.40999999999999998 111.019 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -135.19 157.95 45.61 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.902 -1.124 . . . . 2.1499999999999999 109.444 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.49 88.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.547 -0.72 . . . . 1.03 112.051 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -56.36 -18.13 9.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.721 -1.237 . . . . 0.92000000000000004 110.551 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.13 -31.36 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.884 -1.135 . . . . 1.0800000000000001 108.279 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.52 -38.75 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 1.0700000000000001 108.425 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.03 -38.3 82.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.573 -1.64 . . . . 1.1499999999999999 106.573 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.74 -45.6 60.43 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.68 -1.368 . . . . 0.19 109.68 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -41.8 93.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.225 . . . . 1.8200000000000001 109.356 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.0 -40.49 89.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.017 -1.052 . . . . 0.40000000000000002 108.753 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -69.77 -40.04 76.31 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.662 -0.866 . . . . 1.0700000000000001 108.662 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.68 -21.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 110.613 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.91 14.02 13.14 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.048 -1.032 . . . . 1.0900000000000001 110.663 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 38' ' ' GLY . 59.8 mttp 50.79 36.32 14.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.812 -1.18 . . . . 2.23 110.227 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 55.91 19.41 3.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.308 -0.87 . . . . 2.7999999999999998 110.618 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -69.01 105.58 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.72 -1.237 . . . . 1.8 108.18 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 83.5 tt0 -63.17 -39.96 96.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.88 111.977 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.45 -40.08 89.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.815 -1.178 . . . . 0.73999999999999999 109.553 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -71.1 -37.79 72.38 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.396 -0.921 . . . . 1.2 108.848 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.8 -42.19 95.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.612 -0.68 . . . . 0.44 109.898 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 99.2 mtt180 -59.99 -48.96 79.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.244 -0.91 . . . . 3.3399999999999999 110.35 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.54 -39.94 92.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.689 -1.257 . . . . 2.3799999999999999 109.832 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.8 t90 -61.7 -49.97 74.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.921 -1.112 . . . . 0.40999999999999998 110.706 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.2 tp -68.43 -48.7 63.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.079 -1.013 . . . . 1.0700000000000001 110.032 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.06 -47.12 86.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 2.6000000000000001 109.767 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -68.85 -29.96 68.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 1.8999999999999999 109.656 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 53.4 m -80.17 -32.58 38.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 1.1000000000000001 111.045 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 32.0 p -132.94 -35.29 1.07 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.66 -1.275 . . . . 0.95999999999999996 112.045 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.72 16.48 9.28 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.292 -1.523 . . . . 0.37 109.292 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 152.32 3.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.063 -1.257 . . . . 1.0900000000000001 109.76 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.1 173.62 8.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 2.3700000000000001 109.98 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.92 -34.3 75.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 1.1100000000000001 110.093 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -71.38 -40.1 70.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 2.9700000000000002 109.593 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.6 mm100 -66.53 -39.15 88.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.488 -0.757 . . . . 2.6200000000000001 110.25 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 74.2 m -62.94 -38.58 91.61 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.268 -0.895 . . . . 1.8899999999999999 109.748 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.158 -0.964 . . . . 3.3199999999999998 109.626 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -69.32 -39.99 77.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.839 -1.163 . . . . 0.40000000000000002 110.716 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -70.14 -40.05 75.03 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.682 -1.261 . . . . 0.95999999999999996 109.968 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -61.18 -60.31 3.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.861 -1.149 . . . . 0.5 110.162 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.34 82.14 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.46 -1.056 . . . . 0.27000000000000002 110.46 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.66 -49.63 57.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.302 . . . . 0.93999999999999995 109.699 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.03 -40.04 75.42 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.295 -0.962 . . . . 1.0900000000000001 109.324 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -62.0 -40.68 96.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 3.1899999999999999 109.566 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -38.69 76.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.166 -0.959 . . . . 1.9099999999999999 110.153 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.555 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.2 t90 -61.75 -46.61 88.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.456 -1.403 . . . . 0.40000000000000002 108.702 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' B' ' 89' ' ' LEU . 51.6 m -60.08 -39.91 87.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.751 -0.78 . . . . 0.96999999999999997 109.686 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.05 -30.79 68.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.384 -0.822 . . . . 0.55000000000000004 109.406 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 -35.21 13.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.835 . . . . 1.1299999999999999 111.057 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.4 m-85 -108.31 -6.13 16.44 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.129 -0.982 . . . . 1.24 112.663 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.4 tp . . . . . 0 N--CA 1.502 2.171 0 O-C-N 120.355 -1.466 . . . . 1.8300000000000001 109.371 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.389 -0.597 . . . . 6.1100000000000003 109.389 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.2 p -90.84 111.32 22.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.204 -0.935 . . . . 3.5800000000000001 109.435 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.5 p -86.21 164.22 17.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 1.3200000000000001 109.321 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.7 m -78.85 170.91 15.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.932 . . . . 1.98 109.124 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.91 -28.66 67.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.548 -0.72 . . . . 2.6000000000000001 110.114 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -60.32 -39.62 87.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.949 -1.095 . . . . 2.5099999999999998 109.644 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -59.85 -51.17 70.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.931 . . . . 0.51000000000000001 110.656 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -70.25 -34.45 72.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.814 -1.179 . . . . 3.7200000000000002 109.685 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -68.74 -38.88 80.46 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.368 -0.833 . . . . 0.76000000000000001 110.023 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.55 -45.78 82.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.5 110.173 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -86.26 7.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.124 -0.985 . . . . 1.1799999999999999 110.812 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.2 -13.62 17.35 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.201 -0.937 . . . . 1.1799999999999999 110.056 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -154.54 153.55 28.05 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.977 . . . . 1.26 108.998 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -37.72 156.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 122.071 1.847 . . . . 0.53000000000000003 111.741 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.7 ptm -93.31 -28.2 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 1.1399999999999999 110.296 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.51 42.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.433 -1.067 . . . . 0.41999999999999998 110.433 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.64 35.89 3.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.614 -0.933 . . . . 0.84999999999999998 110.379 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -57.93 149.58 54.04 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.047 -1.033 . . . . 2.4900000000000002 108.313 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.94 155.31 55.93 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.069 1.846 . . . . 0.39000000000000001 112.551 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 22' ' ' SER . 3.4 p -57.07 -47.16 84.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.479 0.657 . . . . 1.1200000000000001 110.387 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.67 -5.42 0.86 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 121.467 -0.77 . . . . 0.27000000000000002 111.223 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 20' ' ' VAL . 60.8 m -84.21 -19.94 33.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.448 -1.619 . . . . 1.75 109.498 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.46 134.07 55.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 1.05 109.29 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 77' ' ' CYS . . . -64.21 133.33 52.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.669 -0.812 . . . . 1.0600000000000001 109.675 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.52 -21.22 47.07 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.129 -1.588 . . . . 0.23000000000000001 109.129 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.75 112.4 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 1.0800000000000001 108.405 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.98 -178.77 36.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.287 -1.525 . . . . 0.31 109.287 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.88 -40.28 83.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -1.093 . . . . 2.0099999999999998 110.631 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.05 -46.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.72 -1.238 . . . . 1.1399999999999999 109.14 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.3 -40.07 86.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 1.1299999999999999 109.483 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.69 96.73 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.913 -1.275 . . . . 0.34999999999999998 109.913 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.34 -38.18 85.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.001 -1.294 . . . . 3.2200000000000002 110.332 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.84 -45.15 87.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 2.1000000000000001 109.748 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.8 mt -62.17 -40.09 94.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.013 -1.055 . . . . 1.0800000000000001 109.798 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.03 -40.1 88.19 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.476 -0.889 . . . . 1.6699999999999999 109.053 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -67.79 -19.16 65.06 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.81 6.61 40.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 3.1499999999999999 109.601 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 9.05 57.06 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 121.005 -1.059 . . . . 0.47999999999999998 111.544 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -103.71 75.36 1.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.854 -1.38 . . . . 0.38 108.858 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' H ' ' HZ2' ' B' ' 53' ' ' LYS . 44.8 p-10 -74.18 -10.08 59.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.40999999999999998 111.248 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -140.69 161.57 37.47 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.896 -1.127 . . . . 2.1600000000000001 110.69 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.67 -43.64 92.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 1.03 112.355 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 6.4 p90 -58.2 -18.43 25.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.801 -1.187 . . . . 0.92000000000000004 110.669 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.06 -31.37 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.79 -1.189 . . . . 1.0700000000000001 107.79 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.63 -40.03 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.185 -1.042 . . . . 1.0600000000000001 108.185 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.8 tp -59.02 -34.65 72.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.882 -1.525 . . . . 1.1599999999999999 106.882 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.01 -40.72 97.37 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.593 -1.403 . . . . 0.20000000000000001 109.593 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -41.97 93.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.261 . . . . 1.8200000000000001 108.987 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -60.24 -41.54 93.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.40000000000000002 108.705 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -70.27 -40.0 74.61 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.548 -0.861 . . . . 1.0900000000000001 108.921 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.93 -25.11 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 1.0900000000000001 110.671 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -92.29 15.3 14.05 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.949 -1.095 . . . . 1.0900000000000001 110.491 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 67.8 mttm 52.41 40.29 29.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.088 -1.007 . . . . 2.2200000000000002 110.548 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 pttt 40.3 19.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.01 -1.056 . . . . 2.7999999999999998 111.873 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 17.9 t0 -66.85 117.55 9.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.671 -1.603 . . . . 1.8 106.671 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.87 -40.17 94.45 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.483 0.92 . . . . 0.87 113.483 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 96.1 m-20 -70.21 -39.86 74.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.416 -1.428 . . . . 0.72999999999999998 109.937 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.09 -39.86 68.64 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.935 -1.106 . . . . 1.2 108.6 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -61.83 -49.92 74.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.44 109.957 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.4 mtm180 -61.84 -42.65 99.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 3.3399999999999999 110.616 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.73 -39.24 93.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 2.3700000000000001 109.25 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.422 ' O ' ' OG1' ' A' ' 66' ' ' THR . 70.3 t90 -61.22 -49.28 77.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.029 -1.044 . . . . 0.40999999999999998 110.735 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.23 -49.28 65.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 1.0800000000000001 109.857 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -61.89 -47.26 85.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.393 -0.817 . . . . 2.6099999999999999 109.864 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.0 t0 -69.04 -31.13 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 1.8999999999999999 109.864 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 56.6 m -79.75 -33.08 41.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 1.1100000000000001 111.366 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.1 p -132.54 -31.72 1.36 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.58 -1.325 . . . . 0.96999999999999997 111.574 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 15.79 12.63 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.075 -1.61 . . . . 0.38 109.075 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.02 153.49 3.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -1.205 . . . . 1.1000000000000001 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -94.93 176.22 6.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 2.3700000000000001 109.825 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -35.35 75.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.586 -0.696 . . . . 1.1200000000000001 111.23 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -70.13 -42.84 72.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.52 -1.362 . . . . 2.9700000000000002 110.57 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 73' ' ' GLN . 16.7 mp0 -67.94 -39.18 83.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -0.963 . . . . 2.6200000000000001 110.965 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 t -67.95 -38.35 82.7 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.809 -1.182 . . . . 1.8899999999999999 110.198 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -60.72 -38.79 86.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.742 -1.224 . . . . 3.3199999999999998 109.913 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.26 -39.62 82.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.561 -1.337 . . . . 0.40000000000000002 110.417 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 24' ' ' ALA . 96.5 m -69.71 -40.09 76.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.965 -1.085 . . . . 0.95999999999999996 109.518 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -59.4 -60.34 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.179 -0.95 . . . . 0.5 109.424 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.51 -33.63 87.76 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.694 -0.962 . . . . 0.27000000000000002 110.694 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -1.234 . . . . 0.93999999999999995 109.636 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.1 mt -70.27 -39.97 74.62 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.962 -1.095 . . . . 1.0900000000000001 108.391 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -65.1 -40.16 94.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.86 . . . . 3.1800000000000002 110.309 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.62 -39.69 80.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 1.9099999999999999 110.6 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 88.4 t90 -60.23 -42.28 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.343 -1.473 . . . . 0.40000000000000002 107.581 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 89' ' ' LEU . 63.5 m -60.16 -40.09 88.7 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.783 0.801 . . . . 0.96999999999999997 109.279 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.6 -33.95 72.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.218 -0.927 . . . . 0.55000000000000004 109.698 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.18 -34.56 14.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.195 -0.94 . . . . 1.1200000000000001 111.285 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.551 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.8 m-85 -108.98 3.11 21.81 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.116 -0.99 . . . . 1.24 111.482 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 85' ' ' CYS . 8.5 tp . . . . . 0 N--CA 1.497 1.88 0 O-C-N 120.936 -1.102 . . . . 1.8300000000000001 109.357 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.37 -0.604 . . . . 6.0999999999999996 109.37 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 34.5 p -90.72 111.11 22.33 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.13 -0.981 . . . . 3.5800000000000001 109.397 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 30.4 p -85.93 164.16 17.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 1.3200000000000001 109.413 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -78.63 170.82 16.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 1.97 109.1 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.19 -28.24 67.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.612 -0.68 . . . . 2.5899999999999999 110.07 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.5 -39.57 88.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.123 -0.986 . . . . 2.5 109.637 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -59.84 -51.32 70.23 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.261 -0.899 . . . . 0.51000000000000001 110.635 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -70.19 -34.23 72.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.896 -1.127 . . . . 3.73 109.854 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -68.88 -39.35 79.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.376 -0.828 . . . . 0.76000000000000001 109.785 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.13 -46.17 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.5 110.119 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.0 m -86.09 8.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.141 -0.975 . . . . 1.1799999999999999 110.749 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.7 -13.44 17.08 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.192 -0.942 . . . . 1.1799999999999999 109.911 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.54 153.38 27.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 1.27 108.98 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -37.89 156.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.059 1.839 . . . . 0.53000000000000003 111.719 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.401 ' H ' ' HG2' ' B' ' 15' ' ' MET . 11.6 ptm -93.2 -28.13 16.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 1.1299999999999999 110.271 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.18 -133.33 41.87 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.412 -1.075 . . . . 0.40999999999999998 110.412 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.81 36.01 3.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.596 -0.944 . . . . 0.83999999999999997 110.302 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -58.09 149.83 54.53 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.871 -1.143 . . . . 2.4900000000000002 108.329 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.87 155.17 56.34 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.168 1.912 . . . . 0.38 112.537 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' B' ' 22' ' ' SER . 3.5 p -57.16 -46.53 84.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.602 0.715 . . . . 1.1200000000000001 110.496 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.07 -5.25 0.95 Allowed Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.45 -0.782 . . . . 0.27000000000000002 111.248 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 20' ' ' VAL . 59.5 m -84.4 -20.32 32.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.553 -1.557 . . . . 1.75 109.435 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.14 133.86 55.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 1.0600000000000001 109.237 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.14 133.34 52.75 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.586 -0.845 . . . . 1.05 109.714 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.62 -20.98 48.26 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.25 -1.54 . . . . 0.22 109.25 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.03 112.6 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -1.088 . . . . 1.0800000000000001 108.365 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.22 -178.86 35.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.174 -1.57 . . . . 0.29999999999999999 109.174 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -58.65 -40.07 82.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.422 -1.046 . . . . 2.0 110.713 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.04 -46.57 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.642 -1.286 . . . . 1.1399999999999999 109.196 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.21 -39.95 86.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 1.1299999999999999 109.545 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.56 97.19 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.835 -1.306 . . . . 0.35999999999999999 109.835 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.21 -38.64 87.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.266 . . . . 3.2200000000000002 110.189 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.59 -45.06 88.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.712 -1.243 . . . . 2.1200000000000001 109.603 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.13 -39.9 94.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.835 -1.166 . . . . 1.0800000000000001 109.822 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.42 -40.05 89.66 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.579 -0.848 . . . . 1.6799999999999999 108.896 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -67.82 -19.18 65.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.215 -1.031 . . . . 1.99 108.215 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.86 6.87 39.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.533 -0.73 . . . . 3.1499999999999999 109.603 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.42 9.07 57.06 Favored Glycine 0 N--CA 1.5 2.939 0 O-C-N 120.961 -1.087 . . . . 0.48999999999999999 111.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -104.1 75.46 1.27 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.929 -1.336 . . . . 0.38 108.948 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.37 -9.98 59.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.883 . . . . 0.40999999999999998 111.176 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -140.66 161.78 36.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.852 -1.155 . . . . 2.1499999999999999 110.712 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.77 -43.84 91.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.835 -0.54 . . . . 1.03 112.314 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 5.7 p90 -57.84 -18.72 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.92000000000000004 110.733 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.12 -31.11 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.79 -1.194 . . . . 1.0800000000000001 107.849 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.81 -39.92 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.173 -1.047 . . . . 1.0700000000000001 108.173 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.6 tp -59.03 -34.84 72.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.983 -1.488 . . . . 1.1499999999999999 106.983 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.99 97.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.494 -1.442 . . . . 0.19 109.494 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.84 -42.04 92.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 1.8200000000000001 108.961 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.11 -41.54 92.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.40000000000000002 108.727 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.41 -40.18 74.02 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.537 -0.865 . . . . 1.0700000000000001 108.889 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.92 -24.66 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 110.785 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.55 15.81 13.4 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.037 -1.039 . . . . 1.0900000000000001 110.368 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' B' ' 55' ' ' ASP . 67.8 mttm 51.98 40.19 27.74 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.904 -1.122 . . . . 2.23 110.635 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 47.8 pttt 40.49 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.135 -0.978 . . . . 2.7999999999999998 111.711 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 53' ' ' LYS . 19.3 t0 -66.78 117.77 9.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.52 -1.659 . . . . 1.8 106.52 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.62 -40.93 96.61 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.127 -0.983 . . . . 0.88 113.458 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.52 -39.97 77.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.437 -1.414 . . . . 0.73999999999999999 110.107 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.18 -39.95 68.29 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.005 -1.078 . . . . 1.2 108.552 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.7 -50.14 73.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.833 . . . . 0.44 109.96 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -61.56 -43.05 99.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 3.3399999999999999 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -64.54 -38.9 92.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.848 -1.158 . . . . 2.3799999999999999 109.392 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -61.33 -49.17 78.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.40999999999999998 110.818 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 32.8 tp -67.38 -49.49 63.71 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.329 -0.857 . . . . 1.0700000000000001 109.835 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.77 -47.02 87.05 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.373 -0.829 . . . . 2.6000000000000001 109.939 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.7 t0 -69.17 -31.08 69.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.436 -0.79 . . . . 1.8999999999999999 109.926 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 55.4 m -79.76 -33.2 40.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 1.1000000000000001 111.341 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.32 -32.26 1.37 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.718 -1.239 . . . . 0.95999999999999996 111.62 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.32 16.13 11.58 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.144 -1.582 . . . . 0.37 109.144 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.16 153.53 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.301 . . . . 1.0900000000000001 109.358 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -94.81 176.22 6.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 2.3700000000000001 109.77 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.17 75.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.608 -0.682 . . . . 1.1100000000000001 111.255 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -70.07 -42.73 72.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.511 -1.368 . . . . 2.9700000000000002 110.611 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' B' ' 73' ' ' GLN . 16.5 mp0 -67.99 -39.43 83.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.198 -0.939 . . . . 2.6200000000000001 111.021 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.8 t -67.83 -38.04 82.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.037 -1.039 . . . . 1.8899999999999999 110.08 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -61.2 -38.34 86.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.775 -1.203 . . . . 3.3199999999999998 109.92 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.5 -39.88 81.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.439 -1.413 . . . . 0.40000000000000002 110.322 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 99.0 m -69.7 -40.2 76.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.824 -1.173 . . . . 0.95999999999999996 109.473 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.51 -60.02 4.51 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.096 -1.003 . . . . 0.5 109.339 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.69 -33.63 87.75 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.618 -0.993 . . . . 0.27000000000000002 110.618 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.38 -46.12 61.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.985 -1.303 . . . . 0.93999999999999995 109.588 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.85 -40.14 75.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.095 -1.042 . . . . 1.0900000000000001 108.247 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -65.14 -40.08 93.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 3.1899999999999999 110.214 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.49 -39.9 81.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 1.9099999999999999 110.419 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.544 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 88.5 t90 -60.44 -42.34 95.91 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.314 -1.491 . . . . 0.40000000000000002 107.521 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' B' ' 89' ' ' LEU . 63.7 m -60.03 -40.14 88.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.436 -0.79 . . . . 0.96999999999999997 109.271 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.46 -33.82 71.77 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.364 -0.835 . . . . 0.55000000000000004 109.842 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.11 13.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.121 -0.987 . . . . 1.1299999999999999 111.192 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.544 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 97.1 m-85 -107.84 2.25 23.38 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.206 -0.934 . . . . 1.24 111.636 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.498 1.962 0 O-C-N 120.938 -1.101 . . . . 1.8300000000000001 109.363 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.98 -0.748 . . . . 6.1100000000000003 108.98 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.82 7.84 22.36 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.238 -1.023 . . . . 3.5800000000000001 108.238 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 p -73.48 169.79 16.47 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.485 0.66 . . . . 1.3200000000000001 110.12 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.481 ' HG ' ' H ' ' A' ' 5' ' ' GLN . 8.4 t -61.84 173.2 1.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 1.98 110.097 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' H ' ' HG ' ' A' ' 4' ' ' SER . 92.3 mm-40 -59.96 -20.87 59.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.75 -0.594 . . . . 2.6000000000000001 110.896 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -60.05 -38.48 82.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.868 -1.145 . . . . 2.5099999999999998 109.543 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -59.93 -51.69 68.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.08 . . . . 0.51000000000000001 110.652 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -69.96 -35.19 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.837 -1.164 . . . . 3.7200000000000002 110.139 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.78 -39.95 84.03 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.396 -0.815 . . . . 0.76000000000000001 109.321 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.19 -48.21 76.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.465 -0.772 . . . . 0.5 109.967 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 m -86.59 8.13 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.129 -0.982 . . . . 1.1799999999999999 110.992 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.5 -16.94 18.14 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.937 -1.102 . . . . 1.1799999999999999 110.035 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.5 pt-20 -155.6 152.49 24.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 1.26 108.469 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 92.4 Cg_exo -35.49 154.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.2 1.933 . . . . 0.53000000000000003 111.713 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.4 ptp -91.16 -23.76 20.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.909 -1.12 . . . . 1.1399999999999999 109.89 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.35 -135.47 32.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.384 -1.086 . . . . 0.41999999999999998 110.384 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -110.0 38.78 2.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.597 -0.943 . . . . 0.84999999999999998 110.158 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -59.93 149.99 71.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.044 . . . . 2.4900000000000002 108.738 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.03 148.92 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.32 2.013 . . . . 0.39000000000000001 112.588 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 p -52.73 -30.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.475 0.655 . . . . 1.1200000000000001 110.387 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.61 -3.57 67.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.745 -0.942 . . . . 0.27000000000000002 110.745 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.0 t -83.29 -20.79 33.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.746 -1.444 . . . . 1.75 109.339 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.54 135.57 57.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 1.05 109.703 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.72 133.19 53.11 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.694 0.759 . . . . 1.0600000000000001 109.671 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.73 -19.98 52.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 0.23000000000000001 109.255 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.423 HG23 HD12 ' A' ' 26' ' ' ILE . 42.3 mm -98.55 112.78 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.069 -1.085 . . . . 1.0800000000000001 108.069 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.48 178.06 39.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.803 -1.319 . . . . 0.31 109.803 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.76 -40.01 75.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.461 -1.023 . . . . 2.0099999999999998 109.766 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.35 -44.9 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 1.1399999999999999 109.671 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.69 -38.05 85.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 1.1299999999999999 109.413 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.43 -38.61 91.24 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.546 -1.422 . . . . 0.34999999999999998 109.546 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.49 -39.16 93.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -1.151 . . . . 3.2200000000000002 110.823 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.1 -44.58 79.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.742 -1.224 . . . . 2.1000000000000001 109.808 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.53 -39.93 95.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 1.0800000000000001 108.742 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.0 -42.46 94.31 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.656 -0.818 . . . . 1.6699999999999999 109.411 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.3 -19.5 65.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.0 108.783 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -91.11 1.81 56.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.654 -0.654 . . . . 3.1499999999999999 109.948 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.45 4.22 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.083 -1.011 . . . . 0.47999999999999998 110.801 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -132.41 70.94 1.46 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -1.231 . . . . 0.38 108.239 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.43 -10.53 59.52 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.272 -0.971 . . . . 0.40999999999999998 109.905 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -131.29 153.16 49.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.375 -0.828 . . . . 2.1600000000000001 108.808 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.9 90.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 1.03 111.205 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.483 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -56.59 -17.67 9.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.884 -1.135 . . . . 0.92000000000000004 110.994 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.77 -29.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.178 . . . . 1.0700000000000001 107.936 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.1 -36.8 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.308 -0.997 . . . . 1.0600000000000001 108.308 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.03 -39.29 85.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.134 -1.432 . . . . 1.1599999999999999 107.134 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.71 -43.7 94.37 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.108 -1.197 . . . . 0.20000000000000001 110.108 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.98 -42.69 94.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.752 -1.44 . . . . 1.8200000000000001 109.053 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.98 -42.27 93.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.863 . . . . 0.40000000000000002 108.943 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -68.96 -38.19 79.27 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.727 -0.842 . . . . 1.0900000000000001 108.727 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.43 -22.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 1.0900000000000001 110.046 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 16.75 10.99 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.144 -0.972 . . . . 1.0900000000000001 109.789 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.8 mttm 50.0 39.55 19.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.975 -1.078 . . . . 2.2200000000000002 110.505 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.31 19.28 4.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.7999999999999998 109.747 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.13 108.54 4.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.727 -1.233 . . . . 1.8 108.021 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -61.04 -40.0 91.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.555 -0.716 . . . . 0.87 112.556 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.09 -40.09 78.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.644 -1.285 . . . . 0.72999999999999998 110.385 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.21 75.34 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.93 -1.108 . . . . 1.2 109.009 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.85 -50.1 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.83 . . . . 0.44 110.05 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -59.94 -46.37 89.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 3.3399999999999999 110.587 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -65.74 -38.57 89.49 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.042 -1.036 . . . . 2.3700000000000001 109.14 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' A' ' 66' ' ' THR . 67.7 t90 -66.06 -48.34 71.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.40999999999999998 111.073 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.446 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 64.5 tp -66.22 -46.32 77.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.211 -0.931 . . . . 1.0800000000000001 109.152 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.91 -45.75 91.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.389 -0.819 . . . . 2.6099999999999999 109.089 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.63 -31.87 70.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.641 -0.662 . . . . 1.8999999999999999 109.85 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 94.3 m -80.41 -31.37 37.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 1.1100000000000001 111.487 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.587 ' HG ' ' H ' ' A' ' 69' ' ' ALA . 31.9 p -132.73 -25.78 1.84 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.528 -1.358 . . . . 0.96999999999999997 111.876 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.14 29.19 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.422 -1.471 . . . . 0.38 109.422 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.587 ' H ' ' HG ' ' A' ' 67' ' ' CYS . . . -50.43 153.49 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.046 -1.267 . . . . 1.1000000000000001 109.252 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -92.12 174.29 7.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.034 -1.041 . . . . 2.3700000000000001 110.242 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.08 78.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.668 -0.645 . . . . 1.1200000000000001 110.826 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.737 ' HZ2' HE21 ' A' ' 73' ' ' GLN . 22.0 pttp -75.11 -38.23 61.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.84 -1.163 . . . . 2.9700000000000002 109.731 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.737 HE21 ' HZ2' ' A' ' 72' ' ' LYS . 85.6 mm-40 -67.13 -38.77 86.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 2.6200000000000001 110.013 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 p -67.12 -37.75 84.39 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 1.8899999999999999 109.895 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.32 -38.39 83.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.079 -1.013 . . . . 3.3199999999999998 109.604 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.56 -40.07 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.707 -1.246 . . . . 0.40000000000000002 110.797 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.1 -40.02 78.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 0.95999999999999996 110.111 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.52 -60.45 3.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.628 -1.295 . . . . 0.5 110.246 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.72 -32.47 81.72 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.483 -1.047 . . . . 0.27000000000000002 110.483 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.72 -47.77 58.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.273 . . . . 0.93999999999999995 109.87 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.1 mt -70.22 -39.92 74.82 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.105 -1.038 . . . . 1.0900000000000001 109.067 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 82' ' ' ARG . 33.2 ttt-85 -63.66 -39.99 95.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 3.1800000000000002 110.322 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.39 -38.18 77.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.105 -0.997 . . . . 1.9099999999999999 110.285 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.448 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.5 t90 -59.99 -45.46 92.64 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.405 -1.435 . . . . 0.40000000000000002 107.809 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . 52.2 m -59.98 -40.11 88.0 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.687 0.756 . . . . 0.96999999999999997 109.344 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.97 -34.61 73.52 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.348 -0.845 . . . . 0.55000000000000004 110.099 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.0 -36.31 13.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.196 -0.94 . . . . 1.1200000000000001 111.176 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.3 m-85 -107.87 1.43 22.74 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.176 -0.952 . . . . 1.24 111.324 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' CYS . 7.1 tp . . . . . 0 N--CA 1.496 1.829 0 O-C-N 120.85 -1.157 . . . . 1.8300000000000001 108.981 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.987 -0.746 . . . . 6.0999999999999996 108.987 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.73 8.0 21.48 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.215 -1.031 . . . . 3.5800000000000001 108.215 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 22.7 p -73.68 169.8 16.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.555 0.693 . . . . 1.3200000000000001 109.966 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.474 ' HG ' ' H ' ' B' ' 5' ' ' GLN . 8.4 t -61.76 173.18 1.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.82 0.819 . . . . 1.97 110.055 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HG ' ' B' ' 4' ' ' SER . 92.4 mm-40 -60.04 -20.89 60.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 2.5899999999999999 110.892 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -60.04 -38.42 82.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.902 -1.124 . . . . 2.5 109.506 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -60.03 -51.73 68.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.979 -1.075 . . . . 0.51000000000000001 110.58 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -69.95 -34.99 74.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 3.73 110.094 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.95 -39.96 83.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.76000000000000001 109.311 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -64.32 -48.28 76.2 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.832 -0.747 . . . . 0.5 109.859 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -86.51 8.33 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.083 -1.011 . . . . 1.1799999999999999 111.014 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.65 -16.86 18.05 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 1.1799999999999999 109.985 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' B' ' 14' ' ' PRO . 13.3 pt-20 -155.64 152.44 24.29 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.111 -0.993 . . . . 1.27 108.422 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' B' ' 13' ' ' GLU . 97.9 Cg_exo -35.42 154.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.159 1.906 . . . . 0.53000000000000003 111.748 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 7.5 ptp -90.92 -23.84 20.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.022 -1.049 . . . . 1.1299999999999999 109.881 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.3 -135.59 31.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.309 -1.117 . . . . 0.40999999999999998 110.309 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -109.95 38.83 2.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.65 -0.912 . . . . 0.83999999999999997 110.092 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.9 149.94 71.07 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 120.999 -1.063 . . . . 2.4900000000000002 108.851 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.95 148.83 92.32 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.398 2.065 . . . . 0.38 112.499 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.1 p -52.81 -29.92 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.62 -0.675 . . . . 1.1200000000000001 110.409 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.77 -3.27 67.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.742 -0.943 . . . . 0.27000000000000002 110.742 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t -83.44 -20.67 33.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.699 -1.471 . . . . 1.75 109.318 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.7 135.62 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 1.0600000000000001 109.642 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.67 133.09 53.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 1.05 109.725 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 -20.01 52.34 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.271 -1.531 . . . . 0.22 109.271 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -98.56 112.73 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.024 -1.102 . . . . 1.0800000000000001 108.024 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.49 178.05 39.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.76 -1.336 . . . . 0.29999999999999999 109.76 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.8 -39.9 74.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.391 -1.064 . . . . 2.0 109.75 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.41 -45.01 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 1.1399999999999999 109.577 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.73 -37.72 85.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 1.1299999999999999 109.437 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.57 -38.68 91.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.509 -1.436 . . . . 0.35999999999999999 109.509 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.45 -39.2 93.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -1.101 . . . . 3.2200000000000002 110.793 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.04 -44.62 79.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.155 . . . . 2.1200000000000001 109.746 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.67 -39.93 95.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.014 . . . . 1.0800000000000001 108.684 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.39 94.13 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.637 -0.825 . . . . 1.6799999999999999 109.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -66.37 -19.52 65.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 1.99 108.765 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -90.97 1.76 56.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.712 -0.617 . . . . 3.1499999999999999 109.973 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.72 37.43 4.21 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.219 -0.991 . . . . 0.48999999999999999 110.734 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -132.34 70.95 1.46 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.027 -1.278 . . . . 0.38 108.213 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -77.53 -10.46 59.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.109 -0.994 . . . . 0.40999999999999998 109.823 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -131.43 153.17 49.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.345 -0.847 . . . . 2.1499999999999999 108.885 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.98 91.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 1.03 111.244 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 4.5 p90 -56.5 -17.81 9.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.999 -1.063 . . . . 0.92000000000000004 111.034 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.62 -29.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 1.0800000000000001 108.003 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.34 -36.75 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.15 -1.056 . . . . 1.0700000000000001 108.15 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.91 -39.32 85.02 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.195 -1.409 . . . . 1.1499999999999999 107.195 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -43.78 94.17 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.134 -1.186 . . . . 0.19 110.134 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.95 -42.63 94.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.868 -1.372 . . . . 1.8200000000000001 109.078 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.02 -42.33 94.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.40000000000000002 108.887 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.94 -38.4 79.46 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.69 -0.856 . . . . 1.0700000000000001 108.69 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.27 -22.68 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -0.9 . . . . 1.0900000000000001 110.065 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 93.8 mt -92.59 16.88 11.08 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.125 -0.984 . . . . 1.0900000000000001 109.786 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 58.8 mttm 49.98 39.64 19.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.926 -1.108 . . . . 2.23 110.539 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.19 19.15 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 2.7999999999999998 109.796 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' B' ' 55' ' ' ASP . 19.8 t0 -70.11 108.54 4.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.714 -1.241 . . . . 1.8 108.089 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.01 -39.93 91.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.685 -0.635 . . . . 0.88 112.653 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.17 -39.97 78.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.648 -1.282 . . . . 0.73999999999999999 110.401 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.32 75.27 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.005 -1.078 . . . . 1.2 109.071 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.78 -50.07 70.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.354 -0.841 . . . . 0.44 110.042 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -60.07 -46.4 89.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 3.3399999999999999 110.513 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -65.8 -38.45 88.99 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.899 -1.125 . . . . 2.3799999999999999 109.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.6 t90 -66.0 -48.33 71.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.99 -1.069 . . . . 0.40999999999999998 111.063 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.432 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 64.3 tp -66.14 -46.61 76.89 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.175 -0.953 . . . . 1.0700000000000001 109.129 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.85 -45.67 91.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.342 -0.849 . . . . 2.6000000000000001 109.125 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.65 -31.85 70.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.653 . . . . 1.8999999999999999 109.839 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 94.3 m -80.36 -31.54 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 1.1000000000000001 111.486 -177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . 0.572 ' HG ' ' H ' ' B' ' 69' ' ' ALA . 31.9 p -132.53 -25.67 1.9 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.486 -1.384 . . . . 0.95999999999999996 112.011 -177.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.39 13.04 29.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.428 -1.469 . . . . 0.37 109.428 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.572 ' H ' ' HG ' ' B' ' 67' ' ' CYS . . . -50.43 153.38 1.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.964 -1.315 . . . . 1.0900000000000001 109.205 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -92.01 174.2 7.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.043 -1.036 . . . . 2.3700000000000001 110.294 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.96 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 1.1100000000000001 110.936 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.738 ' HZ2' HE21 ' B' ' 73' ' ' GLN . 22.0 pttp -75.13 -38.32 61.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.115 . . . . 2.9700000000000002 109.697 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.738 HE21 ' HZ2' ' B' ' 72' ' ' LYS . 85.7 mm-40 -67.13 -38.68 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 2.6200000000000001 109.99 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -67.17 -37.69 84.15 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 1.8899999999999999 109.916 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.33 -38.38 83.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.147 -0.971 . . . . 3.3199999999999998 109.606 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.68 -39.99 84.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.613 -1.305 . . . . 0.40000000000000002 110.727 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -69.26 -39.98 78.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.838 -1.164 . . . . 0.95999999999999996 110.086 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.49 -60.36 3.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.564 -1.335 . . . . 0.5 110.235 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.61 82.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.47 -1.052 . . . . 0.27000000000000002 110.47 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.0 t -70.69 -47.77 58.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.064 -1.256 . . . . 0.93999999999999995 109.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.15 -39.98 75.03 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.089 -1.044 . . . . 1.0900000000000001 109.074 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.4 ' HG2' HH11 ' B' ' 82' ' ' ARG . 33.3 ttt-85 -63.62 -40.04 95.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 3.1899999999999999 110.312 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.31 -38.32 78.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 1.9099999999999999 110.213 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.435 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 86.6 t90 -60.0 -45.35 93.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.468 -1.395 . . . . 0.40000000000000002 107.869 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 52.6 m -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.643 0.735 . . . . 0.96999999999999997 109.284 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.0 -34.64 73.6 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.397 -0.814 . . . . 0.55000000000000004 110.071 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.05 -36.75 13.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.167 -0.958 . . . . 1.1299999999999999 111.161 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.4 m-85 -107.0 0.76 23.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.232 -0.918 . . . . 1.24 111.467 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 85' ' ' CYS . 6.9 tp . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.865 -1.147 . . . . 1.8300000000000001 109.11 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.432 ' O ' ' OG1' ' A' ' 2' ' ' THR . 67.6 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.442 -0.577 . . . . 6.1100000000000003 109.442 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 1' ' ' MET . 7.0 p 55.16 36.75 27.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.218 -0.926 . . . . 3.5800000000000001 109.304 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p -81.71 160.96 23.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 1.3200000000000001 110.493 -179.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 t -78.65 173.29 12.59 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.65 0.738 . . . . 1.98 109.488 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.92 -24.59 64.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.746 -0.596 . . . . 2.6000000000000001 110.127 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.921 -1.112 . . . . 2.5099999999999998 108.98 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -60.04 -49.07 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.51000000000000001 110.201 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 8' ' ' ARG . 53.9 mtt-85 -70.07 -31.99 69.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 3.7200000000000002 109.648 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.54 -40.02 80.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.98 . . . . 0.76000000000000001 109.801 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.3 t80 -62.58 -48.17 80.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.5 110.133 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.98 10.11 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.155 -0.966 . . . . 1.1799999999999999 110.506 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.67 -14.22 15.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.23 -0.919 . . . . 1.1799999999999999 109.881 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.31 152.84 27.17 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.148 -0.97 . . . . 1.26 109.025 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.2 162.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.751 1.634 . . . . 0.53000000000000003 111.5 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.8 ptp -92.49 -21.44 20.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 109.787 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.79 -139.91 16.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.037 -1.225 . . . . 0.41999999999999998 110.037 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.73 30.89 5.4 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.427 -1.043 . . . . 0.84999999999999998 110.481 -178.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -60.1 149.23 75.6 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.872 -1.142 . . . . 2.4900000000000002 108.676 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.2 158.68 50.91 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.984 1.79 . . . . 0.39000000000000001 111.992 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' SER . 14.4 p -57.16 -45.77 84.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.457 -0.777 . . . . 1.1200000000000001 110.483 -179.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -55.54 -3.19 0.38 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.757 -0.937 . . . . 0.27000000000000002 110.757 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' VAL . 47.0 m -82.08 -22.14 36.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.781 -1.423 . . . . 1.75 109.424 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.0 139.2 58.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 1.05 109.776 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 136.38 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.756 -0.777 . . . . 1.0600000000000001 109.718 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.54 -18.43 57.5 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.235 -1.546 . . . . 0.23000000000000001 109.235 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.4 110.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.875 -1.158 . . . . 1.0800000000000001 107.875 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.56 178.65 41.37 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.665 -1.374 . . . . 0.31 109.665 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.31 -40.02 73.68 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.498 -1.001 . . . . 2.0099999999999998 110.351 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.72 -41.22 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.637 -1.289 . . . . 1.1399999999999999 109.625 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.72 -38.45 83.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 1.1299999999999999 109.745 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -40.08 96.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.119 -1.192 . . . . 0.34999999999999998 110.119 -179.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.78 -36.27 83.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.885 -1.362 . . . . 3.2200000000000002 109.486 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.6 -53.65 26.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.139 . . . . 2.1000000000000001 109.546 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.02 -39.96 87.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.118 -1.067 . . . . 1.0800000000000001 108.118 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.09 -46.04 90.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.484 -0.76 . . . . 1.6699999999999999 109.344 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.68 -19.83 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.44 -0.948 . . . . 2.0 108.44 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.91 3.74 52.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.696 -0.627 . . . . 3.1499999999999999 109.726 -179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.21 50.7 Favored Glycine 0 N--CA 1.503 3.107 0 O-C-N 121.039 -1.038 . . . . 0.47999999999999998 111.432 177.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.2 74.98 1.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.913 -1.346 . . . . 0.38 108.941 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -80.31 -9.24 59.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.40999999999999998 110.965 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.92 152.77 50.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.122 -0.986 . . . . 2.1600000000000001 109.836 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.19 96.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.622 -0.674 . . . . 1.03 111.13 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 8.6 p90 -58.45 -18.99 32.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.826 -1.171 . . . . 0.92000000000000004 110.414 -178.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.9 t -80.71 -30.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.904 -1.123 . . . . 1.0700000000000001 108.366 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.64 -39.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.172 -1.047 . . . . 1.0600000000000001 108.172 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.1 tp -59.95 -39.45 85.6 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.624 -1.25 . . . . 1.1599999999999999 107.624 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.13 -45.04 74.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.654 -1.379 . . . . 0.20000000000000001 109.654 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.99 -43.19 95.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.119 -1.224 . . . . 1.8200000000000001 109.153 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.06 -39.98 87.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.427 -0.953 . . . . 0.40000000000000002 108.427 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.81 -38.67 83.59 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.429 -0.952 . . . . 1.0900000000000001 108.429 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.99 -22.13 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 1.0900000000000001 110.736 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -93.15 17.06 11.59 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.96 -1.087 . . . . 1.0900000000000001 110.388 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.77 34.39 10.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.873 -1.142 . . . . 2.2200000000000002 110.229 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.6 mttp 59.55 20.0 8.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.456 -0.778 . . . . 2.7999999999999998 109.83 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.02 114.52 5.25 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.623 -1.251 . . . . 1.8 107.623 178.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 40.0 tt0 -63.46 -41.38 98.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.87 112.519 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.04 -39.76 75.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.604 -1.31 . . . . 0.72999999999999998 110.765 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.16 -39.93 78.47 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.873 -1.131 . . . . 1.2 109.551 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.69 -49.83 71.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.44 109.402 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.439 ' HE ' ' CG ' ' A' ' 56' ' ' GLU . 44.3 mtt-85 -60.0 -46.61 88.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.809 . . . . 3.3399999999999999 110.513 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.37 -38.55 90.38 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.966 -1.084 . . . . 2.3700000000000001 108.943 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' A' ' 66' ' ' THR . 59.5 t90 -64.29 -47.01 81.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.40999999999999998 110.541 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 tp -67.57 -47.02 71.01 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.274 -0.891 . . . . 1.0800000000000001 110.254 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -62.58 -47.5 83.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 2.6099999999999999 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -69.47 -28.68 66.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.885 . . . . 1.8999999999999999 109.732 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.8 m -80.43 -33.94 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.331 -0.856 . . . . 1.1100000000000001 111.41 -178.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.4 p -132.23 -29.82 1.58 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.53 -1.356 . . . . 0.96999999999999997 111.93 -178.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.51 20.95 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.231 -1.548 . . . . 0.38 109.231 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.38 2.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.275 . . . . 1.1000000000000001 109.23 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.584 ' H ' HE21 ' A' ' 73' ' ' GLN . 6.8 m120 -90.61 171.49 9.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 2.3700000000000001 109.529 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.5 75.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 1.1200000000000001 110.416 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.53 -41.26 69.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 2.9700000000000002 109.975 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.584 HE21 ' H ' ' A' ' 70' ' ' ASN . 36.7 mt-30 -67.11 -40.04 86.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 2.6200000000000001 110.12 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.49 -38.94 92.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.436 -0.79 . . . . 1.8899999999999999 110.233 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -60.0 -38.66 83.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 3.3199999999999998 109.016 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -68.48 -39.89 81.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.88 -1.137 . . . . 0.40000000000000002 110.614 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -69.12 -40.18 78.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.632 -1.292 . . . . 0.95999999999999996 109.821 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.31 -60.01 4.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.633 -1.292 . . . . 0.5 109.867 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' OE2' ' A' ' 83' ' ' GLU . . . -59.9 -32.57 75.43 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.047 -1.221 . . . . 0.27000000000000002 110.047 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.3 t -69.08 -49.79 54.14 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.075 -1.25 . . . . 0.93999999999999995 110.014 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.58 -40.23 70.05 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.746 -1.182 . . . . 1.0900000000000001 109.124 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' A' ' 82' ' ' ARG . 1.2 tpt180 -60.8 -42.67 98.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.161 -0.962 . . . . 3.1800000000000002 110.055 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -70.0 -36.42 75.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 1.9099999999999999 110.271 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 84.8 t90 -60.01 -43.18 95.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.521 -1.362 . . . . 0.40000000000000002 107.709 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 89' ' ' LEU . 48.2 m -61.02 -40.29 93.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.604 -0.685 . . . . 0.96999999999999997 110.026 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.04 -33.92 72.69 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -0.969 . . . . 0.55000000000000004 110.274 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.11 14.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.124 -0.985 . . . . 1.1200000000000001 111.028 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.0 1.84 19.26 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.161 -0.962 . . . . 1.24 111.82 -178.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' CYS . 8.0 tp . . . . . 0 N--CA 1.499 1.976 0 O-C-N 120.765 -1.209 . . . . 1.8300000000000001 109.668 -177.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.441 ' O ' ' OG1' ' B' ' 2' ' ' THR . 67.6 mtt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.451 -0.574 . . . . 6.0999999999999996 109.451 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' B' ' 1' ' ' MET . 6.9 p 55.1 36.86 27.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.211 -0.93 . . . . 3.5800000000000001 109.318 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 13.0 p -81.71 161.01 23.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 1.3200000000000001 110.478 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.7 t -78.63 173.38 12.49 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.647 0.737 . . . . 1.97 109.557 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.9 -24.7 64.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 2.5899999999999999 110.178 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.91 -35.31 74.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.034 -1.042 . . . . 2.5 108.971 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.403 ' CD2' ' C ' ' B' ' 7' ' ' HIS . 7.7 t60 -60.06 -49.09 79.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.034 -1.041 . . . . 0.51000000000000001 110.237 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' B' ' 8' ' ' ARG . 54.1 mtt-85 -70.02 -31.89 69.78 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.113 -0.992 . . . . 3.73 109.716 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.68 -39.97 80.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.76000000000000001 109.761 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.439 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.2 t80 -62.54 -48.25 80.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.5 110.098 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.99 10.19 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.052 -1.03 . . . . 1.1799999999999999 110.51 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.61 -14.31 15.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 1.1799999999999999 109.857 178.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' B' ' 14' ' ' PRO . 13.5 pt-20 -154.27 152.78 27.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 1.27 109.12 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.9 Cg_exo -40.15 162.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.879 1.719 . . . . 0.53000000000000003 111.483 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 6.8 ptp -92.45 -21.4 20.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 1.1299999999999999 109.764 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.68 -139.82 16.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.06 -1.216 . . . . 0.40999999999999998 110.06 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.8 30.83 5.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.549 -0.971 . . . . 0.83999999999999997 110.47 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.98 149.24 74.62 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.189 . . . . 2.4900000000000002 108.777 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.19 158.77 50.38 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.941 1.761 . . . . 0.38 112.087 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' B' ' 22' ' ' SER . 14.4 p -57.29 -45.6 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 1.1200000000000001 110.545 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.423 ' N ' ' CG1' ' B' ' 20' ' ' VAL . . . -55.77 -3.04 0.4 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.725 -0.95 . . . . 0.27000000000000002 110.725 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.473 ' H ' ' C ' ' B' ' 20' ' ' VAL . 47.6 m -82.11 -22.15 36.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.713 -1.463 . . . . 1.75 109.3 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.09 139.22 58.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 1.0600000000000001 109.768 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.89 136.4 56.08 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.758 -0.777 . . . . 1.05 109.781 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.3 57.73 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.264 -1.534 . . . . 0.22 109.264 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.48 110.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.817 -1.179 . . . . 1.0800000000000001 107.817 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.66 178.61 41.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.675 -1.37 . . . . 0.29999999999999999 109.675 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.36 -39.95 73.71 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.595 -0.944 . . . . 2.0 110.333 -178.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.68 -41.25 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.604 -1.31 . . . . 1.1399999999999999 109.69 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.72 -38.43 83.56 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.262 -0.898 . . . . 1.1299999999999999 109.755 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.104 -1.198 . . . . 0.35999999999999999 110.104 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.75 -36.32 83.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.368 . . . . 3.2200000000000002 109.502 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.49 -53.72 26.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.751 -1.218 . . . . 2.1200000000000001 109.562 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.208 -1.034 . . . . 1.0800000000000001 108.208 178.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.07 -46.09 90.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 1.6799999999999999 109.345 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -63.58 -19.98 65.27 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.411 -0.959 . . . . 1.99 108.411 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.78 3.72 51.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.612 -0.68 . . . . 3.1499999999999999 109.83 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.2 50.72 Favored Glycine 0 N--CA 1.502 3.044 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 111.468 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -106.16 74.88 1.06 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.96 -1.318 . . . . 0.38 108.971 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -80.25 -9.27 59.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.40999999999999998 111.003 -178.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.97 152.84 50.86 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.093 -1.004 . . . . 2.1499999999999999 109.832 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.576 -0.702 . . . . 1.03 111.096 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 8.7 p90 -58.58 -18.98 34.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 0.92000000000000004 110.486 -177.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 25.8 t -80.77 -30.36 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.047 . . . . 1.0800000000000001 108.343 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.66 -39.05 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.149 -1.056 . . . . 1.0700000000000001 108.149 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.09 -39.3 85.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.632 -1.247 . . . . 1.1499999999999999 107.632 177.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.15 -45.03 74.22 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.579 -1.409 . . . . 0.19 109.579 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.03 -43.19 95.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -1.216 . . . . 1.8200000000000001 109.099 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.441 -0.948 . . . . 0.40000000000000002 108.441 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.88 -38.65 83.31 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.464 -0.939 . . . . 1.0700000000000001 108.464 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.02 -21.97 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.373 -0.83 . . . . 1.0900000000000001 110.764 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 98.6 mt -93.27 17.15 11.65 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.993 -1.067 . . . . 1.0900000000000001 110.363 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.86 34.29 10.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.894 -1.129 . . . . 2.23 110.272 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 59.46 19.91 8.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 2.7999999999999998 109.813 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.88 114.67 5.27 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.571 -1.27 . . . . 1.8 107.571 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.434 ' CG ' ' HE ' ' B' ' 60' ' ' ARG . 40.0 tt0 -63.63 -41.39 98.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.88 112.452 -177.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.04 -39.75 75.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.64 -1.288 . . . . 0.73999999999999999 110.742 -179.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.21 -39.88 78.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.827 -1.149 . . . . 1.2 109.611 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.76 -49.84 71.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.091 -1.006 . . . . 0.44 109.415 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.434 ' HE ' ' CG ' ' B' ' 56' ' ' GLU . 44.8 mtt-85 -59.93 -46.61 88.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.364 -0.835 . . . . 3.3399999999999999 110.55 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.28 -38.69 91.05 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.029 -1.044 . . . . 2.3799999999999999 108.952 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 62' ' ' TRP . . . . . 0.442 ' O ' ' OG1' ' B' ' 66' ' ' THR . 59.6 t90 -64.29 -46.95 81.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.40999999999999998 110.523 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.55 -47.06 70.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.238 -0.914 . . . . 1.0700000000000001 110.17 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -62.54 -47.56 83.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 2.6000000000000001 110.161 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.43 -28.62 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 1.8999999999999999 109.739 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 65.5 m -80.37 -34.14 36.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 1.1000000000000001 111.304 -178.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.6 p -132.24 -29.67 1.59 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.501 -1.375 . . . . 0.95999999999999996 111.839 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.75 14.58 21.02 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.21 -1.556 . . . . 0.37 109.21 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.27 151.27 2.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -1.228 . . . . 1.0900000000000001 109.279 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.573 ' H ' HE21 ' B' ' 73' ' ' GLN . 6.8 m120 -90.52 171.48 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.0 . . . . 2.3700000000000001 109.527 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.33 74.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 1.1100000000000001 110.465 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.65 -41.18 69.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.828 -1.17 . . . . 2.9700000000000002 110.014 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.573 HE21 ' H ' ' B' ' 70' ' ' ASN . 36.7 mt-30 -67.2 -39.97 86.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 2.6200000000000001 110.185 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.53 -38.86 92.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.355 -0.841 . . . . 1.8899999999999999 110.253 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -60.03 -38.63 83.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.954 -1.092 . . . . 3.3199999999999998 109.035 -179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -68.54 -40.03 80.86 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.915 -1.116 . . . . 0.40000000000000002 110.592 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.95 -40.19 79.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.702 -1.249 . . . . 0.95999999999999996 109.901 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.36 -59.98 4.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.61 -1.306 . . . . 0.5 109.915 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 83' ' ' GLU . . . -59.88 -32.52 75.2 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.054 -1.218 . . . . 0.27000000000000002 110.054 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -69.13 -49.83 53.42 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.099 -1.236 . . . . 0.93999999999999995 110.064 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.63 -40.14 69.95 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.744 -1.182 . . . . 1.0900000000000001 109.147 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' B' ' 82' ' ' ARG . 1.2 tpt180 -60.83 -42.67 98.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.147 -0.97 . . . . 3.1899999999999999 110.037 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' B' ' 79' ' ' GLY . 0.3 OUTLIER -70.09 -36.39 74.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 1.9099999999999999 110.053 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 84' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 84.8 t90 -59.98 -43.37 95.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.537 -1.352 . . . . 0.40000000000000002 107.743 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' B' ' 89' ' ' LEU . 50.3 m -60.72 -40.37 92.06 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.562 0.696 . . . . 0.96999999999999997 110.099 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.96 -33.94 72.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.064 -1.023 . . . . 0.55000000000000004 110.342 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.29 14.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.148 -0.97 . . . . 1.1299999999999999 110.969 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 88' ' ' PHE . . . . . 0.403 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 91.0 m-85 -109.78 1.66 19.5 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.275 -0.891 . . . . 1.24 111.925 -178.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.6 tp . . . . . 0 N--CA 1.499 1.992 0 O-C-N 120.795 -1.191 . . . . 1.8300000000000001 109.746 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.576 0.703 . . . . 1.3500000000000001 109.804 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -51.75 -21.0 2.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.641 . . . . 2.3799999999999999 109.693 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.58 -37.23 83.09 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.316 -0.865 . . . . 2.0699999999999998 109.947 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -59.99 -50.07 75.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.029 -1.045 . . . . 0.44 110.047 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -69.92 -36.86 75.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.964 -1.085 . . . . 3.2999999999999998 110.182 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.863 -0.791 . . . . 0.68999999999999995 108.863 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -64.73 -49.6 70.2 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.516 -0.74 . . . . 0.38 110.14 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 m -83.36 8.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.085 -1.009 . . . . 0.34999999999999998 110.672 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.51 -13.48 16.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.153 -0.967 . . . . 0.46999999999999997 110.163 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.85 152.08 24.76 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.125 -0.984 . . . . 1.27 108.839 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -40.01 160.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.927 1.751 . . . . 0.44 112.065 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.688 ' SD ' HD11 ' B' ' 89' ' ' LEU . 3.2 ptp -89.2 -28.11 20.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.933 . . . . 1.0900000000000001 109.738 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.09 -141.1 43.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.787 -1.725 . . . . 0.53000000000000003 108.787 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.08 33.55 4.06 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.304 -1.115 . . . . 1.0700000000000001 109.806 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.9 148.96 75.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 2.1800000000000002 109.568 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.81 152.16 80.17 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.71 2.273 . . . . 0.38 112.911 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.7 p -53.69 -43.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.448 0.642 . . . . 0.29999999999999999 110.191 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.495 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -57.57 -3.85 1.17 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.384 -1.086 . . . . 0.19 110.384 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 20' ' ' VAL . 42.1 t -84.08 -22.5 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.337 . . . . 1.3799999999999999 110.163 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.467 HD22 HD21 ' A' ' 81' ' ' LEU . 74.7 mt -64.16 138.52 58.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.994 -1.066 . . . . 0.20999999999999999 109.895 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 134.43 54.36 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.792 -0.763 . . . . 0.20999999999999999 109.712 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.78 49.29 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.339 -1.504 . . . . 0.19 109.339 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.418 HD11 ' SG ' ' A' ' 77' ' ' CYS . 36.4 mm -98.51 112.26 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.331 -1.099 . . . . 0.19 108.126 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.06 177.28 42.87 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.855 -1.298 . . . . 0.19 109.855 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -58.54 -40.0 81.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.477 -1.014 . . . . 1.8 109.957 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.14 -46.71 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.96 -1.088 . . . . 0.31 108.834 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.689 HD11 ' OE1' ' A' ' 73' ' ' GLN . 88.0 mt -67.94 -39.75 83.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.33000000000000002 109.877 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.27 -33.92 77.7 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.879 -1.688 . . . . 0.31 108.879 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.03 -40.4 87.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.505 -0.997 . . . . 2.8900000000000001 110.292 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -68.47 -44.53 74.61 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.95 -1.094 . . . . 1.51 109.1 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.48 -39.41 93.35 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.933 -1.104 . . . . 0.28000000000000003 108.029 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.99 -42.22 93.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.75 . . . . 1.51 109.269 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -68.05 -18.74 64.77 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.311 -0.996 . . . . 2.4500000000000002 108.311 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.77 3.19 53.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.728 -0.608 . . . . 2.5499999999999998 109.789 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.05 7.57 49.75 Favored Glycine 0 N--CA 1.502 3.073 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 111.335 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CD2' HG12 ' A' ' 44' ' ' VAL . 93.7 m-85 -106.43 74.31 1.01 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.907 -1.349 . . . . 0.34999999999999998 109.048 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -80.23 -9.95 59.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.35999999999999999 110.665 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -129.33 152.36 48.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.227 -0.921 . . . . 1.4299999999999999 109.149 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.95 94.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.22 110.786 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.1 p90 -60.66 -17.84 49.95 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.915 -1.115 . . . . 0.62 110.975 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.597 HG12 ' CD2' ' A' ' 39' ' ' PHE . 44.7 t -78.97 -32.72 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.309 -1.367 . . . . 0.25 107.309 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.93 -39.84 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.582 -0.895 . . . . 0.20000000000000001 108.582 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.87 -35.12 74.16 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.079 -1.452 . . . . 0.29999999999999999 107.079 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.95 -40.76 95.79 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.63 -1.388 . . . . 0.20000000000000001 109.63 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.97 -42.46 94.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.296 -1.12 . . . . 1.1000000000000001 108.596 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.06 -39.96 87.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.32000000000000001 109.57 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD12 HD12 ' B' ' 50' ' ' LEU . 80.4 mt -69.52 -37.72 77.25 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.602 -0.839 . . . . 0.32000000000000001 108.948 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.53 -28.57 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.252 -0.905 . . . . 0.31 109.744 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.29 13.16 10.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.122 -0.986 . . . . 0.38 110.584 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt 49.94 38.96 17.51 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.538 -1.351 . . . . 2.1099999999999999 110.405 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mttm 56.85 19.47 4.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 1.9399999999999999 110.095 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.27 106.77 1.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 117.775 -1.57 . . . . 1.8400000000000001 106.972 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.1 -40.09 88.43 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.664 -0.647 . . . . 1.05 111.304 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -69.67 -40.03 76.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.263 -1.523 . . . . 0.90000000000000002 110.053 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.2 mt -70.6 -40.0 73.48 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.55 -1.26 . . . . 0.45000000000000001 109.196 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.88 -49.93 72.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.32000000000000001 110.511 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -63.23 -41.11 99.07 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.054 -1.059 . . . . 2.77 109.909 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.31 -40.07 93.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.629 -1.294 . . . . 2.1499999999999999 108.14 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -64.53 -50.03 68.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 0.27000000000000002 111.217 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.89 -46.1 83.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.132 -0.98 . . . . 0.33000000000000002 109.667 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -63.27 -49.79 72.69 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.483 -0.76 . . . . 1.9299999999999999 109.954 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.65 -30.51 70.79 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.515 -0.741 . . . . 1.7 109.678 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -78.36 -37.68 43.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.32000000000000001 111.096 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.0 p -127.24 -26.9 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.529 -1.357 . . . . 0.34000000000000002 112.261 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 13.7 27.12 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.249 -1.541 . . . . 0.27000000000000002 109.249 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.12 155.54 1.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.291 . . . . 0.23999999999999999 108.916 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -88.67 166.38 14.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 2.04 109.603 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.89 62.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.34999999999999998 108.351 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -70.16 -48.86 55.51 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.305 0.574 . . . . 3.6299999999999999 112.029 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.689 ' OE1' HD11 ' A' ' 30' ' ' LEU . 44.9 mt-30 -67.96 -30.01 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.068 -1.02 . . . . 2.1299999999999999 110.834 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.9 p -70.02 -34.7 73.62 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.979 -1.088 . . . . 1.45 109.254 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -60.29 -38.84 84.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 2.8300000000000001 109.34 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -66.86 -38.8 87.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 109.597 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 26' ' ' ILE . 93.9 m -69.91 -40.08 75.81 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.994 -1.066 . . . . 0.20000000000000001 109.702 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.74 -61.15 2.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.761 -1.212 . . . . 0.35999999999999999 109.769 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.7 -33.89 88.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.46 -1.056 . . . . 0.28999999999999998 110.46 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.41 -48.37 61.29 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.73 -1.453 . . . . 0.25 109.943 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 23' ' ' LEU . 82.9 mt -70.08 -40.07 75.22 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.9 -1.12 . . . . 0.41999999999999998 108.867 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -65.53 -40.12 92.56 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.4 -0.813 . . . . 2.5800000000000001 111.006 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -70.04 -35.36 74.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.74 -1.225 . . . . 2.0699999999999998 109.319 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.528 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 87.3 t90 -60.07 -43.69 95.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.991 -1.485 . . . . 0.32000000000000001 106.991 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.5 m -61.45 -40.18 93.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.613 0.72 . . . . 0.40999999999999998 109.896 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.96 -34.44 73.28 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.968 -1.082 . . . . 0.59999999999999998 110.328 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.33 -31.99 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.116 -0.99 . . . . 0.56000000000000005 110.299 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 66.0 m-85 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.542 -0.724 . . . . 1.23 112.606 -176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.657 0.742 . . . . 1.3500000000000001 109.699 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.66 -21.17 2.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.629 -0.669 . . . . 2.3700000000000001 109.659 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.33 -37.29 82.77 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.291 -0.881 . . . . 2.0600000000000001 109.876 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -60.05 -49.95 75.64 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.025 -1.047 . . . . 0.42999999999999999 110.038 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.02 -36.91 75.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 3.2999999999999998 110.227 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.06 -38.78 82.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.345 -0.847 . . . . 0.67000000000000004 108.732 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.68 -49.95 71.14 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.595 -0.69 . . . . 0.37 110.08 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.88 10.43 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.1 -1.0 . . . . 0.34000000000000002 110.659 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.67 -14.93 14.89 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.114 -0.991 . . . . 0.46999999999999997 110.192 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -153.51 151.2 24.94 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.139 -0.975 . . . . 1.27 108.748 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.97 160.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.97 1.78 . . . . 0.45000000000000001 112.052 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ptp -89.06 -26.54 21.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.269 -0.895 . . . . 1.0900000000000001 109.46 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.54 -138.27 46.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.709 -1.756 . . . . 0.53000000000000003 108.709 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.59 35.44 3.47 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.355 -1.086 . . . . 1.0800000000000001 109.61 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 149.76 83.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 2.1899999999999999 109.798 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.64 152.21 79.23 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.702 2.268 . . . . 0.37 112.742 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.476 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.5 p -53.85 -42.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.622 -0.674 . . . . 0.29999999999999999 110.349 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.476 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -58.56 -3.34 1.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.514 -1.034 . . . . 0.19 110.514 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.424 ' H ' ' C ' ' B' ' 20' ' ' VAL . 45.7 t -83.28 -22.62 32.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.872 -1.37 . . . . 1.3899999999999999 110.014 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.461 HD22 HD21 ' B' ' 81' ' ' LEU . 73.8 mt -64.35 139.0 58.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.22 109.746 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.19 135.63 55.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.828 -0.749 . . . . 0.20999999999999999 109.668 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.14 -21.73 44.61 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.348 -1.501 . . . . 0.19 109.348 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.417 HD11 ' SG ' ' B' ' 77' ' ' CYS . 36.2 mm -98.48 113.69 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.845 -1.169 . . . . 0.20000000000000001 107.845 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.78 179.36 39.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.787 -1.325 . . . . 0.20000000000000001 109.787 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -58.72 -40.03 82.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.473 -1.016 . . . . 1.8200000000000001 110.206 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.73 -45.76 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.941 -1.099 . . . . 0.34000000000000002 109.058 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.705 HD11 ' OE1' ' B' ' 73' ' ' GLN . 86.5 mt -68.8 -39.99 79.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.34999999999999998 109.87 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.12 -33.56 75.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.869 -1.692 . . . . 0.32000000000000001 108.869 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -39.97 86.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.965 . . . . 2.8500000000000001 110.247 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -68.91 -44.62 72.75 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.924 -1.11 . . . . 1.52 109.158 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.52 -39.47 93.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.948 -1.13 . . . . 0.27000000000000002 107.948 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -60.04 -41.86 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.58 -0.7 . . . . 1.49 109.289 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -68.48 -18.37 64.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.472 -0.936 . . . . 2.4300000000000002 108.472 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -89.93 1.63 56.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 2.5600000000000001 109.775 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 8.45 43.47 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.114 -0.991 . . . . 0.46000000000000002 111.267 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.581 ' CD2' HG12 ' B' ' 44' ' ' VAL . 93.1 m-85 -107.15 74.18 0.96 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.886 -1.361 . . . . 0.34999999999999998 108.984 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -80.07 -10.41 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.34000000000000002 110.718 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -129.3 150.69 50.56 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.208 -0.933 . . . . 1.4299999999999999 109.084 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.28 99.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.199 -0.938 . . . . 0.20999999999999999 110.726 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.465 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 6.2 p90 -56.96 -18.27 12.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.113 . . . . 0.60999999999999999 110.762 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.581 HG12 ' CD2' ' B' ' 39' ' ' PHE . 41.6 t -78.49 -33.92 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.296 -1.372 . . . . 0.23000000000000001 107.296 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.38 -39.63 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.19 108.727 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.4 tp -59.83 -34.28 72.88 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.869 -1.53 . . . . 0.29999999999999999 106.869 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.39 -40.68 96.37 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.503 -1.439 . . . . 0.19 109.503 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -60.06 -42.64 94.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.24 -1.153 . . . . 1.1200000000000001 108.891 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 0.31 109.658 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.4 HD12 HD12 ' A' ' 50' ' ' LEU . 81.9 mt -69.16 -38.07 78.55 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.877 -0.786 . . . . 0.32000000000000001 108.877 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.04 -29.31 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.259 -0.901 . . . . 0.29999999999999999 109.717 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 94.5 mt -87.16 14.56 7.45 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.002 -1.062 . . . . 0.38 110.684 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 49.97 35.48 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.626 -1.296 . . . . 2.1400000000000001 110.917 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 60.05 19.84 9.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.206 -0.934 . . . . 1.95 109.923 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 108.93 2.73 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.638 -1.615 . . . . 1.8100000000000001 106.638 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.78 -40.03 93.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 1.04 111.22 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -69.28 -40.06 78.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.375 -1.453 . . . . 0.90000000000000002 110.008 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.74 -38.82 73.56 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.903 -1.119 . . . . 0.42999999999999999 109.191 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.54 -49.99 69.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.32000000000000001 110.414 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -63.1 -41.61 99.41 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.049 -1.032 . . . . 2.79 109.843 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.19 -40.08 93.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.691 -1.256 . . . . 2.1600000000000001 108.055 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' TRP . . . . . 0.404 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -64.33 -49.07 73.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.27000000000000002 111.138 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.7 tp -66.05 -48.34 71.35 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.943 -1.098 . . . . 0.34000000000000002 109.722 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -60.87 -49.84 75.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.501 -0.749 . . . . 1.9099999999999999 110.156 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -67.53 -28.24 67.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 1.6899999999999999 109.793 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.84 -33.62 34.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.32000000000000001 110.954 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 22.4 p -131.11 -28.44 1.94 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.453 -1.405 . . . . 0.34999999999999998 112.208 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.31 13.12 25.46 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.149 -1.581 . . . . 0.28999999999999998 109.149 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 154.68 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.242 . . . . 0.26000000000000001 108.735 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.49 168.12 12.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.976 -1.077 . . . . 2.0299999999999998 109.691 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.81 63.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.333 -0.988 . . . . 0.35999999999999999 108.333 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -70.06 -49.33 52.21 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-O 121.323 0.582 . . . . 3.6099999999999999 112.07 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.705 ' OE1' HD11 ' B' ' 30' ' ' LEU . 44.4 mt-30 -67.69 -29.99 69.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.977 -1.077 . . . . 2.1299999999999999 110.883 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -69.91 -34.65 73.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.062 -1.055 . . . . 1.46 109.159 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -60.73 -38.83 86.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.758 -1.214 . . . . 2.8100000000000001 109.579 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.83 -39.14 87.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.796 -1.19 . . . . 0.28999999999999998 109.647 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' CYS . . . . . 0.417 ' SG ' HD11 ' B' ' 26' ' ' ILE . 93.0 m -69.42 -40.02 77.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.019 -1.05 . . . . 0.19 109.484 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.93 -60.73 3.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.75 -1.219 . . . . 0.35999999999999999 109.758 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.8 -33.94 88.59 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.526 -1.03 . . . . 0.28000000000000003 110.526 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.49 -48.42 60.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.747 -1.443 . . . . 0.25 109.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.461 HD21 HD22 ' B' ' 23' ' ' LEU . 83.7 mt -69.97 -40.0 75.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.972 -1.091 . . . . 0.41999999999999998 108.539 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -66.9 -40.11 87.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.855 . . . . 2.6000000000000001 111.41 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -69.87 -34.9 74.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.594 -1.316 . . . . 2.0600000000000001 108.813 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.544 ' O ' ' HB2' ' B' ' 88' ' ' PHE . 85.4 t90 -59.46 -48.65 80.83 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.661 -1.978 . . . . 0.32000000000000001 105.661 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' B' ' 89' ' ' LEU . 36.5 m -58.07 -39.93 79.75 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.765 -0.584 . . . . 0.40999999999999998 110.29 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -61.25 -35.24 76.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.31 -1.494 . . . . 0.58999999999999997 111.171 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.03 -25.5 20.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.121 . . . . 0.57999999999999996 107.983 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' B' ' 84' ' ' TRP . 60.6 m-85 -115.15 -2.98 12.61 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 114.792 1.404 . . . . 1.24 114.792 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.688 HD11 ' SD ' ' A' ' 15' ' ' MET . 14.5 tp . . . . . 0 C--N 1.282 -2.344 0 O-C-N 119.009 -2.307 . . . . 1.76 110.051 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.627 0.727 . . . . 1.51 109.251 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.37 -20.81 1.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.618 . . . . 2.1800000000000002 109.734 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.87 -35.81 79.41 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 2.02 108.81 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -60.05 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.48999999999999999 109.934 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' HG2' HH11 ' A' ' 8' ' ' ARG . 30.9 mtt-85 -69.96 -34.62 73.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 3.21 109.959 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.95 -39.81 75.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.367 -0.833 . . . . 0.76000000000000001 109.738 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -65.62 -42.49 91.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.379 -0.826 . . . . 0.46000000000000002 110.338 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.32 14.63 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.901 -1.125 . . . . 0.44 109.869 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.39 -10.33 12.02 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.365 -0.834 . . . . 0.54000000000000004 110.488 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.49 149.98 22.47 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 1.26 109.575 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -39.67 161.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.903 1.735 . . . . 0.48999999999999999 111.619 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.47 -18.0 23.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.998 -1.064 . . . . 0.56999999999999995 109.677 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -143.24 12.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.954 -1.259 . . . . 0.40000000000000002 109.954 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.71 29.89 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.416 -1.049 . . . . 0.84999999999999998 110.274 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -60.05 149.06 75.91 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.093 -1.004 . . . . 2.0099999999999998 108.609 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.7 160.11 41.98 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.26 1.974 . . . . 0.34000000000000002 112.407 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 22' ' ' SER . 6.4 p -57.2 -47.09 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.75 . . . . 0.32000000000000001 110.403 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.54 -1.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.346 -1.102 . . . . 0.23000000000000001 110.346 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 20' ' ' VAL . 21.7 m -82.95 -23.16 33.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.77 -1.429 . . . . 1.24 109.72 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.708 HD22 HD21 ' A' ' 81' ' ' LEU . 95.0 mt -64.19 140.03 58.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.23999999999999999 109.751 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 134.68 55.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.747 0.784 . . . . 0.20999999999999999 109.857 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.23 -17.05 58.48 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.583 -1.407 . . . . 0.22 109.583 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.37 115.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -1.155 . . . . 0.25 107.971 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -89.03 172.44 40.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.697 -1.361 . . . . 0.28000000000000003 109.697 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -55.86 -40.05 72.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.0099999999999998 109.92 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.04 -44.19 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.997 -1.064 . . . . 0.38 109.741 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 27' ' ' GLY . 86.6 mt -64.37 -34.21 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.40000000000000002 109.825 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.93 95.19 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.022 -1.631 . . . . 0.34999999999999998 109.022 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.23 -38.83 92.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -1.171 . . . . 2.7400000000000002 109.575 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.27 -52.88 28.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 1.54 109.172 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.58 -40.0 90.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.082 -1.011 . . . . 0.34000000000000002 108.36 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -42.07 93.58 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.885 -0.726 . . . . 1.6699999999999999 109.223 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.3 -20.17 66.02 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.603 -0.888 . . . . 2.0 108.603 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.521 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.8 OUTLIER -91.09 4.39 52.28 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 2.6899999999999999 110.286 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.04 7.95 51.71 Favored Glycine 0 N--CA 1.502 3.054 0 O-C-N 120.976 -1.077 . . . . 0.47999999999999998 111.611 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.48 ' CD2' HG12 ' A' ' 44' ' ' VAL . 93.8 m-85 -104.81 73.48 1.08 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.717 -1.461 . . . . 0.33000000000000002 108.417 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 22.9 p-10 -77.56 -9.74 59.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.428 -0.795 . . . . 0.40999999999999998 111.104 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -137.46 158.06 45.22 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.056 -1.028 . . . . 1.5600000000000001 110.417 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.67 93.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.577 . . . . 0.20999999999999999 112.327 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -59.25 -18.1 34.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.586 -1.321 . . . . 0.32000000000000001 110.439 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.1 t -79.91 -31.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.878 -1.139 . . . . 0.23999999999999999 108.285 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 20' ' ' VAL . 54.5 t -77.03 -37.71 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.942 -1.133 . . . . 0.22 107.942 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.8 tp -59.96 -37.85 80.78 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.286 -1.375 . . . . 0.40000000000000002 107.286 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.54 89.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.98 -1.248 . . . . 0.17999999999999999 109.98 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -60.04 -42.66 94.9 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.89 -1.359 . . . . 1.0900000000000001 109.134 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -60.03 -40.82 90.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 0.31 108.793 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD21 ' SG ' ' A' ' 85' ' ' CYS . 80.7 mt -69.01 -38.27 79.14 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.544 -0.909 . . . . 0.28000000000000003 108.544 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.94 -22.65 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.269 -0.894 . . . . 0.28000000000000003 110.575 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.8 15.05 13.71 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.006 -1.059 . . . . 0.31 110.676 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.12 42.77 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.671 -1.268 . . . . 1.7 110.778 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 57.82 20.02 6.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.478 -0.764 . . . . 2.2400000000000002 110.421 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -69.2 104.53 2.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.412 -1.43 . . . . 1.8 107.706 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.16 -40.05 92.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.959 0.726 . . . . 0.87 112.959 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 95.0 m-20 -69.93 -39.98 75.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.457 -1.402 . . . . 0.72999999999999998 110.475 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.82 -40.04 72.69 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.985 -1.086 . . . . 0.55000000000000004 109.033 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.27 -49.88 73.94 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.836 . . . . 0.38 110.054 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 79.3 mtm180 -61.5 -43.67 98.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 2.6400000000000001 110.317 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.61 -39.85 94.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.265 -0.897 . . . . 2.3700000000000001 108.747 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -62.41 -49.22 76.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.275 -0.891 . . . . 0.40000000000000002 110.693 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.4 tp -67.78 -47.91 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.161 -0.962 . . . . 0.34000000000000002 110.131 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.49 -45.99 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 2.1099999999999999 109.642 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.84 -30.15 68.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.742 . . . . 1.8999999999999999 109.82 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -77.83 -36.89 49.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.945 . . . . 0.40999999999999998 111.227 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.5 p -130.44 -29.92 1.95 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.593 -1.317 . . . . 0.40000000000000002 111.783 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.33 15.86 11.94 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.311 -1.516 . . . . 0.35999999999999999 109.311 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.29 154.63 2.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.315 . . . . 0.33000000000000002 109.03 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 168.84 12.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 1.8999999999999999 109.95 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.99 71.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.39000000000000001 110.192 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -72.78 -39.98 66.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.935 -1.103 . . . . 2.5800000000000001 109.346 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -68.39 -38.8 81.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.1200000000000001 110.35 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.71 -36.06 77.97 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.13 -0.981 . . . . 1.3600000000000001 109.516 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.93 -38.07 81.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 2.7999999999999998 109.401 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.13 -39.95 82.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.744 -1.222 . . . . 0.40000000000000002 110.451 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.4 m -69.45 -40.7 77.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.667 -1.271 . . . . 0.23999999999999999 109.507 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -58.82 -60.21 4.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.534 -1.354 . . . . 0.42999999999999999 109.41 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.5 90.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.86 -0.896 . . . . 0.26000000000000001 110.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.91 -49.32 59.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.364 . . . . 0.25 110.217 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.708 HD21 HD22 ' A' ' 23' ' ' LEU . 84.5 mt -70.0 -39.62 75.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.902 -1.119 . . . . 0.29999999999999999 108.757 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.94 -41.03 90.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 2.73 109.691 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.01 -37.8 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.9099999999999999 110.628 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.526 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 85.8 t90 -60.86 -42.01 97.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.37 108.974 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.467 ' SG ' HD21 ' A' ' 50' ' ' LEU . 69.8 m -62.08 -40.04 94.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.35999999999999999 109.752 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.66 -31.16 67.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.344 -0.848 . . . . 0.55000000000000004 109.646 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.89 -37.06 12.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.305 -0.872 . . . . 0.47999999999999998 111.325 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 . . . . . 0 N--CA 1.504 2.264 0 O-C-N 121.132 -0.98 . . . . 1.24 112.399 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.561 0.696 . . . . 1.5 109.236 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.49 -20.72 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.714 -0.616 . . . . 2.1800000000000002 109.727 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.81 -35.91 79.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 2.0099999999999998 108.875 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.92 -48.96 79.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.48999999999999999 110.015 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.498 ' HG2' HH11 ' B' ' 8' ' ' ARG . 31.0 mtt-85 -69.94 -34.61 73.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 3.23 110.007 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -69.95 -39.59 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.299 -0.876 . . . . 0.76000000000000001 109.855 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -65.75 -42.47 90.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.448 -0.783 . . . . 0.46000000000000002 110.36 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -84.31 14.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.946 -1.096 . . . . 0.44 109.88 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.3 -10.02 12.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.397 -0.814 . . . . 0.53000000000000003 110.466 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.63 150.02 22.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.86 -1.15 . . . . 1.27 109.456 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.59 161.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.918 1.745 . . . . 0.48999999999999999 111.603 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.44 -18.15 23.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.043 -1.035 . . . . 0.56000000000000005 109.708 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.32 -143.15 12.98 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.018 -1.233 . . . . 0.39000000000000001 110.018 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.88 29.94 5.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.484 -1.01 . . . . 0.83999999999999997 110.221 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -60.16 149.07 76.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 2.02 108.632 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 160.18 41.52 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.194 1.929 . . . . 0.34000000000000002 112.424 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' B' ' 22' ' ' SER . 6.3 p -57.27 -47.05 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.734 . . . . 0.32000000000000001 110.441 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.494 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.43 -2.1 0.1 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.475 -1.05 . . . . 0.22 110.475 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.524 ' H ' ' C ' ' B' ' 20' ' ' VAL . 21.1 m -82.67 -23.26 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.806 -1.408 . . . . 1.24 109.806 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.737 HD22 HD21 ' B' ' 81' ' ' LEU . 94.6 mt -64.12 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.04 -1.037 . . . . 0.23999999999999999 109.718 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.428 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.24 134.93 55.72 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.69 0.757 . . . . 0.20999999999999999 109.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.09 58.66 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.489 -1.444 . . . . 0.22 109.489 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.33 115.41 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.245 -1.15 . . . . 0.25 107.951 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.414 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -88.94 172.51 40.37 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.725 -1.35 . . . . 0.28000000000000003 109.725 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -56.01 -39.94 72.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -1.089 . . . . 2.0 109.907 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.19 -43.99 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.008 -1.057 . . . . 0.38 109.749 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.414 HD12 ' H ' ' B' ' 27' ' ' GLY . 86.8 mt -64.51 -34.13 77.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.40000000000000002 109.742 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.17 -40.03 95.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.973 -1.651 . . . . 0.35999999999999999 108.973 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.26 -38.64 91.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -1.154 . . . . 2.75 109.545 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.4 -52.88 28.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.124 . . . . 1.5600000000000001 109.12 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.7 -39.95 90.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.286 -1.005 . . . . 0.33000000000000002 108.286 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.08 -41.97 93.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.839 -0.744 . . . . 1.6799999999999999 109.168 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.42 -20.07 65.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.653 -0.869 . . . . 1.99 108.653 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.8 OUTLIER -90.98 4.17 52.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.561 -0.712 . . . . 2.6800000000000002 110.321 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.05 7.96 51.65 Favored Glycine 0 N--CA 1.502 3.067 0 C-N-CA 120.139 -1.029 . . . . 0.48999999999999999 111.664 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.488 ' CD2' HG12 ' B' ' 44' ' ' VAL . 93.9 m-85 -104.75 73.44 1.08 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.401 . . . . 0.33000000000000002 108.485 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 40' ' ' ASP . 22.7 p-10 -77.61 -9.75 59.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.40999999999999998 111.021 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -137.39 157.92 45.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.999 -1.063 . . . . 1.5600000000000001 110.423 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.0 94.56 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.702 -0.624 . . . . 0.20999999999999999 112.318 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.476 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 4.6 p90 -59.1 -17.88 30.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.61 -1.306 . . . . 0.32000000000000001 110.578 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.5 t -80.01 -31.93 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.924 -1.11 . . . . 0.23999999999999999 108.231 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.407 HG21 HG23 ' B' ' 20' ' ' VAL . 54.5 t -76.92 -37.65 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.954 -1.128 . . . . 0.22 107.954 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.0 -37.65 80.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.265 -1.383 . . . . 0.40000000000000002 107.265 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.47 90.35 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.96 -1.256 . . . . 0.17999999999999999 109.96 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.774 -1.427 . . . . 1.0900000000000001 109.154 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -59.95 -40.93 90.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.31 108.785 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.456 HD21 ' SG ' ' B' ' 85' ' ' CYS . 80.9 mt -68.96 -38.0 79.16 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.622 -0.881 . . . . 0.27000000000000002 108.622 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.14 -22.79 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.263 -0.898 . . . . 0.28000000000000003 110.499 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.58 14.69 14.31 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.088 -1.008 . . . . 0.29999999999999999 110.732 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.44 42.4 14.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.7 -1.25 . . . . 1.71 110.742 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 58.27 19.95 6.75 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.403 -0.811 . . . . 2.25 110.43 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -69.23 104.52 2.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 1.8 107.817 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.18 -39.99 92.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.899 0.703 . . . . 0.88 112.899 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 94.8 m-20 -70.05 -39.94 75.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.465 -1.397 . . . . 0.73999999999999999 110.362 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.969 -1.092 . . . . 0.55000000000000004 108.92 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.15 -49.98 73.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.328 -0.857 . . . . 0.38 109.939 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.486 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 79.3 mtm180 -61.7 -43.38 98.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 2.6400000000000001 110.295 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -64.71 -39.9 94.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.076 -1.015 . . . . 2.3799999999999999 108.782 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -62.39 -49.32 75.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.343 -0.848 . . . . 0.40000000000000002 110.703 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.6 -47.85 68.49 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.184 -0.948 . . . . 0.34000000000000002 110.209 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.48 -46.13 87.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 2.1000000000000001 109.636 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -68.85 -29.97 68.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 1.8999999999999999 109.903 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -77.91 -36.82 49.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.40000000000000002 111.189 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 13.4 p -130.64 -29.77 1.92 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.564 -1.335 . . . . 0.39000000000000001 111.712 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.31 15.72 12.16 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.345 -1.502 . . . . 0.35999999999999999 109.345 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.08 154.52 2.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.968 -1.313 . . . . 0.32000000000000001 109.125 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -88.34 168.93 12.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.991 -1.068 . . . . 1.9099999999999999 109.922 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.31 71.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.38 110.167 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -72.47 -40.01 67.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 2.5699999999999998 109.409 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -68.54 -38.6 80.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.45 -0.781 . . . . 2.1200000000000001 110.447 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.72 -36.06 77.95 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 1.3600000000000001 109.564 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.87 -38.21 81.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 2.8100000000000001 109.342 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.92 -40.02 83.45 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.40000000000000002 110.428 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.1 m -69.53 -40.73 76.71 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.653 -1.279 . . . . 0.23000000000000001 109.46 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.78 -60.36 3.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.635 -1.291 . . . . 0.42999999999999999 109.37 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.05 -34.58 90.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.779 -0.928 . . . . 0.25 110.779 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 51.1 t -68.79 -49.4 58.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.927 -1.337 . . . . 0.23999999999999999 110.215 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.737 HD21 HD22 ' B' ' 23' ' ' LEU . 84.6 mt -69.99 -39.5 75.86 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.842 -1.143 . . . . 0.28999999999999998 108.799 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.04 -41.0 91.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 2.7400000000000002 109.605 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -70.0 -37.72 75.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.9099999999999999 110.711 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 85.7 t90 -60.81 -42.16 97.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.516 -1.365 . . . . 0.35999999999999999 108.986 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.456 ' SG ' HD21 ' B' ' 50' ' ' LEU . 69.7 m -62.04 -39.96 94.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.474 -0.766 . . . . 0.35999999999999999 109.735 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -58.61 -31.43 68.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.433 -0.792 . . . . 0.55000000000000004 109.67 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.7 -37.19 12.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.46999999999999997 111.416 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.9 m-85 -105.74 -4.35 21.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.084 -1.01 . . . . 1.24 112.501 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.444 -1.41 . . . . 1.6699999999999999 109.419 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.781 0.8 . . . . 1.51 110.078 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -54.57 -19.28 5.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.778 -0.576 . . . . 2.1800000000000002 110.05 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -60.05 -38.36 82.58 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.031 -1.043 . . . . 2.02 109.366 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.409 ' O ' HG22 ' A' ' 11' ' ' VAL . 63.8 t60 -58.93 -50.06 75.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.48999999999999999 110.515 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 30.9 mmt180 -69.97 -33.78 72.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.02 . . . . 3.21 109.831 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -67.17 -39.9 86.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.849 -0.741 . . . . 0.76000000000000001 109.904 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.92 -47.15 75.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.46000000000000002 110.362 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 7' ' ' HIS . 24.3 m -85.77 5.18 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.128 -0.982 . . . . 0.44 110.929 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -100.57 -14.97 17.98 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.06 -1.025 . . . . 0.54000000000000004 109.935 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.6 pt-20 -153.59 153.35 28.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 1.26 108.712 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 13' ' ' GLU . 64.1 Cg_exo -35.87 156.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.236 1.958 . . . . 0.48999999999999999 112.024 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.54 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 10.4 ptm -93.12 -31.59 14.75 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.238 -0.913 . . . . 0.56999999999999995 109.983 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.24 -133.58 41.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.612 -0.995 . . . . 0.40000000000000002 110.612 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.56 -0.964 . . . . 0.84999999999999998 110.972 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.31 65.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.704 -1.248 . . . . 2.0099999999999998 108.23 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.47 155.48 47.02 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.084 1.856 . . . . 0.34000000000000002 112.246 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.8 p -56.23 -47.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.554 -0.716 . . . . 0.32000000000000001 110.384 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.576 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -58.03 -3.28 1.18 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.681 -0.967 . . . . 0.23000000000000001 110.681 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' VAL . 9.6 t -84.52 -22.31 30.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.742 -1.446 . . . . 1.24 109.633 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.601 HD22 HD21 ' A' ' 81' ' ' LEU . 96.4 mt -62.88 138.87 58.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 0.23999999999999999 109.263 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 136.27 57.27 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.91 0.862 . . . . 0.20999999999999999 110.507 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.05 59.67 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.301 -1.52 . . . . 0.22 109.301 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 77' ' ' CYS . 27.1 mm -100.29 113.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.436 -1.038 . . . . 0.25 108.384 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.75 177.72 40.49 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.422 -1.471 . . . . 0.28000000000000003 109.422 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -55.77 -39.72 71.61 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.465 -1.021 . . . . 2.0099999999999998 109.562 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.02 -46.36 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.06 -1.025 . . . . 0.38 110.127 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.68 -39.05 87.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.40000000000000002 109.972 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 -39.96 97.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.168 -1.173 . . . . 0.34999999999999998 110.168 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.34 -39.66 92.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.106 -1.232 . . . . 2.7400000000000002 110.241 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -67.66 -45.68 74.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.936 -1.103 . . . . 1.54 108.974 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.91 -39.42 89.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.655 -1.239 . . . . 0.34000000000000002 107.655 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.02 -40.94 91.04 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.827 -0.749 . . . . 1.6699999999999999 109.141 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -68.03 -20.35 64.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.246 -0.909 . . . . 2.0 108.882 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.421 ' HE ' HG23 ' A' ' 66' ' ' THR . 23.7 mmm180 -91.16 2.43 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 2.6899999999999999 109.679 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.02 38.0 3.72 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 120.346 -0.93 . . . . 0.47999999999999998 111.352 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' A' ' 44' ' ' VAL . 87.2 m-85 -133.63 72.29 1.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.959 -1.318 . . . . 0.33000000000000002 109.073 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 22.9 p-10 -80.07 -10.73 59.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.165 . . . . 0.40999999999999998 110.437 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -129.75 150.93 50.84 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.193 -0.942 . . . . 1.5600000000000001 109.422 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.06 90.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.20999999999999999 111.274 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.74 -17.1 32.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.741 -1.224 . . . . 0.32000000000000001 110.182 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' A' ' 39' ' ' PHE . 61.0 t -79.86 -31.8 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.748 -1.204 . . . . 0.23999999999999999 107.748 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.34 -36.47 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.774 -1.195 . . . . 0.22 107.774 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.01 -36.34 77.01 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.237 -1.394 . . . . 0.40000000000000002 107.237 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.07 98.12 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.736 -1.346 . . . . 0.17999999999999999 109.736 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -60.08 -43.8 95.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.903 -1.351 . . . . 1.0900000000000001 108.431 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.11 -40.91 91.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.31 109.222 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.6 -38.45 80.62 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.426 -0.953 . . . . 0.28000000000000003 108.426 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.76 -21.08 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.259 -0.9 . . . . 0.28000000000000003 110.853 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.48 13.27 14.21 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.933 -1.105 . . . . 0.31 111.351 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 49.92 36.21 11.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.648 -1.282 . . . . 1.7 110.065 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.28 19.96 8.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.411 -0.805 . . . . 2.2400000000000002 110.257 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.9 105.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.526 -1.359 . . . . 1.8 108.209 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 82.5 tt0 -65.11 -40.29 94.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.486 -0.759 . . . . 0.87 112.44 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.61 -39.99 80.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.704 -1.248 . . . . 0.72999999999999998 109.594 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.59 -39.31 77.37 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.385 -0.926 . . . . 0.55000000000000004 108.756 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.5 -46.62 89.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.38 109.117 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 96.9 mtt180 -59.99 -48.21 82.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.497 -0.752 . . . . 2.6400000000000001 110.694 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.32 -39.95 89.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.703 -1.248 . . . . 2.3700000000000001 108.913 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -62.76 -49.94 73.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.40000000000000002 110.647 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 56.6 tp -66.35 -47.64 72.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.328 -0.857 . . . . 0.34000000000000002 109.724 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.27 -44.93 95.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.359 -0.838 . . . . 2.1099999999999999 109.772 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.36 -32.08 70.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.327 -0.858 . . . . 1.8999999999999999 109.244 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.421 HG23 ' HE ' ' A' ' 37' ' ' ARG . 94.4 m -77.1 -38.0 53.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.40999999999999998 111.323 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 10.5 p -131.0 -37.0 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.622 -1.299 . . . . 0.40000000000000002 111.86 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.21 17.75 7.57 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.214 -1.555 . . . . 0.35999999999999999 109.214 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.31 153.84 3.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.034 -1.274 . . . . 0.33000000000000002 109.191 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -91.06 171.66 9.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 1.8999999999999999 109.589 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.84 70.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.467 -0.771 . . . . 0.39000000000000001 110.593 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -71.79 -41.16 68.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.739 -1.226 . . . . 2.5800000000000001 110.317 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.41 -39.16 88.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.198 -0.939 . . . . 2.1200000000000001 110.451 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -66.03 -38.65 88.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.441 -0.787 . . . . 1.3600000000000001 110.195 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.825 -1.172 . . . . 2.7999999999999998 109.384 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -67.9 -39.99 83.53 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.697 -1.252 . . . . 0.40000000000000002 110.476 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.426 ' SG ' HD11 ' A' ' 26' ' ' ILE . 92.4 m -69.74 -39.94 76.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.683 -1.26 . . . . 0.23999999999999999 109.778 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.48 -60.41 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.61 -1.307 . . . . 0.42999999999999999 109.792 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.58 84.67 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 120.305 -0.95 . . . . 0.26000000000000001 110.843 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.21 -49.27 45.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.832 -1.393 . . . . 0.25 110.014 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.601 HD21 HD22 ' A' ' 23' ' ' LEU . 88.5 mt -70.0 -39.98 75.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.29999999999999999 108.745 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.491 ' HG2' HH11 ' A' ' 82' ' ' ARG . 16.4 ttt-85 -64.57 -39.87 94.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.282 -0.886 . . . . 2.73 110.051 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.92 -39.45 79.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 1.9099999999999999 110.345 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.588 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 88.3 t90 -60.14 -43.63 95.57 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.411 -1.431 . . . . 0.37 107.666 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.1 m -61.57 -40.02 93.26 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.457 0.646 . . . . 0.35999999999999999 109.695 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.99 -31.91 70.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.835 . . . . 0.55000000000000004 109.145 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.73 13.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.4 -0.813 . . . . 0.47999999999999998 110.654 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.588 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 85.5 m-85 . . . . . 0 N--CA 1.505 2.315 0 O-C-N 121.278 -0.889 . . . . 1.24 112.831 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.793 0.806 . . . . 1.5 110.07 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -54.73 -19.28 5.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.77 -0.581 . . . . 2.1800000000000002 110.039 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.96 -38.37 82.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.024 -1.047 . . . . 2.0099999999999998 109.364 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.403 ' O ' HG22 ' B' ' 11' ' ' VAL . 63.7 t60 -58.95 -50.12 75.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.996 . . . . 0.48999999999999999 110.428 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 30.9 mmt180 -70.01 -33.72 72.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.035 -1.041 . . . . 3.23 109.825 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.2 -39.93 86.4 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.418 -0.801 . . . . 0.76000000000000001 109.792 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.83 -47.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.46000000000000002 110.303 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 7' ' ' HIS . 24.2 m -85.77 5.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.132 -0.98 . . . . 0.44 110.907 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -100.56 -15.09 17.94 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.049 -1.032 . . . . 0.53000000000000003 109.915 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' B' ' 14' ' ' PRO . 4.6 pt-20 -153.65 153.38 28.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 1.27 108.606 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -35.93 156.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.333 2.022 . . . . 0.48999999999999999 112.001 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.531 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 10.3 ptm -93.24 -31.64 14.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.359 -0.838 . . . . 0.56000000000000005 109.916 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.62 42.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.557 -1.017 . . . . 0.39000000000000001 110.557 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.968 . . . . 0.83999999999999997 110.938 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.34 64.83 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.748 -1.22 . . . . 2.02 108.272 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.54 155.55 46.96 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.016 1.81 . . . . 0.34000000000000002 112.298 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.58 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.6 p -56.26 -47.25 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.536 -0.728 . . . . 0.32000000000000001 110.43 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -58.01 -3.12 1.1 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.781 -0.928 . . . . 0.22 110.781 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 20' ' ' VAL . 9.8 t -84.65 -22.34 29.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.696 -1.473 . . . . 1.24 109.573 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.6 HD22 HD21 ' B' ' 81' ' ' LEU . 96.5 mt -62.91 138.87 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 0.23999999999999999 109.276 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 136.15 57.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.782 0.801 . . . . 0.20999999999999999 110.552 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -16.95 59.9 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.393 -1.483 . . . . 0.22 109.393 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.429 HD11 ' SG ' ' B' ' 77' ' ' CYS . 27.2 mm -100.38 113.19 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.398 -1.06 . . . . 0.25 108.343 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.74 177.56 40.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.419 -1.472 . . . . 0.28000000000000003 109.419 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -55.63 -39.7 71.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.506 -0.996 . . . . 2.0 109.519 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.05 -46.35 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.053 -1.029 . . . . 0.38 110.096 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.72 -38.96 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.40000000000000002 109.865 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.81 -40.1 97.73 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.083 -1.207 . . . . 0.35999999999999999 110.083 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.26 -39.71 93.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.254 . . . . 2.75 110.187 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.56 -45.67 74.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.105 . . . . 1.5600000000000001 109.041 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.95 -39.53 89.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.595 -1.261 . . . . 0.33000000000000002 107.595 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.96 -40.98 90.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.803 -0.759 . . . . 1.6799999999999999 109.082 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.97 -20.26 65.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 1.99 108.934 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.403 ' HE ' HG23 ' B' ' 66' ' ' THR . 23.7 mmm180 -91.39 2.64 56.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.695 . . . . 2.6800000000000002 109.667 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 37.97 3.74 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 121.165 -0.959 . . . . 0.48999999999999999 111.37 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.505 ' CD2' HG12 ' B' ' 44' ' ' VAL . 86.9 m-85 -133.54 72.2 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.921 -1.341 . . . . 0.33000000000000002 109.095 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 40' ' ' ASP . 22.9 p-10 -80.06 -10.63 59.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.40999999999999998 110.413 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -129.81 150.83 50.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.294 -0.879 . . . . 1.5600000000000001 109.489 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -40.09 90.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.461 -0.774 . . . . 0.20999999999999999 111.291 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.79 -17.13 33.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.745 -1.222 . . . . 0.32000000000000001 110.217 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 HG12 ' CD2' ' B' ' 39' ' ' PHE . 61.0 t -79.87 -31.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.745 -1.205 . . . . 0.23999999999999999 107.745 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 59.2 t -78.49 -36.39 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.727 -1.212 . . . . 0.22 107.727 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.06 -36.25 76.93 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.166 -1.42 . . . . 0.40000000000000002 107.166 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.18 98.25 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.635 -1.386 . . . . 0.17999999999999999 109.635 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -59.98 -43.89 94.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.944 -1.327 . . . . 1.0900000000000001 108.514 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -59.91 -41.07 90.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.769 . . . . 0.31 109.275 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.44 -38.52 81.24 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.513 -0.921 . . . . 0.27000000000000002 108.513 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.87 -20.95 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.936 . . . . 0.28000000000000003 110.779 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.52 13.19 14.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.863 -1.148 . . . . 0.29999999999999999 111.41 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 50.05 36.15 11.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.667 -1.271 . . . . 1.71 110.125 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.11 20.03 7.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.38 -0.825 . . . . 2.25 110.285 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -67.92 105.28 1.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.553 -1.342 . . . . 1.8 108.258 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 82.5 tt0 -65.06 -40.32 94.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 0.88 112.375 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.6 -39.82 80.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.844 -1.16 . . . . 0.73999999999999999 109.577 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.79 -39.25 76.72 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.29 -0.964 . . . . 0.55000000000000004 108.764 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.53 -46.72 88.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.38 109.021 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 97.0 mtt180 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.504 -0.748 . . . . 2.6400000000000001 110.664 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.3 -40.01 89.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.782 -1.199 . . . . 2.3799999999999999 108.952 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -62.77 -49.93 73.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.989 -1.069 . . . . 0.40000000000000002 110.656 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.7 tp -66.42 -47.62 72.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.391 -0.818 . . . . 0.34000000000000002 109.708 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.27 -44.86 95.56 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.376 -0.827 . . . . 2.1000000000000001 109.783 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -69.48 -31.95 70.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 1.8999999999999999 109.22 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.403 HG23 ' HE ' ' B' ' 37' ' ' ARG . 94.2 m -77.06 -37.98 53.52 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.448 -0.782 . . . . 0.40000000000000002 111.467 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 10.5 p -131.0 -37.04 1.3 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.649 -1.282 . . . . 0.39000000000000001 111.886 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.17 17.81 7.56 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.282 -1.527 . . . . 0.35999999999999999 109.282 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.35 153.92 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.053 -1.263 . . . . 0.32000000000000001 109.153 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.19 171.77 9.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 1.9099999999999999 109.466 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.85 70.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.413 -0.805 . . . . 0.38 110.511 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.79 -41.22 68.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.784 -1.197 . . . . 2.5699999999999998 110.247 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.37 -39.16 88.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -0.918 . . . . 2.1200000000000001 110.439 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 51.0 m -66.02 -38.74 89.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 1.3600000000000001 110.182 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -59.89 -38.32 81.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.857 -1.152 . . . . 2.8100000000000001 109.452 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -68.11 -39.98 82.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.69 -1.256 . . . . 0.40000000000000002 110.499 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' B' ' 26' ' ' ILE . 93.0 m -69.67 -40.06 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.23000000000000001 109.757 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.38 -60.38 3.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.592 -1.318 . . . . 0.42999999999999999 109.777 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.68 85.01 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.797 -0.921 . . . . 0.25 110.797 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.09 -49.41 44.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.758 -1.436 . . . . 0.23999999999999999 109.982 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.6 HD21 HD22 ' B' ' 23' ' ' LEU . 88.5 mt -70.02 -39.9 75.51 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.004 -1.078 . . . . 0.28999999999999998 108.823 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' B' ' 82' ' ' ARG . 16.5 ttt-85 -64.4 -40.07 95.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 2.7400000000000002 110.061 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.7 -39.65 80.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 1.9099999999999999 110.45 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.586 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 88.3 t90 -60.03 -43.61 95.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.409 -1.432 . . . . 0.35999999999999999 107.658 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.6 m -61.69 -40.01 93.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.35999999999999999 109.647 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -59.99 -31.85 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 0.55000000000000004 109.227 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.16 -35.1 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.307 -0.871 . . . . 0.46999999999999997 110.611 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.586 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 86.9 m-85 -107.2 -6.64 17.18 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.239 -0.913 . . . . 1.24 112.951 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.4 tp . . . . . 0 N--CA 1.504 2.262 0 O-C-N 120.202 -1.561 . . . . 1.6699999999999999 109.342 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.753 0.787 . . . . 1.51 109.557 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -59.72 -22.52 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 2.1800000000000002 110.253 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.13 -38.5 83.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 2.02 109.157 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 14.1 t60 -56.86 -49.84 74.25 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.256 -0.903 . . . . 0.48999999999999999 110.132 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -70.03 -34.0 72.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.922 . . . . 3.21 110.086 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.68 -36.84 73.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.327 -0.858 . . . . 0.76000000000000001 109.74 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -64.49 -43.18 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.46000000000000002 109.803 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -84.11 15.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.209 -0.932 . . . . 0.44 110.243 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.42 -9.49 10.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.298 -0.876 . . . . 0.54000000000000004 110.311 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.71 149.73 19.45 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.859 -1.15 . . . . 1.26 109.461 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -40.61 155.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.742 1.628 . . . . 0.48999999999999999 111.168 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.518 ' CE ' HD22 ' A' ' 46' ' ' LEU . 4.3 ptp -91.21 -19.65 22.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.966 -1.084 . . . . 0.56999999999999995 109.174 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -138.6 39.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.195 -1.162 . . . . 0.40000000000000002 110.195 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -106.18 30.53 5.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.621 -0.929 . . . . 0.84999999999999998 110.487 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -60.06 148.52 77.52 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 2.0099999999999998 107.927 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.81 159.08 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.06 1.84 . . . . 0.34000000000000002 112.633 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.5 p -57.12 -49.25 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 0.32000000000000001 110.517 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.57 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.39 -1.86 0.14 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.763 -0.935 . . . . 0.23000000000000001 110.763 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 64.9 p -82.42 -24.72 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.69 -1.476 . . . . 1.24 109.847 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.11 138.72 58.2 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.887 0.851 . . . . 0.23999999999999999 109.84 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 133.43 53.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.725 0.774 . . . . 0.20999999999999999 109.982 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 97.37 -20.25 51.47 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.213 -1.555 . . . . 0.22 109.213 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.0 mm -99.75 113.17 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -1.162 . . . . 0.25 107.892 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -93.44 179.94 39.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.28000000000000003 109.692 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -56.01 -39.96 72.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.544 -0.974 . . . . 2.0099999999999998 109.874 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.73 -43.17 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.95 -1.094 . . . . 0.38 109.524 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 27' ' ' GLY . 97.2 mt -67.73 -39.91 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.40000000000000002 109.526 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.29 97.81 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.135 -1.186 . . . . 0.34999999999999998 110.135 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -64.36 -38.79 92.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.998 -1.295 . . . . 2.7400000000000002 110.079 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -65.43 -48.87 71.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.872 -1.142 . . . . 1.54 109.177 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.85 -38.6 86.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.21 -0.931 . . . . 0.34000000000000002 108.59 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.11 -40.05 88.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.768 -0.827 . . . . 1.6699999999999999 108.768 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.87 -18.89 64.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.407 -0.96 . . . . 2.0 108.407 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.33 2.89 56.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.594 -0.691 . . . . 2.6899999999999999 110.166 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.56 6.86 49.65 Favored Glycine 0 N--CA 1.503 3.115 0 O-C-N 120.997 -1.064 . . . . 0.47999999999999998 112.244 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 39' ' ' PHE . 44.3 m-85 -106.23 77.12 1.2 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 119.208 1.504 . . . . 0.33000000000000002 109.32 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -77.46 -8.19 57.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.40999999999999998 111.024 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.79 158.54 44.15 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.977 -1.077 . . . . 1.5600000000000001 109.418 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.2 90.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.462 -0.774 . . . . 0.20999999999999999 112.183 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.32 -17.58 20.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.636 -1.29 . . . . 0.32000000000000001 110.635 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.18 -30.02 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.927 -1.108 . . . . 0.23999999999999999 108.152 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.72 -39.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.994 -1.113 . . . . 0.22 107.994 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.518 HD22 ' CE ' ' A' ' 15' ' ' MET . 60.6 tp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.217 -1.401 . . . . 0.40000000000000002 107.217 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.56 -43.79 67.71 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.156 -1.577 . . . . 0.17999999999999999 109.156 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -1.225 . . . . 1.0900000000000001 108.634 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.86 -41.19 90.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.852 . . . . 0.31 109.09 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.03 -39.98 75.44 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.883 -0.727 . . . . 0.28000000000000003 109.073 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.78 -20.27 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.115 -0.991 . . . . 0.28000000000000003 110.626 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.75 18.17 9.27 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.058 -1.026 . . . . 0.31 109.79 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.04 32.44 10.26 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.942 -1.099 . . . . 1.7 110.103 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 60.02 19.91 9.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.62 -0.675 . . . . 2.2400000000000002 109.913 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -67.84 111.88 4.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.777 -1.202 . . . . 1.8 107.927 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.5 -41.17 98.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.87 112.601 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.42 -40.05 77.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.548 -1.345 . . . . 0.72999999999999998 109.669 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.91 -40.01 75.85 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.977 -1.089 . . . . 0.55000000000000004 108.785 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.06 -49.98 70.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.38 110.026 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -61.19 -44.85 96.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 2.6400000000000001 110.431 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 98.8 mt-10 -64.81 -37.92 89.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.805 -1.185 . . . . 2.3700000000000001 108.846 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.407 ' O ' ' OG1' ' A' ' 66' ' ' THR . 65.1 t90 -64.05 -48.04 77.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.303 -0.873 . . . . 0.40000000000000002 110.974 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.17 -46.89 66.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.956 -1.09 . . . . 0.34000000000000002 109.862 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -61.52 -47.0 87.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.067 -1.021 . . . . 2.1099999999999999 109.714 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 61' ' ' GLU . 71.7 m-20 -70.02 -28.33 65.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.849 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 54.5 m -80.61 -31.56 36.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.40999999999999998 111.732 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.6 p -133.19 -23.37 1.94 Allowed 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.374 -1.453 . . . . 0.40000000000000002 111.916 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.85 13.09 32.85 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.171 -1.572 . . . . 0.35999999999999999 109.171 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.88 154.74 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.097 -1.237 . . . . 0.33000000000000002 109.371 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.93 171.88 9.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 1.8999999999999999 110.214 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.51 75.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.694 -0.629 . . . . 0.39000000000000001 110.38 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -73.06 -40.68 64.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.851 -1.155 . . . . 2.5800000000000001 110.105 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.3 mm100 -67.94 -35.13 77.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.974 . . . . 2.1200000000000001 110.284 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.4 -38.22 81.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.363 -0.836 . . . . 1.3600000000000001 110.085 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.06 -36.27 76.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.886 -1.134 . . . . 2.7999999999999998 109.547 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -68.97 -39.89 79.18 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.749 -1.22 . . . . 0.40000000000000002 110.806 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.03 -40.36 75.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.674 -1.266 . . . . 0.23999999999999999 110.061 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.77 -60.01 4.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.717 -1.239 . . . . 0.42999999999999999 109.482 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.64 -33.7 87.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.351 -1.1 . . . . 0.26000000000000001 110.351 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.73 -46.55 62.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.761 -1.435 . . . . 0.25 109.356 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.926 -1.11 . . . . 0.29999999999999999 108.659 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.43 -40.06 95.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 2.73 110.295 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.534 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.6 mt-10 -69.85 -37.74 76.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 1.9099999999999999 110.165 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.8 t90 -60.0 -42.85 95.18 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.53 -1.356 . . . . 0.37 107.821 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 88.3 m -60.79 -40.09 91.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -0.84 . . . . 0.35999999999999999 109.668 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.91 -32.28 69.4 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.017 -1.052 . . . . 0.55000000000000004 110.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.5 -34.03 14.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.107 -0.995 . . . . 0.47999999999999998 110.999 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 91.4 m-85 . . . . . 0 N--CA 1.504 2.251 0 O-C-N 121.089 -1.007 . . . . 1.24 111.357 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.673 0.749 . . . . 1.5 109.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.52 -22.67 61.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.727 -0.608 . . . . 2.1800000000000002 110.202 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -60.09 -38.59 83.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.094 -1.004 . . . . 2.0099999999999998 109.189 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.541 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 14.2 t60 -56.85 -49.73 74.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.48999999999999999 110.144 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -70.11 -34.02 72.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 3.23 110.034 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.73 -36.52 73.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.312 -0.868 . . . . 0.76000000000000001 109.744 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.987 ' CD1' ' CD2' ' B' ' 10' ' ' PHE . . . -64.91 -42.94 94.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.479 -0.763 . . . . 0.46000000000000002 109.869 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 m -84.0 14.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.161 -0.962 . . . . 0.44 110.302 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.07 -9.3 11.09 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.34 -0.85 . . . . 0.53000000000000003 110.297 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.87 149.76 19.34 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.102 . . . . 1.27 109.37 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -40.58 155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.761 1.64 . . . . 0.48999999999999999 111.205 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.524 ' CE ' HD22 ' B' ' 46' ' ' LEU . 4.2 ptp -91.16 -19.83 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.895 -1.128 . . . . 0.56000000000000005 109.239 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.82 -138.44 41.81 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.341 -1.104 . . . . 0.39000000000000001 110.341 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.52 30.52 5.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.635 -0.921 . . . . 0.83999999999999997 110.408 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -60.03 148.31 77.84 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 2.02 107.933 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.78 159.12 34.43 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.096 1.864 . . . . 0.34000000000000002 112.591 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.562 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.5 p -57.19 -49.15 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.485 0.659 . . . . 0.32000000000000001 110.554 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.562 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.38 -2.21 0.15 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.791 -0.924 . . . . 0.22 110.791 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.488 ' H ' ' C ' ' B' ' 20' ' ' VAL . 61.1 p -81.91 -24.73 35.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.766 -1.432 . . . . 1.24 110.032 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.2 138.79 58.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.296 -0.877 . . . . 0.23999999999999999 109.867 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.69 53.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.702 0.763 . . . . 0.20999999999999999 109.836 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.513 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 97.17 -20.42 50.85 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.219 -1.552 . . . . 0.22 109.219 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.8 mm -99.69 113.18 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.894 -1.15 . . . . 0.25 107.894 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.419 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -93.48 179.98 39.14 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.714 -1.354 . . . . 0.28000000000000003 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.433 ' O ' ' NZ ' ' B' ' 32' ' ' LYS . 79.6 mm-40 -56.07 -39.98 72.89 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.437 -1.037 . . . . 2.0 109.787 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.84 -42.99 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.956 -1.09 . . . . 0.38 109.534 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.419 HD12 ' H ' ' B' ' 27' ' ' GLY . 97.2 mt -67.81 -39.99 83.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.40000000000000002 109.437 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.18 97.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.057 -1.217 . . . . 0.35999999999999999 110.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' B' ' 28' ' ' GLU . 33.6 mtmm -64.55 -38.46 91.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.248 . . . . 2.75 110.111 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.67 -48.82 70.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.824 -1.173 . . . . 1.5600000000000001 109.211 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.88 -38.63 86.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.26 -0.9 . . . . 0.33000000000000002 108.579 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.95 -40.16 88.04 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.692 -0.855 . . . . 1.6799999999999999 108.692 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.89 -18.82 64.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.47 -0.937 . . . . 1.99 108.47 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.23 2.44 56.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 2.6800000000000002 110.163 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 7.01 48.44 Favored Glycine 0 N--CA 1.503 3.118 0 O-C-N 121.08 -1.013 . . . . 0.48999999999999999 112.242 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' B' ' 39' ' ' PHE . 45.6 m-85 -106.36 76.95 1.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 119.19 1.495 . . . . 0.33000000000000002 109.314 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -77.18 -8.47 57.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.377 -0.827 . . . . 0.40999999999999998 110.98 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.67 158.31 44.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 1.5600000000000001 109.437 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.4 91.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.48 -0.763 . . . . 0.20999999999999999 112.173 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -58.17 -17.32 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.695 -1.253 . . . . 0.32000000000000001 110.765 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.45 -29.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.908 -1.12 . . . . 0.23999999999999999 108.104 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.88 -39.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.928 -1.138 . . . . 0.22 107.928 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.524 HD22 ' CE ' ' B' ' 15' ' ' MET . 60.7 tp -59.98 -39.84 87.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.257 -1.386 . . . . 0.40000000000000002 107.257 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.7 -43.82 69.2 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.173 -1.571 . . . . 0.17999999999999999 109.173 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.96 -44.62 94.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -1.207 . . . . 1.0900000000000001 108.791 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.97 -41.28 91.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.31 109.007 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 mt -69.96 -39.7 75.86 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.878 -0.729 . . . . 0.27000000000000002 109.186 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.98 -20.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.166 -0.959 . . . . 0.28000000000000003 110.561 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.47 17.82 9.44 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.0 -1.063 . . . . 0.29999999999999999 109.907 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.25 32.52 10.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.959 -1.088 . . . . 1.71 110.151 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt 60.0 20.08 9.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.746 . . . . 2.25 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -67.96 111.5 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.817 -1.177 . . . . 1.8 108.072 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.39 -40.69 97.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.88 112.641 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.86 -39.91 76.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.523 -1.361 . . . . 0.73999999999999999 109.663 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.96 -39.99 75.7 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.929 -1.108 . . . . 0.55000000000000004 108.73 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.02 -50.04 70.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.99 . . . . 0.38 110.096 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -61.27 -44.46 97.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 2.6400000000000001 110.548 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.413 ' O ' ' OD2' ' B' ' 65' ' ' ASP . 98.9 mt-10 -65.03 -38.1 89.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.776 -1.203 . . . . 2.3799999999999999 108.866 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -63.83 -48.27 77.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.40000000000000002 111.013 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.05 -46.46 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.909 -1.119 . . . . 0.34000000000000002 109.989 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -61.73 -47.17 86.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 2.1000000000000001 109.707 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' B' ' 61' ' ' GLU . 71.3 m-20 -69.93 -28.35 65.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.906 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -80.54 -31.6 36.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.40000000000000002 111.737 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.8 p -133.3 -23.2 1.92 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.326 -1.484 . . . . 0.39000000000000001 111.919 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.71 34.11 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 109.237 -1.545 . . . . 0.35999999999999999 109.237 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.55 154.53 1.85 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.091 -1.241 . . . . 0.32000000000000001 109.39 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.74 171.96 9.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 1.9099999999999999 110.177 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.75 75.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.646 -0.658 . . . . 0.38 110.417 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -72.89 -40.69 65.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.859 -1.151 . . . . 2.5699999999999998 110.128 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.2 mm100 -67.92 -35.2 78.03 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.248 -0.907 . . . . 2.1200000000000001 110.354 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.27 -38.37 81.66 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.179 -0.951 . . . . 1.3600000000000001 110.074 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.92 -36.53 77.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.86 -1.15 . . . . 2.8100000000000001 109.531 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -68.6 -40.03 80.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.778 -1.201 . . . . 0.40000000000000002 110.747 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.2 m -70.06 -40.37 75.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.23000000000000001 110.123 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.75 -59.97 4.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.699 -1.251 . . . . 0.42999999999999999 109.525 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.75 87.42 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.344 -1.102 . . . . 0.25 110.344 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.73 -46.41 63.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.725 -1.456 . . . . 0.23999999999999999 109.337 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.6 -40.43 69.86 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.935 -1.106 . . . . 0.28999999999999998 108.628 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.24 -39.99 95.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.98 . . . . 2.7400000000000002 110.316 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.4 mt-10 -69.8 -37.76 76.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.9099999999999999 110.167 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.549 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 87.0 t90 -60.04 -42.72 95.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.5 -1.375 . . . . 0.35999999999999999 107.866 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' B' ' 89' ' ' LEU . 89.4 m -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.35999999999999999 109.748 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.02 -32.55 69.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.049 -1.032 . . . . 0.55000000000000004 109.912 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.2 -34.11 14.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.135 -0.978 . . . . 0.46999999999999997 111.06 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.549 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 92.4 m-85 -107.41 2.02 24.03 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.195 -0.941 . . . . 1.24 111.465 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' B' ' 85' ' ' CYS . 54.7 tp . . . . . 0 N--CA 1.495 1.785 0 O-C-N 120.695 -1.253 . . . . 1.6699999999999999 109.321 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.714 0.769 . . . . 1.51 109.314 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.74 -26.46 63.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.687 -0.633 . . . . 2.1800000000000002 110.074 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -36.0 76.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.001 -1.062 . . . . 2.02 109.567 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -58.86 -50.01 75.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.48999999999999999 110.127 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.6 mmp_? -69.96 -32.83 71.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.044 -1.035 . . . . 3.21 109.751 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.47 -40.02 89.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.234 -0.917 . . . . 0.76000000000000001 109.628 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.97 -49.04 76.28 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.246 -0.909 . . . . 0.46000000000000002 109.792 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.21 4.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.232 -0.917 . . . . 0.44 111.863 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -97.57 -18.92 18.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.686 -1.259 . . . . 0.54000000000000004 110.359 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 1.4 pp20? -155.83 152.26 23.6 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 1.26 108.596 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 48.5 Cg_exo -35.36 155.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.174 1.916 . . . . 0.48999999999999999 112.034 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' HD13 ' B' ' 89' ' ' LEU . 11.4 ptm -90.92 -23.08 20.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.145 -0.972 . . . . 0.56999999999999995 110.484 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.09 -136.35 20.58 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.984 -1.073 . . . . 0.40000000000000002 110.715 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.06 28.37 8.67 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.523 -0.986 . . . . 0.84999999999999998 111.02 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.6 148.34 56.63 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 118.557 -1.257 . . . . 2.0099999999999998 107.756 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.19 159.34 19.12 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.619 2.213 . . . . 0.34000000000000002 113.183 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 22' ' ' SER . 4.3 p -59.63 -48.52 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.32000000000000001 110.576 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -52.95 -1.87 0.07 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.435 -1.066 . . . . 0.23000000000000001 110.435 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 20' ' ' VAL . 10.6 p -83.3 -26.42 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.385 . . . . 1.24 109.973 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.65 137.29 58.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.23999999999999999 110.296 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 132.63 49.08 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.789 0.804 . . . . 0.20999999999999999 110.234 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.95 -18.1 56.29 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.003 -1.639 . . . . 0.22 109.003 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.88 114.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.827 -1.175 . . . . 0.25 107.827 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.1 177.58 38.29 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.458 -1.457 . . . . 0.28000000000000003 109.458 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -58.83 -40.14 83.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -1.125 . . . . 2.0099999999999998 109.494 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.22 -48.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.042 -1.037 . . . . 0.38 109.42 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.41 -39.99 81.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.40000000000000002 109.212 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.03 96.42 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.236 -1.546 . . . . 0.34999999999999998 109.236 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 36' ' ' GLU . 14.7 tmtt? -61.36 -40.0 92.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.338 -1.096 . . . . 2.7400000000000002 110.775 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.04 -40.1 87.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.736 -1.227 . . . . 1.54 109.986 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.58 -38.04 83.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.923 -1.11 . . . . 0.34000000000000002 108.893 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.424 -0.91 . . . . 1.6699999999999999 108.992 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 32' ' ' LYS . 98.9 mt-10 -68.06 -18.62 64.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 2.0 108.822 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -89.97 2.01 55.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.46 -0.775 . . . . 2.6899999999999999 109.859 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.49 5.18 42.89 Favored Glycine 0 N--CA 1.502 3.077 0 O-C-N 121.115 -0.991 . . . . 0.47999999999999998 112.18 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.7 76.97 1.32 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.694 -1.474 . . . . 0.33000000000000002 109.141 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -75.48 -8.86 57.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.40999999999999998 110.437 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.16 160.02 40.78 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.079 -1.013 . . . . 1.5600000000000001 110.263 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.84 92.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.558 -0.714 . . . . 0.20999999999999999 112.512 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 7.5 p90 -58.73 -17.74 25.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.515 -1.366 . . . . 0.32000000000000001 110.555 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -80.01 -32.71 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.794 -1.191 . . . . 0.23999999999999999 108.315 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.06 -39.1 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.22 108.237 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 tp -59.98 -36.38 77.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.866 -1.161 . . . . 0.40000000000000002 107.866 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.52 97.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.17999999999999999 110.02 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.98 -40.03 87.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.245 . . . . 1.0900000000000001 109.035 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.96 -39.95 87.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.373 -0.973 . . . . 0.31 108.373 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.053 -0.721 . . . . 0.28000000000000003 109.053 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.22 -23.97 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.246 -0.909 . . . . 0.28000000000000003 111.001 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.37 17.61 11.06 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.045 -1.034 . . . . 0.31 110.154 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' NZ ' ' O ' ' B' ' 38' ' ' GLY . 12.7 mptt 52.47 29.31 6.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.944 -1.098 . . . . 1.7 109.828 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.03 19.94 9.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 2.2400000000000002 110.255 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.23 117.75 9.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.511 -1.368 . . . . 1.8 107.683 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.11 -40.95 97.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.311 -0.868 . . . . 0.87 112.99 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.488 ' CG ' HH21 ' A' ' 60' ' ' ARG . 7.6 m-20 -69.68 -39.93 76.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.669 -1.27 . . . . 0.72999999999999998 110.115 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.3 mt -69.95 -39.99 75.71 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.007 -1.077 . . . . 0.55000000000000004 109.036 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.46 -49.91 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.38 109.71 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.488 HH21 ' CG ' ' A' ' 57' ' ' ASP . 87.7 mtm180 -60.37 -45.79 92.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.354 -0.841 . . . . 2.6400000000000001 110.622 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.64 -39.77 94.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.931 -1.105 . . . . 2.3700000000000001 108.788 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -65.51 -48.76 71.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.40000000000000002 111.362 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.5 tp -67.42 -47.09 71.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.34000000000000002 110.095 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.01 -45.95 92.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.38 -0.825 . . . . 2.1099999999999999 109.714 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.03 -27.33 64.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.8999999999999999 109.945 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -80.59 -33.9 35.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.40999999999999998 111.526 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.2 p -130.59 -27.27 2.16 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.555 -1.34 . . . . 0.40000000000000002 112.083 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.16 22.64 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.171 -1.572 . . . . 0.35999999999999999 109.171 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 153.1 2.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -1.196 . . . . 0.33000000000000002 109.618 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.6 172.96 8.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.115 -0.991 . . . . 1.8999999999999999 109.715 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.23 72.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.39000000000000001 111.025 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.1 -39.71 63.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.711 -1.243 . . . . 2.5800000000000001 110.05 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.5 mm100 -67.38 -39.88 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 2.1200000000000001 110.694 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -67.52 -37.51 82.89 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.288 -0.882 . . . . 1.3600000000000001 109.958 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 75' ' ' ARG . 25.7 mtt-85 -60.41 -37.24 80.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.114 . . . . 2.7999999999999998 109.632 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.78 -39.9 84.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.571 -1.33 . . . . 0.40000000000000002 110.552 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.8 m -67.94 -40.0 83.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.23999999999999999 109.806 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.43 -60.05 4.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.879 -1.138 . . . . 0.42999999999999999 109.954 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.66 -34.28 88.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.448 -1.061 . . . . 0.26000000000000001 110.448 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.25 -47.33 57.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -1.202 . . . . 0.25 109.804 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.61 -40.07 73.38 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.695 -1.202 . . . . 0.29999999999999999 108.328 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -63.01 -40.07 96.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 2.73 110.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -69.41 -37.81 77.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.02 -1.05 . . . . 1.9099999999999999 110.474 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.487 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 84.6 t90 -59.97 -43.86 94.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.39 -1.444 . . . . 0.37 107.363 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.3 m -60.6 -40.67 92.64 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.894 -0.78 . . . . 0.35999999999999999 108.894 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.631 -0.668 . . . . 0.55000000000000004 109.695 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -36.78 16.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.47999999999999998 110.125 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 83.9 m-85 . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.35 -0.844 . . . . 1.24 110.032 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.768 0.794 . . . . 1.5 109.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.81 -26.53 64.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.702 -0.624 . . . . 2.1800000000000002 110.094 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.13 -35.73 75.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.085 . . . . 2.0099999999999998 109.575 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -58.96 -49.94 75.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.48999999999999999 110.213 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 3.6 mmp_? -70.06 -32.76 71.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 3.23 109.749 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.45 -39.92 89.14 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.483 -0.887 . . . . 0.76000000000000001 109.743 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.0 -49.16 75.76 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.263 -0.898 . . . . 0.46000000000000002 109.71 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.12 4.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.144 -0.973 . . . . 0.44 111.834 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -97.29 -19.0 18.84 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.661 -1.274 . . . . 0.53000000000000003 110.418 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' B' ' 14' ' ' PRO . 1.4 pp20? -155.84 152.34 23.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.955 . . . . 1.27 108.63 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' OE1' ' B' ' 13' ' ' GLU . 48.7 Cg_exo -35.37 155.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.266 1.977 . . . . 0.48999999999999999 111.989 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 11.3 ptm -90.89 -23.25 20.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.56000000000000005 110.432 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.33 21.13 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.894 -1.128 . . . . 0.39000000000000001 110.7 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.2 28.72 8.35 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.634 -0.921 . . . . 0.83999999999999997 111.021 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.77 148.4 58.18 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.648 -1.283 . . . . 2.02 107.608 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.18 159.44 18.84 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.639 2.226 . . . . 0.34000000000000002 113.207 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' B' ' 22' ' ' SER . 4.2 p -59.79 -48.6 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.32000000000000001 110.512 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.489 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -52.7 -2.14 0.07 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.443 -1.063 . . . . 0.22 110.443 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.539 ' H ' ' C ' ' B' ' 20' ' ' VAL . 10.6 p -83.09 -26.43 31.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.787 -1.419 . . . . 1.24 110.055 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.79 137.29 58.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.27 -0.894 . . . . 0.23999999999999999 110.273 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.82 132.63 49.16 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.82 0.819 . . . . 0.20999999999999999 110.175 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.99 -18.31 55.95 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.902 -1.679 . . . . 0.22 108.902 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -101.68 114.78 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.848 -1.167 . . . . 0.25 107.848 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.16 177.65 38.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.493 -1.443 . . . . 0.28000000000000003 109.493 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -58.95 -40.01 83.39 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.337 -1.096 . . . . 2.0 109.48 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.47 -48.9 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.38 109.333 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.51 -39.9 81.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.40000000000000002 109.178 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.98 96.43 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.251 -1.54 . . . . 0.35999999999999999 109.251 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' B' ' 36' ' ' GLU . 14.7 tmtt? -61.25 -39.94 92.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 2.75 110.798 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.2 -40.02 86.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.687 -1.258 . . . . 1.5600000000000001 109.977 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -60.74 -38.01 83.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.923 -1.11 . . . . 0.33000000000000002 108.889 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -40.51 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.429 -0.909 . . . . 1.6799999999999999 108.973 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' NZ ' ' B' ' 32' ' ' LYS . 98.9 mt-10 -68.01 -18.61 64.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 1.99 108.88 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -90.03 2.14 55.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.818 . . . . 2.6800000000000002 109.793 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.413 ' O ' ' NZ ' ' A' ' 53' ' ' LYS . . . 104.4 5.26 43.06 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.246 -0.978 . . . . 0.48999999999999999 112.154 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.72 76.89 1.31 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.49 . . . . 0.33000000000000002 109.144 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -75.43 -8.89 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.104 -0.997 . . . . 0.40999999999999998 110.522 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.13 159.95 40.93 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.067 -1.021 . . . . 1.5600000000000001 110.162 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.93 93.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.647 -0.658 . . . . 0.20999999999999999 112.542 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.466 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 7.4 p90 -58.66 -17.77 25.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.532 -1.355 . . . . 0.32000000000000001 110.614 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -79.9 -32.76 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.796 -1.19 . . . . 0.23999999999999999 108.286 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 77.2 t -76.0 -39.13 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.216 -1.031 . . . . 0.22 108.216 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 tp -60.06 -36.2 76.82 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.876 -1.157 . . . . 0.40000000000000002 107.876 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.68 97.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.028 -1.229 . . . . 0.17999999999999999 110.028 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.9 -40.02 87.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.094 -1.239 . . . . 1.0900000000000001 109.154 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.95 -40.07 87.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.297 -1.001 . . . . 0.31 108.297 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.082 -0.71 . . . . 0.27000000000000002 109.082 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.29 -23.99 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.357 -0.84 . . . . 0.28000000000000003 110.973 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.33 17.58 11.05 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.945 -1.097 . . . . 0.29999999999999999 110.164 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mptt 52.72 29.11 7.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.921 -1.112 . . . . 1.71 109.818 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.0 19.99 9.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.416 -0.803 . . . . 2.25 110.208 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.33 117.57 9.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.318 . . . . 1.8 107.739 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.0 -40.92 97.45 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.075 0.769 . . . . 0.88 113.075 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.49 ' CG ' HH21 ' B' ' 60' ' ' ARG . 7.6 m-20 -69.65 -39.98 76.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.535 -1.353 . . . . 0.73999999999999999 110.056 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.98 -40.0 75.62 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.01 -1.076 . . . . 0.55000000000000004 108.94 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.48 -49.96 73.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.38 109.68 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' B' ' 57' ' ' ASP . 87.8 mtm180 -60.4 -45.54 93.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.407 -0.808 . . . . 2.6400000000000001 110.62 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.77 -39.78 94.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.957 -1.09 . . . . 2.3799999999999999 108.756 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 63.0 t90 -65.53 -48.75 71.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.40000000000000002 111.383 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -67.26 -47.19 71.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.007 -1.058 . . . . 0.34000000000000002 110.09 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.03 -45.94 92.76 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.389 -0.819 . . . . 2.1000000000000001 109.787 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.03 -27.34 64.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.445 -0.784 . . . . 1.8999999999999999 109.884 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 96.8 m -80.54 -33.84 35.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.40000000000000002 111.574 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.1 p -130.63 -27.35 2.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.595 -1.316 . . . . 0.39000000000000001 112.027 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 14.09 22.59 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.154 -1.578 . . . . 0.35999999999999999 109.154 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.01 153.24 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -1.185 . . . . 0.32000000000000001 109.654 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.62 172.96 8.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.174 -0.954 . . . . 1.9099999999999999 109.728 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.48 -33.34 72.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 0.38 110.959 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.02 -39.67 63.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.66 -1.275 . . . . 2.5699999999999998 110.049 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.6 mm100 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 2.1200000000000001 110.675 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.8 t -67.5 -37.48 82.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.851 . . . . 1.3600000000000001 110.004 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.487 ' HG2' HH11 ' B' ' 75' ' ' ARG . 25.2 mtt-85 -60.36 -37.33 80.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 2.8100000000000001 109.584 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -67.65 -39.93 84.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.698 -1.251 . . . . 0.40000000000000002 110.588 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.93 -39.99 83.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.854 -1.154 . . . . 0.23000000000000001 109.809 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.39 -59.98 4.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.95 -1.094 . . . . 0.42999999999999999 109.967 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.57 -34.52 88.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.452 -1.059 . . . . 0.25 110.452 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 49.4 t -71.14 -47.22 59.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -1.179 . . . . 0.23999999999999999 109.832 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.68 -40.13 73.12 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.716 -1.194 . . . . 0.28999999999999998 108.326 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -63.03 -40.1 96.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 2.7400000000000002 109.93 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -69.47 -37.6 77.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.054 -1.029 . . . . 1.9099999999999999 110.482 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.484 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 84.8 t90 -60.02 -43.86 94.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.456 -1.403 . . . . 0.35999999999999999 107.318 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 51.6 m -60.65 -40.66 92.83 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.93 -0.767 . . . . 0.35999999999999999 108.93 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.96 -38.19 85.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.615 -0.678 . . . . 0.55000000000000004 109.626 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.8 -37.75 16.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 0.46999999999999997 110.075 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 85.2 m-85 -104.34 -87.69 0.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.901 . . . . 1.24 110.413 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.461 HD13 ' SD ' ' A' ' 15' ' ' MET . 16.4 tp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.133 -0.937 . . . . 1.6699999999999999 109.711 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.641 0.734 . . . . 1.51 109.15 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -62.16 -22.61 66.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.744 -0.597 . . . . 2.1800000000000002 110.648 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.29 -39.26 89.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 2.02 108.998 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 11' ' ' VAL . 16.1 t60 -60.1 -50.28 74.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.48999999999999999 110.806 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.515 ' HG2' HH11 ' A' ' 8' ' ' ARG . 20.5 mtt-85 -69.94 -35.59 74.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.998 -1.064 . . . . 3.21 109.85 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -66.96 -39.79 87.33 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.436 -0.79 . . . . 0.76000000000000001 109.529 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 50.7 t80 -65.25 -45.5 84.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.818 . . . . 0.46000000000000002 110.194 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 7' ' ' HIS . 18.7 m -88.62 5.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.007 -1.058 . . . . 0.44 111.55 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.957 -1.089 . . . . 0.54000000000000004 110.319 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.0 pt-20 -152.06 153.15 30.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.374 -0.973 . . . . 1.26 108.374 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 13' ' ' GLU . 58.0 Cg_exo -37.29 155.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.944 1.763 . . . . 0.48999999999999999 111.641 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.522 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 12.6 ptm -92.75 -28.9 16.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 0.56999999999999995 109.968 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.65 -134.99 46.29 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.422 -1.071 . . . . 0.40000000000000002 110.422 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.5 34.5 3.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.64 -0.918 . . . . 0.84999999999999998 110.061 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -58.81 148.76 67.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 2.0099999999999998 108.695 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.81 155.93 35.48 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.086 1.857 . . . . 0.34000000000000002 112.15 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 21' ' ' GLY . 13.8 p -58.31 -41.9 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.693 0.759 . . . . 0.32000000000000001 110.167 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -61.51 -2.25 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.103 -1.199 . . . . 0.23000000000000001 110.103 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 t -81.59 -21.17 38.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.728 -1.454 . . . . 1.24 108.919 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 81' ' ' LEU . 97.1 mt -65.39 138.52 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.369 -0.832 . . . . 0.23999999999999999 109.652 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.98 57.72 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.948 -0.701 . . . . 0.20999999999999999 109.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 -18.41 56.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.572 -1.411 . . . . 0.22 109.572 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 mm -99.52 112.0 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.715 -1.217 . . . . 0.25 107.715 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.89 -179.05 36.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.649 -1.38 . . . . 0.28000000000000003 109.649 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 59.7 mp0 -57.28 -40.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -1.119 . . . . 2.0099999999999998 109.532 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.9 -45.87 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.38 109.32 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.89 -39.59 83.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.40000000000000002 109.39 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.82 -39.96 96.08 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.96 -1.656 . . . . 0.34999999999999998 108.96 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.91 -39.97 96.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 2.7400000000000002 109.72 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.92 -44.1 77.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 1.54 108.809 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.1 mt -64.84 -40.61 95.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.34000000000000002 108.64 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.14 -44.15 95.18 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.642 -0.661 . . . . 1.6699999999999999 109.55 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.21 -19.58 66.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.398 -0.814 . . . . 2.0 108.917 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -90.39 3.99 52.19 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.521 -0.737 . . . . 2.6899999999999999 109.981 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.81 48.35 Favored Glycine 0 N--CA 1.502 3.048 0 O-C-N 121.167 -0.958 . . . . 0.47999999999999998 111.579 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' A' ' 44' ' ' VAL . 92.4 m-85 -106.51 75.59 1.08 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.714 -1.462 . . . . 0.33000000000000002 109.55 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.73 -9.9 59.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.074 -1.016 . . . . 0.40999999999999998 110.316 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.2 mmtm -134.87 156.67 48.53 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.203 -0.936 . . . . 1.5600000000000001 110.001 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.65 94.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.63 -0.669 . . . . 0.20999999999999999 111.233 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 23.6 p90 -58.59 -20.07 43.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.704 -1.248 . . . . 0.32000000000000001 110.951 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.5 t -78.58 -34.51 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.643 -1.286 . . . . 0.23999999999999999 108.022 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 20' ' ' VAL . 74.4 t -76.32 -38.92 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.187 -1.042 . . . . 0.22 108.187 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.09 -38.8 84.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.296 -1.001 . . . . 0.40000000000000002 108.296 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.84 97.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.817 -1.313 . . . . 0.17999999999999999 109.817 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.275 . . . . 1.0900000000000001 109.341 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -59.22 -40.09 84.76 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.296 -1.001 . . . . 0.31 108.296 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.08 -38.72 79.16 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.377 -0.972 . . . . 0.28000000000000003 108.377 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.14 -24.61 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 0.28000000000000003 110.251 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.24 16.14 17.39 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.118 -0.989 . . . . 0.31 110.678 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.54 40.4 15.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.726 -1.234 . . . . 1.7 110.719 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 59.19 19.62 7.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 2.2400000000000002 109.843 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.31 107.01 2.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.743 -1.223 . . . . 1.8 107.994 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CD ' HH21 ' A' ' 60' ' ' ARG . 88.1 tt0 -61.75 -40.5 95.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.501 -0.75 . . . . 0.87 112.562 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.63 -40.07 76.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.534 -1.353 . . . . 0.72999999999999998 109.728 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.66 -39.99 76.73 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.726 -1.19 . . . . 0.55000000000000004 109.199 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.31 -50.14 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.38 109.483 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.526 HH21 ' CD ' ' A' ' 56' ' ' GLU . 34.1 mtt-85 -60.88 -46.12 91.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.372 -0.83 . . . . 2.6400000000000001 110.682 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.04 -38.31 90.59 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.819 -1.175 . . . . 2.3700000000000001 108.841 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -66.8 -45.25 78.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.40000000000000002 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.27 -48.91 68.92 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.149 -0.969 . . . . 0.34000000000000002 110.046 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -62.0 -44.56 96.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.242 -0.911 . . . . 2.1099999999999999 109.257 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.59 -32.39 71.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.567 -0.708 . . . . 1.8999999999999999 109.739 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -79.97 -31.86 39.86 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.40999999999999998 111.345 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.32 -30.15 1.53 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.572 -1.33 . . . . 0.40000000000000002 112.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.12 19.89 Favored Glycine 0 N--CA 1.501 3.025 0 N-CA-C 109.196 -1.561 . . . . 0.35999999999999999 109.196 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.0 152.9 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.242 . . . . 0.33000000000000002 109.467 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -91.9 175.18 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.071 -1.018 . . . . 1.8999999999999999 109.623 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.81 77.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.39000000000000001 110.103 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -73.79 -39.97 63.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.109 -0.994 . . . . 2.5800000000000001 109.995 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.85 -36.96 83.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 2.1200000000000001 110.539 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 p -69.22 -37.17 77.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.133 -0.979 . . . . 1.3600000000000001 110.027 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.03 -37.61 80.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.831 -1.168 . . . . 2.7999999999999998 109.707 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.05 -40.0 87.02 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.746 -1.221 . . . . 0.40000000000000002 110.442 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 61.5 m -70.04 -42.5 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.726 -1.234 . . . . 0.23999999999999999 110.398 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.421 ' HB3' HH22 ' A' ' 60' ' ' ARG . 79.4 t80 -60.14 -60.17 4.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.57 -1.331 . . . . 0.42999999999999999 110.113 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.86 -34.52 90.03 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.334 -1.106 . . . . 0.26000000000000001 110.334 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.71 -47.91 57.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.726 -1.455 . . . . 0.25 109.781 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 23' ' ' LEU . 96.9 mt -70.11 -40.03 75.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.798 -1.161 . . . . 0.29999999999999999 108.345 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.485 ' HG2' HH11 ' A' ' 82' ' ' ARG . 4.6 ttt-85 -61.36 -40.11 93.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 2.73 109.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -68.8 -37.42 79.24 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 1.9099999999999999 109.878 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.522 ' CZ2' ' SD ' ' A' ' 15' ' ' MET . 80.4 t90 -59.65 -45.67 91.32 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.94 -1.504 . . . . 0.37 106.94 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -61.83 -41.52 97.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.716 -0.615 . . . . 0.35999999999999999 109.46 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -60.27 -37.24 79.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.2 -0.937 . . . . 0.55000000000000004 109.954 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.1 -35.87 19.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.47999999999999998 109.888 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.363 -0.836 . . . . 1.24 110.395 -178.563 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.591 0.71 . . . . 1.5 109.233 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.94 -22.75 65.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.703 -0.623 . . . . 2.1800000000000002 110.671 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -61.21 -39.24 89.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.017 -1.052 . . . . 2.0099999999999998 108.852 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.41 ' O ' HG22 ' B' ' 11' ' ' VAL . 16.0 t60 -60.1 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.48999999999999999 110.746 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.511 ' HG2' HH11 ' B' ' 8' ' ' ARG . 20.8 mtt-85 -70.05 -35.65 74.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.903 -1.123 . . . . 3.23 109.758 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -66.73 -40.03 88.2 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.638 -0.664 . . . . 0.76000000000000001 109.642 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.431 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 49.7 t80 -64.99 -45.91 83.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.46000000000000002 110.25 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 7' ' ' HIS . 18.9 m -88.38 5.71 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.16 -0.962 . . . . 0.44 111.48 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -100.92 -15.98 17.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.881 -1.137 . . . . 0.53000000000000003 110.26 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -152.11 153.26 30.98 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 1.27 108.352 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -37.35 155.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.998 1.798 . . . . 0.48999999999999999 111.584 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.516 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 12.5 ptm -92.77 -28.85 16.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.56000000000000005 110.035 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.71 -135.03 46.47 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.357 -1.097 . . . . 0.39000000000000001 110.357 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.61 34.55 3.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.468 -1.019 . . . . 0.83999999999999997 109.944 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -58.75 148.63 67.21 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 2.02 108.601 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.76 155.82 35.75 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.06 1.84 . . . . 0.34000000000000002 112.175 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.531 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.0 p -58.29 -41.84 82.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.496 -0.753 . . . . 0.32000000000000001 110.093 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.531 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -61.33 -2.31 2.96 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.119 -1.192 . . . . 0.22 110.119 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.7 t -81.73 -21.1 38.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.895 -1.356 . . . . 1.24 108.914 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.59 HD22 HD21 ' B' ' 81' ' ' LEU . 97.3 mt -65.31 138.52 58.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.23999999999999999 109.676 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.36 136.94 57.61 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.743 -0.783 . . . . 0.20999999999999999 109.744 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 -18.34 56.91 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.604 -1.398 . . . . 0.22 109.604 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.52 111.87 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.709 -1.219 . . . . 0.25 107.709 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.87 36.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.731 -1.348 . . . . 0.28000000000000003 109.731 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mp0 -57.48 -39.86 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -1.07 . . . . 2.0 109.567 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.05 -45.89 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.38 109.344 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.88 -39.54 83.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -0.889 . . . . 0.40000000000000002 109.518 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.92 -39.77 95.98 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.915 -1.674 . . . . 0.35999999999999999 108.915 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.05 -40.04 96.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 2.75 109.771 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.74 -43.99 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.074 -1.016 . . . . 1.5600000000000001 108.962 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.01 -40.4 94.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.33000000000000002 108.699 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.19 -44.27 95.23 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.034 -0.666 . . . . 1.6799999999999999 109.478 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.16 -19.71 66.11 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 1.99 109.016 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -90.35 3.93 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.654 -0.654 . . . . 2.6800000000000002 109.925 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 7.4 48.41 Favored Glycine 0 N--CA 1.502 3.08 0 O-C-N 121.095 -1.003 . . . . 0.48999999999999999 111.697 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' B' ' 44' ' ' VAL . 91.4 m-85 -106.26 75.45 1.09 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.866 -1.373 . . . . 0.33000000000000002 109.658 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.76 -10.0 59.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.40999999999999998 110.36 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.473 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.3 mmtm -134.68 156.87 48.01 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.136 -0.978 . . . . 1.5600000000000001 109.886 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.71 94.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.754 -0.591 . . . . 0.20999999999999999 111.242 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 24.0 p90 -58.56 -20.01 42.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.32000000000000001 111.042 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.9 t -78.68 -34.47 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 0.23999999999999999 107.916 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.439 HG21 HG23 ' B' ' 20' ' ' VAL . 74.0 t -76.23 -39.1 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.164 -1.05 . . . . 0.22 108.164 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.95 -39.02 84.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.305 -0.998 . . . . 0.40000000000000002 108.305 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -41.05 97.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.845 -1.302 . . . . 0.17999999999999999 109.845 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.04 -41.94 93.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.112 -1.228 . . . . 1.0900000000000001 109.343 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.26 -40.0 84.62 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 0.31 108.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.17 -38.76 78.9 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.434 -0.95 . . . . 0.27000000000000002 108.434 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.16 -24.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.304 -0.872 . . . . 0.28000000000000003 110.194 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.34 16.15 17.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.108 -0.995 . . . . 0.29999999999999999 110.784 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.41 40.64 15.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.698 -1.252 . . . . 1.71 110.73 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 58.93 19.74 7.42 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.468 -0.77 . . . . 2.25 109.853 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.28 107.04 2.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.698 -1.251 . . . . 1.8 107.729 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.544 ' CD ' HH21 ' B' ' 60' ' ' ARG . 88.2 tt0 -61.63 -40.52 95.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.429 -0.794 . . . . 0.88 112.584 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.75 -39.58 76.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.73999999999999999 109.855 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.96 -39.96 75.69 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.685 -1.206 . . . . 0.55000000000000004 109.025 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.31 -50.32 68.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.38 109.457 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.544 HH21 ' CD ' ' B' ' 56' ' ' GLU . 34.0 mtt-85 -60.76 -46.19 91.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.815 . . . . 2.6400000000000001 110.572 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.92 -38.34 90.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.854 -1.154 . . . . 2.3799999999999999 108.933 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' TRP . . . . . 0.407 ' O ' ' OG1' ' B' ' 66' ' ' THR . 51.2 t90 -66.79 -45.24 79.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.40000000000000002 110.415 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.32 -48.79 69.17 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.266 -0.896 . . . . 0.34000000000000002 109.989 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.391 -0.818 . . . . 2.1000000000000001 109.249 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.43 -32.63 71.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.58 -0.7 . . . . 1.8999999999999999 109.684 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 87.5 m -79.66 -31.92 41.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.40000000000000002 111.471 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.41 -30.0 1.53 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.436 -1.415 . . . . 0.39000000000000001 112.193 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.73 15.02 19.91 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.138 -1.585 . . . . 0.35999999999999999 109.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.77 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.245 . . . . 0.32000000000000001 109.416 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -91.83 175.37 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 1.9099999999999999 109.731 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.96 78.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.483 -0.761 . . . . 0.38 110.122 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -73.81 -39.78 63.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 2.5699999999999998 109.99 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.03 -36.88 83.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 2.1200000000000001 110.545 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 18.8 p -69.25 -37.23 77.84 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.171 -0.956 . . . . 1.3600000000000001 110.003 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -37.88 80.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 2.8100000000000001 109.593 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.98 -39.84 87.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.502 -1.374 . . . . 0.40000000000000002 110.441 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.16 -42.62 72.26 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.69 -1.256 . . . . 0.23000000000000001 110.401 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.411 ' HB3' HH22 ' B' ' 60' ' ' ARG . 79.3 t80 -59.99 -60.12 4.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.575 -1.328 . . . . 0.42999999999999999 110.068 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.95 -34.47 90.0 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.368 -1.093 . . . . 0.25 110.368 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.52 -48.1 57.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.793 -1.416 . . . . 0.23999999999999999 109.84 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.59 HD21 HD22 ' B' ' 23' ' ' LEU . 97.0 mt -70.04 -39.96 75.43 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.799 -1.16 . . . . 0.28999999999999998 108.435 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' B' ' 82' ' ' ARG . 4.7 ttt-85 -61.47 -40.0 92.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 2.7400000000000002 109.515 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.95 -37.23 78.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.379 -0.826 . . . . 1.9099999999999999 109.91 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.516 ' CZ2' ' SD ' ' B' ' 15' ' ' MET . 80.8 t90 -60.0 -45.68 91.93 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.972 -1.492 . . . . 0.35999999999999999 106.972 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 32.7 m -61.83 -41.22 97.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.69 -0.631 . . . . 0.35999999999999999 109.527 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.35 -37.18 79.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.55000000000000004 109.939 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.38 -36.36 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.46999999999999997 109.824 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -104.57 -86.24 0.46 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -0.886 . . . . 1.24 110.777 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.445 HD13 ' SD ' ' A' ' 15' ' ' MET . 11.5 tp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.106 -0.95 . . . . 1.6699999999999999 109.117 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.805 0.812 . . . . 1.51 109.339 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.85 -30.14 68.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.795 -0.566 . . . . 2.1800000000000002 110.598 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.11 -33.67 72.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 2.02 108.965 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 23.8 t60 -59.92 -48.75 80.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.48999999999999999 110.088 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -69.88 -34.06 73.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.157 -0.964 . . . . 3.21 109.888 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.11 -39.84 82.69 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.383 -0.823 . . . . 0.76000000000000001 109.61 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.4 t80 -61.91 -47.3 85.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.429 -0.794 . . . . 0.46000000000000002 110.107 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 m -82.19 9.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.154 -0.966 . . . . 0.44 110.12 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.94 -16.4 15.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.156 -0.965 . . . . 0.54000000000000004 110.944 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -156.63 152.84 23.42 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.115 . . . . 1.26 109.198 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -40.33 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.702 1.601 . . . . 0.48999999999999999 110.839 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.5 ptp -90.37 -24.76 20.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.825 -1.172 . . . . 0.56999999999999995 109.646 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.22 -136.72 45.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.704 -1.358 . . . . 0.40000000000000002 109.704 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.57 28.93 6.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -1.006 . . . . 0.84999999999999998 111.221 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -60.75 148.44 82.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.709 -1.244 . . . . 2.0099999999999998 107.802 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.19 163.33 32.11 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.151 1.901 . . . . 0.34000000000000002 112.801 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 21' ' ' GLY . 8.0 p -58.14 -47.36 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.58 -0.7 . . . . 0.32000000000000001 110.391 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.57 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.13 -3.29 0.12 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.783 -0.927 . . . . 0.23000000000000001 110.783 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' VAL . 11.6 p -82.33 -25.3 34.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.799 -1.412 . . . . 1.24 109.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.54 137.82 58.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.708 0.766 . . . . 0.23999999999999999 109.759 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.92 135.31 55.55 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.692 0.758 . . . . 0.20999999999999999 109.912 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.585 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 96.98 -20.26 51.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.245 -1.542 . . . . 0.22 109.245 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.56 112.82 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.641 -1.244 . . . . 0.25 107.641 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -90.1 177.76 43.06 Favored Glycine 0 N--CA 1.492 2.39 0 O-C-N 120.678 -1.264 . . . . 0.28000000000000003 110.043 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -56.6 -39.94 74.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -1.033 . . . . 2.0099999999999998 109.643 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.76 -44.98 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.076 -1.015 . . . . 0.38 109.496 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.429 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.5 mt -66.35 -36.92 84.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.40000000000000002 109.466 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.82 97.43 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.816 -1.314 . . . . 0.34999999999999998 109.816 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -65.33 -37.03 85.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -1.219 . . . . 2.7400000000000002 109.736 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.59 -48.52 69.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.804 -1.185 . . . . 1.54 109.372 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.99 -38.66 89.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.34000000000000002 108.448 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.04 -42.19 93.88 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.906 -0.717 . . . . 1.6699999999999999 109.296 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.23 -19.42 65.53 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.533 -0.914 . . . . 2.0 108.533 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 2.83 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.747 . . . . 2.6899999999999999 109.725 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.78 5.46 50.9 Favored Glycine 0 N--CA 1.503 3.132 0 C-N-CA 120.264 -0.969 . . . . 0.47999999999999998 111.856 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.482 ' CD2' HG12 ' A' ' 44' ' ' VAL . 97.4 m-85 -106.56 77.07 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.899 -1.353 . . . . 0.33000000000000002 108.942 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -79.36 -7.54 58.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.40999999999999998 110.929 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.05 158.58 44.03 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.053 -1.029 . . . . 1.5600000000000001 110.406 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -40.64 90.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.747 -0.595 . . . . 0.20999999999999999 112.307 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.6 p90 -61.13 -18.49 58.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.499 -1.376 . . . . 0.32000000000000001 110.622 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 39' ' ' PHE . 17.2 t -80.06 -31.03 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.876 -1.157 . . . . 0.23999999999999999 107.876 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.4 t -77.5 -37.41 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.22 108.324 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.94 -35.67 75.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.638 -1.245 . . . . 0.40000000000000002 107.638 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.22 96.69 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.573 -1.411 . . . . 0.17999999999999999 109.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.15 -43.32 95.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.942 -1.328 . . . . 1.0900000000000001 109.096 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.98 -41.62 92.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.31 109.019 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.94 -40.06 75.72 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.808 -0.757 . . . . 0.28000000000000003 108.966 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -66.11 -22.81 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.218 -0.926 . . . . 0.28000000000000003 110.448 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.95 17.05 9.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.204 -0.935 . . . . 0.31 109.777 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.08 -1.013 . . . . 1.7 110.346 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.717 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 64.3 mttm 58.85 19.44 7.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.714 -0.616 . . . . 2.2400000000000002 110.011 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -67.74 106.71 2.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.76 -1.213 . . . . 1.8 108.297 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.32 -41.3 98.42 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.406 -0.809 . . . . 0.87 112.631 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 92.5 m-20 -68.99 -39.94 79.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.789 -1.195 . . . . 0.72999999999999998 109.433 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 58' ' ' LEU . 90.8 mt -69.99 -39.9 75.62 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.032 -1.067 . . . . 0.55000000000000004 108.614 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.26 -50.03 71.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.38 109.772 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.434 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.0 mtm180 -62.45 -44.6 96.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 2.6400000000000001 110.288 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.26 -38.34 90.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 2.3700000000000001 108.989 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.28 -49.57 73.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.263 -0.898 . . . . 0.40000000000000002 110.853 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 tp -65.3 -47.43 76.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.84 . . . . 0.34000000000000002 109.874 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -63.45 -45.25 91.72 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.402 -0.811 . . . . 2.1099999999999999 109.274 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -68.43 -34.06 75.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.418 0.628 . . . . 1.8999999999999999 109.592 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.7 m -79.72 -33.56 40.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -0.79 . . . . 0.40999999999999998 111.336 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.6 p -130.63 -28.95 1.99 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.503 -1.373 . . . . 0.40000000000000002 112.239 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.32 25.62 Favored Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.226 -1.55 . . . . 0.35999999999999999 109.226 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.99 153.0 1.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.122 -1.222 . . . . 0.33000000000000002 109.337 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.08 172.57 8.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 1.8999999999999999 110.036 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.08 78.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.39000000000000001 110.487 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.06 -40.4 75.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.738 -1.226 . . . . 2.5800000000000001 109.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.585 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 22.7 mm100 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.452 -0.78 . . . . 2.1200000000000001 110.69 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p -66.34 -38.18 87.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.139 -0.975 . . . . 1.3600000000000001 110.039 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -60.17 -38.79 84.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.828 -1.17 . . . . 2.7999999999999998 109.341 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.27 -39.24 82.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.764 -1.21 . . . . 0.40000000000000002 110.444 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -68.09 -40.32 82.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.766 -1.209 . . . . 0.23999999999999999 109.476 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.44 -60.33 3.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.014 -1.054 . . . . 0.42999999999999999 109.533 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.72 87.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.199 -1.16 . . . . 0.26000000000000001 110.199 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.21 -47.3 65.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.25 109.638 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -69.97 -40.02 75.63 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.667 -1.213 . . . . 0.29999999999999999 108.591 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.717 HH12 ' NZ ' ' A' ' 54' ' ' LYS . 8.5 tpm_? -63.71 -41.93 98.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 2.73 110.006 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 94.4 mt-10 -69.66 -39.65 76.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 1.9099999999999999 110.665 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 79.1 t90 -60.04 -41.91 93.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.316 -1.49 . . . . 0.37 107.7 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -62.82 -40.51 97.63 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.975 -0.75 . . . . 0.35999999999999999 108.975 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD1' ' NH2' ' A' ' 82' ' ' ARG . 96.1 m-20 -60.27 -36.84 78.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.553 -0.717 . . . . 0.55000000000000004 109.905 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.66 -38.29 18.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 0.47999999999999998 109.952 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.602 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 76.3 m-85 . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.289 -0.882 . . . . 1.24 110.5 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.752 0.787 . . . . 1.5 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -59.88 -30.15 68.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.925 -0.484 . . . . 2.1800000000000002 110.521 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.07 -33.53 72.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -0.992 . . . . 2.0099999999999998 109.034 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 23.9 t60 -59.86 -48.89 79.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.074 -1.016 . . . . 0.48999999999999999 110.139 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -69.85 -34.13 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.994 . . . . 3.23 109.882 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.12 -39.85 82.65 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.426 -0.797 . . . . 0.76000000000000001 109.664 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.1 t80 -61.83 -47.51 84.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.46000000000000002 110.092 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.98 9.92 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.144 -0.972 . . . . 0.44 110.242 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.97 -16.45 15.83 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.204 -0.935 . . . . 0.53000000000000003 110.951 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.64 152.83 23.36 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 1.27 109.14 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.25 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.701 1.6 . . . . 0.48999999999999999 110.966 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.6 ptp -90.4 -24.62 20.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.845 -1.159 . . . . 0.56000000000000005 109.658 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.09 -136.68 45.59 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.831 -1.308 . . . . 0.39000000000000001 109.831 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.8 29.04 6.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -1.076 . . . . 0.83999999999999997 111.124 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.72 148.41 82.23 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.667 -1.234 . . . . 2.02 107.667 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.19 163.3 32.24 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.204 1.936 . . . . 0.34000000000000002 112.794 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.559 HG13 ' N ' ' B' ' 21' ' ' GLY . 8.0 p -58.07 -47.47 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.466 0.65 . . . . 0.32000000000000001 110.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.559 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.11 -3.31 0.12 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.754 -0.939 . . . . 0.22 110.754 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.497 ' H ' ' C ' ' B' ' 20' ' ' VAL . 11.5 p -82.23 -25.32 34.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.817 -1.402 . . . . 1.24 109.495 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.52 137.91 58.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.23999999999999999 109.768 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 135.45 55.65 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.795 0.807 . . . . 0.20999999999999999 109.832 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' B' ' 73' ' ' GLN . . . 96.78 -20.03 52.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.326 -1.51 . . . . 0.22 109.326 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.79 112.72 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.669 -1.234 . . . . 0.25 107.669 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.433 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -89.99 177.84 43.28 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.609 -1.282 . . . . 0.28000000000000003 110.108 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.74 -39.89 74.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 2.0 109.601 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.78 -44.9 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.008 -1.058 . . . . 0.38 109.484 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.433 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.7 mt -66.35 -36.84 83.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.40000000000000002 109.472 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.79 97.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.76 -1.336 . . . . 0.35999999999999999 109.76 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -65.34 -36.92 85.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.074 -1.251 . . . . 2.75 109.85 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.65 -48.61 68.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.708 -1.245 . . . . 1.5600000000000001 109.321 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.85 -38.67 89.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.06 -1.025 . . . . 0.33000000000000002 108.63 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.94 -42.41 93.93 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.933 -0.707 . . . . 1.6799999999999999 109.228 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -66.95 -19.59 65.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.579 -0.897 . . . . 1.99 108.579 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 3.0 54.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.452 -0.78 . . . . 2.6800000000000002 109.797 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.77 5.47 50.92 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.168 -0.957 . . . . 0.48999999999999999 111.836 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.473 ' CD2' HG12 ' B' ' 44' ' ' VAL . 97.5 m-85 -106.3 77.0 1.18 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.772 -1.428 . . . . 0.33000000000000002 109.071 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -79.33 -7.47 58.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.905 . . . . 0.40999999999999998 110.914 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.14 158.44 44.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.965 -1.084 . . . . 1.5600000000000001 110.498 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.72 90.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.628 -0.67 . . . . 0.20999999999999999 112.389 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 7.6 p90 -60.96 -18.61 58.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.526 -1.359 . . . . 0.32000000000000001 110.584 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.473 HG12 ' CD2' ' B' ' 39' ' ' PHE . 16.8 t -79.88 -31.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.964 -1.124 . . . . 0.23999999999999999 107.964 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.61 -37.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.34 -0.985 . . . . 0.22 108.34 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.11 -35.71 75.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.505 -1.294 . . . . 0.40000000000000002 107.505 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.33 96.73 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.706 -1.358 . . . . 0.17999999999999999 109.706 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.03 -43.47 95.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.967 -1.314 . . . . 1.0900000000000001 108.971 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.0 -41.48 92.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.31 108.964 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.01 -39.92 75.55 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.864 -0.734 . . . . 0.27000000000000002 109.064 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.37 -22.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.201 -0.937 . . . . 0.28000000000000003 110.339 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -91.92 17.02 9.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.168 -0.958 . . . . 0.29999999999999999 109.734 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.998 -1.064 . . . . 1.71 110.327 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' LYS . . . . . 0.716 ' NZ ' HH12 ' B' ' 82' ' ' ARG . 64.3 mttm 58.66 19.63 6.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.729 -0.607 . . . . 2.25 110.058 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.75 106.67 2.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.614 -1.304 . . . . 1.8 108.201 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.41 -41.3 98.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.379 -0.826 . . . . 0.88 112.523 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 92.3 m-20 -68.86 -39.84 79.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.886 -1.133 . . . . 0.73999999999999999 109.49 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.06 -40.02 75.32 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 119.063 -1.055 . . . . 0.55000000000000004 108.578 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -63.16 -50.05 71.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.38 109.842 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 82.9 mtm180 -62.3 -44.94 95.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.366 -0.834 . . . . 2.6400000000000001 110.342 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.03 -38.45 90.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.988 -1.07 . . . . 2.3799999999999999 109.042 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.4 -49.4 73.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.40000000000000002 110.818 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.3 -47.39 76.75 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.342 -0.849 . . . . 0.34000000000000002 109.953 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -63.42 -45.19 92.14 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.317 -0.864 . . . . 2.1000000000000001 109.387 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 35.5 t0 -68.61 -33.78 74.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.735 -0.603 . . . . 1.8999999999999999 109.607 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -79.88 -33.64 39.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.40000000000000002 111.249 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.6 p -130.57 -29.04 1.99 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.526 -1.359 . . . . 0.39000000000000001 112.272 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.13 26.09 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.205 -1.558 . . . . 0.35999999999999999 109.205 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.91 152.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.096 -1.238 . . . . 0.32000000000000001 109.409 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.03 172.62 8.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.068 -1.02 . . . . 1.9099999999999999 110.041 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.19 79.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.674 . . . . 0.38 110.548 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.04 -40.39 75.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.839 -1.163 . . . . 2.5699999999999998 109.705 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' B' ' 25' ' ' GLY . 93.8 mm-40 -67.54 -39.55 85.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.444 -0.785 . . . . 2.1200000000000001 110.757 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -66.09 -38.23 87.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.161 -0.962 . . . . 1.3600000000000001 110.106 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.09 -39.02 84.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.723 -1.235 . . . . 2.8100000000000001 109.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.2 -39.3 82.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.842 -1.161 . . . . 0.40000000000000002 110.439 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.2 -40.22 82.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.752 -1.217 . . . . 0.23000000000000001 109.472 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -60.47 -60.08 4.38 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.95 -1.094 . . . . 0.42999999999999999 109.649 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.24 -35.63 88.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.275 -1.13 . . . . 0.25 110.275 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.03 -47.34 65.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.23999999999999999 109.778 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.07 -40.28 75.14 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.735 -1.186 . . . . 0.28999999999999998 108.529 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.716 HH12 ' NZ ' ' B' ' 54' ' ' LYS . 8.5 tpm_? -63.4 -41.91 98.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 2.7400000000000002 110.083 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 94.4 mt-10 -69.77 -39.6 76.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.816 -1.178 . . . . 1.9099999999999999 110.775 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.609 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 79.7 t90 -59.96 -42.08 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.436 -1.415 . . . . 0.35999999999999999 107.534 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 67.4 m -62.74 -40.44 97.23 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.056 -0.72 . . . . 0.35999999999999999 109.056 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' B' ' 82' ' ' ARG . 96.2 m-20 -60.27 -36.9 78.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.552 -0.717 . . . . 0.55000000000000004 109.781 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.72 -38.43 18.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.46999999999999997 110.06 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 76.3 m-85 -102.25 -84.94 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.311 -0.868 . . . . 1.24 110.547 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 118.012 -0.994 . . . . 1.6699999999999999 109.911 -178.529 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.6 0.714 . . . . 1.51 109.49 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -54.55 -18.84 4.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.641 -0.662 . . . . 2.1800000000000002 110.266 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -59.99 -37.09 78.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 2.02 109.75 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -59.88 -50.83 72.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.007 -1.058 . . . . 0.48999999999999999 110.597 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -69.87 -33.28 72.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.068 -1.02 . . . . 3.21 109.881 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.37 -39.7 77.9 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.276 -0.89 . . . . 0.76000000000000001 109.317 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.8 t80 -63.86 -48.52 76.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.525 -0.734 . . . . 0.46000000000000002 110.433 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.6 11.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.44 110.464 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.64 -12.62 14.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.243 -0.911 . . . . 0.54000000000000004 109.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.04 151.23 22.54 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 1.26 109.395 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -42.12 157.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.738 1.625 . . . . 0.48999999999999999 110.994 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.05 -23.24 18.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.847 -1.158 . . . . 0.56999999999999995 109.922 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.77 -138.59 48.21 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.981 -1.247 . . . . 0.40000000000000002 109.981 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.58 29.33 5.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.501 -0.999 . . . . 0.84999999999999998 110.042 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -60.02 148.98 76.0 Favored Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 107.83 -1.174 . . . . 2.0099999999999998 107.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.16 160.93 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.326 2.017 . . . . 0.34000000000000002 113.257 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.3 p -57.29 -49.08 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.739 -0.601 . . . . 0.32000000000000001 110.096 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.575 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -56.22 -2.78 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.223 -1.151 . . . . 0.23000000000000001 110.223 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 22.1 p -81.49 -24.68 36.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.33 . . . . 1.24 108.511 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.627 HD22 HD21 ' A' ' 81' ' ' LEU . 92.3 mt -62.43 139.73 58.57 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.783 0.802 . . . . 0.23999999999999999 109.579 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.81 134.12 52.42 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.831 0.824 . . . . 0.20999999999999999 110.16 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.98 -20.51 48.74 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.925 -1.67 . . . . 0.22 108.925 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mm -99.89 116.8 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.764 -1.198 . . . . 0.25 107.764 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -92.3 177.4 39.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.669 -1.372 . . . . 0.28000000000000003 109.669 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.49 -39.84 73.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.54 -0.976 . . . . 2.0099999999999998 109.539 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.13 -42.67 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.38 109.447 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.591 HD11 ' NE2' ' A' ' 73' ' ' GLN . 95.6 mt -68.4 -40.06 81.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.214 -0.929 . . . . 0.40000000000000002 109.438 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.99 97.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.34999999999999998 109.583 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.29 -39.97 94.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.4 -1.059 . . . . 2.7400000000000002 110.058 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.84 -49.94 68.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.832 -1.168 . . . . 1.54 109.599 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.5 mt -60.03 -39.45 85.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.34000000000000002 108.966 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.02 -44.5 94.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.723 . . . . 1.6699999999999999 110.533 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.76 -19.07 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 2.0 109.113 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 37' ' ' ARG . 27.1 mtt-85 -89.97 1.93 55.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.794 -0.762 . . . . 2.6899999999999999 110.52 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.43 4.37 34.95 Favored Glycine 0 N--CA 1.506 3.353 0 O-C-N 121.019 -1.051 . . . . 0.47999999999999998 112.006 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CD2' HG12 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.08 73.81 1.07 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.794 -1.415 . . . . 0.33000000000000002 108.659 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -80.07 -10.0 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.40999999999999998 110.515 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 29.8 mmtp -130.82 152.68 49.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.171 -0.955 . . . . 1.5600000000000001 109.424 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.393 -0.817 . . . . 0.20999999999999999 111.55 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 22.5 p90 -56.15 -17.61 7.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.711 -1.243 . . . . 0.32000000000000001 110.32 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.2 t -79.66 -33.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.832 -1.167 . . . . 0.23999999999999999 108.073 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 20' ' ' VAL . 55.2 t -76.88 -39.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.266 -1.013 . . . . 0.22 108.266 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.03 -38.07 81.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.578 -1.267 . . . . 0.40000000000000002 107.578 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.98 -41.12 96.21 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.552 -1.419 . . . . 0.17999999999999999 109.552 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -59.9 -43.29 94.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.252 . . . . 1.0900000000000001 108.456 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.02 -39.93 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.31 108.725 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.72 -40.01 76.5 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.509 -0.923 . . . . 0.28000000000000003 108.509 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.81 -26.01 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.28000000000000003 110.198 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.01 13.63 14.32 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.16 -0.962 . . . . 0.31 110.166 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER 48.95 51.63 15.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.881 -1.137 . . . . 1.7 110.312 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.76 20.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.945 -1.097 . . . . 2.2400000000000002 110.913 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-20 -65.33 105.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.937 -1.505 . . . . 1.8 106.937 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.43 -40.27 93.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.361 -0.837 . . . . 0.87 112.62 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.77 -40.03 76.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.256 -1.527 . . . . 0.72999999999999998 109.823 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.3 -40.07 74.45 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.944 -1.102 . . . . 0.55000000000000004 109.2 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.9 -50.03 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.38 109.402 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.79 -45.01 94.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.437 -0.79 . . . . 2.6400000000000001 109.896 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 65' ' ' ASP . 8.3 tm-20 -64.88 -39.99 94.4 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.159 -0.963 . . . . 2.3700000000000001 108.706 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -65.25 -48.02 74.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.40000000000000002 110.866 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.66 -45.88 73.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.208 -0.932 . . . . 0.34000000000000002 110.558 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.65 -48.5 79.07 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.167 -0.958 . . . . 2.1099999999999999 110.213 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 61' ' ' GLU . 57.2 m-20 -70.06 -24.75 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.807 . . . . 1.8999999999999999 110.066 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.0 m -79.62 -34.51 40.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.143 -0.973 . . . . 0.40999999999999998 111.236 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -132.91 -19.84 2.25 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.483 -1.386 . . . . 0.40000000000000002 111.899 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.8 11.5 43.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.137 -1.585 . . . . 0.35999999999999999 109.137 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.68 1.6 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.33000000000000002 109.248 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.26 170.02 10.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 1.8999999999999999 109.817 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -34.36 73.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.562 -0.711 . . . . 0.39000000000000001 110.552 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -71.66 -39.97 69.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.64 -1.287 . . . . 2.5800000000000001 110.222 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.591 ' NE2' HD11 ' A' ' 30' ' ' LEU . 78.3 mt-30 -68.61 -37.98 80.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.43 -0.794 . . . . 2.1200000000000001 110.722 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.9 m -67.41 -38.0 83.93 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.048 -1.032 . . . . 1.3600000000000001 109.958 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.01 -38.06 81.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 2.7999999999999998 109.476 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -68.33 -39.93 81.77 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.705 -1.247 . . . . 0.40000000000000002 110.349 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.9 m -66.97 -39.97 87.35 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.82 -1.175 . . . . 0.23999999999999999 108.968 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.15 -60.73 3.39 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.984 -1.073 . . . . 0.42999999999999999 109.822 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.03 88.82 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.507 -1.037 . . . . 0.26000000000000001 110.507 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.28 -49.88 52.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.432 . . . . 0.25 109.625 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.627 HD21 HD22 ' A' ' 23' ' ' LEU . 96.3 mt -70.01 -39.99 75.5 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.983 -1.087 . . . . 0.29999999999999999 109.019 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -63.01 -40.05 96.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 2.73 110.186 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.049 -1.032 . . . . 1.9099999999999999 109.924 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 71.0 t90 -59.91 -42.76 94.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.437 -1.32 . . . . 0.37 107.437 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.94 -40.01 95.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 0.35999999999999999 108.968 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.39 -37.99 82.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.425 -0.797 . . . . 0.55000000000000004 109.678 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.13 17.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.47999999999999998 109.938 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 73.0 m-85 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.165 -0.959 . . . . 1.24 110.311 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.583 0.706 . . . . 1.5 109.466 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -54.63 -18.87 5.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.634 -0.666 . . . . 2.1800000000000002 110.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -60.02 -36.89 78.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.055 -1.028 . . . . 2.0099999999999998 109.701 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -60.11 -50.58 73.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.995 -1.066 . . . . 0.48999999999999999 110.571 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -70.16 -33.14 71.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.018 -1.051 . . . . 3.23 109.758 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -69.43 -39.59 77.75 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.307 -0.871 . . . . 0.76000000000000001 109.288 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.4 t80 -63.96 -48.52 76.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.46000000000000002 110.462 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -83.51 11.11 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.029 -1.044 . . . . 0.44 110.423 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.54 -12.67 14.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.316 -0.865 . . . . 0.53000000000000003 109.793 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.04 151.14 22.36 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.065 -1.022 . . . . 1.27 109.329 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -42.16 157.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.705 1.603 . . . . 0.48999999999999999 110.926 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.2 ptp -93.01 -23.3 18.72 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.872 -1.143 . . . . 0.56000000000000005 109.958 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.11 -138.48 48.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.081 -1.208 . . . . 0.39000000000000001 110.081 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.82 29.34 5.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.83999999999999997 110.051 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.93 148.88 75.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 107.823 -1.177 . . . . 2.02 107.823 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.99 161.1 38.29 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.285 1.99 . . . . 0.34000000000000002 113.236 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.572 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.4 p -57.36 -49.15 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.568 0.699 . . . . 0.32000000000000001 110.146 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.572 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -56.04 -3.05 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.259 -1.136 . . . . 0.22 110.259 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.449 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.2 p -81.35 -24.4 37.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.955 -1.32 . . . . 1.24 108.53 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.635 HD22 HD21 ' B' ' 81' ' ' LEU . 91.7 mt -62.61 139.69 58.64 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.823 0.821 . . . . 0.23999999999999999 109.581 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 134.14 52.62 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.776 0.798 . . . . 0.20999999999999999 110.173 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -20.92 46.95 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.883 -1.687 . . . . 0.22 108.883 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mm -99.6 116.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.916 -1.142 . . . . 0.25 107.916 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.467 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -92.3 177.48 39.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.679 -1.368 . . . . 0.28000000000000003 109.679 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -56.41 -39.92 73.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.455 -1.027 . . . . 2.0 109.553 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.15 -42.68 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.38 109.438 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.467 HD12 ' H ' ' B' ' 27' ' ' GLY . 95.7 mt -68.42 -39.91 81.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.219 -0.925 . . . . 0.40000000000000002 109.528 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.76 -39.91 97.38 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.35999999999999999 109.591 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.33 -39.98 94.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -1.108 . . . . 2.75 110.049 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.82 -49.99 68.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.837 -1.164 . . . . 1.5600000000000001 109.552 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.02 -39.45 85.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.33000000000000002 108.893 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.05 -44.38 94.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 1.6799999999999999 110.501 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.95 -18.91 65.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.031 -1.043 . . . . 1.99 109.152 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' B' ' 37' ' ' ARG . 27.6 mtt-85 -90.0 1.62 56.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.466 -0.771 . . . . 2.6800000000000002 110.507 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.91 4.27 33.9 Favored Glycine 0 N--CA 1.506 3.309 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 112.024 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.522 ' CD2' HG12 ' B' ' 44' ' ' VAL . 82.6 m-85 -105.08 73.87 1.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.81 -1.406 . . . . 0.33000000000000002 108.755 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.1 -10.03 59.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.40999999999999998 110.405 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.464 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 29.8 mmtp -130.79 152.59 49.97 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.224 -0.922 . . . . 1.5600000000000001 109.493 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.95 92.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.529 -0.732 . . . . 0.20999999999999999 111.501 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.464 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 22.8 p90 -56.1 -17.46 7.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.733 -1.23 . . . . 0.32000000000000001 110.418 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.3 t -79.7 -33.34 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.819 -1.176 . . . . 0.23999999999999999 108.039 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.437 HG21 HG23 ' B' ' 20' ' ' VAL . 55.2 t -76.68 -39.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.262 -1.014 . . . . 0.22 108.262 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.8 tp -60.08 -37.6 80.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.534 -1.284 . . . . 0.40000000000000002 107.534 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 -41.04 96.54 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.627 -1.389 . . . . 0.17999999999999999 109.627 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -60.07 -43.24 95.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.274 . . . . 1.0900000000000001 108.397 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.31 108.794 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.74 -39.91 76.48 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.27000000000000002 108.617 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.85 -26.1 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.312 -0.868 . . . . 0.28000000000000003 110.193 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.93 13.49 14.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.197 -0.939 . . . . 0.29999999999999999 110.131 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 49.01 51.73 15.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.771 -1.205 . . . . 1.71 110.185 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.79 20.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.833 -1.167 . . . . 2.25 110.954 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 53' ' ' LYS . 71.1 m-20 -65.5 105.34 1.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.946 -1.501 . . . . 1.8 106.946 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.42 -40.03 92.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.241 -0.912 . . . . 0.88 112.674 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.99 -39.95 75.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.342 -1.474 . . . . 0.73999999999999999 109.865 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.38 -39.94 74.27 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.846 -1.142 . . . . 0.55000000000000004 109.298 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.86 -49.94 70.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.38 109.433 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.98 -44.82 94.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.461 -0.774 . . . . 2.6400000000000001 109.821 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.444 ' OE2' ' OD2' ' B' ' 65' ' ' ASP . 8.3 tm-20 -64.93 -40.1 94.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.111 -0.993 . . . . 2.3799999999999999 108.745 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -65.11 -48.1 74.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.40000000000000002 110.92 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.0 tp -67.79 -45.64 74.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.28 -0.888 . . . . 0.34000000000000002 110.572 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.84 -48.48 78.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.191 -0.943 . . . . 2.1000000000000001 110.162 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.444 ' OD2' ' OE2' ' B' ' 61' ' ' GLU . 57.3 m-20 -69.96 -24.84 63.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 1.8999999999999999 110.119 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -79.59 -34.34 40.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.996 . . . . 0.40000000000000002 111.33 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -133.02 -19.91 2.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.548 -1.345 . . . . 0.39000000000000001 111.802 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.75 11.51 43.53 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.116 -1.594 . . . . 0.35999999999999999 109.116 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.08 152.87 1.55 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.998 -1.295 . . . . 0.32000000000000001 109.166 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 0.54 ' H ' HE21 ' B' ' 73' ' ' GLN . 27.0 t-20 -89.43 169.98 10.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.058 . . . . 1.9099999999999999 109.843 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.42 73.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.58 -0.7 . . . . 0.38 110.507 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.63 -39.97 70.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.703 -1.248 . . . . 2.5699999999999998 110.202 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.54 HE21 ' H ' ' B' ' 70' ' ' ASN . 37.2 mt-30 -68.68 -37.99 80.02 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.815 . . . . 2.1200000000000001 110.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -67.27 -38.12 84.57 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.036 -1.04 . . . . 1.3600000000000001 109.911 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 -60.05 -38.1 81.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 2.8100000000000001 109.441 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.12 -39.98 82.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.77 -1.206 . . . . 0.40000000000000002 110.348 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 67.2 m -67.01 -39.96 87.2 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.735 -1.228 . . . . 0.23000000000000001 109.053 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.05 -60.82 3.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.984 -1.072 . . . . 0.42999999999999999 109.867 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.13 -34.15 89.14 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.504 -1.038 . . . . 0.25 110.504 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.29 -49.8 52.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.825 -1.397 . . . . 0.23999999999999999 109.713 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.635 HD21 HD22 ' B' ' 23' ' ' LEU . 96.7 mt -69.98 -40.0 75.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.987 -1.085 . . . . 0.28999999999999998 108.969 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -63.11 -40.03 96.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.172 -0.955 . . . . 2.7400000000000002 110.144 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.2 -36.72 77.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 1.9099999999999999 109.882 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.533 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 71.8 t90 -59.95 -42.64 94.49 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.449 -1.315 . . . . 0.35999999999999999 107.449 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.409 ' O ' ' OXT' ' B' ' 89' ' ' LEU . 92.6 m -64.11 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 0.35999999999999999 108.952 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.25 -38.21 82.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.758 . . . . 0.55000000000000004 109.578 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.46 -39.69 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.46999999999999997 110.01 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.533 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.6 m-85 -97.84 -82.49 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 1.24 110.495 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.409 ' OXT' ' O ' ' B' ' 85' ' ' CYS . 18.4 tp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.975 -1.012 . . . . 1.6699999999999999 110.065 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.834 0.826 . . . . 1.51 109.324 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.48 -28.69 67.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.753 -0.592 . . . . 2.1800000000000002 109.95 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.02 -36.9 78.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.939 . . . . 2.02 109.456 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -59.25 -50.08 75.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 110.064 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.98 -34.41 73.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.192 -0.943 . . . . 3.21 110.096 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 91.3 m-20 -67.8 -39.31 84.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.255 -0.903 . . . . 0.76000000000000001 109.447 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -60.03 -47.45 85.8 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.481 -0.888 . . . . 0.46000000000000002 109.369 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 m -83.76 10.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.026 -1.047 . . . . 0.44 110.483 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.6 -19.04 17.04 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.012 -1.055 . . . . 0.54000000000000004 110.91 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -156.95 152.93 23.01 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.886 -1.133 . . . . 1.26 108.606 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' GLU . 55.0 Cg_exo -36.47 150.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.012 1.808 . . . . 0.48999999999999999 111.867 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.442 ' HG2' ' H ' ' A' ' 15' ' ' MET . 8.0 ptm -89.51 -22.74 22.28 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.041 -1.037 . . . . 0.56999999999999995 110.503 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.08 -134.61 40.65 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.101 -1.047 . . . . 0.40000000000000002 110.593 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.98 35.14 3.5 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.99 . . . . 0.84999999999999998 110.557 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -58.55 147.85 68.19 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 120.781 -1.199 . . . . 2.0099999999999998 107.97 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.25 153.69 51.43 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.996 1.797 . . . . 0.34000000000000002 112.08 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.5 p -55.23 -42.03 63.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.544 -0.723 . . . . 0.32000000000000001 109.933 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -62.12 -3.6 5.15 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.281 -1.128 . . . . 0.23000000000000001 110.281 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -83.33 -21.0 33.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.888 -1.36 . . . . 1.24 109.242 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.14 137.73 58.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.23999999999999999 109.68 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.98 133.89 55.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.754 0.788 . . . . 0.20999999999999999 109.841 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 96.89 -17.34 59.44 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.167 -1.573 . . . . 0.22 109.167 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -101.17 114.79 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -1.128 . . . . 0.25 108.094 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -94.76 178.55 36.48 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.724 -1.351 . . . . 0.28000000000000003 109.724 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.23 -40.01 73.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -1.148 . . . . 2.0099999999999998 109.958 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.28 -44.44 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.974 -1.079 . . . . 0.38 109.545 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.8 mt -66.29 -38.35 87.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.40000000000000002 109.707 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.98 94.5 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.37 -1.492 . . . . 0.34999999999999998 109.37 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.96 -40.0 90.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -1.09 . . . . 2.7400000000000002 110.594 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.19 -45.35 73.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.738 -1.226 . . . . 1.54 109.632 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.49 -39.96 95.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.073 -1.017 . . . . 0.34000000000000002 108.59 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.14 -40.82 91.15 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.809 -0.756 . . . . 1.6699999999999999 109.605 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.17 -19.55 65.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.332 -0.988 . . . . 2.0 108.332 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.513 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.6 OUTLIER -91.12 6.39 45.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.649 -0.657 . . . . 2.6899999999999999 110.043 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.62 9.23 53.33 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.256 -0.973 . . . . 0.47999999999999998 111.899 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.549 ' CD2' HG12 ' A' ' 44' ' ' VAL . 78.3 m-85 -106.26 74.52 1.04 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.764 -1.433 . . . . 0.33000000000000002 109.312 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -79.96 -9.74 59.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.40999999999999998 110.522 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.1 mmtm -132.72 154.97 49.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.088 -1.008 . . . . 1.5600000000000001 109.559 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.92 94.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.657 -0.652 . . . . 0.20999999999999999 111.071 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 21.6 p90 -57.39 -18.85 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.758 -1.214 . . . . 0.32000000000000001 110.7 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 39' ' ' PHE . 24.8 t -79.27 -34.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.619 -1.301 . . . . 0.23999999999999999 107.976 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.75 -39.96 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.472 -0.936 . . . . 0.22 108.472 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.98 -38.33 82.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.623 -1.251 . . . . 0.40000000000000002 107.623 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.97 97.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.664 -1.374 . . . . 0.17999999999999999 109.664 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 1.0900000000000001 109.37 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.97 -40.03 87.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.7 -39.0 77.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.666 -0.813 . . . . 0.28000000000000003 108.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.34 -24.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.28000000000000003 110.147 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.57 15.2 14.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.172 -0.955 . . . . 0.31 110.252 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt 48.82 42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.732 -1.23 . . . . 1.7 110.866 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 56.76 19.41 4.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.389 -0.819 . . . . 2.2400000000000002 109.5 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.82 107.02 2.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.718 -1.239 . . . . 1.8 108.123 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -40.52 97.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.87 112.342 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.11 -39.96 78.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.363 -1.461 . . . . 0.72999999999999998 109.724 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.47 -39.99 73.91 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.917 -1.113 . . . . 0.55000000000000004 108.987 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.9 -49.88 70.92 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.856 . . . . 0.38 109.668 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.22 -46.29 91.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.347 -0.846 . . . . 2.6400000000000001 110.443 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.35 -39.89 94.78 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.064 -1.022 . . . . 2.3700000000000001 108.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.402 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.2 t90 -63.23 -49.49 73.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.269 -0.894 . . . . 0.40000000000000002 110.93 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.98 -49.64 64.76 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 0.34000000000000002 109.784 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.25 86.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.765 . . . . 2.1099999999999999 110.007 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.9 t0 -68.45 -29.62 68.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.521 -0.737 . . . . 1.8999999999999999 109.838 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.9 m -80.45 -32.91 37.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.40999999999999998 111.562 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.2 p -131.65 -28.77 1.79 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.52 -1.363 . . . . 0.40000000000000002 111.982 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.56 14.1 20.68 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.059 -1.616 . . . . 0.35999999999999999 109.059 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.89 153.28 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.014 -1.286 . . . . 0.33000000000000002 109.362 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.54 170.15 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.1 -1.0 . . . . 1.8999999999999999 109.654 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.23 70.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.39000000000000001 110.727 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.18 -40.1 68.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 2.5800000000000001 109.734 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.2 mm100 -67.71 -38.3 83.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.349 -0.844 . . . . 2.1200000000000001 110.236 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -68.45 -37.74 80.49 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.907 . . . . 1.3600000000000001 110.02 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.56 -38.8 85.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 2.7999999999999998 109.412 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -68.46 -39.94 81.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.624 -1.298 . . . . 0.40000000000000002 110.318 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.4 -39.98 81.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.143 . . . . 0.23999999999999999 109.171 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.69 -60.1 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.771 -1.206 . . . . 0.42999999999999999 109.779 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.29 -34.42 89.16 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.298 -1.121 . . . . 0.26000000000000001 110.298 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.32 -46.58 60.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.847 -1.384 . . . . 0.25 109.705 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -70.32 -40.56 74.11 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.793 -1.163 . . . . 0.29999999999999999 108.432 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -64.54 -39.98 94.75 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.84 . . . . 2.73 110.448 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -68.73 -37.64 79.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.983 -1.073 . . . . 1.9099999999999999 109.758 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.592 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.4 t90 -60.01 -45.54 92.41 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.431 -1.322 . . . . 0.37 107.431 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 75.6 m -60.74 -40.02 90.87 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.808 -0.812 . . . . 0.35999999999999999 108.808 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.43 -37.76 81.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.55000000000000004 109.739 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.61 -36.86 18.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.47999999999999998 109.934 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 1.24 110.226 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.801 0.81 . . . . 1.5 109.426 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.71 -28.5 67.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.761 -0.587 . . . . 2.1800000000000002 109.905 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -59.99 -37.03 78.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 2.0099999999999998 109.483 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -59.32 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.101 -1.0 . . . . 0.48999999999999999 109.974 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.96 -34.53 73.53 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.073 -1.017 . . . . 3.23 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ASP . . . . . 0.447 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 91.6 m-20 -67.72 -39.26 84.33 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.223 -0.923 . . . . 0.76000000000000001 109.413 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -59.91 -47.6 85.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.434 -0.906 . . . . 0.46000000000000002 109.39 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.67 10.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.168 -0.957 . . . . 0.44 110.512 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -19.04 17.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.53000000000000003 110.981 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' B' ' 9' ' ' ASP . 0.0 OUTLIER -156.92 152.93 23.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.831 -1.168 . . . . 1.27 108.603 179.542 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' B' ' 13' ' ' GLU . 54.8 Cg_exo -36.36 150.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.088 1.859 . . . . 0.48999999999999999 111.86 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' B' ' 15' ' ' MET . 8.0 ptm -89.38 -22.61 22.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.114 -0.991 . . . . 0.56000000000000005 110.539 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.19 -134.63 41.06 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.918 -1.114 . . . . 0.39000000000000001 110.63 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.02 35.04 3.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.471 -1.017 . . . . 0.83999999999999997 110.552 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -58.4 147.79 66.97 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 120.76 -1.213 . . . . 2.02 108.04 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.28 153.48 52.98 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.019 1.813 . . . . 0.34000000000000002 112.161 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.516 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.7 p -54.96 -42.07 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.32000000000000001 110.03 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.516 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -62.15 -3.68 5.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.263 -1.135 . . . . 0.22 110.263 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -83.08 -21.1 33.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.897 -1.355 . . . . 1.24 109.261 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.15 137.83 58.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.23999999999999999 109.662 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.97 133.81 55.21 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.62 0.724 . . . . 0.20999999999999999 109.833 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 96.99 -17.48 59.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.084 -1.607 . . . . 0.22 109.084 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -101.01 114.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -1.101 . . . . 0.25 108.212 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.411 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -94.62 178.56 36.68 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.725 -1.35 . . . . 0.28000000000000003 109.725 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.27 -40.09 73.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -1.115 . . . . 2.0 109.948 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.22 -44.34 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.02 -1.05 . . . . 0.38 109.566 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.411 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.8 mt -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.40000000000000002 109.657 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.53 -39.05 94.49 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.343 -1.503 . . . . 0.35999999999999999 109.343 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.99 -40.03 90.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 2.75 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.27 -45.41 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.664 -1.272 . . . . 1.5600000000000001 109.533 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.25 -40.03 96.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.092 -1.005 . . . . 0.33000000000000002 108.673 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.05 -40.87 90.91 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.859 -0.736 . . . . 1.6799999999999999 109.634 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.19 -19.49 65.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.353 -0.98 . . . . 1.99 108.353 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.514 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.6 OUTLIER -91.14 6.25 45.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.648 -0.657 . . . . 2.6800000000000002 110.029 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 9.34 52.97 Favored Glycine 0 N--CA 1.501 3.027 0 O-C-N 121.141 -0.975 . . . . 0.48999999999999999 111.834 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.547 ' CD2' HG12 ' B' ' 44' ' ' VAL . 78.8 m-85 -106.22 74.12 1.02 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.761 -1.434 . . . . 0.33000000000000002 109.323 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 -9.97 59.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.912 . . . . 0.40999999999999998 110.534 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.481 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.0 mmtm -132.57 154.94 49.51 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.206 -0.934 . . . . 1.5600000000000001 109.581 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.02 95.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.655 -0.653 . . . . 0.20999999999999999 111.112 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.481 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 20.2 p90 -57.27 -18.72 17.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.238 . . . . 0.32000000000000001 110.672 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.547 HG12 ' CD2' ' B' ' 39' ' ' PHE . 24.7 t -79.38 -34.24 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.58 -1.325 . . . . 0.23999999999999999 108.001 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 75.0 t -77.77 -39.95 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.477 -0.934 . . . . 0.22 108.477 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.07 -38.12 81.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 0.40000000000000002 107.628 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.88 97.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.759 -1.336 . . . . 0.17999999999999999 109.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -40.04 88.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -1.18 . . . . 1.0900000000000001 109.336 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.85 -40.05 87.28 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.107 -1.071 . . . . 0.31 108.107 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.74 -38.65 76.92 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.609 -0.836 . . . . 0.27000000000000002 108.836 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.76 -24.17 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.178 -0.951 . . . . 0.28000000000000003 110.086 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.38 14.87 15.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.058 -1.026 . . . . 0.29999999999999999 110.262 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 49.19 42.24 21.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.772 -1.205 . . . . 1.71 110.824 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 81.5 mttt 57.14 19.6 4.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 2.25 109.484 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.02 107.08 2.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.701 -1.249 . . . . 1.8 108.14 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -40.2 96.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.43 -0.794 . . . . 0.88 112.39 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.39 -40.04 77.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.252 -1.53 . . . . 0.73999999999999999 109.702 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.3 -40.07 74.47 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.924 -1.11 . . . . 0.55000000000000004 109.024 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.74 -49.99 70.86 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.38 109.662 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.36 -45.96 92.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.459 -0.776 . . . . 2.6400000000000001 110.466 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -64.52 -39.93 94.68 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 120.99 -1.068 . . . . 2.3799999999999999 108.788 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -63.16 -49.64 73.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.864 . . . . 0.40000000000000002 110.887 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.95 -49.45 65.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.084 -1.01 . . . . 0.34000000000000002 109.795 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -47.21 86.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 2.1000000000000001 109.96 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 36.5 t0 -68.61 -29.37 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 1.8999999999999999 109.797 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 64.3 m -80.64 -33.06 35.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.40000000000000002 111.451 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.2 p -131.54 -28.62 1.83 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.405 -1.435 . . . . 0.39000000000000001 112.137 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.42 14.03 21.11 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 109.096 -1.601 . . . . 0.35999999999999999 109.096 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.85 153.23 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.05 -1.265 . . . . 0.32000000000000001 109.306 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.46 170.16 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.101 -0.999 . . . . 1.9099999999999999 109.655 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.36 70.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.478 -0.764 . . . . 0.38 110.73 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.06 -40.07 68.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.784 -1.197 . . . . 2.5699999999999998 109.68 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.2 mm100 -67.81 -38.17 82.92 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.323 -0.861 . . . . 2.1200000000000001 110.301 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -68.53 -37.93 80.42 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.266 -0.896 . . . . 1.3600000000000001 110.005 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.41 -38.91 85.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.852 -1.155 . . . . 2.8100000000000001 109.399 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -68.22 -39.97 82.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.651 -1.28 . . . . 0.40000000000000002 110.354 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.1 m -68.45 -39.98 81.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.712 -1.242 . . . . 0.23000000000000001 109.209 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -60.18 4.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.739 -1.226 . . . . 0.42999999999999999 109.8 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -34.49 89.11 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.364 -1.094 . . . . 0.25 110.364 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.3 t -71.41 -46.33 60.46 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.809 -1.406 . . . . 0.23999999999999999 109.792 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.44 -40.59 73.67 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.812 -1.155 . . . . 0.28999999999999998 108.403 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.47 -40.11 95.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 2.7400000000000002 110.454 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -68.85 -37.4 79.1 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.94 -1.1 . . . . 1.9099999999999999 109.672 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.4 t90 -59.92 -45.77 91.52 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.433 -1.321 . . . . 0.35999999999999999 107.433 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' B' ' 89' ' ' LEU . 73.5 m -60.62 -39.95 90.09 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.813 -0.755 . . . . 0.35999999999999999 108.964 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.57 -37.79 82.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 109.721 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.51 -36.83 18.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -0.889 . . . . 0.46999999999999997 109.957 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.1 m-85 -103.62 -85.02 0.46 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.28 -0.887 . . . . 1.24 110.39 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 85' ' ' CYS . 24.6 tp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.051 -0.976 . . . . 1.6699999999999999 109.573 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.67 0.748 . . . . 1.51 109.81 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.45 -20.66 13.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 2.1800000000000002 110.076 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.02 -37.52 79.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.14 -0.975 . . . . 2.02 109.293 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 12.4 t60 -59.97 -50.01 75.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.021 -1.049 . . . . 0.48999999999999999 110.628 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 8' ' ' ARG . 17.9 mmm-85 -70.01 -35.11 74.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.859 -1.151 . . . . 3.21 109.735 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.74 -39.99 84.2 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.386 -0.822 . . . . 0.76000000000000001 109.336 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -63.54 -49.08 74.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.428 -0.795 . . . . 0.46000000000000002 110.085 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.53 9.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.971 -1.081 . . . . 0.44 110.747 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -102.9 -15.01 16.31 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.189 -0.944 . . . . 0.54000000000000004 110.267 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.4 pt-20 -152.71 155.03 32.22 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.169 -0.957 . . . . 1.26 108.938 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' GLU . 65.1 Cg_exo -36.84 152.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.101 1.867 . . . . 0.48999999999999999 111.441 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 11.6 ptm -89.75 -23.23 21.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.038 -1.039 . . . . 0.56999999999999995 109.673 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.0 -138.54 20.64 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.097 -1.201 . . . . 0.40000000000000002 110.097 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.54 43.23 1.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.577 -0.955 . . . . 0.84999999999999998 109.657 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -61.21 147.98 85.84 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.475 -0.935 . . . . 2.0099999999999998 108.475 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 155.09 39.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.275 1.983 . . . . 0.34000000000000002 112.826 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.68 -35.28 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.632 0.73 . . . . 0.32000000000000001 110.202 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.24 -0.48 57.31 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.546 -1.021 . . . . 0.23000000000000001 110.546 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 p -82.44 -25.8 33.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.783 -1.422 . . . . 1.24 109.706 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.559 HD22 HD21 ' A' ' 81' ' ' LEU . 96.2 mt -60.78 138.52 58.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.23999999999999999 109.953 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.84 134.5 55.32 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.8 -0.76 . . . . 0.20999999999999999 109.483 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.11 -21.72 44.58 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.511 -1.436 . . . . 0.22 109.511 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.76 114.73 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.143 -1.21 . . . . 0.25 108.195 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -95.68 -179.2 36.4 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.645 -1.382 . . . . 0.28000000000000003 109.645 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -58.21 -40.04 80.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -1.038 . . . . 2.0099999999999998 109.652 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.67 -47.65 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.06 -1.025 . . . . 0.38 109.285 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.4 HD12 ' H ' ' A' ' 27' ' ' GLY . 95.9 mt -64.89 -35.99 82.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.40000000000000002 109.348 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.78 -39.97 92.19 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.464 -1.454 . . . . 0.34999999999999998 109.464 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -66.79 -37.49 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.268 . . . . 2.7400000000000002 110.308 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.65 -51.74 46.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.709 -1.245 . . . . 1.54 109.303 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.49 -39.81 89.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.051 -1.031 . . . . 0.34000000000000002 108.471 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.06 -42.66 95.0 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.55 -0.86 . . . . 1.6699999999999999 109.409 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.0 -19.12 65.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.178 -0.951 . . . . 2.0 108.6 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -90.75 5.42 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.539 -0.725 . . . . 2.6899999999999999 109.831 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.89 8.96 53.53 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.007 -1.058 . . . . 0.47999999999999998 111.585 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' A' ' 44' ' ' VAL . 95.5 m-85 -107.25 75.09 1.01 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.418 . . . . 0.33000000000000002 109.071 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.54 -7.98 58.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.40999999999999998 110.562 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -138.04 158.62 43.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.071 -1.018 . . . . 1.5600000000000001 110.149 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.5 84.45 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.965 0.728 . . . . 0.20999999999999999 112.965 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -59.98 -17.84 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.38 -1.45 . . . . 0.32000000000000001 110.376 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 39' ' ' PHE . 30.5 t -79.48 -31.93 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.25 -1.389 . . . . 0.23999999999999999 107.25 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 79.4 t -77.17 -39.58 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.236 -1.024 . . . . 0.22 108.236 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.01 -35.93 76.13 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.466 -1.309 . . . . 0.40000000000000002 107.466 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.29 98.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.703 -1.359 . . . . 0.17999999999999999 109.703 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.94 -43.99 94.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 1.0900000000000001 108.908 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.97 -40.46 89.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.505 -0.747 . . . . 0.31 109.195 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -69.05 -38.44 79.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.813 -0.81 . . . . 0.28000000000000003 108.813 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.69 -19.89 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.137 -0.977 . . . . 0.28000000000000003 110.517 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.2 mt -88.26 14.27 9.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.123 -0.985 . . . . 0.31 110.786 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.12 31.86 7.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.778 -1.201 . . . . 1.7 109.868 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 57.98 19.95 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.704 -0.623 . . . . 2.2400000000000002 110.044 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -69.93 108.81 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.732 -1.23 . . . . 1.8 108.077 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.83 -40.01 96.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.084 0.772 . . . . 0.87 113.084 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.44 -39.94 85.41 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.405 -1.434 . . . . 0.72999999999999998 109.996 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.45 -39.51 74.29 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.104 -1.038 . . . . 0.55000000000000004 108.941 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.39 -41.65 93.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.38 109.095 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmm-85 -60.06 -51.18 70.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 2.6400000000000001 110.147 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.58 -37.3 84.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 2.3700000000000001 110.078 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.33 -47.99 79.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.40000000000000002 110.799 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.8 -47.6 71.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.036 -1.04 . . . . 0.34000000000000002 109.707 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.08 -48.55 78.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.293 -0.879 . . . . 2.1099999999999999 109.945 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -67.17 -32.17 73.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.475 -0.766 . . . . 1.8999999999999999 109.758 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -80.17 -34.68 37.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.40999999999999998 111.397 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.72 -26.69 2.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.59 -1.318 . . . . 0.40000000000000002 112.004 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.99 13.53 33.69 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.684 -1.766 . . . . 0.35999999999999999 108.684 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 152.99 2.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -1.095 . . . . 0.33000000000000002 109.421 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.76 174.9 7.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -0.912 . . . . 1.8999999999999999 109.724 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.27 74.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.39000000000000001 110.728 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.46 -39.66 64.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.604 -1.31 . . . . 2.5800000000000001 110.35 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.015 -1.053 . . . . 2.1200000000000001 110.732 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -69.05 -37.96 78.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.176 -0.952 . . . . 1.3600000000000001 110.52 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 75' ' ' ARG . 27.1 mtt-85 -60.03 -37.38 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 2.7999999999999998 109.489 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.52 -40.03 80.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.716 -1.24 . . . . 0.40000000000000002 110.478 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.8 m -69.48 -40.12 77.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.783 -1.198 . . . . 0.23999999999999999 109.8 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.33 -60.13 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.42999999999999999 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.07 86.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.828 -0.909 . . . . 0.26000000000000001 110.828 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.7 t -70.77 -48.66 53.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.946 -1.326 . . . . 0.25 110.223 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.559 HD21 HD22 ' A' ' 23' ' ' LEU . 88.2 mt -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.998 -1.081 . . . . 0.29999999999999999 108.176 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.52 -40.02 93.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 2.73 110.169 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 92.1 mt-10 -70.27 -38.23 75.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 1.9099999999999999 110.956 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 89.3 t90 -60.59 -42.32 96.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.308 -1.495 . . . . 0.37 108.456 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 92.7 m -61.57 -40.43 94.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.509 -0.744 . . . . 0.35999999999999999 110.273 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -29.44 68.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.121 -0.987 . . . . 0.55000000000000004 109.917 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.37 13.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.47999999999999998 110.81 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 88.7 m-85 . . . . . 0 N--CA 1.503 2.208 0 O-C-N 121.312 -0.867 . . . . 1.24 112.42 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.703 0.764 . . . . 1.5 109.809 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.51 -20.68 13.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 2.1800000000000002 110.057 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.03 -37.43 79.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.156 -0.965 . . . . 2.0099999999999998 109.324 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.519 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 12.3 t60 -59.97 -50.06 75.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.029 -1.044 . . . . 0.48999999999999999 110.564 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' B' ' 8' ' ' ARG . 18.1 mmm-85 -70.02 -35.18 74.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.881 -1.137 . . . . 3.23 109.67 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.71 -40.03 84.33 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.445 -0.785 . . . . 0.76000000000000001 109.26 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.65 -49.0 74.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.408 -0.808 . . . . 0.46000000000000002 110.069 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -83.48 9.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.975 -1.078 . . . . 0.44 110.755 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -102.71 -15.02 16.44 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.129 -0.982 . . . . 0.53000000000000003 110.363 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' B' ' 14' ' ' PRO . 4.4 pt-20 -152.72 154.93 32.09 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.047 -1.033 . . . . 1.27 109.019 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -36.8 152.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.124 1.883 . . . . 0.48999999999999999 111.522 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.463 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 11.5 ptm -89.52 -23.21 22.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.044 -1.035 . . . . 0.56000000000000005 109.718 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -138.48 21.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.188 -1.165 . . . . 0.39000000000000001 110.188 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.56 43.03 1.58 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.535 -0.979 . . . . 0.83999999999999997 109.662 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -60.92 147.91 84.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 2.02 108.512 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.84 155.12 39.73 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.304 2.003 . . . . 0.34000000000000002 112.774 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.73 -35.4 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.32000000000000001 110.232 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.09 -0.58 57.04 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.599 -1.0 . . . . 0.22 110.599 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 8.5 p -82.22 -25.93 33.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.727 -1.454 . . . . 1.24 109.731 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.567 HD22 HD21 ' B' ' 81' ' ' LEU . 96.2 mt -60.69 138.51 58.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.411 -0.806 . . . . 0.23999999999999999 109.953 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.78 134.51 55.41 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.86 -0.736 . . . . 0.20999999999999999 109.417 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.0 -21.6 45.22 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.519 -1.432 . . . . 0.22 109.519 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -98.95 114.74 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.273 -1.134 . . . . 0.25 108.203 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.79 -179.26 36.22 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.613 -1.395 . . . . 0.28000000000000003 109.613 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -58.08 -40.0 79.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -1.071 . . . . 2.0 109.783 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.76 -47.57 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.017 -1.052 . . . . 0.38 109.314 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -35.86 82.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.40000000000000002 109.43 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.8 -39.96 92.23 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.447 . . . . 0.35999999999999999 109.481 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.77 -37.35 84.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 2.75 110.39 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.85 -51.58 46.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.62 -1.3 . . . . 1.5600000000000001 109.363 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.63 -39.87 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.33000000000000002 108.306 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.0 -42.54 94.51 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.559 -0.856 . . . . 1.6799999999999999 109.419 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.12 -19.09 65.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 1.99 108.68 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -90.75 5.35 48.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.535 -0.728 . . . . 2.6800000000000002 109.813 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.02 8.92 53.35 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 120.225 -0.988 . . . . 0.48999999999999999 111.575 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' B' ' 44' ' ' VAL . 95.5 m-85 -107.09 75.04 1.01 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.805 -1.409 . . . . 0.33000000000000002 109.116 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.39 -8.14 58.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.40999999999999998 110.542 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -137.98 158.57 44.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.159 -0.963 . . . . 1.5600000000000001 110.179 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.43 84.47 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.925 0.713 . . . . 0.20999999999999999 112.925 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -60.06 -17.68 41.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.431 -1.418 . . . . 0.32000000000000001 110.489 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' B' ' 39' ' ' PHE . 30.6 t -79.56 -31.96 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.258 -1.386 . . . . 0.23999999999999999 107.258 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 79.6 t -77.18 -39.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.244 -1.021 . . . . 0.22 108.244 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 24.5 tp -59.97 -35.87 75.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.432 -1.322 . . . . 0.40000000000000002 107.432 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.34 98.22 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.791 -1.324 . . . . 0.17999999999999999 109.791 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.061 -1.258 . . . . 1.0900000000000001 108.838 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -59.97 -40.5 89.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.31 109.222 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.93 -38.34 79.44 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.828 -0.804 . . . . 0.27000000000000002 108.828 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.78 -19.97 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.187 -0.946 . . . . 0.28000000000000003 110.562 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 14.07 9.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.064 -1.022 . . . . 0.29999999999999999 110.808 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.14 32.1 7.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.693 -1.254 . . . . 1.71 109.848 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 57.91 20.02 6.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.637 -0.664 . . . . 2.25 110.023 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -70.05 108.7 4.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.632 -1.293 . . . . 1.8 108.126 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.74 -40.07 96.07 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.076 0.769 . . . . 0.88 113.076 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.53 -40.03 85.05 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.434 -1.416 . . . . 0.73999999999999999 109.932 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.31 -39.65 74.68 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.061 -1.056 . . . . 0.55000000000000004 109.0 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.16 -41.84 94.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.38 109.132 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -59.96 -51.04 71.4 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.771 . . . . 2.6400000000000001 110.187 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.73 -37.44 84.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.119 -0.988 . . . . 2.3799999999999999 110.025 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' TRP . . . . . 0.448 ' O ' ' OG1' ' B' ' 66' ' ' THR . 74.3 t90 -63.22 -48.0 80.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.40000000000000002 110.882 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -66.83 -47.36 72.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.038 -1.039 . . . . 0.34000000000000002 109.752 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.24 -48.6 77.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.299 -0.875 . . . . 2.1000000000000001 109.859 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -67.27 -32.06 72.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.574 -0.704 . . . . 1.8999999999999999 109.769 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.22 -34.67 37.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.40000000000000002 111.331 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.7 p -128.84 -26.47 2.67 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.615 -1.303 . . . . 0.39000000000000001 111.984 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.31 34.59 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.7 -1.76 . . . . 0.35999999999999999 108.7 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.6 152.92 2.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.32000000000000001 109.412 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.64 174.97 6.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.962 . . . . 1.9099999999999999 109.745 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -35.38 74.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.38 110.691 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.4 -39.59 64.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.673 -1.267 . . . . 2.5699999999999998 110.339 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -67.48 -40.12 85.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.047 . . . . 2.1200000000000001 110.7 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.9 m -69.06 -37.92 78.78 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.138 -0.976 . . . . 1.3600000000000001 110.522 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' B' ' 75' ' ' ARG . 27.1 mtt-85 -60.0 -37.47 79.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.751 -1.218 . . . . 2.8100000000000001 109.509 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.43 -39.99 81.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.645 -1.285 . . . . 0.40000000000000002 110.526 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.57 -40.08 76.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.787 -1.196 . . . . 0.23000000000000001 109.821 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.27 -60.24 4.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.647 -1.283 . . . . 0.42999999999999999 109.824 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.0 -33.08 86.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.83 -0.908 . . . . 0.25 110.83 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -70.8 -48.63 53.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.039 -1.271 . . . . 0.23999999999999999 110.188 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.567 HD21 HD22 ' B' ' 23' ' ' LEU . 88.3 mt -70.02 -39.89 75.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.998 -1.081 . . . . 0.28999999999999998 108.161 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.47 -40.02 93.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 2.7400000000000002 110.114 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 91.9 mt-10 -70.31 -38.24 74.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.965 -1.084 . . . . 1.9099999999999999 110.907 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.498 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 89.3 t90 -60.43 -42.49 96.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.314 -1.491 . . . . 0.35999999999999999 108.478 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.499 ' O ' ' N ' ' B' ' 89' ' ' LEU . 92.7 m -61.33 -40.49 94.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.513 -0.742 . . . . 0.35999999999999999 110.237 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -29.59 68.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.123 -0.986 . . . . 0.55000000000000004 109.896 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.26 -35.58 13.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.222 -0.924 . . . . 0.46999999999999997 110.863 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 90.1 m-85 -108.53 -3.81 17.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.285 -0.884 . . . . 1.24 112.552 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' B' ' 85' ' ' CYS . 9.2 tp . . . . . 0 N--CA 1.503 2.184 0 O-C-N 120.492 -1.38 . . . . 1.6699999999999999 109.384 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.569 0.7 . . . . 1.51 109.188 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -57.54 -20.1 29.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.589 -0.694 . . . . 2.1800000000000002 109.602 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -61.41 -37.65 84.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 2.02 109.129 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -59.94 -49.98 75.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.149 -0.97 . . . . 0.48999999999999999 110.317 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 98.1 mtt180 -70.23 -34.63 73.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.124 -0.985 . . . . 3.21 110.103 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.7 -40.07 80.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.76000000000000001 109.559 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.63 -46.8 81.01 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.557 -0.857 . . . . 0.46000000000000002 109.988 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.63 9.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.097 -1.002 . . . . 0.44 110.895 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -104.43 -15.06 15.5 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.994 -1.066 . . . . 0.54000000000000004 110.206 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 14' ' ' PRO . 8.2 pt-20 -151.97 152.52 30.01 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.066 -1.022 . . . . 1.26 108.941 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 13' ' ' GLU . 66.8 Cg_exo -36.99 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.222 1.948 . . . . 0.48999999999999999 111.636 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.459 ' H ' ' HG2' ' A' ' 15' ' ' MET . 13.2 ptm -95.68 -30.23 13.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 0.56999999999999995 109.958 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.34 -133.58 49.18 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.363 -1.095 . . . . 0.40000000000000002 110.363 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.77 35.51 3.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.767 -0.843 . . . . 0.84999999999999998 110.088 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -54.88 149.81 21.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.925 -1.139 . . . . 2.0099999999999998 107.925 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.23 157.49 34.95 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.076 1.851 . . . . 0.34000000000000002 112.244 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 21' ' ' GLY . 12.7 p -56.85 -45.37 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.742 0.782 . . . . 0.32000000000000001 110.231 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.565 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -61.94 -1.39 2.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.61 -0.996 . . . . 0.23000000000000001 110.61 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.2 p -82.95 -27.54 30.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.484 . . . . 1.24 109.582 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.92 138.24 57.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.23999999999999999 109.562 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . . . -65.59 134.86 54.22 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.733 0.778 . . . . 0.20999999999999999 109.979 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.76 -20.03 51.99 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.246 -1.542 . . . . 0.22 109.246 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.5 mm -99.44 115.58 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -1.133 . . . . 0.25 108.246 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.57 37.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 0.28000000000000003 109.463 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.84 -40.0 75.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -1.064 . . . . 2.0099999999999998 109.86 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.38 -45.3 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.929 -1.107 . . . . 0.38 109.719 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.59 -37.79 85.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.40000000000000002 109.53 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.115 -1.594 . . . . 0.34999999999999998 109.115 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -1.134 . . . . 2.7400000000000002 110.073 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -66.51 -48.44 69.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.851 -1.156 . . . . 1.54 109.609 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.6 -38.1 83.56 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.008 -1.108 . . . . 0.34000000000000002 108.008 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -42.49 94.25 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.245 -0.65 . . . . 1.6699999999999999 109.245 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.5 -19.34 65.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 2.0 108.718 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -90.48 1.64 56.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 2.6899999999999999 110.285 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.61 7.0 43.15 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.944 -1.098 . . . . 0.47999999999999998 111.583 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' HG12 ' A' ' 44' ' ' VAL . 95.7 m-85 -107.2 76.25 1.08 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.878 -1.366 . . . . 0.33000000000000002 109.131 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.72 -7.26 57.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.865 . . . . 0.40999999999999998 111.162 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.18 158.88 43.43 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.072 -1.017 . . . . 1.5600000000000001 110.54 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.9 86.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.762 -0.586 . . . . 0.20999999999999999 112.107 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 3.5 p90 -61.99 -18.82 61.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.433 -1.417 . . . . 0.32000000000000001 109.861 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' A' ' 39' ' ' PHE . 20.8 t -79.95 -31.87 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.773 -1.195 . . . . 0.23999999999999999 107.773 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 20' ' ' VAL . 70.2 t -77.94 -37.34 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.061 -1.089 . . . . 0.22 108.061 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.93 -35.21 74.43 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.993 -1.484 . . . . 0.40000000000000002 106.993 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -43.0 98.75 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 110.198 -1.161 . . . . 0.17999999999999999 110.198 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.078 -1.248 . . . . 1.0900000000000001 109.053 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.92 -41.5 91.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.31 108.66 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.94 -40.04 75.73 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.742 -0.836 . . . . 0.28000000000000003 108.742 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.18 -25.41 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.109 -0.994 . . . . 0.28000000000000003 110.684 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.67 16.29 8.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.15 -0.969 . . . . 0.31 109.785 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 55' ' ' ASP . 8.8 mtmp? 51.94 44.94 29.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 1.7 110.609 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 pttt 40.7 18.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.971 -1.081 . . . . 2.2400000000000002 111.528 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' LYS . 57.9 m-20 -66.59 115.56 6.58 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.847 -1.538 . . . . 1.8 106.847 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.59 -40.37 96.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.87 112.784 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.04 -39.94 75.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.378 -1.451 . . . . 0.72999999999999998 110.107 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.55 -40.0 73.63 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.121 -1.032 . . . . 0.55000000000000004 109.105 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.66 -49.74 73.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.38 109.491 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.54 HH12 ' NH2' ' A' ' 75' ' ' ARG . 64.9 mtp180 -60.01 -46.35 89.79 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.444 -0.785 . . . . 2.6400000000000001 111.249 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.21 -36.36 83.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.674 -1.266 . . . . 2.3700000000000001 108.905 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -63.62 -48.96 75.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.40000000000000002 111.067 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.9 tp -67.75 -46.98 70.52 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.054 -1.029 . . . . 0.34000000000000002 110.548 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -63.11 -46.48 87.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.983 . . . . 2.1099999999999999 109.424 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.4 t0 -67.55 -31.08 70.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.618 . . . . 1.8999999999999999 109.605 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.9 m -78.52 -36.61 44.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.40999999999999998 111.653 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.7 p -130.41 -27.45 2.19 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.474 -1.391 . . . . 0.40000000000000002 112.228 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.17 14.22 19.21 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.3 -1.52 . . . . 0.35999999999999999 109.3 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.14 153.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.913 -1.345 . . . . 0.33000000000000002 109.159 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.02 173.33 8.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.076 -1.015 . . . . 1.8999999999999999 110.133 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.98 74.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.558 -0.714 . . . . 0.39000000000000001 110.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.87 -40.43 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.856 -1.153 . . . . 2.5800000000000001 110.157 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.35 -40.02 81.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.139 -0.975 . . . . 2.1200000000000001 110.676 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 t -68.15 -38.37 82.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.128 -0.982 . . . . 1.3600000000000001 109.927 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.54 ' NH2' HH12 ' A' ' 60' ' ' ARG . 52.6 mtt-85 -60.02 -38.46 82.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.961 -1.087 . . . . 2.7999999999999998 108.973 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -67.94 -40.02 83.37 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.712 -1.242 . . . . 0.40000000000000002 110.392 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.22 -39.94 82.21 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.743 -1.223 . . . . 0.23999999999999999 109.493 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.1 -59.99 4.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.848 -1.157 . . . . 0.42999999999999999 109.899 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.79 -34.26 89.24 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.278 -0.963 . . . . 0.26000000000000001 110.736 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 24' ' ' ALA . 45.2 t -70.09 -47.61 61.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.3 . . . . 0.25 110.061 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.9 mt -70.0 -39.87 75.62 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.29999999999999999 108.234 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.23 -40.5 96.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 2.73 109.883 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -69.23 -39.96 78.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.999 . . . . 1.9099999999999999 110.754 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 84.5 t90 -59.98 -43.79 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.419 -1.426 . . . . 0.37 107.734 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.5 m -60.89 -40.07 91.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.63 0.729 . . . . 0.35999999999999999 109.694 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.01 -34.24 73.08 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.105 -0.997 . . . . 0.55000000000000004 110.148 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.78 -35.26 14.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.963 . . . . 0.47999999999999998 111.151 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 88.0 m-85 . . . . . 0 N--CA 1.505 2.316 0 O-C-N 121.116 -0.99 . . . . 1.24 111.265 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.115 -0.698 . . . . 1.5 109.115 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.64 -20.09 30.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.548 -0.72 . . . . 2.1800000000000002 109.609 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -61.32 -37.55 83.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 2.0099999999999998 109.201 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -60.06 -49.93 75.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.48999999999999999 110.35 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 98.1 mtt180 -70.25 -34.67 73.1 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.125 -0.984 . . . . 3.23 110.11 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.61 -40.05 80.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.76000000000000001 109.573 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.73 -46.71 81.1 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.46000000000000002 110.051 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 m -86.57 9.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.123 -0.986 . . . . 0.44 110.812 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -104.24 -15.01 15.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.992 -1.068 . . . . 0.53000000000000003 110.258 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' B' ' 14' ' ' PRO . 8.2 pt-20 -152.0 152.52 29.97 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.144 -0.973 . . . . 1.27 108.98 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' B' ' 13' ' ' GLU . 69.0 Cg_exo -37.11 155.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.204 1.936 . . . . 0.48999999999999999 111.65 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.419 ' HG2' ' H ' ' B' ' 15' ' ' MET . 13.2 ptm -95.49 -30.44 13.85 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -0.923 . . . . 0.56000000000000005 110.057 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.73 -133.43 50.07 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.343 -1.103 . . . . 0.39000000000000001 110.343 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -113.02 35.48 3.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.729 -0.865 . . . . 0.83999999999999997 110.089 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -54.9 149.63 22.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.98 -1.119 . . . . 2.02 107.98 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.01 157.57 33.53 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.071 1.848 . . . . 0.34000000000000002 112.274 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.576 HG13 ' N ' ' B' ' 21' ' ' GLY . 12.7 p -57.09 -45.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.666 0.746 . . . . 0.32000000000000001 110.215 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.576 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -61.97 -1.59 3.04 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.615 -0.994 . . . . 0.22 110.615 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -82.75 -27.4 31.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.706 -1.467 . . . . 1.24 109.644 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.07 138.17 57.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.23999999999999999 109.487 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' B' ' 80' ' ' CYS . . . -65.51 135.15 54.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.753 0.787 . . . . 0.20999999999999999 109.838 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.49 -20.07 51.88 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.238 -1.545 . . . . 0.22 109.238 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 33.4 mm -99.42 115.45 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.335 -1.097 . . . . 0.25 108.306 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.32 177.55 37.92 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.567 -1.413 . . . . 0.28000000000000003 109.567 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.76 -40.02 75.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.407 -1.055 . . . . 2.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.47 -45.3 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.088 . . . . 0.38 109.722 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.48 -37.94 86.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.40000000000000002 109.449 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.0 95.76 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.139 -1.585 . . . . 0.35999999999999999 109.139 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.808 ' CA ' ' N ' ' B' ' 33' ' ' LYS . 7.3 ttpm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.402 -1.058 . . . . 2.75 . 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.808 ' N ' ' CA ' ' B' ' 32' ' ' LYS . 62.5 mttm . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.628 -0.508 . . . . 1.5600000000000001 109.628 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.5 -38.18 83.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.979 -1.119 . . . . 0.33000000000000002 107.979 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.05 -42.28 94.11 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.204 -0.665 . . . . 1.6799999999999999 109.204 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.75 -19.24 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.691 -0.855 . . . . 1.99 108.691 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -90.25 1.29 56.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 2.6800000000000002 110.299 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.06 6.75 42.18 Favored Glycine 0 N--CA 1.503 3.117 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.558 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.52 ' CD2' HG12 ' B' ' 44' ' ' VAL . 95.7 m-85 -106.98 76.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.789 -1.418 . . . . 0.33000000000000002 109.246 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -78.3 -7.45 57.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.126 -0.984 . . . . 0.40999999999999998 111.112 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.12 158.78 43.63 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.97 -1.081 . . . . 1.5600000000000001 110.529 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.93 -40.38 87.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.20999999999999999 111.952 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 2.8 p90 -61.4 -18.64 59.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.506 -1.371 . . . . 0.32000000000000001 110.24 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' B' ' 39' ' ' PHE . 20.7 t -80.22 -31.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.788 -1.19 . . . . 0.23999999999999999 107.788 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.454 HG21 HG23 ' B' ' 20' ' ' VAL . 69.8 t -78.15 -37.25 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.029 -1.1 . . . . 0.22 108.029 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 tp -59.98 -35.06 74.19 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.017 -1.475 . . . . 0.40000000000000002 107.017 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -43.18 98.55 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 110.223 -1.151 . . . . 0.17999999999999999 110.223 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.136 -1.214 . . . . 1.0900000000000001 109.113 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.99 -41.42 91.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.31 108.669 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.01 -39.87 75.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.686 -0.857 . . . . 0.27000000000000002 108.686 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.48 -25.41 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.062 -1.024 . . . . 0.28000000000000003 110.6 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' B' ' 52' ' ' LEU . 84.3 mt -89.5 15.96 8.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.091 -1.005 . . . . 0.29999999999999999 109.762 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 55' ' ' ASP . 8.8 mtmp? 52.04 45.11 28.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 1.71 110.556 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 pttt 40.6 19.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.912 -1.117 . . . . 2.25 111.564 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 53' ' ' LYS . 61.6 m-20 -66.67 115.21 6.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.917 -1.512 . . . . 1.8 106.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.5 -40.27 96.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.262 -0.899 . . . . 0.88 112.746 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -69.86 -40.07 75.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.341 -1.475 . . . . 0.73999999999999999 110.257 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.67 -39.95 73.25 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.093 -1.043 . . . . 0.55000000000000004 109.008 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.5 -49.89 73.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.38 109.459 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.549 HH12 ' NH2' ' B' ' 75' ' ' ARG . 64.5 mtp180 -60.03 -45.92 91.23 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.528 -0.733 . . . . 2.6400000000000001 111.292 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.58 -36.54 84.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.678 -1.264 . . . . 2.3799999999999999 108.857 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -63.4 -49.07 75.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.40000000000000002 111.038 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.406 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 61.2 tp -67.81 -46.75 70.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.1 -1.0 . . . . 0.34000000000000002 110.564 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -63.3 -46.32 87.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 2.1000000000000001 109.393 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 34.8 t0 -67.64 -31.16 70.97 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.746 -0.596 . . . . 1.8999999999999999 109.652 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 97.2 m -78.49 -36.61 44.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.939 . . . . 0.40000000000000002 111.687 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 18.5 p -130.44 -27.2 2.21 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.49 -1.381 . . . . 0.39000000000000001 112.217 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.98 13.96 20.25 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.333 -1.507 . . . . 0.35999999999999999 109.333 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.98 153.36 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.922 -1.34 . . . . 0.32000000000000001 109.183 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -91.04 173.39 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 1.9099999999999999 110.094 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.38 110.154 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.79 -40.44 69.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 2.5699999999999998 110.097 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 2.1200000000000001 110.656 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 5.7 t -68.14 -38.45 82.17 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -0.983 . . . . 1.3600000000000001 109.916 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.549 ' NH2' HH12 ' B' ' 60' ' ' ARG . 52.6 mtt-85 -59.95 -38.64 83.05 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.907 -1.121 . . . . 2.8100000000000001 109.013 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.81 -39.94 83.92 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.871 -1.143 . . . . 0.40000000000000002 110.304 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.21 -40.06 82.21 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.789 -1.195 . . . . 0.23000000000000001 109.508 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.95 -60.15 4.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.894 -1.129 . . . . 0.42999999999999999 109.888 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.73 -34.35 89.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.653 -0.979 . . . . 0.25 110.653 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' B' ' 24' ' ' ALA . 45.8 t -70.1 -47.56 61.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.322 . . . . 0.23999999999999999 110.024 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.91 -40.0 75.85 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.1 -1.04 . . . . 0.28999999999999998 108.314 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -62.08 -40.75 96.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.312 -0.868 . . . . 2.7400000000000002 109.819 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -69.0 -39.92 79.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 1.9099999999999999 110.754 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 84.8 t90 -59.96 -44.03 94.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.451 -1.406 . . . . 0.35999999999999999 107.622 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' B' ' 89' ' ' LEU . 41.2 m -60.81 -40.01 91.13 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 0.35999999999999999 109.737 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -59.97 -34.46 73.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.988 -1.07 . . . . 0.55000000000000004 110.2 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.6 -35.14 14.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.068 -1.02 . . . . 0.46999999999999997 111.162 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 89.7 m-85 -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.115 -0.991 . . . . 1.24 111.407 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.1 tp . . . . . 0 N--CA 1.496 1.861 0 O-C-N 120.809 -1.182 . . . . 1.6699999999999999 109.535 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.1 -0.704 . . . . 1.51 109.1 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -55.23 -20.65 11.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 2.1800000000000002 110.234 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.25 -36.96 81.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 2.02 109.218 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.427 ' NE2' ' OE2' ' A' ' 83' ' ' GLU . 16.1 t60 -60.06 -50.15 74.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.067 . . . . 0.48999999999999999 110.731 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HG2' HH11 ' A' ' 8' ' ' ARG . 4.1 mmt-85 -70.05 -34.3 73.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.045 -1.034 . . . . 3.21 109.743 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -72.08 -37.55 69.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.76000000000000001 109.987 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.49 84.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.46000000000000002 109.913 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -82.99 15.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.44 109.401 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.39 -8.49 10.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.557 -0.714 . . . . 0.54000000000000004 110.362 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.29 151.0 23.25 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.887 -1.133 . . . . 1.26 109.554 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.5 161.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.916 1.744 . . . . 0.48999999999999999 111.831 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.438 ' CE ' HD22 ' A' ' 46' ' ' LEU . 4.8 ptp -96.13 -24.71 16.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.218 -0.926 . . . . 0.56999999999999995 109.788 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.84 -136.85 44.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.346 -1.501 . . . . 0.40000000000000002 109.346 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -110.83 34.77 3.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.41 -1.053 . . . . 0.84999999999999998 109.965 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -60.0 149.6 73.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.943 -1.098 . . . . 2.0099999999999998 108.974 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.79 156.52 37.58 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.334 2.022 . . . . 0.34000000000000002 112.301 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.4 p -57.95 -48.12 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.819 . . . . 0.32000000000000001 110.267 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.574 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.35 -1.44 0.18 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.494 -1.042 . . . . 0.23000000000000001 110.494 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 80.3 p -81.32 -24.82 36.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.714 -1.462 . . . . 1.24 109.179 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.402 HD22 HD21 ' A' ' 81' ' ' LEU . 92.4 mt -63.6 138.88 58.68 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.65 0.738 . . . . 0.23999999999999999 109.893 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 134.63 54.32 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.815 -0.754 . . . . 0.20999999999999999 109.426 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.2 -20.62 46.52 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.746 -1.342 . . . . 0.22 109.746 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.32 118.57 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.123 -1.222 . . . . 0.25 108.396 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.03 179.95 34.09 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.618 -1.393 . . . . 0.28000000000000003 109.618 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -58.16 -40.09 80.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -1.139 . . . . 2.0099999999999998 110.428 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.89 -47.19 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.793 -1.192 . . . . 0.38 109.326 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.68 -38.56 87.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.827 . . . . 0.40000000000000002 109.412 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.97 96.19 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.439 -1.464 . . . . 0.34999999999999998 109.439 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.32 -39.94 94.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -1.12 . . . . 2.7400000000000002 110.018 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.32 -47.39 73.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 1.54 109.369 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.14 -39.66 93.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.34000000000000002 108.964 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -43.16 95.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.437 -0.905 . . . . 1.6699999999999999 108.867 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -64.72 -19.87 66.02 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 2.0 108.443 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.519 ' HG2' HH11 ' A' ' 37' ' ' ARG . 1.1 mmt-85 -90.06 2.42 55.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.438 -0.789 . . . . 2.6899999999999999 110.271 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.76 6.29 46.69 Favored Glycine 0 N--CA 1.505 3.286 0 O-C-N 121.083 -1.011 . . . . 0.47999999999999998 111.948 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.496 ' CD2' HG12 ' A' ' 44' ' ' VAL . 96.5 m-85 -105.3 75.14 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.726 -1.455 . . . . 0.33000000000000002 109.236 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' B' ' 53' ' ' LYS . 37.2 p-10 -80.02 -10.52 59.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.40999999999999998 110.389 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.75 153.28 51.35 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.182 -0.948 . . . . 1.5600000000000001 110.001 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.93 92.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.731 -0.606 . . . . 0.20999999999999999 111.969 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 27.0 p90 -56.85 -17.95 11.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.834 -1.166 . . . . 0.32000000000000001 110.665 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 39' ' ' PHE . 25.9 t -79.63 -33.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.87 -1.144 . . . . 0.23999999999999999 108.204 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 20' ' ' VAL . 54.7 t -74.09 -38.83 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.562 -1.273 . . . . 0.22 107.562 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD22 ' CE ' ' A' ' 15' ' ' MET . 24.9 tp -58.26 -38.81 77.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.808 -1.182 . . . . 0.40000000000000002 107.808 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.34 -43.22 93.84 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.932 -1.267 . . . . 0.17999999999999999 109.932 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -60.16 -42.75 95.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.268 . . . . 1.0900000000000001 108.559 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.04 -40.05 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.539 -0.911 . . . . 0.31 108.539 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' B' ' 50' ' ' LEU . 98.9 mt -69.92 -39.96 75.83 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.594 -0.891 . . . . 0.28000000000000003 108.594 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.22 -25.65 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.28000000000000003 110.678 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.7 15.23 9.96 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.921 -1.112 . . . . 0.31 109.886 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' B' ' 40' ' ' ASP . 67.9 mttm 52.15 29.47 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.063 -1.023 . . . . 1.7 110.607 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' NZ ' ' NH1' ' A' ' 82' ' ' ARG . 83.4 mttt 60.06 19.83 9.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 2.2400000000000002 110.685 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.19 115.73 7.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.406 -1.434 . . . . 1.8 107.957 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.72 -40.14 96.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.87 112.281 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 90.2 m-20 -68.3 -39.94 81.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.554 -1.341 . . . . 0.72999999999999998 109.961 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.5 -39.69 67.43 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.166 -1.013 . . . . 0.55000000000000004 109.101 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.35 -49.43 73.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.38 110.401 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.534 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 81.3 mtm180 -60.04 -44.8 94.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 2.6400000000000001 110.693 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.71 -37.8 87.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 2.3700000000000001 108.902 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -64.83 -48.73 73.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -0.983 . . . . 0.40000000000000002 110.8 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 54.8 tp -66.97 -46.57 74.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.997 . . . . 0.34000000000000002 109.391 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.88 -46.52 87.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 2.1099999999999999 109.412 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -31.0 69.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.688 -0.633 . . . . 1.8999999999999999 109.91 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.405 ' O ' ' NH2' ' A' ' 37' ' ' ARG . 91.4 m -77.95 -37.51 47.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.40999999999999998 111.809 -177.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 6.2 p -130.13 -25.73 2.45 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.503 -1.373 . . . . 0.40000000000000002 111.933 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 13.43 26.51 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.063 -1.615 . . . . 0.35999999999999999 109.063 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.93 153.94 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.238 . . . . 0.33000000000000002 109.031 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -91.15 -180.0 5.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.989 -1.069 . . . . 1.8999999999999999 109.779 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -33.19 75.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.772 . . . . 0.39000000000000001 110.823 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -71.49 -40.07 70.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.862 -1.149 . . . . 2.5800000000000001 109.789 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.92 -37.7 84.83 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.426 -0.796 . . . . 2.1200000000000001 110.438 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.5 p -67.03 -37.82 84.81 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.135 -0.978 . . . . 1.3600000000000001 110.004 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 75' ' ' ARG . 47.3 mtt-85 -59.97 -37.85 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.762 -1.211 . . . . 2.7999999999999998 108.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.88 -40.01 83.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.837 -1.164 . . . . 0.40000000000000002 110.718 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.25 -40.05 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.605 -1.309 . . . . 0.23999999999999999 109.948 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.27 -60.2 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.741 -1.225 . . . . 0.42999999999999999 109.451 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.01 -33.58 79.73 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.339 -1.105 . . . . 0.26000000000000001 110.339 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.16 -51.06 50.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.105 -1.232 . . . . 0.25 109.91 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.402 HD21 HD22 ' A' ' 23' ' ' LEU . 81.8 mt -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.913 -1.115 . . . . 0.29999999999999999 109.619 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' NH1' ' NZ ' ' A' ' 54' ' ' LYS . 23.8 tpt180 -60.12 -44.48 94.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 2.73 110.117 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' OE2' ' NE2' ' A' ' 7' ' ' HIS . 44.7 mt-10 -70.39 -38.1 74.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.86 . . . . 1.9099999999999999 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 89.3 t90 -61.88 -43.0 99.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.442 -1.411 . . . . 0.37 108.397 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.8 m -61.29 -40.48 94.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.441 -0.787 . . . . 0.35999999999999999 110.379 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.83 -27.88 67.0 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.198 -0.939 . . . . 0.55000000000000004 109.338 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.82 -34.45 12.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 0.47999999999999998 110.801 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.9 m-85 . . . . . 0 N--CA 1.505 2.29 0 O-C-N 121.259 -0.9 . . . . 1.24 112.812 -177.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.009 -0.737 . . . . 1.5 109.009 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -55.2 -20.77 11.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 2.1800000000000002 110.265 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.23 -36.99 81.47 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.891 -1.131 . . . . 2.0099999999999998 109.206 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.421 ' CE1' ' OE2' ' B' ' 83' ' ' GLU . 16.1 t60 -59.99 -50.18 74.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.48999999999999999 110.76 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' B' ' 8' ' ' ARG . 4.0 mmt-85 -69.91 -34.45 73.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 3.23 109.785 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -72.06 -37.53 69.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.76000000000000001 109.959 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.407 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.48 84.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.46000000000000002 109.88 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -83.1 15.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.44 109.374 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.62 -8.41 9.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.597 -0.689 . . . . 0.53000000000000003 110.358 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.33 151.07 23.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.872 -1.142 . . . . 1.27 109.53 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -42.6 161.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.824 1.683 . . . . 0.48999999999999999 111.971 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.436 ' CE ' HD22 ' B' ' 46' ' ' LEU . 4.6 ptp -96.25 -24.4 16.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.56000000000000005 109.769 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.91 43.11 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.364 -1.494 . . . . 0.39000000000000001 109.364 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -110.71 34.78 3.78 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.429 -1.042 . . . . 0.83999999999999997 110.025 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -59.98 149.71 72.69 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.966 -1.084 . . . . 2.02 108.967 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.87 156.42 38.46 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.304 2.003 . . . . 0.34000000000000002 112.352 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.582 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.7 p -57.87 -48.15 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.32000000000000001 110.271 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.582 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -55.43 -1.19 0.16 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.506 -1.038 . . . . 0.22 110.506 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.5 ' H ' ' C ' ' B' ' 20' ' ' VAL . 81.0 p -81.5 -24.72 36.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.699 -1.471 . . . . 1.24 109.148 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.69 138.8 58.64 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.649 0.738 . . . . 0.23999999999999999 109.952 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.94 134.49 54.06 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.765 -0.774 . . . . 0.20999999999999999 109.582 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.38 -20.73 45.73 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.749 -1.34 . . . . 0.22 109.749 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.18 118.62 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.213 -1.169 . . . . 0.25 108.398 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.99 179.96 34.16 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.59 -1.404 . . . . 0.28000000000000003 109.59 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.28 -39.98 80.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.261 -1.14 . . . . 2.0 110.425 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 66.1 t -66.88 -47.25 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.38 109.402 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.46 -38.65 87.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.336 -0.852 . . . . 0.40000000000000002 109.531 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.91 -40.01 96.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.353 -1.499 . . . . 0.35999999999999999 109.353 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.31 -39.88 94.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 2.75 110.107 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.4 -47.21 74.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.86 -1.15 . . . . 1.5600000000000001 109.33 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.28 -39.58 93.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.33000000000000002 109.039 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.464 -0.894 . . . . 1.6799999999999999 108.86 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.68 -19.88 65.99 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.439 -0.949 . . . . 1.99 108.439 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' B' ' 37' ' ' ARG . 1.1 mmt-85 -90.1 2.68 54.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 2.6800000000000002 110.376 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 6.37 47.43 Favored Glycine 0 N--CA 1.504 3.223 0 O-C-N 120.988 -1.07 . . . . 0.48999999999999999 112.057 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' B' ' 44' ' ' VAL . 96.5 m-85 -105.4 75.25 1.14 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.808 -1.407 . . . . 0.33000000000000002 109.143 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 37.3 p-10 -80.21 -10.23 59.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.40999999999999998 110.432 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -133.0 153.37 51.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.246 -0.909 . . . . 1.5600000000000001 109.916 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.77 93.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.838 -0.539 . . . . 0.20999999999999999 112.068 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 27.3 p90 -57.08 -18.01 12.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.32000000000000001 110.524 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.2 t -79.51 -33.56 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.901 -1.124 . . . . 0.23999999999999999 108.248 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.407 HG21 HG23 ' B' ' 20' ' ' VAL . 55.1 t -74.19 -38.79 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.472 -1.307 . . . . 0.22 107.472 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.436 HD22 ' CE ' ' B' ' 15' ' ' MET . 24.8 tp -58.38 -38.98 78.41 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.769 -1.197 . . . . 0.40000000000000002 107.769 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.31 -43.13 93.81 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.856 -1.297 . . . . 0.17999999999999999 109.856 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -60.03 -42.83 95.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.93 -1.335 . . . . 1.0900000000000001 108.548 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.09 -39.95 87.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.559 -0.904 . . . . 0.31 108.559 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' A' ' 50' ' ' LEU . 98.7 mt -69.97 -40.04 75.62 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.27000000000000002 108.538 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.05 -25.56 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 110.694 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.84 15.34 9.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.921 -1.112 . . . . 0.29999999999999999 109.838 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 67.9 mttm 51.98 29.46 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 1.71 110.661 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' LYS . . . . . 0.445 ' NZ ' ' NH1' ' B' ' 82' ' ' ARG . 83.5 mttt 60.01 19.74 8.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.782 -0.573 . . . . 2.25 110.718 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -68.02 115.7 7.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.445 -1.41 . . . . 1.8 107.947 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.65 -40.32 96.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.88 112.205 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 90.4 m-20 -68.28 -39.97 81.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.512 -1.368 . . . . 0.73999999999999999 109.921 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.39 -39.67 67.79 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.141 -1.023 . . . . 0.55000000000000004 109.215 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.45 -49.43 73.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.38 110.43 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 81.5 mtm180 -59.97 -45.03 94.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 2.6400000000000001 110.658 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.53 -37.61 87.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.855 -1.153 . . . . 2.3799999999999999 108.931 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -65.03 -48.55 73.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.004 . . . . 0.40000000000000002 110.876 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.406 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 54.6 tp -67.04 -46.67 73.7 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.135 -0.978 . . . . 0.34000000000000002 109.392 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.84 -46.4 88.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 2.1000000000000001 109.481 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.25 -30.94 69.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 1.8999999999999999 109.835 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.405 ' O ' ' NH2' ' B' ' 37' ' ' ARG . 91.8 m -77.97 -37.52 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.40000000000000002 111.741 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 6.1 p -130.03 -25.94 2.45 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.398 -1.439 . . . . 0.39000000000000001 111.945 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.49 13.65 25.74 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 108.997 -1.641 . . . . 0.35999999999999999 108.997 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.02 154.0 2.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.279 . . . . 0.32000000000000001 108.983 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -91.31 -179.98 5.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.035 -1.04 . . . . 1.9099999999999999 109.829 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.06 74.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.38 110.832 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -71.61 -40.07 70.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 2.5699999999999998 109.823 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.9 -37.64 84.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.503 -0.748 . . . . 2.1200000000000001 110.542 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.4 p -67.14 -37.73 84.31 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.122 -0.987 . . . . 1.3600000000000001 110.004 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' B' ' 75' ' ' ARG . 46.9 mtt-85 -60.01 -37.77 80.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.77 -1.206 . . . . 2.8100000000000001 108.778 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.0 -39.96 83.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.871 -1.143 . . . . 0.40000000000000002 110.728 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.1 m -68.27 -40.05 82.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.641 -1.287 . . . . 0.23000000000000001 109.884 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.35 -60.04 4.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.784 -1.197 . . . . 0.42999999999999999 109.499 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -33.57 79.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.359 -1.096 . . . . 0.25 110.359 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -68.25 -51.01 49.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.046 -1.267 . . . . 0.23999999999999999 109.903 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 82.0 mt -73.18 -41.16 64.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.953 -1.099 . . . . 0.28999999999999998 109.591 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.445 ' NH1' ' NZ ' ' B' ' 54' ' ' LYS . 23.8 tpt180 -60.16 -44.33 95.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.959 . . . . 2.7400000000000002 110.192 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.421 ' OE2' ' CE1' ' B' ' 7' ' ' HIS . 44.7 mt-10 -70.38 -38.21 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 1.9099999999999999 110.585 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.422 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 89.1 t90 -61.79 -43.04 99.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.486 -1.384 . . . . 0.35999999999999999 108.409 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.2 m -61.34 -40.41 94.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.35999999999999999 110.391 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.88 -27.76 66.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.3 -0.875 . . . . 0.55000000000000004 109.368 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.91 -35.01 12.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.46999999999999997 110.724 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.422 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 88.7 m-85 -109.97 -8.08 14.89 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.235 -0.915 . . . . 1.24 112.996 -177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 85' ' ' CYS . 13.2 tp . . . . . 0 N--CA 1.502 2.141 0 O-C-N 120.224 -1.547 . . . . 1.6699999999999999 109.414 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.694 -0.854 . . . . 1.51 108.694 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -59.92 -24.9 64.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.542 -0.724 . . . . 2.1800000000000002 109.304 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.28 -36.93 81.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.909 . . . . 2.02 109.256 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.563 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 60.0 t60 -59.9 -54.37 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.48999999999999999 110.839 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.9 -33.64 72.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.993 -1.067 . . . . 3.21 110.154 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.97 -39.6 75.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.313 -0.867 . . . . 0.76000000000000001 109.342 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.54 -47.62 80.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.46000000000000002 110.384 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.5 m -80.89 14.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.01 -1.056 . . . . 0.44 109.685 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.4 -11.08 13.71 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.508 -0.745 . . . . 0.54000000000000004 110.081 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 14' ' ' PRO . 12.6 pt-20 -153.97 150.99 23.76 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.093 -1.004 . . . . 1.26 109.105 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLU . 93.5 Cg_exo -40.48 166.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.883 1.722 . . . . 0.48999999999999999 112.123 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.0 ptp -92.24 -20.22 21.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.213 -0.93 . . . . 0.56999999999999995 109.171 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.6 -141.52 5.97 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.339 -1.504 . . . . 0.40000000000000002 109.339 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.26 30.05 6.57 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.439 -1.036 . . . . 0.84999999999999998 109.812 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -60.4 148.84 79.1 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 2.0099999999999998 108.908 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.46 155.36 53.12 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.265 1.977 . . . . 0.34000000000000002 112.79 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.581 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.2 p -57.23 -47.18 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.626 0.727 . . . . 0.32000000000000001 110.184 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -51.97 -3.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.514 -1.034 . . . . 0.23000000000000001 110.514 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 20' ' ' VAL . 23.0 t -83.08 -22.3 33.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.758 -1.436 . . . . 1.24 109.47 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.11 58.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.146 -0.971 . . . . 0.23999999999999999 109.766 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.34 133.83 51.32 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.857 -0.737 . . . . 0.20999999999999999 109.83 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.79 -20.01 51.04 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.315 -1.514 . . . . 0.22 109.315 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -99.89 113.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.736 -1.209 . . . . 0.25 107.736 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.47 176.29 43.11 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.828 -1.309 . . . . 0.28000000000000003 109.828 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -58.31 -39.96 80.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.502 -0.999 . . . . 2.0099999999999998 109.702 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.03 -47.88 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.38 109.548 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.84 -39.83 83.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.40000000000000002 109.307 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.97 96.43 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.32 -1.512 . . . . 0.34999999999999998 109.32 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -61.13 -39.98 92.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -1.094 . . . . 2.7400000000000002 110.664 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.19 -41.84 89.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.731 -1.231 . . . . 1.54 110.133 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.9 mt -60.03 -39.61 86.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.34000000000000002 109.089 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -59.96 -40.04 87.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.375 -0.93 . . . . 1.6699999999999999 109.639 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.05 -19.42 64.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.908 . . . . 2.0 108.804 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -90.1 1.35 56.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.587 -0.695 . . . . 2.6899999999999999 109.515 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.11 38.78 3.47 Favored Glycine 0 N--CA 1.497 2.754 0 O-C-N 121.232 -0.918 . . . . 0.47999999999999998 110.985 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 44' ' ' VAL . 84.5 m-85 -132.37 71.9 1.48 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.212 -1.17 . . . . 0.33000000000000002 108.321 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -75.48 -12.38 60.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.053 -1.029 . . . . 0.40999999999999998 110.495 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -134.34 156.86 47.73 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.165 -0.96 . . . . 1.5600000000000001 109.434 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -40.22 93.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.20999999999999999 111.678 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -58.44 -17.34 19.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.837 -1.164 . . . . 0.32000000000000001 110.717 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 39' ' ' PHE . 43.7 t -79.77 -31.62 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.87 -1.159 . . . . 0.23999999999999999 107.87 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.81 -38.69 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.739 -1.208 . . . . 0.22 107.739 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.66 -38.75 82.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.286 -1.375 . . . . 0.40000000000000002 107.286 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.08 71.59 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.965 -1.254 . . . . 0.17999999999999999 109.965 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -60.05 -42.56 94.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -1.213 . . . . 1.0900000000000001 109.885 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.07 -39.96 87.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.096 -1.003 . . . . 0.31 108.68 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.1 -38.34 75.63 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.616 -0.883 . . . . 0.28000000000000003 108.616 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.53 -22.51 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.153 -0.967 . . . . 0.28000000000000003 110.733 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.86 17.85 7.29 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.053 -1.03 . . . . 0.31 109.735 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 52.06 29.43 6.33 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.073 -1.017 . . . . 1.7 109.611 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.4 mttt 60.08 19.88 9.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.855 -0.528 . . . . 2.2400000000000002 109.944 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.99 114.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.821 -1.178 . . . . 1.8 107.821 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.72 -39.99 90.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.87 112.856 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.56 -39.57 84.93 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.462 -1.399 . . . . 0.72999999999999998 110.687 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.98 -38.97 76.21 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.018 -1.073 . . . . 0.55000000000000004 109.566 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.63 -43.69 92.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.38 109.884 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -60.04 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 2.6400000000000001 110.941 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.77 -38.83 90.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.896 -1.127 . . . . 2.3700000000000001 109.25 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -64.34 -49.48 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.019 -1.051 . . . . 0.40000000000000002 110.993 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.3 tp -66.9 -47.25 72.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.04 -1.037 . . . . 0.34000000000000002 109.998 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.83 -44.47 89.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 2.1099999999999999 109.8 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.3 t0 -69.63 -30.95 68.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.557 -0.715 . . . . 1.8999999999999999 109.664 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -79.31 -34.73 42.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.40999999999999998 111.332 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.7 p -130.39 -29.68 1.98 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.598 -1.314 . . . . 0.40000000000000002 112.078 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.98 14.48 20.8 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.401 -1.48 . . . . 0.35999999999999999 109.401 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.73 154.79 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.034 -1.274 . . . . 0.33000000000000002 109.296 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -89.22 169.91 11.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.984 -1.073 . . . . 1.8999999999999999 110.266 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.36 73.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.687 . . . . 0.39000000000000001 111.02 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.01 -40.05 75.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.629 -1.295 . . . . 2.5800000000000001 109.654 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -64.88 -30.1 71.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.537 -0.727 . . . . 2.1200000000000001 110.572 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.7 p -68.79 -39.6 80.07 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.987 -1.07 . . . . 1.3600000000000001 110.611 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -60.01 -37.85 80.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.547 -1.346 . . . . 2.7999999999999998 109.092 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.58 -1.325 . . . . 0.40000000000000002 110.412 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 86.2 m -70.01 -40.27 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.791 -1.193 . . . . 0.23999999999999999 109.502 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.17 -61.03 2.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 0.42999999999999999 109.789 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.53 -33.08 83.55 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.196 -1.161 . . . . 0.26000000000000001 110.196 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 46.7 t -71.0 -46.88 61.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.922 -1.34 . . . . 0.25 109.797 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.89 -40.98 68.52 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.01 -1.076 . . . . 0.29999999999999999 109.068 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.75 -40.44 97.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.121 -0.987 . . . . 2.73 110.147 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.563 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 96.0 mt-10 -70.14 -38.38 75.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 1.9099999999999999 110.459 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.7 t90 -61.49 -47.81 83.93 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.527 -1.358 . . . . 0.37 108.087 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.4 m -59.99 -40.14 88.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.498 -0.751 . . . . 0.35999999999999999 109.841 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.47 -29.82 68.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.005 . . . . 0.55000000000000004 109.364 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.52 -33.67 12.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.302 -0.874 . . . . 0.47999999999999998 110.705 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 86.3 m-85 . . . . . 0 N--CA 1.504 2.273 0 O-C-N 121.277 -0.889 . . . . 1.24 112.45 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 108.653 -0.869 . . . . 1.5 108.653 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -59.93 -25.0 64.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 2.1800000000000002 109.352 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.19 -36.97 81.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 2.0099999999999998 109.322 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.56 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 60.3 t60 -59.93 -54.17 49.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.48999999999999999 110.793 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.95 -33.65 72.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 3.23 110.127 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.01 -39.41 75.84 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.348 -0.845 . . . . 0.76000000000000001 109.367 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.8 -47.59 80.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.46000000000000002 110.316 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.93 14.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.042 -1.036 . . . . 0.44 109.68 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.34 -11.01 13.75 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.552 -0.717 . . . . 0.53000000000000003 110.121 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 14' ' ' PRO . 12.6 pt-20 -154.0 151.17 24.09 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 1.27 109.02 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.5 Cg_exo -40.44 166.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.958 1.772 . . . . 0.48999999999999999 112.074 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 1.9 ptp -92.57 -20.11 21.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.15 -0.968 . . . . 0.56000000000000005 109.081 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.71 -141.43 6.17 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.427 -1.469 . . . . 0.39000000000000001 109.427 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.27 29.95 6.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.527 -0.984 . . . . 0.83999999999999997 109.787 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.47 148.82 79.65 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.89 -1.131 . . . . 2.02 108.812 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.43 155.49 52.12 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.218 1.945 . . . . 0.34000000000000002 112.774 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.577 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.3 p -57.21 -47.15 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.674 0.75 . . . . 0.32000000000000001 110.222 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -52.01 -3.42 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.572 -1.011 . . . . 0.22 110.572 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.523 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.8 t -82.92 -22.21 33.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.413 . . . . 1.24 109.485 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.07 58.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.23999999999999999 109.807 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.9 51.42 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.591 0.71 . . . . 0.20999999999999999 109.792 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.518 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.76 -20.06 50.88 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.399 -1.48 . . . . 0.22 109.399 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.9 113.53 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 107.622 -1.251 . . . . 0.25 107.622 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.51 176.26 43.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.829 -1.308 . . . . 0.28000000000000003 109.829 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -58.26 -39.97 80.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.445 -1.032 . . . . 2.0 109.678 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.21 -47.67 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.049 -1.032 . . . . 0.38 109.559 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.91 -39.86 83.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.40000000000000002 109.301 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.97 96.27 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.343 -1.503 . . . . 0.35999999999999999 109.343 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -61.21 -39.9 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -1.073 . . . . 2.75 110.66 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -66.24 -41.82 89.49 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.705 -1.247 . . . . 1.5600000000000001 110.154 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 63.7 mt -60.03 -39.56 86.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.087 -1.008 . . . . 0.33000000000000002 109.084 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -60.12 -39.93 87.99 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.207 -0.997 . . . . 1.6799999999999999 109.607 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -19.52 64.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 1.99 108.844 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -90.1 1.47 56.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.667 -0.646 . . . . 2.6800000000000002 109.522 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.94 38.88 3.48 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.236 -0.915 . . . . 0.48999999999999999 111.032 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.431 ' CD2' HG12 ' B' ' 44' ' ' VAL . 84.5 m-85 -132.5 71.9 1.48 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -1.213 . . . . 0.33000000000000002 108.323 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -75.46 -12.3 60.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.963 -1.086 . . . . 0.40999999999999998 110.406 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -134.43 156.8 47.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.165 -0.959 . . . . 1.5600000000000001 109.392 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.21 92.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.426 -0.796 . . . . 0.20999999999999999 111.608 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -58.41 -17.32 19.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.805 -1.185 . . . . 0.32000000000000001 110.671 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' B' ' 39' ' ' PHE . 42.9 t -79.71 -31.78 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 0.23999999999999999 107.943 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.76 -38.56 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.837 -1.171 . . . . 0.22 107.837 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -59.76 -38.78 82.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.28 -1.378 . . . . 0.40000000000000002 107.28 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.41 -45.81 74.58 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.955 -1.258 . . . . 0.17999999999999999 109.955 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -60.08 -42.63 95.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.24 . . . . 1.0900000000000001 109.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.1 -39.91 87.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.136 -0.978 . . . . 0.31 108.776 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.96 -38.38 76.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.694 -0.854 . . . . 0.27000000000000002 108.694 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.1 t -66.57 -22.43 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.28000000000000003 110.716 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.92 17.79 7.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.001 -1.062 . . . . 0.29999999999999999 109.737 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 52.02 29.64 6.49 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.031 -1.043 . . . . 1.71 109.499 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 59.93 20.08 9.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.802 -0.562 . . . . 2.25 109.986 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -68.98 114.46 7.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.843 -1.16 . . . . 1.8 107.925 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.68 -40.0 90.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.388 -0.82 . . . . 0.88 112.78 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -67.65 -39.52 84.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.524 -1.36 . . . . 0.73999999999999999 110.634 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.97 -39.06 76.2 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.034 -1.066 . . . . 0.55000000000000004 109.538 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.57 -43.72 92.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.38 109.813 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -59.96 -49.98 75.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 2.6400000000000001 110.959 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.8 -38.79 89.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.78 -1.2 . . . . 2.3799999999999999 109.273 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -64.33 -49.44 71.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.014 -1.054 . . . . 0.40000000000000002 110.991 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.09 -47.03 72.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.028 -1.045 . . . . 0.34000000000000002 110.0 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -64.92 -44.4 89.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.33 -0.856 . . . . 2.1000000000000001 109.8 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.0 t0 -69.73 -30.97 68.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 1.8999999999999999 109.724 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -79.23 -34.8 42.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.40000000000000002 111.399 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.9 p -130.29 -29.78 1.99 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.58 -1.325 . . . . 0.39000000000000001 112.092 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.07 14.33 21.01 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.363 -1.495 . . . . 0.35999999999999999 109.363 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 154.69 1.84 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.015 -1.285 . . . . 0.32000000000000001 109.34 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -89.17 169.99 10.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 1.9099999999999999 110.241 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.29 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.642 -0.661 . . . . 0.38 110.992 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.11 -39.94 75.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.699 -1.25 . . . . 2.5699999999999998 109.694 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.7 mm100 -65.0 -29.99 70.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.454 -0.779 . . . . 2.1200000000000001 110.489 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p -68.82 -39.48 80.0 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.007 -1.058 . . . . 1.3600000000000001 110.62 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' B' ' 75' ' ' ARG . 0.3 OUTLIER -60.25 -37.76 81.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.577 -1.327 . . . . 2.8100000000000001 108.768 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.69 -40.11 76.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.6 -1.312 . . . . 0.40000000000000002 110.431 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.04 -40.19 75.29 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.723 -1.236 . . . . 0.23000000000000001 109.354 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.26 -61.01 2.91 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.041 -1.037 . . . . 0.42999999999999999 109.71 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.56 -33.06 83.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.236 -1.146 . . . . 0.25 110.236 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -70.91 -46.95 61.61 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.933 -1.334 . . . . 0.23999999999999999 109.703 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.9 -41.01 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.957 -1.097 . . . . 0.28999999999999998 109.089 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.59 -40.6 97.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.155 -0.966 . . . . 2.7400000000000002 110.139 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 95.9 mt-10 -70.08 -38.34 75.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 1.9099999999999999 110.502 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.434 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.7 t90 -61.46 -47.87 83.72 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.542 -1.349 . . . . 0.35999999999999999 108.09 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' B' ' 89' ' ' LEU . 56.3 m -59.99 -40.13 88.11 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.365 -0.834 . . . . 0.35999999999999999 109.826 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.41 -29.83 68.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.069 -1.02 . . . . 0.55000000000000004 109.404 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.58 -33.78 12.89 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.323 -0.86 . . . . 0.46999999999999997 110.75 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.0 m-85 -108.3 -5.96 16.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.248 -0.907 . . . . 1.24 112.584 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.503 2.203 0 O-C-N 120.61 -1.306 . . . . 1.6699999999999999 109.548 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.757 0.789 . . . . 1.51 109.742 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.574 ' NE2' ' NH2' ' A' ' 8' ' ' ARG . 7.3 tp-100 -54.68 -24.35 21.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 2.1800000000000002 109.9 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.02 -38.66 86.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.034 -1.041 . . . . 2.02 109.228 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -59.16 -50.63 73.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.141 -0.974 . . . . 0.48999999999999999 110.169 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.574 ' NH2' ' NE2' ' A' ' 5' ' ' GLN . 89.3 mtm180 -69.4 -34.75 74.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.132 -0.98 . . . . 3.21 110.423 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.57 -39.86 80.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.155 -0.966 . . . . 0.76000000000000001 109.289 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.53 -48.94 78.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.445 -0.784 . . . . 0.46000000000000002 109.761 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -83.22 10.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.266 -0.896 . . . . 0.44 110.711 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.66 -14.97 17.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.246 -0.909 . . . . 0.54000000000000004 110.364 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' PRO . 18.6 pt-20 -152.45 152.61 29.37 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.031 -1.043 . . . . 1.26 108.632 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . 75.0 Cg_exo -37.37 155.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.96 1.773 . . . . 0.48999999999999999 111.089 178.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.448 ' H ' ' HG2' ' A' ' 15' ' ' MET . 14.3 ptm -92.64 -24.75 18.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.055 -1.028 . . . . 0.56999999999999995 110.443 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.81 -136.01 37.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.971 -1.109 . . . . 0.40000000000000002 110.401 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.15 42.78 1.71 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.631 -0.923 . . . . 0.84999999999999998 109.902 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -60.12 148.1 79.01 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.146 -0.971 . . . . 2.0099999999999998 108.452 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.38 159.85 33.98 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.037 1.825 . . . . 0.34000000000000002 112.085 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 21' ' ' GLY . 12.8 p -57.58 -39.47 69.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.677 -0.639 . . . . 0.32000000000000001 110.994 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -67.79 -3.81 30.14 Favored Glycine 0 N--CA 1.491 2.331 0 O-C-N 121.432 -0.793 . . . . 0.23000000000000001 111.346 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -83.82 -20.94 32.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.423 -1.633 . . . . 1.24 109.532 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.622 HD22 HD21 ' A' ' 81' ' ' LEU . 90.5 mt -64.15 136.29 57.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.033 -1.042 . . . . 0.23999999999999999 109.078 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 136.13 57.16 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.678 -0.809 . . . . 0.20999999999999999 109.763 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.7 -18.16 57.94 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.296 -1.522 . . . . 0.22 109.296 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.56 114.78 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.251 -1.147 . . . . 0.25 108.215 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.27 175.17 37.61 Favored Glycine 0 N--CA 1.492 2.382 0 O-C-N 120.608 -1.307 . . . . 0.28000000000000003 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.86 -40.02 83.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -1.048 . . . . 2.0099999999999998 109.549 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.41 -47.72 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.38 109.36 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.96 -38.51 88.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.40000000000000002 109.327 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.22 95.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.707 -1.357 . . . . 0.34999999999999998 109.707 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -63.53 -39.78 95.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.376 -1.073 . . . . 2.7400000000000002 110.719 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.21 -43.05 83.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.592 -1.318 . . . . 1.54 109.982 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.95 -39.85 93.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.011 -1.056 . . . . 0.34000000000000002 108.532 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.93 -42.1 93.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 1.6699999999999999 111.007 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -64.68 -20.48 66.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.998 . . . . 2.0 109.418 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -93.54 8.46 40.63 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.841 -0.744 . . . . 2.6899999999999999 110.845 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.8 7.9 49.69 Favored Glycine 0 N--CA 1.501 3.014 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 112.31 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.64 73.48 1.02 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.553 -1.557 . . . . 0.33000000000000002 108.518 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -78.0 -8.1 57.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.40999999999999998 110.952 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -137.15 157.35 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.134 -0.979 . . . . 1.5600000000000001 110.602 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.643 -0.661 . . . . 0.20999999999999999 111.684 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.443 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.2 p90 -60.7 -18.1 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.622 -1.299 . . . . 0.32000000000000001 110.772 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.6 t -80.24 -30.7 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.414 -1.328 . . . . 0.23999999999999999 107.414 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 HG23 ' A' ' 20' ' ' VAL . 70.2 t -78.25 -39.32 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.151 -1.055 . . . . 0.22 108.151 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.77 -36.29 74.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.793 -1.558 . . . . 0.40000000000000002 106.793 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.29 -43.6 93.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.186 -1.165 . . . . 0.17999999999999999 110.186 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -60.18 -42.03 94.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -1.228 . . . . 1.0900000000000001 109.332 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.1 -39.97 88.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.082 -1.011 . . . . 0.31 108.66 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD12 HD12 ' B' ' 50' ' ' LEU . 77.3 mt -69.09 -39.58 78.91 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.095 -0.706 . . . . 0.28000000000000003 109.095 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -67.79 -23.14 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.15 -0.969 . . . . 0.28000000000000003 110.912 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.5 16.85 8.18 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.99 -1.069 . . . . 0.31 110.042 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.65 29.67 7.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.061 -1.024 . . . . 1.7 110.388 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt 59.96 19.8 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.495 -0.753 . . . . 2.2400000000000002 110.367 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -67.65 115.99 7.85 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.377 -1.342 . . . . 1.8 107.377 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.42 -39.98 95.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.894 . . . . 0.87 113.251 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.8 -39.73 76.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.359 -1.463 . . . . 0.72999999999999998 110.437 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.9 -40.07 72.39 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 118.836 -1.145 . . . . 0.55000000000000004 109.379 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.63 -49.87 69.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.38 109.528 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -61.78 -45.31 94.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 2.6400000000000001 109.799 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -64.21 -39.26 93.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.041 -1.037 . . . . 2.3700000000000001 108.664 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' A' ' 66' ' ' THR . 76.2 t90 -66.87 -47.17 72.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.40000000000000002 110.512 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.11 -49.15 68.51 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.129 -0.982 . . . . 0.34000000000000002 109.575 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -61.5 -49.05 78.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.36 -0.837 . . . . 2.1099999999999999 110.101 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.94 -26.14 64.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.467 -0.77 . . . . 1.8999999999999999 109.748 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 22.9 m -79.32 -34.14 42.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.078 -1.014 . . . . 0.40999999999999998 111.294 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.3 p -134.46 -21.66 1.76 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.328 -1.482 . . . . 0.40000000000000002 112.294 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.23 12.16 34.5 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.679 -1.368 . . . . 0.35999999999999999 109.679 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.1 153.72 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.935 -1.332 . . . . 0.33000000000000002 109.169 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -87.7 169.81 11.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.913 -1.117 . . . . 1.8999999999999999 109.772 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.24 -33.08 71.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.588 -0.695 . . . . 0.39000000000000001 110.24 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -72.9 -39.61 66.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 2.5800000000000001 109.804 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.64 -37.1 85.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.84 . . . . 2.1200000000000001 110.491 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -36.6 82.42 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 1.3600000000000001 109.963 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.12 -39.04 84.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.027 -1.046 . . . . 2.7999999999999998 109.117 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.39 -39.66 81.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.898 -1.126 . . . . 0.40000000000000002 110.981 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.23 -40.09 82.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 0.23999999999999999 110.369 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.6 -59.53 5.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.512 -1.367 . . . . 0.42999999999999999 109.554 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.01 79.26 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.621 -0.992 . . . . 0.26000000000000001 110.621 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.44 -51.06 32.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -1.202 . . . . 0.25 110.337 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.622 HD21 HD22 ' A' ' 23' ' ' LEU . 84.1 mt -70.57 -40.39 73.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.847 -1.141 . . . . 0.29999999999999999 108.531 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.78 -41.08 97.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 2.73 110.255 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.74 -38.4 76.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.9099999999999999 110.404 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 90.0 t90 -60.11 -43.5 95.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.437 -1.414 . . . . 0.37 107.895 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 27.8 m -60.12 -40.24 89.05 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.739 0.781 . . . . 0.35999999999999999 109.553 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -33.4 71.93 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.268 -0.895 . . . . 0.55000000000000004 109.871 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.92 -33.98 13.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.991 -1.068 . . . . 0.47999999999999998 111.037 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 97.4 m-85 . . . . . 0 N--CA 1.507 2.404 0 O-C-N 121.094 -1.003 . . . . 1.24 111.794 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.734 0.778 . . . . 1.5 109.716 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 8' ' ' ARG . 7.3 tp-100 -55.05 -24.17 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.342 0.591 . . . . 2.1800000000000002 109.88 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -38.85 87.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.992 -1.068 . . . . 2.0099999999999998 109.212 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -58.96 -50.71 73.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.1 -1.0 . . . . 0.48999999999999999 110.317 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 5' ' ' GLN . 89.2 mtm180 -69.32 -34.95 75.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 3.23 110.234 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.28 -40.03 81.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.187 -0.946 . . . . 0.76000000000000001 109.272 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -61.59 -48.81 79.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.46000000000000002 109.912 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -83.49 10.73 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.238 -0.914 . . . . 0.44 110.664 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.75 -14.95 17.12 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.176 -0.953 . . . . 0.53000000000000003 110.267 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 14' ' ' PRO . 18.7 pt-20 -152.14 152.25 29.23 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 1.27 108.615 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' B' ' 13' ' ' GLU . 68.1 Cg_exo -37.21 155.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.022 1.814 . . . . 0.48999999999999999 111.076 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 14.0 ptm -92.57 -25.1 18.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.093 -1.004 . . . . 0.56000000000000005 110.598 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.0 -136.02 38.77 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.064 -1.065 . . . . 0.39000000000000001 110.44 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.17 42.9 1.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.619 -0.93 . . . . 0.83999999999999997 110.071 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -60.27 148.08 80.0 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.426 -0.953 . . . . 2.02 108.426 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.61 159.41 36.88 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.07 1.847 . . . . 0.34000000000000002 112.033 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.457 HG13 ' N ' ' B' ' 21' ' ' GLY . 12.2 p -57.38 -38.91 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.721 -0.612 . . . . 0.32000000000000001 111.168 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.457 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -68.03 -3.73 31.34 Favored Glycine 0 N--CA 1.493 2.447 0 O-C-N 121.435 -0.79 . . . . 0.22 111.343 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.8 m -84.12 -21.13 31.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.575 -1.544 . . . . 1.24 109.587 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.616 HD22 HD21 ' B' ' 81' ' ' LEU . 88.5 mt -64.18 136.14 56.95 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -0.969 . . . . 0.23999999999999999 109.032 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.23 136.11 57.51 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.753 0.787 . . . . 0.20999999999999999 109.882 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.19 -17.75 58.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.375 -1.49 . . . . 0.22 109.375 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.78 114.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -1.143 . . . . 0.25 108.088 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.85 174.72 37.86 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.907 -1.277 . . . . 0.28000000000000003 109.907 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.52 -39.83 81.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.424 -1.045 . . . . 2.0 109.677 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.59 -47.68 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.38 109.27 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.04 -38.57 88.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.386 -0.821 . . . . 0.40000000000000002 109.46 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -39.07 95.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.35999999999999999 109.692 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -63.7 -39.73 95.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -1.112 . . . . 2.75 110.667 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.07 -43.05 83.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.578 -1.326 . . . . 1.5600000000000001 109.834 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.2 -39.95 94.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.33000000000000002 108.586 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -59.9 -41.73 92.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.787 -0.57 . . . . 1.6799999999999999 110.97 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.67 -20.94 66.59 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.212 -0.93 . . . . 1.99 109.295 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -93.22 8.33 40.68 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 2.6800000000000002 110.79 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.95 8.03 48.98 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 120.911 -1.118 . . . . 0.48999999999999999 112.319 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.79 73.66 1.02 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 119.314 1.557 . . . . 0.33000000000000002 108.368 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -78.04 -8.28 57.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.40999999999999998 110.758 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -137.07 157.46 46.66 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.145 -0.972 . . . . 1.5600000000000001 110.605 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -39.83 89.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.711 -0.618 . . . . 0.20999999999999999 111.724 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 3.3 p90 -60.59 -18.35 52.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.532 -1.355 . . . . 0.32000000000000001 110.849 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -80.19 -30.84 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.429 -1.323 . . . . 0.23999999999999999 107.429 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.451 HG21 HG23 ' B' ' 20' ' ' VAL . 68.9 t -77.91 -39.12 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.204 -1.036 . . . . 0.22 108.204 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.07 -36.14 74.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.865 -1.531 . . . . 0.40000000000000002 106.865 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -43.73 93.83 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.241 -1.144 . . . . 0.17999999999999999 110.241 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.05 -41.71 92.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 1.0900000000000001 109.438 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.13 -40.23 89.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.31 108.762 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.411 HD12 HD12 ' A' ' 50' ' ' LEU . 77.6 mt -69.03 -39.8 78.99 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.987 -0.745 . . . . 0.27000000000000002 108.987 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.43 -23.07 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.28000000000000003 111.02 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.98 17.18 8.23 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.29999999999999999 110.094 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.33 29.86 7.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.07 -1.019 . . . . 1.71 110.47 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 59.88 19.82 8.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.523 -0.736 . . . . 2.25 110.407 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -67.65 115.71 7.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.692 -1.255 . . . . 1.8 107.635 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -62.15 -40.33 95.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.402 -0.811 . . . . 0.88 113.083 -177.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -69.35 -40.02 77.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.393 -1.442 . . . . 0.73999999999999999 110.629 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.82 -40.06 72.7 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.867 -1.133 . . . . 0.55000000000000004 109.296 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.81 -50.01 68.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.38 109.533 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.62 -45.23 94.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.241 -0.912 . . . . 2.6400000000000001 109.786 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -64.2 -39.43 93.96 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.991 -1.068 . . . . 2.3799999999999999 108.708 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -66.61 -47.49 72.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.40000000000000002 110.652 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.88 -49.15 69.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.15 -0.969 . . . . 0.34000000000000002 109.576 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.54 -49.06 78.23 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.482 -0.762 . . . . 2.1000000000000001 110.107 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.69 -26.38 65.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 1.8999999999999999 109.625 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m -79.33 -34.47 42.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.40000000000000002 111.34 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 16.3 p -133.85 -22.19 1.87 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.464 -1.398 . . . . 0.39000000000000001 112.334 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 12.03 33.95 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.628 -1.389 . . . . 0.35999999999999999 109.628 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.01 153.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.387 . . . . 0.32000000000000001 109.213 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.92 169.69 11.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.972 -1.08 . . . . 1.9099999999999999 109.829 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.14 71.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.534 -0.729 . . . . 0.38 110.335 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -73.19 -39.25 65.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.915 -1.116 . . . . 2.5699999999999998 109.774 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.96 -36.83 84.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 2.1200000000000001 110.441 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.9 p -66.93 -36.81 83.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.297 -0.877 . . . . 1.3600000000000001 109.918 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -60.02 -39.19 84.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.95 -1.094 . . . . 2.8100000000000001 109.216 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -68.25 -39.9 82.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.788 -1.195 . . . . 0.40000000000000002 111.059 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.13 -39.97 82.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.782 -1.199 . . . . 0.23000000000000001 110.457 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.55 -59.37 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.559 -1.338 . . . . 0.42999999999999999 109.625 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.44 -33.0 79.4 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.567 -1.013 . . . . 0.25 110.567 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.74 -50.96 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.243 . . . . 0.23999999999999999 110.41 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.616 HD21 HD22 ' B' ' 23' ' ' LEU . 83.8 mt -70.59 -40.48 73.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.768 -1.173 . . . . 0.28999999999999998 108.529 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -61.6 -41.04 96.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.434 -0.791 . . . . 2.7400000000000002 110.207 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -69.8 -38.51 76.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 1.9099999999999999 110.53 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 90.0 t90 -60.03 -43.38 95.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.423 -1.423 . . . . 0.35999999999999999 107.871 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' B' ' 89' ' ' LEU . 23.9 m -60.34 -40.08 89.4 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.7 0.762 . . . . 0.35999999999999999 109.539 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.13 -33.2 71.81 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.256 -0.902 . . . . 0.55000000000000004 109.905 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.07 -34.39 13.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.02 -1.05 . . . . 0.46999999999999997 111.095 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 97.8 m-85 -110.04 1.92 19.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.083 -1.011 . . . . 1.24 111.654 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.5 tp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.837 -1.164 . . . . 1.6699999999999999 109.317 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.655 0.741 . . . . 1.51 110.016 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 4.2 pm0 -58.04 -19.99 35.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.669 -0.644 . . . . 2.1800000000000002 110.845 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.21 -38.38 86.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 2.02 109.197 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.481 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 24.3 t60 -59.95 -53.92 52.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.196 -0.94 . . . . 0.48999999999999999 110.516 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -69.97 -35.57 74.55 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.958 -1.088 . . . . 3.21 110.105 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.02 -39.91 75.53 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.295 -0.878 . . . . 0.76000000000000001 109.737 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.64 -44.52 96.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.46000000000000002 109.784 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.7 m -83.39 15.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.056 -1.027 . . . . 0.44 109.598 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.79 -13.12 14.53 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.486 -0.759 . . . . 0.54000000000000004 110.32 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.77 151.59 20.88 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.979 -1.076 . . . . 1.26 109.537 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -40.13 156.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.067 1.845 . . . . 0.48999999999999999 111.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.64 -18.73 23.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.878 -1.139 . . . . 0.56999999999999995 109.941 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.09 -140.18 35.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.735 -1.346 . . . . 0.40000000000000002 109.735 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -103.82 30.69 4.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.37 -1.077 . . . . 0.84999999999999998 109.982 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -60.07 147.76 79.56 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.065 -1.022 . . . . 2.0099999999999998 108.431 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.67 158.3 46.97 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.372 2.048 . . . . 0.34000000000000002 112.557 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 22' ' ' SER . 2.3 p -56.93 -48.71 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.32000000000000001 110.233 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.07 -3.71 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.402 -1.079 . . . . 0.23000000000000001 110.402 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 7.8 t -82.84 -20.76 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.935 -1.333 . . . . 1.24 109.165 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.514 HD22 HD21 ' A' ' 81' ' ' LEU . 98.4 mt -65.11 139.96 58.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.23999999999999999 109.73 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 133.07 50.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.812 0.815 . . . . 0.20999999999999999 110.282 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.08 -20.34 47.97 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 109.839 -1.304 . . . . 0.22 109.839 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.2 117.1 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -1.198 . . . . 0.25 108.019 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.435 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -93.23 177.31 37.91 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.726 -1.35 . . . . 0.28000000000000003 109.726 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.02 -40.02 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -1.08 . . . . 2.0099999999999998 109.888 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.03 -47.36 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.085 . . . . 0.38 109.1 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.2 mt -65.04 -39.41 93.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.376 -0.828 . . . . 0.40000000000000002 109.407 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.7 97.38 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 110.044 -1.222 . . . . 0.34999999999999998 110.044 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -60.28 -40.02 88.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.406 . . . . 2.7400000000000002 110.517 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.2 -45.95 75.37 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.797 -1.161 . . . . 1.54 109.771 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.0 -41.13 99.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.858 -1.151 . . . . 0.34000000000000002 109.917 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.22 -40.64 90.89 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.114 -1.034 . . . . 1.6699999999999999 109.383 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.65 -19.66 65.81 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.648 -0.871 . . . . 2.0 108.648 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.444 ' HG2' HH11 ' A' ' 37' ' ' ARG . 51.0 mtt-85 -91.01 5.62 48.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.487 -0.758 . . . . 2.6899999999999999 110.433 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.57 49.19 Favored Glycine 0 N--CA 1.502 3.045 0 O-C-N 121.09 -1.006 . . . . 0.47999999999999998 112.075 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.544 ' CD2' HG12 ' A' ' 44' ' ' VAL . 89.3 m-85 -102.38 72.81 1.29 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.597 -1.531 . . . . 0.33000000000000002 108.579 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -77.9 -12.56 59.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.40999999999999998 110.679 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.853 ' C ' ' CA ' ' A' ' 42' ' ' ALA . 43.9 mmtm . . . . . 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 1.5600000000000001 109.423 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.853 ' CA ' ' C ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 120.773 0.32 . . . . 0.20999999999999999 . . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.462 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 26.3 p90 -55.68 -17.4 5.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.683 -1.261 . . . . 0.32000000000000001 110.478 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 39' ' ' PHE . 46.3 t -79.25 -33.14 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.844 -1.169 . . . . 0.23999999999999999 107.844 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.36 -38.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.235 -1.024 . . . . 0.22 108.235 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.97 -36.82 77.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.89 -1.152 . . . . 0.40000000000000002 107.89 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -59.99 -42.04 98.16 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.96 -1.256 . . . . 0.17999999999999999 109.96 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.97 -41.12 91.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.886 -1.361 . . . . 1.0900000000000001 109.208 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.94 -39.99 87.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.99 . . . . 0.31 108.525 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.26 -37.55 80.86 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.573 -0.851 . . . . 0.28000000000000003 108.716 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 47' ' ' GLY . 69.7 t -64.07 -26.75 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.289 -0.882 . . . . 0.28000000000000003 110.142 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -91.59 14.89 13.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.099 -1.001 . . . . 0.31 110.52 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 50.09 40.01 20.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.726 -1.234 . . . . 1.7 111.055 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.28 18.99 4.63 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.267 -0.895 . . . . 2.2400000000000002 110.492 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.78 107.77 3.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.776 -1.203 . . . . 1.8 108.193 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 85.1 tt0 -62.91 -40.81 98.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.407 -0.808 . . . . 0.87 112.679 -178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -68.69 -39.64 80.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.847 -1.158 . . . . 0.72999999999999998 109.686 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.96 -38.63 76.15 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.18 -1.008 . . . . 0.55000000000000004 109.026 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -62.83 -45.91 90.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.38 109.444 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mtt180 -60.0 -47.7 84.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.393 -0.817 . . . . 2.6400000000000001 110.927 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.4 -39.68 94.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.889 -1.132 . . . . 2.3700000000000001 108.923 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.3 t90 -61.91 -49.97 74.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.40000000000000002 111.46 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.67 -46.13 76.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.852 -1.155 . . . . 0.34000000000000002 109.923 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.68 -46.67 81.43 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.322 -0.861 . . . . 2.1099999999999999 109.874 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.1 -31.53 70.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.386 -0.821 . . . . 1.8999999999999999 109.538 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 75.7 m -77.74 -38.26 47.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.259 -0.901 . . . . 0.40999999999999998 111.463 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 p -129.45 -24.33 2.8 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.479 -1.388 . . . . 0.40000000000000002 111.854 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.46 13.55 28.0 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.182 -1.567 . . . . 0.35999999999999999 109.182 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.81 154.57 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.035 -1.274 . . . . 0.33000000000000002 109.097 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.91 170.04 11.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 1.8999999999999999 109.53 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -31.61 70.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.39000000000000001 110.773 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -73.89 -40.02 63.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 2.5800000000000001 110.214 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.51 -33.7 76.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.416 -0.803 . . . . 2.1200000000000001 110.328 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p -68.39 -37.68 80.63 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.219 -0.926 . . . . 1.3600000000000001 109.824 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.47 -38.45 84.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.94 -1.1 . . . . 2.7999999999999998 109.644 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.45 -39.96 81.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.622 -1.299 . . . . 0.40000000000000002 110.485 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -70.01 -40.7 75.08 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.882 -1.136 . . . . 0.23999999999999999 109.327 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -60.19 -60.02 4.48 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.809 -1.182 . . . . 0.42999999999999999 109.654 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.22 91.78 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.212 -0.93 . . . . 0.26000000000000001 110.876 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -68.21 -50.13 56.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.734 -1.45 . . . . 0.25 109.847 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD21 HD22 ' A' ' 23' ' ' LEU . 87.6 mt -70.14 -39.93 75.1 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.146 -1.022 . . . . 0.29999999999999999 109.218 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -62.35 -39.97 94.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -0.99 . . . . 2.73 109.743 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.481 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.8 mt-10 -70.01 -36.62 75.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 1.9099999999999999 109.83 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.596 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 80.5 t90 -59.92 -41.75 92.42 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.488 -1.383 . . . . 0.37 107.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.0 m -63.1 -40.02 96.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.768 -0.827 . . . . 0.35999999999999999 108.768 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.1 -38.16 82.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.593 -0.692 . . . . 0.55000000000000004 109.835 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 -37.07 17.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.47999999999999998 110.065 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.596 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 72.2 m-85 . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 1.24 110.327 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.715 0.769 . . . . 1.5 110.011 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' B' ' 5' ' ' GLN . 4.2 pm0 -58.13 -20.05 37.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.632 -0.668 . . . . 2.1800000000000002 110.756 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -61.15 -38.52 86.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.06 -1.025 . . . . 2.0099999999999998 109.188 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.479 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 24.2 t60 -59.74 -53.91 52.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 110.667 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -70.05 -35.43 74.26 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.002 -1.061 . . . . 3.23 110.162 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.15 -39.9 75.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 0.76000000000000001 109.647 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.51 -44.6 96.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.348 -0.845 . . . . 0.46000000000000002 109.785 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 31.8 m -83.51 15.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.089 -1.007 . . . . 0.44 109.572 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.82 -13.0 14.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.53 -0.731 . . . . 0.53000000000000003 110.368 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.84 151.57 20.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.908 -1.12 . . . . 1.27 109.498 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.06 156.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.992 1.795 . . . . 0.48999999999999999 111.775 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.72 -18.61 23.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.947 -1.095 . . . . 0.56000000000000005 109.963 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.86 -140.11 35.16 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.768 -1.333 . . . . 0.39000000000000001 109.768 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.82 30.59 5.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.45 -1.029 . . . . 0.83999999999999997 109.981 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -59.99 147.66 79.35 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 2.02 108.45 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.59 158.28 46.72 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.365 2.043 . . . . 0.34000000000000002 112.603 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' B' ' 22' ' ' SER . 2.2 p -57.0 -48.64 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.476 -0.765 . . . . 0.32000000000000001 110.169 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.14 -3.58 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.374 -1.09 . . . . 0.22 110.374 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.479 ' H ' ' C ' ' B' ' 20' ' ' VAL . 7.8 t -82.96 -20.85 34.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.295 . . . . 1.24 109.129 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.536 HD22 HD21 ' B' ' 81' ' ' LEU . 98.7 mt -65.02 139.93 58.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.23999999999999999 109.78 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.17 132.9 50.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.784 0.802 . . . . 0.20999999999999999 110.371 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.35 47.76 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.802 -1.319 . . . . 0.22 109.802 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.11 117.07 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.177 -1.19 . . . . 0.25 108.044 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.428 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -93.09 177.26 38.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.697 -1.361 . . . . 0.28000000000000003 109.697 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -40.09 79.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 2.0 109.951 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.94 -47.49 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.38 109.129 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.428 HD12 ' H ' ' B' ' 27' ' ' GLY . 95.5 mt -64.93 -39.54 93.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.40000000000000002 109.436 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.66 97.24 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 110.041 -1.224 . . . . 0.35999999999999999 110.041 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -60.24 -40.1 89.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.852 -1.381 . . . . 2.75 110.503 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.21 -45.76 75.87 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.785 -1.166 . . . . 1.5600000000000001 109.786 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.01 -41.27 99.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.33000000000000002 110.002 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.77 90.5 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.171 -1.012 . . . . 1.6799999999999999 109.382 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.69 -19.62 65.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.631 -0.877 . . . . 1.99 108.631 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' B' ' 37' ' ' ARG . 50.7 mtt-85 -91.1 5.78 47.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.817 . . . . 2.6800000000000002 110.423 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.19 7.54 49.38 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.034 -1.041 . . . . 0.48999999999999999 112.112 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.542 ' CD2' HG12 ' B' ' 44' ' ' VAL . 89.5 m-85 -102.43 72.93 1.29 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.704 -1.468 . . . . 0.33000000000000002 108.624 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -78.06 -12.46 59.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.40999999999999998 110.664 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.46 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 44.0 mmtm -132.31 154.11 50.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.055 -1.028 . . . . 1.5600000000000001 109.419 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.99 91.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.298 -0.876 . . . . 0.20999999999999999 111.73 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 25.7 p90 -55.82 -17.32 5.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.671 -1.268 . . . . 0.32000000000000001 110.397 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.542 HG12 ' CD2' ' B' ' 39' ' ' PHE . 46.2 t -79.21 -33.02 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.93 -1.137 . . . . 0.23999999999999999 107.93 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.5 -38.73 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.208 -1.034 . . . . 0.22 108.208 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.99 -36.9 78.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.899 -1.148 . . . . 0.40000000000000002 107.899 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.422 ' O ' HG23 ' B' ' 51' ' ' VAL . . . -59.89 -42.1 98.05 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.997 -1.241 . . . . 0.17999999999999999 109.997 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.96 -40.99 90.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.004 -1.292 . . . . 1.0900000000000001 109.231 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.95 -40.14 87.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.31 108.43 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.21 -37.84 81.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.611 -0.885 . . . . 0.27000000000000002 108.611 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 47' ' ' GLY . 70.7 t -63.93 -26.59 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.829 . . . . 0.28000000000000003 110.179 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.6 14.95 13.6 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.097 -1.002 . . . . 0.29999999999999999 110.539 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.705 -1.247 . . . . 1.71 111.045 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.26 19.02 4.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.371 -0.831 . . . . 2.25 110.504 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.73 107.82 3.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.809 -1.182 . . . . 1.8 108.131 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 85.2 tt0 -62.84 -41.09 99.2 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.398 -0.813 . . . . 0.88 112.704 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.54 -39.59 81.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.805 -1.184 . . . . 0.73999999999999999 109.692 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.0 -38.52 76.01 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.201 -1.0 . . . . 0.55000000000000004 109.06 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.06 -45.72 90.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.38 109.507 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 98.9 mtt180 -60.05 -47.76 84.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.785 . . . . 2.6400000000000001 110.974 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -64.3 -39.68 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.896 -1.128 . . . . 2.3799999999999999 108.946 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.92 -50.05 73.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.40000000000000002 111.423 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.423 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 22.6 tp -66.63 -46.23 76.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.897 -1.127 . . . . 0.34000000000000002 109.952 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.56 -46.71 81.63 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 2.1000000000000001 109.9 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.08 -31.51 70.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 1.8999999999999999 109.49 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 77.1 m -77.7 -38.3 47.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.868 . . . . 0.40000000000000002 111.496 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 26.6 p -129.43 -24.3 2.81 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.581 -1.325 . . . . 0.39000000000000001 111.891 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.45 13.63 27.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.189 -1.564 . . . . 0.35999999999999999 109.189 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.74 154.63 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.264 . . . . 0.32000000000000001 109.114 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.97 170.02 11.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 1.9099999999999999 109.515 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.03 -31.47 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.38 110.741 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -74.04 -40.0 63.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.961 -1.087 . . . . 2.5699999999999998 110.204 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -66.6 -33.57 75.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.412 -0.805 . . . . 2.1200000000000001 110.272 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 32.9 p -68.52 -37.55 80.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.208 -0.933 . . . . 1.3600000000000001 109.805 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.49 -38.5 84.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.885 -1.134 . . . . 2.8100000000000001 109.689 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -68.34 -39.97 81.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.679 -1.263 . . . . 0.40000000000000002 110.595 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.98 -40.8 75.13 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.845 -1.16 . . . . 0.23000000000000001 109.33 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -60.08 -60.04 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.141 . . . . 0.42999999999999999 109.718 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.18 91.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.829 -0.908 . . . . 0.25 110.829 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.27 -50.16 55.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.731 -1.453 . . . . 0.23999999999999999 109.85 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.536 HD21 HD22 ' B' ' 23' ' ' LEU . 87.7 mt -70.03 -40.02 75.44 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.123 -1.031 . . . . 0.28999999999999998 109.256 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -62.14 -40.11 94.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.123 -0.986 . . . . 2.7400000000000002 109.762 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.479 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.8 mt-10 -70.05 -36.57 75.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.09 -1.006 . . . . 1.9099999999999999 109.866 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 80.2 t90 -59.89 -41.89 92.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.525 -1.36 . . . . 0.35999999999999999 107.702 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.8 m -63.02 -40.11 96.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.816 -0.809 . . . . 0.35999999999999999 108.816 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.0 -38.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.627 -0.671 . . . . 0.55000000000000004 109.858 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -37.65 16.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.198 -0.939 . . . . 0.46999999999999997 110.057 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.8 m-85 -102.26 -86.66 0.42 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.188 -0.945 . . . . 1.24 110.376 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.016 -0.992 . . . . 1.6699999999999999 109.945 -178.39 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.792 0.806 . . . . 1.51 110.349 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.91 -19.52 65.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.88 -0.513 . . . . 2.1800000000000002 110.219 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -60.02 -37.45 79.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.049 -1.032 . . . . 2.02 109.573 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -59.92 -50.78 72.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.167 -0.958 . . . . 0.48999999999999999 110.507 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 8' ' ' ARG . 38.7 mtt-85 -70.02 -33.7 72.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.954 -1.091 . . . . 3.21 110.224 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.66 -38.99 77.32 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.305 -0.872 . . . . 0.76000000000000001 109.43 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -64.6 -47.4 78.75 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.393 -0.817 . . . . 0.46000000000000002 110.506 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -85.11 11.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.154 -0.966 . . . . 0.44 111.054 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.08 -11.73 15.57 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.193 -0.942 . . . . 0.54000000000000004 109.821 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.58 151.49 20.96 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.963 . . . . 1.26 108.976 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -39.9 161.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.892 1.728 . . . . 0.48999999999999999 111.506 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.514 ' CE ' HD22 ' A' ' 46' ' ' LEU . 8.8 ptp -90.6 -20.22 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.029 -1.044 . . . . 0.56999999999999995 109.479 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.56 -139.96 21.01 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.205 -1.158 . . . . 0.40000000000000002 110.205 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.97 24.95 10.55 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.544 -0.974 . . . . 0.84999999999999998 109.792 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -60.8 148.69 82.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.098 -1.001 . . . . 2.0099999999999998 108.934 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.17 158.76 33.34 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.508 2.139 . . . . 0.34000000000000002 113.307 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 21' ' ' GLY . 11.1 p -59.59 -44.96 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.657 0.742 . . . . 0.32000000000000001 110.328 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.544 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.21 -3.0 0.18 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.567 -1.013 . . . . 0.23000000000000001 110.567 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 20' ' ' VAL . 68.4 m -82.7 -19.15 38.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.769 -1.43 . . . . 1.24 109.436 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.18 137.41 56.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.23999999999999999 109.639 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.2 134.75 54.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.737 -0.785 . . . . 0.20999999999999999 109.842 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.08 48.07 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.316 -1.514 . . . . 0.22 109.316 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -98.35 113.18 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.25 108.007 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.8 179.27 38.33 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 120.623 -1.298 . . . . 0.28000000000000003 109.952 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -57.29 -40.1 77.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.525 -0.985 . . . . 2.0099999999999998 110.374 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.95 -46.26 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.38 109.743 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.57 -37.55 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.40000000000000002 109.62 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.79 95.73 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.128 -1.589 . . . . 0.34999999999999998 109.128 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.18 -39.98 95.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -1.087 . . . . 2.7400000000000002 109.935 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.66 -44.72 69.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.88 -1.137 . . . . 1.54 109.44 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.66 -40.01 95.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.955 -1.128 . . . . 0.34000000000000002 107.955 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.04 -41.52 92.43 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.976 -0.75 . . . . 1.6699999999999999 108.976 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.28 -19.91 64.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.682 -0.859 . . . . 2.0 108.682 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -90.35 0.94 57.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 2.6899999999999999 109.68 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 37.79 3.84 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 120.305 -0.95 . . . . 0.47999999999999998 111.239 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.511 ' CD2' HG12 ' A' ' 44' ' ' VAL . 89.1 m-85 -133.84 72.6 1.48 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.968 -1.313 . . . . 0.33000000000000002 108.995 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -80.28 -10.73 59.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.40999999999999998 110.729 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.88 152.04 51.31 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.127 -0.983 . . . . 1.5600000000000001 110.017 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.96 90.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.20999999999999999 111.823 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.46 -17.77 9.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.758 -1.214 . . . . 0.32000000000000001 110.603 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.511 HG12 ' CD2' ' A' ' 39' ' ' PHE . 43.7 t -79.4 -31.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.821 -1.174 . . . . 0.23999999999999999 107.914 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.54 -36.7 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.343 -0.984 . . . . 0.22 108.343 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.514 HD22 ' CE ' ' A' ' 15' ' ' MET . 66.7 tp -60.01 -37.84 80.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.983 -1.488 . . . . 0.40000000000000002 106.983 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.3 87.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.986 -1.246 . . . . 0.17999999999999999 109.986 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -60.08 -42.27 94.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.339 . . . . 1.0900000000000001 108.901 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.357 -0.979 . . . . 0.31 108.357 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.06 -39.93 75.39 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.756 -0.831 . . . . 0.28000000000000003 108.756 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.81 -26.7 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.176 -0.952 . . . . 0.28000000000000003 111.358 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.2 16.13 6.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.9 -1.125 . . . . 0.31 110.217 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.34 21.67 5.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 1.7 110.167 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.15 19.6 8.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.707 -0.62 . . . . 2.2400000000000002 110.311 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.9 122.1 17.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.585 -1.322 . . . . 1.8 107.777 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' OE2' ' CG ' ' A' ' 78' ' ' PHE . 8.5 tp10 -61.97 -41.56 98.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.286 0.847 . . . . 0.87 113.286 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -69.96 -39.86 75.75 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.411 -1.431 . . . . 0.72999999999999998 110.787 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.08 -39.9 75.33 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.917 -1.113 . . . . 0.55000000000000004 109.067 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.6 -48.48 79.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.268 -0.895 . . . . 0.38 109.482 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.08 -47.12 87.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.356 -0.84 . . . . 2.6400000000000001 110.978 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.13 -39.88 94.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.749 -1.219 . . . . 2.3700000000000001 108.885 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -61.58 -50.05 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.40000000000000002 111.414 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.65 -47.29 69.97 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.145 -0.972 . . . . 0.34000000000000002 110.146 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -63.33 -46.7 85.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 2.1099999999999999 109.869 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.37 -30.81 69.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 1.8999999999999999 109.696 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.6 m -79.01 -35.14 43.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.40999999999999998 111.247 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.9 p -131.79 -34.73 1.3 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.541 -1.35 . . . . 0.40000000000000002 111.722 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.97 15.87 10.37 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.422 -1.471 . . . . 0.35999999999999999 109.422 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 153.05 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.282 . . . . 0.33000000000000002 109.04 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -89.68 170.68 10.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 1.8999999999999999 109.348 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.27 72.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.504 -0.748 . . . . 0.39000000000000001 110.94 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 68.5 mttm -71.63 -41.43 68.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.717 -1.24 . . . . 2.5800000000000001 110.566 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -67.32 -36.52 81.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 2.1200000000000001 110.386 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.135 -0.978 . . . . 1.3600000000000001 110.466 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 72' ' ' LYS . 83.5 mtm180 -59.95 -36.59 77.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.675 -1.266 . . . . 2.7999999999999998 108.701 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.4 -39.29 81.71 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.83 -1.169 . . . . 0.40000000000000002 110.27 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.21 -41.14 81.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.791 -1.193 . . . . 0.23999999999999999 109.59 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CG ' ' OE2' ' A' ' 56' ' ' GLU . 64.7 t80 -60.01 -59.81 4.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.819 -1.176 . . . . 0.42999999999999999 109.41 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -34.88 85.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.992 -1.243 . . . . 0.26000000000000001 109.992 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.8 -45.45 67.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -1.186 . . . . 0.25 109.465 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.58 -41.91 68.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.29999999999999999 109.117 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.15 -41.16 96.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 2.73 109.527 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -70.05 -37.89 75.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 1.9099999999999999 110.603 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.48 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.8 t90 -59.99 -43.5 95.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.393 -1.442 . . . . 0.37 107.815 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.0 m -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.572 -0.705 . . . . 0.35999999999999999 109.358 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -59.2 -34.21 71.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.55000000000000004 110.21 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.75 -34.34 13.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.296 -0.878 . . . . 0.47999999999999998 111.352 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 94.8 m-85 . . . . . 0 N--CA 1.506 2.364 0 O-C-N 120.984 -1.073 . . . . 1.24 112.033 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.86 0.838 . . . . 1.5 110.326 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.86 -19.6 65.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.819 -0.551 . . . . 2.1800000000000002 110.21 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.0 -37.35 79.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.108 -0.995 . . . . 2.0099999999999998 109.665 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -59.96 -50.85 72.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.126 -0.984 . . . . 0.48999999999999999 110.449 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' B' ' 8' ' ' ARG . 38.8 mtt-85 -70.04 -33.71 72.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 3.23 110.165 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.58 -39.26 77.44 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.202 -0.936 . . . . 0.76000000000000001 109.377 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.32 -47.54 79.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.838 . . . . 0.46000000000000002 110.457 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -85.3 11.6 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.44 111.139 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.21 -11.92 15.49 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.238 -0.914 . . . . 0.53000000000000003 109.759 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.45 151.63 21.43 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.091 -1.006 . . . . 1.27 108.97 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.97 161.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.847 1.698 . . . . 0.48999999999999999 111.585 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.509 ' CE ' HD22 ' B' ' 46' ' ' LEU . 8.9 ptp -90.74 -19.79 23.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.56000000000000005 109.561 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.11 -140.1 18.32 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.047 -1.221 . . . . 0.39000000000000001 110.047 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.74 25.09 10.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.981 . . . . 0.83999999999999997 109.848 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -61.03 148.92 83.35 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.908 -1.12 . . . . 2.02 108.879 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.22 158.78 33.49 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.412 2.075 . . . . 0.34000000000000002 113.315 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.551 HG13 ' N ' ' B' ' 21' ' ' GLY . 11.2 p -59.64 -44.95 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.625 0.726 . . . . 0.32000000000000001 110.273 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.551 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.22 -2.81 0.17 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.591 -1.003 . . . . 0.22 110.591 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' B' ' 20' ' ' VAL . 68.5 m -82.91 -19.33 37.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.793 -1.416 . . . . 1.24 109.34 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.97 137.42 57.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.965 . . . . 0.23999999999999999 109.651 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.47 134.4 53.34 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.805 . . . . 0.20999999999999999 109.995 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 -20.91 48.79 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.236 -1.545 . . . . 0.22 109.236 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 mm -98.44 113.1 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.263 -1.139 . . . . 0.25 107.961 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.74 179.05 38.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.913 -1.275 . . . . 0.28000000000000003 109.913 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.16 -40.04 76.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 2.0 110.353 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.99 -46.41 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.38 109.725 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 93.3 mt -65.26 -37.68 87.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.40000000000000002 109.666 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.82 95.68 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.256 -1.538 . . . . 0.35999999999999999 109.256 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.24 -39.92 94.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.392 -1.064 . . . . 2.75 109.922 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.6 -44.9 69.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.844 -1.16 . . . . 1.5600000000000001 109.331 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.55 -39.92 95.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.016 -1.105 . . . . 0.33000000000000002 108.016 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -41.56 92.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.945 -0.761 . . . . 1.6799999999999999 108.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -68.19 -20.13 64.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.633 -0.877 . . . . 1.99 108.633 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -90.15 1.3 56.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.495 -0.753 . . . . 2.6800000000000002 109.646 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.45 37.8 3.91 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.115 -0.991 . . . . 0.48999999999999999 111.127 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.518 ' CD2' HG12 ' B' ' 44' ' ' VAL . 89.0 m-85 -134.01 72.75 1.48 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.977 -1.308 . . . . 0.33000000000000002 108.956 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -80.57 -10.57 59.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.089 -1.007 . . . . 0.40999999999999998 110.8 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.95 152.31 51.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.204 -0.935 . . . . 1.5600000000000001 110.038 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.63 91.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.20999999999999999 111.848 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.58 -17.96 10.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.577 -1.327 . . . . 0.32000000000000001 110.51 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.518 HG12 ' CD2' ' B' ' 39' ' ' PHE . 43.8 t -79.43 -31.65 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.797 -1.19 . . . . 0.23999999999999999 107.841 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.46 -36.76 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.39 -0.967 . . . . 0.22 108.39 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.509 HD22 ' CE ' ' B' ' 15' ' ' MET . 67.0 tp -60.01 -38.12 81.73 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.802 -1.555 . . . . 0.40000000000000002 106.802 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.63 85.42 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.936 -1.266 . . . . 0.17999999999999999 109.936 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -60.0 -42.31 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.881 -1.364 . . . . 1.0900000000000001 108.819 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -40.16 88.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.356 -0.979 . . . . 0.31 108.356 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 65.4 mt -69.96 -40.06 75.63 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.725 -0.843 . . . . 0.27000000000000002 108.725 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.62 -26.66 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 111.276 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.38 16.45 6.39 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.035 -1.041 . . . . 0.29999999999999999 110.237 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.16 21.79 5.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.885 . . . . 1.71 110.092 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 80.5 mttt 59.99 19.19 8.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.75 -0.593 . . . . 2.25 110.386 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.62 122.29 17.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.561 -1.337 . . . . 1.8 107.664 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE2' ' CG ' ' B' ' 78' ' ' PHE . 8.5 tp10 -62.0 -42.04 98.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.88 113.289 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.54 -39.97 77.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.339 -1.476 . . . . 0.73999999999999999 110.694 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.09 -40.01 75.23 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.99 -1.084 . . . . 0.55000000000000004 109.035 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.56 -48.38 79.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.38 109.544 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.03 -47.61 85.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 2.6400000000000001 110.846 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.03 -39.46 94.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.715 -1.241 . . . . 2.3799999999999999 108.953 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' TRP . . . . . 0.424 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -61.83 -49.91 74.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.339 -0.85 . . . . 0.40000000000000002 111.377 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.68 -47.67 68.79 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.196 -0.94 . . . . 0.34000000000000002 110.069 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -62.94 -46.78 86.14 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.917 . . . . 2.1000000000000001 109.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.32 -30.75 69.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.8999999999999999 109.655 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 99.7 m -79.11 -35.14 42.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.40000000000000002 111.354 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.9 p -131.59 -35.18 1.31 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.639 -1.288 . . . . 0.39000000000000001 111.787 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.26 16.22 9.82 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 109.341 -1.503 . . . . 0.35999999999999999 109.341 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.51 153.14 1.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.866 -1.373 . . . . 0.32000000000000001 109.078 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -89.86 170.56 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.089 -1.007 . . . . 1.9099999999999999 109.329 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.35 -32.97 71.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.507 -0.746 . . . . 0.38 111.0 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.41 ' HA ' ' HE ' ' B' ' 75' ' ' ARG . 68.5 mttm -71.89 -41.45 67.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.751 -1.218 . . . . 2.5699999999999998 110.441 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -67.32 -36.38 81.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 2.1200000000000001 110.447 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.65 -38.35 83.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.352 -0.842 . . . . 1.3600000000000001 110.442 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' B' ' 72' ' ' LYS . 83.5 mtm180 -60.01 -36.45 77.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.748 -1.22 . . . . 2.8100000000000001 108.746 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.64 -39.47 80.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.782 -1.199 . . . . 0.40000000000000002 110.187 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.07 -41.23 82.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.987 -1.07 . . . . 0.23000000000000001 109.529 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.526 ' CG ' ' OE2' ' B' ' 56' ' ' GLU . 64.4 t80 -60.02 -59.77 4.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.819 -1.176 . . . . 0.42999999999999999 109.507 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.03 -34.86 85.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.935 -1.266 . . . . 0.25 109.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.87 -45.71 67.09 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.152 -1.205 . . . . 0.23999999999999999 109.364 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.41 -41.67 69.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.999 . . . . 0.28999999999999998 109.151 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.37 -40.98 96.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.881 . . . . 2.7400000000000002 109.605 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.96 -38.04 75.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.164 -0.96 . . . . 1.9099999999999999 110.604 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.481 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.9 t90 -59.99 -43.5 95.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.332 -1.48 . . . . 0.35999999999999999 107.718 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' B' ' 89' ' ' LEU . 22.3 m -60.06 -40.05 88.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.637 -0.664 . . . . 0.35999999999999999 109.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -59.07 -34.11 71.58 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 110.288 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.76 -35.02 13.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.009 -1.057 . . . . 0.46999999999999997 111.377 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.481 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.2 m-85 -109.91 2.16 19.62 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.12 -0.987 . . . . 1.24 112.272 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.0 tp . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.716 -1.24 . . . . 1.6699999999999999 109.944 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.734 0.778 . . . . 1.51 109.928 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -56.75 -23.96 46.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.783 -0.573 . . . . 2.1800000000000002 110.208 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.13 -38.41 82.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.921 . . . . 2.02 108.932 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -60.04 -52.23 66.24 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.463 -0.773 . . . . 0.48999999999999999 110.795 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 89.1 mtm180 -69.94 -35.41 74.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.963 -1.086 . . . . 3.21 109.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -65.49 -40.01 92.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.82 . . . . 0.76000000000000001 109.342 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 44.4 t80 -63.14 -49.65 73.53 Favored 'General case' 0 C--N 1.298 -1.63 0 C-N-CA 119.642 -0.823 . . . . 0.46000000000000002 110.003 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.35 6.04 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.105 -0.997 . . . . 0.44 111.231 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -99.27 -18.77 17.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.93 -1.106 . . . . 0.54000000000000004 110.057 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' PRO . 6.5 pt-20 -151.96 151.94 28.96 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.154 -0.967 . . . . 1.26 108.917 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 13' ' ' GLU . 69.6 Cg_exo -36.76 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.2 1.933 . . . . 0.48999999999999999 111.688 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.509 ' SD ' HD13 ' B' ' 89' ' ' LEU . 15.6 ptm -93.66 -29.64 15.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.104 -0.997 . . . . 0.56999999999999995 110.15 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 -135.28 44.7 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.205 -1.158 . . . . 0.40000000000000002 110.205 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.97 35.3 3.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.676 -0.896 . . . . 0.84999999999999998 110.014 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.26 148.59 71.76 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 2.0099999999999998 108.47 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.28 156.2 41.85 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.025 1.817 . . . . 0.34000000000000002 112.048 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.4 p -57.01 -48.13 82.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.442 -0.786 . . . . 0.32000000000000001 110.22 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.84 -3.81 0.23 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.716 -0.954 . . . . 0.23000000000000001 110.716 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 70.7 m -83.16 -21.54 33.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.709 -1.465 . . . . 1.24 109.422 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.36 136.79 57.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.038 -1.039 . . . . 0.23999999999999999 109.418 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.59 136.17 56.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.763 0.792 . . . . 0.20999999999999999 109.758 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.27 -20.07 52.24 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.741 -1.744 . . . . 0.22 108.741 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.83 115.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.908 -1.145 . . . . 0.25 107.908 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -90.21 177.02 42.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.825 -1.31 . . . . 0.28000000000000003 109.825 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.76 -39.93 74.9 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.629 -0.924 . . . . 2.0099999999999998 109.914 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.82 -44.47 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.05 . . . . 0.38 109.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 27' ' ' GLY . 93.6 mt -66.77 -37.46 84.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.9 . . . . 0.40000000000000002 109.47 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.246 -1.542 . . . . 0.34999999999999998 109.246 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.82 -39.86 94.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.405 -1.056 . . . . 2.7400000000000002 110.367 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -65.44 -48.45 72.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.859 -1.151 . . . . 1.54 109.948 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.69 -36.03 79.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.909 -1.119 . . . . 0.34000000000000002 108.485 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.739 -0.601 . . . . 1.6699999999999999 110.058 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.02 -19.37 65.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.995 . . . . 2.0 108.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 37' ' ' ARG . 33.8 mtt-85 -91.05 6.59 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.595 -0.691 . . . . 2.6899999999999999 110.25 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.7 55.43 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.978 -1.076 . . . . 0.47999999999999998 111.688 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD1' HG12 ' A' ' 44' ' ' VAL . 87.2 m-85 -103.86 72.99 1.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.835 -1.391 . . . . 0.33000000000000002 108.341 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.06 -10.72 59.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.459 -0.776 . . . . 0.40999999999999998 110.628 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.5 150.27 50.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.167 -0.958 . . . . 1.5600000000000001 109.62 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.99 94.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.20999999999999999 110.827 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 17.0 p90 -60.55 -18.64 53.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.016 -1.052 . . . . 0.32000000000000001 110.371 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 39' ' ' PHE . 50.1 t -79.57 -32.74 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.434 -1.321 . . . . 0.23999999999999999 107.434 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.74 -37.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.096 -1.075 . . . . 0.22 108.096 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.8 tp -59.99 -35.46 75.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.569 -1.271 . . . . 0.40000000000000002 107.569 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.54 97.08 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.166 -1.173 . . . . 0.17999999999999999 110.166 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -59.97 -41.66 92.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.01 -1.288 . . . . 1.0900000000000001 109.778 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.31 108.741 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -38.77 81.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.723 -0.843 . . . . 0.28000000000000003 108.723 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.02 -24.54 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.347 -0.846 . . . . 0.28000000000000003 110.629 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.23 18.37 9.61 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.121 -0.987 . . . . 0.31 110.444 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.36 33.55 7.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.768 -1.207 . . . . 1.7 110.126 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.05 19.92 9.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.751 -0.593 . . . . 2.2400000000000002 110.382 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.47 113.38 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.609 -1.307 . . . . 1.8 107.719 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.84 -40.03 93.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.87 113.16 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -69.81 -39.7 76.37 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.615 -1.303 . . . . 0.72999999999999998 110.578 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.57 -38.77 77.54 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.75 -1.18 . . . . 0.55000000000000004 108.921 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.92 -50.59 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.38 109.983 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 60' ' ' ARG . 5.4 mtm-85 -62.54 -43.71 98.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 2.6400000000000001 109.841 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.95 -39.78 94.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 2.3700000000000001 108.797 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.461 ' O ' ' OG1' ' A' ' 66' ' ' THR . 55.9 t90 -65.45 -46.32 80.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.40000000000000002 110.526 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 tp -67.56 -49.45 63.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.34000000000000002 110.017 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.75 -48.87 79.86 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.381 -0.825 . . . . 2.1099999999999999 109.969 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 28.8 t0 -68.95 -28.97 67.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.704 . . . . 1.8999999999999999 109.862 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 50.3 m -79.5 -34.55 41.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.254 -0.903 . . . . 0.40999999999999998 111.019 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.3 p -131.56 -29.52 1.74 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.648 -1.283 . . . . 0.40000000000000002 111.749 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.6 14.19 20.38 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.382 -1.487 . . . . 0.35999999999999999 109.382 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.44 1.69 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.047 -1.266 . . . . 0.33000000000000002 109.015 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -90.6 171.19 9.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.084 -1.01 . . . . 1.8999999999999999 109.737 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -34.01 72.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.39000000000000001 110.746 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.19 -40.54 67.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.618 -1.301 . . . . 2.5800000000000001 109.993 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.79 -39.98 79.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.112 -0.993 . . . . 2.1200000000000001 110.409 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -67.41 -39.05 85.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.27 -0.894 . . . . 1.3600000000000001 110.028 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -59.97 -38.65 83.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 2.7999999999999998 109.421 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.43 -39.94 85.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.712 -1.243 . . . . 0.40000000000000002 110.482 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -66.78 -40.03 88.03 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.915 -1.115 . . . . 0.23999999999999999 109.86 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.03 -59.97 4.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.599 -1.313 . . . . 0.42999999999999999 110.044 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.67 84.97 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.443 -1.063 . . . . 0.26000000000000001 110.443 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.13 -49.94 52.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -1.134 . . . . 0.25 109.867 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.07 -39.98 75.31 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.792 -1.163 . . . . 0.29999999999999999 108.775 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.23 -41.18 99.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 2.73 110.18 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -69.87 -35.94 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.927 -1.108 . . . . 1.9099999999999999 109.569 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.443 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 80.2 t90 -59.98 -43.92 94.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.944 -1.502 . . . . 0.37 106.944 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 34.9 m -60.98 -40.03 91.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.827 -0.805 . . . . 0.35999999999999999 108.827 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.66 81.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.431 -0.793 . . . . 0.55000000000000004 110.032 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.58 -38.18 16.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -0.991 . . . . 0.47999999999999998 110.6 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.228 -0.92 . . . . 1.24 110.102 -178.756 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.709 0.766 . . . . 1.5 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -56.79 -23.86 46.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.752 -0.593 . . . . 2.1800000000000002 110.272 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.12 -38.48 83.15 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.216 -0.928 . . . . 2.0099999999999998 108.931 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -59.97 -52.21 66.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.48999999999999999 110.867 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 89.0 mtm180 -70.01 -35.38 74.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.955 -1.091 . . . . 3.23 109.738 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -65.47 -40.01 92.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.37 -0.831 . . . . 0.76000000000000001 109.385 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 44.1 t80 -63.1 -49.67 73.54 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.343 -0.848 . . . . 0.46000000000000002 110.026 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.32 6.07 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.078 -1.014 . . . . 0.44 111.241 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -99.36 -18.68 17.4 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.894 -1.129 . . . . 0.53000000000000003 110.0 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' B' ' 14' ' ' PRO . 6.5 pt-20 -152.0 151.89 28.8 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.097 -1.002 . . . . 1.27 108.95 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' B' ' 13' ' ' GLU . 70.2 Cg_exo -36.75 156.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 122.16 1.907 . . . . 0.48999999999999999 111.795 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.434 ' H ' ' HG2' ' B' ' 15' ' ' MET . 15.7 ptm -93.58 -29.72 15.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.094 -1.004 . . . . 0.56000000000000005 110.158 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -135.3 44.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.227 -1.149 . . . . 0.39000000000000001 110.227 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.94 35.16 3.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.619 -0.93 . . . . 0.83999999999999997 110.005 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.18 148.54 71.39 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.991 . . . . 2.02 108.445 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.3 156.24 41.79 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.998 1.799 . . . . 0.34000000000000002 112.039 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.563 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.4 p -57.02 -48.19 82.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.543 -0.723 . . . . 0.32000000000000001 110.237 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.563 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.7 -3.94 0.22 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.776 -0.93 . . . . 0.22 110.776 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' B' ' 20' ' ' VAL . 70.6 m -83.08 -21.6 33.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.761 -1.435 . . . . 1.24 109.462 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.33 136.79 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.23999999999999999 109.406 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.58 136.18 56.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.755 0.788 . . . . 0.20999999999999999 109.824 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.31 -20.15 51.9 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.742 -1.743 . . . . 0.22 108.742 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -99.76 114.99 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.933 -1.136 . . . . 0.25 107.933 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.423 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -90.31 177.0 42.33 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.825 -1.31 . . . . 0.28000000000000003 109.825 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.62 -39.97 74.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.591 -0.946 . . . . 2.0 110.015 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.84 -44.37 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.38 109.837 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.423 HD12 ' H ' ' B' ' 27' ' ' GLY . 93.5 mt -66.78 -37.5 84.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.40000000000000002 109.487 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.0 96.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.288 -1.525 . . . . 0.35999999999999999 109.288 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -39.76 94.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -1.12 . . . . 2.75 110.371 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -65.4 -48.38 73.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.201 . . . . 1.5600000000000001 109.971 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.8 -36.02 79.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.953 -1.092 . . . . 0.33000000000000002 108.492 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -59.92 -42.51 94.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.732 -0.605 . . . . 1.6799999999999999 110.008 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.05 -19.32 65.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 1.99 108.607 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' B' ' 37' ' ' ARG . 34.0 mtt-85 -90.97 6.56 44.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.595 -0.691 . . . . 2.6800000000000002 110.291 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.73 55.49 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.063 -1.065 . . . . 0.48999999999999999 111.766 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.525 ' CD1' HG12 ' B' ' 44' ' ' VAL . 86.8 m-85 -103.9 73.1 1.14 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.801 -1.411 . . . . 0.33000000000000002 108.328 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.17 -10.61 59.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.40999999999999998 110.639 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.52 150.3 50.92 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.92 . . . . 1.5600000000000001 109.62 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.07 94.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.20999999999999999 110.766 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 16.7 p90 -60.49 -18.57 52.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.32000000000000001 110.514 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' B' ' 39' ' ' PHE . 50.8 t -79.62 -32.77 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.426 -1.324 . . . . 0.23999999999999999 107.426 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.83 -37.26 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.109 -1.071 . . . . 0.22 108.109 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.04 -35.44 75.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.611 -1.255 . . . . 0.40000000000000002 107.611 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.61 97.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.067 -1.213 . . . . 0.17999999999999999 110.067 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -60.02 -41.64 92.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.006 -1.291 . . . . 1.0900000000000001 109.742 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.04 -39.88 87.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.31 108.82 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.52 -38.77 81.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.816 -0.809 . . . . 0.27000000000000002 108.816 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.03 -24.44 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.401 -0.812 . . . . 0.28000000000000003 110.648 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.8 mt -93.18 18.16 9.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.111 -0.993 . . . . 0.29999999999999999 110.434 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.46 33.55 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.67 -1.269 . . . . 1.71 110.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.06 19.89 9.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.764 -0.585 . . . . 2.25 110.332 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -68.48 113.4 6.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 1.8 107.726 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.82 -39.96 93.6 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 113.11 0.782 . . . . 0.88 113.11 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.87 -39.61 76.23 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.575 -1.328 . . . . 0.73999999999999999 110.604 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.59 -38.82 77.49 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.848 -1.141 . . . . 0.55000000000000004 108.937 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.98 -50.44 68.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.38 110.005 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.499 HH11 ' HG3' ' B' ' 60' ' ' ARG . 5.4 mtm-85 -62.62 -43.66 98.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 2.6400000000000001 109.803 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.94 -39.79 94.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 2.3799999999999999 108.745 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' TRP . . . . . 0.408 ' O ' ' OG1' ' B' ' 66' ' ' THR . 55.7 t90 -65.54 -46.29 80.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.912 . . . . 0.40000000000000002 110.513 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -49.45 63.17 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.06 -1.025 . . . . 0.34000000000000002 110.074 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.78 -48.72 80.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.288 -0.882 . . . . 2.1000000000000001 109.937 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.8 t0 -69.13 -28.89 66.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 1.8999999999999999 109.852 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 50.5 m -79.51 -34.61 41.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.40000000000000002 111.011 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.3 p -131.61 -29.45 1.74 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.611 -1.305 . . . . 0.39000000000000001 111.77 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.57 14.27 20.22 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.321 -1.512 . . . . 0.35999999999999999 109.321 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.48 1.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.322 . . . . 0.32000000000000001 109.077 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -90.7 171.12 9.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.075 -1.015 . . . . 1.9099999999999999 109.685 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.97 72.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.52 -0.738 . . . . 0.38 110.828 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.07 -40.63 68.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.558 -1.339 . . . . 2.5699999999999998 110.003 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.81 -39.98 79.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 2.1200000000000001 110.382 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 56.6 m -67.19 -39.22 86.34 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.279 -0.888 . . . . 1.3600000000000001 110.044 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -60.09 -38.46 82.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 2.8100000000000001 109.387 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.58 -39.9 84.86 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.722 -1.236 . . . . 0.40000000000000002 110.357 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.5 m -66.91 -39.93 87.53 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.947 -1.096 . . . . 0.23000000000000001 109.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 -59.97 4.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.638 -1.289 . . . . 0.42999999999999999 110.066 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.54 84.51 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.518 -1.033 . . . . 0.25 110.518 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.18 -50.06 50.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -1.19 . . . . 0.23999999999999999 109.77 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.94 -40.06 75.69 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.827 -1.149 . . . . 0.28999999999999998 108.809 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.15 -41.23 99.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 2.7400000000000002 110.159 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.88 -35.92 75.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.017 -1.052 . . . . 1.9099999999999999 109.594 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.43 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 80.2 t90 -60.03 -43.95 94.95 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.929 -1.508 . . . . 0.35999999999999999 106.929 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.0 m -60.99 -39.96 91.64 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.849 -0.797 . . . . 0.35999999999999999 108.849 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.59 81.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.55000000000000004 110.117 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -38.71 15.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.155 -0.966 . . . . 0.46999999999999997 110.579 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -104.51 -86.79 0.45 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.169 -0.957 . . . . 1.24 110.265 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.509 HD13 ' SD ' ' A' ' 15' ' ' MET . 17.7 tp . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 118.084 -0.96 . . . . 1.6699999999999999 109.602 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.585 0.707 . . . . 1.51 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.68 -21.14 62.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.538 -0.726 . . . . 2.1800000000000002 110.69 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.99 -37.84 80.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.777 -1.202 . . . . 2.02 109.613 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -60.0 -51.85 67.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.841 -1.162 . . . . 0.48999999999999999 110.48 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -69.72 -36.59 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.012 -1.055 . . . . 3.21 109.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.49 -39.96 73.86 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.76000000000000001 109.69 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.32 -41.33 96.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.216 -0.928 . . . . 0.46000000000000002 109.945 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 m -84.31 15.58 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.44 109.842 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.8 -9.78 11.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.449 -0.782 . . . . 0.54000000000000004 110.294 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 10.6 pt-20 -149.86 149.2 27.31 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.943 -1.098 . . . . 1.26 109.252 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 13' ' ' GLU . 89.7 Cg_exo -41.1 166.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.811 1.674 . . . . 0.48999999999999999 111.776 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.458 ' SD ' HD11 ' B' ' 89' ' ' LEU . 3.4 ptp -93.05 -24.95 18.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.56999999999999995 108.621 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.96 -140.65 16.48 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.021 -1.632 . . . . 0.40000000000000002 109.021 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -109.74 30.03 7.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.481 -1.011 . . . . 0.84999999999999998 109.477 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 90.2 mttt -60.18 149.39 75.52 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 2.0099999999999998 108.986 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.12 153.98 54.77 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.182 1.921 . . . . 0.34000000000000002 112.439 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 21' ' ' GLY . 14.5 p -57.52 -44.03 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.603 -0.686 . . . . 0.32000000000000001 110.522 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.64 -2.78 0.2 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.16 -1.176 . . . . 0.23000000000000001 110.16 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 20' ' ' VAL . 40.7 t -82.59 -23.42 34.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.774 -1.427 . . . . 1.24 109.093 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.23999999999999999 109.874 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.14 134.28 52.45 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.763 0.792 . . . . 0.20999999999999999 109.96 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.94 -20.53 48.71 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.283 -1.527 . . . . 0.22 109.283 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.6 mm -99.75 114.2 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.281 -1.129 . . . . 0.25 108.011 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.71 178.4 39.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.271 -1.532 . . . . 0.28000000000000003 109.271 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -57.24 -39.71 76.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.337 -1.096 . . . . 2.0099999999999998 109.209 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.33 -48.38 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.38 109.706 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.0 -39.97 83.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 0.40000000000000002 109.285 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.98 98.69 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.565 -1.414 . . . . 0.34999999999999998 109.565 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.85 -41.06 95.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -1.201 . . . . 2.7400000000000002 110.352 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.46 -40.16 85.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.823 -1.173 . . . . 1.54 109.689 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.83 -40.06 93.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.963 -1.085 . . . . 0.34000000000000002 109.106 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.08 -40.89 91.12 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.723 -0.791 . . . . 1.6699999999999999 109.363 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.77 -19.53 64.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.809 -0.811 . . . . 2.0 108.809 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -89.0 0.18 56.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.631 -0.668 . . . . 2.6899999999999999 109.898 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' B' ' 53' ' ' LYS . . . 107.01 4.35 35.93 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 120.254 -0.974 . . . . 0.47999999999999998 111.577 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.425 ' CD2' HG12 ' A' ' 44' ' ' VAL . 96.2 m-85 -103.17 75.64 1.38 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.825 -1.397 . . . . 0.33000000000000002 109.137 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.16 -11.14 59.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.40999999999999998 111.159 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -135.08 157.84 45.89 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.939 -1.101 . . . . 1.5600000000000001 109.397 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.59 88.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.20999999999999999 112.078 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -56.15 -18.15 9.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.768 -1.208 . . . . 0.32000000000000001 110.457 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.425 HG12 ' CD2' ' A' ' 39' ' ' PHE . 21.6 t -80.15 -31.43 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.832 -1.168 . . . . 0.23999999999999999 108.287 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.52 -38.7 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.413 -0.958 . . . . 0.22 108.413 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.85 -38.2 81.43 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.654 -1.61 . . . . 0.40000000000000002 106.654 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.41 -45.98 58.3 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.878 -1.289 . . . . 0.17999999999999999 109.878 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -60.09 -41.93 93.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -1.181 . . . . 1.0900000000000001 109.329 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.93 -40.57 89.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.0 -1.063 . . . . 0.31 108.828 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.74 -39.7 76.61 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.688 -0.856 . . . . 0.28000000000000003 108.688 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.09 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.28000000000000003 110.554 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.77 13.83 13.39 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.096 . . . . 0.31 110.858 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 51.32 35.91 14.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.209 . . . . 1.7 110.223 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 56.08 19.42 3.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.228 -0.92 . . . . 2.2400000000000002 110.524 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -69.16 105.34 2.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.712 -1.242 . . . . 1.8 108.263 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.538 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 83.3 tt0 -62.94 -39.95 96.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 0.87 111.973 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.65 -39.89 88.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.72999999999999998 109.57 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.32 -37.92 71.73 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.445 -0.902 . . . . 0.55000000000000004 108.747 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.56 -42.13 95.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.565 -0.71 . . . . 0.38 109.941 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.538 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 99.2 mtt180 -60.11 -48.5 81.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.249 -0.907 . . . . 2.6400000000000001 110.361 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.94 -39.89 90.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.682 -1.261 . . . . 2.3700000000000001 109.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -61.65 -50.1 73.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 0.40000000000000002 110.664 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.9 tp -68.4 -48.44 64.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.089 -1.007 . . . . 0.34000000000000002 110.103 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.19 -47.16 85.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 2.1099999999999999 109.797 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -68.71 -30.12 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.555 -0.715 . . . . 1.8999999999999999 109.682 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -80.22 -32.52 38.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.40999999999999998 111.029 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -133.0 -35.05 1.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.575 -1.328 . . . . 0.40000000000000002 112.098 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.65 16.04 9.71 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.338 -1.505 . . . . 0.35999999999999999 109.338 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 152.24 2.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.272 . . . . 0.33000000000000002 109.89 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -90.22 173.49 8.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.109 -0.994 . . . . 1.8999999999999999 109.953 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.61 75.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.715 . . . . 0.39000000000000001 110.03 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.24 -40.01 71.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 2.5800000000000001 109.633 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -66.61 -39.28 88.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.548 -0.72 . . . . 2.1200000000000001 110.151 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.1 m -62.84 -38.61 91.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.299 -0.876 . . . . 1.3600000000000001 109.747 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 2.7999999999999998 109.614 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -69.31 -39.91 77.98 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.737 -1.227 . . . . 0.40000000000000002 110.742 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -70.2 -39.96 74.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.661 -1.275 . . . . 0.23999999999999999 109.996 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.33 -60.38 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.81 -1.181 . . . . 0.42999999999999999 110.046 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.46 82.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.388 -1.085 . . . . 0.26000000000000001 110.388 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.7 t -68.54 -49.63 58.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.295 . . . . 0.25 109.681 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.1 mt -70.09 -40.07 75.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.323 -0.951 . . . . 0.29999999999999999 109.327 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -62.0 -40.59 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 2.73 109.596 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.02 -38.63 75.98 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.277 -0.889 . . . . 1.9099999999999999 110.077 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.557 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.4 t90 -61.69 -46.57 89.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.473 -1.392 . . . . 0.37 108.688 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.9 m -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.462 -0.774 . . . . 0.35999999999999999 109.573 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -58.87 -30.97 68.15 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 109.423 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.48 -34.75 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.269 -0.894 . . . . 0.47999999999999998 111.063 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 87.2 m-85 . . . . . 0 N--CA 1.507 2.42 0 O-C-N 121.149 -0.969 . . . . 1.24 112.717 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 54.3 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.652 0.739 . . . . 1.5 109.642 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.84 -21.06 62.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 2.1800000000000002 110.624 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.97 -37.82 80.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.799 -1.188 . . . . 2.0099999999999998 109.619 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -60.0 -51.9 67.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.081 . . . . 0.48999999999999999 110.527 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -69.73 -36.51 75.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 3.23 109.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.41 -39.93 74.17 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.35 -0.844 . . . . 0.76000000000000001 109.793 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.44 -41.15 96.73 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.503 -0.879 . . . . 0.46000000000000002 109.933 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.53 15.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.081 -1.012 . . . . 0.44 109.857 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.97 -9.81 11.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.466 -0.771 . . . . 0.53000000000000003 110.362 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' B' ' 18' ' ' LYS . 10.5 pt-20 -149.86 149.14 27.14 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 120.903 -1.123 . . . . 1.27 109.208 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' B' ' 13' ' ' GLU . 92.3 Cg_exo -41.04 166.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.798 1.665 . . . . 0.48999999999999999 111.705 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 3.3 ptp -93.29 -24.69 18.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 0.56000000000000005 108.699 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.61 -140.55 14.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.03 -1.628 . . . . 0.39000000000000001 109.03 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -109.65 30.1 6.97 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.512 -0.993 . . . . 0.83999999999999997 109.464 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' B' ' 13' ' ' GLU . 89.8 mttt -60.27 149.55 75.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.938 . . . . 2.02 108.856 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.35 153.98 56.14 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.204 1.936 . . . . 0.34000000000000002 112.422 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.534 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.5 p -57.64 -43.84 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.567 -0.708 . . . . 0.32000000000000001 110.545 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.534 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.83 -2.56 0.2 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.118 -1.193 . . . . 0.22 110.118 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.506 ' H ' ' C ' ' B' ' 20' ' ' VAL . 40.6 t -82.87 -23.39 33.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.399 . . . . 1.24 109.125 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.23999999999999999 109.869 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.16 134.22 52.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.788 0.804 . . . . 0.20999999999999999 110.075 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.528 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.98 -20.5 48.78 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.287 -1.525 . . . . 0.22 109.287 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.65 114.05 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -1.125 . . . . 0.25 108.024 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.6 178.3 39.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.262 -1.535 . . . . 0.28000000000000003 109.262 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -57.19 -39.57 75.62 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.315 -1.109 . . . . 2.0 109.236 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.28 -48.53 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.38 109.721 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.86 -40.07 83.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.159 -0.963 . . . . 0.40000000000000002 109.354 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.95 98.66 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.594 -1.403 . . . . 0.35999999999999999 109.594 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.83 -41.21 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -1.23 . . . . 2.75 110.301 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.41 -39.9 85.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.83 -1.169 . . . . 1.5600000000000001 109.772 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.94 -39.98 93.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.026 . . . . 0.33000000000000002 109.06 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.09 -40.94 91.34 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.79 -0.764 . . . . 1.6799999999999999 109.317 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -68.81 -19.46 64.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.824 -0.806 . . . . 1.99 108.824 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -89.01 0.39 56.71 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.092 -0.643 . . . . 2.6800000000000002 109.969 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.79 4.33 36.58 Favored Glycine 0 N--CA 1.504 3.17 0 O-C-N 121.105 -0.997 . . . . 0.48999999999999999 111.734 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.431 ' CD2' HG12 ' B' ' 44' ' ' VAL . 96.3 m-85 -103.33 75.83 1.38 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.818 -1.401 . . . . 0.33000000000000002 109.096 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -77.43 -10.97 59.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.40999999999999998 111.019 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -135.19 157.95 45.61 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.902 -1.124 . . . . 1.5600000000000001 109.444 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.49 88.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.547 -0.72 . . . . 0.20999999999999999 112.051 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -56.36 -18.13 9.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.721 -1.237 . . . . 0.32000000000000001 110.551 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' B' ' 39' ' ' PHE . 21.5 t -80.13 -31.36 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.884 -1.135 . . . . 0.23999999999999999 108.279 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.52 -38.75 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 0.22 108.425 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.03 -38.3 82.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.573 -1.64 . . . . 0.40000000000000002 106.573 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.74 -45.6 60.43 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.68 -1.368 . . . . 0.17999999999999999 109.68 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -60.17 -41.8 93.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.225 . . . . 1.0900000000000001 109.356 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.0 -40.49 89.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.017 -1.052 . . . . 0.31 108.753 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -69.77 -40.04 76.31 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.662 -0.866 . . . . 0.27000000000000002 108.662 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.68 -21.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.135 -0.978 . . . . 0.28000000000000003 110.613 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.91 14.02 13.14 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.048 -1.032 . . . . 0.29999999999999999 110.663 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 38' ' ' GLY . 59.8 mttp 50.79 36.32 14.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.812 -1.18 . . . . 1.71 110.227 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 55.91 19.41 3.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.308 -0.87 . . . . 2.25 110.618 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -69.01 105.58 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.72 -1.237 . . . . 1.8 108.18 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 83.5 tt0 -63.17 -39.96 96.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.88 111.977 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.45 -40.08 89.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.815 -1.178 . . . . 0.73999999999999999 109.553 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -71.1 -37.79 72.38 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.396 -0.921 . . . . 0.55000000000000004 108.848 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.8 -42.19 95.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.612 -0.68 . . . . 0.38 109.898 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 99.2 mtt180 -59.99 -48.96 79.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.244 -0.91 . . . . 2.6400000000000001 110.35 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.54 -39.94 92.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.689 -1.257 . . . . 2.3799999999999999 109.832 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -61.7 -49.97 74.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.921 -1.112 . . . . 0.40000000000000002 110.706 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.2 tp -68.43 -48.7 63.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.079 -1.013 . . . . 0.34000000000000002 110.032 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.06 -47.12 86.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 2.1000000000000001 109.767 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -68.85 -29.96 68.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 1.8999999999999999 109.656 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -80.17 -32.58 38.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.40000000000000002 111.045 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 32.0 p -132.94 -35.29 1.07 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.66 -1.275 . . . . 0.39000000000000001 112.045 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.72 16.48 9.28 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.292 -1.523 . . . . 0.35999999999999999 109.292 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 152.32 3.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.063 -1.257 . . . . 0.32000000000000001 109.76 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.1 173.62 8.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 1.9099999999999999 109.98 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.92 -34.3 75.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.38 110.093 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -71.38 -40.1 70.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 2.5699999999999998 109.593 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.6 mm100 -66.53 -39.15 88.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.488 -0.757 . . . . 2.1200000000000001 110.25 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 74.2 m -62.94 -38.58 91.61 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.268 -0.895 . . . . 1.3600000000000001 109.748 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.158 -0.964 . . . . 2.8100000000000001 109.626 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -69.32 -39.99 77.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.839 -1.163 . . . . 0.40000000000000002 110.716 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -70.14 -40.05 75.03 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.682 -1.261 . . . . 0.23000000000000001 109.968 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -61.18 -60.31 3.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.861 -1.149 . . . . 0.42999999999999999 110.162 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.34 82.14 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.46 -1.056 . . . . 0.25 110.46 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.66 -49.63 57.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.302 . . . . 0.23999999999999999 109.699 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.03 -40.04 75.42 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.295 -0.962 . . . . 0.28999999999999998 109.324 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -62.0 -40.68 96.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 2.7400000000000002 109.566 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -38.69 76.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.166 -0.959 . . . . 1.9099999999999999 110.153 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.555 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.2 t90 -61.75 -46.61 88.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.456 -1.403 . . . . 0.35999999999999999 108.702 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' B' ' 89' ' ' LEU . 51.6 m -60.08 -39.91 87.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.751 -0.78 . . . . 0.35999999999999999 109.686 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.05 -30.79 68.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.384 -0.822 . . . . 0.55000000000000004 109.406 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 -35.21 13.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.835 . . . . 0.46999999999999997 111.057 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.4 m-85 -108.31 -6.13 16.44 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.129 -0.982 . . . . 1.24 112.663 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.458 HD11 ' SD ' ' A' ' 15' ' ' MET . 10.4 tp . . . . . 0 N--CA 1.502 2.171 0 O-C-N 120.355 -1.466 . . . . 1.6699999999999999 109.371 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.7 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.609 0.718 . . . . 1.51 109.124 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.91 -28.66 67.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.548 -0.72 . . . . 2.1800000000000002 110.114 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -60.32 -39.62 87.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.949 -1.095 . . . . 2.02 109.644 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -59.85 -51.17 70.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.931 . . . . 0.48999999999999999 110.656 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 23.8 mmm180 -70.25 -34.45 72.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.814 -1.179 . . . . 3.21 109.685 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -68.74 -38.88 80.46 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.368 -0.833 . . . . 0.76000000000000001 110.023 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.55 -45.78 82.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.46000000000000002 110.173 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -86.26 7.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.124 -0.985 . . . . 0.44 110.812 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -102.2 -13.62 17.35 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.201 -0.937 . . . . 0.54000000000000004 110.056 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -154.54 153.55 28.05 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.977 . . . . 1.26 108.998 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -37.72 156.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 122.071 1.847 . . . . 0.48999999999999999 111.741 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.476 ' SD ' HD11 ' B' ' 89' ' ' LEU . 11.7 ptm -93.31 -28.2 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.56999999999999995 110.296 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.51 42.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.433 -1.067 . . . . 0.40000000000000002 110.433 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.64 35.89 3.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.614 -0.933 . . . . 0.84999999999999998 110.379 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -57.93 149.58 54.04 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.047 -1.033 . . . . 2.0099999999999998 108.313 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.94 155.31 55.93 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.069 1.846 . . . . 0.34000000000000002 112.551 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 21' ' ' GLY . 3.4 p -57.07 -47.16 84.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.479 0.657 . . . . 0.32000000000000001 110.387 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.67 -5.42 0.86 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 121.467 -0.77 . . . . 0.23000000000000001 111.223 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -84.21 -19.94 33.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.448 -1.619 . . . . 1.24 109.498 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.46 134.07 55.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.23999999999999999 109.29 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.21 133.33 52.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.669 -0.812 . . . . 0.20999999999999999 109.675 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.52 -21.22 47.07 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.129 -1.588 . . . . 0.22 109.129 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.75 112.4 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.25 108.405 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.98 -178.77 36.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.287 -1.525 . . . . 0.28000000000000003 109.287 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.88 -40.28 83.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -1.093 . . . . 2.0099999999999998 110.631 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.05 -46.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.72 -1.238 . . . . 0.38 109.14 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.3 -40.07 86.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.40000000000000002 109.483 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.69 96.73 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.913 -1.275 . . . . 0.34999999999999998 109.913 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.34 -38.18 85.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.001 -1.294 . . . . 2.7400000000000002 110.332 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.84 -45.15 87.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 1.54 109.748 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.8 mt -62.17 -40.09 94.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.013 -1.055 . . . . 0.34000000000000002 109.798 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.03 -40.1 88.19 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.476 -0.889 . . . . 1.6699999999999999 109.053 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -67.79 -19.16 65.06 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.81 6.61 40.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 2.6899999999999999 109.601 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 9.05 57.06 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 121.005 -1.059 . . . . 0.47999999999999998 111.544 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.494 ' CD2' HG12 ' A' ' 44' ' ' VAL . 86.0 m-85 -103.71 75.36 1.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.854 -1.38 . . . . 0.33000000000000002 108.858 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.18 -10.08 59.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.40999999999999998 111.248 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -140.69 161.57 37.47 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.896 -1.127 . . . . 1.5600000000000001 110.69 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.67 -43.64 92.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.20999999999999999 112.355 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 6.4 p90 -58.2 -18.43 25.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.801 -1.187 . . . . 0.32000000000000001 110.669 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.636 HG21 ' HZ3' ' B' ' 53' ' ' LYS . 24.5 t -80.06 -31.37 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.79 -1.189 . . . . 0.23999999999999999 107.79 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.63 -40.03 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.185 -1.042 . . . . 0.22 108.185 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.8 tp -59.02 -34.65 72.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.882 -1.525 . . . . 0.40000000000000002 106.882 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.01 -40.72 97.37 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.593 -1.403 . . . . 0.17999999999999999 109.593 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.403 ' NE2' ' NE1' ' A' ' 62' ' ' TRP . 12.6 tp60 -60.03 -41.97 93.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.261 . . . . 1.0900000000000001 108.987 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -60.24 -41.54 93.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.31 108.705 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -70.27 -40.0 74.61 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.548 -0.861 . . . . 0.28000000000000003 108.921 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.93 -25.11 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.28000000000000003 110.671 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 52' ' ' LEU . 85.9 mt -92.29 15.3 14.05 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.949 -1.095 . . . . 0.31 110.491 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 67.8 mttm 52.41 40.29 29.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.088 -1.007 . . . . 1.7 110.548 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 pttt 40.3 19.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.01 -1.056 . . . . 2.2400000000000002 111.873 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 17.9 t0 -66.85 117.55 9.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.671 -1.603 . . . . 1.8 106.671 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.87 -40.17 94.45 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.483 0.92 . . . . 0.87 113.483 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 96.1 m-20 -70.21 -39.86 74.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.416 -1.428 . . . . 0.72999999999999998 109.937 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.09 -39.86 68.64 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.935 -1.106 . . . . 0.55000000000000004 108.6 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -61.83 -49.92 74.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.38 109.957 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.4 mtm180 -61.84 -42.65 99.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 2.6400000000000001 110.616 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.73 -39.24 93.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 2.3700000000000001 109.25 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.403 ' NE1' ' NE2' ' A' ' 48' ' ' GLN . 70.3 t90 -61.22 -49.28 77.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.029 -1.044 . . . . 0.40000000000000002 110.735 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.23 -49.28 65.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 0.34000000000000002 109.857 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -61.89 -47.26 85.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.393 -0.817 . . . . 2.1099999999999999 109.864 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.0 t0 -69.04 -31.13 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 1.8999999999999999 109.864 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -79.75 -33.08 41.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.40999999999999998 111.366 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.1 p -132.54 -31.72 1.36 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.58 -1.325 . . . . 0.40000000000000002 111.574 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 15.79 12.63 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.075 -1.61 . . . . 0.35999999999999999 109.075 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.02 153.49 3.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -1.205 . . . . 0.33000000000000002 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -94.93 176.22 6.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 1.8999999999999999 109.825 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -35.35 75.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.586 -0.696 . . . . 0.39000000000000001 111.23 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -70.13 -42.84 72.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.52 -1.362 . . . . 2.5800000000000001 110.57 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 73' ' ' GLN . 16.7 mp0 -67.94 -39.18 83.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -0.963 . . . . 2.1200000000000001 110.965 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 t -67.95 -38.35 82.7 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.809 -1.182 . . . . 1.3600000000000001 110.198 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -60.72 -38.79 86.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.742 -1.224 . . . . 2.7999999999999998 109.913 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.26 -39.62 82.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.561 -1.337 . . . . 0.40000000000000002 110.417 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.71 -40.09 76.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.965 -1.085 . . . . 0.23999999999999999 109.518 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -59.4 -60.34 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.179 -0.95 . . . . 0.42999999999999999 109.424 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.51 -33.63 87.76 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.694 -0.962 . . . . 0.26000000000000001 110.694 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -1.234 . . . . 0.25 109.636 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.1 mt -70.27 -39.97 74.62 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.962 -1.095 . . . . 0.29999999999999999 108.391 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -65.1 -40.16 94.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.86 . . . . 2.73 110.309 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.62 -39.69 80.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 1.9099999999999999 110.6 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 88.4 t90 -60.23 -42.28 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.343 -1.473 . . . . 0.37 107.581 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.16 -40.09 88.7 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.783 0.801 . . . . 0.35999999999999999 109.279 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.6 -33.95 72.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.218 -0.927 . . . . 0.55000000000000004 109.698 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.18 -34.56 14.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.195 -0.94 . . . . 0.47999999999999998 111.285 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.551 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.8 m-85 . . . . . 0 N--CA 1.505 2.285 0 O-C-N 121.116 -0.99 . . . . 1.24 111.482 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.656 0.741 . . . . 1.5 109.1 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.19 -28.24 67.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.612 -0.68 . . . . 2.1800000000000002 110.07 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.5 -39.57 88.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.123 -0.986 . . . . 2.0099999999999998 109.637 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -59.84 -51.32 70.23 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.261 -0.899 . . . . 0.48999999999999999 110.635 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 23.8 mmm180 -70.19 -34.23 72.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.896 -1.127 . . . . 3.23 109.854 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -68.88 -39.35 79.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.376 -0.828 . . . . 0.76000000000000001 109.785 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.13 -46.17 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.46000000000000002 110.119 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.0 m -86.09 8.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.141 -0.975 . . . . 0.44 110.749 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -102.7 -13.44 17.08 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.192 -0.942 . . . . 0.53000000000000003 109.911 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.54 153.38 27.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 1.27 108.98 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -37.89 156.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.059 1.839 . . . . 0.48999999999999999 111.719 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 11.6 ptm -93.2 -28.13 16.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.56000000000000005 110.271 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.18 -133.33 41.87 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.412 -1.075 . . . . 0.39000000000000001 110.412 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.81 36.01 3.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.596 -0.944 . . . . 0.83999999999999997 110.302 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -58.09 149.83 54.53 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.871 -1.143 . . . . 2.02 108.329 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.87 155.17 56.34 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.168 1.912 . . . . 0.34000000000000002 112.537 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.443 HG13 ' N ' ' B' ' 21' ' ' GLY . 3.5 p -57.16 -46.53 84.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.602 0.715 . . . . 0.32000000000000001 110.496 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.443 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -56.07 -5.25 0.95 Allowed Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.45 -0.782 . . . . 0.22 111.248 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 59.5 m -84.4 -20.32 32.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.553 -1.557 . . . . 1.24 109.435 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.14 133.86 55.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.23999999999999999 109.237 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.14 133.34 52.75 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.586 -0.845 . . . . 0.20999999999999999 109.714 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.62 -20.98 48.26 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.25 -1.54 . . . . 0.22 109.25 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.03 112.6 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -1.088 . . . . 0.25 108.365 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.22 -178.86 35.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.174 -1.57 . . . . 0.28000000000000003 109.174 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -58.65 -40.07 82.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.422 -1.046 . . . . 2.0 110.713 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.04 -46.57 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.642 -1.286 . . . . 0.38 109.196 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.21 -39.95 86.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.40000000000000002 109.545 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.56 97.19 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.835 -1.306 . . . . 0.35999999999999999 109.835 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.21 -38.64 87.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.266 . . . . 2.75 110.189 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.59 -45.06 88.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.712 -1.243 . . . . 1.5600000000000001 109.603 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.13 -39.9 94.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.835 -1.166 . . . . 0.33000000000000002 109.822 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.42 -40.05 89.66 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.579 -0.848 . . . . 1.6799999999999999 108.896 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -67.82 -19.18 65.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.215 -1.031 . . . . 1.99 108.215 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.86 6.87 39.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.533 -0.73 . . . . 2.6800000000000002 109.603 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.42 9.07 57.06 Favored Glycine 0 N--CA 1.5 2.939 0 O-C-N 120.961 -1.087 . . . . 0.48999999999999999 111.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' B' ' 44' ' ' VAL . 86.6 m-85 -104.1 75.46 1.27 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.929 -1.336 . . . . 0.33000000000000002 108.948 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.37 -9.98 59.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.883 . . . . 0.40999999999999998 111.176 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -140.66 161.78 36.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.852 -1.155 . . . . 1.5600000000000001 110.712 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.77 -43.84 91.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.835 -0.54 . . . . 0.20999999999999999 112.314 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 5.7 p90 -57.84 -18.72 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.32000000000000001 110.733 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.0 t -80.12 -31.11 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.79 -1.194 . . . . 0.23999999999999999 107.849 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.81 -39.92 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.173 -1.047 . . . . 0.22 108.173 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.6 tp -59.03 -34.84 72.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.983 -1.488 . . . . 0.40000000000000002 106.983 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.99 97.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.494 -1.442 . . . . 0.17999999999999999 109.494 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.423 ' NE2' ' NE1' ' B' ' 62' ' ' TRP . 12.1 tp60 -59.84 -42.04 92.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 1.0900000000000001 108.961 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.11 -41.54 92.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.31 108.727 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.41 -40.18 74.02 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.537 -0.865 . . . . 0.27000000000000002 108.889 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.92 -24.66 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 110.785 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 52' ' ' LEU . 84.4 mt -92.55 15.81 13.4 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.037 -1.039 . . . . 0.29999999999999999 110.368 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.636 ' HZ3' HG21 ' A' ' 44' ' ' VAL . 67.8 mttm 51.98 40.19 27.74 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.904 -1.122 . . . . 1.71 110.635 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 47.8 pttt 40.49 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.135 -0.978 . . . . 2.25 111.711 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 53' ' ' LYS . 19.3 t0 -66.78 117.77 9.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.52 -1.659 . . . . 1.8 106.52 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.62 -40.93 96.61 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.127 -0.983 . . . . 0.88 113.458 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.52 -39.97 77.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.437 -1.414 . . . . 0.73999999999999999 110.107 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.18 -39.95 68.29 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.005 -1.078 . . . . 0.55000000000000004 108.552 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.7 -50.14 73.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.833 . . . . 0.38 109.96 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -61.56 -43.05 99.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 2.6400000000000001 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -64.54 -38.9 92.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.848 -1.158 . . . . 2.3799999999999999 109.392 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' TRP . . . . . 0.423 ' NE1' ' NE2' ' B' ' 48' ' ' GLN . 70.8 t90 -61.33 -49.17 78.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.40000000000000002 110.818 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 32.8 tp -67.38 -49.49 63.71 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.329 -0.857 . . . . 0.34000000000000002 109.835 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.77 -47.02 87.05 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.373 -0.829 . . . . 2.1000000000000001 109.939 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.7 t0 -69.17 -31.08 69.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.436 -0.79 . . . . 1.8999999999999999 109.926 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 55.4 m -79.76 -33.2 40.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.40000000000000002 111.341 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.32 -32.26 1.37 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.718 -1.239 . . . . 0.39000000000000001 111.62 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.32 16.13 11.58 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.144 -1.582 . . . . 0.35999999999999999 109.144 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.16 153.53 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.301 . . . . 0.32000000000000001 109.358 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -94.81 176.22 6.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 1.9099999999999999 109.77 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.17 75.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.608 -0.682 . . . . 0.38 111.255 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -70.07 -42.73 72.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.511 -1.368 . . . . 2.5699999999999998 110.611 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' B' ' 73' ' ' GLN . 16.5 mp0 -67.99 -39.43 83.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.198 -0.939 . . . . 2.1200000000000001 111.021 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.8 t -67.83 -38.04 82.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.037 -1.039 . . . . 1.3600000000000001 110.08 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -61.2 -38.34 86.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.775 -1.203 . . . . 2.8100000000000001 109.92 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.5 -39.88 81.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.439 -1.413 . . . . 0.40000000000000002 110.322 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 99.0 m -69.7 -40.2 76.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.824 -1.173 . . . . 0.23000000000000001 109.473 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.51 -60.02 4.51 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.096 -1.003 . . . . 0.42999999999999999 109.339 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.69 -33.63 87.75 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.618 -0.993 . . . . 0.25 110.618 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.38 -46.12 61.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.985 -1.303 . . . . 0.23999999999999999 109.588 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.85 -40.14 75.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.095 -1.042 . . . . 0.28999999999999998 108.247 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -65.14 -40.08 93.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 2.7400000000000002 110.214 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.49 -39.9 81.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 1.9099999999999999 110.419 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.544 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 88.5 t90 -60.44 -42.34 95.91 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.314 -1.491 . . . . 0.35999999999999999 107.521 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' B' ' 89' ' ' LEU . 63.7 m -60.03 -40.14 88.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.436 -0.79 . . . . 0.35999999999999999 109.271 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.46 -33.82 71.77 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.364 -0.835 . . . . 0.55000000000000004 109.842 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.11 13.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.121 -0.987 . . . . 0.46999999999999997 111.192 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.544 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 97.1 m-85 -107.84 2.25 23.38 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.206 -0.934 . . . . 1.24 111.636 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.498 1.962 0 O-C-N 120.938 -1.101 . . . . 1.6699999999999999 109.363 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.761 0.791 . . . . 1.51 110.097 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -59.96 -20.87 59.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.75 -0.594 . . . . 2.1800000000000002 110.896 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -60.05 -38.48 82.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.868 -1.145 . . . . 2.02 109.543 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -59.93 -51.69 68.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.08 . . . . 0.48999999999999999 110.652 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 58.8 mtt-85 -69.96 -35.19 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.837 -1.164 . . . . 3.21 110.139 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.78 -39.95 84.03 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.396 -0.815 . . . . 0.76000000000000001 109.321 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.19 -48.21 76.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.465 -0.772 . . . . 0.46000000000000002 109.967 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 m -86.59 8.13 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.129 -0.982 . . . . 0.44 110.992 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -99.5 -16.94 18.14 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.937 -1.102 . . . . 0.54000000000000004 110.035 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.5 pt-20 -155.6 152.49 24.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 1.26 108.469 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 92.4 Cg_exo -35.49 154.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.2 1.933 . . . . 0.48999999999999999 111.713 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.634 ' CE ' HD22 ' A' ' 46' ' ' LEU . 7.4 ptp -91.16 -23.76 20.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.909 -1.12 . . . . 0.56999999999999995 109.89 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.35 -135.47 32.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.384 -1.086 . . . . 0.40000000000000002 110.384 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -110.0 38.78 2.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.597 -0.943 . . . . 0.84999999999999998 110.158 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -59.93 149.99 71.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.044 . . . . 2.0099999999999998 108.738 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.03 148.92 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.32 2.013 . . . . 0.34000000000000002 112.588 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 p -52.73 -30.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.475 0.655 . . . . 0.32000000000000001 110.387 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.61 -3.57 67.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.745 -0.942 . . . . 0.23000000000000001 110.745 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.0 t -83.29 -20.79 33.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.746 -1.444 . . . . 1.24 109.339 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.481 HD22 HD21 ' A' ' 81' ' ' LEU . 84.3 mt -62.54 135.57 57.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.23999999999999999 109.703 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.72 133.19 53.11 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.694 0.759 . . . . 0.20999999999999999 109.671 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.73 -19.98 52.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 0.22 109.255 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.3 mm -98.55 112.78 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.069 -1.085 . . . . 0.25 108.069 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.48 178.06 39.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.803 -1.319 . . . . 0.28000000000000003 109.803 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.76 -40.01 75.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.461 -1.023 . . . . 2.0099999999999998 109.766 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.35 -44.9 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.38 109.671 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.69 -38.05 85.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.40000000000000002 109.413 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.43 -38.61 91.24 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.546 -1.422 . . . . 0.34999999999999998 109.546 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.49 -39.16 93.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -1.151 . . . . 2.7400000000000002 110.823 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.1 -44.58 79.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.742 -1.224 . . . . 1.54 109.808 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.53 -39.93 95.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.34000000000000002 108.742 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.0 -42.46 94.31 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.656 -0.818 . . . . 1.6699999999999999 109.411 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.3 -19.5 65.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.0 108.783 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -91.11 1.81 56.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.654 -0.654 . . . . 2.6899999999999999 109.948 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.45 4.22 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.083 -1.011 . . . . 0.47999999999999998 110.801 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.476 ' CD2' HG12 ' A' ' 44' ' ' VAL . 82.8 m-85 -132.41 70.94 1.46 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -1.231 . . . . 0.33000000000000002 108.239 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.43 -10.53 59.52 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.272 -0.971 . . . . 0.40999999999999998 109.905 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -131.29 153.16 49.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.375 -0.828 . . . . 1.5600000000000001 108.808 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.9 90.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.20999999999999999 111.205 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.483 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -56.59 -17.67 9.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.884 -1.135 . . . . 0.32000000000000001 110.994 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.476 HG12 ' CD2' ' A' ' 39' ' ' PHE . 46.8 t -79.77 -29.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.178 . . . . 0.23999999999999999 107.936 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.1 -36.8 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.308 -0.997 . . . . 0.22 108.308 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.634 HD22 ' CE ' ' A' ' 15' ' ' MET . 19.0 tp -60.03 -39.29 85.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.134 -1.432 . . . . 0.40000000000000002 107.134 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.71 -43.7 94.37 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.108 -1.197 . . . . 0.17999999999999999 110.108 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.98 -42.69 94.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.752 -1.44 . . . . 1.0900000000000001 109.053 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.98 -42.27 93.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.863 . . . . 0.31 108.943 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -68.96 -38.19 79.27 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.727 -0.842 . . . . 0.28000000000000003 108.727 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.43 -22.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.28000000000000003 110.046 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 16.75 10.99 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.144 -0.972 . . . . 0.31 109.789 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.405 ' NZ ' HG21 ' B' ' 44' ' ' VAL . 58.8 mttm 50.0 39.55 19.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.975 -1.078 . . . . 1.7 110.505 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.31 19.28 4.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.2400000000000002 109.747 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.13 108.54 4.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.727 -1.233 . . . . 1.8 108.021 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -61.04 -40.0 91.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.555 -0.716 . . . . 0.87 112.556 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.09 -40.09 78.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.644 -1.285 . . . . 0.72999999999999998 110.385 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.21 75.34 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.93 -1.108 . . . . 0.55000000000000004 109.009 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.85 -50.1 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.83 . . . . 0.38 110.05 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -59.94 -46.37 89.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 2.6400000000000001 110.587 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -65.74 -38.57 89.49 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.042 -1.036 . . . . 2.3700000000000001 109.14 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -66.06 -48.34 71.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.40000000000000002 111.073 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -66.22 -46.32 77.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.211 -0.931 . . . . 0.34000000000000002 109.152 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.91 -45.75 91.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.389 -0.819 . . . . 2.1099999999999999 109.089 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.63 -31.87 70.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.641 -0.662 . . . . 1.8999999999999999 109.85 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -80.41 -31.37 37.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 0.40999999999999998 111.487 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.73 -25.78 1.84 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.528 -1.358 . . . . 0.40000000000000002 111.876 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.14 29.19 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.422 -1.471 . . . . 0.35999999999999999 109.422 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.43 153.49 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.046 -1.267 . . . . 0.33000000000000002 109.252 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -92.12 174.29 7.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.034 -1.041 . . . . 1.8999999999999999 110.242 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.08 78.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.668 -0.645 . . . . 0.39000000000000001 110.826 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -75.11 -38.23 61.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.84 -1.163 . . . . 2.5800000000000001 109.731 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -67.13 -38.77 86.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 2.1200000000000001 110.013 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 p -67.12 -37.75 84.39 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 1.3600000000000001 109.895 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.32 -38.39 83.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.079 -1.013 . . . . 2.7999999999999998 109.604 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.56 -40.07 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.707 -1.246 . . . . 0.40000000000000002 110.797 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.1 -40.02 78.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 0.23999999999999999 110.111 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.52 -60.45 3.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.628 -1.295 . . . . 0.42999999999999999 110.246 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.72 -32.47 81.72 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.483 -1.047 . . . . 0.26000000000000001 110.483 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.72 -47.77 58.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.273 . . . . 0.25 109.87 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.481 HD21 HD22 ' A' ' 23' ' ' LEU . 61.1 mt -70.22 -39.92 74.82 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.105 -1.038 . . . . 0.29999999999999999 109.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 82' ' ' ARG . 33.2 ttt-85 -63.66 -39.99 95.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 2.73 110.322 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.39 -38.18 77.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.105 -0.997 . . . . 1.9099999999999999 110.285 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.448 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.5 t90 -59.99 -45.46 92.64 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.405 -1.435 . . . . 0.37 107.809 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.2 m -59.98 -40.11 88.0 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.687 0.756 . . . . 0.35999999999999999 109.344 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.97 -34.61 73.52 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.348 -0.845 . . . . 0.55000000000000004 110.099 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.0 -36.31 13.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.196 -0.94 . . . . 0.47999999999999998 111.176 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.3 m-85 . . . . . 0 N--CA 1.503 2.209 0 O-C-N 121.176 -0.952 . . . . 1.24 111.324 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.82 0.819 . . . . 1.5 110.055 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -60.04 -20.89 60.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 2.1800000000000002 110.892 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -60.04 -38.42 82.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.902 -1.124 . . . . 2.0099999999999998 109.506 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -60.03 -51.73 68.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.979 -1.075 . . . . 0.48999999999999999 110.58 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 58.7 mtt-85 -69.95 -34.99 74.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 3.23 110.094 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.95 -39.96 83.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.76000000000000001 109.311 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -64.32 -48.28 76.2 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.832 -0.747 . . . . 0.46000000000000002 109.859 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -86.51 8.33 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.083 -1.011 . . . . 0.44 111.014 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -99.65 -16.86 18.05 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.53000000000000003 109.985 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' B' ' 14' ' ' PRO . 13.3 pt-20 -155.64 152.44 24.29 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.111 -0.993 . . . . 1.27 108.422 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' B' ' 13' ' ' GLU . 97.9 Cg_exo -35.42 154.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.159 1.906 . . . . 0.48999999999999999 111.748 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.632 ' CE ' HD22 ' B' ' 46' ' ' LEU . 7.5 ptp -90.92 -23.84 20.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.022 -1.049 . . . . 0.56000000000000005 109.881 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.3 -135.59 31.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.309 -1.117 . . . . 0.39000000000000001 110.309 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -109.95 38.83 2.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.65 -0.912 . . . . 0.83999999999999997 110.092 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.9 149.94 71.07 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 120.999 -1.063 . . . . 2.02 108.851 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.95 148.83 92.32 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.398 2.065 . . . . 0.34000000000000002 112.499 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.1 p -52.81 -29.92 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.62 -0.675 . . . . 0.32000000000000001 110.409 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.77 -3.27 67.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.742 -0.943 . . . . 0.22 110.742 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t -83.44 -20.67 33.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.699 -1.471 . . . . 1.24 109.318 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.477 HD22 HD21 ' B' ' 81' ' ' LEU . 84.4 mt -62.7 135.62 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.23999999999999999 109.642 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.67 133.09 53.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.20999999999999999 109.725 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 -20.01 52.34 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.271 -1.531 . . . . 0.22 109.271 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -98.56 112.73 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.024 -1.102 . . . . 0.25 108.024 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.49 178.05 39.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.76 -1.336 . . . . 0.28000000000000003 109.76 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.8 -39.9 74.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.391 -1.064 . . . . 2.0 109.75 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.41 -45.01 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.38 109.577 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.73 -37.72 85.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.40000000000000002 109.437 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.57 -38.68 91.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.509 -1.436 . . . . 0.35999999999999999 109.509 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.45 -39.2 93.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -1.101 . . . . 2.75 110.793 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.04 -44.62 79.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.155 . . . . 1.5600000000000001 109.746 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.67 -39.93 95.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.014 . . . . 0.33000000000000002 108.684 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.39 94.13 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.637 -0.825 . . . . 1.6799999999999999 109.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -66.37 -19.52 65.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 1.99 108.765 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -90.97 1.76 56.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.712 -0.617 . . . . 2.6800000000000002 109.973 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.72 37.43 4.21 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.219 -0.991 . . . . 0.48999999999999999 110.734 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.487 ' CD2' HG12 ' B' ' 44' ' ' VAL . 83.2 m-85 -132.34 70.95 1.46 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.027 -1.278 . . . . 0.33000000000000002 108.213 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -77.53 -10.46 59.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.109 -0.994 . . . . 0.40999999999999998 109.823 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -131.43 153.17 49.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.345 -0.847 . . . . 1.5600000000000001 108.885 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.98 91.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.20999999999999999 111.244 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 4.5 p90 -56.5 -17.81 9.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.999 -1.063 . . . . 0.32000000000000001 111.034 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' B' ' 39' ' ' PHE . 46.7 t -79.62 -29.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.23999999999999999 108.003 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.34 -36.75 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.15 -1.056 . . . . 0.22 108.15 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.632 HD22 ' CE ' ' B' ' 15' ' ' MET . 18.7 tp -59.91 -39.32 85.02 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.195 -1.409 . . . . 0.40000000000000002 107.195 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -43.78 94.17 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.134 -1.186 . . . . 0.17999999999999999 110.134 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.95 -42.63 94.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.868 -1.372 . . . . 1.0900000000000001 109.078 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.02 -42.33 94.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.31 108.887 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.94 -38.4 79.46 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.69 -0.856 . . . . 0.27000000000000002 108.69 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.27 -22.68 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -0.9 . . . . 0.28000000000000003 110.065 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 93.8 mt -92.59 16.88 11.08 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.125 -0.984 . . . . 0.29999999999999999 109.786 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.459 ' NZ ' HG21 ' A' ' 44' ' ' VAL . 58.8 mttm 49.98 39.64 19.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.926 -1.108 . . . . 1.71 110.539 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.19 19.15 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 2.25 109.796 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' B' ' 55' ' ' ASP . 19.8 t0 -70.11 108.54 4.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.714 -1.241 . . . . 1.8 108.089 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.01 -39.93 91.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.685 -0.635 . . . . 0.88 112.653 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.17 -39.97 78.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.648 -1.282 . . . . 0.73999999999999999 110.401 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.32 75.27 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.005 -1.078 . . . . 0.55000000000000004 109.071 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.78 -50.07 70.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.354 -0.841 . . . . 0.38 110.042 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -60.07 -46.4 89.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 2.6400000000000001 110.513 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -65.8 -38.45 88.99 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.899 -1.125 . . . . 2.3799999999999999 109.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -66.0 -48.33 71.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.99 -1.069 . . . . 0.40000000000000002 111.063 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.14 -46.61 76.89 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.175 -0.953 . . . . 0.34000000000000002 109.129 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.85 -45.67 91.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.342 -0.849 . . . . 2.1000000000000001 109.125 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.65 -31.85 70.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.653 . . . . 1.8999999999999999 109.839 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -80.36 -31.54 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.40000000000000002 111.486 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.53 -25.67 1.9 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.486 -1.384 . . . . 0.39000000000000001 112.011 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.39 13.04 29.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.428 -1.469 . . . . 0.35999999999999999 109.428 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.43 153.38 1.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.964 -1.315 . . . . 0.32000000000000001 109.205 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -92.01 174.2 7.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.043 -1.036 . . . . 1.9099999999999999 110.294 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.96 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 0.38 110.936 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -75.13 -38.32 61.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.115 . . . . 2.5699999999999998 109.697 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -67.13 -38.68 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 2.1200000000000001 109.99 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -67.17 -37.69 84.15 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 1.3600000000000001 109.916 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.33 -38.38 83.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.147 -0.971 . . . . 2.8100000000000001 109.606 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.68 -39.99 84.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.613 -1.305 . . . . 0.40000000000000002 110.727 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -69.26 -39.98 78.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.838 -1.164 . . . . 0.23000000000000001 110.086 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.49 -60.36 3.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.564 -1.335 . . . . 0.42999999999999999 110.235 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.61 82.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.47 -1.052 . . . . 0.25 110.47 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.0 t -70.69 -47.77 58.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.064 -1.256 . . . . 0.23999999999999999 109.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.477 HD21 HD22 ' B' ' 23' ' ' LEU . 62.2 mt -70.15 -39.98 75.03 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.089 -1.044 . . . . 0.28999999999999998 109.074 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' B' ' 82' ' ' ARG . 33.3 ttt-85 -63.62 -40.04 95.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 2.7400000000000002 110.312 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.31 -38.32 78.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 1.9099999999999999 110.213 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.435 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 86.6 t90 -60.0 -45.35 93.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.468 -1.395 . . . . 0.35999999999999999 107.869 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 52.6 m -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.643 0.735 . . . . 0.35999999999999999 109.284 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.0 -34.64 73.6 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.397 -0.814 . . . . 0.55000000000000004 110.071 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.05 -36.75 13.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.167 -0.958 . . . . 0.46999999999999997 111.161 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.4 m-85 -107.0 0.76 23.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.232 -0.918 . . . . 1.24 111.467 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 85' ' ' CYS . 6.9 tp . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.865 -1.147 . . . . 1.6699999999999999 109.11 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.65 0.738 . . . . 1.51 109.488 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.92 -24.59 64.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.746 -0.596 . . . . 2.1800000000000002 110.127 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.921 -1.112 . . . . 2.02 108.98 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -60.04 -49.07 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.48999999999999999 110.201 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' A' ' 8' ' ' ARG . 53.9 mtt-85 -70.07 -31.99 69.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 3.21 109.648 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.54 -40.02 80.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.98 . . . . 0.76000000000000001 109.801 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.3 t80 -62.58 -48.17 80.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.46000000000000002 110.133 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.98 10.11 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.155 -0.966 . . . . 0.44 110.506 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.67 -14.22 15.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.23 -0.919 . . . . 0.54000000000000004 109.881 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.31 152.84 27.17 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.148 -0.97 . . . . 1.26 109.025 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.2 162.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.751 1.634 . . . . 0.48999999999999999 111.5 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.479 ' SD ' HD11 ' B' ' 89' ' ' LEU . 6.8 ptp -92.49 -21.44 20.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.025 -1.047 . . . . 0.56999999999999995 109.787 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.79 -139.91 16.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.037 -1.225 . . . . 0.40000000000000002 110.037 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.73 30.89 5.4 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.427 -1.043 . . . . 0.84999999999999998 110.481 -178.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -60.1 149.23 75.6 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.872 -1.142 . . . . 2.0099999999999998 108.676 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.2 158.68 50.91 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.984 1.79 . . . . 0.34000000000000002 111.992 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 21' ' ' GLY . 14.4 p -57.16 -45.77 84.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.457 -0.777 . . . . 0.32000000000000001 110.483 -179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.55 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.54 -3.19 0.38 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.757 -0.937 . . . . 0.23000000000000001 110.757 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 20' ' ' VAL . 47.0 m -82.08 -22.14 36.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.781 -1.423 . . . . 1.24 109.424 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.449 HD22 HD21 ' A' ' 81' ' ' LEU . 86.0 mt -64.0 139.2 58.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.23999999999999999 109.776 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 136.38 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.756 -0.777 . . . . 0.20999999999999999 109.718 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.54 -18.43 57.5 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.235 -1.546 . . . . 0.22 109.235 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.4 110.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.875 -1.158 . . . . 0.25 107.875 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.459 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -91.56 178.65 41.37 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.665 -1.374 . . . . 0.28000000000000003 109.665 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.31 -40.02 73.68 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.498 -1.001 . . . . 2.0099999999999998 110.351 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.72 -41.22 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.637 -1.289 . . . . 0.38 109.625 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.485 HD11 ' NE2' ' A' ' 73' ' ' GLN . 96.2 mt -67.72 -38.45 83.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.40000000000000002 109.745 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -40.08 96.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.119 -1.192 . . . . 0.34999999999999998 110.119 -179.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.78 -36.27 83.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.885 -1.362 . . . . 2.7400000000000002 109.486 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.6 -53.65 26.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.139 . . . . 1.54 109.546 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.02 -39.96 87.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.118 -1.067 . . . . 0.34000000000000002 108.118 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.09 -46.04 90.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.484 -0.76 . . . . 1.6699999999999999 109.344 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.68 -19.83 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.44 -0.948 . . . . 2.0 108.44 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.91 3.74 52.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.696 -0.627 . . . . 2.6899999999999999 109.726 -179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.21 50.7 Favored Glycine 0 N--CA 1.503 3.107 0 O-C-N 121.039 -1.038 . . . . 0.47999999999999998 111.432 177.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.556 ' CD2' HG12 ' A' ' 44' ' ' VAL . 90.8 m-85 -106.2 74.98 1.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.913 -1.346 . . . . 0.33000000000000002 108.941 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -80.31 -9.24 59.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.40999999999999998 110.965 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.92 152.77 50.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.122 -0.986 . . . . 1.5600000000000001 109.836 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.19 96.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.622 -0.674 . . . . 0.20999999999999999 111.13 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 8.6 p90 -58.45 -18.99 32.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.826 -1.171 . . . . 0.32000000000000001 110.414 -178.014 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG12 ' CD2' ' A' ' 39' ' ' PHE . 25.9 t -80.71 -30.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.904 -1.123 . . . . 0.23999999999999999 108.366 179.188 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.64 -39.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.172 -1.047 . . . . 0.22 108.172 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.1 tp -59.95 -39.45 85.6 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.624 -1.25 . . . . 0.40000000000000002 107.624 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.13 -45.04 74.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.654 -1.379 . . . . 0.17999999999999999 109.654 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.99 -43.19 95.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.119 -1.224 . . . . 1.0900000000000001 109.153 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.06 -39.98 87.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.427 -0.953 . . . . 0.31 108.427 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.81 -38.67 83.59 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.429 -0.952 . . . . 0.28000000000000003 108.429 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.99 -22.13 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.28000000000000003 110.736 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -93.15 17.06 11.59 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.96 -1.087 . . . . 0.31 110.388 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.77 34.39 10.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.873 -1.142 . . . . 1.7 110.229 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.6 mttp 59.55 20.0 8.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.456 -0.778 . . . . 2.2400000000000002 109.83 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.02 114.52 5.25 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.623 -1.251 . . . . 1.8 107.623 178.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 40.0 tt0 -63.46 -41.38 98.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.87 112.519 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.04 -39.76 75.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.604 -1.31 . . . . 0.72999999999999998 110.765 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.16 -39.93 78.47 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.873 -1.131 . . . . 0.55000000000000004 109.551 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.69 -49.83 71.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.38 109.402 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 60' ' ' ARG . 44.3 mtt-85 -60.0 -46.61 88.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.809 . . . . 2.6400000000000001 110.513 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.37 -38.55 90.38 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.966 -1.084 . . . . 2.3700000000000001 108.943 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.41 ' O ' ' OG1' ' A' ' 66' ' ' THR . 59.5 t90 -64.29 -47.01 81.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.40000000000000002 110.541 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 tp -67.57 -47.02 71.01 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.274 -0.891 . . . . 0.34000000000000002 110.254 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -62.58 -47.5 83.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 2.1099999999999999 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -69.47 -28.68 66.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.885 . . . . 1.8999999999999999 109.732 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.8 m -80.43 -33.94 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.331 -0.856 . . . . 0.40999999999999998 111.41 -178.197 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.4 p -132.23 -29.82 1.58 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.53 -1.356 . . . . 0.40000000000000002 111.93 -178.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.51 20.95 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.231 -1.548 . . . . 0.35999999999999999 109.231 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.38 2.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.275 . . . . 0.33000000000000002 109.23 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -90.61 171.49 9.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 1.8999999999999999 109.529 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.5 75.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.39000000000000001 110.416 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.53 -41.26 69.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 2.5800000000000001 109.975 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.485 ' NE2' HD11 ' A' ' 30' ' ' LEU . 78.6 mt-30 -67.11 -40.04 86.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 2.1200000000000001 110.12 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.49 -38.94 92.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.436 -0.79 . . . . 1.3600000000000001 110.233 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' HH12 ' A' ' 60' ' ' ARG . 19.8 mmm180 -60.0 -38.66 83.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 2.7999999999999998 109.016 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -68.48 -39.89 81.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.88 -1.137 . . . . 0.40000000000000002 110.614 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -69.12 -40.18 78.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.632 -1.292 . . . . 0.23999999999999999 109.821 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.31 -60.01 4.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.633 -1.292 . . . . 0.42999999999999999 109.867 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' OE2' ' A' ' 83' ' ' GLU . . . -59.9 -32.57 75.43 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.047 -1.221 . . . . 0.26000000000000001 110.047 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.3 t -69.08 -49.79 54.14 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.075 -1.25 . . . . 0.25 110.014 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.449 HD21 HD22 ' A' ' 23' ' ' LEU . 86.9 mt -71.58 -40.23 70.05 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.746 -1.182 . . . . 0.29999999999999999 109.124 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.496 ' HG2' HH11 ' A' ' 82' ' ' ARG . 1.2 tpt180 -60.8 -42.67 98.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.161 -0.962 . . . . 2.73 110.055 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -70.0 -36.42 75.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 1.9099999999999999 110.271 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 84.8 t90 -60.01 -43.18 95.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.521 -1.362 . . . . 0.37 107.709 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.2 m -61.02 -40.29 93.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.604 -0.685 . . . . 0.35999999999999999 110.026 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.04 -33.92 72.69 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -0.969 . . . . 0.55000000000000004 110.274 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.11 14.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.124 -0.985 . . . . 0.47999999999999998 111.028 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.506 2.339 0 O-C-N 121.161 -0.962 . . . . 1.24 111.82 -178.048 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.647 0.737 . . . . 1.5 109.557 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.9 -24.7 64.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 2.1800000000000002 110.178 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.91 -35.31 74.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.034 -1.042 . . . . 2.0099999999999998 108.971 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -60.06 -49.09 79.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.034 -1.041 . . . . 0.48999999999999999 110.237 -179.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' B' ' 8' ' ' ARG . 54.1 mtt-85 -70.02 -31.89 69.78 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.113 -0.992 . . . . 3.23 109.716 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.68 -39.97 80.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.76000000000000001 109.761 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.439 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.2 t80 -62.54 -48.25 80.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.46000000000000002 110.098 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.99 10.19 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.052 -1.03 . . . . 0.44 110.51 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.61 -14.31 15.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 0.53000000000000003 109.857 178.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' B' ' 14' ' ' PRO . 13.5 pt-20 -154.27 152.78 27.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 1.27 109.12 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.9 Cg_exo -40.15 162.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.879 1.719 . . . . 0.48999999999999999 111.483 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 6.8 ptp -92.45 -21.4 20.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.56000000000000005 109.764 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.68 -139.82 16.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.06 -1.216 . . . . 0.39000000000000001 110.06 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.8 30.83 5.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.549 -0.971 . . . . 0.83999999999999997 110.47 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.98 149.24 74.62 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.189 . . . . 2.02 108.777 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.19 158.77 50.38 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.941 1.761 . . . . 0.34000000000000002 112.087 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.556 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.4 p -57.29 -45.6 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.32000000000000001 110.545 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.556 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -55.77 -3.04 0.4 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.725 -0.95 . . . . 0.22 110.725 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.453 ' H ' ' C ' ' B' ' 20' ' ' VAL . 47.6 m -82.11 -22.15 36.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.713 -1.463 . . . . 1.24 109.3 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.447 HD22 HD21 ' B' ' 81' ' ' LEU . 85.7 mt -64.09 139.22 58.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.23999999999999999 109.768 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.89 136.4 56.08 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.758 -0.777 . . . . 0.20999999999999999 109.781 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.3 57.73 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.264 -1.534 . . . . 0.22 109.264 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.48 110.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.817 -1.179 . . . . 0.25 107.817 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.466 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -91.66 178.61 41.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.675 -1.37 . . . . 0.28000000000000003 109.675 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.36 -39.95 73.71 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.595 -0.944 . . . . 2.0 110.333 -178.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.68 -41.25 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.604 -1.31 . . . . 0.38 109.69 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.488 HD11 ' NE2' ' B' ' 73' ' ' GLN . 96.2 mt -67.72 -38.43 83.56 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.262 -0.898 . . . . 0.40000000000000002 109.755 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.104 -1.198 . . . . 0.35999999999999999 110.104 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.75 -36.32 83.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.368 . . . . 2.75 109.502 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.49 -53.72 26.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.751 -1.218 . . . . 1.5600000000000001 109.562 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.208 -1.034 . . . . 0.33000000000000002 108.208 178.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.07 -46.09 90.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 1.6799999999999999 109.345 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -63.58 -19.98 65.27 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.411 -0.959 . . . . 1.99 108.411 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.78 3.72 51.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.612 -0.68 . . . . 2.6800000000000002 109.83 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.2 50.72 Favored Glycine 0 N--CA 1.502 3.044 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 111.468 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.557 ' CD2' HG12 ' B' ' 44' ' ' VAL . 90.9 m-85 -106.16 74.88 1.06 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.96 -1.318 . . . . 0.33000000000000002 108.971 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -80.25 -9.27 59.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.40999999999999998 111.003 -178.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.97 152.84 50.86 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.093 -1.004 . . . . 1.5600000000000001 109.832 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.576 -0.702 . . . . 0.20999999999999999 111.096 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.482 ' CE1' HG22 ' B' ' 44' ' ' VAL . 8.7 p90 -58.58 -18.98 34.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 0.32000000000000001 110.486 -177.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.557 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.8 t -80.77 -30.36 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.047 . . . . 0.23999999999999999 108.343 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.66 -39.05 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.149 -1.056 . . . . 0.22 108.149 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.09 -39.3 85.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.632 -1.247 . . . . 0.40000000000000002 107.632 177.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.15 -45.03 74.22 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.579 -1.409 . . . . 0.17999999999999999 109.579 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.03 -43.19 95.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -1.216 . . . . 1.0900000000000001 109.099 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.441 -0.948 . . . . 0.31 108.441 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.88 -38.65 83.31 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.464 -0.939 . . . . 0.27000000000000002 108.464 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.02 -21.97 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.373 -0.83 . . . . 0.28000000000000003 110.764 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 98.6 mt -93.27 17.15 11.65 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.993 -1.067 . . . . 0.29999999999999999 110.363 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.86 34.29 10.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.894 -1.129 . . . . 1.71 110.272 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 59.46 19.91 8.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 2.25 109.813 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.88 114.67 5.27 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.571 -1.27 . . . . 1.8 107.571 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.414 ' CG ' ' HE ' ' B' ' 60' ' ' ARG . 40.0 tt0 -63.63 -41.39 98.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.88 112.452 -177.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.04 -39.75 75.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.64 -1.288 . . . . 0.73999999999999999 110.742 -179.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.21 -39.88 78.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.827 -1.149 . . . . 0.55000000000000004 109.611 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.76 -49.84 71.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.091 -1.006 . . . . 0.38 109.415 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.462 HH11 ' HG2' ' B' ' 60' ' ' ARG . 44.8 mtt-85 -59.93 -46.61 88.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.364 -0.835 . . . . 2.6400000000000001 110.55 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.28 -38.69 91.05 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.029 -1.044 . . . . 2.3799999999999999 108.952 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -64.29 -46.95 81.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.40000000000000002 110.523 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.55 -47.06 70.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.238 -0.914 . . . . 0.34000000000000002 110.17 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -62.54 -47.56 83.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 2.1000000000000001 110.161 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.43 -28.62 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 1.8999999999999999 109.739 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -80.37 -34.14 36.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.40000000000000002 111.304 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.6 p -132.24 -29.67 1.59 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.501 -1.375 . . . . 0.39000000000000001 111.839 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.75 14.58 21.02 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.21 -1.556 . . . . 0.35999999999999999 109.21 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.27 151.27 2.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -1.228 . . . . 0.32000000000000001 109.279 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.52 171.48 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.0 . . . . 1.9099999999999999 109.527 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.33 74.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.38 110.465 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.65 -41.18 69.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.828 -1.17 . . . . 2.5699999999999998 110.014 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.488 ' NE2' HD11 ' B' ' 30' ' ' LEU . 78.6 mt-30 -67.2 -39.97 86.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 2.1200000000000001 110.185 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.53 -38.86 92.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.355 -0.841 . . . . 1.3600000000000001 110.253 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.42 ' HA ' HH12 ' B' ' 60' ' ' ARG . 19.8 mmm180 -60.03 -38.63 83.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.954 -1.092 . . . . 2.8100000000000001 109.035 -179.417 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -68.54 -40.03 80.86 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.915 -1.116 . . . . 0.40000000000000002 110.592 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.95 -40.19 79.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.702 -1.249 . . . . 0.23000000000000001 109.901 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.36 -59.98 4.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.61 -1.306 . . . . 0.42999999999999999 109.915 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 83' ' ' GLU . . . -59.88 -32.52 75.2 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.054 -1.218 . . . . 0.25 110.054 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -69.13 -49.83 53.42 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.099 -1.236 . . . . 0.23999999999999999 110.064 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.447 HD21 HD22 ' B' ' 23' ' ' LEU . 86.9 mt -71.63 -40.14 69.95 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.744 -1.182 . . . . 0.28999999999999998 109.147 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' B' ' 82' ' ' ARG . 1.2 tpt180 -60.83 -42.67 98.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.147 -0.97 . . . . 2.7400000000000002 110.037 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' B' ' 79' ' ' GLY . 0.3 OUTLIER -70.09 -36.39 74.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 1.9099999999999999 110.053 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 84' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 84.8 t90 -59.98 -43.37 95.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.537 -1.352 . . . . 0.35999999999999999 107.743 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' B' ' 89' ' ' LEU . 50.3 m -60.72 -40.37 92.06 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.562 0.696 . . . . 0.35999999999999999 110.099 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.96 -33.94 72.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.064 -1.023 . . . . 0.55000000000000004 110.342 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.29 14.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.148 -0.97 . . . . 0.46999999999999997 110.969 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 88' ' ' PHE . . . . . 0.403 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 91.0 m-85 -109.78 1.66 19.5 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.275 -0.891 . . . . 1.24 111.925 -178.01 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.6 tp . . . . . 0 N--CA 1.499 1.992 0 O-C-N 120.795 -1.191 . . . . 1.6699999999999999 109.746 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.628 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 106.857 -1.534 . . . . 5.4000000000000004 106.857 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 p -56.3 61.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.631 -0.713 . . . . 2.2799999999999998 111.291 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.628 ' N ' ' O ' ' A' ' 1' ' ' MET . 72.5 p -72.43 152.07 42.2 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.28 -1.008 . . . . 0.96999999999999997 108.28 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t -71.26 164.44 25.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 1.3500000000000001 109.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -51.75 -21.0 2.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.641 . . . . 2.3799999999999999 109.693 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.58 -37.23 83.09 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.316 -0.865 . . . . 2.0699999999999998 109.947 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -59.99 -50.07 75.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.029 -1.045 . . . . 0.44 110.047 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -69.92 -36.86 75.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.964 -1.085 . . . . 3.2999999999999998 110.182 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.863 -0.791 . . . . 0.68999999999999995 108.863 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -64.73 -49.6 70.2 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.516 -0.74 . . . . 0.38 110.14 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 m -83.36 8.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.085 -1.009 . . . . 0.34999999999999998 110.672 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.51 -13.48 16.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.153 -0.967 . . . . 0.46999999999999997 110.163 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.85 152.08 24.76 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.125 -0.984 . . . . 1.27 108.839 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -40.01 160.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.927 1.751 . . . . 0.44 112.065 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.688 ' SD ' HD11 ' B' ' 89' ' ' LEU . 3.2 ptp -89.2 -28.11 20.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.933 . . . . 1.0900000000000001 109.738 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.09 -141.1 43.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.787 -1.725 . . . . 0.53000000000000003 108.787 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.08 33.55 4.06 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.304 -1.115 . . . . 1.0700000000000001 109.806 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.9 148.96 75.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 2.1800000000000002 109.568 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.81 152.16 80.17 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.71 2.273 . . . . 0.38 112.911 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.7 p -53.69 -43.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.448 0.642 . . . . 0.29999999999999999 110.191 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.495 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -57.57 -3.85 1.17 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.384 -1.086 . . . . 0.19 110.384 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 20' ' ' VAL . 42.1 t -84.08 -22.5 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.337 . . . . 1.3799999999999999 110.163 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.467 HD22 HD21 ' A' ' 81' ' ' LEU . 74.7 mt -64.16 138.52 58.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.994 -1.066 . . . . 0.20999999999999999 109.895 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 134.43 54.36 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.792 -0.763 . . . . 0.20999999999999999 109.712 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.78 49.29 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.339 -1.504 . . . . 0.19 109.339 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.418 HD11 ' SG ' ' A' ' 77' ' ' CYS . 36.4 mm -98.51 112.26 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.331 -1.099 . . . . 0.19 108.126 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.06 177.28 42.87 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.855 -1.298 . . . . 0.19 109.855 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -58.54 -40.0 81.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.477 -1.014 . . . . 1.8 109.957 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.14 -46.71 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.96 -1.088 . . . . 0.31 108.834 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.689 HD11 ' OE1' ' A' ' 73' ' ' GLN . 88.0 mt -67.94 -39.75 83.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.33000000000000002 109.877 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.27 -33.92 77.7 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.879 -1.688 . . . . 0.31 108.879 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.03 -40.4 87.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.505 -0.997 . . . . 2.8900000000000001 110.292 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -68.47 -44.53 74.61 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.95 -1.094 . . . . 1.51 109.1 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.48 -39.41 93.35 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.933 -1.104 . . . . 0.28000000000000003 108.029 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.99 -42.22 93.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.75 . . . . 1.51 109.269 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -68.05 -18.74 64.77 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.311 -0.996 . . . . 2.4500000000000002 108.311 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.77 3.19 53.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.728 -0.608 . . . . 2.5499999999999998 109.789 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.05 7.57 49.75 Favored Glycine 0 N--CA 1.502 3.073 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 111.335 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CD2' HG12 ' A' ' 44' ' ' VAL . 93.7 m-85 -106.43 74.31 1.01 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.907 -1.349 . . . . 0.34999999999999998 109.048 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -80.23 -9.95 59.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.35999999999999999 110.665 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -129.33 152.36 48.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.227 -0.921 . . . . 1.4299999999999999 109.149 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.95 94.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.22 110.786 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.1 p90 -60.66 -17.84 49.95 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.915 -1.115 . . . . 0.62 110.975 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.597 HG12 ' CD2' ' A' ' 39' ' ' PHE . 44.7 t -78.97 -32.72 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.309 -1.367 . . . . 0.25 107.309 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.93 -39.84 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.582 -0.895 . . . . 0.20000000000000001 108.582 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.87 -35.12 74.16 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.079 -1.452 . . . . 0.29999999999999999 107.079 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.95 -40.76 95.79 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.63 -1.388 . . . . 0.20000000000000001 109.63 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.97 -42.46 94.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.296 -1.12 . . . . 1.1000000000000001 108.596 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.06 -39.96 87.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.32000000000000001 109.57 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD12 HD12 ' B' ' 50' ' ' LEU . 80.4 mt -69.52 -37.72 77.25 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.602 -0.839 . . . . 0.32000000000000001 108.948 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.53 -28.57 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.252 -0.905 . . . . 0.31 109.744 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.29 13.16 10.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.122 -0.986 . . . . 0.38 110.584 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt 49.94 38.96 17.51 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.538 -1.351 . . . . 2.1099999999999999 110.405 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mttm 56.85 19.47 4.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 1.9399999999999999 110.095 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.27 106.77 1.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 117.775 -1.57 . . . . 1.8400000000000001 106.972 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.1 -40.09 88.43 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.664 -0.647 . . . . 1.05 111.304 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -69.67 -40.03 76.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.263 -1.523 . . . . 0.90000000000000002 110.053 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.2 mt -70.6 -40.0 73.48 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.55 -1.26 . . . . 0.45000000000000001 109.196 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.88 -49.93 72.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.32000000000000001 110.511 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -63.23 -41.11 99.07 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.054 -1.059 . . . . 2.77 109.909 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.31 -40.07 93.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.629 -1.294 . . . . 2.1499999999999999 108.14 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -64.53 -50.03 68.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 0.27000000000000002 111.217 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.89 -46.1 83.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.132 -0.98 . . . . 0.33000000000000002 109.667 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -63.27 -49.79 72.69 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.483 -0.76 . . . . 1.9299999999999999 109.954 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.65 -30.51 70.79 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.515 -0.741 . . . . 1.7 109.678 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -78.36 -37.68 43.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.32000000000000001 111.096 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.0 p -127.24 -26.9 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.529 -1.357 . . . . 0.34000000000000002 112.261 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 13.7 27.12 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.249 -1.541 . . . . 0.27000000000000002 109.249 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.12 155.54 1.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.291 . . . . 0.23999999999999999 108.916 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -88.67 166.38 14.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 2.04 109.603 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.89 62.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.34999999999999998 108.351 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -70.16 -48.86 55.51 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.305 0.574 . . . . 3.6299999999999999 112.029 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.689 ' OE1' HD11 ' A' ' 30' ' ' LEU . 44.9 mt-30 -67.96 -30.01 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.068 -1.02 . . . . 2.1299999999999999 110.834 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.9 p -70.02 -34.7 73.62 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.979 -1.088 . . . . 1.45 109.254 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -60.29 -38.84 84.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 2.8300000000000001 109.34 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -66.86 -38.8 87.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 109.597 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 26' ' ' ILE . 93.9 m -69.91 -40.08 75.81 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.994 -1.066 . . . . 0.20000000000000001 109.702 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.74 -61.15 2.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.761 -1.212 . . . . 0.35999999999999999 109.769 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.7 -33.89 88.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.46 -1.056 . . . . 0.28999999999999998 110.46 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.41 -48.37 61.29 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.73 -1.453 . . . . 0.25 109.943 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 23' ' ' LEU . 82.9 mt -70.08 -40.07 75.22 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.9 -1.12 . . . . 0.41999999999999998 108.867 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -65.53 -40.12 92.56 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.4 -0.813 . . . . 2.5800000000000001 111.006 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -70.04 -35.36 74.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.74 -1.225 . . . . 2.0699999999999998 109.319 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.528 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 87.3 t90 -60.07 -43.69 95.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.991 -1.485 . . . . 0.32000000000000001 106.991 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.547 ' O ' ' N ' ' A' ' 89' ' ' LEU . 51.5 m -61.45 -40.18 93.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.613 0.72 . . . . 0.40999999999999998 109.896 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.96 -34.44 73.28 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.968 -1.082 . . . . 0.59999999999999998 110.328 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.33 -31.99 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.116 -0.99 . . . . 0.56000000000000005 110.299 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 66.0 m-85 -110.36 -3.13 16.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.542 -0.724 . . . . 1.23 112.606 -176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.66 HD11 ' SD ' ' B' ' 15' ' ' MET . 18.4 tp . . . . . 0 N--CA 1.504 2.226 0 O-C-N 120.77 -1.206 . . . . 1.74 109.714 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.634 ' O ' ' N ' ' B' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 106.836 -1.542 . . . . 5.4100000000000001 106.836 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 2.8 p -56.03 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.55 -0.75 . . . . 2.2799999999999998 111.347 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.634 ' N ' ' O ' ' B' ' 1' ' ' MET . 72.2 p -72.73 152.18 41.77 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.319 -0.993 . . . . 0.95999999999999996 108.319 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t -71.28 164.37 25.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.117 -0.989 . . . . 1.3500000000000001 109.699 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.66 -21.17 2.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.629 -0.669 . . . . 2.3700000000000001 109.659 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.33 -37.29 82.77 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.291 -0.881 . . . . 2.0600000000000001 109.876 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -60.05 -49.95 75.64 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.025 -1.047 . . . . 0.42999999999999999 110.038 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.02 -36.91 75.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 3.2999999999999998 110.227 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.06 -38.78 82.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.345 -0.847 . . . . 0.67000000000000004 108.732 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.68 -49.95 71.14 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.595 -0.69 . . . . 0.37 110.08 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.88 10.43 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.1 -1.0 . . . . 0.34000000000000002 110.659 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.67 -14.93 14.89 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.114 -0.991 . . . . 0.46999999999999997 110.192 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -153.51 151.2 24.94 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.139 -0.975 . . . . 1.27 108.748 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.97 160.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.97 1.78 . . . . 0.45000000000000001 112.052 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.66 ' SD ' HD11 ' A' ' 89' ' ' LEU . 3.8 ptp -89.06 -26.54 21.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.269 -0.895 . . . . 1.0900000000000001 109.46 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.54 -138.27 46.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.709 -1.756 . . . . 0.53000000000000003 108.709 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.59 35.44 3.47 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.355 -1.086 . . . . 1.0800000000000001 109.61 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 149.76 83.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 2.1899999999999999 109.798 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.64 152.21 79.23 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.702 2.268 . . . . 0.37 112.742 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.476 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.5 p -53.85 -42.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.622 -0.674 . . . . 0.29999999999999999 110.349 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.476 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -58.56 -3.34 1.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.514 -1.034 . . . . 0.19 110.514 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.424 ' H ' ' C ' ' B' ' 20' ' ' VAL . 45.7 t -83.28 -22.62 32.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.872 -1.37 . . . . 1.3899999999999999 110.014 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.461 HD22 HD21 ' B' ' 81' ' ' LEU . 73.8 mt -64.35 139.0 58.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.22 109.746 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.19 135.63 55.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.828 -0.749 . . . . 0.20999999999999999 109.668 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.14 -21.73 44.61 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.348 -1.501 . . . . 0.19 109.348 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.417 HD11 ' SG ' ' B' ' 77' ' ' CYS . 36.2 mm -98.48 113.69 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.845 -1.169 . . . . 0.20000000000000001 107.845 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.78 179.36 39.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.787 -1.325 . . . . 0.20000000000000001 109.787 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -58.72 -40.03 82.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.473 -1.016 . . . . 1.8200000000000001 110.206 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.73 -45.76 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.941 -1.099 . . . . 0.34000000000000002 109.058 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.705 HD11 ' OE1' ' B' ' 73' ' ' GLN . 86.5 mt -68.8 -39.99 79.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.34999999999999998 109.87 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.12 -33.56 75.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.869 -1.692 . . . . 0.32000000000000001 108.869 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -39.97 86.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.965 . . . . 2.8500000000000001 110.247 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -68.91 -44.62 72.75 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.924 -1.11 . . . . 1.52 109.158 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.52 -39.47 93.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.948 -1.13 . . . . 0.27000000000000002 107.948 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -60.04 -41.86 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.58 -0.7 . . . . 1.49 109.289 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -68.48 -18.37 64.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.472 -0.936 . . . . 2.4300000000000002 108.472 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -89.93 1.63 56.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 2.5600000000000001 109.775 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 8.45 43.47 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.114 -0.991 . . . . 0.46000000000000002 111.267 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.581 ' CD2' HG12 ' B' ' 44' ' ' VAL . 93.1 m-85 -107.15 74.18 0.96 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.886 -1.361 . . . . 0.34999999999999998 108.984 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -80.07 -10.41 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.34000000000000002 110.718 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -129.3 150.69 50.56 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.208 -0.933 . . . . 1.4299999999999999 109.084 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.28 99.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.199 -0.938 . . . . 0.20999999999999999 110.726 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.465 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 6.2 p90 -56.96 -18.27 12.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.113 . . . . 0.60999999999999999 110.762 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.581 HG12 ' CD2' ' B' ' 39' ' ' PHE . 41.6 t -78.49 -33.92 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.296 -1.372 . . . . 0.23000000000000001 107.296 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.38 -39.63 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.19 108.727 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.4 tp -59.83 -34.28 72.88 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.869 -1.53 . . . . 0.29999999999999999 106.869 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.39 -40.68 96.37 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.503 -1.439 . . . . 0.19 109.503 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -60.06 -42.64 94.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.24 -1.153 . . . . 1.1200000000000001 108.891 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 0.31 109.658 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.4 HD12 HD12 ' A' ' 50' ' ' LEU . 81.9 mt -69.16 -38.07 78.55 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.877 -0.786 . . . . 0.32000000000000001 108.877 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.04 -29.31 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.259 -0.901 . . . . 0.29999999999999999 109.717 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 94.5 mt -87.16 14.56 7.45 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.002 -1.062 . . . . 0.38 110.684 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 49.97 35.48 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.626 -1.296 . . . . 2.1400000000000001 110.917 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 60.05 19.84 9.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.206 -0.934 . . . . 1.95 109.923 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 108.93 2.73 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.638 -1.615 . . . . 1.8100000000000001 106.638 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.78 -40.03 93.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 1.04 111.22 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -69.28 -40.06 78.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.375 -1.453 . . . . 0.90000000000000002 110.008 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.74 -38.82 73.56 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.903 -1.119 . . . . 0.42999999999999999 109.191 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.54 -49.99 69.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.32000000000000001 110.414 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -63.1 -41.61 99.41 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.049 -1.032 . . . . 2.79 109.843 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.19 -40.08 93.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.691 -1.256 . . . . 2.1600000000000001 108.055 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' TRP . . . . . 0.404 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -64.33 -49.07 73.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.27000000000000002 111.138 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.7 tp -66.05 -48.34 71.35 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.943 -1.098 . . . . 0.34000000000000002 109.722 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -60.87 -49.84 75.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.501 -0.749 . . . . 1.9099999999999999 110.156 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -67.53 -28.24 67.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 1.6899999999999999 109.793 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.84 -33.62 34.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.32000000000000001 110.954 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 22.4 p -131.11 -28.44 1.94 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.453 -1.405 . . . . 0.34999999999999998 112.208 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.31 13.12 25.46 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.149 -1.581 . . . . 0.28999999999999998 109.149 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 154.68 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.242 . . . . 0.26000000000000001 108.735 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.49 168.12 12.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.976 -1.077 . . . . 2.0299999999999998 109.691 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.81 63.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.333 -0.988 . . . . 0.35999999999999999 108.333 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -70.06 -49.33 52.21 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-O 121.323 0.582 . . . . 3.6099999999999999 112.07 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.705 ' OE1' HD11 ' B' ' 30' ' ' LEU . 44.4 mt-30 -67.69 -29.99 69.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.977 -1.077 . . . . 2.1299999999999999 110.883 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -69.91 -34.65 73.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.062 -1.055 . . . . 1.46 109.159 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -60.73 -38.83 86.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.758 -1.214 . . . . 2.8100000000000001 109.579 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.83 -39.14 87.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.796 -1.19 . . . . 0.28999999999999998 109.647 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' CYS . . . . . 0.417 ' SG ' HD11 ' B' ' 26' ' ' ILE . 93.0 m -69.42 -40.02 77.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.019 -1.05 . . . . 0.19 109.484 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.93 -60.73 3.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.75 -1.219 . . . . 0.35999999999999999 109.758 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.8 -33.94 88.59 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.526 -1.03 . . . . 0.28000000000000003 110.526 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.49 -48.42 60.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.747 -1.443 . . . . 0.25 109.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.461 HD21 HD22 ' B' ' 23' ' ' LEU . 83.7 mt -69.97 -40.0 75.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.972 -1.091 . . . . 0.41999999999999998 108.539 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -66.9 -40.11 87.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.855 . . . . 2.6000000000000001 111.41 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -69.87 -34.9 74.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.594 -1.316 . . . . 2.0600000000000001 108.813 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.544 ' O ' ' HB2' ' B' ' 88' ' ' PHE . 85.4 t90 -59.46 -48.65 80.83 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.661 -1.978 . . . . 0.32000000000000001 105.661 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' B' ' 89' ' ' LEU . 36.5 m -58.07 -39.93 79.75 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.765 -0.584 . . . . 0.40999999999999998 110.29 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -61.25 -35.24 76.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.31 -1.494 . . . . 0.58999999999999997 111.171 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.03 -25.5 20.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.121 . . . . 0.57999999999999996 107.983 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' B' ' 84' ' ' TRP . 60.6 m-85 -115.15 -2.98 12.61 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 114.792 1.404 . . . . 1.24 114.792 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.688 HD11 ' SD ' ' A' ' 15' ' ' MET . 14.5 tp . . . . . 0 C--N 1.282 -2.344 0 O-C-N 119.009 -2.307 . . . . 1.76 110.051 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.328 0.585 . . . . 5.6799999999999997 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 3' ' ' THR . 0.2 OUTLIER 56.39 -159.9 0.22 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 3.02 109.113 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 2' ' ' THR . 17.7 p -100.03 127.3 46.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.267 -0.895 . . . . 0.95999999999999996 109.498 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 t -79.46 162.43 25.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 1.51 109.251 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.37 -20.81 1.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.618 . . . . 2.1800000000000002 109.734 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.87 -35.81 79.41 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 2.02 108.81 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -60.05 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.48999999999999999 109.934 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' HG2' HH11 ' A' ' 8' ' ' ARG . 30.9 mtt-85 -69.96 -34.62 73.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 3.21 109.959 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.95 -39.81 75.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.367 -0.833 . . . . 0.76000000000000001 109.738 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -65.62 -42.49 91.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.379 -0.826 . . . . 0.46000000000000002 110.338 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.32 14.63 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.901 -1.125 . . . . 0.44 109.869 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.39 -10.33 12.02 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.365 -0.834 . . . . 0.54000000000000004 110.488 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.49 149.98 22.47 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 1.26 109.575 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -39.67 161.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.903 1.735 . . . . 0.48999999999999999 111.619 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.47 -18.0 23.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.998 -1.064 . . . . 0.56999999999999995 109.677 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -143.24 12.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.954 -1.259 . . . . 0.40000000000000002 109.954 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.71 29.89 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.416 -1.049 . . . . 0.84999999999999998 110.274 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -60.05 149.06 75.91 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.093 -1.004 . . . . 2.0099999999999998 108.609 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.7 160.11 41.98 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.26 1.974 . . . . 0.34000000000000002 112.407 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 22' ' ' SER . 6.4 p -57.2 -47.09 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.75 . . . . 0.32000000000000001 110.403 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.54 -1.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.346 -1.102 . . . . 0.23000000000000001 110.346 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 20' ' ' VAL . 21.7 m -82.95 -23.16 33.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.77 -1.429 . . . . 1.24 109.72 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.708 HD22 HD21 ' A' ' 81' ' ' LEU . 95.0 mt -64.19 140.03 58.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.23999999999999999 109.751 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 134.68 55.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.747 0.784 . . . . 0.20999999999999999 109.857 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.23 -17.05 58.48 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.583 -1.407 . . . . 0.22 109.583 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.37 115.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -1.155 . . . . 0.25 107.971 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -89.03 172.44 40.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.697 -1.361 . . . . 0.28000000000000003 109.697 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -55.86 -40.05 72.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.0099999999999998 109.92 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.04 -44.19 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.997 -1.064 . . . . 0.38 109.741 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 27' ' ' GLY . 86.6 mt -64.37 -34.21 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.40000000000000002 109.825 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.93 95.19 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.022 -1.631 . . . . 0.34999999999999998 109.022 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.23 -38.83 92.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -1.171 . . . . 2.7400000000000002 109.575 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.27 -52.88 28.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 1.54 109.172 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.58 -40.0 90.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.082 -1.011 . . . . 0.34000000000000002 108.36 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -42.07 93.58 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.885 -0.726 . . . . 1.6699999999999999 109.223 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.3 -20.17 66.02 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.603 -0.888 . . . . 2.0 108.603 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.521 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.8 OUTLIER -91.09 4.39 52.28 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 2.6899999999999999 110.286 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.04 7.95 51.71 Favored Glycine 0 N--CA 1.502 3.054 0 O-C-N 120.976 -1.077 . . . . 0.47999999999999998 111.611 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.48 ' CD2' HG12 ' A' ' 44' ' ' VAL . 93.8 m-85 -104.81 73.48 1.08 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.717 -1.461 . . . . 0.33000000000000002 108.417 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 22.9 p-10 -77.56 -9.74 59.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.428 -0.795 . . . . 0.40999999999999998 111.104 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -137.46 158.06 45.22 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.056 -1.028 . . . . 1.5600000000000001 110.417 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.67 93.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.577 . . . . 0.20999999999999999 112.327 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -59.25 -18.1 34.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.586 -1.321 . . . . 0.32000000000000001 110.439 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.1 t -79.91 -31.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.878 -1.139 . . . . 0.23999999999999999 108.285 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 20' ' ' VAL . 54.5 t -77.03 -37.71 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.942 -1.133 . . . . 0.22 107.942 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.8 tp -59.96 -37.85 80.78 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.286 -1.375 . . . . 0.40000000000000002 107.286 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.54 89.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.98 -1.248 . . . . 0.17999999999999999 109.98 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -60.04 -42.66 94.9 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.89 -1.359 . . . . 1.0900000000000001 109.134 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -60.03 -40.82 90.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 0.31 108.793 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD21 ' SG ' ' A' ' 85' ' ' CYS . 80.7 mt -69.01 -38.27 79.14 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.544 -0.909 . . . . 0.28000000000000003 108.544 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.94 -22.65 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.269 -0.894 . . . . 0.28000000000000003 110.575 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.8 15.05 13.71 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.006 -1.059 . . . . 0.31 110.676 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.12 42.77 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.671 -1.268 . . . . 1.7 110.778 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 57.82 20.02 6.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.478 -0.764 . . . . 2.2400000000000002 110.421 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -69.2 104.53 2.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.412 -1.43 . . . . 1.8 107.706 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.16 -40.05 92.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.959 0.726 . . . . 0.87 112.959 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 95.0 m-20 -69.93 -39.98 75.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.457 -1.402 . . . . 0.72999999999999998 110.475 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.82 -40.04 72.69 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.985 -1.086 . . . . 0.55000000000000004 109.033 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.27 -49.88 73.94 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.836 . . . . 0.38 110.054 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 79.3 mtm180 -61.5 -43.67 98.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 2.6400000000000001 110.317 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.61 -39.85 94.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.265 -0.897 . . . . 2.3700000000000001 108.747 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -62.41 -49.22 76.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.275 -0.891 . . . . 0.40000000000000002 110.693 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.4 tp -67.78 -47.91 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.161 -0.962 . . . . 0.34000000000000002 110.131 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.49 -45.99 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 2.1099999999999999 109.642 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.84 -30.15 68.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.742 . . . . 1.8999999999999999 109.82 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -77.83 -36.89 49.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.945 . . . . 0.40999999999999998 111.227 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.5 p -130.44 -29.92 1.95 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.593 -1.317 . . . . 0.40000000000000002 111.783 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.33 15.86 11.94 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.311 -1.516 . . . . 0.35999999999999999 109.311 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.29 154.63 2.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.315 . . . . 0.33000000000000002 109.03 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 168.84 12.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 1.8999999999999999 109.95 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.99 71.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.39000000000000001 110.192 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -72.78 -39.98 66.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.935 -1.103 . . . . 2.5800000000000001 109.346 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -68.39 -38.8 81.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.1200000000000001 110.35 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.71 -36.06 77.97 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.13 -0.981 . . . . 1.3600000000000001 109.516 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.93 -38.07 81.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 2.7999999999999998 109.401 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.13 -39.95 82.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.744 -1.222 . . . . 0.40000000000000002 110.451 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.4 m -69.45 -40.7 77.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.667 -1.271 . . . . 0.23999999999999999 109.507 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -58.82 -60.21 4.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.534 -1.354 . . . . 0.42999999999999999 109.41 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.5 90.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.86 -0.896 . . . . 0.26000000000000001 110.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.91 -49.32 59.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.364 . . . . 0.25 110.217 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.708 HD21 HD22 ' A' ' 23' ' ' LEU . 84.5 mt -70.0 -39.62 75.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.902 -1.119 . . . . 0.29999999999999999 108.757 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.94 -41.03 90.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 2.73 109.691 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.01 -37.8 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.9099999999999999 110.628 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.526 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 85.8 t90 -60.86 -42.01 97.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.37 108.974 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.467 ' SG ' HD21 ' A' ' 50' ' ' LEU . 69.8 m -62.08 -40.04 94.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.35999999999999999 109.752 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.66 -31.16 67.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.344 -0.848 . . . . 0.55000000000000004 109.646 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.89 -37.06 12.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.305 -0.872 . . . . 0.47999999999999998 111.325 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 -106.05 -4.38 20.52 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.132 -0.98 . . . . 1.24 112.399 -177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 85' ' ' CYS . 8.3 tp . . . . . 0 N--CA 1.502 2.154 0 O-C-N 120.54 -1.35 . . . . 1.6599999999999999 109.317 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.465 -0.568 . . . . 5.6600000000000001 109.465 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.465 HG22 ' H ' ' B' ' 3' ' ' THR . 0.2 OUTLIER 56.45 -160.01 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 3.02 109.094 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.465 ' H ' HG22 ' B' ' 2' ' ' THR . 17.7 p -100.03 127.29 46.26 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.35 -0.844 . . . . 0.95999999999999996 109.467 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t -79.44 162.41 25.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 1.5 109.236 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.49 -20.72 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.714 -0.616 . . . . 2.1800000000000002 109.727 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.81 -35.91 79.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 2.0099999999999998 108.875 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.92 -48.96 79.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.48999999999999999 110.015 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.498 ' HG2' HH11 ' B' ' 8' ' ' ARG . 31.0 mtt-85 -69.94 -34.61 73.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 3.23 110.007 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -69.95 -39.59 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.299 -0.876 . . . . 0.76000000000000001 109.855 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -65.75 -42.47 90.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.448 -0.783 . . . . 0.46000000000000002 110.36 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -84.31 14.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.946 -1.096 . . . . 0.44 109.88 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.3 -10.02 12.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.397 -0.814 . . . . 0.53000000000000003 110.466 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.63 150.02 22.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.86 -1.15 . . . . 1.27 109.456 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.59 161.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.918 1.745 . . . . 0.48999999999999999 111.603 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.44 -18.15 23.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.043 -1.035 . . . . 0.56000000000000005 109.708 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.32 -143.15 12.98 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.018 -1.233 . . . . 0.39000000000000001 110.018 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.88 29.94 5.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.484 -1.01 . . . . 0.83999999999999997 110.221 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -60.16 149.07 76.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 2.02 108.632 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 160.18 41.52 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.194 1.929 . . . . 0.34000000000000002 112.424 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' B' ' 22' ' ' SER . 6.3 p -57.27 -47.05 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.734 . . . . 0.32000000000000001 110.441 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.494 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.43 -2.1 0.1 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.475 -1.05 . . . . 0.22 110.475 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.524 ' H ' ' C ' ' B' ' 20' ' ' VAL . 21.1 m -82.67 -23.26 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.806 -1.408 . . . . 1.24 109.806 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.737 HD22 HD21 ' B' ' 81' ' ' LEU . 94.6 mt -64.12 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.04 -1.037 . . . . 0.23999999999999999 109.718 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.428 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.24 134.93 55.72 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.69 0.757 . . . . 0.20999999999999999 109.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.09 58.66 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.489 -1.444 . . . . 0.22 109.489 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.33 115.41 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.245 -1.15 . . . . 0.25 107.951 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.414 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -88.94 172.51 40.37 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.725 -1.35 . . . . 0.28000000000000003 109.725 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -56.01 -39.94 72.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -1.089 . . . . 2.0 109.907 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.19 -43.99 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.008 -1.057 . . . . 0.38 109.749 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.414 HD12 ' H ' ' B' ' 27' ' ' GLY . 86.8 mt -64.51 -34.13 77.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.40000000000000002 109.742 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.17 -40.03 95.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.973 -1.651 . . . . 0.35999999999999999 108.973 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.26 -38.64 91.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -1.154 . . . . 2.75 109.545 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.4 -52.88 28.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.124 . . . . 1.5600000000000001 109.12 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.7 -39.95 90.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.286 -1.005 . . . . 0.33000000000000002 108.286 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.08 -41.97 93.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.839 -0.744 . . . . 1.6799999999999999 109.168 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.42 -20.07 65.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.653 -0.869 . . . . 1.99 108.653 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.8 OUTLIER -90.98 4.17 52.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.561 -0.712 . . . . 2.6800000000000002 110.321 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.05 7.96 51.65 Favored Glycine 0 N--CA 1.502 3.067 0 C-N-CA 120.139 -1.029 . . . . 0.48999999999999999 111.664 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.488 ' CD2' HG12 ' B' ' 44' ' ' VAL . 93.9 m-85 -104.75 73.44 1.08 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.401 . . . . 0.33000000000000002 108.485 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 40' ' ' ASP . 22.7 p-10 -77.61 -9.75 59.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.40999999999999998 111.021 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -137.39 157.92 45.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.999 -1.063 . . . . 1.5600000000000001 110.423 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.0 94.56 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.702 -0.624 . . . . 0.20999999999999999 112.318 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.476 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 4.6 p90 -59.1 -17.88 30.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.61 -1.306 . . . . 0.32000000000000001 110.578 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.5 t -80.01 -31.93 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.924 -1.11 . . . . 0.23999999999999999 108.231 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.407 HG21 HG23 ' B' ' 20' ' ' VAL . 54.5 t -76.92 -37.65 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.954 -1.128 . . . . 0.22 107.954 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.0 -37.65 80.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.265 -1.383 . . . . 0.40000000000000002 107.265 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.47 90.35 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.96 -1.256 . . . . 0.17999999999999999 109.96 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.774 -1.427 . . . . 1.0900000000000001 109.154 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -59.95 -40.93 90.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.31 108.785 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.456 HD21 ' SG ' ' B' ' 85' ' ' CYS . 80.9 mt -68.96 -38.0 79.16 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.622 -0.881 . . . . 0.27000000000000002 108.622 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.14 -22.79 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.263 -0.898 . . . . 0.28000000000000003 110.499 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.58 14.69 14.31 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.088 -1.008 . . . . 0.29999999999999999 110.732 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.44 42.4 14.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.7 -1.25 . . . . 1.71 110.742 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 58.27 19.95 6.75 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.403 -0.811 . . . . 2.25 110.43 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -69.23 104.52 2.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 1.8 107.817 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.18 -39.99 92.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.899 0.703 . . . . 0.88 112.899 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 94.8 m-20 -70.05 -39.94 75.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.465 -1.397 . . . . 0.73999999999999999 110.362 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.969 -1.092 . . . . 0.55000000000000004 108.92 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.15 -49.98 73.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.328 -0.857 . . . . 0.38 109.939 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.486 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 79.3 mtm180 -61.7 -43.38 98.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 2.6400000000000001 110.295 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -64.71 -39.9 94.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.076 -1.015 . . . . 2.3799999999999999 108.782 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -62.39 -49.32 75.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.343 -0.848 . . . . 0.40000000000000002 110.703 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.6 -47.85 68.49 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.184 -0.948 . . . . 0.34000000000000002 110.209 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.48 -46.13 87.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 2.1000000000000001 109.636 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -68.85 -29.97 68.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 1.8999999999999999 109.903 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -77.91 -36.82 49.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.40000000000000002 111.189 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 13.4 p -130.64 -29.77 1.92 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.564 -1.335 . . . . 0.39000000000000001 111.712 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.31 15.72 12.16 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.345 -1.502 . . . . 0.35999999999999999 109.345 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.08 154.52 2.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.968 -1.313 . . . . 0.32000000000000001 109.125 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -88.34 168.93 12.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.991 -1.068 . . . . 1.9099999999999999 109.922 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.31 71.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.38 110.167 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -72.47 -40.01 67.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 2.5699999999999998 109.409 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -68.54 -38.6 80.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.45 -0.781 . . . . 2.1200000000000001 110.447 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.72 -36.06 77.95 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 1.3600000000000001 109.564 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.87 -38.21 81.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 2.8100000000000001 109.342 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.92 -40.02 83.45 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.40000000000000002 110.428 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.1 m -69.53 -40.73 76.71 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.653 -1.279 . . . . 0.23000000000000001 109.46 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.78 -60.36 3.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.635 -1.291 . . . . 0.42999999999999999 109.37 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.05 -34.58 90.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.779 -0.928 . . . . 0.25 110.779 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 51.1 t -68.79 -49.4 58.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.927 -1.337 . . . . 0.23999999999999999 110.215 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.737 HD21 HD22 ' B' ' 23' ' ' LEU . 84.6 mt -69.99 -39.5 75.86 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.842 -1.143 . . . . 0.28999999999999998 108.799 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.04 -41.0 91.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 2.7400000000000002 109.605 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -70.0 -37.72 75.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.9099999999999999 110.711 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 85.7 t90 -60.81 -42.16 97.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.516 -1.365 . . . . 0.35999999999999999 108.986 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.456 ' SG ' HD21 ' B' ' 50' ' ' LEU . 69.7 m -62.04 -39.96 94.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.474 -0.766 . . . . 0.35999999999999999 109.735 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -58.61 -31.43 68.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.433 -0.792 . . . . 0.55000000000000004 109.67 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.7 -37.19 12.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.46999999999999997 111.416 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.9 m-85 -105.74 -4.35 21.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.084 -1.01 . . . . 1.24 112.501 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.444 -1.41 . . . . 1.6699999999999999 109.419 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.315 -0.624 . . . . 5.6799999999999997 109.315 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 m -86.33 12.23 10.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.188 -0.945 . . . . 3.02 109.254 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.2 p -69.48 165.25 21.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.95999999999999996 109.396 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p -71.93 170.07 14.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 1.51 110.078 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -54.57 -19.28 5.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.778 -0.576 . . . . 2.1800000000000002 110.05 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -60.05 -38.36 82.58 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.031 -1.043 . . . . 2.02 109.366 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.409 ' O ' HG22 ' A' ' 11' ' ' VAL . 63.8 t60 -58.93 -50.06 75.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.48999999999999999 110.515 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 30.9 mmt180 -69.97 -33.78 72.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.02 . . . . 3.21 109.831 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -67.17 -39.9 86.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.849 -0.741 . . . . 0.76000000000000001 109.904 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.92 -47.15 75.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.46000000000000002 110.362 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 7' ' ' HIS . 24.3 m -85.77 5.18 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.128 -0.982 . . . . 0.44 110.929 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -100.57 -14.97 17.98 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.06 -1.025 . . . . 0.54000000000000004 109.935 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.6 pt-20 -153.59 153.35 28.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 1.26 108.712 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 13' ' ' GLU . 64.1 Cg_exo -35.87 156.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.236 1.958 . . . . 0.48999999999999999 112.024 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.54 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 10.4 ptm -93.12 -31.59 14.75 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.238 -0.913 . . . . 0.56999999999999995 109.983 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.24 -133.58 41.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.612 -0.995 . . . . 0.40000000000000002 110.612 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.56 -0.964 . . . . 0.84999999999999998 110.972 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.31 65.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.704 -1.248 . . . . 2.0099999999999998 108.23 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.47 155.48 47.02 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.084 1.856 . . . . 0.34000000000000002 112.246 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.8 p -56.23 -47.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.554 -0.716 . . . . 0.32000000000000001 110.384 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.576 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -58.03 -3.28 1.18 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.681 -0.967 . . . . 0.23000000000000001 110.681 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' VAL . 9.6 t -84.52 -22.31 30.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.742 -1.446 . . . . 1.24 109.633 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.601 HD22 HD21 ' A' ' 81' ' ' LEU . 96.4 mt -62.88 138.87 58.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 0.23999999999999999 109.263 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 136.27 57.27 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.91 0.862 . . . . 0.20999999999999999 110.507 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.05 59.67 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.301 -1.52 . . . . 0.22 109.301 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 77' ' ' CYS . 27.1 mm -100.29 113.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.436 -1.038 . . . . 0.25 108.384 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.75 177.72 40.49 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.422 -1.471 . . . . 0.28000000000000003 109.422 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -55.77 -39.72 71.61 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.465 -1.021 . . . . 2.0099999999999998 109.562 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.02 -46.36 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.06 -1.025 . . . . 0.38 110.127 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.68 -39.05 87.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.40000000000000002 109.972 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 -39.96 97.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.168 -1.173 . . . . 0.34999999999999998 110.168 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.34 -39.66 92.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.106 -1.232 . . . . 2.7400000000000002 110.241 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -67.66 -45.68 74.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.936 -1.103 . . . . 1.54 108.974 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.91 -39.42 89.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.655 -1.239 . . . . 0.34000000000000002 107.655 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.02 -40.94 91.04 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.827 -0.749 . . . . 1.6699999999999999 109.141 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -68.03 -20.35 64.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.246 -0.909 . . . . 2.0 108.882 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.421 ' HE ' HG23 ' A' ' 66' ' ' THR . 23.7 mmm180 -91.16 2.43 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 2.6899999999999999 109.679 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.02 38.0 3.72 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 120.346 -0.93 . . . . 0.47999999999999998 111.352 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' A' ' 44' ' ' VAL . 87.2 m-85 -133.63 72.29 1.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.959 -1.318 . . . . 0.33000000000000002 109.073 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 22.9 p-10 -80.07 -10.73 59.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.165 . . . . 0.40999999999999998 110.437 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -129.75 150.93 50.84 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.193 -0.942 . . . . 1.5600000000000001 109.422 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.06 90.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.20999999999999999 111.274 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.74 -17.1 32.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.741 -1.224 . . . . 0.32000000000000001 110.182 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' A' ' 39' ' ' PHE . 61.0 t -79.86 -31.8 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.748 -1.204 . . . . 0.23999999999999999 107.748 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.34 -36.47 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.774 -1.195 . . . . 0.22 107.774 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.01 -36.34 77.01 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.237 -1.394 . . . . 0.40000000000000002 107.237 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.07 98.12 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.736 -1.346 . . . . 0.17999999999999999 109.736 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -60.08 -43.8 95.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.903 -1.351 . . . . 1.0900000000000001 108.431 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.11 -40.91 91.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.31 109.222 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.6 -38.45 80.62 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.426 -0.953 . . . . 0.28000000000000003 108.426 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.76 -21.08 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.259 -0.9 . . . . 0.28000000000000003 110.853 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.48 13.27 14.21 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.933 -1.105 . . . . 0.31 111.351 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 49.92 36.21 11.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.648 -1.282 . . . . 1.7 110.065 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.28 19.96 8.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.411 -0.805 . . . . 2.2400000000000002 110.257 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.9 105.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.526 -1.359 . . . . 1.8 108.209 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 82.5 tt0 -65.11 -40.29 94.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.486 -0.759 . . . . 0.87 112.44 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.61 -39.99 80.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.704 -1.248 . . . . 0.72999999999999998 109.594 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.59 -39.31 77.37 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.385 -0.926 . . . . 0.55000000000000004 108.756 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.5 -46.62 89.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.38 109.117 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 96.9 mtt180 -59.99 -48.21 82.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.497 -0.752 . . . . 2.6400000000000001 110.694 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.32 -39.95 89.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.703 -1.248 . . . . 2.3700000000000001 108.913 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -62.76 -49.94 73.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.40000000000000002 110.647 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 56.6 tp -66.35 -47.64 72.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.328 -0.857 . . . . 0.34000000000000002 109.724 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.27 -44.93 95.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.359 -0.838 . . . . 2.1099999999999999 109.772 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.36 -32.08 70.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.327 -0.858 . . . . 1.8999999999999999 109.244 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.421 HG23 ' HE ' ' A' ' 37' ' ' ARG . 94.4 m -77.1 -38.0 53.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.40999999999999998 111.323 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 10.5 p -131.0 -37.0 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.622 -1.299 . . . . 0.40000000000000002 111.86 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.21 17.75 7.57 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.214 -1.555 . . . . 0.35999999999999999 109.214 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.31 153.84 3.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.034 -1.274 . . . . 0.33000000000000002 109.191 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -91.06 171.66 9.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 1.8999999999999999 109.589 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.84 70.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.467 -0.771 . . . . 0.39000000000000001 110.593 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -71.79 -41.16 68.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.739 -1.226 . . . . 2.5800000000000001 110.317 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.41 -39.16 88.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.198 -0.939 . . . . 2.1200000000000001 110.451 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -66.03 -38.65 88.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.441 -0.787 . . . . 1.3600000000000001 110.195 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.825 -1.172 . . . . 2.7999999999999998 109.384 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -67.9 -39.99 83.53 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.697 -1.252 . . . . 0.40000000000000002 110.476 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.426 ' SG ' HD11 ' A' ' 26' ' ' ILE . 92.4 m -69.74 -39.94 76.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.683 -1.26 . . . . 0.23999999999999999 109.778 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.48 -60.41 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.61 -1.307 . . . . 0.42999999999999999 109.792 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.58 84.67 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 120.305 -0.95 . . . . 0.26000000000000001 110.843 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.21 -49.27 45.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.832 -1.393 . . . . 0.25 110.014 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.601 HD21 HD22 ' A' ' 23' ' ' LEU . 88.5 mt -70.0 -39.98 75.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.29999999999999999 108.745 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.491 ' HG2' HH11 ' A' ' 82' ' ' ARG . 16.4 ttt-85 -64.57 -39.87 94.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.282 -0.886 . . . . 2.73 110.051 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.92 -39.45 79.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 1.9099999999999999 110.345 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.588 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 88.3 t90 -60.14 -43.63 95.57 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.411 -1.431 . . . . 0.37 107.666 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 89' ' ' LEU . 59.1 m -61.57 -40.02 93.26 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.457 0.646 . . . . 0.35999999999999999 109.695 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.99 -31.91 70.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.835 . . . . 0.55000000000000004 109.145 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.73 13.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.4 -0.813 . . . . 0.47999999999999998 110.654 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.588 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 85.5 m-85 -107.8 -6.34 16.81 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.278 -0.889 . . . . 1.24 112.831 -177.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 85' ' ' CYS . 10.5 tp . . . . . 0 N--CA 1.504 2.258 0 O-C-N 120.335 -1.478 . . . . 1.6599999999999999 109.297 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptp . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.302 -0.629 . . . . 5.6600000000000001 109.302 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 2.6 m -86.29 12.17 10.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.92 . . . . 3.02 109.223 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 59.6 p -69.46 165.18 21.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.95999999999999996 109.459 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p -71.89 170.21 14.2 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.793 0.806 . . . . 1.5 110.07 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -54.73 -19.28 5.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.77 -0.581 . . . . 2.1800000000000002 110.039 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.96 -38.37 82.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.024 -1.047 . . . . 2.0099999999999998 109.364 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.403 ' O ' HG22 ' B' ' 11' ' ' VAL . 63.7 t60 -58.95 -50.12 75.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.996 . . . . 0.48999999999999999 110.428 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 30.9 mmt180 -70.01 -33.72 72.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.035 -1.041 . . . . 3.23 109.825 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.2 -39.93 86.4 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.418 -0.801 . . . . 0.76000000000000001 109.792 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.83 -47.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.46000000000000002 110.303 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 7' ' ' HIS . 24.2 m -85.77 5.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.132 -0.98 . . . . 0.44 110.907 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -100.56 -15.09 17.94 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.049 -1.032 . . . . 0.53000000000000003 109.915 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' B' ' 14' ' ' PRO . 4.6 pt-20 -153.65 153.38 28.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 1.27 108.606 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -35.93 156.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.333 2.022 . . . . 0.48999999999999999 112.001 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.531 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 10.3 ptm -93.24 -31.64 14.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.359 -0.838 . . . . 0.56000000000000005 109.916 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.62 42.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.557 -1.017 . . . . 0.39000000000000001 110.557 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.968 . . . . 0.83999999999999997 110.938 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.34 64.83 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.748 -1.22 . . . . 2.02 108.272 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.54 155.55 46.96 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.016 1.81 . . . . 0.34000000000000002 112.298 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.58 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.6 p -56.26 -47.25 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.536 -0.728 . . . . 0.32000000000000001 110.43 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -58.01 -3.12 1.1 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.781 -0.928 . . . . 0.22 110.781 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 20' ' ' VAL . 9.8 t -84.65 -22.34 29.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.696 -1.473 . . . . 1.24 109.573 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.6 HD22 HD21 ' B' ' 81' ' ' LEU . 96.5 mt -62.91 138.87 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 0.23999999999999999 109.276 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 136.15 57.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.782 0.801 . . . . 0.20999999999999999 110.552 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -16.95 59.9 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.393 -1.483 . . . . 0.22 109.393 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.429 HD11 ' SG ' ' B' ' 77' ' ' CYS . 27.2 mm -100.38 113.19 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.398 -1.06 . . . . 0.25 108.343 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.74 177.56 40.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.419 -1.472 . . . . 0.28000000000000003 109.419 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -55.63 -39.7 71.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.506 -0.996 . . . . 2.0 109.519 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.05 -46.35 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.053 -1.029 . . . . 0.38 110.096 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.72 -38.96 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.40000000000000002 109.865 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.81 -40.1 97.73 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.083 -1.207 . . . . 0.35999999999999999 110.083 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.26 -39.71 93.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.254 . . . . 2.75 110.187 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.56 -45.67 74.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.105 . . . . 1.5600000000000001 109.041 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.95 -39.53 89.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.595 -1.261 . . . . 0.33000000000000002 107.595 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.96 -40.98 90.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.803 -0.759 . . . . 1.6799999999999999 109.082 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.97 -20.26 65.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 1.99 108.934 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.403 ' HE ' HG23 ' B' ' 66' ' ' THR . 23.7 mmm180 -91.39 2.64 56.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.695 . . . . 2.6800000000000002 109.667 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 37.97 3.74 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 121.165 -0.959 . . . . 0.48999999999999999 111.37 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.505 ' CD2' HG12 ' B' ' 44' ' ' VAL . 86.9 m-85 -133.54 72.2 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.921 -1.341 . . . . 0.33000000000000002 109.095 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 40' ' ' ASP . 22.9 p-10 -80.06 -10.63 59.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.40999999999999998 110.413 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -129.81 150.83 50.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.294 -0.879 . . . . 1.5600000000000001 109.489 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -40.09 90.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.461 -0.774 . . . . 0.20999999999999999 111.291 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.79 -17.13 33.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.745 -1.222 . . . . 0.32000000000000001 110.217 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 HG12 ' CD2' ' B' ' 39' ' ' PHE . 61.0 t -79.87 -31.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.745 -1.205 . . . . 0.23999999999999999 107.745 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 59.2 t -78.49 -36.39 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.727 -1.212 . . . . 0.22 107.727 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.06 -36.25 76.93 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.166 -1.42 . . . . 0.40000000000000002 107.166 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.18 98.25 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.635 -1.386 . . . . 0.17999999999999999 109.635 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -59.98 -43.89 94.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.944 -1.327 . . . . 1.0900000000000001 108.514 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -59.91 -41.07 90.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.769 . . . . 0.31 109.275 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.44 -38.52 81.24 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.513 -0.921 . . . . 0.27000000000000002 108.513 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.87 -20.95 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.936 . . . . 0.28000000000000003 110.779 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.52 13.19 14.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.863 -1.148 . . . . 0.29999999999999999 111.41 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 50.05 36.15 11.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.667 -1.271 . . . . 1.71 110.125 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.11 20.03 7.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.38 -0.825 . . . . 2.25 110.285 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -67.92 105.28 1.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.553 -1.342 . . . . 1.8 108.258 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 82.5 tt0 -65.06 -40.32 94.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 0.88 112.375 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.6 -39.82 80.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.844 -1.16 . . . . 0.73999999999999999 109.577 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.79 -39.25 76.72 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.29 -0.964 . . . . 0.55000000000000004 108.764 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.53 -46.72 88.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.38 109.021 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 97.0 mtt180 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.504 -0.748 . . . . 2.6400000000000001 110.664 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.3 -40.01 89.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.782 -1.199 . . . . 2.3799999999999999 108.952 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -62.77 -49.93 73.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.989 -1.069 . . . . 0.40000000000000002 110.656 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.7 tp -66.42 -47.62 72.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.391 -0.818 . . . . 0.34000000000000002 109.708 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.27 -44.86 95.56 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.376 -0.827 . . . . 2.1000000000000001 109.783 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -69.48 -31.95 70.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 1.8999999999999999 109.22 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.403 HG23 ' HE ' ' B' ' 37' ' ' ARG . 94.2 m -77.06 -37.98 53.52 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.448 -0.782 . . . . 0.40000000000000002 111.467 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 10.5 p -131.0 -37.04 1.3 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.649 -1.282 . . . . 0.39000000000000001 111.886 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.17 17.81 7.56 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.282 -1.527 . . . . 0.35999999999999999 109.282 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.35 153.92 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.053 -1.263 . . . . 0.32000000000000001 109.153 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.19 171.77 9.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 1.9099999999999999 109.466 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.85 70.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.413 -0.805 . . . . 0.38 110.511 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.79 -41.22 68.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.784 -1.197 . . . . 2.5699999999999998 110.247 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.37 -39.16 88.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -0.918 . . . . 2.1200000000000001 110.439 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 51.0 m -66.02 -38.74 89.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 1.3600000000000001 110.182 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -59.89 -38.32 81.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.857 -1.152 . . . . 2.8100000000000001 109.452 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -68.11 -39.98 82.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.69 -1.256 . . . . 0.40000000000000002 110.499 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' B' ' 26' ' ' ILE . 93.0 m -69.67 -40.06 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.23000000000000001 109.757 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.38 -60.38 3.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.592 -1.318 . . . . 0.42999999999999999 109.777 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.68 85.01 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.797 -0.921 . . . . 0.25 110.797 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.09 -49.41 44.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.758 -1.436 . . . . 0.23999999999999999 109.982 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.6 HD21 HD22 ' B' ' 23' ' ' LEU . 88.5 mt -70.02 -39.9 75.51 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.004 -1.078 . . . . 0.28999999999999998 108.823 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' B' ' 82' ' ' ARG . 16.5 ttt-85 -64.4 -40.07 95.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 2.7400000000000002 110.061 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.7 -39.65 80.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 1.9099999999999999 110.45 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.586 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 88.3 t90 -60.03 -43.61 95.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.409 -1.432 . . . . 0.35999999999999999 107.658 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.6 m -61.69 -40.01 93.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.35999999999999999 109.647 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -59.99 -31.85 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 0.55000000000000004 109.227 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.16 -35.1 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.307 -0.871 . . . . 0.46999999999999997 110.611 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.586 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 86.9 m-85 -107.2 -6.64 17.18 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.239 -0.913 . . . . 1.24 112.951 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.4 tp . . . . . 0 N--CA 1.504 2.262 0 O-C-N 120.202 -1.561 . . . . 1.6699999999999999 109.342 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OG1' ' A' ' 2' ' ' THR . 19.5 mmm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.006 -0.739 . . . . 5.6799999999999997 109.006 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 1' ' ' MET . 3.4 p 49.62 42.65 23.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 3.02 109.685 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.9 p -78.71 161.63 26.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.95999999999999996 109.815 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.3 p -72.53 169.29 16.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.342 -0.849 . . . . 1.51 109.557 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -59.72 -22.52 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 2.1800000000000002 110.253 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.13 -38.5 83.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 2.02 109.157 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 14.1 t60 -56.86 -49.84 74.25 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.256 -0.903 . . . . 0.48999999999999999 110.132 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -70.03 -34.0 72.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.922 . . . . 3.21 110.086 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.68 -36.84 73.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.327 -0.858 . . . . 0.76000000000000001 109.74 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -64.49 -43.18 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.46000000000000002 109.803 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -84.11 15.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.209 -0.932 . . . . 0.44 110.243 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.42 -9.49 10.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.298 -0.876 . . . . 0.54000000000000004 110.311 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.71 149.73 19.45 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.859 -1.15 . . . . 1.26 109.461 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -40.61 155.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.742 1.628 . . . . 0.48999999999999999 111.168 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.518 ' CE ' HD22 ' A' ' 46' ' ' LEU . 4.3 ptp -91.21 -19.65 22.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.966 -1.084 . . . . 0.56999999999999995 109.174 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -138.6 39.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.195 -1.162 . . . . 0.40000000000000002 110.195 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -106.18 30.53 5.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.621 -0.929 . . . . 0.84999999999999998 110.487 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -60.06 148.52 77.52 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 2.0099999999999998 107.927 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.81 159.08 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.06 1.84 . . . . 0.34000000000000002 112.633 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.5 p -57.12 -49.25 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 0.32000000000000001 110.517 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.57 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.39 -1.86 0.14 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.763 -0.935 . . . . 0.23000000000000001 110.763 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 64.9 p -82.42 -24.72 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.69 -1.476 . . . . 1.24 109.847 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.11 138.72 58.2 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.887 0.851 . . . . 0.23999999999999999 109.84 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 133.43 53.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.725 0.774 . . . . 0.20999999999999999 109.982 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 97.37 -20.25 51.47 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.213 -1.555 . . . . 0.22 109.213 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.0 mm -99.75 113.17 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -1.162 . . . . 0.25 107.892 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -93.44 179.94 39.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.28000000000000003 109.692 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -56.01 -39.96 72.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.544 -0.974 . . . . 2.0099999999999998 109.874 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.73 -43.17 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.95 -1.094 . . . . 0.38 109.524 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 27' ' ' GLY . 97.2 mt -67.73 -39.91 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.40000000000000002 109.526 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.29 97.81 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.135 -1.186 . . . . 0.34999999999999998 110.135 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -64.36 -38.79 92.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.998 -1.295 . . . . 2.7400000000000002 110.079 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -65.43 -48.87 71.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.872 -1.142 . . . . 1.54 109.177 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.85 -38.6 86.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.21 -0.931 . . . . 0.34000000000000002 108.59 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.11 -40.05 88.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.768 -0.827 . . . . 1.6699999999999999 108.768 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.87 -18.89 64.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.407 -0.96 . . . . 2.0 108.407 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.33 2.89 56.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.594 -0.691 . . . . 2.6899999999999999 110.166 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.56 6.86 49.65 Favored Glycine 0 N--CA 1.503 3.115 0 O-C-N 120.997 -1.064 . . . . 0.47999999999999998 112.244 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 39' ' ' PHE . 44.3 m-85 -106.23 77.12 1.2 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 119.208 1.504 . . . . 0.33000000000000002 109.32 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -77.46 -8.19 57.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.40999999999999998 111.024 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.79 158.54 44.15 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.977 -1.077 . . . . 1.5600000000000001 109.418 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.2 90.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.462 -0.774 . . . . 0.20999999999999999 112.183 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.32 -17.58 20.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.636 -1.29 . . . . 0.32000000000000001 110.635 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.18 -30.02 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.927 -1.108 . . . . 0.23999999999999999 108.152 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.72 -39.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.994 -1.113 . . . . 0.22 107.994 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.518 HD22 ' CE ' ' A' ' 15' ' ' MET . 60.6 tp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.217 -1.401 . . . . 0.40000000000000002 107.217 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.56 -43.79 67.71 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.156 -1.577 . . . . 0.17999999999999999 109.156 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -1.225 . . . . 1.0900000000000001 108.634 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.86 -41.19 90.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.852 . . . . 0.31 109.09 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.03 -39.98 75.44 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.883 -0.727 . . . . 0.28000000000000003 109.073 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.78 -20.27 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.115 -0.991 . . . . 0.28000000000000003 110.626 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.75 18.17 9.27 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.058 -1.026 . . . . 0.31 109.79 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.04 32.44 10.26 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.942 -1.099 . . . . 1.7 110.103 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 60.02 19.91 9.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.62 -0.675 . . . . 2.2400000000000002 109.913 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -67.84 111.88 4.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.777 -1.202 . . . . 1.8 107.927 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.5 -41.17 98.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.87 112.601 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.42 -40.05 77.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.548 -1.345 . . . . 0.72999999999999998 109.669 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.91 -40.01 75.85 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.977 -1.089 . . . . 0.55000000000000004 108.785 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.06 -49.98 70.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.38 110.026 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -61.19 -44.85 96.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 2.6400000000000001 110.431 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 98.8 mt-10 -64.81 -37.92 89.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.805 -1.185 . . . . 2.3700000000000001 108.846 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.407 ' O ' ' OG1' ' A' ' 66' ' ' THR . 65.1 t90 -64.05 -48.04 77.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.303 -0.873 . . . . 0.40000000000000002 110.974 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.17 -46.89 66.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.956 -1.09 . . . . 0.34000000000000002 109.862 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -61.52 -47.0 87.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.067 -1.021 . . . . 2.1099999999999999 109.714 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 61' ' ' GLU . 71.7 m-20 -70.02 -28.33 65.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.849 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 54.5 m -80.61 -31.56 36.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.40999999999999998 111.732 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.6 p -133.19 -23.37 1.94 Allowed 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.374 -1.453 . . . . 0.40000000000000002 111.916 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.85 13.09 32.85 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.171 -1.572 . . . . 0.35999999999999999 109.171 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.88 154.74 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.097 -1.237 . . . . 0.33000000000000002 109.371 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.93 171.88 9.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 1.8999999999999999 110.214 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.51 75.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.694 -0.629 . . . . 0.39000000000000001 110.38 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -73.06 -40.68 64.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.851 -1.155 . . . . 2.5800000000000001 110.105 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.3 mm100 -67.94 -35.13 77.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.974 . . . . 2.1200000000000001 110.284 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.4 -38.22 81.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.363 -0.836 . . . . 1.3600000000000001 110.085 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.06 -36.27 76.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.886 -1.134 . . . . 2.7999999999999998 109.547 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -68.97 -39.89 79.18 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.749 -1.22 . . . . 0.40000000000000002 110.806 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.03 -40.36 75.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.674 -1.266 . . . . 0.23999999999999999 110.061 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.77 -60.01 4.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.717 -1.239 . . . . 0.42999999999999999 109.482 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.64 -33.7 87.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.351 -1.1 . . . . 0.26000000000000001 110.351 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.73 -46.55 62.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.761 -1.435 . . . . 0.25 109.356 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.926 -1.11 . . . . 0.29999999999999999 108.659 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.43 -40.06 95.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 2.73 110.295 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.534 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.6 mt-10 -69.85 -37.74 76.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 1.9099999999999999 110.165 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.8 t90 -60.0 -42.85 95.18 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.53 -1.356 . . . . 0.37 107.821 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 89' ' ' LEU . 88.3 m -60.79 -40.09 91.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -0.84 . . . . 0.35999999999999999 109.668 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.91 -32.28 69.4 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.017 -1.052 . . . . 0.55000000000000004 110.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.5 -34.03 14.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.107 -0.995 . . . . 0.47999999999999998 110.999 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 91.4 m-85 -107.61 2.2 23.79 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.089 -1.007 . . . . 1.24 111.357 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 85' ' ' CYS . 54.9 tp . . . . . 0 N--CA 1.495 1.802 0 O-C-N 120.856 -1.152 . . . . 1.6599999999999999 109.404 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.432 ' O ' ' OG1' ' B' ' 2' ' ' THR . 19.3 mmm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.946 -0.761 . . . . 5.6600000000000001 108.946 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' B' ' 1' ' ' MET . 3.4 p 49.62 42.54 23.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.905 . . . . 3.02 109.726 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 44.0 p -78.66 161.63 26.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -0.959 . . . . 0.95999999999999996 109.828 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 98.0 p -72.51 169.14 17.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.442 -0.786 . . . . 1.5 109.582 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.52 -22.67 61.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.727 -0.608 . . . . 2.1800000000000002 110.202 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -60.09 -38.59 83.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.094 -1.004 . . . . 2.0099999999999998 109.189 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.541 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 14.2 t60 -56.85 -49.73 74.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.48999999999999999 110.144 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -70.11 -34.02 72.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 3.23 110.034 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.73 -36.52 73.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.312 -0.868 . . . . 0.76000000000000001 109.744 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.987 ' CD1' ' CD2' ' B' ' 10' ' ' PHE . . . -64.91 -42.94 94.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.479 -0.763 . . . . 0.46000000000000002 109.869 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 m -84.0 14.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.161 -0.962 . . . . 0.44 110.302 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.07 -9.3 11.09 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.34 -0.85 . . . . 0.53000000000000003 110.297 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.87 149.76 19.34 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.102 . . . . 1.27 109.37 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -40.58 155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.761 1.64 . . . . 0.48999999999999999 111.205 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.524 ' CE ' HD22 ' B' ' 46' ' ' LEU . 4.2 ptp -91.16 -19.83 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.895 -1.128 . . . . 0.56000000000000005 109.239 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.82 -138.44 41.81 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.341 -1.104 . . . . 0.39000000000000001 110.341 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.52 30.52 5.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.635 -0.921 . . . . 0.83999999999999997 110.408 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -60.03 148.31 77.84 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 2.02 107.933 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.78 159.12 34.43 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.096 1.864 . . . . 0.34000000000000002 112.591 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.562 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.5 p -57.19 -49.15 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.485 0.659 . . . . 0.32000000000000001 110.554 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.562 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.38 -2.21 0.15 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.791 -0.924 . . . . 0.22 110.791 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.488 ' H ' ' C ' ' B' ' 20' ' ' VAL . 61.1 p -81.91 -24.73 35.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.766 -1.432 . . . . 1.24 110.032 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.2 138.79 58.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.296 -0.877 . . . . 0.23999999999999999 109.867 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.69 53.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.702 0.763 . . . . 0.20999999999999999 109.836 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.513 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 97.17 -20.42 50.85 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.219 -1.552 . . . . 0.22 109.219 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.8 mm -99.69 113.18 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.894 -1.15 . . . . 0.25 107.894 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.419 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -93.48 179.98 39.14 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.714 -1.354 . . . . 0.28000000000000003 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.433 ' O ' ' NZ ' ' B' ' 32' ' ' LYS . 79.6 mm-40 -56.07 -39.98 72.89 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.437 -1.037 . . . . 2.0 109.787 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.84 -42.99 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.956 -1.09 . . . . 0.38 109.534 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.419 HD12 ' H ' ' B' ' 27' ' ' GLY . 97.2 mt -67.81 -39.99 83.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.40000000000000002 109.437 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.18 97.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.057 -1.217 . . . . 0.35999999999999999 110.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' B' ' 28' ' ' GLU . 33.6 mtmm -64.55 -38.46 91.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.248 . . . . 2.75 110.111 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.67 -48.82 70.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.824 -1.173 . . . . 1.5600000000000001 109.211 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.88 -38.63 86.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.26 -0.9 . . . . 0.33000000000000002 108.579 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.95 -40.16 88.04 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.692 -0.855 . . . . 1.6799999999999999 108.692 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.89 -18.82 64.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.47 -0.937 . . . . 1.99 108.47 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.23 2.44 56.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 2.6800000000000002 110.163 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 7.01 48.44 Favored Glycine 0 N--CA 1.503 3.118 0 O-C-N 121.08 -1.013 . . . . 0.48999999999999999 112.242 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' B' ' 39' ' ' PHE . 45.6 m-85 -106.36 76.95 1.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 119.19 1.495 . . . . 0.33000000000000002 109.314 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -77.18 -8.47 57.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.377 -0.827 . . . . 0.40999999999999998 110.98 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.67 158.31 44.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 1.5600000000000001 109.437 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.4 91.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.48 -0.763 . . . . 0.20999999999999999 112.173 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -58.17 -17.32 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.695 -1.253 . . . . 0.32000000000000001 110.765 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.45 -29.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.908 -1.12 . . . . 0.23999999999999999 108.104 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.88 -39.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.928 -1.138 . . . . 0.22 107.928 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.524 HD22 ' CE ' ' B' ' 15' ' ' MET . 60.7 tp -59.98 -39.84 87.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.257 -1.386 . . . . 0.40000000000000002 107.257 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.7 -43.82 69.2 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.173 -1.571 . . . . 0.17999999999999999 109.173 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.96 -44.62 94.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -1.207 . . . . 1.0900000000000001 108.791 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.97 -41.28 91.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.31 109.007 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 mt -69.96 -39.7 75.86 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.878 -0.729 . . . . 0.27000000000000002 109.186 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.98 -20.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.166 -0.959 . . . . 0.28000000000000003 110.561 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.47 17.82 9.44 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.0 -1.063 . . . . 0.29999999999999999 109.907 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.25 32.52 10.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.959 -1.088 . . . . 1.71 110.151 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt 60.0 20.08 9.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.746 . . . . 2.25 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -67.96 111.5 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.817 -1.177 . . . . 1.8 108.072 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.39 -40.69 97.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.88 112.641 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.86 -39.91 76.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.523 -1.361 . . . . 0.73999999999999999 109.663 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.96 -39.99 75.7 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.929 -1.108 . . . . 0.55000000000000004 108.73 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.02 -50.04 70.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.99 . . . . 0.38 110.096 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -61.27 -44.46 97.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 2.6400000000000001 110.548 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.413 ' O ' ' OD2' ' B' ' 65' ' ' ASP . 98.9 mt-10 -65.03 -38.1 89.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.776 -1.203 . . . . 2.3799999999999999 108.866 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -63.83 -48.27 77.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.40000000000000002 111.013 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.05 -46.46 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.909 -1.119 . . . . 0.34000000000000002 109.989 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -61.73 -47.17 86.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 2.1000000000000001 109.707 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' B' ' 61' ' ' GLU . 71.3 m-20 -69.93 -28.35 65.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.906 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -80.54 -31.6 36.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.40000000000000002 111.737 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.8 p -133.3 -23.2 1.92 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.326 -1.484 . . . . 0.39000000000000001 111.919 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.71 34.11 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 109.237 -1.545 . . . . 0.35999999999999999 109.237 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.55 154.53 1.85 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.091 -1.241 . . . . 0.32000000000000001 109.39 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.74 171.96 9.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 1.9099999999999999 110.177 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.75 75.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.646 -0.658 . . . . 0.38 110.417 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -72.89 -40.69 65.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.859 -1.151 . . . . 2.5699999999999998 110.128 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.2 mm100 -67.92 -35.2 78.03 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.248 -0.907 . . . . 2.1200000000000001 110.354 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.27 -38.37 81.66 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.179 -0.951 . . . . 1.3600000000000001 110.074 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.92 -36.53 77.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.86 -1.15 . . . . 2.8100000000000001 109.531 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -68.6 -40.03 80.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.778 -1.201 . . . . 0.40000000000000002 110.747 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.2 m -70.06 -40.37 75.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.23000000000000001 110.123 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.75 -59.97 4.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.699 -1.251 . . . . 0.42999999999999999 109.525 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.75 87.42 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.344 -1.102 . . . . 0.25 110.344 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.73 -46.41 63.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.725 -1.456 . . . . 0.23999999999999999 109.337 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.6 -40.43 69.86 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.935 -1.106 . . . . 0.28999999999999998 108.628 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.24 -39.99 95.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.98 . . . . 2.7400000000000002 110.316 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.4 mt-10 -69.8 -37.76 76.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.9099999999999999 110.167 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.549 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 87.0 t90 -60.04 -42.72 95.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.5 -1.375 . . . . 0.35999999999999999 107.866 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' B' ' 89' ' ' LEU . 89.4 m -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.35999999999999999 109.748 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.02 -32.55 69.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.049 -1.032 . . . . 0.55000000000000004 109.912 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.2 -34.11 14.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.135 -0.978 . . . . 0.46999999999999997 111.06 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.549 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 92.4 m-85 -107.41 2.02 24.03 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.195 -0.941 . . . . 1.24 111.465 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' B' ' 85' ' ' CYS . 54.7 tp . . . . . 0 N--CA 1.495 1.785 0 O-C-N 120.695 -1.253 . . . . 1.6699999999999999 109.321 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtm . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.525 -0.546 . . . . 5.6799999999999997 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.7 m -86.18 110.1 19.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.946 . . . . 3.02 109.438 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.2 p -98.81 164.61 12.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.37 -0.831 . . . . 0.95999999999999996 109.273 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 t -69.92 164.86 22.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 1.51 109.314 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.74 -26.46 63.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.687 -0.633 . . . . 2.1800000000000002 110.074 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -36.0 76.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.001 -1.062 . . . . 2.02 109.567 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -58.86 -50.01 75.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.48999999999999999 110.127 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.6 mmp_? -69.96 -32.83 71.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.044 -1.035 . . . . 3.21 109.751 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.47 -40.02 89.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.234 -0.917 . . . . 0.76000000000000001 109.628 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.97 -49.04 76.28 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.246 -0.909 . . . . 0.46000000000000002 109.792 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.21 4.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.232 -0.917 . . . . 0.44 111.863 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -97.57 -18.92 18.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.686 -1.259 . . . . 0.54000000000000004 110.359 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 1.4 pp20? -155.83 152.26 23.6 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 1.26 108.596 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 48.5 Cg_exo -35.36 155.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.174 1.916 . . . . 0.48999999999999999 112.034 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' HD13 ' B' ' 89' ' ' LEU . 11.4 ptm -90.92 -23.08 20.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.145 -0.972 . . . . 0.56999999999999995 110.484 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.09 -136.35 20.58 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.984 -1.073 . . . . 0.40000000000000002 110.715 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.06 28.37 8.67 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.523 -0.986 . . . . 0.84999999999999998 111.02 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.6 148.34 56.63 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 118.557 -1.257 . . . . 2.0099999999999998 107.756 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.19 159.34 19.12 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.619 2.213 . . . . 0.34000000000000002 113.183 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 22' ' ' SER . 4.3 p -59.63 -48.52 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.32000000000000001 110.576 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -52.95 -1.87 0.07 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.435 -1.066 . . . . 0.23000000000000001 110.435 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 20' ' ' VAL . 10.6 p -83.3 -26.42 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.385 . . . . 1.24 109.973 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.65 137.29 58.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.23999999999999999 110.296 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 132.63 49.08 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.789 0.804 . . . . 0.20999999999999999 110.234 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.95 -18.1 56.29 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.003 -1.639 . . . . 0.22 109.003 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.88 114.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.827 -1.175 . . . . 0.25 107.827 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.1 177.58 38.29 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.458 -1.457 . . . . 0.28000000000000003 109.458 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -58.83 -40.14 83.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -1.125 . . . . 2.0099999999999998 109.494 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.22 -48.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.042 -1.037 . . . . 0.38 109.42 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.41 -39.99 81.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.40000000000000002 109.212 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.03 96.42 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.236 -1.546 . . . . 0.34999999999999998 109.236 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 36' ' ' GLU . 14.7 tmtt? -61.36 -40.0 92.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.338 -1.096 . . . . 2.7400000000000002 110.775 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.04 -40.1 87.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.736 -1.227 . . . . 1.54 109.986 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.58 -38.04 83.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.923 -1.11 . . . . 0.34000000000000002 108.893 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.424 -0.91 . . . . 1.6699999999999999 108.992 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 32' ' ' LYS . 98.9 mt-10 -68.06 -18.62 64.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 2.0 108.822 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -89.97 2.01 55.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.46 -0.775 . . . . 2.6899999999999999 109.859 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.49 5.18 42.89 Favored Glycine 0 N--CA 1.502 3.077 0 O-C-N 121.115 -0.991 . . . . 0.47999999999999998 112.18 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.7 76.97 1.32 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.694 -1.474 . . . . 0.33000000000000002 109.141 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -75.48 -8.86 57.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.40999999999999998 110.437 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.16 160.02 40.78 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.079 -1.013 . . . . 1.5600000000000001 110.263 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.84 92.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.558 -0.714 . . . . 0.20999999999999999 112.512 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 7.5 p90 -58.73 -17.74 25.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.515 -1.366 . . . . 0.32000000000000001 110.555 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -80.01 -32.71 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.794 -1.191 . . . . 0.23999999999999999 108.315 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.06 -39.1 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.22 108.237 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 tp -59.98 -36.38 77.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.866 -1.161 . . . . 0.40000000000000002 107.866 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.52 97.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.17999999999999999 110.02 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.98 -40.03 87.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.245 . . . . 1.0900000000000001 109.035 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.96 -39.95 87.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.373 -0.973 . . . . 0.31 108.373 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.053 -0.721 . . . . 0.28000000000000003 109.053 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.22 -23.97 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.246 -0.909 . . . . 0.28000000000000003 111.001 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.37 17.61 11.06 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.045 -1.034 . . . . 0.31 110.154 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' NZ ' ' O ' ' B' ' 38' ' ' GLY . 12.7 mptt 52.47 29.31 6.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.944 -1.098 . . . . 1.7 109.828 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.03 19.94 9.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 2.2400000000000002 110.255 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.23 117.75 9.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.511 -1.368 . . . . 1.8 107.683 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.11 -40.95 97.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.311 -0.868 . . . . 0.87 112.99 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.488 ' CG ' HH21 ' A' ' 60' ' ' ARG . 7.6 m-20 -69.68 -39.93 76.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.669 -1.27 . . . . 0.72999999999999998 110.115 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.3 mt -69.95 -39.99 75.71 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.007 -1.077 . . . . 0.55000000000000004 109.036 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.46 -49.91 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.38 109.71 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.488 HH21 ' CG ' ' A' ' 57' ' ' ASP . 87.7 mtm180 -60.37 -45.79 92.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.354 -0.841 . . . . 2.6400000000000001 110.622 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.64 -39.77 94.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.931 -1.105 . . . . 2.3700000000000001 108.788 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -65.51 -48.76 71.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.40000000000000002 111.362 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.5 tp -67.42 -47.09 71.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.34000000000000002 110.095 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.01 -45.95 92.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.38 -0.825 . . . . 2.1099999999999999 109.714 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.03 -27.33 64.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.8999999999999999 109.945 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -80.59 -33.9 35.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.40999999999999998 111.526 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.2 p -130.59 -27.27 2.16 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.555 -1.34 . . . . 0.40000000000000002 112.083 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.16 22.64 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.171 -1.572 . . . . 0.35999999999999999 109.171 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 153.1 2.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -1.196 . . . . 0.33000000000000002 109.618 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.6 172.96 8.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.115 -0.991 . . . . 1.8999999999999999 109.715 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.23 72.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.39000000000000001 111.025 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.1 -39.71 63.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.711 -1.243 . . . . 2.5800000000000001 110.05 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.5 mm100 -67.38 -39.88 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 2.1200000000000001 110.694 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -67.52 -37.51 82.89 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.288 -0.882 . . . . 1.3600000000000001 109.958 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 75' ' ' ARG . 25.7 mtt-85 -60.41 -37.24 80.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.114 . . . . 2.7999999999999998 109.632 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.78 -39.9 84.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.571 -1.33 . . . . 0.40000000000000002 110.552 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.8 m -67.94 -40.0 83.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.23999999999999999 109.806 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.43 -60.05 4.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.879 -1.138 . . . . 0.42999999999999999 109.954 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.66 -34.28 88.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.448 -1.061 . . . . 0.26000000000000001 110.448 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.25 -47.33 57.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -1.202 . . . . 0.25 109.804 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.61 -40.07 73.38 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.695 -1.202 . . . . 0.29999999999999999 108.328 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -63.01 -40.07 96.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 2.73 110.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -69.41 -37.81 77.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.02 -1.05 . . . . 1.9099999999999999 110.474 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.487 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 84.6 t90 -59.97 -43.86 94.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.39 -1.444 . . . . 0.37 107.363 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.3 m -60.6 -40.67 92.64 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.894 -0.78 . . . . 0.35999999999999999 108.894 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.631 -0.668 . . . . 0.55000000000000004 109.695 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -36.78 16.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.47999999999999998 110.125 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 83.9 m-85 -105.56 -88.17 0.45 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.35 -0.844 . . . . 1.24 110.032 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.466 HD13 ' SD ' ' B' ' 15' ' ' MET . 16.2 tp . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.097 -0.954 . . . . 1.6599999999999999 109.78 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.472 -0.566 . . . . 5.6600000000000001 109.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 89.0 m -86.25 110.13 19.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.079 -1.013 . . . . 3.02 109.434 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 82.4 p -98.75 164.61 12.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.32 -0.863 . . . . 0.95999999999999996 109.24 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t -69.87 164.94 22.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.91 . . . . 1.5 109.21 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.81 -26.53 64.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.702 -0.624 . . . . 2.1800000000000002 110.094 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.13 -35.73 75.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.085 . . . . 2.0099999999999998 109.575 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -58.96 -49.94 75.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.48999999999999999 110.213 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 3.6 mmp_? -70.06 -32.76 71.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 3.23 109.749 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.45 -39.92 89.14 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.483 -0.887 . . . . 0.76000000000000001 109.743 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.0 -49.16 75.76 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.263 -0.898 . . . . 0.46000000000000002 109.71 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.12 4.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.144 -0.973 . . . . 0.44 111.834 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -97.29 -19.0 18.84 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.661 -1.274 . . . . 0.53000000000000003 110.418 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' B' ' 14' ' ' PRO . 1.4 pp20? -155.84 152.34 23.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.955 . . . . 1.27 108.63 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' OE1' ' B' ' 13' ' ' GLU . 48.7 Cg_exo -35.37 155.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.266 1.977 . . . . 0.48999999999999999 111.989 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.466 ' SD ' HD13 ' A' ' 89' ' ' LEU . 11.3 ptm -90.89 -23.25 20.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.56000000000000005 110.432 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.33 21.13 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.894 -1.128 . . . . 0.39000000000000001 110.7 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.2 28.72 8.35 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.634 -0.921 . . . . 0.83999999999999997 111.021 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.77 148.4 58.18 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.648 -1.283 . . . . 2.02 107.608 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.18 159.44 18.84 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.639 2.226 . . . . 0.34000000000000002 113.207 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' B' ' 22' ' ' SER . 4.2 p -59.79 -48.6 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.32000000000000001 110.512 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.489 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -52.7 -2.14 0.07 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.443 -1.063 . . . . 0.22 110.443 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.539 ' H ' ' C ' ' B' ' 20' ' ' VAL . 10.6 p -83.09 -26.43 31.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.787 -1.419 . . . . 1.24 110.055 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.79 137.29 58.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.27 -0.894 . . . . 0.23999999999999999 110.273 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.82 132.63 49.16 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.82 0.819 . . . . 0.20999999999999999 110.175 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.99 -18.31 55.95 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.902 -1.679 . . . . 0.22 108.902 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -101.68 114.78 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.848 -1.167 . . . . 0.25 107.848 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.16 177.65 38.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.493 -1.443 . . . . 0.28000000000000003 109.493 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -58.95 -40.01 83.39 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.337 -1.096 . . . . 2.0 109.48 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.47 -48.9 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.38 109.333 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.51 -39.9 81.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.40000000000000002 109.178 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.98 96.43 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.251 -1.54 . . . . 0.35999999999999999 109.251 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' B' ' 36' ' ' GLU . 14.7 tmtt? -61.25 -39.94 92.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 2.75 110.798 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.2 -40.02 86.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.687 -1.258 . . . . 1.5600000000000001 109.977 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -60.74 -38.01 83.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.923 -1.11 . . . . 0.33000000000000002 108.889 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -40.51 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.429 -0.909 . . . . 1.6799999999999999 108.973 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' NZ ' ' B' ' 32' ' ' LYS . 98.9 mt-10 -68.01 -18.61 64.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 1.99 108.88 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -90.03 2.14 55.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.818 . . . . 2.6800000000000002 109.793 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.413 ' O ' ' NZ ' ' A' ' 53' ' ' LYS . . . 104.4 5.26 43.06 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.246 -0.978 . . . . 0.48999999999999999 112.154 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.72 76.89 1.31 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.49 . . . . 0.33000000000000002 109.144 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -75.43 -8.89 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.104 -0.997 . . . . 0.40999999999999998 110.522 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.13 159.95 40.93 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.067 -1.021 . . . . 1.5600000000000001 110.162 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.93 93.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.647 -0.658 . . . . 0.20999999999999999 112.542 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.466 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 7.4 p90 -58.66 -17.77 25.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.532 -1.355 . . . . 0.32000000000000001 110.614 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -79.9 -32.76 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.796 -1.19 . . . . 0.23999999999999999 108.286 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 77.2 t -76.0 -39.13 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.216 -1.031 . . . . 0.22 108.216 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 tp -60.06 -36.2 76.82 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.876 -1.157 . . . . 0.40000000000000002 107.876 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.68 97.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.028 -1.229 . . . . 0.17999999999999999 110.028 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.9 -40.02 87.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.094 -1.239 . . . . 1.0900000000000001 109.154 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.95 -40.07 87.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.297 -1.001 . . . . 0.31 108.297 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.082 -0.71 . . . . 0.27000000000000002 109.082 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.29 -23.99 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.357 -0.84 . . . . 0.28000000000000003 110.973 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.33 17.58 11.05 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.945 -1.097 . . . . 0.29999999999999999 110.164 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mptt 52.72 29.11 7.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.921 -1.112 . . . . 1.71 109.818 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.0 19.99 9.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.416 -0.803 . . . . 2.25 110.208 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.33 117.57 9.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.318 . . . . 1.8 107.739 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.0 -40.92 97.45 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.075 0.769 . . . . 0.88 113.075 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.49 ' CG ' HH21 ' B' ' 60' ' ' ARG . 7.6 m-20 -69.65 -39.98 76.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.535 -1.353 . . . . 0.73999999999999999 110.056 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.98 -40.0 75.62 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.01 -1.076 . . . . 0.55000000000000004 108.94 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.48 -49.96 73.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.38 109.68 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' B' ' 57' ' ' ASP . 87.8 mtm180 -60.4 -45.54 93.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.407 -0.808 . . . . 2.6400000000000001 110.62 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.77 -39.78 94.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.957 -1.09 . . . . 2.3799999999999999 108.756 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 63.0 t90 -65.53 -48.75 71.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.40000000000000002 111.383 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -67.26 -47.19 71.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.007 -1.058 . . . . 0.34000000000000002 110.09 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.03 -45.94 92.76 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.389 -0.819 . . . . 2.1000000000000001 109.787 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.03 -27.34 64.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.445 -0.784 . . . . 1.8999999999999999 109.884 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 96.8 m -80.54 -33.84 35.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.40000000000000002 111.574 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.1 p -130.63 -27.35 2.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.595 -1.316 . . . . 0.39000000000000001 112.027 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 14.09 22.59 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.154 -1.578 . . . . 0.35999999999999999 109.154 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.01 153.24 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -1.185 . . . . 0.32000000000000001 109.654 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.62 172.96 8.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.174 -0.954 . . . . 1.9099999999999999 109.728 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.48 -33.34 72.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 0.38 110.959 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.02 -39.67 63.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.66 -1.275 . . . . 2.5699999999999998 110.049 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.6 mm100 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 2.1200000000000001 110.675 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.8 t -67.5 -37.48 82.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.851 . . . . 1.3600000000000001 110.004 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.487 ' HG2' HH11 ' B' ' 75' ' ' ARG . 25.2 mtt-85 -60.36 -37.33 80.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 2.8100000000000001 109.584 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -67.65 -39.93 84.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.698 -1.251 . . . . 0.40000000000000002 110.588 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.93 -39.99 83.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.854 -1.154 . . . . 0.23000000000000001 109.809 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.39 -59.98 4.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.95 -1.094 . . . . 0.42999999999999999 109.967 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.57 -34.52 88.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.452 -1.059 . . . . 0.25 110.452 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 49.4 t -71.14 -47.22 59.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -1.179 . . . . 0.23999999999999999 109.832 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.68 -40.13 73.12 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.716 -1.194 . . . . 0.28999999999999998 108.326 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -63.03 -40.1 96.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 2.7400000000000002 109.93 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -69.47 -37.6 77.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.054 -1.029 . . . . 1.9099999999999999 110.482 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.484 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 84.8 t90 -60.02 -43.86 94.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.456 -1.403 . . . . 0.35999999999999999 107.318 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 51.6 m -60.65 -40.66 92.83 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.93 -0.767 . . . . 0.35999999999999999 108.93 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.96 -38.19 85.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.615 -0.678 . . . . 0.55000000000000004 109.626 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.8 -37.75 16.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 0.46999999999999997 110.075 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 85.2 m-85 -104.34 -87.69 0.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.901 . . . . 1.24 110.413 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.461 HD13 ' SD ' ' A' ' 15' ' ' MET . 16.4 tp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.133 -0.937 . . . . 1.6699999999999999 109.711 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.189 0.518 . . . . 5.6799999999999997 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.7 m -82.2 110.42 17.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.069 -1.02 . . . . 3.02 109.433 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.9 p -112.0 156.75 21.64 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.431 -0.793 . . . . 0.95999999999999996 109.842 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -84.88 177.74 7.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.232 -0.918 . . . . 1.51 109.15 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -62.16 -22.61 66.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.744 -0.597 . . . . 2.1800000000000002 110.648 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.29 -39.26 89.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 2.02 108.998 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 11' ' ' VAL . 16.1 t60 -60.1 -50.28 74.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.48999999999999999 110.806 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.515 ' HG2' HH11 ' A' ' 8' ' ' ARG . 20.5 mtt-85 -69.94 -35.59 74.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.998 -1.064 . . . . 3.21 109.85 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -66.96 -39.79 87.33 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.436 -0.79 . . . . 0.76000000000000001 109.529 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 50.7 t80 -65.25 -45.5 84.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.818 . . . . 0.46000000000000002 110.194 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 7' ' ' HIS . 18.7 m -88.62 5.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.007 -1.058 . . . . 0.44 111.55 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.957 -1.089 . . . . 0.54000000000000004 110.319 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.0 pt-20 -152.06 153.15 30.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.374 -0.973 . . . . 1.26 108.374 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 13' ' ' GLU . 58.0 Cg_exo -37.29 155.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.944 1.763 . . . . 0.48999999999999999 111.641 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.522 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 12.6 ptm -92.75 -28.9 16.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 0.56999999999999995 109.968 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.65 -134.99 46.29 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.422 -1.071 . . . . 0.40000000000000002 110.422 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.5 34.5 3.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.64 -0.918 . . . . 0.84999999999999998 110.061 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -58.81 148.76 67.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 2.0099999999999998 108.695 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.81 155.93 35.48 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.086 1.857 . . . . 0.34000000000000002 112.15 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 21' ' ' GLY . 13.8 p -58.31 -41.9 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.693 0.759 . . . . 0.32000000000000001 110.167 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -61.51 -2.25 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.103 -1.199 . . . . 0.23000000000000001 110.103 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 t -81.59 -21.17 38.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.728 -1.454 . . . . 1.24 108.919 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 81' ' ' LEU . 97.1 mt -65.39 138.52 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.369 -0.832 . . . . 0.23999999999999999 109.652 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.98 57.72 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.948 -0.701 . . . . 0.20999999999999999 109.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 -18.41 56.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.572 -1.411 . . . . 0.22 109.572 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 mm -99.52 112.0 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.715 -1.217 . . . . 0.25 107.715 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.89 -179.05 36.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.649 -1.38 . . . . 0.28000000000000003 109.649 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 59.7 mp0 -57.28 -40.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -1.119 . . . . 2.0099999999999998 109.532 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.9 -45.87 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.38 109.32 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.89 -39.59 83.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.40000000000000002 109.39 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.82 -39.96 96.08 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.96 -1.656 . . . . 0.34999999999999998 108.96 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.91 -39.97 96.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 2.7400000000000002 109.72 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.92 -44.1 77.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 1.54 108.809 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.1 mt -64.84 -40.61 95.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.34000000000000002 108.64 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.14 -44.15 95.18 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.642 -0.661 . . . . 1.6699999999999999 109.55 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.21 -19.58 66.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.398 -0.814 . . . . 2.0 108.917 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -90.39 3.99 52.19 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.521 -0.737 . . . . 2.6899999999999999 109.981 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.81 48.35 Favored Glycine 0 N--CA 1.502 3.048 0 O-C-N 121.167 -0.958 . . . . 0.47999999999999998 111.579 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' A' ' 44' ' ' VAL . 92.4 m-85 -106.51 75.59 1.08 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.714 -1.462 . . . . 0.33000000000000002 109.55 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.73 -9.9 59.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.074 -1.016 . . . . 0.40999999999999998 110.316 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.2 mmtm -134.87 156.67 48.53 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.203 -0.936 . . . . 1.5600000000000001 110.001 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.65 94.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.63 -0.669 . . . . 0.20999999999999999 111.233 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 23.6 p90 -58.59 -20.07 43.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.704 -1.248 . . . . 0.32000000000000001 110.951 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.5 t -78.58 -34.51 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.643 -1.286 . . . . 0.23999999999999999 108.022 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 20' ' ' VAL . 74.4 t -76.32 -38.92 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.187 -1.042 . . . . 0.22 108.187 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.09 -38.8 84.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.296 -1.001 . . . . 0.40000000000000002 108.296 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.84 97.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.817 -1.313 . . . . 0.17999999999999999 109.817 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.275 . . . . 1.0900000000000001 109.341 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -59.22 -40.09 84.76 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.296 -1.001 . . . . 0.31 108.296 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.08 -38.72 79.16 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.377 -0.972 . . . . 0.28000000000000003 108.377 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.14 -24.61 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 0.28000000000000003 110.251 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.24 16.14 17.39 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.118 -0.989 . . . . 0.31 110.678 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.54 40.4 15.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.726 -1.234 . . . . 1.7 110.719 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 59.19 19.62 7.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 2.2400000000000002 109.843 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.31 107.01 2.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.743 -1.223 . . . . 1.8 107.994 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CD ' HH21 ' A' ' 60' ' ' ARG . 88.1 tt0 -61.75 -40.5 95.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.501 -0.75 . . . . 0.87 112.562 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.63 -40.07 76.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.534 -1.353 . . . . 0.72999999999999998 109.728 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.66 -39.99 76.73 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.726 -1.19 . . . . 0.55000000000000004 109.199 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.31 -50.14 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.38 109.483 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.526 HH21 ' CD ' ' A' ' 56' ' ' GLU . 34.1 mtt-85 -60.88 -46.12 91.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.372 -0.83 . . . . 2.6400000000000001 110.682 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.04 -38.31 90.59 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.819 -1.175 . . . . 2.3700000000000001 108.841 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -66.8 -45.25 78.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.40000000000000002 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.27 -48.91 68.92 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.149 -0.969 . . . . 0.34000000000000002 110.046 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -62.0 -44.56 96.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.242 -0.911 . . . . 2.1099999999999999 109.257 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.59 -32.39 71.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.567 -0.708 . . . . 1.8999999999999999 109.739 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -79.97 -31.86 39.86 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.40999999999999998 111.345 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.32 -30.15 1.53 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.572 -1.33 . . . . 0.40000000000000002 112.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.12 19.89 Favored Glycine 0 N--CA 1.501 3.025 0 N-CA-C 109.196 -1.561 . . . . 0.35999999999999999 109.196 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.0 152.9 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.242 . . . . 0.33000000000000002 109.467 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -91.9 175.18 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.071 -1.018 . . . . 1.8999999999999999 109.623 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.81 77.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.39000000000000001 110.103 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -73.79 -39.97 63.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.109 -0.994 . . . . 2.5800000000000001 109.995 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.85 -36.96 83.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 2.1200000000000001 110.539 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 p -69.22 -37.17 77.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.133 -0.979 . . . . 1.3600000000000001 110.027 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.03 -37.61 80.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.831 -1.168 . . . . 2.7999999999999998 109.707 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.05 -40.0 87.02 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.746 -1.221 . . . . 0.40000000000000002 110.442 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 61.5 m -70.04 -42.5 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.726 -1.234 . . . . 0.23999999999999999 110.398 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.421 ' HB3' HH22 ' A' ' 60' ' ' ARG . 79.4 t80 -60.14 -60.17 4.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.57 -1.331 . . . . 0.42999999999999999 110.113 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.86 -34.52 90.03 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.334 -1.106 . . . . 0.26000000000000001 110.334 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.71 -47.91 57.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.726 -1.455 . . . . 0.25 109.781 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 23' ' ' LEU . 96.9 mt -70.11 -40.03 75.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.798 -1.161 . . . . 0.29999999999999999 108.345 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.485 ' HG2' HH11 ' A' ' 82' ' ' ARG . 4.6 ttt-85 -61.36 -40.11 93.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 2.73 109.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -68.8 -37.42 79.24 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 1.9099999999999999 109.878 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.522 ' CZ2' ' SD ' ' A' ' 15' ' ' MET . 80.4 t90 -59.65 -45.67 91.32 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.94 -1.504 . . . . 0.37 106.94 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -61.83 -41.52 97.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.716 -0.615 . . . . 0.35999999999999999 109.46 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -60.27 -37.24 79.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.2 -0.937 . . . . 0.55000000000000004 109.954 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.1 -35.87 19.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.47999999999999998 109.888 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -105.7 -86.73 0.47 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.363 -0.836 . . . . 1.24 110.395 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.419 HD13 ' SD ' ' B' ' 15' ' ' MET . 11.6 tp . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.148 -0.93 . . . . 1.6599999999999999 109.161 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.561 -0.533 . . . . 5.6600000000000001 109.561 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 41.8 m -81.95 110.41 17.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.075 -1.016 . . . . 3.02 109.357 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.6 p -112.0 156.6 21.88 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.586 -0.696 . . . . 0.95999999999999996 109.997 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 50.4 m -84.63 177.34 8.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.19 -0.944 . . . . 1.5 109.233 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.94 -22.75 65.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.703 -0.623 . . . . 2.1800000000000002 110.671 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -61.21 -39.24 89.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.017 -1.052 . . . . 2.0099999999999998 108.852 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.41 ' O ' HG22 ' B' ' 11' ' ' VAL . 16.0 t60 -60.1 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.48999999999999999 110.746 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.511 ' HG2' HH11 ' B' ' 8' ' ' ARG . 20.8 mtt-85 -70.05 -35.65 74.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.903 -1.123 . . . . 3.23 109.758 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -66.73 -40.03 88.2 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.638 -0.664 . . . . 0.76000000000000001 109.642 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.431 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 49.7 t80 -64.99 -45.91 83.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.46000000000000002 110.25 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 7' ' ' HIS . 18.9 m -88.38 5.71 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.16 -0.962 . . . . 0.44 111.48 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -100.92 -15.98 17.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.881 -1.137 . . . . 0.53000000000000003 110.26 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -152.11 153.26 30.98 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 1.27 108.352 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -37.35 155.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.998 1.798 . . . . 0.48999999999999999 111.584 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.516 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 12.5 ptm -92.77 -28.85 16.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.56000000000000005 110.035 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.71 -135.03 46.47 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.357 -1.097 . . . . 0.39000000000000001 110.357 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.61 34.55 3.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.468 -1.019 . . . . 0.83999999999999997 109.944 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -58.75 148.63 67.21 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 2.02 108.601 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.76 155.82 35.75 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.06 1.84 . . . . 0.34000000000000002 112.175 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.531 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.0 p -58.29 -41.84 82.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.496 -0.753 . . . . 0.32000000000000001 110.093 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.531 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -61.33 -2.31 2.96 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.119 -1.192 . . . . 0.22 110.119 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.7 t -81.73 -21.1 38.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.895 -1.356 . . . . 1.24 108.914 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.59 HD22 HD21 ' B' ' 81' ' ' LEU . 97.3 mt -65.31 138.52 58.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.23999999999999999 109.676 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.36 136.94 57.61 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.743 -0.783 . . . . 0.20999999999999999 109.744 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 -18.34 56.91 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.604 -1.398 . . . . 0.22 109.604 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.52 111.87 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.709 -1.219 . . . . 0.25 107.709 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.87 36.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.731 -1.348 . . . . 0.28000000000000003 109.731 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mp0 -57.48 -39.86 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -1.07 . . . . 2.0 109.567 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.05 -45.89 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.38 109.344 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.88 -39.54 83.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -0.889 . . . . 0.40000000000000002 109.518 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.92 -39.77 95.98 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.915 -1.674 . . . . 0.35999999999999999 108.915 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.05 -40.04 96.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 2.75 109.771 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.74 -43.99 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.074 -1.016 . . . . 1.5600000000000001 108.962 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.01 -40.4 94.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.33000000000000002 108.699 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.19 -44.27 95.23 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.034 -0.666 . . . . 1.6799999999999999 109.478 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.16 -19.71 66.11 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 1.99 109.016 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -90.35 3.93 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.654 -0.654 . . . . 2.6800000000000002 109.925 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 7.4 48.41 Favored Glycine 0 N--CA 1.502 3.08 0 O-C-N 121.095 -1.003 . . . . 0.48999999999999999 111.697 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' B' ' 44' ' ' VAL . 91.4 m-85 -106.26 75.45 1.09 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.866 -1.373 . . . . 0.33000000000000002 109.658 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.76 -10.0 59.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.40999999999999998 110.36 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.473 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.3 mmtm -134.68 156.87 48.01 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.136 -0.978 . . . . 1.5600000000000001 109.886 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.71 94.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.754 -0.591 . . . . 0.20999999999999999 111.242 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 24.0 p90 -58.56 -20.01 42.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.32000000000000001 111.042 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.9 t -78.68 -34.47 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 0.23999999999999999 107.916 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.439 HG21 HG23 ' B' ' 20' ' ' VAL . 74.0 t -76.23 -39.1 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.164 -1.05 . . . . 0.22 108.164 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.95 -39.02 84.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.305 -0.998 . . . . 0.40000000000000002 108.305 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -41.05 97.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.845 -1.302 . . . . 0.17999999999999999 109.845 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.04 -41.94 93.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.112 -1.228 . . . . 1.0900000000000001 109.343 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.26 -40.0 84.62 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 0.31 108.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.17 -38.76 78.9 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.434 -0.95 . . . . 0.27000000000000002 108.434 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.16 -24.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.304 -0.872 . . . . 0.28000000000000003 110.194 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.34 16.15 17.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.108 -0.995 . . . . 0.29999999999999999 110.784 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.41 40.64 15.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.698 -1.252 . . . . 1.71 110.73 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 58.93 19.74 7.42 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.468 -0.77 . . . . 2.25 109.853 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.28 107.04 2.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.698 -1.251 . . . . 1.8 107.729 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.544 ' CD ' HH21 ' B' ' 60' ' ' ARG . 88.2 tt0 -61.63 -40.52 95.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.429 -0.794 . . . . 0.88 112.584 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.75 -39.58 76.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.73999999999999999 109.855 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.96 -39.96 75.69 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.685 -1.206 . . . . 0.55000000000000004 109.025 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.31 -50.32 68.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.38 109.457 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.544 HH21 ' CD ' ' B' ' 56' ' ' GLU . 34.0 mtt-85 -60.76 -46.19 91.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.815 . . . . 2.6400000000000001 110.572 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.92 -38.34 90.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.854 -1.154 . . . . 2.3799999999999999 108.933 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' TRP . . . . . 0.407 ' O ' ' OG1' ' B' ' 66' ' ' THR . 51.2 t90 -66.79 -45.24 79.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.40000000000000002 110.415 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.32 -48.79 69.17 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.266 -0.896 . . . . 0.34000000000000002 109.989 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.391 -0.818 . . . . 2.1000000000000001 109.249 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.43 -32.63 71.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.58 -0.7 . . . . 1.8999999999999999 109.684 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 87.5 m -79.66 -31.92 41.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.40000000000000002 111.471 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.41 -30.0 1.53 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.436 -1.415 . . . . 0.39000000000000001 112.193 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.73 15.02 19.91 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.138 -1.585 . . . . 0.35999999999999999 109.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.77 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.245 . . . . 0.32000000000000001 109.416 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -91.83 175.37 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 1.9099999999999999 109.731 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.96 78.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.483 -0.761 . . . . 0.38 110.122 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -73.81 -39.78 63.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 2.5699999999999998 109.99 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.03 -36.88 83.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 2.1200000000000001 110.545 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 18.8 p -69.25 -37.23 77.84 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.171 -0.956 . . . . 1.3600000000000001 110.003 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -37.88 80.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 2.8100000000000001 109.593 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.98 -39.84 87.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.502 -1.374 . . . . 0.40000000000000002 110.441 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.16 -42.62 72.26 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.69 -1.256 . . . . 0.23000000000000001 110.401 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.411 ' HB3' HH22 ' B' ' 60' ' ' ARG . 79.3 t80 -59.99 -60.12 4.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.575 -1.328 . . . . 0.42999999999999999 110.068 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.95 -34.47 90.0 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.368 -1.093 . . . . 0.25 110.368 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.52 -48.1 57.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.793 -1.416 . . . . 0.23999999999999999 109.84 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.59 HD21 HD22 ' B' ' 23' ' ' LEU . 97.0 mt -70.04 -39.96 75.43 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.799 -1.16 . . . . 0.28999999999999998 108.435 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' B' ' 82' ' ' ARG . 4.7 ttt-85 -61.47 -40.0 92.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 2.7400000000000002 109.515 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.95 -37.23 78.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.379 -0.826 . . . . 1.9099999999999999 109.91 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.516 ' CZ2' ' SD ' ' B' ' 15' ' ' MET . 80.8 t90 -60.0 -45.68 91.93 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.972 -1.492 . . . . 0.35999999999999999 106.972 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 32.7 m -61.83 -41.22 97.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.69 -0.631 . . . . 0.35999999999999999 109.527 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.35 -37.18 79.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.55000000000000004 109.939 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.38 -36.36 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.46999999999999997 109.824 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -104.57 -86.24 0.46 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -0.886 . . . . 1.24 110.777 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.445 HD13 ' SD ' ' A' ' 15' ' ' MET . 11.5 tp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.106 -0.95 . . . . 1.6699999999999999 109.117 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' THR . 26.1 ptt? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.462 -0.569 . . . . 5.6799999999999997 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 65.58 -37.67 0.25 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 3.02 110.163 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 1' ' ' MET . 68.8 p -80.02 169.76 17.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.067 -1.021 . . . . 0.95999999999999996 109.873 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m -75.82 170.05 16.96 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.805 0.812 . . . . 1.51 109.339 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.85 -30.14 68.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.795 -0.566 . . . . 2.1800000000000002 110.598 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.11 -33.67 72.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 2.02 108.965 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 23.8 t60 -59.92 -48.75 80.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.48999999999999999 110.088 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -69.88 -34.06 73.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.157 -0.964 . . . . 3.21 109.888 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.11 -39.84 82.69 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.383 -0.823 . . . . 0.76000000000000001 109.61 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.4 t80 -61.91 -47.3 85.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.429 -0.794 . . . . 0.46000000000000002 110.107 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 m -82.19 9.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.154 -0.966 . . . . 0.44 110.12 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.94 -16.4 15.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.156 -0.965 . . . . 0.54000000000000004 110.944 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -156.63 152.84 23.42 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.115 . . . . 1.26 109.198 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -40.33 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.702 1.601 . . . . 0.48999999999999999 110.839 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.5 ptp -90.37 -24.76 20.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.825 -1.172 . . . . 0.56999999999999995 109.646 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.22 -136.72 45.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.704 -1.358 . . . . 0.40000000000000002 109.704 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.57 28.93 6.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -1.006 . . . . 0.84999999999999998 111.221 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -60.75 148.44 82.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.709 -1.244 . . . . 2.0099999999999998 107.802 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.19 163.33 32.11 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.151 1.901 . . . . 0.34000000000000002 112.801 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 21' ' ' GLY . 8.0 p -58.14 -47.36 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.58 -0.7 . . . . 0.32000000000000001 110.391 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.57 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.13 -3.29 0.12 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.783 -0.927 . . . . 0.23000000000000001 110.783 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' VAL . 11.6 p -82.33 -25.3 34.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.799 -1.412 . . . . 1.24 109.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.54 137.82 58.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.708 0.766 . . . . 0.23999999999999999 109.759 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.92 135.31 55.55 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.692 0.758 . . . . 0.20999999999999999 109.912 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.585 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 96.98 -20.26 51.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.245 -1.542 . . . . 0.22 109.245 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.56 112.82 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.641 -1.244 . . . . 0.25 107.641 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.429 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -90.1 177.76 43.06 Favored Glycine 0 N--CA 1.492 2.39 0 O-C-N 120.678 -1.264 . . . . 0.28000000000000003 110.043 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -56.6 -39.94 74.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -1.033 . . . . 2.0099999999999998 109.643 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.76 -44.98 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.076 -1.015 . . . . 0.38 109.496 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.429 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.5 mt -66.35 -36.92 84.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.40000000000000002 109.466 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.82 97.43 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.816 -1.314 . . . . 0.34999999999999998 109.816 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -65.33 -37.03 85.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -1.219 . . . . 2.7400000000000002 109.736 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.59 -48.52 69.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.804 -1.185 . . . . 1.54 109.372 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.99 -38.66 89.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.34000000000000002 108.448 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.04 -42.19 93.88 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.906 -0.717 . . . . 1.6699999999999999 109.296 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.23 -19.42 65.53 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.533 -0.914 . . . . 2.0 108.533 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 2.83 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.747 . . . . 2.6899999999999999 109.725 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.78 5.46 50.9 Favored Glycine 0 N--CA 1.503 3.132 0 C-N-CA 120.264 -0.969 . . . . 0.47999999999999998 111.856 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' CD2' HG12 ' A' ' 44' ' ' VAL . 97.4 m-85 -106.56 77.07 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.899 -1.353 . . . . 0.33000000000000002 108.942 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -79.36 -7.54 58.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.40999999999999998 110.929 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.05 158.58 44.03 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.053 -1.029 . . . . 1.5600000000000001 110.406 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -40.64 90.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.747 -0.595 . . . . 0.20999999999999999 112.307 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.6 p90 -61.13 -18.49 58.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.499 -1.376 . . . . 0.32000000000000001 110.622 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 39' ' ' PHE . 17.2 t -80.06 -31.03 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.876 -1.157 . . . . 0.23999999999999999 107.876 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.4 t -77.5 -37.41 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.22 108.324 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.94 -35.67 75.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.638 -1.245 . . . . 0.40000000000000002 107.638 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.22 96.69 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.573 -1.411 . . . . 0.17999999999999999 109.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.15 -43.32 95.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.942 -1.328 . . . . 1.0900000000000001 109.096 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.98 -41.62 92.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.31 109.019 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.94 -40.06 75.72 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.808 -0.757 . . . . 0.28000000000000003 108.966 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -66.11 -22.81 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.218 -0.926 . . . . 0.28000000000000003 110.448 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.95 17.05 9.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.204 -0.935 . . . . 0.31 109.777 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.08 -1.013 . . . . 1.7 110.346 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.717 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 64.3 mttm 58.85 19.44 7.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.714 -0.616 . . . . 2.2400000000000002 110.011 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -67.74 106.71 2.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.76 -1.213 . . . . 1.8 108.297 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.32 -41.3 98.42 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.406 -0.809 . . . . 0.87 112.631 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 92.5 m-20 -68.99 -39.94 79.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.789 -1.195 . . . . 0.72999999999999998 109.433 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 58' ' ' LEU . 90.8 mt -69.99 -39.9 75.62 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.032 -1.067 . . . . 0.55000000000000004 108.614 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.26 -50.03 71.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.38 109.772 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.434 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.0 mtm180 -62.45 -44.6 96.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 2.6400000000000001 110.288 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.26 -38.34 90.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 2.3700000000000001 108.989 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.28 -49.57 73.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.263 -0.898 . . . . 0.40000000000000002 110.853 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 tp -65.3 -47.43 76.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.84 . . . . 0.34000000000000002 109.874 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -63.45 -45.25 91.72 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.402 -0.811 . . . . 2.1099999999999999 109.274 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -68.43 -34.06 75.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.418 0.628 . . . . 1.8999999999999999 109.592 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.7 m -79.72 -33.56 40.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -0.79 . . . . 0.40999999999999998 111.336 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.6 p -130.63 -28.95 1.99 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.503 -1.373 . . . . 0.40000000000000002 112.239 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.32 25.62 Favored Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.226 -1.55 . . . . 0.35999999999999999 109.226 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.99 153.0 1.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.122 -1.222 . . . . 0.33000000000000002 109.337 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.08 172.57 8.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 1.8999999999999999 110.036 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.08 78.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.39000000000000001 110.487 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.06 -40.4 75.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.738 -1.226 . . . . 2.5800000000000001 109.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.585 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 22.7 mm100 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.452 -0.78 . . . . 2.1200000000000001 110.69 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p -66.34 -38.18 87.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.139 -0.975 . . . . 1.3600000000000001 110.039 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -60.17 -38.79 84.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.828 -1.17 . . . . 2.7999999999999998 109.341 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.27 -39.24 82.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.764 -1.21 . . . . 0.40000000000000002 110.444 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -68.09 -40.32 82.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.766 -1.209 . . . . 0.23999999999999999 109.476 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.44 -60.33 3.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.014 -1.054 . . . . 0.42999999999999999 109.533 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.72 87.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.199 -1.16 . . . . 0.26000000000000001 110.199 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.21 -47.3 65.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.25 109.638 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -69.97 -40.02 75.63 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.667 -1.213 . . . . 0.29999999999999999 108.591 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.717 HH12 ' NZ ' ' A' ' 54' ' ' LYS . 8.5 tpm_? -63.71 -41.93 98.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 2.73 110.006 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 94.4 mt-10 -69.66 -39.65 76.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 1.9099999999999999 110.665 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 79.1 t90 -60.04 -41.91 93.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.316 -1.49 . . . . 0.37 107.7 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -62.82 -40.51 97.63 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.975 -0.75 . . . . 0.35999999999999999 108.975 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD1' ' NH2' ' A' ' 82' ' ' ARG . 96.1 m-20 -60.27 -36.84 78.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.553 -0.717 . . . . 0.55000000000000004 109.905 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.66 -38.29 18.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 0.47999999999999998 109.952 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.602 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 76.3 m-85 -102.59 -84.86 0.45 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.289 -0.882 . . . . 1.24 110.5 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 117.963 -1.018 . . . . 1.6599999999999999 109.932 -178.529 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' B' ' 3' ' ' THR . 26.1 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.485 -0.561 . . . . 5.6600000000000001 109.485 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 65.57 -37.83 0.26 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.458 -0.776 . . . . 3.02 110.07 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.53 ' N ' ' O ' ' B' ' 1' ' ' MET . 68.3 p -79.84 169.67 17.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.123 -0.986 . . . . 0.95999999999999996 110.083 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m -75.69 170.01 17.01 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.752 0.787 . . . . 1.5 109.306 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -59.88 -30.15 68.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.925 -0.484 . . . . 2.1800000000000002 110.521 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.07 -33.53 72.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -0.992 . . . . 2.0099999999999998 109.034 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 23.9 t60 -59.86 -48.89 79.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.074 -1.016 . . . . 0.48999999999999999 110.139 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -69.85 -34.13 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.994 . . . . 3.23 109.882 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.12 -39.85 82.65 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.426 -0.797 . . . . 0.76000000000000001 109.664 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.1 t80 -61.83 -47.51 84.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.46000000000000002 110.092 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.98 9.92 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.144 -0.972 . . . . 0.44 110.242 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.97 -16.45 15.83 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.204 -0.935 . . . . 0.53000000000000003 110.951 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.64 152.83 23.36 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 1.27 109.14 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.25 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.701 1.6 . . . . 0.48999999999999999 110.966 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.6 ptp -90.4 -24.62 20.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.845 -1.159 . . . . 0.56000000000000005 109.658 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.09 -136.68 45.59 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.831 -1.308 . . . . 0.39000000000000001 109.831 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.8 29.04 6.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -1.076 . . . . 0.83999999999999997 111.124 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.72 148.41 82.23 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.667 -1.234 . . . . 2.02 107.667 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.19 163.3 32.24 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.204 1.936 . . . . 0.34000000000000002 112.794 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.559 HG13 ' N ' ' B' ' 21' ' ' GLY . 8.0 p -58.07 -47.47 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.466 0.65 . . . . 0.32000000000000001 110.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.559 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.11 -3.31 0.12 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.754 -0.939 . . . . 0.22 110.754 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.497 ' H ' ' C ' ' B' ' 20' ' ' VAL . 11.5 p -82.23 -25.32 34.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.817 -1.402 . . . . 1.24 109.495 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.52 137.91 58.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.23999999999999999 109.768 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 135.45 55.65 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.795 0.807 . . . . 0.20999999999999999 109.832 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' B' ' 73' ' ' GLN . . . 96.78 -20.03 52.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.326 -1.51 . . . . 0.22 109.326 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.79 112.72 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.669 -1.234 . . . . 0.25 107.669 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.433 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -89.99 177.84 43.28 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.609 -1.282 . . . . 0.28000000000000003 110.108 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.74 -39.89 74.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 2.0 109.601 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.78 -44.9 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.008 -1.058 . . . . 0.38 109.484 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.433 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.7 mt -66.35 -36.84 83.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.40000000000000002 109.472 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.79 97.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.76 -1.336 . . . . 0.35999999999999999 109.76 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -65.34 -36.92 85.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.074 -1.251 . . . . 2.75 109.85 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.65 -48.61 68.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.708 -1.245 . . . . 1.5600000000000001 109.321 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.85 -38.67 89.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.06 -1.025 . . . . 0.33000000000000002 108.63 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.94 -42.41 93.93 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.933 -0.707 . . . . 1.6799999999999999 109.228 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -66.95 -19.59 65.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.579 -0.897 . . . . 1.99 108.579 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 3.0 54.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.452 -0.78 . . . . 2.6800000000000002 109.797 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.77 5.47 50.92 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.168 -0.957 . . . . 0.48999999999999999 111.836 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.473 ' CD2' HG12 ' B' ' 44' ' ' VAL . 97.5 m-85 -106.3 77.0 1.18 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.772 -1.428 . . . . 0.33000000000000002 109.071 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -79.33 -7.47 58.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.905 . . . . 0.40999999999999998 110.914 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.14 158.44 44.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.965 -1.084 . . . . 1.5600000000000001 110.498 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.72 90.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.628 -0.67 . . . . 0.20999999999999999 112.389 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 7.6 p90 -60.96 -18.61 58.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.526 -1.359 . . . . 0.32000000000000001 110.584 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.473 HG12 ' CD2' ' B' ' 39' ' ' PHE . 16.8 t -79.88 -31.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.964 -1.124 . . . . 0.23999999999999999 107.964 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.61 -37.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.34 -0.985 . . . . 0.22 108.34 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.11 -35.71 75.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.505 -1.294 . . . . 0.40000000000000002 107.505 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.33 96.73 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.706 -1.358 . . . . 0.17999999999999999 109.706 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.03 -43.47 95.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.967 -1.314 . . . . 1.0900000000000001 108.971 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.0 -41.48 92.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.31 108.964 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.01 -39.92 75.55 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.864 -0.734 . . . . 0.27000000000000002 109.064 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.37 -22.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.201 -0.937 . . . . 0.28000000000000003 110.339 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -91.92 17.02 9.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.168 -0.958 . . . . 0.29999999999999999 109.734 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.998 -1.064 . . . . 1.71 110.327 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' LYS . . . . . 0.716 ' NZ ' HH12 ' B' ' 82' ' ' ARG . 64.3 mttm 58.66 19.63 6.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.729 -0.607 . . . . 2.25 110.058 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.75 106.67 2.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.614 -1.304 . . . . 1.8 108.201 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.41 -41.3 98.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.379 -0.826 . . . . 0.88 112.523 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 92.3 m-20 -68.86 -39.84 79.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.886 -1.133 . . . . 0.73999999999999999 109.49 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.06 -40.02 75.32 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 119.063 -1.055 . . . . 0.55000000000000004 108.578 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -63.16 -50.05 71.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.38 109.842 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 82.9 mtm180 -62.3 -44.94 95.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.366 -0.834 . . . . 2.6400000000000001 110.342 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.03 -38.45 90.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.988 -1.07 . . . . 2.3799999999999999 109.042 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.4 -49.4 73.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.40000000000000002 110.818 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.3 -47.39 76.75 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.342 -0.849 . . . . 0.34000000000000002 109.953 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -63.42 -45.19 92.14 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.317 -0.864 . . . . 2.1000000000000001 109.387 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 35.5 t0 -68.61 -33.78 74.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.735 -0.603 . . . . 1.8999999999999999 109.607 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -79.88 -33.64 39.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.40000000000000002 111.249 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.6 p -130.57 -29.04 1.99 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.526 -1.359 . . . . 0.39000000000000001 112.272 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.13 26.09 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.205 -1.558 . . . . 0.35999999999999999 109.205 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.91 152.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.096 -1.238 . . . . 0.32000000000000001 109.409 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.03 172.62 8.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.068 -1.02 . . . . 1.9099999999999999 110.041 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.19 79.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.674 . . . . 0.38 110.548 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.04 -40.39 75.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.839 -1.163 . . . . 2.5699999999999998 109.705 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' B' ' 25' ' ' GLY . 93.8 mm-40 -67.54 -39.55 85.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.444 -0.785 . . . . 2.1200000000000001 110.757 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -66.09 -38.23 87.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.161 -0.962 . . . . 1.3600000000000001 110.106 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.09 -39.02 84.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.723 -1.235 . . . . 2.8100000000000001 109.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.2 -39.3 82.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.842 -1.161 . . . . 0.40000000000000002 110.439 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.2 -40.22 82.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.752 -1.217 . . . . 0.23000000000000001 109.472 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -60.47 -60.08 4.38 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.95 -1.094 . . . . 0.42999999999999999 109.649 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.24 -35.63 88.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.275 -1.13 . . . . 0.25 110.275 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.03 -47.34 65.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.23999999999999999 109.778 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.07 -40.28 75.14 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.735 -1.186 . . . . 0.28999999999999998 108.529 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.716 HH12 ' NZ ' ' B' ' 54' ' ' LYS . 8.5 tpm_? -63.4 -41.91 98.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 2.7400000000000002 110.083 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 94.4 mt-10 -69.77 -39.6 76.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.816 -1.178 . . . . 1.9099999999999999 110.775 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.609 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 79.7 t90 -59.96 -42.08 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.436 -1.415 . . . . 0.35999999999999999 107.534 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 67.4 m -62.74 -40.44 97.23 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.056 -0.72 . . . . 0.35999999999999999 109.056 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' B' ' 82' ' ' ARG . 96.2 m-20 -60.27 -36.9 78.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.552 -0.717 . . . . 0.55000000000000004 109.781 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.72 -38.43 18.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.46999999999999997 110.06 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 76.3 m-85 -102.25 -84.94 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.311 -0.868 . . . . 1.24 110.547 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 118.012 -0.994 . . . . 1.6699999999999999 109.911 -178.529 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.433 -0.58 . . . . 5.6799999999999997 109.433 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.1 m -89.94 96.17 10.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.113 -0.992 . . . . 3.02 108.72 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.3 p -112.12 164.26 13.37 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.56 0.695 . . . . 0.95999999999999996 110.215 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t -73.11 173.3 9.58 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.6 0.714 . . . . 1.51 109.49 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -54.55 -18.84 4.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.641 -0.662 . . . . 2.1800000000000002 110.266 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -59.99 -37.09 78.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 2.02 109.75 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -59.88 -50.83 72.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.007 -1.058 . . . . 0.48999999999999999 110.597 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -69.87 -33.28 72.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.068 -1.02 . . . . 3.21 109.881 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.37 -39.7 77.9 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.276 -0.89 . . . . 0.76000000000000001 109.317 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.8 t80 -63.86 -48.52 76.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.525 -0.734 . . . . 0.46000000000000002 110.433 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.6 11.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.44 110.464 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.64 -12.62 14.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.243 -0.911 . . . . 0.54000000000000004 109.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.04 151.23 22.54 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 1.26 109.395 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -42.12 157.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.738 1.625 . . . . 0.48999999999999999 110.994 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.05 -23.24 18.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.847 -1.158 . . . . 0.56999999999999995 109.922 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.77 -138.59 48.21 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.981 -1.247 . . . . 0.40000000000000002 109.981 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.58 29.33 5.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.501 -0.999 . . . . 0.84999999999999998 110.042 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -60.02 148.98 76.0 Favored Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 107.83 -1.174 . . . . 2.0099999999999998 107.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.16 160.93 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.326 2.017 . . . . 0.34000000000000002 113.257 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.3 p -57.29 -49.08 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.739 -0.601 . . . . 0.32000000000000001 110.096 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.575 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -56.22 -2.78 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.223 -1.151 . . . . 0.23000000000000001 110.223 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 22.1 p -81.49 -24.68 36.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.33 . . . . 1.24 108.511 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.627 HD22 HD21 ' A' ' 81' ' ' LEU . 92.3 mt -62.43 139.73 58.57 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.783 0.802 . . . . 0.23999999999999999 109.579 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.81 134.12 52.42 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.831 0.824 . . . . 0.20999999999999999 110.16 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.98 -20.51 48.74 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.925 -1.67 . . . . 0.22 108.925 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mm -99.89 116.8 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.764 -1.198 . . . . 0.25 107.764 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -92.3 177.4 39.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.669 -1.372 . . . . 0.28000000000000003 109.669 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.49 -39.84 73.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.54 -0.976 . . . . 2.0099999999999998 109.539 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.13 -42.67 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.38 109.447 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.591 HD11 ' NE2' ' A' ' 73' ' ' GLN . 95.6 mt -68.4 -40.06 81.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.214 -0.929 . . . . 0.40000000000000002 109.438 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.99 97.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.34999999999999998 109.583 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.29 -39.97 94.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.4 -1.059 . . . . 2.7400000000000002 110.058 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.84 -49.94 68.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.832 -1.168 . . . . 1.54 109.599 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.5 mt -60.03 -39.45 85.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.34000000000000002 108.966 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.02 -44.5 94.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.723 . . . . 1.6699999999999999 110.533 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.76 -19.07 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 2.0 109.113 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 37' ' ' ARG . 27.1 mtt-85 -89.97 1.93 55.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.794 -0.762 . . . . 2.6899999999999999 110.52 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.43 4.37 34.95 Favored Glycine 0 N--CA 1.506 3.353 0 O-C-N 121.019 -1.051 . . . . 0.47999999999999998 112.006 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CD2' HG12 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.08 73.81 1.07 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.794 -1.415 . . . . 0.33000000000000002 108.659 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -80.07 -10.0 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.40999999999999998 110.515 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 29.8 mmtp -130.82 152.68 49.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.171 -0.955 . . . . 1.5600000000000001 109.424 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.393 -0.817 . . . . 0.20999999999999999 111.55 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 22.5 p90 -56.15 -17.61 7.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.711 -1.243 . . . . 0.32000000000000001 110.32 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.2 t -79.66 -33.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.832 -1.167 . . . . 0.23999999999999999 108.073 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 20' ' ' VAL . 55.2 t -76.88 -39.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.266 -1.013 . . . . 0.22 108.266 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.03 -38.07 81.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.578 -1.267 . . . . 0.40000000000000002 107.578 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.98 -41.12 96.21 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.552 -1.419 . . . . 0.17999999999999999 109.552 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -59.9 -43.29 94.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.252 . . . . 1.0900000000000001 108.456 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.02 -39.93 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.31 108.725 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.72 -40.01 76.5 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.509 -0.923 . . . . 0.28000000000000003 108.509 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.81 -26.01 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.28000000000000003 110.198 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.01 13.63 14.32 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.16 -0.962 . . . . 0.31 110.166 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER 48.95 51.63 15.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.881 -1.137 . . . . 1.7 110.312 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.76 20.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.945 -1.097 . . . . 2.2400000000000002 110.913 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-20 -65.33 105.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.937 -1.505 . . . . 1.8 106.937 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.43 -40.27 93.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.361 -0.837 . . . . 0.87 112.62 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.77 -40.03 76.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.256 -1.527 . . . . 0.72999999999999998 109.823 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.3 -40.07 74.45 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.944 -1.102 . . . . 0.55000000000000004 109.2 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.9 -50.03 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.38 109.402 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.79 -45.01 94.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.437 -0.79 . . . . 2.6400000000000001 109.896 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 65' ' ' ASP . 8.3 tm-20 -64.88 -39.99 94.4 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.159 -0.963 . . . . 2.3700000000000001 108.706 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -65.25 -48.02 74.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.40000000000000002 110.866 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.66 -45.88 73.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.208 -0.932 . . . . 0.34000000000000002 110.558 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.65 -48.5 79.07 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.167 -0.958 . . . . 2.1099999999999999 110.213 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 61' ' ' GLU . 57.2 m-20 -70.06 -24.75 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.807 . . . . 1.8999999999999999 110.066 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.0 m -79.62 -34.51 40.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.143 -0.973 . . . . 0.40999999999999998 111.236 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -132.91 -19.84 2.25 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.483 -1.386 . . . . 0.40000000000000002 111.899 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.8 11.5 43.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.137 -1.585 . . . . 0.35999999999999999 109.137 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.68 1.6 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.33000000000000002 109.248 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.26 170.02 10.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 1.8999999999999999 109.817 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -34.36 73.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.562 -0.711 . . . . 0.39000000000000001 110.552 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -71.66 -39.97 69.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.64 -1.287 . . . . 2.5800000000000001 110.222 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.591 ' NE2' HD11 ' A' ' 30' ' ' LEU . 78.3 mt-30 -68.61 -37.98 80.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.43 -0.794 . . . . 2.1200000000000001 110.722 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.9 m -67.41 -38.0 83.93 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.048 -1.032 . . . . 1.3600000000000001 109.958 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.01 -38.06 81.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 2.7999999999999998 109.476 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -68.33 -39.93 81.77 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.705 -1.247 . . . . 0.40000000000000002 110.349 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.9 m -66.97 -39.97 87.35 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.82 -1.175 . . . . 0.23999999999999999 108.968 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.15 -60.73 3.39 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.984 -1.073 . . . . 0.42999999999999999 109.822 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.03 88.82 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.507 -1.037 . . . . 0.26000000000000001 110.507 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.28 -49.88 52.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.432 . . . . 0.25 109.625 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.627 HD21 HD22 ' A' ' 23' ' ' LEU . 96.3 mt -70.01 -39.99 75.5 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.983 -1.087 . . . . 0.29999999999999999 109.019 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -63.01 -40.05 96.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 2.73 110.186 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.049 -1.032 . . . . 1.9099999999999999 109.924 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 71.0 t90 -59.91 -42.76 94.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.437 -1.32 . . . . 0.37 107.437 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.415 ' O ' ' OXT' ' A' ' 89' ' ' LEU . 92.1 m -63.94 -40.01 95.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 0.35999999999999999 108.968 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.39 -37.99 82.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.425 -0.797 . . . . 0.55000000000000004 109.678 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.13 17.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.47999999999999998 109.938 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 73.0 m-85 -98.93 -82.2 0.44 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.165 -0.959 . . . . 1.24 110.311 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' OXT' ' O ' ' A' ' 85' ' ' CYS . 18.5 tp . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.989 -1.005 . . . . 1.6599999999999999 110.217 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.502 -0.555 . . . . 5.6600000000000001 109.502 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m -89.86 96.18 10.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.082 -1.011 . . . . 3.02 108.778 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 77.7 p -112.12 164.4 13.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.553 -0.717 . . . . 0.95999999999999996 110.282 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 28.4 t -73.2 173.28 9.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.468 -0.77 . . . . 1.5 109.466 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -54.63 -18.87 5.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.634 -0.666 . . . . 2.1800000000000002 110.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -60.02 -36.89 78.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.055 -1.028 . . . . 2.0099999999999998 109.701 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -60.11 -50.58 73.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.995 -1.066 . . . . 0.48999999999999999 110.571 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -70.16 -33.14 71.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.018 -1.051 . . . . 3.23 109.758 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -69.43 -39.59 77.75 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.307 -0.871 . . . . 0.76000000000000001 109.288 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.4 t80 -63.96 -48.52 76.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.46000000000000002 110.462 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -83.51 11.11 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.029 -1.044 . . . . 0.44 110.423 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.54 -12.67 14.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.316 -0.865 . . . . 0.53000000000000003 109.793 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.04 151.14 22.36 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.065 -1.022 . . . . 1.27 109.329 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -42.16 157.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.705 1.603 . . . . 0.48999999999999999 110.926 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.2 ptp -93.01 -23.3 18.72 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.872 -1.143 . . . . 0.56000000000000005 109.958 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.11 -138.48 48.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.081 -1.208 . . . . 0.39000000000000001 110.081 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.82 29.34 5.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.83999999999999997 110.051 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.93 148.88 75.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 107.823 -1.177 . . . . 2.02 107.823 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.99 161.1 38.29 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.285 1.99 . . . . 0.34000000000000002 113.236 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.572 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.4 p -57.36 -49.15 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.568 0.699 . . . . 0.32000000000000001 110.146 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.572 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -56.04 -3.05 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.259 -1.136 . . . . 0.22 110.259 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.449 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.2 p -81.35 -24.4 37.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.955 -1.32 . . . . 1.24 108.53 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.635 HD22 HD21 ' B' ' 81' ' ' LEU . 91.7 mt -62.61 139.69 58.64 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.823 0.821 . . . . 0.23999999999999999 109.581 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 134.14 52.62 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.776 0.798 . . . . 0.20999999999999999 110.173 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -20.92 46.95 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.883 -1.687 . . . . 0.22 108.883 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mm -99.6 116.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.916 -1.142 . . . . 0.25 107.916 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.467 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -92.3 177.48 39.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.679 -1.368 . . . . 0.28000000000000003 109.679 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -56.41 -39.92 73.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.455 -1.027 . . . . 2.0 109.553 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.15 -42.68 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.38 109.438 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.467 HD12 ' H ' ' B' ' 27' ' ' GLY . 95.7 mt -68.42 -39.91 81.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.219 -0.925 . . . . 0.40000000000000002 109.528 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.76 -39.91 97.38 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.35999999999999999 109.591 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.33 -39.98 94.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -1.108 . . . . 2.75 110.049 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.82 -49.99 68.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.837 -1.164 . . . . 1.5600000000000001 109.552 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.02 -39.45 85.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.33000000000000002 108.893 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.05 -44.38 94.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 1.6799999999999999 110.501 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.95 -18.91 65.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.031 -1.043 . . . . 1.99 109.152 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' B' ' 37' ' ' ARG . 27.6 mtt-85 -90.0 1.62 56.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.466 -0.771 . . . . 2.6800000000000002 110.507 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.91 4.27 33.9 Favored Glycine 0 N--CA 1.506 3.309 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 112.024 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.522 ' CD2' HG12 ' B' ' 44' ' ' VAL . 82.6 m-85 -105.08 73.87 1.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.81 -1.406 . . . . 0.33000000000000002 108.755 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.1 -10.03 59.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.40999999999999998 110.405 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.464 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 29.8 mmtp -130.79 152.59 49.97 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.224 -0.922 . . . . 1.5600000000000001 109.493 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.95 92.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.529 -0.732 . . . . 0.20999999999999999 111.501 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.464 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 22.8 p90 -56.1 -17.46 7.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.733 -1.23 . . . . 0.32000000000000001 110.418 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.3 t -79.7 -33.34 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.819 -1.176 . . . . 0.23999999999999999 108.039 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.437 HG21 HG23 ' B' ' 20' ' ' VAL . 55.2 t -76.68 -39.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.262 -1.014 . . . . 0.22 108.262 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.8 tp -60.08 -37.6 80.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.534 -1.284 . . . . 0.40000000000000002 107.534 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 -41.04 96.54 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.627 -1.389 . . . . 0.17999999999999999 109.627 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -60.07 -43.24 95.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.274 . . . . 1.0900000000000001 108.397 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.31 108.794 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.74 -39.91 76.48 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.27000000000000002 108.617 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.85 -26.1 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.312 -0.868 . . . . 0.28000000000000003 110.193 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.93 13.49 14.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.197 -0.939 . . . . 0.29999999999999999 110.131 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 49.01 51.73 15.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.771 -1.205 . . . . 1.71 110.185 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.79 20.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.833 -1.167 . . . . 2.25 110.954 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 53' ' ' LYS . 71.1 m-20 -65.5 105.34 1.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.946 -1.501 . . . . 1.8 106.946 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.42 -40.03 92.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.241 -0.912 . . . . 0.88 112.674 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.99 -39.95 75.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.342 -1.474 . . . . 0.73999999999999999 109.865 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.38 -39.94 74.27 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.846 -1.142 . . . . 0.55000000000000004 109.298 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.86 -49.94 70.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.38 109.433 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.98 -44.82 94.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.461 -0.774 . . . . 2.6400000000000001 109.821 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.444 ' OE2' ' OD2' ' B' ' 65' ' ' ASP . 8.3 tm-20 -64.93 -40.1 94.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.111 -0.993 . . . . 2.3799999999999999 108.745 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -65.11 -48.1 74.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.40000000000000002 110.92 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.0 tp -67.79 -45.64 74.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.28 -0.888 . . . . 0.34000000000000002 110.572 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.84 -48.48 78.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.191 -0.943 . . . . 2.1000000000000001 110.162 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.444 ' OD2' ' OE2' ' B' ' 61' ' ' GLU . 57.3 m-20 -69.96 -24.84 63.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 1.8999999999999999 110.119 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -79.59 -34.34 40.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.996 . . . . 0.40000000000000002 111.33 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -133.02 -19.91 2.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.548 -1.345 . . . . 0.39000000000000001 111.802 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.75 11.51 43.53 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.116 -1.594 . . . . 0.35999999999999999 109.116 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.08 152.87 1.55 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.998 -1.295 . . . . 0.32000000000000001 109.166 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.54 ' H ' HE21 ' B' ' 73' ' ' GLN . 27.0 t-20 -89.43 169.98 10.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.058 . . . . 1.9099999999999999 109.843 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.42 73.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.58 -0.7 . . . . 0.38 110.507 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.63 -39.97 70.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.703 -1.248 . . . . 2.5699999999999998 110.202 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.54 HE21 ' H ' ' B' ' 70' ' ' ASN . 37.2 mt-30 -68.68 -37.99 80.02 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.815 . . . . 2.1200000000000001 110.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -67.27 -38.12 84.57 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.036 -1.04 . . . . 1.3600000000000001 109.911 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 -60.05 -38.1 81.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 2.8100000000000001 109.441 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.12 -39.98 82.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.77 -1.206 . . . . 0.40000000000000002 110.348 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 67.2 m -67.01 -39.96 87.2 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.735 -1.228 . . . . 0.23000000000000001 109.053 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.05 -60.82 3.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.984 -1.072 . . . . 0.42999999999999999 109.867 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.13 -34.15 89.14 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.504 -1.038 . . . . 0.25 110.504 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.29 -49.8 52.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.825 -1.397 . . . . 0.23999999999999999 109.713 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.635 HD21 HD22 ' B' ' 23' ' ' LEU . 96.7 mt -69.98 -40.0 75.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.987 -1.085 . . . . 0.28999999999999998 108.969 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -63.11 -40.03 96.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.172 -0.955 . . . . 2.7400000000000002 110.144 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.2 -36.72 77.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 1.9099999999999999 109.882 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.533 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 71.8 t90 -59.95 -42.64 94.49 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.449 -1.315 . . . . 0.35999999999999999 107.449 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.409 ' O ' ' OXT' ' B' ' 89' ' ' LEU . 92.6 m -64.11 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 0.35999999999999999 108.952 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.25 -38.21 82.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.758 . . . . 0.55000000000000004 109.578 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.46 -39.69 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.46999999999999997 110.01 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.533 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.6 m-85 -97.84 -82.49 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 1.24 110.495 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.409 ' OXT' ' O ' ' B' ' 85' ' ' CYS . 18.4 tp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.975 -1.012 . . . . 1.6699999999999999 110.065 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.274 0.559 . . . . 5.6799999999999997 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.3 p -91.0 98.6 11.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.103 -0.998 . . . . 3.02 109.121 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.7 p -97.99 162.19 13.35 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.247 -0.908 . . . . 0.95999999999999996 109.738 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.1 t -69.59 164.92 22.22 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.834 0.826 . . . . 1.51 109.324 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.48 -28.69 67.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.753 -0.592 . . . . 2.1800000000000002 109.95 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.02 -36.9 78.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.939 . . . . 2.02 109.456 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -59.25 -50.08 75.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 110.064 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.98 -34.41 73.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.192 -0.943 . . . . 3.21 110.096 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 91.3 m-20 -67.8 -39.31 84.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.255 -0.903 . . . . 0.76000000000000001 109.447 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -60.03 -47.45 85.8 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.481 -0.888 . . . . 0.46000000000000002 109.369 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 m -83.76 10.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.026 -1.047 . . . . 0.44 110.483 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.6 -19.04 17.04 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.012 -1.055 . . . . 0.54000000000000004 110.91 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -156.95 152.93 23.01 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.886 -1.133 . . . . 1.26 108.606 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' GLU . 55.0 Cg_exo -36.47 150.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.012 1.808 . . . . 0.48999999999999999 111.867 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.442 ' HG2' ' H ' ' A' ' 15' ' ' MET . 8.0 ptm -89.51 -22.74 22.28 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.041 -1.037 . . . . 0.56999999999999995 110.503 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.08 -134.61 40.65 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.101 -1.047 . . . . 0.40000000000000002 110.593 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.98 35.14 3.5 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.99 . . . . 0.84999999999999998 110.557 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -58.55 147.85 68.19 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 120.781 -1.199 . . . . 2.0099999999999998 107.97 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.25 153.69 51.43 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.996 1.797 . . . . 0.34000000000000002 112.08 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.5 p -55.23 -42.03 63.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.544 -0.723 . . . . 0.32000000000000001 109.933 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -62.12 -3.6 5.15 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.281 -1.128 . . . . 0.23000000000000001 110.281 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -83.33 -21.0 33.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.888 -1.36 . . . . 1.24 109.242 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.14 137.73 58.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.23999999999999999 109.68 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.98 133.89 55.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.754 0.788 . . . . 0.20999999999999999 109.841 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 96.89 -17.34 59.44 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.167 -1.573 . . . . 0.22 109.167 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -101.17 114.79 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -1.128 . . . . 0.25 108.094 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -94.76 178.55 36.48 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.724 -1.351 . . . . 0.28000000000000003 109.724 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.23 -40.01 73.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -1.148 . . . . 2.0099999999999998 109.958 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.28 -44.44 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.974 -1.079 . . . . 0.38 109.545 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.8 mt -66.29 -38.35 87.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.40000000000000002 109.707 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.98 94.5 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.37 -1.492 . . . . 0.34999999999999998 109.37 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.96 -40.0 90.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -1.09 . . . . 2.7400000000000002 110.594 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.19 -45.35 73.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.738 -1.226 . . . . 1.54 109.632 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.49 -39.96 95.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.073 -1.017 . . . . 0.34000000000000002 108.59 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.14 -40.82 91.15 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.809 -0.756 . . . . 1.6699999999999999 109.605 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.17 -19.55 65.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.332 -0.988 . . . . 2.0 108.332 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.513 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.6 OUTLIER -91.12 6.39 45.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.649 -0.657 . . . . 2.6899999999999999 110.043 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.62 9.23 53.33 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.256 -0.973 . . . . 0.47999999999999998 111.899 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.549 ' CD2' HG12 ' A' ' 44' ' ' VAL . 78.3 m-85 -106.26 74.52 1.04 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.764 -1.433 . . . . 0.33000000000000002 109.312 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -79.96 -9.74 59.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.40999999999999998 110.522 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.1 mmtm -132.72 154.97 49.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.088 -1.008 . . . . 1.5600000000000001 109.559 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.92 94.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.657 -0.652 . . . . 0.20999999999999999 111.071 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 21.6 p90 -57.39 -18.85 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.758 -1.214 . . . . 0.32000000000000001 110.7 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 39' ' ' PHE . 24.8 t -79.27 -34.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.619 -1.301 . . . . 0.23999999999999999 107.976 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.75 -39.96 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.472 -0.936 . . . . 0.22 108.472 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.98 -38.33 82.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.623 -1.251 . . . . 0.40000000000000002 107.623 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.97 97.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.664 -1.374 . . . . 0.17999999999999999 109.664 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 1.0900000000000001 109.37 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.97 -40.03 87.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.7 -39.0 77.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.666 -0.813 . . . . 0.28000000000000003 108.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.34 -24.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.28000000000000003 110.147 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.57 15.2 14.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.172 -0.955 . . . . 0.31 110.252 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt 48.82 42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.732 -1.23 . . . . 1.7 110.866 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 56.76 19.41 4.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.389 -0.819 . . . . 2.2400000000000002 109.5 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.82 107.02 2.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.718 -1.239 . . . . 1.8 108.123 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -40.52 97.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.87 112.342 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.11 -39.96 78.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.363 -1.461 . . . . 0.72999999999999998 109.724 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.47 -39.99 73.91 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.917 -1.113 . . . . 0.55000000000000004 108.987 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.9 -49.88 70.92 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.856 . . . . 0.38 109.668 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.22 -46.29 91.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.347 -0.846 . . . . 2.6400000000000001 110.443 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.35 -39.89 94.78 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.064 -1.022 . . . . 2.3700000000000001 108.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.402 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.2 t90 -63.23 -49.49 73.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.269 -0.894 . . . . 0.40000000000000002 110.93 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.98 -49.64 64.76 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 0.34000000000000002 109.784 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.25 86.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.765 . . . . 2.1099999999999999 110.007 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.9 t0 -68.45 -29.62 68.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.521 -0.737 . . . . 1.8999999999999999 109.838 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.9 m -80.45 -32.91 37.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.40999999999999998 111.562 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.2 p -131.65 -28.77 1.79 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.52 -1.363 . . . . 0.40000000000000002 111.982 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.56 14.1 20.68 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.059 -1.616 . . . . 0.35999999999999999 109.059 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.89 153.28 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.014 -1.286 . . . . 0.33000000000000002 109.362 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.54 170.15 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.1 -1.0 . . . . 1.8999999999999999 109.654 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.23 70.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.39000000000000001 110.727 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.18 -40.1 68.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 2.5800000000000001 109.734 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.2 mm100 -67.71 -38.3 83.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.349 -0.844 . . . . 2.1200000000000001 110.236 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -68.45 -37.74 80.49 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.907 . . . . 1.3600000000000001 110.02 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.56 -38.8 85.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 2.7999999999999998 109.412 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -68.46 -39.94 81.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.624 -1.298 . . . . 0.40000000000000002 110.318 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.4 -39.98 81.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.143 . . . . 0.23999999999999999 109.171 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.69 -60.1 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.771 -1.206 . . . . 0.42999999999999999 109.779 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.29 -34.42 89.16 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.298 -1.121 . . . . 0.26000000000000001 110.298 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.32 -46.58 60.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.847 -1.384 . . . . 0.25 109.705 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -70.32 -40.56 74.11 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.793 -1.163 . . . . 0.29999999999999999 108.432 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -64.54 -39.98 94.75 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.84 . . . . 2.73 110.448 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -68.73 -37.64 79.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.983 -1.073 . . . . 1.9099999999999999 109.758 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.592 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.4 t90 -60.01 -45.54 92.41 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.431 -1.322 . . . . 0.37 107.431 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.411 ' O ' ' O ' ' A' ' 89' ' ' LEU . 75.6 m -60.74 -40.02 90.87 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.808 -0.812 . . . . 0.35999999999999999 108.808 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.43 -37.76 81.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.55000000000000004 109.739 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.61 -36.86 18.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.47999999999999998 109.934 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 -103.74 -85.26 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 1.24 110.226 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 85' ' ' CYS . 24.4 tp . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.086 -0.959 . . . . 1.6599999999999999 109.63 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.284 0.564 . . . . 5.6600000000000001 109.598 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 69.0 p -91.17 98.85 11.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 3.02 109.144 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -98.23 162.35 13.24 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.313 -0.867 . . . . 0.95999999999999996 109.642 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 35.8 t -69.66 165.02 22.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 1.5 109.426 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.71 -28.5 67.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.761 -0.587 . . . . 2.1800000000000002 109.905 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -59.99 -37.03 78.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 2.0099999999999998 109.483 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -59.32 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.101 -1.0 . . . . 0.48999999999999999 109.974 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.96 -34.53 73.53 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.073 -1.017 . . . . 3.23 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ASP . . . . . 0.447 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 91.6 m-20 -67.72 -39.26 84.33 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.223 -0.923 . . . . 0.76000000000000001 109.413 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -59.91 -47.6 85.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.434 -0.906 . . . . 0.46000000000000002 109.39 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.67 10.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.168 -0.957 . . . . 0.44 110.512 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -19.04 17.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.53000000000000003 110.981 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' B' ' 9' ' ' ASP . 0.0 OUTLIER -156.92 152.93 23.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.831 -1.168 . . . . 1.27 108.603 179.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' B' ' 13' ' ' GLU . 54.8 Cg_exo -36.36 150.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.088 1.859 . . . . 0.48999999999999999 111.86 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' B' ' 15' ' ' MET . 8.0 ptm -89.38 -22.61 22.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.114 -0.991 . . . . 0.56000000000000005 110.539 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.19 -134.63 41.06 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.918 -1.114 . . . . 0.39000000000000001 110.63 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.02 35.04 3.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.471 -1.017 . . . . 0.83999999999999997 110.552 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -58.4 147.79 66.97 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 120.76 -1.213 . . . . 2.02 108.04 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.28 153.48 52.98 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.019 1.813 . . . . 0.34000000000000002 112.161 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.516 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.7 p -54.96 -42.07 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.32000000000000001 110.03 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.516 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -62.15 -3.68 5.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.263 -1.135 . . . . 0.22 110.263 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -83.08 -21.1 33.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.897 -1.355 . . . . 1.24 109.261 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.15 137.83 58.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.23999999999999999 109.662 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.97 133.81 55.21 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.62 0.724 . . . . 0.20999999999999999 109.833 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 96.99 -17.48 59.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.084 -1.607 . . . . 0.22 109.084 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -101.01 114.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -1.101 . . . . 0.25 108.212 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.411 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -94.62 178.56 36.68 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.725 -1.35 . . . . 0.28000000000000003 109.725 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.27 -40.09 73.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -1.115 . . . . 2.0 109.948 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.22 -44.34 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.02 -1.05 . . . . 0.38 109.566 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.411 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.8 mt -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.40000000000000002 109.657 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.53 -39.05 94.49 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.343 -1.503 . . . . 0.35999999999999999 109.343 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.99 -40.03 90.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 2.75 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.27 -45.41 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.664 -1.272 . . . . 1.5600000000000001 109.533 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.25 -40.03 96.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.092 -1.005 . . . . 0.33000000000000002 108.673 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.05 -40.87 90.91 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.859 -0.736 . . . . 1.6799999999999999 109.634 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.19 -19.49 65.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.353 -0.98 . . . . 1.99 108.353 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.514 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.6 OUTLIER -91.14 6.25 45.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.648 -0.657 . . . . 2.6800000000000002 110.029 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 9.34 52.97 Favored Glycine 0 N--CA 1.501 3.027 0 O-C-N 121.141 -0.975 . . . . 0.48999999999999999 111.834 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.547 ' CD2' HG12 ' B' ' 44' ' ' VAL . 78.8 m-85 -106.22 74.12 1.02 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.761 -1.434 . . . . 0.33000000000000002 109.323 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 -9.97 59.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.912 . . . . 0.40999999999999998 110.534 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.481 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.0 mmtm -132.57 154.94 49.51 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.206 -0.934 . . . . 1.5600000000000001 109.581 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.02 95.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.655 -0.653 . . . . 0.20999999999999999 111.112 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.481 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 20.2 p90 -57.27 -18.72 17.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.238 . . . . 0.32000000000000001 110.672 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.547 HG12 ' CD2' ' B' ' 39' ' ' PHE . 24.7 t -79.38 -34.24 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.58 -1.325 . . . . 0.23999999999999999 108.001 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 75.0 t -77.77 -39.95 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.477 -0.934 . . . . 0.22 108.477 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.07 -38.12 81.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 0.40000000000000002 107.628 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.88 97.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.759 -1.336 . . . . 0.17999999999999999 109.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -40.04 88.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -1.18 . . . . 1.0900000000000001 109.336 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.85 -40.05 87.28 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.107 -1.071 . . . . 0.31 108.107 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.74 -38.65 76.92 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.609 -0.836 . . . . 0.27000000000000002 108.836 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.76 -24.17 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.178 -0.951 . . . . 0.28000000000000003 110.086 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.38 14.87 15.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.058 -1.026 . . . . 0.29999999999999999 110.262 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 49.19 42.24 21.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.772 -1.205 . . . . 1.71 110.824 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 81.5 mttt 57.14 19.6 4.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 2.25 109.484 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.02 107.08 2.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.701 -1.249 . . . . 1.8 108.14 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -40.2 96.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.43 -0.794 . . . . 0.88 112.39 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.39 -40.04 77.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.252 -1.53 . . . . 0.73999999999999999 109.702 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.3 -40.07 74.47 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.924 -1.11 . . . . 0.55000000000000004 109.024 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.74 -49.99 70.86 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.38 109.662 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.36 -45.96 92.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.459 -0.776 . . . . 2.6400000000000001 110.466 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -64.52 -39.93 94.68 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 120.99 -1.068 . . . . 2.3799999999999999 108.788 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -63.16 -49.64 73.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.864 . . . . 0.40000000000000002 110.887 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.95 -49.45 65.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.084 -1.01 . . . . 0.34000000000000002 109.795 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -47.21 86.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 2.1000000000000001 109.96 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 36.5 t0 -68.61 -29.37 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 1.8999999999999999 109.797 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 64.3 m -80.64 -33.06 35.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.40000000000000002 111.451 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.2 p -131.54 -28.62 1.83 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.405 -1.435 . . . . 0.39000000000000001 112.137 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.42 14.03 21.11 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 109.096 -1.601 . . . . 0.35999999999999999 109.096 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.85 153.23 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.05 -1.265 . . . . 0.32000000000000001 109.306 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.46 170.16 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.101 -0.999 . . . . 1.9099999999999999 109.655 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.36 70.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.478 -0.764 . . . . 0.38 110.73 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.06 -40.07 68.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.784 -1.197 . . . . 2.5699999999999998 109.68 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.2 mm100 -67.81 -38.17 82.92 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.323 -0.861 . . . . 2.1200000000000001 110.301 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -68.53 -37.93 80.42 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.266 -0.896 . . . . 1.3600000000000001 110.005 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.41 -38.91 85.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.852 -1.155 . . . . 2.8100000000000001 109.399 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -68.22 -39.97 82.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.651 -1.28 . . . . 0.40000000000000002 110.354 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.1 m -68.45 -39.98 81.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.712 -1.242 . . . . 0.23000000000000001 109.209 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -60.18 4.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.739 -1.226 . . . . 0.42999999999999999 109.8 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -34.49 89.11 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.364 -1.094 . . . . 0.25 110.364 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.3 t -71.41 -46.33 60.46 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.809 -1.406 . . . . 0.23999999999999999 109.792 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.44 -40.59 73.67 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.812 -1.155 . . . . 0.28999999999999998 108.403 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.47 -40.11 95.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 2.7400000000000002 110.454 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -68.85 -37.4 79.1 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.94 -1.1 . . . . 1.9099999999999999 109.672 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.4 t90 -59.92 -45.77 91.52 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.433 -1.321 . . . . 0.35999999999999999 107.433 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' B' ' 89' ' ' LEU . 73.5 m -60.62 -39.95 90.09 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.813 -0.755 . . . . 0.35999999999999999 108.964 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.57 -37.79 82.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 109.721 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.51 -36.83 18.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -0.889 . . . . 0.46999999999999997 109.957 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.1 m-85 -103.62 -85.02 0.46 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.28 -0.887 . . . . 1.24 110.39 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 85' ' ' CYS . 24.6 tp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.051 -0.976 . . . . 1.6699999999999999 109.573 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.305 0.574 . . . . 5.6799999999999997 109.585 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.9 m -76.48 125.12 28.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 3.02 109.623 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.1 p -92.34 170.05 10.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.268 -0.895 . . . . 0.95999999999999996 110.045 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t -79.99 170.04 17.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 1.51 109.81 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.45 -20.66 13.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 2.1800000000000002 110.076 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.02 -37.52 79.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.14 -0.975 . . . . 2.02 109.293 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 12.4 t60 -59.97 -50.01 75.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.021 -1.049 . . . . 0.48999999999999999 110.628 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 8' ' ' ARG . 17.9 mmm-85 -70.01 -35.11 74.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.859 -1.151 . . . . 3.21 109.735 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.74 -39.99 84.2 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.386 -0.822 . . . . 0.76000000000000001 109.336 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -63.54 -49.08 74.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.428 -0.795 . . . . 0.46000000000000002 110.085 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.53 9.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.971 -1.081 . . . . 0.44 110.747 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -102.9 -15.01 16.31 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.189 -0.944 . . . . 0.54000000000000004 110.267 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.4 pt-20 -152.71 155.03 32.22 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.169 -0.957 . . . . 1.26 108.938 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' GLU . 65.1 Cg_exo -36.84 152.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.101 1.867 . . . . 0.48999999999999999 111.441 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 11.6 ptm -89.75 -23.23 21.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.038 -1.039 . . . . 0.56999999999999995 109.673 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.0 -138.54 20.64 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.097 -1.201 . . . . 0.40000000000000002 110.097 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.54 43.23 1.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.577 -0.955 . . . . 0.84999999999999998 109.657 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -61.21 147.98 85.84 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.475 -0.935 . . . . 2.0099999999999998 108.475 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 155.09 39.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.275 1.983 . . . . 0.34000000000000002 112.826 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.68 -35.28 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.632 0.73 . . . . 0.32000000000000001 110.202 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.24 -0.48 57.31 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.546 -1.021 . . . . 0.23000000000000001 110.546 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 p -82.44 -25.8 33.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.783 -1.422 . . . . 1.24 109.706 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.559 HD22 HD21 ' A' ' 81' ' ' LEU . 96.2 mt -60.78 138.52 58.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.23999999999999999 109.953 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.84 134.5 55.32 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.8 -0.76 . . . . 0.20999999999999999 109.483 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.11 -21.72 44.58 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.511 -1.436 . . . . 0.22 109.511 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.76 114.73 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.143 -1.21 . . . . 0.25 108.195 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -95.68 -179.2 36.4 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.645 -1.382 . . . . 0.28000000000000003 109.645 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -58.21 -40.04 80.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -1.038 . . . . 2.0099999999999998 109.652 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.67 -47.65 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.06 -1.025 . . . . 0.38 109.285 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.4 HD12 ' H ' ' A' ' 27' ' ' GLY . 95.9 mt -64.89 -35.99 82.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.40000000000000002 109.348 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.78 -39.97 92.19 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.464 -1.454 . . . . 0.34999999999999998 109.464 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -66.79 -37.49 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.268 . . . . 2.7400000000000002 110.308 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.65 -51.74 46.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.709 -1.245 . . . . 1.54 109.303 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.49 -39.81 89.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.051 -1.031 . . . . 0.34000000000000002 108.471 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.06 -42.66 95.0 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.55 -0.86 . . . . 1.6699999999999999 109.409 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.0 -19.12 65.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.178 -0.951 . . . . 2.0 108.6 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -90.75 5.42 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.539 -0.725 . . . . 2.6899999999999999 109.831 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.89 8.96 53.53 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.007 -1.058 . . . . 0.47999999999999998 111.585 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' A' ' 44' ' ' VAL . 95.5 m-85 -107.25 75.09 1.01 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.418 . . . . 0.33000000000000002 109.071 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.54 -7.98 58.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.40999999999999998 110.562 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -138.04 158.62 43.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.071 -1.018 . . . . 1.5600000000000001 110.149 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.5 84.45 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.965 0.728 . . . . 0.20999999999999999 112.965 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -59.98 -17.84 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.38 -1.45 . . . . 0.32000000000000001 110.376 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 39' ' ' PHE . 30.5 t -79.48 -31.93 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.25 -1.389 . . . . 0.23999999999999999 107.25 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 79.4 t -77.17 -39.58 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.236 -1.024 . . . . 0.22 108.236 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.01 -35.93 76.13 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.466 -1.309 . . . . 0.40000000000000002 107.466 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.29 98.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.703 -1.359 . . . . 0.17999999999999999 109.703 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.94 -43.99 94.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 1.0900000000000001 108.908 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.97 -40.46 89.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.505 -0.747 . . . . 0.31 109.195 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -69.05 -38.44 79.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.813 -0.81 . . . . 0.28000000000000003 108.813 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.69 -19.89 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.137 -0.977 . . . . 0.28000000000000003 110.517 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.2 mt -88.26 14.27 9.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.123 -0.985 . . . . 0.31 110.786 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.12 31.86 7.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.778 -1.201 . . . . 1.7 109.868 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 57.98 19.95 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.704 -0.623 . . . . 2.2400000000000002 110.044 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -69.93 108.81 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.732 -1.23 . . . . 1.8 108.077 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.83 -40.01 96.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.084 0.772 . . . . 0.87 113.084 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.44 -39.94 85.41 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.405 -1.434 . . . . 0.72999999999999998 109.996 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.45 -39.51 74.29 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.104 -1.038 . . . . 0.55000000000000004 108.941 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.39 -41.65 93.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.38 109.095 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmm-85 -60.06 -51.18 70.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 2.6400000000000001 110.147 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.58 -37.3 84.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 2.3700000000000001 110.078 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.33 -47.99 79.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.40000000000000002 110.799 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.8 -47.6 71.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.036 -1.04 . . . . 0.34000000000000002 109.707 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.08 -48.55 78.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.293 -0.879 . . . . 2.1099999999999999 109.945 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -67.17 -32.17 73.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.475 -0.766 . . . . 1.8999999999999999 109.758 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -80.17 -34.68 37.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.40999999999999998 111.397 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.72 -26.69 2.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.59 -1.318 . . . . 0.40000000000000002 112.004 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.99 13.53 33.69 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.684 -1.766 . . . . 0.35999999999999999 108.684 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 152.99 2.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -1.095 . . . . 0.33000000000000002 109.421 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.76 174.9 7.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -0.912 . . . . 1.8999999999999999 109.724 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.27 74.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.39000000000000001 110.728 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.46 -39.66 64.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.604 -1.31 . . . . 2.5800000000000001 110.35 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.015 -1.053 . . . . 2.1200000000000001 110.732 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -69.05 -37.96 78.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.176 -0.952 . . . . 1.3600000000000001 110.52 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 75' ' ' ARG . 27.1 mtt-85 -60.03 -37.38 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 2.7999999999999998 109.489 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.52 -40.03 80.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.716 -1.24 . . . . 0.40000000000000002 110.478 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.8 m -69.48 -40.12 77.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.783 -1.198 . . . . 0.23999999999999999 109.8 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.33 -60.13 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.42999999999999999 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.07 86.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.828 -0.909 . . . . 0.26000000000000001 110.828 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.7 t -70.77 -48.66 53.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.946 -1.326 . . . . 0.25 110.223 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.559 HD21 HD22 ' A' ' 23' ' ' LEU . 88.2 mt -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.998 -1.081 . . . . 0.29999999999999999 108.176 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.52 -40.02 93.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 2.73 110.169 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 92.1 mt-10 -70.27 -38.23 75.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 1.9099999999999999 110.956 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 89.3 t90 -60.59 -42.32 96.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.308 -1.495 . . . . 0.37 108.456 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 89' ' ' LEU . 92.7 m -61.57 -40.43 94.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.509 -0.744 . . . . 0.35999999999999999 110.273 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -29.44 68.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.121 -0.987 . . . . 0.55000000000000004 109.917 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.37 13.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.47999999999999998 110.81 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 88.7 m-85 -109.02 -3.64 17.28 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.312 -0.867 . . . . 1.24 112.42 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . 9.4 tp . . . . . 0 N--CA 1.503 2.214 0 O-C-N 120.586 -1.321 . . . . 1.6599999999999999 109.254 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.506 -0.553 . . . . 5.6600000000000001 109.506 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 96.0 m -76.29 125.2 28.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 3.02 109.587 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 74.0 p -92.45 170.04 10.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.332 -0.855 . . . . 0.95999999999999996 110.098 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t -80.07 170.15 16.85 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.703 0.764 . . . . 1.5 109.809 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.51 -20.68 13.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 2.1800000000000002 110.057 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.03 -37.43 79.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.156 -0.965 . . . . 2.0099999999999998 109.324 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.519 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 12.3 t60 -59.97 -50.06 75.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.029 -1.044 . . . . 0.48999999999999999 110.564 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' B' ' 8' ' ' ARG . 18.1 mmm-85 -70.02 -35.18 74.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.881 -1.137 . . . . 3.23 109.67 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.71 -40.03 84.33 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.445 -0.785 . . . . 0.76000000000000001 109.26 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.65 -49.0 74.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.408 -0.808 . . . . 0.46000000000000002 110.069 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -83.48 9.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.975 -1.078 . . . . 0.44 110.755 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -102.71 -15.02 16.44 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.129 -0.982 . . . . 0.53000000000000003 110.363 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' B' ' 14' ' ' PRO . 4.4 pt-20 -152.72 154.93 32.09 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.047 -1.033 . . . . 1.27 109.019 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -36.8 152.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.124 1.883 . . . . 0.48999999999999999 111.522 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.463 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 11.5 ptm -89.52 -23.21 22.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.044 -1.035 . . . . 0.56000000000000005 109.718 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -138.48 21.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.188 -1.165 . . . . 0.39000000000000001 110.188 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.56 43.03 1.58 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.535 -0.979 . . . . 0.83999999999999997 109.662 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -60.92 147.91 84.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 2.02 108.512 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.84 155.12 39.73 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.304 2.003 . . . . 0.34000000000000002 112.774 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.73 -35.4 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.32000000000000001 110.232 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.09 -0.58 57.04 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.599 -1.0 . . . . 0.22 110.599 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 8.5 p -82.22 -25.93 33.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.727 -1.454 . . . . 1.24 109.731 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.567 HD22 HD21 ' B' ' 81' ' ' LEU . 96.2 mt -60.69 138.51 58.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.411 -0.806 . . . . 0.23999999999999999 109.953 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.78 134.51 55.41 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.86 -0.736 . . . . 0.20999999999999999 109.417 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.0 -21.6 45.22 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.519 -1.432 . . . . 0.22 109.519 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -98.95 114.74 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.273 -1.134 . . . . 0.25 108.203 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.79 -179.26 36.22 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.613 -1.395 . . . . 0.28000000000000003 109.613 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -58.08 -40.0 79.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -1.071 . . . . 2.0 109.783 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.76 -47.57 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.017 -1.052 . . . . 0.38 109.314 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -35.86 82.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.40000000000000002 109.43 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.8 -39.96 92.23 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.447 . . . . 0.35999999999999999 109.481 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.77 -37.35 84.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 2.75 110.39 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.85 -51.58 46.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.62 -1.3 . . . . 1.5600000000000001 109.363 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.63 -39.87 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.33000000000000002 108.306 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.0 -42.54 94.51 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.559 -0.856 . . . . 1.6799999999999999 109.419 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.12 -19.09 65.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 1.99 108.68 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -90.75 5.35 48.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.535 -0.728 . . . . 2.6800000000000002 109.813 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.02 8.92 53.35 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 120.225 -0.988 . . . . 0.48999999999999999 111.575 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' B' ' 44' ' ' VAL . 95.5 m-85 -107.09 75.04 1.01 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.805 -1.409 . . . . 0.33000000000000002 109.116 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.39 -8.14 58.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.40999999999999998 110.542 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -137.98 158.57 44.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.159 -0.963 . . . . 1.5600000000000001 110.179 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.43 84.47 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.925 0.713 . . . . 0.20999999999999999 112.925 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -60.06 -17.68 41.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.431 -1.418 . . . . 0.32000000000000001 110.489 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' B' ' 39' ' ' PHE . 30.6 t -79.56 -31.96 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.258 -1.386 . . . . 0.23999999999999999 107.258 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 79.6 t -77.18 -39.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.244 -1.021 . . . . 0.22 108.244 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 24.5 tp -59.97 -35.87 75.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.432 -1.322 . . . . 0.40000000000000002 107.432 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.34 98.22 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.791 -1.324 . . . . 0.17999999999999999 109.791 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.061 -1.258 . . . . 1.0900000000000001 108.838 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -59.97 -40.5 89.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.31 109.222 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.93 -38.34 79.44 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.828 -0.804 . . . . 0.27000000000000002 108.828 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.78 -19.97 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.187 -0.946 . . . . 0.28000000000000003 110.562 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 14.07 9.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.064 -1.022 . . . . 0.29999999999999999 110.808 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.14 32.1 7.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.693 -1.254 . . . . 1.71 109.848 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 57.91 20.02 6.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.637 -0.664 . . . . 2.25 110.023 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -70.05 108.7 4.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.632 -1.293 . . . . 1.8 108.126 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.74 -40.07 96.07 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.076 0.769 . . . . 0.88 113.076 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.53 -40.03 85.05 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.434 -1.416 . . . . 0.73999999999999999 109.932 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.31 -39.65 74.68 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.061 -1.056 . . . . 0.55000000000000004 109.0 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.16 -41.84 94.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.38 109.132 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -59.96 -51.04 71.4 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.771 . . . . 2.6400000000000001 110.187 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.73 -37.44 84.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.119 -0.988 . . . . 2.3799999999999999 110.025 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' TRP . . . . . 0.448 ' O ' ' OG1' ' B' ' 66' ' ' THR . 74.3 t90 -63.22 -48.0 80.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.40000000000000002 110.882 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -66.83 -47.36 72.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.038 -1.039 . . . . 0.34000000000000002 109.752 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.24 -48.6 77.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.299 -0.875 . . . . 2.1000000000000001 109.859 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -67.27 -32.06 72.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.574 -0.704 . . . . 1.8999999999999999 109.769 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.22 -34.67 37.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.40000000000000002 111.331 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.7 p -128.84 -26.47 2.67 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.615 -1.303 . . . . 0.39000000000000001 111.984 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.31 34.59 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.7 -1.76 . . . . 0.35999999999999999 108.7 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.6 152.92 2.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.32000000000000001 109.412 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.64 174.97 6.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.962 . . . . 1.9099999999999999 109.745 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -35.38 74.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.38 110.691 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.4 -39.59 64.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.673 -1.267 . . . . 2.5699999999999998 110.339 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -67.48 -40.12 85.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.047 . . . . 2.1200000000000001 110.7 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.9 m -69.06 -37.92 78.78 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.138 -0.976 . . . . 1.3600000000000001 110.522 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' B' ' 75' ' ' ARG . 27.1 mtt-85 -60.0 -37.47 79.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.751 -1.218 . . . . 2.8100000000000001 109.509 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.43 -39.99 81.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.645 -1.285 . . . . 0.40000000000000002 110.526 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.57 -40.08 76.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.787 -1.196 . . . . 0.23000000000000001 109.821 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.27 -60.24 4.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.647 -1.283 . . . . 0.42999999999999999 109.824 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.0 -33.08 86.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.83 -0.908 . . . . 0.25 110.83 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -70.8 -48.63 53.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.039 -1.271 . . . . 0.23999999999999999 110.188 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.567 HD21 HD22 ' B' ' 23' ' ' LEU . 88.3 mt -70.02 -39.89 75.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.998 -1.081 . . . . 0.28999999999999998 108.161 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.47 -40.02 93.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 2.7400000000000002 110.114 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 91.9 mt-10 -70.31 -38.24 74.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.965 -1.084 . . . . 1.9099999999999999 110.907 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.498 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 89.3 t90 -60.43 -42.49 96.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.314 -1.491 . . . . 0.35999999999999999 108.478 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.499 ' O ' ' N ' ' B' ' 89' ' ' LEU . 92.7 m -61.33 -40.49 94.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.513 -0.742 . . . . 0.35999999999999999 110.237 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -29.59 68.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.123 -0.986 . . . . 0.55000000000000004 109.896 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.26 -35.58 13.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.222 -0.924 . . . . 0.46999999999999997 110.863 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 90.1 m-85 -108.53 -3.81 17.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.285 -0.884 . . . . 1.24 112.552 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' B' ' 85' ' ' CYS . 9.2 tp . . . . . 0 N--CA 1.503 2.184 0 O-C-N 120.492 -1.38 . . . . 1.6699999999999999 109.384 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.384 0.612 . . . . 5.6799999999999997 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -67.35 -80.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.228 -0.92 . . . . 3.02 109.233 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 2' ' ' THR . 72.0 p -78.84 130.3 35.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.95999999999999996 109.941 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.7 p -84.38 175.66 9.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.38 -0.825 . . . . 1.51 109.188 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -57.54 -20.1 29.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.589 -0.694 . . . . 2.1800000000000002 109.602 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -61.41 -37.65 84.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 2.02 109.129 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -59.94 -49.98 75.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.149 -0.97 . . . . 0.48999999999999999 110.317 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 98.1 mtt180 -70.23 -34.63 73.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.124 -0.985 . . . . 3.21 110.103 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.7 -40.07 80.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.76000000000000001 109.559 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.63 -46.8 81.01 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.557 -0.857 . . . . 0.46000000000000002 109.988 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.63 9.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.097 -1.002 . . . . 0.44 110.895 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -104.43 -15.06 15.5 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.994 -1.066 . . . . 0.54000000000000004 110.206 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 14' ' ' PRO . 8.2 pt-20 -151.97 152.52 30.01 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.066 -1.022 . . . . 1.26 108.941 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 13' ' ' GLU . 66.8 Cg_exo -36.99 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.222 1.948 . . . . 0.48999999999999999 111.636 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.459 ' H ' ' HG2' ' A' ' 15' ' ' MET . 13.2 ptm -95.68 -30.23 13.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 0.56999999999999995 109.958 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.34 -133.58 49.18 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.363 -1.095 . . . . 0.40000000000000002 110.363 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.77 35.51 3.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.767 -0.843 . . . . 0.84999999999999998 110.088 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -54.88 149.81 21.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.925 -1.139 . . . . 2.0099999999999998 107.925 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.23 157.49 34.95 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.076 1.851 . . . . 0.34000000000000002 112.244 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 21' ' ' GLY . 12.7 p -56.85 -45.37 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.742 0.782 . . . . 0.32000000000000001 110.231 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.565 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -61.94 -1.39 2.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.61 -0.996 . . . . 0.23000000000000001 110.61 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.2 p -82.95 -27.54 30.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.484 . . . . 1.24 109.582 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.92 138.24 57.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.23999999999999999 109.562 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . . . -65.59 134.86 54.22 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.733 0.778 . . . . 0.20999999999999999 109.979 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.76 -20.03 51.99 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.246 -1.542 . . . . 0.22 109.246 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.5 mm -99.44 115.58 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -1.133 . . . . 0.25 108.246 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.57 37.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 0.28000000000000003 109.463 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.84 -40.0 75.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -1.064 . . . . 2.0099999999999998 109.86 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.38 -45.3 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.929 -1.107 . . . . 0.38 109.719 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.59 -37.79 85.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.40000000000000002 109.53 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.115 -1.594 . . . . 0.34999999999999998 109.115 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -1.134 . . . . 2.7400000000000002 110.073 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -66.51 -48.44 69.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.851 -1.156 . . . . 1.54 109.609 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.6 -38.1 83.56 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.008 -1.108 . . . . 0.34000000000000002 108.008 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -42.49 94.25 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.245 -0.65 . . . . 1.6699999999999999 109.245 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.5 -19.34 65.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 2.0 108.718 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -90.48 1.64 56.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 2.6899999999999999 110.285 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.61 7.0 43.15 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.944 -1.098 . . . . 0.47999999999999998 111.583 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' HG12 ' A' ' 44' ' ' VAL . 95.7 m-85 -107.2 76.25 1.08 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.878 -1.366 . . . . 0.33000000000000002 109.131 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.72 -7.26 57.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.865 . . . . 0.40999999999999998 111.162 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.18 158.88 43.43 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.072 -1.017 . . . . 1.5600000000000001 110.54 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.9 86.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.762 -0.586 . . . . 0.20999999999999999 112.107 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 3.5 p90 -61.99 -18.82 61.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.433 -1.417 . . . . 0.32000000000000001 109.861 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' A' ' 39' ' ' PHE . 20.8 t -79.95 -31.87 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.773 -1.195 . . . . 0.23999999999999999 107.773 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 20' ' ' VAL . 70.2 t -77.94 -37.34 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.061 -1.089 . . . . 0.22 108.061 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.93 -35.21 74.43 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.993 -1.484 . . . . 0.40000000000000002 106.993 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -43.0 98.75 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 110.198 -1.161 . . . . 0.17999999999999999 110.198 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.078 -1.248 . . . . 1.0900000000000001 109.053 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.92 -41.5 91.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.31 108.66 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.94 -40.04 75.73 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.742 -0.836 . . . . 0.28000000000000003 108.742 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.18 -25.41 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.109 -0.994 . . . . 0.28000000000000003 110.684 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.67 16.29 8.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.15 -0.969 . . . . 0.31 109.785 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 55' ' ' ASP . 8.8 mtmp? 51.94 44.94 29.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 1.7 110.609 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 pttt 40.7 18.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.971 -1.081 . . . . 2.2400000000000002 111.528 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' LYS . 57.9 m-20 -66.59 115.56 6.58 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.847 -1.538 . . . . 1.8 106.847 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.59 -40.37 96.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.87 112.784 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.04 -39.94 75.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.378 -1.451 . . . . 0.72999999999999998 110.107 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.55 -40.0 73.63 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.121 -1.032 . . . . 0.55000000000000004 109.105 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.66 -49.74 73.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.38 109.491 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.54 HH12 ' NH2' ' A' ' 75' ' ' ARG . 64.9 mtp180 -60.01 -46.35 89.79 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.444 -0.785 . . . . 2.6400000000000001 111.249 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.21 -36.36 83.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.674 -1.266 . . . . 2.3700000000000001 108.905 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -63.62 -48.96 75.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.40000000000000002 111.067 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.9 tp -67.75 -46.98 70.52 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.054 -1.029 . . . . 0.34000000000000002 110.548 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -63.11 -46.48 87.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.983 . . . . 2.1099999999999999 109.424 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.4 t0 -67.55 -31.08 70.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.618 . . . . 1.8999999999999999 109.605 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.9 m -78.52 -36.61 44.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.40999999999999998 111.653 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.7 p -130.41 -27.45 2.19 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.474 -1.391 . . . . 0.40000000000000002 112.228 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.17 14.22 19.21 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.3 -1.52 . . . . 0.35999999999999999 109.3 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.14 153.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.913 -1.345 . . . . 0.33000000000000002 109.159 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.02 173.33 8.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.076 -1.015 . . . . 1.8999999999999999 110.133 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.98 74.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.558 -0.714 . . . . 0.39000000000000001 110.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.87 -40.43 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.856 -1.153 . . . . 2.5800000000000001 110.157 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.35 -40.02 81.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.139 -0.975 . . . . 2.1200000000000001 110.676 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 t -68.15 -38.37 82.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.128 -0.982 . . . . 1.3600000000000001 109.927 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.54 ' NH2' HH12 ' A' ' 60' ' ' ARG . 52.6 mtt-85 -60.02 -38.46 82.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.961 -1.087 . . . . 2.7999999999999998 108.973 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -67.94 -40.02 83.37 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.712 -1.242 . . . . 0.40000000000000002 110.392 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.22 -39.94 82.21 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.743 -1.223 . . . . 0.23999999999999999 109.493 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.1 -59.99 4.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.848 -1.157 . . . . 0.42999999999999999 109.899 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.79 -34.26 89.24 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.278 -0.963 . . . . 0.26000000000000001 110.736 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 24' ' ' ALA . 45.2 t -70.09 -47.61 61.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.3 . . . . 0.25 110.061 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.9 mt -70.0 -39.87 75.62 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.29999999999999999 108.234 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.23 -40.5 96.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 2.73 109.883 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -69.23 -39.96 78.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.999 . . . . 1.9099999999999999 110.754 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 84.5 t90 -59.98 -43.79 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.419 -1.426 . . . . 0.37 107.734 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . 41.5 m -60.89 -40.07 91.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.63 0.729 . . . . 0.35999999999999999 109.694 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.01 -34.24 73.08 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.105 -0.997 . . . . 0.55000000000000004 110.148 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.78 -35.26 14.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.963 . . . . 0.47999999999999998 111.151 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 88.0 m-85 -108.51 2.46 22.24 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.116 -0.99 . . . . 1.24 111.265 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' CYS . 7.6 tp . . . . . 0 N--CA 1.497 1.89 0 O-C-N 120.889 -1.132 . . . . 1.6599999999999999 109.484 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.38 -0.6 . . . . 5.6600000000000001 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.457 HG23 ' H ' ' B' ' 3' ' ' THR . 0.2 OUTLIER -67.52 -80.06 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -0.878 . . . . 3.02 109.294 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.457 ' H ' HG23 ' B' ' 2' ' ' THR . 73.0 p -78.84 130.25 35.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.091 -1.006 . . . . 0.95999999999999996 109.863 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -84.35 175.79 9.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.496 -0.752 . . . . 1.5 109.115 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.64 -20.09 30.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.548 -0.72 . . . . 2.1800000000000002 109.609 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -61.32 -37.55 83.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 2.0099999999999998 109.201 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -60.06 -49.93 75.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.48999999999999999 110.35 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 98.1 mtt180 -70.25 -34.67 73.1 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.125 -0.984 . . . . 3.23 110.11 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.61 -40.05 80.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.76000000000000001 109.573 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.73 -46.71 81.1 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.46000000000000002 110.051 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 m -86.57 9.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.123 -0.986 . . . . 0.44 110.812 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -104.24 -15.01 15.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.992 -1.068 . . . . 0.53000000000000003 110.258 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' B' ' 14' ' ' PRO . 8.2 pt-20 -152.0 152.52 29.97 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.144 -0.973 . . . . 1.27 108.98 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' B' ' 13' ' ' GLU . 69.0 Cg_exo -37.11 155.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.204 1.936 . . . . 0.48999999999999999 111.65 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.468 ' SD ' HD11 ' A' ' 89' ' ' LEU . 13.2 ptm -95.49 -30.44 13.85 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -0.923 . . . . 0.56000000000000005 110.057 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.73 -133.43 50.07 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.343 -1.103 . . . . 0.39000000000000001 110.343 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -113.02 35.48 3.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.729 -0.865 . . . . 0.83999999999999997 110.089 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -54.9 149.63 22.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.98 -1.119 . . . . 2.02 107.98 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.01 157.57 33.53 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.071 1.848 . . . . 0.34000000000000002 112.274 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.576 HG13 ' N ' ' B' ' 21' ' ' GLY . 12.7 p -57.09 -45.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.666 0.746 . . . . 0.32000000000000001 110.215 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.576 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -61.97 -1.59 3.04 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.615 -0.994 . . . . 0.22 110.615 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -82.75 -27.4 31.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.706 -1.467 . . . . 1.24 109.644 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.07 138.17 57.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.23999999999999999 109.487 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' B' ' 80' ' ' CYS . . . -65.51 135.15 54.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.753 0.787 . . . . 0.20999999999999999 109.838 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.49 -20.07 51.88 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.238 -1.545 . . . . 0.22 109.238 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 33.4 mm -99.42 115.45 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.335 -1.097 . . . . 0.25 108.306 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.32 177.55 37.92 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.567 -1.413 . . . . 0.28000000000000003 109.567 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.76 -40.02 75.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.407 -1.055 . . . . 2.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.47 -45.3 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.088 . . . . 0.38 109.722 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.48 -37.94 86.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.40000000000000002 109.449 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.0 95.76 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.139 -1.585 . . . . 0.35999999999999999 109.139 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.808 ' CA ' ' N ' ' B' ' 33' ' ' LYS . 7.3 ttpm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.402 -1.058 . . . . 2.75 . 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.808 ' N ' ' CA ' ' B' ' 32' ' ' LYS . 62.5 mttm . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.628 -0.508 . . . . 1.5600000000000001 109.628 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.5 -38.18 83.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.979 -1.119 . . . . 0.33000000000000002 107.979 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.05 -42.28 94.11 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.204 -0.665 . . . . 1.6799999999999999 109.204 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.75 -19.24 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.691 -0.855 . . . . 1.99 108.691 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -90.25 1.29 56.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 2.6800000000000002 110.299 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.06 6.75 42.18 Favored Glycine 0 N--CA 1.503 3.117 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.558 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.52 ' CD2' HG12 ' B' ' 44' ' ' VAL . 95.7 m-85 -106.98 76.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.789 -1.418 . . . . 0.33000000000000002 109.246 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -78.3 -7.45 57.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.126 -0.984 . . . . 0.40999999999999998 111.112 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.12 158.78 43.63 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.97 -1.081 . . . . 1.5600000000000001 110.529 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.93 -40.38 87.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.20999999999999999 111.952 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 2.8 p90 -61.4 -18.64 59.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.506 -1.371 . . . . 0.32000000000000001 110.24 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' B' ' 39' ' ' PHE . 20.7 t -80.22 -31.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.788 -1.19 . . . . 0.23999999999999999 107.788 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.454 HG21 HG23 ' B' ' 20' ' ' VAL . 69.8 t -78.15 -37.25 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.029 -1.1 . . . . 0.22 108.029 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 tp -59.98 -35.06 74.19 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.017 -1.475 . . . . 0.40000000000000002 107.017 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -43.18 98.55 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 110.223 -1.151 . . . . 0.17999999999999999 110.223 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.136 -1.214 . . . . 1.0900000000000001 109.113 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.99 -41.42 91.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.31 108.669 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.01 -39.87 75.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.686 -0.857 . . . . 0.27000000000000002 108.686 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.48 -25.41 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.062 -1.024 . . . . 0.28000000000000003 110.6 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' B' ' 52' ' ' LEU . 84.3 mt -89.5 15.96 8.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.091 -1.005 . . . . 0.29999999999999999 109.762 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 55' ' ' ASP . 8.8 mtmp? 52.04 45.11 28.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 1.71 110.556 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 pttt 40.6 19.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.912 -1.117 . . . . 2.25 111.564 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 53' ' ' LYS . 61.6 m-20 -66.67 115.21 6.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.917 -1.512 . . . . 1.8 106.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.5 -40.27 96.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.262 -0.899 . . . . 0.88 112.746 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -69.86 -40.07 75.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.341 -1.475 . . . . 0.73999999999999999 110.257 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.67 -39.95 73.25 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.093 -1.043 . . . . 0.55000000000000004 109.008 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.5 -49.89 73.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.38 109.459 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.549 HH12 ' NH2' ' B' ' 75' ' ' ARG . 64.5 mtp180 -60.03 -45.92 91.23 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.528 -0.733 . . . . 2.6400000000000001 111.292 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.58 -36.54 84.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.678 -1.264 . . . . 2.3799999999999999 108.857 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -63.4 -49.07 75.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.40000000000000002 111.038 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.406 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 61.2 tp -67.81 -46.75 70.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.1 -1.0 . . . . 0.34000000000000002 110.564 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -63.3 -46.32 87.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 2.1000000000000001 109.393 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 34.8 t0 -67.64 -31.16 70.97 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.746 -0.596 . . . . 1.8999999999999999 109.652 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 97.2 m -78.49 -36.61 44.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.939 . . . . 0.40000000000000002 111.687 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 18.5 p -130.44 -27.2 2.21 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.49 -1.381 . . . . 0.39000000000000001 112.217 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.98 13.96 20.25 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.333 -1.507 . . . . 0.35999999999999999 109.333 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.98 153.36 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.922 -1.34 . . . . 0.32000000000000001 109.183 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -91.04 173.39 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 1.9099999999999999 110.094 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.38 110.154 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.79 -40.44 69.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 2.5699999999999998 110.097 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 2.1200000000000001 110.656 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 5.7 t -68.14 -38.45 82.17 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -0.983 . . . . 1.3600000000000001 109.916 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.549 ' NH2' HH12 ' B' ' 60' ' ' ARG . 52.6 mtt-85 -59.95 -38.64 83.05 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.907 -1.121 . . . . 2.8100000000000001 109.013 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.81 -39.94 83.92 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.871 -1.143 . . . . 0.40000000000000002 110.304 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.21 -40.06 82.21 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.789 -1.195 . . . . 0.23000000000000001 109.508 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.95 -60.15 4.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.894 -1.129 . . . . 0.42999999999999999 109.888 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.73 -34.35 89.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.653 -0.979 . . . . 0.25 110.653 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' B' ' 24' ' ' ALA . 45.8 t -70.1 -47.56 61.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.322 . . . . 0.23999999999999999 110.024 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.91 -40.0 75.85 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.1 -1.04 . . . . 0.28999999999999998 108.314 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -62.08 -40.75 96.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.312 -0.868 . . . . 2.7400000000000002 109.819 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -69.0 -39.92 79.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 1.9099999999999999 110.754 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 84.8 t90 -59.96 -44.03 94.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.451 -1.406 . . . . 0.35999999999999999 107.622 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' B' ' 89' ' ' LEU . 41.2 m -60.81 -40.01 91.13 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 0.35999999999999999 109.737 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -59.97 -34.46 73.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.988 -1.07 . . . . 0.55000000000000004 110.2 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.6 -35.14 14.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.068 -1.02 . . . . 0.46999999999999997 111.162 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 89.7 m-85 -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.115 -0.991 . . . . 1.24 111.407 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.1 tp . . . . . 0 N--CA 1.496 1.861 0 O-C-N 120.809 -1.182 . . . . 1.6699999999999999 109.535 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.189 -0.671 . . . . 5.6799999999999997 109.189 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.8 p -90.03 -0.08 57.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.022 -1.049 . . . . 3.02 109.004 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -95.06 136.24 35.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.95999999999999996 109.325 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -78.33 165.11 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 1.51 109.1 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -55.23 -20.65 11.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 2.1800000000000002 110.234 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.25 -36.96 81.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 2.02 109.218 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.427 ' NE2' ' OE2' ' A' ' 83' ' ' GLU . 16.1 t60 -60.06 -50.15 74.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.067 . . . . 0.48999999999999999 110.731 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HG2' HH11 ' A' ' 8' ' ' ARG . 4.1 mmt-85 -70.05 -34.3 73.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.045 -1.034 . . . . 3.21 109.743 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -72.08 -37.55 69.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.76000000000000001 109.987 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.49 84.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.46000000000000002 109.913 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -82.99 15.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.44 109.401 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.39 -8.49 10.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.557 -0.714 . . . . 0.54000000000000004 110.362 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.29 151.0 23.25 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.887 -1.133 . . . . 1.26 109.554 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.5 161.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.916 1.744 . . . . 0.48999999999999999 111.831 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.438 ' CE ' HD22 ' A' ' 46' ' ' LEU . 4.8 ptp -96.13 -24.71 16.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.218 -0.926 . . . . 0.56999999999999995 109.788 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.84 -136.85 44.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.346 -1.501 . . . . 0.40000000000000002 109.346 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -110.83 34.77 3.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.41 -1.053 . . . . 0.84999999999999998 109.965 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -60.0 149.6 73.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.943 -1.098 . . . . 2.0099999999999998 108.974 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.79 156.52 37.58 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.334 2.022 . . . . 0.34000000000000002 112.301 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.4 p -57.95 -48.12 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.819 . . . . 0.32000000000000001 110.267 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.574 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.35 -1.44 0.18 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.494 -1.042 . . . . 0.23000000000000001 110.494 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 80.3 p -81.32 -24.82 36.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.714 -1.462 . . . . 1.24 109.179 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.402 HD22 HD21 ' A' ' 81' ' ' LEU . 92.4 mt -63.6 138.88 58.68 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.65 0.738 . . . . 0.23999999999999999 109.893 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 134.63 54.32 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.815 -0.754 . . . . 0.20999999999999999 109.426 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.2 -20.62 46.52 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.746 -1.342 . . . . 0.22 109.746 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.32 118.57 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.123 -1.222 . . . . 0.25 108.396 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.03 179.95 34.09 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.618 -1.393 . . . . 0.28000000000000003 109.618 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -58.16 -40.09 80.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -1.139 . . . . 2.0099999999999998 110.428 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.89 -47.19 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.793 -1.192 . . . . 0.38 109.326 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.68 -38.56 87.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.827 . . . . 0.40000000000000002 109.412 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.97 96.19 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.439 -1.464 . . . . 0.34999999999999998 109.439 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.32 -39.94 94.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -1.12 . . . . 2.7400000000000002 110.018 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.32 -47.39 73.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 1.54 109.369 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.14 -39.66 93.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.34000000000000002 108.964 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -43.16 95.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.437 -0.905 . . . . 1.6699999999999999 108.867 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -64.72 -19.87 66.02 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 2.0 108.443 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.519 ' HG2' HH11 ' A' ' 37' ' ' ARG . 1.1 mmt-85 -90.06 2.42 55.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.438 -0.789 . . . . 2.6899999999999999 110.271 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.76 6.29 46.69 Favored Glycine 0 N--CA 1.505 3.286 0 O-C-N 121.083 -1.011 . . . . 0.47999999999999998 111.948 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.496 ' CD2' HG12 ' A' ' 44' ' ' VAL . 96.5 m-85 -105.3 75.14 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.726 -1.455 . . . . 0.33000000000000002 109.236 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' B' ' 53' ' ' LYS . 37.2 p-10 -80.02 -10.52 59.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.40999999999999998 110.389 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.75 153.28 51.35 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.182 -0.948 . . . . 1.5600000000000001 110.001 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.93 92.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.731 -0.606 . . . . 0.20999999999999999 111.969 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 27.0 p90 -56.85 -17.95 11.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.834 -1.166 . . . . 0.32000000000000001 110.665 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 39' ' ' PHE . 25.9 t -79.63 -33.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.87 -1.144 . . . . 0.23999999999999999 108.204 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 20' ' ' VAL . 54.7 t -74.09 -38.83 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.562 -1.273 . . . . 0.22 107.562 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD22 ' CE ' ' A' ' 15' ' ' MET . 24.9 tp -58.26 -38.81 77.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.808 -1.182 . . . . 0.40000000000000002 107.808 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.34 -43.22 93.84 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.932 -1.267 . . . . 0.17999999999999999 109.932 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -60.16 -42.75 95.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.268 . . . . 1.0900000000000001 108.559 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.04 -40.05 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.539 -0.911 . . . . 0.31 108.539 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' B' ' 50' ' ' LEU . 98.9 mt -69.92 -39.96 75.83 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.594 -0.891 . . . . 0.28000000000000003 108.594 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.22 -25.65 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.28000000000000003 110.678 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.7 15.23 9.96 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.921 -1.112 . . . . 0.31 109.886 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' B' ' 40' ' ' ASP . 67.9 mttm 52.15 29.47 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.063 -1.023 . . . . 1.7 110.607 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' NZ ' ' NH1' ' A' ' 82' ' ' ARG . 83.4 mttt 60.06 19.83 9.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 2.2400000000000002 110.685 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.19 115.73 7.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.406 -1.434 . . . . 1.8 107.957 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.72 -40.14 96.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.87 112.281 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 90.2 m-20 -68.3 -39.94 81.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.554 -1.341 . . . . 0.72999999999999998 109.961 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.5 -39.69 67.43 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.166 -1.013 . . . . 0.55000000000000004 109.101 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.35 -49.43 73.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.38 110.401 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.534 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 81.3 mtm180 -60.04 -44.8 94.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 2.6400000000000001 110.693 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.71 -37.8 87.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 2.3700000000000001 108.902 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -64.83 -48.73 73.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -0.983 . . . . 0.40000000000000002 110.8 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 54.8 tp -66.97 -46.57 74.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.997 . . . . 0.34000000000000002 109.391 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.88 -46.52 87.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 2.1099999999999999 109.412 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -31.0 69.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.688 -0.633 . . . . 1.8999999999999999 109.91 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.405 ' O ' ' NH2' ' A' ' 37' ' ' ARG . 91.4 m -77.95 -37.51 47.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.40999999999999998 111.809 -177.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 6.2 p -130.13 -25.73 2.45 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.503 -1.373 . . . . 0.40000000000000002 111.933 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 13.43 26.51 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.063 -1.615 . . . . 0.35999999999999999 109.063 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.93 153.94 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.238 . . . . 0.33000000000000002 109.031 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -91.15 -180.0 5.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.989 -1.069 . . . . 1.8999999999999999 109.779 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -33.19 75.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.772 . . . . 0.39000000000000001 110.823 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -71.49 -40.07 70.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.862 -1.149 . . . . 2.5800000000000001 109.789 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.92 -37.7 84.83 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.426 -0.796 . . . . 2.1200000000000001 110.438 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.5 p -67.03 -37.82 84.81 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.135 -0.978 . . . . 1.3600000000000001 110.004 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 75' ' ' ARG . 47.3 mtt-85 -59.97 -37.85 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.762 -1.211 . . . . 2.7999999999999998 108.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.88 -40.01 83.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.837 -1.164 . . . . 0.40000000000000002 110.718 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.25 -40.05 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.605 -1.309 . . . . 0.23999999999999999 109.948 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.27 -60.2 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.741 -1.225 . . . . 0.42999999999999999 109.451 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.01 -33.58 79.73 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.339 -1.105 . . . . 0.26000000000000001 110.339 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.16 -51.06 50.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.105 -1.232 . . . . 0.25 109.91 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.402 HD21 HD22 ' A' ' 23' ' ' LEU . 81.8 mt -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.913 -1.115 . . . . 0.29999999999999999 109.619 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' NH1' ' NZ ' ' A' ' 54' ' ' LYS . 23.8 tpt180 -60.12 -44.48 94.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 2.73 110.117 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' OE2' ' NE2' ' A' ' 7' ' ' HIS . 44.7 mt-10 -70.39 -38.1 74.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.86 . . . . 1.9099999999999999 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 89.3 t90 -61.88 -43.0 99.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.442 -1.411 . . . . 0.37 108.397 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 89' ' ' LEU . 58.8 m -61.29 -40.48 94.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.441 -0.787 . . . . 0.35999999999999999 110.379 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.83 -27.88 67.0 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.198 -0.939 . . . . 0.55000000000000004 109.338 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.82 -34.45 12.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 0.47999999999999998 110.801 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.9 m-85 -110.68 -7.83 14.63 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.259 -0.9 . . . . 1.24 112.812 -177.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' CYS . 13.2 tp . . . . . 0 N--CA 1.502 2.142 0 O-C-N 120.331 -1.481 . . . . 1.6599999999999999 109.442 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.203 -0.665 . . . . 5.6600000000000001 109.203 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 43.8 p -90.07 -0.02 57.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.037 -1.039 . . . . 3.02 109.033 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 17.9 p -95.06 136.32 35.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.456 -0.778 . . . . 0.95999999999999996 109.382 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.7 m -78.4 165.12 24.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 1.5 109.009 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -55.2 -20.77 11.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 2.1800000000000002 110.265 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.23 -36.99 81.47 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.891 -1.131 . . . . 2.0099999999999998 109.206 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.421 ' CE1' ' OE2' ' B' ' 83' ' ' GLU . 16.1 t60 -59.99 -50.18 74.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.48999999999999999 110.76 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' B' ' 8' ' ' ARG . 4.0 mmt-85 -69.91 -34.45 73.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 3.23 109.785 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -72.06 -37.53 69.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.76000000000000001 109.959 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.407 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.48 84.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.46000000000000002 109.88 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -83.1 15.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.44 109.374 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.62 -8.41 9.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.597 -0.689 . . . . 0.53000000000000003 110.358 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.33 151.07 23.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.872 -1.142 . . . . 1.27 109.53 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -42.6 161.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.824 1.683 . . . . 0.48999999999999999 111.971 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.436 ' CE ' HD22 ' B' ' 46' ' ' LEU . 4.6 ptp -96.25 -24.4 16.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.56000000000000005 109.769 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.91 43.11 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.364 -1.494 . . . . 0.39000000000000001 109.364 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -110.71 34.78 3.78 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.429 -1.042 . . . . 0.83999999999999997 110.025 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -59.98 149.71 72.69 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.966 -1.084 . . . . 2.02 108.967 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.87 156.42 38.46 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.304 2.003 . . . . 0.34000000000000002 112.352 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.582 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.7 p -57.87 -48.15 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.32000000000000001 110.271 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.582 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -55.43 -1.19 0.16 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.506 -1.038 . . . . 0.22 110.506 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.5 ' H ' ' C ' ' B' ' 20' ' ' VAL . 81.0 p -81.5 -24.72 36.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.699 -1.471 . . . . 1.24 109.148 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.69 138.8 58.64 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.649 0.738 . . . . 0.23999999999999999 109.952 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.94 134.49 54.06 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.765 -0.774 . . . . 0.20999999999999999 109.582 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.38 -20.73 45.73 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.749 -1.34 . . . . 0.22 109.749 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.18 118.62 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.213 -1.169 . . . . 0.25 108.398 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.99 179.96 34.16 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.59 -1.404 . . . . 0.28000000000000003 109.59 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.28 -39.98 80.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.261 -1.14 . . . . 2.0 110.425 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 66.1 t -66.88 -47.25 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.38 109.402 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.46 -38.65 87.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.336 -0.852 . . . . 0.40000000000000002 109.531 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.91 -40.01 96.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.353 -1.499 . . . . 0.35999999999999999 109.353 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.31 -39.88 94.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 2.75 110.107 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.4 -47.21 74.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.86 -1.15 . . . . 1.5600000000000001 109.33 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.28 -39.58 93.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.33000000000000002 109.039 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.464 -0.894 . . . . 1.6799999999999999 108.86 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.68 -19.88 65.99 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.439 -0.949 . . . . 1.99 108.439 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' B' ' 37' ' ' ARG . 1.1 mmt-85 -90.1 2.68 54.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 2.6800000000000002 110.376 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 6.37 47.43 Favored Glycine 0 N--CA 1.504 3.223 0 O-C-N 120.988 -1.07 . . . . 0.48999999999999999 112.057 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' B' ' 44' ' ' VAL . 96.5 m-85 -105.4 75.25 1.14 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.808 -1.407 . . . . 0.33000000000000002 109.143 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 37.3 p-10 -80.21 -10.23 59.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.40999999999999998 110.432 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -133.0 153.37 51.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.246 -0.909 . . . . 1.5600000000000001 109.916 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.77 93.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.838 -0.539 . . . . 0.20999999999999999 112.068 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 27.3 p90 -57.08 -18.01 12.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.32000000000000001 110.524 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.2 t -79.51 -33.56 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.901 -1.124 . . . . 0.23999999999999999 108.248 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.407 HG21 HG23 ' B' ' 20' ' ' VAL . 55.1 t -74.19 -38.79 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.472 -1.307 . . . . 0.22 107.472 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.436 HD22 ' CE ' ' B' ' 15' ' ' MET . 24.8 tp -58.38 -38.98 78.41 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.769 -1.197 . . . . 0.40000000000000002 107.769 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.31 -43.13 93.81 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.856 -1.297 . . . . 0.17999999999999999 109.856 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -60.03 -42.83 95.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.93 -1.335 . . . . 1.0900000000000001 108.548 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.09 -39.95 87.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.559 -0.904 . . . . 0.31 108.559 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' A' ' 50' ' ' LEU . 98.7 mt -69.97 -40.04 75.62 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.27000000000000002 108.538 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.05 -25.56 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 110.694 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.84 15.34 9.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.921 -1.112 . . . . 0.29999999999999999 109.838 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 67.9 mttm 51.98 29.46 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 1.71 110.661 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' LYS . . . . . 0.445 ' NZ ' ' NH1' ' B' ' 82' ' ' ARG . 83.5 mttt 60.01 19.74 8.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.782 -0.573 . . . . 2.25 110.718 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -68.02 115.7 7.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.445 -1.41 . . . . 1.8 107.947 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.65 -40.32 96.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.88 112.205 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 90.4 m-20 -68.28 -39.97 81.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.512 -1.368 . . . . 0.73999999999999999 109.921 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.39 -39.67 67.79 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.141 -1.023 . . . . 0.55000000000000004 109.215 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.45 -49.43 73.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.38 110.43 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 81.5 mtm180 -59.97 -45.03 94.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 2.6400000000000001 110.658 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.53 -37.61 87.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.855 -1.153 . . . . 2.3799999999999999 108.931 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -65.03 -48.55 73.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.004 . . . . 0.40000000000000002 110.876 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.406 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 54.6 tp -67.04 -46.67 73.7 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.135 -0.978 . . . . 0.34000000000000002 109.392 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.84 -46.4 88.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 2.1000000000000001 109.481 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.25 -30.94 69.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 1.8999999999999999 109.835 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.405 ' O ' ' NH2' ' B' ' 37' ' ' ARG . 91.8 m -77.97 -37.52 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.40000000000000002 111.741 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 6.1 p -130.03 -25.94 2.45 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.398 -1.439 . . . . 0.39000000000000001 111.945 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.49 13.65 25.74 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 108.997 -1.641 . . . . 0.35999999999999999 108.997 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.02 154.0 2.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.279 . . . . 0.32000000000000001 108.983 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -91.31 -179.98 5.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.035 -1.04 . . . . 1.9099999999999999 109.829 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.06 74.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.38 110.832 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -71.61 -40.07 70.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 2.5699999999999998 109.823 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.9 -37.64 84.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.503 -0.748 . . . . 2.1200000000000001 110.542 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.4 p -67.14 -37.73 84.31 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.122 -0.987 . . . . 1.3600000000000001 110.004 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' B' ' 75' ' ' ARG . 46.9 mtt-85 -60.01 -37.77 80.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.77 -1.206 . . . . 2.8100000000000001 108.778 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.0 -39.96 83.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.871 -1.143 . . . . 0.40000000000000002 110.728 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.1 m -68.27 -40.05 82.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.641 -1.287 . . . . 0.23000000000000001 109.884 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.35 -60.04 4.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.784 -1.197 . . . . 0.42999999999999999 109.499 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -33.57 79.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.359 -1.096 . . . . 0.25 110.359 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -68.25 -51.01 49.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.046 -1.267 . . . . 0.23999999999999999 109.903 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 82.0 mt -73.18 -41.16 64.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.953 -1.099 . . . . 0.28999999999999998 109.591 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.445 ' NH1' ' NZ ' ' B' ' 54' ' ' LYS . 23.8 tpt180 -60.16 -44.33 95.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.959 . . . . 2.7400000000000002 110.192 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.421 ' OE2' ' CE1' ' B' ' 7' ' ' HIS . 44.7 mt-10 -70.38 -38.21 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 1.9099999999999999 110.585 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.422 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 89.1 t90 -61.79 -43.04 99.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.486 -1.384 . . . . 0.35999999999999999 108.409 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.2 m -61.34 -40.41 94.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.35999999999999999 110.391 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.88 -27.76 66.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.3 -0.875 . . . . 0.55000000000000004 109.368 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.91 -35.01 12.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.46999999999999997 110.724 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.422 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 88.7 m-85 -109.97 -8.08 14.89 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.235 -0.915 . . . . 1.24 112.996 -177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 85' ' ' CYS . 13.2 tp . . . . . 0 N--CA 1.502 2.141 0 O-C-N 120.224 -1.547 . . . . 1.6699999999999999 109.414 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.578 -0.527 . . . . 5.6799999999999997 109.578 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.6 m -68.87 125.41 26.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 3.02 108.878 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 p -106.92 135.16 48.95 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.471 -0.768 . . . . 0.95999999999999996 110.037 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.5 m -88.65 178.28 6.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 1.51 108.694 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -59.92 -24.9 64.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.542 -0.724 . . . . 2.1800000000000002 109.304 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.28 -36.93 81.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.909 . . . . 2.02 109.256 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.563 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 60.0 t60 -59.9 -54.37 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.48999999999999999 110.839 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.9 -33.64 72.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.993 -1.067 . . . . 3.21 110.154 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.97 -39.6 75.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.313 -0.867 . . . . 0.76000000000000001 109.342 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.54 -47.62 80.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.46000000000000002 110.384 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.5 m -80.89 14.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.01 -1.056 . . . . 0.44 109.685 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.4 -11.08 13.71 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.508 -0.745 . . . . 0.54000000000000004 110.081 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 14' ' ' PRO . 12.6 pt-20 -153.97 150.99 23.76 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.093 -1.004 . . . . 1.26 109.105 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLU . 93.5 Cg_exo -40.48 166.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.883 1.722 . . . . 0.48999999999999999 112.123 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.0 ptp -92.24 -20.22 21.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.213 -0.93 . . . . 0.56999999999999995 109.171 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.6 -141.52 5.97 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.339 -1.504 . . . . 0.40000000000000002 109.339 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.26 30.05 6.57 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.439 -1.036 . . . . 0.84999999999999998 109.812 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -60.4 148.84 79.1 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 2.0099999999999998 108.908 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.46 155.36 53.12 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.265 1.977 . . . . 0.34000000000000002 112.79 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.581 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.2 p -57.23 -47.18 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.626 0.727 . . . . 0.32000000000000001 110.184 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -51.97 -3.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.514 -1.034 . . . . 0.23000000000000001 110.514 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 20' ' ' VAL . 23.0 t -83.08 -22.3 33.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.758 -1.436 . . . . 1.24 109.47 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.11 58.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.146 -0.971 . . . . 0.23999999999999999 109.766 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.34 133.83 51.32 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.857 -0.737 . . . . 0.20999999999999999 109.83 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.79 -20.01 51.04 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.315 -1.514 . . . . 0.22 109.315 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -99.89 113.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.736 -1.209 . . . . 0.25 107.736 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.47 176.29 43.11 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.828 -1.309 . . . . 0.28000000000000003 109.828 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -58.31 -39.96 80.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.502 -0.999 . . . . 2.0099999999999998 109.702 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.03 -47.88 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.38 109.548 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.84 -39.83 83.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.40000000000000002 109.307 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.97 96.43 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.32 -1.512 . . . . 0.34999999999999998 109.32 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -61.13 -39.98 92.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -1.094 . . . . 2.7400000000000002 110.664 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.19 -41.84 89.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.731 -1.231 . . . . 1.54 110.133 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.9 mt -60.03 -39.61 86.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.34000000000000002 109.089 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -59.96 -40.04 87.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.375 -0.93 . . . . 1.6699999999999999 109.639 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.05 -19.42 64.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.908 . . . . 2.0 108.804 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -90.1 1.35 56.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.587 -0.695 . . . . 2.6899999999999999 109.515 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.11 38.78 3.47 Favored Glycine 0 N--CA 1.497 2.754 0 O-C-N 121.232 -0.918 . . . . 0.47999999999999998 110.985 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 44' ' ' VAL . 84.5 m-85 -132.37 71.9 1.48 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.212 -1.17 . . . . 0.33000000000000002 108.321 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -75.48 -12.38 60.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.053 -1.029 . . . . 0.40999999999999998 110.495 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -134.34 156.86 47.73 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.165 -0.96 . . . . 1.5600000000000001 109.434 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -40.22 93.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.20999999999999999 111.678 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -58.44 -17.34 19.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.837 -1.164 . . . . 0.32000000000000001 110.717 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 39' ' ' PHE . 43.7 t -79.77 -31.62 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.87 -1.159 . . . . 0.23999999999999999 107.87 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.81 -38.69 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.739 -1.208 . . . . 0.22 107.739 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.66 -38.75 82.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.286 -1.375 . . . . 0.40000000000000002 107.286 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.08 71.59 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.965 -1.254 . . . . 0.17999999999999999 109.965 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -60.05 -42.56 94.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -1.213 . . . . 1.0900000000000001 109.885 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.07 -39.96 87.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.096 -1.003 . . . . 0.31 108.68 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.1 -38.34 75.63 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.616 -0.883 . . . . 0.28000000000000003 108.616 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.53 -22.51 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.153 -0.967 . . . . 0.28000000000000003 110.733 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.86 17.85 7.29 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.053 -1.03 . . . . 0.31 109.735 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 52.06 29.43 6.33 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.073 -1.017 . . . . 1.7 109.611 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.4 mttt 60.08 19.88 9.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.855 -0.528 . . . . 2.2400000000000002 109.944 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.99 114.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.821 -1.178 . . . . 1.8 107.821 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.72 -39.99 90.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.87 112.856 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.56 -39.57 84.93 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.462 -1.399 . . . . 0.72999999999999998 110.687 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.98 -38.97 76.21 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.018 -1.073 . . . . 0.55000000000000004 109.566 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.63 -43.69 92.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.38 109.884 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -60.04 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 2.6400000000000001 110.941 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.77 -38.83 90.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.896 -1.127 . . . . 2.3700000000000001 109.25 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -64.34 -49.48 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.019 -1.051 . . . . 0.40000000000000002 110.993 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.3 tp -66.9 -47.25 72.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.04 -1.037 . . . . 0.34000000000000002 109.998 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.83 -44.47 89.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 2.1099999999999999 109.8 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.3 t0 -69.63 -30.95 68.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.557 -0.715 . . . . 1.8999999999999999 109.664 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -79.31 -34.73 42.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.40999999999999998 111.332 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.7 p -130.39 -29.68 1.98 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.598 -1.314 . . . . 0.40000000000000002 112.078 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.98 14.48 20.8 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.401 -1.48 . . . . 0.35999999999999999 109.401 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.73 154.79 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.034 -1.274 . . . . 0.33000000000000002 109.296 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -89.22 169.91 11.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.984 -1.073 . . . . 1.8999999999999999 110.266 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.36 73.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.687 . . . . 0.39000000000000001 111.02 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.01 -40.05 75.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.629 -1.295 . . . . 2.5800000000000001 109.654 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -64.88 -30.1 71.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.537 -0.727 . . . . 2.1200000000000001 110.572 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.7 p -68.79 -39.6 80.07 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.987 -1.07 . . . . 1.3600000000000001 110.611 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -60.01 -37.85 80.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.547 -1.346 . . . . 2.7999999999999998 109.092 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.58 -1.325 . . . . 0.40000000000000002 110.412 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 86.2 m -70.01 -40.27 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.791 -1.193 . . . . 0.23999999999999999 109.502 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.17 -61.03 2.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 0.42999999999999999 109.789 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.53 -33.08 83.55 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.196 -1.161 . . . . 0.26000000000000001 110.196 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 46.7 t -71.0 -46.88 61.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.922 -1.34 . . . . 0.25 109.797 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.89 -40.98 68.52 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.01 -1.076 . . . . 0.29999999999999999 109.068 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.75 -40.44 97.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.121 -0.987 . . . . 2.73 110.147 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.563 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 96.0 mt-10 -70.14 -38.38 75.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 1.9099999999999999 110.459 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.7 t90 -61.49 -47.81 83.93 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.527 -1.358 . . . . 0.37 108.087 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 89' ' ' LEU . 56.4 m -59.99 -40.14 88.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.498 -0.751 . . . . 0.35999999999999999 109.841 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.47 -29.82 68.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.005 . . . . 0.55000000000000004 109.364 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.52 -33.67 12.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.302 -0.874 . . . . 0.47999999999999998 110.705 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 86.3 m-85 -108.79 -5.82 16.11 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.277 -0.889 . . . . 1.24 112.45 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 85' ' ' CYS . 8.2 tp . . . . . 0 N--CA 1.503 2.225 0 O-C-N 120.451 -1.406 . . . . 1.6599999999999999 109.512 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.641 -0.503 . . . . 5.6600000000000001 109.641 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 29.1 m -68.8 125.28 26.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 3.02 108.95 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.8 p -106.76 135.09 48.88 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.533 -0.729 . . . . 0.95999999999999996 110.042 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m -88.59 178.37 6.53 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.653 -0.869 . . . . 1.5 108.653 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -59.93 -25.0 64.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 2.1800000000000002 109.352 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.19 -36.97 81.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 2.0099999999999998 109.322 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.56 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 60.3 t60 -59.93 -54.17 49.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.48999999999999999 110.793 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.95 -33.65 72.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 3.23 110.127 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.01 -39.41 75.84 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.348 -0.845 . . . . 0.76000000000000001 109.367 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.8 -47.59 80.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.46000000000000002 110.316 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.93 14.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.042 -1.036 . . . . 0.44 109.68 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.34 -11.01 13.75 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.552 -0.717 . . . . 0.53000000000000003 110.121 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 14' ' ' PRO . 12.6 pt-20 -154.0 151.17 24.09 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 1.27 109.02 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.5 Cg_exo -40.44 166.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.958 1.772 . . . . 0.48999999999999999 112.074 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 1.9 ptp -92.57 -20.11 21.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.15 -0.968 . . . . 0.56000000000000005 109.081 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.71 -141.43 6.17 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.427 -1.469 . . . . 0.39000000000000001 109.427 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.27 29.95 6.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.527 -0.984 . . . . 0.83999999999999997 109.787 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.47 148.82 79.65 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.89 -1.131 . . . . 2.02 108.812 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.43 155.49 52.12 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.218 1.945 . . . . 0.34000000000000002 112.774 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.577 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.3 p -57.21 -47.15 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.674 0.75 . . . . 0.32000000000000001 110.222 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -52.01 -3.42 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.572 -1.011 . . . . 0.22 110.572 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.523 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.8 t -82.92 -22.21 33.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.413 . . . . 1.24 109.485 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.07 58.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.23999999999999999 109.807 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.9 51.42 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.591 0.71 . . . . 0.20999999999999999 109.792 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.518 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.76 -20.06 50.88 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.399 -1.48 . . . . 0.22 109.399 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.9 113.53 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 107.622 -1.251 . . . . 0.25 107.622 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.51 176.26 43.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.829 -1.308 . . . . 0.28000000000000003 109.829 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -58.26 -39.97 80.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.445 -1.032 . . . . 2.0 109.678 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.21 -47.67 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.049 -1.032 . . . . 0.38 109.559 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.91 -39.86 83.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.40000000000000002 109.301 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.97 96.27 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.343 -1.503 . . . . 0.35999999999999999 109.343 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -61.21 -39.9 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -1.073 . . . . 2.75 110.66 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -66.24 -41.82 89.49 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.705 -1.247 . . . . 1.5600000000000001 110.154 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 63.7 mt -60.03 -39.56 86.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.087 -1.008 . . . . 0.33000000000000002 109.084 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -60.12 -39.93 87.99 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.207 -0.997 . . . . 1.6799999999999999 109.607 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -19.52 64.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 1.99 108.844 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -90.1 1.47 56.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.667 -0.646 . . . . 2.6800000000000002 109.522 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.94 38.88 3.48 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.236 -0.915 . . . . 0.48999999999999999 111.032 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.431 ' CD2' HG12 ' B' ' 44' ' ' VAL . 84.5 m-85 -132.5 71.9 1.48 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -1.213 . . . . 0.33000000000000002 108.323 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -75.46 -12.3 60.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.963 -1.086 . . . . 0.40999999999999998 110.406 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -134.43 156.8 47.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.165 -0.959 . . . . 1.5600000000000001 109.392 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.21 92.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.426 -0.796 . . . . 0.20999999999999999 111.608 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -58.41 -17.32 19.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.805 -1.185 . . . . 0.32000000000000001 110.671 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' B' ' 39' ' ' PHE . 42.9 t -79.71 -31.78 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 0.23999999999999999 107.943 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.76 -38.56 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.837 -1.171 . . . . 0.22 107.837 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -59.76 -38.78 82.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.28 -1.378 . . . . 0.40000000000000002 107.28 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.41 -45.81 74.58 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.955 -1.258 . . . . 0.17999999999999999 109.955 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -60.08 -42.63 95.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.24 . . . . 1.0900000000000001 109.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.1 -39.91 87.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.136 -0.978 . . . . 0.31 108.776 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.96 -38.38 76.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.694 -0.854 . . . . 0.27000000000000002 108.694 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.1 t -66.57 -22.43 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.28000000000000003 110.716 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.92 17.79 7.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.001 -1.062 . . . . 0.29999999999999999 109.737 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 52.02 29.64 6.49 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.031 -1.043 . . . . 1.71 109.499 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 59.93 20.08 9.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.802 -0.562 . . . . 2.25 109.986 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -68.98 114.46 7.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.843 -1.16 . . . . 1.8 107.925 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.68 -40.0 90.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.388 -0.82 . . . . 0.88 112.78 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -67.65 -39.52 84.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.524 -1.36 . . . . 0.73999999999999999 110.634 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.97 -39.06 76.2 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.034 -1.066 . . . . 0.55000000000000004 109.538 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.57 -43.72 92.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.38 109.813 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -59.96 -49.98 75.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 2.6400000000000001 110.959 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.8 -38.79 89.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.78 -1.2 . . . . 2.3799999999999999 109.273 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -64.33 -49.44 71.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.014 -1.054 . . . . 0.40000000000000002 110.991 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.09 -47.03 72.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.028 -1.045 . . . . 0.34000000000000002 110.0 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -64.92 -44.4 89.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.33 -0.856 . . . . 2.1000000000000001 109.8 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.0 t0 -69.73 -30.97 68.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 1.8999999999999999 109.724 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -79.23 -34.8 42.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.40000000000000002 111.399 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.9 p -130.29 -29.78 1.99 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.58 -1.325 . . . . 0.39000000000000001 112.092 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.07 14.33 21.01 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.363 -1.495 . . . . 0.35999999999999999 109.363 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 154.69 1.84 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.015 -1.285 . . . . 0.32000000000000001 109.34 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -89.17 169.99 10.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 1.9099999999999999 110.241 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.29 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.642 -0.661 . . . . 0.38 110.992 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.11 -39.94 75.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.699 -1.25 . . . . 2.5699999999999998 109.694 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.7 mm100 -65.0 -29.99 70.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.454 -0.779 . . . . 2.1200000000000001 110.489 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p -68.82 -39.48 80.0 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.007 -1.058 . . . . 1.3600000000000001 110.62 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' B' ' 75' ' ' ARG . 0.3 OUTLIER -60.25 -37.76 81.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.577 -1.327 . . . . 2.8100000000000001 108.768 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.69 -40.11 76.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.6 -1.312 . . . . 0.40000000000000002 110.431 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.04 -40.19 75.29 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.723 -1.236 . . . . 0.23000000000000001 109.354 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.26 -61.01 2.91 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.041 -1.037 . . . . 0.42999999999999999 109.71 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.56 -33.06 83.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.236 -1.146 . . . . 0.25 110.236 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -70.91 -46.95 61.61 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.933 -1.334 . . . . 0.23999999999999999 109.703 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.9 -41.01 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.957 -1.097 . . . . 0.28999999999999998 109.089 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.59 -40.6 97.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.155 -0.966 . . . . 2.7400000000000002 110.139 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 95.9 mt-10 -70.08 -38.34 75.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 1.9099999999999999 110.502 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.434 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.7 t90 -61.46 -47.87 83.72 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.542 -1.349 . . . . 0.35999999999999999 108.09 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' B' ' 89' ' ' LEU . 56.3 m -59.99 -40.13 88.11 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.365 -0.834 . . . . 0.35999999999999999 109.826 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.41 -29.83 68.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.069 -1.02 . . . . 0.55000000000000004 109.404 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.58 -33.78 12.89 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.323 -0.86 . . . . 0.46999999999999997 110.75 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.0 m-85 -108.3 -5.96 16.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.248 -0.907 . . . . 1.24 112.584 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.503 2.203 0 O-C-N 120.61 -1.306 . . . . 1.6699999999999999 109.548 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.331 0.586 . . . . 5.6799999999999997 109.812 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 2' ' ' THR . 11.9 t -165.01 125.18 1.91 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 3.02 109.451 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -100.96 123.65 45.48 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.339 -0.851 . . . . 0.95999999999999996 109.585 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.4 m -81.07 172.56 13.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.321 -0.862 . . . . 1.51 109.742 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.574 ' NE2' ' NH2' ' A' ' 8' ' ' ARG . 7.3 tp-100 -54.68 -24.35 21.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 2.1800000000000002 109.9 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.02 -38.66 86.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.034 -1.041 . . . . 2.02 109.228 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -59.16 -50.63 73.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.141 -0.974 . . . . 0.48999999999999999 110.169 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.574 ' NH2' ' NE2' ' A' ' 5' ' ' GLN . 89.3 mtm180 -69.4 -34.75 74.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.132 -0.98 . . . . 3.21 110.423 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.57 -39.86 80.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.155 -0.966 . . . . 0.76000000000000001 109.289 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.53 -48.94 78.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.445 -0.784 . . . . 0.46000000000000002 109.761 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -83.22 10.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.266 -0.896 . . . . 0.44 110.711 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.66 -14.97 17.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.246 -0.909 . . . . 0.54000000000000004 110.364 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' PRO . 18.6 pt-20 -152.45 152.61 29.37 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.031 -1.043 . . . . 1.26 108.632 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . 75.0 Cg_exo -37.37 155.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.96 1.773 . . . . 0.48999999999999999 111.089 178.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.448 ' H ' ' HG2' ' A' ' 15' ' ' MET . 14.3 ptm -92.64 -24.75 18.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.055 -1.028 . . . . 0.56999999999999995 110.443 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.81 -136.01 37.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.971 -1.109 . . . . 0.40000000000000002 110.401 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.15 42.78 1.71 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.631 -0.923 . . . . 0.84999999999999998 109.902 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -60.12 148.1 79.01 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.146 -0.971 . . . . 2.0099999999999998 108.452 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.38 159.85 33.98 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.037 1.825 . . . . 0.34000000000000002 112.085 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 21' ' ' GLY . 12.8 p -57.58 -39.47 69.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.677 -0.639 . . . . 0.32000000000000001 110.994 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -67.79 -3.81 30.14 Favored Glycine 0 N--CA 1.491 2.331 0 O-C-N 121.432 -0.793 . . . . 0.23000000000000001 111.346 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -83.82 -20.94 32.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.423 -1.633 . . . . 1.24 109.532 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.622 HD22 HD21 ' A' ' 81' ' ' LEU . 90.5 mt -64.15 136.29 57.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.033 -1.042 . . . . 0.23999999999999999 109.078 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 136.13 57.16 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.678 -0.809 . . . . 0.20999999999999999 109.763 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.7 -18.16 57.94 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.296 -1.522 . . . . 0.22 109.296 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.56 114.78 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.251 -1.147 . . . . 0.25 108.215 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.27 175.17 37.61 Favored Glycine 0 N--CA 1.492 2.382 0 O-C-N 120.608 -1.307 . . . . 0.28000000000000003 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.86 -40.02 83.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -1.048 . . . . 2.0099999999999998 109.549 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.41 -47.72 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.38 109.36 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.96 -38.51 88.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.40000000000000002 109.327 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.22 95.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.707 -1.357 . . . . 0.34999999999999998 109.707 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -63.53 -39.78 95.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.376 -1.073 . . . . 2.7400000000000002 110.719 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.21 -43.05 83.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.592 -1.318 . . . . 1.54 109.982 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.95 -39.85 93.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.011 -1.056 . . . . 0.34000000000000002 108.532 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.93 -42.1 93.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 1.6699999999999999 111.007 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -64.68 -20.48 66.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.998 . . . . 2.0 109.418 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -93.54 8.46 40.63 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.841 -0.744 . . . . 2.6899999999999999 110.845 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.8 7.9 49.69 Favored Glycine 0 N--CA 1.501 3.014 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 112.31 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.64 73.48 1.02 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.553 -1.557 . . . . 0.33000000000000002 108.518 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -78.0 -8.1 57.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.40999999999999998 110.952 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -137.15 157.35 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.134 -0.979 . . . . 1.5600000000000001 110.602 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.643 -0.661 . . . . 0.20999999999999999 111.684 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.443 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.2 p90 -60.7 -18.1 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.622 -1.299 . . . . 0.32000000000000001 110.772 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.6 t -80.24 -30.7 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.414 -1.328 . . . . 0.23999999999999999 107.414 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 HG23 ' A' ' 20' ' ' VAL . 70.2 t -78.25 -39.32 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.151 -1.055 . . . . 0.22 108.151 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.77 -36.29 74.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.793 -1.558 . . . . 0.40000000000000002 106.793 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.29 -43.6 93.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.186 -1.165 . . . . 0.17999999999999999 110.186 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -60.18 -42.03 94.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -1.228 . . . . 1.0900000000000001 109.332 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.1 -39.97 88.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.082 -1.011 . . . . 0.31 108.66 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD12 HD12 ' B' ' 50' ' ' LEU . 77.3 mt -69.09 -39.58 78.91 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.095 -0.706 . . . . 0.28000000000000003 109.095 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -67.79 -23.14 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.15 -0.969 . . . . 0.28000000000000003 110.912 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.5 16.85 8.18 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.99 -1.069 . . . . 0.31 110.042 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.65 29.67 7.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.061 -1.024 . . . . 1.7 110.388 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt 59.96 19.8 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.495 -0.753 . . . . 2.2400000000000002 110.367 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -67.65 115.99 7.85 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.377 -1.342 . . . . 1.8 107.377 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.42 -39.98 95.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.894 . . . . 0.87 113.251 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.8 -39.73 76.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.359 -1.463 . . . . 0.72999999999999998 110.437 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.9 -40.07 72.39 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 118.836 -1.145 . . . . 0.55000000000000004 109.379 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.63 -49.87 69.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.38 109.528 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -61.78 -45.31 94.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 2.6400000000000001 109.799 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -64.21 -39.26 93.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.041 -1.037 . . . . 2.3700000000000001 108.664 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' A' ' 66' ' ' THR . 76.2 t90 -66.87 -47.17 72.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.40000000000000002 110.512 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.11 -49.15 68.51 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.129 -0.982 . . . . 0.34000000000000002 109.575 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -61.5 -49.05 78.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.36 -0.837 . . . . 2.1099999999999999 110.101 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.94 -26.14 64.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.467 -0.77 . . . . 1.8999999999999999 109.748 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 22.9 m -79.32 -34.14 42.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.078 -1.014 . . . . 0.40999999999999998 111.294 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.3 p -134.46 -21.66 1.76 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.328 -1.482 . . . . 0.40000000000000002 112.294 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.23 12.16 34.5 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.679 -1.368 . . . . 0.35999999999999999 109.679 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.1 153.72 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.935 -1.332 . . . . 0.33000000000000002 109.169 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -87.7 169.81 11.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.913 -1.117 . . . . 1.8999999999999999 109.772 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.24 -33.08 71.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.588 -0.695 . . . . 0.39000000000000001 110.24 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -72.9 -39.61 66.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 2.5800000000000001 109.804 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.64 -37.1 85.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.84 . . . . 2.1200000000000001 110.491 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -36.6 82.42 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 1.3600000000000001 109.963 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.12 -39.04 84.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.027 -1.046 . . . . 2.7999999999999998 109.117 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.39 -39.66 81.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.898 -1.126 . . . . 0.40000000000000002 110.981 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.23 -40.09 82.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 0.23999999999999999 110.369 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.6 -59.53 5.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.512 -1.367 . . . . 0.42999999999999999 109.554 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.01 79.26 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.621 -0.992 . . . . 0.26000000000000001 110.621 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.44 -51.06 32.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -1.202 . . . . 0.25 110.337 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.622 HD21 HD22 ' A' ' 23' ' ' LEU . 84.1 mt -70.57 -40.39 73.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.847 -1.141 . . . . 0.29999999999999999 108.531 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.78 -41.08 97.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 2.73 110.255 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.74 -38.4 76.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.9099999999999999 110.404 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 90.0 t90 -60.11 -43.5 95.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.437 -1.414 . . . . 0.37 107.895 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 89' ' ' LEU . 27.8 m -60.12 -40.24 89.05 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.739 0.781 . . . . 0.35999999999999999 109.553 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -33.4 71.93 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.268 -0.895 . . . . 0.55000000000000004 109.871 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.92 -33.98 13.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.991 -1.068 . . . . 0.47999999999999998 111.037 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 97.4 m-85 -110.65 1.98 18.3 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.094 -1.003 . . . . 1.24 111.794 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 85' ' ' CYS . 9.0 tp . . . . . 0 N--CA 1.497 1.912 0 O-C-N 120.945 -1.097 . . . . 1.6599999999999999 109.185 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.362 0.601 . . . . 5.6600000000000001 109.849 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.464 HG23 ' O ' ' B' ' 2' ' ' THR . 12.4 t -165.54 125.95 1.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -0.918 . . . . 3.02 109.346 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 69.2 p -101.76 123.97 46.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.41 -0.806 . . . . 0.95999999999999996 109.543 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m -81.26 172.88 13.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.255 -0.903 . . . . 1.5 109.716 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 8' ' ' ARG . 7.3 tp-100 -55.05 -24.17 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.342 0.591 . . . . 2.1800000000000002 109.88 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -38.85 87.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.992 -1.068 . . . . 2.0099999999999998 109.212 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -58.96 -50.71 73.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.1 -1.0 . . . . 0.48999999999999999 110.317 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 5' ' ' GLN . 89.2 mtm180 -69.32 -34.95 75.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 3.23 110.234 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.28 -40.03 81.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.187 -0.946 . . . . 0.76000000000000001 109.272 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -61.59 -48.81 79.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.46000000000000002 109.912 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -83.49 10.73 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.238 -0.914 . . . . 0.44 110.664 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.75 -14.95 17.12 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.176 -0.953 . . . . 0.53000000000000003 110.267 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 14' ' ' PRO . 18.7 pt-20 -152.14 152.25 29.23 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 1.27 108.615 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' B' ' 13' ' ' GLU . 68.1 Cg_exo -37.21 155.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.022 1.814 . . . . 0.48999999999999999 111.076 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 14.0 ptm -92.57 -25.1 18.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.093 -1.004 . . . . 0.56000000000000005 110.598 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.0 -136.02 38.77 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.064 -1.065 . . . . 0.39000000000000001 110.44 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.17 42.9 1.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.619 -0.93 . . . . 0.83999999999999997 110.071 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -60.27 148.08 80.0 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.426 -0.953 . . . . 2.02 108.426 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.61 159.41 36.88 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.07 1.847 . . . . 0.34000000000000002 112.033 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.457 HG13 ' N ' ' B' ' 21' ' ' GLY . 12.2 p -57.38 -38.91 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.721 -0.612 . . . . 0.32000000000000001 111.168 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.457 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -68.03 -3.73 31.34 Favored Glycine 0 N--CA 1.493 2.447 0 O-C-N 121.435 -0.79 . . . . 0.22 111.343 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.8 m -84.12 -21.13 31.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.575 -1.544 . . . . 1.24 109.587 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.616 HD22 HD21 ' B' ' 81' ' ' LEU . 88.5 mt -64.18 136.14 56.95 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -0.969 . . . . 0.23999999999999999 109.032 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.23 136.11 57.51 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.753 0.787 . . . . 0.20999999999999999 109.882 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.19 -17.75 58.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.375 -1.49 . . . . 0.22 109.375 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.78 114.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -1.143 . . . . 0.25 108.088 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.85 174.72 37.86 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.907 -1.277 . . . . 0.28000000000000003 109.907 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.52 -39.83 81.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.424 -1.045 . . . . 2.0 109.677 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.59 -47.68 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.38 109.27 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.04 -38.57 88.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.386 -0.821 . . . . 0.40000000000000002 109.46 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -39.07 95.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.35999999999999999 109.692 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -63.7 -39.73 95.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -1.112 . . . . 2.75 110.667 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.07 -43.05 83.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.578 -1.326 . . . . 1.5600000000000001 109.834 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.2 -39.95 94.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.33000000000000002 108.586 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -59.9 -41.73 92.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.787 -0.57 . . . . 1.6799999999999999 110.97 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.67 -20.94 66.59 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.212 -0.93 . . . . 1.99 109.295 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -93.22 8.33 40.68 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 2.6800000000000002 110.79 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.95 8.03 48.98 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 120.911 -1.118 . . . . 0.48999999999999999 112.319 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.79 73.66 1.02 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 119.314 1.557 . . . . 0.33000000000000002 108.368 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -78.04 -8.28 57.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.40999999999999998 110.758 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -137.07 157.46 46.66 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.145 -0.972 . . . . 1.5600000000000001 110.605 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -39.83 89.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.711 -0.618 . . . . 0.20999999999999999 111.724 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 3.3 p90 -60.59 -18.35 52.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.532 -1.355 . . . . 0.32000000000000001 110.849 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -80.19 -30.84 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.429 -1.323 . . . . 0.23999999999999999 107.429 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.451 HG21 HG23 ' B' ' 20' ' ' VAL . 68.9 t -77.91 -39.12 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.204 -1.036 . . . . 0.22 108.204 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.07 -36.14 74.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.865 -1.531 . . . . 0.40000000000000002 106.865 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -43.73 93.83 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.241 -1.144 . . . . 0.17999999999999999 110.241 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.05 -41.71 92.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 1.0900000000000001 109.438 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.13 -40.23 89.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.31 108.762 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.411 HD12 HD12 ' A' ' 50' ' ' LEU . 77.6 mt -69.03 -39.8 78.99 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.987 -0.745 . . . . 0.27000000000000002 108.987 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.43 -23.07 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.28000000000000003 111.02 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.98 17.18 8.23 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.29999999999999999 110.094 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.33 29.86 7.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.07 -1.019 . . . . 1.71 110.47 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 59.88 19.82 8.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.523 -0.736 . . . . 2.25 110.407 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -67.65 115.71 7.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.692 -1.255 . . . . 1.8 107.635 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -62.15 -40.33 95.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.402 -0.811 . . . . 0.88 113.083 -177.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -69.35 -40.02 77.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.393 -1.442 . . . . 0.73999999999999999 110.629 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.82 -40.06 72.7 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.867 -1.133 . . . . 0.55000000000000004 109.296 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.81 -50.01 68.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.38 109.533 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.62 -45.23 94.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.241 -0.912 . . . . 2.6400000000000001 109.786 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -64.2 -39.43 93.96 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.991 -1.068 . . . . 2.3799999999999999 108.708 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -66.61 -47.49 72.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.40000000000000002 110.652 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.88 -49.15 69.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.15 -0.969 . . . . 0.34000000000000002 109.576 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.54 -49.06 78.23 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.482 -0.762 . . . . 2.1000000000000001 110.107 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.69 -26.38 65.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 1.8999999999999999 109.625 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m -79.33 -34.47 42.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.40000000000000002 111.34 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 16.3 p -133.85 -22.19 1.87 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.464 -1.398 . . . . 0.39000000000000001 112.334 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 12.03 33.95 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.628 -1.389 . . . . 0.35999999999999999 109.628 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.01 153.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.387 . . . . 0.32000000000000001 109.213 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.92 169.69 11.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.972 -1.08 . . . . 1.9099999999999999 109.829 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.14 71.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.534 -0.729 . . . . 0.38 110.335 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -73.19 -39.25 65.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.915 -1.116 . . . . 2.5699999999999998 109.774 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.96 -36.83 84.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 2.1200000000000001 110.441 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.9 p -66.93 -36.81 83.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.297 -0.877 . . . . 1.3600000000000001 109.918 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -60.02 -39.19 84.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.95 -1.094 . . . . 2.8100000000000001 109.216 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -68.25 -39.9 82.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.788 -1.195 . . . . 0.40000000000000002 111.059 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.13 -39.97 82.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.782 -1.199 . . . . 0.23000000000000001 110.457 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.55 -59.37 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.559 -1.338 . . . . 0.42999999999999999 109.625 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.44 -33.0 79.4 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.567 -1.013 . . . . 0.25 110.567 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.74 -50.96 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.243 . . . . 0.23999999999999999 110.41 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.616 HD21 HD22 ' B' ' 23' ' ' LEU . 83.8 mt -70.59 -40.48 73.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.768 -1.173 . . . . 0.28999999999999998 108.529 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -61.6 -41.04 96.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.434 -0.791 . . . . 2.7400000000000002 110.207 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -69.8 -38.51 76.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 1.9099999999999999 110.53 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 90.0 t90 -60.03 -43.38 95.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.423 -1.423 . . . . 0.35999999999999999 107.871 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' B' ' 89' ' ' LEU . 23.9 m -60.34 -40.08 89.4 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.7 0.762 . . . . 0.35999999999999999 109.539 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.13 -33.2 71.81 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.256 -0.902 . . . . 0.55000000000000004 109.905 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.07 -34.39 13.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.02 -1.05 . . . . 0.46999999999999997 111.095 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 97.8 m-85 -110.04 1.92 19.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.083 -1.011 . . . . 1.24 111.654 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.5 tp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.837 -1.164 . . . . 1.6699999999999999 109.317 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.28 0.562 . . . . 5.6799999999999997 109.522 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m -89.99 -1.41 57.96 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.699 -0.852 . . . . 3.02 108.699 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -71.45 164.82 25.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.485 -0.76 . . . . 0.95999999999999996 109.843 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.8 p -62.02 169.98 2.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 1.51 110.016 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 4.2 pm0 -58.04 -19.99 35.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.669 -0.644 . . . . 2.1800000000000002 110.845 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.21 -38.38 86.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 2.02 109.197 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.481 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 24.3 t60 -59.95 -53.92 52.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.196 -0.94 . . . . 0.48999999999999999 110.516 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -69.97 -35.57 74.55 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.958 -1.088 . . . . 3.21 110.105 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.02 -39.91 75.53 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.295 -0.878 . . . . 0.76000000000000001 109.737 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.64 -44.52 96.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.46000000000000002 109.784 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.7 m -83.39 15.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.056 -1.027 . . . . 0.44 109.598 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.79 -13.12 14.53 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.486 -0.759 . . . . 0.54000000000000004 110.32 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.77 151.59 20.88 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.979 -1.076 . . . . 1.26 109.537 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -40.13 156.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.067 1.845 . . . . 0.48999999999999999 111.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.64 -18.73 23.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.878 -1.139 . . . . 0.56999999999999995 109.941 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.09 -140.18 35.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.735 -1.346 . . . . 0.40000000000000002 109.735 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -103.82 30.69 4.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.37 -1.077 . . . . 0.84999999999999998 109.982 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -60.07 147.76 79.56 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.065 -1.022 . . . . 2.0099999999999998 108.431 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.67 158.3 46.97 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.372 2.048 . . . . 0.34000000000000002 112.557 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 22' ' ' SER . 2.3 p -56.93 -48.71 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.32000000000000001 110.233 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.07 -3.71 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.402 -1.079 . . . . 0.23000000000000001 110.402 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 7.8 t -82.84 -20.76 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.935 -1.333 . . . . 1.24 109.165 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.514 HD22 HD21 ' A' ' 81' ' ' LEU . 98.4 mt -65.11 139.96 58.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.23999999999999999 109.73 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 133.07 50.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.812 0.815 . . . . 0.20999999999999999 110.282 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.08 -20.34 47.97 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 109.839 -1.304 . . . . 0.22 109.839 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.2 117.1 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -1.198 . . . . 0.25 108.019 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.435 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -93.23 177.31 37.91 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.726 -1.35 . . . . 0.28000000000000003 109.726 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.02 -40.02 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -1.08 . . . . 2.0099999999999998 109.888 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.03 -47.36 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.085 . . . . 0.38 109.1 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.2 mt -65.04 -39.41 93.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.376 -0.828 . . . . 0.40000000000000002 109.407 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.7 97.38 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 110.044 -1.222 . . . . 0.34999999999999998 110.044 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -60.28 -40.02 88.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.406 . . . . 2.7400000000000002 110.517 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.2 -45.95 75.37 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.797 -1.161 . . . . 1.54 109.771 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.0 -41.13 99.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.858 -1.151 . . . . 0.34000000000000002 109.917 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.22 -40.64 90.89 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.114 -1.034 . . . . 1.6699999999999999 109.383 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.65 -19.66 65.81 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.648 -0.871 . . . . 2.0 108.648 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.444 ' HG2' HH11 ' A' ' 37' ' ' ARG . 51.0 mtt-85 -91.01 5.62 48.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.487 -0.758 . . . . 2.6899999999999999 110.433 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.57 49.19 Favored Glycine 0 N--CA 1.502 3.045 0 O-C-N 121.09 -1.006 . . . . 0.47999999999999998 112.075 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.544 ' CD2' HG12 ' A' ' 44' ' ' VAL . 89.3 m-85 -102.38 72.81 1.29 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.597 -1.531 . . . . 0.33000000000000002 108.579 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -77.9 -12.56 59.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.40999999999999998 110.679 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.853 ' C ' ' CA ' ' A' ' 42' ' ' ALA . 43.9 mmtm . . . . . 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 1.5600000000000001 109.423 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.853 ' CA ' ' C ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 120.773 0.32 . . . . 0.20999999999999999 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.462 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 26.3 p90 -55.68 -17.4 5.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.683 -1.261 . . . . 0.32000000000000001 110.478 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 39' ' ' PHE . 46.3 t -79.25 -33.14 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.844 -1.169 . . . . 0.23999999999999999 107.844 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.36 -38.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.235 -1.024 . . . . 0.22 108.235 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.97 -36.82 77.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.89 -1.152 . . . . 0.40000000000000002 107.89 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -59.99 -42.04 98.16 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.96 -1.256 . . . . 0.17999999999999999 109.96 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.97 -41.12 91.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.886 -1.361 . . . . 1.0900000000000001 109.208 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.94 -39.99 87.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.99 . . . . 0.31 108.525 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.26 -37.55 80.86 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.573 -0.851 . . . . 0.28000000000000003 108.716 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 47' ' ' GLY . 69.7 t -64.07 -26.75 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.289 -0.882 . . . . 0.28000000000000003 110.142 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -91.59 14.89 13.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.099 -1.001 . . . . 0.31 110.52 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 50.09 40.01 20.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.726 -1.234 . . . . 1.7 111.055 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.28 18.99 4.63 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.267 -0.895 . . . . 2.2400000000000002 110.492 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.78 107.77 3.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.776 -1.203 . . . . 1.8 108.193 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 85.1 tt0 -62.91 -40.81 98.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.407 -0.808 . . . . 0.87 112.679 -178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -68.69 -39.64 80.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.847 -1.158 . . . . 0.72999999999999998 109.686 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.96 -38.63 76.15 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.18 -1.008 . . . . 0.55000000000000004 109.026 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -62.83 -45.91 90.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.38 109.444 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mtt180 -60.0 -47.7 84.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.393 -0.817 . . . . 2.6400000000000001 110.927 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.4 -39.68 94.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.889 -1.132 . . . . 2.3700000000000001 108.923 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.3 t90 -61.91 -49.97 74.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.40000000000000002 111.46 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.67 -46.13 76.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.852 -1.155 . . . . 0.34000000000000002 109.923 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.68 -46.67 81.43 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.322 -0.861 . . . . 2.1099999999999999 109.874 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.1 -31.53 70.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.386 -0.821 . . . . 1.8999999999999999 109.538 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 75.7 m -77.74 -38.26 47.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.259 -0.901 . . . . 0.40999999999999998 111.463 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 p -129.45 -24.33 2.8 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.479 -1.388 . . . . 0.40000000000000002 111.854 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.46 13.55 28.0 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.182 -1.567 . . . . 0.35999999999999999 109.182 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.81 154.57 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.035 -1.274 . . . . 0.33000000000000002 109.097 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.91 170.04 11.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 1.8999999999999999 109.53 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -31.61 70.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.39000000000000001 110.773 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -73.89 -40.02 63.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 2.5800000000000001 110.214 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.51 -33.7 76.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.416 -0.803 . . . . 2.1200000000000001 110.328 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p -68.39 -37.68 80.63 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.219 -0.926 . . . . 1.3600000000000001 109.824 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.47 -38.45 84.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.94 -1.1 . . . . 2.7999999999999998 109.644 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.45 -39.96 81.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.622 -1.299 . . . . 0.40000000000000002 110.485 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -70.01 -40.7 75.08 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.882 -1.136 . . . . 0.23999999999999999 109.327 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -60.19 -60.02 4.48 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.809 -1.182 . . . . 0.42999999999999999 109.654 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.22 91.78 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.212 -0.93 . . . . 0.26000000000000001 110.876 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -68.21 -50.13 56.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.734 -1.45 . . . . 0.25 109.847 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD21 HD22 ' A' ' 23' ' ' LEU . 87.6 mt -70.14 -39.93 75.1 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.146 -1.022 . . . . 0.29999999999999999 109.218 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -62.35 -39.97 94.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -0.99 . . . . 2.73 109.743 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.8 mt-10 -70.01 -36.62 75.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 1.9099999999999999 109.83 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.596 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 80.5 t90 -59.92 -41.75 92.42 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.488 -1.383 . . . . 0.37 107.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.0 m -63.1 -40.02 96.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.768 -0.827 . . . . 0.35999999999999999 108.768 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.1 -38.16 82.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.593 -0.692 . . . . 0.55000000000000004 109.835 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 -37.07 17.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.47999999999999998 110.065 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.596 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 72.2 m-85 -103.24 -86.68 0.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 1.24 110.327 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.917 -1.04 . . . . 1.6599999999999999 109.915 -178.55 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.328 0.585 . . . . 5.6600000000000001 109.501 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m -90.03 -1.53 57.98 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.641 -0.874 . . . . 3.02 108.641 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -71.34 164.65 25.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.506 -0.746 . . . . 0.95999999999999996 109.814 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 99.5 p -61.89 170.03 2.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.452 -0.78 . . . . 1.5 110.011 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' B' ' 5' ' ' GLN . 4.2 pm0 -58.13 -20.05 37.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.632 -0.668 . . . . 2.1800000000000002 110.756 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -61.15 -38.52 86.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.06 -1.025 . . . . 2.0099999999999998 109.188 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.479 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 24.2 t60 -59.74 -53.91 52.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 110.667 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -70.05 -35.43 74.26 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.002 -1.061 . . . . 3.23 110.162 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.15 -39.9 75.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 0.76000000000000001 109.647 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.51 -44.6 96.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.348 -0.845 . . . . 0.46000000000000002 109.785 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 31.8 m -83.51 15.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.089 -1.007 . . . . 0.44 109.572 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.82 -13.0 14.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.53 -0.731 . . . . 0.53000000000000003 110.368 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.84 151.57 20.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.908 -1.12 . . . . 1.27 109.498 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.06 156.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.992 1.795 . . . . 0.48999999999999999 111.775 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.72 -18.61 23.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.947 -1.095 . . . . 0.56000000000000005 109.963 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.86 -140.11 35.16 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.768 -1.333 . . . . 0.39000000000000001 109.768 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.82 30.59 5.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.45 -1.029 . . . . 0.83999999999999997 109.981 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -59.99 147.66 79.35 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 2.02 108.45 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.59 158.28 46.72 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.365 2.043 . . . . 0.34000000000000002 112.603 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' B' ' 22' ' ' SER . 2.2 p -57.0 -48.64 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.476 -0.765 . . . . 0.32000000000000001 110.169 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.14 -3.58 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.374 -1.09 . . . . 0.22 110.374 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.479 ' H ' ' C ' ' B' ' 20' ' ' VAL . 7.8 t -82.96 -20.85 34.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.295 . . . . 1.24 109.129 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.536 HD22 HD21 ' B' ' 81' ' ' LEU . 98.7 mt -65.02 139.93 58.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.23999999999999999 109.78 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.17 132.9 50.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.784 0.802 . . . . 0.20999999999999999 110.371 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.35 47.76 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.802 -1.319 . . . . 0.22 109.802 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.11 117.07 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.177 -1.19 . . . . 0.25 108.044 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.428 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -93.09 177.26 38.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.697 -1.361 . . . . 0.28000000000000003 109.697 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -40.09 79.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 2.0 109.951 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.94 -47.49 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.38 109.129 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.428 HD12 ' H ' ' B' ' 27' ' ' GLY . 95.5 mt -64.93 -39.54 93.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.40000000000000002 109.436 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.66 97.24 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 110.041 -1.224 . . . . 0.35999999999999999 110.041 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -60.24 -40.1 89.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.852 -1.381 . . . . 2.75 110.503 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.21 -45.76 75.87 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.785 -1.166 . . . . 1.5600000000000001 109.786 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.01 -41.27 99.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.33000000000000002 110.002 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.77 90.5 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.171 -1.012 . . . . 1.6799999999999999 109.382 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.69 -19.62 65.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.631 -0.877 . . . . 1.99 108.631 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' B' ' 37' ' ' ARG . 50.7 mtt-85 -91.1 5.78 47.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.817 . . . . 2.6800000000000002 110.423 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.19 7.54 49.38 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.034 -1.041 . . . . 0.48999999999999999 112.112 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.542 ' CD2' HG12 ' B' ' 44' ' ' VAL . 89.5 m-85 -102.43 72.93 1.29 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.704 -1.468 . . . . 0.33000000000000002 108.624 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -78.06 -12.46 59.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.40999999999999998 110.664 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.46 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 44.0 mmtm -132.31 154.11 50.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.055 -1.028 . . . . 1.5600000000000001 109.419 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.99 91.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.298 -0.876 . . . . 0.20999999999999999 111.73 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 25.7 p90 -55.82 -17.32 5.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.671 -1.268 . . . . 0.32000000000000001 110.397 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.542 HG12 ' CD2' ' B' ' 39' ' ' PHE . 46.2 t -79.21 -33.02 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.93 -1.137 . . . . 0.23999999999999999 107.93 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.5 -38.73 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.208 -1.034 . . . . 0.22 108.208 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.99 -36.9 78.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.899 -1.148 . . . . 0.40000000000000002 107.899 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.422 ' O ' HG23 ' B' ' 51' ' ' VAL . . . -59.89 -42.1 98.05 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.997 -1.241 . . . . 0.17999999999999999 109.997 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.96 -40.99 90.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.004 -1.292 . . . . 1.0900000000000001 109.231 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.95 -40.14 87.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.31 108.43 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.21 -37.84 81.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.611 -0.885 . . . . 0.27000000000000002 108.611 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 47' ' ' GLY . 70.7 t -63.93 -26.59 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.829 . . . . 0.28000000000000003 110.179 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.6 14.95 13.6 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.097 -1.002 . . . . 0.29999999999999999 110.539 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.705 -1.247 . . . . 1.71 111.045 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.26 19.02 4.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.371 -0.831 . . . . 2.25 110.504 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.73 107.82 3.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.809 -1.182 . . . . 1.8 108.131 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 85.2 tt0 -62.84 -41.09 99.2 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.398 -0.813 . . . . 0.88 112.704 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.54 -39.59 81.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.805 -1.184 . . . . 0.73999999999999999 109.692 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.0 -38.52 76.01 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.201 -1.0 . . . . 0.55000000000000004 109.06 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.06 -45.72 90.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.38 109.507 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 98.9 mtt180 -60.05 -47.76 84.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.785 . . . . 2.6400000000000001 110.974 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -64.3 -39.68 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.896 -1.128 . . . . 2.3799999999999999 108.946 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.92 -50.05 73.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.40000000000000002 111.423 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.423 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 22.6 tp -66.63 -46.23 76.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.897 -1.127 . . . . 0.34000000000000002 109.952 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.56 -46.71 81.63 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 2.1000000000000001 109.9 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.08 -31.51 70.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 1.8999999999999999 109.49 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 77.1 m -77.7 -38.3 47.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.868 . . . . 0.40000000000000002 111.496 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 26.6 p -129.43 -24.3 2.81 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.581 -1.325 . . . . 0.39000000000000001 111.891 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.45 13.63 27.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.189 -1.564 . . . . 0.35999999999999999 109.189 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.74 154.63 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.264 . . . . 0.32000000000000001 109.114 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.97 170.02 11.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 1.9099999999999999 109.515 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.03 -31.47 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.38 110.741 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -74.04 -40.0 63.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.961 -1.087 . . . . 2.5699999999999998 110.204 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -66.6 -33.57 75.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.412 -0.805 . . . . 2.1200000000000001 110.272 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 32.9 p -68.52 -37.55 80.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.208 -0.933 . . . . 1.3600000000000001 109.805 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.49 -38.5 84.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.885 -1.134 . . . . 2.8100000000000001 109.689 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -68.34 -39.97 81.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.679 -1.263 . . . . 0.40000000000000002 110.595 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.98 -40.8 75.13 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.845 -1.16 . . . . 0.23000000000000001 109.33 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -60.08 -60.04 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.141 . . . . 0.42999999999999999 109.718 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.18 91.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.829 -0.908 . . . . 0.25 110.829 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.27 -50.16 55.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.731 -1.453 . . . . 0.23999999999999999 109.85 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.536 HD21 HD22 ' B' ' 23' ' ' LEU . 87.7 mt -70.03 -40.02 75.44 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.123 -1.031 . . . . 0.28999999999999998 109.256 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -62.14 -40.11 94.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.123 -0.986 . . . . 2.7400000000000002 109.762 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.479 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.8 mt-10 -70.05 -36.57 75.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.09 -1.006 . . . . 1.9099999999999999 109.866 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 80.2 t90 -59.89 -41.89 92.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.525 -1.36 . . . . 0.35999999999999999 107.702 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.8 m -63.02 -40.11 96.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.816 -0.809 . . . . 0.35999999999999999 108.816 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.0 -38.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.627 -0.671 . . . . 0.55000000000000004 109.858 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -37.65 16.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.198 -0.939 . . . . 0.46999999999999997 110.057 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.8 m-85 -102.26 -86.66 0.42 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.188 -0.945 . . . . 1.24 110.376 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.016 -0.992 . . . . 1.6699999999999999 109.945 -178.39 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.484 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 76.1 mtm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.382 0.61 . . . . 5.6799999999999997 109.398 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.2 p -90.77 6.04 45.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.382 -0.823 . . . . 3.02 109.356 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.433 ' OG1' ' CB ' ' A' ' 7' ' ' HIS . 19.7 p -69.57 167.17 17.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.95999999999999996 109.941 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.4 p -55.24 176.61 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -0.81 . . . . 1.51 110.349 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.91 -19.52 65.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.88 -0.513 . . . . 2.1800000000000002 110.219 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -60.02 -37.45 79.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.049 -1.032 . . . . 2.02 109.573 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.433 ' CB ' ' OG1' ' A' ' 3' ' ' THR . 18.9 t-80 -59.92 -50.78 72.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.167 -0.958 . . . . 0.48999999999999999 110.507 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' NH2' ' O ' ' A' ' 1' ' ' MET . 38.7 mtt-85 -70.02 -33.7 72.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.954 -1.091 . . . . 3.21 110.224 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.66 -38.99 77.32 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.305 -0.872 . . . . 0.76000000000000001 109.43 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -64.6 -47.4 78.75 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.393 -0.817 . . . . 0.46000000000000002 110.506 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -85.11 11.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.154 -0.966 . . . . 0.44 111.054 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.08 -11.73 15.57 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.193 -0.942 . . . . 0.54000000000000004 109.821 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.58 151.49 20.96 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.963 . . . . 1.26 108.976 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -39.9 161.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.892 1.728 . . . . 0.48999999999999999 111.506 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.514 ' CE ' HD22 ' A' ' 46' ' ' LEU . 8.8 ptp -90.6 -20.22 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.029 -1.044 . . . . 0.56999999999999995 109.479 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.56 -139.96 21.01 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.205 -1.158 . . . . 0.40000000000000002 110.205 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.97 24.95 10.55 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.544 -0.974 . . . . 0.84999999999999998 109.792 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -60.8 148.69 82.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.098 -1.001 . . . . 2.0099999999999998 108.934 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.17 158.76 33.34 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.508 2.139 . . . . 0.34000000000000002 113.307 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 21' ' ' GLY . 11.1 p -59.59 -44.96 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.657 0.742 . . . . 0.32000000000000001 110.328 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.544 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.21 -3.0 0.18 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.567 -1.013 . . . . 0.23000000000000001 110.567 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 20' ' ' VAL . 68.4 m -82.7 -19.15 38.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.769 -1.43 . . . . 1.24 109.436 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.18 137.41 56.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.23999999999999999 109.639 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.2 134.75 54.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.737 -0.785 . . . . 0.20999999999999999 109.842 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.08 48.07 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.316 -1.514 . . . . 0.22 109.316 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -98.35 113.18 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.25 108.007 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.8 179.27 38.33 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 120.623 -1.298 . . . . 0.28000000000000003 109.952 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -57.29 -40.1 77.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.525 -0.985 . . . . 2.0099999999999998 110.374 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.95 -46.26 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.38 109.743 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.57 -37.55 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.40000000000000002 109.62 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.79 95.73 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.128 -1.589 . . . . 0.34999999999999998 109.128 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.18 -39.98 95.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -1.087 . . . . 2.7400000000000002 109.935 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.66 -44.72 69.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.88 -1.137 . . . . 1.54 109.44 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.66 -40.01 95.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.955 -1.128 . . . . 0.34000000000000002 107.955 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.04 -41.52 92.43 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.976 -0.75 . . . . 1.6699999999999999 108.976 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.28 -19.91 64.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.682 -0.859 . . . . 2.0 108.682 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -90.35 0.94 57.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 2.6899999999999999 109.68 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 37.79 3.84 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 120.305 -0.95 . . . . 0.47999999999999998 111.239 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' CD2' HG12 ' A' ' 44' ' ' VAL . 89.1 m-85 -133.84 72.6 1.48 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.968 -1.313 . . . . 0.33000000000000002 108.995 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -80.28 -10.73 59.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.40999999999999998 110.729 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.88 152.04 51.31 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.127 -0.983 . . . . 1.5600000000000001 110.017 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.96 90.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.20999999999999999 111.823 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.46 -17.77 9.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.758 -1.214 . . . . 0.32000000000000001 110.603 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.511 HG12 ' CD2' ' A' ' 39' ' ' PHE . 43.7 t -79.4 -31.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.821 -1.174 . . . . 0.23999999999999999 107.914 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.54 -36.7 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.343 -0.984 . . . . 0.22 108.343 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.514 HD22 ' CE ' ' A' ' 15' ' ' MET . 66.7 tp -60.01 -37.84 80.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.983 -1.488 . . . . 0.40000000000000002 106.983 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.3 87.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.986 -1.246 . . . . 0.17999999999999999 109.986 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -60.08 -42.27 94.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.339 . . . . 1.0900000000000001 108.901 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.357 -0.979 . . . . 0.31 108.357 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.06 -39.93 75.39 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.756 -0.831 . . . . 0.28000000000000003 108.756 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.81 -26.7 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.176 -0.952 . . . . 0.28000000000000003 111.358 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.2 16.13 6.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.9 -1.125 . . . . 0.31 110.217 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.34 21.67 5.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 1.7 110.167 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.15 19.6 8.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.707 -0.62 . . . . 2.2400000000000002 110.311 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.9 122.1 17.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.585 -1.322 . . . . 1.8 107.777 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' OE2' ' CG ' ' A' ' 78' ' ' PHE . 8.5 tp10 -61.97 -41.56 98.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.286 0.847 . . . . 0.87 113.286 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -69.96 -39.86 75.75 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.411 -1.431 . . . . 0.72999999999999998 110.787 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.08 -39.9 75.33 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.917 -1.113 . . . . 0.55000000000000004 109.067 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.6 -48.48 79.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.268 -0.895 . . . . 0.38 109.482 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.08 -47.12 87.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.356 -0.84 . . . . 2.6400000000000001 110.978 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.13 -39.88 94.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.749 -1.219 . . . . 2.3700000000000001 108.885 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -61.58 -50.05 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.40000000000000002 111.414 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.65 -47.29 69.97 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.145 -0.972 . . . . 0.34000000000000002 110.146 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -63.33 -46.7 85.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 2.1099999999999999 109.869 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.37 -30.81 69.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 1.8999999999999999 109.696 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.6 m -79.01 -35.14 43.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.40999999999999998 111.247 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.9 p -131.79 -34.73 1.3 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.541 -1.35 . . . . 0.40000000000000002 111.722 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.97 15.87 10.37 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.422 -1.471 . . . . 0.35999999999999999 109.422 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 153.05 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.282 . . . . 0.33000000000000002 109.04 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -89.68 170.68 10.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 1.8999999999999999 109.348 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.27 72.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.504 -0.748 . . . . 0.39000000000000001 110.94 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 68.5 mttm -71.63 -41.43 68.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.717 -1.24 . . . . 2.5800000000000001 110.566 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -67.32 -36.52 81.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 2.1200000000000001 110.386 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.135 -0.978 . . . . 1.3600000000000001 110.466 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 72' ' ' LYS . 83.5 mtm180 -59.95 -36.59 77.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.675 -1.266 . . . . 2.7999999999999998 108.701 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.4 -39.29 81.71 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.83 -1.169 . . . . 0.40000000000000002 110.27 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.21 -41.14 81.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.791 -1.193 . . . . 0.23999999999999999 109.59 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CG ' ' OE2' ' A' ' 56' ' ' GLU . 64.7 t80 -60.01 -59.81 4.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.819 -1.176 . . . . 0.42999999999999999 109.41 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -34.88 85.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.992 -1.243 . . . . 0.26000000000000001 109.992 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.8 -45.45 67.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -1.186 . . . . 0.25 109.465 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.58 -41.91 68.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.29999999999999999 109.117 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.15 -41.16 96.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 2.73 109.527 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -70.05 -37.89 75.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 1.9099999999999999 110.603 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.48 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.8 t90 -59.99 -43.5 95.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.393 -1.442 . . . . 0.37 107.815 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 89' ' ' LEU . 22.0 m -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.572 -0.705 . . . . 0.35999999999999999 109.358 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -59.2 -34.21 71.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.55000000000000004 110.21 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.75 -34.34 13.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.296 -0.878 . . . . 0.47999999999999998 111.352 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 94.8 m-85 -111.19 3.08 18.18 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 120.984 -1.073 . . . . 1.24 112.033 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . 10.5 tp . . . . . 0 N--CA 1.5 2.07 0 O-C-N 120.839 -1.163 . . . . 1.6599999999999999 109.892 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.48 ' O ' ' NH2' ' B' ' 8' ' ' ARG . 76.2 mtm . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.448 0.642 . . . . 5.6600000000000001 109.402 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 39.9 p -90.76 6.05 45.76 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.334 -0.854 . . . . 3.02 109.348 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.423 ' OG1' ' CB ' ' B' ' 7' ' ' HIS . 20.0 p -69.53 167.17 17.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.95999999999999996 110.007 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p -55.23 176.7 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.86 0.838 . . . . 1.5 110.326 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.86 -19.6 65.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.819 -0.551 . . . . 2.1800000000000002 110.21 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.0 -37.35 79.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.108 -0.995 . . . . 2.0099999999999998 109.665 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.423 ' CB ' ' OG1' ' B' ' 3' ' ' THR . 18.8 t-80 -59.96 -50.85 72.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.126 -0.984 . . . . 0.48999999999999999 110.449 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' B' ' 1' ' ' MET . 38.8 mtt-85 -70.04 -33.71 72.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 3.23 110.165 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.58 -39.26 77.44 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.202 -0.936 . . . . 0.76000000000000001 109.377 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.32 -47.54 79.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.838 . . . . 0.46000000000000002 110.457 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -85.3 11.6 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.44 111.139 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.21 -11.92 15.49 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.238 -0.914 . . . . 0.53000000000000003 109.759 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.45 151.63 21.43 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.091 -1.006 . . . . 1.27 108.97 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.97 161.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.847 1.698 . . . . 0.48999999999999999 111.585 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.509 ' CE ' HD22 ' B' ' 46' ' ' LEU . 8.9 ptp -90.74 -19.79 23.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.56000000000000005 109.561 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.11 -140.1 18.32 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.047 -1.221 . . . . 0.39000000000000001 110.047 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.74 25.09 10.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.981 . . . . 0.83999999999999997 109.848 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -61.03 148.92 83.35 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.908 -1.12 . . . . 2.02 108.879 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.22 158.78 33.49 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.412 2.075 . . . . 0.34000000000000002 113.315 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.551 HG13 ' N ' ' B' ' 21' ' ' GLY . 11.2 p -59.64 -44.95 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.625 0.726 . . . . 0.32000000000000001 110.273 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.551 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.22 -2.81 0.17 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.591 -1.003 . . . . 0.22 110.591 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' B' ' 20' ' ' VAL . 68.5 m -82.91 -19.33 37.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.793 -1.416 . . . . 1.24 109.34 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.97 137.42 57.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.965 . . . . 0.23999999999999999 109.651 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.47 134.4 53.34 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.805 . . . . 0.20999999999999999 109.995 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 -20.91 48.79 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.236 -1.545 . . . . 0.22 109.236 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 mm -98.44 113.1 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.263 -1.139 . . . . 0.25 107.961 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.74 179.05 38.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.913 -1.275 . . . . 0.28000000000000003 109.913 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.16 -40.04 76.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 2.0 110.353 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.99 -46.41 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.38 109.725 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 93.3 mt -65.26 -37.68 87.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.40000000000000002 109.666 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.82 95.68 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.256 -1.538 . . . . 0.35999999999999999 109.256 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.24 -39.92 94.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.392 -1.064 . . . . 2.75 109.922 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.6 -44.9 69.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.844 -1.16 . . . . 1.5600000000000001 109.331 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.55 -39.92 95.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.016 -1.105 . . . . 0.33000000000000002 108.016 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -41.56 92.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.945 -0.761 . . . . 1.6799999999999999 108.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -68.19 -20.13 64.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.633 -0.877 . . . . 1.99 108.633 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -90.15 1.3 56.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.495 -0.753 . . . . 2.6800000000000002 109.646 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.45 37.8 3.91 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.115 -0.991 . . . . 0.48999999999999999 111.127 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.518 ' CD2' HG12 ' B' ' 44' ' ' VAL . 89.0 m-85 -134.01 72.75 1.48 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.977 -1.308 . . . . 0.33000000000000002 108.956 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -80.57 -10.57 59.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.089 -1.007 . . . . 0.40999999999999998 110.8 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.95 152.31 51.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.204 -0.935 . . . . 1.5600000000000001 110.038 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.63 91.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.20999999999999999 111.848 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.58 -17.96 10.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.577 -1.327 . . . . 0.32000000000000001 110.51 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.518 HG12 ' CD2' ' B' ' 39' ' ' PHE . 43.8 t -79.43 -31.65 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.797 -1.19 . . . . 0.23999999999999999 107.841 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.46 -36.76 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.39 -0.967 . . . . 0.22 108.39 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.509 HD22 ' CE ' ' B' ' 15' ' ' MET . 67.0 tp -60.01 -38.12 81.73 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.802 -1.555 . . . . 0.40000000000000002 106.802 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.63 85.42 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.936 -1.266 . . . . 0.17999999999999999 109.936 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -60.0 -42.31 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.881 -1.364 . . . . 1.0900000000000001 108.819 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -40.16 88.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.356 -0.979 . . . . 0.31 108.356 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 65.4 mt -69.96 -40.06 75.63 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.725 -0.843 . . . . 0.27000000000000002 108.725 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.62 -26.66 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 111.276 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.38 16.45 6.39 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.035 -1.041 . . . . 0.29999999999999999 110.237 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.16 21.79 5.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.885 . . . . 1.71 110.092 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 80.5 mttt 59.99 19.19 8.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.75 -0.593 . . . . 2.25 110.386 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.62 122.29 17.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.561 -1.337 . . . . 1.8 107.664 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE2' ' CG ' ' B' ' 78' ' ' PHE . 8.5 tp10 -62.0 -42.04 98.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.88 113.289 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.54 -39.97 77.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.339 -1.476 . . . . 0.73999999999999999 110.694 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.09 -40.01 75.23 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.99 -1.084 . . . . 0.55000000000000004 109.035 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.56 -48.38 79.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.38 109.544 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.03 -47.61 85.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 2.6400000000000001 110.846 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.03 -39.46 94.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.715 -1.241 . . . . 2.3799999999999999 108.953 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' TRP . . . . . 0.424 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -61.83 -49.91 74.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.339 -0.85 . . . . 0.40000000000000002 111.377 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.68 -47.67 68.79 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.196 -0.94 . . . . 0.34000000000000002 110.069 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -62.94 -46.78 86.14 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.917 . . . . 2.1000000000000001 109.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.32 -30.75 69.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.8999999999999999 109.655 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 99.7 m -79.11 -35.14 42.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.40000000000000002 111.354 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.9 p -131.59 -35.18 1.31 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.639 -1.288 . . . . 0.39000000000000001 111.787 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.26 16.22 9.82 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 109.341 -1.503 . . . . 0.35999999999999999 109.341 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.51 153.14 1.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.866 -1.373 . . . . 0.32000000000000001 109.078 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -89.86 170.56 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.089 -1.007 . . . . 1.9099999999999999 109.329 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.35 -32.97 71.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.507 -0.746 . . . . 0.38 111.0 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.41 ' HA ' ' HE ' ' B' ' 75' ' ' ARG . 68.5 mttm -71.89 -41.45 67.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.751 -1.218 . . . . 2.5699999999999998 110.441 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -67.32 -36.38 81.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 2.1200000000000001 110.447 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.65 -38.35 83.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.352 -0.842 . . . . 1.3600000000000001 110.442 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' B' ' 72' ' ' LYS . 83.5 mtm180 -60.01 -36.45 77.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.748 -1.22 . . . . 2.8100000000000001 108.746 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.64 -39.47 80.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.782 -1.199 . . . . 0.40000000000000002 110.187 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.07 -41.23 82.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.987 -1.07 . . . . 0.23000000000000001 109.529 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.526 ' CG ' ' OE2' ' B' ' 56' ' ' GLU . 64.4 t80 -60.02 -59.77 4.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.819 -1.176 . . . . 0.42999999999999999 109.507 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.03 -34.86 85.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.935 -1.266 . . . . 0.25 109.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.87 -45.71 67.09 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.152 -1.205 . . . . 0.23999999999999999 109.364 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.41 -41.67 69.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.999 . . . . 0.28999999999999998 109.151 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.37 -40.98 96.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.881 . . . . 2.7400000000000002 109.605 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.96 -38.04 75.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.164 -0.96 . . . . 1.9099999999999999 110.604 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.481 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.9 t90 -59.99 -43.5 95.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.332 -1.48 . . . . 0.35999999999999999 107.718 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' B' ' 89' ' ' LEU . 22.3 m -60.06 -40.05 88.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.637 -0.664 . . . . 0.35999999999999999 109.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -59.07 -34.11 71.58 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 110.288 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.76 -35.02 13.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.009 -1.057 . . . . 0.46999999999999997 111.377 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.481 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.2 m-85 -109.91 2.16 19.62 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.12 -0.987 . . . . 1.24 112.272 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.0 tp . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.716 -1.24 . . . . 1.6699999999999999 109.944 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.313 -0.625 . . . . 5.6799999999999997 109.313 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 59.94 8.28 1.38 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.919 . . . . 3.02 109.013 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.1 p -87.03 169.99 11.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.459 -0.776 . . . . 0.95999999999999996 109.564 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.5 m -62.44 162.96 9.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 1.51 109.928 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -56.75 -23.96 46.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.783 -0.573 . . . . 2.1800000000000002 110.208 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.13 -38.41 82.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.921 . . . . 2.02 108.932 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -60.04 -52.23 66.24 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.463 -0.773 . . . . 0.48999999999999999 110.795 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 89.1 mtm180 -69.94 -35.41 74.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.963 -1.086 . . . . 3.21 109.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -65.49 -40.01 92.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.82 . . . . 0.76000000000000001 109.342 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 44.4 t80 -63.14 -49.65 73.53 Favored 'General case' 0 C--N 1.298 -1.63 0 C-N-CA 119.642 -0.823 . . . . 0.46000000000000002 110.003 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.35 6.04 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.105 -0.997 . . . . 0.44 111.231 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -99.27 -18.77 17.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.93 -1.106 . . . . 0.54000000000000004 110.057 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' PRO . 6.5 pt-20 -151.96 151.94 28.96 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.154 -0.967 . . . . 1.26 108.917 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 13' ' ' GLU . 69.6 Cg_exo -36.76 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.2 1.933 . . . . 0.48999999999999999 111.688 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.509 ' SD ' HD13 ' B' ' 89' ' ' LEU . 15.6 ptm -93.66 -29.64 15.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.104 -0.997 . . . . 0.56999999999999995 110.15 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 -135.28 44.7 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.205 -1.158 . . . . 0.40000000000000002 110.205 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.97 35.3 3.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.676 -0.896 . . . . 0.84999999999999998 110.014 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.26 148.59 71.76 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 2.0099999999999998 108.47 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.28 156.2 41.85 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.025 1.817 . . . . 0.34000000000000002 112.048 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.4 p -57.01 -48.13 82.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.442 -0.786 . . . . 0.32000000000000001 110.22 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.84 -3.81 0.23 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.716 -0.954 . . . . 0.23000000000000001 110.716 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 70.7 m -83.16 -21.54 33.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.709 -1.465 . . . . 1.24 109.422 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.36 136.79 57.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.038 -1.039 . . . . 0.23999999999999999 109.418 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.59 136.17 56.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.763 0.792 . . . . 0.20999999999999999 109.758 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.27 -20.07 52.24 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.741 -1.744 . . . . 0.22 108.741 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.83 115.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.908 -1.145 . . . . 0.25 107.908 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -90.21 177.02 42.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.825 -1.31 . . . . 0.28000000000000003 109.825 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.76 -39.93 74.9 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.629 -0.924 . . . . 2.0099999999999998 109.914 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.82 -44.47 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.05 . . . . 0.38 109.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 27' ' ' GLY . 93.6 mt -66.77 -37.46 84.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.9 . . . . 0.40000000000000002 109.47 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.246 -1.542 . . . . 0.34999999999999998 109.246 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.82 -39.86 94.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.405 -1.056 . . . . 2.7400000000000002 110.367 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -65.44 -48.45 72.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.859 -1.151 . . . . 1.54 109.948 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.69 -36.03 79.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.909 -1.119 . . . . 0.34000000000000002 108.485 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.739 -0.601 . . . . 1.6699999999999999 110.058 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.02 -19.37 65.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.995 . . . . 2.0 108.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 37' ' ' ARG . 33.8 mtt-85 -91.05 6.59 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.595 -0.691 . . . . 2.6899999999999999 110.25 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.7 55.43 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.978 -1.076 . . . . 0.47999999999999998 111.688 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD1' HG12 ' A' ' 44' ' ' VAL . 87.2 m-85 -103.86 72.99 1.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.835 -1.391 . . . . 0.33000000000000002 108.341 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.06 -10.72 59.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.459 -0.776 . . . . 0.40999999999999998 110.628 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.5 150.27 50.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.167 -0.958 . . . . 1.5600000000000001 109.62 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.99 94.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.20999999999999999 110.827 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 17.0 p90 -60.55 -18.64 53.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.016 -1.052 . . . . 0.32000000000000001 110.371 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 39' ' ' PHE . 50.1 t -79.57 -32.74 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.434 -1.321 . . . . 0.23999999999999999 107.434 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.74 -37.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.096 -1.075 . . . . 0.22 108.096 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.8 tp -59.99 -35.46 75.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.569 -1.271 . . . . 0.40000000000000002 107.569 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.54 97.08 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.166 -1.173 . . . . 0.17999999999999999 110.166 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -59.97 -41.66 92.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.01 -1.288 . . . . 1.0900000000000001 109.778 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.31 108.741 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -38.77 81.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.723 -0.843 . . . . 0.28000000000000003 108.723 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.02 -24.54 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.347 -0.846 . . . . 0.28000000000000003 110.629 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.23 18.37 9.61 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.121 -0.987 . . . . 0.31 110.444 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.36 33.55 7.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.768 -1.207 . . . . 1.7 110.126 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.05 19.92 9.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.751 -0.593 . . . . 2.2400000000000002 110.382 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.47 113.38 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.609 -1.307 . . . . 1.8 107.719 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.84 -40.03 93.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.87 113.16 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -69.81 -39.7 76.37 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.615 -1.303 . . . . 0.72999999999999998 110.578 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.57 -38.77 77.54 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.75 -1.18 . . . . 0.55000000000000004 108.921 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.92 -50.59 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.38 109.983 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 60' ' ' ARG . 5.4 mtm-85 -62.54 -43.71 98.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 2.6400000000000001 109.841 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.95 -39.78 94.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 2.3700000000000001 108.797 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.461 ' O ' ' OG1' ' A' ' 66' ' ' THR . 55.9 t90 -65.45 -46.32 80.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.40000000000000002 110.526 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 tp -67.56 -49.45 63.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.34000000000000002 110.017 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.75 -48.87 79.86 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.381 -0.825 . . . . 2.1099999999999999 109.969 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 28.8 t0 -68.95 -28.97 67.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.704 . . . . 1.8999999999999999 109.862 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 50.3 m -79.5 -34.55 41.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.254 -0.903 . . . . 0.40999999999999998 111.019 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.3 p -131.56 -29.52 1.74 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.648 -1.283 . . . . 0.40000000000000002 111.749 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.6 14.19 20.38 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.382 -1.487 . . . . 0.35999999999999999 109.382 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.44 1.69 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.047 -1.266 . . . . 0.33000000000000002 109.015 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -90.6 171.19 9.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.084 -1.01 . . . . 1.8999999999999999 109.737 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -34.01 72.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.39000000000000001 110.746 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.19 -40.54 67.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.618 -1.301 . . . . 2.5800000000000001 109.993 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.79 -39.98 79.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.112 -0.993 . . . . 2.1200000000000001 110.409 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -67.41 -39.05 85.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.27 -0.894 . . . . 1.3600000000000001 110.028 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -59.97 -38.65 83.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 2.7999999999999998 109.421 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.43 -39.94 85.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.712 -1.243 . . . . 0.40000000000000002 110.482 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -66.78 -40.03 88.03 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.915 -1.115 . . . . 0.23999999999999999 109.86 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.03 -59.97 4.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.599 -1.313 . . . . 0.42999999999999999 110.044 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.67 84.97 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.443 -1.063 . . . . 0.26000000000000001 110.443 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.13 -49.94 52.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -1.134 . . . . 0.25 109.867 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.07 -39.98 75.31 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.792 -1.163 . . . . 0.29999999999999999 108.775 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.23 -41.18 99.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 2.73 110.18 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -69.87 -35.94 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.927 -1.108 . . . . 1.9099999999999999 109.569 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.443 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 80.2 t90 -59.98 -43.92 94.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.944 -1.502 . . . . 0.37 106.944 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 34.9 m -60.98 -40.03 91.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.827 -0.805 . . . . 0.35999999999999999 108.827 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.66 81.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.431 -0.793 . . . . 0.55000000000000004 110.032 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.58 -38.18 16.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -0.991 . . . . 0.47999999999999998 110.6 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.22 -87.09 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.228 -0.92 . . . . 1.24 110.102 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.5 HD13 ' SD ' ' B' ' 15' ' ' MET . 17.7 tp . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 118.099 -0.953 . . . . 1.6599999999999999 109.659 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.2 mmt . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.274 -0.639 . . . . 5.6600000000000001 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 60.09 7.98 1.36 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 3.02 108.98 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 20.3 p -86.87 170.0 12.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.307 -0.871 . . . . 0.95999999999999996 109.626 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -62.43 162.94 9.37 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.35 -0.844 . . . . 1.5 109.91 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -56.79 -23.86 46.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.752 -0.593 . . . . 2.1800000000000002 110.272 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.12 -38.48 83.15 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.216 -0.928 . . . . 2.0099999999999998 108.931 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -59.97 -52.21 66.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.48999999999999999 110.867 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 89.0 mtm180 -70.01 -35.38 74.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.955 -1.091 . . . . 3.23 109.738 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -65.47 -40.01 92.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.37 -0.831 . . . . 0.76000000000000001 109.385 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 44.1 t80 -63.1 -49.67 73.54 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.343 -0.848 . . . . 0.46000000000000002 110.026 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.32 6.07 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.078 -1.014 . . . . 0.44 111.241 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -99.36 -18.68 17.4 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.894 -1.129 . . . . 0.53000000000000003 110.0 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' B' ' 14' ' ' PRO . 6.5 pt-20 -152.0 151.89 28.8 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.097 -1.002 . . . . 1.27 108.95 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' B' ' 13' ' ' GLU . 70.2 Cg_exo -36.75 156.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 122.16 1.907 . . . . 0.48999999999999999 111.795 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.5 ' SD ' HD13 ' A' ' 89' ' ' LEU . 15.7 ptm -93.58 -29.72 15.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.094 -1.004 . . . . 0.56000000000000005 110.158 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -135.3 44.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.227 -1.149 . . . . 0.39000000000000001 110.227 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.94 35.16 3.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.619 -0.93 . . . . 0.83999999999999997 110.005 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.18 148.54 71.39 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.991 . . . . 2.02 108.445 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.3 156.24 41.79 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.998 1.799 . . . . 0.34000000000000002 112.039 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.563 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.4 p -57.02 -48.19 82.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.543 -0.723 . . . . 0.32000000000000001 110.237 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.563 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.7 -3.94 0.22 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.776 -0.93 . . . . 0.22 110.776 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' B' ' 20' ' ' VAL . 70.6 m -83.08 -21.6 33.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.761 -1.435 . . . . 1.24 109.462 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.33 136.79 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.23999999999999999 109.406 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.58 136.18 56.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.755 0.788 . . . . 0.20999999999999999 109.824 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.31 -20.15 51.9 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.742 -1.743 . . . . 0.22 108.742 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -99.76 114.99 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.933 -1.136 . . . . 0.25 107.933 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.423 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -90.31 177.0 42.33 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.825 -1.31 . . . . 0.28000000000000003 109.825 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.62 -39.97 74.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.591 -0.946 . . . . 2.0 110.015 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.84 -44.37 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.38 109.837 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.423 HD12 ' H ' ' B' ' 27' ' ' GLY . 93.5 mt -66.78 -37.5 84.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.40000000000000002 109.487 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.0 96.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.288 -1.525 . . . . 0.35999999999999999 109.288 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -39.76 94.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -1.12 . . . . 2.75 110.371 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -65.4 -48.38 73.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.201 . . . . 1.5600000000000001 109.971 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.8 -36.02 79.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.953 -1.092 . . . . 0.33000000000000002 108.492 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -59.92 -42.51 94.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.732 -0.605 . . . . 1.6799999999999999 110.008 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.05 -19.32 65.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 1.99 108.607 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' B' ' 37' ' ' ARG . 34.0 mtt-85 -90.97 6.56 44.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.595 -0.691 . . . . 2.6800000000000002 110.291 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.73 55.49 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.063 -1.065 . . . . 0.48999999999999999 111.766 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.525 ' CD1' HG12 ' B' ' 44' ' ' VAL . 86.8 m-85 -103.9 73.1 1.14 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.801 -1.411 . . . . 0.33000000000000002 108.328 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.17 -10.61 59.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.40999999999999998 110.639 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.52 150.3 50.92 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.92 . . . . 1.5600000000000001 109.62 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.07 94.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.20999999999999999 110.766 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 16.7 p90 -60.49 -18.57 52.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.32000000000000001 110.514 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' B' ' 39' ' ' PHE . 50.8 t -79.62 -32.77 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.426 -1.324 . . . . 0.23999999999999999 107.426 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.83 -37.26 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.109 -1.071 . . . . 0.22 108.109 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.04 -35.44 75.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.611 -1.255 . . . . 0.40000000000000002 107.611 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.61 97.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.067 -1.213 . . . . 0.17999999999999999 110.067 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -60.02 -41.64 92.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.006 -1.291 . . . . 1.0900000000000001 109.742 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.04 -39.88 87.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.31 108.82 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.52 -38.77 81.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.816 -0.809 . . . . 0.27000000000000002 108.816 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.03 -24.44 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.401 -0.812 . . . . 0.28000000000000003 110.648 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.8 mt -93.18 18.16 9.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.111 -0.993 . . . . 0.29999999999999999 110.434 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.46 33.55 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.67 -1.269 . . . . 1.71 110.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.06 19.89 9.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.764 -0.585 . . . . 2.25 110.332 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -68.48 113.4 6.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 1.8 107.726 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.82 -39.96 93.6 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 113.11 0.782 . . . . 0.88 113.11 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.87 -39.61 76.23 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.575 -1.328 . . . . 0.73999999999999999 110.604 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.59 -38.82 77.49 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.848 -1.141 . . . . 0.55000000000000004 108.937 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.98 -50.44 68.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.38 110.005 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.499 HH11 ' HG3' ' B' ' 60' ' ' ARG . 5.4 mtm-85 -62.62 -43.66 98.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 2.6400000000000001 109.803 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.94 -39.79 94.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 2.3799999999999999 108.745 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' TRP . . . . . 0.408 ' O ' ' OG1' ' B' ' 66' ' ' THR . 55.7 t90 -65.54 -46.29 80.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.912 . . . . 0.40000000000000002 110.513 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -49.45 63.17 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.06 -1.025 . . . . 0.34000000000000002 110.074 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.78 -48.72 80.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.288 -0.882 . . . . 2.1000000000000001 109.937 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.8 t0 -69.13 -28.89 66.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 1.8999999999999999 109.852 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 50.5 m -79.51 -34.61 41.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.40000000000000002 111.011 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.3 p -131.61 -29.45 1.74 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.611 -1.305 . . . . 0.39000000000000001 111.77 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.57 14.27 20.22 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.321 -1.512 . . . . 0.35999999999999999 109.321 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.48 1.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.322 . . . . 0.32000000000000001 109.077 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -90.7 171.12 9.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.075 -1.015 . . . . 1.9099999999999999 109.685 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.97 72.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.52 -0.738 . . . . 0.38 110.828 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.07 -40.63 68.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.558 -1.339 . . . . 2.5699999999999998 110.003 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.81 -39.98 79.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 2.1200000000000001 110.382 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 56.6 m -67.19 -39.22 86.34 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.279 -0.888 . . . . 1.3600000000000001 110.044 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -60.09 -38.46 82.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 2.8100000000000001 109.387 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.58 -39.9 84.86 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.722 -1.236 . . . . 0.40000000000000002 110.357 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.5 m -66.91 -39.93 87.53 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.947 -1.096 . . . . 0.23000000000000001 109.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 -59.97 4.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.638 -1.289 . . . . 0.42999999999999999 110.066 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.54 84.51 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.518 -1.033 . . . . 0.25 110.518 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.18 -50.06 50.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -1.19 . . . . 0.23999999999999999 109.77 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.94 -40.06 75.69 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.827 -1.149 . . . . 0.28999999999999998 108.809 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.15 -41.23 99.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 2.7400000000000002 110.159 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.88 -35.92 75.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.017 -1.052 . . . . 1.9099999999999999 109.594 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.43 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 80.2 t90 -60.03 -43.95 94.95 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.929 -1.508 . . . . 0.35999999999999999 106.929 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.0 m -60.99 -39.96 91.64 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.849 -0.797 . . . . 0.35999999999999999 108.849 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.59 81.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.55000000000000004 110.117 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -38.71 15.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.155 -0.966 . . . . 0.46999999999999997 110.579 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -104.51 -86.79 0.45 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.169 -0.957 . . . . 1.24 110.265 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.509 HD13 ' SD ' ' A' ' 15' ' ' MET . 17.7 tp . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 118.084 -0.96 . . . . 1.6699999999999999 109.602 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptm . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.349 0.595 . . . . 5.6799999999999997 109.457 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 64.9 p -77.93 125.16 28.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 3.02 109.403 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.9 p -99.25 158.29 15.8 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.433 -0.792 . . . . 0.95999999999999996 109.608 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 p -80.13 177.61 8.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.22 -0.925 . . . . 1.51 109.576 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.68 -21.14 62.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.538 -0.726 . . . . 2.1800000000000002 110.69 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.99 -37.84 80.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.777 -1.202 . . . . 2.02 109.613 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -60.0 -51.85 67.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.841 -1.162 . . . . 0.48999999999999999 110.48 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -69.72 -36.59 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.012 -1.055 . . . . 3.21 109.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.49 -39.96 73.86 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.76000000000000001 109.69 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.32 -41.33 96.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.216 -0.928 . . . . 0.46000000000000002 109.945 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 m -84.31 15.58 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.44 109.842 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.8 -9.78 11.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.449 -0.782 . . . . 0.54000000000000004 110.294 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 10.6 pt-20 -149.86 149.2 27.31 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.943 -1.098 . . . . 1.26 109.252 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 13' ' ' GLU . 89.7 Cg_exo -41.1 166.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.811 1.674 . . . . 0.48999999999999999 111.776 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.458 ' SD ' HD11 ' B' ' 89' ' ' LEU . 3.4 ptp -93.05 -24.95 18.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.56999999999999995 108.621 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.96 -140.65 16.48 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.021 -1.632 . . . . 0.40000000000000002 109.021 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -109.74 30.03 7.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.481 -1.011 . . . . 0.84999999999999998 109.477 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 90.2 mttt -60.18 149.39 75.52 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 2.0099999999999998 108.986 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.12 153.98 54.77 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.182 1.921 . . . . 0.34000000000000002 112.439 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 21' ' ' GLY . 14.5 p -57.52 -44.03 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.603 -0.686 . . . . 0.32000000000000001 110.522 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.64 -2.78 0.2 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.16 -1.176 . . . . 0.23000000000000001 110.16 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 20' ' ' VAL . 40.7 t -82.59 -23.42 34.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.774 -1.427 . . . . 1.24 109.093 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.23999999999999999 109.874 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.14 134.28 52.45 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.763 0.792 . . . . 0.20999999999999999 109.96 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.94 -20.53 48.71 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.283 -1.527 . . . . 0.22 109.283 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.6 mm -99.75 114.2 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.281 -1.129 . . . . 0.25 108.011 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.71 178.4 39.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.271 -1.532 . . . . 0.28000000000000003 109.271 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -57.24 -39.71 76.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.337 -1.096 . . . . 2.0099999999999998 109.209 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.33 -48.38 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.38 109.706 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.0 -39.97 83.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 0.40000000000000002 109.285 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.98 98.69 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.565 -1.414 . . . . 0.34999999999999998 109.565 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.85 -41.06 95.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -1.201 . . . . 2.7400000000000002 110.352 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.46 -40.16 85.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.823 -1.173 . . . . 1.54 109.689 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.83 -40.06 93.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.963 -1.085 . . . . 0.34000000000000002 109.106 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.08 -40.89 91.12 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.723 -0.791 . . . . 1.6699999999999999 109.363 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.77 -19.53 64.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.809 -0.811 . . . . 2.0 108.809 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -89.0 0.18 56.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.631 -0.668 . . . . 2.6899999999999999 109.898 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' B' ' 53' ' ' LYS . . . 107.01 4.35 35.93 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 120.254 -0.974 . . . . 0.47999999999999998 111.577 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.425 ' CD2' HG12 ' A' ' 44' ' ' VAL . 96.2 m-85 -103.17 75.64 1.38 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.825 -1.397 . . . . 0.33000000000000002 109.137 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.16 -11.14 59.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.40999999999999998 111.159 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -135.08 157.84 45.89 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.939 -1.101 . . . . 1.5600000000000001 109.397 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.59 88.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.20999999999999999 112.078 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -56.15 -18.15 9.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.768 -1.208 . . . . 0.32000000000000001 110.457 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.425 HG12 ' CD2' ' A' ' 39' ' ' PHE . 21.6 t -80.15 -31.43 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.832 -1.168 . . . . 0.23999999999999999 108.287 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.52 -38.7 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.413 -0.958 . . . . 0.22 108.413 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.85 -38.2 81.43 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.654 -1.61 . . . . 0.40000000000000002 106.654 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.41 -45.98 58.3 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.878 -1.289 . . . . 0.17999999999999999 109.878 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -60.09 -41.93 93.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -1.181 . . . . 1.0900000000000001 109.329 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.93 -40.57 89.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.0 -1.063 . . . . 0.31 108.828 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.74 -39.7 76.61 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.688 -0.856 . . . . 0.28000000000000003 108.688 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.09 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.28000000000000003 110.554 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.77 13.83 13.39 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.096 . . . . 0.31 110.858 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 51.32 35.91 14.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.209 . . . . 1.7 110.223 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 56.08 19.42 3.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.228 -0.92 . . . . 2.2400000000000002 110.524 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -69.16 105.34 2.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.712 -1.242 . . . . 1.8 108.263 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.538 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 83.3 tt0 -62.94 -39.95 96.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 0.87 111.973 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.65 -39.89 88.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.72999999999999998 109.57 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.32 -37.92 71.73 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.445 -0.902 . . . . 0.55000000000000004 108.747 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.56 -42.13 95.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.565 -0.71 . . . . 0.38 109.941 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.538 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 99.2 mtt180 -60.11 -48.5 81.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.249 -0.907 . . . . 2.6400000000000001 110.361 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.94 -39.89 90.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.682 -1.261 . . . . 2.3700000000000001 109.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -61.65 -50.1 73.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 0.40000000000000002 110.664 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.9 tp -68.4 -48.44 64.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.089 -1.007 . . . . 0.34000000000000002 110.103 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.19 -47.16 85.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 2.1099999999999999 109.797 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -68.71 -30.12 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.555 -0.715 . . . . 1.8999999999999999 109.682 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -80.22 -32.52 38.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.40999999999999998 111.029 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -133.0 -35.05 1.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.575 -1.328 . . . . 0.40000000000000002 112.098 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.65 16.04 9.71 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.338 -1.505 . . . . 0.35999999999999999 109.338 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 152.24 2.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.272 . . . . 0.33000000000000002 109.89 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -90.22 173.49 8.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.109 -0.994 . . . . 1.8999999999999999 109.953 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.61 75.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.715 . . . . 0.39000000000000001 110.03 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.24 -40.01 71.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 2.5800000000000001 109.633 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -66.61 -39.28 88.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.548 -0.72 . . . . 2.1200000000000001 110.151 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.1 m -62.84 -38.61 91.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.299 -0.876 . . . . 1.3600000000000001 109.747 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 2.7999999999999998 109.614 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -69.31 -39.91 77.98 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.737 -1.227 . . . . 0.40000000000000002 110.742 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -70.2 -39.96 74.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.661 -1.275 . . . . 0.23999999999999999 109.996 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.33 -60.38 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.81 -1.181 . . . . 0.42999999999999999 110.046 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.46 82.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.388 -1.085 . . . . 0.26000000000000001 110.388 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.7 t -68.54 -49.63 58.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.295 . . . . 0.25 109.681 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.1 mt -70.09 -40.07 75.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.323 -0.951 . . . . 0.29999999999999999 109.327 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -62.0 -40.59 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 2.73 109.596 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.02 -38.63 75.98 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.277 -0.889 . . . . 1.9099999999999999 110.077 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.557 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.4 t90 -61.69 -46.57 89.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.473 -1.392 . . . . 0.37 108.688 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 51.9 m -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.462 -0.774 . . . . 0.35999999999999999 109.573 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -58.87 -30.97 68.15 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 109.423 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.48 -34.75 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.269 -0.894 . . . . 0.47999999999999998 111.063 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 87.2 m-85 -108.94 -5.52 16.09 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.149 -0.969 . . . . 1.24 112.717 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.434 HD11 ' SD ' ' B' ' 15' ' ' MET . 10.5 tp . . . . . 0 N--CA 1.502 2.151 0 O-C-N 120.382 -1.448 . . . . 1.6599999999999999 109.288 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.46 -0.57 . . . . 5.6600000000000001 109.46 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 64.0 p -77.65 125.52 29.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 3.02 109.363 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -99.59 158.59 15.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.411 -0.806 . . . . 0.95999999999999996 109.467 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 54.3 p -80.17 177.72 8.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 1.5 109.642 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.84 -21.06 62.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 2.1800000000000002 110.624 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.97 -37.82 80.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.799 -1.188 . . . . 2.0099999999999998 109.619 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -60.0 -51.9 67.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.081 . . . . 0.48999999999999999 110.527 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -69.73 -36.51 75.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 3.23 109.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.41 -39.93 74.17 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.35 -0.844 . . . . 0.76000000000000001 109.793 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.44 -41.15 96.73 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.503 -0.879 . . . . 0.46000000000000002 109.933 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.53 15.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.081 -1.012 . . . . 0.44 109.857 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.97 -9.81 11.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.466 -0.771 . . . . 0.53000000000000003 110.362 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' B' ' 18' ' ' LYS . 10.5 pt-20 -149.86 149.14 27.14 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 120.903 -1.123 . . . . 1.27 109.208 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' B' ' 13' ' ' GLU . 92.3 Cg_exo -41.04 166.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.798 1.665 . . . . 0.48999999999999999 111.705 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 89' ' ' LEU . 3.3 ptp -93.29 -24.69 18.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 0.56000000000000005 108.699 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.61 -140.55 14.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.03 -1.628 . . . . 0.39000000000000001 109.03 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -109.65 30.1 6.97 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.512 -0.993 . . . . 0.83999999999999997 109.464 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' B' ' 13' ' ' GLU . 89.8 mttt -60.27 149.55 75.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.938 . . . . 2.02 108.856 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.35 153.98 56.14 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.204 1.936 . . . . 0.34000000000000002 112.422 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.534 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.5 p -57.64 -43.84 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.567 -0.708 . . . . 0.32000000000000001 110.545 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.534 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.83 -2.56 0.2 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.118 -1.193 . . . . 0.22 110.118 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.506 ' H ' ' C ' ' B' ' 20' ' ' VAL . 40.6 t -82.87 -23.39 33.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.399 . . . . 1.24 109.125 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.23999999999999999 109.869 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.16 134.22 52.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.788 0.804 . . . . 0.20999999999999999 110.075 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.528 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.98 -20.5 48.78 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.287 -1.525 . . . . 0.22 109.287 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.65 114.05 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -1.125 . . . . 0.25 108.024 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.6 178.3 39.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.262 -1.535 . . . . 0.28000000000000003 109.262 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -57.19 -39.57 75.62 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.315 -1.109 . . . . 2.0 109.236 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.28 -48.53 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.38 109.721 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.86 -40.07 83.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.159 -0.963 . . . . 0.40000000000000002 109.354 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.95 98.66 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.594 -1.403 . . . . 0.35999999999999999 109.594 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.83 -41.21 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -1.23 . . . . 2.75 110.301 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.41 -39.9 85.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.83 -1.169 . . . . 1.5600000000000001 109.772 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.94 -39.98 93.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.026 . . . . 0.33000000000000002 109.06 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.09 -40.94 91.34 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.79 -0.764 . . . . 1.6799999999999999 109.317 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -68.81 -19.46 64.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.824 -0.806 . . . . 1.99 108.824 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -89.01 0.39 56.71 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.092 -0.643 . . . . 2.6800000000000002 109.969 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.79 4.33 36.58 Favored Glycine 0 N--CA 1.504 3.17 0 O-C-N 121.105 -0.997 . . . . 0.48999999999999999 111.734 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.431 ' CD2' HG12 ' B' ' 44' ' ' VAL . 96.3 m-85 -103.33 75.83 1.38 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.818 -1.401 . . . . 0.33000000000000002 109.096 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -77.43 -10.97 59.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.40999999999999998 111.019 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -135.19 157.95 45.61 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.902 -1.124 . . . . 1.5600000000000001 109.444 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.49 88.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.547 -0.72 . . . . 0.20999999999999999 112.051 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -56.36 -18.13 9.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.721 -1.237 . . . . 0.32000000000000001 110.551 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' B' ' 39' ' ' PHE . 21.5 t -80.13 -31.36 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.884 -1.135 . . . . 0.23999999999999999 108.279 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.52 -38.75 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 0.22 108.425 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.03 -38.3 82.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.573 -1.64 . . . . 0.40000000000000002 106.573 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.74 -45.6 60.43 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.68 -1.368 . . . . 0.17999999999999999 109.68 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -60.17 -41.8 93.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.225 . . . . 1.0900000000000001 109.356 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.0 -40.49 89.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.017 -1.052 . . . . 0.31 108.753 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -69.77 -40.04 76.31 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.662 -0.866 . . . . 0.27000000000000002 108.662 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.68 -21.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.135 -0.978 . . . . 0.28000000000000003 110.613 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.91 14.02 13.14 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.048 -1.032 . . . . 0.29999999999999999 110.663 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 38' ' ' GLY . 59.8 mttp 50.79 36.32 14.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.812 -1.18 . . . . 1.71 110.227 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 55.91 19.41 3.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.308 -0.87 . . . . 2.25 110.618 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -69.01 105.58 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.72 -1.237 . . . . 1.8 108.18 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 83.5 tt0 -63.17 -39.96 96.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.88 111.977 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.45 -40.08 89.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.815 -1.178 . . . . 0.73999999999999999 109.553 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -71.1 -37.79 72.38 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.396 -0.921 . . . . 0.55000000000000004 108.848 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.8 -42.19 95.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.612 -0.68 . . . . 0.38 109.898 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 99.2 mtt180 -59.99 -48.96 79.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.244 -0.91 . . . . 2.6400000000000001 110.35 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.54 -39.94 92.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.689 -1.257 . . . . 2.3799999999999999 109.832 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -61.7 -49.97 74.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.921 -1.112 . . . . 0.40000000000000002 110.706 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.2 tp -68.43 -48.7 63.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.079 -1.013 . . . . 0.34000000000000002 110.032 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.06 -47.12 86.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 2.1000000000000001 109.767 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -68.85 -29.96 68.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 1.8999999999999999 109.656 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -80.17 -32.58 38.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.40000000000000002 111.045 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 32.0 p -132.94 -35.29 1.07 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.66 -1.275 . . . . 0.39000000000000001 112.045 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.72 16.48 9.28 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.292 -1.523 . . . . 0.35999999999999999 109.292 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 152.32 3.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.063 -1.257 . . . . 0.32000000000000001 109.76 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.1 173.62 8.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 1.9099999999999999 109.98 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.92 -34.3 75.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.38 110.093 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -71.38 -40.1 70.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 2.5699999999999998 109.593 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.6 mm100 -66.53 -39.15 88.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.488 -0.757 . . . . 2.1200000000000001 110.25 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 74.2 m -62.94 -38.58 91.61 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.268 -0.895 . . . . 1.3600000000000001 109.748 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.158 -0.964 . . . . 2.8100000000000001 109.626 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -69.32 -39.99 77.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.839 -1.163 . . . . 0.40000000000000002 110.716 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -70.14 -40.05 75.03 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.682 -1.261 . . . . 0.23000000000000001 109.968 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -61.18 -60.31 3.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.861 -1.149 . . . . 0.42999999999999999 110.162 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.34 82.14 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.46 -1.056 . . . . 0.25 110.46 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.66 -49.63 57.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.302 . . . . 0.23999999999999999 109.699 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.03 -40.04 75.42 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.295 -0.962 . . . . 0.28999999999999998 109.324 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -62.0 -40.68 96.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 2.7400000000000002 109.566 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -38.69 76.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.166 -0.959 . . . . 1.9099999999999999 110.153 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.555 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.2 t90 -61.75 -46.61 88.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.456 -1.403 . . . . 0.35999999999999999 108.702 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' B' ' 89' ' ' LEU . 51.6 m -60.08 -39.91 87.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.751 -0.78 . . . . 0.35999999999999999 109.686 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.05 -30.79 68.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.384 -0.822 . . . . 0.55000000000000004 109.406 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 -35.21 13.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.835 . . . . 0.46999999999999997 111.057 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.4 m-85 -108.31 -6.13 16.44 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.129 -0.982 . . . . 1.24 112.663 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.458 HD11 ' SD ' ' A' ' 15' ' ' MET . 10.4 tp . . . . . 0 N--CA 1.502 2.171 0 O-C-N 120.355 -1.466 . . . . 1.6699999999999999 109.371 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.389 -0.597 . . . . 5.6799999999999997 109.389 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.2 p -90.84 111.32 22.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.204 -0.935 . . . . 3.02 109.435 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.5 p -86.21 164.22 17.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.95999999999999996 109.321 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.7 m -78.85 170.91 15.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.932 . . . . 1.51 109.124 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.91 -28.66 67.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.548 -0.72 . . . . 2.1800000000000002 110.114 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -60.32 -39.62 87.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.949 -1.095 . . . . 2.02 109.644 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -59.85 -51.17 70.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.931 . . . . 0.48999999999999999 110.656 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 23.8 mmm180 -70.25 -34.45 72.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.814 -1.179 . . . . 3.21 109.685 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -68.74 -38.88 80.46 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.368 -0.833 . . . . 0.76000000000000001 110.023 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.55 -45.78 82.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.46000000000000002 110.173 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -86.26 7.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.124 -0.985 . . . . 0.44 110.812 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -102.2 -13.62 17.35 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.201 -0.937 . . . . 0.54000000000000004 110.056 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -154.54 153.55 28.05 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.977 . . . . 1.26 108.998 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -37.72 156.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 122.071 1.847 . . . . 0.48999999999999999 111.741 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.476 ' SD ' HD11 ' B' ' 89' ' ' LEU . 11.7 ptm -93.31 -28.2 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.56999999999999995 110.296 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.51 42.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.433 -1.067 . . . . 0.40000000000000002 110.433 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.64 35.89 3.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.614 -0.933 . . . . 0.84999999999999998 110.379 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -57.93 149.58 54.04 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.047 -1.033 . . . . 2.0099999999999998 108.313 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.94 155.31 55.93 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.069 1.846 . . . . 0.34000000000000002 112.551 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 21' ' ' GLY . 3.4 p -57.07 -47.16 84.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.479 0.657 . . . . 0.32000000000000001 110.387 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.67 -5.42 0.86 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 121.467 -0.77 . . . . 0.23000000000000001 111.223 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -84.21 -19.94 33.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.448 -1.619 . . . . 1.24 109.498 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.46 134.07 55.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.23999999999999999 109.29 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.21 133.33 52.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.669 -0.812 . . . . 0.20999999999999999 109.675 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.52 -21.22 47.07 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.129 -1.588 . . . . 0.22 109.129 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.75 112.4 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.25 108.405 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.98 -178.77 36.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.287 -1.525 . . . . 0.28000000000000003 109.287 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.88 -40.28 83.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -1.093 . . . . 2.0099999999999998 110.631 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.05 -46.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.72 -1.238 . . . . 0.38 109.14 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.3 -40.07 86.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.40000000000000002 109.483 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.69 96.73 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.913 -1.275 . . . . 0.34999999999999998 109.913 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.34 -38.18 85.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.001 -1.294 . . . . 2.7400000000000002 110.332 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.84 -45.15 87.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 1.54 109.748 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.8 mt -62.17 -40.09 94.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.013 -1.055 . . . . 0.34000000000000002 109.798 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.03 -40.1 88.19 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.476 -0.889 . . . . 1.6699999999999999 109.053 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -67.79 -19.16 65.06 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.81 6.61 40.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 2.6899999999999999 109.601 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 9.05 57.06 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 121.005 -1.059 . . . . 0.47999999999999998 111.544 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.494 ' CD2' HG12 ' A' ' 44' ' ' VAL . 86.0 m-85 -103.71 75.36 1.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.854 -1.38 . . . . 0.33000000000000002 108.858 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.18 -10.08 59.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.40999999999999998 111.248 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -140.69 161.57 37.47 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.896 -1.127 . . . . 1.5600000000000001 110.69 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.67 -43.64 92.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.20999999999999999 112.355 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 6.4 p90 -58.2 -18.43 25.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.801 -1.187 . . . . 0.32000000000000001 110.669 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.636 HG21 ' HZ3' ' B' ' 53' ' ' LYS . 24.5 t -80.06 -31.37 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.79 -1.189 . . . . 0.23999999999999999 107.79 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.63 -40.03 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.185 -1.042 . . . . 0.22 108.185 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.8 tp -59.02 -34.65 72.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.882 -1.525 . . . . 0.40000000000000002 106.882 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.01 -40.72 97.37 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.593 -1.403 . . . . 0.17999999999999999 109.593 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.403 ' NE2' ' NE1' ' A' ' 62' ' ' TRP . 12.6 tp60 -60.03 -41.97 93.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.261 . . . . 1.0900000000000001 108.987 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -60.24 -41.54 93.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.31 108.705 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -70.27 -40.0 74.61 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.548 -0.861 . . . . 0.28000000000000003 108.921 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.93 -25.11 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.28000000000000003 110.671 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 52' ' ' LEU . 85.9 mt -92.29 15.3 14.05 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.949 -1.095 . . . . 0.31 110.491 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 67.8 mttm 52.41 40.29 29.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.088 -1.007 . . . . 1.7 110.548 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 pttt 40.3 19.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.01 -1.056 . . . . 2.2400000000000002 111.873 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 17.9 t0 -66.85 117.55 9.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.671 -1.603 . . . . 1.8 106.671 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.87 -40.17 94.45 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.483 0.92 . . . . 0.87 113.483 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 96.1 m-20 -70.21 -39.86 74.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.416 -1.428 . . . . 0.72999999999999998 109.937 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.09 -39.86 68.64 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.935 -1.106 . . . . 0.55000000000000004 108.6 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -61.83 -49.92 74.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.38 109.957 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.4 mtm180 -61.84 -42.65 99.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 2.6400000000000001 110.616 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.73 -39.24 93.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 2.3700000000000001 109.25 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.403 ' NE1' ' NE2' ' A' ' 48' ' ' GLN . 70.3 t90 -61.22 -49.28 77.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.029 -1.044 . . . . 0.40000000000000002 110.735 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.23 -49.28 65.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 0.34000000000000002 109.857 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -61.89 -47.26 85.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.393 -0.817 . . . . 2.1099999999999999 109.864 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.0 t0 -69.04 -31.13 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 1.8999999999999999 109.864 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -79.75 -33.08 41.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.40999999999999998 111.366 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.1 p -132.54 -31.72 1.36 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.58 -1.325 . . . . 0.40000000000000002 111.574 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 15.79 12.63 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.075 -1.61 . . . . 0.35999999999999999 109.075 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.02 153.49 3.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -1.205 . . . . 0.33000000000000002 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -94.93 176.22 6.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 1.8999999999999999 109.825 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -35.35 75.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.586 -0.696 . . . . 0.39000000000000001 111.23 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -70.13 -42.84 72.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.52 -1.362 . . . . 2.5800000000000001 110.57 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 73' ' ' GLN . 16.7 mp0 -67.94 -39.18 83.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -0.963 . . . . 2.1200000000000001 110.965 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 t -67.95 -38.35 82.7 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.809 -1.182 . . . . 1.3600000000000001 110.198 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -60.72 -38.79 86.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.742 -1.224 . . . . 2.7999999999999998 109.913 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.26 -39.62 82.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.561 -1.337 . . . . 0.40000000000000002 110.417 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.71 -40.09 76.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.965 -1.085 . . . . 0.23999999999999999 109.518 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -59.4 -60.34 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.179 -0.95 . . . . 0.42999999999999999 109.424 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.51 -33.63 87.76 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.694 -0.962 . . . . 0.26000000000000001 110.694 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -1.234 . . . . 0.25 109.636 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.1 mt -70.27 -39.97 74.62 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.962 -1.095 . . . . 0.29999999999999999 108.391 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -65.1 -40.16 94.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.86 . . . . 2.73 110.309 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.62 -39.69 80.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 1.9099999999999999 110.6 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 88.4 t90 -60.23 -42.28 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.343 -1.473 . . . . 0.37 107.581 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 89' ' ' LEU . 63.5 m -60.16 -40.09 88.7 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.783 0.801 . . . . 0.35999999999999999 109.279 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.6 -33.95 72.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.218 -0.927 . . . . 0.55000000000000004 109.698 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.18 -34.56 14.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.195 -0.94 . . . . 0.47999999999999998 111.285 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.551 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.8 m-85 -108.98 3.11 21.81 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.116 -0.99 . . . . 1.24 111.482 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' CYS . 8.5 tp . . . . . 0 N--CA 1.497 1.88 0 O-C-N 120.936 -1.102 . . . . 1.6599999999999999 109.357 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.37 -0.604 . . . . 5.6600000000000001 109.37 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 34.5 p -90.72 111.11 22.33 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.13 -0.981 . . . . 3.02 109.397 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 30.4 p -85.93 164.16 17.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.95999999999999996 109.413 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -78.63 170.82 16.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 1.5 109.1 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.19 -28.24 67.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.612 -0.68 . . . . 2.1800000000000002 110.07 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.5 -39.57 88.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.123 -0.986 . . . . 2.0099999999999998 109.637 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -59.84 -51.32 70.23 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.261 -0.899 . . . . 0.48999999999999999 110.635 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 23.8 mmm180 -70.19 -34.23 72.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.896 -1.127 . . . . 3.23 109.854 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -68.88 -39.35 79.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.376 -0.828 . . . . 0.76000000000000001 109.785 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.13 -46.17 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.46000000000000002 110.119 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.0 m -86.09 8.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.141 -0.975 . . . . 0.44 110.749 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -102.7 -13.44 17.08 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.192 -0.942 . . . . 0.53000000000000003 109.911 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.54 153.38 27.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 1.27 108.98 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -37.89 156.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.059 1.839 . . . . 0.48999999999999999 111.719 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 11.6 ptm -93.2 -28.13 16.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.56000000000000005 110.271 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.18 -133.33 41.87 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.412 -1.075 . . . . 0.39000000000000001 110.412 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.81 36.01 3.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.596 -0.944 . . . . 0.83999999999999997 110.302 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -58.09 149.83 54.53 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.871 -1.143 . . . . 2.02 108.329 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.87 155.17 56.34 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.168 1.912 . . . . 0.34000000000000002 112.537 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.443 HG13 ' N ' ' B' ' 21' ' ' GLY . 3.5 p -57.16 -46.53 84.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.602 0.715 . . . . 0.32000000000000001 110.496 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.443 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -56.07 -5.25 0.95 Allowed Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.45 -0.782 . . . . 0.22 111.248 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 59.5 m -84.4 -20.32 32.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.553 -1.557 . . . . 1.24 109.435 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.14 133.86 55.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.23999999999999999 109.237 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.14 133.34 52.75 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.586 -0.845 . . . . 0.20999999999999999 109.714 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.62 -20.98 48.26 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.25 -1.54 . . . . 0.22 109.25 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.03 112.6 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -1.088 . . . . 0.25 108.365 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.22 -178.86 35.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.174 -1.57 . . . . 0.28000000000000003 109.174 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -58.65 -40.07 82.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.422 -1.046 . . . . 2.0 110.713 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.04 -46.57 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.642 -1.286 . . . . 0.38 109.196 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.21 -39.95 86.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.40000000000000002 109.545 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.56 97.19 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.835 -1.306 . . . . 0.35999999999999999 109.835 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.21 -38.64 87.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.266 . . . . 2.75 110.189 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.59 -45.06 88.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.712 -1.243 . . . . 1.5600000000000001 109.603 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.13 -39.9 94.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.835 -1.166 . . . . 0.33000000000000002 109.822 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.42 -40.05 89.66 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.579 -0.848 . . . . 1.6799999999999999 108.896 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -67.82 -19.18 65.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.215 -1.031 . . . . 1.99 108.215 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.86 6.87 39.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.533 -0.73 . . . . 2.6800000000000002 109.603 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.42 9.07 57.06 Favored Glycine 0 N--CA 1.5 2.939 0 O-C-N 120.961 -1.087 . . . . 0.48999999999999999 111.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' B' ' 44' ' ' VAL . 86.6 m-85 -104.1 75.46 1.27 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.929 -1.336 . . . . 0.33000000000000002 108.948 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.37 -9.98 59.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.883 . . . . 0.40999999999999998 111.176 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -140.66 161.78 36.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.852 -1.155 . . . . 1.5600000000000001 110.712 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.77 -43.84 91.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.835 -0.54 . . . . 0.20999999999999999 112.314 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 5.7 p90 -57.84 -18.72 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.32000000000000001 110.733 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.0 t -80.12 -31.11 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.79 -1.194 . . . . 0.23999999999999999 107.849 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.81 -39.92 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.173 -1.047 . . . . 0.22 108.173 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.6 tp -59.03 -34.84 72.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.983 -1.488 . . . . 0.40000000000000002 106.983 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.99 97.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.494 -1.442 . . . . 0.17999999999999999 109.494 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.423 ' NE2' ' NE1' ' B' ' 62' ' ' TRP . 12.1 tp60 -59.84 -42.04 92.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 1.0900000000000001 108.961 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.11 -41.54 92.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.31 108.727 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.41 -40.18 74.02 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.537 -0.865 . . . . 0.27000000000000002 108.889 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.92 -24.66 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 110.785 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 52' ' ' LEU . 84.4 mt -92.55 15.81 13.4 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.037 -1.039 . . . . 0.29999999999999999 110.368 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.636 ' HZ3' HG21 ' A' ' 44' ' ' VAL . 67.8 mttm 51.98 40.19 27.74 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.904 -1.122 . . . . 1.71 110.635 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 47.8 pttt 40.49 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.135 -0.978 . . . . 2.25 111.711 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 53' ' ' LYS . 19.3 t0 -66.78 117.77 9.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.52 -1.659 . . . . 1.8 106.52 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.62 -40.93 96.61 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.127 -0.983 . . . . 0.88 113.458 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.52 -39.97 77.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.437 -1.414 . . . . 0.73999999999999999 110.107 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.18 -39.95 68.29 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.005 -1.078 . . . . 0.55000000000000004 108.552 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.7 -50.14 73.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.833 . . . . 0.38 109.96 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -61.56 -43.05 99.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 2.6400000000000001 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -64.54 -38.9 92.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.848 -1.158 . . . . 2.3799999999999999 109.392 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' TRP . . . . . 0.423 ' NE1' ' NE2' ' B' ' 48' ' ' GLN . 70.8 t90 -61.33 -49.17 78.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.40000000000000002 110.818 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 32.8 tp -67.38 -49.49 63.71 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.329 -0.857 . . . . 0.34000000000000002 109.835 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.77 -47.02 87.05 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.373 -0.829 . . . . 2.1000000000000001 109.939 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' B' ' 65' ' ' ASP . 33.7 t0 -69.17 -31.08 69.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.436 -0.79 . . . . 1.8999999999999999 109.926 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 55.4 m -79.76 -33.2 40.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.40000000000000002 111.341 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.32 -32.26 1.37 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.718 -1.239 . . . . 0.39000000000000001 111.62 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.32 16.13 11.58 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.144 -1.582 . . . . 0.35999999999999999 109.144 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.16 153.53 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.301 . . . . 0.32000000000000001 109.358 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -94.81 176.22 6.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 1.9099999999999999 109.77 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.17 75.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.608 -0.682 . . . . 0.38 111.255 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -70.07 -42.73 72.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.511 -1.368 . . . . 2.5699999999999998 110.611 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' B' ' 73' ' ' GLN . 16.5 mp0 -67.99 -39.43 83.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.198 -0.939 . . . . 2.1200000000000001 111.021 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.8 t -67.83 -38.04 82.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.037 -1.039 . . . . 1.3600000000000001 110.08 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -61.2 -38.34 86.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.775 -1.203 . . . . 2.8100000000000001 109.92 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.5 -39.88 81.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.439 -1.413 . . . . 0.40000000000000002 110.322 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 99.0 m -69.7 -40.2 76.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.824 -1.173 . . . . 0.23000000000000001 109.473 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.51 -60.02 4.51 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.096 -1.003 . . . . 0.42999999999999999 109.339 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.69 -33.63 87.75 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.618 -0.993 . . . . 0.25 110.618 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.38 -46.12 61.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.985 -1.303 . . . . 0.23999999999999999 109.588 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.85 -40.14 75.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.095 -1.042 . . . . 0.28999999999999998 108.247 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -65.14 -40.08 93.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 2.7400000000000002 110.214 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.49 -39.9 81.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 1.9099999999999999 110.419 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.544 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 88.5 t90 -60.44 -42.34 95.91 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.314 -1.491 . . . . 0.35999999999999999 107.521 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' B' ' 89' ' ' LEU . 63.7 m -60.03 -40.14 88.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.436 -0.79 . . . . 0.35999999999999999 109.271 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.46 -33.82 71.77 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.364 -0.835 . . . . 0.55000000000000004 109.842 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.11 13.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.121 -0.987 . . . . 0.46999999999999997 111.192 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.544 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 97.1 m-85 -107.84 2.25 23.38 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.206 -0.934 . . . . 1.24 111.636 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.498 1.962 0 O-C-N 120.938 -1.101 . . . . 1.6699999999999999 109.363 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.98 -0.748 . . . . 5.6799999999999997 108.98 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 2' ' ' THR . 0.5 OUTLIER -85.82 7.84 22.36 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.238 -1.023 . . . . 3.02 108.238 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 p -73.48 169.79 16.47 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.485 0.66 . . . . 0.95999999999999996 110.12 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -61.84 173.2 1.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 1.51 110.097 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -59.96 -20.87 59.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.75 -0.594 . . . . 2.1800000000000002 110.896 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -60.05 -38.48 82.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.868 -1.145 . . . . 2.02 109.543 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -59.93 -51.69 68.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.08 . . . . 0.48999999999999999 110.652 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 58.8 mtt-85 -69.96 -35.19 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.837 -1.164 . . . . 3.21 110.139 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.78 -39.95 84.03 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.396 -0.815 . . . . 0.76000000000000001 109.321 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.19 -48.21 76.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.465 -0.772 . . . . 0.46000000000000002 109.967 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 m -86.59 8.13 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.129 -0.982 . . . . 0.44 110.992 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -99.5 -16.94 18.14 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.937 -1.102 . . . . 0.54000000000000004 110.035 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.5 pt-20 -155.6 152.49 24.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 1.26 108.469 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 92.4 Cg_exo -35.49 154.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.2 1.933 . . . . 0.48999999999999999 111.713 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.634 ' CE ' HD22 ' A' ' 46' ' ' LEU . 7.4 ptp -91.16 -23.76 20.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.909 -1.12 . . . . 0.56999999999999995 109.89 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.35 -135.47 32.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.384 -1.086 . . . . 0.40000000000000002 110.384 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -110.0 38.78 2.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.597 -0.943 . . . . 0.84999999999999998 110.158 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -59.93 149.99 71.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.044 . . . . 2.0099999999999998 108.738 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.03 148.92 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.32 2.013 . . . . 0.34000000000000002 112.588 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 p -52.73 -30.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.475 0.655 . . . . 0.32000000000000001 110.387 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.61 -3.57 67.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.745 -0.942 . . . . 0.23000000000000001 110.745 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.0 t -83.29 -20.79 33.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.746 -1.444 . . . . 1.24 109.339 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.481 HD22 HD21 ' A' ' 81' ' ' LEU . 84.3 mt -62.54 135.57 57.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.23999999999999999 109.703 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.72 133.19 53.11 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.694 0.759 . . . . 0.20999999999999999 109.671 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.73 -19.98 52.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 0.22 109.255 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.3 mm -98.55 112.78 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.069 -1.085 . . . . 0.25 108.069 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.48 178.06 39.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.803 -1.319 . . . . 0.28000000000000003 109.803 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.76 -40.01 75.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.461 -1.023 . . . . 2.0099999999999998 109.766 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.35 -44.9 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.38 109.671 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.69 -38.05 85.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.40000000000000002 109.413 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.43 -38.61 91.24 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.546 -1.422 . . . . 0.34999999999999998 109.546 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.49 -39.16 93.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -1.151 . . . . 2.7400000000000002 110.823 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.1 -44.58 79.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.742 -1.224 . . . . 1.54 109.808 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.53 -39.93 95.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.34000000000000002 108.742 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.0 -42.46 94.31 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.656 -0.818 . . . . 1.6699999999999999 109.411 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.3 -19.5 65.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.0 108.783 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -91.11 1.81 56.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.654 -0.654 . . . . 2.6899999999999999 109.948 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.45 4.22 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.083 -1.011 . . . . 0.47999999999999998 110.801 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.476 ' CD2' HG12 ' A' ' 44' ' ' VAL . 82.8 m-85 -132.41 70.94 1.46 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -1.231 . . . . 0.33000000000000002 108.239 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.43 -10.53 59.52 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.272 -0.971 . . . . 0.40999999999999998 109.905 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -131.29 153.16 49.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.375 -0.828 . . . . 1.5600000000000001 108.808 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.9 90.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.20999999999999999 111.205 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.483 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -56.59 -17.67 9.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.884 -1.135 . . . . 0.32000000000000001 110.994 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.476 HG12 ' CD2' ' A' ' 39' ' ' PHE . 46.8 t -79.77 -29.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.178 . . . . 0.23999999999999999 107.936 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.1 -36.8 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.308 -0.997 . . . . 0.22 108.308 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.634 HD22 ' CE ' ' A' ' 15' ' ' MET . 19.0 tp -60.03 -39.29 85.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.134 -1.432 . . . . 0.40000000000000002 107.134 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.71 -43.7 94.37 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.108 -1.197 . . . . 0.17999999999999999 110.108 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.98 -42.69 94.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.752 -1.44 . . . . 1.0900000000000001 109.053 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.98 -42.27 93.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.863 . . . . 0.31 108.943 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -68.96 -38.19 79.27 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.727 -0.842 . . . . 0.28000000000000003 108.727 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.43 -22.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.28000000000000003 110.046 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 16.75 10.99 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.144 -0.972 . . . . 0.31 109.789 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' NZ ' HG21 ' B' ' 44' ' ' VAL . 58.8 mttm 50.0 39.55 19.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.975 -1.078 . . . . 1.7 110.505 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.31 19.28 4.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.2400000000000002 109.747 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.13 108.54 4.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.727 -1.233 . . . . 1.8 108.021 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -61.04 -40.0 91.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.555 -0.716 . . . . 0.87 112.556 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.09 -40.09 78.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.644 -1.285 . . . . 0.72999999999999998 110.385 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.21 75.34 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.93 -1.108 . . . . 0.55000000000000004 109.009 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.85 -50.1 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.83 . . . . 0.38 110.05 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -59.94 -46.37 89.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 2.6400000000000001 110.587 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -65.74 -38.57 89.49 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.042 -1.036 . . . . 2.3700000000000001 109.14 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -66.06 -48.34 71.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.40000000000000002 111.073 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -66.22 -46.32 77.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.211 -0.931 . . . . 0.34000000000000002 109.152 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.91 -45.75 91.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.389 -0.819 . . . . 2.1099999999999999 109.089 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.63 -31.87 70.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.641 -0.662 . . . . 1.8999999999999999 109.85 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -80.41 -31.37 37.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 0.40999999999999998 111.487 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.73 -25.78 1.84 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.528 -1.358 . . . . 0.40000000000000002 111.876 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.14 29.19 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.422 -1.471 . . . . 0.35999999999999999 109.422 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.43 153.49 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.046 -1.267 . . . . 0.33000000000000002 109.252 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -92.12 174.29 7.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.034 -1.041 . . . . 1.8999999999999999 110.242 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.08 78.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.668 -0.645 . . . . 0.39000000000000001 110.826 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -75.11 -38.23 61.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.84 -1.163 . . . . 2.5800000000000001 109.731 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -67.13 -38.77 86.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 2.1200000000000001 110.013 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 p -67.12 -37.75 84.39 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 1.3600000000000001 109.895 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.32 -38.39 83.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.079 -1.013 . . . . 2.7999999999999998 109.604 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.56 -40.07 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.707 -1.246 . . . . 0.40000000000000002 110.797 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.1 -40.02 78.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 0.23999999999999999 110.111 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.52 -60.45 3.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.628 -1.295 . . . . 0.42999999999999999 110.246 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.72 -32.47 81.72 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.483 -1.047 . . . . 0.26000000000000001 110.483 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.72 -47.77 58.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.273 . . . . 0.25 109.87 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.481 HD21 HD22 ' A' ' 23' ' ' LEU . 61.1 mt -70.22 -39.92 74.82 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.105 -1.038 . . . . 0.29999999999999999 109.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 82' ' ' ARG . 33.2 ttt-85 -63.66 -39.99 95.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 2.73 110.322 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.39 -38.18 77.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.105 -0.997 . . . . 1.9099999999999999 110.285 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.448 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.5 t90 -59.99 -45.46 92.64 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.405 -1.435 . . . . 0.37 107.809 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . 52.2 m -59.98 -40.11 88.0 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.687 0.756 . . . . 0.35999999999999999 109.344 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.97 -34.61 73.52 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.348 -0.845 . . . . 0.55000000000000004 110.099 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.0 -36.31 13.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.196 -0.94 . . . . 0.47999999999999998 111.176 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.3 m-85 -107.87 1.43 22.74 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.176 -0.952 . . . . 1.24 111.324 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' CYS . 7.1 tp . . . . . 0 N--CA 1.496 1.829 0 O-C-N 120.85 -1.157 . . . . 1.6599999999999999 108.981 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.987 -0.746 . . . . 5.6600000000000001 108.987 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.73 8.0 21.48 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.215 -1.031 . . . . 3.02 108.215 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 22.7 p -73.68 169.8 16.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.555 0.693 . . . . 0.95999999999999996 109.966 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -61.76 173.18 1.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.82 0.819 . . . . 1.5 110.055 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -60.04 -20.89 60.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 2.1800000000000002 110.892 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -60.04 -38.42 82.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.902 -1.124 . . . . 2.0099999999999998 109.506 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -60.03 -51.73 68.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.979 -1.075 . . . . 0.48999999999999999 110.58 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 58.7 mtt-85 -69.95 -34.99 74.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 3.23 110.094 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.95 -39.96 83.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.76000000000000001 109.311 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -64.32 -48.28 76.2 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.832 -0.747 . . . . 0.46000000000000002 109.859 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -86.51 8.33 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.083 -1.011 . . . . 0.44 111.014 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -99.65 -16.86 18.05 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.53000000000000003 109.985 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' B' ' 14' ' ' PRO . 13.3 pt-20 -155.64 152.44 24.29 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.111 -0.993 . . . . 1.27 108.422 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' B' ' 13' ' ' GLU . 97.9 Cg_exo -35.42 154.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.159 1.906 . . . . 0.48999999999999999 111.748 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.632 ' CE ' HD22 ' B' ' 46' ' ' LEU . 7.5 ptp -90.92 -23.84 20.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.022 -1.049 . . . . 0.56000000000000005 109.881 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.3 -135.59 31.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.309 -1.117 . . . . 0.39000000000000001 110.309 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -109.95 38.83 2.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.65 -0.912 . . . . 0.83999999999999997 110.092 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.9 149.94 71.07 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 120.999 -1.063 . . . . 2.02 108.851 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.95 148.83 92.32 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.398 2.065 . . . . 0.34000000000000002 112.499 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.1 p -52.81 -29.92 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.62 -0.675 . . . . 0.32000000000000001 110.409 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.77 -3.27 67.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.742 -0.943 . . . . 0.22 110.742 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t -83.44 -20.67 33.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.699 -1.471 . . . . 1.24 109.318 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.477 HD22 HD21 ' B' ' 81' ' ' LEU . 84.4 mt -62.7 135.62 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.23999999999999999 109.642 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.67 133.09 53.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.20999999999999999 109.725 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 -20.01 52.34 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.271 -1.531 . . . . 0.22 109.271 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -98.56 112.73 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.024 -1.102 . . . . 0.25 108.024 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.49 178.05 39.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.76 -1.336 . . . . 0.28000000000000003 109.76 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.8 -39.9 74.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.391 -1.064 . . . . 2.0 109.75 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.41 -45.01 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.38 109.577 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.73 -37.72 85.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.40000000000000002 109.437 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.57 -38.68 91.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.509 -1.436 . . . . 0.35999999999999999 109.509 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.45 -39.2 93.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -1.101 . . . . 2.75 110.793 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.04 -44.62 79.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.155 . . . . 1.5600000000000001 109.746 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.67 -39.93 95.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.014 . . . . 0.33000000000000002 108.684 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.39 94.13 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.637 -0.825 . . . . 1.6799999999999999 109.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -66.37 -19.52 65.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 1.99 108.765 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -90.97 1.76 56.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.712 -0.617 . . . . 2.6800000000000002 109.973 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.72 37.43 4.21 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.219 -0.991 . . . . 0.48999999999999999 110.734 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.487 ' CD2' HG12 ' B' ' 44' ' ' VAL . 83.2 m-85 -132.34 70.95 1.46 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.027 -1.278 . . . . 0.33000000000000002 108.213 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -77.53 -10.46 59.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.109 -0.994 . . . . 0.40999999999999998 109.823 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -131.43 153.17 49.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.345 -0.847 . . . . 1.5600000000000001 108.885 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.98 91.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.20999999999999999 111.244 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' B' ' 43' ' ' TYR . 4.5 p90 -56.5 -17.81 9.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.999 -1.063 . . . . 0.32000000000000001 111.034 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' B' ' 39' ' ' PHE . 46.7 t -79.62 -29.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.23999999999999999 108.003 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.34 -36.75 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.15 -1.056 . . . . 0.22 108.15 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.632 HD22 ' CE ' ' B' ' 15' ' ' MET . 18.7 tp -59.91 -39.32 85.02 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.195 -1.409 . . . . 0.40000000000000002 107.195 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -43.78 94.17 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.134 -1.186 . . . . 0.17999999999999999 110.134 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.95 -42.63 94.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.868 -1.372 . . . . 1.0900000000000001 109.078 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.02 -42.33 94.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.31 108.887 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.94 -38.4 79.46 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.69 -0.856 . . . . 0.27000000000000002 108.69 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.27 -22.68 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -0.9 . . . . 0.28000000000000003 110.065 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 93.8 mt -92.59 16.88 11.08 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.125 -0.984 . . . . 0.29999999999999999 109.786 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.459 ' NZ ' HG21 ' A' ' 44' ' ' VAL . 58.8 mttm 49.98 39.64 19.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.926 -1.108 . . . . 1.71 110.539 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.19 19.15 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 2.25 109.796 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' B' ' 55' ' ' ASP . 19.8 t0 -70.11 108.54 4.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.714 -1.241 . . . . 1.8 108.089 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.01 -39.93 91.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.685 -0.635 . . . . 0.88 112.653 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.17 -39.97 78.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.648 -1.282 . . . . 0.73999999999999999 110.401 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.32 75.27 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.005 -1.078 . . . . 0.55000000000000004 109.071 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.78 -50.07 70.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.354 -0.841 . . . . 0.38 110.042 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -60.07 -46.4 89.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 2.6400000000000001 110.513 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -65.8 -38.45 88.99 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.899 -1.125 . . . . 2.3799999999999999 109.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -66.0 -48.33 71.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.99 -1.069 . . . . 0.40000000000000002 111.063 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.14 -46.61 76.89 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.175 -0.953 . . . . 0.34000000000000002 109.129 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.85 -45.67 91.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.342 -0.849 . . . . 2.1000000000000001 109.125 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.65 -31.85 70.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.653 . . . . 1.8999999999999999 109.839 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -80.36 -31.54 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.40000000000000002 111.486 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.53 -25.67 1.9 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.486 -1.384 . . . . 0.39000000000000001 112.011 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.39 13.04 29.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.428 -1.469 . . . . 0.35999999999999999 109.428 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.43 153.38 1.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.964 -1.315 . . . . 0.32000000000000001 109.205 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -92.01 174.2 7.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.043 -1.036 . . . . 1.9099999999999999 110.294 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.96 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 0.38 110.936 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -75.13 -38.32 61.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.115 . . . . 2.5699999999999998 109.697 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -67.13 -38.68 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 2.1200000000000001 109.99 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -67.17 -37.69 84.15 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 1.3600000000000001 109.916 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.33 -38.38 83.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.147 -0.971 . . . . 2.8100000000000001 109.606 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.68 -39.99 84.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.613 -1.305 . . . . 0.40000000000000002 110.727 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -69.26 -39.98 78.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.838 -1.164 . . . . 0.23000000000000001 110.086 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.49 -60.36 3.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.564 -1.335 . . . . 0.42999999999999999 110.235 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.61 82.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.47 -1.052 . . . . 0.25 110.47 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.0 t -70.69 -47.77 58.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.064 -1.256 . . . . 0.23999999999999999 109.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.477 HD21 HD22 ' B' ' 23' ' ' LEU . 62.2 mt -70.15 -39.98 75.03 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.089 -1.044 . . . . 0.28999999999999998 109.074 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' B' ' 82' ' ' ARG . 33.3 ttt-85 -63.62 -40.04 95.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 2.7400000000000002 110.312 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.31 -38.32 78.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 1.9099999999999999 110.213 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.435 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 86.6 t90 -60.0 -45.35 93.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.468 -1.395 . . . . 0.35999999999999999 107.869 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 52.6 m -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.643 0.735 . . . . 0.35999999999999999 109.284 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.0 -34.64 73.6 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.397 -0.814 . . . . 0.55000000000000004 110.071 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.05 -36.75 13.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.167 -0.958 . . . . 0.46999999999999997 111.161 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.4 m-85 -107.0 0.76 23.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.232 -0.918 . . . . 1.24 111.467 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 85' ' ' CYS . 6.9 tp . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.865 -1.147 . . . . 1.6699999999999999 109.11 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.442 -0.577 . . . . 5.6799999999999997 109.442 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 p 55.16 36.75 27.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.218 -0.926 . . . . 3.02 109.304 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p -81.71 160.96 23.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.95999999999999996 110.493 -179.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 t -78.65 173.29 12.59 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.65 0.738 . . . . 1.51 109.488 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.92 -24.59 64.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.746 -0.596 . . . . 2.1800000000000002 110.127 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.921 -1.112 . . . . 2.02 108.98 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -60.04 -49.07 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.48999999999999999 110.201 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' A' ' 8' ' ' ARG . 53.9 mtt-85 -70.07 -31.99 69.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 3.21 109.648 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.54 -40.02 80.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.98 . . . . 0.76000000000000001 109.801 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.3 t80 -62.58 -48.17 80.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.46000000000000002 110.133 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.98 10.11 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.155 -0.966 . . . . 0.44 110.506 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.67 -14.22 15.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.23 -0.919 . . . . 0.54000000000000004 109.881 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.31 152.84 27.17 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.148 -0.97 . . . . 1.26 109.025 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.2 162.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.751 1.634 . . . . 0.48999999999999999 111.5 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.479 ' SD ' HD11 ' B' ' 89' ' ' LEU . 6.8 ptp -92.49 -21.44 20.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.025 -1.047 . . . . 0.56999999999999995 109.787 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.79 -139.91 16.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.037 -1.225 . . . . 0.40000000000000002 110.037 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.73 30.89 5.4 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.427 -1.043 . . . . 0.84999999999999998 110.481 -178.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -60.1 149.23 75.6 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.872 -1.142 . . . . 2.0099999999999998 108.676 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.2 158.68 50.91 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.984 1.79 . . . . 0.34000000000000002 111.992 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 21' ' ' GLY . 14.4 p -57.16 -45.77 84.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.457 -0.777 . . . . 0.32000000000000001 110.483 -179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.55 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.54 -3.19 0.38 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.757 -0.937 . . . . 0.23000000000000001 110.757 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 20' ' ' VAL . 47.0 m -82.08 -22.14 36.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.781 -1.423 . . . . 1.24 109.424 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.449 HD22 HD21 ' A' ' 81' ' ' LEU . 86.0 mt -64.0 139.2 58.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.23999999999999999 109.776 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 136.38 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.756 -0.777 . . . . 0.20999999999999999 109.718 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.54 -18.43 57.5 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.235 -1.546 . . . . 0.22 109.235 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.4 110.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.875 -1.158 . . . . 0.25 107.875 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.459 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -91.56 178.65 41.37 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.665 -1.374 . . . . 0.28000000000000003 109.665 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.31 -40.02 73.68 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.498 -1.001 . . . . 2.0099999999999998 110.351 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.72 -41.22 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.637 -1.289 . . . . 0.38 109.625 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.485 HD11 ' NE2' ' A' ' 73' ' ' GLN . 96.2 mt -67.72 -38.45 83.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.40000000000000002 109.745 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -40.08 96.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.119 -1.192 . . . . 0.34999999999999998 110.119 -179.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.78 -36.27 83.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.885 -1.362 . . . . 2.7400000000000002 109.486 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.6 -53.65 26.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.139 . . . . 1.54 109.546 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.02 -39.96 87.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.118 -1.067 . . . . 0.34000000000000002 108.118 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.09 -46.04 90.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.484 -0.76 . . . . 1.6699999999999999 109.344 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.68 -19.83 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.44 -0.948 . . . . 2.0 108.44 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.91 3.74 52.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.696 -0.627 . . . . 2.6899999999999999 109.726 -179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.21 50.7 Favored Glycine 0 N--CA 1.503 3.107 0 O-C-N 121.039 -1.038 . . . . 0.47999999999999998 111.432 177.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.556 ' CD2' HG12 ' A' ' 44' ' ' VAL . 90.8 m-85 -106.2 74.98 1.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.913 -1.346 . . . . 0.33000000000000002 108.941 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -80.31 -9.24 59.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.40999999999999998 110.965 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.92 152.77 50.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.122 -0.986 . . . . 1.5600000000000001 109.836 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.19 96.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.622 -0.674 . . . . 0.20999999999999999 111.13 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 8.6 p90 -58.45 -18.99 32.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.826 -1.171 . . . . 0.32000000000000001 110.414 -178.014 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG12 ' CD2' ' A' ' 39' ' ' PHE . 25.9 t -80.71 -30.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.904 -1.123 . . . . 0.23999999999999999 108.366 179.188 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.64 -39.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.172 -1.047 . . . . 0.22 108.172 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.1 tp -59.95 -39.45 85.6 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.624 -1.25 . . . . 0.40000000000000002 107.624 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.13 -45.04 74.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.654 -1.379 . . . . 0.17999999999999999 109.654 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.99 -43.19 95.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.119 -1.224 . . . . 1.0900000000000001 109.153 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.06 -39.98 87.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.427 -0.953 . . . . 0.31 108.427 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.81 -38.67 83.59 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.429 -0.952 . . . . 0.28000000000000003 108.429 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.99 -22.13 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.28000000000000003 110.736 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -93.15 17.06 11.59 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.96 -1.087 . . . . 0.31 110.388 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.77 34.39 10.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.873 -1.142 . . . . 1.7 110.229 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.6 mttp 59.55 20.0 8.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.456 -0.778 . . . . 2.2400000000000002 109.83 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.02 114.52 5.25 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.623 -1.251 . . . . 1.8 107.623 178.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 40.0 tt0 -63.46 -41.38 98.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.87 112.519 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.04 -39.76 75.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.604 -1.31 . . . . 0.72999999999999998 110.765 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.16 -39.93 78.47 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.873 -1.131 . . . . 0.55000000000000004 109.551 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.69 -49.83 71.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.38 109.402 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 60' ' ' ARG . 44.3 mtt-85 -60.0 -46.61 88.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.809 . . . . 2.6400000000000001 110.513 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.37 -38.55 90.38 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.966 -1.084 . . . . 2.3700000000000001 108.943 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.41 ' O ' ' OG1' ' A' ' 66' ' ' THR . 59.5 t90 -64.29 -47.01 81.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.40000000000000002 110.541 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 tp -67.57 -47.02 71.01 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.274 -0.891 . . . . 0.34000000000000002 110.254 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -62.58 -47.5 83.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 2.1099999999999999 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -69.47 -28.68 66.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.885 . . . . 1.8999999999999999 109.732 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.8 m -80.43 -33.94 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.331 -0.856 . . . . 0.40999999999999998 111.41 -178.197 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.4 p -132.23 -29.82 1.58 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.53 -1.356 . . . . 0.40000000000000002 111.93 -178.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.51 20.95 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.231 -1.548 . . . . 0.35999999999999999 109.231 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.38 2.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.275 . . . . 0.33000000000000002 109.23 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -90.61 171.49 9.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 1.8999999999999999 109.529 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.5 75.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.39000000000000001 110.416 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.53 -41.26 69.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 2.5800000000000001 109.975 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.485 ' NE2' HD11 ' A' ' 30' ' ' LEU . 78.6 mt-30 -67.11 -40.04 86.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 2.1200000000000001 110.12 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.49 -38.94 92.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.436 -0.79 . . . . 1.3600000000000001 110.233 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' HH12 ' A' ' 60' ' ' ARG . 19.8 mmm180 -60.0 -38.66 83.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 2.7999999999999998 109.016 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -68.48 -39.89 81.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.88 -1.137 . . . . 0.40000000000000002 110.614 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -69.12 -40.18 78.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.632 -1.292 . . . . 0.23999999999999999 109.821 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.31 -60.01 4.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.633 -1.292 . . . . 0.42999999999999999 109.867 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' OE2' ' A' ' 83' ' ' GLU . . . -59.9 -32.57 75.43 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.047 -1.221 . . . . 0.26000000000000001 110.047 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.3 t -69.08 -49.79 54.14 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.075 -1.25 . . . . 0.25 110.014 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.449 HD21 HD22 ' A' ' 23' ' ' LEU . 86.9 mt -71.58 -40.23 70.05 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.746 -1.182 . . . . 0.29999999999999999 109.124 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.496 ' HG2' HH11 ' A' ' 82' ' ' ARG . 1.2 tpt180 -60.8 -42.67 98.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.161 -0.962 . . . . 2.73 110.055 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -70.0 -36.42 75.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 1.9099999999999999 110.271 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 84.8 t90 -60.01 -43.18 95.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.521 -1.362 . . . . 0.37 107.709 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 89' ' ' LEU . 48.2 m -61.02 -40.29 93.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.604 -0.685 . . . . 0.35999999999999999 110.026 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.04 -33.92 72.69 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -0.969 . . . . 0.55000000000000004 110.274 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.11 14.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.124 -0.985 . . . . 0.47999999999999998 111.028 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.0 1.84 19.26 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.161 -0.962 . . . . 1.24 111.82 -178.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' CYS . 8.0 tp . . . . . 0 N--CA 1.499 1.976 0 O-C-N 120.765 -1.209 . . . . 1.6599999999999999 109.668 -177.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.402 ' O ' ' OG1' ' B' ' 2' ' ' THR . 67.6 mtt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.451 -0.574 . . . . 5.6600000000000001 109.451 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' B' ' 1' ' ' MET . 6.9 p 55.1 36.86 27.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.211 -0.93 . . . . 3.02 109.318 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 13.0 p -81.71 161.01 23.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.95999999999999996 110.478 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.7 t -78.63 173.38 12.49 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.647 0.737 . . . . 1.5 109.557 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.9 -24.7 64.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 2.1800000000000002 110.178 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.91 -35.31 74.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.034 -1.042 . . . . 2.0099999999999998 108.971 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -60.06 -49.09 79.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.034 -1.041 . . . . 0.48999999999999999 110.237 -179.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' B' ' 8' ' ' ARG . 54.1 mtt-85 -70.02 -31.89 69.78 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.113 -0.992 . . . . 3.23 109.716 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.68 -39.97 80.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.76000000000000001 109.761 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.439 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.2 t80 -62.54 -48.25 80.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.46000000000000002 110.098 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.99 10.19 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.052 -1.03 . . . . 0.44 110.51 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.61 -14.31 15.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 0.53000000000000003 109.857 178.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' B' ' 14' ' ' PRO . 13.5 pt-20 -154.27 152.78 27.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 1.27 109.12 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.9 Cg_exo -40.15 162.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.879 1.719 . . . . 0.48999999999999999 111.483 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.469 ' SD ' HD11 ' A' ' 89' ' ' LEU . 6.8 ptp -92.45 -21.4 20.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.56000000000000005 109.764 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.68 -139.82 16.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.06 -1.216 . . . . 0.39000000000000001 110.06 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.8 30.83 5.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.549 -0.971 . . . . 0.83999999999999997 110.47 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.98 149.24 74.62 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.189 . . . . 2.02 108.777 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.19 158.77 50.38 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.941 1.761 . . . . 0.34000000000000002 112.087 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.556 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.4 p -57.29 -45.6 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.32000000000000001 110.545 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.556 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -55.77 -3.04 0.4 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.725 -0.95 . . . . 0.22 110.725 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.453 ' H ' ' C ' ' B' ' 20' ' ' VAL . 47.6 m -82.11 -22.15 36.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.713 -1.463 . . . . 1.24 109.3 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.447 HD22 HD21 ' B' ' 81' ' ' LEU . 85.7 mt -64.09 139.22 58.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.23999999999999999 109.768 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.89 136.4 56.08 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.758 -0.777 . . . . 0.20999999999999999 109.781 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.3 57.73 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.264 -1.534 . . . . 0.22 109.264 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.48 110.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.817 -1.179 . . . . 0.25 107.817 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.466 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -91.66 178.61 41.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.675 -1.37 . . . . 0.28000000000000003 109.675 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.36 -39.95 73.71 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.595 -0.944 . . . . 2.0 110.333 -178.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.68 -41.25 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.604 -1.31 . . . . 0.38 109.69 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.488 HD11 ' NE2' ' B' ' 73' ' ' GLN . 96.2 mt -67.72 -38.43 83.56 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.262 -0.898 . . . . 0.40000000000000002 109.755 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.104 -1.198 . . . . 0.35999999999999999 110.104 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.75 -36.32 83.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.368 . . . . 2.75 109.502 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.49 -53.72 26.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.751 -1.218 . . . . 1.5600000000000001 109.562 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.208 -1.034 . . . . 0.33000000000000002 108.208 178.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.07 -46.09 90.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 1.6799999999999999 109.345 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -63.58 -19.98 65.27 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.411 -0.959 . . . . 1.99 108.411 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.78 3.72 51.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.612 -0.68 . . . . 2.6800000000000002 109.83 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.2 50.72 Favored Glycine 0 N--CA 1.502 3.044 0 O-C-N 121.041 -1.037 . . . . 0.48999999999999999 111.468 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.557 ' CD2' HG12 ' B' ' 44' ' ' VAL . 90.9 m-85 -106.16 74.88 1.06 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.96 -1.318 . . . . 0.33000000000000002 108.971 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -80.25 -9.27 59.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.40999999999999998 111.003 -178.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.97 152.84 50.86 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.093 -1.004 . . . . 1.5600000000000001 109.832 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.576 -0.702 . . . . 0.20999999999999999 111.096 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.482 ' CE1' HG22 ' B' ' 44' ' ' VAL . 8.7 p90 -58.58 -18.98 34.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 0.32000000000000001 110.486 -177.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.557 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.8 t -80.77 -30.36 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.047 . . . . 0.23999999999999999 108.343 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.66 -39.05 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.149 -1.056 . . . . 0.22 108.149 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.09 -39.3 85.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.632 -1.247 . . . . 0.40000000000000002 107.632 177.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.15 -45.03 74.22 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.579 -1.409 . . . . 0.17999999999999999 109.579 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.03 -43.19 95.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -1.216 . . . . 1.0900000000000001 109.099 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.441 -0.948 . . . . 0.31 108.441 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.88 -38.65 83.31 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.464 -0.939 . . . . 0.27000000000000002 108.464 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.02 -21.97 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.373 -0.83 . . . . 0.28000000000000003 110.764 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 98.6 mt -93.27 17.15 11.65 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.993 -1.067 . . . . 0.29999999999999999 110.363 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.86 34.29 10.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.894 -1.129 . . . . 1.71 110.272 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 59.46 19.91 8.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 2.25 109.813 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.88 114.67 5.27 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.571 -1.27 . . . . 1.8 107.571 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.414 ' CG ' ' HE ' ' B' ' 60' ' ' ARG . 40.0 tt0 -63.63 -41.39 98.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.88 112.452 -177.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.04 -39.75 75.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.64 -1.288 . . . . 0.73999999999999999 110.742 -179.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.21 -39.88 78.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.827 -1.149 . . . . 0.55000000000000004 109.611 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.76 -49.84 71.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.091 -1.006 . . . . 0.38 109.415 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.462 HH11 ' HG2' ' B' ' 60' ' ' ARG . 44.8 mtt-85 -59.93 -46.61 88.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.364 -0.835 . . . . 2.6400000000000001 110.55 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.28 -38.69 91.05 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.029 -1.044 . . . . 2.3799999999999999 108.952 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -64.29 -46.95 81.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.40000000000000002 110.523 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.55 -47.06 70.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.238 -0.914 . . . . 0.34000000000000002 110.17 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -62.54 -47.56 83.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 2.1000000000000001 110.161 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.43 -28.62 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 1.8999999999999999 109.739 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -80.37 -34.14 36.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.40000000000000002 111.304 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.6 p -132.24 -29.67 1.59 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.501 -1.375 . . . . 0.39000000000000001 111.839 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.75 14.58 21.02 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.21 -1.556 . . . . 0.35999999999999999 109.21 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.27 151.27 2.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -1.228 . . . . 0.32000000000000001 109.279 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.52 171.48 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.0 . . . . 1.9099999999999999 109.527 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.33 74.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.38 110.465 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.65 -41.18 69.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.828 -1.17 . . . . 2.5699999999999998 110.014 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.488 ' NE2' HD11 ' B' ' 30' ' ' LEU . 78.6 mt-30 -67.2 -39.97 86.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 2.1200000000000001 110.185 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.53 -38.86 92.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.355 -0.841 . . . . 1.3600000000000001 110.253 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.42 ' HA ' HH12 ' B' ' 60' ' ' ARG . 19.8 mmm180 -60.03 -38.63 83.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.954 -1.092 . . . . 2.8100000000000001 109.035 -179.417 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -68.54 -40.03 80.86 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.915 -1.116 . . . . 0.40000000000000002 110.592 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.95 -40.19 79.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.702 -1.249 . . . . 0.23000000000000001 109.901 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.36 -59.98 4.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.61 -1.306 . . . . 0.42999999999999999 109.915 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 83' ' ' GLU . . . -59.88 -32.52 75.2 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.054 -1.218 . . . . 0.25 110.054 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -69.13 -49.83 53.42 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.099 -1.236 . . . . 0.23999999999999999 110.064 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.447 HD21 HD22 ' B' ' 23' ' ' LEU . 86.9 mt -71.63 -40.14 69.95 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.744 -1.182 . . . . 0.28999999999999998 109.147 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' B' ' 82' ' ' ARG . 1.2 tpt180 -60.83 -42.67 98.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.147 -0.97 . . . . 2.7400000000000002 110.037 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' B' ' 79' ' ' GLY . 0.3 OUTLIER -70.09 -36.39 74.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 1.9099999999999999 110.053 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 84' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 84.8 t90 -59.98 -43.37 95.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.537 -1.352 . . . . 0.35999999999999999 107.743 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' B' ' 89' ' ' LEU . 50.3 m -60.72 -40.37 92.06 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.562 0.696 . . . . 0.35999999999999999 110.099 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.96 -33.94 72.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.064 -1.023 . . . . 0.55000000000000004 110.342 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.29 14.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.148 -0.97 . . . . 0.46999999999999997 110.969 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 88' ' ' PHE . . . . . 0.403 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 91.0 m-85 -109.78 1.66 19.5 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.275 -0.891 . . . . 1.24 111.925 -178.01 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.6 tp . . . . . 0 N--CA 1.499 1.992 0 O-C-N 120.795 -1.191 . . . . 1.6699999999999999 109.746 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.576 0.703 . . . . 1.35 109.804 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -51.75 -21.0 2.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.641 . . . . 2.38 109.693 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.58 -37.23 83.09 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.316 -0.865 . . . . 2.07 109.947 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -59.99 -50.07 75.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.029 -1.045 . . . . 0.44 110.047 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -69.92 -36.86 75.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.964 -1.085 . . . . 3.3 110.182 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.863 -0.791 . . . . 0.69 108.863 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -64.73 -49.6 70.2 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.516 -0.74 . . . . 0.38 110.14 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 m -83.36 8.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.085 -1.009 . . . . 0.35 110.672 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.51 -13.48 16.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.153 -0.967 . . . . 0.47 110.163 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.85 152.08 24.76 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.125 -0.984 . . . . 1.27 108.839 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -40.01 160.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.927 1.751 . . . . 0.44 112.065 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.688 ' SD ' HD11 ' B' ' 89' ' ' LEU . 3.2 ptp -89.2 -28.11 20.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.933 . . . . 1.09 109.738 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.09 -141.1 43.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.787 -1.725 . . . . 0.53 108.787 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.08 33.55 4.06 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.304 -1.115 . . . . 1.07 109.806 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.9 148.96 75.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 2.18 109.568 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.81 152.16 80.17 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.71 2.273 . . . . 0.38 112.911 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.7 p -53.69 -43.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.448 0.642 . . . . 0.3 110.191 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.495 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -57.57 -3.85 1.17 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.384 -1.086 . . . . 0.19 110.384 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 20' ' ' VAL . 42.1 t -84.08 -22.5 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.337 . . . . 1.38 110.163 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.467 HD22 HD21 ' A' ' 81' ' ' LEU . 74.7 mt -64.16 138.52 58.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.994 -1.066 . . . . 0.21 109.895 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 134.43 54.36 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.792 -0.763 . . . . 0.21 109.712 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.78 49.29 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.339 -1.504 . . . . 0.19 109.339 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.418 HD11 ' SG ' ' A' ' 77' ' ' CYS . 36.4 mm -98.51 112.26 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.331 -1.099 . . . . 0.19 108.126 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.06 177.28 42.87 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.855 -1.298 . . . . 0.19 109.855 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -58.54 -40.0 81.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.477 -1.014 . . . . 1.8 109.957 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.14 -46.71 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.96 -1.088 . . . . 0.31 108.834 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.689 HD11 ' OE1' ' A' ' 73' ' ' GLN . 88.0 mt -67.94 -39.75 83.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.33 109.877 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.27 -33.92 77.7 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.879 -1.688 . . . . 0.31 108.879 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.03 -40.4 87.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.505 -0.997 . . . . 2.89 110.292 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -68.47 -44.53 74.61 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.95 -1.094 . . . . 1.51 109.1 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.48 -39.41 93.35 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.933 -1.104 . . . . 0.28 108.029 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.99 -42.22 93.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.75 . . . . 1.51 109.269 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -68.05 -18.74 64.77 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.311 -0.996 . . . . 2.45 108.311 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.77 3.19 53.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.728 -0.608 . . . . 2.55 109.789 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.05 7.57 49.75 Favored Glycine 0 N--CA 1.502 3.073 0 O-C-N 121.015 -1.053 . . . . 0.48 111.335 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CD2' HG12 ' A' ' 44' ' ' VAL . 93.7 m-85 -106.43 74.31 1.01 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.907 -1.349 . . . . 0.35 109.048 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -80.23 -9.95 59.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.36 110.665 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -129.33 152.36 48.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.227 -0.921 . . . . 1.43 109.149 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.95 94.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.22 110.786 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.1 p90 -60.66 -17.84 49.95 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.915 -1.115 . . . . 0.62 110.975 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.597 HG12 ' CD2' ' A' ' 39' ' ' PHE . 44.7 t -78.97 -32.72 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.309 -1.367 . . . . 0.25 107.309 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.93 -39.84 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.582 -0.895 . . . . 0.2 108.582 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.87 -35.12 74.16 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.079 -1.452 . . . . 0.3 107.079 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.95 -40.76 95.79 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.63 -1.388 . . . . 0.2 109.63 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.97 -42.46 94.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.296 -1.12 . . . . 1.1 108.596 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.06 -39.96 87.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.32 109.57 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD12 HD12 ' B' ' 50' ' ' LEU . 80.4 mt -69.52 -37.72 77.25 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.602 -0.839 . . . . 0.32 108.948 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.53 -28.57 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.252 -0.905 . . . . 0.31 109.744 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.29 13.16 10.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.122 -0.986 . . . . 0.38 110.584 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt 49.94 38.96 17.51 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.538 -1.351 . . . . 2.11 110.405 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mttm 56.85 19.47 4.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 1.94 110.095 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.27 106.77 1.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 117.775 -1.57 . . . . 1.84 106.972 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.1 -40.09 88.43 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.664 -0.647 . . . . 1.05 111.304 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -69.67 -40.03 76.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.263 -1.523 . . . . 0.9 110.053 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.2 mt -70.6 -40.0 73.48 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.55 -1.26 . . . . 0.45 109.196 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.88 -49.93 72.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.32 110.511 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -63.23 -41.11 99.07 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.054 -1.059 . . . . 2.77 109.909 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.31 -40.07 93.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.629 -1.294 . . . . 2.15 108.14 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -64.53 -50.03 68.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 0.27 111.217 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.89 -46.1 83.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.132 -0.98 . . . . 0.33 109.667 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -63.27 -49.79 72.69 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.483 -0.76 . . . . 1.93 109.954 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.65 -30.51 70.79 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.515 -0.741 . . . . 1.7 109.678 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -78.36 -37.68 43.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.32 111.096 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.0 p -127.24 -26.9 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.529 -1.357 . . . . 0.34 112.261 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 13.7 27.12 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.249 -1.541 . . . . 0.27 109.249 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.12 155.54 1.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.291 . . . . 0.24 108.916 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -88.67 166.38 14.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 2.04 109.603 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.89 62.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.35 108.351 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -70.16 -48.86 55.51 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.305 0.574 . . . . 3.63 112.029 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.689 ' OE1' HD11 ' A' ' 30' ' ' LEU . 44.9 mt-30 -67.96 -30.01 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.068 -1.02 . . . . 2.13 110.834 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.9 p -70.02 -34.7 73.62 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.979 -1.088 . . . . 1.45 109.254 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -60.29 -38.84 84.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 2.83 109.34 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -66.86 -38.8 87.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.877 -1.139 . . . . 0.3 109.597 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 26' ' ' ILE . 93.9 m -69.91 -40.08 75.81 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.994 -1.066 . . . . 0.2 109.702 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.74 -61.15 2.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.761 -1.212 . . . . 0.36 109.769 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.7 -33.89 88.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.46 -1.056 . . . . 0.29 110.46 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.41 -48.37 61.29 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.73 -1.453 . . . . 0.25 109.943 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 23' ' ' LEU . 82.9 mt -70.08 -40.07 75.22 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.9 -1.12 . . . . 0.42 108.867 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -65.53 -40.12 92.56 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.4 -0.813 . . . . 2.58 111.006 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -70.04 -35.36 74.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.74 -1.225 . . . . 2.07 109.319 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.528 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 87.3 t90 -60.07 -43.69 95.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.991 -1.485 . . . . 0.32 106.991 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.5 m -61.45 -40.18 93.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.613 0.72 . . . . 0.41 109.896 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.96 -34.44 73.28 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.968 -1.082 . . . . 0.6 110.328 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.33 -31.99 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.116 -0.99 . . . . 0.56 110.299 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 66.0 m-85 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.542 -0.724 . . . . 1.23 112.606 -176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.657 0.742 . . . . 1.35 109.699 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.66 -21.17 2.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.629 -0.669 . . . . 2.37 109.659 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.33 -37.29 82.77 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.291 -0.881 . . . . 2.06 109.876 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -60.05 -49.95 75.64 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.025 -1.047 . . . . 0.43 110.038 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.02 -36.91 75.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 3.3 110.227 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.06 -38.78 82.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.345 -0.847 . . . . 0.67 108.732 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.68 -49.95 71.14 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.595 -0.69 . . . . 0.37 110.08 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.88 10.43 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.1 -1.0 . . . . 0.34 110.659 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.67 -14.93 14.89 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.114 -0.991 . . . . 0.47 110.192 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -153.51 151.2 24.94 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.139 -0.975 . . . . 1.27 108.748 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.97 160.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.97 1.78 . . . . 0.45 112.052 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ptp -89.06 -26.54 21.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.269 -0.895 . . . . 1.09 109.46 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.54 -138.27 46.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.709 -1.756 . . . . 0.53 108.709 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.59 35.44 3.47 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.355 -1.086 . . . . 1.08 109.61 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 149.76 83.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 2.19 109.798 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.64 152.21 79.23 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.702 2.268 . . . . 0.37 112.742 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.476 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.5 p -53.85 -42.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.622 -0.674 . . . . 0.3 110.349 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.476 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -58.56 -3.34 1.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.514 -1.034 . . . . 0.19 110.514 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.424 ' H ' ' C ' ' B' ' 20' ' ' VAL . 45.7 t -83.28 -22.62 32.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.872 -1.37 . . . . 1.39 110.014 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.461 HD22 HD21 ' B' ' 81' ' ' LEU . 73.8 mt -64.35 139.0 58.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.22 109.746 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.19 135.63 55.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.828 -0.749 . . . . 0.21 109.668 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.14 -21.73 44.61 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.348 -1.501 . . . . 0.19 109.348 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.417 HD11 ' SG ' ' B' ' 77' ' ' CYS . 36.2 mm -98.48 113.69 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.845 -1.169 . . . . 0.2 107.845 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.78 179.36 39.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.787 -1.325 . . . . 0.2 109.787 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -58.72 -40.03 82.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.473 -1.016 . . . . 1.82 110.206 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.73 -45.76 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.941 -1.099 . . . . 0.34 109.058 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.705 HD11 ' OE1' ' B' ' 73' ' ' GLN . 86.5 mt -68.8 -39.99 79.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.35 109.87 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.12 -33.56 75.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.869 -1.692 . . . . 0.32 108.869 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -39.97 86.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.965 . . . . 2.85 110.247 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -68.91 -44.62 72.75 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.924 -1.11 . . . . 1.52 109.158 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.52 -39.47 93.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.948 -1.13 . . . . 0.27 107.948 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -60.04 -41.86 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.58 -0.7 . . . . 1.49 109.289 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -68.48 -18.37 64.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.472 -0.936 . . . . 2.43 108.472 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -89.93 1.63 56.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 2.56 109.775 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 8.45 43.47 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.114 -0.991 . . . . 0.46 111.267 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.581 ' CD2' HG12 ' B' ' 44' ' ' VAL . 93.1 m-85 -107.15 74.18 0.96 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.886 -1.361 . . . . 0.35 108.984 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -80.07 -10.41 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.34 110.718 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -129.3 150.69 50.56 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.208 -0.933 . . . . 1.43 109.084 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.28 99.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.199 -0.938 . . . . 0.21 110.726 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 6.2 p90 -56.96 -18.27 12.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.113 . . . . 0.61 110.762 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.581 HG12 ' CD2' ' B' ' 39' ' ' PHE . 41.6 t -78.49 -33.92 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.296 -1.372 . . . . 0.23 107.296 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.38 -39.63 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.19 108.727 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.4 tp -59.83 -34.28 72.88 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.869 -1.53 . . . . 0.3 106.869 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.39 -40.68 96.37 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.503 -1.439 . . . . 0.19 109.503 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -60.06 -42.64 94.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.24 -1.153 . . . . 1.12 108.891 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 0.31 109.658 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.4 HD12 HD12 ' A' ' 50' ' ' LEU . 81.9 mt -69.16 -38.07 78.55 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.877 -0.786 . . . . 0.32 108.877 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.04 -29.31 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.259 -0.901 . . . . 0.3 109.717 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 94.5 mt -87.16 14.56 7.45 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.002 -1.062 . . . . 0.38 110.684 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 49.97 35.48 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.626 -1.296 . . . . 2.14 110.917 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 60.05 19.84 9.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.206 -0.934 . . . . 1.95 109.923 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 108.93 2.73 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.638 -1.615 . . . . 1.81 106.638 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.78 -40.03 93.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 1.04 111.22 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -69.28 -40.06 78.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.375 -1.453 . . . . 0.9 110.008 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.74 -38.82 73.56 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.903 -1.119 . . . . 0.43 109.191 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.54 -49.99 69.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.32 110.414 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -63.1 -41.61 99.41 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.049 -1.032 . . . . 2.79 109.843 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.19 -40.08 93.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.691 -1.256 . . . . 2.16 108.055 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . 0.404 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -64.33 -49.07 73.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.27 111.138 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.7 tp -66.05 -48.34 71.35 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.943 -1.098 . . . . 0.34 109.722 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -60.87 -49.84 75.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.501 -0.749 . . . . 1.91 110.156 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -67.53 -28.24 67.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 1.69 109.793 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.84 -33.62 34.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.32 110.954 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 22.4 p -131.11 -28.44 1.94 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.453 -1.405 . . . . 0.35 112.208 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.31 13.12 25.46 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.149 -1.581 . . . . 0.29 109.149 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 154.68 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.242 . . . . 0.26 108.735 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.49 168.12 12.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.976 -1.077 . . . . 2.03 109.691 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.81 63.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.333 -0.988 . . . . 0.36 108.333 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -70.06 -49.33 52.21 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-O 121.323 0.582 . . . . 3.61 112.07 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.705 ' OE1' HD11 ' B' ' 30' ' ' LEU . 44.4 mt-30 -67.69 -29.99 69.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.977 -1.077 . . . . 2.13 110.883 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -69.91 -34.65 73.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.062 -1.055 . . . . 1.46 109.159 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -60.73 -38.83 86.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.758 -1.214 . . . . 2.81 109.579 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.83 -39.14 87.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.796 -1.19 . . . . 0.29 109.647 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . 0.417 ' SG ' HD11 ' B' ' 26' ' ' ILE . 93.0 m -69.42 -40.02 77.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.019 -1.05 . . . . 0.19 109.484 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.93 -60.73 3.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.75 -1.219 . . . . 0.36 109.758 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.8 -33.94 88.59 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.526 -1.03 . . . . 0.28 110.526 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.49 -48.42 60.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.747 -1.443 . . . . 0.25 109.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.461 HD21 HD22 ' B' ' 23' ' ' LEU . 83.7 mt -69.97 -40.0 75.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.972 -1.091 . . . . 0.42 108.539 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -66.9 -40.11 87.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.855 . . . . 2.6 111.41 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -69.87 -34.9 74.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.594 -1.316 . . . . 2.06 108.813 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.544 ' O ' ' HB2' ' B' ' 88' ' ' PHE . 85.4 t90 -59.46 -48.65 80.83 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.661 -1.978 . . . . 0.32 105.661 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' B' ' 89' ' ' LEU . 36.5 m -58.07 -39.93 79.75 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.765 -0.584 . . . . 0.41 110.29 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -61.25 -35.24 76.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.31 -1.494 . . . . 0.59 111.171 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.03 -25.5 20.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.121 . . . . 0.58 107.983 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' B' ' 84' ' ' TRP . 60.6 m-85 -115.15 -2.98 12.61 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 114.792 1.404 . . . . 1.24 114.792 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.688 HD11 ' SD ' ' A' ' 15' ' ' MET . 14.5 tp . . . . . 0 C--N 1.282 -2.344 0 O-C-N 119.009 -2.307 . . . . 1.76 110.051 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.627 0.727 . . . . 1.51 109.251 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.37 -20.81 1.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.618 . . . . 2.18 109.734 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.87 -35.81 79.41 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 2.02 108.81 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -60.05 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.49 109.934 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.491 HH11 ' HG2' ' A' ' 8' ' ' ARG . 30.9 mtt-85 -69.96 -34.62 73.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 3.21 109.959 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.95 -39.81 75.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.367 -0.833 . . . . 0.76 109.738 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -65.62 -42.49 91.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.379 -0.826 . . . . 0.46 110.338 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.32 14.63 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.901 -1.125 . . . . 0.44 109.869 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.39 -10.33 12.02 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.365 -0.834 . . . . 0.54 110.488 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.49 149.98 22.47 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 1.26 109.575 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -39.67 161.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.903 1.735 . . . . 0.49 111.619 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.47 -18.0 23.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.998 -1.064 . . . . 0.57 109.677 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -143.24 12.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.954 -1.259 . . . . 0.4 109.954 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.71 29.89 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.416 -1.049 . . . . 0.85 110.274 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -60.05 149.06 75.91 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.093 -1.004 . . . . 2.01 108.609 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.7 160.11 41.98 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.26 1.974 . . . . 0.34 112.407 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 22' ' ' SER . 6.4 p -57.2 -47.09 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.75 . . . . 0.32 110.403 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.54 -1.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.346 -1.102 . . . . 0.23 110.346 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 20' ' ' VAL . 21.7 m -82.95 -23.16 33.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.77 -1.429 . . . . 1.24 109.72 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.708 HD22 HD21 ' A' ' 81' ' ' LEU . 95.0 mt -64.19 140.03 58.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.24 109.751 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 134.68 55.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.747 0.784 . . . . 0.21 109.857 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.23 -17.05 58.48 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.583 -1.407 . . . . 0.22 109.583 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.37 115.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -1.155 . . . . 0.25 107.971 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -89.03 172.44 40.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.697 -1.361 . . . . 0.28 109.697 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -55.86 -40.05 72.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.01 109.92 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.04 -44.19 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.997 -1.064 . . . . 0.38 109.741 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 27' ' ' GLY . 86.6 mt -64.37 -34.21 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.4 109.825 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.93 95.19 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.022 -1.631 . . . . 0.35 109.022 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.23 -38.83 92.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -1.171 . . . . 2.74 109.575 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.27 -52.88 28.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 1.54 109.172 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.58 -40.0 90.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.082 -1.011 . . . . 0.34 108.36 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -42.07 93.58 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.885 -0.726 . . . . 1.67 109.223 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.3 -20.17 66.02 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.603 -0.888 . . . . 2.0 108.603 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 37' ' ' ARG . 0.8 OUTLIER -91.09 4.39 52.28 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 2.69 110.286 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.04 7.95 51.71 Favored Glycine 0 N--CA 1.502 3.054 0 O-C-N 120.976 -1.077 . . . . 0.48 111.611 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.48 ' CD2' HG12 ' A' ' 44' ' ' VAL . 93.8 m-85 -104.81 73.48 1.08 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.717 -1.461 . . . . 0.33 108.417 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 22.9 p-10 -77.56 -9.74 59.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.428 -0.795 . . . . 0.41 111.104 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -137.46 158.06 45.22 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.056 -1.028 . . . . 1.56 110.417 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.67 93.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.577 . . . . 0.21 112.327 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -59.25 -18.1 34.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.586 -1.321 . . . . 0.32 110.439 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.1 t -79.91 -31.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.878 -1.139 . . . . 0.24 108.285 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 20' ' ' VAL . 54.5 t -77.03 -37.71 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.942 -1.133 . . . . 0.22 107.942 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.8 tp -59.96 -37.85 80.78 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.286 -1.375 . . . . 0.4 107.286 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.54 89.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.98 -1.248 . . . . 0.18 109.98 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -60.04 -42.66 94.9 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.89 -1.359 . . . . 1.09 109.134 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -60.03 -40.82 90.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 0.31 108.793 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD21 ' SG ' ' A' ' 85' ' ' CYS . 80.7 mt -69.01 -38.27 79.14 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.544 -0.909 . . . . 0.28 108.544 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.94 -22.65 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.269 -0.894 . . . . 0.28 110.575 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.8 15.05 13.71 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.006 -1.059 . . . . 0.31 110.676 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.12 42.77 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.671 -1.268 . . . . 1.7 110.778 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 57.82 20.02 6.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.478 -0.764 . . . . 2.24 110.421 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -69.2 104.53 2.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.412 -1.43 . . . . 1.8 107.706 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.16 -40.05 92.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.959 0.726 . . . . 0.87 112.959 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 95.0 m-20 -69.93 -39.98 75.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.457 -1.402 . . . . 0.73 110.475 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.82 -40.04 72.69 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.985 -1.086 . . . . 0.55 109.033 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.27 -49.88 73.94 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.836 . . . . 0.38 110.054 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 79.3 mtm180 -61.5 -43.67 98.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 2.64 110.317 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.61 -39.85 94.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.265 -0.897 . . . . 2.37 108.747 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -62.41 -49.22 76.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.275 -0.891 . . . . 0.4 110.693 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.4 tp -67.78 -47.91 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.161 -0.962 . . . . 0.34 110.131 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.49 -45.99 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 2.11 109.642 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.84 -30.15 68.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.742 . . . . 1.9 109.82 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -77.83 -36.89 49.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.945 . . . . 0.41 111.227 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.5 p -130.44 -29.92 1.95 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.593 -1.317 . . . . 0.4 111.783 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.33 15.86 11.94 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.311 -1.516 . . . . 0.36 109.311 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.29 154.63 2.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.315 . . . . 0.33 109.03 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 168.84 12.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 1.9 109.95 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.99 71.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.39 110.192 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -72.78 -39.98 66.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.935 -1.103 . . . . 2.58 109.346 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -68.39 -38.8 81.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.12 110.35 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.71 -36.06 77.97 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.13 -0.981 . . . . 1.36 109.516 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.93 -38.07 81.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 2.8 109.401 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.13 -39.95 82.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.744 -1.222 . . . . 0.4 110.451 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.4 m -69.45 -40.7 77.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.667 -1.271 . . . . 0.24 109.507 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -58.82 -60.21 4.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.534 -1.354 . . . . 0.43 109.41 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.5 90.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.86 -0.896 . . . . 0.26 110.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.91 -49.32 59.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.364 . . . . 0.25 110.217 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.708 HD21 HD22 ' A' ' 23' ' ' LEU . 84.5 mt -70.0 -39.62 75.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.902 -1.119 . . . . 0.3 108.757 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.94 -41.03 90.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 2.73 109.691 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.01 -37.8 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.91 110.628 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.526 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 85.8 t90 -60.86 -42.01 97.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.37 108.974 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.467 ' SG ' HD21 ' A' ' 50' ' ' LEU . 69.8 m -62.08 -40.04 94.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.36 109.752 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.66 -31.16 67.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.344 -0.848 . . . . 0.55 109.646 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.89 -37.06 12.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.305 -0.872 . . . . 0.48 111.325 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 . . . . . 0 N--CA 1.504 2.264 0 O-C-N 121.132 -0.98 . . . . 1.24 112.399 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.561 0.696 . . . . 1.5 109.236 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.49 -20.72 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.714 -0.616 . . . . 2.18 109.727 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.81 -35.91 79.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 2.01 108.875 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.92 -48.96 79.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.49 110.015 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' B' ' 8' ' ' ARG . 31.0 mtt-85 -69.94 -34.61 73.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 3.23 110.007 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -69.95 -39.59 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.299 -0.876 . . . . 0.76 109.855 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -65.75 -42.47 90.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.448 -0.783 . . . . 0.46 110.36 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -84.31 14.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.946 -1.096 . . . . 0.44 109.88 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.3 -10.02 12.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.397 -0.814 . . . . 0.53 110.466 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.63 150.02 22.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.86 -1.15 . . . . 1.27 109.456 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.59 161.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.918 1.745 . . . . 0.49 111.603 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.44 -18.15 23.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.043 -1.035 . . . . 0.56 109.708 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.32 -143.15 12.98 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.018 -1.233 . . . . 0.39 110.018 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.88 29.94 5.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.484 -1.01 . . . . 0.84 110.221 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -60.16 149.07 76.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 2.02 108.632 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 160.18 41.52 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.194 1.929 . . . . 0.34 112.424 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' B' ' 22' ' ' SER . 6.3 p -57.27 -47.05 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.734 . . . . 0.32 110.441 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.494 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.43 -2.1 0.1 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.475 -1.05 . . . . 0.22 110.475 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.524 ' H ' ' C ' ' B' ' 20' ' ' VAL . 21.1 m -82.67 -23.26 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.806 -1.408 . . . . 1.24 109.806 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.737 HD22 HD21 ' B' ' 81' ' ' LEU . 94.6 mt -64.12 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.04 -1.037 . . . . 0.24 109.718 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.428 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.24 134.93 55.72 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.69 0.757 . . . . 0.21 109.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.09 58.66 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.489 -1.444 . . . . 0.22 109.489 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.33 115.41 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.245 -1.15 . . . . 0.25 107.951 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.414 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -88.94 172.51 40.37 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.725 -1.35 . . . . 0.28 109.725 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -56.01 -39.94 72.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -1.089 . . . . 2.0 109.907 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.19 -43.99 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.008 -1.057 . . . . 0.38 109.749 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.414 HD12 ' H ' ' B' ' 27' ' ' GLY . 86.8 mt -64.51 -34.13 77.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.4 109.742 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.17 -40.03 95.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.973 -1.651 . . . . 0.36 108.973 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.26 -38.64 91.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -1.154 . . . . 2.75 109.545 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.4 -52.88 28.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.124 . . . . 1.56 109.12 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.7 -39.95 90.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.286 -1.005 . . . . 0.33 108.286 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.08 -41.97 93.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.839 -0.744 . . . . 1.68 109.168 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.42 -20.07 65.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.653 -0.869 . . . . 1.99 108.653 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.8 OUTLIER -90.98 4.17 52.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.561 -0.712 . . . . 2.68 110.321 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.05 7.96 51.65 Favored Glycine 0 N--CA 1.502 3.067 0 C-N-CA 120.139 -1.029 . . . . 0.49 111.664 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.488 ' CD2' HG12 ' B' ' 44' ' ' VAL . 93.9 m-85 -104.75 73.44 1.08 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.401 . . . . 0.33 108.485 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 40' ' ' ASP . 22.7 p-10 -77.61 -9.75 59.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.41 111.021 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -137.39 157.92 45.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.999 -1.063 . . . . 1.56 110.423 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.0 94.56 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.702 -0.624 . . . . 0.21 112.318 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 4.6 p90 -59.1 -17.88 30.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.61 -1.306 . . . . 0.32 110.578 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.5 t -80.01 -31.93 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.924 -1.11 . . . . 0.24 108.231 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.407 HG21 HG23 ' B' ' 20' ' ' VAL . 54.5 t -76.92 -37.65 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.954 -1.128 . . . . 0.22 107.954 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.0 -37.65 80.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.265 -1.383 . . . . 0.4 107.265 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.47 90.35 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.96 -1.256 . . . . 0.18 109.96 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.774 -1.427 . . . . 1.09 109.154 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -59.95 -40.93 90.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.31 108.785 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.456 HD21 ' SG ' ' B' ' 85' ' ' CYS . 80.9 mt -68.96 -38.0 79.16 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.622 -0.881 . . . . 0.27 108.622 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.14 -22.79 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.263 -0.898 . . . . 0.28 110.499 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.58 14.69 14.31 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.088 -1.008 . . . . 0.3 110.732 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.44 42.4 14.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.7 -1.25 . . . . 1.71 110.742 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 58.27 19.95 6.75 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.403 -0.811 . . . . 2.25 110.43 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -69.23 104.52 2.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 1.8 107.817 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.18 -39.99 92.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.899 0.703 . . . . 0.88 112.899 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 94.8 m-20 -70.05 -39.94 75.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.465 -1.397 . . . . 0.74 110.362 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.969 -1.092 . . . . 0.55 108.92 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.15 -49.98 73.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.328 -0.857 . . . . 0.38 109.939 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.486 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 79.3 mtm180 -61.7 -43.38 98.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 2.64 110.295 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -64.71 -39.9 94.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.076 -1.015 . . . . 2.38 108.782 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -62.39 -49.32 75.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.343 -0.848 . . . . 0.4 110.703 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.6 -47.85 68.49 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.184 -0.948 . . . . 0.34 110.209 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.48 -46.13 87.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 2.1 109.636 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -68.85 -29.97 68.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 1.9 109.903 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -77.91 -36.82 49.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.4 111.189 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 13.4 p -130.64 -29.77 1.92 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.564 -1.335 . . . . 0.39 111.712 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.31 15.72 12.16 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.345 -1.502 . . . . 0.36 109.345 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.08 154.52 2.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.968 -1.313 . . . . 0.32 109.125 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -88.34 168.93 12.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.991 -1.068 . . . . 1.91 109.922 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.31 71.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.38 110.167 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -72.47 -40.01 67.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 2.57 109.409 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -68.54 -38.6 80.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.45 -0.781 . . . . 2.12 110.447 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.72 -36.06 77.95 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 1.36 109.564 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.87 -38.21 81.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 2.81 109.342 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.92 -40.02 83.45 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.4 110.428 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.1 m -69.53 -40.73 76.71 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.653 -1.279 . . . . 0.23 109.46 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.78 -60.36 3.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.635 -1.291 . . . . 0.43 109.37 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.05 -34.58 90.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.779 -0.928 . . . . 0.25 110.779 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 51.1 t -68.79 -49.4 58.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.927 -1.337 . . . . 0.24 110.215 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.737 HD21 HD22 ' B' ' 23' ' ' LEU . 84.6 mt -69.99 -39.5 75.86 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.842 -1.143 . . . . 0.29 108.799 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.04 -41.0 91.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 2.74 109.605 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -70.0 -37.72 75.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.91 110.711 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 85.7 t90 -60.81 -42.16 97.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.516 -1.365 . . . . 0.36 108.986 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.456 ' SG ' HD21 ' B' ' 50' ' ' LEU . 69.7 m -62.04 -39.96 94.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.474 -0.766 . . . . 0.36 109.735 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -58.61 -31.43 68.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.433 -0.792 . . . . 0.55 109.67 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.7 -37.19 12.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.47 111.416 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.9 m-85 -105.74 -4.35 21.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.084 -1.01 . . . . 1.24 112.501 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.444 -1.41 . . . . 1.67 109.419 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.781 0.8 . . . . 1.51 110.078 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -54.57 -19.28 5.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.778 -0.576 . . . . 2.18 110.05 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -60.05 -38.36 82.58 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.031 -1.043 . . . . 2.02 109.366 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.409 ' O ' HG22 ' A' ' 11' ' ' VAL . 63.8 t60 -58.93 -50.06 75.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.49 110.515 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 30.9 mmt180 -69.97 -33.78 72.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.02 . . . . 3.21 109.831 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -67.17 -39.9 86.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.849 -0.741 . . . . 0.76 109.904 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.92 -47.15 75.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.46 110.362 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 7' ' ' HIS . 24.3 m -85.77 5.18 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.128 -0.982 . . . . 0.44 110.929 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -100.57 -14.97 17.98 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.06 -1.025 . . . . 0.54 109.935 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.6 pt-20 -153.59 153.35 28.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 1.26 108.712 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 13' ' ' GLU . 64.1 Cg_exo -35.87 156.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.236 1.958 . . . . 0.49 112.024 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.54 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 10.4 ptm -93.12 -31.59 14.75 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.238 -0.913 . . . . 0.57 109.983 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.24 -133.58 41.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.612 -0.995 . . . . 0.4 110.612 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.56 -0.964 . . . . 0.85 110.972 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.31 65.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.704 -1.248 . . . . 2.01 108.23 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.47 155.48 47.02 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.084 1.856 . . . . 0.34 112.246 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.8 p -56.23 -47.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.554 -0.716 . . . . 0.32 110.384 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.576 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -58.03 -3.28 1.18 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.681 -0.967 . . . . 0.23 110.681 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' VAL . 9.6 t -84.52 -22.31 30.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.742 -1.446 . . . . 1.24 109.633 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.601 HD22 HD21 ' A' ' 81' ' ' LEU . 96.4 mt -62.88 138.87 58.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 0.24 109.263 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 136.27 57.27 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.91 0.862 . . . . 0.21 110.507 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.05 59.67 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.301 -1.52 . . . . 0.22 109.301 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 77' ' ' CYS . 27.1 mm -100.29 113.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.436 -1.038 . . . . 0.25 108.384 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.75 177.72 40.49 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.422 -1.471 . . . . 0.28 109.422 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -55.77 -39.72 71.61 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.465 -1.021 . . . . 2.01 109.562 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.02 -46.36 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.06 -1.025 . . . . 0.38 110.127 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.68 -39.05 87.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.4 109.972 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 -39.96 97.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.168 -1.173 . . . . 0.35 110.168 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.34 -39.66 92.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.106 -1.232 . . . . 2.74 110.241 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -67.66 -45.68 74.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.936 -1.103 . . . . 1.54 108.974 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.91 -39.42 89.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.655 -1.239 . . . . 0.34 107.655 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.02 -40.94 91.04 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.827 -0.749 . . . . 1.67 109.141 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -68.03 -20.35 64.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.246 -0.909 . . . . 2.0 108.882 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.421 ' HE ' HG23 ' A' ' 66' ' ' THR . 23.7 mmm180 -91.16 2.43 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 2.69 109.679 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.02 38.0 3.72 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 120.346 -0.93 . . . . 0.48 111.352 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' A' ' 44' ' ' VAL . 87.2 m-85 -133.63 72.29 1.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.959 -1.318 . . . . 0.33 109.073 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 22.9 p-10 -80.07 -10.73 59.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.165 . . . . 0.41 110.437 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -129.75 150.93 50.84 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.193 -0.942 . . . . 1.56 109.422 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.06 90.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.21 111.274 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.74 -17.1 32.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.741 -1.224 . . . . 0.32 110.182 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' A' ' 39' ' ' PHE . 61.0 t -79.86 -31.8 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.748 -1.204 . . . . 0.24 107.748 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.34 -36.47 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.774 -1.195 . . . . 0.22 107.774 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.01 -36.34 77.01 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.237 -1.394 . . . . 0.4 107.237 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.07 98.12 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.736 -1.346 . . . . 0.18 109.736 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -60.08 -43.8 95.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.903 -1.351 . . . . 1.09 108.431 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.11 -40.91 91.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.31 109.222 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.6 -38.45 80.62 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.426 -0.953 . . . . 0.28 108.426 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.76 -21.08 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.259 -0.9 . . . . 0.28 110.853 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.48 13.27 14.21 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.933 -1.105 . . . . 0.31 111.351 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 49.92 36.21 11.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.648 -1.282 . . . . 1.7 110.065 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.28 19.96 8.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.411 -0.805 . . . . 2.24 110.257 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.9 105.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.526 -1.359 . . . . 1.8 108.209 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 82.5 tt0 -65.11 -40.29 94.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.486 -0.759 . . . . 0.87 112.44 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.61 -39.99 80.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.704 -1.248 . . . . 0.73 109.594 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.59 -39.31 77.37 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.385 -0.926 . . . . 0.55 108.756 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.5 -46.62 89.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.38 109.117 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 96.9 mtt180 -59.99 -48.21 82.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.497 -0.752 . . . . 2.64 110.694 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.32 -39.95 89.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.703 -1.248 . . . . 2.37 108.913 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -62.76 -49.94 73.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.4 110.647 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 56.6 tp -66.35 -47.64 72.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.328 -0.857 . . . . 0.34 109.724 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.27 -44.93 95.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.359 -0.838 . . . . 2.11 109.772 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.36 -32.08 70.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.327 -0.858 . . . . 1.9 109.244 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.421 HG23 ' HE ' ' A' ' 37' ' ' ARG . 94.4 m -77.1 -38.0 53.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.41 111.323 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 10.5 p -131.0 -37.0 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.622 -1.299 . . . . 0.4 111.86 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.21 17.75 7.57 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.214 -1.555 . . . . 0.36 109.214 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.31 153.84 3.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.034 -1.274 . . . . 0.33 109.191 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -91.06 171.66 9.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 1.9 109.589 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.84 70.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.467 -0.771 . . . . 0.39 110.593 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -71.79 -41.16 68.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.739 -1.226 . . . . 2.58 110.317 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.41 -39.16 88.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.198 -0.939 . . . . 2.12 110.451 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -66.03 -38.65 88.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.441 -0.787 . . . . 1.36 110.195 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.825 -1.172 . . . . 2.8 109.384 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -67.9 -39.99 83.53 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.697 -1.252 . . . . 0.4 110.476 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.426 ' SG ' HD11 ' A' ' 26' ' ' ILE . 92.4 m -69.74 -39.94 76.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.683 -1.26 . . . . 0.24 109.778 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.48 -60.41 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.61 -1.307 . . . . 0.43 109.792 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.58 84.67 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 120.305 -0.95 . . . . 0.26 110.843 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.21 -49.27 45.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.832 -1.393 . . . . 0.25 110.014 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.601 HD21 HD22 ' A' ' 23' ' ' LEU . 88.5 mt -70.0 -39.98 75.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.3 108.745 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.491 HH11 ' HG2' ' A' ' 82' ' ' ARG . 16.4 ttt-85 -64.57 -39.87 94.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.282 -0.886 . . . . 2.73 110.051 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.92 -39.45 79.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 1.91 110.345 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.588 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 88.3 t90 -60.14 -43.63 95.57 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.411 -1.431 . . . . 0.37 107.666 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.1 m -61.57 -40.02 93.26 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.457 0.646 . . . . 0.36 109.695 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.99 -31.91 70.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.835 . . . . 0.55 109.145 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.73 13.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.4 -0.813 . . . . 0.48 110.654 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.588 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 85.5 m-85 . . . . . 0 N--CA 1.505 2.315 0 O-C-N 121.278 -0.889 . . . . 1.24 112.831 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.793 0.806 . . . . 1.5 110.07 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -54.73 -19.28 5.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.77 -0.581 . . . . 2.18 110.039 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.96 -38.37 82.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.024 -1.047 . . . . 2.01 109.364 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.403 ' O ' HG22 ' B' ' 11' ' ' VAL . 63.7 t60 -58.95 -50.12 75.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.996 . . . . 0.49 110.428 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 30.9 mmt180 -70.01 -33.72 72.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.035 -1.041 . . . . 3.23 109.825 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.2 -39.93 86.4 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.418 -0.801 . . . . 0.76 109.792 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.83 -47.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.46 110.303 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 7' ' ' HIS . 24.2 m -85.77 5.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.132 -0.98 . . . . 0.44 110.907 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -100.56 -15.09 17.94 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.049 -1.032 . . . . 0.53 109.915 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' B' ' 14' ' ' PRO . 4.6 pt-20 -153.65 153.38 28.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 1.27 108.606 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -35.93 156.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.333 2.022 . . . . 0.49 112.001 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.531 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 10.3 ptm -93.24 -31.64 14.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.359 -0.838 . . . . 0.56 109.916 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.62 42.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.557 -1.017 . . . . 0.39 110.557 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.968 . . . . 0.84 110.938 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.34 64.83 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.748 -1.22 . . . . 2.02 108.272 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.54 155.55 46.96 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.016 1.81 . . . . 0.34 112.298 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.58 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.6 p -56.26 -47.25 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.536 -0.728 . . . . 0.32 110.43 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -58.01 -3.12 1.1 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.781 -0.928 . . . . 0.22 110.781 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 20' ' ' VAL . 9.8 t -84.65 -22.34 29.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.696 -1.473 . . . . 1.24 109.573 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.6 HD22 HD21 ' B' ' 81' ' ' LEU . 96.5 mt -62.91 138.87 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 0.24 109.276 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 136.15 57.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.782 0.801 . . . . 0.21 110.552 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -16.95 59.9 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.393 -1.483 . . . . 0.22 109.393 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.429 HD11 ' SG ' ' B' ' 77' ' ' CYS . 27.2 mm -100.38 113.19 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.398 -1.06 . . . . 0.25 108.343 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.74 177.56 40.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.419 -1.472 . . . . 0.28 109.419 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -55.63 -39.7 71.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.506 -0.996 . . . . 2.0 109.519 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.05 -46.35 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.053 -1.029 . . . . 0.38 110.096 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.72 -38.96 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.4 109.865 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.81 -40.1 97.73 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.083 -1.207 . . . . 0.36 110.083 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.26 -39.71 93.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.254 . . . . 2.75 110.187 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.56 -45.67 74.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.105 . . . . 1.56 109.041 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.95 -39.53 89.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.595 -1.261 . . . . 0.33 107.595 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.96 -40.98 90.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.803 -0.759 . . . . 1.68 109.082 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.97 -20.26 65.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 1.99 108.934 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.403 ' HE ' HG23 ' B' ' 66' ' ' THR . 23.7 mmm180 -91.39 2.64 56.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.695 . . . . 2.68 109.667 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 37.97 3.74 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 121.165 -0.959 . . . . 0.49 111.37 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.505 ' CD2' HG12 ' B' ' 44' ' ' VAL . 86.9 m-85 -133.54 72.2 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.921 -1.341 . . . . 0.33 109.095 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 40' ' ' ASP . 22.9 p-10 -80.06 -10.63 59.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.41 110.413 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -129.81 150.83 50.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.294 -0.879 . . . . 1.56 109.489 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -40.09 90.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.461 -0.774 . . . . 0.21 111.291 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.79 -17.13 33.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.745 -1.222 . . . . 0.32 110.217 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 HG12 ' CD2' ' B' ' 39' ' ' PHE . 61.0 t -79.87 -31.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.745 -1.205 . . . . 0.24 107.745 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 59.2 t -78.49 -36.39 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.727 -1.212 . . . . 0.22 107.727 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.06 -36.25 76.93 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.166 -1.42 . . . . 0.4 107.166 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.18 98.25 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.635 -1.386 . . . . 0.18 109.635 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -59.98 -43.89 94.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.944 -1.327 . . . . 1.09 108.514 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -59.91 -41.07 90.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.769 . . . . 0.31 109.275 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.44 -38.52 81.24 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.513 -0.921 . . . . 0.27 108.513 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.87 -20.95 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.936 . . . . 0.28 110.779 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.52 13.19 14.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.863 -1.148 . . . . 0.3 111.41 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 50.05 36.15 11.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.667 -1.271 . . . . 1.71 110.125 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.11 20.03 7.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.38 -0.825 . . . . 2.25 110.285 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -67.92 105.28 1.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.553 -1.342 . . . . 1.8 108.258 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 82.5 tt0 -65.06 -40.32 94.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 0.88 112.375 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.6 -39.82 80.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.844 -1.16 . . . . 0.74 109.577 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.79 -39.25 76.72 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.29 -0.964 . . . . 0.55 108.764 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.53 -46.72 88.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.38 109.021 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 97.0 mtt180 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.504 -0.748 . . . . 2.64 110.664 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.3 -40.01 89.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.782 -1.199 . . . . 2.38 108.952 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -62.77 -49.93 73.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.989 -1.069 . . . . 0.4 110.656 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.7 tp -66.42 -47.62 72.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.391 -0.818 . . . . 0.34 109.708 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.27 -44.86 95.56 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.376 -0.827 . . . . 2.1 109.783 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -69.48 -31.95 70.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 1.9 109.22 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.403 HG23 ' HE ' ' B' ' 37' ' ' ARG . 94.2 m -77.06 -37.98 53.52 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.448 -0.782 . . . . 0.4 111.467 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 10.5 p -131.0 -37.04 1.3 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.649 -1.282 . . . . 0.39 111.886 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.17 17.81 7.56 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.282 -1.527 . . . . 0.36 109.282 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.35 153.92 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.053 -1.263 . . . . 0.32 109.153 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.19 171.77 9.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 1.91 109.466 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.85 70.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.413 -0.805 . . . . 0.38 110.511 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.79 -41.22 68.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.784 -1.197 . . . . 2.57 110.247 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.37 -39.16 88.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -0.918 . . . . 2.12 110.439 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 51.0 m -66.02 -38.74 89.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 1.36 110.182 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -59.89 -38.32 81.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.857 -1.152 . . . . 2.81 109.452 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -68.11 -39.98 82.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.69 -1.256 . . . . 0.4 110.499 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' B' ' 26' ' ' ILE . 93.0 m -69.67 -40.06 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.23 109.757 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.38 -60.38 3.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.592 -1.318 . . . . 0.43 109.777 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.68 85.01 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.797 -0.921 . . . . 0.25 110.797 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.09 -49.41 44.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.758 -1.436 . . . . 0.24 109.982 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.6 HD21 HD22 ' B' ' 23' ' ' LEU . 88.5 mt -70.02 -39.9 75.51 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.004 -1.078 . . . . 0.29 108.823 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' B' ' 82' ' ' ARG . 16.5 ttt-85 -64.4 -40.07 95.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 2.74 110.061 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.7 -39.65 80.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 1.91 110.45 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.586 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 88.3 t90 -60.03 -43.61 95.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.409 -1.432 . . . . 0.36 107.658 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.6 m -61.69 -40.01 93.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.36 109.647 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -59.99 -31.85 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 0.55 109.227 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.16 -35.1 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.307 -0.871 . . . . 0.47 110.611 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.586 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 86.9 m-85 -107.2 -6.64 17.18 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.239 -0.913 . . . . 1.24 112.951 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.4 tp . . . . . 0 N--CA 1.504 2.262 0 O-C-N 120.202 -1.561 . . . . 1.67 109.342 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.753 0.787 . . . . 1.51 109.557 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -59.72 -22.52 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 2.18 110.253 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.13 -38.5 83.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 2.02 109.157 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 14.1 t60 -56.86 -49.84 74.25 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.256 -0.903 . . . . 0.49 110.132 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -70.03 -34.0 72.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.922 . . . . 3.21 110.086 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.68 -36.84 73.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.327 -0.858 . . . . 0.76 109.74 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -64.49 -43.18 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.46 109.803 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -84.11 15.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.209 -0.932 . . . . 0.44 110.243 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.42 -9.49 10.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.298 -0.876 . . . . 0.54 110.311 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.71 149.73 19.45 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.859 -1.15 . . . . 1.26 109.461 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -40.61 155.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.742 1.628 . . . . 0.49 111.168 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.518 ' CE ' HD22 ' A' ' 46' ' ' LEU . 4.3 ptp -91.21 -19.65 22.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.966 -1.084 . . . . 0.57 109.174 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -138.6 39.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.195 -1.162 . . . . 0.4 110.195 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -106.18 30.53 5.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.621 -0.929 . . . . 0.85 110.487 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -60.06 148.52 77.52 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 2.01 107.927 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.81 159.08 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.06 1.84 . . . . 0.34 112.633 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.5 p -57.12 -49.25 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 0.32 110.517 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.57 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.39 -1.86 0.14 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.763 -0.935 . . . . 0.23 110.763 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 64.9 p -82.42 -24.72 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.69 -1.476 . . . . 1.24 109.847 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.11 138.72 58.2 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.887 0.851 . . . . 0.24 109.84 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 133.43 53.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.725 0.774 . . . . 0.21 109.982 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 97.37 -20.25 51.47 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.213 -1.555 . . . . 0.22 109.213 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.0 mm -99.75 113.17 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -1.162 . . . . 0.25 107.892 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -93.44 179.94 39.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.28 109.692 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -56.01 -39.96 72.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.544 -0.974 . . . . 2.01 109.874 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.73 -43.17 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.95 -1.094 . . . . 0.38 109.524 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 27' ' ' GLY . 97.2 mt -67.73 -39.91 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.4 109.526 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.29 97.81 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.135 -1.186 . . . . 0.35 110.135 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -64.36 -38.79 92.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.998 -1.295 . . . . 2.74 110.079 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -65.43 -48.87 71.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.872 -1.142 . . . . 1.54 109.177 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.85 -38.6 86.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.21 -0.931 . . . . 0.34 108.59 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.11 -40.05 88.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.768 -0.827 . . . . 1.67 108.768 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.87 -18.89 64.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.407 -0.96 . . . . 2.0 108.407 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.33 2.89 56.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.594 -0.691 . . . . 2.69 110.166 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.56 6.86 49.65 Favored Glycine 0 N--CA 1.503 3.115 0 O-C-N 120.997 -1.064 . . . . 0.48 112.244 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 39' ' ' PHE . 44.3 m-85 -106.23 77.12 1.2 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 119.208 1.504 . . . . 0.33 109.32 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -77.46 -8.19 57.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.41 111.024 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.79 158.54 44.15 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.977 -1.077 . . . . 1.56 109.418 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.2 90.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.462 -0.774 . . . . 0.21 112.183 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.32 -17.58 20.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.636 -1.29 . . . . 0.32 110.635 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.18 -30.02 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.927 -1.108 . . . . 0.24 108.152 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.72 -39.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.994 -1.113 . . . . 0.22 107.994 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.518 HD22 ' CE ' ' A' ' 15' ' ' MET . 60.6 tp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.217 -1.401 . . . . 0.4 107.217 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.56 -43.79 67.71 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.156 -1.577 . . . . 0.18 109.156 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -1.225 . . . . 1.09 108.634 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.86 -41.19 90.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.852 . . . . 0.31 109.09 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.03 -39.98 75.44 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.883 -0.727 . . . . 0.28 109.073 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.78 -20.27 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.115 -0.991 . . . . 0.28 110.626 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.75 18.17 9.27 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.058 -1.026 . . . . 0.31 109.79 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.04 32.44 10.26 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.942 -1.099 . . . . 1.7 110.103 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 60.02 19.91 9.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.62 -0.675 . . . . 2.24 109.913 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -67.84 111.88 4.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.777 -1.202 . . . . 1.8 107.927 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.5 -41.17 98.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.87 112.601 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.42 -40.05 77.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.548 -1.345 . . . . 0.73 109.669 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.91 -40.01 75.85 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.977 -1.089 . . . . 0.55 108.785 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.06 -49.98 70.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.38 110.026 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -61.19 -44.85 96.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 2.64 110.431 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 98.8 mt-10 -64.81 -37.92 89.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.805 -1.185 . . . . 2.37 108.846 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.407 ' O ' ' OG1' ' A' ' 66' ' ' THR . 65.1 t90 -64.05 -48.04 77.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.303 -0.873 . . . . 0.4 110.974 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.17 -46.89 66.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.956 -1.09 . . . . 0.34 109.862 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -61.52 -47.0 87.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.067 -1.021 . . . . 2.11 109.714 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 61' ' ' GLU . 71.7 m-20 -70.02 -28.33 65.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.598 -0.689 . . . . 1.9 109.849 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 54.5 m -80.61 -31.56 36.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.41 111.732 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.6 p -133.19 -23.37 1.94 Allowed 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.374 -1.453 . . . . 0.4 111.916 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.85 13.09 32.85 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.171 -1.572 . . . . 0.36 109.171 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.88 154.74 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.097 -1.237 . . . . 0.33 109.371 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.93 171.88 9.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 1.9 110.214 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.51 75.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.694 -0.629 . . . . 0.39 110.38 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -73.06 -40.68 64.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.851 -1.155 . . . . 2.58 110.105 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.3 mm100 -67.94 -35.13 77.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.974 . . . . 2.12 110.284 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.4 -38.22 81.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.363 -0.836 . . . . 1.36 110.085 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.06 -36.27 76.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.886 -1.134 . . . . 2.8 109.547 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -68.97 -39.89 79.18 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.749 -1.22 . . . . 0.4 110.806 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.03 -40.36 75.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.674 -1.266 . . . . 0.24 110.061 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.77 -60.01 4.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.717 -1.239 . . . . 0.43 109.482 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.64 -33.7 87.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.351 -1.1 . . . . 0.26 110.351 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.73 -46.55 62.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.761 -1.435 . . . . 0.25 109.356 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.926 -1.11 . . . . 0.3 108.659 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.43 -40.06 95.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 2.73 110.295 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.534 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.6 mt-10 -69.85 -37.74 76.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 1.91 110.165 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.8 t90 -60.0 -42.85 95.18 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.53 -1.356 . . . . 0.37 107.821 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 88.3 m -60.79 -40.09 91.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -0.84 . . . . 0.36 109.668 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.91 -32.28 69.4 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.017 -1.052 . . . . 0.55 110.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.5 -34.03 14.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.107 -0.995 . . . . 0.48 110.999 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 91.4 m-85 . . . . . 0 N--CA 1.504 2.251 0 O-C-N 121.089 -1.007 . . . . 1.24 111.357 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.673 0.749 . . . . 1.5 109.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.52 -22.67 61.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.727 -0.608 . . . . 2.18 110.202 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -60.09 -38.59 83.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.094 -1.004 . . . . 2.01 109.189 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.541 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 14.2 t60 -56.85 -49.73 74.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.49 110.144 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -70.11 -34.02 72.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 3.23 110.034 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.73 -36.52 73.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.312 -0.868 . . . . 0.76 109.744 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.987 ' CD2' ' CD1' ' B' ' 10' ' ' PHE . . . -64.91 -42.94 94.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.479 -0.763 . . . . 0.46 109.869 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 m -84.0 14.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.161 -0.962 . . . . 0.44 110.302 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.07 -9.3 11.09 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.34 -0.85 . . . . 0.53 110.297 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.87 149.76 19.34 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.102 . . . . 1.27 109.37 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -40.58 155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.761 1.64 . . . . 0.49 111.205 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.524 ' CE ' HD22 ' B' ' 46' ' ' LEU . 4.2 ptp -91.16 -19.83 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.895 -1.128 . . . . 0.56 109.239 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.82 -138.44 41.81 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.341 -1.104 . . . . 0.39 110.341 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.52 30.52 5.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.635 -0.921 . . . . 0.84 110.408 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -60.03 148.31 77.84 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 2.02 107.933 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.78 159.12 34.43 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.096 1.864 . . . . 0.34 112.591 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.562 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.5 p -57.19 -49.15 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.485 0.659 . . . . 0.32 110.554 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.562 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.38 -2.21 0.15 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.791 -0.924 . . . . 0.22 110.791 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.488 ' H ' ' C ' ' B' ' 20' ' ' VAL . 61.1 p -81.91 -24.73 35.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.766 -1.432 . . . . 1.24 110.032 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.2 138.79 58.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.296 -0.877 . . . . 0.24 109.867 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.69 53.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.702 0.763 . . . . 0.21 109.836 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.513 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 97.17 -20.42 50.85 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.219 -1.552 . . . . 0.22 109.219 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.8 mm -99.69 113.18 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.894 -1.15 . . . . 0.25 107.894 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.419 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -93.48 179.98 39.14 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.714 -1.354 . . . . 0.28 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.433 ' O ' ' NZ ' ' B' ' 32' ' ' LYS . 79.6 mm-40 -56.07 -39.98 72.89 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.437 -1.037 . . . . 2.0 109.787 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.84 -42.99 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.956 -1.09 . . . . 0.38 109.534 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.419 HD12 ' H ' ' B' ' 27' ' ' GLY . 97.2 mt -67.81 -39.99 83.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.4 109.437 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.18 97.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.057 -1.217 . . . . 0.36 110.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' B' ' 28' ' ' GLU . 33.6 mtmm -64.55 -38.46 91.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.248 . . . . 2.75 110.111 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.67 -48.82 70.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.824 -1.173 . . . . 1.56 109.211 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.88 -38.63 86.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.26 -0.9 . . . . 0.33 108.579 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.95 -40.16 88.04 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.692 -0.855 . . . . 1.68 108.692 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.89 -18.82 64.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.47 -0.937 . . . . 1.99 108.47 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.23 2.44 56.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 2.68 110.163 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 7.01 48.44 Favored Glycine 0 N--CA 1.503 3.118 0 O-C-N 121.08 -1.013 . . . . 0.49 112.242 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' B' ' 39' ' ' PHE . 45.6 m-85 -106.36 76.95 1.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 119.19 1.495 . . . . 0.33 109.314 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -77.18 -8.47 57.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.377 -0.827 . . . . 0.41 110.98 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.67 158.31 44.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 1.56 109.437 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.4 91.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.48 -0.763 . . . . 0.21 112.173 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -58.17 -17.32 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.695 -1.253 . . . . 0.32 110.765 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.45 -29.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.908 -1.12 . . . . 0.24 108.104 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.88 -39.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.928 -1.138 . . . . 0.22 107.928 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.524 HD22 ' CE ' ' B' ' 15' ' ' MET . 60.7 tp -59.98 -39.84 87.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.257 -1.386 . . . . 0.4 107.257 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.7 -43.82 69.2 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.173 -1.571 . . . . 0.18 109.173 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.96 -44.62 94.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -1.207 . . . . 1.09 108.791 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.97 -41.28 91.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.31 109.007 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 mt -69.96 -39.7 75.86 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.878 -0.729 . . . . 0.27 109.186 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.98 -20.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.166 -0.959 . . . . 0.28 110.561 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.47 17.82 9.44 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.0 -1.063 . . . . 0.3 109.907 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.25 32.52 10.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.959 -1.088 . . . . 1.71 110.151 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt 60.0 20.08 9.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.746 . . . . 2.25 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -67.96 111.5 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.817 -1.177 . . . . 1.8 108.072 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.39 -40.69 97.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.88 112.641 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.86 -39.91 76.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.523 -1.361 . . . . 0.74 109.663 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.96 -39.99 75.7 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.929 -1.108 . . . . 0.55 108.73 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.02 -50.04 70.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.99 . . . . 0.38 110.096 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -61.27 -44.46 97.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 2.64 110.548 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.413 ' O ' ' OD2' ' B' ' 65' ' ' ASP . 98.9 mt-10 -65.03 -38.1 89.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.776 -1.203 . . . . 2.38 108.866 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -63.83 -48.27 77.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.4 111.013 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.05 -46.46 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.909 -1.119 . . . . 0.34 109.989 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -61.73 -47.17 86.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 2.1 109.707 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' B' ' 61' ' ' GLU . 71.3 m-20 -69.93 -28.35 65.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.689 . . . . 1.9 109.906 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -80.54 -31.6 36.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.4 111.737 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.8 p -133.3 -23.2 1.92 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.326 -1.484 . . . . 0.39 111.919 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.71 34.11 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 109.237 -1.545 . . . . 0.36 109.237 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.55 154.53 1.85 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.091 -1.241 . . . . 0.32 109.39 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.74 171.96 9.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 1.91 110.177 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.75 75.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.646 -0.658 . . . . 0.38 110.417 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -72.89 -40.69 65.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.859 -1.151 . . . . 2.57 110.128 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.2 mm100 -67.92 -35.2 78.03 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.248 -0.907 . . . . 2.12 110.354 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.27 -38.37 81.66 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.179 -0.951 . . . . 1.36 110.074 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.92 -36.53 77.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.86 -1.15 . . . . 2.81 109.531 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -68.6 -40.03 80.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.778 -1.201 . . . . 0.4 110.747 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.2 m -70.06 -40.37 75.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.23 110.123 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.75 -59.97 4.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.699 -1.251 . . . . 0.43 109.525 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.75 87.42 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.344 -1.102 . . . . 0.25 110.344 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.73 -46.41 63.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.725 -1.456 . . . . 0.24 109.337 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.6 -40.43 69.86 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.935 -1.106 . . . . 0.29 108.628 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.24 -39.99 95.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.98 . . . . 2.74 110.316 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.4 mt-10 -69.8 -37.76 76.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.91 110.167 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.549 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 87.0 t90 -60.04 -42.72 95.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.5 -1.375 . . . . 0.36 107.866 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' B' ' 89' ' ' LEU . 89.4 m -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.36 109.748 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.02 -32.55 69.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.049 -1.032 . . . . 0.55 109.912 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.2 -34.11 14.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.135 -0.978 . . . . 0.47 111.06 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.549 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 92.4 m-85 -107.41 2.02 24.03 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.195 -0.941 . . . . 1.24 111.465 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' B' ' 85' ' ' CYS . 54.7 tp . . . . . 0 N--CA 1.495 1.785 0 O-C-N 120.695 -1.253 . . . . 1.67 109.321 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.714 0.769 . . . . 1.51 109.314 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.74 -26.46 63.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.687 -0.633 . . . . 2.18 110.074 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -36.0 76.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.001 -1.062 . . . . 2.02 109.567 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -58.86 -50.01 75.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.49 110.127 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.6 mmp_? -69.96 -32.83 71.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.044 -1.035 . . . . 3.21 109.751 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.47 -40.02 89.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.234 -0.917 . . . . 0.76 109.628 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.97 -49.04 76.28 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.246 -0.909 . . . . 0.46 109.792 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.21 4.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.232 -0.917 . . . . 0.44 111.863 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -97.57 -18.92 18.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.686 -1.259 . . . . 0.54 110.359 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 1.4 pp20? -155.83 152.26 23.6 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 1.26 108.596 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 48.5 Cg_exo -35.36 155.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.174 1.916 . . . . 0.49 112.034 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' HD13 ' B' ' 89' ' ' LEU . 11.4 ptm -90.92 -23.08 20.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.145 -0.972 . . . . 0.57 110.484 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.09 -136.35 20.58 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.984 -1.073 . . . . 0.4 110.715 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.06 28.37 8.67 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.523 -0.986 . . . . 0.85 111.02 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.6 148.34 56.63 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 118.557 -1.257 . . . . 2.01 107.756 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.19 159.34 19.12 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.619 2.213 . . . . 0.34 113.183 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 22' ' ' SER . 4.3 p -59.63 -48.52 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.32 110.576 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -52.95 -1.87 0.07 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.435 -1.066 . . . . 0.23 110.435 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 20' ' ' VAL . 10.6 p -83.3 -26.42 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.385 . . . . 1.24 109.973 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.65 137.29 58.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.24 110.296 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 132.63 49.08 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.789 0.804 . . . . 0.21 110.234 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.95 -18.1 56.29 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.003 -1.639 . . . . 0.22 109.003 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.88 114.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.827 -1.175 . . . . 0.25 107.827 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.1 177.58 38.29 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.458 -1.457 . . . . 0.28 109.458 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -58.83 -40.14 83.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -1.125 . . . . 2.01 109.494 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.22 -48.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.042 -1.037 . . . . 0.38 109.42 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.41 -39.99 81.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.4 109.212 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.03 96.42 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.236 -1.546 . . . . 0.35 109.236 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 36' ' ' GLU . 14.7 tmtt? -61.36 -40.0 92.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.338 -1.096 . . . . 2.74 110.775 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.04 -40.1 87.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.736 -1.227 . . . . 1.54 109.986 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.58 -38.04 83.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.923 -1.11 . . . . 0.34 108.893 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.424 -0.91 . . . . 1.67 108.992 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 32' ' ' LYS . 98.9 mt-10 -68.06 -18.62 64.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 2.0 108.822 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -89.97 2.01 55.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.46 -0.775 . . . . 2.69 109.859 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.49 5.18 42.89 Favored Glycine 0 N--CA 1.502 3.077 0 O-C-N 121.115 -0.991 . . . . 0.48 112.18 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.7 76.97 1.32 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.694 -1.474 . . . . 0.33 109.141 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -75.48 -8.86 57.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.41 110.437 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.16 160.02 40.78 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.079 -1.013 . . . . 1.56 110.263 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.84 92.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.558 -0.714 . . . . 0.21 112.512 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 7.5 p90 -58.73 -17.74 25.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.515 -1.366 . . . . 0.32 110.555 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -80.01 -32.71 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.794 -1.191 . . . . 0.24 108.315 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.06 -39.1 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.22 108.237 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 tp -59.98 -36.38 77.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.866 -1.161 . . . . 0.4 107.866 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.52 97.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.18 110.02 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.98 -40.03 87.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.245 . . . . 1.09 109.035 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.96 -39.95 87.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.373 -0.973 . . . . 0.31 108.373 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.053 -0.721 . . . . 0.28 109.053 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.22 -23.97 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.246 -0.909 . . . . 0.28 111.001 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.37 17.61 11.06 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.045 -1.034 . . . . 0.31 110.154 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' NZ ' ' O ' ' B' ' 38' ' ' GLY . 12.7 mptt 52.47 29.31 6.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.944 -1.098 . . . . 1.7 109.828 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.03 19.94 9.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 2.24 110.255 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.23 117.75 9.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.511 -1.368 . . . . 1.8 107.683 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.11 -40.95 97.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.311 -0.868 . . . . 0.87 112.99 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.488 ' CG ' HH21 ' A' ' 60' ' ' ARG . 7.6 m-20 -69.68 -39.93 76.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.669 -1.27 . . . . 0.73 110.115 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.3 mt -69.95 -39.99 75.71 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.007 -1.077 . . . . 0.55 109.036 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.46 -49.91 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.38 109.71 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.488 HH21 ' CG ' ' A' ' 57' ' ' ASP . 87.7 mtm180 -60.37 -45.79 92.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.354 -0.841 . . . . 2.64 110.622 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.64 -39.77 94.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.931 -1.105 . . . . 2.37 108.788 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -65.51 -48.76 71.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.4 111.362 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.5 tp -67.42 -47.09 71.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.34 110.095 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.01 -45.95 92.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.38 -0.825 . . . . 2.11 109.714 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.03 -27.33 64.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.9 109.945 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -80.59 -33.9 35.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.41 111.526 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.2 p -130.59 -27.27 2.16 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.555 -1.34 . . . . 0.4 112.083 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.16 22.64 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.171 -1.572 . . . . 0.36 109.171 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 153.1 2.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -1.196 . . . . 0.33 109.618 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.6 172.96 8.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.115 -0.991 . . . . 1.9 109.715 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.23 72.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.39 111.025 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.1 -39.71 63.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.711 -1.243 . . . . 2.58 110.05 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.5 mm100 -67.38 -39.88 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 2.12 110.694 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -67.52 -37.51 82.89 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.288 -0.882 . . . . 1.36 109.958 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 75' ' ' ARG . 25.7 mtt-85 -60.41 -37.24 80.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.114 . . . . 2.8 109.632 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.78 -39.9 84.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.571 -1.33 . . . . 0.4 110.552 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.8 m -67.94 -40.0 83.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.24 109.806 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.43 -60.05 4.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.879 -1.138 . . . . 0.43 109.954 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.66 -34.28 88.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.448 -1.061 . . . . 0.26 110.448 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.25 -47.33 57.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -1.202 . . . . 0.25 109.804 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.61 -40.07 73.38 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.695 -1.202 . . . . 0.3 108.328 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -63.01 -40.07 96.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 2.73 110.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -69.41 -37.81 77.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.02 -1.05 . . . . 1.91 110.474 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.487 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 84.6 t90 -59.97 -43.86 94.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.39 -1.444 . . . . 0.37 107.363 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.3 m -60.6 -40.67 92.64 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.894 -0.78 . . . . 0.36 108.894 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.631 -0.668 . . . . 0.55 109.695 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -36.78 16.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.48 110.125 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 83.9 m-85 . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.35 -0.844 . . . . 1.24 110.032 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.768 0.794 . . . . 1.5 109.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.81 -26.53 64.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.702 -0.624 . . . . 2.18 110.094 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.13 -35.73 75.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.085 . . . . 2.01 109.575 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -58.96 -49.94 75.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.49 110.213 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 3.6 mmp_? -70.06 -32.76 71.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 3.23 109.749 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.45 -39.92 89.14 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.483 -0.887 . . . . 0.76 109.743 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.0 -49.16 75.76 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.263 -0.898 . . . . 0.46 109.71 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.12 4.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.144 -0.973 . . . . 0.44 111.834 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -97.29 -19.0 18.84 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.661 -1.274 . . . . 0.53 110.418 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' B' ' 14' ' ' PRO . 1.4 pp20? -155.84 152.34 23.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.955 . . . . 1.27 108.63 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' OE1' ' B' ' 13' ' ' GLU . 48.7 Cg_exo -35.37 155.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.266 1.977 . . . . 0.49 111.989 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 11.3 ptm -90.89 -23.25 20.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.56 110.432 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.33 21.13 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.894 -1.128 . . . . 0.39 110.7 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.2 28.72 8.35 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.634 -0.921 . . . . 0.84 111.021 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.77 148.4 58.18 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.648 -1.283 . . . . 2.02 107.608 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.18 159.44 18.84 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.639 2.226 . . . . 0.34 113.207 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' B' ' 22' ' ' SER . 4.2 p -59.79 -48.6 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.32 110.512 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.489 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -52.7 -2.14 0.07 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.443 -1.063 . . . . 0.22 110.443 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.539 ' H ' ' C ' ' B' ' 20' ' ' VAL . 10.6 p -83.09 -26.43 31.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.787 -1.419 . . . . 1.24 110.055 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.79 137.29 58.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.27 -0.894 . . . . 0.24 110.273 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.82 132.63 49.16 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.82 0.819 . . . . 0.21 110.175 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.99 -18.31 55.95 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.902 -1.679 . . . . 0.22 108.902 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -101.68 114.78 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.848 -1.167 . . . . 0.25 107.848 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.16 177.65 38.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.493 -1.443 . . . . 0.28 109.493 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -58.95 -40.01 83.39 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.337 -1.096 . . . . 2.0 109.48 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.47 -48.9 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.38 109.333 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.51 -39.9 81.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.4 109.178 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.98 96.43 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.251 -1.54 . . . . 0.36 109.251 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' B' ' 36' ' ' GLU . 14.7 tmtt? -61.25 -39.94 92.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 2.75 110.798 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.2 -40.02 86.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.687 -1.258 . . . . 1.56 109.977 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -60.74 -38.01 83.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.923 -1.11 . . . . 0.33 108.889 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -40.51 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.429 -0.909 . . . . 1.68 108.973 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' NZ ' ' B' ' 32' ' ' LYS . 98.9 mt-10 -68.01 -18.61 64.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 1.99 108.88 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -90.03 2.14 55.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.818 . . . . 2.68 109.793 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.413 ' O ' ' NZ ' ' A' ' 53' ' ' LYS . . . 104.4 5.26 43.06 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.246 -0.978 . . . . 0.49 112.154 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.72 76.89 1.31 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.49 . . . . 0.33 109.144 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -75.43 -8.89 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.104 -0.997 . . . . 0.41 110.522 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.13 159.95 40.93 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.067 -1.021 . . . . 1.56 110.162 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.93 93.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.647 -0.658 . . . . 0.21 112.542 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 7.4 p90 -58.66 -17.77 25.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.532 -1.355 . . . . 0.32 110.614 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -79.9 -32.76 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.796 -1.19 . . . . 0.24 108.286 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 77.2 t -76.0 -39.13 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.216 -1.031 . . . . 0.22 108.216 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 tp -60.06 -36.2 76.82 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.876 -1.157 . . . . 0.4 107.876 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.68 97.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.028 -1.229 . . . . 0.18 110.028 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.9 -40.02 87.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.094 -1.239 . . . . 1.09 109.154 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.95 -40.07 87.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.297 -1.001 . . . . 0.31 108.297 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.082 -0.71 . . . . 0.27 109.082 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.29 -23.99 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.357 -0.84 . . . . 0.28 110.973 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.33 17.58 11.05 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.945 -1.097 . . . . 0.3 110.164 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mptt 52.72 29.11 7.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.921 -1.112 . . . . 1.71 109.818 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.0 19.99 9.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.416 -0.803 . . . . 2.25 110.208 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.33 117.57 9.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.318 . . . . 1.8 107.739 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.0 -40.92 97.45 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.075 0.769 . . . . 0.88 113.075 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.49 ' CG ' HH21 ' B' ' 60' ' ' ARG . 7.6 m-20 -69.65 -39.98 76.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.535 -1.353 . . . . 0.74 110.056 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.98 -40.0 75.62 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.01 -1.076 . . . . 0.55 108.94 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.48 -49.96 73.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.38 109.68 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' B' ' 57' ' ' ASP . 87.8 mtm180 -60.4 -45.54 93.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.407 -0.808 . . . . 2.64 110.62 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.77 -39.78 94.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.957 -1.09 . . . . 2.38 108.756 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 63.0 t90 -65.53 -48.75 71.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.4 111.383 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -67.26 -47.19 71.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.007 -1.058 . . . . 0.34 110.09 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.03 -45.94 92.76 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.389 -0.819 . . . . 2.1 109.787 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.03 -27.34 64.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.445 -0.784 . . . . 1.9 109.884 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 96.8 m -80.54 -33.84 35.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.4 111.574 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.1 p -130.63 -27.35 2.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.595 -1.316 . . . . 0.39 112.027 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 14.09 22.59 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.154 -1.578 . . . . 0.36 109.154 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.01 153.24 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -1.185 . . . . 0.32 109.654 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.62 172.96 8.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.174 -0.954 . . . . 1.91 109.728 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.48 -33.34 72.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 0.38 110.959 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.02 -39.67 63.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.66 -1.275 . . . . 2.57 110.049 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.6 mm100 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 2.12 110.675 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.8 t -67.5 -37.48 82.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.851 . . . . 1.36 110.004 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.487 HH11 ' HG2' ' B' ' 75' ' ' ARG . 25.2 mtt-85 -60.36 -37.33 80.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 2.81 109.584 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -67.65 -39.93 84.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.698 -1.251 . . . . 0.4 110.588 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.93 -39.99 83.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.854 -1.154 . . . . 0.23 109.809 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.39 -59.98 4.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.95 -1.094 . . . . 0.43 109.967 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.57 -34.52 88.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.452 -1.059 . . . . 0.25 110.452 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 49.4 t -71.14 -47.22 59.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -1.179 . . . . 0.24 109.832 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.68 -40.13 73.12 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.716 -1.194 . . . . 0.29 108.326 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -63.03 -40.1 96.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 2.74 109.93 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -69.47 -37.6 77.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.054 -1.029 . . . . 1.91 110.482 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.484 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 84.8 t90 -60.02 -43.86 94.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.456 -1.403 . . . . 0.36 107.318 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 51.6 m -60.65 -40.66 92.83 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.93 -0.767 . . . . 0.36 108.93 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.96 -38.19 85.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.615 -0.678 . . . . 0.55 109.626 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.8 -37.75 16.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 0.47 110.075 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 85.2 m-85 -104.34 -87.69 0.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.901 . . . . 1.24 110.413 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.461 HD13 ' SD ' ' A' ' 15' ' ' MET . 16.4 tp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.133 -0.937 . . . . 1.67 109.711 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.641 0.734 . . . . 1.51 109.15 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -62.16 -22.61 66.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.744 -0.597 . . . . 2.18 110.648 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.29 -39.26 89.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 2.02 108.998 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 11' ' ' VAL . 16.1 t60 -60.1 -50.28 74.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.49 110.806 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.515 HH11 ' HG2' ' A' ' 8' ' ' ARG . 20.5 mtt-85 -69.94 -35.59 74.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.998 -1.064 . . . . 3.21 109.85 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -66.96 -39.79 87.33 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.436 -0.79 . . . . 0.76 109.529 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 50.7 t80 -65.25 -45.5 84.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.818 . . . . 0.46 110.194 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 7' ' ' HIS . 18.7 m -88.62 5.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.007 -1.058 . . . . 0.44 111.55 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.957 -1.089 . . . . 0.54 110.319 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.0 pt-20 -152.06 153.15 30.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.374 -0.973 . . . . 1.26 108.374 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 13' ' ' GLU . 58.0 Cg_exo -37.29 155.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.944 1.763 . . . . 0.49 111.641 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.522 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 12.6 ptm -92.75 -28.9 16.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 0.57 109.968 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.65 -134.99 46.29 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.422 -1.071 . . . . 0.4 110.422 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.5 34.5 3.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.64 -0.918 . . . . 0.85 110.061 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -58.81 148.76 67.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 2.01 108.695 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.81 155.93 35.48 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.086 1.857 . . . . 0.34 112.15 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 21' ' ' GLY . 13.8 p -58.31 -41.9 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.693 0.759 . . . . 0.32 110.167 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -61.51 -2.25 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.103 -1.199 . . . . 0.23 110.103 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 t -81.59 -21.17 38.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.728 -1.454 . . . . 1.24 108.919 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 81' ' ' LEU . 97.1 mt -65.39 138.52 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.369 -0.832 . . . . 0.24 109.652 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.98 57.72 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.948 -0.701 . . . . 0.21 109.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 -18.41 56.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.572 -1.411 . . . . 0.22 109.572 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 mm -99.52 112.0 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.715 -1.217 . . . . 0.25 107.715 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.89 -179.05 36.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.649 -1.38 . . . . 0.28 109.649 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 59.7 mp0 -57.28 -40.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -1.119 . . . . 2.01 109.532 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.9 -45.87 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.38 109.32 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.89 -39.59 83.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.4 109.39 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.82 -39.96 96.08 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.96 -1.656 . . . . 0.35 108.96 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.91 -39.97 96.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 2.74 109.72 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.92 -44.1 77.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 1.54 108.809 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.1 mt -64.84 -40.61 95.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.34 108.64 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.14 -44.15 95.18 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.642 -0.661 . . . . 1.67 109.55 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.21 -19.58 66.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.398 -0.814 . . . . 2.0 108.917 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -90.39 3.99 52.19 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.521 -0.737 . . . . 2.69 109.981 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.81 48.35 Favored Glycine 0 N--CA 1.502 3.048 0 O-C-N 121.167 -0.958 . . . . 0.48 111.579 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' A' ' 44' ' ' VAL . 92.4 m-85 -106.51 75.59 1.08 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.714 -1.462 . . . . 0.33 109.55 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.73 -9.9 59.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.074 -1.016 . . . . 0.41 110.316 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.2 mmtm -134.87 156.67 48.53 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.203 -0.936 . . . . 1.56 110.001 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.65 94.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.63 -0.669 . . . . 0.21 111.233 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 23.6 p90 -58.59 -20.07 43.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.704 -1.248 . . . . 0.32 110.951 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.5 t -78.58 -34.51 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.643 -1.286 . . . . 0.24 108.022 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 20' ' ' VAL . 74.4 t -76.32 -38.92 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.187 -1.042 . . . . 0.22 108.187 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.09 -38.8 84.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.296 -1.001 . . . . 0.4 108.296 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.84 97.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.817 -1.313 . . . . 0.18 109.817 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.275 . . . . 1.09 109.341 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -59.22 -40.09 84.76 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.296 -1.001 . . . . 0.31 108.296 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.08 -38.72 79.16 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.377 -0.972 . . . . 0.28 108.377 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.14 -24.61 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 0.28 110.251 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.24 16.14 17.39 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.118 -0.989 . . . . 0.31 110.678 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.54 40.4 15.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.726 -1.234 . . . . 1.7 110.719 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 59.19 19.62 7.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 2.24 109.843 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.31 107.01 2.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.743 -1.223 . . . . 1.8 107.994 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CD ' HH21 ' A' ' 60' ' ' ARG . 88.1 tt0 -61.75 -40.5 95.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.501 -0.75 . . . . 0.87 112.562 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.63 -40.07 76.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.534 -1.353 . . . . 0.73 109.728 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.66 -39.99 76.73 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.726 -1.19 . . . . 0.55 109.199 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.31 -50.14 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.38 109.483 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.526 HH21 ' CD ' ' A' ' 56' ' ' GLU . 34.1 mtt-85 -60.88 -46.12 91.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.372 -0.83 . . . . 2.64 110.682 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.04 -38.31 90.59 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.819 -1.175 . . . . 2.37 108.841 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -66.8 -45.25 78.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.4 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.27 -48.91 68.92 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.149 -0.969 . . . . 0.34 110.046 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -62.0 -44.56 96.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.242 -0.911 . . . . 2.11 109.257 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.59 -32.39 71.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.567 -0.708 . . . . 1.9 109.739 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -79.97 -31.86 39.86 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.41 111.345 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.32 -30.15 1.53 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.572 -1.33 . . . . 0.4 112.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.12 19.89 Favored Glycine 0 N--CA 1.501 3.025 0 N-CA-C 109.196 -1.561 . . . . 0.36 109.196 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.0 152.9 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.242 . . . . 0.33 109.467 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -91.9 175.18 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.071 -1.018 . . . . 1.9 109.623 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.81 77.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.39 110.103 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -73.79 -39.97 63.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.109 -0.994 . . . . 2.58 109.995 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.85 -36.96 83.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 2.12 110.539 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 p -69.22 -37.17 77.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.133 -0.979 . . . . 1.36 110.027 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.03 -37.61 80.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.831 -1.168 . . . . 2.8 109.707 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.05 -40.0 87.02 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.746 -1.221 . . . . 0.4 110.442 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 61.5 m -70.04 -42.5 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.726 -1.234 . . . . 0.24 110.398 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.421 ' HB3' HH22 ' A' ' 60' ' ' ARG . 79.4 t80 -60.14 -60.17 4.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.57 -1.331 . . . . 0.43 110.113 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.86 -34.52 90.03 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.334 -1.106 . . . . 0.26 110.334 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.71 -47.91 57.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.726 -1.455 . . . . 0.25 109.781 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 23' ' ' LEU . 96.9 mt -70.11 -40.03 75.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.798 -1.161 . . . . 0.3 108.345 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.485 HH11 ' HG2' ' A' ' 82' ' ' ARG . 4.6 ttt-85 -61.36 -40.11 93.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 2.73 109.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -68.8 -37.42 79.24 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 1.91 109.878 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.522 ' CZ2' ' SD ' ' A' ' 15' ' ' MET . 80.4 t90 -59.65 -45.67 91.32 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.94 -1.504 . . . . 0.37 106.94 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -61.83 -41.52 97.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.716 -0.615 . . . . 0.36 109.46 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -60.27 -37.24 79.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.2 -0.937 . . . . 0.55 109.954 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.1 -35.87 19.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.48 109.888 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.363 -0.836 . . . . 1.24 110.395 -178.563 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.591 0.71 . . . . 1.5 109.233 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.94 -22.75 65.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.703 -0.623 . . . . 2.18 110.671 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -61.21 -39.24 89.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.017 -1.052 . . . . 2.01 108.852 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.41 ' O ' HG22 ' B' ' 11' ' ' VAL . 16.0 t60 -60.1 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.49 110.746 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.511 HH11 ' HG2' ' B' ' 8' ' ' ARG . 20.8 mtt-85 -70.05 -35.65 74.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.903 -1.123 . . . . 3.23 109.758 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -66.73 -40.03 88.2 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.638 -0.664 . . . . 0.76 109.642 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.431 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 49.7 t80 -64.99 -45.91 83.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.46 110.25 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 7' ' ' HIS . 18.9 m -88.38 5.71 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.16 -0.962 . . . . 0.44 111.48 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -100.92 -15.98 17.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.881 -1.137 . . . . 0.53 110.26 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -152.11 153.26 30.98 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 1.27 108.352 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -37.35 155.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.998 1.798 . . . . 0.49 111.584 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.516 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 12.5 ptm -92.77 -28.85 16.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.56 110.035 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.71 -135.03 46.47 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.357 -1.097 . . . . 0.39 110.357 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.61 34.55 3.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.468 -1.019 . . . . 0.84 109.944 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -58.75 148.63 67.21 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 2.02 108.601 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.76 155.82 35.75 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.06 1.84 . . . . 0.34 112.175 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.531 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.0 p -58.29 -41.84 82.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.496 -0.753 . . . . 0.32 110.093 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.531 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -61.33 -2.31 2.96 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.119 -1.192 . . . . 0.22 110.119 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.7 t -81.73 -21.1 38.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.895 -1.356 . . . . 1.24 108.914 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.59 HD22 HD21 ' B' ' 81' ' ' LEU . 97.3 mt -65.31 138.52 58.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.24 109.676 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.36 136.94 57.61 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.743 -0.783 . . . . 0.21 109.744 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 -18.34 56.91 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.604 -1.398 . . . . 0.22 109.604 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.52 111.87 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.709 -1.219 . . . . 0.25 107.709 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.87 36.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.731 -1.348 . . . . 0.28 109.731 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mp0 -57.48 -39.86 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -1.07 . . . . 2.0 109.567 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.05 -45.89 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.38 109.344 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.88 -39.54 83.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -0.889 . . . . 0.4 109.518 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.92 -39.77 95.98 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.915 -1.674 . . . . 0.36 108.915 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.05 -40.04 96.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 2.75 109.771 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.74 -43.99 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.074 -1.016 . . . . 1.56 108.962 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.01 -40.4 94.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.33 108.699 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.19 -44.27 95.23 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.034 -0.666 . . . . 1.68 109.478 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.16 -19.71 66.11 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 1.99 109.016 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -90.35 3.93 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.654 -0.654 . . . . 2.68 109.925 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 7.4 48.41 Favored Glycine 0 N--CA 1.502 3.08 0 O-C-N 121.095 -1.003 . . . . 0.49 111.697 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' B' ' 44' ' ' VAL . 91.4 m-85 -106.26 75.45 1.09 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.866 -1.373 . . . . 0.33 109.658 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.76 -10.0 59.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.41 110.36 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.473 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.3 mmtm -134.68 156.87 48.01 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.136 -0.978 . . . . 1.56 109.886 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.71 94.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.754 -0.591 . . . . 0.21 111.242 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 24.0 p90 -58.56 -20.01 42.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.32 111.042 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.9 t -78.68 -34.47 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 0.24 107.916 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.439 HG21 HG23 ' B' ' 20' ' ' VAL . 74.0 t -76.23 -39.1 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.164 -1.05 . . . . 0.22 108.164 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.95 -39.02 84.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.305 -0.998 . . . . 0.4 108.305 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -41.05 97.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.845 -1.302 . . . . 0.18 109.845 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.04 -41.94 93.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.112 -1.228 . . . . 1.09 109.343 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.26 -40.0 84.62 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 0.31 108.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.17 -38.76 78.9 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.434 -0.95 . . . . 0.27 108.434 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.16 -24.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.304 -0.872 . . . . 0.28 110.194 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.34 16.15 17.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.108 -0.995 . . . . 0.3 110.784 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.41 40.64 15.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.698 -1.252 . . . . 1.71 110.73 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 58.93 19.74 7.42 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.468 -0.77 . . . . 2.25 109.853 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.28 107.04 2.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.698 -1.251 . . . . 1.8 107.729 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.544 ' CD ' HH21 ' B' ' 60' ' ' ARG . 88.2 tt0 -61.63 -40.52 95.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.429 -0.794 . . . . 0.88 112.584 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.75 -39.58 76.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.74 109.855 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.96 -39.96 75.69 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.685 -1.206 . . . . 0.55 109.025 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.31 -50.32 68.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.38 109.457 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.544 HH21 ' CD ' ' B' ' 56' ' ' GLU . 34.0 mtt-85 -60.76 -46.19 91.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.815 . . . . 2.64 110.572 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.92 -38.34 90.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.854 -1.154 . . . . 2.38 108.933 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . 0.407 ' O ' ' OG1' ' B' ' 66' ' ' THR . 51.2 t90 -66.79 -45.24 79.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.4 110.415 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.32 -48.79 69.17 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.266 -0.896 . . . . 0.34 109.989 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.391 -0.818 . . . . 2.1 109.249 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.43 -32.63 71.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.58 -0.7 . . . . 1.9 109.684 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 87.5 m -79.66 -31.92 41.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.4 111.471 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.41 -30.0 1.53 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.436 -1.415 . . . . 0.39 112.193 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.73 15.02 19.91 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.138 -1.585 . . . . 0.36 109.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.77 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.245 . . . . 0.32 109.416 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -91.83 175.37 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 1.91 109.731 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.96 78.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.483 -0.761 . . . . 0.38 110.122 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -73.81 -39.78 63.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 2.57 109.99 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.03 -36.88 83.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 2.12 110.545 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 18.8 p -69.25 -37.23 77.84 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.171 -0.956 . . . . 1.36 110.003 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -37.88 80.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 2.81 109.593 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.98 -39.84 87.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.502 -1.374 . . . . 0.4 110.441 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.16 -42.62 72.26 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.69 -1.256 . . . . 0.23 110.401 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.411 ' HB3' HH22 ' B' ' 60' ' ' ARG . 79.3 t80 -59.99 -60.12 4.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.575 -1.328 . . . . 0.43 110.068 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.95 -34.47 90.0 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.368 -1.093 . . . . 0.25 110.368 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.52 -48.1 57.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.793 -1.416 . . . . 0.24 109.84 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.59 HD21 HD22 ' B' ' 23' ' ' LEU . 97.0 mt -70.04 -39.96 75.43 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.799 -1.16 . . . . 0.29 108.435 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' B' ' 82' ' ' ARG . 4.7 ttt-85 -61.47 -40.0 92.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 2.74 109.515 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.95 -37.23 78.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.379 -0.826 . . . . 1.91 109.91 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.516 ' CZ2' ' SD ' ' B' ' 15' ' ' MET . 80.8 t90 -60.0 -45.68 91.93 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.972 -1.492 . . . . 0.36 106.972 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 32.7 m -61.83 -41.22 97.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.69 -0.631 . . . . 0.36 109.527 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.35 -37.18 79.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.55 109.939 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.38 -36.36 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.47 109.824 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -104.57 -86.24 0.46 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -0.886 . . . . 1.24 110.777 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.445 HD13 ' SD ' ' A' ' 15' ' ' MET . 11.5 tp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.106 -0.95 . . . . 1.67 109.117 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.805 0.812 . . . . 1.51 109.339 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.85 -30.14 68.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.795 -0.566 . . . . 2.18 110.598 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.11 -33.67 72.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 2.02 108.965 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 23.8 t60 -59.92 -48.75 80.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.49 110.088 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -69.88 -34.06 73.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.157 -0.964 . . . . 3.21 109.888 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.11 -39.84 82.69 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.383 -0.823 . . . . 0.76 109.61 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.4 t80 -61.91 -47.3 85.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.429 -0.794 . . . . 0.46 110.107 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 m -82.19 9.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.154 -0.966 . . . . 0.44 110.12 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.94 -16.4 15.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.156 -0.965 . . . . 0.54 110.944 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -156.63 152.84 23.42 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.115 . . . . 1.26 109.198 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -40.33 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.702 1.601 . . . . 0.49 110.839 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.5 ptp -90.37 -24.76 20.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.825 -1.172 . . . . 0.57 109.646 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.22 -136.72 45.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.704 -1.358 . . . . 0.4 109.704 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.57 28.93 6.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -1.006 . . . . 0.85 111.221 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -60.75 148.44 82.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.709 -1.244 . . . . 2.01 107.802 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.19 163.33 32.11 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.151 1.901 . . . . 0.34 112.801 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 21' ' ' GLY . 8.0 p -58.14 -47.36 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.58 -0.7 . . . . 0.32 110.391 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.57 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.13 -3.29 0.12 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.783 -0.927 . . . . 0.23 110.783 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' VAL . 11.6 p -82.33 -25.3 34.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.799 -1.412 . . . . 1.24 109.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.54 137.82 58.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.708 0.766 . . . . 0.24 109.759 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.92 135.31 55.55 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.692 0.758 . . . . 0.21 109.912 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 73' ' ' GLN . . . 96.98 -20.26 51.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.245 -1.542 . . . . 0.22 109.245 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.56 112.82 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.641 -1.244 . . . . 0.25 107.641 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -90.1 177.76 43.06 Favored Glycine 0 N--CA 1.492 2.39 0 O-C-N 120.678 -1.264 . . . . 0.28 110.043 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -56.6 -39.94 74.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -1.033 . . . . 2.01 109.643 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.76 -44.98 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.076 -1.015 . . . . 0.38 109.496 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.429 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.5 mt -66.35 -36.92 84.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.4 109.466 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.82 97.43 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.816 -1.314 . . . . 0.35 109.816 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -65.33 -37.03 85.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -1.219 . . . . 2.74 109.736 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.59 -48.52 69.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.804 -1.185 . . . . 1.54 109.372 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.99 -38.66 89.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.34 108.448 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.04 -42.19 93.88 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.906 -0.717 . . . . 1.67 109.296 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.23 -19.42 65.53 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.533 -0.914 . . . . 2.0 108.533 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 2.83 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.747 . . . . 2.69 109.725 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.78 5.46 50.9 Favored Glycine 0 N--CA 1.503 3.132 0 C-N-CA 120.264 -0.969 . . . . 0.48 111.856 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.482 ' CD2' HG12 ' A' ' 44' ' ' VAL . 97.4 m-85 -106.56 77.07 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.899 -1.353 . . . . 0.33 108.942 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -79.36 -7.54 58.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.41 110.929 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.05 158.58 44.03 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.053 -1.029 . . . . 1.56 110.406 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -40.64 90.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.747 -0.595 . . . . 0.21 112.307 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.6 p90 -61.13 -18.49 58.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.499 -1.376 . . . . 0.32 110.622 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 39' ' ' PHE . 17.2 t -80.06 -31.03 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.876 -1.157 . . . . 0.24 107.876 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.4 t -77.5 -37.41 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.22 108.324 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.94 -35.67 75.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.638 -1.245 . . . . 0.4 107.638 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.22 96.69 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.573 -1.411 . . . . 0.18 109.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.15 -43.32 95.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.942 -1.328 . . . . 1.09 109.096 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.98 -41.62 92.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.31 109.019 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.94 -40.06 75.72 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.808 -0.757 . . . . 0.28 108.966 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -66.11 -22.81 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.218 -0.926 . . . . 0.28 110.448 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.95 17.05 9.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.204 -0.935 . . . . 0.31 109.777 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.08 -1.013 . . . . 1.7 110.346 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.717 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 64.3 mttm 58.85 19.44 7.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.714 -0.616 . . . . 2.24 110.011 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -67.74 106.71 2.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.76 -1.213 . . . . 1.8 108.297 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.32 -41.3 98.42 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.406 -0.809 . . . . 0.87 112.631 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 92.5 m-20 -68.99 -39.94 79.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.789 -1.195 . . . . 0.73 109.433 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 58' ' ' LEU . 90.8 mt -69.99 -39.9 75.62 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.032 -1.067 . . . . 0.55 108.614 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.26 -50.03 71.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.38 109.772 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.434 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.0 mtm180 -62.45 -44.6 96.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 2.64 110.288 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.26 -38.34 90.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 2.37 108.989 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.28 -49.57 73.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.263 -0.898 . . . . 0.4 110.853 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 tp -65.3 -47.43 76.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.84 . . . . 0.34 109.874 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -63.45 -45.25 91.72 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.402 -0.811 . . . . 2.11 109.274 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -68.43 -34.06 75.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.418 0.628 . . . . 1.9 109.592 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.7 m -79.72 -33.56 40.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -0.79 . . . . 0.41 111.336 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.6 p -130.63 -28.95 1.99 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.503 -1.373 . . . . 0.4 112.239 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.32 25.62 Favored Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.226 -1.55 . . . . 0.36 109.226 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.99 153.0 1.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.122 -1.222 . . . . 0.33 109.337 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.08 172.57 8.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 1.9 110.036 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.08 78.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.39 110.487 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.06 -40.4 75.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.738 -1.226 . . . . 2.58 109.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 25' ' ' GLY . 94.0 mm-40 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.452 -0.78 . . . . 2.12 110.69 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p -66.34 -38.18 87.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.139 -0.975 . . . . 1.36 110.039 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -60.17 -38.79 84.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.828 -1.17 . . . . 2.8 109.341 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.27 -39.24 82.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.764 -1.21 . . . . 0.4 110.444 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -68.09 -40.32 82.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.766 -1.209 . . . . 0.24 109.476 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.44 -60.33 3.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.014 -1.054 . . . . 0.43 109.533 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.72 87.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.199 -1.16 . . . . 0.26 110.199 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.21 -47.3 65.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.25 109.638 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -69.97 -40.02 75.63 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.667 -1.213 . . . . 0.3 108.591 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.717 HH12 ' NZ ' ' A' ' 54' ' ' LYS . 8.5 tpm_? -63.71 -41.93 98.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 2.73 110.006 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 94.4 mt-10 -69.66 -39.65 76.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 1.91 110.665 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 79.1 t90 -60.04 -41.91 93.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.316 -1.49 . . . . 0.37 107.7 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -62.82 -40.51 97.63 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.975 -0.75 . . . . 0.36 108.975 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD1' ' NH2' ' A' ' 82' ' ' ARG . 96.1 m-20 -60.27 -36.84 78.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.553 -0.717 . . . . 0.55 109.905 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.66 -38.29 18.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 0.48 109.952 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.602 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 76.3 m-85 . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.289 -0.882 . . . . 1.24 110.5 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.752 0.787 . . . . 1.5 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -59.88 -30.15 68.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.925 -0.484 . . . . 2.18 110.521 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.07 -33.53 72.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -0.992 . . . . 2.01 109.034 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 23.9 t60 -59.86 -48.89 79.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.074 -1.016 . . . . 0.49 110.139 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -69.85 -34.13 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.994 . . . . 3.23 109.882 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.12 -39.85 82.65 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.426 -0.797 . . . . 0.76 109.664 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.1 t80 -61.83 -47.51 84.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.46 110.092 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.98 9.92 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.144 -0.972 . . . . 0.44 110.242 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.97 -16.45 15.83 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.204 -0.935 . . . . 0.53 110.951 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.64 152.83 23.36 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 1.27 109.14 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.25 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.701 1.6 . . . . 0.49 110.966 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.6 ptp -90.4 -24.62 20.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.845 -1.159 . . . . 0.56 109.658 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.09 -136.68 45.59 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.831 -1.308 . . . . 0.39 109.831 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.8 29.04 6.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -1.076 . . . . 0.84 111.124 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.72 148.41 82.23 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.667 -1.234 . . . . 2.02 107.667 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.19 163.3 32.24 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.204 1.936 . . . . 0.34 112.794 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.559 HG13 ' N ' ' B' ' 21' ' ' GLY . 8.0 p -58.07 -47.47 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.466 0.65 . . . . 0.32 110.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.559 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.11 -3.31 0.12 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.754 -0.939 . . . . 0.22 110.754 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.497 ' H ' ' C ' ' B' ' 20' ' ' VAL . 11.5 p -82.23 -25.32 34.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.817 -1.402 . . . . 1.24 109.495 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.52 137.91 58.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.24 109.768 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 135.45 55.65 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.795 0.807 . . . . 0.21 109.832 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' B' ' 73' ' ' GLN . . . 96.78 -20.03 52.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.326 -1.51 . . . . 0.22 109.326 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.79 112.72 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.669 -1.234 . . . . 0.25 107.669 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.433 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -89.99 177.84 43.28 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.609 -1.282 . . . . 0.28 110.108 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.74 -39.89 74.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 2.0 109.601 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.78 -44.9 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.008 -1.058 . . . . 0.38 109.484 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.433 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.7 mt -66.35 -36.84 83.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.4 109.472 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.79 97.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.76 -1.336 . . . . 0.36 109.76 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -65.34 -36.92 85.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.074 -1.251 . . . . 2.75 109.85 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.65 -48.61 68.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.708 -1.245 . . . . 1.56 109.321 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.85 -38.67 89.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.06 -1.025 . . . . 0.33 108.63 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.94 -42.41 93.93 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.933 -0.707 . . . . 1.68 109.228 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -66.95 -19.59 65.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.579 -0.897 . . . . 1.99 108.579 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 3.0 54.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.452 -0.78 . . . . 2.68 109.797 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.77 5.47 50.92 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.168 -0.957 . . . . 0.49 111.836 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.473 ' CD2' HG12 ' B' ' 44' ' ' VAL . 97.5 m-85 -106.3 77.0 1.18 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.772 -1.428 . . . . 0.33 109.071 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -79.33 -7.47 58.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.905 . . . . 0.41 110.914 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.14 158.44 44.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.965 -1.084 . . . . 1.56 110.498 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.72 90.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.628 -0.67 . . . . 0.21 112.389 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 7.6 p90 -60.96 -18.61 58.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.526 -1.359 . . . . 0.32 110.584 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.473 HG12 ' CD2' ' B' ' 39' ' ' PHE . 16.8 t -79.88 -31.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.964 -1.124 . . . . 0.24 107.964 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.61 -37.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.34 -0.985 . . . . 0.22 108.34 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.11 -35.71 75.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.505 -1.294 . . . . 0.4 107.505 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.33 96.73 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.706 -1.358 . . . . 0.18 109.706 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.03 -43.47 95.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.967 -1.314 . . . . 1.09 108.971 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.0 -41.48 92.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.31 108.964 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.01 -39.92 75.55 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.864 -0.734 . . . . 0.27 109.064 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.37 -22.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.201 -0.937 . . . . 0.28 110.339 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -91.92 17.02 9.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.168 -0.958 . . . . 0.3 109.734 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.998 -1.064 . . . . 1.71 110.327 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . 0.716 ' NZ ' HH12 ' B' ' 82' ' ' ARG . 64.3 mttm 58.66 19.63 6.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.729 -0.607 . . . . 2.25 110.058 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.75 106.67 2.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.614 -1.304 . . . . 1.8 108.201 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.41 -41.3 98.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.379 -0.826 . . . . 0.88 112.523 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 92.3 m-20 -68.86 -39.84 79.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.886 -1.133 . . . . 0.74 109.49 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.06 -40.02 75.32 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 119.063 -1.055 . . . . 0.55 108.578 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -63.16 -50.05 71.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.38 109.842 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 82.9 mtm180 -62.3 -44.94 95.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.366 -0.834 . . . . 2.64 110.342 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.03 -38.45 90.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.988 -1.07 . . . . 2.38 109.042 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.4 -49.4 73.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.4 110.818 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.3 -47.39 76.75 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.342 -0.849 . . . . 0.34 109.953 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -63.42 -45.19 92.14 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.317 -0.864 . . . . 2.1 109.387 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 35.5 t0 -68.61 -33.78 74.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.735 -0.603 . . . . 1.9 109.607 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -79.88 -33.64 39.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.4 111.249 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.6 p -130.57 -29.04 1.99 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.526 -1.359 . . . . 0.39 112.272 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.13 26.09 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.205 -1.558 . . . . 0.36 109.205 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.91 152.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.096 -1.238 . . . . 0.32 109.409 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.03 172.62 8.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.068 -1.02 . . . . 1.91 110.041 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.19 79.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.674 . . . . 0.38 110.548 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.04 -40.39 75.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.839 -1.163 . . . . 2.57 109.705 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' B' ' 25' ' ' GLY . 93.8 mm-40 -67.54 -39.55 85.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.444 -0.785 . . . . 2.12 110.757 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -66.09 -38.23 87.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.161 -0.962 . . . . 1.36 110.106 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.09 -39.02 84.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.723 -1.235 . . . . 2.81 109.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.2 -39.3 82.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.842 -1.161 . . . . 0.4 110.439 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.2 -40.22 82.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.752 -1.217 . . . . 0.23 109.472 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -60.47 -60.08 4.38 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.95 -1.094 . . . . 0.43 109.649 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.24 -35.63 88.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.275 -1.13 . . . . 0.25 110.275 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.03 -47.34 65.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.24 109.778 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.07 -40.28 75.14 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.735 -1.186 . . . . 0.29 108.529 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.716 HH12 ' NZ ' ' B' ' 54' ' ' LYS . 8.5 tpm_? -63.4 -41.91 98.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 2.74 110.083 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 94.4 mt-10 -69.77 -39.6 76.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.816 -1.178 . . . . 1.91 110.775 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.609 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 79.7 t90 -59.96 -42.08 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.436 -1.415 . . . . 0.36 107.534 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 67.4 m -62.74 -40.44 97.23 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.056 -0.72 . . . . 0.36 109.056 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' B' ' 82' ' ' ARG . 96.2 m-20 -60.27 -36.9 78.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.552 -0.717 . . . . 0.55 109.781 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.72 -38.43 18.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.47 110.06 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 76.3 m-85 -102.25 -84.94 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.311 -0.868 . . . . 1.24 110.547 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 118.012 -0.994 . . . . 1.67 109.911 -178.529 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.6 0.714 . . . . 1.51 109.49 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -54.55 -18.84 4.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.641 -0.662 . . . . 2.18 110.266 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -59.99 -37.09 78.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 2.02 109.75 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -59.88 -50.83 72.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.007 -1.058 . . . . 0.49 110.597 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -69.87 -33.28 72.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.068 -1.02 . . . . 3.21 109.881 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.37 -39.7 77.9 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.276 -0.89 . . . . 0.76 109.317 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.8 t80 -63.86 -48.52 76.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.525 -0.734 . . . . 0.46 110.433 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.6 11.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.44 110.464 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.64 -12.62 14.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.243 -0.911 . . . . 0.54 109.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.04 151.23 22.54 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 1.26 109.395 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -42.12 157.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.738 1.625 . . . . 0.49 110.994 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.05 -23.24 18.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.847 -1.158 . . . . 0.57 109.922 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.77 -138.59 48.21 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.981 -1.247 . . . . 0.4 109.981 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.58 29.33 5.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.501 -0.999 . . . . 0.85 110.042 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -60.02 148.98 76.0 Favored Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 107.83 -1.174 . . . . 2.01 107.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.16 160.93 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.326 2.017 . . . . 0.34 113.257 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.3 p -57.29 -49.08 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.739 -0.601 . . . . 0.32 110.096 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.575 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -56.22 -2.78 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.223 -1.151 . . . . 0.23 110.223 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 22.1 p -81.49 -24.68 36.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.33 . . . . 1.24 108.511 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.627 HD22 HD21 ' A' ' 81' ' ' LEU . 92.3 mt -62.43 139.73 58.57 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.783 0.802 . . . . 0.24 109.579 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.81 134.12 52.42 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.831 0.824 . . . . 0.21 110.16 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.98 -20.51 48.74 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.925 -1.67 . . . . 0.22 108.925 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mm -99.89 116.8 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.764 -1.198 . . . . 0.25 107.764 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -92.3 177.4 39.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.669 -1.372 . . . . 0.28 109.669 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.49 -39.84 73.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.54 -0.976 . . . . 2.01 109.539 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.13 -42.67 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.38 109.447 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 27' ' ' GLY . 95.6 mt -68.4 -40.06 81.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.214 -0.929 . . . . 0.4 109.438 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.99 97.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.35 109.583 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.29 -39.97 94.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.4 -1.059 . . . . 2.74 110.058 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.84 -49.94 68.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.832 -1.168 . . . . 1.54 109.599 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.5 mt -60.03 -39.45 85.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.34 108.966 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.02 -44.5 94.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.723 . . . . 1.67 110.533 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.76 -19.07 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 2.0 109.113 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.495 HH11 ' HG2' ' A' ' 37' ' ' ARG . 27.1 mtt-85 -89.97 1.93 55.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.794 -0.762 . . . . 2.69 110.52 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.43 4.37 34.95 Favored Glycine 0 N--CA 1.506 3.353 0 O-C-N 121.019 -1.051 . . . . 0.48 112.006 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CD2' HG12 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.08 73.81 1.07 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.794 -1.415 . . . . 0.33 108.659 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -80.07 -10.0 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.41 110.515 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 29.8 mmtp -130.82 152.68 49.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.171 -0.955 . . . . 1.56 109.424 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.393 -0.817 . . . . 0.21 111.55 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 22.5 p90 -56.15 -17.61 7.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.711 -1.243 . . . . 0.32 110.32 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.2 t -79.66 -33.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.832 -1.167 . . . . 0.24 108.073 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 20' ' ' VAL . 55.2 t -76.88 -39.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.266 -1.013 . . . . 0.22 108.266 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.03 -38.07 81.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.578 -1.267 . . . . 0.4 107.578 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.98 -41.12 96.21 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.552 -1.419 . . . . 0.18 109.552 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -59.9 -43.29 94.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.252 . . . . 1.09 108.456 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.02 -39.93 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.31 108.725 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.72 -40.01 76.5 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.509 -0.923 . . . . 0.28 108.509 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.81 -26.01 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.28 110.198 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.01 13.63 14.32 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.16 -0.962 . . . . 0.31 110.166 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER 48.95 51.63 15.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.881 -1.137 . . . . 1.7 110.312 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.76 20.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.945 -1.097 . . . . 2.24 110.913 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-20 -65.33 105.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.937 -1.505 . . . . 1.8 106.937 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.43 -40.27 93.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.361 -0.837 . . . . 0.87 112.62 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.77 -40.03 76.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.256 -1.527 . . . . 0.73 109.823 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.3 -40.07 74.45 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.944 -1.102 . . . . 0.55 109.2 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.9 -50.03 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.38 109.402 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.79 -45.01 94.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.437 -0.79 . . . . 2.64 109.896 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 65' ' ' ASP . 8.3 tm-20 -64.88 -39.99 94.4 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.159 -0.963 . . . . 2.37 108.706 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -65.25 -48.02 74.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.4 110.866 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.66 -45.88 73.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.208 -0.932 . . . . 0.34 110.558 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.65 -48.5 79.07 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.167 -0.958 . . . . 2.11 110.213 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 61' ' ' GLU . 57.2 m-20 -70.06 -24.75 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.807 . . . . 1.9 110.066 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.0 m -79.62 -34.51 40.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.143 -0.973 . . . . 0.41 111.236 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -132.91 -19.84 2.25 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.483 -1.386 . . . . 0.4 111.899 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.8 11.5 43.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.137 -1.585 . . . . 0.36 109.137 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.68 1.6 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.33 109.248 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.548 ' H ' HE21 ' A' ' 73' ' ' GLN . 26.9 t-20 -89.26 170.02 10.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 1.9 109.817 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -34.36 73.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.562 -0.711 . . . . 0.39 110.552 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -71.66 -39.97 69.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.64 -1.287 . . . . 2.58 110.222 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.548 HE21 ' H ' ' A' ' 70' ' ' ASN . 37.4 mt-30 -68.61 -37.98 80.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.43 -0.794 . . . . 2.12 110.722 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.9 m -67.41 -38.0 83.93 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.048 -1.032 . . . . 1.36 109.958 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.01 -38.06 81.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 2.8 109.476 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -68.33 -39.93 81.77 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.705 -1.247 . . . . 0.4 110.349 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.9 m -66.97 -39.97 87.35 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.82 -1.175 . . . . 0.24 108.968 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.15 -60.73 3.39 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.984 -1.073 . . . . 0.43 109.822 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.03 88.82 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.507 -1.037 . . . . 0.26 110.507 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.28 -49.88 52.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.432 . . . . 0.25 109.625 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.627 HD21 HD22 ' A' ' 23' ' ' LEU . 96.3 mt -70.01 -39.99 75.5 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.983 -1.087 . . . . 0.3 109.019 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -63.01 -40.05 96.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 2.73 110.186 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.049 -1.032 . . . . 1.91 109.924 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 71.0 t90 -59.91 -42.76 94.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.437 -1.32 . . . . 0.37 107.437 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.94 -40.01 95.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 0.36 108.968 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.39 -37.99 82.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.425 -0.797 . . . . 0.55 109.678 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.13 17.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.48 109.938 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 73.0 m-85 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.165 -0.959 . . . . 1.24 110.311 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.583 0.706 . . . . 1.5 109.466 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -54.63 -18.87 5.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.634 -0.666 . . . . 2.18 110.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -60.02 -36.89 78.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.055 -1.028 . . . . 2.01 109.701 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -60.11 -50.58 73.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.995 -1.066 . . . . 0.49 110.571 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -70.16 -33.14 71.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.018 -1.051 . . . . 3.23 109.758 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -69.43 -39.59 77.75 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.307 -0.871 . . . . 0.76 109.288 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.4 t80 -63.96 -48.52 76.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.46 110.462 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -83.51 11.11 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.029 -1.044 . . . . 0.44 110.423 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.54 -12.67 14.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.316 -0.865 . . . . 0.53 109.793 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.04 151.14 22.36 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.065 -1.022 . . . . 1.27 109.329 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -42.16 157.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.705 1.603 . . . . 0.49 110.926 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.2 ptp -93.01 -23.3 18.72 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.872 -1.143 . . . . 0.56 109.958 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.11 -138.48 48.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.081 -1.208 . . . . 0.39 110.081 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.82 29.34 5.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.84 110.051 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.93 148.88 75.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 107.823 -1.177 . . . . 2.02 107.823 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.99 161.1 38.29 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.285 1.99 . . . . 0.34 113.236 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.572 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.4 p -57.36 -49.15 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.568 0.699 . . . . 0.32 110.146 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.572 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -56.04 -3.05 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.259 -1.136 . . . . 0.22 110.259 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.449 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.2 p -81.35 -24.4 37.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.955 -1.32 . . . . 1.24 108.53 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.635 HD22 HD21 ' B' ' 81' ' ' LEU . 91.7 mt -62.61 139.69 58.64 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.823 0.821 . . . . 0.24 109.581 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 134.14 52.62 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.776 0.798 . . . . 0.21 110.173 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -20.92 46.95 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.883 -1.687 . . . . 0.22 108.883 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mm -99.6 116.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.916 -1.142 . . . . 0.25 107.916 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.467 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -92.3 177.48 39.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.679 -1.368 . . . . 0.28 109.679 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -56.41 -39.92 73.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.455 -1.027 . . . . 2.0 109.553 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.15 -42.68 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.38 109.438 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.467 HD12 ' H ' ' B' ' 27' ' ' GLY . 95.7 mt -68.42 -39.91 81.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.219 -0.925 . . . . 0.4 109.528 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.76 -39.91 97.38 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.36 109.591 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.33 -39.98 94.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -1.108 . . . . 2.75 110.049 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.82 -49.99 68.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.837 -1.164 . . . . 1.56 109.552 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.02 -39.45 85.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.33 108.893 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.05 -44.38 94.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 1.68 110.501 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.95 -18.91 65.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.031 -1.043 . . . . 1.99 109.152 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' B' ' 37' ' ' ARG . 27.6 mtt-85 -90.0 1.62 56.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.466 -0.771 . . . . 2.68 110.507 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.91 4.27 33.9 Favored Glycine 0 N--CA 1.506 3.309 0 O-C-N 121.041 -1.037 . . . . 0.49 112.024 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.522 ' CD2' HG12 ' B' ' 44' ' ' VAL . 82.6 m-85 -105.08 73.87 1.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.81 -1.406 . . . . 0.33 108.755 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.1 -10.03 59.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.41 110.405 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.464 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 29.8 mmtp -130.79 152.59 49.97 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.224 -0.922 . . . . 1.56 109.493 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.95 92.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.529 -0.732 . . . . 0.21 111.501 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.464 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 22.8 p90 -56.1 -17.46 7.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.733 -1.23 . . . . 0.32 110.418 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.3 t -79.7 -33.34 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.819 -1.176 . . . . 0.24 108.039 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.437 HG21 HG23 ' B' ' 20' ' ' VAL . 55.2 t -76.68 -39.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.262 -1.014 . . . . 0.22 108.262 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.8 tp -60.08 -37.6 80.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.534 -1.284 . . . . 0.4 107.534 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 -41.04 96.54 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.627 -1.389 . . . . 0.18 109.627 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -60.07 -43.24 95.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.274 . . . . 1.09 108.397 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.31 108.794 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.74 -39.91 76.48 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.27 108.617 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.85 -26.1 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.312 -0.868 . . . . 0.28 110.193 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.93 13.49 14.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.197 -0.939 . . . . 0.3 110.131 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 49.01 51.73 15.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.771 -1.205 . . . . 1.71 110.185 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.79 20.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.833 -1.167 . . . . 2.25 110.954 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 53' ' ' LYS . 71.1 m-20 -65.5 105.34 1.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.946 -1.501 . . . . 1.8 106.946 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.42 -40.03 92.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.241 -0.912 . . . . 0.88 112.674 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.99 -39.95 75.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.342 -1.474 . . . . 0.74 109.865 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.38 -39.94 74.27 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.846 -1.142 . . . . 0.55 109.298 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.86 -49.94 70.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.38 109.433 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.98 -44.82 94.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.461 -0.774 . . . . 2.64 109.821 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.444 ' OE2' ' OD2' ' B' ' 65' ' ' ASP . 8.3 tm-20 -64.93 -40.1 94.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.111 -0.993 . . . . 2.38 108.745 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -65.11 -48.1 74.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.4 110.92 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.0 tp -67.79 -45.64 74.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.28 -0.888 . . . . 0.34 110.572 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.84 -48.48 78.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.191 -0.943 . . . . 2.1 110.162 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.444 ' OD2' ' OE2' ' B' ' 61' ' ' GLU . 57.3 m-20 -69.96 -24.84 63.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 1.9 110.119 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -79.59 -34.34 40.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.996 . . . . 0.4 111.33 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -133.02 -19.91 2.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.548 -1.345 . . . . 0.39 111.802 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.75 11.51 43.53 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.116 -1.594 . . . . 0.36 109.116 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.08 152.87 1.55 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.998 -1.295 . . . . 0.32 109.166 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.54 ' H ' HE21 ' B' ' 73' ' ' GLN . 27.0 t-20 -89.43 169.98 10.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.058 . . . . 1.91 109.843 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.42 73.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.58 -0.7 . . . . 0.38 110.507 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.63 -39.97 70.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.703 -1.248 . . . . 2.57 110.202 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.54 HE21 ' H ' ' B' ' 70' ' ' ASN . 37.2 mt-30 -68.68 -37.99 80.02 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.815 . . . . 2.12 110.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -67.27 -38.12 84.57 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.036 -1.04 . . . . 1.36 109.911 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 -60.05 -38.1 81.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 2.81 109.441 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.12 -39.98 82.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.77 -1.206 . . . . 0.4 110.348 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 67.2 m -67.01 -39.96 87.2 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.735 -1.228 . . . . 0.23 109.053 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.05 -60.82 3.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.984 -1.072 . . . . 0.43 109.867 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.13 -34.15 89.14 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.504 -1.038 . . . . 0.25 110.504 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.29 -49.8 52.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.825 -1.397 . . . . 0.24 109.713 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.635 HD21 HD22 ' B' ' 23' ' ' LEU . 96.7 mt -69.98 -40.0 75.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.987 -1.085 . . . . 0.29 108.969 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -63.11 -40.03 96.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.172 -0.955 . . . . 2.74 110.144 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.2 -36.72 77.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 1.91 109.882 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.533 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 71.8 t90 -59.95 -42.64 94.49 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.449 -1.315 . . . . 0.36 107.449 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.409 ' O ' ' OXT' ' B' ' 89' ' ' LEU . 92.6 m -64.11 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 0.36 108.952 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.25 -38.21 82.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.758 . . . . 0.55 109.578 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.46 -39.69 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.47 110.01 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.533 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.6 m-85 -97.84 -82.49 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 1.24 110.495 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.409 ' OXT' ' O ' ' B' ' 85' ' ' CYS . 18.4 tp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.975 -1.012 . . . . 1.67 110.065 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.834 0.826 . . . . 1.51 109.324 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.48 -28.69 67.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.753 -0.592 . . . . 2.18 109.95 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.02 -36.9 78.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.939 . . . . 2.02 109.456 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -59.25 -50.08 75.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.041 -1.037 . . . . 0.49 110.064 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.98 -34.41 73.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.192 -0.943 . . . . 3.21 110.096 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 91.3 m-20 -67.8 -39.31 84.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.255 -0.903 . . . . 0.76 109.447 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -60.03 -47.45 85.8 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.481 -0.888 . . . . 0.46 109.369 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 m -83.76 10.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.026 -1.047 . . . . 0.44 110.483 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.6 -19.04 17.04 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.012 -1.055 . . . . 0.54 110.91 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -156.95 152.93 23.01 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.886 -1.133 . . . . 1.26 108.606 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' GLU . 55.0 Cg_exo -36.47 150.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.012 1.808 . . . . 0.49 111.867 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.442 ' HG2' ' H ' ' A' ' 15' ' ' MET . 8.0 ptm -89.51 -22.74 22.28 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.041 -1.037 . . . . 0.57 110.503 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.08 -134.61 40.65 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.101 -1.047 . . . . 0.4 110.593 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.98 35.14 3.5 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.99 . . . . 0.85 110.557 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -58.55 147.85 68.19 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 120.781 -1.199 . . . . 2.01 107.97 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.25 153.69 51.43 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.996 1.797 . . . . 0.34 112.08 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.5 p -55.23 -42.03 63.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.544 -0.723 . . . . 0.32 109.933 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -62.12 -3.6 5.15 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.281 -1.128 . . . . 0.23 110.281 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -83.33 -21.0 33.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.888 -1.36 . . . . 1.24 109.242 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.14 137.73 58.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.24 109.68 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.98 133.89 55.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.754 0.788 . . . . 0.21 109.841 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 96.89 -17.34 59.44 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.167 -1.573 . . . . 0.22 109.167 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -101.17 114.79 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -1.128 . . . . 0.25 108.094 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -94.76 178.55 36.48 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.724 -1.351 . . . . 0.28 109.724 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.23 -40.01 73.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -1.148 . . . . 2.01 109.958 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.28 -44.44 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.974 -1.079 . . . . 0.38 109.545 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.8 mt -66.29 -38.35 87.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.4 109.707 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.98 94.5 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.37 -1.492 . . . . 0.35 109.37 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.96 -40.0 90.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -1.09 . . . . 2.74 110.594 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.19 -45.35 73.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.738 -1.226 . . . . 1.54 109.632 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.49 -39.96 95.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.073 -1.017 . . . . 0.34 108.59 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.14 -40.82 91.15 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.809 -0.756 . . . . 1.67 109.605 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.17 -19.55 65.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.332 -0.988 . . . . 2.0 108.332 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -91.12 6.39 45.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.649 -0.657 . . . . 2.69 110.043 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.62 9.23 53.33 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.256 -0.973 . . . . 0.48 111.899 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.549 ' CD2' HG12 ' A' ' 44' ' ' VAL . 78.3 m-85 -106.26 74.52 1.04 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.764 -1.433 . . . . 0.33 109.312 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -79.96 -9.74 59.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.41 110.522 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.1 mmtm -132.72 154.97 49.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.088 -1.008 . . . . 1.56 109.559 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.92 94.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.657 -0.652 . . . . 0.21 111.071 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 21.6 p90 -57.39 -18.85 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.758 -1.214 . . . . 0.32 110.7 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 39' ' ' PHE . 24.8 t -79.27 -34.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.619 -1.301 . . . . 0.24 107.976 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.75 -39.96 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.472 -0.936 . . . . 0.22 108.472 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.98 -38.33 82.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.623 -1.251 . . . . 0.4 107.623 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.97 97.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.664 -1.374 . . . . 0.18 109.664 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 1.09 109.37 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.97 -40.03 87.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.7 -39.0 77.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.666 -0.813 . . . . 0.28 108.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.34 -24.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.28 110.147 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.57 15.2 14.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.172 -0.955 . . . . 0.31 110.252 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt 48.82 42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.732 -1.23 . . . . 1.7 110.866 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 56.76 19.41 4.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.389 -0.819 . . . . 2.24 109.5 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.82 107.02 2.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.718 -1.239 . . . . 1.8 108.123 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -40.52 97.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.87 112.342 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.11 -39.96 78.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.363 -1.461 . . . . 0.73 109.724 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.47 -39.99 73.91 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.917 -1.113 . . . . 0.55 108.987 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.9 -49.88 70.92 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.856 . . . . 0.38 109.668 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.22 -46.29 91.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.347 -0.846 . . . . 2.64 110.443 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.35 -39.89 94.78 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.064 -1.022 . . . . 2.37 108.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.402 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.2 t90 -63.23 -49.49 73.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.269 -0.894 . . . . 0.4 110.93 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.98 -49.64 64.76 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 0.34 109.784 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.25 86.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.765 . . . . 2.11 110.007 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 30.9 t0 -68.45 -29.62 68.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.521 -0.737 . . . . 1.9 109.838 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.9 m -80.45 -32.91 37.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.41 111.562 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.2 p -131.65 -28.77 1.79 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.52 -1.363 . . . . 0.4 111.982 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.56 14.1 20.68 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.059 -1.616 . . . . 0.36 109.059 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.89 153.28 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.014 -1.286 . . . . 0.33 109.362 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.54 170.15 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.1 -1.0 . . . . 1.9 109.654 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.23 70.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.39 110.727 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.18 -40.1 68.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 2.58 109.734 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.2 mm100 -67.71 -38.3 83.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.349 -0.844 . . . . 2.12 110.236 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -68.45 -37.74 80.49 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.907 . . . . 1.36 110.02 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.56 -38.8 85.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 2.8 109.412 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -68.46 -39.94 81.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.624 -1.298 . . . . 0.4 110.318 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.4 -39.98 81.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.143 . . . . 0.24 109.171 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.69 -60.1 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.771 -1.206 . . . . 0.43 109.779 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.29 -34.42 89.16 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.298 -1.121 . . . . 0.26 110.298 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.32 -46.58 60.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.847 -1.384 . . . . 0.25 109.705 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -70.32 -40.56 74.11 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.793 -1.163 . . . . 0.3 108.432 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -64.54 -39.98 94.75 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.84 . . . . 2.73 110.448 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -68.73 -37.64 79.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.983 -1.073 . . . . 1.91 109.758 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.592 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.4 t90 -60.01 -45.54 92.41 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.431 -1.322 . . . . 0.37 107.431 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 75.6 m -60.74 -40.02 90.87 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.808 -0.812 . . . . 0.36 108.808 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.43 -37.76 81.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.55 109.739 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.61 -36.86 18.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.48 109.934 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 1.24 110.226 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.801 0.81 . . . . 1.5 109.426 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.71 -28.5 67.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.761 -0.587 . . . . 2.18 109.905 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -59.99 -37.03 78.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 2.01 109.483 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -59.32 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.101 -1.0 . . . . 0.49 109.974 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.96 -34.53 73.53 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.073 -1.017 . . . . 3.23 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . 0.447 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 91.6 m-20 -67.72 -39.26 84.33 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.223 -0.923 . . . . 0.76 109.413 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -59.91 -47.6 85.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.434 -0.906 . . . . 0.46 109.39 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.67 10.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.168 -0.957 . . . . 0.44 110.512 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -19.04 17.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.53 110.981 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' B' ' 9' ' ' ASP . 0.0 OUTLIER -156.92 152.93 23.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.831 -1.168 . . . . 1.27 108.603 179.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' B' ' 13' ' ' GLU . 54.8 Cg_exo -36.36 150.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.088 1.859 . . . . 0.49 111.86 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' B' ' 15' ' ' MET . 8.0 ptm -89.38 -22.61 22.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.114 -0.991 . . . . 0.56 110.539 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.19 -134.63 41.06 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.918 -1.114 . . . . 0.39 110.63 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.02 35.04 3.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.471 -1.017 . . . . 0.84 110.552 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -58.4 147.79 66.97 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 120.76 -1.213 . . . . 2.02 108.04 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.28 153.48 52.98 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.019 1.813 . . . . 0.34 112.161 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.516 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.7 p -54.96 -42.07 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.32 110.03 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.516 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -62.15 -3.68 5.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.263 -1.135 . . . . 0.22 110.263 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -83.08 -21.1 33.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.897 -1.355 . . . . 1.24 109.261 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.15 137.83 58.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.24 109.662 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.97 133.81 55.21 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.62 0.724 . . . . 0.21 109.833 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 96.99 -17.48 59.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.084 -1.607 . . . . 0.22 109.084 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -101.01 114.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -1.101 . . . . 0.25 108.212 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.411 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -94.62 178.56 36.68 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.725 -1.35 . . . . 0.28 109.725 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.27 -40.09 73.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -1.115 . . . . 2.0 109.948 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.22 -44.34 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.02 -1.05 . . . . 0.38 109.566 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.411 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.8 mt -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.4 109.657 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.53 -39.05 94.49 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.343 -1.503 . . . . 0.36 109.343 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.99 -40.03 90.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 2.75 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.27 -45.41 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.664 -1.272 . . . . 1.56 109.533 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.25 -40.03 96.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.092 -1.005 . . . . 0.33 108.673 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.05 -40.87 90.91 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.859 -0.736 . . . . 1.68 109.634 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.19 -19.49 65.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.353 -0.98 . . . . 1.99 108.353 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.514 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.6 OUTLIER -91.14 6.25 45.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.648 -0.657 . . . . 2.68 110.029 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 9.34 52.97 Favored Glycine 0 N--CA 1.501 3.027 0 O-C-N 121.141 -0.975 . . . . 0.49 111.834 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.547 ' CD2' HG12 ' B' ' 44' ' ' VAL . 78.8 m-85 -106.22 74.12 1.02 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.761 -1.434 . . . . 0.33 109.323 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 -9.97 59.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.912 . . . . 0.41 110.534 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.481 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.0 mmtm -132.57 154.94 49.51 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.206 -0.934 . . . . 1.56 109.581 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.02 95.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.655 -0.653 . . . . 0.21 111.112 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.481 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 20.2 p90 -57.27 -18.72 17.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.238 . . . . 0.32 110.672 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.547 HG12 ' CD2' ' B' ' 39' ' ' PHE . 24.7 t -79.38 -34.24 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.58 -1.325 . . . . 0.24 108.001 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 75.0 t -77.77 -39.95 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.477 -0.934 . . . . 0.22 108.477 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.07 -38.12 81.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 0.4 107.628 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.88 97.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.759 -1.336 . . . . 0.18 109.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -40.04 88.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -1.18 . . . . 1.09 109.336 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.85 -40.05 87.28 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.107 -1.071 . . . . 0.31 108.107 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.74 -38.65 76.92 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.609 -0.836 . . . . 0.27 108.836 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.76 -24.17 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.178 -0.951 . . . . 0.28 110.086 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.38 14.87 15.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.058 -1.026 . . . . 0.3 110.262 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 49.19 42.24 21.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.772 -1.205 . . . . 1.71 110.824 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 81.5 mttt 57.14 19.6 4.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 2.25 109.484 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.02 107.08 2.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.701 -1.249 . . . . 1.8 108.14 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -40.2 96.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.43 -0.794 . . . . 0.88 112.39 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.39 -40.04 77.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.252 -1.53 . . . . 0.74 109.702 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.3 -40.07 74.47 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.924 -1.11 . . . . 0.55 109.024 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.74 -49.99 70.86 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.38 109.662 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.36 -45.96 92.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.459 -0.776 . . . . 2.64 110.466 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -64.52 -39.93 94.68 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 120.99 -1.068 . . . . 2.38 108.788 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -63.16 -49.64 73.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.864 . . . . 0.4 110.887 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.95 -49.45 65.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.084 -1.01 . . . . 0.34 109.795 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -47.21 86.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 2.1 109.96 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 36.5 t0 -68.61 -29.37 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 1.9 109.797 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 64.3 m -80.64 -33.06 35.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.4 111.451 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.2 p -131.54 -28.62 1.83 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.405 -1.435 . . . . 0.39 112.137 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.42 14.03 21.11 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 109.096 -1.601 . . . . 0.36 109.096 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.85 153.23 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.05 -1.265 . . . . 0.32 109.306 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.46 170.16 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.101 -0.999 . . . . 1.91 109.655 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.36 70.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.478 -0.764 . . . . 0.38 110.73 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.06 -40.07 68.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.784 -1.197 . . . . 2.57 109.68 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.2 mm100 -67.81 -38.17 82.92 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.323 -0.861 . . . . 2.12 110.301 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -68.53 -37.93 80.42 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.266 -0.896 . . . . 1.36 110.005 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.41 -38.91 85.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.852 -1.155 . . . . 2.81 109.399 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -68.22 -39.97 82.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.651 -1.28 . . . . 0.4 110.354 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.1 m -68.45 -39.98 81.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.712 -1.242 . . . . 0.23 109.209 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -60.18 4.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.739 -1.226 . . . . 0.43 109.8 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -34.49 89.11 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.364 -1.094 . . . . 0.25 110.364 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.3 t -71.41 -46.33 60.46 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.809 -1.406 . . . . 0.24 109.792 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.44 -40.59 73.67 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.812 -1.155 . . . . 0.29 108.403 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.47 -40.11 95.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 2.74 110.454 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -68.85 -37.4 79.1 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.94 -1.1 . . . . 1.91 109.672 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.4 t90 -59.92 -45.77 91.52 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.433 -1.321 . . . . 0.36 107.433 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' B' ' 89' ' ' LEU . 73.5 m -60.62 -39.95 90.09 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.813 -0.755 . . . . 0.36 108.964 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.57 -37.79 82.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.55 109.721 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.51 -36.83 18.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -0.889 . . . . 0.47 109.957 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.1 m-85 -103.62 -85.02 0.46 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.28 -0.887 . . . . 1.24 110.39 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 85' ' ' CYS . 24.6 tp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.051 -0.976 . . . . 1.67 109.573 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.67 0.748 . . . . 1.51 109.81 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.45 -20.66 13.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 2.18 110.076 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.02 -37.52 79.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.14 -0.975 . . . . 2.02 109.293 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 12.4 t60 -59.97 -50.01 75.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.021 -1.049 . . . . 0.49 110.628 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 8' ' ' ARG . 17.9 mmm-85 -70.01 -35.11 74.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.859 -1.151 . . . . 3.21 109.735 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.74 -39.99 84.2 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.386 -0.822 . . . . 0.76 109.336 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -63.54 -49.08 74.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.428 -0.795 . . . . 0.46 110.085 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.53 9.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.971 -1.081 . . . . 0.44 110.747 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -102.9 -15.01 16.31 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.189 -0.944 . . . . 0.54 110.267 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.4 pt-20 -152.71 155.03 32.22 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.169 -0.957 . . . . 1.26 108.938 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' GLU . 65.1 Cg_exo -36.84 152.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.101 1.867 . . . . 0.49 111.441 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 11.6 ptm -89.75 -23.23 21.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.038 -1.039 . . . . 0.57 109.673 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.0 -138.54 20.64 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.097 -1.201 . . . . 0.4 110.097 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.54 43.23 1.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.577 -0.955 . . . . 0.85 109.657 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -61.21 147.98 85.84 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.475 -0.935 . . . . 2.01 108.475 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 155.09 39.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.275 1.983 . . . . 0.34 112.826 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.68 -35.28 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.632 0.73 . . . . 0.32 110.202 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.24 -0.48 57.31 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.546 -1.021 . . . . 0.23 110.546 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 p -82.44 -25.8 33.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.783 -1.422 . . . . 1.24 109.706 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.559 HD22 HD21 ' A' ' 81' ' ' LEU . 96.2 mt -60.78 138.52 58.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.24 109.953 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.84 134.5 55.32 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.8 -0.76 . . . . 0.21 109.483 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.11 -21.72 44.58 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.511 -1.436 . . . . 0.22 109.511 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.76 114.73 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.143 -1.21 . . . . 0.25 108.195 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -95.68 -179.2 36.4 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.645 -1.382 . . . . 0.28 109.645 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -58.21 -40.04 80.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -1.038 . . . . 2.01 109.652 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.67 -47.65 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.06 -1.025 . . . . 0.38 109.285 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.4 HD12 ' H ' ' A' ' 27' ' ' GLY . 95.9 mt -64.89 -35.99 82.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.4 109.348 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.78 -39.97 92.19 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.464 -1.454 . . . . 0.35 109.464 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -66.79 -37.49 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.268 . . . . 2.74 110.308 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.65 -51.74 46.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.709 -1.245 . . . . 1.54 109.303 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.49 -39.81 89.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.051 -1.031 . . . . 0.34 108.471 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.06 -42.66 95.0 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.55 -0.86 . . . . 1.67 109.409 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.0 -19.12 65.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.178 -0.951 . . . . 2.0 108.6 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -90.75 5.42 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.539 -0.725 . . . . 2.69 109.831 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.89 8.96 53.53 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.007 -1.058 . . . . 0.48 111.585 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' A' ' 44' ' ' VAL . 95.5 m-85 -107.25 75.09 1.01 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.418 . . . . 0.33 109.071 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.54 -7.98 58.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.41 110.562 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -138.04 158.62 43.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.071 -1.018 . . . . 1.56 110.149 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.5 84.45 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.965 0.728 . . . . 0.21 112.965 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -59.98 -17.84 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.38 -1.45 . . . . 0.32 110.376 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 39' ' ' PHE . 30.5 t -79.48 -31.93 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.25 -1.389 . . . . 0.24 107.25 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 79.4 t -77.17 -39.58 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.236 -1.024 . . . . 0.22 108.236 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.01 -35.93 76.13 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.466 -1.309 . . . . 0.4 107.466 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.29 98.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.703 -1.359 . . . . 0.18 109.703 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.94 -43.99 94.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 1.09 108.908 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.97 -40.46 89.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.505 -0.747 . . . . 0.31 109.195 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -69.05 -38.44 79.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.813 -0.81 . . . . 0.28 108.813 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.69 -19.89 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.137 -0.977 . . . . 0.28 110.517 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.2 mt -88.26 14.27 9.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.123 -0.985 . . . . 0.31 110.786 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.12 31.86 7.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.778 -1.201 . . . . 1.7 109.868 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 57.98 19.95 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.704 -0.623 . . . . 2.24 110.044 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -69.93 108.81 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.732 -1.23 . . . . 1.8 108.077 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.83 -40.01 96.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.084 0.772 . . . . 0.87 113.084 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.44 -39.94 85.41 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.405 -1.434 . . . . 0.73 109.996 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.45 -39.51 74.29 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.104 -1.038 . . . . 0.55 108.941 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.39 -41.65 93.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.38 109.095 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmm-85 -60.06 -51.18 70.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 2.64 110.147 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.58 -37.3 84.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 2.37 110.078 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.33 -47.99 79.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.4 110.799 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.8 -47.6 71.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.036 -1.04 . . . . 0.34 109.707 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.08 -48.55 78.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.293 -0.879 . . . . 2.11 109.945 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -67.17 -32.17 73.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.475 -0.766 . . . . 1.9 109.758 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -80.17 -34.68 37.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.41 111.397 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.72 -26.69 2.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.59 -1.318 . . . . 0.4 112.004 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.99 13.53 33.69 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.684 -1.766 . . . . 0.36 108.684 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 152.99 2.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -1.095 . . . . 0.33 109.421 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.76 174.9 7.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -0.912 . . . . 1.9 109.724 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.27 74.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.39 110.728 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.46 -39.66 64.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.604 -1.31 . . . . 2.58 110.35 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.015 -1.053 . . . . 2.12 110.732 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -69.05 -37.96 78.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.176 -0.952 . . . . 1.36 110.52 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 75' ' ' ARG . 27.1 mtt-85 -60.03 -37.38 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 2.8 109.489 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.52 -40.03 80.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.716 -1.24 . . . . 0.4 110.478 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.8 m -69.48 -40.12 77.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.783 -1.198 . . . . 0.24 109.8 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.33 -60.13 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.43 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.07 86.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.828 -0.909 . . . . 0.26 110.828 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.7 t -70.77 -48.66 53.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.946 -1.326 . . . . 0.25 110.223 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.559 HD21 HD22 ' A' ' 23' ' ' LEU . 88.2 mt -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.998 -1.081 . . . . 0.3 108.176 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.52 -40.02 93.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 2.73 110.169 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 92.1 mt-10 -70.27 -38.23 75.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 1.91 110.956 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 89.3 t90 -60.59 -42.32 96.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.308 -1.495 . . . . 0.37 108.456 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 92.7 m -61.57 -40.43 94.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.509 -0.744 . . . . 0.36 110.273 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -29.44 68.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.121 -0.987 . . . . 0.55 109.917 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.37 13.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.48 110.81 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 88.7 m-85 . . . . . 0 N--CA 1.503 2.208 0 O-C-N 121.312 -0.867 . . . . 1.24 112.42 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.703 0.764 . . . . 1.5 109.809 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.51 -20.68 13.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 2.18 110.057 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.03 -37.43 79.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.156 -0.965 . . . . 2.01 109.324 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.519 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 12.3 t60 -59.97 -50.06 75.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.029 -1.044 . . . . 0.49 110.564 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' B' ' 8' ' ' ARG . 18.1 mmm-85 -70.02 -35.18 74.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.881 -1.137 . . . . 3.23 109.67 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.71 -40.03 84.33 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.445 -0.785 . . . . 0.76 109.26 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.65 -49.0 74.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.408 -0.808 . . . . 0.46 110.069 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -83.48 9.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.975 -1.078 . . . . 0.44 110.755 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -102.71 -15.02 16.44 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.129 -0.982 . . . . 0.53 110.363 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' B' ' 14' ' ' PRO . 4.4 pt-20 -152.72 154.93 32.09 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.047 -1.033 . . . . 1.27 109.019 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -36.8 152.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.124 1.883 . . . . 0.49 111.522 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.463 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 11.5 ptm -89.52 -23.21 22.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.044 -1.035 . . . . 0.56 109.718 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -138.48 21.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.188 -1.165 . . . . 0.39 110.188 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.56 43.03 1.58 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.535 -0.979 . . . . 0.84 109.662 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -60.92 147.91 84.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 2.02 108.512 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.84 155.12 39.73 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.304 2.003 . . . . 0.34 112.774 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.73 -35.4 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.32 110.232 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.09 -0.58 57.04 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.599 -1.0 . . . . 0.22 110.599 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 8.5 p -82.22 -25.93 33.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.727 -1.454 . . . . 1.24 109.731 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.567 HD22 HD21 ' B' ' 81' ' ' LEU . 96.2 mt -60.69 138.51 58.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.411 -0.806 . . . . 0.24 109.953 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.78 134.51 55.41 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.86 -0.736 . . . . 0.21 109.417 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.0 -21.6 45.22 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.519 -1.432 . . . . 0.22 109.519 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -98.95 114.74 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.273 -1.134 . . . . 0.25 108.203 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.79 -179.26 36.22 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.613 -1.395 . . . . 0.28 109.613 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -58.08 -40.0 79.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -1.071 . . . . 2.0 109.783 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.76 -47.57 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.017 -1.052 . . . . 0.38 109.314 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -35.86 82.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.4 109.43 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.8 -39.96 92.23 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.447 . . . . 0.36 109.481 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.77 -37.35 84.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 2.75 110.39 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.85 -51.58 46.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.62 -1.3 . . . . 1.56 109.363 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.63 -39.87 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.33 108.306 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.0 -42.54 94.51 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.559 -0.856 . . . . 1.68 109.419 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.12 -19.09 65.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 1.99 108.68 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -90.75 5.35 48.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.535 -0.728 . . . . 2.68 109.813 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.02 8.92 53.35 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 120.225 -0.988 . . . . 0.49 111.575 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' B' ' 44' ' ' VAL . 95.5 m-85 -107.09 75.04 1.01 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.805 -1.409 . . . . 0.33 109.116 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.39 -8.14 58.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.41 110.542 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -137.98 158.57 44.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.159 -0.963 . . . . 1.56 110.179 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.43 84.47 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.925 0.713 . . . . 0.21 112.925 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -60.06 -17.68 41.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.431 -1.418 . . . . 0.32 110.489 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' B' ' 39' ' ' PHE . 30.6 t -79.56 -31.96 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.258 -1.386 . . . . 0.24 107.258 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 79.6 t -77.18 -39.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.244 -1.021 . . . . 0.22 108.244 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 24.5 tp -59.97 -35.87 75.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.432 -1.322 . . . . 0.4 107.432 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.34 98.22 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.791 -1.324 . . . . 0.18 109.791 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.061 -1.258 . . . . 1.09 108.838 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -59.97 -40.5 89.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.31 109.222 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.93 -38.34 79.44 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.828 -0.804 . . . . 0.27 108.828 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.78 -19.97 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.187 -0.946 . . . . 0.28 110.562 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 14.07 9.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.064 -1.022 . . . . 0.3 110.808 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.14 32.1 7.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.693 -1.254 . . . . 1.71 109.848 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 57.91 20.02 6.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.637 -0.664 . . . . 2.25 110.023 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -70.05 108.7 4.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.632 -1.293 . . . . 1.8 108.126 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.74 -40.07 96.07 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.076 0.769 . . . . 0.88 113.076 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.53 -40.03 85.05 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.434 -1.416 . . . . 0.74 109.932 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.31 -39.65 74.68 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.061 -1.056 . . . . 0.55 109.0 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.16 -41.84 94.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.38 109.132 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -59.96 -51.04 71.4 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.771 . . . . 2.64 110.187 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.73 -37.44 84.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.119 -0.988 . . . . 2.38 110.025 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . 0.448 ' O ' ' OG1' ' B' ' 66' ' ' THR . 74.3 t90 -63.22 -48.0 80.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.4 110.882 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -66.83 -47.36 72.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.038 -1.039 . . . . 0.34 109.752 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.24 -48.6 77.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.299 -0.875 . . . . 2.1 109.859 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -67.27 -32.06 72.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.574 -0.704 . . . . 1.9 109.769 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.22 -34.67 37.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.4 111.331 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.7 p -128.84 -26.47 2.67 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.615 -1.303 . . . . 0.39 111.984 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.31 34.59 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.7 -1.76 . . . . 0.36 108.7 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.6 152.92 2.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.32 109.412 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.64 174.97 6.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.962 . . . . 1.91 109.745 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -35.38 74.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.38 110.691 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.4 -39.59 64.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.673 -1.267 . . . . 2.57 110.339 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -67.48 -40.12 85.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.047 . . . . 2.12 110.7 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.9 m -69.06 -37.92 78.78 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.138 -0.976 . . . . 1.36 110.522 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' B' ' 75' ' ' ARG . 27.1 mtt-85 -60.0 -37.47 79.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.751 -1.218 . . . . 2.81 109.509 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.43 -39.99 81.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.645 -1.285 . . . . 0.4 110.526 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.57 -40.08 76.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.787 -1.196 . . . . 0.23 109.821 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.27 -60.24 4.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.647 -1.283 . . . . 0.43 109.824 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.0 -33.08 86.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.83 -0.908 . . . . 0.25 110.83 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -70.8 -48.63 53.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.039 -1.271 . . . . 0.24 110.188 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.567 HD21 HD22 ' B' ' 23' ' ' LEU . 88.3 mt -70.02 -39.89 75.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.998 -1.081 . . . . 0.29 108.161 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.47 -40.02 93.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 2.74 110.114 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 91.9 mt-10 -70.31 -38.24 74.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.965 -1.084 . . . . 1.91 110.907 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.498 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 89.3 t90 -60.43 -42.49 96.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.314 -1.491 . . . . 0.36 108.478 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.499 ' O ' ' N ' ' B' ' 89' ' ' LEU . 92.7 m -61.33 -40.49 94.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.513 -0.742 . . . . 0.36 110.237 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -29.59 68.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.123 -0.986 . . . . 0.55 109.896 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.26 -35.58 13.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.222 -0.924 . . . . 0.47 110.863 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 90.1 m-85 -108.53 -3.81 17.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.285 -0.884 . . . . 1.24 112.552 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' B' ' 85' ' ' CYS . 9.2 tp . . . . . 0 N--CA 1.503 2.184 0 O-C-N 120.492 -1.38 . . . . 1.67 109.384 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.569 0.7 . . . . 1.51 109.188 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -57.54 -20.1 29.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.589 -0.694 . . . . 2.18 109.602 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -61.41 -37.65 84.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 2.02 109.129 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -59.94 -49.98 75.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.149 -0.97 . . . . 0.49 110.317 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 98.1 mtt180 -70.23 -34.63 73.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.124 -0.985 . . . . 3.21 110.103 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.7 -40.07 80.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.76 109.559 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.63 -46.8 81.01 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.557 -0.857 . . . . 0.46 109.988 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.63 9.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.097 -1.002 . . . . 0.44 110.895 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -104.43 -15.06 15.5 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.994 -1.066 . . . . 0.54 110.206 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 14' ' ' PRO . 8.2 pt-20 -151.97 152.52 30.01 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.066 -1.022 . . . . 1.26 108.941 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 13' ' ' GLU . 66.8 Cg_exo -36.99 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.222 1.948 . . . . 0.49 111.636 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.459 ' H ' ' HG2' ' A' ' 15' ' ' MET . 13.2 ptm -95.68 -30.23 13.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 0.57 109.958 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.34 -133.58 49.18 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.363 -1.095 . . . . 0.4 110.363 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.77 35.51 3.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.767 -0.843 . . . . 0.85 110.088 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -54.88 149.81 21.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.925 -1.139 . . . . 2.01 107.925 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.23 157.49 34.95 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.076 1.851 . . . . 0.34 112.244 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 21' ' ' GLY . 12.7 p -56.85 -45.37 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.742 0.782 . . . . 0.32 110.231 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.565 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -61.94 -1.39 2.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.61 -0.996 . . . . 0.23 110.61 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.2 p -82.95 -27.54 30.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.484 . . . . 1.24 109.582 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.92 138.24 57.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.24 109.562 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . . . -65.59 134.86 54.22 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.733 0.778 . . . . 0.21 109.979 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.76 -20.03 51.99 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.246 -1.542 . . . . 0.22 109.246 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.5 mm -99.44 115.58 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -1.133 . . . . 0.25 108.246 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.57 37.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 0.28 109.463 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.84 -40.0 75.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -1.064 . . . . 2.01 109.86 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.38 -45.3 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.929 -1.107 . . . . 0.38 109.719 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.59 -37.79 85.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.4 109.53 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.115 -1.594 . . . . 0.35 109.115 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -1.134 . . . . 2.74 110.073 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -66.51 -48.44 69.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.851 -1.156 . . . . 1.54 109.609 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.6 -38.1 83.56 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.008 -1.108 . . . . 0.34 108.008 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -42.49 94.25 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.245 -0.65 . . . . 1.67 109.245 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.5 -19.34 65.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 2.0 108.718 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -90.48 1.64 56.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 2.69 110.285 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.61 7.0 43.15 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.944 -1.098 . . . . 0.48 111.583 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' HG12 ' A' ' 44' ' ' VAL . 95.7 m-85 -107.2 76.25 1.08 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.878 -1.366 . . . . 0.33 109.131 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.72 -7.26 57.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.865 . . . . 0.41 111.162 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.18 158.88 43.43 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.072 -1.017 . . . . 1.56 110.54 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.9 86.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.762 -0.586 . . . . 0.21 112.107 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 3.5 p90 -61.99 -18.82 61.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.433 -1.417 . . . . 0.32 109.861 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' A' ' 39' ' ' PHE . 20.8 t -79.95 -31.87 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.773 -1.195 . . . . 0.24 107.773 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 20' ' ' VAL . 70.2 t -77.94 -37.34 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.061 -1.089 . . . . 0.22 108.061 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.93 -35.21 74.43 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.993 -1.484 . . . . 0.4 106.993 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -43.0 98.75 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 110.198 -1.161 . . . . 0.18 110.198 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.078 -1.248 . . . . 1.09 109.053 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.92 -41.5 91.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.31 108.66 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.94 -40.04 75.73 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.742 -0.836 . . . . 0.28 108.742 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.18 -25.41 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.109 -0.994 . . . . 0.28 110.684 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.67 16.29 8.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.15 -0.969 . . . . 0.31 109.785 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 55' ' ' ASP . 8.8 mtmp? 51.94 44.94 29.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 1.7 110.609 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 pttt 40.7 18.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.971 -1.081 . . . . 2.24 111.528 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' LYS . 57.9 m-20 -66.59 115.56 6.58 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.847 -1.538 . . . . 1.8 106.847 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.59 -40.37 96.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.87 112.784 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.04 -39.94 75.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.378 -1.451 . . . . 0.73 110.107 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.55 -40.0 73.63 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.121 -1.032 . . . . 0.55 109.105 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.66 -49.74 73.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.38 109.491 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.54 HH12 ' NH2' ' A' ' 75' ' ' ARG . 64.9 mtp180 -60.01 -46.35 89.79 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.444 -0.785 . . . . 2.64 111.249 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.21 -36.36 83.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.674 -1.266 . . . . 2.37 108.905 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -63.62 -48.96 75.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.4 111.067 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.9 tp -67.75 -46.98 70.52 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.054 -1.029 . . . . 0.34 110.548 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -63.11 -46.48 87.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.983 . . . . 2.11 109.424 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 30.4 t0 -67.55 -31.08 70.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.618 . . . . 1.9 109.605 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.9 m -78.52 -36.61 44.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.41 111.653 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.7 p -130.41 -27.45 2.19 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.474 -1.391 . . . . 0.4 112.228 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.17 14.22 19.21 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.3 -1.52 . . . . 0.36 109.3 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.14 153.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.913 -1.345 . . . . 0.33 109.159 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.02 173.33 8.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.076 -1.015 . . . . 1.9 110.133 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.98 74.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.558 -0.714 . . . . 0.39 110.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.87 -40.43 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.856 -1.153 . . . . 2.58 110.157 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.35 -40.02 81.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.139 -0.975 . . . . 2.12 110.676 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 t -68.15 -38.37 82.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.128 -0.982 . . . . 1.36 109.927 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.54 ' NH2' HH12 ' A' ' 60' ' ' ARG . 52.6 mtt-85 -60.02 -38.46 82.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.961 -1.087 . . . . 2.8 108.973 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -67.94 -40.02 83.37 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.712 -1.242 . . . . 0.4 110.392 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.22 -39.94 82.21 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.743 -1.223 . . . . 0.24 109.493 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.1 -59.99 4.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.848 -1.157 . . . . 0.43 109.899 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.79 -34.26 89.24 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.278 -0.963 . . . . 0.26 110.736 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 24' ' ' ALA . 45.2 t -70.09 -47.61 61.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.3 . . . . 0.25 110.061 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.9 mt -70.0 -39.87 75.62 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.3 108.234 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.23 -40.5 96.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 2.73 109.883 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -69.23 -39.96 78.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.999 . . . . 1.91 110.754 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 84.5 t90 -59.98 -43.79 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.419 -1.426 . . . . 0.37 107.734 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.5 m -60.89 -40.07 91.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.63 0.729 . . . . 0.36 109.694 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.01 -34.24 73.08 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.105 -0.997 . . . . 0.55 110.148 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.78 -35.26 14.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.963 . . . . 0.48 111.151 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 88.0 m-85 . . . . . 0 N--CA 1.505 2.316 0 O-C-N 121.116 -0.99 . . . . 1.24 111.265 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.115 -0.698 . . . . 1.5 109.115 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.64 -20.09 30.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.548 -0.72 . . . . 2.18 109.609 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -61.32 -37.55 83.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 2.01 109.201 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -60.06 -49.93 75.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.49 110.35 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 98.1 mtt180 -70.25 -34.67 73.1 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.125 -0.984 . . . . 3.23 110.11 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.61 -40.05 80.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.76 109.573 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.73 -46.71 81.1 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.46 110.051 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 m -86.57 9.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.123 -0.986 . . . . 0.44 110.812 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -104.24 -15.01 15.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.992 -1.068 . . . . 0.53 110.258 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' B' ' 14' ' ' PRO . 8.2 pt-20 -152.0 152.52 29.97 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.144 -0.973 . . . . 1.27 108.98 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' B' ' 13' ' ' GLU . 69.0 Cg_exo -37.11 155.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.204 1.936 . . . . 0.49 111.65 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.419 ' HG2' ' H ' ' B' ' 15' ' ' MET . 13.2 ptm -95.49 -30.44 13.85 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -0.923 . . . . 0.56 110.057 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.73 -133.43 50.07 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.343 -1.103 . . . . 0.39 110.343 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -113.02 35.48 3.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.729 -0.865 . . . . 0.84 110.089 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -54.9 149.63 22.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.98 -1.119 . . . . 2.02 107.98 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.01 157.57 33.53 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.071 1.848 . . . . 0.34 112.274 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.576 HG13 ' N ' ' B' ' 21' ' ' GLY . 12.7 p -57.09 -45.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.666 0.746 . . . . 0.32 110.215 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.576 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -61.97 -1.59 3.04 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.615 -0.994 . . . . 0.22 110.615 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -82.75 -27.4 31.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.706 -1.467 . . . . 1.24 109.644 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.07 138.17 57.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.24 109.487 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' B' ' 80' ' ' CYS . . . -65.51 135.15 54.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.753 0.787 . . . . 0.21 109.838 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.49 -20.07 51.88 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.238 -1.545 . . . . 0.22 109.238 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 33.4 mm -99.42 115.45 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.335 -1.097 . . . . 0.25 108.306 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.32 177.55 37.92 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.567 -1.413 . . . . 0.28 109.567 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.76 -40.02 75.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.407 -1.055 . . . . 2.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.47 -45.3 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.088 . . . . 0.38 109.722 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.48 -37.94 86.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.4 109.449 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.0 95.76 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.139 -1.585 . . . . 0.36 109.139 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.808 ' CA ' ' N ' ' B' ' 33' ' ' LYS . 7.3 ttpm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.402 -1.058 . . . . 2.75 . 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.808 ' N ' ' CA ' ' B' ' 32' ' ' LYS . 62.5 mttm . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.628 -0.508 . . . . 1.56 109.628 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.5 -38.18 83.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.979 -1.119 . . . . 0.33 107.979 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.05 -42.28 94.11 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.204 -0.665 . . . . 1.68 109.204 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.75 -19.24 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.691 -0.855 . . . . 1.99 108.691 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -90.25 1.29 56.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 2.68 110.299 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.06 6.75 42.18 Favored Glycine 0 N--CA 1.503 3.117 0 O-C-N 120.937 -1.102 . . . . 0.49 111.558 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.52 ' CD2' HG12 ' B' ' 44' ' ' VAL . 95.7 m-85 -106.98 76.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.789 -1.418 . . . . 0.33 109.246 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -78.3 -7.45 57.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.126 -0.984 . . . . 0.41 111.112 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.12 158.78 43.63 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.97 -1.081 . . . . 1.56 110.529 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.93 -40.38 87.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.21 111.952 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 2.8 p90 -61.4 -18.64 59.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.506 -1.371 . . . . 0.32 110.24 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' B' ' 39' ' ' PHE . 20.7 t -80.22 -31.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.788 -1.19 . . . . 0.24 107.788 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.454 HG21 HG23 ' B' ' 20' ' ' VAL . 69.8 t -78.15 -37.25 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.029 -1.1 . . . . 0.22 108.029 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 tp -59.98 -35.06 74.19 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.017 -1.475 . . . . 0.4 107.017 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -43.18 98.55 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 110.223 -1.151 . . . . 0.18 110.223 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.136 -1.214 . . . . 1.09 109.113 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.99 -41.42 91.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.31 108.669 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.01 -39.87 75.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.686 -0.857 . . . . 0.27 108.686 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.48 -25.41 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.062 -1.024 . . . . 0.28 110.6 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' B' ' 52' ' ' LEU . 84.3 mt -89.5 15.96 8.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.091 -1.005 . . . . 0.3 109.762 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 55' ' ' ASP . 8.8 mtmp? 52.04 45.11 28.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 1.71 110.556 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 pttt 40.6 19.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.912 -1.117 . . . . 2.25 111.564 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 53' ' ' LYS . 61.6 m-20 -66.67 115.21 6.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.917 -1.512 . . . . 1.8 106.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.5 -40.27 96.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.262 -0.899 . . . . 0.88 112.746 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -69.86 -40.07 75.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.341 -1.475 . . . . 0.74 110.257 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.67 -39.95 73.25 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.093 -1.043 . . . . 0.55 109.008 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.5 -49.89 73.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.38 109.459 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.549 HH12 ' NH2' ' B' ' 75' ' ' ARG . 64.5 mtp180 -60.03 -45.92 91.23 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.528 -0.733 . . . . 2.64 111.292 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.58 -36.54 84.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.678 -1.264 . . . . 2.38 108.857 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -63.4 -49.07 75.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.4 111.038 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.406 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 61.2 tp -67.81 -46.75 70.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.1 -1.0 . . . . 0.34 110.564 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -63.3 -46.32 87.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 2.1 109.393 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 34.8 t0 -67.64 -31.16 70.97 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.746 -0.596 . . . . 1.9 109.652 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 97.2 m -78.49 -36.61 44.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.939 . . . . 0.4 111.687 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 18.5 p -130.44 -27.2 2.21 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.49 -1.381 . . . . 0.39 112.217 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.98 13.96 20.25 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.333 -1.507 . . . . 0.36 109.333 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.98 153.36 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.922 -1.34 . . . . 0.32 109.183 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -91.04 173.39 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 1.91 110.094 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.38 110.154 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.79 -40.44 69.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 2.57 110.097 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 2.12 110.656 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 5.7 t -68.14 -38.45 82.17 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -0.983 . . . . 1.36 109.916 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.549 ' NH2' HH12 ' B' ' 60' ' ' ARG . 52.6 mtt-85 -59.95 -38.64 83.05 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.907 -1.121 . . . . 2.81 109.013 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.81 -39.94 83.92 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.871 -1.143 . . . . 0.4 110.304 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.21 -40.06 82.21 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.789 -1.195 . . . . 0.23 109.508 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.95 -60.15 4.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.894 -1.129 . . . . 0.43 109.888 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.73 -34.35 89.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.653 -0.979 . . . . 0.25 110.653 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' B' ' 24' ' ' ALA . 45.8 t -70.1 -47.56 61.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.322 . . . . 0.24 110.024 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.91 -40.0 75.85 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.1 -1.04 . . . . 0.29 108.314 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -62.08 -40.75 96.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.312 -0.868 . . . . 2.74 109.819 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -69.0 -39.92 79.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 1.91 110.754 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 84.8 t90 -59.96 -44.03 94.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.451 -1.406 . . . . 0.36 107.622 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' B' ' 89' ' ' LEU . 41.2 m -60.81 -40.01 91.13 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 0.36 109.737 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -59.97 -34.46 73.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.988 -1.07 . . . . 0.55 110.2 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.6 -35.14 14.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.068 -1.02 . . . . 0.47 111.162 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 89.7 m-85 -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.115 -0.991 . . . . 1.24 111.407 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.1 tp . . . . . 0 N--CA 1.496 1.861 0 O-C-N 120.809 -1.182 . . . . 1.67 109.535 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.1 -0.704 . . . . 1.51 109.1 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -55.23 -20.65 11.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 2.18 110.234 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.25 -36.96 81.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 2.02 109.218 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.427 ' NE2' ' OE2' ' A' ' 83' ' ' GLU . 16.1 t60 -60.06 -50.15 74.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.067 . . . . 0.49 110.731 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 8' ' ' ARG . 4.1 mmt-85 -70.05 -34.3 73.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.045 -1.034 . . . . 3.21 109.743 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -72.08 -37.55 69.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.76 109.987 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.49 84.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.46 109.913 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -82.99 15.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.44 109.401 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.39 -8.49 10.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.557 -0.714 . . . . 0.54 110.362 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.29 151.0 23.25 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.887 -1.133 . . . . 1.26 109.554 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.5 161.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.916 1.744 . . . . 0.49 111.831 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.438 ' CE ' HD22 ' A' ' 46' ' ' LEU . 4.8 ptp -96.13 -24.71 16.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.218 -0.926 . . . . 0.57 109.788 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.84 -136.85 44.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.346 -1.501 . . . . 0.4 109.346 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -110.83 34.77 3.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.41 -1.053 . . . . 0.85 109.965 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -60.0 149.6 73.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.943 -1.098 . . . . 2.01 108.974 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.79 156.52 37.58 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.334 2.022 . . . . 0.34 112.301 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.4 p -57.95 -48.12 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.819 . . . . 0.32 110.267 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.574 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.35 -1.44 0.18 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.494 -1.042 . . . . 0.23 110.494 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 80.3 p -81.32 -24.82 36.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.714 -1.462 . . . . 1.24 109.179 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.402 HD22 HD21 ' A' ' 81' ' ' LEU . 92.4 mt -63.6 138.88 58.68 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.65 0.738 . . . . 0.24 109.893 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 134.63 54.32 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.815 -0.754 . . . . 0.21 109.426 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.2 -20.62 46.52 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.746 -1.342 . . . . 0.22 109.746 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.32 118.57 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.123 -1.222 . . . . 0.25 108.396 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.03 179.95 34.09 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.618 -1.393 . . . . 0.28 109.618 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -58.16 -40.09 80.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -1.139 . . . . 2.01 110.428 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.89 -47.19 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.793 -1.192 . . . . 0.38 109.326 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.68 -38.56 87.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.827 . . . . 0.4 109.412 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.97 96.19 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.439 -1.464 . . . . 0.35 109.439 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.32 -39.94 94.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -1.12 . . . . 2.74 110.018 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.32 -47.39 73.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 1.54 109.369 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.14 -39.66 93.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.34 108.964 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -43.16 95.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.437 -0.905 . . . . 1.67 108.867 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -64.72 -19.87 66.02 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 2.0 108.443 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.519 HH11 ' HG2' ' A' ' 37' ' ' ARG . 1.1 mmt-85 -90.06 2.42 55.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.438 -0.789 . . . . 2.69 110.271 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.76 6.29 46.69 Favored Glycine 0 N--CA 1.505 3.286 0 O-C-N 121.083 -1.011 . . . . 0.48 111.948 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.496 ' CD2' HG12 ' A' ' 44' ' ' VAL . 96.5 m-85 -105.3 75.14 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.726 -1.455 . . . . 0.33 109.236 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' B' ' 53' ' ' LYS . 37.2 p-10 -80.02 -10.52 59.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.41 110.389 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.75 153.28 51.35 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.182 -0.948 . . . . 1.56 110.001 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.93 92.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.731 -0.606 . . . . 0.21 111.969 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 27.0 p90 -56.85 -17.95 11.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.834 -1.166 . . . . 0.32 110.665 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 39' ' ' PHE . 25.9 t -79.63 -33.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.87 -1.144 . . . . 0.24 108.204 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 20' ' ' VAL . 54.7 t -74.09 -38.83 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.562 -1.273 . . . . 0.22 107.562 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD22 ' CE ' ' A' ' 15' ' ' MET . 24.9 tp -58.26 -38.81 77.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.808 -1.182 . . . . 0.4 107.808 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.34 -43.22 93.84 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.932 -1.267 . . . . 0.18 109.932 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -60.16 -42.75 95.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.268 . . . . 1.09 108.559 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.04 -40.05 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.539 -0.911 . . . . 0.31 108.539 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' B' ' 50' ' ' LEU . 98.9 mt -69.92 -39.96 75.83 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.594 -0.891 . . . . 0.28 108.594 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.22 -25.65 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.28 110.678 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.7 15.23 9.96 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.921 -1.112 . . . . 0.31 109.886 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' B' ' 40' ' ' ASP . 67.9 mttm 52.15 29.47 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.063 -1.023 . . . . 1.7 110.607 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' NZ ' ' NH1' ' A' ' 82' ' ' ARG . 83.4 mttt 60.06 19.83 9.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 2.24 110.685 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.19 115.73 7.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.406 -1.434 . . . . 1.8 107.957 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.72 -40.14 96.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.87 112.281 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 90.2 m-20 -68.3 -39.94 81.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.554 -1.341 . . . . 0.73 109.961 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.5 -39.69 67.43 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.166 -1.013 . . . . 0.55 109.101 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.35 -49.43 73.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.38 110.401 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.534 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 81.3 mtm180 -60.04 -44.8 94.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 2.64 110.693 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.71 -37.8 87.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 2.37 108.902 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -64.83 -48.73 73.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -0.983 . . . . 0.4 110.8 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 54.8 tp -66.97 -46.57 74.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.997 . . . . 0.34 109.391 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.88 -46.52 87.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 2.11 109.412 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -31.0 69.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.688 -0.633 . . . . 1.9 109.91 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.405 ' O ' ' NH2' ' A' ' 37' ' ' ARG . 91.4 m -77.95 -37.51 47.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.41 111.809 -177.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 6.2 p -130.13 -25.73 2.45 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.503 -1.373 . . . . 0.4 111.933 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 13.43 26.51 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.063 -1.615 . . . . 0.36 109.063 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.93 153.94 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.238 . . . . 0.33 109.031 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -91.15 -180.0 5.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.989 -1.069 . . . . 1.9 109.779 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -33.19 75.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.772 . . . . 0.39 110.823 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -71.49 -40.07 70.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.862 -1.149 . . . . 2.58 109.789 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.92 -37.7 84.83 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.426 -0.796 . . . . 2.12 110.438 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.5 p -67.03 -37.82 84.81 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.135 -0.978 . . . . 1.36 110.004 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' A' ' 75' ' ' ARG . 47.3 mtt-85 -59.97 -37.85 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.762 -1.211 . . . . 2.8 108.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.88 -40.01 83.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.837 -1.164 . . . . 0.4 110.718 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.25 -40.05 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.605 -1.309 . . . . 0.24 109.948 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.27 -60.2 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.741 -1.225 . . . . 0.43 109.451 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.01 -33.58 79.73 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.339 -1.105 . . . . 0.26 110.339 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.16 -51.06 50.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.105 -1.232 . . . . 0.25 109.91 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.402 HD21 HD22 ' A' ' 23' ' ' LEU . 81.8 mt -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.913 -1.115 . . . . 0.3 109.619 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' NH1' ' NZ ' ' A' ' 54' ' ' LYS . 23.8 tpt180 -60.12 -44.48 94.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 2.73 110.117 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' OE2' ' NE2' ' A' ' 7' ' ' HIS . 44.7 mt-10 -70.39 -38.1 74.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.86 . . . . 1.91 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 89.3 t90 -61.88 -43.0 99.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.442 -1.411 . . . . 0.37 108.397 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.8 m -61.29 -40.48 94.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.441 -0.787 . . . . 0.36 110.379 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.83 -27.88 67.0 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.198 -0.939 . . . . 0.55 109.338 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.82 -34.45 12.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 0.48 110.801 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.9 m-85 . . . . . 0 N--CA 1.505 2.29 0 O-C-N 121.259 -0.9 . . . . 1.24 112.812 -177.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.009 -0.737 . . . . 1.5 109.009 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -55.2 -20.77 11.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 2.18 110.265 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.23 -36.99 81.47 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.891 -1.131 . . . . 2.01 109.206 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.421 ' CE1' ' OE2' ' B' ' 83' ' ' GLU . 16.1 t60 -59.99 -50.18 74.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.49 110.76 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.523 HH11 ' HG2' ' B' ' 8' ' ' ARG . 4.0 mmt-85 -69.91 -34.45 73.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 3.23 109.785 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -72.06 -37.53 69.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.76 109.959 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.407 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.48 84.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.46 109.88 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -83.1 15.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.44 109.374 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.62 -8.41 9.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.597 -0.689 . . . . 0.53 110.358 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.33 151.07 23.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.872 -1.142 . . . . 1.27 109.53 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -42.6 161.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.824 1.683 . . . . 0.49 111.971 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.436 ' CE ' HD22 ' B' ' 46' ' ' LEU . 4.6 ptp -96.25 -24.4 16.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.56 109.769 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.91 43.11 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.364 -1.494 . . . . 0.39 109.364 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -110.71 34.78 3.78 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.429 -1.042 . . . . 0.84 110.025 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -59.98 149.71 72.69 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.966 -1.084 . . . . 2.02 108.967 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.87 156.42 38.46 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.304 2.003 . . . . 0.34 112.352 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.582 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.7 p -57.87 -48.15 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.32 110.271 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.582 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -55.43 -1.19 0.16 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.506 -1.038 . . . . 0.22 110.506 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.5 ' H ' ' C ' ' B' ' 20' ' ' VAL . 81.0 p -81.5 -24.72 36.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.699 -1.471 . . . . 1.24 109.148 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.69 138.8 58.64 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.649 0.738 . . . . 0.24 109.952 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.94 134.49 54.06 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.765 -0.774 . . . . 0.21 109.582 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.38 -20.73 45.73 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.749 -1.34 . . . . 0.22 109.749 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.18 118.62 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.213 -1.169 . . . . 0.25 108.398 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.99 179.96 34.16 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.59 -1.404 . . . . 0.28 109.59 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.28 -39.98 80.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.261 -1.14 . . . . 2.0 110.425 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 66.1 t -66.88 -47.25 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.38 109.402 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.46 -38.65 87.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.336 -0.852 . . . . 0.4 109.531 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.91 -40.01 96.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.353 -1.499 . . . . 0.36 109.353 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.31 -39.88 94.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 2.75 110.107 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.4 -47.21 74.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.86 -1.15 . . . . 1.56 109.33 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.28 -39.58 93.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.33 109.039 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.464 -0.894 . . . . 1.68 108.86 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.68 -19.88 65.99 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.439 -0.949 . . . . 1.99 108.439 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' B' ' 37' ' ' ARG . 1.1 mmt-85 -90.1 2.68 54.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 2.68 110.376 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 6.37 47.43 Favored Glycine 0 N--CA 1.504 3.223 0 O-C-N 120.988 -1.07 . . . . 0.49 112.057 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' B' ' 44' ' ' VAL . 96.5 m-85 -105.4 75.25 1.14 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.808 -1.407 . . . . 0.33 109.143 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 37.3 p-10 -80.21 -10.23 59.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.41 110.432 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -133.0 153.37 51.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.246 -0.909 . . . . 1.56 109.916 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.77 93.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.838 -0.539 . . . . 0.21 112.068 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 27.3 p90 -57.08 -18.01 12.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.32 110.524 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.2 t -79.51 -33.56 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.901 -1.124 . . . . 0.24 108.248 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.407 HG21 HG23 ' B' ' 20' ' ' VAL . 55.1 t -74.19 -38.79 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.472 -1.307 . . . . 0.22 107.472 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.436 HD22 ' CE ' ' B' ' 15' ' ' MET . 24.8 tp -58.38 -38.98 78.41 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.769 -1.197 . . . . 0.4 107.769 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.31 -43.13 93.81 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.856 -1.297 . . . . 0.18 109.856 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -60.03 -42.83 95.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.93 -1.335 . . . . 1.09 108.548 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.09 -39.95 87.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.559 -0.904 . . . . 0.31 108.559 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' A' ' 50' ' ' LEU . 98.7 mt -69.97 -40.04 75.62 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.27 108.538 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.05 -25.56 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.242 -0.911 . . . . 0.28 110.694 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.84 15.34 9.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.921 -1.112 . . . . 0.3 109.838 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 67.9 mttm 51.98 29.46 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 1.71 110.661 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . 0.445 ' NZ ' ' NH1' ' B' ' 82' ' ' ARG . 83.5 mttt 60.01 19.74 8.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.782 -0.573 . . . . 2.25 110.718 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -68.02 115.7 7.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.445 -1.41 . . . . 1.8 107.947 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.65 -40.32 96.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.88 112.205 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 90.4 m-20 -68.28 -39.97 81.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.512 -1.368 . . . . 0.74 109.921 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.39 -39.67 67.79 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.141 -1.023 . . . . 0.55 109.215 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.45 -49.43 73.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.38 110.43 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 81.5 mtm180 -59.97 -45.03 94.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 2.64 110.658 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.53 -37.61 87.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.855 -1.153 . . . . 2.38 108.931 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -65.03 -48.55 73.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.004 . . . . 0.4 110.876 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.406 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 54.6 tp -67.04 -46.67 73.7 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.135 -0.978 . . . . 0.34 109.392 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.84 -46.4 88.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 2.1 109.481 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.25 -30.94 69.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 1.9 109.835 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.405 ' O ' ' NH2' ' B' ' 37' ' ' ARG . 91.8 m -77.97 -37.52 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.4 111.741 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 6.1 p -130.03 -25.94 2.45 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.398 -1.439 . . . . 0.39 111.945 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.49 13.65 25.74 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 108.997 -1.641 . . . . 0.36 108.997 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.02 154.0 2.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.279 . . . . 0.32 108.983 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -91.31 -179.98 5.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.035 -1.04 . . . . 1.91 109.829 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.06 74.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.38 110.832 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -71.61 -40.07 70.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 2.57 109.823 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.9 -37.64 84.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.503 -0.748 . . . . 2.12 110.542 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.4 p -67.14 -37.73 84.31 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.122 -0.987 . . . . 1.36 110.004 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' B' ' 75' ' ' ARG . 46.9 mtt-85 -60.01 -37.77 80.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.77 -1.206 . . . . 2.81 108.778 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.0 -39.96 83.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.871 -1.143 . . . . 0.4 110.728 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.1 m -68.27 -40.05 82.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.641 -1.287 . . . . 0.23 109.884 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.35 -60.04 4.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.784 -1.197 . . . . 0.43 109.499 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -33.57 79.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.359 -1.096 . . . . 0.25 110.359 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -68.25 -51.01 49.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.046 -1.267 . . . . 0.24 109.903 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 82.0 mt -73.18 -41.16 64.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.953 -1.099 . . . . 0.29 109.591 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.445 ' NH1' ' NZ ' ' B' ' 54' ' ' LYS . 23.8 tpt180 -60.16 -44.33 95.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.959 . . . . 2.74 110.192 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.421 ' OE2' ' CE1' ' B' ' 7' ' ' HIS . 44.7 mt-10 -70.38 -38.21 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 1.91 110.585 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.422 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 89.1 t90 -61.79 -43.04 99.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.486 -1.384 . . . . 0.36 108.409 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.2 m -61.34 -40.41 94.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.36 110.391 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.88 -27.76 66.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.3 -0.875 . . . . 0.55 109.368 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.91 -35.01 12.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.47 110.724 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.422 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 88.7 m-85 -109.97 -8.08 14.89 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.235 -0.915 . . . . 1.24 112.996 -177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 85' ' ' CYS . 13.2 tp . . . . . 0 N--CA 1.502 2.141 0 O-C-N 120.224 -1.547 . . . . 1.67 109.414 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.694 -0.854 . . . . 1.51 108.694 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.92 -24.9 64.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.542 -0.724 . . . . 2.18 109.304 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.28 -36.93 81.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.909 . . . . 2.02 109.256 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.563 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 60.0 t60 -59.9 -54.37 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.49 110.839 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.9 -33.64 72.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.993 -1.067 . . . . 3.21 110.154 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.97 -39.6 75.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.313 -0.867 . . . . 0.76 109.342 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.54 -47.62 80.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.46 110.384 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.5 m -80.89 14.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.01 -1.056 . . . . 0.44 109.685 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.4 -11.08 13.71 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.508 -0.745 . . . . 0.54 110.081 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 14' ' ' PRO . 12.6 pt-20 -153.97 150.99 23.76 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.093 -1.004 . . . . 1.26 109.105 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLU . 93.5 Cg_exo -40.48 166.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.883 1.722 . . . . 0.49 112.123 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.0 ptp -92.24 -20.22 21.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.213 -0.93 . . . . 0.57 109.171 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.6 -141.52 5.97 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.339 -1.504 . . . . 0.4 109.339 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.26 30.05 6.57 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.439 -1.036 . . . . 0.85 109.812 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -60.4 148.84 79.1 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 2.01 108.908 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.46 155.36 53.12 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.265 1.977 . . . . 0.34 112.79 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.581 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.2 p -57.23 -47.18 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.626 0.727 . . . . 0.32 110.184 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -51.97 -3.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.514 -1.034 . . . . 0.23 110.514 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 20' ' ' VAL . 23.0 t -83.08 -22.3 33.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.758 -1.436 . . . . 1.24 109.47 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.11 58.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.146 -0.971 . . . . 0.24 109.766 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.34 133.83 51.32 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.857 -0.737 . . . . 0.21 109.83 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.79 -20.01 51.04 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.315 -1.514 . . . . 0.22 109.315 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -99.89 113.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.736 -1.209 . . . . 0.25 107.736 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.47 176.29 43.11 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.828 -1.309 . . . . 0.28 109.828 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -58.31 -39.96 80.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.502 -0.999 . . . . 2.01 109.702 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.03 -47.88 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.38 109.548 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.84 -39.83 83.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.4 109.307 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.97 96.43 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.32 -1.512 . . . . 0.35 109.32 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -61.13 -39.98 92.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -1.094 . . . . 2.74 110.664 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.19 -41.84 89.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.731 -1.231 . . . . 1.54 110.133 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.9 mt -60.03 -39.61 86.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.34 109.089 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -59.96 -40.04 87.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.375 -0.93 . . . . 1.67 109.639 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.05 -19.42 64.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.908 . . . . 2.0 108.804 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -90.1 1.35 56.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.587 -0.695 . . . . 2.69 109.515 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.11 38.78 3.47 Favored Glycine 0 N--CA 1.497 2.754 0 O-C-N 121.232 -0.918 . . . . 0.48 110.985 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 44' ' ' VAL . 84.5 m-85 -132.37 71.9 1.48 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.212 -1.17 . . . . 0.33 108.321 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -75.48 -12.38 60.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.053 -1.029 . . . . 0.41 110.495 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -134.34 156.86 47.73 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.165 -0.96 . . . . 1.56 109.434 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -40.22 93.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.21 111.678 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -58.44 -17.34 19.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.837 -1.164 . . . . 0.32 110.717 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 39' ' ' PHE . 43.7 t -79.77 -31.62 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.87 -1.159 . . . . 0.24 107.87 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.81 -38.69 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.739 -1.208 . . . . 0.22 107.739 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.66 -38.75 82.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.286 -1.375 . . . . 0.4 107.286 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.08 71.59 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.965 -1.254 . . . . 0.18 109.965 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -60.05 -42.56 94.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -1.213 . . . . 1.09 109.885 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.07 -39.96 87.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.096 -1.003 . . . . 0.31 108.68 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.1 -38.34 75.63 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.616 -0.883 . . . . 0.28 108.616 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.53 -22.51 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.153 -0.967 . . . . 0.28 110.733 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.86 17.85 7.29 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.053 -1.03 . . . . 0.31 109.735 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 52.06 29.43 6.33 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.073 -1.017 . . . . 1.7 109.611 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.4 mttt 60.08 19.88 9.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.855 -0.528 . . . . 2.24 109.944 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.99 114.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.821 -1.178 . . . . 1.8 107.821 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.72 -39.99 90.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.87 112.856 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.56 -39.57 84.93 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.462 -1.399 . . . . 0.73 110.687 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.98 -38.97 76.21 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.018 -1.073 . . . . 0.55 109.566 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.63 -43.69 92.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.38 109.884 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -60.04 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 2.64 110.941 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.77 -38.83 90.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.896 -1.127 . . . . 2.37 109.25 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -64.34 -49.48 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.019 -1.051 . . . . 0.4 110.993 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.3 tp -66.9 -47.25 72.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.04 -1.037 . . . . 0.34 109.998 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.83 -44.47 89.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 2.11 109.8 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 30.3 t0 -69.63 -30.95 68.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.557 -0.715 . . . . 1.9 109.664 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -79.31 -34.73 42.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.41 111.332 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.7 p -130.39 -29.68 1.98 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.598 -1.314 . . . . 0.4 112.078 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.98 14.48 20.8 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.401 -1.48 . . . . 0.36 109.401 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.73 154.79 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.034 -1.274 . . . . 0.33 109.296 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -89.22 169.91 11.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.984 -1.073 . . . . 1.9 110.266 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.36 73.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.687 . . . . 0.39 111.02 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.01 -40.05 75.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.629 -1.295 . . . . 2.58 109.654 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -64.88 -30.1 71.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.537 -0.727 . . . . 2.12 110.572 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.7 p -68.79 -39.6 80.07 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.987 -1.07 . . . . 1.36 110.611 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -60.01 -37.85 80.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.547 -1.346 . . . . 2.8 109.092 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.58 -1.325 . . . . 0.4 110.412 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 86.2 m -70.01 -40.27 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.791 -1.193 . . . . 0.24 109.502 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.17 -61.03 2.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 0.43 109.789 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.53 -33.08 83.55 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.196 -1.161 . . . . 0.26 110.196 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 46.7 t -71.0 -46.88 61.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.922 -1.34 . . . . 0.25 109.797 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.89 -40.98 68.52 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.01 -1.076 . . . . 0.3 109.068 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.75 -40.44 97.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.121 -0.987 . . . . 2.73 110.147 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.563 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 96.0 mt-10 -70.14 -38.38 75.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 1.91 110.459 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.7 t90 -61.49 -47.81 83.93 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.527 -1.358 . . . . 0.37 108.087 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.4 m -59.99 -40.14 88.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.498 -0.751 . . . . 0.36 109.841 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.47 -29.82 68.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.005 . . . . 0.55 109.364 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.52 -33.67 12.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.302 -0.874 . . . . 0.48 110.705 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 86.3 m-85 . . . . . 0 N--CA 1.504 2.273 0 O-C-N 121.277 -0.889 . . . . 1.24 112.45 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 108.653 -0.869 . . . . 1.5 108.653 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.93 -25.0 64.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 2.18 109.352 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.19 -36.97 81.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 2.01 109.322 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.56 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 60.3 t60 -59.93 -54.17 49.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.49 110.793 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.95 -33.65 72.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 3.23 110.127 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.01 -39.41 75.84 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.348 -0.845 . . . . 0.76 109.367 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.8 -47.59 80.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.46 110.316 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.93 14.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.042 -1.036 . . . . 0.44 109.68 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.34 -11.01 13.75 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.552 -0.717 . . . . 0.53 110.121 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 14' ' ' PRO . 12.6 pt-20 -154.0 151.17 24.09 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 1.27 109.02 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.5 Cg_exo -40.44 166.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.958 1.772 . . . . 0.49 112.074 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 1.9 ptp -92.57 -20.11 21.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.15 -0.968 . . . . 0.56 109.081 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.71 -141.43 6.17 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.427 -1.469 . . . . 0.39 109.427 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.27 29.95 6.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.527 -0.984 . . . . 0.84 109.787 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.47 148.82 79.65 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.89 -1.131 . . . . 2.02 108.812 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.43 155.49 52.12 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.218 1.945 . . . . 0.34 112.774 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.577 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.3 p -57.21 -47.15 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.674 0.75 . . . . 0.32 110.222 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -52.01 -3.42 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.572 -1.011 . . . . 0.22 110.572 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.523 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.8 t -82.92 -22.21 33.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.413 . . . . 1.24 109.485 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.07 58.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.24 109.807 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.9 51.42 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.591 0.71 . . . . 0.21 109.792 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.518 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.76 -20.06 50.88 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.399 -1.48 . . . . 0.22 109.399 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.9 113.53 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 107.622 -1.251 . . . . 0.25 107.622 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.51 176.26 43.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.829 -1.308 . . . . 0.28 109.829 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -58.26 -39.97 80.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.445 -1.032 . . . . 2.0 109.678 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.21 -47.67 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.049 -1.032 . . . . 0.38 109.559 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.91 -39.86 83.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.4 109.301 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.97 96.27 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.343 -1.503 . . . . 0.36 109.343 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -61.21 -39.9 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -1.073 . . . . 2.75 110.66 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -66.24 -41.82 89.49 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.705 -1.247 . . . . 1.56 110.154 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 63.7 mt -60.03 -39.56 86.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.087 -1.008 . . . . 0.33 109.084 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -60.12 -39.93 87.99 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.207 -0.997 . . . . 1.68 109.607 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -19.52 64.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 1.99 108.844 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -90.1 1.47 56.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.667 -0.646 . . . . 2.68 109.522 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.94 38.88 3.48 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.236 -0.915 . . . . 0.49 111.032 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.431 ' CD2' HG12 ' B' ' 44' ' ' VAL . 84.5 m-85 -132.5 71.9 1.48 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -1.213 . . . . 0.33 108.323 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -75.46 -12.3 60.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.963 -1.086 . . . . 0.41 110.406 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -134.43 156.8 47.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.165 -0.959 . . . . 1.56 109.392 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.21 92.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.426 -0.796 . . . . 0.21 111.608 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -58.41 -17.32 19.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.805 -1.185 . . . . 0.32 110.671 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' B' ' 39' ' ' PHE . 42.9 t -79.71 -31.78 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 0.24 107.943 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.76 -38.56 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.837 -1.171 . . . . 0.22 107.837 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -59.76 -38.78 82.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.28 -1.378 . . . . 0.4 107.28 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.41 -45.81 74.58 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.955 -1.258 . . . . 0.18 109.955 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -60.08 -42.63 95.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.24 . . . . 1.09 109.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.1 -39.91 87.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.136 -0.978 . . . . 0.31 108.776 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.96 -38.38 76.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.694 -0.854 . . . . 0.27 108.694 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.1 t -66.57 -22.43 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.28 110.716 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.92 17.79 7.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.001 -1.062 . . . . 0.3 109.737 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 52.02 29.64 6.49 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.031 -1.043 . . . . 1.71 109.499 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 59.93 20.08 9.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.802 -0.562 . . . . 2.25 109.986 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -68.98 114.46 7.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.843 -1.16 . . . . 1.8 107.925 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.68 -40.0 90.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.388 -0.82 . . . . 0.88 112.78 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -67.65 -39.52 84.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.524 -1.36 . . . . 0.74 110.634 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.97 -39.06 76.2 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.034 -1.066 . . . . 0.55 109.538 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.57 -43.72 92.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.38 109.813 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -59.96 -49.98 75.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 2.64 110.959 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.8 -38.79 89.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.78 -1.2 . . . . 2.38 109.273 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -64.33 -49.44 71.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.014 -1.054 . . . . 0.4 110.991 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.09 -47.03 72.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.028 -1.045 . . . . 0.34 110.0 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -64.92 -44.4 89.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.33 -0.856 . . . . 2.1 109.8 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 33.0 t0 -69.73 -30.97 68.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 1.9 109.724 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -79.23 -34.8 42.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.4 111.399 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.9 p -130.29 -29.78 1.99 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.58 -1.325 . . . . 0.39 112.092 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.07 14.33 21.01 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.363 -1.495 . . . . 0.36 109.363 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 154.69 1.84 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.015 -1.285 . . . . 0.32 109.34 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.17 169.99 10.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 1.91 110.241 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.29 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.642 -0.661 . . . . 0.38 110.992 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.11 -39.94 75.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.699 -1.25 . . . . 2.57 109.694 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.7 mm100 -65.0 -29.99 70.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.454 -0.779 . . . . 2.12 110.489 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p -68.82 -39.48 80.0 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.007 -1.058 . . . . 1.36 110.62 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' B' ' 75' ' ' ARG . 0.3 OUTLIER -60.25 -37.76 81.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.577 -1.327 . . . . 2.81 108.768 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.69 -40.11 76.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.6 -1.312 . . . . 0.4 110.431 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.04 -40.19 75.29 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.723 -1.236 . . . . 0.23 109.354 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.26 -61.01 2.91 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.041 -1.037 . . . . 0.43 109.71 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.56 -33.06 83.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.236 -1.146 . . . . 0.25 110.236 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -70.91 -46.95 61.61 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.933 -1.334 . . . . 0.24 109.703 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.9 -41.01 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.957 -1.097 . . . . 0.29 109.089 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.59 -40.6 97.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.155 -0.966 . . . . 2.74 110.139 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 95.9 mt-10 -70.08 -38.34 75.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 1.91 110.502 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.434 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.7 t90 -61.46 -47.87 83.72 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.542 -1.349 . . . . 0.36 108.09 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' B' ' 89' ' ' LEU . 56.3 m -59.99 -40.13 88.11 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.365 -0.834 . . . . 0.36 109.826 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.41 -29.83 68.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.069 -1.02 . . . . 0.55 109.404 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.58 -33.78 12.89 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.323 -0.86 . . . . 0.47 110.75 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.0 m-85 -108.3 -5.96 16.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.248 -0.907 . . . . 1.24 112.584 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.503 2.203 0 O-C-N 120.61 -1.306 . . . . 1.67 109.548 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.757 0.789 . . . . 1.51 109.742 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.574 ' NE2' ' NH2' ' A' ' 8' ' ' ARG . 7.3 tp-100 -54.68 -24.35 21.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 2.18 109.9 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.02 -38.66 86.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.034 -1.041 . . . . 2.02 109.228 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -59.16 -50.63 73.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.141 -0.974 . . . . 0.49 110.169 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.574 ' NH2' ' NE2' ' A' ' 5' ' ' GLN . 89.3 mtm180 -69.4 -34.75 74.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.132 -0.98 . . . . 3.21 110.423 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.57 -39.86 80.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.155 -0.966 . . . . 0.76 109.289 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.53 -48.94 78.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.445 -0.784 . . . . 0.46 109.761 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -83.22 10.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.266 -0.896 . . . . 0.44 110.711 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.66 -14.97 17.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.246 -0.909 . . . . 0.54 110.364 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' PRO . 18.6 pt-20 -152.45 152.61 29.37 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.031 -1.043 . . . . 1.26 108.632 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . 75.0 Cg_exo -37.37 155.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.96 1.773 . . . . 0.49 111.089 178.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.448 ' H ' ' HG2' ' A' ' 15' ' ' MET . 14.3 ptm -92.64 -24.75 18.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.055 -1.028 . . . . 0.57 110.443 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.81 -136.01 37.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.971 -1.109 . . . . 0.4 110.401 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.15 42.78 1.71 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.631 -0.923 . . . . 0.85 109.902 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -60.12 148.1 79.01 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.146 -0.971 . . . . 2.01 108.452 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.38 159.85 33.98 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.037 1.825 . . . . 0.34 112.085 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 21' ' ' GLY . 12.8 p -57.58 -39.47 69.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.677 -0.639 . . . . 0.32 110.994 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -67.79 -3.81 30.14 Favored Glycine 0 N--CA 1.491 2.331 0 O-C-N 121.432 -0.793 . . . . 0.23 111.346 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -83.82 -20.94 32.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.423 -1.633 . . . . 1.24 109.532 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.622 HD22 HD21 ' A' ' 81' ' ' LEU . 90.5 mt -64.15 136.29 57.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.033 -1.042 . . . . 0.24 109.078 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 136.13 57.16 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.678 -0.809 . . . . 0.21 109.763 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.7 -18.16 57.94 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.296 -1.522 . . . . 0.22 109.296 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.56 114.78 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.251 -1.147 . . . . 0.25 108.215 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.27 175.17 37.61 Favored Glycine 0 N--CA 1.492 2.382 0 O-C-N 120.608 -1.307 . . . . 0.28 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.86 -40.02 83.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -1.048 . . . . 2.01 109.549 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.41 -47.72 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.38 109.36 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.96 -38.51 88.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.4 109.327 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.22 95.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.707 -1.357 . . . . 0.35 109.707 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -63.53 -39.78 95.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.376 -1.073 . . . . 2.74 110.719 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.21 -43.05 83.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.592 -1.318 . . . . 1.54 109.982 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.95 -39.85 93.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.011 -1.056 . . . . 0.34 108.532 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.93 -42.1 93.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 1.67 111.007 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -64.68 -20.48 66.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.998 . . . . 2.0 109.418 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -93.54 8.46 40.63 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.841 -0.744 . . . . 2.69 110.845 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.8 7.9 49.69 Favored Glycine 0 N--CA 1.501 3.014 0 O-C-N 121.015 -1.053 . . . . 0.48 112.31 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.64 73.48 1.02 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.553 -1.557 . . . . 0.33 108.518 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -78.0 -8.1 57.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.41 110.952 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -137.15 157.35 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.134 -0.979 . . . . 1.56 110.602 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.643 -0.661 . . . . 0.21 111.684 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.443 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.2 p90 -60.7 -18.1 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.622 -1.299 . . . . 0.32 110.772 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.6 t -80.24 -30.7 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.414 -1.328 . . . . 0.24 107.414 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 HG23 ' A' ' 20' ' ' VAL . 70.2 t -78.25 -39.32 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.151 -1.055 . . . . 0.22 108.151 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.77 -36.29 74.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.793 -1.558 . . . . 0.4 106.793 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.29 -43.6 93.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.186 -1.165 . . . . 0.18 110.186 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -60.18 -42.03 94.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -1.228 . . . . 1.09 109.332 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.1 -39.97 88.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.082 -1.011 . . . . 0.31 108.66 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD12 HD12 ' B' ' 50' ' ' LEU . 77.3 mt -69.09 -39.58 78.91 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.095 -0.706 . . . . 0.28 109.095 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -67.79 -23.14 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.15 -0.969 . . . . 0.28 110.912 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.5 16.85 8.18 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.99 -1.069 . . . . 0.31 110.042 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.65 29.67 7.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.061 -1.024 . . . . 1.7 110.388 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt 59.96 19.8 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.495 -0.753 . . . . 2.24 110.367 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -67.65 115.99 7.85 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.377 -1.342 . . . . 1.8 107.377 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.42 -39.98 95.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.894 . . . . 0.87 113.251 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.8 -39.73 76.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.359 -1.463 . . . . 0.73 110.437 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.9 -40.07 72.39 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 118.836 -1.145 . . . . 0.55 109.379 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.63 -49.87 69.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.38 109.528 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -61.78 -45.31 94.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 2.64 109.799 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -64.21 -39.26 93.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.041 -1.037 . . . . 2.37 108.664 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' A' ' 66' ' ' THR . 76.2 t90 -66.87 -47.17 72.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.4 110.512 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.11 -49.15 68.51 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.129 -0.982 . . . . 0.34 109.575 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -61.5 -49.05 78.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.36 -0.837 . . . . 2.11 110.101 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.94 -26.14 64.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.467 -0.77 . . . . 1.9 109.748 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 22.9 m -79.32 -34.14 42.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.078 -1.014 . . . . 0.41 111.294 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.3 p -134.46 -21.66 1.76 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.328 -1.482 . . . . 0.4 112.294 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.23 12.16 34.5 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.679 -1.368 . . . . 0.36 109.679 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.1 153.72 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.935 -1.332 . . . . 0.33 109.169 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -87.7 169.81 11.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.913 -1.117 . . . . 1.9 109.772 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.24 -33.08 71.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.588 -0.695 . . . . 0.39 110.24 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -72.9 -39.61 66.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 2.58 109.804 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.64 -37.1 85.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.84 . . . . 2.12 110.491 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -36.6 82.42 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 1.36 109.963 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.12 -39.04 84.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.027 -1.046 . . . . 2.8 109.117 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.39 -39.66 81.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.898 -1.126 . . . . 0.4 110.981 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.23 -40.09 82.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 0.24 110.369 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.6 -59.53 5.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.512 -1.367 . . . . 0.43 109.554 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.01 79.26 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.621 -0.992 . . . . 0.26 110.621 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.44 -51.06 32.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -1.202 . . . . 0.25 110.337 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.622 HD21 HD22 ' A' ' 23' ' ' LEU . 84.1 mt -70.57 -40.39 73.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.847 -1.141 . . . . 0.3 108.531 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.78 -41.08 97.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 2.73 110.255 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.74 -38.4 76.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.91 110.404 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 90.0 t90 -60.11 -43.5 95.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.437 -1.414 . . . . 0.37 107.895 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 27.8 m -60.12 -40.24 89.05 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.739 0.781 . . . . 0.36 109.553 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -33.4 71.93 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.268 -0.895 . . . . 0.55 109.871 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.92 -33.98 13.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.991 -1.068 . . . . 0.48 111.037 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 97.4 m-85 . . . . . 0 N--CA 1.507 2.404 0 O-C-N 121.094 -1.003 . . . . 1.24 111.794 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.734 0.778 . . . . 1.5 109.716 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 8' ' ' ARG . 7.3 tp-100 -55.05 -24.17 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.342 0.591 . . . . 2.18 109.88 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -38.85 87.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.992 -1.068 . . . . 2.01 109.212 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -58.96 -50.71 73.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.1 -1.0 . . . . 0.49 110.317 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 5' ' ' GLN . 89.2 mtm180 -69.32 -34.95 75.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 3.23 110.234 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.28 -40.03 81.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.187 -0.946 . . . . 0.76 109.272 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -61.59 -48.81 79.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.46 109.912 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -83.49 10.73 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.238 -0.914 . . . . 0.44 110.664 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.75 -14.95 17.12 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.176 -0.953 . . . . 0.53 110.267 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 14' ' ' PRO . 18.7 pt-20 -152.14 152.25 29.23 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 1.27 108.615 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' B' ' 13' ' ' GLU . 68.1 Cg_exo -37.21 155.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.022 1.814 . . . . 0.49 111.076 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 14.0 ptm -92.57 -25.1 18.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.093 -1.004 . . . . 0.56 110.598 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.0 -136.02 38.77 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.064 -1.065 . . . . 0.39 110.44 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.17 42.9 1.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.619 -0.93 . . . . 0.84 110.071 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -60.27 148.08 80.0 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.426 -0.953 . . . . 2.02 108.426 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.61 159.41 36.88 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.07 1.847 . . . . 0.34 112.033 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.457 HG13 ' N ' ' B' ' 21' ' ' GLY . 12.2 p -57.38 -38.91 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.721 -0.612 . . . . 0.32 111.168 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.457 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -68.03 -3.73 31.34 Favored Glycine 0 N--CA 1.493 2.447 0 O-C-N 121.435 -0.79 . . . . 0.22 111.343 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.8 m -84.12 -21.13 31.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.575 -1.544 . . . . 1.24 109.587 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.616 HD22 HD21 ' B' ' 81' ' ' LEU . 88.5 mt -64.18 136.14 56.95 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -0.969 . . . . 0.24 109.032 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.23 136.11 57.51 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.753 0.787 . . . . 0.21 109.882 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.19 -17.75 58.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.375 -1.49 . . . . 0.22 109.375 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.78 114.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -1.143 . . . . 0.25 108.088 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.85 174.72 37.86 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.907 -1.277 . . . . 0.28 109.907 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.52 -39.83 81.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.424 -1.045 . . . . 2.0 109.677 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.59 -47.68 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.38 109.27 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.04 -38.57 88.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.386 -0.821 . . . . 0.4 109.46 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -39.07 95.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.36 109.692 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -63.7 -39.73 95.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -1.112 . . . . 2.75 110.667 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.07 -43.05 83.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.578 -1.326 . . . . 1.56 109.834 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.2 -39.95 94.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.33 108.586 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -59.9 -41.73 92.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.787 -0.57 . . . . 1.68 110.97 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.67 -20.94 66.59 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.212 -0.93 . . . . 1.99 109.295 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -93.22 8.33 40.68 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 2.68 110.79 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.95 8.03 48.98 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 120.911 -1.118 . . . . 0.49 112.319 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.79 73.66 1.02 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 119.314 1.557 . . . . 0.33 108.368 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -78.04 -8.28 57.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.41 110.758 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -137.07 157.46 46.66 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.145 -0.972 . . . . 1.56 110.605 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -39.83 89.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.711 -0.618 . . . . 0.21 111.724 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 3.3 p90 -60.59 -18.35 52.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.532 -1.355 . . . . 0.32 110.849 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -80.19 -30.84 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.429 -1.323 . . . . 0.24 107.429 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.451 HG21 HG23 ' B' ' 20' ' ' VAL . 68.9 t -77.91 -39.12 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.204 -1.036 . . . . 0.22 108.204 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.07 -36.14 74.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.865 -1.531 . . . . 0.4 106.865 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -43.73 93.83 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.241 -1.144 . . . . 0.18 110.241 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -60.05 -41.71 92.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 1.09 109.438 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.13 -40.23 89.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.31 108.762 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.411 HD12 HD12 ' A' ' 50' ' ' LEU . 77.6 mt -69.03 -39.8 78.99 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.987 -0.745 . . . . 0.27 108.987 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.43 -23.07 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.28 111.02 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.98 17.18 8.23 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.3 110.094 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.33 29.86 7.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.07 -1.019 . . . . 1.71 110.47 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 59.88 19.82 8.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.523 -0.736 . . . . 2.25 110.407 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -67.65 115.71 7.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.692 -1.255 . . . . 1.8 107.635 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -62.15 -40.33 95.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.402 -0.811 . . . . 0.88 113.083 -177.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -69.35 -40.02 77.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.393 -1.442 . . . . 0.74 110.629 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.82 -40.06 72.7 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.867 -1.133 . . . . 0.55 109.296 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.81 -50.01 68.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.38 109.533 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.62 -45.23 94.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.241 -0.912 . . . . 2.64 109.786 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -64.2 -39.43 93.96 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.991 -1.068 . . . . 2.38 108.708 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -66.61 -47.49 72.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.4 110.652 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.88 -49.15 69.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.15 -0.969 . . . . 0.34 109.576 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.54 -49.06 78.23 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.482 -0.762 . . . . 2.1 110.107 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.69 -26.38 65.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 1.9 109.625 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m -79.33 -34.47 42.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.4 111.34 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 16.3 p -133.85 -22.19 1.87 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.464 -1.398 . . . . 0.39 112.334 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 12.03 33.95 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.628 -1.389 . . . . 0.36 109.628 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.01 153.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.387 . . . . 0.32 109.213 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.92 169.69 11.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.972 -1.08 . . . . 1.91 109.829 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.14 71.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.534 -0.729 . . . . 0.38 110.335 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -73.19 -39.25 65.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.915 -1.116 . . . . 2.57 109.774 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.96 -36.83 84.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 2.12 110.441 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.9 p -66.93 -36.81 83.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.297 -0.877 . . . . 1.36 109.918 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -60.02 -39.19 84.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.95 -1.094 . . . . 2.81 109.216 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -68.25 -39.9 82.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.788 -1.195 . . . . 0.4 111.059 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.13 -39.97 82.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.782 -1.199 . . . . 0.23 110.457 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.55 -59.37 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.559 -1.338 . . . . 0.43 109.625 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.44 -33.0 79.4 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.567 -1.013 . . . . 0.25 110.567 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.74 -50.96 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.243 . . . . 0.24 110.41 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.616 HD21 HD22 ' B' ' 23' ' ' LEU . 83.8 mt -70.59 -40.48 73.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.768 -1.173 . . . . 0.29 108.529 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -61.6 -41.04 96.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.434 -0.791 . . . . 2.74 110.207 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -69.8 -38.51 76.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 1.91 110.53 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 90.0 t90 -60.03 -43.38 95.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.423 -1.423 . . . . 0.36 107.871 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' B' ' 89' ' ' LEU . 23.9 m -60.34 -40.08 89.4 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.7 0.762 . . . . 0.36 109.539 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.13 -33.2 71.81 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.256 -0.902 . . . . 0.55 109.905 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.07 -34.39 13.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.02 -1.05 . . . . 0.47 111.095 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 97.8 m-85 -110.04 1.92 19.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.083 -1.011 . . . . 1.24 111.654 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.5 tp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.837 -1.164 . . . . 1.67 109.317 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.655 0.741 . . . . 1.51 110.016 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -58.04 -19.99 35.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.669 -0.644 . . . . 2.18 110.845 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.21 -38.38 86.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 2.02 109.197 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.481 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 24.3 t60 -59.95 -53.92 52.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.196 -0.94 . . . . 0.49 110.516 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -69.97 -35.57 74.55 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.958 -1.088 . . . . 3.21 110.105 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.02 -39.91 75.53 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.295 -0.878 . . . . 0.76 109.737 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.64 -44.52 96.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.46 109.784 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.7 m -83.39 15.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.056 -1.027 . . . . 0.44 109.598 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.79 -13.12 14.53 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.486 -0.759 . . . . 0.54 110.32 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.77 151.59 20.88 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.979 -1.076 . . . . 1.26 109.537 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -40.13 156.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.067 1.845 . . . . 0.49 111.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.64 -18.73 23.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.878 -1.139 . . . . 0.57 109.941 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.09 -140.18 35.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.735 -1.346 . . . . 0.4 109.735 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -103.82 30.69 4.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.37 -1.077 . . . . 0.85 109.982 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -60.07 147.76 79.56 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.065 -1.022 . . . . 2.01 108.431 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.67 158.3 46.97 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.372 2.048 . . . . 0.34 112.557 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 22' ' ' SER . 2.3 p -56.93 -48.71 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.32 110.233 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.07 -3.71 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.402 -1.079 . . . . 0.23 110.402 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 7.8 t -82.84 -20.76 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.935 -1.333 . . . . 1.24 109.165 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.514 HD22 HD21 ' A' ' 81' ' ' LEU . 98.4 mt -65.11 139.96 58.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.24 109.73 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 133.07 50.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.812 0.815 . . . . 0.21 110.282 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.08 -20.34 47.97 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 109.839 -1.304 . . . . 0.22 109.839 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.2 117.1 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -1.198 . . . . 0.25 108.019 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.435 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -93.23 177.31 37.91 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.726 -1.35 . . . . 0.28 109.726 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.02 -40.02 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -1.08 . . . . 2.01 109.888 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.03 -47.36 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.085 . . . . 0.38 109.1 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.2 mt -65.04 -39.41 93.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.376 -0.828 . . . . 0.4 109.407 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.7 97.38 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 110.044 -1.222 . . . . 0.35 110.044 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -60.28 -40.02 88.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.406 . . . . 2.74 110.517 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.2 -45.95 75.37 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.797 -1.161 . . . . 1.54 109.771 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.0 -41.13 99.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.858 -1.151 . . . . 0.34 109.917 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.22 -40.64 90.89 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.114 -1.034 . . . . 1.67 109.383 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.65 -19.66 65.81 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.648 -0.871 . . . . 2.0 108.648 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 37' ' ' ARG . 51.0 mtt-85 -91.01 5.62 48.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.487 -0.758 . . . . 2.69 110.433 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.57 49.19 Favored Glycine 0 N--CA 1.502 3.045 0 O-C-N 121.09 -1.006 . . . . 0.48 112.075 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.544 ' CD2' HG12 ' A' ' 44' ' ' VAL . 89.3 m-85 -102.38 72.81 1.29 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.597 -1.531 . . . . 0.33 108.579 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -77.9 -12.56 59.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.41 110.679 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.853 ' C ' ' CA ' ' A' ' 42' ' ' ALA . 43.9 mmtm . . . . . 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 1.56 109.423 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.853 ' CA ' ' C ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 120.773 0.32 . . . . 0.21 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.462 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 26.3 p90 -55.68 -17.4 5.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.683 -1.261 . . . . 0.32 110.478 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 39' ' ' PHE . 46.3 t -79.25 -33.14 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.844 -1.169 . . . . 0.24 107.844 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.36 -38.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.235 -1.024 . . . . 0.22 108.235 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.97 -36.82 77.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.89 -1.152 . . . . 0.4 107.89 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -59.99 -42.04 98.16 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.96 -1.256 . . . . 0.18 109.96 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.97 -41.12 91.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.886 -1.361 . . . . 1.09 109.208 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.94 -39.99 87.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.99 . . . . 0.31 108.525 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.26 -37.55 80.86 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.573 -0.851 . . . . 0.28 108.716 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 47' ' ' GLY . 69.7 t -64.07 -26.75 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.289 -0.882 . . . . 0.28 110.142 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -91.59 14.89 13.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.099 -1.001 . . . . 0.31 110.52 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 50.09 40.01 20.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.726 -1.234 . . . . 1.7 111.055 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.28 18.99 4.63 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.267 -0.895 . . . . 2.24 110.492 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.78 107.77 3.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.776 -1.203 . . . . 1.8 108.193 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 85.1 tt0 -62.91 -40.81 98.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.407 -0.808 . . . . 0.87 112.679 -178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -68.69 -39.64 80.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.847 -1.158 . . . . 0.73 109.686 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.96 -38.63 76.15 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.18 -1.008 . . . . 0.55 109.026 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -62.83 -45.91 90.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.38 109.444 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mtt180 -60.0 -47.7 84.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.393 -0.817 . . . . 2.64 110.927 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.4 -39.68 94.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.889 -1.132 . . . . 2.37 108.923 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.3 t90 -61.91 -49.97 74.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.4 111.46 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.67 -46.13 76.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.852 -1.155 . . . . 0.34 109.923 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.68 -46.67 81.43 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.322 -0.861 . . . . 2.11 109.874 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.1 -31.53 70.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.386 -0.821 . . . . 1.9 109.538 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 75.7 m -77.74 -38.26 47.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.259 -0.901 . . . . 0.41 111.463 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 p -129.45 -24.33 2.8 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.479 -1.388 . . . . 0.4 111.854 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.46 13.55 28.0 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.182 -1.567 . . . . 0.36 109.182 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.81 154.57 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.035 -1.274 . . . . 0.33 109.097 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.91 170.04 11.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 1.9 109.53 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -31.61 70.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.39 110.773 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -73.89 -40.02 63.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 2.58 110.214 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.51 -33.7 76.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.416 -0.803 . . . . 2.12 110.328 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p -68.39 -37.68 80.63 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.219 -0.926 . . . . 1.36 109.824 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.47 -38.45 84.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.94 -1.1 . . . . 2.8 109.644 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.45 -39.96 81.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.622 -1.299 . . . . 0.4 110.485 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -70.01 -40.7 75.08 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.882 -1.136 . . . . 0.24 109.327 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -60.19 -60.02 4.48 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.809 -1.182 . . . . 0.43 109.654 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.22 91.78 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.212 -0.93 . . . . 0.26 110.876 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -68.21 -50.13 56.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.734 -1.45 . . . . 0.25 109.847 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD21 HD22 ' A' ' 23' ' ' LEU . 87.6 mt -70.14 -39.93 75.1 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.146 -1.022 . . . . 0.3 109.218 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -62.35 -39.97 94.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -0.99 . . . . 2.73 109.743 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.481 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.8 mt-10 -70.01 -36.62 75.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 1.91 109.83 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.596 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 80.5 t90 -59.92 -41.75 92.42 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.488 -1.383 . . . . 0.37 107.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.0 m -63.1 -40.02 96.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.768 -0.827 . . . . 0.36 108.768 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.1 -38.16 82.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.593 -0.692 . . . . 0.55 109.835 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 -37.07 17.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.48 110.065 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.596 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 72.2 m-85 . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 1.24 110.327 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.715 0.769 . . . . 1.5 110.011 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.609 ' CD ' ' H ' ' B' ' 5' ' ' GLN . 0.0 OUTLIER -58.13 -20.05 37.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.632 -0.668 . . . . 2.18 110.756 -178.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -61.15 -38.52 86.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.06 -1.025 . . . . 2.01 109.188 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.479 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 24.2 t60 -59.74 -53.91 52.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.49 110.667 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -70.05 -35.43 74.26 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.002 -1.061 . . . . 3.23 110.162 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.15 -39.9 75.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 0.76 109.647 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.51 -44.6 96.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.348 -0.845 . . . . 0.46 109.785 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 31.8 m -83.51 15.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.089 -1.007 . . . . 0.44 109.572 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.82 -13.0 14.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.53 -0.731 . . . . 0.53 110.368 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.84 151.57 20.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.908 -1.12 . . . . 1.27 109.498 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.06 156.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.992 1.795 . . . . 0.49 111.775 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.72 -18.61 23.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.947 -1.095 . . . . 0.56 109.963 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.86 -140.11 35.16 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.768 -1.333 . . . . 0.39 109.768 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.82 30.59 5.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.45 -1.029 . . . . 0.84 109.981 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -59.99 147.66 79.35 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 2.02 108.45 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.59 158.28 46.72 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.365 2.043 . . . . 0.34 112.603 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' B' ' 22' ' ' SER . 2.2 p -57.0 -48.64 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.476 -0.765 . . . . 0.32 110.169 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.14 -3.58 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.374 -1.09 . . . . 0.22 110.374 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.479 ' H ' ' C ' ' B' ' 20' ' ' VAL . 7.8 t -82.96 -20.85 34.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.295 . . . . 1.24 109.129 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.536 HD22 HD21 ' B' ' 81' ' ' LEU . 98.7 mt -65.02 139.93 58.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.24 109.78 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.17 132.9 50.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.784 0.802 . . . . 0.21 110.371 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.35 47.76 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.802 -1.319 . . . . 0.22 109.802 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.11 117.07 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.177 -1.19 . . . . 0.25 108.044 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.428 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -93.09 177.26 38.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.697 -1.361 . . . . 0.28 109.697 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -40.09 79.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 2.0 109.951 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.94 -47.49 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.38 109.129 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.428 HD12 ' H ' ' B' ' 27' ' ' GLY . 95.5 mt -64.93 -39.54 93.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.4 109.436 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.66 97.24 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 110.041 -1.224 . . . . 0.36 110.041 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -60.24 -40.1 89.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.852 -1.381 . . . . 2.75 110.503 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.21 -45.76 75.87 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.785 -1.166 . . . . 1.56 109.786 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.01 -41.27 99.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.33 110.002 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.77 90.5 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.171 -1.012 . . . . 1.68 109.382 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.69 -19.62 65.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.631 -0.877 . . . . 1.99 108.631 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' B' ' 37' ' ' ARG . 50.7 mtt-85 -91.1 5.78 47.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.817 . . . . 2.68 110.423 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.19 7.54 49.38 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.034 -1.041 . . . . 0.49 112.112 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.542 ' CD2' HG12 ' B' ' 44' ' ' VAL . 89.5 m-85 -102.43 72.93 1.29 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.704 -1.468 . . . . 0.33 108.624 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -78.06 -12.46 59.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.41 110.664 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.46 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 44.0 mmtm -132.31 154.11 50.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.055 -1.028 . . . . 1.56 109.419 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.99 91.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.298 -0.876 . . . . 0.21 111.73 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 25.7 p90 -55.82 -17.32 5.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.671 -1.268 . . . . 0.32 110.397 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.542 HG12 ' CD2' ' B' ' 39' ' ' PHE . 46.2 t -79.21 -33.02 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.93 -1.137 . . . . 0.24 107.93 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.5 -38.73 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.208 -1.034 . . . . 0.22 108.208 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.99 -36.9 78.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.899 -1.148 . . . . 0.4 107.899 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.422 ' O ' HG23 ' B' ' 51' ' ' VAL . . . -59.89 -42.1 98.05 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.997 -1.241 . . . . 0.18 109.997 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.96 -40.99 90.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.004 -1.292 . . . . 1.09 109.231 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.95 -40.14 87.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.31 108.43 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.21 -37.84 81.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.611 -0.885 . . . . 0.27 108.611 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 47' ' ' GLY . 70.7 t -63.93 -26.59 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.829 . . . . 0.28 110.179 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.6 14.95 13.6 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.097 -1.002 . . . . 0.3 110.539 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.705 -1.247 . . . . 1.71 111.045 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.26 19.02 4.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.371 -0.831 . . . . 2.25 110.504 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.73 107.82 3.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.809 -1.182 . . . . 1.8 108.131 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 85.2 tt0 -62.84 -41.09 99.2 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.398 -0.813 . . . . 0.88 112.704 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.54 -39.59 81.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.805 -1.184 . . . . 0.74 109.692 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.0 -38.52 76.01 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.201 -1.0 . . . . 0.55 109.06 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.06 -45.72 90.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.38 109.507 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 98.9 mtt180 -60.05 -47.76 84.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.785 . . . . 2.64 110.974 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -64.3 -39.68 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.896 -1.128 . . . . 2.38 108.946 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.92 -50.05 73.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.4 111.423 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.423 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 22.6 tp -66.63 -46.23 76.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.897 -1.127 . . . . 0.34 109.952 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.56 -46.71 81.63 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 2.1 109.9 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.08 -31.51 70.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 1.9 109.49 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 77.1 m -77.7 -38.3 47.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.868 . . . . 0.4 111.496 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 26.6 p -129.43 -24.3 2.81 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.581 -1.325 . . . . 0.39 111.891 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.45 13.63 27.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.189 -1.564 . . . . 0.36 109.189 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.74 154.63 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.264 . . . . 0.32 109.114 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.97 170.02 11.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 1.91 109.515 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.03 -31.47 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.38 110.741 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -74.04 -40.0 63.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.961 -1.087 . . . . 2.57 110.204 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -66.6 -33.57 75.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.412 -0.805 . . . . 2.12 110.272 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 32.9 p -68.52 -37.55 80.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.208 -0.933 . . . . 1.36 109.805 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.49 -38.5 84.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.885 -1.134 . . . . 2.81 109.689 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -68.34 -39.97 81.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.679 -1.263 . . . . 0.4 110.595 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.98 -40.8 75.13 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.845 -1.16 . . . . 0.23 109.33 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -60.08 -60.04 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.141 . . . . 0.43 109.718 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.18 91.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.829 -0.908 . . . . 0.25 110.829 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.27 -50.16 55.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.731 -1.453 . . . . 0.24 109.85 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.536 HD21 HD22 ' B' ' 23' ' ' LEU . 87.7 mt -70.03 -40.02 75.44 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.123 -1.031 . . . . 0.29 109.256 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -62.14 -40.11 94.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.123 -0.986 . . . . 2.74 109.762 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.479 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.8 mt-10 -70.05 -36.57 75.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.09 -1.006 . . . . 1.91 109.866 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 80.2 t90 -59.89 -41.89 92.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.525 -1.36 . . . . 0.36 107.702 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.8 m -63.02 -40.11 96.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.816 -0.809 . . . . 0.36 108.816 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.0 -38.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.627 -0.671 . . . . 0.55 109.858 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -37.65 16.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.198 -0.939 . . . . 0.47 110.057 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.8 m-85 -102.26 -86.66 0.42 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.188 -0.945 . . . . 1.24 110.376 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.016 -0.992 . . . . 1.67 109.945 -178.39 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.792 0.806 . . . . 1.51 110.349 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.91 -19.52 65.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.88 -0.513 . . . . 2.18 110.219 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -60.02 -37.45 79.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.049 -1.032 . . . . 2.02 109.573 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -59.92 -50.78 72.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.167 -0.958 . . . . 0.49 110.507 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 8' ' ' ARG . 38.7 mtt-85 -70.02 -33.7 72.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.954 -1.091 . . . . 3.21 110.224 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.66 -38.99 77.32 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.305 -0.872 . . . . 0.76 109.43 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -64.6 -47.4 78.75 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.393 -0.817 . . . . 0.46 110.506 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -85.11 11.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.154 -0.966 . . . . 0.44 111.054 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.08 -11.73 15.57 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.193 -0.942 . . . . 0.54 109.821 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.58 151.49 20.96 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.963 . . . . 1.26 108.976 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -39.9 161.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.892 1.728 . . . . 0.49 111.506 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.514 ' CE ' HD22 ' A' ' 46' ' ' LEU . 8.8 ptp -90.6 -20.22 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.029 -1.044 . . . . 0.57 109.479 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.56 -139.96 21.01 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.205 -1.158 . . . . 0.4 110.205 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.97 24.95 10.55 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.544 -0.974 . . . . 0.85 109.792 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -60.8 148.69 82.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.098 -1.001 . . . . 2.01 108.934 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.17 158.76 33.34 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.508 2.139 . . . . 0.34 113.307 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 21' ' ' GLY . 11.1 p -59.59 -44.96 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.657 0.742 . . . . 0.32 110.328 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.544 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.21 -3.0 0.18 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.567 -1.013 . . . . 0.23 110.567 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 20' ' ' VAL . 68.4 m -82.7 -19.15 38.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.769 -1.43 . . . . 1.24 109.436 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.18 137.41 56.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.24 109.639 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.2 134.75 54.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.737 -0.785 . . . . 0.21 109.842 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.08 48.07 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.316 -1.514 . . . . 0.22 109.316 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -98.35 113.18 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.25 108.007 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.8 179.27 38.33 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 120.623 -1.298 . . . . 0.28 109.952 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -57.29 -40.1 77.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.525 -0.985 . . . . 2.01 110.374 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.95 -46.26 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.38 109.743 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.57 -37.55 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.4 109.62 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.79 95.73 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.128 -1.589 . . . . 0.35 109.128 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.18 -39.98 95.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -1.087 . . . . 2.74 109.935 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.66 -44.72 69.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.88 -1.137 . . . . 1.54 109.44 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.66 -40.01 95.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.955 -1.128 . . . . 0.34 107.955 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.04 -41.52 92.43 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.976 -0.75 . . . . 1.67 108.976 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.28 -19.91 64.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.682 -0.859 . . . . 2.0 108.682 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -90.35 0.94 57.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 2.69 109.68 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 37.79 3.84 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 120.305 -0.95 . . . . 0.48 111.239 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.511 ' CD2' HG12 ' A' ' 44' ' ' VAL . 89.1 m-85 -133.84 72.6 1.48 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.968 -1.313 . . . . 0.33 108.995 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -80.28 -10.73 59.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.41 110.729 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.88 152.04 51.31 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.127 -0.983 . . . . 1.56 110.017 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.96 90.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.21 111.823 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.46 -17.77 9.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.758 -1.214 . . . . 0.32 110.603 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.511 HG12 ' CD2' ' A' ' 39' ' ' PHE . 43.7 t -79.4 -31.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.821 -1.174 . . . . 0.24 107.914 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.54 -36.7 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.343 -0.984 . . . . 0.22 108.343 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.514 HD22 ' CE ' ' A' ' 15' ' ' MET . 66.7 tp -60.01 -37.84 80.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.983 -1.488 . . . . 0.4 106.983 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.3 87.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.986 -1.246 . . . . 0.18 109.986 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.08 -42.27 94.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.339 . . . . 1.09 108.901 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.357 -0.979 . . . . 0.31 108.357 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.06 -39.93 75.39 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.756 -0.831 . . . . 0.28 108.756 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.81 -26.7 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.176 -0.952 . . . . 0.28 111.358 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.2 16.13 6.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.9 -1.125 . . . . 0.31 110.217 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.34 21.67 5.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 1.7 110.167 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.15 19.6 8.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.707 -0.62 . . . . 2.24 110.311 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.9 122.1 17.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.585 -1.322 . . . . 1.8 107.777 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' OE2' ' CG ' ' A' ' 78' ' ' PHE . 8.5 tp10 -61.97 -41.56 98.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.286 0.847 . . . . 0.87 113.286 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -69.96 -39.86 75.75 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.411 -1.431 . . . . 0.73 110.787 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.08 -39.9 75.33 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.917 -1.113 . . . . 0.55 109.067 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.6 -48.48 79.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.268 -0.895 . . . . 0.38 109.482 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.08 -47.12 87.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.356 -0.84 . . . . 2.64 110.978 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.13 -39.88 94.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.749 -1.219 . . . . 2.37 108.885 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -61.58 -50.05 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.4 111.414 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.65 -47.29 69.97 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.145 -0.972 . . . . 0.34 110.146 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -63.33 -46.7 85.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 2.11 109.869 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.37 -30.81 69.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 1.9 109.696 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.6 m -79.01 -35.14 43.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.41 111.247 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.9 p -131.79 -34.73 1.3 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.541 -1.35 . . . . 0.4 111.722 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.97 15.87 10.37 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.422 -1.471 . . . . 0.36 109.422 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 153.05 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.282 . . . . 0.33 109.04 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.579 ' H ' HE21 ' A' ' 73' ' ' GLN . 28.1 t-20 -89.68 170.68 10.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 1.9 109.348 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.27 72.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.504 -0.748 . . . . 0.39 110.94 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 68.5 mttm -71.63 -41.43 68.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.717 -1.24 . . . . 2.58 110.566 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.579 HE21 ' H ' ' A' ' 70' ' ' ASN . 36.6 mt-30 -67.32 -36.52 81.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 2.12 110.386 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.135 -0.978 . . . . 1.36 110.466 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 72' ' ' LYS . 83.5 mtm180 -59.95 -36.59 77.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.675 -1.266 . . . . 2.8 108.701 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.4 -39.29 81.71 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.83 -1.169 . . . . 0.4 110.27 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.21 -41.14 81.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.791 -1.193 . . . . 0.24 109.59 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CG ' ' OE2' ' A' ' 56' ' ' GLU . 64.7 t80 -60.01 -59.81 4.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.819 -1.176 . . . . 0.43 109.41 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -34.88 85.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.992 -1.243 . . . . 0.26 109.992 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.8 -45.45 67.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -1.186 . . . . 0.25 109.465 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.58 -41.91 68.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.3 109.117 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.15 -41.16 96.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 2.73 109.527 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -70.05 -37.89 75.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 1.91 110.603 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.48 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.8 t90 -59.99 -43.5 95.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.393 -1.442 . . . . 0.37 107.815 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.0 m -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.572 -0.705 . . . . 0.36 109.358 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -59.2 -34.21 71.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.55 110.21 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.75 -34.34 13.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.296 -0.878 . . . . 0.48 111.352 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 94.8 m-85 . . . . . 0 N--CA 1.506 2.364 0 O-C-N 120.984 -1.073 . . . . 1.24 112.033 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.86 0.838 . . . . 1.5 110.326 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.86 -19.6 65.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.819 -0.551 . . . . 2.18 110.21 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.0 -37.35 79.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.108 -0.995 . . . . 2.01 109.665 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -59.96 -50.85 72.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.126 -0.984 . . . . 0.49 110.449 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' B' ' 8' ' ' ARG . 38.8 mtt-85 -70.04 -33.71 72.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 3.23 110.165 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.58 -39.26 77.44 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.202 -0.936 . . . . 0.76 109.377 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.32 -47.54 79.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.838 . . . . 0.46 110.457 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -85.3 11.6 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.44 111.139 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.21 -11.92 15.49 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.238 -0.914 . . . . 0.53 109.759 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.45 151.63 21.43 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.091 -1.006 . . . . 1.27 108.97 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.97 161.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.847 1.698 . . . . 0.49 111.585 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.509 ' CE ' HD22 ' B' ' 46' ' ' LEU . 8.9 ptp -90.74 -19.79 23.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.56 109.561 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.11 -140.1 18.32 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.047 -1.221 . . . . 0.39 110.047 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.74 25.09 10.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.981 . . . . 0.84 109.848 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -61.03 148.92 83.35 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.908 -1.12 . . . . 2.02 108.879 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.22 158.78 33.49 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.412 2.075 . . . . 0.34 113.315 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.551 HG13 ' N ' ' B' ' 21' ' ' GLY . 11.2 p -59.64 -44.95 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.625 0.726 . . . . 0.32 110.273 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.551 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.22 -2.81 0.17 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.591 -1.003 . . . . 0.22 110.591 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' B' ' 20' ' ' VAL . 68.5 m -82.91 -19.33 37.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.793 -1.416 . . . . 1.24 109.34 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.97 137.42 57.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.965 . . . . 0.24 109.651 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.47 134.4 53.34 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.805 . . . . 0.21 109.995 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 -20.91 48.79 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.236 -1.545 . . . . 0.22 109.236 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 mm -98.44 113.1 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.263 -1.139 . . . . 0.25 107.961 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.74 179.05 38.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.913 -1.275 . . . . 0.28 109.913 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.16 -40.04 76.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 2.0 110.353 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.99 -46.41 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.38 109.725 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 93.3 mt -65.26 -37.68 87.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.4 109.666 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.82 95.68 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.256 -1.538 . . . . 0.36 109.256 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.24 -39.92 94.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.392 -1.064 . . . . 2.75 109.922 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.6 -44.9 69.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.844 -1.16 . . . . 1.56 109.331 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.55 -39.92 95.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.016 -1.105 . . . . 0.33 108.016 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -41.56 92.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.945 -0.761 . . . . 1.68 108.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -68.19 -20.13 64.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.633 -0.877 . . . . 1.99 108.633 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -90.15 1.3 56.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.495 -0.753 . . . . 2.68 109.646 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.45 37.8 3.91 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.115 -0.991 . . . . 0.49 111.127 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.518 ' CD2' HG12 ' B' ' 44' ' ' VAL . 89.0 m-85 -134.01 72.75 1.48 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.977 -1.308 . . . . 0.33 108.956 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -80.57 -10.57 59.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.089 -1.007 . . . . 0.41 110.8 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.95 152.31 51.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.204 -0.935 . . . . 1.56 110.038 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.63 91.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.21 111.848 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.58 -17.96 10.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.577 -1.327 . . . . 0.32 110.51 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.518 HG12 ' CD2' ' B' ' 39' ' ' PHE . 43.8 t -79.43 -31.65 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.797 -1.19 . . . . 0.24 107.841 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.46 -36.76 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.39 -0.967 . . . . 0.22 108.39 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.509 HD22 ' CE ' ' B' ' 15' ' ' MET . 67.0 tp -60.01 -38.12 81.73 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.802 -1.555 . . . . 0.4 106.802 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.63 85.42 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.936 -1.266 . . . . 0.18 109.936 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -42.31 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.881 -1.364 . . . . 1.09 108.819 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -40.16 88.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.356 -0.979 . . . . 0.31 108.356 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 65.4 mt -69.96 -40.06 75.63 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.725 -0.843 . . . . 0.27 108.725 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.62 -26.66 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.167 -0.958 . . . . 0.28 111.276 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.38 16.45 6.39 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.035 -1.041 . . . . 0.3 110.237 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.16 21.79 5.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.885 . . . . 1.71 110.092 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 80.5 mttt 59.99 19.19 8.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.75 -0.593 . . . . 2.25 110.386 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.62 122.29 17.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.561 -1.337 . . . . 1.8 107.664 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE2' ' CG ' ' B' ' 78' ' ' PHE . 8.5 tp10 -62.0 -42.04 98.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.88 113.289 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.54 -39.97 77.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.339 -1.476 . . . . 0.74 110.694 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.09 -40.01 75.23 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.99 -1.084 . . . . 0.55 109.035 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.56 -48.38 79.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.38 109.544 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.03 -47.61 85.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 2.64 110.846 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.03 -39.46 94.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.715 -1.241 . . . . 2.38 108.953 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . 0.424 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -61.83 -49.91 74.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.339 -0.85 . . . . 0.4 111.377 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.68 -47.67 68.79 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.196 -0.94 . . . . 0.34 110.069 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -62.94 -46.78 86.14 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.917 . . . . 2.1 109.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.32 -30.75 69.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.9 109.655 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 99.7 m -79.11 -35.14 42.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.4 111.354 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.9 p -131.59 -35.18 1.31 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.639 -1.288 . . . . 0.39 111.787 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.26 16.22 9.82 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 109.341 -1.503 . . . . 0.36 109.341 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.51 153.14 1.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.866 -1.373 . . . . 0.32 109.078 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.579 ' H ' HE21 ' B' ' 73' ' ' GLN . 28.1 t-20 -89.86 170.56 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.089 -1.007 . . . . 1.91 109.329 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.35 -32.97 71.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.507 -0.746 . . . . 0.38 111.0 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.41 ' HA ' ' HE ' ' B' ' 75' ' ' ARG . 68.5 mttm -71.89 -41.45 67.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.751 -1.218 . . . . 2.57 110.441 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.579 HE21 ' H ' ' B' ' 70' ' ' ASN . 36.6 mt-30 -67.32 -36.38 81.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 2.12 110.447 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.65 -38.35 83.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.352 -0.842 . . . . 1.36 110.442 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' B' ' 72' ' ' LYS . 83.5 mtm180 -60.01 -36.45 77.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.748 -1.22 . . . . 2.81 108.746 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.64 -39.47 80.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.782 -1.199 . . . . 0.4 110.187 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.07 -41.23 82.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.987 -1.07 . . . . 0.23 109.529 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.526 ' CG ' ' OE2' ' B' ' 56' ' ' GLU . 64.4 t80 -60.02 -59.77 4.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.819 -1.176 . . . . 0.43 109.507 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.03 -34.86 85.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.935 -1.266 . . . . 0.25 109.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.87 -45.71 67.09 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.152 -1.205 . . . . 0.24 109.364 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.41 -41.67 69.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.999 . . . . 0.29 109.151 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.37 -40.98 96.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.881 . . . . 2.74 109.605 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.96 -38.04 75.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.164 -0.96 . . . . 1.91 110.604 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.481 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.9 t90 -59.99 -43.5 95.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.332 -1.48 . . . . 0.36 107.718 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' B' ' 89' ' ' LEU . 22.3 m -60.06 -40.05 88.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.637 -0.664 . . . . 0.36 109.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -59.07 -34.11 71.58 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.949 . . . . 0.55 110.288 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.76 -35.02 13.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.009 -1.057 . . . . 0.47 111.377 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.481 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.2 m-85 -109.91 2.16 19.62 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.12 -0.987 . . . . 1.24 112.272 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.0 tp . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.716 -1.24 . . . . 1.67 109.944 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.734 0.778 . . . . 1.51 109.928 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.75 -23.96 46.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.783 -0.573 . . . . 2.18 110.208 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.13 -38.41 82.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.921 . . . . 2.02 108.932 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -60.04 -52.23 66.24 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.463 -0.773 . . . . 0.49 110.795 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 89.1 mtm180 -69.94 -35.41 74.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.963 -1.086 . . . . 3.21 109.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -65.49 -40.01 92.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.82 . . . . 0.76 109.342 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 44.4 t80 -63.14 -49.65 73.53 Favored 'General case' 0 C--N 1.298 -1.63 0 C-N-CA 119.642 -0.823 . . . . 0.46 110.003 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.35 6.04 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.105 -0.997 . . . . 0.44 111.231 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -99.27 -18.77 17.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.93 -1.106 . . . . 0.54 110.057 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' PRO . 6.5 pt-20 -151.96 151.94 28.96 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.154 -0.967 . . . . 1.26 108.917 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 13' ' ' GLU . 69.6 Cg_exo -36.76 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.2 1.933 . . . . 0.49 111.688 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.509 ' SD ' HD13 ' B' ' 89' ' ' LEU . 15.6 ptm -93.66 -29.64 15.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.104 -0.997 . . . . 0.57 110.15 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 -135.28 44.7 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.205 -1.158 . . . . 0.4 110.205 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.97 35.3 3.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.676 -0.896 . . . . 0.85 110.014 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.26 148.59 71.76 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 2.01 108.47 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.28 156.2 41.85 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.025 1.817 . . . . 0.34 112.048 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.4 p -57.01 -48.13 82.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.442 -0.786 . . . . 0.32 110.22 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.84 -3.81 0.23 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.716 -0.954 . . . . 0.23 110.716 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 70.7 m -83.16 -21.54 33.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.709 -1.465 . . . . 1.24 109.422 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.36 136.79 57.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.038 -1.039 . . . . 0.24 109.418 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.59 136.17 56.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.763 0.792 . . . . 0.21 109.758 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.27 -20.07 52.24 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.741 -1.744 . . . . 0.22 108.741 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.83 115.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.908 -1.145 . . . . 0.25 107.908 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -90.21 177.02 42.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.825 -1.31 . . . . 0.28 109.825 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.76 -39.93 74.9 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.629 -0.924 . . . . 2.01 109.914 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.82 -44.47 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.05 . . . . 0.38 109.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 27' ' ' GLY . 93.6 mt -66.77 -37.46 84.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.9 . . . . 0.4 109.47 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.246 -1.542 . . . . 0.35 109.246 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.82 -39.86 94.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.405 -1.056 . . . . 2.74 110.367 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -65.44 -48.45 72.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.859 -1.151 . . . . 1.54 109.948 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.69 -36.03 79.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.909 -1.119 . . . . 0.34 108.485 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.739 -0.601 . . . . 1.67 110.058 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.02 -19.37 65.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.995 . . . . 2.0 108.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 37' ' ' ARG . 33.8 mtt-85 -91.05 6.59 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.595 -0.691 . . . . 2.69 110.25 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.7 55.43 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.978 -1.076 . . . . 0.48 111.688 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD1' HG12 ' A' ' 44' ' ' VAL . 87.2 m-85 -103.86 72.99 1.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.835 -1.391 . . . . 0.33 108.341 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.06 -10.72 59.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.459 -0.776 . . . . 0.41 110.628 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.5 150.27 50.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.167 -0.958 . . . . 1.56 109.62 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.99 94.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.21 110.827 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 17.0 p90 -60.55 -18.64 53.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.016 -1.052 . . . . 0.32 110.371 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 39' ' ' PHE . 50.1 t -79.57 -32.74 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.434 -1.321 . . . . 0.24 107.434 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.74 -37.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.096 -1.075 . . . . 0.22 108.096 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.8 tp -59.99 -35.46 75.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.569 -1.271 . . . . 0.4 107.569 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.54 97.08 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.166 -1.173 . . . . 0.18 110.166 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -59.97 -41.66 92.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.01 -1.288 . . . . 1.09 109.778 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.31 108.741 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -38.77 81.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.723 -0.843 . . . . 0.28 108.723 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.02 -24.54 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.347 -0.846 . . . . 0.28 110.629 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.23 18.37 9.61 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.121 -0.987 . . . . 0.31 110.444 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.36 33.55 7.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.768 -1.207 . . . . 1.7 110.126 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.05 19.92 9.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.751 -0.593 . . . . 2.24 110.382 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.47 113.38 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.609 -1.307 . . . . 1.8 107.719 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.84 -40.03 93.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.87 113.16 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -69.81 -39.7 76.37 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.615 -1.303 . . . . 0.73 110.578 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.57 -38.77 77.54 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.75 -1.18 . . . . 0.55 108.921 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.92 -50.59 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.38 109.983 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.51 ' HG3' HH11 ' A' ' 60' ' ' ARG . 5.4 mtm-85 -62.54 -43.71 98.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 2.64 109.841 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.95 -39.78 94.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 2.37 108.797 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.461 ' O ' ' OG1' ' A' ' 66' ' ' THR . 55.9 t90 -65.45 -46.32 80.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.4 110.526 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 tp -67.56 -49.45 63.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.34 110.017 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.75 -48.87 79.86 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.381 -0.825 . . . . 2.11 109.969 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 28.8 t0 -68.95 -28.97 67.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.704 . . . . 1.9 109.862 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 50.3 m -79.5 -34.55 41.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.254 -0.903 . . . . 0.41 111.019 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.3 p -131.56 -29.52 1.74 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.648 -1.283 . . . . 0.4 111.749 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.6 14.19 20.38 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.382 -1.487 . . . . 0.36 109.382 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.44 1.69 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.047 -1.266 . . . . 0.33 109.015 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -90.6 171.19 9.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.084 -1.01 . . . . 1.9 109.737 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -34.01 72.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.39 110.746 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.19 -40.54 67.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.618 -1.301 . . . . 2.58 109.993 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.79 -39.98 79.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.112 -0.993 . . . . 2.12 110.409 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -67.41 -39.05 85.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.27 -0.894 . . . . 1.36 110.028 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -59.97 -38.65 83.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 2.8 109.421 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.43 -39.94 85.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.712 -1.243 . . . . 0.4 110.482 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -66.78 -40.03 88.03 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.915 -1.115 . . . . 0.24 109.86 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.03 -59.97 4.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.599 -1.313 . . . . 0.43 110.044 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.67 84.97 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.443 -1.063 . . . . 0.26 110.443 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.13 -49.94 52.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -1.134 . . . . 0.25 109.867 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.07 -39.98 75.31 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.792 -1.163 . . . . 0.3 108.775 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.23 -41.18 99.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 2.73 110.18 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -69.87 -35.94 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.927 -1.108 . . . . 1.91 109.569 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.443 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 80.2 t90 -59.98 -43.92 94.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.944 -1.502 . . . . 0.37 106.944 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 34.9 m -60.98 -40.03 91.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.827 -0.805 . . . . 0.36 108.827 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.66 81.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.431 -0.793 . . . . 0.55 110.032 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.58 -38.18 16.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -0.991 . . . . 0.48 110.6 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.228 -0.92 . . . . 1.24 110.102 -178.756 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.709 0.766 . . . . 1.5 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.79 -23.86 46.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.752 -0.593 . . . . 2.18 110.272 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.12 -38.48 83.15 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.216 -0.928 . . . . 2.01 108.931 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -59.97 -52.21 66.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.49 110.867 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 89.0 mtm180 -70.01 -35.38 74.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.955 -1.091 . . . . 3.23 109.738 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -65.47 -40.01 92.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.37 -0.831 . . . . 0.76 109.385 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 44.1 t80 -63.1 -49.67 73.54 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.343 -0.848 . . . . 0.46 110.026 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.32 6.07 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.078 -1.014 . . . . 0.44 111.241 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -99.36 -18.68 17.4 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.894 -1.129 . . . . 0.53 110.0 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' B' ' 14' ' ' PRO . 6.5 pt-20 -152.0 151.89 28.8 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.097 -1.002 . . . . 1.27 108.95 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' B' ' 13' ' ' GLU . 70.2 Cg_exo -36.75 156.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 122.16 1.907 . . . . 0.49 111.795 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.434 ' H ' ' HG2' ' B' ' 15' ' ' MET . 15.7 ptm -93.58 -29.72 15.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.094 -1.004 . . . . 0.56 110.158 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -135.3 44.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.227 -1.149 . . . . 0.39 110.227 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.94 35.16 3.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.619 -0.93 . . . . 0.84 110.005 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.18 148.54 71.39 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.991 . . . . 2.02 108.445 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.3 156.24 41.79 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.998 1.799 . . . . 0.34 112.039 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.563 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.4 p -57.02 -48.19 82.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.543 -0.723 . . . . 0.32 110.237 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.563 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.7 -3.94 0.22 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.776 -0.93 . . . . 0.22 110.776 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' B' ' 20' ' ' VAL . 70.6 m -83.08 -21.6 33.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.761 -1.435 . . . . 1.24 109.462 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.33 136.79 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.24 109.406 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.58 136.18 56.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.755 0.788 . . . . 0.21 109.824 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.31 -20.15 51.9 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.742 -1.743 . . . . 0.22 108.742 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -99.76 114.99 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.933 -1.136 . . . . 0.25 107.933 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.423 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -90.31 177.0 42.33 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.825 -1.31 . . . . 0.28 109.825 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.62 -39.97 74.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.591 -0.946 . . . . 2.0 110.015 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.84 -44.37 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.38 109.837 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.423 HD12 ' H ' ' B' ' 27' ' ' GLY . 93.5 mt -66.78 -37.5 84.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.4 109.487 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.0 96.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.288 -1.525 . . . . 0.36 109.288 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -39.76 94.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -1.12 . . . . 2.75 110.371 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -65.4 -48.38 73.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.201 . . . . 1.56 109.971 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.8 -36.02 79.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.953 -1.092 . . . . 0.33 108.492 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -59.92 -42.51 94.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.732 -0.605 . . . . 1.68 110.008 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.05 -19.32 65.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 1.99 108.607 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' B' ' 37' ' ' ARG . 34.0 mtt-85 -90.97 6.56 44.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.595 -0.691 . . . . 2.68 110.291 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.73 55.49 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.063 -1.065 . . . . 0.49 111.766 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.525 ' CD1' HG12 ' B' ' 44' ' ' VAL . 86.8 m-85 -103.9 73.1 1.14 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.801 -1.411 . . . . 0.33 108.328 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.17 -10.61 59.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.41 110.639 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.52 150.3 50.92 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.92 . . . . 1.56 109.62 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.07 94.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.21 110.766 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 16.7 p90 -60.49 -18.57 52.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.32 110.514 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' B' ' 39' ' ' PHE . 50.8 t -79.62 -32.77 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.426 -1.324 . . . . 0.24 107.426 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.83 -37.26 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.109 -1.071 . . . . 0.22 108.109 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.04 -35.44 75.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.611 -1.255 . . . . 0.4 107.611 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.61 97.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.067 -1.213 . . . . 0.18 110.067 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -60.02 -41.64 92.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.006 -1.291 . . . . 1.09 109.742 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.04 -39.88 87.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.31 108.82 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.52 -38.77 81.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.816 -0.809 . . . . 0.27 108.816 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.03 -24.44 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.401 -0.812 . . . . 0.28 110.648 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.8 mt -93.18 18.16 9.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.111 -0.993 . . . . 0.3 110.434 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.46 33.55 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.67 -1.269 . . . . 1.71 110.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.06 19.89 9.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.764 -0.585 . . . . 2.25 110.332 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -68.48 113.4 6.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 1.8 107.726 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.82 -39.96 93.6 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 113.11 0.782 . . . . 0.88 113.11 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.87 -39.61 76.23 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.575 -1.328 . . . . 0.74 110.604 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.59 -38.82 77.49 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.848 -1.141 . . . . 0.55 108.937 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.98 -50.44 68.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.38 110.005 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.499 ' HG3' HH11 ' B' ' 60' ' ' ARG . 5.4 mtm-85 -62.62 -43.66 98.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 2.64 109.803 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.94 -39.79 94.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 2.38 108.745 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . 0.408 ' O ' ' OG1' ' B' ' 66' ' ' THR . 55.7 t90 -65.54 -46.29 80.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.912 . . . . 0.4 110.513 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -49.45 63.17 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.06 -1.025 . . . . 0.34 110.074 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.78 -48.72 80.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.288 -0.882 . . . . 2.1 109.937 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 33.8 t0 -69.13 -28.89 66.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 1.9 109.852 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 50.5 m -79.51 -34.61 41.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.4 111.011 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.3 p -131.61 -29.45 1.74 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.611 -1.305 . . . . 0.39 111.77 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.57 14.27 20.22 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.321 -1.512 . . . . 0.36 109.321 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.48 1.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.322 . . . . 0.32 109.077 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -90.7 171.12 9.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.075 -1.015 . . . . 1.91 109.685 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.97 72.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.52 -0.738 . . . . 0.38 110.828 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.07 -40.63 68.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.558 -1.339 . . . . 2.57 110.003 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.81 -39.98 79.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 2.12 110.382 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 56.6 m -67.19 -39.22 86.34 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.279 -0.888 . . . . 1.36 110.044 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -60.09 -38.46 82.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 2.81 109.387 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.58 -39.9 84.86 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.722 -1.236 . . . . 0.4 110.357 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.5 m -66.91 -39.93 87.53 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.947 -1.096 . . . . 0.23 109.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 -59.97 4.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.638 -1.289 . . . . 0.43 110.066 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.54 84.51 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.518 -1.033 . . . . 0.25 110.518 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.18 -50.06 50.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -1.19 . . . . 0.24 109.77 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.94 -40.06 75.69 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.827 -1.149 . . . . 0.29 108.809 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.15 -41.23 99.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 2.74 110.159 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.88 -35.92 75.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.017 -1.052 . . . . 1.91 109.594 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.43 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 80.2 t90 -60.03 -43.95 94.95 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.929 -1.508 . . . . 0.36 106.929 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.0 m -60.99 -39.96 91.64 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.849 -0.797 . . . . 0.36 108.849 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.59 81.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.55 110.117 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -38.71 15.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.155 -0.966 . . . . 0.47 110.579 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -104.51 -86.79 0.45 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.169 -0.957 . . . . 1.24 110.265 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.509 HD13 ' SD ' ' A' ' 15' ' ' MET . 17.7 tp . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 118.084 -0.96 . . . . 1.67 109.602 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.585 0.707 . . . . 1.51 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.68 -21.14 62.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.538 -0.726 . . . . 2.18 110.69 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.99 -37.84 80.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.777 -1.202 . . . . 2.02 109.613 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -60.0 -51.85 67.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.841 -1.162 . . . . 0.49 110.48 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -69.72 -36.59 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.012 -1.055 . . . . 3.21 109.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.49 -39.96 73.86 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.76 109.69 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.32 -41.33 96.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.216 -0.928 . . . . 0.46 109.945 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 m -84.31 15.58 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.44 109.842 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.8 -9.78 11.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.449 -0.782 . . . . 0.54 110.294 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 10.6 pt-20 -149.86 149.2 27.31 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.943 -1.098 . . . . 1.26 109.252 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 13' ' ' GLU . 89.7 Cg_exo -41.1 166.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.811 1.674 . . . . 0.49 111.776 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.458 ' SD ' HD11 ' B' ' 89' ' ' LEU . 3.4 ptp -93.05 -24.95 18.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.57 108.621 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.96 -140.65 16.48 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.021 -1.632 . . . . 0.4 109.021 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -109.74 30.03 7.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.481 -1.011 . . . . 0.85 109.477 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 90.2 mttt -60.18 149.39 75.52 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 2.01 108.986 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.12 153.98 54.77 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.182 1.921 . . . . 0.34 112.439 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 21' ' ' GLY . 14.5 p -57.52 -44.03 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.603 -0.686 . . . . 0.32 110.522 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.64 -2.78 0.2 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.16 -1.176 . . . . 0.23 110.16 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 20' ' ' VAL . 40.7 t -82.59 -23.42 34.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.774 -1.427 . . . . 1.24 109.093 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.24 109.874 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.14 134.28 52.45 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.763 0.792 . . . . 0.21 109.96 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.94 -20.53 48.71 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.283 -1.527 . . . . 0.22 109.283 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.6 mm -99.75 114.2 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.281 -1.129 . . . . 0.25 108.011 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.71 178.4 39.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.271 -1.532 . . . . 0.28 109.271 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -57.24 -39.71 76.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.337 -1.096 . . . . 2.01 109.209 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.33 -48.38 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.38 109.706 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.0 -39.97 83.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 0.4 109.285 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.98 98.69 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.565 -1.414 . . . . 0.35 109.565 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.85 -41.06 95.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -1.201 . . . . 2.74 110.352 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.46 -40.16 85.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.823 -1.173 . . . . 1.54 109.689 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.83 -40.06 93.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.963 -1.085 . . . . 0.34 109.106 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.08 -40.89 91.12 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.723 -0.791 . . . . 1.67 109.363 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.77 -19.53 64.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.809 -0.811 . . . . 2.0 108.809 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -89.0 0.18 56.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.631 -0.668 . . . . 2.69 109.898 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' B' ' 53' ' ' LYS . . . 107.01 4.35 35.93 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 120.254 -0.974 . . . . 0.48 111.577 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.425 ' CD2' HG12 ' A' ' 44' ' ' VAL . 96.2 m-85 -103.17 75.64 1.38 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.825 -1.397 . . . . 0.33 109.137 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.16 -11.14 59.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.41 111.159 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -135.08 157.84 45.89 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.939 -1.101 . . . . 1.56 109.397 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.59 88.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.21 112.078 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -56.15 -18.15 9.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.768 -1.208 . . . . 0.32 110.457 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.425 HG12 ' CD2' ' A' ' 39' ' ' PHE . 21.6 t -80.15 -31.43 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.832 -1.168 . . . . 0.24 108.287 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.52 -38.7 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.413 -0.958 . . . . 0.22 108.413 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.85 -38.2 81.43 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.654 -1.61 . . . . 0.4 106.654 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.41 -45.98 58.3 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.878 -1.289 . . . . 0.18 109.878 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -41.93 93.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -1.181 . . . . 1.09 109.329 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.93 -40.57 89.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.0 -1.063 . . . . 0.31 108.828 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.74 -39.7 76.61 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.688 -0.856 . . . . 0.28 108.688 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.09 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.28 110.554 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.77 13.83 13.39 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.096 . . . . 0.31 110.858 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 51.32 35.91 14.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.209 . . . . 1.7 110.223 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 56.08 19.42 3.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.228 -0.92 . . . . 2.24 110.524 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -69.16 105.34 2.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.712 -1.242 . . . . 1.8 108.263 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.538 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 83.3 tt0 -62.94 -39.95 96.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 0.87 111.973 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.65 -39.89 88.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.73 109.57 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.32 -37.92 71.73 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.445 -0.902 . . . . 0.55 108.747 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.56 -42.13 95.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.565 -0.71 . . . . 0.38 109.941 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.538 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 99.2 mtt180 -60.11 -48.5 81.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.249 -0.907 . . . . 2.64 110.361 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.94 -39.89 90.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.682 -1.261 . . . . 2.37 109.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -61.65 -50.1 73.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 0.4 110.664 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.9 tp -68.4 -48.44 64.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.089 -1.007 . . . . 0.34 110.103 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.19 -47.16 85.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 2.11 109.797 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -68.71 -30.12 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.555 -0.715 . . . . 1.9 109.682 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -80.22 -32.52 38.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.41 111.029 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -133.0 -35.05 1.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.575 -1.328 . . . . 0.4 112.098 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.65 16.04 9.71 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.338 -1.505 . . . . 0.36 109.338 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 152.24 2.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.272 . . . . 0.33 109.89 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -90.22 173.49 8.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.109 -0.994 . . . . 1.9 109.953 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.61 75.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.715 . . . . 0.39 110.03 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.24 -40.01 71.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 2.58 109.633 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -66.61 -39.28 88.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.548 -0.72 . . . . 2.12 110.151 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.1 m -62.84 -38.61 91.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.299 -0.876 . . . . 1.36 109.747 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 2.8 109.614 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -69.31 -39.91 77.98 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.737 -1.227 . . . . 0.4 110.742 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -70.2 -39.96 74.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.661 -1.275 . . . . 0.24 109.996 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.33 -60.38 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.81 -1.181 . . . . 0.43 110.046 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.46 82.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.388 -1.085 . . . . 0.26 110.388 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.7 t -68.54 -49.63 58.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.295 . . . . 0.25 109.681 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.1 mt -70.09 -40.07 75.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.323 -0.951 . . . . 0.3 109.327 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -62.0 -40.59 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 2.73 109.596 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.02 -38.63 75.98 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.277 -0.889 . . . . 1.91 110.077 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.557 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.4 t90 -61.69 -46.57 89.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.473 -1.392 . . . . 0.37 108.688 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.9 m -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.462 -0.774 . . . . 0.36 109.573 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -58.87 -30.97 68.15 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.373 -0.829 . . . . 0.55 109.423 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.48 -34.75 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.269 -0.894 . . . . 0.48 111.063 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 87.2 m-85 . . . . . 0 N--CA 1.507 2.42 0 O-C-N 121.149 -0.969 . . . . 1.24 112.717 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 54.3 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.652 0.739 . . . . 1.5 109.642 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.84 -21.06 62.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 2.18 110.624 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.97 -37.82 80.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.799 -1.188 . . . . 2.01 109.619 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -60.0 -51.9 67.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.081 . . . . 0.49 110.527 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -69.73 -36.51 75.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 3.23 109.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.41 -39.93 74.17 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.35 -0.844 . . . . 0.76 109.793 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.44 -41.15 96.73 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.503 -0.879 . . . . 0.46 109.933 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.53 15.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.081 -1.012 . . . . 0.44 109.857 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.97 -9.81 11.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.466 -0.771 . . . . 0.53 110.362 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' B' ' 18' ' ' LYS . 10.5 pt-20 -149.86 149.14 27.14 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 120.903 -1.123 . . . . 1.27 109.208 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' B' ' 13' ' ' GLU . 92.3 Cg_exo -41.04 166.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.798 1.665 . . . . 0.49 111.705 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 3.3 ptp -93.29 -24.69 18.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 0.56 108.699 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.61 -140.55 14.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.03 -1.628 . . . . 0.39 109.03 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -109.65 30.1 6.97 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.512 -0.993 . . . . 0.84 109.464 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' B' ' 13' ' ' GLU . 89.8 mttt -60.27 149.55 75.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.938 . . . . 2.02 108.856 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.35 153.98 56.14 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.204 1.936 . . . . 0.34 112.422 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.534 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.5 p -57.64 -43.84 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.567 -0.708 . . . . 0.32 110.545 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.534 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.83 -2.56 0.2 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.118 -1.193 . . . . 0.22 110.118 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.506 ' H ' ' C ' ' B' ' 20' ' ' VAL . 40.6 t -82.87 -23.39 33.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.399 . . . . 1.24 109.125 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.24 109.869 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.16 134.22 52.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.788 0.804 . . . . 0.21 110.075 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.528 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.98 -20.5 48.78 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.287 -1.525 . . . . 0.22 109.287 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.65 114.05 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -1.125 . . . . 0.25 108.024 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.6 178.3 39.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.262 -1.535 . . . . 0.28 109.262 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -57.19 -39.57 75.62 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.315 -1.109 . . . . 2.0 109.236 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.28 -48.53 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.38 109.721 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.86 -40.07 83.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.159 -0.963 . . . . 0.4 109.354 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.95 98.66 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.594 -1.403 . . . . 0.36 109.594 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.83 -41.21 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -1.23 . . . . 2.75 110.301 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.41 -39.9 85.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.83 -1.169 . . . . 1.56 109.772 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.94 -39.98 93.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.026 . . . . 0.33 109.06 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.09 -40.94 91.34 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.79 -0.764 . . . . 1.68 109.317 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -68.81 -19.46 64.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.824 -0.806 . . . . 1.99 108.824 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -89.01 0.39 56.71 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.092 -0.643 . . . . 2.68 109.969 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.79 4.33 36.58 Favored Glycine 0 N--CA 1.504 3.17 0 O-C-N 121.105 -0.997 . . . . 0.49 111.734 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.431 ' CD2' HG12 ' B' ' 44' ' ' VAL . 96.3 m-85 -103.33 75.83 1.38 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.818 -1.401 . . . . 0.33 109.096 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -77.43 -10.97 59.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.41 111.019 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -135.19 157.95 45.61 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.902 -1.124 . . . . 1.56 109.444 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.49 88.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.547 -0.72 . . . . 0.21 112.051 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -56.36 -18.13 9.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.721 -1.237 . . . . 0.32 110.551 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' B' ' 39' ' ' PHE . 21.5 t -80.13 -31.36 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.884 -1.135 . . . . 0.24 108.279 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.52 -38.75 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 0.22 108.425 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.03 -38.3 82.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.573 -1.64 . . . . 0.4 106.573 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.74 -45.6 60.43 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.68 -1.368 . . . . 0.18 109.68 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -41.8 93.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.225 . . . . 1.09 109.356 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.0 -40.49 89.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.017 -1.052 . . . . 0.31 108.753 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -69.77 -40.04 76.31 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.662 -0.866 . . . . 0.27 108.662 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.68 -21.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.135 -0.978 . . . . 0.28 110.613 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.91 14.02 13.14 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.048 -1.032 . . . . 0.3 110.663 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 38' ' ' GLY . 59.8 mttp 50.79 36.32 14.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.812 -1.18 . . . . 1.71 110.227 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 55.91 19.41 3.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.308 -0.87 . . . . 2.25 110.618 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -69.01 105.58 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.72 -1.237 . . . . 1.8 108.18 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 83.5 tt0 -63.17 -39.96 96.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.88 111.977 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.45 -40.08 89.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.815 -1.178 . . . . 0.74 109.553 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -71.1 -37.79 72.38 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.396 -0.921 . . . . 0.55 108.848 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.8 -42.19 95.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.612 -0.68 . . . . 0.38 109.898 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 99.2 mtt180 -59.99 -48.96 79.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.244 -0.91 . . . . 2.64 110.35 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.54 -39.94 92.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.689 -1.257 . . . . 2.38 109.832 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -61.7 -49.97 74.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.921 -1.112 . . . . 0.4 110.706 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.2 tp -68.43 -48.7 63.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.079 -1.013 . . . . 0.34 110.032 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.06 -47.12 86.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 2.1 109.767 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -68.85 -29.96 68.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 1.9 109.656 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -80.17 -32.58 38.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.4 111.045 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 32.0 p -132.94 -35.29 1.07 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.66 -1.275 . . . . 0.39 112.045 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.72 16.48 9.28 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.292 -1.523 . . . . 0.36 109.292 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 152.32 3.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.063 -1.257 . . . . 0.32 109.76 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.1 173.62 8.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 1.91 109.98 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.92 -34.3 75.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.38 110.093 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -71.38 -40.1 70.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 2.57 109.593 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.6 mm100 -66.53 -39.15 88.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.488 -0.757 . . . . 2.12 110.25 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 74.2 m -62.94 -38.58 91.61 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.268 -0.895 . . . . 1.36 109.748 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.158 -0.964 . . . . 2.81 109.626 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -69.32 -39.99 77.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.839 -1.163 . . . . 0.4 110.716 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -70.14 -40.05 75.03 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.682 -1.261 . . . . 0.23 109.968 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -61.18 -60.31 3.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.861 -1.149 . . . . 0.43 110.162 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.34 82.14 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.46 -1.056 . . . . 0.25 110.46 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.66 -49.63 57.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.302 . . . . 0.24 109.699 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.03 -40.04 75.42 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.295 -0.962 . . . . 0.29 109.324 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -62.0 -40.68 96.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 2.74 109.566 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -38.69 76.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.166 -0.959 . . . . 1.91 110.153 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.555 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.2 t90 -61.75 -46.61 88.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.456 -1.403 . . . . 0.36 108.702 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' B' ' 89' ' ' LEU . 51.6 m -60.08 -39.91 87.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.751 -0.78 . . . . 0.36 109.686 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.05 -30.79 68.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.384 -0.822 . . . . 0.55 109.406 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 -35.21 13.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.835 . . . . 0.47 111.057 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.4 m-85 -108.31 -6.13 16.44 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.129 -0.982 . . . . 1.24 112.663 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.458 HD11 ' SD ' ' A' ' 15' ' ' MET . 10.4 tp . . . . . 0 N--CA 1.502 2.171 0 O-C-N 120.355 -1.466 . . . . 1.67 109.371 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.7 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.609 0.718 . . . . 1.51 109.124 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.91 -28.66 67.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.548 -0.72 . . . . 2.18 110.114 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -60.32 -39.62 87.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.949 -1.095 . . . . 2.02 109.644 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -59.85 -51.17 70.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.931 . . . . 0.49 110.656 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 23.8 mmm180 -70.25 -34.45 72.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.814 -1.179 . . . . 3.21 109.685 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -68.74 -38.88 80.46 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.368 -0.833 . . . . 0.76 110.023 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.55 -45.78 82.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.46 110.173 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -86.26 7.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.124 -0.985 . . . . 0.44 110.812 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -102.2 -13.62 17.35 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.201 -0.937 . . . . 0.54 110.056 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -154.54 153.55 28.05 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.977 . . . . 1.26 108.998 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -37.72 156.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 122.071 1.847 . . . . 0.49 111.741 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.476 ' SD ' HD11 ' B' ' 89' ' ' LEU . 11.7 ptm -93.31 -28.2 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.57 110.296 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.51 42.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.433 -1.067 . . . . 0.4 110.433 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.64 35.89 3.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.614 -0.933 . . . . 0.85 110.379 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -57.93 149.58 54.04 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.047 -1.033 . . . . 2.01 108.313 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.94 155.31 55.93 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.069 1.846 . . . . 0.34 112.551 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 21' ' ' GLY . 3.4 p -57.07 -47.16 84.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.479 0.657 . . . . 0.32 110.387 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.67 -5.42 0.86 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 121.467 -0.77 . . . . 0.23 111.223 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -84.21 -19.94 33.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.448 -1.619 . . . . 1.24 109.498 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.46 134.07 55.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.24 109.29 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.21 133.33 52.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.669 -0.812 . . . . 0.21 109.675 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.52 -21.22 47.07 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.129 -1.588 . . . . 0.22 109.129 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.75 112.4 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.25 108.405 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.98 -178.77 36.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.287 -1.525 . . . . 0.28 109.287 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.88 -40.28 83.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -1.093 . . . . 2.01 110.631 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.05 -46.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.72 -1.238 . . . . 0.38 109.14 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.3 -40.07 86.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.4 109.483 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.69 96.73 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.913 -1.275 . . . . 0.35 109.913 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.34 -38.18 85.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.001 -1.294 . . . . 2.74 110.332 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.84 -45.15 87.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 1.54 109.748 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.8 mt -62.17 -40.09 94.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.013 -1.055 . . . . 0.34 109.798 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.03 -40.1 88.19 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.476 -0.889 . . . . 1.67 109.053 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -67.79 -19.16 65.06 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.81 6.61 40.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 2.69 109.601 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 9.05 57.06 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 121.005 -1.059 . . . . 0.48 111.544 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.494 ' CD2' HG12 ' A' ' 44' ' ' VAL . 86.0 m-85 -103.71 75.36 1.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.854 -1.38 . . . . 0.33 108.858 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.18 -10.08 59.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.41 111.248 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -140.69 161.57 37.47 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.896 -1.127 . . . . 1.56 110.69 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.67 -43.64 92.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.21 112.355 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 6.4 p90 -58.2 -18.43 25.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.801 -1.187 . . . . 0.32 110.669 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.636 HG21 ' HZ3' ' B' ' 53' ' ' LYS . 24.5 t -80.06 -31.37 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.79 -1.189 . . . . 0.24 107.79 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.63 -40.03 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.185 -1.042 . . . . 0.22 108.185 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.8 tp -59.02 -34.65 72.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.882 -1.525 . . . . 0.4 106.882 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.01 -40.72 97.37 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.593 -1.403 . . . . 0.18 109.593 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -41.97 93.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.261 . . . . 1.09 108.987 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -60.24 -41.54 93.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.31 108.705 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -70.27 -40.0 74.61 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.548 -0.861 . . . . 0.28 108.921 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.93 -25.11 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.28 110.671 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 52' ' ' LEU . 85.9 mt -92.29 15.3 14.05 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.949 -1.095 . . . . 0.31 110.491 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 67.8 mttm 52.41 40.29 29.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.088 -1.007 . . . . 1.7 110.548 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 pttt 40.3 19.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.01 -1.056 . . . . 2.24 111.873 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 17.9 t0 -66.85 117.55 9.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.671 -1.603 . . . . 1.8 106.671 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.87 -40.17 94.45 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.483 0.92 . . . . 0.87 113.483 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 96.1 m-20 -70.21 -39.86 74.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.416 -1.428 . . . . 0.73 109.937 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.09 -39.86 68.64 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.935 -1.106 . . . . 0.55 108.6 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -61.83 -49.92 74.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.38 109.957 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.4 mtm180 -61.84 -42.65 99.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 2.64 110.616 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.73 -39.24 93.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 2.37 109.25 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -61.22 -49.28 77.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.029 -1.044 . . . . 0.4 110.735 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.23 -49.28 65.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 0.34 109.857 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -61.89 -47.26 85.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.393 -0.817 . . . . 2.11 109.864 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 30.0 t0 -69.04 -31.13 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 1.9 109.864 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -79.75 -33.08 41.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.41 111.366 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.1 p -132.54 -31.72 1.36 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.58 -1.325 . . . . 0.4 111.574 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 15.79 12.63 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.075 -1.61 . . . . 0.36 109.075 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.02 153.49 3.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -1.205 . . . . 0.33 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -94.93 176.22 6.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 1.9 109.825 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -35.35 75.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.586 -0.696 . . . . 0.39 111.23 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -70.13 -42.84 72.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.52 -1.362 . . . . 2.58 110.57 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 73' ' ' GLN . 16.7 mp0 -67.94 -39.18 83.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -0.963 . . . . 2.12 110.965 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 t -67.95 -38.35 82.7 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.809 -1.182 . . . . 1.36 110.198 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -60.72 -38.79 86.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.742 -1.224 . . . . 2.8 109.913 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.26 -39.62 82.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.561 -1.337 . . . . 0.4 110.417 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.71 -40.09 76.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.965 -1.085 . . . . 0.24 109.518 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -59.4 -60.34 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.179 -0.95 . . . . 0.43 109.424 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.51 -33.63 87.76 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.694 -0.962 . . . . 0.26 110.694 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -1.234 . . . . 0.25 109.636 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.1 mt -70.27 -39.97 74.62 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.962 -1.095 . . . . 0.3 108.391 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -65.1 -40.16 94.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.86 . . . . 2.73 110.309 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.62 -39.69 80.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 1.91 110.6 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 88.4 t90 -60.23 -42.28 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.343 -1.473 . . . . 0.37 107.581 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.16 -40.09 88.7 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.783 0.801 . . . . 0.36 109.279 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.6 -33.95 72.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.218 -0.927 . . . . 0.55 109.698 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.18 -34.56 14.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.195 -0.94 . . . . 0.48 111.285 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.551 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.8 m-85 . . . . . 0 N--CA 1.505 2.285 0 O-C-N 121.116 -0.99 . . . . 1.24 111.482 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.656 0.741 . . . . 1.5 109.1 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.19 -28.24 67.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.612 -0.68 . . . . 2.18 110.07 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.5 -39.57 88.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.123 -0.986 . . . . 2.01 109.637 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -59.84 -51.32 70.23 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.261 -0.899 . . . . 0.49 110.635 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 23.8 mmm180 -70.19 -34.23 72.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.896 -1.127 . . . . 3.23 109.854 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -68.88 -39.35 79.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.376 -0.828 . . . . 0.76 109.785 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.13 -46.17 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.46 110.119 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.0 m -86.09 8.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.141 -0.975 . . . . 0.44 110.749 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -102.7 -13.44 17.08 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.192 -0.942 . . . . 0.53 109.911 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.54 153.38 27.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 1.27 108.98 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -37.89 156.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.059 1.839 . . . . 0.49 111.719 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 11.6 ptm -93.2 -28.13 16.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.56 110.271 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.18 -133.33 41.87 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.412 -1.075 . . . . 0.39 110.412 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.81 36.01 3.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.596 -0.944 . . . . 0.84 110.302 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -58.09 149.83 54.53 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.871 -1.143 . . . . 2.02 108.329 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.87 155.17 56.34 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.168 1.912 . . . . 0.34 112.537 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.443 HG13 ' N ' ' B' ' 21' ' ' GLY . 3.5 p -57.16 -46.53 84.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.602 0.715 . . . . 0.32 110.496 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.443 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -56.07 -5.25 0.95 Allowed Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.45 -0.782 . . . . 0.22 111.248 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 59.5 m -84.4 -20.32 32.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.553 -1.557 . . . . 1.24 109.435 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.14 133.86 55.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.24 109.237 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.14 133.34 52.75 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.586 -0.845 . . . . 0.21 109.714 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.62 -20.98 48.26 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.25 -1.54 . . . . 0.22 109.25 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.03 112.6 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -1.088 . . . . 0.25 108.365 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.22 -178.86 35.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.174 -1.57 . . . . 0.28 109.174 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -58.65 -40.07 82.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.422 -1.046 . . . . 2.0 110.713 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.04 -46.57 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.642 -1.286 . . . . 0.38 109.196 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.21 -39.95 86.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.4 109.545 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.56 97.19 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.835 -1.306 . . . . 0.36 109.835 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.21 -38.64 87.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.266 . . . . 2.75 110.189 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.59 -45.06 88.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.712 -1.243 . . . . 1.56 109.603 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.13 -39.9 94.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.835 -1.166 . . . . 0.33 109.822 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.42 -40.05 89.66 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.579 -0.848 . . . . 1.68 108.896 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -67.82 -19.18 65.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.215 -1.031 . . . . 1.99 108.215 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.86 6.87 39.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.533 -0.73 . . . . 2.68 109.603 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.42 9.07 57.06 Favored Glycine 0 N--CA 1.5 2.939 0 O-C-N 120.961 -1.087 . . . . 0.49 111.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' B' ' 44' ' ' VAL . 86.6 m-85 -104.1 75.46 1.27 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.929 -1.336 . . . . 0.33 108.948 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.37 -9.98 59.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.883 . . . . 0.41 111.176 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -140.66 161.78 36.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.852 -1.155 . . . . 1.56 110.712 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.77 -43.84 91.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.835 -0.54 . . . . 0.21 112.314 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 5.7 p90 -57.84 -18.72 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.32 110.733 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.0 t -80.12 -31.11 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.79 -1.194 . . . . 0.24 107.849 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.81 -39.92 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.173 -1.047 . . . . 0.22 108.173 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.6 tp -59.03 -34.84 72.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.983 -1.488 . . . . 0.4 106.983 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.99 97.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.494 -1.442 . . . . 0.18 109.494 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.84 -42.04 92.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 1.09 108.961 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.11 -41.54 92.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.31 108.727 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.41 -40.18 74.02 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.537 -0.865 . . . . 0.27 108.889 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.92 -24.66 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 0.28 110.785 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 52' ' ' LEU . 84.4 mt -92.55 15.81 13.4 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.037 -1.039 . . . . 0.3 110.368 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.636 ' HZ3' HG21 ' A' ' 44' ' ' VAL . 67.8 mttm 51.98 40.19 27.74 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.904 -1.122 . . . . 1.71 110.635 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 47.8 pttt 40.49 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.135 -0.978 . . . . 2.25 111.711 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 53' ' ' LYS . 19.3 t0 -66.78 117.77 9.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.52 -1.659 . . . . 1.8 106.52 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.62 -40.93 96.61 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.127 -0.983 . . . . 0.88 113.458 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.52 -39.97 77.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.437 -1.414 . . . . 0.74 110.107 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.18 -39.95 68.29 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.005 -1.078 . . . . 0.55 108.552 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.7 -50.14 73.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.833 . . . . 0.38 109.96 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -61.56 -43.05 99.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 2.64 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -64.54 -38.9 92.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.848 -1.158 . . . . 2.38 109.392 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -61.33 -49.17 78.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.4 110.818 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 32.8 tp -67.38 -49.49 63.71 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.329 -0.857 . . . . 0.34 109.835 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.77 -47.02 87.05 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.373 -0.829 . . . . 2.1 109.939 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 33.7 t0 -69.17 -31.08 69.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.436 -0.79 . . . . 1.9 109.926 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 55.4 m -79.76 -33.2 40.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.4 111.341 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.32 -32.26 1.37 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.718 -1.239 . . . . 0.39 111.62 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.32 16.13 11.58 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.144 -1.582 . . . . 0.36 109.144 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.16 153.53 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.301 . . . . 0.32 109.358 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -94.81 176.22 6.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 1.91 109.77 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.17 75.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.608 -0.682 . . . . 0.38 111.255 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -70.07 -42.73 72.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.511 -1.368 . . . . 2.57 110.611 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' B' ' 73' ' ' GLN . 16.5 mp0 -67.99 -39.43 83.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.198 -0.939 . . . . 2.12 111.021 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.8 t -67.83 -38.04 82.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.037 -1.039 . . . . 1.36 110.08 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -61.2 -38.34 86.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.775 -1.203 . . . . 2.81 109.92 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.5 -39.88 81.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.439 -1.413 . . . . 0.4 110.322 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 99.0 m -69.7 -40.2 76.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.824 -1.173 . . . . 0.23 109.473 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.51 -60.02 4.51 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.096 -1.003 . . . . 0.43 109.339 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.69 -33.63 87.75 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.618 -0.993 . . . . 0.25 110.618 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.38 -46.12 61.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.985 -1.303 . . . . 0.24 109.588 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.85 -40.14 75.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.095 -1.042 . . . . 0.29 108.247 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -65.14 -40.08 93.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 2.74 110.214 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.49 -39.9 81.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 1.91 110.419 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.544 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 88.5 t90 -60.44 -42.34 95.91 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.314 -1.491 . . . . 0.36 107.521 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' B' ' 89' ' ' LEU . 63.7 m -60.03 -40.14 88.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.436 -0.79 . . . . 0.36 109.271 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.46 -33.82 71.77 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.364 -0.835 . . . . 0.55 109.842 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.11 13.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.121 -0.987 . . . . 0.47 111.192 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.544 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 97.1 m-85 -107.84 2.25 23.38 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.206 -0.934 . . . . 1.24 111.636 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.498 1.962 0 O-C-N 120.938 -1.101 . . . . 1.67 109.363 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.761 0.791 . . . . 1.51 110.097 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -59.96 -20.87 59.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.75 -0.594 . . . . 2.18 110.896 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -60.05 -38.48 82.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.868 -1.145 . . . . 2.02 109.543 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -59.93 -51.69 68.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.08 . . . . 0.49 110.652 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 58.8 mtt-85 -69.96 -35.19 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.837 -1.164 . . . . 3.21 110.139 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.78 -39.95 84.03 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.396 -0.815 . . . . 0.76 109.321 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.19 -48.21 76.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.465 -0.772 . . . . 0.46 109.967 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 m -86.59 8.13 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.129 -0.982 . . . . 0.44 110.992 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -99.5 -16.94 18.14 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.937 -1.102 . . . . 0.54 110.035 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.5 pt-20 -155.6 152.49 24.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 1.26 108.469 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 92.4 Cg_exo -35.49 154.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.2 1.933 . . . . 0.49 111.713 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.634 ' CE ' HD22 ' A' ' 46' ' ' LEU . 7.4 ptp -91.16 -23.76 20.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.909 -1.12 . . . . 0.57 109.89 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.35 -135.47 32.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.384 -1.086 . . . . 0.4 110.384 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -110.0 38.78 2.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.597 -0.943 . . . . 0.85 110.158 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -59.93 149.99 71.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.044 . . . . 2.01 108.738 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.03 148.92 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.32 2.013 . . . . 0.34 112.588 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 p -52.73 -30.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.475 0.655 . . . . 0.32 110.387 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.61 -3.57 67.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.745 -0.942 . . . . 0.23 110.745 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.0 t -83.29 -20.79 33.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.746 -1.444 . . . . 1.24 109.339 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.481 HD22 HD21 ' A' ' 81' ' ' LEU . 84.3 mt -62.54 135.57 57.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.24 109.703 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.72 133.19 53.11 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.694 0.759 . . . . 0.21 109.671 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.73 -19.98 52.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 0.22 109.255 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.3 mm -98.55 112.78 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.069 -1.085 . . . . 0.25 108.069 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.48 178.06 39.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.803 -1.319 . . . . 0.28 109.803 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.76 -40.01 75.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.461 -1.023 . . . . 2.01 109.766 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.35 -44.9 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.38 109.671 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.69 -38.05 85.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.4 109.413 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.43 -38.61 91.24 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.546 -1.422 . . . . 0.35 109.546 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.49 -39.16 93.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -1.151 . . . . 2.74 110.823 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.1 -44.58 79.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.742 -1.224 . . . . 1.54 109.808 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.53 -39.93 95.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.34 108.742 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.0 -42.46 94.31 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.656 -0.818 . . . . 1.67 109.411 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.3 -19.5 65.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.0 108.783 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -91.11 1.81 56.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.654 -0.654 . . . . 2.69 109.948 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.45 4.22 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.083 -1.011 . . . . 0.48 110.801 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.476 ' CD2' HG12 ' A' ' 44' ' ' VAL . 82.8 m-85 -132.41 70.94 1.46 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -1.231 . . . . 0.33 108.239 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.43 -10.53 59.52 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.272 -0.971 . . . . 0.41 109.905 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -131.29 153.16 49.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.375 -0.828 . . . . 1.56 108.808 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.9 90.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.21 111.205 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.483 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -56.59 -17.67 9.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.884 -1.135 . . . . 0.32 110.994 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.476 HG12 ' CD2' ' A' ' 39' ' ' PHE . 46.8 t -79.77 -29.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.178 . . . . 0.24 107.936 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.1 -36.8 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.308 -0.997 . . . . 0.22 108.308 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.634 HD22 ' CE ' ' A' ' 15' ' ' MET . 19.0 tp -60.03 -39.29 85.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.134 -1.432 . . . . 0.4 107.134 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.71 -43.7 94.37 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.108 -1.197 . . . . 0.18 110.108 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.98 -42.69 94.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.752 -1.44 . . . . 1.09 109.053 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.98 -42.27 93.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.863 . . . . 0.31 108.943 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -68.96 -38.19 79.27 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.727 -0.842 . . . . 0.28 108.727 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.43 -22.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.28 110.046 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 16.75 10.99 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.144 -0.972 . . . . 0.31 109.789 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.405 ' NZ ' HG21 ' B' ' 44' ' ' VAL . 58.8 mttm 50.0 39.55 19.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.975 -1.078 . . . . 1.7 110.505 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.31 19.28 4.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.24 109.747 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.13 108.54 4.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.727 -1.233 . . . . 1.8 108.021 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -61.04 -40.0 91.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.555 -0.716 . . . . 0.87 112.556 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.09 -40.09 78.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.644 -1.285 . . . . 0.73 110.385 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.21 75.34 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.93 -1.108 . . . . 0.55 109.009 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.85 -50.1 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.83 . . . . 0.38 110.05 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -59.94 -46.37 89.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 2.64 110.587 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -65.74 -38.57 89.49 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.042 -1.036 . . . . 2.37 109.14 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -66.06 -48.34 71.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.4 111.073 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -66.22 -46.32 77.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.211 -0.931 . . . . 0.34 109.152 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.91 -45.75 91.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.389 -0.819 . . . . 2.11 109.089 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.63 -31.87 70.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.641 -0.662 . . . . 1.9 109.85 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -80.41 -31.37 37.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 0.41 111.487 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.73 -25.78 1.84 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.528 -1.358 . . . . 0.4 111.876 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.14 29.19 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.422 -1.471 . . . . 0.36 109.422 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.43 153.49 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.046 -1.267 . . . . 0.33 109.252 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -92.12 174.29 7.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.034 -1.041 . . . . 1.9 110.242 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.08 78.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.668 -0.645 . . . . 0.39 110.826 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.471 ' NZ ' HE21 ' A' ' 73' ' ' GLN . 22.0 pttp -75.11 -38.23 61.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.84 -1.163 . . . . 2.58 109.731 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.471 HE21 ' NZ ' ' A' ' 72' ' ' LYS . 85.6 mm-40 -67.13 -38.77 86.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 2.12 110.013 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 p -67.12 -37.75 84.39 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 1.36 109.895 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.32 -38.39 83.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.079 -1.013 . . . . 2.8 109.604 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.56 -40.07 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.707 -1.246 . . . . 0.4 110.797 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.1 -40.02 78.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 0.24 110.111 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.52 -60.45 3.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.628 -1.295 . . . . 0.43 110.246 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.72 -32.47 81.72 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.483 -1.047 . . . . 0.26 110.483 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.72 -47.77 58.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.273 . . . . 0.25 109.87 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.481 HD21 HD22 ' A' ' 23' ' ' LEU . 61.1 mt -70.22 -39.92 74.82 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.105 -1.038 . . . . 0.3 109.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 82' ' ' ARG . 33.2 ttt-85 -63.66 -39.99 95.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 2.73 110.322 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.39 -38.18 77.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.105 -0.997 . . . . 1.91 110.285 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.448 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.5 t90 -59.99 -45.46 92.64 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.405 -1.435 . . . . 0.37 107.809 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.2 m -59.98 -40.11 88.0 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.687 0.756 . . . . 0.36 109.344 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.97 -34.61 73.52 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.348 -0.845 . . . . 0.55 110.099 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.0 -36.31 13.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.196 -0.94 . . . . 0.48 111.176 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.3 m-85 . . . . . 0 N--CA 1.503 2.209 0 O-C-N 121.176 -0.952 . . . . 1.24 111.324 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.82 0.819 . . . . 1.5 110.055 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -60.04 -20.89 60.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 2.18 110.892 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -60.04 -38.42 82.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.902 -1.124 . . . . 2.01 109.506 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -60.03 -51.73 68.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.979 -1.075 . . . . 0.49 110.58 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 58.7 mtt-85 -69.95 -34.99 74.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 3.23 110.094 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.95 -39.96 83.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.76 109.311 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -64.32 -48.28 76.2 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.832 -0.747 . . . . 0.46 109.859 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -86.51 8.33 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.083 -1.011 . . . . 0.44 111.014 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -99.65 -16.86 18.05 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.53 109.985 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' B' ' 14' ' ' PRO . 13.3 pt-20 -155.64 152.44 24.29 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.111 -0.993 . . . . 1.27 108.422 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' B' ' 13' ' ' GLU . 97.9 Cg_exo -35.42 154.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.159 1.906 . . . . 0.49 111.748 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.632 ' CE ' HD22 ' B' ' 46' ' ' LEU . 7.5 ptp -90.92 -23.84 20.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.022 -1.049 . . . . 0.56 109.881 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.3 -135.59 31.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.309 -1.117 . . . . 0.39 110.309 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -109.95 38.83 2.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.65 -0.912 . . . . 0.84 110.092 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.9 149.94 71.07 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 120.999 -1.063 . . . . 2.02 108.851 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.95 148.83 92.32 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.398 2.065 . . . . 0.34 112.499 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.1 p -52.81 -29.92 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.62 -0.675 . . . . 0.32 110.409 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.77 -3.27 67.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.742 -0.943 . . . . 0.22 110.742 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t -83.44 -20.67 33.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.699 -1.471 . . . . 1.24 109.318 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.477 HD22 HD21 ' B' ' 81' ' ' LEU . 84.4 mt -62.7 135.62 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.24 109.642 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.67 133.09 53.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.21 109.725 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 -20.01 52.34 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.271 -1.531 . . . . 0.22 109.271 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -98.56 112.73 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.024 -1.102 . . . . 0.25 108.024 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.49 178.05 39.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.76 -1.336 . . . . 0.28 109.76 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.8 -39.9 74.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.391 -1.064 . . . . 2.0 109.75 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.41 -45.01 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.38 109.577 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.73 -37.72 85.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.4 109.437 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.57 -38.68 91.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.509 -1.436 . . . . 0.36 109.509 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.45 -39.2 93.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -1.101 . . . . 2.75 110.793 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.04 -44.62 79.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.155 . . . . 1.56 109.746 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.67 -39.93 95.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.014 . . . . 0.33 108.684 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.39 94.13 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.637 -0.825 . . . . 1.68 109.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -66.37 -19.52 65.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 1.99 108.765 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -90.97 1.76 56.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.712 -0.617 . . . . 2.68 109.973 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.72 37.43 4.21 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.219 -0.991 . . . . 0.49 110.734 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.487 ' CD2' HG12 ' B' ' 44' ' ' VAL . 83.2 m-85 -132.34 70.95 1.46 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.027 -1.278 . . . . 0.33 108.213 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -77.53 -10.46 59.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.109 -0.994 . . . . 0.41 109.823 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -131.43 153.17 49.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.345 -0.847 . . . . 1.56 108.885 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.98 91.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.21 111.244 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 4.5 p90 -56.5 -17.81 9.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.999 -1.063 . . . . 0.32 111.034 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' B' ' 39' ' ' PHE . 46.7 t -79.62 -29.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.24 108.003 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.34 -36.75 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.15 -1.056 . . . . 0.22 108.15 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.632 HD22 ' CE ' ' B' ' 15' ' ' MET . 18.7 tp -59.91 -39.32 85.02 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.195 -1.409 . . . . 0.4 107.195 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -43.78 94.17 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.134 -1.186 . . . . 0.18 110.134 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.95 -42.63 94.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.868 -1.372 . . . . 1.09 109.078 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.02 -42.33 94.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.31 108.887 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.94 -38.4 79.46 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.69 -0.856 . . . . 0.27 108.69 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.27 -22.68 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -0.9 . . . . 0.28 110.065 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 93.8 mt -92.59 16.88 11.08 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.125 -0.984 . . . . 0.3 109.786 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.459 ' NZ ' HG21 ' A' ' 44' ' ' VAL . 58.8 mttm 49.98 39.64 19.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.926 -1.108 . . . . 1.71 110.539 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.19 19.15 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 2.25 109.796 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' B' ' 55' ' ' ASP . 19.8 t0 -70.11 108.54 4.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.714 -1.241 . . . . 1.8 108.089 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.01 -39.93 91.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.685 -0.635 . . . . 0.88 112.653 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.17 -39.97 78.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.648 -1.282 . . . . 0.74 110.401 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.32 75.27 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.005 -1.078 . . . . 0.55 109.071 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.78 -50.07 70.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.354 -0.841 . . . . 0.38 110.042 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -60.07 -46.4 89.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 2.64 110.513 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -65.8 -38.45 88.99 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.899 -1.125 . . . . 2.38 109.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -66.0 -48.33 71.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.99 -1.069 . . . . 0.4 111.063 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.14 -46.61 76.89 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.175 -0.953 . . . . 0.34 109.129 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.85 -45.67 91.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.342 -0.849 . . . . 2.1 109.125 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.65 -31.85 70.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.653 . . . . 1.9 109.839 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -80.36 -31.54 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.4 111.486 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.53 -25.67 1.9 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.486 -1.384 . . . . 0.39 112.011 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.39 13.04 29.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.428 -1.469 . . . . 0.36 109.428 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.43 153.38 1.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.964 -1.315 . . . . 0.32 109.205 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -92.01 174.2 7.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.043 -1.036 . . . . 1.91 110.294 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.96 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 0.38 110.936 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.479 ' NZ ' HE21 ' B' ' 73' ' ' GLN . 22.0 pttp -75.13 -38.32 61.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.115 . . . . 2.57 109.697 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.479 HE21 ' NZ ' ' B' ' 72' ' ' LYS . 85.7 mm-40 -67.13 -38.68 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 2.12 109.99 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -67.17 -37.69 84.15 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 1.36 109.916 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.33 -38.38 83.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.147 -0.971 . . . . 2.81 109.606 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.68 -39.99 84.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.613 -1.305 . . . . 0.4 110.727 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -69.26 -39.98 78.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.838 -1.164 . . . . 0.23 110.086 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.49 -60.36 3.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.564 -1.335 . . . . 0.43 110.235 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.61 82.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.47 -1.052 . . . . 0.25 110.47 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.0 t -70.69 -47.77 58.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.064 -1.256 . . . . 0.24 109.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.477 HD21 HD22 ' B' ' 23' ' ' LEU . 62.2 mt -70.15 -39.98 75.03 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.089 -1.044 . . . . 0.29 109.074 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' B' ' 82' ' ' ARG . 33.3 ttt-85 -63.62 -40.04 95.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 2.74 110.312 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.31 -38.32 78.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 1.91 110.213 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.435 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 86.6 t90 -60.0 -45.35 93.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.468 -1.395 . . . . 0.36 107.869 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 52.6 m -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.643 0.735 . . . . 0.36 109.284 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.0 -34.64 73.6 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.397 -0.814 . . . . 0.55 110.071 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.05 -36.75 13.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.167 -0.958 . . . . 0.47 111.161 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.4 m-85 -107.0 0.76 23.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.232 -0.918 . . . . 1.24 111.467 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 85' ' ' CYS . 6.9 tp . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.865 -1.147 . . . . 1.67 109.11 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.65 0.738 . . . . 1.51 109.488 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.92 -24.59 64.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.746 -0.596 . . . . 2.18 110.127 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.921 -1.112 . . . . 2.02 108.98 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -60.04 -49.07 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.49 110.201 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 8' ' ' ARG . 53.9 mtt-85 -70.07 -31.99 69.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 3.21 109.648 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.54 -40.02 80.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.98 . . . . 0.76 109.801 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.3 t80 -62.58 -48.17 80.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.46 110.133 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.98 10.11 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.155 -0.966 . . . . 0.44 110.506 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.67 -14.22 15.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.23 -0.919 . . . . 0.54 109.881 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.31 152.84 27.17 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.148 -0.97 . . . . 1.26 109.025 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.2 162.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.751 1.634 . . . . 0.49 111.5 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.479 ' SD ' HD11 ' B' ' 89' ' ' LEU . 6.8 ptp -92.49 -21.44 20.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.025 -1.047 . . . . 0.57 109.787 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.79 -139.91 16.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.037 -1.225 . . . . 0.4 110.037 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.73 30.89 5.4 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.427 -1.043 . . . . 0.85 110.481 -178.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -60.1 149.23 75.6 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.872 -1.142 . . . . 2.01 108.676 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.2 158.68 50.91 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.984 1.79 . . . . 0.34 111.992 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 21' ' ' GLY . 14.4 p -57.16 -45.77 84.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.457 -0.777 . . . . 0.32 110.483 -179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.55 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.54 -3.19 0.38 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.757 -0.937 . . . . 0.23 110.757 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 20' ' ' VAL . 47.0 m -82.08 -22.14 36.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.781 -1.423 . . . . 1.24 109.424 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.449 HD22 HD21 ' A' ' 81' ' ' LEU . 86.0 mt -64.0 139.2 58.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.24 109.776 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 136.38 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.756 -0.777 . . . . 0.21 109.718 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.54 -18.43 57.5 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.235 -1.546 . . . . 0.22 109.235 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.4 110.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.875 -1.158 . . . . 0.25 107.875 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.459 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -91.56 178.65 41.37 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.665 -1.374 . . . . 0.28 109.665 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.31 -40.02 73.68 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.498 -1.001 . . . . 2.01 110.351 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.72 -41.22 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.637 -1.289 . . . . 0.38 109.625 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.459 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.2 mt -67.72 -38.45 83.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.4 109.745 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -40.08 96.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.119 -1.192 . . . . 0.35 110.119 -179.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.78 -36.27 83.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.885 -1.362 . . . . 2.74 109.486 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.6 -53.65 26.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.139 . . . . 1.54 109.546 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.02 -39.96 87.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.118 -1.067 . . . . 0.34 108.118 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.09 -46.04 90.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.484 -0.76 . . . . 1.67 109.344 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.68 -19.83 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.44 -0.948 . . . . 2.0 108.44 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.91 3.74 52.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.696 -0.627 . . . . 2.69 109.726 -179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.21 50.7 Favored Glycine 0 N--CA 1.503 3.107 0 O-C-N 121.039 -1.038 . . . . 0.48 111.432 177.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.556 ' CD2' HG12 ' A' ' 44' ' ' VAL . 90.8 m-85 -106.2 74.98 1.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.913 -1.346 . . . . 0.33 108.941 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -80.31 -9.24 59.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.41 110.965 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.92 152.77 50.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.122 -0.986 . . . . 1.56 109.836 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.19 96.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.622 -0.674 . . . . 0.21 111.13 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 8.6 p90 -58.45 -18.99 32.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.826 -1.171 . . . . 0.32 110.414 -178.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG12 ' CD2' ' A' ' 39' ' ' PHE . 25.9 t -80.71 -30.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.904 -1.123 . . . . 0.24 108.366 179.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.64 -39.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.172 -1.047 . . . . 0.22 108.172 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.1 tp -59.95 -39.45 85.6 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.624 -1.25 . . . . 0.4 107.624 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.13 -45.04 74.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.654 -1.379 . . . . 0.18 109.654 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.99 -43.19 95.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.119 -1.224 . . . . 1.09 109.153 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.06 -39.98 87.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.427 -0.953 . . . . 0.31 108.427 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.81 -38.67 83.59 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.429 -0.952 . . . . 0.28 108.429 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.99 -22.13 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.28 110.736 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -93.15 17.06 11.59 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.96 -1.087 . . . . 0.31 110.388 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.77 34.39 10.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.873 -1.142 . . . . 1.7 110.229 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.6 mttp 59.55 20.0 8.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.456 -0.778 . . . . 2.24 109.83 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.02 114.52 5.25 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.623 -1.251 . . . . 1.8 107.623 178.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 40.0 tt0 -63.46 -41.38 98.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.87 112.519 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.04 -39.76 75.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.604 -1.31 . . . . 0.73 110.765 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.16 -39.93 78.47 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.873 -1.131 . . . . 0.55 109.551 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.69 -49.83 71.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.38 109.402 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 60' ' ' ARG . 44.3 mtt-85 -60.0 -46.61 88.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.809 . . . . 2.64 110.513 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.37 -38.55 90.38 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.966 -1.084 . . . . 2.37 108.943 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.41 ' O ' ' OG1' ' A' ' 66' ' ' THR . 59.5 t90 -64.29 -47.01 81.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.4 110.541 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 tp -67.57 -47.02 71.01 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.274 -0.891 . . . . 0.34 110.254 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -62.58 -47.5 83.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 2.11 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -69.47 -28.68 66.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.885 . . . . 1.9 109.732 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.8 m -80.43 -33.94 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.331 -0.856 . . . . 0.41 111.41 -178.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.4 p -132.23 -29.82 1.58 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.53 -1.356 . . . . 0.4 111.93 -178.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.51 20.95 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.231 -1.548 . . . . 0.36 109.231 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.38 2.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.275 . . . . 0.33 109.23 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.641 ' H ' HE21 ' A' ' 73' ' ' GLN . 6.8 m120 -90.61 171.49 9.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 1.9 109.529 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.5 75.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.39 110.416 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.53 -41.26 69.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 2.58 109.975 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.641 HE21 ' H ' ' A' ' 70' ' ' ASN . 36.7 mt-30 -67.11 -40.04 86.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 2.12 110.12 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.49 -38.94 92.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.436 -0.79 . . . . 1.36 110.233 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' HH12 ' A' ' 60' ' ' ARG . 19.8 mmm180 -60.0 -38.66 83.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 2.8 109.016 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -68.48 -39.89 81.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.88 -1.137 . . . . 0.4 110.614 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -69.12 -40.18 78.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.632 -1.292 . . . . 0.24 109.821 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.31 -60.01 4.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.633 -1.292 . . . . 0.43 109.867 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' OE2' ' A' ' 83' ' ' GLU . . . -59.9 -32.57 75.43 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.047 -1.221 . . . . 0.26 110.047 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.3 t -69.08 -49.79 54.14 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.075 -1.25 . . . . 0.25 110.014 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.449 HD21 HD22 ' A' ' 23' ' ' LEU . 86.9 mt -71.58 -40.23 70.05 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.746 -1.182 . . . . 0.3 109.124 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 82' ' ' ARG . 1.2 tpt180 -60.8 -42.67 98.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.161 -0.962 . . . . 2.73 110.055 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -70.0 -36.42 75.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 1.91 110.271 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 84.8 t90 -60.01 -43.18 95.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.521 -1.362 . . . . 0.37 107.709 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.2 m -61.02 -40.29 93.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.604 -0.685 . . . . 0.36 110.026 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.04 -33.92 72.69 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -0.969 . . . . 0.55 110.274 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.11 14.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.124 -0.985 . . . . 0.48 111.028 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.506 2.339 0 O-C-N 121.161 -0.962 . . . . 1.24 111.82 -178.048 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.647 0.737 . . . . 1.5 109.557 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.9 -24.7 64.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 2.18 110.178 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.91 -35.31 74.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.034 -1.042 . . . . 2.01 108.971 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.403 ' CD2' ' C ' ' B' ' 7' ' ' HIS . 7.7 t60 -60.06 -49.09 79.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.034 -1.041 . . . . 0.49 110.237 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' B' ' 8' ' ' ARG . 54.1 mtt-85 -70.02 -31.89 69.78 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.113 -0.992 . . . . 3.23 109.716 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.68 -39.97 80.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.76 109.761 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.439 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.2 t80 -62.54 -48.25 80.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.46 110.098 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.99 10.19 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.052 -1.03 . . . . 0.44 110.51 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.61 -14.31 15.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 0.53 109.857 178.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' B' ' 14' ' ' PRO . 13.5 pt-20 -154.27 152.78 27.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 1.27 109.12 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.9 Cg_exo -40.15 162.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.879 1.719 . . . . 0.49 111.483 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 6.8 ptp -92.45 -21.4 20.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.56 109.764 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.68 -139.82 16.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.06 -1.216 . . . . 0.39 110.06 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.8 30.83 5.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.549 -0.971 . . . . 0.84 110.47 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.98 149.24 74.62 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.189 . . . . 2.02 108.777 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.19 158.77 50.38 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.941 1.761 . . . . 0.34 112.087 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.556 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.4 p -57.29 -45.6 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.32 110.545 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.556 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -55.77 -3.04 0.4 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.725 -0.95 . . . . 0.22 110.725 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.453 ' H ' ' C ' ' B' ' 20' ' ' VAL . 47.6 m -82.11 -22.15 36.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.713 -1.463 . . . . 1.24 109.3 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.447 HD22 HD21 ' B' ' 81' ' ' LEU . 85.7 mt -64.09 139.22 58.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.24 109.768 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.89 136.4 56.08 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.758 -0.777 . . . . 0.21 109.781 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.3 57.73 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.264 -1.534 . . . . 0.22 109.264 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.48 110.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.817 -1.179 . . . . 0.25 107.817 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.466 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -91.66 178.61 41.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.675 -1.37 . . . . 0.28 109.675 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.36 -39.95 73.71 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.595 -0.944 . . . . 2.0 110.333 -178.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.68 -41.25 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.604 -1.31 . . . . 0.38 109.69 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.466 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.2 mt -67.72 -38.43 83.56 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.262 -0.898 . . . . 0.4 109.755 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.104 -1.198 . . . . 0.36 110.104 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.75 -36.32 83.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.368 . . . . 2.75 109.502 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.49 -53.72 26.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.751 -1.218 . . . . 1.56 109.562 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.208 -1.034 . . . . 0.33 108.208 178.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.07 -46.09 90.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 1.68 109.345 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -63.58 -19.98 65.27 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.411 -0.959 . . . . 1.99 108.411 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.78 3.72 51.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.612 -0.68 . . . . 2.68 109.83 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.2 50.72 Favored Glycine 0 N--CA 1.502 3.044 0 O-C-N 121.041 -1.037 . . . . 0.49 111.468 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.557 ' CD2' HG12 ' B' ' 44' ' ' VAL . 90.9 m-85 -106.16 74.88 1.06 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.96 -1.318 . . . . 0.33 108.971 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -80.25 -9.27 59.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.41 111.003 -178.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.97 152.84 50.86 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.093 -1.004 . . . . 1.56 109.832 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.576 -0.702 . . . . 0.21 111.096 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.482 ' CE1' HG22 ' B' ' 44' ' ' VAL . 8.7 p90 -58.58 -18.98 34.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 0.32 110.486 -177.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.557 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.8 t -80.77 -30.36 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.047 . . . . 0.24 108.343 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.66 -39.05 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.149 -1.056 . . . . 0.22 108.149 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.09 -39.3 85.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.632 -1.247 . . . . 0.4 107.632 177.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.15 -45.03 74.22 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.579 -1.409 . . . . 0.18 109.579 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.03 -43.19 95.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -1.216 . . . . 1.09 109.099 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.441 -0.948 . . . . 0.31 108.441 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.88 -38.65 83.31 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.464 -0.939 . . . . 0.27 108.464 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.02 -21.97 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.373 -0.83 . . . . 0.28 110.764 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 98.6 mt -93.27 17.15 11.65 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.993 -1.067 . . . . 0.3 110.363 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.86 34.29 10.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.894 -1.129 . . . . 1.71 110.272 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 59.46 19.91 8.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 2.25 109.813 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.88 114.67 5.27 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.571 -1.27 . . . . 1.8 107.571 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.414 ' CG ' ' HE ' ' B' ' 60' ' ' ARG . 40.0 tt0 -63.63 -41.39 98.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.88 112.452 -177.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.04 -39.75 75.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.64 -1.288 . . . . 0.74 110.742 -179.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.21 -39.88 78.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.827 -1.149 . . . . 0.55 109.611 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.76 -49.84 71.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.091 -1.006 . . . . 0.38 109.415 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.462 ' HG2' HH11 ' B' ' 60' ' ' ARG . 44.8 mtt-85 -59.93 -46.61 88.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.364 -0.835 . . . . 2.64 110.55 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.28 -38.69 91.05 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.029 -1.044 . . . . 2.38 108.952 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -64.29 -46.95 81.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.4 110.523 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.55 -47.06 70.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.238 -0.914 . . . . 0.34 110.17 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -62.54 -47.56 83.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 2.1 110.161 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.43 -28.62 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 1.9 109.739 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -80.37 -34.14 36.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.4 111.304 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.6 p -132.24 -29.67 1.59 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.501 -1.375 . . . . 0.39 111.839 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.75 14.58 21.02 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.21 -1.556 . . . . 0.36 109.21 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.27 151.27 2.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -1.228 . . . . 0.32 109.279 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.641 ' H ' HE21 ' B' ' 73' ' ' GLN . 6.8 m120 -90.52 171.48 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.0 . . . . 1.91 109.527 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.33 74.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.38 110.465 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.65 -41.18 69.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.828 -1.17 . . . . 2.57 110.014 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.641 HE21 ' H ' ' B' ' 70' ' ' ASN . 36.7 mt-30 -67.2 -39.97 86.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 2.12 110.185 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.53 -38.86 92.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.355 -0.841 . . . . 1.36 110.253 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.42 ' HA ' HH12 ' B' ' 60' ' ' ARG . 19.8 mmm180 -60.03 -38.63 83.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.954 -1.092 . . . . 2.81 109.035 -179.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -68.54 -40.03 80.86 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.915 -1.116 . . . . 0.4 110.592 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.95 -40.19 79.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.702 -1.249 . . . . 0.23 109.901 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.36 -59.98 4.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.61 -1.306 . . . . 0.43 109.915 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 83' ' ' GLU . . . -59.88 -32.52 75.2 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.054 -1.218 . . . . 0.25 110.054 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -69.13 -49.83 53.42 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.099 -1.236 . . . . 0.24 110.064 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.447 HD21 HD22 ' B' ' 23' ' ' LEU . 86.9 mt -71.63 -40.14 69.95 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.744 -1.182 . . . . 0.29 109.147 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' B' ' 82' ' ' ARG . 1.2 tpt180 -60.83 -42.67 98.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.147 -0.97 . . . . 2.74 110.037 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' B' ' 79' ' ' GLY . 0.3 OUTLIER -70.09 -36.39 74.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 1.91 110.053 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 84' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 84.8 t90 -59.98 -43.37 95.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.537 -1.352 . . . . 0.36 107.743 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' B' ' 89' ' ' LEU . 50.3 m -60.72 -40.37 92.06 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.562 0.696 . . . . 0.36 110.099 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.96 -33.94 72.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.064 -1.023 . . . . 0.55 110.342 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.29 14.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.148 -0.97 . . . . 0.47 110.969 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 88' ' ' PHE . . . . . 0.403 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 91.0 m-85 -109.78 1.66 19.5 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.275 -0.891 . . . . 1.24 111.925 -178.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.6 tp . . . . . 0 N--CA 1.499 1.992 0 O-C-N 120.795 -1.191 . . . . 1.67 109.746 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.628 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 106.857 -1.534 . . . . 5.4 106.857 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 p -56.3 61.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.631 -0.713 . . . . 2.28 111.291 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.628 ' N ' ' O ' ' A' ' 1' ' ' MET . 72.5 p -72.43 152.07 42.2 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.28 -1.008 . . . . 0.97 108.28 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t -71.26 164.44 25.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 1.35 109.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -51.75 -21.0 2.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.641 . . . . 2.38 109.693 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.58 -37.23 83.09 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.316 -0.865 . . . . 2.07 109.947 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -59.99 -50.07 75.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.029 -1.045 . . . . 0.44 110.047 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -69.92 -36.86 75.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.964 -1.085 . . . . 3.3 110.182 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.863 -0.791 . . . . 0.69 108.863 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -64.73 -49.6 70.2 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.516 -0.74 . . . . 0.38 110.14 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 m -83.36 8.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.085 -1.009 . . . . 0.35 110.672 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.51 -13.48 16.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.153 -0.967 . . . . 0.47 110.163 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.85 152.08 24.76 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.125 -0.984 . . . . 1.27 108.839 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -40.01 160.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.927 1.751 . . . . 0.44 112.065 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.688 ' SD ' HD11 ' B' ' 89' ' ' LEU . 3.2 ptp -89.2 -28.11 20.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.933 . . . . 1.09 109.738 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.09 -141.1 43.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.787 -1.725 . . . . 0.53 108.787 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.08 33.55 4.06 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.304 -1.115 . . . . 1.07 109.806 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.9 148.96 75.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 2.18 109.568 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.81 152.16 80.17 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.71 2.273 . . . . 0.38 112.911 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.7 p -53.69 -43.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 121.448 0.642 . . . . 0.3 110.191 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.495 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -57.57 -3.85 1.17 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.384 -1.086 . . . . 0.19 110.384 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 20' ' ' VAL . 42.1 t -84.08 -22.5 31.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.337 . . . . 1.38 110.163 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.467 HD22 HD21 ' A' ' 81' ' ' LEU . 74.7 mt -64.16 138.52 58.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.994 -1.066 . . . . 0.21 109.895 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 134.43 54.36 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.792 -0.763 . . . . 0.21 109.712 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.78 49.29 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.339 -1.504 . . . . 0.19 109.339 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.418 HD11 ' SG ' ' A' ' 77' ' ' CYS . 36.4 mm -98.51 112.26 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.331 -1.099 . . . . 0.19 108.126 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.06 177.28 42.87 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.855 -1.298 . . . . 0.19 109.855 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -58.54 -40.0 81.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.477 -1.014 . . . . 1.8 109.957 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.14 -46.71 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.96 -1.088 . . . . 0.31 108.834 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.689 HD11 ' OE1' ' A' ' 73' ' ' GLN . 88.0 mt -67.94 -39.75 83.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.33 109.877 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.27 -33.92 77.7 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.879 -1.688 . . . . 0.31 108.879 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.03 -40.4 87.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.505 -0.997 . . . . 2.89 110.292 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -68.47 -44.53 74.61 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.95 -1.094 . . . . 1.51 109.1 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.48 -39.41 93.35 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.933 -1.104 . . . . 0.28 108.029 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.99 -42.22 93.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.75 . . . . 1.51 109.269 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -68.05 -18.74 64.77 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.311 -0.996 . . . . 2.45 108.311 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.77 3.19 53.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.728 -0.608 . . . . 2.55 109.789 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.05 7.57 49.75 Favored Glycine 0 N--CA 1.502 3.073 0 O-C-N 121.015 -1.053 . . . . 0.48 111.335 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CD2' HG12 ' A' ' 44' ' ' VAL . 93.7 m-85 -106.43 74.31 1.01 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.907 -1.349 . . . . 0.35 109.048 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -80.23 -9.95 59.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.36 110.665 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -129.33 152.36 48.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.227 -0.921 . . . . 1.43 109.149 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.95 94.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.22 110.786 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.1 p90 -60.66 -17.84 49.95 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.915 -1.115 . . . . 0.62 110.975 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.597 HG12 ' CD2' ' A' ' 39' ' ' PHE . 44.7 t -78.97 -32.72 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.309 -1.367 . . . . 0.25 107.309 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.93 -39.84 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.582 -0.895 . . . . 0.2 108.582 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.87 -35.12 74.16 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.079 -1.452 . . . . 0.3 107.079 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.95 -40.76 95.79 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.63 -1.388 . . . . 0.2 109.63 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.97 -42.46 94.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.296 -1.12 . . . . 1.1 108.596 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.06 -39.96 87.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.32 109.57 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD12 HD12 ' B' ' 50' ' ' LEU . 80.4 mt -69.52 -37.72 77.25 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.602 -0.839 . . . . 0.32 108.948 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.53 -28.57 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.252 -0.905 . . . . 0.31 109.744 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.29 13.16 10.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.122 -0.986 . . . . 0.38 110.584 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt 49.94 38.96 17.51 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.538 -1.351 . . . . 2.11 110.405 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mttm 56.85 19.47 4.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 1.94 110.095 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.27 106.77 1.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 117.775 -1.57 . . . . 1.84 106.972 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.1 -40.09 88.43 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.664 -0.647 . . . . 1.05 111.304 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -69.67 -40.03 76.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.263 -1.523 . . . . 0.9 110.053 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.2 mt -70.6 -40.0 73.48 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.55 -1.26 . . . . 0.45 109.196 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.88 -49.93 72.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.32 110.511 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -63.23 -41.11 99.07 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.054 -1.059 . . . . 2.77 109.909 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.31 -40.07 93.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.629 -1.294 . . . . 2.15 108.14 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -64.53 -50.03 68.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 0.27 111.217 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.89 -46.1 83.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.132 -0.98 . . . . 0.33 109.667 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -63.27 -49.79 72.69 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.483 -0.76 . . . . 1.93 109.954 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -66.65 -30.51 70.79 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.515 -0.741 . . . . 1.7 109.678 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -78.36 -37.68 43.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.32 111.096 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.0 p -127.24 -26.9 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.529 -1.357 . . . . 0.34 112.261 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 13.7 27.12 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.249 -1.541 . . . . 0.27 109.249 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.12 155.54 1.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.291 . . . . 0.24 108.916 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -88.67 166.38 14.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 2.04 109.603 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.89 62.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.35 108.351 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -70.16 -48.86 55.51 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.305 0.574 . . . . 3.63 112.029 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.689 ' OE1' HD11 ' A' ' 30' ' ' LEU . 44.9 mt-30 -67.96 -30.01 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.068 -1.02 . . . . 2.13 110.834 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.9 p -70.02 -34.7 73.62 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.979 -1.088 . . . . 1.45 109.254 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -60.29 -38.84 84.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 2.83 109.34 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -66.86 -38.8 87.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.877 -1.139 . . . . 0.3 109.597 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 26' ' ' ILE . 93.9 m -69.91 -40.08 75.81 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.994 -1.066 . . . . 0.2 109.702 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.74 -61.15 2.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.761 -1.212 . . . . 0.36 109.769 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.7 -33.89 88.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.46 -1.056 . . . . 0.29 110.46 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.41 -48.37 61.29 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.73 -1.453 . . . . 0.25 109.943 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 23' ' ' LEU . 82.9 mt -70.08 -40.07 75.22 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.9 -1.12 . . . . 0.42 108.867 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -65.53 -40.12 92.56 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.4 -0.813 . . . . 2.58 111.006 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -70.04 -35.36 74.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.74 -1.225 . . . . 2.07 109.319 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.528 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 87.3 t90 -60.07 -43.69 95.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.991 -1.485 . . . . 0.32 106.991 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.547 ' O ' ' N ' ' A' ' 89' ' ' LEU . 51.5 m -61.45 -40.18 93.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.613 0.72 . . . . 0.41 109.896 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.96 -34.44 73.28 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.968 -1.082 . . . . 0.6 110.328 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.33 -31.99 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.116 -0.99 . . . . 0.56 110.299 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 66.0 m-85 -110.36 -3.13 16.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.542 -0.724 . . . . 1.23 112.606 -176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.66 HD11 ' SD ' ' B' ' 15' ' ' MET . 18.4 tp . . . . . 0 N--CA 1.504 2.226 0 O-C-N 120.77 -1.206 . . . . 1.74 109.714 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.634 ' O ' ' N ' ' B' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 106.836 -1.542 . . . . 5.41 106.836 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 2.8 p -56.03 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.55 -0.75 . . . . 2.28 111.347 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.634 ' N ' ' O ' ' B' ' 1' ' ' MET . 72.2 p -72.73 152.18 41.77 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.319 -0.993 . . . . 0.96 108.319 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 4.2 t -71.28 164.37 25.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.117 -0.989 . . . . 1.35 109.699 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.66 -21.17 2.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.629 -0.669 . . . . 2.37 109.659 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.33 -37.29 82.77 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.291 -0.881 . . . . 2.06 109.876 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -60.05 -49.95 75.64 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.025 -1.047 . . . . 0.43 110.038 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.02 -36.91 75.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 3.3 110.227 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.06 -38.78 82.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.345 -0.847 . . . . 0.67 108.732 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.68 -49.95 71.14 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.595 -0.69 . . . . 0.37 110.08 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.88 10.43 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.1 -1.0 . . . . 0.34 110.659 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.67 -14.93 14.89 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.114 -0.991 . . . . 0.47 110.192 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -153.51 151.2 24.94 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.139 -0.975 . . . . 1.27 108.748 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.97 160.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.97 1.78 . . . . 0.45 112.052 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.66 ' SD ' HD11 ' A' ' 89' ' ' LEU . 3.8 ptp -89.06 -26.54 21.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.269 -0.895 . . . . 1.09 109.46 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.54 -138.27 46.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.709 -1.756 . . . . 0.53 108.709 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.59 35.44 3.47 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.355 -1.086 . . . . 1.08 109.61 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 149.76 83.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 2.19 109.798 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.64 152.21 79.23 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.702 2.268 . . . . 0.37 112.742 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.476 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.5 p -53.85 -42.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.622 -0.674 . . . . 0.3 110.349 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.476 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -58.56 -3.34 1.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.514 -1.034 . . . . 0.19 110.514 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.424 ' H ' ' C ' ' B' ' 20' ' ' VAL . 45.7 t -83.28 -22.62 32.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.872 -1.37 . . . . 1.39 110.014 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.461 HD22 HD21 ' B' ' 81' ' ' LEU . 73.8 mt -64.35 139.0 58.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.22 109.746 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.19 135.63 55.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.828 -0.749 . . . . 0.21 109.668 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.14 -21.73 44.61 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.348 -1.501 . . . . 0.19 109.348 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.417 HD11 ' SG ' ' B' ' 77' ' ' CYS . 36.2 mm -98.48 113.69 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.845 -1.169 . . . . 0.2 107.845 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.78 179.36 39.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.787 -1.325 . . . . 0.2 109.787 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -58.72 -40.03 82.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.473 -1.016 . . . . 1.82 110.206 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.73 -45.76 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.941 -1.099 . . . . 0.34 109.058 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.705 HD11 ' OE1' ' B' ' 73' ' ' GLN . 86.5 mt -68.8 -39.99 79.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.35 109.87 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.12 -33.56 75.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.869 -1.692 . . . . 0.32 108.869 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -39.97 86.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.965 . . . . 2.85 110.247 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -68.91 -44.62 72.75 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.924 -1.11 . . . . 1.52 109.158 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.52 -39.47 93.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.948 -1.13 . . . . 0.27 107.948 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -60.04 -41.86 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.58 -0.7 . . . . 1.49 109.289 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -68.48 -18.37 64.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.472 -0.936 . . . . 2.43 108.472 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -89.93 1.63 56.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 2.56 109.775 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 8.45 43.47 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.114 -0.991 . . . . 0.46 111.267 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.581 ' CD2' HG12 ' B' ' 44' ' ' VAL . 93.1 m-85 -107.15 74.18 0.96 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.886 -1.361 . . . . 0.35 108.984 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -80.07 -10.41 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.34 110.718 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -129.3 150.69 50.56 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.208 -0.933 . . . . 1.43 109.084 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.28 99.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.199 -0.938 . . . . 0.21 110.726 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 6.2 p90 -56.96 -18.27 12.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.113 . . . . 0.61 110.762 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.581 HG12 ' CD2' ' B' ' 39' ' ' PHE . 41.6 t -78.49 -33.92 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.296 -1.372 . . . . 0.23 107.296 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.38 -39.63 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.727 -0.842 . . . . 0.19 108.727 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.4 tp -59.83 -34.28 72.88 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.869 -1.53 . . . . 0.3 106.869 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.39 -40.68 96.37 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.503 -1.439 . . . . 0.19 109.503 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -60.06 -42.64 94.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.24 -1.153 . . . . 1.12 108.891 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -59.94 -40.3 88.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 0.31 109.658 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.4 HD12 HD12 ' A' ' 50' ' ' LEU . 81.9 mt -69.16 -38.07 78.55 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.877 -0.786 . . . . 0.32 108.877 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.04 -29.31 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.259 -0.901 . . . . 0.3 109.717 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 94.5 mt -87.16 14.56 7.45 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.002 -1.062 . . . . 0.38 110.684 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 49.97 35.48 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.626 -1.296 . . . . 2.14 110.917 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 60.05 19.84 9.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.206 -0.934 . . . . 1.95 109.923 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 108.93 2.73 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.638 -1.615 . . . . 1.81 106.638 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.78 -40.03 93.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 1.04 111.22 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -69.28 -40.06 78.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.375 -1.453 . . . . 0.9 110.008 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.74 -38.82 73.56 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.903 -1.119 . . . . 0.43 109.191 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.54 -49.99 69.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.32 110.414 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -63.1 -41.61 99.41 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.049 -1.032 . . . . 2.79 109.843 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.19 -40.08 93.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.691 -1.256 . . . . 2.16 108.055 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . 0.404 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -64.33 -49.07 73.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.27 111.138 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.7 tp -66.05 -48.34 71.35 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.943 -1.098 . . . . 0.34 109.722 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -60.87 -49.84 75.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.501 -0.749 . . . . 1.91 110.156 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -67.53 -28.24 67.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 1.69 109.793 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.84 -33.62 34.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.32 110.954 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 22.4 p -131.11 -28.44 1.94 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.453 -1.405 . . . . 0.35 112.208 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.31 13.12 25.46 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.149 -1.581 . . . . 0.29 109.149 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 154.68 1.73 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.242 . . . . 0.26 108.735 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.49 168.12 12.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.976 -1.077 . . . . 2.03 109.691 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.81 63.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.333 -0.988 . . . . 0.36 108.333 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -70.06 -49.33 52.21 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-O 121.323 0.582 . . . . 3.61 112.07 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.705 ' OE1' HD11 ' B' ' 30' ' ' LEU . 44.4 mt-30 -67.69 -29.99 69.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.977 -1.077 . . . . 2.13 110.883 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -69.91 -34.65 73.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.062 -1.055 . . . . 1.46 109.159 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -60.73 -38.83 86.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.758 -1.214 . . . . 2.81 109.579 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.83 -39.14 87.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.796 -1.19 . . . . 0.29 109.647 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . 0.417 ' SG ' HD11 ' B' ' 26' ' ' ILE . 93.0 m -69.42 -40.02 77.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.019 -1.05 . . . . 0.19 109.484 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.93 -60.73 3.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.75 -1.219 . . . . 0.36 109.758 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.8 -33.94 88.59 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.526 -1.03 . . . . 0.28 110.526 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.49 -48.42 60.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.747 -1.443 . . . . 0.25 109.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.461 HD21 HD22 ' B' ' 23' ' ' LEU . 83.7 mt -69.97 -40.0 75.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.972 -1.091 . . . . 0.42 108.539 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -66.9 -40.11 87.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.855 . . . . 2.6 111.41 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -69.87 -34.9 74.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.594 -1.316 . . . . 2.06 108.813 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.544 ' O ' ' HB2' ' B' ' 88' ' ' PHE . 85.4 t90 -59.46 -48.65 80.83 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.661 -1.978 . . . . 0.32 105.661 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.661 ' O ' ' N ' ' B' ' 89' ' ' LEU . 36.5 m -58.07 -39.93 79.75 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.765 -0.584 . . . . 0.41 110.29 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -61.25 -35.24 76.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.31 -1.494 . . . . 0.59 111.171 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.03 -25.5 20.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.121 . . . . 0.58 107.983 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' B' ' 84' ' ' TRP . 60.6 m-85 -115.15 -2.98 12.61 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 114.792 1.404 . . . . 1.24 114.792 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.688 HD11 ' SD ' ' A' ' 15' ' ' MET . 14.5 tp . . . . . 0 C--N 1.282 -2.344 0 O-C-N 119.009 -2.307 . . . . 1.76 110.051 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.328 0.585 . . . . 5.68 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 3' ' ' THR . 0.2 OUTLIER 56.39 -159.9 0.22 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 3.02 109.113 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 2' ' ' THR . 17.7 p -100.03 127.3 46.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.267 -0.895 . . . . 0.96 109.498 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 t -79.46 162.43 25.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 1.51 109.251 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.37 -20.81 1.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.618 . . . . 2.18 109.734 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.87 -35.81 79.41 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 2.02 108.81 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -60.05 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.49 109.934 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.491 HH11 ' HG2' ' A' ' 8' ' ' ARG . 30.9 mtt-85 -69.96 -34.62 73.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 3.21 109.959 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.95 -39.81 75.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.367 -0.833 . . . . 0.76 109.738 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -65.62 -42.49 91.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.379 -0.826 . . . . 0.46 110.338 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.32 14.63 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.901 -1.125 . . . . 0.44 109.869 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.39 -10.33 12.02 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.365 -0.834 . . . . 0.54 110.488 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.49 149.98 22.47 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 1.26 109.575 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -39.67 161.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.903 1.735 . . . . 0.49 111.619 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.47 -18.0 23.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.998 -1.064 . . . . 0.57 109.677 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -143.24 12.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.954 -1.259 . . . . 0.4 109.954 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.71 29.89 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.416 -1.049 . . . . 0.85 110.274 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -60.05 149.06 75.91 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.093 -1.004 . . . . 2.01 108.609 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.7 160.11 41.98 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.26 1.974 . . . . 0.34 112.407 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 22' ' ' SER . 6.4 p -57.2 -47.09 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.75 . . . . 0.32 110.403 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.54 -1.87 0.1 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.346 -1.102 . . . . 0.23 110.346 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 20' ' ' VAL . 21.7 m -82.95 -23.16 33.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.77 -1.429 . . . . 1.24 109.72 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.708 HD22 HD21 ' A' ' 81' ' ' LEU . 95.0 mt -64.19 140.03 58.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.24 109.751 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 134.68 55.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.747 0.784 . . . . 0.21 109.857 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.23 -17.05 58.48 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.583 -1.407 . . . . 0.22 109.583 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.37 115.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -1.155 . . . . 0.25 107.971 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -89.03 172.44 40.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.697 -1.361 . . . . 0.28 109.697 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -55.86 -40.05 72.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.01 109.92 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.04 -44.19 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.997 -1.064 . . . . 0.38 109.741 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 27' ' ' GLY . 86.6 mt -64.37 -34.21 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.4 109.825 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.93 95.19 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.022 -1.631 . . . . 0.35 109.022 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.23 -38.83 92.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -1.171 . . . . 2.74 109.575 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.27 -52.88 28.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.723 -1.235 . . . . 1.54 109.172 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.58 -40.0 90.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.082 -1.011 . . . . 0.34 108.36 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -42.07 93.58 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.885 -0.726 . . . . 1.67 109.223 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.3 -20.17 66.02 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.603 -0.888 . . . . 2.0 108.603 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 37' ' ' ARG . 0.8 OUTLIER -91.09 4.39 52.28 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 2.69 110.286 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.04 7.95 51.71 Favored Glycine 0 N--CA 1.502 3.054 0 O-C-N 120.976 -1.077 . . . . 0.48 111.611 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.48 ' CD2' HG12 ' A' ' 44' ' ' VAL . 93.8 m-85 -104.81 73.48 1.08 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.717 -1.461 . . . . 0.33 108.417 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 22.9 p-10 -77.56 -9.74 59.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.428 -0.795 . . . . 0.41 111.104 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -137.46 158.06 45.22 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.056 -1.028 . . . . 1.56 110.417 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.67 93.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.577 . . . . 0.21 112.327 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -59.25 -18.1 34.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.586 -1.321 . . . . 0.32 110.439 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.1 t -79.91 -31.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.878 -1.139 . . . . 0.24 108.285 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 20' ' ' VAL . 54.5 t -77.03 -37.71 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.942 -1.133 . . . . 0.22 107.942 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.8 tp -59.96 -37.85 80.78 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.286 -1.375 . . . . 0.4 107.286 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.54 89.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.98 -1.248 . . . . 0.18 109.98 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -60.04 -42.66 94.9 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.89 -1.359 . . . . 1.09 109.134 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -60.03 -40.82 90.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 0.31 108.793 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD21 ' SG ' ' A' ' 85' ' ' CYS . 80.7 mt -69.01 -38.27 79.14 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.544 -0.909 . . . . 0.28 108.544 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.94 -22.65 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.269 -0.894 . . . . 0.28 110.575 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.8 15.05 13.71 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.006 -1.059 . . . . 0.31 110.676 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.12 42.77 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.671 -1.268 . . . . 1.7 110.778 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 57.82 20.02 6.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.478 -0.764 . . . . 2.24 110.421 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -69.2 104.53 2.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.412 -1.43 . . . . 1.8 107.706 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.16 -40.05 92.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.959 0.726 . . . . 0.87 112.959 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 95.0 m-20 -69.93 -39.98 75.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.457 -1.402 . . . . 0.73 110.475 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.82 -40.04 72.69 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.985 -1.086 . . . . 0.55 109.033 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.27 -49.88 73.94 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.836 . . . . 0.38 110.054 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 79.3 mtm180 -61.5 -43.67 98.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 2.64 110.317 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.61 -39.85 94.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.265 -0.897 . . . . 2.37 108.747 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -62.41 -49.22 76.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.275 -0.891 . . . . 0.4 110.693 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.4 tp -67.78 -47.91 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.161 -0.962 . . . . 0.34 110.131 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.49 -45.99 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 2.11 109.642 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.84 -30.15 68.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.742 . . . . 1.9 109.82 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -77.83 -36.89 49.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.945 . . . . 0.41 111.227 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.5 p -130.44 -29.92 1.95 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.593 -1.317 . . . . 0.4 111.783 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.33 15.86 11.94 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.311 -1.516 . . . . 0.36 109.311 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.29 154.63 2.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.315 . . . . 0.33 109.03 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 168.84 12.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 1.9 109.95 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.99 71.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.39 110.192 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -72.78 -39.98 66.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.935 -1.103 . . . . 2.58 109.346 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -68.39 -38.8 81.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.12 110.35 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.71 -36.06 77.97 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.13 -0.981 . . . . 1.36 109.516 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.93 -38.07 81.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 2.8 109.401 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.13 -39.95 82.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.744 -1.222 . . . . 0.4 110.451 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.4 m -69.45 -40.7 77.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.667 -1.271 . . . . 0.24 109.507 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -58.82 -60.21 4.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.534 -1.354 . . . . 0.43 109.41 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.5 90.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.86 -0.896 . . . . 0.26 110.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.91 -49.32 59.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.364 . . . . 0.25 110.217 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.708 HD21 HD22 ' A' ' 23' ' ' LEU . 84.5 mt -70.0 -39.62 75.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.902 -1.119 . . . . 0.3 108.757 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.94 -41.03 90.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 2.73 109.691 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.01 -37.8 75.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 1.91 110.628 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.526 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 85.8 t90 -60.86 -42.01 97.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.37 108.974 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.467 ' SG ' HD21 ' A' ' 50' ' ' LEU . 69.8 m -62.08 -40.04 94.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.36 109.752 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.66 -31.16 67.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.344 -0.848 . . . . 0.55 109.646 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.89 -37.06 12.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.305 -0.872 . . . . 0.48 111.325 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 -106.05 -4.38 20.52 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.132 -0.98 . . . . 1.24 112.399 -177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 85' ' ' CYS . 8.3 tp . . . . . 0 N--CA 1.502 2.154 0 O-C-N 120.54 -1.35 . . . . 1.66 109.317 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.465 -0.568 . . . . 5.66 109.465 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.465 HG22 ' H ' ' B' ' 3' ' ' THR . 0.2 OUTLIER 56.45 -160.01 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 3.02 109.094 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.465 ' H ' HG22 ' B' ' 2' ' ' THR . 17.7 p -100.03 127.29 46.26 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.35 -0.844 . . . . 0.96 109.467 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t -79.44 162.41 25.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 1.5 109.236 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -50.49 -20.72 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.714 -0.616 . . . . 2.18 109.727 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.81 -35.91 79.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 2.01 108.875 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.92 -48.96 79.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.49 110.015 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' B' ' 8' ' ' ARG . 31.0 mtt-85 -69.94 -34.61 73.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 3.23 110.007 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -69.95 -39.59 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.299 -0.876 . . . . 0.76 109.855 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -65.75 -42.47 90.9 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.448 -0.783 . . . . 0.46 110.36 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -84.31 14.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.946 -1.096 . . . . 0.44 109.88 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.3 -10.02 12.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.397 -0.814 . . . . 0.53 110.466 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.63 150.02 22.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.86 -1.15 . . . . 1.27 109.456 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.59 161.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.918 1.745 . . . . 0.49 111.603 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 5.6 ptp -92.44 -18.15 23.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.043 -1.035 . . . . 0.56 109.708 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.32 -143.15 12.98 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.018 -1.233 . . . . 0.39 110.018 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.88 29.94 5.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.484 -1.01 . . . . 0.84 110.221 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -60.16 149.07 76.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 2.02 108.632 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 160.18 41.52 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.194 1.929 . . . . 0.34 112.424 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' B' ' 22' ' ' SER . 6.3 p -57.27 -47.05 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.734 . . . . 0.32 110.441 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.494 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.43 -2.1 0.1 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.475 -1.05 . . . . 0.22 110.475 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.524 ' H ' ' C ' ' B' ' 20' ' ' VAL . 21.1 m -82.67 -23.26 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.806 -1.408 . . . . 1.24 109.806 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.737 HD22 HD21 ' B' ' 81' ' ' LEU . 94.6 mt -64.12 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.04 -1.037 . . . . 0.24 109.718 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.428 ' O ' ' SG ' ' B' ' 77' ' ' CYS . . . -64.24 134.93 55.72 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.69 0.757 . . . . 0.21 109.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.09 58.66 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.489 -1.444 . . . . 0.22 109.489 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.33 115.41 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.245 -1.15 . . . . 0.25 107.951 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.414 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -88.94 172.51 40.37 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.725 -1.35 . . . . 0.28 109.725 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -56.01 -39.94 72.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -1.089 . . . . 2.0 109.907 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.19 -43.99 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.008 -1.057 . . . . 0.38 109.749 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.414 HD12 ' H ' ' B' ' 27' ' ' GLY . 86.8 mt -64.51 -34.13 77.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.4 109.742 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.17 -40.03 95.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.973 -1.651 . . . . 0.36 108.973 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.26 -38.64 91.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -1.154 . . . . 2.75 109.545 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.4 -52.88 28.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.124 . . . . 1.56 109.12 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.7 -39.95 90.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.286 -1.005 . . . . 0.33 108.286 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.08 -41.97 93.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.839 -0.744 . . . . 1.68 109.168 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.42 -20.07 65.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.653 -0.869 . . . . 1.99 108.653 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.8 OUTLIER -90.98 4.17 52.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.561 -0.712 . . . . 2.68 110.321 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.05 7.96 51.65 Favored Glycine 0 N--CA 1.502 3.067 0 C-N-CA 120.139 -1.029 . . . . 0.49 111.664 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.488 ' CD2' HG12 ' B' ' 44' ' ' VAL . 93.9 m-85 -104.75 73.44 1.08 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.401 . . . . 0.33 108.485 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 40' ' ' ASP . 22.7 p-10 -77.61 -9.75 59.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.41 111.021 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -137.39 157.92 45.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.999 -1.063 . . . . 1.56 110.423 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.0 94.56 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.702 -0.624 . . . . 0.21 112.318 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 4.6 p90 -59.1 -17.88 30.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.61 -1.306 . . . . 0.32 110.578 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.5 t -80.01 -31.93 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.924 -1.11 . . . . 0.24 108.231 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.407 HG21 HG23 ' B' ' 20' ' ' VAL . 54.5 t -76.92 -37.65 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.954 -1.128 . . . . 0.22 107.954 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.0 -37.65 80.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.265 -1.383 . . . . 0.4 107.265 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.47 90.35 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.96 -1.256 . . . . 0.18 109.96 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.774 -1.427 . . . . 1.09 109.154 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -59.95 -40.93 90.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.31 108.785 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.456 HD21 ' SG ' ' B' ' 85' ' ' CYS . 80.9 mt -68.96 -38.0 79.16 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.622 -0.881 . . . . 0.27 108.622 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.14 -22.79 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.263 -0.898 . . . . 0.28 110.499 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.58 14.69 14.31 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.088 -1.008 . . . . 0.3 110.732 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt 47.44 42.4 14.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.7 -1.25 . . . . 1.71 110.742 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 58.27 19.95 6.75 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.403 -0.811 . . . . 2.25 110.43 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -69.23 104.52 2.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 1.8 107.817 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.18 -39.99 92.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.899 0.703 . . . . 0.88 112.899 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 94.8 m-20 -70.05 -39.94 75.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.465 -1.397 . . . . 0.74 110.362 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.0 -40.0 72.08 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.969 -1.092 . . . . 0.55 108.92 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.15 -49.98 73.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.328 -0.857 . . . . 0.38 109.939 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.486 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 79.3 mtm180 -61.7 -43.38 98.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 2.64 110.295 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -64.71 -39.9 94.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.076 -1.015 . . . . 2.38 108.782 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -62.39 -49.32 75.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.343 -0.848 . . . . 0.4 110.703 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.6 -47.85 68.49 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.184 -0.948 . . . . 0.34 110.209 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -63.48 -46.13 87.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 2.1 109.636 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -68.85 -29.97 68.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 1.9 109.903 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 66.9 m -77.91 -36.82 49.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.4 111.189 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 13.4 p -130.64 -29.77 1.92 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.564 -1.335 . . . . 0.39 111.712 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.31 15.72 12.16 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.345 -1.502 . . . . 0.36 109.345 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.08 154.52 2.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.968 -1.313 . . . . 0.32 109.125 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -88.34 168.93 12.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.991 -1.068 . . . . 1.91 109.922 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.31 71.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.38 110.167 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -72.47 -40.01 67.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 2.57 109.409 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -68.54 -38.6 80.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.45 -0.781 . . . . 2.12 110.447 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.4 m -68.72 -36.06 77.95 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 1.36 109.564 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -59.87 -38.21 81.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 2.81 109.342 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.92 -40.02 83.45 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.4 110.428 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' B' ' 24' ' ' ALA . 93.1 m -69.53 -40.73 76.71 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.653 -1.279 . . . . 0.23 109.46 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.78 -60.36 3.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.635 -1.291 . . . . 0.43 109.37 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.05 -34.58 90.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.779 -0.928 . . . . 0.25 110.779 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 51.1 t -68.79 -49.4 58.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.927 -1.337 . . . . 0.24 110.215 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.737 HD21 HD22 ' B' ' 23' ' ' LEU . 84.6 mt -69.99 -39.5 75.86 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.842 -1.143 . . . . 0.29 108.799 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.04 -41.0 91.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 2.74 109.605 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -70.0 -37.72 75.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.91 110.711 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 85.7 t90 -60.81 -42.16 97.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.516 -1.365 . . . . 0.36 108.986 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.456 ' SG ' HD21 ' B' ' 50' ' ' LEU . 69.7 m -62.04 -39.96 94.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.474 -0.766 . . . . 0.36 109.735 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -58.61 -31.43 68.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.433 -0.792 . . . . 0.55 109.67 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.7 -37.19 12.52 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.47 111.416 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.9 m-85 -105.74 -4.35 21.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.084 -1.01 . . . . 1.24 112.501 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.444 -1.41 . . . . 1.67 109.419 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.315 -0.624 . . . . 5.68 109.315 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 m -86.33 12.23 10.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.188 -0.945 . . . . 3.02 109.254 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.2 p -69.48 165.25 21.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.96 109.396 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p -71.93 170.07 14.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 1.51 110.078 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -54.57 -19.28 5.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.778 -0.576 . . . . 2.18 110.05 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -60.05 -38.36 82.58 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.031 -1.043 . . . . 2.02 109.366 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.409 ' O ' HG22 ' A' ' 11' ' ' VAL . 63.8 t60 -58.93 -50.06 75.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.49 110.515 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 30.9 mmt180 -69.97 -33.78 72.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.069 -1.02 . . . . 3.21 109.831 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -67.17 -39.9 86.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.849 -0.741 . . . . 0.76 109.904 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.92 -47.15 75.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.46 110.362 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 7' ' ' HIS . 24.3 m -85.77 5.18 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.128 -0.982 . . . . 0.44 110.929 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -100.57 -14.97 17.98 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.06 -1.025 . . . . 0.54 109.935 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.6 pt-20 -153.59 153.35 28.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 1.26 108.712 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 13' ' ' GLU . 64.1 Cg_exo -35.87 156.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.236 1.958 . . . . 0.49 112.024 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.54 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 10.4 ptm -93.12 -31.59 14.75 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.238 -0.913 . . . . 0.57 109.983 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.24 -133.58 41.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.612 -0.995 . . . . 0.4 110.612 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.56 -0.964 . . . . 0.85 110.972 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.31 65.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.704 -1.248 . . . . 2.01 108.23 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.47 155.48 47.02 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.084 1.856 . . . . 0.34 112.246 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.8 p -56.23 -47.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.554 -0.716 . . . . 0.32 110.384 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.576 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -58.03 -3.28 1.18 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.681 -0.967 . . . . 0.23 110.681 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' VAL . 9.6 t -84.52 -22.31 30.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.742 -1.446 . . . . 1.24 109.633 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.601 HD22 HD21 ' A' ' 81' ' ' LEU . 96.4 mt -62.88 138.87 58.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 0.24 109.263 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 136.27 57.27 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.91 0.862 . . . . 0.21 110.507 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.05 59.67 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.301 -1.52 . . . . 0.22 109.301 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 77' ' ' CYS . 27.1 mm -100.29 113.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.436 -1.038 . . . . 0.25 108.384 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.75 177.72 40.49 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.422 -1.471 . . . . 0.28 109.422 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -55.77 -39.72 71.61 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.465 -1.021 . . . . 2.01 109.562 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.02 -46.36 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.06 -1.025 . . . . 0.38 110.127 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.68 -39.05 87.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.4 109.972 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 -39.96 97.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.168 -1.173 . . . . 0.35 110.168 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.34 -39.66 92.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.106 -1.232 . . . . 2.74 110.241 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -67.66 -45.68 74.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.936 -1.103 . . . . 1.54 108.974 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.91 -39.42 89.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.655 -1.239 . . . . 0.34 107.655 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.02 -40.94 91.04 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.827 -0.749 . . . . 1.67 109.141 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -68.03 -20.35 64.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.246 -0.909 . . . . 2.0 108.882 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.421 ' HE ' HG23 ' A' ' 66' ' ' THR . 23.7 mmm180 -91.16 2.43 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 2.69 109.679 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.02 38.0 3.72 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 120.346 -0.93 . . . . 0.48 111.352 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' A' ' 44' ' ' VAL . 87.2 m-85 -133.63 72.29 1.48 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.959 -1.318 . . . . 0.33 109.073 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 22.9 p-10 -80.07 -10.73 59.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.165 . . . . 0.41 110.437 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -129.75 150.93 50.84 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.193 -0.942 . . . . 1.56 109.422 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.06 90.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.21 111.274 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.74 -17.1 32.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.741 -1.224 . . . . 0.32 110.182 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' A' ' 39' ' ' PHE . 61.0 t -79.86 -31.8 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.748 -1.204 . . . . 0.24 107.748 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.34 -36.47 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.774 -1.195 . . . . 0.22 107.774 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.01 -36.34 77.01 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.237 -1.394 . . . . 0.4 107.237 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.07 98.12 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.736 -1.346 . . . . 0.18 109.736 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -60.08 -43.8 95.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.903 -1.351 . . . . 1.09 108.431 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.11 -40.91 91.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.31 109.222 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.6 -38.45 80.62 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.426 -0.953 . . . . 0.28 108.426 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.76 -21.08 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.259 -0.9 . . . . 0.28 110.853 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.48 13.27 14.21 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.933 -1.105 . . . . 0.31 111.351 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 49.92 36.21 11.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.648 -1.282 . . . . 1.7 110.065 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.28 19.96 8.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.411 -0.805 . . . . 2.24 110.257 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.9 105.48 2.0 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.526 -1.359 . . . . 1.8 108.209 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 82.5 tt0 -65.11 -40.29 94.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.486 -0.759 . . . . 0.87 112.44 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.61 -39.99 80.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.704 -1.248 . . . . 0.73 109.594 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.59 -39.31 77.37 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.385 -0.926 . . . . 0.55 108.756 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.5 -46.62 89.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.38 109.117 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 96.9 mtt180 -59.99 -48.21 82.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.497 -0.752 . . . . 2.64 110.694 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.32 -39.95 89.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.703 -1.248 . . . . 2.37 108.913 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -62.76 -49.94 73.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.4 110.647 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 56.6 tp -66.35 -47.64 72.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.328 -0.857 . . . . 0.34 109.724 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.27 -44.93 95.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.359 -0.838 . . . . 2.11 109.772 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.36 -32.08 70.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.327 -0.858 . . . . 1.9 109.244 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.421 HG23 ' HE ' ' A' ' 37' ' ' ARG . 94.4 m -77.1 -38.0 53.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.41 111.323 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 10.5 p -131.0 -37.0 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.622 -1.299 . . . . 0.4 111.86 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.21 17.75 7.57 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.214 -1.555 . . . . 0.36 109.214 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.31 153.84 3.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.034 -1.274 . . . . 0.33 109.191 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -91.06 171.66 9.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 1.9 109.589 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.84 70.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.467 -0.771 . . . . 0.39 110.593 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -71.79 -41.16 68.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.739 -1.226 . . . . 2.58 110.317 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.41 -39.16 88.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.198 -0.939 . . . . 2.12 110.451 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -66.03 -38.65 88.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.441 -0.787 . . . . 1.36 110.195 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.825 -1.172 . . . . 2.8 109.384 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -67.9 -39.99 83.53 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.697 -1.252 . . . . 0.4 110.476 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.426 ' SG ' HD11 ' A' ' 26' ' ' ILE . 92.4 m -69.74 -39.94 76.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.683 -1.26 . . . . 0.24 109.778 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.48 -60.41 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.61 -1.307 . . . . 0.43 109.792 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.58 84.67 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 120.305 -0.95 . . . . 0.26 110.843 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.21 -49.27 45.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.832 -1.393 . . . . 0.25 110.014 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.601 HD21 HD22 ' A' ' 23' ' ' LEU . 88.5 mt -70.0 -39.98 75.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.3 108.745 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.491 HH11 ' HG2' ' A' ' 82' ' ' ARG . 16.4 ttt-85 -64.57 -39.87 94.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.282 -0.886 . . . . 2.73 110.051 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.92 -39.45 79.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 1.91 110.345 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.588 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 88.3 t90 -60.14 -43.63 95.57 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.411 -1.431 . . . . 0.37 107.666 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 89' ' ' LEU . 59.1 m -61.57 -40.02 93.26 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.457 0.646 . . . . 0.36 109.695 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.99 -31.91 70.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.835 . . . . 0.55 109.145 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.73 13.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.4 -0.813 . . . . 0.48 110.654 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.588 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 85.5 m-85 -107.8 -6.34 16.81 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.278 -0.889 . . . . 1.24 112.831 -177.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 85' ' ' CYS . 10.5 tp . . . . . 0 N--CA 1.504 2.258 0 O-C-N 120.335 -1.478 . . . . 1.66 109.297 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptp . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.302 -0.629 . . . . 5.66 109.302 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 2.6 m -86.29 12.17 10.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.92 . . . . 3.02 109.223 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 59.6 p -69.46 165.18 21.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.96 109.459 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p -71.89 170.21 14.2 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.793 0.806 . . . . 1.5 110.07 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -54.73 -19.28 5.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.77 -0.581 . . . . 2.18 110.039 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.96 -38.37 82.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.024 -1.047 . . . . 2.01 109.364 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.403 ' O ' HG22 ' B' ' 11' ' ' VAL . 63.7 t60 -58.95 -50.12 75.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.996 . . . . 0.49 110.428 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 30.9 mmt180 -70.01 -33.72 72.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.035 -1.041 . . . . 3.23 109.825 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.2 -39.93 86.4 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.418 -0.801 . . . . 0.76 109.792 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.83 -47.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.46 110.303 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 7' ' ' HIS . 24.2 m -85.77 5.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.132 -0.98 . . . . 0.44 110.907 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -100.56 -15.09 17.94 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.049 -1.032 . . . . 0.53 109.915 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' B' ' 14' ' ' PRO . 4.6 pt-20 -153.65 153.38 28.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 1.27 108.606 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -35.93 156.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.333 2.022 . . . . 0.49 112.001 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.531 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 10.3 ptm -93.24 -31.64 14.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.359 -0.838 . . . . 0.56 109.916 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.62 42.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.557 -1.017 . . . . 0.39 110.557 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.02 35.78 3.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.968 . . . . 0.84 110.938 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -58.41 148.34 64.83 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.748 -1.22 . . . . 2.02 108.272 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.54 155.55 46.96 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.016 1.81 . . . . 0.34 112.298 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.58 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.6 p -56.26 -47.25 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.536 -0.728 . . . . 0.32 110.43 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -58.01 -3.12 1.1 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.781 -0.928 . . . . 0.22 110.781 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 20' ' ' VAL . 9.8 t -84.65 -22.34 29.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.696 -1.473 . . . . 1.24 109.573 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.6 HD22 HD21 ' B' ' 81' ' ' LEU . 96.5 mt -62.91 138.87 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 0.24 109.276 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 136.15 57.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.782 0.801 . . . . 0.21 110.552 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 -16.95 59.9 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.393 -1.483 . . . . 0.22 109.393 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.429 HD11 ' SG ' ' B' ' 77' ' ' CYS . 27.2 mm -100.38 113.19 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.398 -1.06 . . . . 0.25 108.343 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.74 177.56 40.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.419 -1.472 . . . . 0.28 109.419 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -55.63 -39.7 71.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.506 -0.996 . . . . 2.0 109.519 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.05 -46.35 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.053 -1.029 . . . . 0.38 110.096 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.72 -38.96 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.4 109.865 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.81 -40.1 97.73 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.083 -1.207 . . . . 0.36 110.083 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -65.26 -39.71 93.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.254 . . . . 2.75 110.187 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.56 -45.67 74.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.105 . . . . 1.56 109.041 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.95 -39.53 89.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.595 -1.261 . . . . 0.33 107.595 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.96 -40.98 90.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.803 -0.759 . . . . 1.68 109.082 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.97 -20.26 65.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 1.99 108.934 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.403 ' HE ' HG23 ' B' ' 66' ' ' THR . 23.7 mmm180 -91.39 2.64 56.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.695 . . . . 2.68 109.667 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 37.97 3.74 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 121.165 -0.959 . . . . 0.49 111.37 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.505 ' CD2' HG12 ' B' ' 44' ' ' VAL . 86.9 m-85 -133.54 72.2 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.921 -1.341 . . . . 0.33 109.095 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 40' ' ' ASP . 22.9 p-10 -80.06 -10.63 59.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.41 110.413 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -129.81 150.83 50.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.294 -0.879 . . . . 1.56 109.489 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -40.09 90.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.461 -0.774 . . . . 0.21 111.291 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -59.79 -17.13 33.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.745 -1.222 . . . . 0.32 110.217 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 HG12 ' CD2' ' B' ' 39' ' ' PHE . 61.0 t -79.87 -31.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.745 -1.205 . . . . 0.24 107.745 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 59.2 t -78.49 -36.39 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.727 -1.212 . . . . 0.22 107.727 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.3 tp -60.06 -36.25 76.93 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.166 -1.42 . . . . 0.4 107.166 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.18 98.25 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.635 -1.386 . . . . 0.18 109.635 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -59.98 -43.89 94.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.944 -1.327 . . . . 1.09 108.514 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -59.91 -41.07 90.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.47 -0.769 . . . . 0.31 109.275 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.44 -38.52 81.24 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.513 -0.921 . . . . 0.27 108.513 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.87 -20.95 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.936 . . . . 0.28 110.779 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.52 13.19 14.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.863 -1.148 . . . . 0.3 111.41 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 50.05 36.15 11.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.667 -1.271 . . . . 1.71 110.125 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.11 20.03 7.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.38 -0.825 . . . . 2.25 110.285 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -67.92 105.28 1.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.553 -1.342 . . . . 1.8 108.258 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 82.5 tt0 -65.06 -40.32 94.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 0.88 112.375 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.6 -39.82 80.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.844 -1.16 . . . . 0.74 109.577 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.79 -39.25 76.72 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.29 -0.964 . . . . 0.55 108.764 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.53 -46.72 88.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.38 109.021 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 97.0 mtt180 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.504 -0.748 . . . . 2.64 110.664 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.3 -40.01 89.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.782 -1.199 . . . . 2.38 108.952 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -62.77 -49.93 73.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.989 -1.069 . . . . 0.4 110.656 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.7 tp -66.42 -47.62 72.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.391 -0.818 . . . . 0.34 109.708 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.27 -44.86 95.56 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.376 -0.827 . . . . 2.1 109.783 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -69.48 -31.95 70.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 1.9 109.22 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.403 HG23 ' HE ' ' B' ' 37' ' ' ARG . 94.2 m -77.06 -37.98 53.52 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.448 -0.782 . . . . 0.4 111.467 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 10.5 p -131.0 -37.04 1.3 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.649 -1.282 . . . . 0.39 111.886 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.17 17.81 7.56 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.282 -1.527 . . . . 0.36 109.282 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.35 153.92 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.053 -1.263 . . . . 0.32 109.153 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.19 171.77 9.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 1.91 109.466 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.85 70.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.413 -0.805 . . . . 0.38 110.511 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.79 -41.22 68.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.784 -1.197 . . . . 2.57 110.247 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.37 -39.16 88.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -0.918 . . . . 2.12 110.439 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 51.0 m -66.02 -38.74 89.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 1.36 110.182 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -59.89 -38.32 81.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.857 -1.152 . . . . 2.81 109.452 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -68.11 -39.98 82.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.69 -1.256 . . . . 0.4 110.499 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' B' ' 26' ' ' ILE . 93.0 m -69.67 -40.06 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.23 109.757 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.38 -60.38 3.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.592 -1.318 . . . . 0.43 109.777 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.68 85.01 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.797 -0.921 . . . . 0.25 110.797 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.09 -49.41 44.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.758 -1.436 . . . . 0.24 109.982 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.6 HD21 HD22 ' B' ' 23' ' ' LEU . 88.5 mt -70.02 -39.9 75.51 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.004 -1.078 . . . . 0.29 108.823 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' B' ' 82' ' ' ARG . 16.5 ttt-85 -64.4 -40.07 95.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 2.74 110.061 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.7 -39.65 80.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 1.91 110.45 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.586 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 88.3 t90 -60.03 -43.61 95.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.409 -1.432 . . . . 0.36 107.658 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.6 m -61.69 -40.01 93.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.36 109.647 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -59.99 -31.85 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.408 -0.807 . . . . 0.55 109.227 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.16 -35.1 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.307 -0.871 . . . . 0.47 110.611 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.586 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 86.9 m-85 -107.2 -6.64 17.18 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.239 -0.913 . . . . 1.24 112.951 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.4 tp . . . . . 0 N--CA 1.504 2.262 0 O-C-N 120.202 -1.561 . . . . 1.67 109.342 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OG1' ' A' ' 2' ' ' THR . 19.5 mmm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.006 -0.739 . . . . 5.68 109.006 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 1' ' ' MET . 3.4 p 49.62 42.65 23.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 3.02 109.685 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.9 p -78.71 161.63 26.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.96 109.815 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.3 p -72.53 169.29 16.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.342 -0.849 . . . . 1.51 109.557 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -59.72 -22.52 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 2.18 110.253 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.13 -38.5 83.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 2.02 109.157 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 14.1 t60 -56.86 -49.84 74.25 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.256 -0.903 . . . . 0.49 110.132 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -70.03 -34.0 72.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.922 . . . . 3.21 110.086 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.68 -36.84 73.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.327 -0.858 . . . . 0.76 109.74 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -64.49 -43.18 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.46 109.803 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -84.11 15.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.209 -0.932 . . . . 0.44 110.243 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.42 -9.49 10.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.298 -0.876 . . . . 0.54 110.311 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.71 149.73 19.45 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.859 -1.15 . . . . 1.26 109.461 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -40.61 155.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.742 1.628 . . . . 0.49 111.168 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.518 ' CE ' HD22 ' A' ' 46' ' ' LEU . 4.3 ptp -91.21 -19.65 22.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.966 -1.084 . . . . 0.57 109.174 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -138.6 39.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.195 -1.162 . . . . 0.4 110.195 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -106.18 30.53 5.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.621 -0.929 . . . . 0.85 110.487 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -60.06 148.52 77.52 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 2.01 107.927 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.81 159.08 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.06 1.84 . . . . 0.34 112.633 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.5 p -57.12 -49.25 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 0.32 110.517 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.57 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.39 -1.86 0.14 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.763 -0.935 . . . . 0.23 110.763 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 64.9 p -82.42 -24.72 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.69 -1.476 . . . . 1.24 109.847 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.11 138.72 58.2 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.887 0.851 . . . . 0.24 109.84 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 133.43 53.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.725 0.774 . . . . 0.21 109.982 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 97.37 -20.25 51.47 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.213 -1.555 . . . . 0.22 109.213 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.0 mm -99.75 113.17 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -1.162 . . . . 0.25 107.892 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -93.44 179.94 39.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.28 109.692 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -56.01 -39.96 72.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.544 -0.974 . . . . 2.01 109.874 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.73 -43.17 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.95 -1.094 . . . . 0.38 109.524 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 27' ' ' GLY . 97.2 mt -67.73 -39.91 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.4 109.526 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.29 97.81 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.135 -1.186 . . . . 0.35 110.135 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -64.36 -38.79 92.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.998 -1.295 . . . . 2.74 110.079 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -65.43 -48.87 71.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.872 -1.142 . . . . 1.54 109.177 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.85 -38.6 86.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.21 -0.931 . . . . 0.34 108.59 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.11 -40.05 88.32 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.768 -0.827 . . . . 1.67 108.768 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.87 -18.89 64.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.407 -0.96 . . . . 2.0 108.407 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.33 2.89 56.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.594 -0.691 . . . . 2.69 110.166 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.56 6.86 49.65 Favored Glycine 0 N--CA 1.503 3.115 0 O-C-N 120.997 -1.064 . . . . 0.48 112.244 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 39' ' ' PHE . 44.3 m-85 -106.23 77.12 1.2 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 119.208 1.504 . . . . 0.33 109.32 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -77.46 -8.19 57.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.41 111.024 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.79 158.54 44.15 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.977 -1.077 . . . . 1.56 109.418 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.2 90.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.462 -0.774 . . . . 0.21 112.183 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.32 -17.58 20.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.636 -1.29 . . . . 0.32 110.635 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.18 -30.02 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.927 -1.108 . . . . 0.24 108.152 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.72 -39.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.994 -1.113 . . . . 0.22 107.994 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.518 HD22 ' CE ' ' A' ' 15' ' ' MET . 60.6 tp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.217 -1.401 . . . . 0.4 107.217 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.56 -43.79 67.71 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.156 -1.577 . . . . 0.18 109.156 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -1.225 . . . . 1.09 108.634 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.86 -41.19 90.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.852 . . . . 0.31 109.09 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.03 -39.98 75.44 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.883 -0.727 . . . . 0.28 109.073 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.78 -20.27 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.115 -0.991 . . . . 0.28 110.626 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.75 18.17 9.27 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.058 -1.026 . . . . 0.31 109.79 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.04 32.44 10.26 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.942 -1.099 . . . . 1.7 110.103 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 60.02 19.91 9.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.62 -0.675 . . . . 2.24 109.913 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -67.84 111.88 4.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.777 -1.202 . . . . 1.8 107.927 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.5 -41.17 98.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.87 112.601 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.42 -40.05 77.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.548 -1.345 . . . . 0.73 109.669 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.91 -40.01 75.85 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.977 -1.089 . . . . 0.55 108.785 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.06 -49.98 70.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.38 110.026 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -61.19 -44.85 96.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 2.64 110.431 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 98.8 mt-10 -64.81 -37.92 89.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.805 -1.185 . . . . 2.37 108.846 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.407 ' O ' ' OG1' ' A' ' 66' ' ' THR . 65.1 t90 -64.05 -48.04 77.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.303 -0.873 . . . . 0.4 110.974 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.17 -46.89 66.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.956 -1.09 . . . . 0.34 109.862 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -61.52 -47.0 87.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.067 -1.021 . . . . 2.11 109.714 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 61' ' ' GLU . 71.7 m-20 -70.02 -28.33 65.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.598 -0.689 . . . . 1.9 109.849 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 54.5 m -80.61 -31.56 36.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.41 111.732 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.6 p -133.19 -23.37 1.94 Allowed 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.374 -1.453 . . . . 0.4 111.916 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.85 13.09 32.85 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.171 -1.572 . . . . 0.36 109.171 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.88 154.74 2.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.097 -1.237 . . . . 0.33 109.371 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.93 171.88 9.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 1.9 110.214 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.51 75.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.694 -0.629 . . . . 0.39 110.38 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -73.06 -40.68 64.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.851 -1.155 . . . . 2.58 110.105 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.3 mm100 -67.94 -35.13 77.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.974 . . . . 2.12 110.284 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.4 -38.22 81.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.363 -0.836 . . . . 1.36 110.085 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.06 -36.27 76.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.886 -1.134 . . . . 2.8 109.547 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -68.97 -39.89 79.18 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.749 -1.22 . . . . 0.4 110.806 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.03 -40.36 75.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.674 -1.266 . . . . 0.24 110.061 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.77 -60.01 4.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.717 -1.239 . . . . 0.43 109.482 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.64 -33.7 87.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.351 -1.1 . . . . 0.26 110.351 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.73 -46.55 62.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.761 -1.435 . . . . 0.25 109.356 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.926 -1.11 . . . . 0.3 108.659 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.43 -40.06 95.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 2.73 110.295 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.534 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.6 mt-10 -69.85 -37.74 76.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 1.91 110.165 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.8 t90 -60.0 -42.85 95.18 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.53 -1.356 . . . . 0.37 107.821 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 89' ' ' LEU . 88.3 m -60.79 -40.09 91.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -0.84 . . . . 0.36 109.668 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.91 -32.28 69.4 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.017 -1.052 . . . . 0.55 110.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.5 -34.03 14.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.107 -0.995 . . . . 0.48 110.999 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 91.4 m-85 -107.61 2.2 23.79 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.089 -1.007 . . . . 1.24 111.357 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 85' ' ' CYS . 54.9 tp . . . . . 0 N--CA 1.495 1.802 0 O-C-N 120.856 -1.152 . . . . 1.66 109.404 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.432 ' O ' ' OG1' ' B' ' 2' ' ' THR . 19.3 mmm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.946 -0.761 . . . . 5.66 108.946 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' B' ' 1' ' ' MET . 3.4 p 49.62 42.54 23.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.905 . . . . 3.02 109.726 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 44.0 p -78.66 161.63 26.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -0.959 . . . . 0.96 109.828 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 98.0 p -72.51 169.14 17.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.442 -0.786 . . . . 1.5 109.582 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.52 -22.67 61.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.727 -0.608 . . . . 2.18 110.202 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -60.09 -38.59 83.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.094 -1.004 . . . . 2.01 109.189 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.541 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 14.2 t60 -56.85 -49.73 74.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.49 110.144 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -70.11 -34.02 72.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 3.23 110.034 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -70.73 -36.52 73.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.312 -0.868 . . . . 0.76 109.744 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.987 ' CD2' ' CD1' ' B' ' 10' ' ' PHE . . . -64.91 -42.94 94.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.479 -0.763 . . . . 0.46 109.869 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 m -84.0 14.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.161 -0.962 . . . . 0.44 110.302 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.07 -9.3 11.09 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.34 -0.85 . . . . 0.53 110.297 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.87 149.76 19.34 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.102 . . . . 1.27 109.37 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -40.58 155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.761 1.64 . . . . 0.49 111.205 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.524 ' CE ' HD22 ' B' ' 46' ' ' LEU . 4.2 ptp -91.16 -19.83 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.895 -1.128 . . . . 0.56 109.239 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.82 -138.44 41.81 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.341 -1.104 . . . . 0.39 110.341 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.52 30.52 5.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.635 -0.921 . . . . 0.84 110.408 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -60.03 148.31 77.84 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 2.02 107.933 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.78 159.12 34.43 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.096 1.864 . . . . 0.34 112.591 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.562 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.5 p -57.19 -49.15 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.485 0.659 . . . . 0.32 110.554 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.562 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.38 -2.21 0.15 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.791 -0.924 . . . . 0.22 110.791 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.488 ' H ' ' C ' ' B' ' 20' ' ' VAL . 61.1 p -81.91 -24.73 35.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.766 -1.432 . . . . 1.24 110.032 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.2 138.79 58.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.296 -0.877 . . . . 0.24 109.867 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.69 53.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.702 0.763 . . . . 0.21 109.836 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.513 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 97.17 -20.42 50.85 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.219 -1.552 . . . . 0.22 109.219 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.8 mm -99.69 113.18 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.894 -1.15 . . . . 0.25 107.894 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.419 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -93.48 179.98 39.14 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.714 -1.354 . . . . 0.28 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.433 ' O ' ' NZ ' ' B' ' 32' ' ' LYS . 79.6 mm-40 -56.07 -39.98 72.89 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.437 -1.037 . . . . 2.0 109.787 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.84 -42.99 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.956 -1.09 . . . . 0.38 109.534 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.419 HD12 ' H ' ' B' ' 27' ' ' GLY . 97.2 mt -67.81 -39.99 83.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.4 109.437 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.18 97.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.057 -1.217 . . . . 0.36 110.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' B' ' 28' ' ' GLU . 33.6 mtmm -64.55 -38.46 91.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.248 . . . . 2.75 110.111 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.67 -48.82 70.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.824 -1.173 . . . . 1.56 109.211 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.88 -38.63 86.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.26 -0.9 . . . . 0.33 108.579 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.95 -40.16 88.04 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.692 -0.855 . . . . 1.68 108.692 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.89 -18.82 64.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.47 -0.937 . . . . 1.99 108.47 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -91.23 2.44 56.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 2.68 110.163 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 7.01 48.44 Favored Glycine 0 N--CA 1.503 3.118 0 O-C-N 121.08 -1.013 . . . . 0.49 112.242 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' B' ' 39' ' ' PHE . 45.6 m-85 -106.36 76.95 1.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 119.19 1.495 . . . . 0.33 109.314 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -77.18 -8.47 57.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.377 -0.827 . . . . 0.41 110.98 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.67 158.31 44.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 1.56 109.437 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.4 91.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.48 -0.763 . . . . 0.21 112.173 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -58.17 -17.32 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.695 -1.253 . . . . 0.32 110.765 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.45 -29.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.908 -1.12 . . . . 0.24 108.104 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.88 -39.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.928 -1.138 . . . . 0.22 107.928 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.524 HD22 ' CE ' ' B' ' 15' ' ' MET . 60.7 tp -59.98 -39.84 87.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.257 -1.386 . . . . 0.4 107.257 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.7 -43.82 69.2 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.173 -1.571 . . . . 0.18 109.173 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.96 -44.62 94.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -1.207 . . . . 1.09 108.791 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.97 -41.28 91.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.31 109.007 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 mt -69.96 -39.7 75.86 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.878 -0.729 . . . . 0.27 109.186 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.98 -20.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.166 -0.959 . . . . 0.28 110.561 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.47 17.82 9.44 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.0 -1.063 . . . . 0.3 109.907 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm 52.25 32.52 10.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.959 -1.088 . . . . 1.71 110.151 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt 60.0 20.08 9.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.746 . . . . 2.25 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -67.96 111.5 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.817 -1.177 . . . . 1.8 108.072 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.39 -40.69 97.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.88 112.641 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.86 -39.91 76.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.523 -1.361 . . . . 0.74 109.663 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.96 -39.99 75.7 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.929 -1.108 . . . . 0.55 108.73 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.02 -50.04 70.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.99 . . . . 0.38 110.096 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -61.27 -44.46 97.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 2.64 110.548 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.413 ' O ' ' OD2' ' B' ' 65' ' ' ASP . 98.9 mt-10 -65.03 -38.1 89.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.776 -1.203 . . . . 2.38 108.866 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -63.83 -48.27 77.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.4 111.013 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.05 -46.46 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.909 -1.119 . . . . 0.34 109.989 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -61.73 -47.17 86.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 2.1 109.707 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' B' ' 61' ' ' GLU . 71.3 m-20 -69.93 -28.35 65.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.689 . . . . 1.9 109.906 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -80.54 -31.6 36.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.4 111.737 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.8 p -133.3 -23.2 1.92 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.326 -1.484 . . . . 0.39 111.919 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.71 34.11 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 109.237 -1.545 . . . . 0.36 109.237 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.55 154.53 1.85 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.091 -1.241 . . . . 0.32 109.39 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -88.74 171.96 9.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 1.91 110.177 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.75 75.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.646 -0.658 . . . . 0.38 110.417 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -72.89 -40.69 65.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.859 -1.151 . . . . 2.57 110.128 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.2 mm100 -67.92 -35.2 78.03 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.248 -0.907 . . . . 2.12 110.354 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.1 t -68.27 -38.37 81.66 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.179 -0.951 . . . . 1.36 110.074 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.92 -36.53 77.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.86 -1.15 . . . . 2.81 109.531 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -68.6 -40.03 80.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.778 -1.201 . . . . 0.4 110.747 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.2 m -70.06 -40.37 75.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.749 -1.219 . . . . 0.23 110.123 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.75 -59.97 4.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.699 -1.251 . . . . 0.43 109.525 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.75 87.42 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.344 -1.102 . . . . 0.25 110.344 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.73 -46.41 63.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.725 -1.456 . . . . 0.24 109.337 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.6 -40.43 69.86 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.935 -1.106 . . . . 0.29 108.628 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.24 -39.99 95.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.98 . . . . 2.74 110.316 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.4 mt-10 -69.8 -37.76 76.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 1.91 110.167 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.549 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 87.0 t90 -60.04 -42.72 95.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.5 -1.375 . . . . 0.36 107.866 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' B' ' 89' ' ' LEU . 89.4 m -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.36 109.748 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.02 -32.55 69.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.049 -1.032 . . . . 0.55 109.912 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.2 -34.11 14.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.135 -0.978 . . . . 0.47 111.06 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.549 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 92.4 m-85 -107.41 2.02 24.03 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.195 -0.941 . . . . 1.24 111.465 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' B' ' 85' ' ' CYS . 54.7 tp . . . . . 0 N--CA 1.495 1.785 0 O-C-N 120.695 -1.253 . . . . 1.67 109.321 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtm . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.525 -0.546 . . . . 5.68 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.7 m -86.18 110.1 19.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.946 . . . . 3.02 109.438 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.2 p -98.81 164.61 12.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.37 -0.831 . . . . 0.96 109.273 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 t -69.92 164.86 22.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 1.51 109.314 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.74 -26.46 63.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.687 -0.633 . . . . 2.18 110.074 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -36.0 76.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.001 -1.062 . . . . 2.02 109.567 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -58.86 -50.01 75.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.49 110.127 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.6 mmp_? -69.96 -32.83 71.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.044 -1.035 . . . . 3.21 109.751 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.47 -40.02 89.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.234 -0.917 . . . . 0.76 109.628 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.97 -49.04 76.28 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.246 -0.909 . . . . 0.46 109.792 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.21 4.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.232 -0.917 . . . . 0.44 111.863 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -97.57 -18.92 18.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.686 -1.259 . . . . 0.54 110.359 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 1.4 pp20? -155.83 152.26 23.6 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 1.26 108.596 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 48.5 Cg_exo -35.36 155.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.174 1.916 . . . . 0.49 112.034 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' HD13 ' B' ' 89' ' ' LEU . 11.4 ptm -90.92 -23.08 20.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.145 -0.972 . . . . 0.57 110.484 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.09 -136.35 20.58 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.984 -1.073 . . . . 0.4 110.715 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.06 28.37 8.67 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.523 -0.986 . . . . 0.85 111.02 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.6 148.34 56.63 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 118.557 -1.257 . . . . 2.01 107.756 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.19 159.34 19.12 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.619 2.213 . . . . 0.34 113.183 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 22' ' ' SER . 4.3 p -59.63 -48.52 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.32 110.576 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -52.95 -1.87 0.07 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.435 -1.066 . . . . 0.23 110.435 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 20' ' ' VAL . 10.6 p -83.3 -26.42 30.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.385 . . . . 1.24 109.973 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.65 137.29 58.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.24 110.296 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 132.63 49.08 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.789 0.804 . . . . 0.21 110.234 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.95 -18.1 56.29 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.003 -1.639 . . . . 0.22 109.003 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.88 114.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.827 -1.175 . . . . 0.25 107.827 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.1 177.58 38.29 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.458 -1.457 . . . . 0.28 109.458 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -58.83 -40.14 83.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -1.125 . . . . 2.01 109.494 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.22 -48.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.042 -1.037 . . . . 0.38 109.42 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.41 -39.99 81.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.4 109.212 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.03 96.42 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.236 -1.546 . . . . 0.35 109.236 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 36' ' ' GLU . 14.7 tmtt? -61.36 -40.0 92.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.338 -1.096 . . . . 2.74 110.775 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.04 -40.1 87.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.736 -1.227 . . . . 1.54 109.986 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.58 -38.04 83.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.923 -1.11 . . . . 0.34 108.893 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.424 -0.91 . . . . 1.67 108.992 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 32' ' ' LYS . 98.9 mt-10 -68.06 -18.62 64.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 2.0 108.822 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -89.97 2.01 55.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.46 -0.775 . . . . 2.69 109.859 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.49 5.18 42.89 Favored Glycine 0 N--CA 1.502 3.077 0 O-C-N 121.115 -0.991 . . . . 0.48 112.18 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.7 76.97 1.32 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.694 -1.474 . . . . 0.33 109.141 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -75.48 -8.86 57.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.41 110.437 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.16 160.02 40.78 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.079 -1.013 . . . . 1.56 110.263 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.84 92.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.558 -0.714 . . . . 0.21 112.512 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 7.5 p90 -58.73 -17.74 25.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.515 -1.366 . . . . 0.32 110.555 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -80.01 -32.71 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.794 -1.191 . . . . 0.24 108.315 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.06 -39.1 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.22 108.237 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 tp -59.98 -36.38 77.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.866 -1.161 . . . . 0.4 107.866 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.52 97.06 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.18 110.02 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.98 -40.03 87.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.245 . . . . 1.09 109.035 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.96 -39.95 87.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.373 -0.973 . . . . 0.31 108.373 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.053 -0.721 . . . . 0.28 109.053 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.22 -23.97 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.246 -0.909 . . . . 0.28 111.001 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.37 17.61 11.06 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.045 -1.034 . . . . 0.31 110.154 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' NZ ' ' O ' ' B' ' 38' ' ' GLY . 12.7 mptt 52.47 29.31 6.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.944 -1.098 . . . . 1.7 109.828 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.03 19.94 9.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 2.24 110.255 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -67.23 117.75 9.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.511 -1.368 . . . . 1.8 107.683 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.11 -40.95 97.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.311 -0.868 . . . . 0.87 112.99 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.488 ' CG ' HH21 ' A' ' 60' ' ' ARG . 7.6 m-20 -69.68 -39.93 76.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.669 -1.27 . . . . 0.73 110.115 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.3 mt -69.95 -39.99 75.71 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.007 -1.077 . . . . 0.55 109.036 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.46 -49.91 73.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.38 109.71 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.488 HH21 ' CG ' ' A' ' 57' ' ' ASP . 87.7 mtm180 -60.37 -45.79 92.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.354 -0.841 . . . . 2.64 110.622 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.64 -39.77 94.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.931 -1.105 . . . . 2.37 108.788 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -65.51 -48.76 71.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.4 111.362 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.5 tp -67.42 -47.09 71.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.34 110.095 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.01 -45.95 92.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.38 -0.825 . . . . 2.11 109.714 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.03 -27.33 64.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.9 109.945 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -80.59 -33.9 35.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.41 111.526 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.2 p -130.59 -27.27 2.16 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.555 -1.34 . . . . 0.4 112.083 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.16 22.64 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.171 -1.572 . . . . 0.36 109.171 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 153.1 2.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -1.196 . . . . 0.33 109.618 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.6 172.96 8.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.115 -0.991 . . . . 1.9 109.715 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.23 72.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.39 111.025 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.1 -39.71 63.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.711 -1.243 . . . . 2.58 110.05 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 28.5 mm100 -67.38 -39.88 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 2.12 110.694 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -67.52 -37.51 82.89 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.288 -0.882 . . . . 1.36 109.958 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 75' ' ' ARG . 25.7 mtt-85 -60.41 -37.24 80.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.114 . . . . 2.8 109.632 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.78 -39.9 84.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.571 -1.33 . . . . 0.4 110.552 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.8 m -67.94 -40.0 83.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.24 109.806 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.43 -60.05 4.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.879 -1.138 . . . . 0.43 109.954 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.66 -34.28 88.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.448 -1.061 . . . . 0.26 110.448 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.25 -47.33 57.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -1.202 . . . . 0.25 109.804 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.61 -40.07 73.38 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.695 -1.202 . . . . 0.3 108.328 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -63.01 -40.07 96.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 2.73 110.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -69.41 -37.81 77.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.02 -1.05 . . . . 1.91 110.474 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.487 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 84.6 t90 -59.97 -43.86 94.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.39 -1.444 . . . . 0.37 107.363 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.3 m -60.6 -40.67 92.64 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.894 -0.78 . . . . 0.36 108.894 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.631 -0.668 . . . . 0.55 109.695 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -36.78 16.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.48 110.125 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 83.9 m-85 -105.56 -88.17 0.45 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.35 -0.844 . . . . 1.24 110.032 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.466 HD13 ' SD ' ' B' ' 15' ' ' MET . 16.2 tp . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.097 -0.954 . . . . 1.66 109.78 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.472 -0.566 . . . . 5.66 109.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 89.0 m -86.25 110.13 19.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.079 -1.013 . . . . 3.02 109.434 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 82.4 p -98.75 164.61 12.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.32 -0.863 . . . . 0.96 109.24 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t -69.87 164.94 22.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.91 . . . . 1.5 109.21 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -58.81 -26.53 64.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.702 -0.624 . . . . 2.18 110.094 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.13 -35.73 75.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.085 . . . . 2.01 109.575 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -58.96 -49.94 75.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.49 110.213 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 3.6 mmp_? -70.06 -32.76 71.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 3.23 109.749 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.45 -39.92 89.14 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.483 -0.887 . . . . 0.76 109.743 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.0 -49.16 75.76 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.263 -0.898 . . . . 0.46 109.71 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -88.12 4.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.144 -0.973 . . . . 0.44 111.834 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -97.29 -19.0 18.84 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.661 -1.274 . . . . 0.53 110.418 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' B' ' 14' ' ' PRO . 1.4 pp20? -155.84 152.34 23.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.955 . . . . 1.27 108.63 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' OE1' ' B' ' 13' ' ' GLU . 48.7 Cg_exo -35.37 155.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.266 1.977 . . . . 0.49 111.989 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.466 ' SD ' HD13 ' A' ' 89' ' ' LEU . 11.3 ptm -90.89 -23.25 20.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.56 110.432 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.33 21.13 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.894 -1.128 . . . . 0.39 110.7 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.2 28.72 8.35 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.634 -0.921 . . . . 0.84 111.021 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -57.77 148.4 58.18 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.648 -1.283 . . . . 2.02 107.608 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.18 159.44 18.84 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.639 2.226 . . . . 0.34 113.207 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' B' ' 22' ' ' SER . 4.2 p -59.79 -48.6 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.32 110.512 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.489 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -52.7 -2.14 0.07 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.443 -1.063 . . . . 0.22 110.443 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.539 ' H ' ' C ' ' B' ' 20' ' ' VAL . 10.6 p -83.09 -26.43 31.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.787 -1.419 . . . . 1.24 110.055 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.79 137.29 58.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.27 -0.894 . . . . 0.24 110.273 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.82 132.63 49.16 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.82 0.819 . . . . 0.21 110.175 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.99 -18.31 55.95 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.902 -1.679 . . . . 0.22 108.902 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -101.68 114.78 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.848 -1.167 . . . . 0.25 107.848 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.16 177.65 38.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.493 -1.443 . . . . 0.28 109.493 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -58.95 -40.01 83.39 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.337 -1.096 . . . . 2.0 109.48 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.47 -48.9 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.38 109.333 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.51 -39.9 81.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.4 109.178 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.98 96.43 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.251 -1.54 . . . . 0.36 109.251 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' B' ' 36' ' ' GLU . 14.7 tmtt? -61.25 -39.94 92.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 2.75 110.798 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.2 -40.02 86.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.687 -1.258 . . . . 1.56 109.977 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -60.74 -38.01 83.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.923 -1.11 . . . . 0.33 108.889 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -40.51 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.429 -0.909 . . . . 1.68 108.973 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' NZ ' ' B' ' 32' ' ' LYS . 98.9 mt-10 -68.01 -18.61 64.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 1.99 108.88 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -90.03 2.14 55.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.818 . . . . 2.68 109.793 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.413 ' O ' ' NZ ' ' A' ' 53' ' ' LYS . . . 104.4 5.26 43.06 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.246 -0.978 . . . . 0.49 112.154 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.72 76.89 1.31 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.49 . . . . 0.33 109.144 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -75.43 -8.89 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.104 -0.997 . . . . 0.41 110.522 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -139.13 159.95 40.93 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.067 -1.021 . . . . 1.56 110.162 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.93 93.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.647 -0.658 . . . . 0.21 112.542 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 7.4 p90 -58.66 -17.77 25.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.532 -1.355 . . . . 0.32 110.614 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.0 t -79.9 -32.76 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.796 -1.19 . . . . 0.24 108.286 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 77.2 t -76.0 -39.13 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.216 -1.031 . . . . 0.22 108.216 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 tp -60.06 -36.2 76.82 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.876 -1.157 . . . . 0.4 107.876 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.68 97.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.028 -1.229 . . . . 0.18 110.028 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.9 -40.02 87.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.094 -1.239 . . . . 1.09 109.154 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.95 -40.07 87.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.297 -1.001 . . . . 0.31 108.297 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.082 -0.71 . . . . 0.27 109.082 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.29 -23.99 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.357 -0.84 . . . . 0.28 110.973 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.33 17.58 11.05 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.945 -1.097 . . . . 0.3 110.164 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mptt 52.72 29.11 7.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.921 -1.112 . . . . 1.71 109.818 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 60.0 19.99 9.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.416 -0.803 . . . . 2.25 110.208 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.33 117.57 9.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.318 . . . . 1.8 107.739 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.0 -40.92 97.45 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.075 0.769 . . . . 0.88 113.075 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.49 ' CG ' HH21 ' B' ' 60' ' ' ARG . 7.6 m-20 -69.65 -39.98 76.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.535 -1.353 . . . . 0.74 110.056 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.98 -40.0 75.62 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.01 -1.076 . . . . 0.55 108.94 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.48 -49.96 73.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.38 109.68 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' B' ' 57' ' ' ASP . 87.8 mtm180 -60.4 -45.54 93.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.407 -0.808 . . . . 2.64 110.62 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.77 -39.78 94.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.957 -1.09 . . . . 2.38 108.756 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 63.0 t90 -65.53 -48.75 71.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.4 111.383 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -67.26 -47.19 71.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.007 -1.058 . . . . 0.34 110.09 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -61.03 -45.94 92.76 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.389 -0.819 . . . . 2.1 109.787 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.03 -27.34 64.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.445 -0.784 . . . . 1.9 109.884 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 96.8 m -80.54 -33.84 35.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.4 111.574 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.1 p -130.63 -27.35 2.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.595 -1.316 . . . . 0.39 112.027 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 14.09 22.59 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.154 -1.578 . . . . 0.36 109.154 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.01 153.24 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -1.185 . . . . 0.32 109.654 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -91.62 172.96 8.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.174 -0.954 . . . . 1.91 109.728 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.48 -33.34 72.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 0.38 110.959 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.02 -39.67 63.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.66 -1.275 . . . . 2.57 110.049 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 28.6 mm100 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 2.12 110.675 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.8 t -67.5 -37.48 82.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.851 . . . . 1.36 110.004 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.487 HH11 ' HG2' ' B' ' 75' ' ' ARG . 25.2 mtt-85 -60.36 -37.33 80.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.015 -1.053 . . . . 2.81 109.584 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -67.65 -39.93 84.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.698 -1.251 . . . . 0.4 110.588 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.93 -39.99 83.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.854 -1.154 . . . . 0.23 109.809 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.39 -59.98 4.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.95 -1.094 . . . . 0.43 109.967 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.57 -34.52 88.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.452 -1.059 . . . . 0.25 110.452 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 49.4 t -71.14 -47.22 59.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -1.179 . . . . 0.24 109.832 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.7 mt -70.68 -40.13 73.12 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.716 -1.194 . . . . 0.29 108.326 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -63.03 -40.1 96.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 2.74 109.93 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -69.47 -37.6 77.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.054 -1.029 . . . . 1.91 110.482 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.484 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 84.8 t90 -60.02 -43.86 94.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.456 -1.403 . . . . 0.36 107.318 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 51.6 m -60.65 -40.66 92.83 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.93 -0.767 . . . . 0.36 108.93 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.96 -38.19 85.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.615 -0.678 . . . . 0.55 109.626 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.8 -37.75 16.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 0.47 110.075 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 85.2 m-85 -104.34 -87.69 0.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.901 . . . . 1.24 110.413 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.461 HD13 ' SD ' ' A' ' 15' ' ' MET . 16.4 tp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.133 -0.937 . . . . 1.67 109.711 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.189 0.518 . . . . 5.68 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.7 m -82.2 110.42 17.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.069 -1.02 . . . . 3.02 109.433 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.9 p -112.0 156.75 21.64 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.431 -0.793 . . . . 0.96 109.842 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -84.88 177.74 7.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.232 -0.918 . . . . 1.51 109.15 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -62.16 -22.61 66.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.744 -0.597 . . . . 2.18 110.648 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.29 -39.26 89.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 2.02 108.998 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 11' ' ' VAL . 16.1 t60 -60.1 -50.28 74.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.49 110.806 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.515 HH11 ' HG2' ' A' ' 8' ' ' ARG . 20.5 mtt-85 -69.94 -35.59 74.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.998 -1.064 . . . . 3.21 109.85 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -66.96 -39.79 87.33 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.436 -0.79 . . . . 0.76 109.529 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 50.7 t80 -65.25 -45.5 84.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.818 . . . . 0.46 110.194 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 7' ' ' HIS . 18.7 m -88.62 5.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.007 -1.058 . . . . 0.44 111.55 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.957 -1.089 . . . . 0.54 110.319 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.0 pt-20 -152.06 153.15 30.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.374 -0.973 . . . . 1.26 108.374 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 13' ' ' GLU . 58.0 Cg_exo -37.29 155.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.944 1.763 . . . . 0.49 111.641 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.522 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 12.6 ptm -92.75 -28.9 16.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 0.57 109.968 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.65 -134.99 46.29 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.422 -1.071 . . . . 0.4 110.422 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.5 34.5 3.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.64 -0.918 . . . . 0.85 110.061 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -58.81 148.76 67.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 2.01 108.695 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.81 155.93 35.48 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.086 1.857 . . . . 0.34 112.15 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 21' ' ' GLY . 13.8 p -58.31 -41.9 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.693 0.759 . . . . 0.32 110.167 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -61.51 -2.25 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.103 -1.199 . . . . 0.23 110.103 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 t -81.59 -21.17 38.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.728 -1.454 . . . . 1.24 108.919 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 81' ' ' LEU . 97.1 mt -65.39 138.52 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.369 -0.832 . . . . 0.24 109.652 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.98 57.72 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.948 -0.701 . . . . 0.21 109.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 -18.41 56.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.572 -1.411 . . . . 0.22 109.572 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.6 mm -99.52 112.0 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.715 -1.217 . . . . 0.25 107.715 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.89 -179.05 36.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.649 -1.38 . . . . 0.28 109.649 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 59.7 mp0 -57.28 -40.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -1.119 . . . . 2.01 109.532 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.9 -45.87 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.38 109.32 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.89 -39.59 83.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.4 109.39 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.82 -39.96 96.08 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.96 -1.656 . . . . 0.35 108.96 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.91 -39.97 96.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 2.74 109.72 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.92 -44.1 77.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 1.54 108.809 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.1 mt -64.84 -40.61 95.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.34 108.64 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.14 -44.15 95.18 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.642 -0.661 . . . . 1.67 109.55 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.21 -19.58 66.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.398 -0.814 . . . . 2.0 108.917 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -90.39 3.99 52.19 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.521 -0.737 . . . . 2.69 109.981 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.81 48.35 Favored Glycine 0 N--CA 1.502 3.048 0 O-C-N 121.167 -0.958 . . . . 0.48 111.579 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' A' ' 44' ' ' VAL . 92.4 m-85 -106.51 75.59 1.08 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.714 -1.462 . . . . 0.33 109.55 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.73 -9.9 59.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.074 -1.016 . . . . 0.41 110.316 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.2 mmtm -134.87 156.67 48.53 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.203 -0.936 . . . . 1.56 110.001 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.65 94.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.63 -0.669 . . . . 0.21 111.233 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 23.6 p90 -58.59 -20.07 43.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.704 -1.248 . . . . 0.32 110.951 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.5 t -78.58 -34.51 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.643 -1.286 . . . . 0.24 108.022 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 20' ' ' VAL . 74.4 t -76.32 -38.92 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.187 -1.042 . . . . 0.22 108.187 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.09 -38.8 84.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.296 -1.001 . . . . 0.4 108.296 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.84 97.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.817 -1.313 . . . . 0.18 109.817 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.08 -42.03 93.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.275 . . . . 1.09 109.341 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -59.22 -40.09 84.76 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.296 -1.001 . . . . 0.31 108.296 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.08 -38.72 79.16 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.377 -0.972 . . . . 0.28 108.377 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.14 -24.61 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.394 -0.816 . . . . 0.28 110.251 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.24 16.14 17.39 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.118 -0.989 . . . . 0.31 110.678 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.54 40.4 15.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.726 -1.234 . . . . 1.7 110.719 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 59.19 19.62 7.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 2.24 109.843 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.31 107.01 2.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.743 -1.223 . . . . 1.8 107.994 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CD ' HH21 ' A' ' 60' ' ' ARG . 88.1 tt0 -61.75 -40.5 95.34 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.501 -0.75 . . . . 0.87 112.562 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.63 -40.07 76.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.534 -1.353 . . . . 0.73 109.728 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.66 -39.99 76.73 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.726 -1.19 . . . . 0.55 109.199 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.31 -50.14 68.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.38 109.483 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.526 HH21 ' CD ' ' A' ' 56' ' ' GLU . 34.1 mtt-85 -60.88 -46.12 91.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.372 -0.83 . . . . 2.64 110.682 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.04 -38.31 90.59 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.819 -1.175 . . . . 2.37 108.841 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -66.8 -45.25 78.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.4 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.27 -48.91 68.92 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.149 -0.969 . . . . 0.34 110.046 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -62.0 -44.56 96.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.242 -0.911 . . . . 2.11 109.257 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.59 -32.39 71.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.567 -0.708 . . . . 1.9 109.739 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -79.97 -31.86 39.86 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.41 111.345 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.32 -30.15 1.53 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.572 -1.33 . . . . 0.4 112.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.12 19.89 Favored Glycine 0 N--CA 1.501 3.025 0 N-CA-C 109.196 -1.561 . . . . 0.36 109.196 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.0 152.9 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.242 . . . . 0.33 109.467 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -91.9 175.18 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.071 -1.018 . . . . 1.9 109.623 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.81 77.87 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.39 110.103 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -73.79 -39.97 63.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.109 -0.994 . . . . 2.58 109.995 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.85 -36.96 83.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 2.12 110.539 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 p -69.22 -37.17 77.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.133 -0.979 . . . . 1.36 110.027 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.03 -37.61 80.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.831 -1.168 . . . . 2.8 109.707 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.05 -40.0 87.02 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.746 -1.221 . . . . 0.4 110.442 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 61.5 m -70.04 -42.5 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.726 -1.234 . . . . 0.24 110.398 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.421 ' HB3' HH22 ' A' ' 60' ' ' ARG . 79.4 t80 -60.14 -60.17 4.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.57 -1.331 . . . . 0.43 110.113 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.86 -34.52 90.03 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.334 -1.106 . . . . 0.26 110.334 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.71 -47.91 57.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.726 -1.455 . . . . 0.25 109.781 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 23' ' ' LEU . 96.9 mt -70.11 -40.03 75.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.798 -1.161 . . . . 0.3 108.345 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.485 HH11 ' HG2' ' A' ' 82' ' ' ARG . 4.6 ttt-85 -61.36 -40.11 93.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 2.73 109.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -68.8 -37.42 79.24 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 1.91 109.878 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.522 ' CZ2' ' SD ' ' A' ' 15' ' ' MET . 80.4 t90 -59.65 -45.67 91.32 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.94 -1.504 . . . . 0.37 106.94 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -61.83 -41.52 97.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.716 -0.615 . . . . 0.36 109.46 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -60.27 -37.24 79.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.2 -0.937 . . . . 0.55 109.954 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.1 -35.87 19.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.48 109.888 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -105.7 -86.73 0.47 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.363 -0.836 . . . . 1.24 110.395 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.419 HD13 ' SD ' ' B' ' 15' ' ' MET . 11.6 tp . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.148 -0.93 . . . . 1.66 109.161 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.561 -0.533 . . . . 5.66 109.561 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 41.8 m -81.95 110.41 17.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.075 -1.016 . . . . 3.02 109.357 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.6 p -112.0 156.6 21.88 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.586 -0.696 . . . . 0.96 109.997 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 50.4 m -84.63 177.34 8.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.19 -0.944 . . . . 1.5 109.233 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.94 -22.75 65.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.703 -0.623 . . . . 2.18 110.671 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -61.21 -39.24 89.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.017 -1.052 . . . . 2.01 108.852 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.41 ' O ' HG22 ' B' ' 11' ' ' VAL . 16.0 t60 -60.1 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.49 110.746 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.511 HH11 ' HG2' ' B' ' 8' ' ' ARG . 20.8 mtt-85 -70.05 -35.65 74.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.903 -1.123 . . . . 3.23 109.758 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -66.73 -40.03 88.2 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.638 -0.664 . . . . 0.76 109.642 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.431 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 49.7 t80 -64.99 -45.91 83.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.46 110.25 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 7' ' ' HIS . 18.9 m -88.38 5.71 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.16 -0.962 . . . . 0.44 111.48 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -100.92 -15.98 17.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.881 -1.137 . . . . 0.53 110.26 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -152.11 153.26 30.98 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 1.27 108.352 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -37.35 155.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.998 1.798 . . . . 0.49 111.584 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.516 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 12.5 ptm -92.77 -28.85 16.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.56 110.035 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.71 -135.03 46.47 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.357 -1.097 . . . . 0.39 110.357 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -110.61 34.55 3.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.468 -1.019 . . . . 0.84 109.944 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -58.75 148.63 67.21 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 2.02 108.601 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.76 155.82 35.75 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.06 1.84 . . . . 0.34 112.175 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.531 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.0 p -58.29 -41.84 82.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.496 -0.753 . . . . 0.32 110.093 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.531 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -61.33 -2.31 2.96 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.119 -1.192 . . . . 0.22 110.119 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.7 t -81.73 -21.1 38.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.895 -1.356 . . . . 1.24 108.914 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.59 HD22 HD21 ' B' ' 81' ' ' LEU . 97.3 mt -65.31 138.52 58.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.24 109.676 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.36 136.94 57.61 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.743 -0.783 . . . . 0.21 109.744 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 -18.34 56.91 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.604 -1.398 . . . . 0.22 109.604 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.52 111.87 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.709 -1.219 . . . . 0.25 107.709 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.87 36.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.731 -1.348 . . . . 0.28 109.731 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 59.5 mp0 -57.48 -39.86 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -1.07 . . . . 2.0 109.567 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.05 -45.89 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.38 109.344 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.88 -39.54 83.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -0.889 . . . . 0.4 109.518 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.92 -39.77 95.98 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.915 -1.674 . . . . 0.36 108.915 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.05 -40.04 96.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 2.75 109.771 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.74 -43.99 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.074 -1.016 . . . . 1.56 108.962 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.01 -40.4 94.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.33 108.699 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -60.19 -44.27 95.23 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.034 -0.666 . . . . 1.68 109.478 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.16 -19.71 66.11 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 1.99 109.016 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -90.35 3.93 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.654 -0.654 . . . . 2.68 109.925 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 7.4 48.41 Favored Glycine 0 N--CA 1.502 3.08 0 O-C-N 121.095 -1.003 . . . . 0.49 111.697 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' B' ' 44' ' ' VAL . 91.4 m-85 -106.26 75.45 1.09 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.866 -1.373 . . . . 0.33 109.658 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -79.76 -10.0 59.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.41 110.36 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.473 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.3 mmtm -134.68 156.87 48.01 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.136 -0.978 . . . . 1.56 109.886 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.71 94.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.754 -0.591 . . . . 0.21 111.242 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 24.0 p90 -58.56 -20.01 42.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.32 111.042 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.9 t -78.68 -34.47 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 0.24 107.916 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.439 HG21 HG23 ' B' ' 20' ' ' VAL . 74.0 t -76.23 -39.1 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.164 -1.05 . . . . 0.22 108.164 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.95 -39.02 84.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.305 -0.998 . . . . 0.4 108.305 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -41.05 97.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.845 -1.302 . . . . 0.18 109.845 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -60.04 -41.94 93.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.112 -1.228 . . . . 1.09 109.343 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.26 -40.0 84.62 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 0.31 108.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.17 -38.76 78.9 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.434 -0.95 . . . . 0.27 108.434 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.16 -24.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.304 -0.872 . . . . 0.28 110.194 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.34 16.15 17.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.108 -0.995 . . . . 0.3 110.784 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? 48.41 40.64 15.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.698 -1.252 . . . . 1.71 110.73 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 58.93 19.74 7.42 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.468 -0.77 . . . . 2.25 109.853 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.28 107.04 2.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.698 -1.251 . . . . 1.8 107.729 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.544 ' CD ' HH21 ' B' ' 60' ' ' ARG . 88.2 tt0 -61.63 -40.52 95.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.429 -0.794 . . . . 0.88 112.584 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.75 -39.58 76.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.74 109.855 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.96 -39.96 75.69 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.685 -1.206 . . . . 0.55 109.025 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.31 -50.32 68.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.38 109.457 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.544 HH21 ' CD ' ' B' ' 56' ' ' GLU . 34.0 mtt-85 -60.76 -46.19 91.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.815 . . . . 2.64 110.572 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.92 -38.34 90.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.854 -1.154 . . . . 2.38 108.933 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . 0.407 ' O ' ' OG1' ' B' ' 66' ' ' THR . 51.2 t90 -66.79 -45.24 79.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.4 110.415 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.32 -48.79 69.17 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.266 -0.896 . . . . 0.34 109.989 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.391 -0.818 . . . . 2.1 109.249 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.43 -32.63 71.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.58 -0.7 . . . . 1.9 109.684 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 87.5 m -79.66 -31.92 41.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.4 111.471 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.0 p -132.41 -30.0 1.53 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.436 -1.415 . . . . 0.39 112.193 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.73 15.02 19.91 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.138 -1.585 . . . . 0.36 109.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.77 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.245 . . . . 0.32 109.416 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -91.83 175.37 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 1.91 109.731 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.96 78.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.483 -0.761 . . . . 0.38 110.122 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -73.81 -39.78 63.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 2.57 109.99 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.03 -36.88 83.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 2.12 110.545 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 18.8 p -69.25 -37.23 77.84 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.171 -0.956 . . . . 1.36 110.003 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -37.88 80.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.06 -1.025 . . . . 2.81 109.593 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.98 -39.84 87.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.502 -1.374 . . . . 0.4 110.441 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.16 -42.62 72.26 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.69 -1.256 . . . . 0.23 110.401 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.411 ' HB3' HH22 ' B' ' 60' ' ' ARG . 79.3 t80 -59.99 -60.12 4.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.575 -1.328 . . . . 0.43 110.068 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.95 -34.47 90.0 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.368 -1.093 . . . . 0.25 110.368 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 47.1 t -70.52 -48.1 57.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.793 -1.416 . . . . 0.24 109.84 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.59 HD21 HD22 ' B' ' 23' ' ' LEU . 97.0 mt -70.04 -39.96 75.43 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.799 -1.16 . . . . 0.29 108.435 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' B' ' 82' ' ' ARG . 4.7 ttt-85 -61.47 -40.0 92.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 2.74 109.515 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.95 -37.23 78.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.379 -0.826 . . . . 1.91 109.91 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.516 ' CZ2' ' SD ' ' B' ' 15' ' ' MET . 80.8 t90 -60.0 -45.68 91.93 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.972 -1.492 . . . . 0.36 106.972 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 32.7 m -61.83 -41.22 97.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.69 -0.631 . . . . 0.36 109.527 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.35 -37.18 79.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.55 109.939 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.38 -36.36 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.47 109.824 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -104.57 -86.24 0.46 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -0.886 . . . . 1.24 110.777 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.445 HD13 ' SD ' ' A' ' 15' ' ' MET . 11.5 tp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.106 -0.95 . . . . 1.67 109.117 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' THR . 26.1 ptt? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.462 -0.569 . . . . 5.68 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 65.58 -37.67 0.25 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 3.02 110.163 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 1' ' ' MET . 68.8 p -80.02 169.76 17.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.067 -1.021 . . . . 0.96 109.873 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m -75.82 170.05 16.96 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.805 0.812 . . . . 1.51 109.339 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.85 -30.14 68.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.795 -0.566 . . . . 2.18 110.598 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.11 -33.67 72.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.119 -0.988 . . . . 2.02 108.965 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 23.8 t60 -59.92 -48.75 80.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.49 110.088 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -69.88 -34.06 73.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.157 -0.964 . . . . 3.21 109.888 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.11 -39.84 82.69 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.383 -0.823 . . . . 0.76 109.61 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.4 t80 -61.91 -47.3 85.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.429 -0.794 . . . . 0.46 110.107 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 m -82.19 9.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.154 -0.966 . . . . 0.44 110.12 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.94 -16.4 15.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.156 -0.965 . . . . 0.54 110.944 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -156.63 152.84 23.42 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.115 . . . . 1.26 109.198 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -40.33 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.702 1.601 . . . . 0.49 110.839 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.5 ptp -90.37 -24.76 20.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.825 -1.172 . . . . 0.57 109.646 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.22 -136.72 45.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.704 -1.358 . . . . 0.4 109.704 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.57 28.93 6.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -1.006 . . . . 0.85 111.221 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -60.75 148.44 82.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.709 -1.244 . . . . 2.01 107.802 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.19 163.33 32.11 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.151 1.901 . . . . 0.34 112.801 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 21' ' ' GLY . 8.0 p -58.14 -47.36 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.58 -0.7 . . . . 0.32 110.391 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.57 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.13 -3.29 0.12 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.783 -0.927 . . . . 0.23 110.783 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' VAL . 11.6 p -82.33 -25.3 34.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.799 -1.412 . . . . 1.24 109.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.54 137.82 58.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.708 0.766 . . . . 0.24 109.759 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.92 135.31 55.55 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.692 0.758 . . . . 0.21 109.912 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 73' ' ' GLN . . . 96.98 -20.26 51.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.245 -1.542 . . . . 0.22 109.245 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.56 112.82 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.641 -1.244 . . . . 0.25 107.641 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.429 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -90.1 177.76 43.06 Favored Glycine 0 N--CA 1.492 2.39 0 O-C-N 120.678 -1.264 . . . . 0.28 110.043 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -56.6 -39.94 74.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.445 -1.033 . . . . 2.01 109.643 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.76 -44.98 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.076 -1.015 . . . . 0.38 109.496 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.429 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.5 mt -66.35 -36.92 84.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.4 109.466 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.82 97.43 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.816 -1.314 . . . . 0.35 109.816 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -65.33 -37.03 85.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -1.219 . . . . 2.74 109.736 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.59 -48.52 69.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.804 -1.185 . . . . 1.54 109.372 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.99 -38.66 89.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.34 108.448 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.04 -42.19 93.88 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.906 -0.717 . . . . 1.67 109.296 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.23 -19.42 65.53 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.533 -0.914 . . . . 2.0 108.533 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 2.83 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.747 . . . . 2.69 109.725 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.78 5.46 50.9 Favored Glycine 0 N--CA 1.503 3.132 0 C-N-CA 120.264 -0.969 . . . . 0.48 111.856 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' CD2' HG12 ' A' ' 44' ' ' VAL . 97.4 m-85 -106.56 77.07 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.899 -1.353 . . . . 0.33 108.942 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -79.36 -7.54 58.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.41 110.929 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.05 158.58 44.03 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.053 -1.029 . . . . 1.56 110.406 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -40.64 90.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.747 -0.595 . . . . 0.21 112.307 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 7.6 p90 -61.13 -18.49 58.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.499 -1.376 . . . . 0.32 110.622 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 39' ' ' PHE . 17.2 t -80.06 -31.03 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.876 -1.157 . . . . 0.24 107.876 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.4 t -77.5 -37.41 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.22 108.324 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.94 -35.67 75.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.638 -1.245 . . . . 0.4 107.638 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.22 96.69 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.573 -1.411 . . . . 0.18 109.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.15 -43.32 95.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.942 -1.328 . . . . 1.09 109.096 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.98 -41.62 92.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.31 109.019 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.94 -40.06 75.72 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.808 -0.757 . . . . 0.28 108.966 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -66.11 -22.81 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.218 -0.926 . . . . 0.28 110.448 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.95 17.05 9.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.204 -0.935 . . . . 0.31 109.777 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.08 -1.013 . . . . 1.7 110.346 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.717 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 64.3 mttm 58.85 19.44 7.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.714 -0.616 . . . . 2.24 110.011 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -67.74 106.71 2.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.76 -1.213 . . . . 1.8 108.297 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.32 -41.3 98.42 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.406 -0.809 . . . . 0.87 112.631 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 92.5 m-20 -68.99 -39.94 79.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.789 -1.195 . . . . 0.73 109.433 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 58' ' ' LEU . 90.8 mt -69.99 -39.9 75.62 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.032 -1.067 . . . . 0.55 108.614 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.26 -50.03 71.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.38 109.772 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.434 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.0 mtm180 -62.45 -44.6 96.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 2.64 110.288 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.26 -38.34 90.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 2.37 108.989 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.28 -49.57 73.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.263 -0.898 . . . . 0.4 110.853 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 tp -65.3 -47.43 76.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.84 . . . . 0.34 109.874 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -63.45 -45.25 91.72 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.402 -0.811 . . . . 2.11 109.274 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -68.43 -34.06 75.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.418 0.628 . . . . 1.9 109.592 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.7 m -79.72 -33.56 40.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -0.79 . . . . 0.41 111.336 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.6 p -130.63 -28.95 1.99 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.503 -1.373 . . . . 0.4 112.239 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.32 25.62 Favored Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.226 -1.55 . . . . 0.36 109.226 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.99 153.0 1.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.122 -1.222 . . . . 0.33 109.337 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.08 172.57 8.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 1.9 110.036 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.08 78.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.39 110.487 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.06 -40.4 75.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.738 -1.226 . . . . 2.58 109.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 25' ' ' GLY . 94.0 mm-40 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.452 -0.78 . . . . 2.12 110.69 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p -66.34 -38.18 87.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.139 -0.975 . . . . 1.36 110.039 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -60.17 -38.79 84.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.828 -1.17 . . . . 2.8 109.341 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.27 -39.24 82.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.764 -1.21 . . . . 0.4 110.444 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -68.09 -40.32 82.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.766 -1.209 . . . . 0.24 109.476 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.44 -60.33 3.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.014 -1.054 . . . . 0.43 109.533 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.72 87.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.199 -1.16 . . . . 0.26 110.199 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.21 -47.3 65.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.25 109.638 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.8 mt -69.97 -40.02 75.63 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.667 -1.213 . . . . 0.3 108.591 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.717 HH12 ' NZ ' ' A' ' 54' ' ' LYS . 8.5 tpm_? -63.71 -41.93 98.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 2.73 110.006 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 94.4 mt-10 -69.66 -39.65 76.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 1.91 110.665 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 79.1 t90 -60.04 -41.91 93.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.316 -1.49 . . . . 0.37 107.7 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -62.82 -40.51 97.63 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.975 -0.75 . . . . 0.36 108.975 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD1' ' NH2' ' A' ' 82' ' ' ARG . 96.1 m-20 -60.27 -36.84 78.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.553 -0.717 . . . . 0.55 109.905 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.66 -38.29 18.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 0.48 109.952 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.602 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 76.3 m-85 -102.59 -84.86 0.45 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.289 -0.882 . . . . 1.24 110.5 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 117.963 -1.018 . . . . 1.66 109.932 -178.529 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' B' ' 3' ' ' THR . 26.1 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.485 -0.561 . . . . 5.66 109.485 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 65.57 -37.83 0.26 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.458 -0.776 . . . . 3.02 110.07 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.53 ' N ' ' O ' ' B' ' 1' ' ' MET . 68.3 p -79.84 169.67 17.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.123 -0.986 . . . . 0.96 110.083 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m -75.69 170.01 17.01 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.752 0.787 . . . . 1.5 109.306 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -59.88 -30.15 68.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.925 -0.484 . . . . 2.18 110.521 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.07 -33.53 72.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -0.992 . . . . 2.01 109.034 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.499 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 23.9 t60 -59.86 -48.89 79.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.074 -1.016 . . . . 0.49 110.139 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -69.85 -34.13 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.994 . . . . 3.23 109.882 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.12 -39.85 82.65 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.426 -0.797 . . . . 0.76 109.664 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.1 t80 -61.83 -47.51 84.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.46 110.092 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.98 9.92 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.144 -0.972 . . . . 0.44 110.242 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.97 -16.45 15.83 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.204 -0.935 . . . . 0.53 110.951 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.64 152.83 23.36 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 1.27 109.14 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.25 158.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.701 1.6 . . . . 0.49 110.966 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 4.6 ptp -90.4 -24.62 20.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.845 -1.159 . . . . 0.56 109.658 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.09 -136.68 45.59 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.831 -1.308 . . . . 0.39 109.831 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -104.8 29.04 6.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -1.076 . . . . 0.84 111.124 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.72 148.41 82.23 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.667 -1.234 . . . . 2.02 107.667 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.19 163.3 32.24 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.204 1.936 . . . . 0.34 112.794 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.559 HG13 ' N ' ' B' ' 21' ' ' GLY . 8.0 p -58.07 -47.47 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.466 0.65 . . . . 0.32 110.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.559 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.11 -3.31 0.12 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.754 -0.939 . . . . 0.22 110.754 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.497 ' H ' ' C ' ' B' ' 20' ' ' VAL . 11.5 p -82.23 -25.32 34.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.817 -1.402 . . . . 1.24 109.495 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.52 137.91 58.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.24 109.768 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 135.45 55.65 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.795 0.807 . . . . 0.21 109.832 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' B' ' 73' ' ' GLN . . . 96.78 -20.03 52.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.326 -1.51 . . . . 0.22 109.326 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.79 112.72 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.669 -1.234 . . . . 0.25 107.669 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.433 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -89.99 177.84 43.28 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.609 -1.282 . . . . 0.28 110.108 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.74 -39.89 74.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 2.0 109.601 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.78 -44.9 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.008 -1.058 . . . . 0.38 109.484 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.433 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.7 mt -66.35 -36.84 83.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.4 109.472 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.79 97.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.76 -1.336 . . . . 0.36 109.76 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -65.34 -36.92 85.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.074 -1.251 . . . . 2.75 109.85 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.65 -48.61 68.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.708 -1.245 . . . . 1.56 109.321 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.85 -38.67 89.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.06 -1.025 . . . . 0.33 108.63 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.94 -42.41 93.93 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.933 -0.707 . . . . 1.68 109.228 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -66.95 -19.59 65.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.579 -0.897 . . . . 1.99 108.579 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -89.98 3.0 54.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.452 -0.78 . . . . 2.68 109.797 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.77 5.47 50.92 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.168 -0.957 . . . . 0.49 111.836 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.473 ' CD2' HG12 ' B' ' 44' ' ' VAL . 97.5 m-85 -106.3 77.0 1.18 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.772 -1.428 . . . . 0.33 109.071 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -79.33 -7.47 58.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.905 . . . . 0.41 110.914 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -138.14 158.44 44.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.965 -1.084 . . . . 1.56 110.498 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.72 90.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.628 -0.67 . . . . 0.21 112.389 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 7.6 p90 -60.96 -18.61 58.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.526 -1.359 . . . . 0.32 110.584 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.473 HG12 ' CD2' ' B' ' 39' ' ' PHE . 16.8 t -79.88 -31.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.964 -1.124 . . . . 0.24 107.964 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.61 -37.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.34 -0.985 . . . . 0.22 108.34 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.11 -35.71 75.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.505 -1.294 . . . . 0.4 107.505 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.33 96.73 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.706 -1.358 . . . . 0.18 109.706 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -60.03 -43.47 95.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.967 -1.314 . . . . 1.09 108.971 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.0 -41.48 92.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.31 108.964 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.01 -39.92 75.55 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.864 -0.734 . . . . 0.27 109.064 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.37 -22.67 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.201 -0.937 . . . . 0.28 110.339 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -91.92 17.02 9.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.168 -0.958 . . . . 0.3 109.734 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm 48.11 39.94 12.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.998 -1.064 . . . . 1.71 110.327 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . 0.716 ' NZ ' HH12 ' B' ' 82' ' ' ARG . 64.3 mttm 58.66 19.63 6.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.729 -0.607 . . . . 2.25 110.058 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.75 106.67 2.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.614 -1.304 . . . . 1.8 108.201 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -62.41 -41.3 98.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.379 -0.826 . . . . 0.88 112.523 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.431 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 92.3 m-20 -68.86 -39.84 79.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.886 -1.133 . . . . 0.74 109.49 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.06 -40.02 75.32 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 119.063 -1.055 . . . . 0.55 108.578 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -63.16 -50.05 71.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.38 109.842 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 82.9 mtm180 -62.3 -44.94 95.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.366 -0.834 . . . . 2.64 110.342 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.03 -38.45 90.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.988 -1.07 . . . . 2.38 109.042 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.4 -49.4 73.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.4 110.818 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.3 -47.39 76.75 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.342 -0.849 . . . . 0.34 109.953 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -63.42 -45.19 92.14 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.317 -0.864 . . . . 2.1 109.387 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 35.5 t0 -68.61 -33.78 74.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.735 -0.603 . . . . 1.9 109.607 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -79.88 -33.64 39.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.4 111.249 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.6 p -130.57 -29.04 1.99 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.526 -1.359 . . . . 0.39 112.272 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.13 26.09 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.205 -1.558 . . . . 0.36 109.205 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.91 152.87 1.46 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.096 -1.238 . . . . 0.32 109.409 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -91.03 172.62 8.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.068 -1.02 . . . . 1.91 110.041 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.19 79.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.674 . . . . 0.38 110.548 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.04 -40.39 75.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.839 -1.163 . . . . 2.57 109.705 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' B' ' 25' ' ' GLY . 93.8 mm-40 -67.54 -39.55 85.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.444 -0.785 . . . . 2.12 110.757 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -66.09 -38.23 87.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.161 -0.962 . . . . 1.36 110.106 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.09 -39.02 84.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.723 -1.235 . . . . 2.81 109.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.2 -39.3 82.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.842 -1.161 . . . . 0.4 110.439 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.2 -40.22 82.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.752 -1.217 . . . . 0.23 109.472 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -60.47 -60.08 4.38 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.95 -1.094 . . . . 0.43 109.649 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.24 -35.63 88.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.275 -1.13 . . . . 0.25 110.275 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.03 -47.34 65.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.24 109.778 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.07 -40.28 75.14 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.735 -1.186 . . . . 0.29 108.529 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.716 HH12 ' NZ ' ' B' ' 54' ' ' LYS . 8.5 tpm_? -63.4 -41.91 98.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 2.74 110.083 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.499 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 94.4 mt-10 -69.77 -39.6 76.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.816 -1.178 . . . . 1.91 110.775 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.609 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 79.7 t90 -59.96 -42.08 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.436 -1.415 . . . . 0.36 107.534 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 67.4 m -62.74 -40.44 97.23 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.056 -0.72 . . . . 0.36 109.056 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' B' ' 82' ' ' ARG . 96.2 m-20 -60.27 -36.9 78.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.552 -0.717 . . . . 0.55 109.781 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.72 -38.43 18.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.47 110.06 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 76.3 m-85 -102.25 -84.94 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.311 -0.868 . . . . 1.24 110.547 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 118.012 -0.994 . . . . 1.67 109.911 -178.529 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.433 -0.58 . . . . 5.68 109.433 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.1 m -89.94 96.17 10.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.113 -0.992 . . . . 3.02 108.72 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.3 p -112.12 164.26 13.37 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.56 0.695 . . . . 0.96 110.215 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t -73.11 173.3 9.58 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.6 0.714 . . . . 1.51 109.49 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -54.55 -18.84 4.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.641 -0.662 . . . . 2.18 110.266 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -59.99 -37.09 78.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 2.02 109.75 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -59.88 -50.83 72.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.007 -1.058 . . . . 0.49 110.597 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -69.87 -33.28 72.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.068 -1.02 . . . . 3.21 109.881 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.37 -39.7 77.9 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.276 -0.89 . . . . 0.76 109.317 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.8 t80 -63.86 -48.52 76.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.525 -0.734 . . . . 0.46 110.433 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.6 11.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.44 110.464 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.64 -12.62 14.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.243 -0.911 . . . . 0.54 109.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.04 151.23 22.54 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 1.26 109.395 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -42.12 157.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.738 1.625 . . . . 0.49 110.994 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.05 -23.24 18.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.847 -1.158 . . . . 0.57 109.922 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 57.77 -138.59 48.21 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.981 -1.247 . . . . 0.4 109.981 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.58 29.33 5.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.501 -0.999 . . . . 0.85 110.042 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -60.02 148.98 76.0 Favored Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 107.83 -1.174 . . . . 2.01 107.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.16 160.93 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.326 2.017 . . . . 0.34 113.257 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.3 p -57.29 -49.08 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.739 -0.601 . . . . 0.32 110.096 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.575 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -56.22 -2.78 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.223 -1.151 . . . . 0.23 110.223 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 22.1 p -81.49 -24.68 36.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.33 . . . . 1.24 108.511 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.627 HD22 HD21 ' A' ' 81' ' ' LEU . 92.3 mt -62.43 139.73 58.57 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.783 0.802 . . . . 0.24 109.579 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.81 134.12 52.42 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.831 0.824 . . . . 0.21 110.16 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.98 -20.51 48.74 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.925 -1.67 . . . . 0.22 108.925 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mm -99.89 116.8 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.764 -1.198 . . . . 0.25 107.764 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -92.3 177.4 39.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.669 -1.372 . . . . 0.28 109.669 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.49 -39.84 73.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.54 -0.976 . . . . 2.01 109.539 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.13 -42.67 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.38 109.447 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 27' ' ' GLY . 95.6 mt -68.4 -40.06 81.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.214 -0.929 . . . . 0.4 109.438 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.99 97.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.35 109.583 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.29 -39.97 94.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.4 -1.059 . . . . 2.74 110.058 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.84 -49.94 68.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.832 -1.168 . . . . 1.54 109.599 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.5 mt -60.03 -39.45 85.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.34 108.966 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.02 -44.5 94.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.542 -0.723 . . . . 1.67 110.533 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.76 -19.07 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 2.0 109.113 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.495 HH11 ' HG2' ' A' ' 37' ' ' ARG . 27.1 mtt-85 -89.97 1.93 55.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.794 -0.762 . . . . 2.69 110.52 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.43 4.37 34.95 Favored Glycine 0 N--CA 1.506 3.353 0 O-C-N 121.019 -1.051 . . . . 0.48 112.006 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CD2' HG12 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.08 73.81 1.07 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.794 -1.415 . . . . 0.33 108.659 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -80.07 -10.0 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.246 -0.909 . . . . 0.41 110.515 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 29.8 mmtp -130.82 152.68 49.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.171 -0.955 . . . . 1.56 109.424 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.393 -0.817 . . . . 0.21 111.55 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 22.5 p90 -56.15 -17.61 7.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.711 -1.243 . . . . 0.32 110.32 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 39' ' ' PHE . 22.2 t -79.66 -33.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.832 -1.167 . . . . 0.24 108.073 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 20' ' ' VAL . 55.2 t -76.88 -39.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.266 -1.013 . . . . 0.22 108.266 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.03 -38.07 81.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.578 -1.267 . . . . 0.4 107.578 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.98 -41.12 96.21 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.552 -1.419 . . . . 0.18 109.552 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -59.9 -43.29 94.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.252 . . . . 1.09 108.456 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.02 -39.93 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.31 108.725 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.72 -40.01 76.5 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.509 -0.923 . . . . 0.28 108.509 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.81 -26.01 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.28 110.198 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.01 13.63 14.32 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.16 -0.962 . . . . 0.31 110.166 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER 48.95 51.63 15.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.881 -1.137 . . . . 1.7 110.312 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.76 20.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.945 -1.097 . . . . 2.24 110.913 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-20 -65.33 105.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.937 -1.505 . . . . 1.8 106.937 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -61.43 -40.27 93.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.361 -0.837 . . . . 0.87 112.62 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.77 -40.03 76.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.256 -1.527 . . . . 0.73 109.823 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.3 -40.07 74.45 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.944 -1.102 . . . . 0.55 109.2 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.9 -50.03 70.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.38 109.402 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.79 -45.01 94.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.437 -0.79 . . . . 2.64 109.896 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 65' ' ' ASP . 8.3 tm-20 -64.88 -39.99 94.4 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.159 -0.963 . . . . 2.37 108.706 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -65.25 -48.02 74.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.4 110.866 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.66 -45.88 73.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.208 -0.932 . . . . 0.34 110.558 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.65 -48.5 79.07 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.167 -0.958 . . . . 2.11 110.213 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 61' ' ' GLU . 57.2 m-20 -70.06 -24.75 63.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.807 . . . . 1.9 110.066 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.0 m -79.62 -34.51 40.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.143 -0.973 . . . . 0.41 111.236 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -132.91 -19.84 2.25 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.483 -1.386 . . . . 0.4 111.899 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.8 11.5 43.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.137 -1.585 . . . . 0.36 109.137 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.68 1.6 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.33 109.248 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.548 ' H ' HE21 ' A' ' 73' ' ' GLN . 26.9 t-20 -89.26 170.02 10.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 1.9 109.817 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -34.36 73.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.562 -0.711 . . . . 0.39 110.552 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -71.66 -39.97 69.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.64 -1.287 . . . . 2.58 110.222 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.548 HE21 ' H ' ' A' ' 70' ' ' ASN . 37.4 mt-30 -68.61 -37.98 80.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.43 -0.794 . . . . 2.12 110.722 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.9 m -67.41 -38.0 83.93 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.048 -1.032 . . . . 1.36 109.958 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.01 -38.06 81.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 2.8 109.476 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -68.33 -39.93 81.77 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.705 -1.247 . . . . 0.4 110.349 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.9 m -66.97 -39.97 87.35 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.82 -1.175 . . . . 0.24 108.968 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.15 -60.73 3.39 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.984 -1.073 . . . . 0.43 109.822 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.03 88.82 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.507 -1.037 . . . . 0.26 110.507 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.28 -49.88 52.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.432 . . . . 0.25 109.625 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.627 HD21 HD22 ' A' ' 23' ' ' LEU . 96.3 mt -70.01 -39.99 75.5 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.983 -1.087 . . . . 0.3 109.019 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -63.01 -40.05 96.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 2.73 110.186 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.049 -1.032 . . . . 1.91 109.924 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.519 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 71.0 t90 -59.91 -42.76 94.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.437 -1.32 . . . . 0.37 107.437 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.415 ' O ' ' OXT' ' A' ' 89' ' ' LEU . 92.1 m -63.94 -40.01 95.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 0.36 108.968 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.39 -37.99 82.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.425 -0.797 . . . . 0.55 109.678 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.13 17.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.48 109.938 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.519 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 73.0 m-85 -98.93 -82.2 0.44 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.165 -0.959 . . . . 1.24 110.311 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' OXT' ' O ' ' A' ' 85' ' ' CYS . 18.5 tp . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.989 -1.005 . . . . 1.66 110.217 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.502 -0.555 . . . . 5.66 109.502 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m -89.86 96.18 10.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.082 -1.011 . . . . 3.02 108.778 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 77.7 p -112.12 164.4 13.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.553 -0.717 . . . . 0.96 110.282 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 28.4 t -73.2 173.28 9.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.468 -0.77 . . . . 1.5 109.466 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -54.63 -18.87 5.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.634 -0.666 . . . . 2.18 110.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -60.02 -36.89 78.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.055 -1.028 . . . . 2.01 109.701 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -60.11 -50.58 73.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.995 -1.066 . . . . 0.49 110.571 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -70.16 -33.14 71.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.018 -1.051 . . . . 3.23 109.758 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -69.43 -39.59 77.75 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.307 -0.871 . . . . 0.76 109.288 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.4 t80 -63.96 -48.52 76.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.46 110.462 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -83.51 11.11 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.029 -1.044 . . . . 0.44 110.423 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.54 -12.67 14.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.316 -0.865 . . . . 0.53 109.793 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.04 151.14 22.36 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.065 -1.022 . . . . 1.27 109.329 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -42.16 157.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.705 1.603 . . . . 0.49 110.926 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.2 ptp -93.01 -23.3 18.72 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.872 -1.143 . . . . 0.56 109.958 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.11 -138.48 48.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.081 -1.208 . . . . 0.39 110.081 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.82 29.34 5.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.84 110.051 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -59.93 148.88 75.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 107.823 -1.177 . . . . 2.02 107.823 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.99 161.1 38.29 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.285 1.99 . . . . 0.34 113.236 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.572 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.4 p -57.36 -49.15 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.568 0.699 . . . . 0.32 110.146 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.572 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -56.04 -3.05 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.259 -1.136 . . . . 0.22 110.259 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.449 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.2 p -81.35 -24.4 37.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.955 -1.32 . . . . 1.24 108.53 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.635 HD22 HD21 ' B' ' 81' ' ' LEU . 91.7 mt -62.61 139.69 58.64 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.823 0.821 . . . . 0.24 109.581 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 134.14 52.62 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.776 0.798 . . . . 0.21 110.173 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -20.92 46.95 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.883 -1.687 . . . . 0.22 108.883 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mm -99.6 116.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.916 -1.142 . . . . 0.25 107.916 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.467 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -92.3 177.48 39.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.679 -1.368 . . . . 0.28 109.679 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -56.41 -39.92 73.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.455 -1.027 . . . . 2.0 109.553 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.15 -42.68 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.38 109.438 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.467 HD12 ' H ' ' B' ' 27' ' ' GLY . 95.7 mt -68.42 -39.91 81.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.219 -0.925 . . . . 0.4 109.528 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.76 -39.91 97.38 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.36 109.591 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -62.33 -39.98 94.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -1.108 . . . . 2.75 110.049 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.82 -49.99 68.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.837 -1.164 . . . . 1.56 109.552 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.02 -39.45 85.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.33 108.893 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.05 -44.38 94.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 1.68 110.501 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.95 -18.91 65.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.031 -1.043 . . . . 1.99 109.152 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' B' ' 37' ' ' ARG . 27.6 mtt-85 -90.0 1.62 56.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.466 -0.771 . . . . 2.68 110.507 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.91 4.27 33.9 Favored Glycine 0 N--CA 1.506 3.309 0 O-C-N 121.041 -1.037 . . . . 0.49 112.024 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.522 ' CD2' HG12 ' B' ' 44' ' ' VAL . 82.6 m-85 -105.08 73.87 1.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.81 -1.406 . . . . 0.33 108.755 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.1 -10.03 59.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.41 110.405 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.464 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 29.8 mmtp -130.79 152.59 49.97 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.224 -0.922 . . . . 1.56 109.493 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.95 92.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.529 -0.732 . . . . 0.21 111.501 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.464 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 22.8 p90 -56.1 -17.46 7.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.733 -1.23 . . . . 0.32 110.418 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' B' ' 39' ' ' PHE . 22.3 t -79.7 -33.34 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.819 -1.176 . . . . 0.24 108.039 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.437 HG21 HG23 ' B' ' 20' ' ' VAL . 55.2 t -76.68 -39.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.262 -1.014 . . . . 0.22 108.262 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.8 tp -60.08 -37.6 80.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.534 -1.284 . . . . 0.4 107.534 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 -41.04 96.54 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.627 -1.389 . . . . 0.18 109.627 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -60.07 -43.24 95.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.274 . . . . 1.09 108.397 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.31 108.794 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.74 -39.91 76.48 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.27 108.617 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.85 -26.1 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.312 -0.868 . . . . 0.28 110.193 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.93 13.49 14.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.197 -0.939 . . . . 0.3 110.131 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 49.01 51.73 15.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.771 -1.205 . . . . 1.71 110.185 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 41.79 20.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.833 -1.167 . . . . 2.25 110.954 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 53' ' ' LYS . 71.1 m-20 -65.5 105.34 1.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.946 -1.501 . . . . 1.8 106.946 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.42 -40.03 92.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.241 -0.912 . . . . 0.88 112.674 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.99 -39.95 75.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.342 -1.474 . . . . 0.74 109.865 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.38 -39.94 74.27 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.846 -1.142 . . . . 0.55 109.298 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.86 -49.94 70.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.38 109.433 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -62.98 -44.82 94.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.461 -0.774 . . . . 2.64 109.821 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.444 ' OE2' ' OD2' ' B' ' 65' ' ' ASP . 8.3 tm-20 -64.93 -40.1 94.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.111 -0.993 . . . . 2.38 108.745 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -65.11 -48.1 74.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.4 110.92 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.0 tp -67.79 -45.64 74.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.28 -0.888 . . . . 0.34 110.572 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -62.84 -48.48 78.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.191 -0.943 . . . . 2.1 110.162 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.444 ' OD2' ' OE2' ' B' ' 61' ' ' GLU . 57.3 m-20 -69.96 -24.84 63.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 1.9 110.119 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 29.5 m -79.59 -34.34 40.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.996 . . . . 0.4 111.33 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.0 p -133.02 -19.91 2.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.548 -1.345 . . . . 0.39 111.802 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.75 11.51 43.53 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.116 -1.594 . . . . 0.36 109.116 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.08 152.87 1.55 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.998 -1.295 . . . . 0.32 109.166 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.54 ' H ' HE21 ' B' ' 73' ' ' GLN . 27.0 t-20 -89.43 169.98 10.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.058 . . . . 1.91 109.843 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.42 73.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.58 -0.7 . . . . 0.38 110.507 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.63 -39.97 70.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.703 -1.248 . . . . 2.57 110.202 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.54 HE21 ' H ' ' B' ' 70' ' ' ASN . 37.2 mt-30 -68.68 -37.99 80.02 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.815 . . . . 2.12 110.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -67.27 -38.12 84.57 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.036 -1.04 . . . . 1.36 109.911 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 -60.05 -38.1 81.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 2.81 109.441 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.12 -39.98 82.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.77 -1.206 . . . . 0.4 110.348 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 67.2 m -67.01 -39.96 87.2 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.735 -1.228 . . . . 0.23 109.053 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -59.05 -60.82 3.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.984 -1.072 . . . . 0.43 109.867 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.13 -34.15 89.14 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.504 -1.038 . . . . 0.25 110.504 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.29 -49.8 52.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.825 -1.397 . . . . 0.24 109.713 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.635 HD21 HD22 ' B' ' 23' ' ' LEU . 96.7 mt -69.98 -40.0 75.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.987 -1.085 . . . . 0.29 108.969 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -63.11 -40.03 96.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.172 -0.955 . . . . 2.74 110.144 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.2 -36.72 77.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 1.91 109.882 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.533 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 71.8 t90 -59.95 -42.64 94.49 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.449 -1.315 . . . . 0.36 107.449 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.409 ' O ' ' OXT' ' B' ' 89' ' ' LEU . 92.6 m -64.11 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 0.36 108.952 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.25 -38.21 82.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.758 . . . . 0.55 109.578 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.46 -39.69 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.47 110.01 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.533 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.6 m-85 -97.84 -82.49 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 1.24 110.495 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.409 ' OXT' ' O ' ' B' ' 85' ' ' CYS . 18.4 tp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.975 -1.012 . . . . 1.67 110.065 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.274 0.559 . . . . 5.68 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.3 p -91.0 98.6 11.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.103 -0.998 . . . . 3.02 109.121 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.7 p -97.99 162.19 13.35 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.247 -0.908 . . . . 0.96 109.738 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.1 t -69.59 164.92 22.22 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.834 0.826 . . . . 1.51 109.324 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.48 -28.69 67.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.753 -0.592 . . . . 2.18 109.95 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.02 -36.9 78.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.939 . . . . 2.02 109.456 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -59.25 -50.08 75.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.041 -1.037 . . . . 0.49 110.064 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.98 -34.41 73.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.192 -0.943 . . . . 3.21 110.096 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 91.3 m-20 -67.8 -39.31 84.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.255 -0.903 . . . . 0.76 109.447 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -60.03 -47.45 85.8 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.481 -0.888 . . . . 0.46 109.369 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 m -83.76 10.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.026 -1.047 . . . . 0.44 110.483 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.6 -19.04 17.04 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.012 -1.055 . . . . 0.54 110.91 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -156.95 152.93 23.01 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.886 -1.133 . . . . 1.26 108.606 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' GLU . 55.0 Cg_exo -36.47 150.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.012 1.808 . . . . 0.49 111.867 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.442 ' HG2' ' H ' ' A' ' 15' ' ' MET . 8.0 ptm -89.51 -22.74 22.28 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.041 -1.037 . . . . 0.57 110.503 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.08 -134.61 40.65 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.101 -1.047 . . . . 0.4 110.593 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.98 35.14 3.5 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.517 -0.99 . . . . 0.85 110.557 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -58.55 147.85 68.19 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 120.781 -1.199 . . . . 2.01 107.97 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.25 153.69 51.43 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.996 1.797 . . . . 0.34 112.08 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.5 p -55.23 -42.03 63.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.544 -0.723 . . . . 0.32 109.933 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -62.12 -3.6 5.15 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.281 -1.128 . . . . 0.23 110.281 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -83.33 -21.0 33.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.888 -1.36 . . . . 1.24 109.242 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.14 137.73 58.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.24 109.68 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.98 133.89 55.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.754 0.788 . . . . 0.21 109.841 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 96.89 -17.34 59.44 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.167 -1.573 . . . . 0.22 109.167 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -101.17 114.79 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.282 -1.128 . . . . 0.25 108.094 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -94.76 178.55 36.48 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.724 -1.351 . . . . 0.28 109.724 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.23 -40.01 73.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -1.148 . . . . 2.01 109.958 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.28 -44.44 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.974 -1.079 . . . . 0.38 109.545 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.8 mt -66.29 -38.35 87.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.4 109.707 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.98 94.5 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.37 -1.492 . . . . 0.35 109.37 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.96 -40.0 90.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -1.09 . . . . 2.74 110.594 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.19 -45.35 73.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.738 -1.226 . . . . 1.54 109.632 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.49 -39.96 95.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.073 -1.017 . . . . 0.34 108.59 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.14 -40.82 91.15 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.809 -0.756 . . . . 1.67 109.605 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.17 -19.55 65.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.332 -0.988 . . . . 2.0 108.332 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -91.12 6.39 45.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.649 -0.657 . . . . 2.69 110.043 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.62 9.23 53.33 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.256 -0.973 . . . . 0.48 111.899 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.549 ' CD2' HG12 ' A' ' 44' ' ' VAL . 78.3 m-85 -106.26 74.52 1.04 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.764 -1.433 . . . . 0.33 109.312 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -79.96 -9.74 59.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.41 110.522 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 43' ' ' TYR . 45.1 mmtm -132.72 154.97 49.67 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.088 -1.008 . . . . 1.56 109.559 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.92 94.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.657 -0.652 . . . . 0.21 111.071 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 21.6 p90 -57.39 -18.85 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.758 -1.214 . . . . 0.32 110.7 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 39' ' ' PHE . 24.8 t -79.27 -34.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.619 -1.301 . . . . 0.24 107.976 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.75 -39.96 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.472 -0.936 . . . . 0.22 108.472 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.98 -38.33 82.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.623 -1.251 . . . . 0.4 107.623 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.97 97.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.664 -1.374 . . . . 0.18 109.664 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 1.09 109.37 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.97 -40.03 87.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.7 -39.0 77.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.666 -0.813 . . . . 0.28 108.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.34 -24.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.184 -0.948 . . . . 0.28 110.147 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.57 15.2 14.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.172 -0.955 . . . . 0.31 110.252 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt 48.82 42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.732 -1.23 . . . . 1.7 110.866 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 56.76 19.41 4.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.389 -0.819 . . . . 2.24 109.5 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.82 107.02 2.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.718 -1.239 . . . . 1.8 108.123 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -40.52 97.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.87 112.342 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.11 -39.96 78.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.363 -1.461 . . . . 0.73 109.724 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.47 -39.99 73.91 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.917 -1.113 . . . . 0.55 108.987 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.9 -49.88 70.92 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.856 . . . . 0.38 109.668 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.22 -46.29 91.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.347 -0.846 . . . . 2.64 110.443 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -64.35 -39.89 94.78 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.064 -1.022 . . . . 2.37 108.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.402 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.2 t90 -63.23 -49.49 73.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.269 -0.894 . . . . 0.4 110.93 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.98 -49.64 64.76 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 0.34 109.784 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.25 86.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.477 -0.765 . . . . 2.11 110.007 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 30.9 t0 -68.45 -29.62 68.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.521 -0.737 . . . . 1.9 109.838 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.9 m -80.45 -32.91 37.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.41 111.562 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.2 p -131.65 -28.77 1.79 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.52 -1.363 . . . . 0.4 111.982 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.56 14.1 20.68 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.059 -1.616 . . . . 0.36 109.059 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.89 153.28 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.014 -1.286 . . . . 0.33 109.362 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.54 170.15 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.1 -1.0 . . . . 1.9 109.654 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.23 70.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.39 110.727 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.18 -40.1 68.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 2.58 109.734 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.2 mm100 -67.71 -38.3 83.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.349 -0.844 . . . . 2.12 110.236 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -68.45 -37.74 80.49 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.907 . . . . 1.36 110.02 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.56 -38.8 85.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 2.8 109.412 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -68.46 -39.94 81.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.624 -1.298 . . . . 0.4 110.318 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.4 -39.98 81.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.872 -1.143 . . . . 0.24 109.171 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.69 -60.1 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.771 -1.206 . . . . 0.43 109.779 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.29 -34.42 89.16 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.298 -1.121 . . . . 0.26 110.298 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.32 -46.58 60.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.847 -1.384 . . . . 0.25 109.705 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -70.32 -40.56 74.11 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.793 -1.163 . . . . 0.3 108.432 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -64.54 -39.98 94.75 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.84 . . . . 2.73 110.448 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -68.73 -37.64 79.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.983 -1.073 . . . . 1.91 109.758 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.592 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.4 t90 -60.01 -45.54 92.41 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.431 -1.322 . . . . 0.37 107.431 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.411 ' O ' ' O ' ' A' ' 89' ' ' LEU . 75.6 m -60.74 -40.02 90.87 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.808 -0.812 . . . . 0.36 108.808 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.43 -37.76 81.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.55 109.739 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.61 -36.86 18.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.48 109.934 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.0 m-85 -103.74 -85.26 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 1.24 110.226 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 85' ' ' CYS . 24.4 tp . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.086 -0.959 . . . . 1.66 109.63 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.284 0.564 . . . . 5.66 109.598 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 69.0 p -91.17 98.85 11.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 3.02 109.144 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -98.23 162.35 13.24 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.313 -0.867 . . . . 0.96 109.642 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 35.8 t -69.66 165.02 22.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 1.5 109.426 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.71 -28.5 67.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.761 -0.587 . . . . 2.18 109.905 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -59.99 -37.03 78.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 2.01 109.483 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -59.32 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.101 -1.0 . . . . 0.49 109.974 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.96 -34.53 73.53 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.073 -1.017 . . . . 3.23 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . 0.447 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 91.6 m-20 -67.72 -39.26 84.33 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.223 -0.923 . . . . 0.76 109.413 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -59.91 -47.6 85.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.434 -0.906 . . . . 0.46 109.39 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.67 10.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.168 -0.957 . . . . 0.44 110.512 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -19.04 17.11 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.53 110.981 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' B' ' 9' ' ' ASP . 0.0 OUTLIER -156.92 152.93 23.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.831 -1.168 . . . . 1.27 108.603 179.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' B' ' 13' ' ' GLU . 54.8 Cg_exo -36.36 150.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.088 1.859 . . . . 0.49 111.86 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' B' ' 15' ' ' MET . 8.0 ptm -89.38 -22.61 22.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.114 -0.991 . . . . 0.56 110.539 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.19 -134.63 41.06 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.918 -1.114 . . . . 0.39 110.63 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.02 35.04 3.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.471 -1.017 . . . . 0.84 110.552 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -58.4 147.79 66.97 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 120.76 -1.213 . . . . 2.02 108.04 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.28 153.48 52.98 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.019 1.813 . . . . 0.34 112.161 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.516 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.7 p -54.96 -42.07 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.32 110.03 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.516 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -62.15 -3.68 5.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.263 -1.135 . . . . 0.22 110.263 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -83.08 -21.1 33.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.897 -1.355 . . . . 1.24 109.261 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.15 137.83 58.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.24 109.662 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.97 133.81 55.21 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.62 0.724 . . . . 0.21 109.833 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 96.99 -17.48 59.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.084 -1.607 . . . . 0.22 109.084 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -101.01 114.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -1.101 . . . . 0.25 108.212 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.411 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -94.62 178.56 36.68 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.725 -1.35 . . . . 0.28 109.725 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.27 -40.09 73.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -1.115 . . . . 2.0 109.948 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.22 -44.34 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.02 -1.05 . . . . 0.38 109.566 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.411 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.8 mt -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.4 109.657 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.53 -39.05 94.49 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.343 -1.503 . . . . 0.36 109.343 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -65.99 -40.03 90.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 2.75 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.27 -45.41 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.664 -1.272 . . . . 1.56 109.533 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.25 -40.03 96.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.092 -1.005 . . . . 0.33 108.673 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.05 -40.87 90.91 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.859 -0.736 . . . . 1.68 109.634 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.19 -19.49 65.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.353 -0.98 . . . . 1.99 108.353 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.514 HH11 ' HG2' ' B' ' 37' ' ' ARG . 0.6 OUTLIER -91.14 6.25 45.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.648 -0.657 . . . . 2.68 110.029 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 9.34 52.97 Favored Glycine 0 N--CA 1.501 3.027 0 O-C-N 121.141 -0.975 . . . . 0.49 111.834 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.547 ' CD2' HG12 ' B' ' 44' ' ' VAL . 78.8 m-85 -106.22 74.12 1.02 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.761 -1.434 . . . . 0.33 109.323 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 -9.97 59.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.912 . . . . 0.41 110.534 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.481 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 45.0 mmtm -132.57 154.94 49.51 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.206 -0.934 . . . . 1.56 109.581 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.02 95.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.655 -0.653 . . . . 0.21 111.112 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.481 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 20.2 p90 -57.27 -18.72 17.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.238 . . . . 0.32 110.672 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.547 HG12 ' CD2' ' B' ' 39' ' ' PHE . 24.7 t -79.38 -34.24 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.58 -1.325 . . . . 0.24 108.001 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 75.0 t -77.77 -39.95 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.477 -0.934 . . . . 0.22 108.477 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 36.7 tp -60.07 -38.12 81.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 0.4 107.628 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.88 97.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.759 -1.336 . . . . 0.18 109.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -60.06 -40.04 88.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -1.18 . . . . 1.09 109.336 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.85 -40.05 87.28 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.107 -1.071 . . . . 0.31 108.107 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.74 -38.65 76.92 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.609 -0.836 . . . . 0.27 108.836 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.76 -24.17 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.178 -0.951 . . . . 0.28 110.086 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -92.38 14.87 15.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.058 -1.026 . . . . 0.3 110.262 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 49.19 42.24 21.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.772 -1.205 . . . . 1.71 110.824 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 81.5 mttt 57.14 19.6 4.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 2.25 109.484 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.02 107.08 2.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.701 -1.249 . . . . 1.8 108.14 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -40.2 96.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.43 -0.794 . . . . 0.88 112.39 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -69.39 -40.04 77.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.252 -1.53 . . . . 0.74 109.702 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.3 -40.07 74.47 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.924 -1.11 . . . . 0.55 109.024 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.74 -49.99 70.86 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.38 109.662 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -61.36 -45.96 92.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.459 -0.776 . . . . 2.64 110.466 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -64.52 -39.93 94.68 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 120.99 -1.068 . . . . 2.38 108.788 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -63.16 -49.64 73.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.864 . . . . 0.4 110.887 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.95 -49.45 65.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.084 -1.01 . . . . 0.34 109.795 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -47.21 86.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 2.1 109.96 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 36.5 t0 -68.61 -29.37 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.451 -0.781 . . . . 1.9 109.797 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 64.3 m -80.64 -33.06 35.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.4 111.451 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 25.2 p -131.54 -28.62 1.83 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.405 -1.435 . . . . 0.39 112.137 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.42 14.03 21.11 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 109.096 -1.601 . . . . 0.36 109.096 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.85 153.23 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.05 -1.265 . . . . 0.32 109.306 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.46 170.16 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.101 -0.999 . . . . 1.91 109.655 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.36 70.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.478 -0.764 . . . . 0.38 110.73 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.06 -40.07 68.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.784 -1.197 . . . . 2.57 109.68 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.2 mm100 -67.81 -38.17 82.92 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.323 -0.861 . . . . 2.12 110.301 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -68.53 -37.93 80.42 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.266 -0.896 . . . . 1.36 110.005 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.41 -38.91 85.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.852 -1.155 . . . . 2.81 109.399 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -68.22 -39.97 82.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.651 -1.28 . . . . 0.4 110.354 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.1 m -68.45 -39.98 81.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.712 -1.242 . . . . 0.23 109.209 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -60.18 4.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.739 -1.226 . . . . 0.43 109.8 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -34.49 89.11 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.364 -1.094 . . . . 0.25 110.364 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.3 t -71.41 -46.33 60.46 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.809 -1.406 . . . . 0.24 109.792 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.44 -40.59 73.67 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.812 -1.155 . . . . 0.29 108.403 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.47 -40.11 95.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 2.74 110.454 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -68.85 -37.4 79.1 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.94 -1.1 . . . . 1.91 109.672 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.4 t90 -59.92 -45.77 91.52 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.433 -1.321 . . . . 0.36 107.433 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' B' ' 89' ' ' LEU . 73.5 m -60.62 -39.95 90.09 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.813 -0.755 . . . . 0.36 108.964 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.57 -37.79 82.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.55 109.721 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.51 -36.83 18.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -0.889 . . . . 0.47 109.957 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 87.1 m-85 -103.62 -85.02 0.46 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.28 -0.887 . . . . 1.24 110.39 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 85' ' ' CYS . 24.6 tp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.051 -0.976 . . . . 1.67 109.573 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.305 0.574 . . . . 5.68 109.585 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.9 m -76.48 125.12 28.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 3.02 109.623 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.1 p -92.34 170.05 10.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.268 -0.895 . . . . 0.96 110.045 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 t -79.99 170.04 17.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 1.51 109.81 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.45 -20.66 13.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 2.18 110.076 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.02 -37.52 79.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.14 -0.975 . . . . 2.02 109.293 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 12.4 t60 -59.97 -50.01 75.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.021 -1.049 . . . . 0.49 110.628 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 8' ' ' ARG . 17.9 mmm-85 -70.01 -35.11 74.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.859 -1.151 . . . . 3.21 109.735 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.74 -39.99 84.2 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.386 -0.822 . . . . 0.76 109.336 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -63.54 -49.08 74.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.428 -0.795 . . . . 0.46 110.085 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.53 9.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.971 -1.081 . . . . 0.44 110.747 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -102.9 -15.01 16.31 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.189 -0.944 . . . . 0.54 110.267 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 14' ' ' PRO . 4.4 pt-20 -152.71 155.03 32.22 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.169 -0.957 . . . . 1.26 108.938 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' GLU . 65.1 Cg_exo -36.84 152.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.101 1.867 . . . . 0.49 111.441 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CZ2' ' A' ' 84' ' ' TRP . 11.6 ptm -89.75 -23.23 21.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.038 -1.039 . . . . 0.57 109.673 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.0 -138.54 20.64 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.097 -1.201 . . . . 0.4 110.097 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.54 43.23 1.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.577 -0.955 . . . . 0.85 109.657 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -61.21 147.98 85.84 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.475 -0.935 . . . . 2.01 108.475 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 155.09 39.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.275 1.983 . . . . 0.34 112.826 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.68 -35.28 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.632 0.73 . . . . 0.32 110.202 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.24 -0.48 57.31 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.546 -1.021 . . . . 0.23 110.546 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 p -82.44 -25.8 33.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.783 -1.422 . . . . 1.24 109.706 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.559 HD22 HD21 ' A' ' 81' ' ' LEU . 96.2 mt -60.78 138.52 58.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.24 109.953 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.84 134.5 55.32 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.8 -0.76 . . . . 0.21 109.483 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.11 -21.72 44.58 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.511 -1.436 . . . . 0.22 109.511 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.76 114.73 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.143 -1.21 . . . . 0.25 108.195 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -95.68 -179.2 36.4 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.645 -1.382 . . . . 0.28 109.645 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -58.21 -40.04 80.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -1.038 . . . . 2.01 109.652 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.67 -47.65 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.06 -1.025 . . . . 0.38 109.285 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.4 HD12 ' H ' ' A' ' 27' ' ' GLY . 95.9 mt -64.89 -35.99 82.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.4 109.348 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.78 -39.97 92.19 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.464 -1.454 . . . . 0.35 109.464 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -66.79 -37.49 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.268 . . . . 2.74 110.308 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.65 -51.74 46.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.709 -1.245 . . . . 1.54 109.303 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.49 -39.81 89.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.051 -1.031 . . . . 0.34 108.471 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.06 -42.66 95.0 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.55 -0.86 . . . . 1.67 109.409 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.0 -19.12 65.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.178 -0.951 . . . . 2.0 108.6 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -90.75 5.42 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.539 -0.725 . . . . 2.69 109.831 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.89 8.96 53.53 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.007 -1.058 . . . . 0.48 111.585 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' A' ' 44' ' ' VAL . 95.5 m-85 -107.25 75.09 1.01 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.418 . . . . 0.33 109.071 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.54 -7.98 58.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.41 110.562 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -138.04 158.62 43.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.071 -1.018 . . . . 1.56 110.149 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.5 84.45 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.965 0.728 . . . . 0.21 112.965 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -59.98 -17.84 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.38 -1.45 . . . . 0.32 110.376 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 39' ' ' PHE . 30.5 t -79.48 -31.93 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.25 -1.389 . . . . 0.24 107.25 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 79.4 t -77.17 -39.58 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.236 -1.024 . . . . 0.22 108.236 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.01 -35.93 76.13 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.466 -1.309 . . . . 0.4 107.466 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.29 98.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.703 -1.359 . . . . 0.18 109.703 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.94 -43.99 94.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 1.09 108.908 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.97 -40.46 89.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.505 -0.747 . . . . 0.31 109.195 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -69.05 -38.44 79.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.813 -0.81 . . . . 0.28 108.813 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.69 -19.89 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.137 -0.977 . . . . 0.28 110.517 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.2 mt -88.26 14.27 9.76 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.123 -0.985 . . . . 0.31 110.786 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.12 31.86 7.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.778 -1.201 . . . . 1.7 109.868 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 57.98 19.95 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.704 -0.623 . . . . 2.24 110.044 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -69.93 108.81 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.732 -1.23 . . . . 1.8 108.077 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.83 -40.01 96.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.084 0.772 . . . . 0.87 113.084 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.44 -39.94 85.41 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.405 -1.434 . . . . 0.73 109.996 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.45 -39.51 74.29 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.104 -1.038 . . . . 0.55 108.941 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.39 -41.65 93.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.38 109.095 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmm-85 -60.06 -51.18 70.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 2.64 110.147 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.58 -37.3 84.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 2.37 110.078 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.33 -47.99 79.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.4 110.799 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.8 -47.6 71.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.036 -1.04 . . . . 0.34 109.707 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.08 -48.55 78.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.293 -0.879 . . . . 2.11 109.945 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -67.17 -32.17 73.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.475 -0.766 . . . . 1.9 109.758 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -80.17 -34.68 37.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.41 111.397 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.72 -26.69 2.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.59 -1.318 . . . . 0.4 112.004 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.99 13.53 33.69 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.684 -1.766 . . . . 0.36 108.684 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 152.99 2.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -1.095 . . . . 0.33 109.421 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.76 174.9 7.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -0.912 . . . . 1.9 109.724 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.27 74.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.39 110.728 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.46 -39.66 64.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.604 -1.31 . . . . 2.58 110.35 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.015 -1.053 . . . . 2.12 110.732 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -69.05 -37.96 78.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.176 -0.952 . . . . 1.36 110.52 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 75' ' ' ARG . 27.1 mtt-85 -60.03 -37.38 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 2.8 109.489 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.52 -40.03 80.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.716 -1.24 . . . . 0.4 110.478 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.8 m -69.48 -40.12 77.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.783 -1.198 . . . . 0.24 109.8 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.33 -60.13 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.43 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.07 86.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.828 -0.909 . . . . 0.26 110.828 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.7 t -70.77 -48.66 53.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.946 -1.326 . . . . 0.25 110.223 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.559 HD21 HD22 ' A' ' 23' ' ' LEU . 88.2 mt -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.998 -1.081 . . . . 0.3 108.176 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.52 -40.02 93.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 2.73 110.169 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 92.1 mt-10 -70.27 -38.23 75.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 1.91 110.956 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 89.3 t90 -60.59 -42.32 96.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.308 -1.495 . . . . 0.37 108.456 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 89' ' ' LEU . 92.7 m -61.57 -40.43 94.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.509 -0.744 . . . . 0.36 110.273 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -29.44 68.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.121 -0.987 . . . . 0.55 109.917 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.37 13.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.48 110.81 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 88.7 m-85 -109.02 -3.64 17.28 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.312 -0.867 . . . . 1.24 112.42 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . 9.4 tp . . . . . 0 N--CA 1.503 2.214 0 O-C-N 120.586 -1.321 . . . . 1.66 109.254 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.506 -0.553 . . . . 5.66 109.506 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 96.0 m -76.29 125.2 28.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 3.02 109.587 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 74.0 p -92.45 170.04 10.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.332 -0.855 . . . . 0.96 110.098 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t -80.07 170.15 16.85 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.703 0.764 . . . . 1.5 109.809 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.51 -20.68 13.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 2.18 110.057 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -60.03 -37.43 79.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.156 -0.965 . . . . 2.01 109.324 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.519 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 12.3 t60 -59.97 -50.06 75.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.029 -1.044 . . . . 0.49 110.564 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' B' ' 8' ' ' ARG . 18.1 mmm-85 -70.02 -35.18 74.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.881 -1.137 . . . . 3.23 109.67 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.71 -40.03 84.33 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.445 -0.785 . . . . 0.76 109.26 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.65 -49.0 74.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.408 -0.808 . . . . 0.46 110.069 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -83.48 9.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.975 -1.078 . . . . 0.44 110.755 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -102.71 -15.02 16.44 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.129 -0.982 . . . . 0.53 110.363 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' B' ' 14' ' ' PRO . 4.4 pt-20 -152.72 154.93 32.09 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.047 -1.033 . . . . 1.27 109.019 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' B' ' 13' ' ' GLU . 64.6 Cg_exo -36.8 152.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.124 1.883 . . . . 0.49 111.522 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.463 ' SD ' ' CZ2' ' B' ' 84' ' ' TRP . 11.5 ptm -89.52 -23.21 22.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.044 -1.035 . . . . 0.56 109.718 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.1 -138.48 21.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.188 -1.165 . . . . 0.39 110.188 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.56 43.03 1.58 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.535 -0.979 . . . . 0.84 109.662 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -60.92 147.91 84.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 2.02 108.512 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.84 155.12 39.73 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.304 2.003 . . . . 0.34 112.774 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -54.73 -35.4 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.32 110.232 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.09 -0.58 57.04 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.599 -1.0 . . . . 0.22 110.599 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 8.5 p -82.22 -25.93 33.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.727 -1.454 . . . . 1.24 109.731 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.567 HD22 HD21 ' B' ' 81' ' ' LEU . 96.2 mt -60.69 138.51 58.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.411 -0.806 . . . . 0.24 109.953 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.78 134.51 55.41 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.86 -0.736 . . . . 0.21 109.417 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.0 -21.6 45.22 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.519 -1.432 . . . . 0.22 109.519 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -98.95 114.74 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.273 -1.134 . . . . 0.25 108.203 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.79 -179.26 36.22 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.613 -1.395 . . . . 0.28 109.613 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -58.08 -40.0 79.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -1.071 . . . . 2.0 109.783 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.76 -47.57 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.017 -1.052 . . . . 0.38 109.314 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -35.86 82.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.4 109.43 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.8 -39.96 92.23 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.447 . . . . 0.36 109.481 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.77 -37.35 84.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 2.75 110.39 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -67.85 -51.58 46.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.62 -1.3 . . . . 1.56 109.363 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.63 -39.87 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.33 108.306 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.0 -42.54 94.51 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.559 -0.856 . . . . 1.68 109.419 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -65.12 -19.09 65.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 1.99 108.68 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -90.75 5.35 48.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.535 -0.728 . . . . 2.68 109.813 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.02 8.92 53.35 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 120.225 -0.988 . . . . 0.49 111.575 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' B' ' 44' ' ' VAL . 95.5 m-85 -107.09 75.04 1.01 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.805 -1.409 . . . . 0.33 109.116 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -78.39 -8.14 58.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.41 110.542 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -137.98 158.57 44.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.159 -0.963 . . . . 1.56 110.179 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.43 84.47 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.925 0.713 . . . . 0.21 112.925 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -60.06 -17.68 41.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.431 -1.418 . . . . 0.32 110.489 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' B' ' 39' ' ' PHE . 30.6 t -79.56 -31.96 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.258 -1.386 . . . . 0.24 107.258 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 79.6 t -77.18 -39.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.244 -1.021 . . . . 0.22 108.244 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 24.5 tp -59.97 -35.87 75.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.432 -1.322 . . . . 0.4 107.432 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.34 98.22 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.791 -1.324 . . . . 0.18 109.791 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.061 -1.258 . . . . 1.09 108.838 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -59.97 -40.5 89.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.31 109.222 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.93 -38.34 79.44 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.828 -0.804 . . . . 0.27 108.828 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.78 -19.97 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.187 -0.946 . . . . 0.28 110.562 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 14.07 9.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.064 -1.022 . . . . 0.3 110.808 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm 51.14 32.1 7.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.693 -1.254 . . . . 1.71 109.848 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 57.91 20.02 6.31 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.637 -0.664 . . . . 2.25 110.023 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -70.05 108.7 4.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.632 -1.293 . . . . 1.8 108.126 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.74 -40.07 96.07 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.076 0.769 . . . . 0.88 113.076 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.53 -40.03 85.05 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.434 -1.416 . . . . 0.74 109.932 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.31 -39.65 74.68 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.061 -1.056 . . . . 0.55 109.0 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.16 -41.84 94.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.38 109.132 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -59.96 -51.04 71.4 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.771 . . . . 2.64 110.187 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.73 -37.44 84.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.119 -0.988 . . . . 2.38 110.025 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . 0.448 ' O ' ' OG1' ' B' ' 66' ' ' THR . 74.3 t90 -63.22 -48.0 80.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.4 110.882 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -66.83 -47.36 72.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.038 -1.039 . . . . 0.34 109.752 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.24 -48.6 77.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.299 -0.875 . . . . 2.1 109.859 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -67.27 -32.06 72.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.574 -0.704 . . . . 1.9 109.769 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 91.2 m -80.22 -34.67 37.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.4 111.331 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.7 p -128.84 -26.47 2.67 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.615 -1.303 . . . . 0.39 111.984 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.31 34.59 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.7 -1.76 . . . . 0.36 108.7 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.6 152.92 2.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.32 109.412 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -92.64 174.97 6.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.962 . . . . 1.91 109.745 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -35.38 74.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.38 110.691 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.4 -39.59 64.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.673 -1.267 . . . . 2.57 110.339 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -67.48 -40.12 85.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.047 . . . . 2.12 110.7 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.9 m -69.06 -37.92 78.78 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.138 -0.976 . . . . 1.36 110.522 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' B' ' 75' ' ' ARG . 27.1 mtt-85 -60.0 -37.47 79.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.751 -1.218 . . . . 2.81 109.509 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.43 -39.99 81.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.645 -1.285 . . . . 0.4 110.526 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.57 -40.08 76.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.787 -1.196 . . . . 0.23 109.821 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.27 -60.24 4.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.647 -1.283 . . . . 0.43 109.824 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.0 -33.08 86.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.83 -0.908 . . . . 0.25 110.83 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -70.8 -48.63 53.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.039 -1.271 . . . . 0.24 110.188 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.567 HD21 HD22 ' B' ' 23' ' ' LEU . 88.3 mt -70.02 -39.89 75.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.998 -1.081 . . . . 0.29 108.161 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -61.47 -40.02 93.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 2.74 110.114 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 91.9 mt-10 -70.31 -38.24 74.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.965 -1.084 . . . . 1.91 110.907 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.498 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 89.3 t90 -60.43 -42.49 96.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.314 -1.491 . . . . 0.36 108.478 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.499 ' O ' ' N ' ' B' ' 89' ' ' LEU . 92.7 m -61.33 -40.49 94.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.513 -0.742 . . . . 0.36 110.237 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -29.59 68.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.123 -0.986 . . . . 0.55 109.896 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.26 -35.58 13.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.222 -0.924 . . . . 0.47 110.863 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 90.1 m-85 -108.53 -3.81 17.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.285 -0.884 . . . . 1.24 112.552 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' B' ' 85' ' ' CYS . 9.2 tp . . . . . 0 N--CA 1.503 2.184 0 O-C-N 120.492 -1.38 . . . . 1.67 109.384 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.384 0.612 . . . . 5.68 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -67.35 -80.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.228 -0.92 . . . . 3.02 109.233 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 2' ' ' THR . 72.0 p -78.84 130.3 35.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.96 109.941 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.7 p -84.38 175.66 9.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.38 -0.825 . . . . 1.51 109.188 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -57.54 -20.1 29.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.589 -0.694 . . . . 2.18 109.602 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -61.41 -37.65 84.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 2.02 109.129 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -59.94 -49.98 75.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.149 -0.97 . . . . 0.49 110.317 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 98.1 mtt180 -70.23 -34.63 73.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.124 -0.985 . . . . 3.21 110.103 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.7 -40.07 80.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.76 109.559 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.63 -46.8 81.01 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.557 -0.857 . . . . 0.46 109.988 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.63 9.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.097 -1.002 . . . . 0.44 110.895 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -104.43 -15.06 15.5 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.994 -1.066 . . . . 0.54 110.206 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 14' ' ' PRO . 8.2 pt-20 -151.97 152.52 30.01 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.066 -1.022 . . . . 1.26 108.941 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 13' ' ' GLU . 66.8 Cg_exo -36.99 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.222 1.948 . . . . 0.49 111.636 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.459 ' H ' ' HG2' ' A' ' 15' ' ' MET . 13.2 ptm -95.68 -30.23 13.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 0.57 109.958 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.34 -133.58 49.18 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.363 -1.095 . . . . 0.4 110.363 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.77 35.51 3.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.767 -0.843 . . . . 0.85 110.088 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -54.88 149.81 21.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.925 -1.139 . . . . 2.01 107.925 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.23 157.49 34.95 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.076 1.851 . . . . 0.34 112.244 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 21' ' ' GLY . 12.7 p -56.85 -45.37 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.742 0.782 . . . . 0.32 110.231 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.565 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -61.94 -1.39 2.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.61 -0.996 . . . . 0.23 110.61 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.2 p -82.95 -27.54 30.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.484 . . . . 1.24 109.582 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.92 138.24 57.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.24 109.562 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . . . -65.59 134.86 54.22 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.733 0.778 . . . . 0.21 109.979 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.76 -20.03 51.99 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.246 -1.542 . . . . 0.22 109.246 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.5 mm -99.44 115.58 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.273 -1.133 . . . . 0.25 108.246 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.57 37.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 0.28 109.463 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.84 -40.0 75.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -1.064 . . . . 2.01 109.86 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.38 -45.3 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.929 -1.107 . . . . 0.38 109.719 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.59 -37.79 85.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.4 109.53 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.115 -1.594 . . . . 0.35 109.115 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -1.134 . . . . 2.74 110.073 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -66.51 -48.44 69.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.851 -1.156 . . . . 1.54 109.609 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.6 -38.1 83.56 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.008 -1.108 . . . . 0.34 108.008 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -42.49 94.25 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.245 -0.65 . . . . 1.67 109.245 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.5 -19.34 65.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 2.0 108.718 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -90.48 1.64 56.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 2.69 110.285 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.61 7.0 43.15 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.944 -1.098 . . . . 0.48 111.583 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' HG12 ' A' ' 44' ' ' VAL . 95.7 m-85 -107.2 76.25 1.08 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.878 -1.366 . . . . 0.33 109.131 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.72 -7.26 57.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.865 . . . . 0.41 111.162 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.18 158.88 43.43 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.072 -1.017 . . . . 1.56 110.54 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.9 86.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.762 -0.586 . . . . 0.21 112.107 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 3.5 p90 -61.99 -18.82 61.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.433 -1.417 . . . . 0.32 109.861 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' A' ' 39' ' ' PHE . 20.8 t -79.95 -31.87 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.773 -1.195 . . . . 0.24 107.773 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 20' ' ' VAL . 70.2 t -77.94 -37.34 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.061 -1.089 . . . . 0.22 108.061 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.93 -35.21 74.43 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.993 -1.484 . . . . 0.4 106.993 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -43.0 98.75 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 110.198 -1.161 . . . . 0.18 110.198 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.078 -1.248 . . . . 1.09 109.053 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.92 -41.5 91.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.31 108.66 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.94 -40.04 75.73 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.742 -0.836 . . . . 0.28 108.742 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.18 -25.41 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.109 -0.994 . . . . 0.28 110.684 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.67 16.29 8.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.15 -0.969 . . . . 0.31 109.785 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 55' ' ' ASP . 8.8 mtmp? 51.94 44.94 29.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 1.7 110.609 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 pttt 40.7 18.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.971 -1.081 . . . . 2.24 111.528 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' LYS . 57.9 m-20 -66.59 115.56 6.58 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.847 -1.538 . . . . 1.8 106.847 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.59 -40.37 96.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.87 112.784 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.04 -39.94 75.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.378 -1.451 . . . . 0.73 110.107 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.55 -40.0 73.63 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.121 -1.032 . . . . 0.55 109.105 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.66 -49.74 73.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.38 109.491 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.54 HH12 ' NH2' ' A' ' 75' ' ' ARG . 64.9 mtp180 -60.01 -46.35 89.79 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.444 -0.785 . . . . 2.64 111.249 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.21 -36.36 83.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.674 -1.266 . . . . 2.37 108.905 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -63.62 -48.96 75.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.4 111.067 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.9 tp -67.75 -46.98 70.52 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.054 -1.029 . . . . 0.34 110.548 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -63.11 -46.48 87.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.983 . . . . 2.11 109.424 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 30.4 t0 -67.55 -31.08 70.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.618 . . . . 1.9 109.605 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.9 m -78.52 -36.61 44.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.41 111.653 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.7 p -130.41 -27.45 2.19 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.474 -1.391 . . . . 0.4 112.228 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.17 14.22 19.21 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.3 -1.52 . . . . 0.36 109.3 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.14 153.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.913 -1.345 . . . . 0.33 109.159 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.02 173.33 8.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.076 -1.015 . . . . 1.9 110.133 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.98 74.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.558 -0.714 . . . . 0.39 110.162 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.87 -40.43 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.856 -1.153 . . . . 2.58 110.157 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.35 -40.02 81.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.139 -0.975 . . . . 2.12 110.676 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 t -68.15 -38.37 82.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.128 -0.982 . . . . 1.36 109.927 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.54 ' NH2' HH12 ' A' ' 60' ' ' ARG . 52.6 mtt-85 -60.02 -38.46 82.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.961 -1.087 . . . . 2.8 108.973 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -67.94 -40.02 83.37 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.712 -1.242 . . . . 0.4 110.392 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.22 -39.94 82.21 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.743 -1.223 . . . . 0.24 109.493 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.1 -59.99 4.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.848 -1.157 . . . . 0.43 109.899 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.79 -34.26 89.24 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.278 -0.963 . . . . 0.26 110.736 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 24' ' ' ALA . 45.2 t -70.09 -47.61 61.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.3 . . . . 0.25 110.061 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.9 mt -70.0 -39.87 75.62 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.3 108.234 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.23 -40.5 96.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 2.73 109.883 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -69.23 -39.96 78.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.999 . . . . 1.91 110.754 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 84.5 t90 -59.98 -43.79 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.419 -1.426 . . . . 0.37 107.734 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . 41.5 m -60.89 -40.07 91.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.63 0.729 . . . . 0.36 109.694 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.01 -34.24 73.08 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.105 -0.997 . . . . 0.55 110.148 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.78 -35.26 14.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.963 . . . . 0.48 111.151 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 88.0 m-85 -108.51 2.46 22.24 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.116 -0.99 . . . . 1.24 111.265 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' CYS . 7.6 tp . . . . . 0 N--CA 1.497 1.89 0 O-C-N 120.889 -1.132 . . . . 1.66 109.484 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.38 -0.6 . . . . 5.66 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.457 HG23 ' H ' ' B' ' 3' ' ' THR . 0.2 OUTLIER -67.52 -80.06 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -0.878 . . . . 3.02 109.294 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.457 ' H ' HG23 ' B' ' 2' ' ' THR . 73.0 p -78.84 130.25 35.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.091 -1.006 . . . . 0.96 109.863 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -84.35 175.79 9.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.496 -0.752 . . . . 1.5 109.115 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.64 -20.09 30.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.548 -0.72 . . . . 2.18 109.609 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -61.32 -37.55 83.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 2.01 109.201 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -60.06 -49.93 75.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.49 110.35 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 98.1 mtt180 -70.25 -34.67 73.1 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.125 -0.984 . . . . 3.23 110.11 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.61 -40.05 80.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.76 109.573 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.73 -46.71 81.1 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.46 110.051 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 m -86.57 9.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.123 -0.986 . . . . 0.44 110.812 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -104.24 -15.01 15.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.992 -1.068 . . . . 0.53 110.258 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' B' ' 14' ' ' PRO . 8.2 pt-20 -152.0 152.52 29.97 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.144 -0.973 . . . . 1.27 108.98 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' B' ' 13' ' ' GLU . 69.0 Cg_exo -37.11 155.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.204 1.936 . . . . 0.49 111.65 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.468 ' SD ' HD11 ' A' ' 89' ' ' LEU . 13.2 ptm -95.49 -30.44 13.85 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -0.923 . . . . 0.56 110.057 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.73 -133.43 50.07 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.343 -1.103 . . . . 0.39 110.343 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -113.02 35.48 3.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.729 -0.865 . . . . 0.84 110.089 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -54.9 149.63 22.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.98 -1.119 . . . . 2.02 107.98 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.01 157.57 33.53 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.071 1.848 . . . . 0.34 112.274 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.576 HG13 ' N ' ' B' ' 21' ' ' GLY . 12.7 p -57.09 -45.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.666 0.746 . . . . 0.32 110.215 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.576 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -61.97 -1.59 3.04 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.615 -0.994 . . . . 0.22 110.615 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -82.75 -27.4 31.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.706 -1.467 . . . . 1.24 109.644 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.07 138.17 57.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.24 109.487 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' B' ' 80' ' ' CYS . . . -65.51 135.15 54.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.753 0.787 . . . . 0.21 109.838 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.49 -20.07 51.88 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.238 -1.545 . . . . 0.22 109.238 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 33.4 mm -99.42 115.45 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.335 -1.097 . . . . 0.25 108.306 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.32 177.55 37.92 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.567 -1.413 . . . . 0.28 109.567 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.76 -40.02 75.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.407 -1.055 . . . . 2.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.47 -45.3 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.958 -1.088 . . . . 0.38 109.722 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.48 -37.94 86.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.4 109.449 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.0 95.76 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.139 -1.585 . . . . 0.36 109.139 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.808 ' CA ' ' N ' ' B' ' 33' ' ' LYS . 7.3 ttpm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.402 -1.058 . . . . 2.75 . 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.808 ' N ' ' CA ' ' B' ' 32' ' ' LYS . 62.5 mttm . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.628 -0.508 . . . . 1.56 109.628 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.5 -38.18 83.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.979 -1.119 . . . . 0.33 107.979 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.05 -42.28 94.11 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.204 -0.665 . . . . 1.68 109.204 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.75 -19.24 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.691 -0.855 . . . . 1.99 108.691 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -90.25 1.29 56.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 2.68 110.299 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.06 6.75 42.18 Favored Glycine 0 N--CA 1.503 3.117 0 O-C-N 120.937 -1.102 . . . . 0.49 111.558 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.52 ' CD2' HG12 ' B' ' 44' ' ' VAL . 95.7 m-85 -106.98 76.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.789 -1.418 . . . . 0.33 109.246 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -78.3 -7.45 57.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.126 -0.984 . . . . 0.41 111.112 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.12 158.78 43.63 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.97 -1.081 . . . . 1.56 110.529 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.93 -40.38 87.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.21 111.952 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 2.8 p90 -61.4 -18.64 59.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.506 -1.371 . . . . 0.32 110.24 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' B' ' 39' ' ' PHE . 20.7 t -80.22 -31.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.788 -1.19 . . . . 0.24 107.788 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.454 HG21 HG23 ' B' ' 20' ' ' VAL . 69.8 t -78.15 -37.25 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.029 -1.1 . . . . 0.22 108.029 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 tp -59.98 -35.06 74.19 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.017 -1.475 . . . . 0.4 107.017 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -43.18 98.55 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 110.223 -1.151 . . . . 0.18 110.223 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.136 -1.214 . . . . 1.09 109.113 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.99 -41.42 91.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.31 108.669 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.01 -39.87 75.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.686 -0.857 . . . . 0.27 108.686 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.48 -25.41 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.062 -1.024 . . . . 0.28 110.6 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' B' ' 52' ' ' LEU . 84.3 mt -89.5 15.96 8.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.091 -1.005 . . . . 0.3 109.762 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 55' ' ' ASP . 8.8 mtmp? 52.04 45.11 28.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 1.71 110.556 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 pttt 40.6 19.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.912 -1.117 . . . . 2.25 111.564 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 53' ' ' LYS . 61.6 m-20 -66.67 115.21 6.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.917 -1.512 . . . . 1.8 106.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.5 -40.27 96.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.262 -0.899 . . . . 0.88 112.746 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -69.86 -40.07 75.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.341 -1.475 . . . . 0.74 110.257 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.67 -39.95 73.25 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.093 -1.043 . . . . 0.55 109.008 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.5 -49.89 73.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.38 109.459 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.549 HH12 ' NH2' ' B' ' 75' ' ' ARG . 64.5 mtp180 -60.03 -45.92 91.23 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.528 -0.733 . . . . 2.64 111.292 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.58 -36.54 84.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.678 -1.264 . . . . 2.38 108.857 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -63.4 -49.07 75.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.4 111.038 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.406 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 61.2 tp -67.81 -46.75 70.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.1 -1.0 . . . . 0.34 110.564 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -63.3 -46.32 87.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 2.1 109.393 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 34.8 t0 -67.64 -31.16 70.97 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.746 -0.596 . . . . 1.9 109.652 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 97.2 m -78.49 -36.61 44.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.939 . . . . 0.4 111.687 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 18.5 p -130.44 -27.2 2.21 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.49 -1.381 . . . . 0.39 112.217 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.98 13.96 20.25 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.333 -1.507 . . . . 0.36 109.333 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.98 153.36 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.922 -1.34 . . . . 0.32 109.183 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -91.04 173.39 7.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 1.91 110.094 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.38 110.154 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -71.79 -40.44 69.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 2.57 110.097 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.28 -39.99 81.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 2.12 110.656 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 5.7 t -68.14 -38.45 82.17 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -0.983 . . . . 1.36 109.916 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.549 ' NH2' HH12 ' B' ' 60' ' ' ARG . 52.6 mtt-85 -59.95 -38.64 83.05 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.907 -1.121 . . . . 2.81 109.013 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.81 -39.94 83.92 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.871 -1.143 . . . . 0.4 110.304 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.0 m -68.21 -40.06 82.21 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.789 -1.195 . . . . 0.23 109.508 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.95 -60.15 4.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.894 -1.129 . . . . 0.43 109.888 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.73 -34.35 89.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.653 -0.979 . . . . 0.25 110.653 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' B' ' 24' ' ' ALA . 45.8 t -70.1 -47.56 61.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.322 . . . . 0.24 110.024 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.91 -40.0 75.85 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.1 -1.04 . . . . 0.29 108.314 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -62.08 -40.75 96.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.312 -0.868 . . . . 2.74 109.819 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -69.0 -39.92 79.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 1.91 110.754 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.433 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 84.8 t90 -59.96 -44.03 94.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.451 -1.406 . . . . 0.36 107.622 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' B' ' 89' ' ' LEU . 41.2 m -60.81 -40.01 91.13 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 0.36 109.737 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -59.97 -34.46 73.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.988 -1.07 . . . . 0.55 110.2 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.6 -35.14 14.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.068 -1.02 . . . . 0.47 111.162 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.433 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 89.7 m-85 -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.115 -0.991 . . . . 1.24 111.407 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.1 tp . . . . . 0 N--CA 1.496 1.861 0 O-C-N 120.809 -1.182 . . . . 1.67 109.535 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.189 -0.671 . . . . 5.68 109.189 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.8 p -90.03 -0.08 57.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.022 -1.049 . . . . 3.02 109.004 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -95.06 136.24 35.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.96 109.325 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -78.33 165.11 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 1.51 109.1 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -55.23 -20.65 11.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 2.18 110.234 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.25 -36.96 81.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 2.02 109.218 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.427 ' NE2' ' OE2' ' A' ' 83' ' ' GLU . 16.1 t60 -60.06 -50.15 74.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.067 . . . . 0.49 110.731 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 8' ' ' ARG . 4.1 mmt-85 -70.05 -34.3 73.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.045 -1.034 . . . . 3.21 109.743 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -72.08 -37.55 69.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.76 109.987 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.49 84.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.46 109.913 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.2 m -82.99 15.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.44 109.401 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.39 -8.49 10.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.557 -0.714 . . . . 0.54 110.362 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.29 151.0 23.25 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.887 -1.133 . . . . 1.26 109.554 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.5 161.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.916 1.744 . . . . 0.49 111.831 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.438 ' CE ' HD22 ' A' ' 46' ' ' LEU . 4.8 ptp -96.13 -24.71 16.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.218 -0.926 . . . . 0.57 109.788 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.84 -136.85 44.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.346 -1.501 . . . . 0.4 109.346 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -110.83 34.77 3.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.41 -1.053 . . . . 0.85 109.965 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -60.0 149.6 73.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.943 -1.098 . . . . 2.01 108.974 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.79 156.52 37.58 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.334 2.022 . . . . 0.34 112.301 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 21' ' ' GLY . 10.4 p -57.95 -48.12 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.389 -0.819 . . . . 0.32 110.267 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.574 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.35 -1.44 0.18 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.494 -1.042 . . . . 0.23 110.494 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 80.3 p -81.32 -24.82 36.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.714 -1.462 . . . . 1.24 109.179 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.402 HD22 HD21 ' A' ' 81' ' ' LEU . 92.4 mt -63.6 138.88 58.68 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.65 0.738 . . . . 0.24 109.893 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 134.63 54.32 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.815 -0.754 . . . . 0.21 109.426 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.2 -20.62 46.52 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.746 -1.342 . . . . 0.22 109.746 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.32 118.57 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.123 -1.222 . . . . 0.25 108.396 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.03 179.95 34.09 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.618 -1.393 . . . . 0.28 109.618 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -58.16 -40.09 80.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -1.139 . . . . 2.01 110.428 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.89 -47.19 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.793 -1.192 . . . . 0.38 109.326 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.68 -38.56 87.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.827 . . . . 0.4 109.412 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.97 96.19 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.439 -1.464 . . . . 0.35 109.439 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.32 -39.94 94.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -1.12 . . . . 2.74 110.018 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.32 -47.39 73.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 1.54 109.369 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.14 -39.66 93.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.34 108.964 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -43.16 95.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.437 -0.905 . . . . 1.67 108.867 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -64.72 -19.87 66.02 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 2.0 108.443 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.519 HH11 ' HG2' ' A' ' 37' ' ' ARG . 1.1 mmt-85 -90.06 2.42 55.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.438 -0.789 . . . . 2.69 110.271 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.76 6.29 46.69 Favored Glycine 0 N--CA 1.505 3.286 0 O-C-N 121.083 -1.011 . . . . 0.48 111.948 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.496 ' CD2' HG12 ' A' ' 44' ' ' VAL . 96.5 m-85 -105.3 75.14 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.726 -1.455 . . . . 0.33 109.236 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' B' ' 53' ' ' LYS . 37.2 p-10 -80.02 -10.52 59.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.904 . . . . 0.41 110.389 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.75 153.28 51.35 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.182 -0.948 . . . . 1.56 110.001 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.93 92.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.731 -0.606 . . . . 0.21 111.969 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 27.0 p90 -56.85 -17.95 11.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.834 -1.166 . . . . 0.32 110.665 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 39' ' ' PHE . 25.9 t -79.63 -33.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.87 -1.144 . . . . 0.24 108.204 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 20' ' ' VAL . 54.7 t -74.09 -38.83 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.562 -1.273 . . . . 0.22 107.562 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD22 ' CE ' ' A' ' 15' ' ' MET . 24.9 tp -58.26 -38.81 77.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.808 -1.182 . . . . 0.4 107.808 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.34 -43.22 93.84 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.932 -1.267 . . . . 0.18 109.932 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -60.16 -42.75 95.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.268 . . . . 1.09 108.559 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.04 -40.05 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.539 -0.911 . . . . 0.31 108.539 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' B' ' 50' ' ' LEU . 98.9 mt -69.92 -39.96 75.83 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.594 -0.891 . . . . 0.28 108.594 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.22 -25.65 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.28 110.678 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.7 15.23 9.96 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.921 -1.112 . . . . 0.31 109.886 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' B' ' 40' ' ' ASP . 67.9 mttm 52.15 29.47 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.063 -1.023 . . . . 1.7 110.607 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' NZ ' ' NH1' ' A' ' 82' ' ' ARG . 83.4 mttt 60.06 19.83 9.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 2.24 110.685 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.19 115.73 7.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.406 -1.434 . . . . 1.8 107.957 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.72 -40.14 96.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.87 112.281 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 90.2 m-20 -68.3 -39.94 81.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.554 -1.341 . . . . 0.73 109.961 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.5 -39.69 67.43 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.166 -1.013 . . . . 0.55 109.101 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.35 -49.43 73.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.38 110.401 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.534 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 81.3 mtm180 -60.04 -44.8 94.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 2.64 110.693 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.71 -37.8 87.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.873 -1.142 . . . . 2.37 108.902 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -64.83 -48.73 73.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -0.983 . . . . 0.4 110.8 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 54.8 tp -66.97 -46.57 74.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.997 . . . . 0.34 109.391 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.88 -46.52 87.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 2.11 109.412 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -31.0 69.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.688 -0.633 . . . . 1.9 109.91 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.405 ' O ' ' NH2' ' A' ' 37' ' ' ARG . 91.4 m -77.95 -37.51 47.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.41 111.809 -177.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 63' ' ' LEU . 6.2 p -130.13 -25.73 2.45 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.503 -1.373 . . . . 0.4 111.933 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 13.43 26.51 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.063 -1.615 . . . . 0.36 109.063 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.93 153.94 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.238 . . . . 0.33 109.031 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -91.15 -180.0 5.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.989 -1.069 . . . . 1.9 109.779 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -33.19 75.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.772 . . . . 0.39 110.823 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -71.49 -40.07 70.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.862 -1.149 . . . . 2.58 109.789 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.92 -37.7 84.83 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.426 -0.796 . . . . 2.12 110.438 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.5 p -67.03 -37.82 84.81 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.135 -0.978 . . . . 1.36 110.004 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' A' ' 75' ' ' ARG . 47.3 mtt-85 -59.97 -37.85 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.762 -1.211 . . . . 2.8 108.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.88 -40.01 83.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.837 -1.164 . . . . 0.4 110.718 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.25 -40.05 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.605 -1.309 . . . . 0.24 109.948 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.27 -60.2 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.741 -1.225 . . . . 0.43 109.451 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.01 -33.58 79.73 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.339 -1.105 . . . . 0.26 110.339 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.16 -51.06 50.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.105 -1.232 . . . . 0.25 109.91 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.402 HD21 HD22 ' A' ' 23' ' ' LEU . 81.8 mt -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.913 -1.115 . . . . 0.3 109.619 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' NH1' ' NZ ' ' A' ' 54' ' ' LYS . 23.8 tpt180 -60.12 -44.48 94.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 2.73 110.117 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' OE2' ' NE2' ' A' ' 7' ' ' HIS . 44.7 mt-10 -70.39 -38.1 74.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.86 . . . . 1.91 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 89.3 t90 -61.88 -43.0 99.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.442 -1.411 . . . . 0.37 108.397 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 89' ' ' LEU . 58.8 m -61.29 -40.48 94.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.441 -0.787 . . . . 0.36 110.379 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.83 -27.88 67.0 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.198 -0.939 . . . . 0.55 109.338 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.82 -34.45 12.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 0.48 110.801 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 87.9 m-85 -110.68 -7.83 14.63 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.259 -0.9 . . . . 1.24 112.812 -177.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' CYS . 13.2 tp . . . . . 0 N--CA 1.502 2.142 0 O-C-N 120.331 -1.481 . . . . 1.66 109.442 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.203 -0.665 . . . . 5.66 109.203 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 43.8 p -90.07 -0.02 57.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.037 -1.039 . . . . 3.02 109.033 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 17.9 p -95.06 136.32 35.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.456 -0.778 . . . . 0.96 109.382 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 14.7 m -78.4 165.12 24.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 1.5 109.009 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -55.2 -20.77 11.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.534 -0.729 . . . . 2.18 110.265 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.23 -36.99 81.47 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.891 -1.131 . . . . 2.01 109.206 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.421 ' CE1' ' OE2' ' B' ' 83' ' ' GLU . 16.1 t60 -59.99 -50.18 74.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.49 110.76 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.523 HH11 ' HG2' ' B' ' 8' ' ' ARG . 4.0 mmt-85 -69.91 -34.45 73.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 3.23 109.785 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -72.06 -37.53 69.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.76 109.959 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.407 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 57.7 t80 -67.16 -42.48 84.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.46 109.88 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -83.1 15.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.44 109.374 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.62 -8.41 9.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.597 -0.689 . . . . 0.53 110.358 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -154.33 151.07 23.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.872 -1.142 . . . . 1.27 109.53 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -42.6 161.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.824 1.683 . . . . 0.49 111.971 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.436 ' CE ' HD22 ' B' ' 46' ' ' LEU . 4.6 ptp -96.25 -24.4 16.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.56 109.769 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.91 43.11 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.364 -1.494 . . . . 0.39 109.364 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -110.71 34.78 3.78 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.429 -1.042 . . . . 0.84 110.025 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -59.98 149.71 72.69 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.966 -1.084 . . . . 2.02 108.967 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.87 156.42 38.46 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.304 2.003 . . . . 0.34 112.352 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.582 HG13 ' N ' ' B' ' 21' ' ' GLY . 10.7 p -57.87 -48.15 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.32 110.271 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.582 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -55.43 -1.19 0.16 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.506 -1.038 . . . . 0.22 110.506 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.5 ' H ' ' C ' ' B' ' 20' ' ' VAL . 81.0 p -81.5 -24.72 36.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.699 -1.471 . . . . 1.24 109.148 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.69 138.8 58.64 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.649 0.738 . . . . 0.24 109.952 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.94 134.49 54.06 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.765 -0.774 . . . . 0.21 109.582 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.38 -20.73 45.73 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.749 -1.34 . . . . 0.22 109.749 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.18 118.62 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.213 -1.169 . . . . 0.25 108.398 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.99 179.96 34.16 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.59 -1.404 . . . . 0.28 109.59 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.28 -39.98 80.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.261 -1.14 . . . . 2.0 110.425 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 66.1 t -66.88 -47.25 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.38 109.402 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.46 -38.65 87.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.336 -0.852 . . . . 0.4 109.531 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.91 -40.01 96.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.353 -1.499 . . . . 0.36 109.353 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.31 -39.88 94.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 2.75 110.107 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.4 -47.21 74.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.86 -1.15 . . . . 1.56 109.33 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.28 -39.58 93.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.33 109.039 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.464 -0.894 . . . . 1.68 108.86 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.68 -19.88 65.99 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.439 -0.949 . . . . 1.99 108.439 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' B' ' 37' ' ' ARG . 1.1 mmt-85 -90.1 2.68 54.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 2.68 110.376 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.48 6.37 47.43 Favored Glycine 0 N--CA 1.504 3.223 0 O-C-N 120.988 -1.07 . . . . 0.49 112.057 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.503 ' CD2' HG12 ' B' ' 44' ' ' VAL . 96.5 m-85 -105.4 75.25 1.14 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.808 -1.407 . . . . 0.33 109.143 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 37.3 p-10 -80.21 -10.23 59.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.41 110.432 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -133.0 153.37 51.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.246 -0.909 . . . . 1.56 109.916 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.77 93.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.838 -0.539 . . . . 0.21 112.068 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 27.3 p90 -57.08 -18.01 12.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.32 110.524 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.2 t -79.51 -33.56 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.901 -1.124 . . . . 0.24 108.248 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.407 HG21 HG23 ' B' ' 20' ' ' VAL . 55.1 t -74.19 -38.79 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.472 -1.307 . . . . 0.22 107.472 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.436 HD22 ' CE ' ' B' ' 15' ' ' MET . 24.8 tp -58.38 -38.98 78.41 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.769 -1.197 . . . . 0.4 107.769 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.31 -43.13 93.81 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.856 -1.297 . . . . 0.18 109.856 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -60.03 -42.83 95.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.93 -1.335 . . . . 1.09 108.548 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.09 -39.95 87.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.559 -0.904 . . . . 0.31 108.559 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' A' ' 50' ' ' LEU . 98.7 mt -69.97 -40.04 75.62 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.27 108.538 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.05 -25.56 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.242 -0.911 . . . . 0.28 110.694 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.84 15.34 9.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.921 -1.112 . . . . 0.3 109.838 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 67.9 mttm 51.98 29.46 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 1.71 110.661 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . 0.445 ' NZ ' ' NH1' ' B' ' 82' ' ' ARG . 83.5 mttt 60.01 19.74 8.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.782 -0.573 . . . . 2.25 110.718 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -68.02 115.7 7.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.445 -1.41 . . . . 1.8 107.947 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.65 -40.32 96.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.88 112.205 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' NH2' ' B' ' 60' ' ' ARG . 90.4 m-20 -68.28 -39.97 81.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.512 -1.368 . . . . 0.74 109.921 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.39 -39.67 67.79 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.141 -1.023 . . . . 0.55 109.215 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.45 -49.43 73.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.38 110.43 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OD1' ' B' ' 57' ' ' ASP . 81.5 mtm180 -59.97 -45.03 94.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 2.64 110.658 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.53 -37.61 87.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.855 -1.153 . . . . 2.38 108.931 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -65.03 -48.55 73.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.004 . . . . 0.4 110.876 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.406 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 54.6 tp -67.04 -46.67 73.7 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.135 -0.978 . . . . 0.34 109.392 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -62.84 -46.4 88.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 2.1 109.481 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.25 -30.94 69.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 1.9 109.835 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.405 ' O ' ' NH2' ' B' ' 37' ' ' ARG . 91.8 m -77.97 -37.52 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.4 111.741 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 6.1 p -130.03 -25.94 2.45 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.398 -1.439 . . . . 0.39 111.945 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.49 13.65 25.74 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 108.997 -1.641 . . . . 0.36 108.997 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.02 154.0 2.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.279 . . . . 0.32 108.983 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -91.31 -179.98 5.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.035 -1.04 . . . . 1.91 109.829 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.06 74.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.38 110.832 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -71.61 -40.07 70.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 2.57 109.823 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -66.9 -37.64 84.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.503 -0.748 . . . . 2.12 110.542 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.4 p -67.14 -37.73 84.31 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.122 -0.987 . . . . 1.36 110.004 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' B' ' 75' ' ' ARG . 46.9 mtt-85 -60.01 -37.77 80.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.77 -1.206 . . . . 2.81 108.778 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.0 -39.96 83.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.871 -1.143 . . . . 0.4 110.728 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 94.1 m -68.27 -40.05 82.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.641 -1.287 . . . . 0.23 109.884 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.35 -60.04 4.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.784 -1.197 . . . . 0.43 109.499 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -33.57 79.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.359 -1.096 . . . . 0.25 110.359 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -68.25 -51.01 49.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.046 -1.267 . . . . 0.24 109.903 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 82.0 mt -73.18 -41.16 64.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.953 -1.099 . . . . 0.29 109.591 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.445 ' NH1' ' NZ ' ' B' ' 54' ' ' LYS . 23.8 tpt180 -60.16 -44.33 95.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.959 . . . . 2.74 110.192 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.421 ' OE2' ' CE1' ' B' ' 7' ' ' HIS . 44.7 mt-10 -70.38 -38.21 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 1.91 110.585 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.422 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 89.1 t90 -61.79 -43.04 99.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.486 -1.384 . . . . 0.36 108.409 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' B' ' 89' ' ' LEU . 58.2 m -61.34 -40.41 94.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.36 110.391 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -59.88 -27.76 66.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.3 -0.875 . . . . 0.55 109.368 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.91 -35.01 12.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.47 110.724 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.422 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 88.7 m-85 -109.97 -8.08 14.89 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.235 -0.915 . . . . 1.24 112.996 -177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 85' ' ' CYS . 13.2 tp . . . . . 0 N--CA 1.502 2.141 0 O-C-N 120.224 -1.547 . . . . 1.67 109.414 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.578 -0.527 . . . . 5.68 109.578 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.6 m -68.87 125.41 26.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 3.02 108.878 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 p -106.92 135.16 48.95 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.471 -0.768 . . . . 0.96 110.037 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.5 m -88.65 178.28 6.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 1.51 108.694 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.92 -24.9 64.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.542 -0.724 . . . . 2.18 109.304 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.28 -36.93 81.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.909 . . . . 2.02 109.256 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.563 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 60.0 t60 -59.9 -54.37 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.49 110.839 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.9 -33.64 72.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.993 -1.067 . . . . 3.21 110.154 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.97 -39.6 75.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.313 -0.867 . . . . 0.76 109.342 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.54 -47.62 80.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 0.46 110.384 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.5 m -80.89 14.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.01 -1.056 . . . . 0.44 109.685 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.4 -11.08 13.71 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.508 -0.745 . . . . 0.54 110.081 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 14' ' ' PRO . 12.6 pt-20 -153.97 150.99 23.76 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.093 -1.004 . . . . 1.26 109.105 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLU . 93.5 Cg_exo -40.48 166.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.883 1.722 . . . . 0.49 112.123 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.0 ptp -92.24 -20.22 21.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.213 -0.93 . . . . 0.57 109.171 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.6 -141.52 5.97 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.339 -1.504 . . . . 0.4 109.339 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.26 30.05 6.57 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.439 -1.036 . . . . 0.85 109.812 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -60.4 148.84 79.1 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 2.01 108.908 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.46 155.36 53.12 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.265 1.977 . . . . 0.34 112.79 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.581 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.2 p -57.23 -47.18 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.626 0.727 . . . . 0.32 110.184 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -51.97 -3.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.514 -1.034 . . . . 0.23 110.514 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 20' ' ' VAL . 23.0 t -83.08 -22.3 33.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.758 -1.436 . . . . 1.24 109.47 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.11 58.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.146 -0.971 . . . . 0.24 109.766 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.34 133.83 51.32 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.857 -0.737 . . . . 0.21 109.83 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.79 -20.01 51.04 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.315 -1.514 . . . . 0.22 109.315 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -99.89 113.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.736 -1.209 . . . . 0.25 107.736 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.47 176.29 43.11 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.828 -1.309 . . . . 0.28 109.828 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -58.31 -39.96 80.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.502 -0.999 . . . . 2.01 109.702 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.03 -47.88 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.38 109.548 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.84 -39.83 83.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.4 109.307 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.97 96.43 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.32 -1.512 . . . . 0.35 109.32 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -61.13 -39.98 92.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -1.094 . . . . 2.74 110.664 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.19 -41.84 89.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.731 -1.231 . . . . 1.54 110.133 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.9 mt -60.03 -39.61 86.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.34 109.089 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -59.96 -40.04 87.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.375 -0.93 . . . . 1.67 109.639 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.05 -19.42 64.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.908 . . . . 2.0 108.804 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -90.1 1.35 56.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.587 -0.695 . . . . 2.69 109.515 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.11 38.78 3.47 Favored Glycine 0 N--CA 1.497 2.754 0 O-C-N 121.232 -0.918 . . . . 0.48 110.985 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 44' ' ' VAL . 84.5 m-85 -132.37 71.9 1.48 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.212 -1.17 . . . . 0.33 108.321 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -75.48 -12.38 60.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.053 -1.029 . . . . 0.41 110.495 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -134.34 156.86 47.73 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.165 -0.96 . . . . 1.56 109.434 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -40.22 93.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.21 111.678 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -58.44 -17.34 19.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.837 -1.164 . . . . 0.32 110.717 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 39' ' ' PHE . 43.7 t -79.77 -31.62 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.87 -1.159 . . . . 0.24 107.87 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.81 -38.69 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.739 -1.208 . . . . 0.22 107.739 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.66 -38.75 82.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.286 -1.375 . . . . 0.4 107.286 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.08 71.59 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.965 -1.254 . . . . 0.18 109.965 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -60.05 -42.56 94.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -1.213 . . . . 1.09 109.885 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.07 -39.96 87.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.096 -1.003 . . . . 0.31 108.68 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.1 -38.34 75.63 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.616 -0.883 . . . . 0.28 108.616 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.53 -22.51 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.153 -0.967 . . . . 0.28 110.733 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.86 17.85 7.29 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.053 -1.03 . . . . 0.31 109.735 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 52.06 29.43 6.33 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.073 -1.017 . . . . 1.7 109.611 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.4 mttt 60.08 19.88 9.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.855 -0.528 . . . . 2.24 109.944 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.99 114.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.821 -1.178 . . . . 1.8 107.821 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.72 -39.99 90.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.87 112.856 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.56 -39.57 84.93 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.462 -1.399 . . . . 0.73 110.687 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.98 -38.97 76.21 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.018 -1.073 . . . . 0.55 109.566 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.63 -43.69 92.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.38 109.884 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -60.04 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 2.64 110.941 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.77 -38.83 90.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.896 -1.127 . . . . 2.37 109.25 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -64.34 -49.48 71.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.019 -1.051 . . . . 0.4 110.993 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.3 tp -66.9 -47.25 72.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.04 -1.037 . . . . 0.34 109.998 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.83 -44.47 89.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 2.11 109.8 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 30.3 t0 -69.63 -30.95 68.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.557 -0.715 . . . . 1.9 109.664 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -79.31 -34.73 42.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.41 111.332 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.7 p -130.39 -29.68 1.98 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.598 -1.314 . . . . 0.4 112.078 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.98 14.48 20.8 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.401 -1.48 . . . . 0.36 109.401 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.73 154.79 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.034 -1.274 . . . . 0.33 109.296 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -89.22 169.91 11.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.984 -1.073 . . . . 1.9 110.266 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.36 73.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.687 . . . . 0.39 111.02 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.01 -40.05 75.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.629 -1.295 . . . . 2.58 109.654 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -64.88 -30.1 71.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.537 -0.727 . . . . 2.12 110.572 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.7 p -68.79 -39.6 80.07 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.987 -1.07 . . . . 1.36 110.611 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -60.01 -37.85 80.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.547 -1.346 . . . . 2.8 109.092 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.58 -1.325 . . . . 0.4 110.412 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 86.2 m -70.01 -40.27 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.791 -1.193 . . . . 0.24 109.502 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.17 -61.03 2.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.05 -1.031 . . . . 0.43 109.789 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.53 -33.08 83.55 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.196 -1.161 . . . . 0.26 110.196 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 46.7 t -71.0 -46.88 61.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.922 -1.34 . . . . 0.25 109.797 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.89 -40.98 68.52 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.01 -1.076 . . . . 0.3 109.068 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.75 -40.44 97.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.121 -0.987 . . . . 2.73 110.147 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.563 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 96.0 mt-10 -70.14 -38.38 75.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 1.91 110.459 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.7 t90 -61.49 -47.81 83.93 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.527 -1.358 . . . . 0.37 108.087 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 89' ' ' LEU . 56.4 m -59.99 -40.14 88.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.498 -0.751 . . . . 0.36 109.841 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.47 -29.82 68.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.005 . . . . 0.55 109.364 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.52 -33.67 12.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.302 -0.874 . . . . 0.48 110.705 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 86.3 m-85 -108.79 -5.82 16.11 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.277 -0.889 . . . . 1.24 112.45 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 85' ' ' CYS . 8.2 tp . . . . . 0 N--CA 1.503 2.225 0 O-C-N 120.451 -1.406 . . . . 1.66 109.512 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.641 -0.503 . . . . 5.66 109.641 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 29.1 m -68.8 125.28 26.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 3.02 108.95 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.8 p -106.76 135.09 48.88 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.533 -0.729 . . . . 0.96 110.042 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m -88.59 178.37 6.53 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.653 -0.869 . . . . 1.5 108.653 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.93 -25.0 64.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 2.18 109.352 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.19 -36.97 81.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 2.01 109.322 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.56 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 60.3 t60 -59.93 -54.17 49.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.49 110.793 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -69.95 -33.65 72.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 3.23 110.127 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.01 -39.41 75.84 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.348 -0.845 . . . . 0.76 109.367 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.8 -47.59 80.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.46 110.316 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.93 14.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.042 -1.036 . . . . 0.44 109.68 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.34 -11.01 13.75 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.552 -0.717 . . . . 0.53 110.121 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 14' ' ' PRO . 12.6 pt-20 -154.0 151.17 24.09 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 1.27 109.02 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.5 Cg_exo -40.44 166.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.958 1.772 . . . . 0.49 112.074 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 1.9 ptp -92.57 -20.11 21.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.15 -0.968 . . . . 0.56 109.081 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.71 -141.43 6.17 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.427 -1.469 . . . . 0.39 109.427 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -107.27 29.95 6.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.527 -0.984 . . . . 0.84 109.787 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.47 148.82 79.65 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.89 -1.131 . . . . 2.02 108.812 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.43 155.49 52.12 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.218 1.945 . . . . 0.34 112.774 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.577 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.3 p -57.21 -47.15 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.674 0.75 . . . . 0.32 110.222 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -52.01 -3.42 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.572 -1.011 . . . . 0.22 110.572 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.523 ' H ' ' C ' ' B' ' 20' ' ' VAL . 22.8 t -82.92 -22.21 33.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.413 . . . . 1.24 109.485 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.05 137.07 58.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.24 109.807 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.9 51.42 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.591 0.71 . . . . 0.21 109.792 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.518 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.76 -20.06 50.88 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.399 -1.48 . . . . 0.22 109.399 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.9 113.53 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 107.622 -1.251 . . . . 0.25 107.622 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.51 176.26 43.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.829 -1.308 . . . . 0.28 109.829 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -58.26 -39.97 80.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.445 -1.032 . . . . 2.0 109.678 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.21 -47.67 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.049 -1.032 . . . . 0.38 109.559 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.91 -39.86 83.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.4 109.301 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.97 96.27 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.343 -1.503 . . . . 0.36 109.343 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -61.21 -39.9 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -1.073 . . . . 2.75 110.66 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -66.24 -41.82 89.49 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.705 -1.247 . . . . 1.56 110.154 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 63.7 mt -60.03 -39.56 86.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.087 -1.008 . . . . 0.33 109.084 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -60.12 -39.93 87.99 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.207 -0.997 . . . . 1.68 109.607 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -19.52 64.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 1.99 108.844 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -90.1 1.47 56.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.667 -0.646 . . . . 2.68 109.522 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.94 38.88 3.48 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.236 -0.915 . . . . 0.49 111.032 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.431 ' CD2' HG12 ' B' ' 44' ' ' VAL . 84.5 m-85 -132.5 71.9 1.48 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -1.213 . . . . 0.33 108.323 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -75.46 -12.3 60.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.963 -1.086 . . . . 0.41 110.406 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -134.43 156.8 47.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.165 -0.959 . . . . 1.56 109.392 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.21 92.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.426 -0.796 . . . . 0.21 111.608 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -58.41 -17.32 19.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.805 -1.185 . . . . 0.32 110.671 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' B' ' 39' ' ' PHE . 42.9 t -79.71 -31.78 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 0.24 107.943 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.76 -38.56 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.837 -1.171 . . . . 0.22 107.837 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -59.76 -38.78 82.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.28 -1.378 . . . . 0.4 107.28 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.41 -45.81 74.58 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.955 -1.258 . . . . 0.18 109.955 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -60.08 -42.63 95.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.24 . . . . 1.09 109.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.1 -39.91 87.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.136 -0.978 . . . . 0.31 108.776 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.96 -38.38 76.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.694 -0.854 . . . . 0.27 108.694 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.1 t -66.57 -22.43 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.28 110.716 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.92 17.79 7.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.001 -1.062 . . . . 0.3 109.737 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 52.02 29.64 6.49 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.031 -1.043 . . . . 1.71 109.499 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 78.6 mttt 59.93 20.08 9.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.802 -0.562 . . . . 2.25 109.986 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -68.98 114.46 7.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.843 -1.16 . . . . 1.8 107.925 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.68 -40.0 90.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.388 -0.82 . . . . 0.88 112.78 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -67.65 -39.52 84.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.524 -1.36 . . . . 0.74 110.634 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.97 -39.06 76.2 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 119.034 -1.066 . . . . 0.55 109.538 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -64.57 -43.72 92.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.38 109.813 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -59.96 -49.98 75.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 2.64 110.959 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.8 -38.79 89.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.78 -1.2 . . . . 2.38 109.273 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -64.33 -49.44 71.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.014 -1.054 . . . . 0.4 110.991 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.09 -47.03 72.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.028 -1.045 . . . . 0.34 110.0 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -64.92 -44.4 89.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.33 -0.856 . . . . 2.1 109.8 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 33.0 t0 -69.73 -30.97 68.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 1.9 109.724 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 96.5 m -79.23 -34.8 42.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.4 111.399 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.9 p -130.29 -29.78 1.99 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.58 -1.325 . . . . 0.39 112.092 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.07 14.33 21.01 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.363 -1.495 . . . . 0.36 109.363 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.63 154.69 1.84 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.015 -1.285 . . . . 0.32 109.34 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.17 169.99 10.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 1.91 110.241 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.29 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.642 -0.661 . . . . 0.38 110.992 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.11 -39.94 75.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.699 -1.25 . . . . 2.57 109.694 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.7 mm100 -65.0 -29.99 70.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.454 -0.779 . . . . 2.12 110.489 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p -68.82 -39.48 80.0 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.007 -1.058 . . . . 1.36 110.62 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' B' ' 75' ' ' ARG . 0.3 OUTLIER -60.25 -37.76 81.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.577 -1.327 . . . . 2.81 108.768 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.69 -40.11 76.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.6 -1.312 . . . . 0.4 110.431 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.04 -40.19 75.29 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.723 -1.236 . . . . 0.23 109.354 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.26 -61.01 2.91 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.041 -1.037 . . . . 0.43 109.71 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.56 -33.06 83.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.236 -1.146 . . . . 0.25 110.236 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 45.1 t -70.91 -46.95 61.61 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.933 -1.334 . . . . 0.24 109.703 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.9 -41.01 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.957 -1.097 . . . . 0.29 109.089 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -62.59 -40.6 97.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.155 -0.966 . . . . 2.74 110.139 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 95.9 mt-10 -70.08 -38.34 75.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 1.91 110.502 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.434 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.7 t90 -61.46 -47.87 83.72 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.542 -1.349 . . . . 0.36 108.09 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' B' ' 89' ' ' LEU . 56.3 m -59.99 -40.13 88.11 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.365 -0.834 . . . . 0.36 109.826 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.41 -29.83 68.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.069 -1.02 . . . . 0.55 109.404 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.58 -33.78 12.89 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.323 -0.86 . . . . 0.47 110.75 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.0 m-85 -108.3 -5.96 16.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.248 -0.907 . . . . 1.24 112.584 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.503 2.203 0 O-C-N 120.61 -1.306 . . . . 1.67 109.548 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.331 0.586 . . . . 5.68 109.812 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 2' ' ' THR . 11.9 t -165.01 125.18 1.91 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 3.02 109.451 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -100.96 123.65 45.48 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.339 -0.851 . . . . 0.96 109.585 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.4 m -81.07 172.56 13.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.321 -0.862 . . . . 1.51 109.742 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.574 ' NE2' ' NH2' ' A' ' 8' ' ' ARG . 7.3 tp-100 -54.68 -24.35 21.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 2.18 109.9 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.02 -38.66 86.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.034 -1.041 . . . . 2.02 109.228 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -59.16 -50.63 73.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.141 -0.974 . . . . 0.49 110.169 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.574 ' NH2' ' NE2' ' A' ' 5' ' ' GLN . 89.3 mtm180 -69.4 -34.75 74.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.132 -0.98 . . . . 3.21 110.423 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.57 -39.86 80.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.155 -0.966 . . . . 0.76 109.289 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.53 -48.94 78.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.445 -0.784 . . . . 0.46 109.761 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 m -83.22 10.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.266 -0.896 . . . . 0.44 110.711 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.66 -14.97 17.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.246 -0.909 . . . . 0.54 110.364 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' PRO . 18.6 pt-20 -152.45 152.61 29.37 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.031 -1.043 . . . . 1.26 108.632 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . 75.0 Cg_exo -37.37 155.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.96 1.773 . . . . 0.49 111.089 178.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.448 ' H ' ' HG2' ' A' ' 15' ' ' MET . 14.3 ptm -92.64 -24.75 18.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.055 -1.028 . . . . 0.57 110.443 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.81 -136.01 37.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.971 -1.109 . . . . 0.4 110.401 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.15 42.78 1.71 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.631 -0.923 . . . . 0.85 109.902 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -60.12 148.1 79.01 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.146 -0.971 . . . . 2.01 108.452 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.38 159.85 33.98 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.037 1.825 . . . . 0.34 112.085 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 21' ' ' GLY . 12.8 p -57.58 -39.47 69.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.677 -0.639 . . . . 0.32 110.994 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -67.79 -3.81 30.14 Favored Glycine 0 N--CA 1.491 2.331 0 O-C-N 121.432 -0.793 . . . . 0.23 111.346 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -83.82 -20.94 32.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.423 -1.633 . . . . 1.24 109.532 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.622 HD22 HD21 ' A' ' 81' ' ' LEU . 90.5 mt -64.15 136.29 57.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.033 -1.042 . . . . 0.24 109.078 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 136.13 57.16 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.678 -0.809 . . . . 0.21 109.763 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.7 -18.16 57.94 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.296 -1.522 . . . . 0.22 109.296 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.56 114.78 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.251 -1.147 . . . . 0.25 108.215 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.27 175.17 37.61 Favored Glycine 0 N--CA 1.492 2.382 0 O-C-N 120.608 -1.307 . . . . 0.28 109.964 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.86 -40.02 83.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -1.048 . . . . 2.01 109.549 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.41 -47.72 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.38 109.36 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.96 -38.51 88.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.4 109.327 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.22 95.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.707 -1.357 . . . . 0.35 109.707 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -63.53 -39.78 95.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.376 -1.073 . . . . 2.74 110.719 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.21 -43.05 83.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.592 -1.318 . . . . 1.54 109.982 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.95 -39.85 93.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.011 -1.056 . . . . 0.34 108.532 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.93 -42.1 93.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 1.67 111.007 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -64.68 -20.48 66.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.998 . . . . 2.0 109.418 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -93.54 8.46 40.63 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.841 -0.744 . . . . 2.69 110.845 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.8 7.9 49.69 Favored Glycine 0 N--CA 1.501 3.014 0 O-C-N 121.015 -1.053 . . . . 0.48 112.31 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.64 73.48 1.02 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.553 -1.557 . . . . 0.33 108.518 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -78.0 -8.1 57.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.41 110.952 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -137.15 157.35 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.134 -0.979 . . . . 1.56 110.602 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.643 -0.661 . . . . 0.21 111.684 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.443 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.2 p90 -60.7 -18.1 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.622 -1.299 . . . . 0.32 110.772 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.6 t -80.24 -30.7 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.414 -1.328 . . . . 0.24 107.414 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 HG23 ' A' ' 20' ' ' VAL . 70.2 t -78.25 -39.32 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.151 -1.055 . . . . 0.22 108.151 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.77 -36.29 74.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.793 -1.558 . . . . 0.4 106.793 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.29 -43.6 93.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.186 -1.165 . . . . 0.18 110.186 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -60.18 -42.03 94.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.112 -1.228 . . . . 1.09 109.332 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.1 -39.97 88.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.082 -1.011 . . . . 0.31 108.66 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD12 HD12 ' B' ' 50' ' ' LEU . 77.3 mt -69.09 -39.58 78.91 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.095 -0.706 . . . . 0.28 109.095 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -67.79 -23.14 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.15 -0.969 . . . . 0.28 110.912 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.5 16.85 8.18 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.99 -1.069 . . . . 0.31 110.042 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.65 29.67 7.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.061 -1.024 . . . . 1.7 110.388 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt 59.96 19.8 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.495 -0.753 . . . . 2.24 110.367 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -67.65 115.99 7.85 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.377 -1.342 . . . . 1.8 107.377 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.42 -39.98 95.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.894 . . . . 0.87 113.251 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.8 -39.73 76.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.359 -1.463 . . . . 0.73 110.437 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.9 -40.07 72.39 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 118.836 -1.145 . . . . 0.55 109.379 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.63 -49.87 69.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.38 109.528 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -61.78 -45.31 94.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 2.64 109.799 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -64.21 -39.26 93.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.041 -1.037 . . . . 2.37 108.664 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' A' ' 66' ' ' THR . 76.2 t90 -66.87 -47.17 72.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.4 110.512 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.11 -49.15 68.51 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.129 -0.982 . . . . 0.34 109.575 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -61.5 -49.05 78.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.36 -0.837 . . . . 2.11 110.101 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.94 -26.14 64.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.467 -0.77 . . . . 1.9 109.748 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 22.9 m -79.32 -34.14 42.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.078 -1.014 . . . . 0.41 111.294 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.3 p -134.46 -21.66 1.76 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.328 -1.482 . . . . 0.4 112.294 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.23 12.16 34.5 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.679 -1.368 . . . . 0.36 109.679 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.1 153.72 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.935 -1.332 . . . . 0.33 109.169 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -87.7 169.81 11.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.913 -1.117 . . . . 1.9 109.772 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.24 -33.08 71.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.588 -0.695 . . . . 0.39 110.24 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -72.9 -39.61 66.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 2.58 109.804 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.64 -37.1 85.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.84 . . . . 2.12 110.491 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -36.6 82.42 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 1.36 109.963 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.12 -39.04 84.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.027 -1.046 . . . . 2.8 109.117 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.39 -39.66 81.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.898 -1.126 . . . . 0.4 110.981 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.23 -40.09 82.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 0.24 110.369 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.6 -59.53 5.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.512 -1.367 . . . . 0.43 109.554 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.01 79.26 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.621 -0.992 . . . . 0.26 110.621 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.44 -51.06 32.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -1.202 . . . . 0.25 110.337 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.622 HD21 HD22 ' A' ' 23' ' ' LEU . 84.1 mt -70.57 -40.39 73.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.847 -1.141 . . . . 0.3 108.531 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.78 -41.08 97.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 2.73 110.255 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.74 -38.4 76.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.91 110.404 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' NE1' ' CD2' ' A' ' 88' ' ' PHE . 90.0 t90 -60.11 -43.5 95.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.437 -1.414 . . . . 0.37 107.895 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 89' ' ' LEU . 27.8 m -60.12 -40.24 89.05 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.739 0.781 . . . . 0.36 109.553 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -33.4 71.93 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.268 -0.895 . . . . 0.55 109.871 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.92 -33.98 13.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.991 -1.068 . . . . 0.48 111.037 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD2' ' NE1' ' A' ' 84' ' ' TRP . 97.4 m-85 -110.65 1.98 18.3 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.094 -1.003 . . . . 1.24 111.794 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 85' ' ' CYS . 9.0 tp . . . . . 0 N--CA 1.497 1.912 0 O-C-N 120.945 -1.097 . . . . 1.66 109.185 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.362 0.601 . . . . 5.66 109.849 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.464 ' O ' HG23 ' B' ' 2' ' ' THR . 12.4 t -165.54 125.95 1.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -0.918 . . . . 3.02 109.346 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 69.2 p -101.76 123.97 46.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.41 -0.806 . . . . 0.96 109.543 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m -81.26 172.88 13.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.255 -0.903 . . . . 1.5 109.716 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 8' ' ' ARG . 7.3 tp-100 -55.05 -24.17 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.342 0.591 . . . . 2.18 109.88 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -38.85 87.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.992 -1.068 . . . . 2.01 109.212 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -58.96 -50.71 73.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.1 -1.0 . . . . 0.49 110.317 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 5' ' ' GLN . 89.2 mtm180 -69.32 -34.95 75.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 3.23 110.234 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.28 -40.03 81.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.187 -0.946 . . . . 0.76 109.272 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -61.59 -48.81 79.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.46 109.912 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -83.49 10.73 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.238 -0.914 . . . . 0.44 110.664 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.75 -14.95 17.12 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.176 -0.953 . . . . 0.53 110.267 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 14' ' ' PRO . 18.7 pt-20 -152.14 152.25 29.23 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.087 -1.008 . . . . 1.27 108.615 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' B' ' 13' ' ' GLU . 68.1 Cg_exo -37.21 155.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.022 1.814 . . . . 0.49 111.076 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 14.0 ptm -92.57 -25.1 18.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.093 -1.004 . . . . 0.56 110.598 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.0 -136.02 38.77 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.064 -1.065 . . . . 0.39 110.44 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.17 42.9 1.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.619 -0.93 . . . . 0.84 110.071 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -60.27 148.08 80.0 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.426 -0.953 . . . . 2.02 108.426 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.61 159.41 36.88 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.07 1.847 . . . . 0.34 112.033 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.457 HG13 ' N ' ' B' ' 21' ' ' GLY . 12.2 p -57.38 -38.91 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.721 -0.612 . . . . 0.32 111.168 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.457 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -68.03 -3.73 31.34 Favored Glycine 0 N--CA 1.493 2.447 0 O-C-N 121.435 -0.79 . . . . 0.22 111.343 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.8 m -84.12 -21.13 31.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.575 -1.544 . . . . 1.24 109.587 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.616 HD22 HD21 ' B' ' 81' ' ' LEU . 88.5 mt -64.18 136.14 56.95 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -0.969 . . . . 0.24 109.032 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.23 136.11 57.51 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.753 0.787 . . . . 0.21 109.882 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.19 -17.75 58.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.375 -1.49 . . . . 0.22 109.375 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.78 114.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -1.143 . . . . 0.25 108.088 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.85 174.72 37.86 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.907 -1.277 . . . . 0.28 109.907 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.52 -39.83 81.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.424 -1.045 . . . . 2.0 109.677 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.59 -47.68 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.38 109.27 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.04 -38.57 88.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.386 -0.821 . . . . 0.4 109.46 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -39.07 95.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.36 109.692 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -63.7 -39.73 95.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -1.112 . . . . 2.75 110.667 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.07 -43.05 83.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.578 -1.326 . . . . 1.56 109.834 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.2 -39.95 94.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.091 -1.005 . . . . 0.33 108.586 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -59.9 -41.73 92.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.787 -0.57 . . . . 1.68 110.97 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.67 -20.94 66.59 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.212 -0.93 . . . . 1.99 109.295 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -93.22 8.33 40.68 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 2.68 110.79 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.95 8.03 48.98 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 120.911 -1.118 . . . . 0.49 112.319 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.79 73.66 1.02 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 119.314 1.557 . . . . 0.33 108.368 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -78.04 -8.28 57.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.41 110.758 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -137.07 157.46 46.66 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.145 -0.972 . . . . 1.56 110.605 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -39.83 89.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.711 -0.618 . . . . 0.21 111.724 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 3.3 p90 -60.59 -18.35 52.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.532 -1.355 . . . . 0.32 110.849 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -80.19 -30.84 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.429 -1.323 . . . . 0.24 107.429 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.451 HG21 HG23 ' B' ' 20' ' ' VAL . 68.9 t -77.91 -39.12 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.204 -1.036 . . . . 0.22 108.204 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.07 -36.14 74.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.865 -1.531 . . . . 0.4 106.865 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -43.73 93.83 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.241 -1.144 . . . . 0.18 110.241 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -60.05 -41.71 92.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 1.09 109.438 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.13 -40.23 89.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.31 108.762 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.411 HD12 HD12 ' A' ' 50' ' ' LEU . 77.6 mt -69.03 -39.8 78.99 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.987 -0.745 . . . . 0.27 108.987 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.43 -23.07 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.28 111.02 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 95.3 mt -90.98 17.18 8.23 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.3 110.094 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? 52.33 29.86 7.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.07 -1.019 . . . . 1.71 110.47 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 59.88 19.82 8.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.523 -0.736 . . . . 2.25 110.407 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -67.65 115.71 7.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.692 -1.255 . . . . 1.8 107.635 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -62.15 -40.33 95.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.402 -0.811 . . . . 0.88 113.083 -177.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -69.35 -40.02 77.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.393 -1.442 . . . . 0.74 110.629 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.82 -40.06 72.7 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 118.867 -1.133 . . . . 0.55 109.296 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.81 -50.01 68.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.38 109.533 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.62 -45.23 94.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.241 -0.912 . . . . 2.64 109.786 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -64.2 -39.43 93.96 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.991 -1.068 . . . . 2.38 108.708 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -66.61 -47.49 72.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.4 110.652 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.88 -49.15 69.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.15 -0.969 . . . . 0.34 109.576 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.54 -49.06 78.23 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.482 -0.762 . . . . 2.1 110.107 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.69 -26.38 65.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 1.9 109.625 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m -79.33 -34.47 42.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.4 111.34 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 16.3 p -133.85 -22.19 1.87 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.464 -1.398 . . . . 0.39 112.334 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 12.03 33.95 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.628 -1.389 . . . . 0.36 109.628 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.01 153.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.387 . . . . 0.32 109.213 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.92 169.69 11.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.972 -1.08 . . . . 1.91 109.829 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.14 71.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.534 -0.729 . . . . 0.38 110.335 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -73.19 -39.25 65.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.915 -1.116 . . . . 2.57 109.774 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.96 -36.83 84.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 2.12 110.441 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 4.9 p -66.93 -36.81 83.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.297 -0.877 . . . . 1.36 109.918 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -60.02 -39.19 84.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.95 -1.094 . . . . 2.81 109.216 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -68.25 -39.9 82.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.788 -1.195 . . . . 0.4 111.059 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.13 -39.97 82.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.782 -1.199 . . . . 0.23 110.457 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.55 -59.37 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.559 -1.338 . . . . 0.43 109.625 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.44 -33.0 79.4 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.567 -1.013 . . . . 0.25 110.567 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.74 -50.96 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.243 . . . . 0.24 110.41 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.616 HD21 HD22 ' B' ' 23' ' ' LEU . 83.8 mt -70.59 -40.48 73.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.768 -1.173 . . . . 0.29 108.529 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -61.6 -41.04 96.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.434 -0.791 . . . . 2.74 110.207 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -69.8 -38.51 76.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 1.91 110.53 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' B' ' 88' ' ' PHE . 90.0 t90 -60.03 -43.38 95.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.423 -1.423 . . . . 0.36 107.871 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' B' ' 89' ' ' LEU . 23.9 m -60.34 -40.08 89.4 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.7 0.762 . . . . 0.36 109.539 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.13 -33.2 71.81 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.256 -0.902 . . . . 0.55 109.905 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.07 -34.39 13.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.02 -1.05 . . . . 0.47 111.095 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' NE1' ' B' ' 84' ' ' TRP . 97.8 m-85 -110.04 1.92 19.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.083 -1.011 . . . . 1.24 111.654 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.5 tp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.837 -1.164 . . . . 1.67 109.317 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.28 0.562 . . . . 5.68 109.522 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m -89.99 -1.41 57.96 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.699 -0.852 . . . . 3.02 108.699 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -71.45 164.82 25.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.485 -0.76 . . . . 0.96 109.843 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.8 p -62.02 169.98 2.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 1.51 110.016 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -58.04 -19.99 35.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.669 -0.644 . . . . 2.18 110.845 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -61.21 -38.38 86.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 2.02 109.197 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.481 ' NE2' ' OE1' ' A' ' 83' ' ' GLU . 24.3 t60 -59.95 -53.92 52.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.196 -0.94 . . . . 0.49 110.516 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -69.97 -35.57 74.55 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.958 -1.088 . . . . 3.21 110.105 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.02 -39.91 75.53 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.295 -0.878 . . . . 0.76 109.737 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.64 -44.52 96.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.46 109.784 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.7 m -83.39 15.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.056 -1.027 . . . . 0.44 109.598 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.79 -13.12 14.53 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.486 -0.759 . . . . 0.54 110.32 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.77 151.59 20.88 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.979 -1.076 . . . . 1.26 109.537 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -40.13 156.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.067 1.845 . . . . 0.49 111.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.64 -18.73 23.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.878 -1.139 . . . . 0.57 109.941 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.09 -140.18 35.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.735 -1.346 . . . . 0.4 109.735 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -103.82 30.69 4.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.37 -1.077 . . . . 0.85 109.982 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -60.07 147.76 79.56 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.065 -1.022 . . . . 2.01 108.431 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.67 158.3 46.97 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.372 2.048 . . . . 0.34 112.557 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 22' ' ' SER . 2.3 p -56.93 -48.71 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.32 110.233 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.07 -3.71 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.402 -1.079 . . . . 0.23 110.402 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' VAL . 7.8 t -82.84 -20.76 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.935 -1.333 . . . . 1.24 109.165 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.514 HD22 HD21 ' A' ' 81' ' ' LEU . 98.4 mt -65.11 139.96 58.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.24 109.73 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 133.07 50.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.812 0.815 . . . . 0.21 110.282 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.08 -20.34 47.97 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 109.839 -1.304 . . . . 0.22 109.839 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.2 117.1 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -1.198 . . . . 0.25 108.019 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.435 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -93.23 177.31 37.91 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.726 -1.35 . . . . 0.28 109.726 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.02 -40.02 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -1.08 . . . . 2.01 109.888 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.03 -47.36 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.085 . . . . 0.38 109.1 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.2 mt -65.04 -39.41 93.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.376 -0.828 . . . . 0.4 109.407 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.7 97.38 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 110.044 -1.222 . . . . 0.35 110.044 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -60.28 -40.02 88.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.406 . . . . 2.74 110.517 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.2 -45.95 75.37 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.797 -1.161 . . . . 1.54 109.771 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.0 -41.13 99.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.858 -1.151 . . . . 0.34 109.917 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.22 -40.64 90.89 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.114 -1.034 . . . . 1.67 109.383 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.65 -19.66 65.81 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.648 -0.871 . . . . 2.0 108.648 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 37' ' ' ARG . 51.0 mtt-85 -91.01 5.62 48.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.487 -0.758 . . . . 2.69 110.433 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.57 49.19 Favored Glycine 0 N--CA 1.502 3.045 0 O-C-N 121.09 -1.006 . . . . 0.48 112.075 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.544 ' CD2' HG12 ' A' ' 44' ' ' VAL . 89.3 m-85 -102.38 72.81 1.29 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.597 -1.531 . . . . 0.33 108.579 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -77.9 -12.56 59.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.41 110.679 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.853 ' C ' ' CA ' ' A' ' 42' ' ' ALA . 43.9 mmtm . . . . . 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 1.56 109.423 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.853 ' CA ' ' C ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 120.773 0.32 . . . . 0.21 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.462 ' CE2' ' CB ' ' A' ' 41' ' ' LYS . 26.3 p90 -55.68 -17.4 5.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.683 -1.261 . . . . 0.32 110.478 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 39' ' ' PHE . 46.3 t -79.25 -33.14 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.844 -1.169 . . . . 0.24 107.844 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.36 -38.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.235 -1.024 . . . . 0.22 108.235 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.97 -36.82 77.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.89 -1.152 . . . . 0.4 107.89 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -59.99 -42.04 98.16 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.96 -1.256 . . . . 0.18 109.96 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.97 -41.12 91.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.886 -1.361 . . . . 1.09 109.208 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.94 -39.99 87.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.99 . . . . 0.31 108.525 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.26 -37.55 80.86 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.573 -0.851 . . . . 0.28 108.716 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 47' ' ' GLY . 69.7 t -64.07 -26.75 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.289 -0.882 . . . . 0.28 110.142 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -91.59 14.89 13.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.099 -1.001 . . . . 0.31 110.52 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 50.09 40.01 20.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.726 -1.234 . . . . 1.7 111.055 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.28 18.99 4.63 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.267 -0.895 . . . . 2.24 110.492 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.78 107.77 3.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.776 -1.203 . . . . 1.8 108.193 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 85.1 tt0 -62.91 -40.81 98.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.407 -0.808 . . . . 0.87 112.679 -178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -68.69 -39.64 80.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.847 -1.158 . . . . 0.73 109.686 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.96 -38.63 76.15 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.18 -1.008 . . . . 0.55 109.026 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -62.83 -45.91 90.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.38 109.444 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mtt180 -60.0 -47.7 84.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.393 -0.817 . . . . 2.64 110.927 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.4 -39.68 94.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.889 -1.132 . . . . 2.37 108.923 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 66' ' ' THR . 68.3 t90 -61.91 -49.97 74.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.4 111.46 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.67 -46.13 76.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.852 -1.155 . . . . 0.34 109.923 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.68 -46.67 81.43 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.322 -0.861 . . . . 2.11 109.874 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.1 -31.53 70.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.386 -0.821 . . . . 1.9 109.538 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 75.7 m -77.74 -38.26 47.43 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.259 -0.901 . . . . 0.41 111.463 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 p -129.45 -24.33 2.8 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.479 -1.388 . . . . 0.4 111.854 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.46 13.55 28.0 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.182 -1.567 . . . . 0.36 109.182 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.81 154.57 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.035 -1.274 . . . . 0.33 109.097 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.91 170.04 11.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 1.9 109.53 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -31.61 70.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.39 110.773 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -73.89 -40.02 63.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 2.58 110.214 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.51 -33.7 76.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.416 -0.803 . . . . 2.12 110.328 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p -68.39 -37.68 80.63 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.219 -0.926 . . . . 1.36 109.824 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.47 -38.45 84.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.94 -1.1 . . . . 2.8 109.644 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.45 -39.96 81.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.622 -1.299 . . . . 0.4 110.485 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -70.01 -40.7 75.08 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.882 -1.136 . . . . 0.24 109.327 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -60.19 -60.02 4.48 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.809 -1.182 . . . . 0.43 109.654 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.22 91.78 Favored Glycine 0 N--CA 1.489 2.2 0 O-C-N 121.212 -0.93 . . . . 0.26 110.876 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -68.21 -50.13 56.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.734 -1.45 . . . . 0.25 109.847 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD21 HD22 ' A' ' 23' ' ' LEU . 87.6 mt -70.14 -39.93 75.1 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.146 -1.022 . . . . 0.3 109.218 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -62.35 -39.97 94.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -0.99 . . . . 2.73 109.743 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' OE1' ' NE2' ' A' ' 7' ' ' HIS . 87.8 mt-10 -70.01 -36.62 75.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 1.91 109.83 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.596 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 80.5 t90 -59.92 -41.75 92.42 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.488 -1.383 . . . . 0.37 107.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.0 m -63.1 -40.02 96.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.768 -0.827 . . . . 0.36 108.768 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.1 -38.16 82.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.593 -0.692 . . . . 0.55 109.835 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 -37.07 17.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.48 110.065 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.596 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 72.2 m-85 -103.24 -86.68 0.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 1.24 110.327 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.917 -1.04 . . . . 1.66 109.915 -178.55 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.328 0.585 . . . . 5.66 109.501 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m -90.03 -1.53 57.98 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.641 -0.874 . . . . 3.02 108.641 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -71.34 164.65 25.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.506 -0.746 . . . . 0.96 109.814 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 99.5 p -61.89 170.03 2.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.452 -0.78 . . . . 1.5 110.011 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.609 ' CD ' ' H ' ' B' ' 5' ' ' GLN . 0.0 OUTLIER -58.13 -20.05 37.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.632 -0.668 . . . . 2.18 110.756 -178.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -61.15 -38.52 86.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.06 -1.025 . . . . 2.01 109.188 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.479 ' NE2' ' OE1' ' B' ' 83' ' ' GLU . 24.2 t60 -59.74 -53.91 52.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.49 110.667 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -70.05 -35.43 74.26 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.002 -1.061 . . . . 3.23 110.162 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.15 -39.9 75.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 0.76 109.647 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.51 -44.6 96.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.348 -0.845 . . . . 0.46 109.785 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 31.8 m -83.51 15.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.089 -1.007 . . . . 0.44 109.572 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.82 -13.0 14.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.53 -0.731 . . . . 0.53 110.368 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.84 151.57 20.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.908 -1.12 . . . . 1.27 109.498 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.06 156.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.992 1.795 . . . . 0.49 111.775 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ptp -91.72 -18.61 23.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.947 -1.095 . . . . 0.56 109.963 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.86 -140.11 35.16 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.768 -1.333 . . . . 0.39 109.768 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.82 30.59 5.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.45 -1.029 . . . . 0.84 109.981 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -59.99 147.66 79.35 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 2.02 108.45 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.59 158.28 46.72 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.365 2.043 . . . . 0.34 112.603 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' B' ' 22' ' ' SER . 2.2 p -57.0 -48.64 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.476 -0.765 . . . . 0.32 110.169 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.14 -3.58 0.24 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.374 -1.09 . . . . 0.22 110.374 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.479 ' H ' ' C ' ' B' ' 20' ' ' VAL . 7.8 t -82.96 -20.85 34.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.295 . . . . 1.24 109.129 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.536 HD22 HD21 ' B' ' 81' ' ' LEU . 98.7 mt -65.02 139.93 58.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.24 109.78 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.17 132.9 50.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.784 0.802 . . . . 0.21 110.371 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.35 47.76 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.802 -1.319 . . . . 0.22 109.802 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -100.11 117.07 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.177 -1.19 . . . . 0.25 108.044 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.428 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -93.09 177.26 38.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.697 -1.361 . . . . 0.28 109.697 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -40.09 79.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 2.0 109.951 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.94 -47.49 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.38 109.129 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.428 HD12 ' H ' ' B' ' 27' ' ' GLY . 95.5 mt -64.93 -39.54 93.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.4 109.436 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.66 97.24 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 110.041 -1.224 . . . . 0.36 110.041 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -60.24 -40.1 89.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.852 -1.381 . . . . 2.75 110.503 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.21 -45.76 75.87 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.785 -1.166 . . . . 1.56 109.786 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.01 -41.27 99.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.33 110.002 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.77 90.5 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.171 -1.012 . . . . 1.68 109.382 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.69 -19.62 65.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.631 -0.877 . . . . 1.99 108.631 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' B' ' 37' ' ' ARG . 50.7 mtt-85 -91.1 5.78 47.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.817 . . . . 2.68 110.423 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.19 7.54 49.38 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.034 -1.041 . . . . 0.49 112.112 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.542 ' CD2' HG12 ' B' ' 44' ' ' VAL . 89.5 m-85 -102.43 72.93 1.29 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.704 -1.468 . . . . 0.33 108.624 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -78.06 -12.46 59.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.41 110.664 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.46 ' CB ' ' CE2' ' B' ' 43' ' ' TYR . 44.0 mmtm -132.31 154.11 50.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.055 -1.028 . . . . 1.56 109.419 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.99 91.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.298 -0.876 . . . . 0.21 111.73 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' B' ' 41' ' ' LYS . 25.7 p90 -55.82 -17.32 5.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.671 -1.268 . . . . 0.32 110.397 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.542 HG12 ' CD2' ' B' ' 39' ' ' PHE . 46.2 t -79.21 -33.02 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.93 -1.137 . . . . 0.24 107.93 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.5 -38.73 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.208 -1.034 . . . . 0.22 108.208 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.99 -36.9 78.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.899 -1.148 . . . . 0.4 107.899 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.422 ' O ' HG23 ' B' ' 51' ' ' VAL . . . -59.89 -42.1 98.05 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.997 -1.241 . . . . 0.18 109.997 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.96 -40.99 90.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.004 -1.292 . . . . 1.09 109.231 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.95 -40.14 87.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.31 108.43 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.21 -37.84 81.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.611 -0.885 . . . . 0.27 108.611 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 47' ' ' GLY . 70.7 t -63.93 -26.59 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.829 . . . . 0.28 110.179 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.6 14.95 13.6 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.097 -1.002 . . . . 0.3 110.539 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.705 -1.247 . . . . 1.71 111.045 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.26 19.02 4.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.371 -0.831 . . . . 2.25 110.504 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -68.73 107.82 3.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.809 -1.182 . . . . 1.8 108.131 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 85.2 tt0 -62.84 -41.09 99.2 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.398 -0.813 . . . . 0.88 112.704 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.54 -39.59 81.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.805 -1.184 . . . . 0.74 109.692 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.0 -38.52 76.01 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.201 -1.0 . . . . 0.55 109.06 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -63.06 -45.72 90.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.38 109.507 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 98.9 mtt180 -60.05 -47.76 84.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.785 . . . . 2.64 110.974 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -64.3 -39.68 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.896 -1.128 . . . . 2.38 108.946 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.92 -50.05 73.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.4 111.423 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.423 ' O ' ' SG ' ' B' ' 67' ' ' CYS . 22.6 tp -66.63 -46.23 76.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.897 -1.127 . . . . 0.34 109.952 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.56 -46.71 81.63 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 2.1 109.9 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.08 -31.51 70.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 1.9 109.49 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 77.1 m -77.7 -38.3 47.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.868 . . . . 0.4 111.496 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' B' ' 63' ' ' LEU . 26.6 p -129.43 -24.3 2.81 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.581 -1.325 . . . . 0.39 111.891 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.45 13.63 27.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.189 -1.564 . . . . 0.36 109.189 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.74 154.63 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.264 . . . . 0.32 109.114 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -88.97 170.02 11.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 1.91 109.515 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.03 -31.47 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.38 110.741 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -74.04 -40.0 63.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.961 -1.087 . . . . 2.57 110.204 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -66.6 -33.57 75.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.412 -0.805 . . . . 2.12 110.272 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 32.9 p -68.52 -37.55 80.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.208 -0.933 . . . . 1.36 109.805 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.49 -38.5 84.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.885 -1.134 . . . . 2.81 109.689 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -68.34 -39.97 81.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.679 -1.263 . . . . 0.4 110.595 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.98 -40.8 75.13 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.845 -1.16 . . . . 0.23 109.33 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -60.08 -60.04 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.141 . . . . 0.43 109.718 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.18 91.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.829 -0.908 . . . . 0.25 110.829 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.27 -50.16 55.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.731 -1.453 . . . . 0.24 109.85 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.536 HD21 HD22 ' B' ' 23' ' ' LEU . 87.7 mt -70.03 -40.02 75.44 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.123 -1.031 . . . . 0.29 109.256 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -62.14 -40.11 94.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.123 -0.986 . . . . 2.74 109.762 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.479 ' OE1' ' NE2' ' B' ' 7' ' ' HIS . 87.8 mt-10 -70.05 -36.57 75.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.09 -1.006 . . . . 1.91 109.866 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 80.2 t90 -59.89 -41.89 92.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.525 -1.36 . . . . 0.36 107.702 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.8 m -63.02 -40.11 96.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.816 -0.809 . . . . 0.36 108.816 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -60.0 -38.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.627 -0.671 . . . . 0.55 109.858 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -37.65 16.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.198 -0.939 . . . . 0.47 110.057 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.595 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 72.8 m-85 -102.26 -86.66 0.42 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.188 -0.945 . . . . 1.24 110.376 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.016 -0.992 . . . . 1.67 109.945 -178.39 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.484 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 76.1 mtm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.382 0.61 . . . . 5.68 109.398 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.2 p -90.77 6.04 45.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.382 -0.823 . . . . 3.02 109.356 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.433 ' OG1' ' CB ' ' A' ' 7' ' ' HIS . 19.7 p -69.57 167.17 17.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.96 109.941 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.4 p -55.24 176.61 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -0.81 . . . . 1.51 110.349 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.91 -19.52 65.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.88 -0.513 . . . . 2.18 110.219 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -60.02 -37.45 79.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.049 -1.032 . . . . 2.02 109.573 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.433 ' CB ' ' OG1' ' A' ' 3' ' ' THR . 30.9 t60 -59.92 -50.78 72.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.167 -0.958 . . . . 0.49 110.507 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' NH2' ' O ' ' A' ' 1' ' ' MET . 38.7 mtt-85 -70.02 -33.7 72.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.954 -1.091 . . . . 3.21 110.224 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -69.66 -38.99 77.32 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.305 -0.872 . . . . 0.76 109.43 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -64.6 -47.4 78.75 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.393 -0.817 . . . . 0.46 110.506 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -85.11 11.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.154 -0.966 . . . . 0.44 111.054 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.08 -11.73 15.57 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.193 -0.942 . . . . 0.54 109.821 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.58 151.49 20.96 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.963 . . . . 1.26 108.976 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -39.9 161.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.892 1.728 . . . . 0.49 111.506 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.514 ' CE ' HD22 ' A' ' 46' ' ' LEU . 8.8 ptp -90.6 -20.22 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.029 -1.044 . . . . 0.57 109.479 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.56 -139.96 21.01 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.205 -1.158 . . . . 0.4 110.205 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.97 24.95 10.55 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.544 -0.974 . . . . 0.85 109.792 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -60.8 148.69 82.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.098 -1.001 . . . . 2.01 108.934 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.17 158.76 33.34 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.508 2.139 . . . . 0.34 113.307 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 21' ' ' GLY . 11.1 p -59.59 -44.96 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.657 0.742 . . . . 0.32 110.328 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.544 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.21 -3.0 0.18 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.567 -1.013 . . . . 0.23 110.567 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 20' ' ' VAL . 68.4 m -82.7 -19.15 38.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.769 -1.43 . . . . 1.24 109.436 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.18 137.41 56.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.24 109.639 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.2 134.75 54.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.737 -0.785 . . . . 0.21 109.842 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.08 48.07 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.316 -1.514 . . . . 0.22 109.316 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -98.35 113.18 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.25 108.007 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.8 179.27 38.33 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 120.623 -1.298 . . . . 0.28 109.952 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -57.29 -40.1 77.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.525 -0.985 . . . . 2.01 110.374 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.95 -46.26 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.38 109.743 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.57 -37.55 87.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.4 109.62 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.79 95.73 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.128 -1.589 . . . . 0.35 109.128 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.18 -39.98 95.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.352 -1.087 . . . . 2.74 109.935 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.66 -44.72 69.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.88 -1.137 . . . . 1.54 109.44 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.66 -40.01 95.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.955 -1.128 . . . . 0.34 107.955 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.04 -41.52 92.43 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.976 -0.75 . . . . 1.67 108.976 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.28 -19.91 64.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.682 -0.859 . . . . 2.0 108.682 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -90.35 0.94 57.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 2.69 109.68 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 37.79 3.84 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 120.305 -0.95 . . . . 0.48 111.239 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' CD2' HG12 ' A' ' 44' ' ' VAL . 89.1 m-85 -133.84 72.6 1.48 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.968 -1.313 . . . . 0.33 108.995 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -80.28 -10.73 59.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.41 110.729 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.88 152.04 51.31 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.127 -0.983 . . . . 1.56 110.017 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.96 90.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.21 111.823 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.46 -17.77 9.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.758 -1.214 . . . . 0.32 110.603 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.511 HG12 ' CD2' ' A' ' 39' ' ' PHE . 43.7 t -79.4 -31.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.821 -1.174 . . . . 0.24 107.914 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.54 -36.7 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.343 -0.984 . . . . 0.22 108.343 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.514 HD22 ' CE ' ' A' ' 15' ' ' MET . 66.7 tp -60.01 -37.84 80.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.983 -1.488 . . . . 0.4 106.983 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.3 87.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.986 -1.246 . . . . 0.18 109.986 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.08 -42.27 94.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.339 . . . . 1.09 108.901 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.357 -0.979 . . . . 0.31 108.357 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.06 -39.93 75.39 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.756 -0.831 . . . . 0.28 108.756 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.81 -26.7 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.176 -0.952 . . . . 0.28 111.358 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.2 16.13 6.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.9 -1.125 . . . . 0.31 110.217 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.34 21.67 5.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 1.7 110.167 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.15 19.6 8.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.707 -0.62 . . . . 2.24 110.311 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.9 122.1 17.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.585 -1.322 . . . . 1.8 107.777 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' OE2' ' CG ' ' A' ' 78' ' ' PHE . 8.5 tp10 -61.97 -41.56 98.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.286 0.847 . . . . 0.87 113.286 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -69.96 -39.86 75.75 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.411 -1.431 . . . . 0.73 110.787 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.08 -39.9 75.33 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.917 -1.113 . . . . 0.55 109.067 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.6 -48.48 79.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.268 -0.895 . . . . 0.38 109.482 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.08 -47.12 87.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.356 -0.84 . . . . 2.64 110.978 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.13 -39.88 94.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.749 -1.219 . . . . 2.37 108.885 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -61.58 -50.05 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.4 111.414 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.65 -47.29 69.97 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.145 -0.972 . . . . 0.34 110.146 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -63.33 -46.7 85.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 2.11 109.869 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.37 -30.81 69.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 1.9 109.696 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.6 m -79.01 -35.14 43.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.41 111.247 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.9 p -131.79 -34.73 1.3 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.541 -1.35 . . . . 0.4 111.722 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.97 15.87 10.37 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.422 -1.471 . . . . 0.36 109.422 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 153.05 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.282 . . . . 0.33 109.04 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.579 ' H ' HE21 ' A' ' 73' ' ' GLN . 28.1 t-20 -89.68 170.68 10.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 1.9 109.348 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.27 72.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.504 -0.748 . . . . 0.39 110.94 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 68.5 mttm -71.63 -41.43 68.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.717 -1.24 . . . . 2.58 110.566 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.579 HE21 ' H ' ' A' ' 70' ' ' ASN . 36.6 mt-30 -67.32 -36.52 81.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 2.12 110.386 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.135 -0.978 . . . . 1.36 110.466 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 72' ' ' LYS . 83.5 mtm180 -59.95 -36.59 77.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.675 -1.266 . . . . 2.8 108.701 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.4 -39.29 81.71 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.83 -1.169 . . . . 0.4 110.27 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.21 -41.14 81.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.791 -1.193 . . . . 0.24 109.59 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CG ' ' OE2' ' A' ' 56' ' ' GLU . 64.7 t80 -60.01 -59.81 4.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.819 -1.176 . . . . 0.43 109.41 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.06 -34.88 85.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.992 -1.243 . . . . 0.26 109.992 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.8 -45.45 67.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -1.186 . . . . 0.25 109.465 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.58 -41.91 68.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.3 109.117 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.15 -41.16 96.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 2.73 109.527 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -70.05 -37.89 75.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 1.91 110.603 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.48 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 83.8 t90 -59.99 -43.5 95.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.393 -1.442 . . . . 0.37 107.815 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 89' ' ' LEU . 22.0 m -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.572 -0.705 . . . . 0.36 109.358 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -59.2 -34.21 71.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.55 110.21 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.75 -34.34 13.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.296 -0.878 . . . . 0.48 111.352 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 94.8 m-85 -111.19 3.08 18.18 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 120.984 -1.073 . . . . 1.24 112.033 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . 10.5 tp . . . . . 0 N--CA 1.5 2.07 0 O-C-N 120.839 -1.163 . . . . 1.66 109.892 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.48 ' O ' ' NH2' ' B' ' 8' ' ' ARG . 76.2 mtm . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.448 0.642 . . . . 5.66 109.402 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 39.9 p -90.76 6.05 45.76 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.334 -0.854 . . . . 3.02 109.348 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.423 ' OG1' ' CB ' ' B' ' 7' ' ' HIS . 20.0 p -69.53 167.17 17.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.96 110.007 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p -55.23 176.7 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.86 0.838 . . . . 1.5 110.326 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.86 -19.6 65.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.819 -0.551 . . . . 2.18 110.21 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.0 -37.35 79.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.108 -0.995 . . . . 2.01 109.665 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.423 ' CB ' ' OG1' ' B' ' 3' ' ' THR . 31.4 t60 -59.96 -50.85 72.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.126 -0.984 . . . . 0.49 110.449 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' B' ' 1' ' ' MET . 38.8 mtt-85 -70.04 -33.71 72.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 3.23 110.165 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.58 -39.26 77.44 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.202 -0.936 . . . . 0.76 109.377 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.32 -47.54 79.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.838 . . . . 0.46 110.457 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -85.3 11.6 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.44 111.139 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.21 -11.92 15.49 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.238 -0.914 . . . . 0.53 109.759 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.45 151.63 21.43 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.091 -1.006 . . . . 1.27 108.97 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -39.97 161.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.847 1.698 . . . . 0.49 111.585 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.509 ' CE ' HD22 ' B' ' 46' ' ' LEU . 8.9 ptp -90.74 -19.79 23.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.56 109.561 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.11 -140.1 18.32 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.047 -1.221 . . . . 0.39 110.047 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.74 25.09 10.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.981 . . . . 0.84 109.848 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -61.03 148.92 83.35 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.908 -1.12 . . . . 2.02 108.879 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.22 158.78 33.49 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.412 2.075 . . . . 0.34 113.315 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.551 HG13 ' N ' ' B' ' 21' ' ' GLY . 11.2 p -59.64 -44.95 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.625 0.726 . . . . 0.32 110.273 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.551 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.22 -2.81 0.17 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.591 -1.003 . . . . 0.22 110.591 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.489 ' H ' ' C ' ' B' ' 20' ' ' VAL . 68.5 m -82.91 -19.33 37.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.793 -1.416 . . . . 1.24 109.34 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.97 137.42 57.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.965 . . . . 0.24 109.651 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.47 134.4 53.34 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.805 . . . . 0.21 109.995 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 -20.91 48.79 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.236 -1.545 . . . . 0.22 109.236 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 mm -98.44 113.1 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.263 -1.139 . . . . 0.25 107.961 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.74 179.05 38.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.913 -1.275 . . . . 0.28 109.913 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.16 -40.04 76.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 2.0 110.353 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.99 -46.41 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.38 109.725 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 93.3 mt -65.26 -37.68 87.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.4 109.666 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.82 95.68 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.256 -1.538 . . . . 0.36 109.256 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -64.24 -39.92 94.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.392 -1.064 . . . . 2.75 109.922 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.6 -44.9 69.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.844 -1.16 . . . . 1.56 109.331 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.55 -39.92 95.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.016 -1.105 . . . . 0.33 108.016 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -41.56 92.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.945 -0.761 . . . . 1.68 108.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -68.19 -20.13 64.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.633 -0.877 . . . . 1.99 108.633 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -90.15 1.3 56.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.495 -0.753 . . . . 2.68 109.646 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.45 37.8 3.91 Favored Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.115 -0.991 . . . . 0.49 111.127 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.518 ' CD2' HG12 ' B' ' 44' ' ' VAL . 89.0 m-85 -134.01 72.75 1.48 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.977 -1.308 . . . . 0.33 108.956 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -80.57 -10.57 59.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.089 -1.007 . . . . 0.41 110.8 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -131.95 152.31 51.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.204 -0.935 . . . . 1.56 110.038 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.63 91.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.21 111.848 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -56.58 -17.96 10.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.577 -1.327 . . . . 0.32 110.51 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.518 HG12 ' CD2' ' B' ' 39' ' ' PHE . 43.8 t -79.43 -31.65 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.797 -1.19 . . . . 0.24 107.841 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 64.8 t -77.46 -36.76 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.39 -0.967 . . . . 0.22 108.39 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.509 HD22 ' CE ' ' B' ' 15' ' ' MET . 67.0 tp -60.01 -38.12 81.73 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.802 -1.555 . . . . 0.4 106.802 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.63 85.42 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.936 -1.266 . . . . 0.18 109.936 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -42.31 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.881 -1.364 . . . . 1.09 108.819 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -40.16 88.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.356 -0.979 . . . . 0.31 108.356 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 65.4 mt -69.96 -40.06 75.63 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.725 -0.843 . . . . 0.27 108.725 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.62 -26.66 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.167 -0.958 . . . . 0.28 111.276 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.38 16.45 6.39 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.035 -1.041 . . . . 0.3 110.237 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.16 21.79 5.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.885 . . . . 1.71 110.092 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 80.5 mttt 59.99 19.19 8.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.75 -0.593 . . . . 2.25 110.386 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.62 122.29 17.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.561 -1.337 . . . . 1.8 107.664 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE2' ' CG ' ' B' ' 78' ' ' PHE . 8.5 tp10 -62.0 -42.04 98.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.88 113.289 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.54 -39.97 77.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.339 -1.476 . . . . 0.74 110.694 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.09 -40.01 75.23 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.99 -1.084 . . . . 0.55 109.035 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.56 -48.38 79.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -0.92 . . . . 0.38 109.544 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.03 -47.61 85.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 2.64 110.846 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.03 -39.46 94.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.715 -1.241 . . . . 2.38 108.953 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . 0.424 ' O ' ' OG1' ' B' ' 66' ' ' THR . 67.9 t90 -61.83 -49.91 74.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.339 -0.85 . . . . 0.4 111.377 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.68 -47.67 68.79 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.196 -0.94 . . . . 0.34 110.069 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -62.94 -46.78 86.14 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.917 . . . . 2.1 109.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.32 -30.75 69.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.9 109.655 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 99.7 m -79.11 -35.14 42.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.4 111.354 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 27.9 p -131.59 -35.18 1.31 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.639 -1.288 . . . . 0.39 111.787 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.26 16.22 9.82 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 109.341 -1.503 . . . . 0.36 109.341 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.51 153.14 1.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.866 -1.373 . . . . 0.32 109.078 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.579 ' H ' HE21 ' B' ' 73' ' ' GLN . 28.1 t-20 -89.86 170.56 10.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.089 -1.007 . . . . 1.91 109.329 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.35 -32.97 71.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.507 -0.746 . . . . 0.38 111.0 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.41 ' HA ' ' HE ' ' B' ' 75' ' ' ARG . 68.5 mttm -71.89 -41.45 67.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.751 -1.218 . . . . 2.57 110.441 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.579 HE21 ' H ' ' B' ' 70' ' ' ASN . 36.6 mt-30 -67.32 -36.38 81.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 2.12 110.447 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -67.65 -38.35 83.71 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.352 -0.842 . . . . 1.36 110.442 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' B' ' 72' ' ' LYS . 83.5 mtm180 -60.01 -36.45 77.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.748 -1.22 . . . . 2.81 108.746 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.64 -39.47 80.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.782 -1.199 . . . . 0.4 110.187 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -68.07 -41.23 82.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.987 -1.07 . . . . 0.23 109.529 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.526 ' CG ' ' OE2' ' B' ' 56' ' ' GLU . 64.4 t80 -60.02 -59.77 4.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.819 -1.176 . . . . 0.43 109.507 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.03 -34.86 85.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.935 -1.266 . . . . 0.25 109.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 53.0 t -69.87 -45.71 67.09 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.152 -1.205 . . . . 0.24 109.364 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.41 -41.67 69.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.999 . . . . 0.29 109.151 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.37 -40.98 96.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.881 . . . . 2.74 109.605 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.96 -38.04 75.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.164 -0.96 . . . . 1.91 110.604 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.481 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 83.9 t90 -59.99 -43.5 95.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.332 -1.48 . . . . 0.36 107.718 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' B' ' 89' ' ' LEU . 22.3 m -60.06 -40.05 88.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.637 -0.664 . . . . 0.36 109.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -59.07 -34.11 71.58 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.949 . . . . 0.55 110.288 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.76 -35.02 13.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.009 -1.057 . . . . 0.47 111.377 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.481 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.2 m-85 -109.91 2.16 19.62 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.12 -0.987 . . . . 1.24 112.272 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' B' ' 85' ' ' CYS . 10.0 tp . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.716 -1.24 . . . . 1.67 109.944 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.313 -0.625 . . . . 5.68 109.313 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 59.94 8.28 1.38 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.919 . . . . 3.02 109.013 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.1 p -87.03 169.99 11.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.459 -0.776 . . . . 0.96 109.564 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.5 m -62.44 162.96 9.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 1.51 109.928 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.75 -23.96 46.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.783 -0.573 . . . . 2.18 110.208 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.13 -38.41 82.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.921 . . . . 2.02 108.932 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -60.04 -52.23 66.24 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.463 -0.773 . . . . 0.49 110.795 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 89.1 mtm180 -69.94 -35.41 74.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.963 -1.086 . . . . 3.21 109.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -65.49 -40.01 92.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.82 . . . . 0.76 109.342 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 44.4 t80 -63.14 -49.65 73.53 Favored 'General case' 0 C--N 1.298 -1.63 0 C-N-CA 119.642 -0.823 . . . . 0.46 110.003 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.35 6.04 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.105 -0.997 . . . . 0.44 111.231 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -99.27 -18.77 17.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.93 -1.106 . . . . 0.54 110.057 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' PRO . 6.5 pt-20 -151.96 151.94 28.96 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.154 -0.967 . . . . 1.26 108.917 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 13' ' ' GLU . 69.6 Cg_exo -36.76 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.2 1.933 . . . . 0.49 111.688 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.509 ' SD ' HD13 ' B' ' 89' ' ' LEU . 15.6 ptm -93.66 -29.64 15.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.104 -0.997 . . . . 0.57 110.15 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 -135.28 44.7 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.205 -1.158 . . . . 0.4 110.205 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.97 35.3 3.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.676 -0.896 . . . . 0.85 110.014 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -59.26 148.59 71.76 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 2.01 108.47 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.28 156.2 41.85 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.025 1.817 . . . . 0.34 112.048 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 21' ' ' GLY . 7.4 p -57.01 -48.13 82.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.442 -0.786 . . . . 0.32 110.22 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -53.84 -3.81 0.23 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.716 -0.954 . . . . 0.23 110.716 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 70.7 m -83.16 -21.54 33.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.709 -1.465 . . . . 1.24 109.422 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.36 136.79 57.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.038 -1.039 . . . . 0.24 109.418 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.59 136.17 56.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.763 0.792 . . . . 0.21 109.758 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.27 -20.07 52.24 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.741 -1.744 . . . . 0.22 108.741 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.83 115.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.908 -1.145 . . . . 0.25 107.908 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -90.21 177.02 42.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.825 -1.31 . . . . 0.28 109.825 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -56.76 -39.93 74.9 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.629 -0.924 . . . . 2.01 109.914 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.82 -44.47 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.05 . . . . 0.38 109.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 27' ' ' GLY . 93.6 mt -66.77 -37.46 84.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.9 . . . . 0.4 109.47 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.246 -1.542 . . . . 0.35 109.246 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.82 -39.86 94.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.405 -1.056 . . . . 2.74 110.367 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -65.44 -48.45 72.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.859 -1.151 . . . . 1.54 109.948 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.69 -36.03 79.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.909 -1.119 . . . . 0.34 108.485 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.739 -0.601 . . . . 1.67 110.058 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.02 -19.37 65.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.995 . . . . 2.0 108.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 37' ' ' ARG . 33.8 mtt-85 -91.05 6.59 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.595 -0.691 . . . . 2.69 110.25 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.7 55.43 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.978 -1.076 . . . . 0.48 111.688 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD1' HG12 ' A' ' 44' ' ' VAL . 87.2 m-85 -103.86 72.99 1.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.835 -1.391 . . . . 0.33 108.341 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.06 -10.72 59.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.459 -0.776 . . . . 0.41 110.628 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.5 150.27 50.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.167 -0.958 . . . . 1.56 109.62 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.99 94.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.21 110.827 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 17.0 p90 -60.55 -18.64 53.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.016 -1.052 . . . . 0.32 110.371 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 39' ' ' PHE . 50.1 t -79.57 -32.74 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.434 -1.321 . . . . 0.24 107.434 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.74 -37.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.096 -1.075 . . . . 0.22 108.096 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.8 tp -59.99 -35.46 75.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.569 -1.271 . . . . 0.4 107.569 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.54 97.08 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.166 -1.173 . . . . 0.18 110.166 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -59.97 -41.66 92.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.01 -1.288 . . . . 1.09 109.778 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.31 108.741 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -38.77 81.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.723 -0.843 . . . . 0.28 108.723 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.02 -24.54 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.347 -0.846 . . . . 0.28 110.629 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.23 18.37 9.61 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.121 -0.987 . . . . 0.31 110.444 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.36 33.55 7.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.768 -1.207 . . . . 1.7 110.126 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.05 19.92 9.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.751 -0.593 . . . . 2.24 110.382 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.47 113.38 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.609 -1.307 . . . . 1.8 107.719 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.84 -40.03 93.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.87 113.16 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -69.81 -39.7 76.37 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.615 -1.303 . . . . 0.73 110.578 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.57 -38.77 77.54 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.75 -1.18 . . . . 0.55 108.921 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.92 -50.59 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.38 109.983 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.51 ' HG3' HH11 ' A' ' 60' ' ' ARG . 5.4 mtm-85 -62.54 -43.71 98.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 2.64 109.841 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.95 -39.78 94.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 2.37 108.797 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.461 ' O ' ' OG1' ' A' ' 66' ' ' THR . 55.9 t90 -65.45 -46.32 80.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.4 110.526 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 tp -67.56 -49.45 63.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.34 110.017 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.75 -48.87 79.86 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.381 -0.825 . . . . 2.11 109.969 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 28.8 t0 -68.95 -28.97 67.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.704 . . . . 1.9 109.862 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 50.3 m -79.5 -34.55 41.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.254 -0.903 . . . . 0.41 111.019 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.3 p -131.56 -29.52 1.74 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.648 -1.283 . . . . 0.4 111.749 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.6 14.19 20.38 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.382 -1.487 . . . . 0.36 109.382 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.44 1.69 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.047 -1.266 . . . . 0.33 109.015 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -90.6 171.19 9.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.084 -1.01 . . . . 1.9 109.737 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -34.01 72.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.39 110.746 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.19 -40.54 67.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.618 -1.301 . . . . 2.58 109.993 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.79 -39.98 79.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.112 -0.993 . . . . 2.12 110.409 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -67.41 -39.05 85.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.27 -0.894 . . . . 1.36 110.028 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -59.97 -38.65 83.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 2.8 109.421 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.43 -39.94 85.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.712 -1.243 . . . . 0.4 110.482 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.6 m -66.78 -40.03 88.03 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.915 -1.115 . . . . 0.24 109.86 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.03 -59.97 4.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.599 -1.313 . . . . 0.43 110.044 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.67 84.97 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.443 -1.063 . . . . 0.26 110.443 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.13 -49.94 52.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -1.134 . . . . 0.25 109.867 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.07 -39.98 75.31 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.792 -1.163 . . . . 0.3 108.775 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.23 -41.18 99.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 2.73 110.18 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -69.87 -35.94 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.927 -1.108 . . . . 1.91 109.569 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.443 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 80.2 t90 -59.98 -43.92 94.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.944 -1.502 . . . . 0.37 106.944 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 34.9 m -60.98 -40.03 91.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.827 -0.805 . . . . 0.36 108.827 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.66 81.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.431 -0.793 . . . . 0.55 110.032 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.58 -38.18 16.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -0.991 . . . . 0.48 110.6 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.22 -87.09 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.228 -0.92 . . . . 1.24 110.102 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.5 HD13 ' SD ' ' B' ' 15' ' ' MET . 17.7 tp . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 118.099 -0.953 . . . . 1.66 109.659 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.2 mmt . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.274 -0.639 . . . . 5.66 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 60.09 7.98 1.36 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 3.02 108.98 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 20.3 p -86.87 170.0 12.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.307 -0.871 . . . . 0.96 109.626 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -62.43 162.94 9.37 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.35 -0.844 . . . . 1.5 109.91 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.79 -23.86 46.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.752 -0.593 . . . . 2.18 110.272 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -60.12 -38.48 83.15 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.216 -0.928 . . . . 2.01 108.931 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -59.97 -52.21 66.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.49 110.867 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 89.0 mtm180 -70.01 -35.38 74.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.955 -1.091 . . . . 3.23 109.738 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -65.47 -40.01 92.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.37 -0.831 . . . . 0.76 109.385 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.43 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 44.1 t80 -63.1 -49.67 73.54 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.343 -0.848 . . . . 0.46 110.026 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 m -86.32 6.07 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.078 -1.014 . . . . 0.44 111.241 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -99.36 -18.68 17.4 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.894 -1.129 . . . . 0.53 110.0 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' B' ' 14' ' ' PRO . 6.5 pt-20 -152.0 151.89 28.8 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.097 -1.002 . . . . 1.27 108.95 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' B' ' 13' ' ' GLU . 70.2 Cg_exo -36.75 156.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 122.16 1.907 . . . . 0.49 111.795 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.5 ' SD ' HD13 ' A' ' 89' ' ' LEU . 15.7 ptm -93.58 -29.72 15.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.094 -1.004 . . . . 0.56 110.158 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.33 -135.3 44.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.227 -1.149 . . . . 0.39 110.227 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.94 35.16 3.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.619 -0.93 . . . . 0.84 110.005 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.18 148.54 71.39 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.991 . . . . 2.02 108.445 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.3 156.24 41.79 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.998 1.799 . . . . 0.34 112.039 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.563 HG13 ' N ' ' B' ' 21' ' ' GLY . 7.4 p -57.02 -48.19 82.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.543 -0.723 . . . . 0.32 110.237 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.563 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -53.7 -3.94 0.22 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.776 -0.93 . . . . 0.22 110.776 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.468 ' H ' ' C ' ' B' ' 20' ' ' VAL . 70.6 m -83.08 -21.6 33.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.761 -1.435 . . . . 1.24 109.462 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.33 136.79 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.24 109.406 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.58 136.18 56.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.755 0.788 . . . . 0.21 109.824 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.31 -20.15 51.9 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.742 -1.743 . . . . 0.22 108.742 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mm -99.76 114.99 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.933 -1.136 . . . . 0.25 107.933 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.423 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -90.31 177.0 42.33 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.825 -1.31 . . . . 0.28 109.825 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.62 -39.97 74.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.591 -0.946 . . . . 2.0 110.015 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.84 -44.37 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.38 109.837 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.423 HD12 ' H ' ' B' ' 27' ' ' GLY . 93.5 mt -66.78 -37.5 84.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.4 109.487 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.0 96.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.288 -1.525 . . . . 0.36 109.288 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -39.76 94.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -1.12 . . . . 2.75 110.371 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -65.4 -48.38 73.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.201 . . . . 1.56 109.971 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.8 -36.02 79.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.953 -1.092 . . . . 0.33 108.492 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -59.92 -42.51 94.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.732 -0.605 . . . . 1.68 110.008 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.05 -19.32 65.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 1.99 108.607 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' B' ' 37' ' ' ARG . 34.0 mtt-85 -90.97 6.56 44.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.595 -0.691 . . . . 2.68 110.291 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.73 55.49 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.063 -1.065 . . . . 0.49 111.766 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.525 ' CD1' HG12 ' B' ' 44' ' ' VAL . 86.8 m-85 -103.9 73.1 1.14 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.801 -1.411 . . . . 0.33 108.328 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -81.17 -10.61 59.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.41 110.639 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -129.52 150.3 50.92 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.92 . . . . 1.56 109.62 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.07 94.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.21 110.766 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 16.7 p90 -60.49 -18.57 52.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.32 110.514 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' B' ' 39' ' ' PHE . 50.8 t -79.62 -32.77 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.426 -1.324 . . . . 0.24 107.426 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.83 -37.26 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.109 -1.071 . . . . 0.22 108.109 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.04 -35.44 75.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.611 -1.255 . . . . 0.4 107.611 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.61 97.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.067 -1.213 . . . . 0.18 110.067 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -60.02 -41.64 92.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.006 -1.291 . . . . 1.09 109.742 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.04 -39.88 87.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.31 108.82 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.52 -38.77 81.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.816 -0.809 . . . . 0.27 108.816 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.03 -24.44 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.401 -0.812 . . . . 0.28 110.648 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.8 mt -93.18 18.16 9.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.111 -0.993 . . . . 0.3 110.434 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 50.46 33.55 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.67 -1.269 . . . . 1.71 110.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 60.06 19.89 9.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.764 -0.585 . . . . 2.25 110.332 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -68.48 113.4 6.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 1.8 107.726 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -61.82 -39.96 93.6 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 113.11 0.782 . . . . 0.88 113.11 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.87 -39.61 76.23 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.575 -1.328 . . . . 0.74 110.604 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 98.7 mt -69.59 -38.82 77.49 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.848 -1.141 . . . . 0.55 108.937 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.98 -50.44 68.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.38 110.005 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.499 ' HG3' HH11 ' B' ' 60' ' ' ARG . 5.4 mtm-85 -62.62 -43.66 98.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 2.64 109.803 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.94 -39.79 94.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 2.38 108.745 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . 0.408 ' O ' ' OG1' ' B' ' 66' ' ' THR . 55.7 t90 -65.54 -46.29 80.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.912 . . . . 0.4 110.513 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -49.45 63.17 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.06 -1.025 . . . . 0.34 110.074 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -60.78 -48.72 80.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.288 -0.882 . . . . 2.1 109.937 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 33.8 t0 -69.13 -28.89 66.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 1.9 109.852 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' B' ' 62' ' ' TRP . 50.5 m -79.51 -34.61 41.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.4 111.011 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 23.3 p -131.61 -29.45 1.74 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.611 -1.305 . . . . 0.39 111.77 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.57 14.27 20.22 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.321 -1.512 . . . . 0.36 109.321 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.71 153.48 1.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.322 . . . . 0.32 109.077 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -90.7 171.12 9.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.075 -1.015 . . . . 1.91 109.685 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.97 72.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.52 -0.738 . . . . 0.38 110.828 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.07 -40.63 68.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.558 -1.339 . . . . 2.57 110.003 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.81 -39.98 79.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 2.12 110.382 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 56.6 m -67.19 -39.22 86.34 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.279 -0.888 . . . . 1.36 110.044 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -60.09 -38.46 82.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 2.81 109.387 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.58 -39.9 84.86 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.722 -1.236 . . . . 0.4 110.357 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 93.5 m -66.91 -39.93 87.53 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.947 -1.096 . . . . 0.23 109.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 -59.97 4.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.638 -1.289 . . . . 0.43 110.066 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.54 84.51 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.518 -1.033 . . . . 0.25 110.518 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.18 -50.06 50.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -1.19 . . . . 0.24 109.77 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.94 -40.06 75.69 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.827 -1.149 . . . . 0.29 108.809 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -63.15 -41.23 99.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 2.74 110.159 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.88 -35.92 75.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.017 -1.052 . . . . 1.91 109.594 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.43 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 80.2 t90 -60.03 -43.95 94.95 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.929 -1.508 . . . . 0.36 106.929 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 35.0 m -60.99 -39.96 91.64 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.849 -0.797 . . . . 0.36 108.849 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.49 -37.59 81.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.55 110.117 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.6 -38.71 15.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.155 -0.966 . . . . 0.47 110.579 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -104.51 -86.79 0.45 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.169 -0.957 . . . . 1.24 110.265 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.509 HD13 ' SD ' ' A' ' 15' ' ' MET . 17.7 tp . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 118.084 -0.96 . . . . 1.67 109.602 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptm . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.349 0.595 . . . . 5.68 109.457 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 64.9 p -77.93 125.16 28.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 3.02 109.403 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.9 p -99.25 158.29 15.8 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.433 -0.792 . . . . 0.96 109.608 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 p -80.13 177.61 8.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.22 -0.925 . . . . 1.51 109.576 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.68 -21.14 62.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.538 -0.726 . . . . 2.18 110.69 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.99 -37.84 80.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.777 -1.202 . . . . 2.02 109.613 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -60.0 -51.85 67.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.841 -1.162 . . . . 0.49 110.48 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -69.72 -36.59 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.012 -1.055 . . . . 3.21 109.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.49 -39.96 73.86 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.76 109.69 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.32 -41.33 96.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.216 -0.928 . . . . 0.46 109.945 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 m -84.31 15.58 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.44 109.842 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.8 -9.78 11.17 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.449 -0.782 . . . . 0.54 110.294 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 10.6 pt-20 -149.86 149.2 27.31 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.943 -1.098 . . . . 1.26 109.252 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 13' ' ' GLU . 89.7 Cg_exo -41.1 166.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.811 1.674 . . . . 0.49 111.776 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.458 ' SD ' HD11 ' B' ' 89' ' ' LEU . 3.4 ptp -93.05 -24.95 18.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.57 108.621 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.96 -140.65 16.48 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.021 -1.632 . . . . 0.4 109.021 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -109.74 30.03 7.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.481 -1.011 . . . . 0.85 109.477 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 90.2 mttt -60.18 149.39 75.52 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 2.01 108.986 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.12 153.98 54.77 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.182 1.921 . . . . 0.34 112.439 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 21' ' ' GLY . 14.5 p -57.52 -44.03 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.603 -0.686 . . . . 0.32 110.522 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -54.64 -2.78 0.2 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.16 -1.176 . . . . 0.23 110.16 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 20' ' ' VAL . 40.7 t -82.59 -23.42 34.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.774 -1.427 . . . . 1.24 109.093 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.24 109.874 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.14 134.28 52.45 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.763 0.792 . . . . 0.21 109.96 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 73' ' ' GLN . . . 99.94 -20.53 48.71 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.283 -1.527 . . . . 0.22 109.283 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.6 mm -99.75 114.2 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.281 -1.129 . . . . 0.25 108.011 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.71 178.4 39.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.271 -1.532 . . . . 0.28 109.271 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -57.24 -39.71 76.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.337 -1.096 . . . . 2.01 109.209 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.33 -48.38 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.38 109.706 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.0 -39.97 83.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 0.4 109.285 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.98 98.69 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.565 -1.414 . . . . 0.35 109.565 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.85 -41.06 95.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -1.201 . . . . 2.74 110.352 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.46 -40.16 85.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.823 -1.173 . . . . 1.54 109.689 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.83 -40.06 93.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.963 -1.085 . . . . 0.34 109.106 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.08 -40.89 91.12 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.723 -0.791 . . . . 1.67 109.363 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.77 -19.53 64.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.809 -0.811 . . . . 2.0 108.809 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -89.0 0.18 56.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.631 -0.668 . . . . 2.69 109.898 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' B' ' 53' ' ' LYS . . . 107.01 4.35 35.93 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 120.254 -0.974 . . . . 0.48 111.577 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.425 ' CD2' HG12 ' A' ' 44' ' ' VAL . 96.2 m-85 -103.17 75.64 1.38 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.825 -1.397 . . . . 0.33 109.137 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.16 -11.14 59.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.41 111.159 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -135.08 157.84 45.89 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.939 -1.101 . . . . 1.56 109.397 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.59 88.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.21 112.078 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -56.15 -18.15 9.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.768 -1.208 . . . . 0.32 110.457 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.425 HG12 ' CD2' ' A' ' 39' ' ' PHE . 21.6 t -80.15 -31.43 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.832 -1.168 . . . . 0.24 108.287 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.52 -38.7 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.413 -0.958 . . . . 0.22 108.413 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.85 -38.2 81.43 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.654 -1.61 . . . . 0.4 106.654 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.41 -45.98 58.3 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.878 -1.289 . . . . 0.18 109.878 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -41.93 93.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -1.181 . . . . 1.09 109.329 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.93 -40.57 89.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.0 -1.063 . . . . 0.31 108.828 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.74 -39.7 76.61 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.688 -0.856 . . . . 0.28 108.688 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.09 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.28 110.554 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -89.77 13.83 13.39 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.096 . . . . 0.31 110.858 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 51.32 35.91 14.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.209 . . . . 1.7 110.223 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 56.08 19.42 3.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.228 -0.92 . . . . 2.24 110.524 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -69.16 105.34 2.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.712 -1.242 . . . . 1.8 108.263 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.538 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 83.3 tt0 -62.94 -39.95 96.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 0.87 111.973 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.65 -39.89 88.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.73 109.57 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.32 -37.92 71.73 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.445 -0.902 . . . . 0.55 108.747 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.56 -42.13 95.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.565 -0.71 . . . . 0.38 109.941 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.538 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 99.2 mtt180 -60.11 -48.5 81.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.249 -0.907 . . . . 2.64 110.361 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.94 -39.89 90.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.682 -1.261 . . . . 2.37 109.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -61.65 -50.1 73.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 0.4 110.664 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.9 tp -68.4 -48.44 64.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.089 -1.007 . . . . 0.34 110.103 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.19 -47.16 85.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 2.11 109.797 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -68.71 -30.12 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.555 -0.715 . . . . 1.9 109.682 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.3 m -80.22 -32.52 38.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.41 111.029 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -133.0 -35.05 1.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.575 -1.328 . . . . 0.4 112.098 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.65 16.04 9.71 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.338 -1.505 . . . . 0.36 109.338 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.45 152.24 2.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.272 . . . . 0.33 109.89 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -90.22 173.49 8.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.109 -0.994 . . . . 1.9 109.953 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.61 75.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.715 . . . . 0.39 110.03 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.24 -40.01 71.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.106 -0.996 . . . . 2.58 109.633 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 25' ' ' GLY . 29.6 mm100 -66.61 -39.28 88.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.548 -0.72 . . . . 2.12 110.151 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.1 m -62.84 -38.61 91.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.299 -0.876 . . . . 1.36 109.747 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 2.8 109.614 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -69.31 -39.91 77.98 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.737 -1.227 . . . . 0.4 110.742 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -70.2 -39.96 74.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.661 -1.275 . . . . 0.24 109.996 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.33 -60.38 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.81 -1.181 . . . . 0.43 110.046 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.46 82.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.388 -1.085 . . . . 0.26 110.388 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 40.7 t -68.54 -49.63 58.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.295 . . . . 0.25 109.681 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.1 mt -70.09 -40.07 75.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.323 -0.951 . . . . 0.3 109.327 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -62.0 -40.59 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 2.73 109.596 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.02 -38.63 75.98 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.277 -0.889 . . . . 1.91 110.077 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.557 ' CE2' ' CD1' ' A' ' 88' ' ' PHE . 88.4 t90 -61.69 -46.57 89.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.473 -1.392 . . . . 0.37 108.688 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 51.9 m -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.462 -0.774 . . . . 0.36 109.573 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -58.87 -30.97 68.15 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.373 -0.829 . . . . 0.55 109.423 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.48 -34.75 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.269 -0.894 . . . . 0.48 111.063 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CD1' ' CE2' ' A' ' 84' ' ' TRP . 87.2 m-85 -108.94 -5.52 16.09 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.149 -0.969 . . . . 1.24 112.717 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.434 HD11 ' SD ' ' B' ' 15' ' ' MET . 10.5 tp . . . . . 0 N--CA 1.502 2.151 0 O-C-N 120.382 -1.448 . . . . 1.66 109.288 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.46 -0.57 . . . . 5.66 109.46 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 64.0 p -77.65 125.52 29.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 3.02 109.363 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -99.59 158.59 15.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.411 -0.806 . . . . 0.96 109.467 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 54.3 p -80.17 177.72 8.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 1.5 109.642 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.84 -21.06 62.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 2.18 110.624 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.97 -37.82 80.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.799 -1.188 . . . . 2.01 109.619 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -60.0 -51.9 67.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.081 . . . . 0.49 110.527 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -69.73 -36.51 75.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 3.23 109.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.41 -39.93 74.17 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.35 -0.844 . . . . 0.76 109.793 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.44 -41.15 96.73 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.503 -0.879 . . . . 0.46 109.933 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.53 15.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.081 -1.012 . . . . 0.44 109.857 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.97 -9.81 11.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.466 -0.771 . . . . 0.53 110.362 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' B' ' 18' ' ' LYS . 10.5 pt-20 -149.86 149.14 27.14 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 120.903 -1.123 . . . . 1.27 109.208 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' B' ' 13' ' ' GLU . 92.3 Cg_exo -41.04 166.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.798 1.665 . . . . 0.49 111.705 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 89' ' ' LEU . 3.3 ptp -93.29 -24.69 18.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 0.56 108.699 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.61 -140.55 14.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.03 -1.628 . . . . 0.39 109.03 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -109.65 30.1 6.97 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.512 -0.993 . . . . 0.84 109.464 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' B' ' 13' ' ' GLU . 89.8 mttt -60.27 149.55 75.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.938 . . . . 2.02 108.856 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.35 153.98 56.14 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.204 1.936 . . . . 0.34 112.422 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.534 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.5 p -57.64 -43.84 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.567 -0.708 . . . . 0.32 110.545 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.534 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -54.83 -2.56 0.2 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.118 -1.193 . . . . 0.22 110.118 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.506 ' H ' ' C ' ' B' ' 20' ' ' VAL . 40.6 t -82.87 -23.39 33.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.399 . . . . 1.24 109.125 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.46 136.38 57.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.24 109.869 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.16 134.22 52.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.788 0.804 . . . . 0.21 110.075 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.528 ' O ' ' NE2' ' B' ' 73' ' ' GLN . . . 99.98 -20.5 48.78 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.287 -1.525 . . . . 0.22 109.287 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.65 114.05 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -1.125 . . . . 0.25 108.024 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.6 178.3 39.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.262 -1.535 . . . . 0.28 109.262 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -57.19 -39.57 75.62 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.315 -1.109 . . . . 2.0 109.236 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.28 -48.53 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.38 109.721 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.86 -40.07 83.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.159 -0.963 . . . . 0.4 109.354 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.95 98.66 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.594 -1.403 . . . . 0.36 109.594 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.83 -41.21 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -1.23 . . . . 2.75 110.301 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.41 -39.9 85.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.83 -1.169 . . . . 1.56 109.772 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.94 -39.98 93.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.059 -1.026 . . . . 0.33 109.06 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.09 -40.94 91.34 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.79 -0.764 . . . . 1.68 109.317 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -68.81 -19.46 64.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.824 -0.806 . . . . 1.99 108.824 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -89.01 0.39 56.71 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.092 -0.643 . . . . 2.68 109.969 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.79 4.33 36.58 Favored Glycine 0 N--CA 1.504 3.17 0 O-C-N 121.105 -0.997 . . . . 0.49 111.734 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.431 ' CD2' HG12 ' B' ' 44' ' ' VAL . 96.3 m-85 -103.33 75.83 1.38 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.818 -1.401 . . . . 0.33 109.096 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -77.43 -10.97 59.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.41 111.019 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -135.19 157.95 45.61 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.902 -1.124 . . . . 1.56 109.444 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.49 88.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.547 -0.72 . . . . 0.21 112.051 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -56.36 -18.13 9.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.721 -1.237 . . . . 0.32 110.551 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' B' ' 39' ' ' PHE . 21.5 t -80.13 -31.36 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.884 -1.135 . . . . 0.24 108.279 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.52 -38.75 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 0.22 108.425 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.03 -38.3 82.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.573 -1.64 . . . . 0.4 106.573 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.74 -45.6 60.43 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.68 -1.368 . . . . 0.18 109.68 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -41.8 93.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.225 . . . . 1.09 109.356 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.0 -40.49 89.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.017 -1.052 . . . . 0.31 108.753 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -69.77 -40.04 76.31 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.662 -0.866 . . . . 0.27 108.662 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.68 -21.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.135 -0.978 . . . . 0.28 110.613 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.91 14.02 13.14 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.048 -1.032 . . . . 0.3 110.663 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 38' ' ' GLY . 59.8 mttp 50.79 36.32 14.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.812 -1.18 . . . . 1.71 110.227 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 55.91 19.41 3.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.308 -0.87 . . . . 2.25 110.618 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -69.01 105.58 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.72 -1.237 . . . . 1.8 108.18 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' B' ' 60' ' ' ARG . 83.5 tt0 -63.17 -39.96 96.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.901 . . . . 0.88 111.977 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.45 -40.08 89.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.815 -1.178 . . . . 0.74 109.553 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -71.1 -37.79 72.38 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.396 -0.921 . . . . 0.55 108.848 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.8 -42.19 95.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.612 -0.68 . . . . 0.38 109.898 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' B' ' 56' ' ' GLU . 99.2 mtt180 -59.99 -48.96 79.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.244 -0.91 . . . . 2.64 110.35 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.54 -39.94 92.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.689 -1.257 . . . . 2.38 109.832 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -61.7 -49.97 74.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.921 -1.112 . . . . 0.4 110.706 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 56.2 tp -68.43 -48.7 63.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.079 -1.013 . . . . 0.34 110.032 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.06 -47.12 86.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 2.1 109.767 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -68.85 -29.96 68.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 1.9 109.656 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 53.4 m -80.17 -32.58 38.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.4 111.045 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 32.0 p -132.94 -35.29 1.07 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.66 -1.275 . . . . 0.39 112.045 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.72 16.48 9.28 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.292 -1.523 . . . . 0.36 109.292 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 152.32 3.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.063 -1.257 . . . . 0.32 109.76 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -90.1 173.62 8.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 1.91 109.98 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.92 -34.3 75.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.38 110.093 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -71.38 -40.1 70.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 2.57 109.593 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' B' ' 25' ' ' GLY . 29.6 mm100 -66.53 -39.15 88.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.488 -0.757 . . . . 2.12 110.25 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 74.2 m -62.94 -38.58 91.61 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.268 -0.895 . . . . 1.36 109.748 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.158 -0.964 . . . . 2.81 109.626 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -69.32 -39.99 77.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.839 -1.163 . . . . 0.4 110.716 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -70.14 -40.05 75.03 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.682 -1.261 . . . . 0.23 109.968 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -61.18 -60.31 3.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.861 -1.149 . . . . 0.43 110.162 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.34 82.14 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.46 -1.056 . . . . 0.25 110.46 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.66 -49.63 57.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.302 . . . . 0.24 109.699 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.03 -40.04 75.42 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.295 -0.962 . . . . 0.29 109.324 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -62.0 -40.68 96.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 2.74 109.566 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -38.69 76.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.166 -0.959 . . . . 1.91 110.153 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.555 ' CE2' ' CD1' ' B' ' 88' ' ' PHE . 88.2 t90 -61.75 -46.61 88.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.456 -1.403 . . . . 0.36 108.702 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' B' ' 89' ' ' LEU . 51.6 m -60.08 -39.91 87.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.751 -0.78 . . . . 0.36 109.686 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.05 -30.79 68.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.384 -0.822 . . . . 0.55 109.406 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 -35.21 13.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.835 . . . . 0.47 111.057 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' B' ' 84' ' ' TRP . 87.4 m-85 -108.31 -6.13 16.44 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.129 -0.982 . . . . 1.24 112.663 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.458 HD11 ' SD ' ' A' ' 15' ' ' MET . 10.4 tp . . . . . 0 N--CA 1.502 2.171 0 O-C-N 120.355 -1.466 . . . . 1.67 109.371 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.389 -0.597 . . . . 5.68 109.389 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.2 p -90.84 111.32 22.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.204 -0.935 . . . . 3.02 109.435 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.5 p -86.21 164.22 17.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.96 109.321 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.7 m -78.85 170.91 15.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.932 . . . . 1.51 109.124 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.91 -28.66 67.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.548 -0.72 . . . . 2.18 110.114 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -60.32 -39.62 87.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.949 -1.095 . . . . 2.02 109.644 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -59.85 -51.17 70.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.931 . . . . 0.49 110.656 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 23.8 mmm180 -70.25 -34.45 72.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.814 -1.179 . . . . 3.21 109.685 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -68.74 -38.88 80.46 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.368 -0.833 . . . . 0.76 110.023 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.55 -45.78 82.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.46 110.173 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -86.26 7.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.124 -0.985 . . . . 0.44 110.812 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -102.2 -13.62 17.35 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.201 -0.937 . . . . 0.54 110.056 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -154.54 153.55 28.05 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.977 . . . . 1.26 108.998 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -37.72 156.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 122.071 1.847 . . . . 0.49 111.741 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.476 ' SD ' HD11 ' B' ' 89' ' ' LEU . 11.7 ptm -93.31 -28.2 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.57 110.296 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.35 -133.51 42.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.433 -1.067 . . . . 0.4 110.433 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.64 35.89 3.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.614 -0.933 . . . . 0.85 110.379 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -57.93 149.58 54.04 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.047 -1.033 . . . . 2.01 108.313 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.94 155.31 55.93 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.069 1.846 . . . . 0.34 112.551 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 21' ' ' GLY . 3.4 p -57.07 -47.16 84.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.479 0.657 . . . . 0.32 110.387 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.67 -5.42 0.86 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 121.467 -0.77 . . . . 0.23 111.223 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -84.21 -19.94 33.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.448 -1.619 . . . . 1.24 109.498 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.46 134.07 55.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.24 109.29 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.21 133.33 52.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.669 -0.812 . . . . 0.21 109.675 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.52 -21.22 47.07 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.129 -1.588 . . . . 0.22 109.129 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.75 112.4 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.25 108.405 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.98 -178.77 36.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.287 -1.525 . . . . 0.28 109.287 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.88 -40.28 83.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -1.093 . . . . 2.01 110.631 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.05 -46.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.72 -1.238 . . . . 0.38 109.14 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.3 -40.07 86.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.4 109.483 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.69 96.73 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.913 -1.275 . . . . 0.35 109.913 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.34 -38.18 85.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.001 -1.294 . . . . 2.74 110.332 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.84 -45.15 87.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 1.54 109.748 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.8 mt -62.17 -40.09 94.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.013 -1.055 . . . . 0.34 109.798 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.03 -40.1 88.19 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.476 -0.889 . . . . 1.67 109.053 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -67.79 -19.16 65.06 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.81 6.61 40.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.482 -0.761 . . . . 2.69 109.601 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 9.05 57.06 Favored Glycine 0 N--CA 1.5 2.955 0 O-C-N 121.005 -1.059 . . . . 0.48 111.544 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.494 ' CD2' HG12 ' A' ' 44' ' ' VAL . 86.0 m-85 -103.71 75.36 1.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.854 -1.38 . . . . 0.33 108.858 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.18 -10.08 59.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 0.41 111.248 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -140.69 161.57 37.47 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.896 -1.127 . . . . 1.56 110.69 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.67 -43.64 92.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.21 112.355 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' TYR . 6.4 p90 -58.2 -18.43 25.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.801 -1.187 . . . . 0.32 110.669 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.636 HG21 ' HZ3' ' B' ' 53' ' ' LYS . 24.5 t -80.06 -31.37 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.79 -1.189 . . . . 0.24 107.79 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.63 -40.03 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.185 -1.042 . . . . 0.22 108.185 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.8 tp -59.02 -34.65 72.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.882 -1.525 . . . . 0.4 106.882 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.01 -40.72 97.37 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.593 -1.403 . . . . 0.18 109.593 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -41.97 93.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.261 . . . . 1.09 108.987 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -60.24 -41.54 93.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.31 108.705 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -70.27 -40.0 74.61 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.548 -0.861 . . . . 0.28 108.921 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.93 -25.11 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.28 110.671 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 52' ' ' LEU . 85.9 mt -92.29 15.3 14.05 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.949 -1.095 . . . . 0.31 110.491 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 67.8 mttm 52.41 40.29 29.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.088 -1.007 . . . . 1.7 110.548 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 pttt 40.3 19.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.01 -1.056 . . . . 2.24 111.873 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 17.9 t0 -66.85 117.55 9.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.671 -1.603 . . . . 1.8 106.671 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.87 -40.17 94.45 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.483 0.92 . . . . 0.87 113.483 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 96.1 m-20 -70.21 -39.86 74.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.416 -1.428 . . . . 0.73 109.937 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.09 -39.86 68.64 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.935 -1.106 . . . . 0.55 108.6 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -61.83 -49.92 74.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.38 109.957 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 83.4 mtm180 -61.84 -42.65 99.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 2.64 110.616 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.73 -39.24 93.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 2.37 109.25 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -61.22 -49.28 77.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.029 -1.044 . . . . 0.4 110.735 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.23 -49.28 65.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 0.34 109.857 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -61.89 -47.26 85.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.393 -0.817 . . . . 2.11 109.864 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 30.0 t0 -69.04 -31.13 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 1.9 109.864 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -79.75 -33.08 41.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.41 111.366 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.1 p -132.54 -31.72 1.36 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.58 -1.325 . . . . 0.4 111.574 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 15.79 12.63 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.075 -1.61 . . . . 0.36 109.075 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.02 153.49 3.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -1.205 . . . . 0.33 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -94.93 176.22 6.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 1.9 109.825 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -35.35 75.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.586 -0.696 . . . . 0.39 111.23 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -70.13 -42.84 72.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.52 -1.362 . . . . 2.58 110.57 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 73' ' ' GLN . 16.7 mp0 -67.94 -39.18 83.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -0.963 . . . . 2.12 110.965 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 t -67.95 -38.35 82.7 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.809 -1.182 . . . . 1.36 110.198 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -60.72 -38.79 86.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.742 -1.224 . . . . 2.8 109.913 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.26 -39.62 82.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.561 -1.337 . . . . 0.4 110.417 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.71 -40.09 76.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.965 -1.085 . . . . 0.24 109.518 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -59.4 -60.34 4.01 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.179 -0.95 . . . . 0.43 109.424 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.51 -33.63 87.76 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.694 -0.962 . . . . 0.26 110.694 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -1.234 . . . . 0.25 109.636 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.1 mt -70.27 -39.97 74.62 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.962 -1.095 . . . . 0.3 108.391 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -65.1 -40.16 94.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.86 . . . . 2.73 110.309 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.62 -39.69 80.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 1.91 110.6 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 88.4 t90 -60.23 -42.28 94.91 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.343 -1.473 . . . . 0.37 107.581 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 89' ' ' LEU . 63.5 m -60.16 -40.09 88.7 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.783 0.801 . . . . 0.36 109.279 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.6 -33.95 72.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.218 -0.927 . . . . 0.55 109.698 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.18 -34.56 14.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.195 -0.94 . . . . 0.48 111.285 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.551 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.8 m-85 -108.98 3.11 21.81 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.116 -0.99 . . . . 1.24 111.482 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' CYS . 8.5 tp . . . . . 0 N--CA 1.497 1.88 0 O-C-N 120.936 -1.102 . . . . 1.66 109.357 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.37 -0.604 . . . . 5.66 109.37 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 34.5 p -90.72 111.11 22.33 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.13 -0.981 . . . . 3.02 109.397 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 30.4 p -85.93 164.16 17.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.96 109.413 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -78.63 170.82 16.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 1.5 109.1 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.19 -28.24 67.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.612 -0.68 . . . . 2.18 110.07 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.5 -39.57 88.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.123 -0.986 . . . . 2.01 109.637 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -59.84 -51.32 70.23 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.261 -0.899 . . . . 0.49 110.635 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 23.8 mmm180 -70.19 -34.23 72.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.896 -1.127 . . . . 3.23 109.854 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -68.88 -39.35 79.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.376 -0.828 . . . . 0.76 109.785 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -65.13 -46.17 82.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.46 110.119 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.0 m -86.09 8.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.141 -0.975 . . . . 0.44 110.749 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -102.7 -13.44 17.08 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.192 -0.942 . . . . 0.53 109.911 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.54 153.38 27.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 1.27 108.98 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -37.89 156.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.059 1.839 . . . . 0.49 111.719 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 11.6 ptm -93.2 -28.13 16.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.56 110.271 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.18 -133.33 41.87 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.412 -1.075 . . . . 0.39 110.412 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -111.81 36.01 3.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.596 -0.944 . . . . 0.84 110.302 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -58.09 149.83 54.53 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.871 -1.143 . . . . 2.02 108.329 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.87 155.17 56.34 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.168 1.912 . . . . 0.34 112.537 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.443 HG13 ' N ' ' B' ' 21' ' ' GLY . 3.5 p -57.16 -46.53 84.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.602 0.715 . . . . 0.32 110.496 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.443 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -56.07 -5.25 0.95 Allowed Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.45 -0.782 . . . . 0.22 111.248 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 59.5 m -84.4 -20.32 32.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.553 -1.557 . . . . 1.24 109.435 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.14 133.86 55.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.24 109.237 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.14 133.34 52.75 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.586 -0.845 . . . . 0.21 109.714 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.62 -20.98 48.26 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.25 -1.54 . . . . 0.22 109.25 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.03 112.6 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -1.088 . . . . 0.25 108.365 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.22 -178.86 35.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.174 -1.57 . . . . 0.28 109.174 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -58.65 -40.07 82.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.422 -1.046 . . . . 2.0 110.713 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.04 -46.57 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.642 -1.286 . . . . 0.38 109.196 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.21 -39.95 86.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.4 109.545 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.56 97.19 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.835 -1.306 . . . . 0.36 109.835 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -61.21 -38.64 87.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.266 . . . . 2.75 110.189 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.59 -45.06 88.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.712 -1.243 . . . . 1.56 109.603 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.13 -39.9 94.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.835 -1.166 . . . . 0.33 109.822 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.42 -40.05 89.66 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.579 -0.848 . . . . 1.68 108.896 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -67.82 -19.18 65.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.215 -1.031 . . . . 1.99 108.215 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.86 6.87 39.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.533 -0.73 . . . . 2.68 109.603 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.42 9.07 57.06 Favored Glycine 0 N--CA 1.5 2.939 0 O-C-N 120.961 -1.087 . . . . 0.49 111.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' B' ' 44' ' ' VAL . 86.6 m-85 -104.1 75.46 1.27 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.929 -1.336 . . . . 0.33 108.948 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -74.37 -9.98 59.13 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.883 . . . . 0.41 111.176 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -140.66 161.78 36.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.852 -1.155 . . . . 1.56 110.712 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.77 -43.84 91.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.835 -0.54 . . . . 0.21 112.314 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 5.7 p90 -57.84 -18.72 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.32 110.733 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.0 t -80.12 -31.11 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.79 -1.194 . . . . 0.24 107.849 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.81 -39.92 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.173 -1.047 . . . . 0.22 108.173 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 37.6 tp -59.03 -34.84 72.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.983 -1.488 . . . . 0.4 106.983 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.99 97.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.494 -1.442 . . . . 0.18 109.494 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.84 -42.04 92.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 1.09 108.961 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.11 -41.54 92.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.31 108.727 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.41 -40.18 74.02 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.537 -0.865 . . . . 0.27 108.889 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.92 -24.66 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 0.28 110.785 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 52' ' ' LEU . 84.4 mt -92.55 15.81 13.4 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.037 -1.039 . . . . 0.3 110.368 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.636 ' HZ3' HG21 ' A' ' 44' ' ' VAL . 67.8 mttm 51.98 40.19 27.74 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.904 -1.122 . . . . 1.71 110.635 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 47.8 pttt 40.49 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.135 -0.978 . . . . 2.25 111.711 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 53' ' ' LYS . 19.3 t0 -66.78 117.77 9.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.52 -1.659 . . . . 1.8 106.52 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.62 -40.93 96.61 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.127 -0.983 . . . . 0.88 113.458 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.52 -39.97 77.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.437 -1.414 . . . . 0.74 110.107 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.18 -39.95 68.29 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.005 -1.078 . . . . 0.55 108.552 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.7 -50.14 73.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.833 . . . . 0.38 109.96 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -61.56 -43.05 99.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 2.64 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -64.54 -38.9 92.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.848 -1.158 . . . . 2.38 109.392 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -61.33 -49.17 78.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.4 110.818 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 32.8 tp -67.38 -49.49 63.71 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.329 -0.857 . . . . 0.34 109.835 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.77 -47.02 87.05 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.373 -0.829 . . . . 2.1 109.939 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' B' ' 65' ' ' ASP . 33.7 t0 -69.17 -31.08 69.47 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.436 -0.79 . . . . 1.9 109.926 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 55.4 m -79.76 -33.2 40.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.4 111.341 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.32 -32.26 1.37 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.718 -1.239 . . . . 0.39 111.62 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.32 16.13 11.58 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.144 -1.582 . . . . 0.36 109.144 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.16 153.53 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.301 . . . . 0.32 109.358 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -94.81 176.22 6.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 1.91 109.77 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.17 75.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.608 -0.682 . . . . 0.38 111.255 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -70.07 -42.73 72.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.511 -1.368 . . . . 2.57 110.611 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' B' ' 73' ' ' GLN . 16.5 mp0 -67.99 -39.43 83.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.198 -0.939 . . . . 2.12 111.021 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.8 t -67.83 -38.04 82.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.037 -1.039 . . . . 1.36 110.08 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -61.2 -38.34 86.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.775 -1.203 . . . . 2.81 109.92 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.5 -39.88 81.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.439 -1.413 . . . . 0.4 110.322 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 99.0 m -69.7 -40.2 76.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.824 -1.173 . . . . 0.23 109.473 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.51 -60.02 4.51 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.096 -1.003 . . . . 0.43 109.339 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.69 -33.63 87.75 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.618 -0.993 . . . . 0.25 110.618 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.38 -46.12 61.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.985 -1.303 . . . . 0.24 109.588 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.85 -40.14 75.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.095 -1.042 . . . . 0.29 108.247 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -65.14 -40.08 93.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 2.74 110.214 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.49 -39.9 81.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 1.91 110.419 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.544 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 88.5 t90 -60.44 -42.34 95.91 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.314 -1.491 . . . . 0.36 107.521 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' B' ' 89' ' ' LEU . 63.7 m -60.03 -40.14 88.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.436 -0.79 . . . . 0.36 109.271 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.46 -33.82 71.77 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.364 -0.835 . . . . 0.55 109.842 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.36 -35.11 13.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.121 -0.987 . . . . 0.47 111.192 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.544 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 97.1 m-85 -107.84 2.25 23.38 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.206 -0.934 . . . . 1.24 111.636 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 85' ' ' CYS . 8.1 tp . . . . . 0 N--CA 1.498 1.962 0 O-C-N 120.938 -1.101 . . . . 1.67 109.363 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.98 -0.748 . . . . 5.68 108.98 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 2' ' ' THR . 0.5 OUTLIER -85.82 7.84 22.36 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.238 -1.023 . . . . 3.02 108.238 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 p -73.48 169.79 16.47 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.485 0.66 . . . . 0.96 110.12 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -61.84 173.2 1.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 1.51 110.097 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -59.96 -20.87 59.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.75 -0.594 . . . . 2.18 110.896 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -60.05 -38.48 82.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.868 -1.145 . . . . 2.02 109.543 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -59.93 -51.69 68.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.08 . . . . 0.49 110.652 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 58.8 mtt-85 -69.96 -35.19 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.837 -1.164 . . . . 3.21 110.139 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.78 -39.95 84.03 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.396 -0.815 . . . . 0.76 109.321 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.19 -48.21 76.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.465 -0.772 . . . . 0.46 109.967 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 m -86.59 8.13 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.129 -0.982 . . . . 0.44 110.992 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 8' ' ' ARG . . . -99.5 -16.94 18.14 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.937 -1.102 . . . . 0.54 110.035 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 14' ' ' PRO . 13.5 pt-20 -155.6 152.49 24.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 1.26 108.469 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . 92.4 Cg_exo -35.49 154.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.2 1.933 . . . . 0.49 111.713 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.634 ' CE ' HD22 ' A' ' 46' ' ' LEU . 7.4 ptp -91.16 -23.76 20.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.909 -1.12 . . . . 0.57 109.89 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.35 -135.47 32.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.384 -1.086 . . . . 0.4 110.384 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -110.0 38.78 2.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.597 -0.943 . . . . 0.85 110.158 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -59.93 149.99 71.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.044 . . . . 2.01 108.738 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.03 148.92 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.32 2.013 . . . . 0.34 112.588 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 p -52.73 -30.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.475 0.655 . . . . 0.32 110.387 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.61 -3.57 67.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.745 -0.942 . . . . 0.23 110.745 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.0 t -83.29 -20.79 33.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.746 -1.444 . . . . 1.24 109.339 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.481 HD22 HD21 ' A' ' 81' ' ' LEU . 84.3 mt -62.54 135.57 57.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.24 109.703 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.72 133.19 53.11 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.694 0.759 . . . . 0.21 109.671 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.73 -19.98 52.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 0.22 109.255 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.3 mm -98.55 112.78 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.069 -1.085 . . . . 0.25 108.069 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.48 178.06 39.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.803 -1.319 . . . . 0.28 109.803 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.76 -40.01 75.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.461 -1.023 . . . . 2.01 109.766 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.35 -44.9 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.38 109.671 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.69 -38.05 85.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.4 109.413 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.43 -38.61 91.24 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.546 -1.422 . . . . 0.35 109.546 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.49 -39.16 93.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -1.151 . . . . 2.74 110.823 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.1 -44.58 79.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.742 -1.224 . . . . 1.54 109.808 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.53 -39.93 95.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.34 108.742 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.0 -42.46 94.31 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.656 -0.818 . . . . 1.67 109.411 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.3 -19.5 65.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.0 108.783 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -91.11 1.81 56.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.654 -0.654 . . . . 2.69 109.948 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.45 4.22 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.083 -1.011 . . . . 0.48 110.801 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.476 ' CD2' HG12 ' A' ' 44' ' ' VAL . 82.8 m-85 -132.41 70.94 1.46 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -1.231 . . . . 0.33 108.239 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -77.43 -10.53 59.52 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.272 -0.971 . . . . 0.41 109.905 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -131.29 153.16 49.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.375 -0.828 . . . . 1.56 108.808 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.04 -39.9 90.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.21 111.205 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.483 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 4.7 p90 -56.59 -17.67 9.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.884 -1.135 . . . . 0.32 110.994 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.476 HG12 ' CD2' ' A' ' 39' ' ' PHE . 46.8 t -79.77 -29.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.178 . . . . 0.24 107.936 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.1 -36.8 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.308 -0.997 . . . . 0.22 108.308 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.634 HD22 ' CE ' ' A' ' 15' ' ' MET . 19.0 tp -60.03 -39.29 85.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.134 -1.432 . . . . 0.4 107.134 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.71 -43.7 94.37 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.108 -1.197 . . . . 0.18 110.108 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.98 -42.69 94.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.752 -1.44 . . . . 1.09 109.053 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.98 -42.27 93.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.863 . . . . 0.31 108.943 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -68.96 -38.19 79.27 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.727 -0.842 . . . . 0.28 108.727 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.43 -22.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.28 110.046 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 16.75 10.99 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.144 -0.972 . . . . 0.31 109.789 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' NZ ' HG21 ' B' ' 44' ' ' VAL . 58.8 mttm 50.0 39.55 19.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.975 -1.078 . . . . 1.7 110.505 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.31 19.28 4.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.24 109.747 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.13 108.54 4.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.727 -1.233 . . . . 1.8 108.021 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -61.04 -40.0 91.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.555 -0.716 . . . . 0.87 112.556 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.09 -40.09 78.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.644 -1.285 . . . . 0.73 110.385 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.21 75.34 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.93 -1.108 . . . . 0.55 109.009 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.85 -50.1 70.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.83 . . . . 0.38 110.05 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -59.94 -46.37 89.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 2.64 110.587 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -65.74 -38.57 89.49 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.042 -1.036 . . . . 2.37 109.14 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -66.06 -48.34 71.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.4 111.073 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.5 tp -66.22 -46.32 77.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.211 -0.931 . . . . 0.34 109.152 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.91 -45.75 91.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.389 -0.819 . . . . 2.11 109.089 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.63 -31.87 70.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.641 -0.662 . . . . 1.9 109.85 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -80.41 -31.37 37.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 0.41 111.487 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.73 -25.78 1.84 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.528 -1.358 . . . . 0.4 111.876 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.14 29.19 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.422 -1.471 . . . . 0.36 109.422 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.43 153.49 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.046 -1.267 . . . . 0.33 109.252 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -92.12 174.29 7.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.034 -1.041 . . . . 1.9 110.242 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.08 78.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.668 -0.645 . . . . 0.39 110.826 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.471 ' NZ ' HE21 ' A' ' 73' ' ' GLN . 22.0 pttp -75.11 -38.23 61.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.84 -1.163 . . . . 2.58 109.731 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.471 HE21 ' NZ ' ' A' ' 72' ' ' LYS . 85.6 mm-40 -67.13 -38.77 86.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 2.12 110.013 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 p -67.12 -37.75 84.39 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 1.36 109.895 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.32 -38.39 83.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.079 -1.013 . . . . 2.8 109.604 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.56 -40.07 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.707 -1.246 . . . . 0.4 110.797 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.3 m -69.1 -40.02 78.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 0.24 110.111 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.52 -60.45 3.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.628 -1.295 . . . . 0.43 110.246 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.72 -32.47 81.72 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.483 -1.047 . . . . 0.26 110.483 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.72 -47.77 58.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.273 . . . . 0.25 109.87 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.481 HD21 HD22 ' A' ' 23' ' ' LEU . 61.1 mt -70.22 -39.92 74.82 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.105 -1.038 . . . . 0.3 109.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 82' ' ' ARG . 33.2 ttt-85 -63.66 -39.99 95.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 2.73 110.322 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.39 -38.18 77.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.105 -0.997 . . . . 1.91 110.285 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.448 ' CE2' ' CD2' ' A' ' 88' ' ' PHE . 86.5 t90 -59.99 -45.46 92.64 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.405 -1.435 . . . . 0.37 107.809 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . 52.2 m -59.98 -40.11 88.0 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.687 0.756 . . . . 0.36 109.344 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.97 -34.61 73.52 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.348 -0.845 . . . . 0.55 110.099 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.0 -36.31 13.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.196 -0.94 . . . . 0.48 111.176 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 84' ' ' TRP . 96.3 m-85 -107.87 1.43 22.74 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.176 -0.952 . . . . 1.24 111.324 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' CYS . 7.1 tp . . . . . 0 N--CA 1.496 1.829 0 O-C-N 120.85 -1.157 . . . . 1.66 108.981 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.987 -0.746 . . . . 5.66 108.987 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.73 8.0 21.48 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.215 -1.031 . . . . 3.02 108.215 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 22.7 p -73.68 169.8 16.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.555 0.693 . . . . 0.96 109.966 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -61.76 173.18 1.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.82 0.819 . . . . 1.5 110.055 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -60.04 -20.89 60.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.705 -0.622 . . . . 2.18 110.892 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -60.04 -38.42 82.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.902 -1.124 . . . . 2.01 109.506 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -60.03 -51.73 68.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.979 -1.075 . . . . 0.49 110.58 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 58.7 mtt-85 -69.95 -34.99 74.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 3.23 110.094 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.95 -39.96 83.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.76 109.311 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -64.32 -48.28 76.2 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.832 -0.747 . . . . 0.46 109.859 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -86.51 8.33 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.083 -1.011 . . . . 0.44 111.014 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' B' ' 8' ' ' ARG . . . -99.65 -16.86 18.05 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.53 109.985 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' B' ' 14' ' ' PRO . 13.3 pt-20 -155.64 152.44 24.29 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.111 -0.993 . . . . 1.27 108.422 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' B' ' 13' ' ' GLU . 97.9 Cg_exo -35.42 154.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.159 1.906 . . . . 0.49 111.748 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.632 ' CE ' HD22 ' B' ' 46' ' ' LEU . 7.5 ptp -90.92 -23.84 20.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.022 -1.049 . . . . 0.56 109.881 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 51.3 -135.59 31.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.309 -1.117 . . . . 0.39 110.309 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -109.95 38.83 2.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.65 -0.912 . . . . 0.84 110.092 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.9 149.94 71.07 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 120.999 -1.063 . . . . 2.02 108.851 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.95 148.83 92.32 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.398 2.065 . . . . 0.34 112.499 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.1 p -52.81 -29.92 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.62 -0.675 . . . . 0.32 110.409 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.77 -3.27 67.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.742 -0.943 . . . . 0.22 110.742 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t -83.44 -20.67 33.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.699 -1.471 . . . . 1.24 109.318 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.477 HD22 HD21 ' B' ' 81' ' ' LEU . 84.4 mt -62.7 135.62 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.24 109.642 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.67 133.09 53.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.21 109.725 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 -20.01 52.34 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.271 -1.531 . . . . 0.22 109.271 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -98.56 112.73 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.024 -1.102 . . . . 0.25 108.024 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.49 178.05 39.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.76 -1.336 . . . . 0.28 109.76 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -56.8 -39.9 74.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.391 -1.064 . . . . 2.0 109.75 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.41 -45.01 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.38 109.577 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.73 -37.72 85.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.4 109.437 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.57 -38.68 91.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.509 -1.436 . . . . 0.36 109.509 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -64.45 -39.2 93.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -1.101 . . . . 2.75 110.793 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -67.04 -44.62 79.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.155 . . . . 1.56 109.746 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.67 -39.93 95.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.014 . . . . 0.33 108.684 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.39 94.13 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.637 -0.825 . . . . 1.68 109.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -66.37 -19.52 65.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 1.99 108.765 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -90.97 1.76 56.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.712 -0.617 . . . . 2.68 109.973 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.72 37.43 4.21 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.219 -0.991 . . . . 0.49 110.734 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.487 ' CD2' HG12 ' B' ' 44' ' ' VAL . 83.2 m-85 -132.34 70.95 1.46 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.027 -1.278 . . . . 0.33 108.213 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -77.53 -10.46 59.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.109 -0.994 . . . . 0.41 109.823 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -131.43 153.17 49.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.345 -0.847 . . . . 1.56 108.885 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.98 91.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.21 111.244 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' B' ' 43' ' ' TYR . 4.5 p90 -56.5 -17.81 9.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.999 -1.063 . . . . 0.32 111.034 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' B' ' 39' ' ' PHE . 46.7 t -79.62 -29.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.24 108.003 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.34 -36.75 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.15 -1.056 . . . . 0.22 108.15 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.632 HD22 ' CE ' ' B' ' 15' ' ' MET . 18.7 tp -59.91 -39.32 85.02 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.195 -1.409 . . . . 0.4 107.195 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -43.78 94.17 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.134 -1.186 . . . . 0.18 110.134 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 73.6 tp60 -59.95 -42.63 94.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.868 -1.372 . . . . 1.09 109.078 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.02 -42.33 94.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.31 108.887 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.94 -38.4 79.46 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.69 -0.856 . . . . 0.27 108.69 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.27 -22.68 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -0.9 . . . . 0.28 110.065 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 93.8 mt -92.59 16.88 11.08 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.125 -0.984 . . . . 0.3 109.786 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.459 ' NZ ' HG21 ' A' ' 44' ' ' VAL . 58.8 mttm 49.98 39.64 19.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.926 -1.108 . . . . 1.71 110.539 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 57.19 19.15 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 2.25 109.796 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' B' ' 55' ' ' ASP . 19.8 t0 -70.11 108.54 4.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.714 -1.241 . . . . 1.8 108.089 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -61.01 -39.93 91.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.685 -0.635 . . . . 0.88 112.653 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.17 -39.97 78.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.648 -1.282 . . . . 0.74 110.401 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.19 -39.32 75.27 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.005 -1.078 . . . . 0.55 109.071 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.78 -50.07 70.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.354 -0.841 . . . . 0.38 110.042 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -60.07 -46.4 89.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.327 -0.858 . . . . 2.64 110.513 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -65.8 -38.45 88.99 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.899 -1.125 . . . . 2.38 109.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -66.0 -48.33 71.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.99 -1.069 . . . . 0.4 111.063 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.14 -46.61 76.89 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.175 -0.953 . . . . 0.34 109.129 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.85 -45.67 91.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.342 -0.849 . . . . 2.1 109.125 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.65 -31.85 70.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.653 . . . . 1.9 109.839 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -80.36 -31.54 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.4 111.486 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.53 -25.67 1.9 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.486 -1.384 . . . . 0.39 112.011 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.39 13.04 29.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.428 -1.469 . . . . 0.36 109.428 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.43 153.38 1.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.964 -1.315 . . . . 0.32 109.205 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -92.01 174.2 7.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.043 -1.036 . . . . 1.91 110.294 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.96 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 0.38 110.936 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.479 ' NZ ' HE21 ' B' ' 73' ' ' GLN . 22.0 pttp -75.13 -38.32 61.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.115 . . . . 2.57 109.697 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.479 HE21 ' NZ ' ' B' ' 72' ' ' LYS . 85.7 mm-40 -67.13 -38.68 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 2.12 109.99 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -67.17 -37.69 84.15 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 1.36 109.916 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.33 -38.38 83.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.147 -0.971 . . . . 2.81 109.606 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.68 -39.99 84.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.613 -1.305 . . . . 0.4 110.727 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 92.5 m -69.26 -39.98 78.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.838 -1.164 . . . . 0.23 110.086 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -59.49 -60.36 3.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.564 -1.335 . . . . 0.43 110.235 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.61 82.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.47 -1.052 . . . . 0.25 110.47 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.0 t -70.69 -47.77 58.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.064 -1.256 . . . . 0.24 109.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.477 HD21 HD22 ' B' ' 23' ' ' LEU . 62.2 mt -70.15 -39.98 75.03 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.089 -1.044 . . . . 0.29 109.074 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' B' ' 82' ' ' ARG . 33.3 ttt-85 -63.62 -40.04 95.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 2.74 110.312 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.31 -38.32 78.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 1.91 110.213 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.435 ' CE2' ' CD2' ' B' ' 88' ' ' PHE . 86.6 t90 -60.0 -45.35 93.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.468 -1.395 . . . . 0.36 107.869 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 52.6 m -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.643 0.735 . . . . 0.36 109.284 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.0 -34.64 73.6 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.397 -0.814 . . . . 0.55 110.071 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.05 -36.75 13.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.167 -0.958 . . . . 0.47 111.161 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 96.4 m-85 -107.0 0.76 23.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.232 -0.918 . . . . 1.24 111.467 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 85' ' ' CYS . 6.9 tp . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.865 -1.147 . . . . 1.67 109.11 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.442 -0.577 . . . . 5.68 109.442 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 p 55.16 36.75 27.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.218 -0.926 . . . . 3.02 109.304 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p -81.71 160.96 23.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.96 110.493 -179.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 t -78.65 173.29 12.59 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.65 0.738 . . . . 1.51 109.488 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.92 -24.59 64.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.746 -0.596 . . . . 2.18 110.127 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.921 -1.112 . . . . 2.02 108.98 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -60.04 -49.07 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.49 110.201 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 8' ' ' ARG . 53.9 mtt-85 -70.07 -31.99 69.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 3.21 109.648 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.54 -40.02 80.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.98 . . . . 0.76 109.801 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CD1' ' A' ' 84' ' ' TRP . 53.3 t80 -62.58 -48.17 80.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.46 110.133 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.98 10.11 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.155 -0.966 . . . . 0.44 110.506 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.67 -14.22 15.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.23 -0.919 . . . . 0.54 109.881 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.31 152.84 27.17 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.148 -0.97 . . . . 1.26 109.025 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.2 162.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.751 1.634 . . . . 0.49 111.5 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.479 ' SD ' HD11 ' B' ' 89' ' ' LEU . 6.8 ptp -92.49 -21.44 20.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.025 -1.047 . . . . 0.57 109.787 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.79 -139.91 16.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.037 -1.225 . . . . 0.4 110.037 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.73 30.89 5.4 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.427 -1.043 . . . . 0.85 110.481 -178.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -60.1 149.23 75.6 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.872 -1.142 . . . . 2.01 108.676 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.2 158.68 50.91 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.984 1.79 . . . . 0.34 111.992 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 21' ' ' GLY . 14.4 p -57.16 -45.77 84.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.457 -0.777 . . . . 0.32 110.483 -179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.55 ' N ' HG13 ' A' ' 20' ' ' VAL . . . -55.54 -3.19 0.38 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.757 -0.937 . . . . 0.23 110.757 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 20' ' ' VAL . 47.0 m -82.08 -22.14 36.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.781 -1.423 . . . . 1.24 109.424 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.449 HD22 HD21 ' A' ' 81' ' ' LEU . 86.0 mt -64.0 139.2 58.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.24 109.776 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 136.38 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.756 -0.777 . . . . 0.21 109.718 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.54 -18.43 57.5 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.235 -1.546 . . . . 0.22 109.235 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.4 110.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.875 -1.158 . . . . 0.25 107.875 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.459 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -91.56 178.65 41.37 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.665 -1.374 . . . . 0.28 109.665 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.31 -40.02 73.68 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.498 -1.001 . . . . 2.01 110.351 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.72 -41.22 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.637 -1.289 . . . . 0.38 109.625 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.459 HD12 ' H ' ' A' ' 27' ' ' GLY . 96.2 mt -67.72 -38.45 83.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.4 109.745 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -40.08 96.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.119 -1.192 . . . . 0.35 110.119 -179.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.78 -36.27 83.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.885 -1.362 . . . . 2.74 109.486 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.6 -53.65 26.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.139 . . . . 1.54 109.546 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.02 -39.96 87.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.118 -1.067 . . . . 0.34 108.118 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.09 -46.04 90.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.484 -0.76 . . . . 1.67 109.344 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.68 -19.83 65.22 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.44 -0.948 . . . . 2.0 108.44 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.91 3.74 52.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.696 -0.627 . . . . 2.69 109.726 -179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.21 50.7 Favored Glycine 0 N--CA 1.503 3.107 0 O-C-N 121.039 -1.038 . . . . 0.48 111.432 177.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.556 ' CD2' HG12 ' A' ' 44' ' ' VAL . 90.8 m-85 -106.2 74.98 1.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.913 -1.346 . . . . 0.33 108.941 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -80.31 -9.24 59.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.41 110.965 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.92 152.77 50.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.122 -0.986 . . . . 1.56 109.836 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.19 96.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.622 -0.674 . . . . 0.21 111.13 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 8.6 p90 -58.45 -18.99 32.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.826 -1.171 . . . . 0.32 110.414 -178.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG12 ' CD2' ' A' ' 39' ' ' PHE . 25.9 t -80.71 -30.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.904 -1.123 . . . . 0.24 108.366 179.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.64 -39.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.172 -1.047 . . . . 0.22 108.172 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.1 tp -59.95 -39.45 85.6 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.624 -1.25 . . . . 0.4 107.624 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.13 -45.04 74.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.654 -1.379 . . . . 0.18 109.654 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.99 -43.19 95.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.119 -1.224 . . . . 1.09 109.153 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.06 -39.98 87.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.427 -0.953 . . . . 0.31 108.427 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.81 -38.67 83.59 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.429 -0.952 . . . . 0.28 108.429 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.99 -22.13 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.28 110.736 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -93.15 17.06 11.59 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.96 -1.087 . . . . 0.31 110.388 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.77 34.39 10.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.873 -1.142 . . . . 1.7 110.229 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.6 mttp 59.55 20.0 8.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.456 -0.778 . . . . 2.24 109.83 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.02 114.52 5.25 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.623 -1.251 . . . . 1.8 107.623 178.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 40.0 tt0 -63.46 -41.38 98.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.385 -0.822 . . . . 0.87 112.519 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.04 -39.76 75.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.604 -1.31 . . . . 0.73 110.765 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.16 -39.93 78.47 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.873 -1.131 . . . . 0.55 109.551 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.69 -49.83 71.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.38 109.402 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 60' ' ' ARG . 44.3 mtt-85 -60.0 -46.61 88.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.809 . . . . 2.64 110.513 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.37 -38.55 90.38 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.966 -1.084 . . . . 2.37 108.943 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.41 ' O ' ' OG1' ' A' ' 66' ' ' THR . 59.5 t90 -64.29 -47.01 81.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.4 110.541 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 tp -67.57 -47.02 71.01 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.274 -0.891 . . . . 0.34 110.254 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -62.58 -47.5 83.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 2.11 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -69.47 -28.68 66.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.885 . . . . 1.9 109.732 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 62' ' ' TRP . 65.8 m -80.43 -33.94 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.331 -0.856 . . . . 0.41 111.41 -178.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.4 p -132.23 -29.82 1.58 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.53 -1.356 . . . . 0.4 111.93 -178.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.51 20.95 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.231 -1.548 . . . . 0.36 109.231 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.38 2.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.275 . . . . 0.33 109.23 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.641 ' H ' HE21 ' A' ' 73' ' ' GLN . 6.8 m120 -90.61 171.49 9.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 1.9 109.529 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.5 75.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.39 110.416 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.53 -41.26 69.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 2.58 109.975 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.641 HE21 ' H ' ' A' ' 70' ' ' ASN . 36.7 mt-30 -67.11 -40.04 86.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 2.12 110.12 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.49 -38.94 92.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.436 -0.79 . . . . 1.36 110.233 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' HH12 ' A' ' 60' ' ' ARG . 19.8 mmm180 -60.0 -38.66 83.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 2.8 109.016 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -68.48 -39.89 81.18 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.88 -1.137 . . . . 0.4 110.614 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -69.12 -40.18 78.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.632 -1.292 . . . . 0.24 109.821 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.31 -60.01 4.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.633 -1.292 . . . . 0.43 109.867 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' OE2' ' A' ' 83' ' ' GLU . . . -59.9 -32.57 75.43 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.047 -1.221 . . . . 0.26 110.047 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.3 t -69.08 -49.79 54.14 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.075 -1.25 . . . . 0.25 110.014 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.449 HD21 HD22 ' A' ' 23' ' ' LEU . 86.9 mt -71.58 -40.23 70.05 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.746 -1.182 . . . . 0.3 109.124 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 82' ' ' ARG . 1.2 tpt180 -60.8 -42.67 98.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.161 -0.962 . . . . 2.73 110.055 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -70.0 -36.42 75.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 1.91 110.271 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.436 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 84.8 t90 -60.01 -43.18 95.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.521 -1.362 . . . . 0.37 107.709 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 89' ' ' LEU . 48.2 m -61.02 -40.29 93.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.604 -0.685 . . . . 0.36 110.026 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.04 -33.92 72.69 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -0.969 . . . . 0.55 110.274 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.11 14.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.124 -0.985 . . . . 0.48 111.028 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.0 1.84 19.26 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.161 -0.962 . . . . 1.24 111.82 -178.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' CYS . 8.0 tp . . . . . 0 N--CA 1.499 1.976 0 O-C-N 120.765 -1.209 . . . . 1.66 109.668 -177.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.402 ' O ' ' OG1' ' B' ' 2' ' ' THR . 67.6 mtt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.451 -0.574 . . . . 5.66 109.451 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' B' ' 1' ' ' MET . 6.9 p 55.1 36.86 27.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.211 -0.93 . . . . 3.02 109.318 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 13.0 p -81.71 161.01 23.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.96 110.478 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.7 t -78.63 173.38 12.49 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.647 0.737 . . . . 1.5 109.557 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.9 -24.7 64.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 2.18 110.178 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -59.91 -35.31 74.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.034 -1.042 . . . . 2.01 108.971 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.403 ' CD2' ' C ' ' B' ' 7' ' ' HIS . 7.7 t60 -60.06 -49.09 79.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.034 -1.041 . . . . 0.49 110.237 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' B' ' 8' ' ' ARG . 54.1 mtt-85 -70.02 -31.89 69.78 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.113 -0.992 . . . . 3.23 109.716 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -68.68 -39.97 80.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.76 109.761 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.439 ' CE2' ' CD1' ' B' ' 84' ' ' TRP . 53.2 t80 -62.54 -48.25 80.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.46 110.098 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.99 10.19 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.052 -1.03 . . . . 0.44 110.51 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.61 -14.31 15.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.233 -0.917 . . . . 0.53 109.857 178.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' B' ' 14' ' ' PRO . 13.5 pt-20 -154.27 152.78 27.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 1.27 109.12 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' B' ' 13' ' ' GLU . 96.9 Cg_exo -40.15 162.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.879 1.719 . . . . 0.49 111.483 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.469 ' SD ' HD11 ' A' ' 89' ' ' LEU . 6.8 ptp -92.45 -21.4 20.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.56 109.764 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.68 -139.82 16.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.06 -1.216 . . . . 0.39 110.06 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -105.8 30.83 5.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.549 -0.971 . . . . 0.84 110.47 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.98 149.24 74.62 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.189 . . . . 2.02 108.777 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.19 158.77 50.38 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.941 1.761 . . . . 0.34 112.087 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.556 HG13 ' N ' ' B' ' 21' ' ' GLY . 14.4 p -57.29 -45.6 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.32 110.545 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.556 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -55.77 -3.04 0.4 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.725 -0.95 . . . . 0.22 110.725 -178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.453 ' H ' ' C ' ' B' ' 20' ' ' VAL . 47.6 m -82.11 -22.15 36.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.713 -1.463 . . . . 1.24 109.3 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.447 HD22 HD21 ' B' ' 81' ' ' LEU . 85.7 mt -64.09 139.22 58.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.24 109.768 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.89 136.4 56.08 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.758 -0.777 . . . . 0.21 109.781 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.3 57.73 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.264 -1.534 . . . . 0.22 109.264 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.6 mm -99.48 110.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.817 -1.179 . . . . 0.25 107.817 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.466 ' H ' HD12 ' B' ' 30' ' ' LEU . . . -91.66 178.61 41.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.675 -1.37 . . . . 0.28 109.675 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.36 -39.95 73.71 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.595 -0.944 . . . . 2.0 110.333 -178.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.68 -41.25 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.604 -1.31 . . . . 0.38 109.69 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.466 HD12 ' H ' ' B' ' 27' ' ' GLY . 96.2 mt -67.72 -38.43 83.56 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.262 -0.898 . . . . 0.4 109.755 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -40.02 96.43 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.104 -1.198 . . . . 0.36 110.104 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.75 -36.32 83.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.368 . . . . 2.75 109.502 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.49 -53.72 26.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.751 -1.218 . . . . 1.56 109.562 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.208 -1.034 . . . . 0.33 108.208 178.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.07 -46.09 90.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 1.68 109.345 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -63.58 -19.98 65.27 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.411 -0.959 . . . . 1.99 108.411 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -89.78 3.72 51.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.612 -0.68 . . . . 2.68 109.83 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.01 7.2 50.72 Favored Glycine 0 N--CA 1.502 3.044 0 O-C-N 121.041 -1.037 . . . . 0.49 111.468 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.557 ' CD2' HG12 ' B' ' 44' ' ' VAL . 90.9 m-85 -106.16 74.88 1.06 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.96 -1.318 . . . . 0.33 108.971 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -80.25 -9.27 59.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.41 111.003 -178.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -131.97 152.84 50.86 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.093 -1.004 . . . . 1.56 109.832 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.576 -0.702 . . . . 0.21 111.096 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.482 ' CE1' HG22 ' B' ' 44' ' ' VAL . 8.7 p90 -58.58 -18.98 34.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 0.32 110.486 -177.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.557 HG12 ' CD2' ' B' ' 39' ' ' PHE . 25.8 t -80.77 -30.36 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.047 . . . . 0.24 108.343 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.66 -39.05 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.149 -1.056 . . . . 0.22 108.149 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.09 -39.3 85.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.632 -1.247 . . . . 0.4 107.632 177.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.15 -45.03 74.22 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.579 -1.409 . . . . 0.18 109.579 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.03 -43.19 95.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.133 -1.216 . . . . 1.09 109.099 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.441 -0.948 . . . . 0.31 108.441 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.88 -38.65 83.31 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.464 -0.939 . . . . 0.27 108.464 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.02 -21.97 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.373 -0.83 . . . . 0.28 110.764 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 98.6 mt -93.27 17.15 11.65 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.993 -1.067 . . . . 0.3 110.363 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 50.86 34.29 10.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.894 -1.129 . . . . 1.71 110.272 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 59.46 19.91 8.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 2.25 109.813 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.88 114.67 5.27 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.571 -1.27 . . . . 1.8 107.571 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.414 ' CG ' ' HE ' ' B' ' 60' ' ' ARG . 40.0 tt0 -63.63 -41.39 98.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.88 112.452 -177.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.04 -39.75 75.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.64 -1.288 . . . . 0.74 110.742 -179.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.21 -39.88 78.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.827 -1.149 . . . . 0.55 109.611 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -63.76 -49.84 71.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.091 -1.006 . . . . 0.38 109.415 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.462 ' HG2' HH11 ' B' ' 60' ' ' ARG . 44.8 mtt-85 -59.93 -46.61 88.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.364 -0.835 . . . . 2.64 110.55 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.28 -38.69 91.05 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.029 -1.044 . . . . 2.38 108.952 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 62' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -64.29 -46.95 81.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.4 110.523 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.55 -47.06 70.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.238 -0.914 . . . . 0.34 110.17 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -62.54 -47.56 83.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 2.1 110.161 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.43 -28.62 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 1.9 109.739 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 65.5 m -80.37 -34.14 36.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.4 111.304 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 67' ' ' CYS . . . . . . . . . . . . . 28.6 p -132.24 -29.67 1.59 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.501 -1.375 . . . . 0.39 111.839 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.75 14.58 21.02 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.21 -1.556 . . . . 0.36 109.21 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.27 151.27 2.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -1.228 . . . . 0.32 109.279 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.641 ' H ' HE21 ' B' ' 73' ' ' GLN . 6.8 m120 -90.52 171.48 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.0 . . . . 1.91 109.527 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.33 74.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.38 110.465 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -71.65 -41.18 69.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.828 -1.17 . . . . 2.57 110.014 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.641 HE21 ' H ' ' B' ' 70' ' ' ASN . 36.7 mt-30 -67.2 -39.97 86.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 2.12 110.185 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 52.7 m -64.53 -38.86 92.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.355 -0.841 . . . . 1.36 110.253 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.42 ' HA ' HH12 ' B' ' 60' ' ' ARG . 19.8 mmm180 -60.03 -38.63 83.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.954 -1.092 . . . . 2.81 109.035 -179.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -68.54 -40.03 80.86 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.915 -1.116 . . . . 0.4 110.592 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.95 -40.19 79.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.702 -1.249 . . . . 0.23 109.901 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.36 -59.98 4.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.61 -1.306 . . . . 0.43 109.915 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 83' ' ' GLU . . . -59.88 -32.52 75.2 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.054 -1.218 . . . . 0.25 110.054 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -69.13 -49.83 53.42 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.099 -1.236 . . . . 0.24 110.064 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.447 HD21 HD22 ' B' ' 23' ' ' LEU . 86.9 mt -71.63 -40.14 69.95 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.744 -1.182 . . . . 0.29 109.147 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' B' ' 82' ' ' ARG . 1.2 tpt180 -60.83 -42.67 98.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.147 -0.97 . . . . 2.74 110.037 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' B' ' 79' ' ' GLY . 0.3 OUTLIER -70.09 -36.39 74.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 1.91 110.053 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 84' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' B' ' 10' ' ' PHE . 84.8 t90 -59.98 -43.37 95.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.537 -1.352 . . . . 0.36 107.743 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' B' ' 89' ' ' LEU . 50.3 m -60.72 -40.37 92.06 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.562 0.696 . . . . 0.36 110.099 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.96 -33.94 72.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.064 -1.023 . . . . 0.55 110.342 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.29 14.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.148 -0.97 . . . . 0.47 110.969 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 88' ' ' PHE . . . . . 0.403 ' CD2' ' CE2' ' B' ' 84' ' ' TRP . 91.0 m-85 -109.78 1.66 19.5 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.275 -0.891 . . . . 1.24 111.925 -178.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 85' ' ' CYS . 7.6 tp . . . . . 0 N--CA 1.499 1.992 0 O-C-N 120.795 -1.191 . . . . 1.67 109.746 -177.773 . . . . . . . . 1 1 . 1 stop_ save_